<SEC-DOCUMENT>0001193125-21-099162.txt : 20210330
<SEC-HEADER>0001193125-21-099162.hdr.sgml : 20210330
<ACCEPTANCE-DATETIME>20210330075131
ACCESSION NUMBER:		0001193125-21-099162
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		161
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210330
DATE AS OF CHANGE:		20210330

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Immatics N.V.
		CENTRAL INDEX KEY:			0001809196
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			P7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39363
		FILM NUMBER:		21783658

	BUSINESS ADDRESS:	
		STREET 1:		PAUL EHRLICH-STRASSE 15
		CITY:			TUBINGEN
		STATE:			2M
		ZIP:			72076
		BUSINESS PHONE:		49 7071 5397 700

	MAIL ADDRESS:	
		STREET 1:		PAUL EHRLICH-STRASSE 15
		CITY:			TUBINGEN
		STATE:			2M
		ZIP:			72076

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Immatics B.V.
		DATE OF NAME CHANGE:	20200413
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>d149615d20f.htm
<DESCRIPTION>20-F
<TEXT>
<HTML><HEAD>
<TITLE>20-F</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">20-F</FONT> </B></P> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman"><B>(Mark One) </B></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B>&#9744;<B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left"><B>REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g)&nbsp;OF THE SECURITIES EXCHANGE ACT OF 1934
</B></P></TD></TR></TABLE> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>OR </B></P> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B>&#9746;<B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left"><B>ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
</B></P></TD></TR></TABLE> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>For the fiscal year ended December&nbsp;31, 2020 </B></P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>OR </B></P> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B>&#9744;<B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left"><B>TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
</B></P></TD></TR></TABLE> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>OR </B></P> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B>&#9744;<B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left"><B>SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
</B></P></TD></TR></TABLE> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Commission file number: <FONT STYLE="white-space:nowrap">001-39363</FONT> </B></P>
<P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Immatics N.V. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:6.5pt; font-family:Times New Roman" ALIGN="center">(Exact name
of Registrant as specified in its charter) </P> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>The Netherlands
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:6.5pt; font-family:Times New Roman" ALIGN="center">(Jurisdiction of incorporation or organization) </P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Paul-Ehrlich-Stra&szlig;e 15 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>72076 T&uuml;bingen, Federal Republic of Germany </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:6.5pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive offices) </B></P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Edward A. Sturchio </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Immatics US, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>2130 W.
Holcombe Blvd., Suite 900 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Houston, Texas 77030 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:6.5pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">(281)&nbsp;810-7545</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:6.5pt; font-family:Times New Roman" ALIGN="center"><B>(Name, Telephone, <FONT STYLE="white-space:nowrap">E-mail</FONT> and/or Facsimile number and Address of Company Contact Person) </B></P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman"><B>Securities registered or to be registered, pursuant to Section&nbsp;12(b) of the Act. </B></P>
<P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:6.5pt; font-family:Times New Roman" ALIGN="center"><B>Title of each class</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:6.5pt; font-family:Times New Roman" ALIGN="center"><B>Trading</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:6.5pt; font-family:Times New Roman" ALIGN="center"><B>Symbol(s)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:6.5pt; font-family:Times New Roman" ALIGN="center"><B>Name of each exchange on which registered</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top" ALIGN="center"><B>Ordinary shares, nominal value &#128;0.01 per share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>IMTX</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>The Nasdaq Stock Market</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top" ALIGN="center"><B>Warrants to purchase ordinary shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>IMTXW</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>The Nasdaq Stock Market</B></TD></TR>
</TABLE> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman"><B>Securities registered or to be registered pursuant to Section&nbsp;12(g) of the Act: None </B></P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman"><B>Securities for which there is a reporting obligation pursuant to Section&nbsp;15(d) of the Act: None </B></P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman">Indicate the number of outstanding shares of each of the issuer&#146;s classes of capital stock or common stock as of the close of business covered by the
annual report. Ordinary shares, nominal value &#128;0.01 per share: 62,908,617 </P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman">Indicate by check mark if the registrant is a well-known seasoned issuer, as
defined in Rule 405 of the Securities Act.&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;&#9744;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;&#9746; </P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman">If this report is an
annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section&nbsp;13 or 15(d) of the Securities Exchange Act of
1934.&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;&#9744;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;&#9746; </P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman">Indicate by check mark whether the registrant (1)&nbsp;has
filed all reports required to be filed by Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&nbsp;has been
subject to such filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of
Regulation <FONT STYLE="white-space:nowrap">S-T</FONT> (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such
files).&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a <FONT STYLE="white-space:nowrap">non-accelerated</FONT> filer, or an emerging growth company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; and &#147;emerging
growth company&#148; in Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Exchange Act. </P> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">Large&nbsp;accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">Non-accelerated filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Emerging&nbsp;growth&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD></TR>
</TABLE> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman">If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards&nbsp;&#134; provided pursuant to Section&nbsp;13(a) of the Exchange Act.&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman">&#134; The term &#147;new or revised financial accounting standard&#148; refers to any update issued by the Financial Accounting Standards Board to its
Accounting Standards Codification after April&nbsp;5, 2012. </P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman">Indicate by check mark whether the registrant has filed a report on and attestation to its
management&#146;s assessment of the effectiveness of its internal control over financial reporting under Section&nbsp;404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit
report.&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman">Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this
filing: </P> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top" ALIGN="center">U.S. GAAP&nbsp;&nbsp;&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">International&nbsp;Financial&nbsp;Reporting&nbsp;Standards&nbsp;as&nbsp;issued</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">by&nbsp;the&nbsp;International&nbsp;Accounting&nbsp;Standards&nbsp;Board&nbsp;&nbsp;&#9746;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">Other&nbsp;&nbsp;&#9744;</TD></TR>
</TABLE> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman">If &#147;Other&#148; has been checked in response to the previous question indicate by check mark which financial statement item
the registrant has elected to follow. Item 17&nbsp;&nbsp;&#9744; Item 18&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman">If this is an annual report, indicate by check mark whether the
registrant is a shell company (as defined in Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Exchange Act).&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;&#9744;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;&#9746; </P>
<P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A><U>TABLE OF CONTENTS</U> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><A HREF="#rom149615_1">ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_2">A. Directors and Senior Management</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_3">B. Advisers</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_4">C. Auditors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><A HREF="#rom149615_5">ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_6">A. Offer Statistics</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_7">B. Method and Expected Timetable</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><A HREF="#rom149615_8">ITEM 3. KEY INFORMATION</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_9">A. Selected Financial Data</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_10">B. Capitalization and Indebtedness</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_11">C. Reasons for the Offer and Use of Proceeds</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_12">D. Risk Factors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><A HREF="#rom149615_13">ITEM 4. INFORMATION ON THE COMPANY</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_14">A. History and Development of the Company</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_15">B. Business Overview</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_16">C. Organizational Structure</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">114</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_17">D. Property, Plant and Equipment</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">114</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><A HREF="#rom149615_18">ITEM 4A. UNRESOLVED STAFF COMMENTS</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><A HREF="#rom149615_19">ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_20">A. Operating Results</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_21">B. Liquidity and Capital Resources</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">124</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_22">C. Research and Development, Patents and Licenses, etc.</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">127</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_23">D. Trend Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">127</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_24">E. <FONT STYLE="white-space:nowrap">Off-Balance</FONT> Sheet
Arrangements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">127</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_25">G. Safe Harbor</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">128</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><A HREF="#rom149615_26">ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">128</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_27">A. Directors and Senior Management</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">128</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_28">B. Compensation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_29">C. Board Practices</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">140</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_30">D. Employees</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">145</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_31">E. Share Ownership</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">146</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><A HREF="#rom149615_32">ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">146</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_33">A. Major Shareholders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">146</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_34">B. Related Party Transactions</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">148</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_35">C. Interests of Experts and Counsel</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">150</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><A HREF="#rom149615_36">ITEM 8. FINANCIAL INFORMATION</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">150</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_37">A. Consolidated Statements and Other Financial Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">150</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_38">B. Significant Changes</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">151</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><A HREF="#rom149615_39">ITEM 9. THE OFFER AND LISTING</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">151</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_40">A. Offering and Listing Details</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">151</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_41">B. Plan of Distribution</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">151</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_42">C. Markets</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">151</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_43">D. Selling Shareholders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">151</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_44">E. Dilution</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">151</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_45">F. Expenses of the Issue</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">151</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><A HREF="#rom149615_46">ITEM 10. ADDITIONAL INFORMATION</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">151</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_47">A. Share Capital</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">151</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_48">B. Memorandum and Articles of Association</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">151</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_49">C. Material Contracts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">159</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="96%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_50">D. Exchange Controls</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">159</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_51">E. Taxation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">160</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_52">F. Dividends and Paying Agents</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">180</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_53">G. Statement by Experts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">180</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_54">H. Documents on Display</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">181</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_55">I. Subsidiary Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">181</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><A HREF="#rom149615_56">ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">181</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><A HREF="#rom149615_57">ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">182</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_58">A. Debt Securities</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">182</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_59">B. Warrants and Rights</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">182</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_60">C. Other Securities</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">182</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_61">D. American Depositary Shares</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">182</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><A HREF="#rom149615_62">ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">183</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_63">A. Defaults</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">183</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_64">B. Arrears and Delinquencies</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">183</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><A HREF="#rom149615_65">ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">183</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><A HREF="#rom149615_66">ITEM 15. CONTROLS AND PROCEDURES</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">183</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_67">A. Disclosure Controls and Procedures</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">183</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_68">B. Management&#146;s Annual Report on Internal Control over Financial Reporting
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">183</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_69">C. Attestation Report of the Registered Public Accounting
Firm</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">183</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom149615_70">D. Changes in Internal Control Over Financial Reporting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">184</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><A HREF="#rom149615_71">ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERTS</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">184</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><A HREF="#rom149615_72">ITEM 16B. CODE OF ETHICS</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">184</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><A HREF="#rom149615_73">ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">184</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><A HREF="#rom149615_74">ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">184</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><A HREF="#rom149615_75">ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">185</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><A HREF="#rom149615_76">ITEM 16F. CHANGE IN REGISTRANT&#146;S CERTIFYING ACCOUNTANT</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">185</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><A HREF="#rom149615_77">ITEM 16G. CORPORATE GOVERNANCE</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">185</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><A HREF="#rom149615_78">ITEM 16H. MINE SAFETY DISCLOSURE</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">185</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><A HREF="#rom149615_79">ITEM 17. FINANCIAL STATEMENTS</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">186</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><A HREF="#rom149615_80">ITEM 18. FINANCIAL STATEMENTS</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">186</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><A HREF="#rom149615_81">ITEM 19. EXHIBITS</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">186</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PRESENTATION OF FINANCIAL AND OTHER INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise stated or the context otherwise indicates, (i)&nbsp;references to the &#147;company&#148;, &#147;we&#148;, &#147;our&#148; or
&#147;us&#148; refer to Immatics N.V., together with its subsidiaries, including Immatics Biotechnologies GmbH; (ii)&nbsp;references to &#147;Immatics&#148; refer solely to Immatics N.V.; and (iii)&nbsp;references to &#147;Immatics OpCo&#148; refer
solely to Immatics Biotechnologies GmbH. Immatics N.V. is a Dutch public limited liability company (<I>naamloze vennootschap</I>) incorporated on March&nbsp;10, 2020 and the holding company of Immatics Biotechnologies GmbH, a German
biopharmaceutical company incorporated in 2000 focused on the development of T cell receptor-based immunotherapies for the treatment of cancer. Immatics Biotechnologies GmbH holds all material assets and conducts all business activities and
operations of Immatics N.V. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Trademarks, Service Marks </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Immatics logo


<IMG SRC="g149615g04g99.jpg" ALT="LOGO">
, Immatics<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, XPRESIDENT<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, ACTengine<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, ACTallo<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, ACTolog<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, XCEPTOR<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP>,
TCER<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP>, AbsQuant<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP>, IMADetect<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> and other trademarks or service marks of
Immatics appearing in this Annual Report are the property of the company. Solely for convenience, some of the trademarks, service marks, logos and trade names referred to in this Annual Report are presented without the <SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP> and <SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under
applicable law, our rights or the rights of the applicable licensors to these trademarks, service marks and trade names. This Annual Report contains additional trademarks, service marks and trade names of others. All trademarks, service marks and
trade names appearing in this Annual Report are, to our knowledge, the property of their respective owners. We do not intend our use or display of other companies&#146; trademarks, service marks, copyrights or trade names to imply a relationship
with, or endorsement or sponsorship of us by, any other companies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Financial Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The terms &#147;dollar,&#148; &#147;USD&#148; or &#147;$&#148; refer to the U.S. dollar and the term &#147;euro,&#148; &#147;EUR&#148; or
&#147;&#128;&#148; refer to the euro, unless otherwise indicated. The exchange rate used for conversion between U.S. dollars and euros is based on the ECB euro reference exchange rate published by the European Central Bank. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our consolidated financial statements are presented in euros and have been prepared in accordance with International Financial Reporting
Standards as issued by the International Accounting Standards Board (&#147;IFRS&#148;). None of the consolidated financial statements were prepared in accordance with generally accepted accounting principles in the United States (&#147;U.S.
GAAP&#148;). We have made rounding adjustments to some of the figures included in this Annual Report. Accordingly, any numerical discrepancies in any table between totals and sums of the amounts listed are due to rounding. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Market and Industry Data </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Annual
Report contains industry, market and competitive position data that are based on general and industry publications, surveys and studies conducted by third parties, some of which may not be publicly available, and our own internal estimates and
research. Third-party publications, surveys and studies generally state that they have obtained information from sources believed to be reliable, but do not guarantee the accuracy and completeness of such information. These data involve a number of
assumptions and limitations and contain projections and estimates of the future performance of the industries in which we operate that are subject to a high degree of uncertainty. We&nbsp;caution you not to give undue weight to such projections,
assumptions and estimates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Annual Report contains forward-looking statements regarding our current expectations or forecasts of future events. All statements other
than statements of historical facts contained in this Annual Report, including statements regarding our future results of operations and financial position, business strategy, product candidates, research pipeline, ongoing and planned preclinical
studies and clinical trials, regulatory submissions and approvals, research and development costs, timing and likelihood of success, as well as plans and objectives of management for future operations are forward-looking statements. Many of the
forward-looking statements contained in this Annual Report can be identified by the use of forward-looking words such as &#147;anticipate,&#148; &#147;believe,&#148; &#147;could,&#148; &#147;expect,&#148; &#147;should,&#148; &#147;plan,&#148;
&#147;intend,&#148; &#147;estimate,&#148; &#147;will&#148; and &#147;potential,&#148; among others. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward-looking statements appear in a number of
places in this Annual Report and include, but are not limited to, statements regarding our intent, belief or current expectations. Forward-looking statements are based on our management&#146;s beliefs and assumptions and on information currently
available to our management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to,
those identified under &#147;Item 3. Key Information&#151;D. Risk Factors.&#148; These forward-looking statements include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the commencement, timing, progress and results of our research and development programs, preclinical studies and
clinical trials, including our Adoptive Cell Therapy (&#147;ACT&#148;) and bispecific T cell engaging receptor (&#147;TCR Bispecific&#148;) trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing of investigational new drug application (&#147;IND&#148;) or clinical trial application
(&#147;CTA&#148;), biologics license application (&#147;BLA&#148;), Marketing Authorization Application (&#147;MAA&#148;) and other regulatory submissions with the U.S. Food and Drug Administration (&#147;FDA&#148;), the European Medicines Agency
(&#147;EMA&#148;) or comparable regulatory authorities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the proposed clinical development pathway for our product candidates and the acceptability of the results of
clinical trials for regulatory approval of such product candidates by the FDA, the EMA or comparable regulatory authorities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">assumptions relating to the identification of serious adverse, undesirable or unacceptable side effects related
to our product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing of and our ability to obtain and maintain regulatory approval for our product candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the potential advantages and differentiated profile of ACT and TCER Bispecific product candidates compared to
existing therapies for the applicable indications; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to successfully manufacture or have manufactured drug product for clinical trials and
commercialization; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations regarding the size of the patient populations amenable to treatment with our product candidates,
if approved; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">assumptions relating to the rate and degree of market acceptance of any approved product candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the pricing and reimbursement of our product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to identify and develop additional product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability of our competitors to discover, develop or commercialize competing products before or more
successfully than we do; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our competitive position and the development of and projections relating to our competitors or our industry;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our estimates of our expenses, ongoing losses, future revenue, capital requirements and our needs for or ability
to obtain additional financing; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iv </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to raise capital when needed in order to continue our research and development programs or
commercialization efforts; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to identify and successfully enter into strategic collaborations or licensing opportunities in the
future, and our assumptions regarding any potential revenue that we may generate thereunder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to obtain, maintain, protect and enforce intellectual property protection for our product candidates,
and the scope of such protection; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to operate our business without infringing, misappropriating or otherwise violating the intellectual
property rights of third parties; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations regarding the impact of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to attract and retain qualified key management and technical personnel; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations regarding the time during which we will be an emerging growth company under the Jumpstart our
Business Startups Act of 2012 (&#147;JOBS Act&#148;) and a foreign private issuer. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These forward-looking statements
speak only as of the date of this Annual Report and are subject to a number of risks, uncertainties and assumptions described under the sections in this Annual Report titled &#147;Item 3. Key Information&#151;D. Risk Factors&#148; and &#147;Item 5.
Operating and Financial Review and Prospects&#148; and elsewhere in this Annual Report. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified and some of which are
beyond our control, you should not rely on these forward-looking statements as predictions of future events. The events and circumstances reflected in our forward-looking statements may not be achieved or occur and actual results could differ
materially from those projected in the forward-looking statements. Moreover, we operate in an evolving environment. New risk factors and uncertainties may emerge from time to time, and it is not possible for management to predict all risk factors
and uncertainties. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, statements that &#147;we believe&#148; and similar statements reflect our beliefs and opinions on the relevant subject. These
statements are based upon information available to us as of the date of this Annual Report, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should
not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">v </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART I </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="rom149615_1"></A>ITEM&nbsp;1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_2"></A>A. Directors and Senior Management </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_3"></A>B.
Advisers </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_4">
</A>C. Auditors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="rom149615_5"></A>ITEM&nbsp;2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>OFFER STATISTICS AND EXPECTED TIMETABLE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_6"></A>A. Offer Statistics </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_7"></A>B.
Method and Expected Timetable </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="rom149615_8"></A>ITEM&nbsp;3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>KEY INFORMATION </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_9"></A>A. Selected Financial Data </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following selected consolidated financial data should be read in conjunction with &#147;Item 5. Operating and Financial Review and
Prospects&#148; and our consolidated financial statements, including the notes thereto, included elsewhere in this Annual Report. The selected consolidated statement of operations data for the years ended December&nbsp;31, 2020, 2019 and 2018 and
the selected consolidated balance sheet data as of December&nbsp;31, 2020 and 2019 are derived from our audited consolidated financial statements included elsewhere in this Annual Report. As an emerging growth company, the presentation of selected
financial data is limited to periods for which audited financial statements have been presented in connection with our first registration statement that became effective under the Securities Act. Our historical results are not necessarily indicative
of the results that may be expected in the future. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Consolidated Statement of Loss of Immatics N.V. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(Euros in thousands, except share and per<BR>share data)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue from collaboration agreements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31,253</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18,449</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,770</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(67,085</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(40,091</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(33,971</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(34,186</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(11,756</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(7,666</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">303</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">385</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,458</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Operating result</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(69,715</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(33,013</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(34,409</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financial result</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(159,901</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">526</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,054</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Loss before taxes</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(229,616</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(32,487</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(32,355</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxes on income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net loss</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(229,616</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(32,487</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(32,355</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share - basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4.77</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.95</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.95</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average shares outstanding - basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48,001,228</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33,093,838</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33,093,838</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Consolidated Statement of Financial Position of Immatics N.V. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">207,530</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">103,353</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39,367</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">254,646</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">134,277</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61,318</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">150,390</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">175,112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70,489</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">104,256</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(40,835</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(9,171</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_10"></A>B. Capitalization and Indebtedness </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_11"></A>C. Reasons for the Offer and Use of Proceeds </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_12"></A>D. Risk Factors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risk
Factors Summary </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our business faces significant risks and uncertainties. You should carefully consider all of the information set forth
in this Annual Report and in other documents we file with or furnish to the SEC, including the following risk factors, before deciding to invest in or to maintain an investment in our securities. Our business, as well as our reputation, financial
condition, results of operations and share price, could be materially adversely affected by any of these risks, as well as other risks and uncertainties not currently known to us or not currently considered material. These risks include, among
others, the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We have a history of operating losses and expect to continue to incur losses. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our product candidates represent novel approaches to the treatment of diseases, and there are many uncertainties
regarding the development of our product candidates. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our current product candidates are in various stages of development, and it is possible that none of our product
candidates will ever become commercial products. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Delays in the commencement and completion of clinical trials could increase costs and delay or prevent regulatory
approval and commercialization of our product candidates. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Clinical trials are expensive, time-consuming and difficult to design and implement, and our clinical trial costs
may be higher than for more conventional therapeutic technologies or drug products. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our product candidates may cause undesirable side effects or have other properties that may delay or prevent
their development or regulatory approval or limit their commercial potential. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The regulatory review and approval processes of the FDA, the EMA and comparable regulatory authorities are
lengthy, time-consuming and uncertain. If we are unable to obtain, or if there are delays in obtaining, regulatory approval for our product candidates, we will not be able to commercialize our product candidates and our ability to generate revenue
will be materially impaired. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The regulatory landscape that will govern our product candidates is still evolving. Regulations relating to more
established gene therapy and cell therapy products and TCR Bispecific products are still developing, and changes in regulatory requirements could result in delays or discontinuation of development of our product candidates or unexpected costs in
obtaining regulatory approval. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our product candidates are complex and difficult to manufacture. We could experience manufacturing problems that
result in delays in our development or commercialization programs. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We rely on third parties to conduct preclinical studies and/or clinical trials of our product candidates. If they
do not properly and successfully perform their obligations to us, we may not be able to obtain regulatory approvals for our product candidates. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We rely on third parties for the manufacture of our product candidates. Our dependence on these third parties may
impair the clinical advancement and commercialization of our product candidates. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We face substantial competition, which may result in others discovering, developing or commercializing products,
treatment methods and/or technologies before or more successfully than we do. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We have identified material weaknesses in our internal control over financial reporting. If we are unable to
remediate these material weaknesses or otherwise fail to maintain an effective system of internal controls, we may not be able to accurately or timely report our financial condition or results of operations, which may adversely affect our business
and the price of our securities. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Financial Position and Need for Additional Capital </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We have a history of operating losses and expect to continue to incur losses. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a clinical-stage biopharmaceutical company active in the development and discovery of potential T cell redirecting immunotherapies for
the treatment of cancer. We have no products approved for commercial sale and have not generated revenue from operations. We have incurred net losses in each year since inception, including consolidated net losses of &#128;229.6&nbsp;million,
&#128;32.5&nbsp;million and &#128;32.4&nbsp;million for the years ended December&nbsp;31, 2020, 2019 and 2018 respectively. As of December&nbsp;31, 2020, we had accumulated consolidated losses of &#128;462.3&nbsp;million. We do not expect to
generate any meaningful product sales or royalty revenues for the foreseeable future. We expect to incur significant additional operating losses in the future as we continue and expand our research and development efforts for our product candidates.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even if we obtain regulatory approval of and are successful in commercializing one or more of our product candidates, we may incur
substantial research and development and other expenditures to develop and market additional product candidates. We may encounter unforeseen expenses, difficulties, complications, delays and unknown factors that may adversely affect our business.
The size of our future operating losses will depend, in part, on the rate of future growth of our expenses and our ability to generate revenue. Our operating losses may fluctuate significantly from quarter to quarter and from year to year. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We may never achieve or sustain profitability. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not know when or whether we will become profitable. We have no products approved for commercial sale and have not generated revenue from
operations. To become and remain profitable, we must succeed in developing, obtaining regulatory approval for and commercializing one or more of our product candidates. This will require us to be successful in a range of challenging activities,
including completing preclinical studies and clinical trials of our product candidates, discovering and developing additional product candidates, obtaining regulatory approval for any product candidates that successfully complete clinical trials,
establishing commercialization capabilities for any approved products and achieving market acceptance for any approved products. We may never succeed in these activities. Even if we succeed in these activities, we may never generate revenue in an
amount sufficient to achieve profitability. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because of the numerous risks and uncertainties associated with biotechnology product
development and commercialization, we are unable to accurately predict whether and when we will achieve profitability. If we are required by the FDA, the EMA or any comparable regulatory authority to perform preclinical studies or clinical trials in
addition to those we currently expect to conduct, or if there are any delays or complications in completing preclinical studies of our product candidates or, if preclinical studies are successful, in submitting an IND or CTA to the FDA and
comparable regulatory authorities, and if clinical trials are successful, in submitting a BLA or MAA to the FDA and comparable regulatory authorities, manufacturing clinical trial supplies and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
completing clinical trials, our expenses could increase substantially and our ability to achieve profitability could be further delayed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even if we achieve profitability, we may not be able to sustain profitability in subsequent periods. After we achieve profitability, if ever,
we expect to continue to engage in substantial research and development activities and to incur substantial expenses to develop and commercialize additional product candidates. In addition, we may encounter unforeseen expenses, difficulties,
complications, delays and other unknown factors that may adversely affect our revenues, expenses and profitability. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our failure to
achieve or sustain profitability would depress our market value and could impair our ability to execute our business plan, raise capital, develop additional product candidates or continue our operations. A decline in the value of our company could
cause our shareholders to lose all or part of their investment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We have never generated any revenue from product sales, which may
make it difficult to evaluate the success of our business to date and to assess our future viability. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since our inception, our
operations have been largely focused on developing our product candidates, including conducting preclinical studies and clinical trials, raising capital and building our management team and infrastructure. We have not yet demonstrated an ability to
obtain regulatory approvals, manufacture products, or partner with contract manufacturing organizations (&#147;CMOs&#148;) to manufacture products, on a commercial scale or conduct sales and marketing activities necessary for successful
commercialization. Additionally, the markets for our product candidates are competitive. Consequently, any predictions about our future success or viability may not be as accurate as they could be if we had a longer operating history or a history of
successfully developing and commercializing products. Moreover, if our research and development efforts are successful, we will need to transition from a company with a research and development focus to a company capable of undertaking commercial
activities. We may encounter unforeseen expenses, difficulties, complications and delays, and may not be successful in such a transition. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We will need additional capital to fund our operations and complete the development and commercialization of our product candidates. Our
inability to obtain this capital when needed could force us to delay, limit, reduce or terminate our product development efforts. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our operations have consumed substantial amounts of cash since inception. The development of biotechnology product candidates is capital
intensive and we expect that we will continue to expend substantial resources for the foreseeable future to develop and commercialize our current and future product candidates. Our expenditures in the foreseeable future may include costs associated
with conducting research and development activities, conducting preclinical studies and clinical trials, obtaining regulatory approvals, undertaking commercialization activities, establishing our sales and marketing capabilities, manufacturing and
selling approved products and potentially acquiring new technologies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2020, we had &#128;232.0&nbsp;million in
cash and cash equivalents and other financial assets. We believe that we have sufficient financial resources available to fund our projected operating requirements for at least the next twelve months. Because the outcome of our current and planned
clinical trials is highly uncertain, we cannot reasonably estimate the actual amounts necessary to successfully complete the development and commercialization of our product candidates. For example, our costs will increase if we experience any
delays in our current and planned clinical trials. Our future funding requirements will depend on many factors, including, but not limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">progress, timing, scope and costs of our clinical trials, including the ability to timely initiate clinical
sites, enroll subjects and manufacture ACT and TCR Bispecific product candidates for our ongoing, planned and potential future clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">time and cost to conduct <FONT STYLE="white-space:nowrap">IND-</FONT> or
<FONT STYLE="white-space:nowrap">CTA-enabling</FONT> studies for our preclinical programs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">time and costs required to perform research and development to identify and characterize new product candidates
from our research programs; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">time and cost necessary to obtain regulatory authorizations and approvals that may be required by regulatory
authorities to execute clinical trials or commercialize our products; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to successfully commercialize our product candidates, if approved; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to have clinical and commercial products successfully manufactured consistent with FDA, the EMA and
comparable regulatory authorities&#146; regulations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">amount of sales and other revenues from product candidates that we may commercialize, if any, including the
selling prices for such potential products and the availability of adequate third-party coverage and reimbursement for patients; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">sales and marketing costs associated with commercializing our products, if approved, including the cost and
timing of building our marketing and sales capabilities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">cost of building, staffing and validating our manufacturing processes, which may include capital expenditure;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">terms and timing of our current and any potential future collaborations, licensing or other arrangements that we
have established or may establish; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">cash requirements of any future acquisitions or the development of other product candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">costs of operating as a public company; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">time and cost necessary to respond to technological, regulatory, political and market developments;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights;
and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">costs associated with any potential business or product acquisitions, strategic collaborations, licensing
agreements or other arrangements that we may establish. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additional funds may not be available when we need them or on
terms that are acceptable to us. In addition, market volatility resulting from the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic and other factors could also adversely impact our ability to access capital as and when needed. If adequate
funds are not available to us on a timely basis or on terms acceptable to us, we may be required to delay, limit, reduce or terminate our product development efforts. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Raising additional capital may cause dilution to our existing shareholders, restrict our operations or require us to relinquish rights
to our intellectual property or product candidates on unfavorable terms. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless and until we can generate sufficient revenue to
finance our cash requirements, which may never happen, we may seek additional capital through a variety of means, including through public and private equity offerings and debt financings, credit and loan facilities and additional collaborations. If
we raise additional capital through the sale of equity or convertible debt securities, our existing shareholders&#146; ownership interest will be diluted, and the terms of such equity or convertible debt securities may include liquidation or other
preferences that are senior to or otherwise adversely affect the rights of our existing shareholders. If we raise additional capital through the sale of debt securities or through entering into credit or loan facilities, we may be restricted in our
ability to take certain actions, such as incurring additional debt, making capital expenditures, acquiring or licensing intellectual property rights, declaring dividends or encumbering our assets to secure future indebtedness. Such restrictions
could adversely impact our ability to conduct our operations and execute our business plan. If we raise additional capital through collaborations with third parties, we may be required to relinquish valuable rights to our intellectual property or
product candidates or we may be required to grant licenses for our intellectual property or product candidates on unfavorable terms. If we are unable to raise additional capital when needed, we may be required to delay, limit, reduce or terminate
our product development efforts or we may be required to grant rights to third parties to develop and market our product candidates that we would otherwise prefer to develop and market ourselves. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We may expend our resources to pursue particular product candidates and fail to
capitalize on product candidates that may be more profitable or for which there is a greater likelihood of success. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because we
have limited financial resources and personnel, we focus on the development of specific product candidates based on our product development strategy. As a result, we may forgo or delay the pursuit of other product candidates that later prove to have
greater commercial potential. Decision making about which product candidates to prioritize involves inherent subjectivity and/or uncertainty. Our resource allocation decisions may cause us to fail to capitalize on viable commercial products or
profitable market opportunities. Failure to properly assess potential product candidates could result in our focus on product candidates with low market potential, which would harm our business and financial condition. Our spending on current and
future research programs and product candidates for specific indications may not yield any commercially viable product candidates. If we do not accurately evaluate the commercial potential or target market for a particular product candidate, we may
relinquish valuable rights to that product candidate through partnering, licensing or other arrangements in cases in which it would have been more advantageous for us to retain sole development and commercialization rights to such product candidate.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We are exposed to risks related to currency exchange rates. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We operate internationally and are exposed to fluctuations in foreign exchange rates between the euro and other currencies, particularly the
U.S. dollar. Our reporting currency is the euro and, as a result, financial line items are converted into euros at the applicable foreign exchange rates. As our business grows, we expect that at least some of our revenues and expenses will continue
to be denominated in currencies other than the euro. Unfavorable developments in the value of the euro relative to other relevant currencies, especially the U.S. dollar, could adversely affect our business and financial condition. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>The use of net operating loss carryforwards may be limited. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Both Immatics OpCo and Immatics US, Inc. (&#147;Immatics US&#148;) incurred significant losses in the past and therefore are entitled to use
net operating loss carryforwards. As of December&nbsp;31, 2020, we had German federal net operating loss carryforwards of &#128;203.4&nbsp;million and Immatics US had U.S. federal net operating loss carryforwards of $95.5&nbsp;million. German
federal net operating loss carryforwards and U.S. federal net operating loss carryforwards arising in taxable years ending after December&nbsp;31, 2017 do not expire, whereas U.S. federal net operating loss carryforwards arising before or in taxable
years ending December&nbsp;31, 2017 will begin to expire in 2027. These operating loss carryforwards are subject to various limitations, including limitations under Sections 382 and 383 of the U.S. Internal Revenue Code of 1986, as amended (the
&#147;Code&#148;) if Immatics US has a cumulative change in ownership of more than 50% within a three-year period. Further, due to our limited income, there is a high risk that our operating loss carryforwards will expire in part and cannot be used
to offset future taxable income. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, any operating loss carryforwards that we report on our tax returns are subject to review by
the relevant tax authorities. Consequently, we are exposed to the risk that the tax authorities may not accept the reported operating loss carryforwards in part or in their entirety. Any limitations in our ability to use operating loss carryforwards
to offset taxable income could adversely affect our financial condition. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to the Development of Our Product Candidates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our product candidates represent novel approaches to the treatment of diseases, and there are many uncertainties regarding the
development of our product candidates. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Human immunotherapy products are a new category of therapeutics. Because this is a
relatively new and expanding area of novel therapeutic interventions, there are many uncertainties related to development of our product candidates. There can be no assurance as to the number of required clinical trials, the length of the trial
period, the number of patients the FDA, the EMA or comparable regulatory authorities will require to be enrolled in the trials in order to establish the safety and efficacy of immunotherapy products, or that the data generated in these trials will
be acceptable to the FDA, the EMA or comparable regulatory authorities to support marketing </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
approval. The FDA, the EMA and comparable regulatory authorities may take longer than usual to come to a decision on any BLA, MAA or similar marketing application that we submit and may
ultimately determine that there is not enough data, information or experience with our product candidates to support an approval decision. Regulatory authorities may also require that we conduct additional post-marketing studies or implement risk
management programs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may also find that the manufacture of our product candidates is more difficult or more expensive than
anticipated, resulting in an inability to produce a sufficient amount of our product candidates for our clinical trials or, if approved, commercial supply. Moreover, because of the complexity and novelty of our manufacturing process, there are only
a limited number of manufacturers who have the capability of producing our product candidates. Should any of our contract manufacturers no longer produce our product candidates, it may take us significant time to find a replacement, if we are able
to find a replacement at all. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our current product candidates are in various stages of development, and it is possible that none of
our product candidates will ever become commercial products. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our success depends heavily on the successful further development of
our current and future product candidates and our research pipeline and regulatory approval of our current and future product candidates, all of which are subject to risks and uncertainties beyond our control. We are conducting clinical trials for
IMA201, IMA202 and IMA203 and preclinical studies for our other product candidates. However, the FDA, the EMA and comparable regulatory authorities may ultimately disagree that data generated from our clinical trials are sufficient for regulatory
approval. There can be no assurance that any of our product candidates will prove to be safe, effective or commercially viable treatments for cancer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we discontinue development of a product candidate, we will not receive the anticipated revenues from that product candidate, and we may not
receive any return on our investment in that product candidate. In the future, we may discontinue other product candidates for clinical reasons if such product candidates do not prove to be safe and effective. Any unexpected safety events or our
failure to generate sufficient data in our clinical trials to demonstrate efficacy may cause a product candidate to fail clinical development. Furthermore, even if that product candidate meets its safety and efficacy endpoints, we may discontinue
its development for various reasons, such as changes in the competitive environment or the standard of care and the prioritization of our resources. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may also find that the development of a companion diagnostic for our product candidates is more difficult or more expensive than
anticipated, resulting in an inability to provide the required diagnostic testing for our clinical trials, or if approved, for the market. Moreover, because of the complexity and novelty of our companion diagnostic biomarker, there are only a
limited number of providers who have the capability of supporting the development of a companion diagnostic. Should any of our clinical research organizations (&#147;CROs&#148;) fail to meet our development goals, it may take us significant time to
find a replacement, if we are able to find a replacement at all. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Due to the uncertain and time-consuming clinical development and
regulatory approval process, we may not successfully develop any of our product candidates and may choose to discontinue the development of any of our product candidates. Therefore, it is possible that none of our current product candidates will
ever become commercial products. Our failure to develop and commercialize our current and future product candidates could have a material adverse effect on our business, results of operations, financial condition and prospects. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Delays in the commencement and completion of clinical trials could increase costs and delay or prevent regulatory approval and
commercialization of our product candidates. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We cannot guarantee that clinical trials of our product candidates will be conducted
as planned or completed on schedule, if at all. A failure of one or more clinical trials can occur at any stage of the clinical trial process, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and other events may cause us to temporarily or permanently stop a clinical trial. Events that may prevent successful or timely commencement and completion of clinical development include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">negative preclinical data; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays in receiving the required regulatory clearance from the appropriate regulatory authorities to commence
clinical trials or amend clinical trial protocols, including any objections to our INDs or CTAs or protocol amendments from regulatory authorities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays in reaching, or a failure to reach, a consensus with regulatory authorities on study design;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays in reaching, or a failure to reach, an agreement on acceptable terms with prospective independent clinical
investigators, CROs and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different investigators, CROs and clinical trial sites; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">difficulties in obtaining required Institutional Review Board (&#147;IRB&#148;) or ethics committee approval at
each clinical trial site; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">challenges in recruiting and enrolling suitable patients that meet the study criteria to participate in clinical
trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the inability to enroll a sufficient number of patients in clinical trials to ensure adequate statistical power
to detect statistically significant treatment effects; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">imposition of a clinical hold by regulatory authorities or IRBs for any reason, including safety concerns and <FONT
STYLE="white-space:nowrap">non-compliance</FONT> with regulatory requirements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure by independent clinical investigators, CROs, other third parties or us to adhere to clinical trial
requirements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure to perform in accordance with the FDA&#146;s good clinical practices (&#147;GCP&#148;) or applicable
regulatory guidelines in other jurisdictions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the inability to manufacture adequate quantities of a product candidate or other materials necessary in
accordance with current Good Manufacturing Practices (&#147;cGMPs&#148;) and current Good Tissue Practices (&#147;cGTPs&#148;) to conduct clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">lower than anticipated patient retention rates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">difficulties in maintaining contact with patients after treatment, resulting in incomplete data;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ambiguous or negative interim results; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our independent clinical investigators, CROs or clinical trial sites failing to comply with regulatory
requirements or meet their contractual obligations to us in a timely manner, or at all, deviating from the protocol or dropping out of a clinical trial; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">unforeseen safety issues, including occurrence of adverse events associated with the product candidate that are
viewed to outweigh the product candidate&#146;s potential benefits; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in regulatory requirements and guidance that require amending or submitting new clinical protocols;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">lack of adequate funding to continue the clinical trial; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays and disruptions as a result of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Delays, including delays caused by the above factors, can be costly and could negatively affect our ability to complete
a clinical trial. Further, there can be no assurance that submission of an IND, IND amendment or CTA will result in the FDA or any comparable regulatory authority allowing testing and clinical trials to begin, or that, once begun, issues will not
arise that suspend or terminate such clinical trials. The manufacturing and preclinical safety and efficacy testing requirements of both ACT and TCR Bispecifics remain emerging and evolving fields. Accordingly, we expect chemistry, manufacturing and
control related topics, including product specification, as </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
well as preclinical safety testing, will be a focus of IND reviews, which may delay the allowance of INDs by the FDA or CTA approval by comparable regulatory authorities. If we are not able to
successfully complete clinical trials, we will not be able to obtain regulatory approval and will not be able to commercialize our product candidates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>If we experience delays or difficulties in patient enrollment for clinical trials, our research and development efforts and the receipt
of necessary regulatory approvals could be significantly delayed or prevented. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Commencement and successful and timely completion
of clinical trials require us to enroll a sufficient number of eligible patients to participate in these trials as required by the FDA, the EMA or comparable regulatory authorities. Any delay or difficulty in patient enrollment could significantly
delay or otherwise hinder our research and development efforts and delay or prevent receipt of necessary regulatory approvals. Despite diligent planning of our clinical trials and analysis of their feasibility regarding patient recruitment, we may
experience difficulties, delays or inability in patient enrollment in our clinical trials for a variety of reasons, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the size and nature of the patient population; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the severity and incidence of the disease under investigation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the eligibility criteria for the study in question, including any misjudgment of, and resultant adjustment to,
the appropriate ranges applicable to the exclusion and inclusion criteria; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the size of the study population required for analysis of the trial&#146;s primary endpoints;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability to recruit clinical trial investigators with the appropriate competencies and experience;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number of clinical trial sites and the proximity of prospective patients to those sites;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the design of the trial and the complexity for patients and clinical sites; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the nature, severity and frequency of adverse side effects associated with our product candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the screening procedures and the rate of patients failing screening procedures; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability to provide appropriate screening assays; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risk that patients&#146; general health conditions do not allow the conduct of study/screening procedures
(for example, tumor biopsy, or leukapheresis) or application of lymphodepletion regimen; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability to manufacture patient products appropriately (for example, at a sufficient high dose, or with
sufficiently active T cells); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the efforts to facilitate timely enrollment in clinical trials and the effectiveness of recruiting publicity;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the patient referral practices of physicians within the same hospital as well as within other hospitals or
private practices; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">competing clinical trials for similar therapies, other new therapeutics, new combination treatments, new
medicinal products; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approval of new indications for existing therapies or approval of new therapies in general or changes in standard
of care; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">clinicians&#146; and patients&#146; perceptions as to the potential advantages and side effects of the product
candidate being studied in relation to other available therapies, including any new drugs or treatments that may be approved or become standard of care for the indications we are investigating; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability to obtain and maintain patient consents; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">inability of clinical sites to enroll patients as healthcare capacities are required to cope with natural
disasters, epidemics or other health system emergencies, such as the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not all patients suffering from a specific cancer that is in principle addressable by our product candidates are eligible for our clinical
trials and therapies. First, patients must express a specific genetic marker called </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<FONT STYLE="white-space:nowrap">HLA-A*02.</FONT> While this marker is found on approximately <FONT STYLE="white-space:nowrap">40-50%</FONT> of individuals in North America and Europe, it is less
frequent in other populations, such as China or Japan. If human leukocyte antigen (&#147;HLA&#148;) screening for a patient shows that <FONT STYLE="white-space:nowrap">HLA-A*02</FONT> is not expressed, he or she cannot be treated with our current
product candidates. Second, the prevalence of the targets addressed by IMA201, IMA202, IMA203 and IMA204 differs between different tumor entities. For a given patient, a biomarker assay must be performed in order to find out whether he or she
expresses one of the targets and can be treated with one of our product candidates. We cannot be certain that the anticipated and assumed target prevalence rates are confirmed in the patient populations of our Phase 1 trials, and lower target
prevalence rates may be experienced. Third, further eligibility criteria are in place to ensure that the patients can tolerate and potentially benefit from the treatment. Thus, only a few of the patients screened for our clinical trials will finally
receive cellular products. Patients may therefore be hesitant to consent to our trials, and overall, many more patients will have to be screened to treat the targeted number of patients. It is uncertain how many more patients we will be required to
screen. If the required number of patient screenings is much higher than anticipated, our clinical trial costs may increase. We may combine two or more product candidates into multi-target trials to mitigate this risk. However, we cannot be certain
whether this measure will be effective in enhancing recruitment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our clinical trials will compete with other clinical trials for product
candidates that are in the same therapeutic areas as our product candidates, and this competition will reduce the number and types of patients available to us because some eligible patients may instead opt to enroll in a competitor&#146;s trial.
Because the number of qualified clinical investigators is limited, we expect to conduct some of our clinical trials at the same clinical trial sites that some of our competitors use, which will reduce the number of patients who are available for our
clinical trials at such clinical trial sites. Enrolling patients at the same sites as our competitors may compromise the quality and conclusiveness of our clinical data by introducing bias. Moreover, because our product candidates represent a
departure from more commonly used methods for cancer treatment, potential patients and their doctors may be inclined to use conventional therapies, such as chemotherapy and approved immunotherapies, rather than enroll patients in any clinical trial.
In addition, potential enrollees in our ACT trials with IMA201, IMA202, IMA203 or IMA204 may opt to participate in other clinical trials because of the length of time between the time that their tumor is analyzed, and the cellular product is
manufactured and infused back into the patient. Challenges in recruiting and enrolling suitable patients to participate in clinical trials could increase costs, affect the timing and outcome of our planned clinical trials and result in delays to our
current development plan for our product candidates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Clinical trials are expensive, time-consuming and difficult to design and
implement, and our clinical trial costs may be higher than for more conventional therapeutic technologies or drug products. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Clinical trials are expensive and difficult to design, implement and conduct, in part because they are subject to rigorous regulatory
requirements. Because our ACT product candidates are based on new cell therapy technologies and manufactured on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">patient-by-patient</FONT></FONT> basis, we expect that such
candidates will require extensive research and development and have substantial manufacturing costs per dose. Our TCR Bispecific product candidates also require extensive research and development, as the applicable technology is new and experience
with developing such biologics is rare in the field. Moreover, the development of a companion diagnostic will also require extensive research and development, and such companion diagnostic must be suitable to support both enrollment into larger
clinical trials and routine hospital procedures after marketing approval. Any failure or delay in developing a suitable companion diagnostic will delay or make it impossible to conduct larger clinical trials for ACT product candidates and/or TCR
Bispecific product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, costs to treat patients with recurrent and/or refractory cancer and to treat potential side
effects that may result from our product candidates, <FONT STYLE="white-space:nowrap">non-investigational</FONT> medicinal products, rescue or prophylactic medication applied in our clinical trials can be significant. Some clinical trial sites do
not bill or obtain coverage from Medicare, Medicaid, health insurance or other third-party payors for some or all of these costs for patients enrolled in our clinical trials, and we can be required by those trial sites to pay such costs. In
countries outside the United States, we expect that all costs related to the clinical trial and to the management of study patients (for example, management of adverse reactions or hospitalization) are paid by the sponsor of the clinical trial. As
trial </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
designs for development of our product candidates are complex, our clinical trial costs are likely to be significantly higher per patient than those of more conventional therapeutic technologies
or drug products. We may combine two or more of our ACT product candidates within one clinical trial or within a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">multi-TCR-T</FONT></FONT> concept in order to achieve durable clinical
efficacy results and to increase the patient population. The setup and conduct of such <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">multi-TCR-T</FONT></FONT> clinical trials is expensive and may bear unknown risks, such as
regulatory, preclinical, safety and manufacturing risks. In addition, our proposed personalized product candidates involve several complex and costly manufacturing and processing steps, the costs of which will be borne by us. We are also responsible
for the manufacturing costs of products for patients that do not receive the product due to any reason (for example, rapid degradation of general health status, not meeting inclusion/exclusion criteria for infusion). Depending on the number of
patients that we ultimately screen and enroll in our trials, the number of trials that we may need to conduct, and the companion diagnostic we need to develop, our overall clinical trial costs may be higher than for more conventional treatments.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our product candidates may cause undesirable side effects or have other properties that may delay or prevent their development or
regulatory approval or limit their commercial potential. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Undesirable side effects caused by our product candidates or by similar
product candidates developed by others could cause us or regulatory authorities to interrupt, delay or halt clinical trials and could result in more restrictive labeling or the denial of regulatory approval by the FDA, the EMA or comparable
regulatory authorities and potential product liability claims. Such side effects could also affect patient recruitment or the ability of enrolled patients to complete the trial. Many compounds developed in the biotechnology industry that initially
showed promise in early-stage testing for treating cancer have later been found to cause side effects that prevented their further development. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In our clinical trials, reported Grade <FONT STYLE="FONT-FAMILY:SYMBOL">&#179;</FONT>3 treatment-emergent adverse events (&#147;TEAEs&#148;)
included lymphopenia, neutropenia, leukopenia, anemia, thrombocytopenia. In addition, we observed a dose-limiting toxicity (&#147;DLT&#148;) of Grade 3 atrial fibrillation in a patient treated with IMA203. There can be no assurance that patients
treated with our product candidates will not experience these and other serious adverse side effects and there can be no assurance that the FDA, the EMA or comparable regulatory authorities will not place clinical holds on our current or future
clinical trials, the result of which could delay or prevent us from obtaining regulatory approval. In particular, our clinical trials enroll patients who have failed all available
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">standard-of-care</FONT></FONT> treatments. As a result, these patients may be immunocompromised and thus are more susceptible to serious adverse side effects. In addition, certain of
our protocols involve further weakening of patients&#146; immune response (e.g., through lymphodepletion) prior to receiving our product candidates, which may further increase the severity and frequency of serious adverse side effects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, because our product candidates represent novel approaches to the treatment of cancer, we may be less able to predict the nature,
severity and frequency of adverse events and thus less able to undertake measures to prevent serious adverse events and mitigate their effects. For example, infused T cells may be more active than we expect or than we previously observed. Moreover,
because our ACTengine product candidates for a specific patient are manufactured using that patient&#146;s white blood cells, each patient receives an individually manufactured ACTengine product candidate. As a result, it may be difficult to predict
how a patient will respond to that individualized product candidate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For our current and future clinical trials, we have contracted with
and expect to continue to contract with independent clinical investigators and CROs experienced in the assessment and management of toxicities arising during clinical trials. Nonetheless, they may have difficulty observing patients and treating
toxicities, which may be more challenging due to personnel changes, shift changes, house staff coverage or related issues. This risk may be magnified by the novel nature of our product candidates, as independent clinical investigators and CROs may
not be accustomed to using our product candidates at dose levels and in the manner prescribed by our clinical trial designs. This could lead to more severe or prolonged toxicities or even patient deaths, which could result in us or the FDA, the EMA
or comparable regulatory authorities delaying, suspending or terminating one or more of our clinical trials and which could jeopardize regulatory approval. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, clinical trials by their nature utilize a sample of the potential patient
population. With a limited number of subjects and limited duration of exposure, rare and severe side effects of our product candidates or those of our competitors may only be uncovered with a significantly larger number of patients exposed to the
drug. In addition, some of our product candidates are developed or intended to be used in combination with other therapies. When used in combination, the severity and frequency of undesirable side effects may be greater than the cumulative severity
and frequency of such side effects when the therapies are used as monotherapies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we or others identify undesirable side effects caused
by our product candidates or those of our competitors, a number of potentially significant negative consequences could result, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may encounter delays or difficulties in enrolling patients for our clinical trials due to a negative
perception of our product candidates&#146; safety and tolerability profile; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we and/or regulatory authorities may temporarily or permanently put our clinical trials on hold;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may be unable to obtain regulatory approval for our product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulatory authorities may withdraw or limit their approvals of our product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulatory authorities may require the addition of labeling statements, such as a contraindication, boxed
warnings or additional warnings; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the FDA may require development of a Risk Evaluation and Mitigation Strategy with Elements to Assure Safe Use as
a condition of approval; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may decide to remove our product candidates from the marketplace; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may be subject to regulatory investigations and government enforcement actions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we could be sued and held liable for harm caused to patients, including as a result of hospital errors; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our reputation may suffer. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any of these events could prevent us from achieving or maintaining market acceptance of our product candidates and could substantially
increase commercialization costs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Results from preclinical studies and early-stage clinical trials may not be predictive of results
from late-stage or other clinical trials. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Positive and promising results from preclinical studies and early-stage clinical trials
may not be predictive of results from late-stage clinical trials or from clinical trials of the same product candidates. The primary objectives of our current Phase 1 clinical trials are to establish safety and tolerability and, for our ACTengine
Phase 1 clinical trials, to determine the recommended Phase 2 dose. Results from those and future early-stage clinical trials may not be representative of results from later-stage clinical trials. Product candidates in later stages of clinical
trials may fail to show the desired safety and efficacy traits despite having progressed through preclinical studies and initial clinical trials. Late-stage clinical trials could differ in significant ways from early-stage clinical trials, including
changes to inclusion and exclusion criteria, efficacy endpoints, dosing regimen and statistical design. In particular, we expect there may be greater variability in results for products processed and administered on a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">patient-by-patient</FONT></FONT> basis, as for our cellular therapy product candidates, than for
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;off-the-shelf&#148;</FONT></FONT> products, like many other drugs. Many companies in the biotechnology industry have suffered significant setbacks in late-stage clinical trials
after achieving encouraging or positive results in early-stage development. There can be no assurance that we will not face similar setbacks. Therefore, despite positive results observed in early-stage clinical trials, our product candidates may
fail to demonstrate sufficient efficacy in our pivotal or confirmatory clinical trials. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Preliminary interim or <FONT STYLE="white-space:nowrap">&#147;top-line&#148;</FONT>
data that we announce or publish from time to time may change as more data become available and are subject to audit and verification procedures that could result in material changes in the final data. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From time to time, we may announce or publish preliminary interim or <FONT STYLE="white-space:nowrap">&#147;top-line&#148;</FONT> data from
clinical trials. Positive preliminary data may not be predictive of such trial&#146;s subsequent or overall results. Preliminary data are subject to the risk that one or more of the outcomes may materially change as more data become available.
Additionally, preliminary data are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For example, our studies of cellular therapies in patients without any indicated <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">standard-of-care</FONT></FONT> treatment utilize an &#147;open-label, single arm, <FONT STYLE="white-space:nowrap">dose-escalation/de-escalation&#148;</FONT> trial design. An open-label, single arm, <FONT
STYLE="white-space:nowrap">dose-escalation/de-escalation</FONT> trial is one where both the patient and investigator know what investigational treatment (monotherapy or combination) at which dose the patient is receiving. This trial design has the
potential to create selection bias by encouraging the investigators to enroll a more favorable patient population (for example, indications better suitable for immunotherapies, fitter patients, less prior therapies) compared to a broader patient
population. In our current Phase 1 clinical trials, investigators have significant discretion over the selection of patient participants. As the trials continue, the investigators may prioritize patients with more progressed forms of cancer and/or
worse general health condition than the initial patient population, based on the safety/success or perceived safety/success of that initial population. Patients with more progressed forms of cancer or worse general health conditions may experience
more and/or worse adverse events or be less responsive to treatment, and accordingly, interim or final safety and efficacy data may show an increase in frequency or severity of adverse events and/or a decline in patient response rate or change in
other assessment metrics. As the trials continue or in subsequent trials, investigators may shift their approach to the patient population, which may ultimately experience more and/or worse adverse events and/or result in a decline in both interim
and final efficacy data from the preliminary data, or conversely, a decrease in frequency and/or severity of adverse events or an increase in final efficacy data following a decline in the interim efficacy data, as patients with more progressed
forms of cancer or worse general health condition are cycled out of the trials and replaced by patients with less advanced forms of cancer or with better general health conditions. This opportunity for investigator selection bias in our trials as a
result of open-label design, which is standard in <FONT STYLE="white-space:nowrap">dose-escalation/de-escalation</FONT> trials, may not be adequately handled and may cause a decline in or distortion of clinical trial data from our preliminary
results. Any future trial which utilizes an open-label design is similarly susceptible to such bias. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Therefore, positive preliminary
results in any ongoing clinical trial may not be predictive of such results in the completed trial. We also make assumptions, estimations, calculations and conclusions as part of our analyses of data, and we may not have received or had the
opportunity to fully evaluate all data. As a result, preliminary data that we report may differ from future results from the same clinical trials, or different conclusions or considerations may qualify such results, once additional data have been
received and fully evaluated. Preliminary data also remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary data we previously published. As a result, preliminary data
should be viewed with caution until the final data are available. Material adverse changes in the final data compared to preliminary data could significantly harm our business prospects. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We may not be successful in our preclinical development efforts to identify, generate and characterize additional product candidates.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A significant portion of our research activities focus on the identification, generation and characterization of new product
candidates. These activities are expensive, time-consuming and costly, and may never lead to a product candidate that shows appropriate safety and efficacy data in preclinical studies to enter clinical development. This means that success from
research and development is uncertain, early programs may not reach clinical development and we may never produce revenues from our preclinical development activities. If the target criteria for a product candidate are not met, we may also decide to
prolong preclinical development to improve the profile of a product candidate. In addition, if new treatment options are approved for the same indications as our preclinical product candidates, we may discontinue such early development programs.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The targets addressed by IMA201, IMA202, IMA203, IMA301, IMA401, and IMA402 belong to the
class of cancer testis antigens that are well-established immunotherapy targets. Future targets for product development may not belong to well-known target proteins and generation of such product candidates may be challenging. For example, IMA204 is
directed against a tumor stroma target. We are not aware of a comparable product candidate currently in preclinical or clinical development. We may find out during preclinical development that targets like the one addressed by IMA204 cannot be
safely addressed by immunotherapy. We cannot guarantee that we will be able to show safety and efficacy for product candidates addressing new target classes like the one addressed by IMA204, and we may not be able to enter clinical testing with or
to successfully market IMA204 or similar future product candidates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>The deviations in our proposed new products from existing
products may require us to perform additional testing, which will increase the cost, and extend the time for obtaining approval. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our ACT based therapy is based on first-generation adoptive cell therapy technology suitable for delivering for small, early-phase clinical
trials. These current methods of treatment are very labor intensive and expensive, which has limited their widespread application. We have developed new processes that we anticipate will enable more efficient manufacturing of ACT. We may have
difficulty demonstrating that the products produced from our new processes are comparable to the existing products. The FDA, the EMA and comparable regulatory authorities may require additional clinical testing before permitting a larger clinical
trial with the new processes, and the product may not demonstrate the desired activity in new clinical trials. In the manufacturing of cellular products, even small changes in manufacturing processes could alter the cell types, so our ability to
predict the outcomes with newer manufacturing processes is limited. The changes that we have made to the historical manufacturing process may require additional testing, which may increase costs and timelines associated with these developments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our TCR Bispecific product candidates contain features that have not been previously tested in this composition in clinical trials or marketed
products. The FDA, the EMA and comparable regulatory authorities may require additional <FONT STYLE="white-space:nowrap">non-clinical</FONT> studies before permitting us to enter clinical trials with our product candidates. Regulatory authorities
may also ask for additional early-stage trials or production of additional batches of TCR Bispecific product candidates before permitting larger clinical trials or registration trials. To comply with those requests would increase costs and timelines
for the development of our TCR Bispecific product candidates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Regulatory Approval of Our Product Candidates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>The regulatory review and approval processes of the FDA, the EMA and comparable regulatory authorities are lengthy, time-consuming and
uncertain. If we are unable to obtain, or if there are delays in obtaining, regulatory approval for our product candidates, we will not be able to commercialize our product candidates and our ability to generate revenue will be materially impaired.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our product candidates must be approved by the FDA in the United States, by the EMA in the European Union and by comparable
regulatory authorities in other jurisdictions prior to commercialization. In order to obtain regulatory approval for the commercial sale of any product candidates, we must demonstrate through extensive preclinical studies and clinical trials that
the product candidate is safe and effective for use in each target indication and that manufacturing of the product candidate is robust and reproducible. The time required to obtain approval by the FDA, the EMA and comparable regulatory authorities
is uncertain, typically takes many years following the commencement of clinical trials and depends upon numerous factors. Of the large number of drugs in development in the United States, only a small percentage will successfully complete the FDA
regulatory approval process and will be commercialized. Accordingly, there can be no assurance that any of our product candidates will receive regulatory approval in the United States, the European Union or other jurisdictions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Regulatory authorities have substantial discretion in the approval process. They may refuse to accept any application or may decide that our
data are insufficient for approval and require additional clinical trials or other </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
studies. We expect the novel nature of our product candidates to create additional challenges in obtaining regulatory approval. For example, the FDA has limited experience with commercial
development of T cell directed therapies for cancer. Therefore, even if we believe the data collected from clinical trials of our product candidates are promising, such data may not be sufficient to support approval by the FDA, the EMA or any
comparable regulatory authority. If we are required to conduct additional clinical trials or other testing of any of our product candidates beyond those that are contemplated, we may incur significant additional costs and the regulatory approval of
our product candidates may be delayed or prevented. Furthermore, additional clinical trials or other testing could shorten any periods during which we may have the exclusive right to commercialize our product candidates and could allow our
competitors to bring products to market before we do, which may prevent the successful commercialization of our product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, the process and time required to obtain regulatory approval differ by jurisdiction. In many countries outside the United States,
a drug must be approved for reimbursement before it can be approved for sale in that country. Approval by one regulatory authority does not ensure approval by regulatory authorities in other jurisdictions. Obtaining foreign regulatory approvals and
compliance with foreign regulatory requirements could result in significant delays, difficulties and costs for us and could delay or prevent the introduction of our products in certain countries. If we fail to comply with the regulatory requirements
in international markets and/or receive applicable marketing approvals, our target market will be reduced and our ability to realize the full market potential of our product candidates will be harmed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Moreover, principal investigators for our clinical trials may serve as scientific advisors or consultants to us from time to time and receive
compensation in connection with such services at market rates. Under certain circumstances, we may be required to report some of these relationships to the FDA, the EMA or comparable regulatory authorities, which could conclude that a financial
relationship between us and a principal investigator has created a conflict of interest or otherwise affected the integrity of the study. The FDA, the EMA or comparable regulatory authorities may, therefore, question the integrity of the data
generated at the applicable clinical trial site, and the utility of the clinical trial itself may be jeopardized. This could delay, or result in the rejection of, our marketing applications. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Applications for regulatory approval and regulatory approval of our product candidates could be delayed or be denied for many reasons,
including but not limited to the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the FDA, the EMA or comparable regulatory authorities may disagree with the number, design or implementation of
our clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the population studied in the clinical trial may not be considered sufficiently broad or representative to assure
safety in the full population for which we seek approval; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the FDA, the EMA or comparable regulatory authorities may disagree with our interpretation of data from
preclinical studies or clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the data collected from clinical trials of our product candidates may not meet the level of statistical or
clinical significance required by the FDA, the EMA or comparable regulatory authorities or may otherwise not be sufficient to support the submission of a BLA, MAA or other submission or to obtain regulatory approval in the United States, the
European Union or elsewhere; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the FDA, the EMA or comparable regulatory authorities may not accept data generated by our preclinical service
providers and clinical trial sites; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the FDA, the EMA or comparable regulatory authorities may require us to conduct additional preclinical studies
and clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the FDA, the EMA or comparable regulatory authorities may fail to approve the manufacturing processes, test
procedures and specifications applicable to the manufacture of our product candidates, the facilities of third-party manufacturers with which we contract for clinical or commercial supplies may fail to maintain a compliance status acceptable to the
FDA, the EMA or comparable regulatory </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
authorities or the EMA or comparable regulatory authorities may fail to approve facilities of third-party manufacturers with which we contract for clinical and commercial supplies;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we or any third-party service providers may be unable to demonstrate compliance with cGMPs and cGTPs to the
satisfaction of the FDA, the EMA or comparable regulatory authorities, which could result in delays in regulatory approval or require us to withdraw or recall products and interrupt commercial supply of our products; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the approval policies or regulations of the FDA, the EMA or comparable regulatory authorities may change in a
manner rendering our clinical data insufficient for approval; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">political factors surrounding the approval process, such as government shutdowns and political instability.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any of these factors, some of which are beyond our control, may result in our failing to obtain regulatory approval for
any of our product candidates, which would significantly harm our business, financial condition and prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>The regulatory
landscape that will govern our product candidates is still evolving. Regulations relating to more established gene therapy and cell therapy products and TCR Bispecific products are still developing, and changes in regulatory requirements could
result in delays or discontinuation of development of our product candidates or unexpected costs in obtaining regulatory approval. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because we are developing novel cell immunotherapy product candidates that are unique biological entities, the regulatory requirements to which
we will be subject are not entirely clear and may change rapidly. Even with respect to more established products that fit into the categories of gene therapies or cell therapies, the regulatory landscape is still developing. For example, regulatory
requirements governing gene therapy products and cell therapy products have become more stringent and comprehensive frequently and may continue to extend in the future. Moreover, there is substantial, and sometimes uncoordinated, overlap in those
responsible for regulation of existing gene therapy products and cell therapy products. For example, in the United States, the FDA has established the Office of Tissues and Advanced Therapies (&#147;OTAT&#148;), formerly known as the Office of
Cellular, Tissue and Gene Therapies (&#147;OCTGT&#148;), within its Center for Biologics Evaluation and Research (&#147;CBER&#148;) to consolidate the review of gene therapy and related products, and the Cellular, Tissue and Gene Therapies Advisory
Committee to advise CBER on its review. Gene therapy clinical trials in the U.S. are also subject to review and oversight by an institutional biosafety committee (&#147;IBC&#148;), a local institutional committee that reviews and oversees basic and
clinical research conducted at the institution participating in the clinical trial. Similar regulatory bodies exist in Europe and other jurisdictions. In addition, adverse developments in clinical trials of gene therapy products conducted by others
may cause the FDA, the EMA and comparable regulatory authorities to change the requirements for approval of any of our product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While there is already a T cell engaging bispecific molecule approved and regulatory guidelines have been issued for this class of drugs,
bispecific therapeutics are still new in the field and regulators have even less experience with TCR Bispecifics. Thus, guidance for development and regulatory approval of such drugs may change. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Complex regulatory environments exist in the different jurisdictions in which we might consider seeking regulatory approvals for our product
candidates, further complicating the regulatory landscape. For example, in the European Union, a special committee called the Committee for Advanced Therapies was established within the EMA in accordance with Regulation (EC) No.&nbsp;1394/2007 on
advanced therapy medicinal products (&#147;ATMPs&#148;) to assess the quality, safety and efficacy of ATMPs, and to follow scientific developments in the field. ATMPs include gene therapy products as well as somatic cell therapy products and tissue
engineered products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These various regulatory review committees and advisory groups and new or revised guidelines that they promulgate
from time to time may lengthen the regulatory review process, require us to perform additional </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
studies, increase our development costs, lead to changes in regulatory positions and interpretations, delay or prevent approval and commercialization of our product candidates or lead to
significant post-approval limitations or restrictions. Because the regulatory landscape for our cell immunotherapy product candidates is new, our product candidates may face even more cumbersome and complex regulations than those emerging for other
gene therapy products and cell therapy products. Furthermore, even if our product candidates obtain required regulatory approvals, such approvals may later be revoked, suspended or otherwise withdrawn as a result of changes in regulations or the
interpretation of regulations by applicable regulatory agencies. Delay or failure to obtain, or unexpected costs in obtaining, the regulatory approval necessary to bring a potential product to market could decrease our ability to generate sufficient
product revenue to maintain our business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Development of a product candidate intended for use in combination with an already
approved product may present more or different challenges than development of a product candidate for use as a single agent. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
may evaluate our other ACT and TCR Bispecifics product candidates in combination with other therapies, such as checkpoint inhibitor immunotherapies. The development of product candidates for use in combination with another product may present
challenges. For example, the FDA may require us to use more complex clinical trial designs, in order to evaluate the contribution of each product and product candidate to any observed effects. It is possible that the results of these trials could
show that most or any positive results are attributable to the already approved product. Moreover, following product approval, the FDA may require that products used in conjunction with each other be cross-labeled. To the extent that we do not have
rights to already approved products, this may require us to work with another company to satisfy such a requirement. Moreover, developments related to the already approved products may impact our clinical trials for the combination as well as our
commercial prospects should we receive marketing approval. Such developments may include changes to the approved product&#146;s safety or efficacy profile, changes to the availability of the approved product, and changes to the standard of care.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>The FDA may disagree with our regulatory plan and we may fail to obtain regulatory approval of our product candidates. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If and when our ongoing Phase 1 clinical trials for IMA201, IMA202 and IMA203 are completed and, assuming positive data, we expect to advance
to potential registrational trials. We anticipate pursuing registrational trials, for example for IMA201, IMA202 and IMA203, as single agents or in combination that are designed to evaluate the efficacy of the respective product candidate in a
single open-label, <FONT STYLE="white-space:nowrap">non-comparative,</FONT> <FONT STYLE="white-space:nowrap">two-stage,</FONT> pivotal, multicenter, <FONT STYLE="white-space:nowrap">single-arm</FONT> clinical trials in patients who have exhausted
available treatment options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the trial results are sufficiently compelling, we intend to discuss with the FDA a BLA submission for the
relevant product candidate. Further, we plan to have discussions with other authorities, such as the EMA or Health Canada regarding any planned marketing authorization submissions. It cannot be guaranteed that FDA, the EMA and other regulatory
authorities will agree to move to a registrational trial on the basis of data generated from a single completed Phase 1 trial. Authorities may ask for additional early-stage or Phase 2 clinical data first. Even if the FDA, the EMA or other
regulatory authorities agrees with the design and implementation of the clinical trials set forth in an IND and CTA, we cannot guarantee that the regulatory authorities will not change their requirements in the future. For example, the regulatory
authorities may require that we conduct a comparative trial against an approved therapy including potentially an approved autologous T cell therapy, which would significantly delay our development timelines and require substantially more resources.
In addition, the regulatory authorities may only allow us to evaluate patients that have already failed autologous therapy or very late-stage patients, which are extremely difficult patients to treat and patients with advanced and aggressive cancer,
and our product candidates may fail to improve outcomes for such patients. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Certain of our current clinical trials are being
conducted outside the United States, and the FDA may not accept data from trials conducted in foreign locations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain current
clinical trials of our drug candidates are being conducted or planned to be conducted partially outside the United States. We may also conduct future clinical trials for our drug candidates partially or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
fully outside the United States. Although the FDA may accept data from clinical trials conducted outside the United States, acceptance of this data is subject to certain conditions imposed by the
FDA. For example, the clinical trial must be well designed and conducted and performed by qualified investigators in accordance with ethical principles and good clinical practice (&#147;GCP&#148;) requirements. Further, the data must be applicable
to the U.S. population and U.S. medical practice in ways that the FDA deems clinically meaningful. In general, the patient population for any clinical trials conducted outside of the United States must be representative of the population for whom we
intend to label the product in the United States. In addition, while these clinical trials are subject to the applicable local laws, FDA acceptance of the data will be dependent upon its determination that the trials also complied with all
applicable U.S. laws and regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Conducting clinical trials outside the United States also exposes us to additional risks, including
risks associated with: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">additional foreign regulatory requirements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">foreign exchange fluctuations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">compliance with foreign manufacturing, customs, shipment and storage requirements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an inability to negotiate the terms of clinical trial agreements at arms&#146; length in countries where a
template agreement for such trials is required by law; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">cultural differences in medical practice and clinical research; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">diminished protection of intellectual property in some countries. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There can be no assurance that the FDA will accept data from trials conducted outside of the United States. If the FDA does not accept the
data from such clinical trials, it would likely result in the need for additional clinical trials, which would be costly and time-consuming and delay or permanently halt our development of our product candidates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We may seek accelerated approval for some of our product candidates, which may not lead to a faster development or regulatory review or
approval process, and does not increase the likelihood that the product candidates will receive marketing approval. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may attempt
to seek approval on a per indication basis for our product candidates on the basis of a single pivotal trial or on the basis of data from one or more uncontrolled trials. While the FDA requires in most cases two adequate and well-controlled pivotal
clinical trials to demonstrate the efficacy of a product candidate, a single trial with strong confirmatory evidence may be sufficient in instances where the trial is a large multicenter trial demonstrating internal consistency and a statistically
very persuasive finding of a clinically meaningful effect on mortality, irreversible morbidity or prevention of a disease with a potentially serious outcome and if confirmation of the result in a second trial would be practically or ethically
impossible. In rare cancer indications with very limited treatment options, a large and/or controlled trial is often not feasible and thus data from smaller and even uncontrolled trials may be sufficient for regulatory approval. It is difficult for
us to predict with such a novel technology exactly what will be required by the regulatory authorities in order to take our product candidates to market or the timeframes under which the relevant regulatory approvals can be obtained. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For treatments granted accelerated approval, post-marketing confirmatory clinical trials are required to describe the anticipated effect on
irreversible morbidity or mortality or other clinical benefit. These confirmatory clinical trials must be completed with due diligence and, in some cases, the FDA may require that the trial be designed, initiated and/or fully enrolled prior to
approval. If any of our competitors were to receive full approval on the basis of a confirmatory clinical trial for an indication for which we seek accelerated approval before we receive accelerated approval, the indication we are seeking may no
longer qualify as a condition for which there is an unmet </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
medical end and accelerated approval of our product candidate would be more difficult. Moreover, the FDA may withdraw approval of our product candidate approved under the accelerated approval
pathway if, for example: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the clinical trial(s) required to verify the predicted clinical benefit of a product candidate fails to verify
such benefit or does not demonstrate sufficient clinical benefit to justify the risks associated with the product candidate; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other evidence demonstrates that a product candidate is not shown to be safe or effective under the conditions of
use; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we fail to conduct any required post-marketing confirmatory clinical trial with due diligence; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we disseminate false or misleading promotional materials relating to the relevant product candidate.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We may pursue orphan drug designation for certain of our product candidates, which we may not receive, and even
if we receive such designation, we may be unable to maintain the associated benefits. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Regulatory authorities in some
jurisdictions, including the United States and the European Union, may designate drugs for relatively small patient populations as orphan drugs. Under the Orphan Drug Act, the FDA may designate a product as an orphan drug if it is intended to treat
a rare disease or condition, defined as a patient population of fewer than 200,000 in the United States, or a patient population greater than 200,000 in the United States where there is no reasonable expectation that the cost of developing the drug
will be recovered from sales in the United States. In the European Union, the EMA&#146;s Committee for Orphan Medicinal Products grants orphan drug designation to promote the development of products that meet the following criteria: (i)&nbsp;they
are intended for the diagnosis, prevention, or treatment of a life-threatening or chronically debilitating condition affecting not more than five in 10,000 persons in the European Union or they are intended for the diagnosis, prevention, or
treatment of a life-threatening, seriously debilitating or serious and chronic condition when, without incentives, it is unlikely that sales of the drug in the European Union would be sufficient to justify the necessary investment in developing the
drug or biological product and (ii)&nbsp;where there is no satisfactory method of diagnosis, prevention or treatment, or, if such a method exists, the medicine must be of significant benefit to those affected by the condition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the United States, orphan drug designation entitles a party to financial incentives such as opportunities for grant funding towards
clinical trial costs, tax advantages and user fee waivers. In addition, if a product receives the first FDA approval for the indication for which it has orphan designation, the product is entitled to orphan drug exclusivity, which means the FDA may
not approve any other application to market the same biologic (meaning, a product with the same principal molecular structural features) for that indication for a period of seven years, except in limited circumstances, such as a showing of clinical
superiority over the product with orphan exclusivity or where the manufacturer is unable to assure sufficient product quantity. In the European Union, orphan drug designation entitles a party to financial incentives such as reduction of fees or fee
waivers and ten years of market exclusivity for the orphan indication following drug or biological product approval, provided that the criteria for orphan designation are still applicable at the time of the granting of the marketing authorization.
This period may be reduced to six years if, at the end of the fifth year, the orphan drug designation criteria are no longer met, including where it is shown that the product is sufficiently profitable not to justify maintenance of market
exclusivity. However, orphan drug designation neither shortens the development time or regulatory review time of a drug or therapeutic biologic nor gives the drug or therapeutic biologic any advantage in the regulatory review or approval process.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may pursue orphan drug designation for one or more of our product candidates. However, obtaining an orphan drug designation can be
difficult, and we may not be successful in doing so. Even if we obtain orphan drug designation for our product candidates in specific indications, we may not be the first to obtain regulatory approval of these product candidates for the
orphan-designated indication. In addition, exclusive marketing rights in the United States may be limited if we seek approval for an indication broader than the orphan-designated indication or may be lost if the FDA later determines that the request
for designation was materially defective or if the manufacturer is unable to assure sufficient quantities of the product to meet the needs of patients with the rare disease or condition. Furthermore, even if we obtain orphan drug exclusivity for a
product, that exclusivity </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
may not effectively protect the product from competition because a different biologic (with different principal molecular structural features) can be approved for the same condition. Even after
an orphan product is approved, the FDA can subsequently approve the same biologic for the same condition if the FDA concludes that the later biologic is safer, more effective or makes a major contribution to patient care. Our inability to obtain
orphan drug designation for any product candidates for the treatment of rare cancers and/or our inability to maintain that designation for the duration of the applicable exclusivity period, could reduce our ability to make sufficient sales of the
applicable product candidate to balance our expenses incurred to develop it. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Breakthrough Therapy Designation, Fast Track
Designation and Priority Review Designation by the FDA, or comparable designations by comparable regulatory authorities, for our product candidates may not lead to a faster development or regulatory review or approval process and do not increase the
likelihood that a product candidate would receive regulatory approval. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not currently have Breakthrough Therapy Designation,
Fast Track Designation or Priority Review Designation or comparable designations by comparable regulatory authorities for our product candidates. A breakthrough therapy is defined as a product candidate that is intended, alone or in combination with
one or more other drugs, to treat a serious or life-threatening disease or condition, and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over currently approved therapies on one or more clinically
significant endpoints, such as substantial treatment effects observed early in clinical development. For product candidates that have been designated as breakthrough therapies, interaction and communication between the FDA and the sponsor can help
to identify the most efficient path for development. A Fast Track Designation may be available if a product candidate is intended for the treatment of a serious or life-threatening condition and preclinical or clinical data demonstrate the potential
to address an unmet medical need for this condition. Priority review may be granted for products that are intended to treat a serious or life-threatening condition and, if approved, would provide a significant improvement in safety and effectiveness
compared to available therapies. The FDA will attempt to direct additional resources to the evaluation of an application designated for priority review in an effort to facilitate the review. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In Europe, the EMA has implemented the <FONT STYLE="white-space:nowrap">so-called</FONT> &#147;PRIME&#148; (PRIority MEdicines) status in
order support the development and accelerate the approval of complex innovative medicinal products addressing an unmet medical need. The PRIME status enables early dialogue with the relevant EMA scientific committees and, possibly, some payers; and
thus, reinforces the EMA&#146;s scientific and regulatory support. It also opens accelerated assessment of the marketing authorization application (150 days instead of 210 days). The PRIME status, which is decided by the EMA, is reserved to
medicines that may benefit from accelerated assessment, i.e., medicines of major interest from a public health perspective, in particular from a therapeutic innovation perspective and that target unmet medical need. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FDA, the EMA and comparable regulatory authorities have broad discretion whether or not to grant Breakthrough Therapy Designation, Fast
Track Designation and Priority Review Designation and comparable designations. Accordingly, even if we believe, after completing early clinical trials, that one of our product candidates meets the criteria for such designations, the applicable
regulatory authority may disagree and instead determine not to make such designations. Even if we receive such designation for a product candidate, it may not result in a faster development process, review or approval compared to conventional
procedures and does not guarantee ultimate approval by the applicable regulatory authority. Many drugs that have received such designations have failed to obtain ultimate approval. In addition, the applicable regulatory authority may decide to
rescind such designations if it determines that our product candidates no longer meet the conditions for qualification, including as a result of the product candidates&#146; failure to meet endpoints in any clinical trial. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We are required to comply with comprehensive and ongoing regulatory requirements for
any product candidates that receive regulatory approval, including conducting confirmatory clinical trials of any product candidates that receive accelerated approval. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any product candidates for which we receive accelerated approval from the FDA or similar conditional approval from the EMA or comparable
regulatory authorities are required to undergo one or more confirmatory clinical trials. If such a product candidate fails to meet its safety and efficacy endpoints in such confirmatory clinical trials, the regulatory authority may withdraw its
conditional approval. There is no assurance that any such product will successfully advance through its confirmatory clinical trial(s). Therefore, even if a product candidate receives accelerated approval from the FDA or similar conditional approval
from the EMA or comparable regulatory authorities, such approval may be withdrawn at a later date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FDA, the EMA or comparable
regulatory authorities may also impose requirements for costly post-marketing studies or clinical trials and surveillance to monitor the safety or efficacy of any approved product. The FDA may also require a Risk Evaluation Mitigation Strategy
(&#147;REMS&#148;) to approve our product candidates, which could entail requirements for a medication guide, physician communication plans or additional elements to ensure safe use, such as restricted distribution methods, patient registries and
other risk minimization tools. Moreover, the FDA and comparable foreign regulatory authorities will continue to closely monitor the safety profile of any product even after approval. If the FDA or comparable foreign regulatory authorities become
aware of new safety information after approval of any of our product candidates, they may withdraw approval, require labeling changes or establishment of a REMS or similar strategy, impose significant restrictions on a product&#146;s indicated uses
or marketing, or impose ongoing requirements for potentially costly post-approval studies or post-market surveillance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, any
product candidates for which we receive regulatory approval in a particular jurisdiction and the activities associated with their commercialization, including testing, manufacture, recordkeeping, labeling, storage, approval, advertising, promotion,
sale and distribution, will be subject to comprehensive regulation by the FDA, the EMA or comparable regulatory authorities. These requirements include, without limitation, submissions of safety and other post-marketing information and reports,
registration and listing requirements, the FDA&#146;s cGMP and cGTPs requirements or comparable requirements in foreign jurisdictions, requirements relating to manufacturing, quality control, quality assurance and corresponding maintenance of
records and documents, including periodic inspections by the FDA, the EMA or comparable regulatory authorities, requirements regarding the distribution of samples to physicians, tracking and reporting of payments to physicians and other healthcare
providers and recordkeeping. In the United States, the FDA closely regulates the post-approval marketing and promotion of drugs to ensure drugs are marketed only for the approved indications and in a manner consistent with the provisions of the
approved labeling. The FDA also imposes stringent restrictions on manufacturers&#146; communications regarding use of their products and, if we promote our products beyond their approved indications or in a manner inconsistent with the approved
labeling, we may be subject to enforcement action for <FONT STYLE="white-space:nowrap">off-label</FONT> promotion. Violations of the U.S. Federal Food, Drug, and Cosmetic Act (the &#147;FDCA&#148;) relating to the promotion of prescription drugs may
lead to investigations alleging violations of federal and state healthcare fraud and abuse laws, as well as state consumer protection laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the later discovery of previously unknown problems with an approved product, including adverse events of unanticipated severity
or frequency, or with manufacturing operations or processes, or failure to comply with regulatory requirements, may result in, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">restrictions on the marketing or manufacturing of the product; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">withdrawal of the product from the market or voluntary or mandatory product recalls; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">fines, restitution or disgorgement of profits or revenues; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">warning or untitled letters; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">requirements to conduct post-marketing studies or clinical trials; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">holds on clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">refusal by the FDA, the EMA or comparable regulatory authorities to approve pending applications or supplements
to approved applications filed by us, or suspension or revocation of product license approvals; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">product seizure or detention; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">refusal to permit the import or export of products; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">injunctions or the imposition of civil or criminal penalties. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The policies of the FDA, the EMA and comparable regulatory authorities may change and additional regulations may be enacted. If we are slow or
unable to adapt to changes in existing requirements or to the adoption of new requirements, or not able to maintain regulatory compliance, we may lose any regulatory approval that may have been obtained. We cannot predict the likelihood, nature or
extent of government regulation that may arise from future legislation or administrative action, either in the United States or abroad, as the regulatory environment changes rapidly. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risk Related to the Manufacturing of Our Product Candidates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our product candidates are complex and difficult to manufacture. We could experience manufacturing problems that result in delays in our
development or commercialization programs. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our product candidates are cellular products or biologics and the process of
manufacturing our products is complex, highly regulated and subject to multiple risks. The manufacture of our cellular product candidates involves complex processes, including, for example, for ACTengine genetically modified autologous T cell
products (IMA201, IMA202, IMA203, and IMA204), harvesting and transporting blood cells from every patient for T cell isolation, engineering of the T cells to express a specific T cell receptor for a tumor target,<I> ex vivo</I> multiplying the T
cells to obtain the desired cell numbers for the dose, and finally transporting of the T cell product back to the patient for infusing the modified T cells back into the same patient. As a result of the complexities, the cost to manufacture cellular
products per dose is generally higher than traditional small molecule chemical compounds or biologics, and the manufacturing process is less reliable, more variable and is more difficult to reproduce. Our manufacturing process may be susceptible to
product loss or failure due to logistical issues associated with the collection of patients&#146; blood cells, shipping such material to the manufacturing site, shipping the final product back to the patient, and infusing the patient with the
product. Product loss or failure may also be caused by manufacturing issues associated with the variability in patient starting material especially from heavily treated cancer patients, interruptions in the manufacturing process, contamination,
equipment failure, assay failures, improper installation or operation of equipment, vendor or operator error, inconsistency in cell growth, and variability in product characteristics. Even minor deviations from normal manufacturing processes could
result in reduced production yields, product defects, and other supply disruptions. If for any reason we lose a patient&#146;s starting material, or any intermediate product at any point in the process, or if any product does not meet the preset
specifications, the manufacturing process for that patient will need to be restarted, sometimes including <FONT STYLE="white-space:nowrap">re-collection</FONT> of blood cells from the patient, and the resulting delay may adversely affect that
patient&#146;s outcome. It may even happen, that failed product manufacture may prevent a patient from getting a T cell product. If microbial, environmental or other contaminations are discovered in our product candidates or in the manufacturing
facilities in which our product candidates are made, such manufacturing facilities may need to be closed for an extended period of time to investigate and remedy the contamination. If such contaminations or other product quality issues are not
discovered and if as a result thereof patients are exposed to a health risk, we may be held liable. Our insurance may not cover those cases, or the financial coverage may not be sufficient. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because our ACTengine cellular product candidates are manufactured specifically for each individual patient, we will be required to maintain a
chain of identity with respect to the patient&#146;s cellular material as it </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
moves from the patient to the manufacturing facility, through the manufacturing process, and back to the patient. Maintaining such a chain of identity is difficult and complex, and failure to do
so could result in adverse patient outcomes, loss of product, or regulatory action including withdrawal of our products from the market. Further, as product candidates are developed through preclinical to late-stage clinical trials towards approval
and commercialization, it is common that various aspects of the development program, such as manufacturing methods, are altered along the way to optimize processes and results. Such changes carry the risk that they will not achieve these intended
objectives, and any of these changes could cause our product candidates to perform differently and affect the results of planned clinical trials or other future clinical trials or otherwise necessitate the conduct of additional studies, including
bridging clinical trials, which can be costly and time-consuming. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Currently, our cellular product candidates are manufactured using
processes developed or modified by us but based on current industry standards and are designed to deliver a clinical proof of concept (&#147;PoC&#148;). We have selected an open process as the manufacturing process for early-stage clinical trials
through PoC. However, we are currently developing a second-generation process that is closed, partially automated and viable for advanced clinical trials through product registration, and all ongoing and future company-sponsored clinical trials.
Although we believe that the second-generation process is commercially viable, there are risks associated with scaling to the level required for advanced clinical trials or commercialization, including, among others, cost overruns, potential
problems with process upscaling, <FONT STYLE="white-space:nowrap">scale-out,</FONT> process reproducibility, technology transfer, stability issues, lot consistency, and timely availability of raw materials. This includes potential risks associated
with FDA not agreeing with all of the details of our validation data or our potency assay for our Phase 1 or future Phase 2 clinical trials. Furthermore, some of our CMOs may not be able to establish comparability of their products with the ACT
products used in our Phase 1 or future Phase 2 clinical trials or may not be fully validated prior to starting our pivotal or registration clinical trial. As a result of these challenges, we may experience delays in our clinical development and/or
commercialization plans. We may ultimately be unable to reduce the cost of goods for our product candidates to levels that will allow for an attractive return on investment if and when those product candidates are commercialized. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our manufacturing capabilities for our allogenic cellular therapy product candidate IMA301 are still in the process of being developed. We may
not successfully establish a robust production process that fulfills the requirements of the FDA, the EMA and comparable regulatory authorities. If we fail to establish such a manufacturing process, we may not be able to commence clinical trials in
IMA301 or clinical trials may be delayed. There can be no assurance that the production process we are currently developing for IMA301 is viable and can be effectively scaled up or transferred to a CMO for later-phase clinical testing and
commercialization. For example, there is insufficient experience in the field regarding vectors for transduction of the T cells used to manufacture IMA301. If it turns out that we cannot generate a suitable and cGMP-compliant vector, the IMA301
manufacturing process may be endangered. If we fail to develop a process that can be used throughout the life cycle of the product candidate, commercialization of IMA301 may be delayed or may not occur. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Manufacturing of TCR Bispecifics (TCER), such as IMA401, IMA402 and potential future product candidates, is susceptible to product loss due to
contamination, equipment failure or improper installation or operation of equipment, vendor or operator error, inconsistency in yields, issues with purity, variability in product characteristics and difficulties in scaling the production process.
Even minor deviations from normal manufacturing processes could result in reduced production yields, inacceptable purity, product defects, loss of production batches and other supply disruptions. In such cases, our development program may experience
major delays and we may have to produce a new batch of a given TCER. This will be costly and will delay our TCER development program. In particular, production of a new cGMP batch may be time-consuming, as it relies on the availability of facilities
with cGMP capabilities at our CMO, and such facilities must be booked far in advance. We may also experience failure of production of the master cell bank that is used to produce our TCER molecules. For example, missing clonality of the cell line or
<FONT STYLE="white-space:nowrap">non-sterility</FONT> of the cell bank may require production of a new master cell bank which would be associated with additional costs and delays. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any failure to follow cGMP and cGTP or other regulatory requirements or any delay, interruption or other issues that arise in the manufacture,
fill and finish, packaging, or storage of our product candidates as a result of a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
failure of our facilities or the facilities or operations of third parties to comply with regulatory requirements or pass any regulatory authority inspection could significantly impair our
ability to develop and commercialize our product candidates, including leading to significant delays in the availability of drug product for our clinical trials or the termination of or hold on a clinical trial, or the delay or prevention of a
filing or approval of marketing applications for our product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our TCR Bispecific product candidates that have been produced
and are stored for later use may degrade, become contaminated or suffer other quality defects, which may cause the affected product candidates to no longer be suitable for their intended use in clinical trials or other development activities. If the
defective product candidates cannot be replaced in a timely fashion, we may incur significant delays in our development programs that could adversely affect the value of such product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In September 2015, we entered into a lease agreement with the University of Texas Health (&#147;UTH&#148;) facility in Houston, Texas for
clinical production of ACT products, including our product candidates IMA201, IMA202, and IMA203 for clinical trials, and we also intend to manufacture IMA204, IMA301 and potentially also future cellular therapy product candidates in this facility
once INDs or CTAs have been approved for these product candidates, especially for early-stage clinical trials, by the respective regulatory bodies. We would expect that development and construction of our own manufacturing facility would provide us
with enhanced control of material supply for both clinical trials and the commercial market, enable a more efficient implementation of process changes, and allow for better long-term margins. However, we have no experience as a company in developing
a large manufacturing facility, and we may not be successful in finalizing the development of our own manufacturing facility or capability. We may establish multiple manufacturing facilities as we expand our commercial footprint to multiple
geographies, which may lead to regulatory delays or prove costly. Even if we are successful, our manufacturing capabilities could be affected by cost overruns due to idle capacity, unexpected delays, equipment failures, labor shortages, natural
disasters, epidemics, power failures, and numerous other factors that could prevent us from realizing the intended benefits of our manufacturing strategy and have a material adverse effect on our business. The manufacture of cell therapy products
requires significant expertise and capital investment, including the development of advanced manufacturing techniques and process controls. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Manufacturers of cell therapy products often encounter difficulties in production, particularly in scaling up initial production. These
problems include difficulties with production costs and yields, quality control, including stability, patient to patient variability of the product candidate and quality assurance testing, shortages of qualified personnel, and compliance with
strictly enforced federal, state, local and foreign regulations. Any problems or delays we or our CMOs experience in preparing for commercial scale manufacturing of a cell therapy or biologic product candidate or component may result in a delay in
the regulatory approval of the product candidate or may impair our ability to manufacture commercial quantities or such quantities at an acceptable cost, which could result in the delay, prevention, or impairment of clinical development and
commercialization of our product candidates and could adversely affect our business. Furthermore, if we or our commercial manufacturers fail to deliver the required commercial quantities or supply of our product candidates on a timely basis and at
reasonable costs, we would likely be unable to meet demand for our products, and we would lose potential revenues. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the
manufacturing process and facilities for any products that we may develop is subject to FDA, the EMA and comparable regulatory authority approval processes, and we and our CMOs will need to meet all applicable regulatory authority requirements,
including cGMP and cGTP requirements, on an ongoing basis, including requirements pertaining to quality control, quality assurance, and the maintenance of records and documentation. The FDA, the EMA and comparable regulatory authorities enforce
these requirements through facility inspections. Manufacturing facilities must be approved by the FDA pursuant to inspections that will be conducted after we submit our marketing applications. Manufacturers are also subject to continuing FDA, the
EMA and comparable regulatory authority inspections following marketing approval. Further, we, in cooperation with our CMOs, must supply all necessary chemistry, manufacturing, and control documentation in support of a BLA on a timely basis. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We, or our CMOs&#146; manufacturing facilities, may be unable to comply with our
specifications, cGMP and cGTP requirements, and with other regulatory requirements. Poor control of production processes can lead to the introduction of adventitious agents or other contaminants, or to inadvertent changes in the properties or
stability of product candidates that may not be detectable in final product testing. If we or our CMOs are unable to reliably produce products to specifications acceptable to the FDA, the EMA or comparable regulatory authorities, or in accordance
with the strict regulatory requirements, we may not obtain or maintain the approvals we need to commercialize such products. Even if we obtain regulatory approval for any of our product candidates, there can be no assurance that either we or our
CMOs will be able to manufacture the approved product to specifications acceptable to the FDA, the EMA or comparable regulatory authorities, to produce it in sufficient quantities to meet the requirements for the potential launch of the product, or
to meet potential future demand. Deviations from manufacturing requirements may further require remedial measures that may be costly and/or time-consuming for us or a third party to implement and may include the temporary or permanent suspension of
a clinical trial or commercial sales or the temporary or permanent closure of a facility. Any such remedial measures imposed upon us or third parties with whom we contract could materially harm our business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even to the extent we use and continue to use CMOs, we are ultimately responsible for the manufacture of our products and product candidates.
A failure to comply with these requirements may result in regulatory enforcement actions against our manufacturers or us, including fines and civil and criminal penalties, which could result in imprisonment, suspension or restrictions of production,
suspension, injunctions, delay or denial of product approval or supplements to approved products, clinical holds or termination of clinical trials, warning or untitled letters, regulatory authority communications warning the public about safety
issues with the biologic, refusal to permit the import or export of the products, product seizure, detention, or recall, operating restrictions, suits under the civil False Claims Act (&#147;FCA&#148;), corporate integrity agreements, consent
decrees, or withdrawal of product approval. Challenges we may face could delay completion of clinical trials, require bridging clinical trials or the repetition of one or more clinical trials, increase clinical trial costs, delay approval of our
product candidates, impair commercialization efforts, increase our cost of goods, cause a lack of patient participation in clinical trials and have an adverse effect on our business, financial condition, results of operations and prospects. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>If we decide to operate our own manufacturing facility for our ACT product candidates in late-stage clinical testing and for our
marketed products, which would require significant resources, we may fail to successfully operate our facility, which could adversely affect our clinical trials and the commercial viability of our product candidates. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Currently, we have no immediate plans to operate our own manufacturing facility for our product candidates in late-stage clinical testing or
for our marketed products. However, we may not be able to achieve clinical or commercial manufacturing and cell processing at a scale to satisfy demands for late-stage clinical trials or commercialization on our own or with a CMO and thus may decide
to operate a manufacturing facility for our product candidates. While we believe the manufacturing and processing approaches are appropriate to support our clinical product development, we have limited experience in managing a large-scale
manufacturing facility. We cannot be sure that the manufacturing processes we employ or the technologies that we incorporate for manufacturing will result in TCR-T cell product candidates suitable for clinical trials or commercialization. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have exclusive access to the early-stage facility at UTH designed for the manufacturing of cellular products comprised of three fully
functional cGMP suites and support areas where our hired and trained personnel perform all manufacturing related activities. The current lease extends through the end of 2024. In case the lease is not extended, we may decide to build our own
manufacturing facility. There can be no assurance that we will complete the build-out of our manufacturing facility in a timely manner, or at all. We also do not yet have sufficient information to reliably estimate the cost of the clinical and
commercial manufacturing and processing of our product candidates, and the actual cost to manufacture and process our product candidates could materially and adversely affect the commercial viability of our product candidates. In addition, the
ultimate clinical and any commercial dose will affect our ability to scale our costs per dose. As a result, we may never be able to develop a commercially viable product. The commercial manufacturing facility we may build will also require
regulatory approval, including from FDA, which we may never obtain. Even if approved, we would be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
subject to ongoing periodic unannounced inspection by the FDA or authorities from other jurisdictions, the Drug Enforcement Administration and corresponding state agencies to ensure strict
compliance with cGMP and cGTP requirements, and other government regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we were to decide in the future to own and operate a
manufacturing facility, the designing and building process would be time-consuming, expensive, and we may not realize the benefit of this investment. As a manufacturer of pharmaceutical products, we are required to demonstrate and maintain
compliance with cGMP and cGTP requirements, which include requirements related to production processes, quality control and assurance and recordkeeping. Furthermore, establishing and maintaining manufacturing operations requires a reallocation of
other resources, particularly the time and attention of certain of our senior management. Any failure or delay in our manufacturing capabilities could adversely impact the clinical development or commercialization of our or our collaborators&#146;
product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The manufacture of biopharmaceutical products, especially of those cellular in nature like our ACT product
candidates, is complex and requires significant expertise, including the development of advanced manufacturing techniques and process controls. Manufacturers of cell therapy products often encounter difficulties in production, particularly in
scaling up and validating initial production and ensuring the absence of contamination. These problems include difficulties with production costs and yields, quality control, including stability of the product, quality assurance testing, operator
error, shortages of qualified personnel, as well as compliance with strictly enforced federal, state and foreign regulations. The application of new regulatory guidelines or parameters, such as those related to release testing, may also adversely
affect our ability to manufacture our product candidates. Furthermore, if contaminants are discovered in our supply of product candidates or in the manufacturing facilities, such manufacturing facilities may need to be closed for an extended period
of time to investigate and remedy the contamination. We cannot assure that any stability or other issues relating to the manufacture of our product candidates will not occur in the future. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We or any of our CMOs may fail to manage the logistics of storing and shipping our raw materials and product candidates. Storage failures and
shipment delays and problems caused by us, our vendors or other factors not in our control, such as weather, could result in the inability to manufacture product, the loss of usable product or prevent or delay the delivery of product candidates to
patients. We may also experience manufacturing difficulties due to resource constraints or as a result of labor disputes. If we were to encounter any of these difficulties, our ability to provide our product candidates to patients would be
jeopardized. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We have limited experience in large-scale or commercial manufacturing, and there can be no assurance that we will be
able to effectively manufacture clinical or commercial quantities of our products. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In September 2015, we entered into a
collaboration agreement with UTH to gain exclusive access to a cGMP facility specialized in the manufacturing of cellular products. This facility is used exclusively for the manufacturing of our product candidates by our hired and trained personnel.
Although some of our employees have experience in the manufacturing of pharmaceutical products from prior employment at other companies, we as a company do not have experience in large-scale or commercial manufacturing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may not succeed in scaling up our production processes for ACT and/or biologics for pivotal trials and/or commercial supply. We may need a
larger scale manufacturing process for any TCR Bispecifics molecule than we have planned, depending on the dose and regimen that is to be determined in our Phase 1 and future Phase 2 studies. Any changes in our manufacturing processes, including
those utilized by our CMOs, as a result of scaling up may result in the need to obtain additional regulatory approvals. Difficulties in achieving commercial-scale production or the need for additional regulatory approvals could delay the development
and regulatory approval of our product candidates and ultimately affect our success. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to the Commercialization of Our Product Candidates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>As a company, we have never commercialized a product. We currently have no active sales force or commercial infrastructure. We may lack
the necessary expertise, personnel and resources to successfully commercialize our product candidates. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently have no active
sales force or commercial infrastructure. As a company, we have never commercialized a product for any indication. Even if we receive regulatory approval for one or more of our product candidates from the FDA, the EMA or comparable regulatory
authorities, we will need to develop robust internal sales, marketing and distribution capabilities to commercialize such products, which will be expensive and time-consuming, or enter into collaborations with third parties to perform these
services. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are costs and risks involved with establishing our own sales, marketing and distribution capabilities. For example,
recruiting and training a sales force is expensive and time-consuming and could delay any product launch. If the commercial launch of a product candidate for which we recruit a sales force and establish marketing capabilities is delayed or does not
occur for any reason, we would have prematurely or unnecessarily incurred these commercialization expenses. This may be costly, and our investment would be lost if we cannot retain or reposition our sales and marketing personnel. We must also
compete with other biotechnology companies to recruit, hire, train and retain marketing and sales personnel. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Alternatively, we may wish
to establish collaborations with third parties to maximize the potential of our product candidates jurisdictions in which a product candidate has been approved. The biotechnology industry is characterized by intense competition. Therefore, we may
not be successful in entering into such commercialization arrangements with third parties on favorable terms, or at all. In addition, we may have limited control over such third parties, and any of them may fail to devote the necessary resources and
attention to sell, market and distribute our products effectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There can be no assurance that we will be able to develop the
necessary commercial infrastructure and capabilities to successfully commercialize our product candidates or be able to establish or maintain relationships with third parties necessary to perform these services. As a result, we may not successfully
commercialize any product in any jurisdiction. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our commercial success depends upon attaining significant market acceptance of our
product candidates, if approved, among physicians, patients, patient advocacy groups, third-party payors and the medical community. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we obtain regulatory approval for any of our current or future product candidates, that product candidate may nevertheless not gain
sufficient market acceptance among physicians, patients, patient advocacy groups, third-party payors and the medical community. For example, they may prefer current, well-established cancer treatments, such as chemotherapy and radiation therapy, to
the exclusion of our product candidates or may prefer other novel product candidates rather than our product candidates. Efforts to educate physicians, patients, patient advocacy groups and third-party payors on the benefits of our product
candidates may require significant resources and may not be successful. If our product candidates do not achieve an adequate level of acceptance, we may not generate significant product revenues and may not receive a satisfactory return on our
investment into the research and development of those product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Market acceptance of our product candidates is heavily
dependent on patients&#146; and physicians&#146; perceptions that our product candidates are safe and effective treatments. The perceptions of any product are influenced by perceptions of competitors&#146; products that are in the same class or that
have a similar mechanism of action. As a result, adverse public perception of our competitors&#146; products may negatively impact the market acceptance of our product candidates. If any approved products are not accepted by the market to the extent
that we expect, we may not be able to generate significant product revenues and may not become or remain profitable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>The market
opportunities for our product candidates may be smaller than we estimate. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our projections of both the number of people who have
the cancers we are targeting, as well as the subset of people with these cancers who are in a position to receive our product candidates, and who have the potential to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
benefit from treatment with our product candidates, are based on our beliefs and estimates that have been derived from a variety of sources, including scientific literature, surveys of clinics,
patient foundations, or market research by third parties, and may prove to be incorrect. These estimates may be inaccurate or based on imprecise data. We do not have verifiable internal marketing data regarding the potential size of the commercial
market for our product candidates, nor have we obtained current independent marketing surveys to verify the potential size of the commercial markets for our current product candidates or any future product candidates. Since our current product
candidates and any future product candidates will represent novel approaches to treating various conditions, it may be difficult, in any event, to accurately estimate the potential revenues from these product candidates. The number of patients in
the addressable markets may turn out to be lower than expected, patients may not be otherwise amenable to treatment with our product candidates or new patients may become increasingly difficult to identify or gain access to, all of which could
materially adversely affect our business, financial condition, results of operations and prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>For any product candidates
developed in combination with other therapies, regulatory approval, safety or supply issues with these other therapies may delay or prevent the development and approval of our product candidates. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For any product candidates developed for use in combination with an approved therapy, we are subject to the risk that the FDA, the EMA or
comparable regulatory authorities could revoke approval of, or that safety, efficacy, manufacturing or supply issues could arise with, the therapy used in combination with our product candidate. If the therapies we use in combination with our
product candidates are replaced as the standard of care, the FDA, the EMA or comparable regulatory authorities may require us to conduct additional clinical trials. The occurrence of any of these risks could result in our product candidates, if
approved, being removed from the market or being less successful commercially. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For any product candidates developed for us in combination
with a therapy that has not been approved by the FDA, the EMA or comparable regulatory authorities, we may not be able to market our product candidate for use in combination with such an unapproved therapy, unless and until the unapproved therapy
receives regulatory approval. These unapproved therapies face the same risks described with respect to our product candidates currently in development, including serious adverse effects and delays in their clinical trials. In addition, other
companies may also develop their products or product candidates in combination with the unapproved therapies with which we are developing our product candidates for use in combination. Any setbacks in these companies&#146; clinical trials, including
the emergence of serious adverse effects, may delay or prevent the development and approval of our product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the FDA, the
EMA or comparable regulatory authorities do not approve or revoke their approval of, or if safety, efficacy, manufacturing, or supply issues arise with, therapies we choose to evaluate in combination with any of our product candidates, we may be
unable to obtain regulatory approval of or to commercialize such product candidates in combination with these therapies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Coverage
and reimbursement may be limited or unavailable for our product candidates, which could make it difficult to sell our products profitably. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The availability and extent of coverage and adequate reimbursement by governmental and private third-party payors are essential for most
patients to be able to afford expensive medical treatments. In both domestic and foreign markets, sales of our product candidates will depend substantially on the extent to which the costs of our product candidates will be covered by third-party
payors, such as government health programs, commercial insurance and managed healthcare organizations. These third-party payors decide which products will be covered and establish reimbursement levels for those products. We cannot be certain that
coverage and adequate reimbursement will be available for any of our product candidates, if approved, or that reimbursement policies will not reduce the demand for any of our product candidates, if approved. If coverage and adequate
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
reimbursement are not available, or are available only to limited levels, we may not be able to successfully commercialize our product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Obtaining coverage approval and reimbursement for a product from a government or other third-party payor is a time-consuming and costly
process that could require us to provide supporting scientific, clinical and cost-effectiveness data for the use of our products to the payor. We may not be able to provide data sufficient to gain acceptance with respect to coverage and
reimbursement at a satisfactory level. If coverage and adequate reimbursement of our future products, if any, are unavailable or limited in scope or amount, such as may result where alternative or generic treatments are available, we may be unable
to achieve or sustain profitability. Adverse coverage and reimbursement limitations may hinder our ability to recoup our investment in our product candidates, even if such product candidates obtain regulatory approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our ACT product candidate may be provided to patients in combination with other agents provided by third parties. The cost of such combination
therapy may increase the overall cost of ACT therapy and may result in issues regarding the allocation of reimbursements between our therapy and the other agents, all of which may affect our ability to obtain reimbursement coverage for the
combination therapy from third-party medical insurers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, the containment of healthcare costs has become a priority of foreign
and domestic governments as well as private third-party payors. The prices of drugs have been a focus in this effort. Governments and private third-party payors have attempted to control costs by limiting coverage and the amount of reimbursement for
particular medications, which could affect our ability to sell our product candidates profitably. We also expect to experience pricing pressures due to the trend towards managed healthcare, the increasing influence of health maintenance
organizations and additional legislative changes. These and other cost-control initiatives could cause us to decrease the price we might establish for products, which could result in lower-than-anticipated product revenues. In addition, the
publication of discounts by third-party payors or authorities may lead to further pressure on the prices or reimbursement levels within the country of publication and other countries. If pricing is set at unsatisfactory levels or if coverage and
adequate reimbursement of our products is unavailable or limited in scope or amount, our revenues and the potential profitability of our product candidates in those countries would be negatively affected. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Healthcare reform legislation and other changes in the healthcare industry and in healthcare spending may adversely affect our business
model. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our revenue prospects could be affected by changes in healthcare spending and policies in the United States, the European
Union and any other potential jurisdictions we may seek to commercialize our product candidates, if approved. We operate in a highly regulated industry, and new laws, regulations and judicial decisions, or new interpretations of existing laws,
regulations and decisions, related to healthcare availability, the method of delivery and payment for healthcare products and services could negatively affect our business, financial condition and prospects. There is significant interest in
promoting healthcare reforms, and it is likely that federal and state legislatures within the United States and the governments of other countries will continue to consider changes to existing healthcare legislation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, there have been and continue to be a number of initiatives at the United States federal and state levels that seek to reduce
healthcare costs. Any significant spending reductions affecting Medicare, Medicaid or other publicly funded or subsidized health programs that may be implemented, or any significant taxes or fees that may be imposed on us, as part of any broader
healthcare cost reduction effort, could have an adverse impact on our anticipated product revenues. In addition, regional healthcare authorities and individual hospitals are increasingly using bidding procedures to determine what pharmaceutical
products and which suppliers will be included in their prescription drug and other healthcare programs. We expect that additional state and federal healthcare reform measures will be adopted in the future. Any adopted health reform measure could
reduce the ultimate demand for our products, if approved, or put pressure on our product pricing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Relationships with Third Parties </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We rely on third parties to conduct preclinical studies and/or clinical trials of our product candidates. If they do not properly and
successfully perform their obligations to us, we may not be able to obtain regulatory approvals for our product candidates. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
currently, and we expect that we will continue to, rely on independent clinical investigators and CROs to conduct our clinical trials. CROs may also assist us in the collection and analysis of data. As a result of our reliance on these third
parties, we have less direct control over the conduct, timing and completion of these clinical trials and the management of data developed through clinical trials than we would otherwise have if we relied entirely upon our own staff. These third
parties are not our employees and we have limited control over the amount of time and resources that they dedicate to our product candidates. In addition, communications with outside parties can also be challenging, potentially leading to mistakes
as well as difficulties in coordinating activities. Outside parties may: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">have staffing difficulties; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">fail to comply with contractual obligations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">experience regulatory compliance issues; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">undergo changes in priorities or become financially distressed; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">form relationships with other entities, some of which may be our competitors. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If these third parties do not successfully carry out their duties under their agreements, or if the quality or accuracy of the data they
obtain is compromised due to their failure to adhere to clinical trial protocols or to regulatory requirements, or if they otherwise fail to comply with clinical trial protocols or meet expected deadlines, the clinical trials of our product
candidates may not meet regulatory requirements. Specifically, the FDA, the EMA and comparable regulatory authorities require compliance with regulations and standards, including GCP, for designing, conducting, monitoring, recording, analyzing and
reporting the results of clinical trials to assure that the data and results are credible and accurate and that the rights, integrity and confidentiality of study participants are protected. Although we rely, and intend to continue to rely, on third
parties to conduct our clinical trials, they are not our employees, and we are responsible for ensuring that each of these clinical trials is conducted in accordance with its general investigational plan, protocol, legal and regulatory requirements
and scientific standards. Our reliance on these third parties for research and development activities will reduce our control over these activities, but will not relieve us of our responsibilities. If our third-party research and development
partners fail to comply with applicable GCPs or other regulatory requirements, the clinical data generated in our clinical trials may be deemed unreliable and preclinical development activities or clinical trials may be extended, delayed, suspended
or terminated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We compete with many other companies for the resources of these third parties. These third parties may have contractual
relationships with other entities, some of which may be our competitors, which may draw time and resources from our product candidates. The third parties with whom we contract might not be diligent, careful or timely in conducting our preclinical
studies or clinical trials, resulting in the preclinical studies or clinical trials being delayed or unsuccessful. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any of our
relationships with any third-party research and development partner terminates its relationship with us, we may not be able to enter into arrangements with alternative third-party research and development partners or to do so on commercially
reasonable terms. Switching or adding additional third-party research and development partners involves additional cost and requires management time and focus. In addition, there is a natural transition period when a new third-party research and
development partner commences work. As a result, delays may occur in our clinical trials, which can materially impact our ability to meet our desired clinical development timelines. There can be no assurance that we will not encounter challenges or
delays in the future or that these delays or challenges will not have a material adverse impact on our business, results of operations, financial condition and prospects. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We rely on third parties to obtain reagents and raw materials. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The manufacture of our product candidates by us or any of our CMOs requires access to a number of reagents and other critical raw materials
from third-party suppliers. Such third parties may refuse to supply such reagents or other raw materials or alternatively refuse to supply on commercially reasonable terms. There may also be capacity issues at such third-party suppliers that impact
our ability to increase production of our product candidates. Some of the materials used in the manufacture and processing of our product candidates may only be supplied by one or a few vendors, which means that, should those vendors be unable to
supply, for whatever reason, our ability to manufacture product candidates and progress product candidates through clinical trials could be severely impacted and result in additional delays. Such failure to supply could also impact other supply
relationships with other third parties and potentially result in additional payments being made or required in relation to such delays. In addition, where any raw material or precursor material (including, for example, lentiviral vector, cell
culture medium, chromatographic column material or other essential raw material) is currently supplied by one or a few vendors, replacing such raw material or precursor or finding alternative vendors may not be possible or may significantly impact
on the timescales for manufacture and supply of our product candidates. Even where alternative materials or precursors or alternative vendors are identified, such alternative materials, precursors or vendors and their materials will need to be
properly assessed and qualified and additional regulatory approvals may also need to be obtained all of which could result in significant delays to the supply of our product candidates or an inability to supply product candidates within anticipated
timescales, if at all. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We rely on third parties for the manufacture of our product candidates. Our dependence on these third
parties may impair the clinical advancement and commercialization of our product candidates. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Currently, our ACT product candidates are
manufactured by our personnel at the UTH facility. We expect to continue to manufacture product candidates for early-phase trials using our personnel at the UTH facility; but we are currently negotiating contracts with larger CMOs with experience in
cell therapy development and manufacturing to manufacture our products for late-stage clinical trials, including any pivotal trials. The process will involve the development of a given manufacturing process in house using our personnel followed by
technology transfer of each manufacturing process to the CMO. Our manufacturing strategy for TCER includes CMOs for cell line development, process development, formulation development, cGMP manufacturing, analytics, release testing, fill and finish,
packaging and storage. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Reliance on third-party providers may expose us to different risks than if we were to manufacture and supply
product candidates ourselves. The facilities used by our CMOs or other third-party manufacturers to manufacture our product candidates must be approved by the EMA and comparable regulatory authorities, and the FDA requires our CMOs or other
third-party manufacturers to maintain a compliance status acceptable to the FDA, pursuant to inspections that will be conducted after we submit the marketing application to the applicable regulatory authorities. Although we have auditing rights with
all our manufacturing counterparties, we do not have control over a supplier&#146;s or manufacturer&#146;s compliance with these laws, regulations, applicable cGMP and cGTP standards and other laws and regulations, such as those related to
environmental health and safety matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If our CMOs or other third-party manufacturers cannot successfully manufacture material that
conforms to our specifications and the strict regulatory requirements of the FDA, the EMA and comparable regulatory authorities, or if the quality or accuracy of the manufacturing and quality control data they obtain is compromised due to their
failure to adhere to protocols or to regulatory requirements, we will not be able to secure and/or maintain regulatory approval for our product candidates. In addition, we have no control over the ability of our CMOs or other third-party
manufacturers to maintain adequate quality control, quality assurance and qualified personnel. If a CMO or other third-party manufacturer cannot maintain a compliance status acceptable to the FDA, or if the EMA or a comparable regulatory authority
does not approve these facilities for the manufacture of our product candidates or if it withdraws any such approval in the future, we may need to find alternative manufacturing facilities, which would significantly impact our ability to develop,
obtain regulatory approval for or market our product candidates, if approved. Any failure to achieve and maintain compliance with these laws, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
regulations and standards could subject us to the risk that we may have to suspend the manufacturing of our product candidates and that obtained approvals could be revoked, which would adversely
affect our business and reputation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Establishing additional or replacement CMOs could take a substantial amount of time and it may be
difficult to establish replacement CMOs who meet regulatory requirements. There are a limited number of manufacturers that operate under cGMP and, for cellular products, also under cGTP regulations and that are both capable of manufacturing for us
and willing to do so. In addition, there are limited CMOs specialized in the manufacturing of cellular therapy products. If we have to switch to a replacement CMO, the manufacture and delivery of our product candidates could be interrupted for an
extended period, which could adversely affect our business. If we are able to find a replacement CMO, the replacement CMO would need to be qualified and may require additional regulatory authority approval, which could result in further delay
regulatory approval and commercialization of our product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, third-party providers may breach, terminate or decline
to renew agreements they have with us because of factors beyond our control, such as their own financial difficulties or business priorities, international trade restrictions and financial costs, potentially at a time that is costly or otherwise
inconvenient for us or our partners. In such cases, we would face the challenge of transferring complicated manufacturing techniques to other CMOs. We may incur significant costs and be required to devote significant time to verify that the new
manufacturer maintains facilities and procedures that comply with quality standards and with all applicable regulations and guidelines. A transfer of the manufacturing process for our product candidates would be time-consuming, and we or our
partners may not be able to achieve such transfer. If we are unable to find an adequate replacement or another acceptable solution in time, clinical trials of our product candidates could be delayed or our commercial activities could be harmed. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Failure of third-party contractors to successfully develop and commercialize companion diagnostics for use with our product candidates
could harm our ability to commercialize our product candidates. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We plan to develop companion diagnostics for our product
candidates where appropriate. Such developments are expensive and time-consuming. The FDA, the EMA and comparable regulatory authorities may request or require the development and regulatory approval of a companion diagnostic as a condition to
approving one or more of our product candidates. We do not have experience or capabilities in developing, seeking regulatory approval for or commercializing diagnostics and plan to rely in large part on third parties to perform these functions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will likely outsource the development, production and commercialization of companion diagnostics to third parties. By outsourcing these
companion diagnostics to third parties, we become dependent on the efforts of our third-party contractors to successfully develop and commercialize these companion diagnostics. Our contractors: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">may not perform their obligations as expected; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">may encounter production difficulties that could constrain the supply of the companion diagnostic;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">may encounter difficulties in obtaining regulatory approval; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">may have difficulties gaining acceptance of the use of the companion diagnostic in the clinical community;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">may not commit sufficient resources to the marketing and distribution of such product; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">may terminate their relationship with us. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We collaborate with third parties in the research, development and commercialization
of certain of our product candidates and may enter into other collaborations in the future for our other product candidates. If our collaborators do not perform as expected or if we are unable to maintain existing or establish additional
collaborations, our ability to develop and commercialize our product candidates may be adversely affected. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From time to time, we
may enter into collaboration agreements with third parties that have experience in product development, manufacturing and/or commercialization for other product candidates and/or research programs. We may face significant competition in seeking
appropriate partners for our product candidates, and the negotiation process may be time-consuming and complex. In order for us to successfully partner our product candidates, potential collaborators must view these product candidates as
economically valuable in markets they determine to be attractive in light of the terms that we are seeking and other available products for licensing by other companies. Even if we are successful in our efforts to establish collaborations, the terms
that we agree upon may not be favorable to us, and we may not be able to maintain such collaborations if, for example, development or approval of a product candidate is delayed or sales of an approved product are disappointing. If we fail to
establish and maintain collaborations related to our product candidates, we could bear all of the risk and costs related to the development of any such product candidate, and we may need to seek additional financing, hire additional employees and
otherwise develop expertise for which we have not budgeted. This could negatively affect the development and commercialization of our product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have collaboration and license agreements with, for example, MD Anderson, Amgen, Genmab, Celgene Corporation, a Bristol-Myers Squibb
Company (&#147;BMS&#148;), and GlaxoSmithKline (&#147;GSK&#148;). These collaborations have also provided us with important funding for our development programs and technology platforms, and we expect to receive additional funding under these
collaborations in the future. If our therapeutic collaborations do not result in the successful development and commercialization of products or if one of our collaborators terminates its agreement with us, we may not receive any future research
funding or milestone or royalty payments under the collaboration. For example, our collaboration agreement with <FONT STYLE="white-space:nowrap">Hoffmann-La</FONT> Roche Ltd and <FONT STYLE="white-space:nowrap">Hoffmann-La</FONT> Roche Inc. was
terminated in 2020 and our collaboration agreement with MorphoSys AG was terminated in 2021. As a result, we will not receive any future milestone or royalty payments under these collaborations. In addition, any termination of an agreement by the
relevant collaborators could affect our ability to develop further such product candidates or adversely affect how we are perceived in scientific and financial communities. All of the risks relating to product development, regulatory approval and
commercialization described in this Annual Report also apply to the activities of our program collaborators. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In such collaborations, we
will depend on the performance of our collaborators. Our collaborators may fail to perform their obligations under the collaboration agreements or may not perform their obligations in a timely manner. If conflicts arise between our collaborators and
us, the other party may act in a manner adverse to us and could limit our ability to implement our strategies. Furthermore, our collaborators may not properly obtain, maintain, enforce or defend our intellectual property or proprietary rights or may
use our proprietary information in such a way as to invite litigation that could jeopardize or invalidate our proprietary information or expose us to potential litigation. In addition, we cannot control the amount and timing of resources our
collaborators may devote to our product candidates. They may separately pursue competing products, therapeutic approaches or technologies to develop treatments for the diseases targeted by us. Competing products, either developed by the
collaborators or to which the collaborators have rights, may result in the withdrawal of support for our product candidates. Even if our collaborators continue their contributions to the strategic collaborations, they may nevertheless determine not
to actively pursue the development or commercialization of any resulting products. Additionally, if our collaborators pursue different clinical or regulatory strategies with their product candidates based on similar technology as used in our product
candidates, adverse events with their product candidates could negatively affect our product candidates. Any of these developments could harm our product development efforts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If our collaborators terminate or breach our agreements with them, or otherwise fail to complete their obligations in a timely manner, it may
have a detrimental effect on our financial position by reducing or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
eliminating the potential for us to receive technology access and license fees, milestones and royalties, reimbursement of development costs, as well as possibly requiring us to devote additional
efforts and incur costs associated with pursuing internal development of product candidates. Furthermore, if our collaborators do not prioritize and commit sufficient resources to our product candidates, we or our partners may be unable to develop
or commercialize these product candidates, which would limit our ability to generate revenue and become profitable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We may form or
seek strategic alliances or enter into additional licensing arrangements in the future, and we may not realize the benefits of such alliances or licensing arrangements. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may form or seek strategic alliances, create joint ventures or collaborations or enter into additional licensing arrangements with third
parties that we believe will complement or augment our development and commercialization efforts with respect to our product candidates and any future product candidates that we may develop. Additionally, although we intend to develop product
candidates through our own internal research, we may need to obtain additional licenses from others to advance our research or allow commercialization of our product candidates and it is possible that we may be unable to obtain additional licenses
at a reasonable cost or on reasonable terms, if at all. Any of these relationships may require us to incur <FONT STYLE="white-space:nowrap">non-recurring</FONT> and other charges, increase our near and long-term expenditures, issue securities that
dilute our existing shareholders or disrupt our management and business. In addition, we face significant competition in seeking appropriate strategic collaborations and licenses and the negotiation process is time-consuming and complex. We may also
be unable to identify product candidates that we believe are an appropriate strategic fit for our company and intellectual property relating to, or necessary for, such product candidates. The <FONT STYLE="white-space:nowrap">in-licensing</FONT> and
acquisition of third-party intellectual property is a competitive area, and a number of more established companies are also pursuing strategies to <FONT STYLE="white-space:nowrap">in-license</FONT> or acquire third-party intellectual property rights
that we may consider attractive or necessary. These established companies may have a competitive advantage over us due to their size, cash resources and greater clinical development and commercialization capabilities. Furthermore, companies that
perceive us to be a competitor may be unwilling to assign or license rights to us. We also may not be successful in our efforts to establish strategic collaborations or other alternative arrangements for our product candidates because they may be
deemed to be at too early a stage of development for collaborative effort and third parties may not view our product candidates as having the requisite potential to demonstrate safety and efficacy. Any delays in entering into new strategic
collaboration agreements related to our product candidates could delay the development and commercialization of our product candidates in certain geographies for certain indications, which would harm our business prospects, financial condition and
results of operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We depend on intellectual property licensed from third parties and termination of any of these licenses
could result in the loss of significant rights, which would harm our business. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are dependent or may depend in the future on
patents, <FONT STYLE="white-space:nowrap">know-how</FONT> and proprietary technology, both our own and licensed from others. We may also enter into additional license agreements that are material to the development of our product candidates. Our
current license agreements impose, and future agreements may impose, various development, diligence, commercialization and other obligations on us and require us to meet development timelines, or to exercise commercially reasonable efforts to
develop and commercialize licensed products, in order to maintain the licenses. Disputes may arise between us and our licensors and licensees regarding intellectual property subject to a license agreement, including those related to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the scope of rights granted under the license agreement and other interpretation-related issues;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether and the extent to which our technology and processes infringe on intellectual property of the licensor
that is not subject to the licensing agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our right to sublicense patent and other rights to third parties under collaborative development relationships;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our diligence obligations with respect to the use of the licensed technology in relation to our development and
commercialization of our product candidates, and what activities satisfy those diligence obligations; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ownership of inventions and <FONT STYLE="white-space:nowrap">know-how</FONT> resulting from the joint
creation or use of intellectual property by us, our licensors, and our collaborators. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If disputes over intellectual
property that we have licensed, or will license in the future, prevent or impair our ability to maintain our current licensing arrangements on acceptable terms, we may be unable to successfully develop and commercialize the affected product
candidates. Furthermore, if our licenses are terminated, or if the underlying patents fail to provide the intended exclusivity, competitors or other third parties would have the freedom to seek regulatory approval of, and to market, products
identical or competitive to ours and we may be required to cease our development and commercialization of certain of our product candidates. We are generally also subject to all of the same risks with respect to protection of intellectual property
that we license, as it is for intellectual property that we own, which are described below. If we or our licensors fail to adequately protect this intellectual property, our ability to commercialize products could suffer. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Intellectual Property </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>If we are unable to obtain and maintain sufficient patent protection for our product candidates, or if the scope of the patent protection
is not sufficiently broad, our competitors could develop and commercialize products similar or identical to ours, and our ability to commercialize our product candidates successfully may be adversely affected. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our success depends in large part on our ability to obtain and maintain patent protection in the United States and other countries with respect
to our product candidates. If we do not adequately protect or enforce our intellectual property, competitors and other third parties may be able to erode or negate any competitive advantage we may have, which could harm our business. To protect our
proprietary position, we file patent applications in the United States and abroad related to our product candidates that are important to our business. The patent application and approval process is expensive, complex and time-consuming. We may not
be able to file and prosecute all necessary or desirable patent applications at a reasonable cost or in a timely manner. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The patent
position of biotechnology and pharmaceutical companies generally is highly uncertain. No consistent policy regarding the breadth of claims allowed in biotechnology and pharmaceutical patents has emerged to date in the United States or in many
foreign jurisdictions. In addition, the determination of patent rights with respect to biological and pharmaceutical products commonly involves complex legal and factual questions, which has in recent years been the subject of much litigation. As a
result, the issuance, scope, validity, enforceability and commercial value of our patent rights are highly uncertain. Our pending patent applications cannot be enforced against third parties practicing the technology claimed in such applications
unless and until a patent issues from such applications. Assuming the other requirements for patentability are met, currently, the first to file a patent application is generally entitled to the patent. However, prior to March&nbsp;16, 2013, in the
United States, the first to invent was entitled to the patent. Publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not
published until 18 months after filing, or in some cases not at all. Therefore, we cannot be certain that we were the first to make the inventions claimed in our patents or pending patent applications, or that we were the first to file for patent
protection of such inventions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Moreover, because the issuance of a patent is not conclusive as to its inventorship, scope, validity or
enforceability, our patents or pending patent applications may be challenged in the courts or patent offices in the United States and abroad. For example, we may be subject to a third-party preissuance submission of prior art to the U.S. Patent and
Trademark Office (&#147;USPTO&#148;), or become involved in post-grant review procedures, oppositions, derivations, reexaminations, <I>inter partes</I> review or interference proceedings, in the United States or elsewhere, challenging our patent
rights or the patent rights of others. An adverse determination in any such challenges may result in loss of exclusivity or in patent claims being narrowed, invalidated or held unenforceable, in whole or in part, which could limit our ability to
stop others from using or commercializing similar or identical technology and products, or limit the duration of the patent protection of our technology and products. In addition, given the amount of time required for the development, testing and
regulatory review of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even if our patent applications issue as patents, they may not issue in a form that will provide us with any meaningful protection, prevent
competitors from competing with us or otherwise provide us with any competitive advantage. Our competitors may be able to circumvent our patents by developing similar or alternative technologies or products in a
<FONT STYLE="white-space:nowrap">non-infringing</FONT> manner. Alternatively, our competitors may seek to market generic versions of any approved products and may claim that patents owned or licensed by us are invalid, unenforceable or not
infringed. In these circumstances, we may need to defend or assert our patents, or both, including by filing lawsuits alleging patent infringement. In any of these types of proceedings, a court or other agency with jurisdiction may find our patents
invalid or unenforceable, or that our competitors are competing in a <FONT STYLE="white-space:nowrap">non-infringing</FONT> manner. Thus, even if we have valid and enforceable patents, these patents still may not provide protection against competing
products or processes sufficient to achieve our business objectives. Any of the foregoing could have a material adverse effect on our business. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>If third parties claim that our activities or products infringe upon their intellectual property, our operations could be adversely
affected. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There is a substantial amount of litigation, both within and outside the United States, involving patents and other
intellectual property rights in the pharmaceutical industry. We may, from time to time, be notified of claims that we or our third-party suppliers are infringing upon patents, trademarks, copyrights, or other intellectual property rights owned by
third parties, and we cannot provide assurances that other companies will not, in the future, pursue such infringement claims against us or any third-party proprietary technologies we have licensed. If we or our third-party suppliers were found to
infringe upon a patent or other intellectual property right, or if we failed to obtain or renew a license under a patent or other intellectual property right from a third party, or if a third party that we were licensing technologies from was found
to infringe upon a patent or other intellectual property rights of another third party, we may be required to pay damages, including treble damages if the infringement is found to be willful, suspend the manufacture of certain product candidates or
reengineer or rebrand our product candidates, if feasible, or we may be unable to enter certain new product markets. We could also be required to obtain a license to such patents in order to continue the development and commercialization of the
infringing product or technology, however such a license may not be available on commercially reasonable terms or at all. Even if such license were available, it may require substantial payments or cross-licenses under our intellectual property
rights, and it may only be available on a nonexclusive basis, in which case third parties, including our competitors, could use the same licensed intellectual property to compete with us. Any such claims could also be expensive and time-consuming to
defend and divert management&#146;s attention and resources. Our competitive position could suffer as a result. In addition, if we have declined to enter into a valid <FONT STYLE="white-space:nowrap">non-disclosure</FONT> or assignment agreement for
any reason, we may not own an invention or intellectual property rights and may not be adequately protected. Although we have reviewed certain third-party patents and patent filings that we believe may be relevant to our product candidates, we have
not conducted a full <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">freedom-to-operate</FONT></FONT> search or analysis for such product candidates, and we may not be aware of patents or pending or future patent applications that,
if issued, would block us from commercializing our product candidates. In addition, because patent applications can take many years to issue, may be confidential for 18 months or more after filing and can be revised before issuance, there may be
applications now pending which may later result in issued patents that may be infringed by the manufacture, use, sale or importation of our product candidates and we may not be aware of such patents. Thus, we cannot guarantee that we can
successfully commercialize product candidates in a way that will not infringe any third party&#146;s intellectual property. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Where
we license certain technology from a third party, the prosecution, maintenance and defense of the patent rights licensed from such third party may be controlled by the third party which may impact the scope of patent protection which will be
obtained or enforced. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Where we license patent rights or technology from a third party, control of such third-party patent rights
may vest in the licensor, particularly where the license is <FONT STYLE="white-space:nowrap">non-exclusive</FONT> or field restricted. This may mean that </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
we are not able to control or affect the scope of the claims of any relevant third-party patent or have control over any enforcement of such a patent. Therefore, we cannot be certain that such
patents and patent applications will be prepared, filed, prosecuted, maintained, enforced, and defended in a manner consistent with the best interests of our business. Where a licensor brings an enforcement action, this could negatively impact our
business or result in additional restrictions being imposed on the license we have and the scope of such license or result in invalidation or limitation of the scope of the licensed patent. In addition, should we wish to enforce the relevant patent
rights against a third person, we may be reliant on consent from the relevant licensor or the cooperation of the licensor. The licensor may refuse to bring such action and leave us unable to restrict competitor entry into the market. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We may be involved in lawsuits to protect or enforce our patents or the patents of our licensors, or lawsuits accusing our products of
patent infringement, which could be expensive, time-consuming and unsuccessful. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Competitors or third parties may infringe our
patents or the patents of our licensors. To counter infringement or unauthorized use, we may be required to file infringement claims, which can be expensive and time-consuming. In addition, in an infringement proceeding, a court may decide that one
or more of our patents is not valid or is unenforceable or may refuse to stop the other party from using the technology at issue on the grounds that our patents do not cover the technology in question. Further, such third parties could counterclaim
that we infringe, misappropriate or otherwise violate their intellectual property or that a patent or other intellectual property right asserted against them is invalid or unenforceable. In patent litigation in the United States, defendant
counterclaims challenging the validity, enforceability or scope of asserted patents are commonplace. The outcome of any such proceeding is generally unpredictable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An adverse result in any litigation or defense proceedings could put one or more of our patents at risk of being invalidated, held
unenforceable, or interpreted narrowly and could put our patents applications at risk of not issuing. Defense of these claims, regardless of their merit, would involve substantial litigation expense and would be a substantial diversion of employee
resources from our business. In the event of a successful claim of infringement against us, we may be enjoined from manufacturing, using, and marketing our products, or may have to pay substantial damages, including treble damages and
attorneys&#146; fees for willful infringement, obtain one or more licenses from third parties, pay royalties or redesign our infringing products, which may be impossible or require substantial time and monetary expenditure. Any required license may
not be available on commercially reasonable terms or at all. Even if such license were available, it may require substantial payments or cross-licenses under our intellectual property rights, and it may only be available on a nonexclusive basis, in
which case third parties, including our competitors, could use the same licensed intellectual property to compete with us. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation,
there is a risk that some of our confidential information could be compromised by disclosure during litigation. There could also be public announcements of the results of hearing, motions, or other interim developments. If securities analysts or
investors perceive these results to be negative, it could have a material adverse effect on the price of shares of our stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Obtaining and maintaining our patent protection depends on compliance with various procedural, document submission, fee payment, and
other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for <FONT STYLE="white-space:nowrap">non-compliance</FONT> with these requirements. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Periodic maintenance fees on any issued patent are due to be paid to the USPTO and foreign patent agencies in several stages over the lifetime
of the patent. The USPTO and various foreign governmental patent agencies require compliance with several procedural, documentary, fee payment and other similar provisions during the patent application process. While an inadvertent lapse can in many
cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete
loss of patent rights in the relevant jurisdiction. Noncompliance events that could result in abandonment or lapse of a patent or patent application include, but are not limited to, failure to respond to official actions within prescribed time
limits, <FONT STYLE="white-space:nowrap">non-payment</FONT> of fees and failure to properly legalize and submit formal documents. In such an event, our competitors might be able to enter the market, which would have a material adverse effect on our
business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We may incur substantial costs as a result of litigation or other proceedings relating
to patent and other intellectual property rights. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The cost to us of any litigation or other proceeding relating to intellectual
property rights, even if resolved in our favor, could be substantial. Some of our competitors may be better able to sustain the costs of complex patent litigation because they have substantially greater resources. If there is litigation against us,
we may not be able to continue to operate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Should third parties file patent applications or be issued patents claiming technology we also
use or claim, we may be required to participate in interference proceedings in the USPTO to determine priority of invention. We may be required to participate in interference proceedings involving our issued patents and pending applications. We may
be required to cease using the technology or to license rights from prevailing third parties as a result of an unfavorable outcome in an interference proceeding. A prevailing party in that case may not offer us a license on commercially acceptable
terms or at all. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Issued patents covering our product candidates could be found invalid or unenforceable if challenged in court or
the USPTO. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we or one of our licensing collaborators initiates legal proceedings against a third party to enforce a patent
covering one of our product candidates, the defendant could counterclaim that the patent covering our product candidate, as applicable, is invalid and/or unenforceable. In patent litigation in the United States, defendant counterclaims alleging
invalidity and/or unenforceability are commonplace, and there are numerous grounds upon which a third party can assert invalidity or unenforceability of a patent. Third parties may also raise similar claims before administrative bodies in the United
States or abroad, even outside the context of litigation. Such mechanisms include <FONT STYLE="white-space:nowrap">re-examination,</FONT><I> inter partes</I> and post grant review, and equivalent proceedings in foreign jurisdictions (for example,
opposition proceedings). Such proceedings could result in revocation or amendment to our patents in such a way that they no longer cover our product candidates. The outcome following legal assertions of invalidity and unenforceability is
unpredictable. With respect to the validity question, for example, we cannot be certain that there is no invalidating prior art of which we, our patent counsel and the patent examiner were unaware during prosecution. If a defendant were to prevail
on a legal assertion of invalidity and/or unenforceability, we would lose at least part, and perhaps all, of the patent protection on our product candidates. Such a loss of patent protection could have a material adverse impact on our business. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We may be subject to claims challenging the inventorship or ownership of our patents and other intellectual property. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our agreements with employees and our personnel policies generally provide that any inventions conceived by such individuals in the course of
rendering services to us shall be our exclusive property or that we may obtain full rights to such inventions, at our election. However, we may not obtain these agreements in all circumstances, and individuals with whom we have these agreements may
not comply with their terms. We may be subject to claims that former employees, collaborators, or other third parties have an ownership interest in our patents or other intellectual property. Ownership disputes may arise, for example, from
conflicting obligations of consultants or others who are involved in developing our development candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We also face the risk that
present or former employees could continue to hold rights to intellectual property we use, may demand the registration of intellectual property rights in their name and demand damages or compensation pursuant to the German Employee Invention Act. In
addition, under the German Employee Invention Act, certain employees retain rights to patents they invented or <FONT STYLE="white-space:nowrap">co-invented</FONT> and disclosed to us prior to October&nbsp;1, 2009 if the employee inventions were not
actively claimed by us after notification by the employee inventors. While we believe that all of our current and past German employee inventors have assigned to us their interest in inventions and patents they invented or <FONT
STYLE="white-space:nowrap">co-invented,</FONT> there can be no assurance that all such assignments are fully effective. Even if we lawfully own all inventions of our employee inventors who are subject to the German Act on Employees&#146; Inventions,
we are required under German law to reasonably </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
compensate such employees for the use of the inventions. If we are required to pay increased compensation or face other disputes under the German Act on Employees&#146; Inventions, our business
could be adversely affected. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Litigation may be necessary to defend against these and other claims challenging inventorship or ownership.
If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, valuable intellectual property. Such an outcome could have a
material adverse impact on our business. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Confidentiality agreements with employees and third parties may not prevent unauthorized disclosure of trade secrets and other
proprietary information. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the protection afforded by patents, we seek to rely on trade secret protection and
confidentiality agreements to protect proprietary <FONT STYLE="white-space:nowrap">know-how</FONT> that is not patentable, processes for which patents are difficult to enforce and any other elements of our product discovery and development processes
that involve proprietary <FONT STYLE="white-space:nowrap">know-how,</FONT> information or technology that is not covered by patents. Trade secrets, however, may be difficult to protect. Although we require all of our employees to assign their
inventions to us, and require all of our employees and key consultants who have access to our proprietary <FONT STYLE="white-space:nowrap">know-how,</FONT> information, or technology to enter into confidentiality agreements, we cannot be certain
that our trade secrets and other confidential proprietary information will not be disclosed or that competitors will not otherwise gain access to our trade secrets or independently develop substantially equivalent information and techniques.
Furthermore, the laws of some foreign countries do not protect proprietary rights to the same extent or in the same manner as the laws of the United States. As a result, we may encounter significant problems in protecting and defending our
intellectual property both in the United States and abroad. If we are unable to prevent unauthorized material disclosure of our intellectual property to third parties, we will not be able to establish or maintain a competitive advantage in our
market, which could materially adversely affect our business, operating results and financial condition. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We may be subject to
claims that we or our employees, consultants or independent contractors have wrongfully used or disclosed confidential information of third parties, that our employees have wrongfully used or disclosed alleged trade secrets of their former
employers, or claiming ownership of what we regard as our own intellectual property. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We employ individuals who were previously
employed at universities or other biotechnology or pharmaceutical companies, including our competitors or potential competitors. In addition, our employees involved in our strategic collaborations have access to certain joint confidential
information or such information from the collaborator. Although we try to ensure that our employees, consultants, and independent contractors do not use the proprietary information or <FONT STYLE="white-space:nowrap">know-how</FONT> of others in
their work for us, from time to time we may be subject to claims that we, or our employees, consultants, or independent contractors, have inadvertently or otherwise used or disclosed intellectual property, including trade secrets or other
proprietary information, of any of our employees&#146; former employers or other third parties, or that patents and applications we have filed to protect inventions of these individuals, even those related to one or more of our product candidates,
are rightfully owned by their former or concurrent employer. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property
rights or personnel, which could adversely impact our business. Such intellectual property rights could be awarded to a third party, and we could be required to obtain a license from such third party to commercialize our technology or products. Such
a license may not be available on an exclusive basis or on commercially reasonable terms or at all. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other
employees. Such liability can also occur if we publish or disclose confidential information from our collaboration without permission of the respective collaborator. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Changes in U.S. or foreign countries&#146; patent law could diminish the value of
patents in general, thereby impairing our ability to protect our products. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As is the case with other biopharmaceutical companies,
our success is dependent on intellectual property, particularly patents. Obtaining and enforcing patents in the biopharmaceutical industry involve both technological and legal complexity, and is therefore costly, time-consuming and inherently
uncertain. In addition, the U.S. Congress or other foreign legislative bodies may pass patent reform legislation that is unfavorable to us. Recent U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain
circumstances and weakened the rights of patent owners in certain situations. In addition to increasing uncertainty with regard to our ability to obtain patents in the future, this combination of events has created uncertainty with respect to the
value of patents, once obtained. Depending on decisions by the U.S. Congress, the federal courts, and the USPTO, or similar authorities in foreign jurisdictions, the laws and regulations governing patents could change in unpredictable ways that
would weaken our ability to obtain new patents or to enforce our existing patents and patents that we might obtain in the future. We cannot predict how future decisions by the courts, the U.S. Congress or the USPTO may impact the value of our
patents, nor can we predict changes in international patent law. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We may not be able to protect our intellectual property rights
throughout the world. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The legal protection afforded to inventors and owners of intellectual property in countries outside of the
United States may not be as protective or effective as that in the United States and we may, therefore, be unable to acquire and enforce intellectual property rights outside the United States to the same extent as in the United States. Many
countries have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties. In addition, many countries limit the enforceability of patents against government agencies or government contractors. In these
countries, the patent owner may have limited remedies, which could materially diminish the value of such patent. If we or any of our licensors is forced to grant a license to third parties with respect to any patents relevant to our business, our
competitive position may be impaired and our business may be harmed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whether filed in the United States or abroad, our patent
applications may be challenged or may fail to result in issued patents. In addition, our existing patents and any future patents we obtain may not be sufficiently broad to prevent others from utilizing our technologies or from developing or
commercializing competing products. Furthermore, others may independently develop or commercialize similar or alternative technologies or therapies, or design around our patents. Our patents may be challenged, invalidated, circumvented or narrowed,
or fail to provide us with any competitive advantages. In many foreign countries, patent applications and/or issued patents, or parts thereof, must be translated into the native language. If our patent applications or issued patents are translated
incorrectly, they may not adequately cover our technologies; in some countries, it may not be possible to rectify an incorrect translation, which may result in patent protection that does not adequately cover our technologies in those countries.
Filing, prosecuting, enforcing, and defending patents on product candidates in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the United States are less extensive
than those in the United States. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and certain state laws in the United States. Consequently, we may not be able to prevent third
parties from utilizing our inventions in all countries outside the United States, or from selling or importing products made using our inventions in and into the United States or other jurisdictions. Competitors or other third parties may use our
technologies, or technology that we license, in jurisdictions where we have not obtained patent protection to develop our own products and, further, may export otherwise infringing products to territories where we have patent protection, but
enforcement is not as strong as that in the United States. These products may compete with our lead product candidate or any other current or future product candidates and our patents or other intellectual property rights may not be effective or
sufficient to prevent them from competing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Many companies have encountered significant problems in protecting and defending intellectual
property rights in foreign jurisdictions. The legal systems of certain countries, particularly certain developing countries, do </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
not favor the enforcement of patents and other intellectual property protection, particularly those relating to biotechnology. In addition, certain countries have compulsory licensing laws under
which a patent owner may be compelled to grant licenses to third parties. Thus, it may be difficult for us to stop the infringement of our patents or the marketing of competing products in violation of our proprietary rights, generally. Proceedings
to enforce our patent rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly, could place
our patent applications at risk of not issuing, and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful.
Accordingly, our efforts to enforce intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we own or license. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Patent terms may be inadequate to protect our competitive position on our product candidates or any future product candidates for an
adequate amount of time. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Patents have a limited lifespan. In the United States, if all maintenance fees are timely paid, the
natural expiration of a patent is generally 20 years from our earliest U.S. <FONT STYLE="white-space:nowrap">non-provisional</FONT> filing date. Various extensions may be available, but the life of a patent, and the protection it affords, is
limited. Depending upon the timing, duration and specifics of any FDA marketing approval of any product candidates we may develop, one or more of our U.S. patents may be eligible for limited patent term extension under the Drug Price Competition and
Patent Term Restoration Action of 1984 (the &#147;Hatch-Waxman Act&#148;). The Hatch-Waxman Act permits a patent extension term of up to five years as compensation for patent term lost during the FDA regulatory review process. A patent term
extension cannot extend the remaining term of a patent beyond a total of 14 years from the date of product approval, only one patent may be extended and only those claims covering the approved drug, a method for using it, or a method for
manufacturing it may be extended. In the European Union, a maximum of five and a half years of supplementary protection can be achieved for an active ingredient or combinations of active ingredients of a medicinal product protected by a basic
patent, if a valid marketing authorization exists (which must be the first authorization to place the product on the market as a medicinal product) and if the product has not already been the subject of supplementary protection. However, we may not
receive an extension because of, for example, failing to exercise due diligence during the testing phase or regulatory review process, failing to apply within applicable deadlines, failing to apply prior to expiration of relevant patents, or
otherwise failing to satisfy applicable requirements. Moreover, the length of the extension could be less than we request. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even if
patents covering our product candidates or any future product candidates are obtained and even if we are successful in obtaining patent term extension, once the patent life has expired, we may be open to competition from competitive products. The
launch of a similar or biosimilar version of one of our products would likely result in an immediate and substantial reduction in the demand for our product, which could have a material adverse effect on our business. Given the amount of time
required for the development, testing, and regulatory review of new product candidates, patents protecting our current product candidates or any future product candidates might expire before or shortly after we or our collaborators commercialize
those candidates. As a result, our patent portfolio may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our business depends on a strong and trusted brand, and any failure to maintain, protect, and enhance our trademarks, trade names and
brand would have an adverse impact on our business, financial condition, results or operations and prospects. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may rely on
trademarks and trade names to protect our business. Our trademarks or trade names may be challenged, infringed, circumvented or declared generic or determined to be infringing on other marks. We may not be able to protect our rights to these
trademarks and trade names or may be forced to stop using these names or marks which we need for name recognition by potential partners or customers in our markets of interest. During trademark registration proceedings, we may receive rejections.
Although we would be given an opportunity to respond to those rejections, we may be unable to overcome such rejections. In addition, in the USPTO and in comparable agencies in many foreign jurisdictions, third parties are given an opportunity to
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
oppose pending trademark applications and to seek to cancel registered trademarks. Opposition or cancellation proceedings may be filed against our trademarks, and our trademarks may not survive
such proceedings. If we are unable to establish name recognition based on our trademarks and trade names, we may not be able to compete effectively and our business, financial condition, results of operations, and prospects may be adversely
affected. At times, competitors may adopt trade names or trademarks similar to ours, thereby impeding our ability to build brand identity and possibly leading to market confusion. At times, competitors may adopt trade names or trademarks similar to
ours, thereby impeding our ability to build brand identity and possibly leading to market confusion. For example, we have filed an opposition against Immunocore Limited&#146;s U.S. trademark application for IMMTAX and Immunocore Limited has brought
counterclaims against three of our registered U.S. trademarks for IMMATICS. If we are unsuccessful in this opposition or if Immunocore Limited is successful in its counterclaims, we may be required to change our branding which could cause us to
incur substantial costs and impede our ability to build and sustain name recognition for such platform. For more information on the opposition proceeding see &#147;Business &#151; Legal Proceedings.&#148; Over the long term, if we are unable to
establish name recognition based on our trademarks and trade names, then we may not be able to compete effectively, and our business, financial condition, results of operations and prospects may be significantly harmed. Our efforts to enforce or
protect our proprietary rights related to trademarks, trade secrets, domain names, copyrights or other intellectual property may be ineffective and could result in substantial costs and diversion of resources and could significantly harm our
business, financial condition, results of operations and prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Intellectual property rights do not necessarily address all
potential threats to our competitive advantage. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The degree of future protection afforded by our intellectual property rights is
uncertain because intellectual property rights have limitations, and may not adequately protect our business or permit us to maintain our competitive advantage. For example: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may not be able to detect infringement of our issued patents; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">others may be able to develop products that are similar to our products or product candidates, or any future
product candidates we may develop, but that are not covered by the claims of the patents that we may <FONT STYLE="white-space:nowrap">in-license</FONT> in the future or own; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we, or our current or future collaborators or license partners, might not have been the first to make the
inventions covered by the issued patents or patent application that we may <FONT STYLE="white-space:nowrap">in-license</FONT> in the future or own; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we, or our current or future collaborators or license partners, might be found not have been the first to file
patent applications covering certain of our or their inventions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">others may independently develop similar or alternative technologies or duplicate any of our technologies without
infringing our intellectual property rights; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">it is possible that the pending patent applications we may <FONT STYLE="white-space:nowrap">in-license</FONT> in
the future or own will not lead to issued patents; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">it is possible that there are prior public disclosures that could invalidate our patents, or parts of our
patents, for which we are not aware; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">issued patents that we hold rights to may be held invalid or unenforceable, as a result of legal challenges by
our competitors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">issued patents may not have sufficient term or geographic scope to provide meaningful protection;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our competitors might conduct research and development activities in countries where we do not have patent rights
and then use the information learned from such activities to develop competitive products for sale in our major commercial markets; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may not develop additional proprietary technologies that are patentable; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the patents of others may have an adverse effect on our business; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may choose not to file a patent in order to maintain certain trade secrets, and a third party may subsequently
file a patent covering such intellectual property. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Should any of these events occur, it could significantly harm our
business, financial condition, results of operations and prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Business and Industry </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our business could be adversely affected by the effects of health epidemics, including the
<FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, in regions where we or third parties on which we rely have significant manufacturing facilities, concentrations of clinical trial sites or other business operations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our business could be adversely affected by health epidemics in regions where we have clinical trial sites or other business operations;
epidemics could also cause significant disruptions in the operations of third-party manufacturers and CROs upon whom we rely. Our operations, similar to those of other life sciences companies, have been impacted by the
<FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic. The outbreak has resulted in governments implementing numerous measures to contain the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, which are subject to change and the
respective government authorities may tighten the restrictions at any time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The outbreak has caused us to modify our business practices
including restricting employee travel, developing social distancing plans for our employees and canceling physical participation in meetings, events and conferences, and we may take further actions as may be required by government authorities or as
we determine are in the best interests of our employees and business partners. Such modifications may negatively impact productivity, divert resources away from product development, disrupt our business operations and delay and disrupt our clinical
trials and preclinical programs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the outbreak and the resulting government actions may adversely impact our planned and
ongoing clinical trials. Clinical site initiation, including difficulties in recruiting clinical site investigators and clinical site staff, and patient enrollment may be delayed due to prioritization of hospital resources toward the <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic. Some patients may not be willing and/or able to comply with clinical trial protocols due to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, particularly if quarantines impede
patient movement or interrupt healthcare services. Similarly, our ability to recruit and retain patients and principal investigators and site staff who, as healthcare providers, may have heightened exposure to
<FONT STYLE="white-space:nowrap">COVID-19</FONT> may be impeded, which would adversely impact our clinical trial operations. The diversion of healthcare resources away from the conduct of clinical trials to focus on pandemic concerns, including the
attention of physicians serving as our clinical trial investigators and hospitals serving as our clinical trial sites, diversion of hospitals and medical centers or sites serving as our clinical trial sites and hospital or other staff supporting the
conduct of our clinical trials may significantly disrupt our research activities. As a result, the expected timeline for data readouts of our clinical trials and certain regulatory filings may be negatively impacted, which would adversely affect and
delay our ability to obtain regulatory approvals for our product candidates, increase our operating expenses and have a material adverse effect on our financial condition. Furthermore, we could face the interruption of key clinical activities such
as trial site data monitoring, which may impact the integrity of clinical data. As a result of disruptions caused by the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, we may require additional capital to continue our research
activities, which we may be unable to secure on favorable terms, if at all. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The outbreak and the resulting government actions may also
adversely impact the operations of our CROs, CMOs, suppliers and other business partners due to staffing shortages, production slowdowns or stoppages and disruptions in delivery systems. Furthermore, we may experience longer lead times in procuring
raw materials or components necessary to manufacture our product candidates, and our CMOs may be unable to manufacture product candidates in sufficient quantities that meet our standards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic continues to evolve, we believe that the extent of its impact to our
operations, operating results, cash flows, liquidity and financial condition will be primarily driven by the severity and duration of the pandemic, the pandemic&#146;s impact on the U.S. and global economies and the timing, scope and
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
effectiveness of national and local governmental responses to the pandemic, especially in areas where the conditions have recently worsened. Those primary drivers are beyond our knowledge and
control, and as a result, at this time, the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic&#146;s ultimate impact on our results of operations, cash flows and financial position cannot be reasonably predicted. Any prolonged disruption of
our clinical trials, suppliers or contract manufacturers, closures of facilities, such as clinical trial sites, would delay the development of our product candidates. There are no comparable recent events that provide guidance as to the likely
effect of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, and, as a result, the ultimate impact of the outbreak is highly uncertain and subject to change. However, the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic could
have a material adverse effect on our business, results of operations, financial condition and prospects and heighten many of our known risks described in this &#147;Item 3. Key Information&#151;D. Risk Factors&#148; section. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We are highly dependent on our key personnel, and if we are not successful in attracting and retaining highly qualified personnel, we
may not be able to successfully implement our business strategy. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our ability to compete in the highly competitive biotechnology
and pharmaceutical industries depends upon our ability to attract and retain highly qualified managerial, scientific and medical personnel. We are highly dependent on our management, scientific and medical personnel, including our Chief Executive
Officer and other executive officers in our senior management. Despite our efforts to retain valuable employees, members of our management, scientific and development teams could always terminate their employment with us on short notice. Even though
we have employment agreements in place with all our employees including key personnel, these employment agreements provide for <FONT STYLE="white-space:nowrap">at-will</FONT> employment, which means that any of our employees could leave us at any
time, subject to notice periods and <FONT STYLE="white-space:nowrap">non-competition</FONT> clauses. The loss of the services of any of our executive officers, other key employees and other scientific and medical advisors, and our inability to find
suitable replacements could result in delays in product development and harm our business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, our failure to put in place
adequate succession plans for senior and key management roles or the failure of key employees to successfully transition into new roles could have an adverse effect on our business and operating results. The unexpected or abrupt departure of one or
more of our key personnel and the failure to effectively transfer knowledge and effect smooth key personnel transitions may have an adverse effect on our business resulting from the loss of such person&#146;s skills, knowledge of our business, and
years of industry experience. If we cannot effectively manage leadership transitions and management changes in the future, our reputation and future business prospects could be adversely affected. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Competition for skilled personnel is intense, particularly in the biotechnology industry. We conduct substantially all of our operations at
our facilities in T&uuml;bingen, Germany, Houston, Texas and Munich, Germany. We face competition for personnel from other companies, universities, public and private research institutions and other organizations. This competition may limit our
ability to hire and retain highly qualified personnel on acceptable terms, or at all. We may not be able to attract and retain these personnel on acceptable terms. This possibility is further compounded by the novel nature of our product candidates,
as fewer people are trained in or are experienced with product candidates of this type. In addition, we rely on consultants and advisors, including scientific and clinical advisors, to assist us in formulating our research and development and
commercialization strategy. Our consultants and advisors may be employed or may have commitments under consulting or advisory contracts with other entities that may limit their availability to us. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We may encounter difficulties in managing our growth and expanding our operations successfully. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As we seek to advance our product candidates through clinical trials and commercialization, we are expanding our development, regulatory,
manufacturing, marketing and sales capabilities and may need to further expand or contract with third parties to provide these capabilities. In addition, as our operations expand, we expect that we will need to manage additional relationships with
various collaborators, suppliers and other third parties. Our growth will impose significant added responsibilities on members of management. Our management may have to divert a disproportionate amount of its attention away from our <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> activities and devote a substantial amount of time to these growth activities, including identifying, recruiting, integrating, maintaining
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and motivating additional employees, managing our research and development efforts effectively, including the clinical trials and the FDA&#146;s, the EMA&#146;s or comparable regulatory
authority&#146;s review process for our product candidates, while complying with our contractual obligations to contractors and other third parties and improving our operational, financial and management controls, reporting systems and procedures.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our future financial performance and our ability to commercialize our product candidates and to compete effectively will depend, in part,
on our ability to manage our growth effectively. To that end, we must be able to effectively manage our research and development efforts and hire, train and integrate additional management, administrative and sales and marketing personnel. We may
not be able to accomplish these tasks, and our failure to accomplish any of them could prevent us from successfully growing our company or could disrupt our operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we currently rely, and for the foreseeable future will continue to rely, in substantial part on certain independent
organizations, advisors and consultants to provide certain services. There can be no assurance that the services of these independent organizations, advisors and consultants will continue to be available to us on a timely basis when needed or that
we can find qualified replacements. Furthermore, if we are unable to effectively manage our outsourced activities or if the quality or accuracy of the services provided by consultants is compromised for any reason, our clinical trials may be
extended, delayed or terminated, and we may not be able to obtain regulatory approval of our product candidates or otherwise advance our business. There can be no assurance that we will be able to manage our existing consultants or find other
competent outside contractors and consultants on economically reasonable terms, if at all. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we are not able to effectively expand our
organization by hiring new employees and expanding our groups of consultants and contractors, we may not be able to successfully implement the tasks necessary to further develop and commercialize our product candidates and, accordingly, may not
achieve our research, development and commercialization goals. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>As a result of being a public company, we have incurred costs and
expect to continue to incur additional costs, and we may not manage to comply with our internal control procedures and corporate governance structures. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To comply with the requirements imposed on us as a public company, we have incurred, and expect to continue to incur, significant legal,
insurance, accounting and other expenses that we did not incur as a private company. The increased costs may require us to reduce costs in other areas of our business. In addition, our board of directors, management and administrative staff are
required to perform additional tasks. For example, we bear all of the internal and external costs of preparing and distributing periodic public reports in compliance with our obligations under the securities laws. We have invested, and intend to
continue to invest, resources to comply with evolving laws, regulations and standards, and this investment will result in increased general and administrative expenses and may divert management&#146;s time and attention from research and development
activities. These laws, regulations and standards are often subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application in practice may evolve over time as new guidance is provided by
regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters, enforcement proceedings and higher costs necessitated by ongoing revisions to disclosure and governance practices, which could have a material
adverse impact on our business, financial condition, results of operations and prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We face substantial competition, which
may result in others discovering, developing or commercializing products, treatment methods and/or technologies before or more successfully than we do. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The biotechnology industry is characterized by rapidly advancing technologies, intense competition and a strong emphasis on proprietary
products. We face competition with respect to our current product candidates and will face competition with respect to any product candidates that we may seek to develop or commercialize in the future. See &#147;Item 4. Information on the
Company&#151;B. Business Overview&#151;Competition.&#148; Our competitors </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
include large pharmaceutical and biotechnology companies, academic institutions, government agencies and other public and private research organizations that conduct research, seek patent
protection and establish collaborative arrangements for research, development, manufacturing and commercialization. Many of our competitors have significantly greater financial resources and capabilities in research and development, manufacturing,
preclinical testing, conducting clinical trials, obtaining regulatory approval and marketing than we do. In addition, many of these competitors are active in seeking patent protection and licensing arrangements in anticipation of collecting
royalties for use of technology that they have developed. Smaller or early-stage companies may also prove to be significant competitors, particularly through strategic collaborations with large and established companies. Furthermore, mergers and
acquisitions in the biotechnology industry may result in even more resources being concentrated among a smaller number of our competitors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our commercial opportunities could be reduced or eliminated if our competitors develop and commercialize products that are safer, more
effective, have fewer or less severe side effects or are more convenient than any products that we may develop, which would render our products obsolete or noncompetitive. Our competitors also may obtain FDA, the EMA or regulatory approval in other
jurisdictions for their products more rapidly than we may obtain approval for ours, which could result in our competitors establishing a strong market position before we are able to enter the market. We anticipate that we will face increased
competition in the future as additional companies enter our market and scientific developments surrounding other cancer therapies continue to accelerate. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>If we do not achieve our projected development and commercialization goals in the timeframes we announce and expect, the
commercialization of any of our product candidates may be delayed, and our business will be harmed. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For planning purposes, we
sometimes estimate the timing of the accomplishment of various scientific, clinical, regulatory and other product development objectives. These milestones may include our expectations regarding the commencement or completion of scientific studies
and clinical trials, the regulatory submissions or commercialization objectives. From time to time, we may publicly announce the expected timing of some of these milestones, such as the completion of an ongoing clinical trial, the initiation of
other clinical trials, receipt of regulatory approval or the commercial launch of a product. The achievement of many of these milestones may be outside of our control. All of these milestones are based on a variety of assumptions which may cause the
timing of achievement of the milestones to vary considerably from our estimates, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our available capital resources or capital constraints we experience; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the rate of progress, costs and results of our clinical trials and research and development activities, including
the extent of scheduling conflicts with participating clinicians and collaborators; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to identify and enroll patients who meet clinical trial eligibility criteria; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our receipt of approvals by the FDA, the EMA and comparable regulatory authorities, and the timing thereof;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other actions, decisions or rules issued by regulators; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to access sufficient, reliable and affordable supplies of materials used in the manufacture of our
product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to manufacture and supply clinical trial materials to our clinical sites on a timely basis;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the efforts of our collaborators with respect to the commercialization of our products; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the securing of, costs related to, and timing issues associated with, commercial product manufacturing as well as
sales and marketing activities. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we fail to achieve announced milestones in the timeframes we expect, the
commercialization of any of our product candidates may be delayed, and our business, results of operations, financial condition and prospects may be adversely affected. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Failure to comply with health and data protection laws and regulations could lead to
government enforcement actions, private litigation and/or adverse publicity and could negatively affect our operating results and business. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We receive, generate and store significant and increasing volumes of sensitive information, such as employee and patient data. In addition, we
actively seek access to medical information, including patient data, through research and development collaborations or otherwise. We have legal and contractual obligations regarding the protection of confidentiality and appropriate use of personal
data. We and any potential collaborators may be subject to federal, state, local and foreign laws and regulations that apply to the collection, use, retention, protection, disclosure, transfer and other processing of personal data. In the United
States, numerous federal and state laws and regulations, including federal health information privacy laws, state data breach notification laws, state health information privacy laws, and federal and state consumer protection laws (for example,
Section&nbsp;5 of the Federal Trade Commission Act), that govern the collection, use, disclosure and protection of health-related and other personal information could apply to our operations or the operations of our collaborators. In addition, we
may obtain health information from third parties, including research institutions from which we obtain clinical trial data, that are subject to privacy and security requirements under the Health Insurance Portability and Accountability Act of 1996
(&#147;HIPAA&#148;), as amended by the Health Information Technology for Economic and Clinical Health Act of 2009 (&#147;HITECH&#148;). Depending on the facts and circumstances, we could be subject to civil, criminal and administrative penalties if
we knowingly obtain, use, or disclose individually identifiable health information maintained by a HIPAA-covered entity in a manner that is not authorized or permitted by HIPAA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Several foreign jurisdictions, including the European Union, its member states and Australia, among others, have adopted legislation and
regulations that increase or change the requirements governing the collection, use, disclosure and transfer of the personal information of individuals in these jurisdictions and place greater control with the data subject. In the United States, the
California Consumer Privacy Act (&#147;CCPA&#148;) increased the requirements governing the collection, use, disclosure and transfer of the personal information of individuals in the state of California. The CCPA gives California residents expanded
rights to access and request deletion of their personal information, opt out of certain sales of personal information and receive detailed information about how their personal information is used by requiring covered companies to provide new
disclosures to California residents regarding such use. The CCPA provides for civil penalties for violations, as well as a private right of action for data breaches that is expected to increase data breach litigation. Additionally, California voters
approved a new privacy law, the California Privacy Rights Act (&#147;CPRA&#148;), in the November&nbsp;3, 2020 election. Effective starting on January&nbsp;1, 2023 , the CPRA will significantly modify the CCPA, including by expanding consumers&#146;
rights with respect to certain sensitive personal information. The CPRA also creates a new state agency that will be vested with authority to implement and enforce the CCPA and the CPRA. As we expand our operations and research and development
efforts, the CCPA and CPRA may impose new and burdensome privacy compliance obligations on our business, may increase our compliance costs and potential liability. Other states are considering similar laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These laws and regulations are complex and change frequently, at times due to changes in political climate, and existing laws and regulations
are subject to different and conflicting interpretations, which adds to the complexity of processing personal data from these jurisdictions. These laws have the potential to increase costs of compliance, risks of
<FONT STYLE="white-space:nowrap">non-compliance</FONT> and penalties for <FONT STYLE="white-space:nowrap">non-compliance.</FONT> Regulation 2016/679, known as the General Data Protection Regulation (&#147;GDPR&#148;), as well as European Union
member state implementing legislations, apply to the collection and processing of personal data, including health-related information, by companies located in the European Union, or in certain circumstances, by companies located outside of the
European Union and processing personal information of individuals located in the European Union. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These laws impose strict obligations on
the ability to process personal data, including health-related information, in particular in relation to their collection, use, disclosure and transfer. These include several requirements relating to (i)&nbsp;obtaining, in some situations, the
consent of the individuals to whom the personal data relates, (ii)&nbsp;the information provided to the individuals about how their personal information is used, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(iii)&nbsp;ensuring the security and confidentiality of the personal data, (iv)&nbsp;the obligation to notify regulatory authorities and affected individuals of personal data breaches,
(v)&nbsp;extensive internal privacy governance obligations, and (vi)&nbsp;obligations to honor rights of individuals in relation to their personal data (for example, the right to access, correct and delete their data). The GDPR prohibits the
transfer of personal data to countries outside of the European Economic Area (the &#147;EEA&#148;), such as the United States, which are not considered by the European Commission to provide an adequate level of data protection. Switzerland has
adopted similar restrictions. Although there are legal mechanisms to allow for the transfer of personal data from the EEA and Switzerland to the United States, they are subject to legal challenges and uncertainty about compliance with European Union
data protection laws remains. For example, in July 2020, the Court of Justice of the European Union invalidated the <FONT STYLE="white-space:nowrap">so-called</FONT> Privacy Shield, which provided a framework for data transferred from the European
Union to the United States. To the extent that we were to rely on the <FONT STYLE="white-space:nowrap">EU-U.S.</FONT> Privacy Shield Framework, we will not be able to do so in the future, which could increase our costs and limit our ability to
process personal data from the EU. The same decision also cast doubt on the ability to use one of the primary alternatives to the Privacy Shield, namely, the European Commission&#146;s Standard Contractual Clauses, to lawfully transfer personal data
from Europe to the United States and most other countries. At present, there are few if any viable alternatives to the Privacy Shield and the Standard Contractual Clauses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Potential pecuniary fines for noncompliant companies may be up to the greater of &#128;20&nbsp;million or 4% of annual global revenue. Such
penalties are in addition to any civil litigation claims by data controllers, customers and data subjects. The GDPR has increased our responsibility and liability in relation to personal data that we process, and we may be required to put in place
additional potential mechanisms to ensure compliance with new European Union data protection rules. The GDPR also contains a private right of action allowing data subjects and consumer associations to lodge complaints with supervisory authorities,
seek judicial remedies, and obtain compensation for damages resulting from violations of the GDPR. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, the United
Kingdom&#146;s vote in favor of exiting the EU, often referred to as Brexit, and ongoing developments in the United Kingdom have created uncertainty with regard to data protection regulation in the United Kingdom. As of January&nbsp;1, 2021, and the
expiry of transitional arrangements agreed to between the United Kingdom and EU, data processing in the United Kingdom is governed by a United Kingdom version of the GDPR (combining the GDPR and the Data Protection Act 2018), exposing us to two
parallel regimes, each of which potentially authorizes similar fines and other potentially divergent enforcement actions for certain violations. Pursuant to the Trade and Cooperation Agreement, which went into effect on January&nbsp;1, 2021, the
United Kingdom and EU agreed to a specified period during which the United Kingdom will be treated like an EU member state in relation to processing and transfers of personal data for four months from January&nbsp;1, 2021. This period may be
extended by two further months. Unless the European Commission makes an &#147;adequacy finding&#148; in respect of the United Kingdom before the expiration of such specified period, the United Kingdom will become an &#147;inadequate third
country&#148; under the GDPR and transfers of data from the EEA to the United Kingdom will require a &#147;transfer mechanism,&#148; such as the standard contractual clauses. Furthermore, following the expiration of the specified period, there will
be increasing scope for divergence in application, interpretation and enforcement of the data protection law as between the United Kingdom and EEA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Compliance with U.S. and international data protection laws and regulations could require us to take on more onerous obligations in our
contracts, restrict our ability to collect, use and disclose data, or in some cases, impact our ability to operate in certain jurisdictions. Failure to comply with these laws and regulations could result in government enforcement actions, which
could include civil, criminal and administrative penalties, private litigation, and/or adverse publicity and could negatively affect our operating results and business. Moreover, clinical trial subjects, employees and other individuals about whom we
or our potential collaborators obtain personal information, as well as the providers who share this information with us, may limit our ability to collect, use and disclose the information. Claims that we have violated individuals&#146; privacy
rights, failed to comply with data protection laws, or breached our contractual obligations, even if we are not found liable, could be expensive and time-consuming to defend and could result in adverse publicity that could harm our business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our current and future operations are subject to applicable fraud and abuse,
transparency, government price reporting, privacy and security, and other healthcare laws. If we are unable to comply, or do not fully comply, with such laws, we could face substantial penalties. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Healthcare providers, physicians and third-party payors will play a primary role in the recommendation and prescription of any product
candidates for which we obtain marketing approval. Our operations, including any arrangements with healthcare providers, physicians, third-party payors and customers may expose us to broadly applicable fraud and abuse and other healthcare laws that
may affect the business or financial arrangements and relationships through which we would market, sell and distribute our products. The healthcare laws that may affect our ability to operate include, but are not limited to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The federal Anti-Kickback Statute, which prohibits any person or entity from, among other things, knowingly and
willfully soliciting, receiving, offering or paying any remuneration, directly or indirectly, overtly or covertly, in cash or in kind, to induce or reward either the referral of an individual for, or the purchase, order or recommendation of an item
or service reimbursable, in whole or in part, under a federal healthcare program, such as the Medicare and Medicaid programs. The term &#147;remuneration&#148; has been broadly interpreted to include anything of value. The federal Anti-Kickback
Statute has also been interpreted to apply to arrangements between pharmaceutical manufacturers on the one hand and prescribers, purchasers, and formulary managers on the other hand. There are a number of statutory exceptions and regulatory safe
harbors protecting some common activities from prosecution, but the exceptions and safe harbors are drawn narrowly and require strict compliance in order to offer protection. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Federal civil and criminal false claims laws, such as the False Claims Act (&#147;FCA&#148;), which can be
enforced by private citizens through civil qui tam actions, and civil monetary penalty laws prohibit individuals or entities from, among other things, knowingly presenting, or causing to be presented, false, fictitious or fraudulent claims for
payment of federal funds, and knowingly making, using or causing to be made or used a false record or statement material to a false or fraudulent claim to avoid, decrease or conceal an obligation to pay money to the federal government. For example,
pharmaceutical companies have been prosecuted under the FCA in connection with their alleged <FONT STYLE="white-space:nowrap">off-label</FONT> promotion of drugs, purportedly concealing price concessions in the pricing information submitted to the
government for government price reporting purposes, and allegedly providing free product to customers with the expectation that the customers would bill federal healthcare programs for the product. In addition, a claim including items or services
resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the FCA. As a result of a modification made by the Fraud Enforcement and Recovery Act of 2009, a claim includes &#147;any request
or demand&#148; for money or property presented to the U.S. government. In addition, manufacturers can be held liable under the FCA even when they do not submit claims directly to government payors if they are deemed to &#147;cause&#148; the
submission of false or fraudulent claims. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">HIPAA, among other things, imposes criminal liability for executing or attempting to execute a scheme to defraud
any healthcare benefit program, including private third-party payors, knowingly and willfully embezzling or stealing from a healthcare benefit program, willfully obstructing a criminal investigation of a healthcare offense, and creates federal
criminal laws that prohibit knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement or representation, or making or using any false writing or document knowing
the same to contain any materially false, fictitious or fraudulent statement or entry in connection with the delivery of or payment for healthcare benefits, items or services. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">HIPAA, as amended by HITECH, and their implementing regulations, which impose privacy, security and breach
reporting obligations with respect to individually identifiable health information upon entities subject to the law, such as health plans, healthcare clearinghouses and certain healthcare providers, known as covered entities, and their respective
business associates that perform services for them that involve individually identifiable health information. HITECH also created new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
business associates, and gave state attorneys general new authority to file civil actions for damages or injunctions in U.S. federal courts to enforce HIPAA laws and seek attorneys&#146; fees and
costs associated with pursuing federal civil actions. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Federal and state consumer protection and unfair competition laws, which broadly regulate marketplace activities
and activities that potentially harm consumers. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The federal transparency requirements under the Physician Payments Sunshine Act, created under the Health Care
Reform Act, which requires, among other things, certain manufacturers of drugs, devices, biologics and medical supplies reimbursed under Medicare, Medicaid, or the Children&#146;s Health Insurance Program to report annually to CMS information
related to payments and other transfers of value provided to physicians, as defined by such law, and teaching hospitals and physician ownership and investment interests, including such ownership and investment interests held by a physician&#146;s
immediate family members. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">State and foreign laws that are analogous to each of the above federal laws, such as anti-kickback and false
claims laws, that may impose similar or more prohibitive restrictions, and may apply to items or services reimbursed by <FONT STYLE="white-space:nowrap">non-governmental</FONT> third-party payors, including private insurers. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">State and foreign laws that require pharmaceutical companies to implement compliance programs, comply with the
pharmaceutical industry&#146;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government, or to track and report gifts, compensation and other remuneration provided to physicians and other healthcare
providers; state laws that require the reporting of marketing expenditures or drug pricing, including information pertaining to and justifying price increases; state and local laws that require the registration of pharmaceutical sales
representatives; state laws that prohibit various marketing-related activities, such as the provision of certain kinds of gifts or meals; state laws that require the posting of information relating to clinical trials and their outcomes; and other
federal, state and foreign laws that govern the privacy and security of health information or personally identifiable information in certain circumstances, including state health information privacy and data breach notification laws which govern the
collection, use, disclosure, and protection of health-related and other personal information, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus requiring additional compliance efforts.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have entered into consulting and scientific advisory board arrangements with physicians and other healthcare
providers, including some who could influence the use of our product candidates, if approved. Because of the complex and <FONT STYLE="white-space:nowrap">far-reaching</FONT> nature of these laws, regulatory agencies may view these transactions as
prohibited arrangements that must be restructured, or discontinued, or for which we could be subject to other significant penalties. We could be adversely affected if regulatory agencies interpret our financial relationships with providers who may
influence the ordering and use of our drug candidates, if approved, to be in violation of applicable laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Ensuring that our business
arrangements with third parties comply with applicable healthcare laws and regulations will likely be costly. It is possible that governmental authorities will conclude that our business practices do not comply with current or future statutes,
regulations, agency guidance or case law involving applicable fraud and abuse or other healthcare laws. If our operations are found to be in violation of any of these laws or any other current or future healthcare laws that may apply to us, we may
be subject to significant civil, criminal and administrative penalties, damages, fines, disgorgement, imprisonment, exclusion from government funded healthcare programs, such as Medicare and Medicaid, contractual damages, reputational harm,
diminished profits and future earnings, additional reporting obligations and oversight if we become subject to a corporate integrity agreement or other agreement to resolve allegations of <FONT STYLE="white-space:nowrap">non-compliance</FONT> with
these laws, and the curtailment or restructuring of our operations, any of which could substantially disrupt our operations. Although effective compliance programs can mitigate the risk of investigation and prosecution for violations of these laws,
these risks cannot be entirely eliminated. Any action against us for an alleged or suspected violation could cause us to incur significant legal expenses and could divert our management&#146;s attention from the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
operation of our business, even if our defense is successful. In addition, if any of the physicians or other healthcare providers or entities with whom we expect to do business is found not to be
in compliance with applicable laws, they may be subject to significant criminal, civil or administrative sanctions, including exclusions from government-funded healthcare programs. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our employees, agents, contractors or collaborators may engage in misconduct or other improper activities. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We cannot ensure that our compliance controls, policies and procedures will in every instance protect us from acts committed by our employees,
agents, contractors or collaborators that would violate the laws or regulations of the jurisdictions in which we operate, including, without limitation, healthcare, employment, foreign corrupt practices, environmental, competition, and patient
privacy and other privacy laws and regulations. Misconduct by these parties could include intentional failures to comply with FDA, the EMA or other applicable regulations, provide accurate information to the FDA, the EMA and comparable regulatory
authorities, comply with healthcare fraud and abuse laws and regulations in the United States and abroad, report financial information or data accurately or disclose unauthorized activities to us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Such misconduct also could involve the improper use of information obtained in the course of clinical trials or interactions with the FDA, the
EMA or comparable regulatory authorities. If we obtain FDA approval of any of our product candidates and begin commercializing those products in the United States, our potential exposure under these laws will increase significantly, and our costs
associated with compliance with these laws are likely to increase. Such improper actions could subject us to civil or criminal investigations, and monetary and injunctive penalties, and could adversely impact our ability to conduct business,
operating results and reputation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we are subject to the Foreign Corrupt Practices Act (&#147;FCPA&#148;) and similar
anti-bribery or anti-corruption laws, regulations or rules of other countries in which we operate, including the UK Bribery Act. The FCPA generally prohibits offering, promising, giving, or authorizing others to give anything of value, either
directly or indirectly, to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> government official in order to influence official action, or otherwise obtain or retain business. The FCPA also requires public companies to make and keep books and
records that accurately and fairly reflect the transactions of the corporation and to devise and maintain an adequate system of internal accounting controls. Our business is heavily regulated and therefore involves significant interaction with
public officials, including officials of <FONT STYLE="white-space:nowrap">non-U.S.</FONT> governments. Additionally, in many other countries, the healthcare providers who prescribe pharmaceuticals are employed by their government, and the purchasers
of pharmaceuticals are government entities; therefore, our dealings with these prescribers and purchasers are subject to regulation under the FCPA. There is no certainty that all of our employees, agents, contractors, or collaborators, or those of
our affiliates, will comply with all applicable laws and regulations, particularly given the high level of complexity of these laws. We have provisions in our Code of Business Conduct and Ethics, an anti-corruption policy and certain controls and
procedures in place that are designed to mitigate the risk of <FONT STYLE="white-space:nowrap">non-compliance</FONT> with anti-corruption and anti-bribery laws. However, it is not always possible to identify and deter employee misconduct, and the
precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from government investigations or other actions stemming from a failure to comply with these laws or
regulations. Violations of these laws and regulations could result in, among other things, significant administrative, civil and criminal fines and sanctions against us, our officers, or our employees, the closing down of our facilities, exclusion
from participation in federal healthcare programs including Medicare and Medicaid, implementation of compliance programs, integrity oversight and reporting obligations, and prohibitions on the conduct of our business. Any such violations could
include prohibitions on our ability to offer our products in one or more countries and could materially damage our reputation, our brand, our international expansion efforts, our ability to attract and retain employees, and our business, prospects,
operating results and financial condition. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We and our third-party contractors must comply with environmental, health and safety
laws and regulations. A failure to comply with these laws and regulations could expose us to significant costs or liabilities. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
and our third-party contractors are subject to numerous environmental, health and safety laws and regulations, including those governing laboratory procedures and the use, generation, manufacture, distribution, storage, handling, treatment,
remediation and disposal of biohazardous materials and wastes and genetically modified organisms. Hazardous chemicals, including potentially infectious biological substances and genetically modified organisms, are involved in certain aspects of our
business, and we cannot eliminate the risk of injury or contamination from the use, generation, manufacture, distribution, storage, handling, treatment or disposal of hazardous materials and wastes. In the event of contamination or injury, or
failure to comply with environmental, health and safety laws and regulations, we could be held liable for any resulting damages, fines and penalties associated with such liability could exceed our assets and resources. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although we maintain workers&#146; compensation insurance as prescribed by Texas and German laws to cover us for costs and expenses we may
incur due to injuries to our employees resulting from the use of biological or hazardous materials or wastes, this insurance may not provide adequate coverage against potential liabilities. We do not maintain insurance for environmental liability or
toxic tort claims that may be asserted against us in connection with our storage or disposal of biological, hazardous or radioactive materials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Environmental, health and safety laws and regulations are becoming increasingly more stringent. We may incur substantial costs in order to
comply with current or future environmental, health and safety laws and regulations. These current or future laws and regulations may impair our research, development or production efforts. Our failure to comply with these laws and regulations also
may result in substantial fines, penalties or other sanctions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our internal computer systems, or those of our partners, third-party
CROs or other contractors or consultants, may fail or suffer security incidents, which could result in a material disruption of our product development programs and significant monetary losses. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Despite the implementation of security measures, our internal computer systems and those of our current or future partners, third-party CROs
and other contractors and consultants have been subject to attacks by, and may be vulnerable to damage from, various methods, including cybersecurity attacks, breaches, intentional or accidental mistakes or errors, or other technological failures
which can include, among other things, computer viruses, malicious codes, employee theft or misuse, unauthorized copying of our website or its content, unauthorized access attempts including third parties gaining access to systems using stolen or
inferred credentials, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">denial-of-service</FONT></FONT> attacks, phishing attempts, service disruptions, natural disasters, fire, terrorism, war and telecommunication and electrical
failures. As the cyber-threat landscape evolves, these attacks are growing in frequency, sophistication and intensity, and are becoming increasingly difficult to detect. Such attacks could include the use of keystroke loggers or other harmful and
virulent malware, including ransomware or other denials of service, and can be deployed through malicious websites, the use of social engineering and/or other means. We may not be able to anticipate all types of security threats, and we may not be
able to implement preventive measures effective against all such security threats. Further, as the current <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic continues to result in a significant number of people working from home, these
cybersecurity risks may be heightened by an increased attack surface across our business. We cannot guarantee that our efforts, or the efforts of those upon whom we rely and partner with, will be successful in preventing any such information
security incidents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a failure, accident or security breach were to occur and cause interruptions in our, our partners&#146; or our
CROs&#146; operations, it could result in a misappropriation of confidential information, including personally identifiable information and our intellectual property or financial information, a material disruption of our programs and/or significant
monetary losses. For example, the loss of XPRESIDENT raw data, the XPRESIDENT database or other data for our product candidates could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce
the data. In addition, because of our approach </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to running multiple clinical trials in parallel, any breach of our computer systems may result in a loss of data or compromised data integrity across many of our programs in many stages of
development. Any such breach, loss or compromise of clinical trial participant personal data may also subject us to civil fines and penalties, including under the GDPR and relevant member state law in the European Union or the CCPA, HIPAA and other
relevant state and federal privacy laws in the United States. Moreover, because we maintain sensitive company data on our computer networks, including our intellectual property and proprietary business information, any such security breach may
compromise information stored on our networks and may result in significant data losses or theft of our intellectual property or proprietary business information. Our current cybersecurity liability insurance, and any such insurance that we may
obtain in the future, may not cover the damages we would sustain based on any breach of our computer security protocols or other cybersecurity attack. To the extent that any disruption or security breach results in a loss of or damage to our data or
applications or other data or applications relating to our technology or product candidates, or inappropriate disclosure of confidential or proprietary information, our reputation could be harmed and we could incur significant liabilities and the
further development of our product candidates could be disrupted. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Product liability lawsuits could cause us to incur substantial
liabilities and to limit development and commercialization of any products that we may develop. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We face an inherent risk of
product liability as a result of the clinical testing of our product candidates in human clinical trials and will face an even greater risk if we commercialize any products that we successfully develop. Any such product liability claims may include
allegations of defects in manufacturing, defects in design, a failure to warn of dangers inherent in the product, negligence, strict liability and a breach of warranties. We may also still face risks from previous research and development
activities. For example, IMA950, a multi-peptide vaccine we previously developed, is still in clinical use under the responsibility of clinical investigators outside of our clinical trials (investigator-initiated trials). While any sponsor
responsibility is with the investigator, we cannot fully be sure that we will not be held liable in the future for any potential product defects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we cannot successfully defend ourselves against product liability claims, we may incur substantial liabilities or be required to limit
commercialization of our product candidates. Even a successful defense would require significant financial and management resources. Regardless of the merits or eventual outcome, liability claims may result in: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">decreased demand for our product candidates or products that we may develop; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">injury to our reputation and significant negative media attention; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">withdrawal of clinical trial sites and/or study participants; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">significant costs to defend the related litigations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a diversion of management&#146;s time and our resources to pursue our business strategy; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">substantial monetary awards to study participants or patients; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">product recalls, withdrawals or labeling, marketing or promotional restrictions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">loss of revenue; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the inability to commercialize our product candidates that we may develop; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a decline in the price of our securities. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Failure to obtain and retain sufficient product liability insurance at an acceptable cost to protect against potential product liability
claims could prevent or inhibit the commercialization of products we develop. While we have obtained clinical trial insurance for our Phase 1 clinical trials and will also seek to obtain such insurance for future trials, any claim that may be
brought against us could result in a court judgment or settlement in an amount that is not covered, in whole or in part, by our insurance or that is in excess of the limits of our insurance coverage. Our insurance policies also have various
exclusions, and we may be subject to a product liability claim for which we have no coverage. In such instance, we may have to pay any amounts awarded by a court or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
negotiated in a settlement that exceed our coverage limitations or that are not covered by our insurance, and we may not have, or be able to obtain, sufficient capital to pay such amounts. If we
are unable to obtain or maintain sufficient insurance coverage at an acceptable cost or to otherwise protect against potential product liability claims, it could prevent or inhibit the development and commercial production and sale of our product
candidates, which could adversely affect our business, financial condition, results of operations and prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Litigation and
other legal proceedings may adversely affect our business. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From time to time, we may become involved in legal proceedings relating
to patent and other intellectual property matters, product liability claims, employee claims, tort or contract claims, regulatory investigations, securities class action and other legal proceedings or investigations, which could have an adverse
impact on our reputation, business and financial condition and divert the attention of our management from the operation of our business. Litigation is inherently unpredictable and can result in excessive or unanticipated verdicts and/or injunctive
relief that affect how we operate our business. We could incur judgments or enter into settlements of claims for monetary damages or for agreements to change the way we operate our business, or both. Adverse publicity about regulatory or legal
action against us could damage our reputation and brand image, even if the regulatory or legal action is unfounded or not material to our operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our insurance policies are expensive and protect only from some business risks, which leaves us exposed to significant uninsured
liabilities. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not carry insurance for all categories of risks that our business may encounter, and insurance coverage is
becoming increasingly expensive. We do not know if we will be able to maintain existing insurance with adequate levels of coverage, and any liability insurance coverage we acquire in the future may not be sufficient to reimburse us for any expenses
or losses we may suffer. If we obtain marketing approval for any product candidates that we or our collaborators may develop, we intend to acquire insurance coverage to include the sale of commercial products, but we may be unable to obtain such
insurance on commercially reasonable terms or in adequate amounts. Required coverage limits for such insurances are difficult to predict and may not be sufficient. If potential losses exceed our insurance coverage, our financial condition would be
adversely affected. In the event of contamination or injury, we could be held liable for damages or be penalized with fines in an amount exceeding our resources. Clinical trials or regulatory approvals for any of our product candidates could be
suspended, which could adversely affect our results of operations and business, including by preventing or limiting the development and commercialization of any product candidates that we or our collaborators may develop. Additionally, operating as
a public company will make it more expensive for us to obtain director and officer liability insurance. As a result, it may be more difficult to attract and retain qualified individuals to serve on our supervisory board (the &#147;Supervisory
Board&#148;), the board committees or our management board (the &#147;Management Board&#148;). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>If we engage in acquisitions and/or
commercial collaborations in the future, we will incur a variety of costs and we may never realize the anticipated benefits of such acquisitions. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may acquire technologies and assets, form strategic alliances or create joint ventures with third parties that we believe will complement or
augment our existing business. Such efforts may never result in a transaction, and any future growth through acquisition or <FONT STYLE="white-space:nowrap">in-licensing</FONT> will depend upon the availability of suitable products, product
candidates, research programs or companies for acquisition or <FONT STYLE="white-space:nowrap">in-licensing</FONT> on acceptable prices, terms and conditions. Even if appropriate opportunities are available, we may not be able to acquire rights to
them on acceptable terms, or at all. The competition to acquire or <FONT STYLE="white-space:nowrap">in-license</FONT> rights to promising products, product candidates, research programs and companies is fierce, and many of our competitors are large,
multinational pharmaceutical and biotechnology companies with considerably more financial, development and commercialization resources and personnel than we have. In order to compete successfully in the current business climate, we may have to pay
higher prices for assets than may have been paid historically, which may make it more difficult for us to realize an adequate return on any acquisition. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even if we are able to successfully identify and acquire or
<FONT STYLE="white-space:nowrap">in-license</FONT> new products, product candidates, research programs or companies, we may not be able to successfully manage the risks associated with integrating any products, product candidates, research programs
or companies into our business or the risks arising from anticipated and unanticipated problems in connection with an acquisition or <FONT STYLE="white-space:nowrap">in-licensing.</FONT> Further, while we seek to mitigate risks and liabilities of
potential acquisitions through, among other things, due diligence, there may be risks and liabilities that such due diligence efforts fail to discover, that are not disclosed to us or that we inadequately assess. In any event, we may not be able to
realize the anticipated benefits of any acquisition or <FONT STYLE="white-space:nowrap">in-licensing</FONT> for a variety of reasons, including the possibility that a product candidate fails to advance to clinical development, proves not to be safe
or effective in clinical trials, or fails to reach its forecasted commercial potential, or that the integration of a product, product candidate, research program or company gives rise to unforeseen difficulties and expenditures. Any failure in
identifying and managing these risks and uncertainties would have a material adverse effect on our business, results of operations, financial condition and prospects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, acquisitions create other uncertainties and risks, particularly when the acquisition takes the form of a merger or other business
consolidation. We may encounter unexpected difficulties, or incur unexpected costs, in connection with transition activities and integration efforts, which include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">high acquisition costs; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the need to incur substantial debt or engage in dilutive issuances of equity securities to pay for acquisitions;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the potential disruption of our historical business and our activities under our collaboration agreements;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the strain on, and need to expand, our existing operational, technical, financial and administrative
infrastructure; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our lack of experience in late-stage product development and commercialization; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the difficulties in assimilating employees and corporate cultures; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the difficulties in hiring qualified personnel and establishing necessary development and/or commercialization
capabilities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the failure to retain key management and other personnel; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the challenges in controlling additional costs and expenses in connection with and as a result of the
acquisition; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the need to write down assets or recognize impairment charges; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the diversion of our management&#146;s attention to integration of operations and corporate and administrative
infrastructures; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any unanticipated liabilities for activities of or related to the acquired business or its operations, products
or product candidates. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we fail to integrate or otherwise manage an acquired business successfully and in a timely
manner, resulting operating inefficiencies could increase our costs more than we planned, could negatively impact the market price of our ordinary shares and could otherwise distract us from execution of our strategy. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our business is subject to economic, political, regulatory and other risks associated with conducting business internationally.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently conduct clinical trials in the United States and in Germany and we plan to market our product candidates, if
approved, internationally. As a result, our business is subject to risks associated with conducting business internationally. Our future results could be harmed by a variety of factors, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">differing regulatory requirements in <FONT STYLE="white-space:nowrap">non-U.S.</FONT> countries;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">unexpected changes in tariffs, trade barriers, price and exchange controls and other regulatory requirements;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">differing standards for the conduct of clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">increased difficulties in managing the logistics and transportation of storing and shipping product candidates
produced in the United States or elsewhere and shipping the product candidate to patients in other countries; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">import and export requirements and restrictions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">economic weakness, including inflation, or political instability in foreign economies and markets;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">compliance with tax, employment, immigration and labor laws for employees living or traveling abroad;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">foreign taxes, including withholding of payroll taxes; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">foreign currency fluctuations, which could result in increased operating expenses and reduced revenue, and other
obligations incident to doing business in another country; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">difficulties staffing and managing foreign operations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">workforce uncertainty in countries where labor unrest is more common than in the United States or Germany;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">differing payor reimbursement regimes, governmental payors or patient
<FONT STYLE="white-space:nowrap">self-pay</FONT> systems, and price controls; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">potential liability under the FCPA or comparable foreign regulations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">challenges enforcing our contractual and intellectual property rights, especially in those foreign countries that
do not respect and protect intellectual property rights to the same extent as the United States or Germany; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">production shortages resulting from any events affecting raw material supply or manufacturing capabilities
abroad; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">business interruptions resulting from <FONT STYLE="white-space:nowrap">geo-political</FONT> actions, including
war and terrorism. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the formal change in the relationship between the United Kingdom and the European
Union, referred to as &#147;Brexit,&#148; may pose certain implications to our research, commercial and general business operations, including the approval and supply of our product candidates. On December&nbsp;24, 2020, the United Kingdom and
European Union agreed on a new Trade and Cooperation Agreement, and on December&nbsp;31, 2020, the United Kingdom formally left the transition period. The Trade and Cooperation Agreement is comprehensive but does not cover all areas of regulation
pertinent to the pharmaceutical industry, so certain complexities remain. This finalization of the long-term relationship between the United Kingdom and the European Union will dictate how the European Union will be impacted and may result in an
impact on our business operations in Europe. It may be time-consuming and expensive for us to alter our internal operations in order to comply with new regulations as a result of Brexit. Altered regulations could also add time and expense to the
process by which our product candidates receive regulatory approval in the United Kingdom and the European Union. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>If we fail to
maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results or prevent fraud. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Effective internal control over financial reporting is necessary for us to provide reliable financial reports and prevent fraud. Any failure to
implement required new or improved controls, or difficulties encountered in our implementation could cause us to fail to meet our reporting obligations. In addition, any testing conducted by us, or any testing conducted by our independent registered
public accounting firm, may reveal deficiencies in our internal control over financial reporting that are deemed to be material weaknesses or that may require prospective or retroactive changes to our financial statements or identify other areas for
further attention or improvement. Inferior internal controls could also cause investors to lose confidence in our reported financial information, which is likely to negatively affect our business and the market price of our ordinary shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are required to disclose changes made in our internal controls and procedures on a
quarterly basis and our management will be required to assess the effectiveness of these controls annually beginning with our fiscal year 2021. However, for as long as we are an &#147;emerging growth company&#148; under the JOBS Act, our independent
registered public accounting firm will not be required to attest to the effectiveness of our internal control over financial reporting pursuant to Section&nbsp;404(b) of the Sarbanes-Oxley Act of 2002 (the &#147;Sarbanes-Oxley Act&#148;). We could
be an &#147;emerging growth company&#148; for up to five years. An independent assessment of the effectiveness of our internal controls could detect problems that our management&#146;s assessment might not. Undetected material weaknesses in our
internal controls could lead to financial statement restatements and require us to incur the expense of remediation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We have
identified material weaknesses in our internal control over financial reporting. If we are unable to remediate these material weaknesses or otherwise fail to maintain an effective system of internal controls, we may not be able to accurately or
timely report our financial condition or results of operations, which may adversely affect our business and the price of our securities. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have identified material weaknesses in our internal control over financial reporting. A company&#146;s internal control over financial
reporting is a process designed by, or under the supervision of, a company&#146;s principal executive and principal financial officers, or persons performing similar functions, and effected by a company&#146;s board of directors, management and
other personnel to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with IFRS. A material weakness is a deficiency, or a combination of deficiencies, in internal
control over financial reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the audit of our consolidated financial statements for the year ended December&nbsp;31, 2020, our management identified
material weaknesses in our internal control over financial reporting primarily related to (i)&nbsp;clearly defined control processes, roles and segregation of duties within our business processes to ensure appropriate financial reporting, and
(ii)&nbsp;the design and operating effectiveness of IT general controls for information systems that are significant to the preparation of our consolidated financial statements. We have developed a remediation plan designed to address these material
weaknesses and other existing deficiencies. We have <FONT STYLE="white-space:nowrap">re-designed</FONT> the key processes and included significant measures to ensure an effective internal control over financial reporting. We are currently
implementing these processes to ensure operating effectiveness. In doing so, we rely on the assistance of external advisors with expertise in these matters. Additionally, we have and continue to train our accounting and finance staff and hired
financial reporting personnel, to develop and implement appropriate internal controls and reporting procedures. There can be no assurance that the measures we have taken to date, and actions we may take in the future, will be sufficient to remediate
the control deficiencies that led to these material weaknesses in our internal control over financial reporting or that they will prevent or avoid potential future material weaknesses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, neither our management nor an independent registered public accounting firm has performed an evaluation of our internal control
over financial reporting in accordance with the provisions of the Sarbanes-Oxley Act. Had we or our independent registered public accounting firm performed an evaluation of our internal control over financial reporting in accordance with the
provisions of the Sarbanes-Oxley Act, additional material weaknesses may have been identified. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Ownership of Our Securities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>The market price of our securities may be volatile and may fluctuate due to factors beyond our control. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The market price of shares of our securities could be subject to wide fluctuations in response to many risk factors listed in this &#147;Item
3. Key Information&#151;D. Risk Factors&#148; section, and others beyond our control, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">results and timing of preclinical studies and clinical trials of our product candidates; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">results of clinical trials of our competitors&#146; products; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">public concern relating to the commercial value or safety of any of our product candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our inability to adequately protect our proprietary rights, including patents, trademarks and trade secrets;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our inability to raise additional capital and the terms on which we raise it; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">commencement or termination of any strategic collaboration or licensing arrangement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulatory developments, including actions with respect to our products or our competitors&#146; products;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">actual or anticipated fluctuations in our financial condition and operating results; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">publication of research reports by securities analysts about us or our competitors or our industry;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our failure or the failure of our competitors to meet analysts&#146; projections or guidance that we or our
competitors may give to the market; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">additions and departures of key personnel; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">strategic decisions by us or our competitors, such as acquisitions, divestitures, spin-offs, joint ventures,
strategic investments or changes in business strategy; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the passage of legislation or other regulatory developments affecting us or our industry, including changes in
the structure of healthcare payment systems; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">fluctuations in the valuation of companies perceived by investors to be comparable to us; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">sales of our securities by us, our insiders or our other shareholders; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">speculation in the press or investment community; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">announcement or expectation of additional financing efforts; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in market conditions for biopharmaceutical stocks; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in general market and economic conditions. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the stock market has historically experienced significant volatility, particularly with respect to pharmaceutical, biotechnology
and other life sciences company stocks. The volatility of pharmaceutical, biotechnology and other life sciences company stocks often does not relate to the operating performance of the companies represented by the stock. As we operate in a single
industry, we are especially vulnerable to these factors to the extent that they affect our industry or our product candidates, or to a lesser extent, our markets. In the past, securities class action litigation has often been initiated against
companies following periods of volatility in their stock price. This risk is especially relevant for biotechnology companies, which have experienced significant stock price volatility in recent years. Securities litigation could result in
substantial costs and divert our management&#146;s attention and resources, and could also require us to make substantial payments to satisfy judgments or to settle litigation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our warrants may never be in the money and may expire worthless. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The exercise price for our warrants is $11.50 per ordinary share. Our warrants may never be in the money prior to their expiration, and as
such, the warrants may expire worthless. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Warrant holders will have no rights as ordinary shareholders until they acquire our
ordinary shares. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Until warrant holders acquire our ordinary shares upon exercise of such warrants, they will have no rights with
respect to our ordinary shares issuable upon exercise of such warrants, including the right to vote or respond to tender offers. Upon exercise of the warrants, holders will be entitled to exercise the rights of an ordinary shareholder only as to
matters for which the record date occurs after the exercise date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our operating results may fluctuate significantly or may fall below the expectations
of investors or securities analysts, each of which may cause the price of our securities to fluctuate or decline. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect our
operating results to be subject to fluctuations by numerous factors, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if any of our product candidates receives regulatory approval, the timing and the terms of such approval and
market acceptance and demand for such product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">variations in the level of expense related to the ongoing development of our product candidates or research
pipeline; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">results of clinical trials, or the addition or termination of clinical trials or funding support by us, or
existing or future collaborators or licensing partners; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our execution of any additional collaboration, licensing or similar arrangements, and the timing of payments we
may make or receive under existing or future arrangements, or the termination or modification of any such existing or future arrangements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developments or disputes concerning patents or other proprietary rights, including patents, litigation matters
and our ability to obtain patent protection for our products; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any intellectual property infringement lawsuit or any opposition, interference, cancellation or other
intellectual-property-related proceeding in which we may become involved; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">additions and departures of key personnel; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">strategic decisions by us or our competitors, such as acquisitions, divestitures, spin-offs, joint ventures,
strategic investments or changes in business strategy; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">fluctuations in the price of our ordinary shares; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulatory developments affecting our product candidates or those of our competitors; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in general market and economic conditions. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If our operating results fall below the expectations of investors or securities analysts, the price of our securities could decline
substantially. Furthermore, any fluctuations in our operating results may, in turn, cause the price of our securities to fluctuate substantially. We believe that quarterly comparisons of our financial results are not necessarily meaningful and
should not be relied upon as an indication of our future performance. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>If securities or industry analysts do not continue to publish
research, or publish inaccurate or unfavorable research, about our business, the price of our securities and our trading volume could decline. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The trading market for our securities depends, in part, on the research and reports that securities or industry analysts publish about us or
our business. If one or more of the analysts who cover us downgrade our securities or publish inaccurate or unfavorable research about our business, the price of our securities would likely decline. In addition, if our operating results fail to meet
the forecast of analysts, the price of our securities would likely decline. If one or more of these analysts cease coverage of our company or fail to publish reports on us regularly, demand for our securities could decrease, which might cause the
price and trading volume of our securities to decline. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>The issuance of ordinary shares in connection with the exercise of warrants
will dilute the ownership interest of the holders of our ordinary shares and may materially affect the trading price of our ordinary shares. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of February&nbsp;1, 2021, we had outstanding 7,187,500 warrants to purchase an equivalent number of our ordinary shares at an exercise price
of $11.50 per ordinary share. To the extent that warrant holders elect to exercise their warrants, substantial amounts of our ordinary shares may be issued in the future. We cannot quantify the number of ordinary shares that will be issued in
connection with the exercise, if any. However, the issuance of ordinary shares pursuant to such exercise could result in substantial dilution of the ownership interests of holders of our ordinary shares and could materially affect the trading price
of our ordinary shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We have never paid dividends and do not expect to pay any dividends in the foreseeable
future. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our articles of association prescribe that any profits in any financial year will be distributed first to holders of
financing preferred shares, if outstanding. Any remaining profits may be reserved by the Management Board subject to the approval of the Supervisory Board or, after July&nbsp;1, 2021, the Board. Any profits remaining thereafter and our reserves may
be distributed as dividends to the holders of our ordinary shares, subject to the appropriate record date. The general meeting will be authorized to declare distributions on the proposal of the Management Board, which proposal will require the prior
approval of the Supervisory Board or, after July&nbsp;1, 2021, the Board. We will have power to make distributions to shareholders only to the extent that our equity exceeds the aggregate amount of the issued share capital and the reserves which
must be maintained pursuant to Dutch law or by our articles of association. We may not make any distribution of profits on shares held by the company as treasury shares and such treasury shares will not be taken into account when determining the
profit entitlement of our shareholders. The Management Board or, after July&nbsp;1, 2021, the Board, determines whether and how much of the profit shown in the adopted annual accounts it will reserve and the manner and date of any dividend. In
addition, the Management Board is permitted, subject to Supervisory Board approval and subject to certain requirements, to declare interim dividends without the approval of the shareholders. We may reclaim any distributions, whether interim or not
interim, made in contravention of certain restrictions of Dutch law from shareholders that knew or should have known that such distribution was not permissible. In addition, on the basis of Dutch case law, if after a distribution we are not able to
pay our due and collectable debts, then our shareholders or directors who at the time of the distribution knew or reasonably should have foreseen that result may be liable to our creditors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have not paid any cash dividends since our incorporation. Even if future operations lead to significant levels of distributable profits, we
currently intend to reinvest any earnings in our business and do not anticipate declaring or paying any cash dividends until we have an established revenue stream to support continuing dividends. Further, since we are a holding company, our ability
to pay dividends will be dependent upon the financial condition, liquidity and results of operations of, and our receipt of dividends, loans or other funds from, our subsidiaries. Our subsidiaries are separate and distinct legal entities and have no
obligation to make funds available to us. In addition, there are various statutory, regulatory and contractual limitations and business considerations on the extent, if any, to which our subsidiaries may pay dividends, make loans or otherwise
provide funds to us. Accordingly, investors in our securities cannot rely on dividend income, and any returns on an investment in our securities will likely depend entirely upon any future appreciation in the price of such securities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Certain shareholders have representation on the Supervisory Board, and after July&nbsp;1, 2021, the Board, and have a substantial degree
of influence over us, which could delay or prevent a change of corporate control or result in the entrenchment of our management and/or directors. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Two of our principal shareholders, ARYA Sciences Holdings (&#147;ARYA Sponsor&#148;) and dievini Hopp BioTech holding GmbH&nbsp;&amp; Co. KG,
are represented on the Supervisory Board. As a result, such shareholders may be able to significantly influence the outcome of matters submitted for director action, subject to obligation of the Management Board and Supervisory Board or, after
July&nbsp;1, 2021, the Board to act in the interest of all of our stakeholders, and for shareholder action, including the designation and appointment of the Management Board and Supervisory Board and, after July&nbsp;1, 2021, the Board (and
committees thereof) and approval of significant corporate transactions, including business combinations, consolidations and mergers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To
the extent that the interests of our principal shareholders may differ from the interests of our other shareholders, the latter may be disadvantaged by any action that our principal shareholders may seek to pursue. The influence of such shareholders
over our management could also have the effect of delaying or preventing a change in control or otherwise discouraging a potential acquirer from attempting to obtain control of our company, which could cause the market price of our securities to
decline or prevent our shareholders from realizing a premium over the market price for our securities. Additionally, ARYA Sponsor is controlled by Perceptive Advisors LLC and its affiliates (&#147;Perceptive&#148;), which is in the business of
making investments in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
companies and which may from time to time acquire and hold interests in businesses that compete directly or indirectly with us or that supply us with goods and services. Perceptive may also
pursue acquisition opportunities that may be complementary to (or competitive with) our business, and as a result those acquisition opportunities may not be available to us. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We are organized and existing under the laws of the Netherlands, and, as such, the rights of our shareholders and the civil liability of
our directors and executive officers are governed in certain respects by the laws of the Netherlands. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are organized and
existing under the laws of the Netherlands, and, as such, the rights of our shareholders and the civil liability of our directors and executive officers are governed in certain respects by the laws of the Netherlands. The ability of our shareholders
in certain countries other than the Netherlands to bring an action against us, our directors and executive officers may be limited under applicable law. In addition, substantially all of our assets are located outside the United States. As a result,
it may not be possible for shareholders to effect service of process within the United States upon us or our directors and executive officers or to enforce judgments against us or them in U.S. courts, including judgments predicated upon the civil
liability provisions of the federal securities laws of the United States. In addition, it is not clear whether a Dutch court would impose civil liability on us or any of our directors and executive officers in an original action based solely upon
the federal securities laws of the United States brought in a court of competent jurisdiction in the Netherlands. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the date of this
Annual Report, the United States and the Netherlands do not have a treaty providing for the reciprocal recognition and enforcement of judgments, other than arbitration awards, in civil and commercial matters. Accordingly, a judgment rendered by a
court in the United States, whether or not predicated solely upon U.S. securities laws, would not automatically be recognized and enforced by the competent Dutch courts. However, if a person has obtained a final and conclusive judgment for the
payment of money rendered by a court in the United States that is enforceable in the United States and files a claim with the competent Dutch court, the Dutch court will generally give binding effect to such foreign judgment insofar as it finds that
(i)&nbsp;the jurisdiction of the U.S. court has been based on a ground of jurisdiction that is generally acceptable according to international standards, (ii)&nbsp;the judgment by the U.S. court was rendered in legal proceedings that comply with the
Dutch standards of proper administration of justice including sufficient safeguards (<I>behoorlijke rechtspleging</I>) and (iii)&nbsp;the judgment by the U.S. court is not incompatible with a decision rendered between the same parties by a Dutch
court, or with a previous decision rendered between the same parties by a foreign court in a dispute that concerns the same subject and is based on the same cause, provided that the previous decision qualifies for acknowledgment in the Netherlands
and except to the extent that the foreign judgment contravenes Dutch public policy (<I>openbare orde</I>). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on the lack of a treaty
as described above, U.S. investors may not be able to enforce against the company or our directors, representatives or certain experts named herein who are residents of the Netherlands or countries other than the United States any judgments obtained
in U.S. courts in civil and commercial matters, including judgments under the U.S. federal securities laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under our articles of
association, and certain other contractual arrangements between us and our directors, we will indemnify and hold our directors harmless against all claims and suits brought against them, subject to limited exceptions. There is doubt, however, as to
whether U.S. courts would enforce such indemnity provisions in an action brought against one of our directors in the United States under U.S. securities laws. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Provisions of our articles of association or Dutch corporate law might deter acquisition bids for us that our shareholders might
consider to be favorable and prevent or frustrate any attempt to replace or remove the Supervisory Board or Management Board at the time of such acquisition bid. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain provisions of our articles of association may make it more difficult for a third party to acquire control of the Supervisory Board,
Management Board or, after July&nbsp;1, 2021, the Board or effect a change in the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
composition of such boards. These provisions include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a provision that our directors can only be removed (or a binding nomination by the Supervisory Board or, after
July&nbsp;1, 2021, the Board or shareholders representing, individually or jointly, 10% of our issued share capital to appoint directors can only be set aside) by the shareholders by a majority of at least two thirds of the votes cast during a
general meeting, provided such votes represent more than half of the issued share capital (unless the removal was proposed by the Supervisory Board or, after July&nbsp;1, 2021, the Board, in which case a majority of votes cast representing more than
half of the issued share capital is required); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">pursuant to our articles of association, the Management Board and, after July&nbsp;1, 2021, the Board, is
irrevocably authorized for a period of five years from the date of the Business Combination, to issue ordinary shares which could enable us to dilute the holding of an acquirer by issuing ordinary shares to other parties. Issuances of ordinary
shares may make it more difficult for a shareholder or potential acquirer to obtain control over us; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a requirement that certain matters, including an amendment of our articles of association, may only be brought to
the shareholders for a vote upon a proposal by the Management Board, which proposal requires the prior approval of the Supervisory Board or, after July&nbsp;1, 2021, upon a proposal by the Board; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a provision implementing a staggered board, pursuant to which only one class of Supervisory Directors, or after
July&nbsp;1, 2021, our Directors, will be elected at each general meeting, with the other classes continuing for the remainder of their respective terms. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Such provisions could discourage a takeover attempt and impair the ability of shareholders to benefit from a change in control and realize any
potential change of control premium. This may adversely affect the market price of our securities. See &#147;Item 10. Additional Information&#151;B. Memorandum and Articles of Association.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our shareholders may not have any preemptive rights in respect of future issuances of our ordinary shares. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of an increase in our share capital by way of an issue of our ordinary shares, holders of our ordinary shares are generally
entitled under Dutch law to full preemptive rights, unless these rights are limited or excluded either by a resolution of the general meeting or by a resolution of the Management Board, subject to the prior approval of the Supervisory Board or,
after July&nbsp;1, 2021, the Board (if authorized by the general meeting for this purpose), or where shares are issued to our employees or a group company (i.e., certain affiliates, subsidiaries or related companies) or paid up by means of a <FONT
STYLE="white-space:nowrap">non-cash</FONT> contribution, or in case of an exercise of a previously acquired right to subscribe for shares. The same preemptive rights apply when rights to subscribe for shares are granted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under our articles of association, the preemptive rights in respect of newly issued ordinary shares may be restricted or excluded by a
resolution of the general meeting, which resolution requires a <FONT STYLE="white-space:nowrap">two-thirds</FONT> majority of the votes cast if less than half of the issued share capital is present or represented at the meeting. The general meeting
may authorize the Management Board, subject to the prior approval of the Supervisory Board or, after July&nbsp;1, 2021, the Board to limit or exclude the preemptive rights in respect of newly issued ordinary shares. Such authorization for the
Management Board, subject to the prior approval of the Supervisory Board or, after July&nbsp;1, 2021, the Board can be granted and extended, in each case for a period not exceeding five years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to our resolution of the general meeting dated June&nbsp;30, 2020, the Management Board is irrevocably authorized for a period of
five years from the date of the Business Combination to limit or exclude preemptive rights on our ordinary shares up to 100% of the number of our ordinary shares in our authorized share capital (from time to time). Accordingly, holders of our
ordinary shares may not have any preemptive rights in connection with, and may be diluted by, an issue of new ordinary shares and it may be more difficult for a shareholder to obtain control over the general meeting. See &#147;Item 10. Additional
Information&#151;B. Memorandum </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and Articles of Association.&#148; Further, certain of our ordinary shareholders outside the Netherlands, in particular, U.S. ordinary shareholders, may not be allowed to exercise preemptive
rights to which they are entitled, if any, unless a registration statement under the Securities Act is declared effective with respect to ordinary shares issuable upon exercise of such rights or an exemption from the registration requirements is
available. Preemptive rights do not exist with respect to the issue of financing preferred shares and holder of financing preferred shares have no preemptive right to acquire newly issued ordinary shares. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We are not obligated to and do not comply with all the best practice provisions of the DCGC. This could adversely affect the rights of
our shareholders. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As we have our registered office in the Netherlands and our ordinary shares are listed on the Nasdaq, we are
subject to the Dutch Corporate Governance Code, as of December&nbsp;8, 2016 and as amended from time to time (the &#147;DCGC&#148;). The DCGC contains both principles and best practice provisions for the Management Board, the Supervisory Board or,
after July&nbsp;1, 2021, the Board, shareholders and the general meeting, financial reporting, auditors, disclosure compliance and enforcement standards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The DCGC is based on a &#147;comply or explain&#148; principle. Accordingly, we are required to disclose in our management report publicly
filed in the Netherlands, whether or not we are complying with the various provisions of the DCGC. If we do not comply with one or more of those provisions (e.g., because of a conflicting Nasdaq requirement or U.S. market practice), we are required
to explain the reasons for such <FONT STYLE="white-space:nowrap">non-compliance.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We acknowledge the importance of good corporate
governance. However, we do not comply with all the provisions of the DCGC, to a large extent because such provisions conflict with or are inconsistent with the corporate governance rules of the Nasdaq and U.S. securities laws applicable to us, or
because we believe such provisions do not reflect customary practices of global companies listed on Nasdaq. This could adversely affect the rights of our shareholders and our shareholders may not have the same level of protection as a shareholder in
a Dutch company that fully complies with the DCGC. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We are a foreign private issuer, and, as a result, we are not subject to certain
rules and obligations that are applicable to a U.S. domestic public company and are not subject to certain Nasdaq corporate governance listing standards that are applicable to a Nasdaq-listed U.S. domestic public company. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We report under the Exchange Act as a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> company with foreign private issuer status. Because we
qualify as a foreign private issuer under the Exchange Act and although we furnish quarterly financial information to the SEC, we are exempt from certain provisions of the Exchange Act that are applicable to U.S. domestic public companies, including
(i)&nbsp;the sections of the Exchange Act regulating the solicitation of proxies, consents or authorizations in respect of a security registered under the Exchange Act; (ii)&nbsp;the sections of the Exchange Act requiring insiders to file public
reports of their stock ownership and trading activities, and liability for insiders who profit from trades made in a short period of time; and (iii)&nbsp;the rules under the Exchange Act requiring the filing with the SEC of quarterly reports on Form
<FONT STYLE="white-space:nowrap">10-Q</FONT> containing unaudited financial and other specified information, or current reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> upon the occurrence of specified significant events. In addition,
foreign private issuers are not required to file their annual report on Form <FONT STYLE="white-space:nowrap">20-F</FONT> until four months after the end of each financial year, while U.S. domestic issuers are required to file their annual report on
Form <FONT STYLE="white-space:nowrap">10-K</FONT> in less time. Foreign private issuers are also exempt from the Regulation Fair Disclosure, aimed at preventing issuers from making selective disclosures of material information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, because we are a foreign private issuer, we have elected to comply with our home country governance requirements and certain
exemptions thereunder, rather than complying with certain of the Nasdaq corporate governance listing standards that are applicable to U.S. companies listed on the Nasdaq. Furthermore, Nasdaq listing standards generally require Nasdaq-listed U.S.
companies to, among other things, seek shareholder approval for the implementation of certain equity compensation plans and issuances of securities, which we are not required to follow as a foreign private issuer. Accordingly, our shareholders may
not have the same protections afforded to shareholders of companies that are not foreign private issuers. See &#147;Item 16G. Corporate Governance.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We may lose our foreign private issuer status, which would then require us to comply
with the Exchange Act&#146;s domestic reporting regime and cause us to incur significant legal, accounting and other expenses. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
are a foreign private issuer, and therefore we are not required to comply with all of the periodic disclosure and current reporting requirements of the&nbsp;Exchange Act&nbsp;applicable to U.S. domestic issuers. We may no longer be a foreign private
issuer as of June&nbsp;30, 2021, which would require us to comply with all of the periodic disclosure and current reporting requirements of the&nbsp;Exchange Act&nbsp;applicable to U.S. domestic issuers, as of January&nbsp;1, 2022. In order to
maintain our current status as a foreign private issuer, either (a)&nbsp;a majority of our ordinary shares must be either directly or indirectly owned of record by <FONT STYLE="white-space:nowrap">non-residents</FONT> of the United States or (b)(i)
a majority of our executive officers or directors may not be United States citizens or residents, (ii)&nbsp;more than 50% of our assets cannot be located in the United States and (iii)&nbsp;our business must be administered principally outside the
United States. If we lose this status, we would be required to comply with the&nbsp;Exchange Act&nbsp;reporting and other requirements applicable to U.S. domestic issuers, which are more detailed and extensive than the requirements for foreign
private issuers. We may also be required to make changes in our corporate governance practices in accordance with various SEC and stock exchange rules. The regulatory and compliance costs to us under U.S. securities laws if we are required to comply
with the reporting requirements applicable to a U.S. domestic issuer may be significantly higher than the cost we would incur as a foreign private issuer. As a result, we expect that a loss of foreign private issuer status would increase our legal
and financial compliance costs and would make some activities highly time-consuming and costly. We also expect that if we were required to comply with the rules and regulations applicable to U.S. domestic issuers, it would be more difficult and
expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced coverage or incur substantially higher costs to obtain coverage. These rules and regulations could also make it more difficult for us to
attract and retain qualified members of our board of directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We are an emerging growth company, and we cannot be certain if the
reduced reporting requirements applicable to emerging growth companies make our ordinary shares less attractive to investors. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
are an &#147;emerging growth company,&#148; as defined in the JOBS Act. For as long as we continue to be an emerging growth company, we may take advantage of exemptions from various reporting requirements that are applicable to other public
companies that are not emerging growth companies, including, but not limited to, (i)&nbsp;not being required to comply with the auditor attestation requirements of Section&nbsp;404 of the Sarbanes-Oxley Act, (ii)&nbsp;reduced disclosure obligations
regarding executive compensation in this prospectus and our periodic reports and proxy statements and (iii)&nbsp;exemptions from the requirements of holding a nonbinding advisory vote on executive compensation. In addition, as an emerging growth
company, we are required to provide only two years of audited financial statements and two years of selected financial data in our initial registration statement, compared to three and five years, respectively, for comparable data reported by other
public companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We could be an emerging growth company for up to five years from ARYA Sciences Acquisition Corp.&#146;s initial public
offering, although circumstances could cause us to lose that status earlier, including if the market value of our ordinary shares held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> equals or exceeds $700&nbsp;million as of any
June&nbsp;30 (the end of our second fiscal quarter) before that time or if we have total annual gross revenues of $1.07&nbsp;billion or more during any fiscal year before that time, in which cases we would no longer be an emerging growth company as
of the following December&nbsp;31 (our fiscal year end); or, if we issue more than $1.0&nbsp;billion in <FONT STYLE="white-space:nowrap">non-convertible</FONT> debt during any three-year period before that time, we would cease to be an emerging
growth company immediately. Even after we no longer qualify as an emerging growth company, we may still qualify as a &#147;smaller reporting company,&#148; which would allow us to take advantage of many of the same exemptions from disclosure
requirements, including not being required to comply with the auditor attestation requirements of Section&nbsp;404 of the Sarbanes-Oxley Act and reduced disclosure obligations regarding executive compensation in our periodic reports and proxy
statements. We cannot predict if investors will find our securities less attractive because we may rely on these exemptions. If some investors find our securities less attractive as a result, there may be a less </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">active trading market for our securities and the price of our securities may be more volatile. When these exemptions cease to apply, we expect to incur
additional expenses and devote increased management effort </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
towards ensuring compliance with them, and we cannot predict or estimate the amount or timing of such additional costs. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We may be or may become a PFIC, which could result in adverse U.S. federal income tax consequences to U.S. holders. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we or any of our subsidiaries is a passive foreign investment company (a &#147;PFIC&#148;) for any taxable year, or portion thereof, that is
included in the holding period of a beneficial owner of our ordinary shares that is a U.S. Holder, such U.S. Holder (as defined in &#147;Item 10. Additional Information&#151;E. Taxation&#151;Material U.S. Federal Income Tax Considerations for U.S.
Holders&#148;), may be subject to certain adverse U.S. federal income tax consequences and may be subject to additional reporting requirements. It is uncertain whether we or any of our subsidiaries, including Immatics OpCo, will be treated as a PFIC
for U.S. federal income tax purposes for 2020 or for the current or any subsequent tax year. If we determine that we and/or any of our subsidiaries is a PFIC for any taxable year, we intend to provide a U.S. Holder with such information necessary
for the U.S. Holder to make and maintain a QEF Election (as defined in &#147;Item 10. Additional Information&#151;E. Taxation&#151;Material U.S. Federal Income Tax Considerations for U.S. Holders&#148;) with respect to us and/or such subsidiaries,
but there can be no assurance that we will have timely knowledge of our status as a PFIC in the future or of the required information to be provided. See &#147;Item 10. Additional Information&#151;E. Taxation&#151;Material U.S. Federal Income Tax
Considerations for U.S. Holders.&#148; Prospective U.S. Holders of our ordinary shares or warrants are urged to consult their tax advisors regarding the possible application of the PFIC rules to them. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_13"></A>ITEM&nbsp;4. INFORMATION ON THE COMPANY </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_14"></A>A. History and Development of the Company </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We were incorporated as a Dutch private limited liability company (<I>besloten vennootschap met beperkte aansprakelijkheid</I>) under the name
Immatics B.V. on March&nbsp;10, 2020 solely for the purpose of effectuating the business combination (the &#147;Business Combination&#148;) between us, ARYA Sciences Acquisition Corp., a Cayman Islands exempted company (&#147;ARYA&#148;), Immatics
Biotechnologies GmbH, a German limited liability company, Immatics Merger Sub 1, a Cayman Islands exempted company, and Immatics Merger Sub 2, a Cayman Islands exempted company. Upon the closing of the Business Combination on July&nbsp;1, 2020, we
converted into a Dutch public limited liability company (<I>naamloze vennootschap</I>) and changed our name to Immatics N.V. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the
Business Combination, we did not conduct any material activities other than those incident to our formation and certain matters related to the Business Combination, such as the making of certain required securities law filings and the establishment
of subsidiaries to effect the Business Combination. Upon the closing of the Business Combination, Immatics OpCo became the direct, wholly owned subsidiary of Immatics, and holds all material assets and conducts all business activities and operations
of Immatics. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are registered in the Commercial Register of the Chamber of Commerce (<I>Kamer van Koophandel</I>) in the Netherlands
under number 77595726. We have our corporate seat in Amsterdam, the Netherlands and our registered office is at Paul-Ehrlich-Stra&szlig;e 15, 72076 T&uuml;bingen, Federal Republic of Germany, and our telephone number is +49 (7071) <FONT
STYLE="white-space:nowrap">5397-0.</FONT> Our executive office in the United States is located at Immatics US, Inc., 2130 W. Holcombe Boulevard, Houston, Texas, 77030 and our telephone number is +1 (346)
<FONT STYLE="white-space:nowrap">204-5400.</FONT> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_15"></A>B. Business Overview </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a clinical-stage
biotechnology company dedicated to the development of T cell receptor (&#147;TCR&#148;)-based immunotherapies for the treatment of cancer. Our focus is the generation of novel therapeutic options for solid tumor patients. Solid tumors constitute the
majority of all malignancies, and relapsed and/or refractory solid </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
tumor patients have an unmet medical need. We believe that by identifying true cancer targets and the right TCRs, we will be well positioned to transform current solid tumor treatment paradigms
by delivering cellular and bispecific product candidates that have the potential to improve the lives of cancer patients. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">One of the
challenges of effectively treating solid tumors is the lack of cancer-specific targets. By utilizing <FONT STYLE="white-space:nowrap">TCR-based</FONT> therapeutics, we are capable of directing T cells not only to targets on the surface of the cancer
cell but also to intracellular cancer targets that are not accessible through classical antibody-based or <FONT STYLE="white-space:nowrap">CAR-T</FONT> therapies. We have developed a suite of proprietary technologies to identify what we refer to as
&#147;true targets&#148; and &#147;right TCRs.&#148; True targets are (i)&nbsp;naturally occurring at significant levels on native human tumor tissue, and (ii)&nbsp;highly specific to cancer cells. Right TCRs are (i)&nbsp;high-affinity TCRs, and
(ii)&nbsp;highly specific to the respective cancer target, with no or minimized cross-reactivities to healthy tissues. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that
the elucidation of these targets provides us the opportunity to develop a pipeline of <FONT STYLE="white-space:nowrap">novel&nbsp;TCR-based&nbsp;product</FONT> candidates that generate a meaningful therapeutic impact on the lives of cancer patients
by going beyond an incremental clinical benefit. We are developing our targeted immunotherapy product candidates through two distinct treatment modalities: Adoptive Cell Therapies (&#147;ACT&#148;) and antibody-like Bispecifics. Each modality is
designed with distinct attributes to produce the desired therapeutic effect for patients at different disease stages and with different types of tumors. Our current proprietary pipeline presented in <B>Figure 1</B> comprises seven therapeutic
programs, three of which are being evaluated in clinical trials. In addition, we are collaborating with world-leading partners, including Amgen, Genmab, Bristol-Myers Squibb and GlaxoSmithKline, to develop ten additional therapeutic programs
covering ACT and Bispecifics. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Figure 1. Immatics Therapeutic Pipeline </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g149615g68r14.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;Phase&nbsp;1a: Dose escalation, Phase 1b: Dose expansion </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Adoptive Cell Therapy </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our clinical product class ACTengine is based on genetically modifying a patient&#146;s own T cells to express a novel proprietary TCR. The
modified T cells are then reinfused into the patient to attack the tumor, an approach also known as <FONT STYLE="white-space:nowrap">TCR-T.</FONT> We believe that ACTengine is a potent therapy designed to deliver patient benefit even in
advanced-stage disease, which is often accompanied with high tumor burden that is difficult to treat with other approaches. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are currently developing three ACTengine product candidates, which are being evaluated in
Phase 1 clinical trials: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>IMA201:</B> IMA201 T cells are designed to target a peptide derived from melanoma-associated antigen 4 and/or
8 (&#147;MAGEA4/A8&#148;) in patients with relapsed and/or refractory solid tumors. The Phase 1 clinical trial investigating IMA201 focuses on solid tumor indications that include
<FONT STYLE="white-space:nowrap">squamous&nbsp;non-small&nbsp;cell</FONT> lung carcinoma (&#147;squamous NSCLC&#148;), head and neck squamous cell carcinoma (&#147;HNSCC&#148;), and subtypes of sarcoma due to the high prevalence of MAGEA4/8
expression in these tumor indications. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>IMA202:</B> IMA202 T cells are designed to target a peptide derived from melanoma-associated antigen 1
(&#147;MAGEA1&#148;) in patients with relapsed and/or refractory solid tumors. The Phase 1 clinical trial investigating IMA202 focuses on solid tumor indications that include squamous NSCLC, hepatocellular carcinoma (&#147;HCC&#148;) and melanoma.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>IMA203:</B> IMA203 T cells are designed to target a peptide derived from the preferentially expressed antigen
in melanoma (&#147;PRAME&#148;) in patients with relapsed and/or refractory solid tumors. The Phase 1 clinical trial investigating IMA203 focuses on solid tumor indications with a high prevalence of PRAME expression, including uterine cancer
(endometrial cancer and uterine carcinoma), ovarian cancer, melanoma, subtypes of sarcoma and squamous NSCLC. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In March
2021, we reported combined interim data from the Phase 1 dose-escalation stage of our ongoing ACT (IMA201, IMA202 and IMA203) clinical trials. As of the data <FONT STYLE="white-space:nowrap">cut-off,</FONT> February&nbsp;16, 2021, 10 patients were
treated with our ACT product candidates. With respect to safety signals, we did not observe any DLTs in the IMA201 and IMA202 study. One patient receiving IMA203 experienced a DLT at dose level 2, as defined in the trial protocol. The reaction was
transient and fully resolved within 48 hours after onset. The DLT triggered the expansion of dose level 2 from three to six patients. With respect to activity signals, we observed that T cells engrafted in all patients and persisted until the end of
the observation period. Despite dosing at dose levels within early dose-escalation stage, initial disease stabilization across all trials was observed in all but one patient and tumor shrinkage was observed in 8 out of 10 patients. A substantial
decline (&gt;30%) of target lesions was observed in 2 out of 10 of patients, and one patient experienced a partial response (which was unconfirmed as of data <FONT STYLE="white-space:nowrap">cut-off).</FONT> After completion of the dose-escalation
stage of the clinical trials, we intend to recruit patients at the target dose in all three clinical trials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to our
clinical-stage ACT product candidates, we also have a pipeline of preclinical product candidates. IMA204 is our ACTengine product candidate designed to target COL6A3 exon 6, which is a novel, proprietary tumor stroma target. The rigid stroma and the
immunosuppressive microenvironment of solid tumors play a crucial role in tumor initiation, progression and metastasis by providing a protective layer against the body&#146;s immune system and pose a well-known obstacle to T cell accessibility and
activity. We believe that targeting this compartment could provide a novel approach for the treatment of many solid tumors and anticipate submitting a clinical trial application for IMA204 in the second half of 2021. In addition to IMA204, we are
developing an allogeneic preclinical-stage approach (ACTallo) and five additional preclinical ACT programs in strategic collaborations with our industry-leading partners, Bristol-Myers Squibb and GlaxoSmithKline. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All our clinical-stage ACTengine product candidates are manufactured utilizing our proprietary manufacturing process. We have developed this
process with the objective to generate &#147;young&#148; T cells to enhance T cell engraftment and persistence in vivo within a manufacturing period of approximately one week. Manufacturing for our clinical trials is conducted by Immatics personnel
at a facility run in collaboration with the University of Texas in Houston, Texas. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Bispecifics </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to our ACT pipeline, we are also developing Bispecific T cell engaging receptors. Our proprietary TCR Bispecifics (TCER) are engineered <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;off-the-shelf&#148;</FONT></FONT> biologics consisting of a portion of the TCR that directly </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
recognizes cancer cells and a T cell recruiter domain that recruits and activates T&nbsp;cells. TCER are designed to attract patients&#146; circulating T cells to bind to and come into direct
proximity with the cancer cells to destroy them. They are intended for the treatment of both early-stage cancer patients with <FONT STYLE="white-space:nowrap">de-bulked</FONT> tumors as well as advanced-stage cancer patients with reduced tumor
burden. Due to their <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">off-the-shelf</FONT></FONT> availability and less complex treatment regimen, we believe TCER might be a lower cost therapy as compared to ACT and could be
distributed through classical pharmaceutical supply chains, reaching a broad patient population analogous to classical antibody-based biologics. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are currently developing two TCER candidates, which are being evaluated in preclinical studies: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>IMA401:</B> IMA401 is directed against a peptide derived from MAGEA4/8, which is highly prevalent in several
solid tumors. Having delivered preclinical PoC <I>in vivo</I> and <I>in vitro</I>, we anticipate submitting a clinical trial application for IMA401 towards year end 2021. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>IMA402:</B> IMA402 is directed against a peptide derived from an undisclosed cancer-testis antigen prevalent
in a broad range of solid tumors. We plan to start cGMP manufacturing activities in the first half of 2021 to further advance IMA402 towards IND and clinical development. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to our proprietary TCER programs, we are developing five additional antibody and <FONT STYLE="white-space:nowrap">TCR-based</FONT>
Bispecific immunotherapies in strategic collaborations with industry-leading partners, Amgen and Genmab. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our Platforms </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our pipeline has been built using our technology platforms. Our proprietary target discovery platform XPRESIDENT identifies cancer targets that
are presented at significant levels on native tumor tissues but not, or to a far lesser extent, on healthy tissues. Once a suitable target is identified, we leverage our proprietary TCR discovery platform XCEPTOR to develop and engineer cognate TCRs
against these targets. Our product development is based upon our unique ability to screen for relevant <FONT STYLE="white-space:nowrap">on-target</FONT> toxicities on healthy tissues and cross-reactivities in early preclinical development, which
allows us to focus and advance only the most promising TCR candidates towards clinical trial application. Our pool of more than 200 prioritized targets, our TCRs and our technological <FONT STYLE="white-space:nowrap">know-how</FONT> are protected by
a patent estate covering more than 400 patents in the United States and in excess of 1,550 patents globally as of February&nbsp;1, 2021. We believe that with our protected technology and our target base, we are uniquely positioned to advance and
maximize the value of our pipeline. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our Team </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our management team includes the creators and developers of our core technologies, whose expertise, experience and innovations we continue to
leverage, as well as medical and scientific experts and accomplished business leaders. Our management team brings extensive experience in oncology, research and development, clinical development, CMC and regulatory and compliance, having held senior
positions in such companies as GSK, Roche, Micromet, BioNTech and others. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Strategy </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our mission is to deliver the power of T cells to cancer patients. We are developing immunotherapies that are designed to provide a meaningful
impact on the lives of cancer patients to achieve effects beyond an incremental clinical benefit. We are focusing on the treatment of patients with solid tumors who remain inadequately served by existing treatment modalities. We leverage our true
cancer targets and the matching TCRs to potentially substantially lengthen the duration and improve the quality of cancer patients&#146; lives. By doing so, we strive to become an industry leading, global, integrated biopharmaceutical company,
engaged in developing, manufacturing and marketing TCR immunotherapies for the benefit of cancer patients, employees, shareholders </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and partners. Specifically, we seek to execute the following strategy to maximize the value of our technology platforms and broad portfolio of product candidates: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Advance our pipeline of ACTengine product candidates through clinical development.</B> Our ACTengine IMA200
series includes three product candidates in Phase 1 clinical trials (IMA201, IMA202, IMA203) investigating safety, tolerability, biological efficacy and initial signs of clinical response in patients suffering from various types of solid tumors. In
March 2021, we reported combined interim data from the Phase 1 dose-escalation stage of these clinical trials, which showed biological activity, a manageable safety profile, and early signs of anti-tumor activity. We intend to continue to advance
the three clinical-stage product candidates through clinical development as well as advance our IMA204 preclinical product candidate towards clinical trial application in the second half of 2021. Moreover, we are actively investigating multiple
next-generation enhancement strategies (e.g., CD8 <FONT STYLE="white-space:nowrap">co-transduction)</FONT> to render T cells even more potent to combat solid tumors. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Advance our preclinical TCR Bispecifics pipeline towards IND application.</B> We intend to continue advancing
for our TCER programs, IMA401 and IMA402, towards IND application and into clinical development. We anticipate that we will submit a clinical trial application for IMA401 towards year end 2021 and enter cGMP development and <FONT
STYLE="white-space:nowrap">IND-enabling</FONT> activities for IMA402 in the first half of 2021. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Further enhance our manufacturing capabilities.</B> Our proprietary ACTengine manufacturing process aims to
generate cell product candidates within a manufacturing time of approximately one week to deliver young T cells with high proliferative capacity. These cells are designed to infiltrate the patient&#146;s tumor and function in a challenging solid
tumor microenvironment. After showing clinical PoC in early-stage clinical trials, we may engage a contract manufacturing organization (&#147;CMO&#148;) or build or acquire a fully integrated <FONT STYLE="white-space:nowrap">in-house</FONT>
manufacturing facility. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Expand our intellectual property portfolio.</B> We intend to continue building our intellectual property
portfolio in the field of cancer targets, TCRs and technologies. Our portfolio currently includes over 3,500 worldwide active patent applications and more than 1,550 secured patents, of which over 400 are granted in the United States. The protection
of our intellectual property assets is a foundational element of our ability to not only strengthen our product pipeline, but also to successfully defend and expand our position in the field of TCR therapies. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Leverage the full potential of strategic collaborations. </B>Our discovery platforms form the basis of our
collaborations with industry-leading partners including Amgen, Genmab, Bristol-Myers Squibb and GlaxoSmithKline, which involve a total of ten proprietary targets. We intend to continue to maximize the value from these strategic collaborations
through milestone payments and royalties for product candidates that successfully advance into and through clinical development and towards commercial launch. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Enhance the competitive edge of our technology platforms.</B> Our target and TCR discovery platforms
XPRESIDENT and XCEPTOR are the foundation for strengthening our product pipeline and our position in the field of <FONT STYLE="white-space:nowrap">TCR-based</FONT> therapies. To maintain our competitive edge, we intend to continue identifying and
validating true targets and right TCRs to improve outcomes for patients across a broad range of cancers. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Extend the impact of immunotherapy through a novel personalized <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">multi-TCR-T</FONT></FONT> approach.</B> We expect to have the opportunity to take the first step towards <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">multi-TCR-T</FONT></FONT> immunotherapy through
treatment of patients using a combination therapy approach of both anti-tumor and anti-tumor stroma ACTengine product candidates after clinical PoC for the individual TCRs. We aim to establish a TCR warehouse consisting of TCRs targeting multiple
cancer targets and HLA alleles to expand the treatable patient population, reduce the likelihood for tumors to evade immunotherapy and prolong durability of clinical responses. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Introduction&nbsp;&amp; Approach </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Current Cancer Immunotherapies </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cancer incidence continues to increase globally. Despite advances in treatment options, in 2020, cancer ranks second to cardiovascular disease
as an overall cause of mortality in the United States. It is characterized by the uncontrolled growth of abnormal cells whose ability to evade the immune system&#146;s surveillance is a key factor in their proliferation and persistence. In
particular, the prognosis of patients with advanced, recurrent or refractory solid tumors generally is poor, resulting in high unmet medical need. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In recent years, the field of cancer immunotherapy, a form of cancer treatment utilizing a patient&#146;s own immune system to specifically
seek and destroy cancer cells, has significantly changed the standard of care in many segments of oncology and has emerged as a major pillar in cancer treatment. Some <FONT STYLE="white-space:nowrap">end-stage</FONT> cancer patients have experienced
tumor reductions and long-term benefits through immunotherapy. Although treatments with immunotherapy, including checkpoint <FONT STYLE="white-space:nowrap">inhibitors,&nbsp;CAR-T&nbsp;cells</FONT> and monoclonal antibodies, have produced durable
responses mainly in hematological cancers and tumors with high mutational load, the majority of cancers, particularly among solid tumors, typically do not respond well to current immunotherapeutic approaches. This absence of clinical efficacy in
solid tumors is attributable in part to the lack of suitable cancer antigens, heterogeneity of the tumor, the immunosuppressive environment of solid tumors and the cancer cells&#146; escape mechanisms. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Empowering T cells to Address the Unmet Medical Need of Solid Tumor Patients </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">T cells are critical actors in staging an effective immune response against diseased and abnormal cells, such as cancer cells. The human
leukocyte antigen (&#147;HLA&#148;) system is an important part of the immune system because it has the ability to present antigenic peptides (&#147;pHLA targets&#148;) derived from intracellular proteins on the surface of the cell to be recognized
by the T cell receptor. Due to their biologic purpose to bind to peptides presented by HLA molecules (&#147;pHLA targets&#148;), TCRs can target antigens originating from inside the cell. By using pHLA cancer targets, we are broadening the view of
therapeutics from outside to also inside the cell, such that TCRs represent a new therapeutic opportunity for leveraging the power of T cells. Our investigational immunotherapies are designed to use the potency and specificity of natural and
engineered TCRs to attack and kill cancer cells. <B>Figure 2</B> summarizes our approach to transforming treatment paradigms in solid tumors: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Figure 2. Immatics&#146; Approach to Transforming the Solid Tumor Treatment Paradigms </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g149615g72f51.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>True Cancer Targets</B><B></B><B>&nbsp;&amp; Matching Right TCRs</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe the starting point for developing safe and effective immunotherapies is selecting true cancer targets. We define &#147;true
targets&#148; as structures that are (1)&nbsp;presented on native tumors and (2)&nbsp;presented at significant levels on native tumor tissues but not, or to a far lesser extent, on healthy tissues. We first identify and validate these target
peptides through our proprietary target discovery and characterization platform XPRESIDENT. XPRESIDENT is based on ultra-sensitive, high-throughput quantitative mass spectrometry-based peptide sequencing and allows access to pHLA targets derived
from well-known tumor antigens (such as the MAGE antigen family) as well as to tap into novel target spaces including pHLA targets derived from so far uncharacterized parent proteins (such as COL6A3 exon 6) or so called crypto-targets (such as
shared neoantigens). With more than 15 years of research, we have selected more than 8000 tumor-associated pHLA targets covered by hundreds of patent applications and are now focusing on more than 200 prioritized pHLA targets covering various highly
abundant HLA allotypes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Once a true target is found, we identify and characterize the right matching TCR utilizing our XCEPTOR platform.
TCR characterization is critical to ensure high affinity binding of the TCR specifically to the tumor target without or with minimized cross-recognition to healthy tissues. Our XPRESIDENT target database is essential in the process of characterizing
TCRs. It contains an extensive archive of normal tissue profiles which is used to filter out cross-reactive TCRs early in the preclinical development process and focus our preclinical and clinical development efforts on the most promising,
&#147;right TCRs.&#148; </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>A Targeted Approach in Two Distinct Modalities: Adoptive Cell Therapy</B><B></B><B>&nbsp;&amp; TCR
Bispecifics </B> </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are addressing the needs of solid tumor patients at different stages of disease by developing two <FONT
STYLE="white-space:nowrap">TCR-based</FONT> modalities with distinct mechanisms of action: ACT and TCR Bispecifics (TCER). Both modalities offer a complementary profile regarding mode of deployment and suitable patient populations. We believe that
ACT has the potential to improve patient benefit even in advanced-stage disease, which is often accompanied with a high tumor burden that is difficult to treat with other approaches but requires specialized medical centers and a more intricate
personalized autologous supply chain. In contrast, TCER are engineered <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">off-the-shelf</FONT></FONT> biologics deployed through classical pharmaceutical supply chains. We believe TCER
is a lower cost therapy compared to cell therapies, that can be applied more rapidly without waiting times for the patient and have their highest potential to improve patient benefit in earlier-stage disease with
<FONT STYLE="white-space:nowrap">de-bulked</FONT> tumors as well as in advanced-stage disease with reduced tumor burden. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Enhanced Manufacturing to Enhance T Cell Persistence</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To generate a meaningful impact for solid tumor patients, it is crucial for T cells to engraft and persist in the patient, enabling their
infiltration into the patient&#146;s tumor and function in a challenging solid tumor microenvironment. Our proprietary ACT manufacturing process has been designed to generate genetically engineered T cells with a young phenotype and high
proliferative capacity aiming to function in a traditionally challenging solid tumor microenvironment. In addition, we are investigating next-generation enhancement strategies to further improve the potency of our manufactured T cell products. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Targeting the Stroma Within the Tumor Microenvironment </B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The tumor microenvironment is a dynamic network composed of immune cells, blood vessels, stromal cells, signaling molecules and the
extracellular matrix, which imposes a significant barrier to therapeutic approaches. The immunosuppressive environment, together with the rigid extracellular matrix, inhibit drugs and T cells from accessing the tumor. Strategies to overcome these
cancer protection mechanisms are a focus of our development plan. IMA204 is directed towards COL6A3 exon 6, a target that is predominantly expressed by tumor stromal cells but not, or to a far lesser extent, by healthy tissues. We believe that with
IMA204 we can overcome the suppressive tumor microenvironment of solid tumors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Combating Tumor Heterogeneity and Escape</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The tumor of each cancer patient evolves during the disease. As a result, the tumor becomes more heterogenous with <FONT
STYLE="white-space:nowrap">co-existing</FONT> <FONT STYLE="white-space:nowrap">sub-populations</FONT> of tumor cell clones. The associated intra-tumoral heterogeneity of target expression is known to contribute to tumor escape and consequently to
treatment failures and recurrence of the tumor. We are developing an approach that we believe allows treatments to pursue multiple cancer targets per patient at the same time. We are creating a library (or &#147;warehouse&#148;) of TCRs covering
multiple pHLA targets and HLA allotypes. As a result of our access to more than 200 prioritized true targets and our rapid TCR discovery and engineering process, we believe that we are uniquely positioned to develop such multi-targeted therapies. A
first PoC for this approach was demonstrated by our completed IMA101 clinical pilot trial, the results of which we published in November 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Adoptive Cell Therapies </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our ACTengine
programs are based on genetically engineering a patient&#146;s own, autologous T cells with novel TCRs designed to recognize the cancer target on the patient&#146;s tumor. The engineered T cells <FONT STYLE="white-space:nowrap">(TCR-T)</FONT> aim to
induce a robust and specific anti-tumor attack to fight the cancer. The ACTengine mechanism of action is depicted in <B>Figure 3</B>. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Figure 3. Mechanism of Action of Our ACTengine Product Candidates </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g149615g73d45.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Upon infusion of an ACTengine product, T cells &#147;equipped&#148; with the cancer target-specific TCR are supposed to bind
to the pHLA target on the tumor. Subsequent activation of the T cell induces release of cytotoxic granules that might ultimately lead to tumor killing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our interim clinical results from the dose-escalation phase of our ongoing clinical trials highlight the following attributes of our ACTengine
IMA201, IMA202 and IMA203 product candidates: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Prevalence in major tumor indications.</B> The targets of our ACTengine product candidates are expressed in
a broad range of major solid tumor indications as well as niche indications, opening the potential for an accelerated path to regulatory approval. Cancer targets assessed by our product candidates are presented at high target density per tumor cell.
We believe this will reduce the likelihood for early tumor escape. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Safety profile.</B> As of the data <FONT STYLE="white-space:nowrap">cut-off,</FONT> February&nbsp;16, 2021,
ACTengine product candidates were well tolerated. All adverse events were transient and manageable. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>T cell engraftment and persistence.</B> Our proprietary manufacturing process produces engineered
target-specific young T cells that are engrafting and persisting in treated patients until the end of observation. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>First Anti-tumor Activity. </B>Disease stabilization was observed in 9 out of 10 patients at doses below
1&nbsp;billion transduced T cells. Tumor shrinkage was observed in 8 out of 10 patients across the trials, including one unconfirmed partial response as of data <FONT STYLE="white-space:nowrap">cut-off</FONT> in February 2021. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe these results support our continued investigation of tumor response at therapeutic dose level within the dose expansion cohort.
Initial results at the therapeutic dose level for the IMA202 trial are expected in the second half of 2021. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Delivery of ACTengine
Product Candidates </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For clinical trial enrollment and prior to treatment with one of our ACTengine product candidates, patients
enter a multi-step process as summarized in <B>Figure 4</B>. First, patients are tested for expression of <FONT STYLE="white-space:nowrap">HLA-A*02,</FONT> as only those tested positive might benefit from subsequent treatment. After confirmation of
HLA status, patients are biopsied and target expression for one of currently three cancer targets (MAGEA4/8, MAGEA1 and PRAME) is assessed by our proprietary companion diagnostic device candidate, IMADetect. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Figure 4. Patient Flow for ACTengine Clinical Trials </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g149615g74x76.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Dose modifications of lymphodepletion regimen for certain risk groups (e.g. patients with HCC&nbsp;&amp;
patients with reduced renal-clearance). </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Target Screening by IMADetect </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IMADetect is a diagnostic, precision-medicine device that screens tumor biopsies for all targets being studied across all of our ACTengine
clinical programs at the same time within one assay as laid out in <B>Figure 4</B>. If target expression is found by IMADetect, cancer patients are assigned to the corresponding clinical study. The underlying assay is a reverse transcription
quantitative PCR <FONT STYLE="white-space:nowrap">(&#147;RT-qPCR&#148;)</FONT> test. Target expression mRNA thresholds of the assay have been determined by mass-spectrometry-based peptide presentation data from our XPRESIDENT platform during
preclinical development. The thresholds have been designed to be predictive of the presence of the target peptide on the tumor. The assay is currently conducted in <FONT STYLE="white-space:nowrap">our&nbsp;in-house&nbsp;CLIA-certified</FONT>
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and&nbsp;CAP- accredited&nbsp;laboratory at our R&amp;D facilities in Houston, Texas, and will be developed as companion diagnostics for our product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon detection of target expression by IMADetect, the patient is enrolled in the corresponding clinical trial:
<FONT STYLE="white-space:nowrap">IMA201-101,</FONT> <FONT STYLE="white-space:nowrap">IMA202-101</FONT> or <FONT STYLE="white-space:nowrap">IMA203-101,</FONT> and T cell manufacturing commences. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>T cell Manufacturing </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Patients eligible for one of our clinical trials undergo a process called leukapheresis. During leukapheresis, a portion of the patients&acute;
white blood cells is collected, and peripheral blood mononuclear cells (&#147;PBMCs&#148;) are isolated, frozen and then shipped to our central manufacturing site located in Houston, Texas. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our proprietary manufacturing process (<B>Figure 5</B>) is designed to expand and engineer T cells within a manufacturing time of
approximately one week (IMA201/202: <FONT STYLE="white-space:nowrap">7-10</FONT> days; IMA203: <FONT STYLE="white-space:nowrap">6-7</FONT> days) followed by release testing which currently requires approximately two weeks and is targeted to be
reduced to one week in later development. T cells, which are a subset of PBMCs, are activated and subsequently mixed with a lentiviral vector to transduce the T&nbsp;cells with the genes encoding the target-specific TCR. The engineered T cells are
then expanded in the presence of a proprietary cytokine mix, concentrated and frozen before undergoing release testing. The resulting cell product can be stored frozen until the patient is ready to receive the treatment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">T cells are shipped frozen on dry ice
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">(&#147;frozen-in-frozen-out&#148;)</FONT></FONT></FONT> for both delivery of the patient&#146;s PBMCs to our manufacturing site and shipment of the T
cell product to the clinical site. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Figure 5. Proprietary T cell Manufacturing </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g149615g75a36.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Preconditioning, T cell Infusion and <FONT STYLE="white-space:nowrap">Follow-Up</FONT> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Patients being refractory to previous treatments receive a preconditioning lymphodepleting regimen (total dose per protocol: 160 mg
fludarabine, 2000 mg cyclophosphamide) prior to infusion with the &#147;reprogrammed&#148; target-specific T cells. Subsequently, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">low-dose&nbsp;IL-2</FONT></FONT> (dose: 1m
IU)&nbsp;is administered for 14 days to further enhance persistence of the transferred cells. After treatment, patients are closely monitored for safety and efficacy. Twelve months after T cell infusion or upon earlier disease progression, patients
enter long-term <FONT STYLE="white-space:nowrap">follow-up.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Ongoing ACTengine Clinical Trials IMA201, IMA202 and IMA203 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Targeted Antigens and Product Candidates </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our clinical-stage ACT product candidates, IMA201, IMA202 and IMA203, are targeting three antigens (MAGEA4/A8, MAGEA1 and PRAME, respectively)
that are prevalent in various solid tumor indications that have high medical need by high-affinity TCRs. An estimated 290,000 <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">HLA-A*02-positive</FONT></FONT> patients are diagnosed
with these tumors each year in the United States (<B>Figure 6</B> and <B>Table 1</B>). Additionally, these cancer targets are also expressed in niche indications that have historically limited therapeutic options, including sarcoma subtypes, anus
squamous cell cancer and uterine carcinosarcoma. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Figure 6. IMA200 Series Targets Are Prevalent in Major Tumor Indications </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g149615g76u27.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Population size of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">HLA-A*02-positive</FONT></FONT>
patients in the United States by tumor indication. Bars represent target prevalence (blue: MAGEA4/8, red: MAGEA1 and green: PRAME) in the respective tumor indication. Patient populations according to SEER (2020)&nbsp;and <FONT
STYLE="white-space:nowrap">HLA-A*02</FONT> expression rate of 41% in the United States. NSCLC: squamous <FONT STYLE="white-space:nowrap">non-small-cell</FONT> lung cancer; HNSCC: head and neck squamous cell carcinoma. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>IMA201 Targets MAGEA4/A8 Positive Cancers. </I>IMA201 targets <FONT STYLE="white-space:nowrap">HLA-A*02</FONT> and MAGEA4/A8 positive solid
tumors. MAGEA4/8 is a cancer-testis antigen prevalent in a variety of solid tumors at significant levels per tumor cell, but not, or to a far lesser extent, on healthy tissues. <FONT STYLE="white-space:nowrap">The&nbsp;IMA201-101&nbsp;trial</FONT>
(NCT03247309) is a Phase 1 clinical trial in patients with recurrent and/or refractory solid tumors. Among the range of solid cancer indications being studied, this trial focuses on indications that include squamous NSCLC, HNSCC, ovarian cancer,
bladder cancer and subtypes of sarcoma due to the high prevalence of target positivity in these tumors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>IMA202 Targets MAGEA1 Positive
Cancers. </I>IMA202 targets <FONT STYLE="white-space:nowrap">HLA-A*02</FONT> and MAGEA1 positive solid tumors. MAGEA1 is a cancer-testis antigen prevalent on a variety of solid cancers at significant levels per tumor cell but not, or to a far lesser
extent, on healthy tissues. <FONT STYLE="white-space:nowrap">The&nbsp;IMA202-101&nbsp;trial</FONT> (NCT03441100) is a Phase 1 clinical trial in patients with recurrent and/or refractory solid tumors. Among the range of solid cancer indications being
studied, this trial focuses on indications that include squamous NSCLC, HCC and melanoma. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>IMA203 Targets PRAME Positive Cancers.
</I>IMA203 targets <FONT STYLE="white-space:nowrap">HLA-A*02</FONT> and PRAME positive solid tumors. PRAME is a cancer-testis antigen prevalent on a variety of solid tumors at significant levels per tumor cell but not, or to a far lesser extent, on
healthy tissues. <FONT STYLE="white-space:nowrap">The&nbsp;IMA203-101&nbsp;trial</FONT> (NCT03686124) is a Phase 1 clinical trial </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in patients with recurrent and/or refractory solid tumors. Among a range of solid cancer indications being studied, this clinical trial focuses on several subtypes of sarcoma, uterine cancers
(endometrial cancer and uterine carcinoma), ovarian cancer, melanoma, and squamous NSCLC, due to the high prevalence of target positivity in these tumors. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Table 1. IMA200 Series is Targeting True Targets with Right TCRs </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g149615g77c85.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Background on Selected Cancer Indications </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Squamous <FONT STYLE="white-space:nowrap">Non-Small</FONT> Cell Lung Carcinoma (Sq NSCLC):</I> Lung cancer is the second most common cancer
in the United States and the leading cause of cancer-related deaths. In 2020, there were an estimated 229,000 new cases of lung cancer and 136,000 lung cancer-related deaths in the United States. NSCLC accounts for about 84% of all lung cancers,
while squamous cell NSCLC accounts for approximately 25% (an estimated 57,000 cases) of lung cancers. The&nbsp;five-year&nbsp;survival rate for NSCLC is 24% but varies materially by the stage of the disease. For localized NSCLC, the
overall&nbsp;five-year&nbsp;survival rate is about 61%, whereas patients with metastatic lung cancer have a&nbsp;five-year&nbsp;survival rate of only 6%. Treatment options for NSCLC also depend on the stage of the disease. Compared <FONT
STYLE="white-space:nowrap">to&nbsp;non-squamous&nbsp;NSCLC,</FONT> recurrent or refractory squamous NSCLC has fewer treatment options and typically leads to unfavorable outcomes despite recent advances. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Head and Neck Squamous Cell Carcinoma: </I>HNSCC comprises a heterogeneous group of cancers at different anatomic locations, which can be
found in the oral cavity, the pharyngeal area, and the larynx. In 2020, there were an estimated 66,000 new cases of HNSCC and 15,000 HNSCC-related deaths in the United States. The&nbsp;five-year&nbsp;survival for laryngeal cancer, one of the most
common types of HNSCC, has not significantly changed over the past 30 years. Despite several treatment options including radiation and systemic therapies, overall long-term survival rates for recurrent/metastatic HNSCC remain low. Thus, recurrent or
metastatic HNSCC is a severely underserved patient population with limited treatment options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Synovial Sarcoma:</I> Synovial sarcoma
is a rare and aggressive type of soft tissue sarcoma. In 2017, there were an estimated 1000 new cases of synovial sarcoma and 400 synovial sarcoma-related deaths. Synovial sarcoma patients have a poor prognosis and there is a very high unmet medical
need due to limited available treatment options. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">76 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Hepatocellular Carcinoma</I>: HCC is the most common type of primary liver cancer.
According to the World Health Organization, liver cancer was one of the top five causes of cancer-related deaths worldwide in 2018. In 2020, liver and intrahepatic bile duct cancers have an estimated 43,000 new cases of liver cancer and 30,000 liver
cancer-related deaths in the United States. Death rates from liver cancer have been steadily increasing over the last decades and the five-year survival rate for liver cancer remains low at approximately 20%. For metastatic liver cancer, the
relative five-year survival rate is only 2.5%. The standard care therapies for unresectable HCC patients are very limited and comprise various local therapies for early and intermediate patients and systemic therapies for advanced HCC patients. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Melanoma: </I>Melanoma is the fifth most common cancer type in the United States. In 2020, there were an estimated 100,000 new cases of
melanoma and 7,000 melanoma-related deaths in the United States. While localized melanoma has a very favorable prognosis with a&nbsp;five-year&nbsp;survival rate of 93%, metastasized melanoma has a&nbsp;five-year&nbsp;survival rate of only 27%.
Despite recent advances in treatment approaches including immune checkpoint inhibition, the prognosis for advanced melanoma remains poor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Ovarian Cancer:</I> In 2020, there were an estimated 22,000 new cases of ovarian cancer and 14,000 ovarian cancer-related deaths in the
United States. Among all cancers of the female reproductive system, ovarian cancer is the leading cause of cancer-related death. Despite significant advances in the treatment of ovarian cancer including PARP and checkpoint inhibitors over the past
decades, there is a high medical need for novel therapeutic options especially for recurrent disease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Uterine Cancer:</I> Uterine
cancer is another common cancer in women with unfavorable prognosis. In 2020, there were an estimated 66,000 new cases of uterine cancer and 13,000 uterine cancer-related deaths in the United States. Silent at the early stages, uterine cancer is
often diagnosed at late stages. The five-year survival rate for patients with uterine cancer in distant stage, where the cancer has already spread to other parts of the body, is only 17%. Treatment options are limited and comprise hormonal, single
or multi-agent chemotherapy, immunotherapy. Therefore, advances in available treatments are urgently needed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Anal Squamous Cell
Carcinoma:</I> Anal squamous cell carcinoma is a rare cancer and the most common type of anal cancer, accounting for approximately 90% of anal cancers. In 2020, there were an estimated 9,000 new cases of anal cancer and 1,400 anal cancer-related
deaths in the United States. Incidences of anal cancer have been rising throughout the last decades. Treatment of late-stage metastatic anal cancer currently focuses on disease control and relieving symptoms. Innovative targeted therapeutic
approaches for these <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">hard-to-treat</FONT></FONT> cancers are needed. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Clinical Trial Design </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
are currently recruiting patients to the dose-escalation stage (Phase 1a) of the ACTengine clinical trials at various clinical centers in Germany and the United States. The clinical trials are seeking to enroll adult patients with pathologically
confirmed advanced and/or metastatic solid tumor who meet the following selected eligibility criteria: (i)&nbsp;the patient must be <FONT STYLE="white-space:nowrap">HLA-A*02</FONT> positive and (ii)&nbsp;the tumor must express the relevant cancer
target <FONT STYLE="white-space:nowrap">(IMA201-101:</FONT> MAGEA4/A8, <FONT STYLE="white-space:nowrap">IMA202-101:</FONT> MAGEA1, <FONT STYLE="white-space:nowrap">IMA203-101:</FONT> PRAME) as found by IMADetect in a fresh tumor sample. Upon
manufacturing and release of the relevant IMA201, IMA202 or IMA203 cellular product, eligible patients receive study treatment. T cell products are administered when patients have received or are ineligible for all&nbsp;available indicated standard
of care treatments and their tumors are recurrent and/or refractory. Each clinical trial <FONT STYLE="white-space:nowrap">(IMA201-101,</FONT> <FONT STYLE="white-space:nowrap">IMA202-101</FONT> and <FONT STYLE="white-space:nowrap">IMA203-101)</FONT>
consists of two parts as laid out below and in <B>Figure 7</B>. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Phase 1a &#150; Dose Escalation:</B> The focus of the Phase 1a stage is finding the recommended phase 2 dose
(&#147;RP2D&#148;) and investigating the biological activity of the product candidates. In this portion of the clinical trial, patients receive the T cell product candidate (IMA201, IMA202 or IMA203) at three (or, in the case of IMA203, four)
escalating dose levels. The product candidate is infused after lymphodepleting chemotherapy </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">77 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
to determine the RP2D. If a dose level is cleared, the subsequent patients will be treated on the next higher dose level until reaching the target dose. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Phase 1b &#150; Dose Expansion:</B> The objectives of the Phase 1b stage are to further characterizing the
safety and biological activity profile of the product candidates and to evaluate the initial anti-tumor activity of the product candidates, as measured by tumor response according to standard Response Evaluation Criteria In Solid Tumors (RECIST)
v1.1 or immune-related RECIST (irRECIST). In this portion of the clinical trial, we plan to treat a total of ten additional patients at the RP2D with each of IMA201 and IMA202 and 12 additional patients with IMA203. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon signs of clinical activity, we may extend a clinical trial and recruit additional patients of one or more cancer subtypes to assess
anti-tumor activity of the product candidates in the respective indication. For IMA203, after establishing the initial safety profile, we may seek to add atezolizumab to a cohort of patients to test the safety and efficacy of <FONT
STYLE="white-space:nowrap">the&nbsp;IMA203-atezolizumab&nbsp;combination.</FONT> </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Figure 7. Clinical Trial Design </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g149615g79l42.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">*</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Dose: transduced viable CD8 T cells per m<SUP STYLE="font-size:85%; vertical-align:top">2</SUP> body surface
area, NA: not available </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Initial Results from Ongoing Clinical Trials </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Clinical Trial Status and Patient Characteristics </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The primary objectives of the Phase 1 studies are to study the safety profile of the ACTengine product candidates in patients with
target-positive solid cancers and to determine the RP2D. Secondary objectives include the assessment of T cell engraftment, persistence and infiltration into the tumor and the assessment of objective tumor responses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At data <FONT STYLE="white-space:nowrap">cut-off</FONT> on February&nbsp;16, 2021, 14 patients across multiple solid tumor indications,
including squamous <FONT STYLE="white-space:nowrap">non-small</FONT> cell lung cancer, head&nbsp;&amp; neck cancer, melanoma, synovial sarcoma and others, received ACTengine T cell products after lymphodepletion. All patients were heavily <FONT
STYLE="white-space:nowrap">pre-treated,</FONT> failed all previous therapies and entered the study with recurrent and/or refractory tumors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For 10 patients with at least one tumor response assessment available after treatment, biological and clinical activity was assessed. All of
these evaluable patients were dosed with an ACTengine product candidate at the first or second dose level (DL)&nbsp;as part of the dose-escalation protocol. Median total dose infused was 0.11&nbsp;billion transduced cells (range: <FONT
STYLE="white-space:nowrap">0.08-0.65</FONT> billion). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">78 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Median age of this patient population was 61 years and in median had received 5 lines of
previous systemic lines. All patients infused were heavily <FONT STYLE="white-space:nowrap">pre-treated,</FONT> failed all previous therapies and entered the study at recurrent/progressing disease and/or with refractory solid tumors. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Table 2. Patient Characteristics </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Characteristics in Efficacy Pop. (N=10)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Median&nbsp;(range)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Age [years]</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>61&nbsp;(33 - 68)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Number of prior lines of systemic therapies</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5&nbsp;(2 - 7)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Years from diagnosis</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4&nbsp;(1 - 12)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total transduced T cells infused [x10<SUP STYLE="font-size:85%; vertical-align:top">9</SUP>]<SUP
STYLE="font-size:85%; vertical-align:top"> </SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>0.11&nbsp;(0.08<SUP STYLE="font-size:85%; vertical-align:top">&nbsp;</SUP>-&nbsp;0.65)</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Treatment-emergent Adverse Events were Manageable and Transient </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ACTengine product candidates were generally well tolerated. All adverse events were transient and manageable. Most frequent adverse events
included expected cytopenia associated with lymphodepletion in all patients and transient low to moderate (Grade <FONT STYLE="white-space:nowrap">1-2)</FONT> cytokine release syndrome (&#147;CRS&#148;) observed in the majority of patients. Three
patients experienced transient low to moderate (Grade <FONT STYLE="white-space:nowrap">1-2)</FONT> immune effector cell associated neurotoxicity syndrome (ICANS), all completely&nbsp;resolved within a time window of 48 hours. No DLTs were observed
in patients treated with IMA201 and IMA202. One patient receiving IMA203 experienced a DLT at dose level 2, as defined in the trial protocol. The reaction was transient and fully resolved within 48 hours after onset. While occurrence of
atrial-fibrillation has been described in patients treated with <FONT STYLE="white-space:nowrap">IL-2</FONT> and/or cell therapies that induce CRS, this event was not defined as expected in the study protocol and therefore formally represents a DLT.
This DLT triggered an expansion of dose level 2 in the IMA203 protocol from three to six patients.</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Engraftment, Persistence and
Detection of T cells in the Tumor Observed After Infusion </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">T cell engraftment and persistence until the end of the observation period
has been observed in all patients tested (<B>Figure 8</B>). These results were all obtained from patients treated in dose level 1 and 2 and were unexpected based on published data with similar T cell products.&nbsp;Moreover, IMA202 and IMA203 T
cells have been detected in paired&#151;prior and post treatment&#151;tumor biopsies, indicating that T cells can successfully traffic into the tumor where they are supposed to kill cancer cell. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Figure 8. Engraftment, Persistence and Detection of Target-Specific T cells in the Tumor </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g149615g80j66.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Initial data for T cell engraftment and persistence in ACTengine patients (data
<FONT STYLE="white-space:nowrap">cut-off</FONT> February&nbsp;16, 2021). Molecular immune-monitoring in the blood (left) and in tumor biopsies prior to treatment, six weeks after treatment and at the last visit (right). Data <FONT
STYLE="white-space:nowrap">cut-off:</FONT> February&nbsp;16, 2021. Vector copies/&micro;g DNA have been assessed by qPCR. UD: Undetected, NA: Not available, DL: Dose level, EC1: Enrichment cohort with intermediate dose level between DL1 and DL2,
TBD: To be determined. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">79 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Disease Stabilization Observed in 9 out of 10 Patients at Doses below 1 Billion
transduced T cells </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All patients with at least one tumor response assessment post baseline as of the data <FONT
STYLE="white-space:nowrap">cut-off,</FONT> received doses up to dose level 2 and the total number of infused engineered T cells ranged from as low as 80&nbsp;million transduced CD8 T cells in DL1 of IMA203 trial to 650&nbsp;million T cells in DL2 of
the IMA202 trial (<B>Table 3</B>). Patients enrolled are heavily <FONT STYLE="white-space:nowrap">pre-treated,</FONT> suffering from a diverse set of rare and common solid cancers. All patients entered the study after either failing all available
standard treatment lines, and in many cases even additional experimental treatments. The last row shows the best overall response analysis per RECIST1.1. The disease control rate, which includes patients that showed either stable disease or partial
response observed at any time point, was 90%. Tumor shrinkage could be observed in 8 out of 10 patients across all trials. All four IMA203-treated patients had tumor shrinkage with one unconfirmed partial response at DL2 (total dose of
350&nbsp;million transduced cells) as of data <FONT STYLE="white-space:nowrap">cut-off</FONT> (<B>Figure 9</B>). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Table 3. Best Overall
Response Assessment IMA201, IMA202, IMA203 as of February&nbsp;16, 2021 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g149615g81o47.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Best tumor response from baseline as investigated by CT, MRI or PET and assessed by a local radiologist according to
RECIST1.1. Total infused dose of transduced viable CD8 T cells; M: male, F: female, ICI: Immune checkpoint inhibitor, SD: stable disease, PR: partial response, PD: progressive disease, unclean data, <FONT STYLE="white-space:nowrap">data-cut</FONT>
off February&nbsp;16, 2021. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">80 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Figure 9. Change in Target Lesions </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g149615g81l58.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Change in sum of longest diameter of tumor target lesions as assessed by CT, MRI or PET by local radiologists. Best
RECIST1.1 response depicted SD: stable disease, PD: progressive disease, PR: partial response.<SUP STYLE="font-size:85%; vertical-align:top">1</SUP> Shortest diameter for nodal lesions; <SUP STYLE="font-size:85%; vertical-align:top">2 </SUP>Stable
target lesions with parallel growth of a CNS <FONT STYLE="white-space:nowrap">non-target</FONT> lesion; <SUP STYLE="font-size:85%; vertical-align:top">3</SUP> RECIST1.1 response at timepoint of maximum in change of target lesions (week 12): PD due
to growth of <FONT STYLE="white-space:nowrap">non-target</FONT> lesion; <SUP STYLE="font-size:85%; vertical-align:top">4 </SUP>PR unconfirmed as of data <FONT STYLE="white-space:nowrap">cut-off</FONT> February&nbsp;16, 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Overall, these data suggest first anti-tumor activity in heavily pretreated patients with high tumor burden at early phases of dose escalation
consistent with robust biological activity and support the further evaluation of all three product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We plan to focus
throughout 2021 on treating patients at target dose level within the IMA202 dose expansion cohort. For IMA201 and IMA203 trials, we plan to treat additional patients at higher dose levels as part of the dose-escalation phase. For ongoing trials, we
expect to present an additional data update in the second half of 2021. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Next-Generation&nbsp;ACT </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to our goal of delivering the benefits of our IMA200 series to cancer patients as soon as possible, we are also focused on
continually advancing our technologies for the benefit of cancer patients with the objective to make our cell therapies available to a broader patient population. These are the steps towards this goal: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Advancing next-generation enhancement strategies for cell therapies. </B>We are actively investigating
multiple next-generation strategies to enhance the potency of our ACT product candidates. The complex tumor microenvironment is regarded as one of the biggest challenges to successful immunotherapies in solid tumors. We believe that targeting stroma
targets (such as COL6A3 exon 6 in IMA204), as well as by including next-generation enhancement technologies (such as CD8 <FONT STYLE="white-space:nowrap">co-transduction)</FONT> to generate more potent T cells, have the potential to overcome this
challenge. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Enhancing manufacturing and supply.</B>&nbsp;Aside from developing commercial manufacturing of autologous ACT,
we aim to further decrease the cost of goods and to reach patients more quickly with our <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">off-the-shelf</FONT></FONT> allogeneic cell therapy, ACTallo. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Combating target heterogeneity and tumor escape through multi-target approach.</B>&nbsp;Our next-generation
multi-target approach is designed to combat target heterogeneity and tumor escape to deliver deeper and longer clinical responses by deploying T cell products to multiple targets simultaneously. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">81 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Expanding to larger patient populations.</B>&nbsp;We believe that our pool of more than 200 prioritized
targets combined with our streamlined TCR development capabilities offers a unique foundation to develop treatments for a very broad cancer patient population including multiple cancer types and HLA alleles beyond
<FONT STYLE="white-space:nowrap">HLA-A*02</FONT> in an efficient and cost-effective manner. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Next-generation Cell
Therapy: IMA204 is Targeting Tumor Stroma </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The rigid stroma and the immunosuppressive microenvironment of solid tumors play a crucial
role in tumor initiation, progression and metastasis by providing a defensive layer against the body&#146;s immune system and pose a challenge for T cell accessibility. We believe that targeting the tumor stroma could provide a novel approach for
the treatment of many solid tumors either as single-agent approach or as part of a next-generation <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">multi-TCR-T</FONT></FONT> concept targeting both tumor and stroma simultaneously.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our fourth ACTengine program, IMA204, is directed against COL6A3 exon 6, a novel tumor stroma target identified and characterized by our
XPRESIDENT technology platform. COL6A3 exon 6 is presented predominantly by tumor stromal cells and not, or to a far lesser extent, by normal tissues. It is highly prevalent in a broad range of tumor tissues, including those of pancreatic cancer,
breast cancer, gastric cancer, sarcoma, esophageal cancer, <FONT STYLE="white-space:nowrap">non-small</FONT> cell lung cancer, head&nbsp;&amp; neck squamous cell carcinoma, colorectal cancer, mesothelioma and ovarian cancer, with an estimated <FONT
STYLE="white-space:nowrap">40-80%</FONT> of such cancers expressing COL6A3 exon 6. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For IMA204, we have generated two affinity-enhanced
TCR candidates through our XCEPTOR platform. We believe that both TCR candidates offer promising preclinical properties, including high avidity <FONT STYLE="white-space:nowrap">(sub-nanomolar</FONT> EC50) and specificity towards target-positive
tumor cells and tumor eradication <I>in vitro</I> and <I>in vivo</I> at physiological target expression levels. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">One of the two TCR
candidates shows full functionality in <U>both</U> CD8+ and CD4+ T cells without the need for CD8 <FONT STYLE="white-space:nowrap">co-transduction,</FONT> a next-generation technology distinct from the actual TCR being investigated in the <FONT
STYLE="white-space:nowrap">TCR-T</FONT> field (<B>Figure 10</B>). Activation of both T cell types has been reported as favorable for induction and maintenance of anti-tumor responses against solid tumors. In the case of our IMA204 TCR candidate,
this next-generation feature of being able to activate both CD8 as well as CD4 T cells is already engineered within the TCR. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Figure 10.
Overcoming Tumor Microenvironment by IMA204 TCR Candidates Targeting COL6A3 exon&nbsp;6 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g149615g83n97.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Left panel: Expression of the stroma target COL6A3 exon 6 and a tumor target in the same ovarian cancer tissue sample using
RNA in situ hybridization. Both pictures show the same image section. Red dots indicate target mRNA expression, which is tumor cell-specific in the case of the tumor target (right) and restricted predominantly to the tumor stroma cells in case of
the stroma target, COL6A3 exon 6 (left). Right panel: Two affinity-enhanced TCR candidates (TCR1, TCR2) targeting COL6A3 exon 6 appear to eradicate COL6A3 exon <FONT STYLE="white-space:nowrap">6-positive</FONT> tumors implanted in mice. One of the
TCR candidates (TCR2) activates both CD4+ and CD8+ T cells without CD8 <FONT STYLE="white-space:nowrap">co-transduction.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">82 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After completing preclinical safety assessment, we plan to submit a clinical trial
application to the FDA or European authorities for the IMA204 program in the second half of 2021. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">ACTallo&#151;Off-the-Shelf&nbsp;Adoptive</FONT></FONT> Cell Therapy </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Autologous T cell therapies have
demonstrated clinical successes in hematological and first solid tumor indications such as synovial sarcoma. However, products have to be manufactured individually for each patient. Therefore, cost of goods and the supply chain for personalized
medicines can differ from <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">off-the-shelf&nbsp;approaches.</FONT></FONT> We believe allogeneic
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">off-the-shelf&nbsp;approaches</FONT></FONT> can make ACT more easily accessible and affordable to a broader patient population. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ACTallo is our proprietary allogeneic <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">off-the-shelf</FONT></FONT> ACT
platform based on healthy donor-derived <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT> T cells. Due to their <FONT STYLE="white-space:nowrap">HLA-independent</FONT> target recognition, when transplanted
from an independent donor, a <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT> T cell, in contrast to a &#945;<FONT STYLE="FONT-FAMILY:SYMBOL">&#098;</FONT> T cell-transplant from an independent donor does
not cause Graft-versus-Host Disease and react against the body of the patient. We believe that together with their intrinsic anti-tumor activity, this characteristic makes them ideal for designing universal cell therapy products as summarized in
<B>Figure </B><B>11</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have developed a process allowing<I></I><I>&nbsp;ex vivo</I>&nbsp;expansion of&nbsp;<FONT
STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT> T cells by sourcing healthy donor material. In contrast to cancer patients, immune cells from healthy donors are not encumbered by prior therapies or by the
immunosuppressive environment of the tumor. ACTallo genetically engineer allogeneic&nbsp;<FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT> T cells to express a TCR specific to one of our prioritized cancer
targets as well as a <FONT STYLE="white-space:nowrap">CD8&nbsp;co-receptor.</FONT> We have developed a proprietary <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">four-in-one</FONT></FONT> lentiviral vector system for the
engineering step that may significantly reduce the costs and complexity of the process compared to employing separate vector systems. Cells are further expanded before cryopreservation and are then available for immediate patient treatment. At the
laboratory scale, we have observed that our proprietary manufacturing process has the potential of generating hundreds of doses from a single donor. We plan to continue enhancing this process prior to clinical application. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Due to their allogeneic nature, we expect the life span of ACTallo <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT><FONT
STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT> cells in patients to be limited. This provides the advantage of limiting the duration and severity of any autoimmune reactions caused by the ACTallo product candidates. However, a single application might
lead to limited sustainability of anti-tumor activity initially. To prolong in vivo half-life of cells and long-term activity, we are investigating second-generation approaches aimed at reducing rejection by the patient&acute;s immune system in a
second step. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Figure 11. ACTallo &#150; Our Allogeneic ACT Approach </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g149615g84a10.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">83 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Outlook:
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Multi-TCR-T</FONT></FONT> Approach and Expansion to Further HLA Alleles </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that our &gt;200 prioritized cancer targets and TCR discovery capabilities form a strong foundation for the generation of a TCR
warehouse. This warehouse is being designed to contain TCRs for an extended patient population and to create the opportunity to treat patients with more than a single TCR. We call this concept <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Multi-TCR-T.</FONT></FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Within the IMA200 series, patients are treated with engineered T cells that are
designed to recognize a specific cancer target. We are striving to achieve clinical benefit and anti-tumor activity in patients treated with our IMA201, IMA202, IMA203 and IMA204 product candidates. However, these responses may not completely
eradicate tumors or may not be powerful enough for all tumor indications. Therefore, we are working on next-generation approaches aimed at increasing the durability of response as well as expanding the treatable patient population. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our target space of &gt;200 prioritized targets uniquely equips us to build a TCR warehouse covering a range of cancer targets presented by
HLA alleles beyond <FONT STYLE="white-space:nowrap">HLA-A*02.</FONT> By including targets presented by various additional HLA alleles (such as <FONT STYLE="white-space:nowrap">HLA-A*01/</FONT> <FONT STYLE="white-space:nowrap">-A*03/</FONT> <FONT
STYLE="white-space:nowrap">-A*24/</FONT> <FONT STYLE="white-space:nowrap">-B*07/</FONT> <FONT STYLE="white-space:nowrap">-B*44),</FONT> we seek to broaden the patient population that might benefit from our product candidates from approximately <FONT
STYLE="white-space:nowrap">40-45%</FONT> of the population in North America and Europe expressing <FONT STYLE="white-space:nowrap">HLA-A*02</FONT> to more than 90% of the population expressing at least one suitable HLA allele. We also believe that
by addressing tumor heterogeneity and escape, we have the potential to increase the durability of anti-tumor responses when applying more than one <FONT STYLE="white-space:nowrap">TCR-T</FONT> product. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Figure 12. Outlook Towards <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Multi-TCR-T</FONT></FONT> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g149615g85a75.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We develop <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Multi-TCR-T</FONT></FONT> in a
multi-step approach by combining our ability to engineer novel potent TCRs, as used in the ACTengine programs (IMA200 series), with our expertise from our IMA101 multi-target pilot clinical trial (<B>Figure 12</B>). </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>IMA101:</B> The IMA101 pilot study was the first step towards the implementation of a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">multi-TCR-T</FONT></FONT> concept. This pilot trial established clinical feasibility of a personalized multi-target approach against multiple defined cancer targets. The study was based on
selecting and expanding a patient&#146;s own (endogenous) <FONT STYLE="white-space:nowrap">non-engineered</FONT> T cells after confirmation of expression of the relevant cancer target in the patient&#146;s tumor tissue by IMADetect. Up to three
different T cell products, each to a defined peptide target, were infused. The treatment phase of IMA101 trial has been completed and <FONT STYLE="white-space:nowrap">top-line</FONT> data
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">84 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
were reported in November 2020. We believe the results of this clinical pilot study support further exploration of a personalized ACT approach as part of our ACTengine IMA200 Series. We do not
intend to further develop IMA101 as a product candidate. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>IMA200 Series:</B> We are currently focused on advancing our individual ACTengine programs (i.e., IMA201,
IMA202, IMA203 and IMA204) into and through clinical development. With the three ongoing clinical trials and a fourth one reaching IND stage in 2021, we believe that each of these programs has the potential to deliver clinical benefit in specific,
potentially different cancer patient populations. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Combination Trial:</B> As cancer patients in serval indications are expected to express more than one of the
targets investigated in our IMA200 programs (<B>Table 4</B>), we have the opportunity of taking the next step towards <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">multi-TCR-T</FONT></FONT> immunotherapy through combinatorial
treatment of patients using anti-tumor and anti-stroma ACTengine product candidates <FONT STYLE="white-space:nowrap">(IMA201-204).</FONT> By targeting different compartments of the tumor and its microenvironment through different target classes, we
aim to expand the spectrum of tumor types and increase clinical response durability. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Warehouse and beyond:</B> We seek to expand the impact of immunotherapy through a novel, highly personalized
approach creating a library&#151;the <FONT STYLE="white-space:nowrap">multi-TCR</FONT> warehouse&#151;covering multiple TCRs of multiple HLA alleles. This approach is aimed at designing a personalized
<FONT STYLE="white-space:nowrap">multi-TCR</FONT> product for each patient matching the patient&#146;s HLA alleles and tumor target expression. </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Table 4: Several Major Tumor Indications Express Multiple IMA200 Series Targets </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g149615g86c95.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>TCR Bispecifics &#151; TCER </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our TCR Bispecifics, called TCER (T Cell Engaging Receptors), are
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">off-the-shelf</FONT></FONT> biologics that are designed to leverage the body&#146;s immune system by redirecting and activating T cells towards cancer cells expressing specific tumor
targets. The mechanism of action is depicted in <B>Figure 13</B>. The design of these novel biologics allows any T cell in the body to become activated and attack the tumor, regardless of the T&nbsp;cells&#146; intrinsic specificity. Due to their <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">off-the-shelf</FONT></FONT> availability, TCER&#146;s advantages include their potential for cost-effective manufacturing and classical supply chain for treatment of cancer patients,
without the need for specialized medical centers.<B> </B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">85 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Figure 13. Proposed Mechanism of Action of Our TCER, from Administration to Tumor Killing
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g149615g86c04.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Administration of the biologic compound to a biomarker positive cancer patient. TCER molecules are designed to specifically
bind to the pHLA targets on cancer cells, direct and activate any patient&#146;s circulating T cell via the T cell engaging part in close proximity of the cancer cell with the goal of destroying the malignant cell. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that our TCER preclinical studies have demonstrated the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Preclinical activity.</B>&nbsp;IMA401 and IMA402 product candidates have induced killing of tumor cells with
physiological low copy numbers of the target <I>in vivo</I> and <I>in vitro </I>after affinity maturation. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Broad therapeutic window.</B> IMA401-induced T cell mediated tumor killing at &gt;1000-fold lower doses
compared to activity against normal tissues. We believe this suggests a broad therapeutic window for dosing in <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-human</FONT></FONT> clinical trials. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Terminal half-life of several days.</B> We observed a functional half-life of
<FONT STYLE="white-space:nowrap">10-11</FONT> days for IMA401 in mouse models. We believe this supports a weekly dosing regimen for the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-human</FONT></FONT> trial without the
requirement for daily and/or continuous intravenous application. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After completion of cGMP process development and a
scientific advice meeting for IMA401 with the European authority Paul Ehrlich Institute, we intend to submit a clinical trial application for IMA401 towards <FONT STYLE="white-space:nowrap">year-end</FONT> 2021. The start of cGMP manufacturing
activities for our IMA402 program is planned for first half of 2021. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>TCER Format </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">TCER compounds leverage the well-established and validated mode of action
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">and&nbsp;off-the-shelf&nbsp;usage</FONT></FONT> of bispecific T cell engagers (prototyped by Blinatumomab) and combine this mechanism with the expanded target space available to T
cell therapies against pHLA targets. Once administered, TCER compounds are designed to link tumor cells presenting the target peptide to the patient&#146;s own T cells. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">TCER consist of three elements: (i)&nbsp;an affinity- and stability-optimized T cell receptor that recognizes the target presented <FONT
STYLE="white-space:nowrap">by&nbsp;HLA-molecules&nbsp;on</FONT> tumor cells, (ii)&nbsp;a T cell-stimulating and -recruiting proportion derived from an antibody, and (iii)&nbsp;an effector function
<FONT STYLE="white-space:nowrap">silenced&nbsp;Fc-part&nbsp;based</FONT> on human IgG conferring preferential stability, serum half-life and manufacturability. In preclinical studies, we tested our proprietary TCR Bispecific format with respect to
preclinical activity, stability and physicochemical properties, so called &#147;developability.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">86 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
The TCER-scaffold is further designed to offer modularity, which allows for the efficient exchange of the tumor-targeting and T cell-recruiting domain beneficial for the development of further
TCER candidates. We produce TCER product candidates in eukaryotic cell lines for improved physicochemical attributes, manufacturability and streamlined GMP scaling. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Figure 14. Proprietary TCER Format as Compared to Other Bispecific Formats </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g149615g87d98.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Proprietary TCER format (middle) consisting of an affinity and stability optimized T cell receptor (red), a T cell
stimulating and recruiting domain (blue) and an effector function <FONT STYLE="white-space:nowrap">silenced&nbsp;Fc-part&nbsp;as</FONT> compared to six alternative formats, partially used in immuno-oncology. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>TCER Product Candidates </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For all TCER programs, we generate a comprehensive preclinical data package for TCER characterization, including assessment of specificity,
safety, efficacy, manufacturability, developability and target validation. We are currently developing two TCR Bispecific product candidates, IMA401 and IMA402, in advanced preclinical studies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>IMA401 Is Targeting MAGEA4/8 Positive Cancers. </I>IMA401 TCER is our lead TCR Bispecific program targeting a peptide derived from the
melanoma-associated antigen 4 and/or 8 (&#147;MAGEA4/8&#148;). The target peptide is highly prevalent in several solid tumor types, including sq NSCLC, HNSCC, bladder, uterine, esophageal and ovarian carcinomas as well as melanoma, sarcoma subtypes
and other solid tumor types (<B>Figure </B><B>6</B>). In addition, the target peptide is presented at higher target density compared to most <FONT STYLE="white-space:nowrap">peptide-HLA</FONT> targets and specifically at a more than five-fold
increase in comparison to another commonly used MAGEA4 peptide. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Affinity-Enhanced IMA401 TCER Molecule Induces Tumor Cell Killing in
Preclinical Studies.</I><B> </B>IMA401 contains a high-affinity TCR (2 nM) generated by <FONT STYLE="white-space:nowrap">&gt;10,000-fold</FONT> affinity-maturation via yeast display. We believe that preclinical PoC data demonstrate
high<I></I><I>&nbsp;in vitro</I>&nbsp;potency (EC<SUB STYLE="font-size:85%; vertical-align:bottom">50</SUB>&lt;100 pM) of our IMA401 in killing tumor cells with MAGEA4/8 peptide levels similar to levels found in cancer patients. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In two independent xenograft studies, tumor-bearing mice treated with IMA401 displayed tumor regression or full tumor eradication. In these
studies, mice were implanted with human melanoma or <FONT STYLE="white-space:nowrap">non-small</FONT> cell lung tumor cells. Two or three weeks after tumor injection, animals with established tumors were treated with human white blood cells (PBMCs)
and IMA401 or a vehicle control. One week after treatment, tumor shrinkage was observed in all IMA401-treated mice but not in mice treated with a control. IMA401 treatment led to complete tumor remission in all but one animal (<B>Figure 15</B>).
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">87 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Figure 15. Potency of Our Lead TCER Candidate IMA401&nbsp;In Vivo </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g149615g88g23.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Left panel: NOG mice were injected subcutaneously with human Hs695T melanoma cells expressing the target peptide. After 20
days of engraftment visible tumors have developed. At day 1 PBMCs derived from two healthy donors were intravenously injected. IMA401 TCER or control vehicle was administered at low doses and tumor volume was assessed by caliper measurements. Right
panel: Human LXFA 1012 tumor tissue expressing the target peptide was implanted in NOG mice. After 14 days of engraftment visible tumors had developed. On day 1 PBMCs derived from two healthy donors were injected intravenously. IMA401 TCER or
control vehicle was administered at low doses and tumor volume was assessed by caliper measurements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>A broad therapeutic window has
been established for IMA401 in vitro.</I><B><I> </I></B>Tolerability of the IMA401 was tested through assessment of cytotoxicity against N<FONT STYLE="FONT-FAMILY:SYMBOL">&#179;</FONT>15 different human normal tissue cell types. We believe the data
presented to date demonstrate the potential for a favorable tolerability profile. IMA401 induced T cell mediated tumor killing at &gt;1000-fold lower doses compared to activity against normal tissues. We believe this suggests a broad therapeutic
window for dosing in <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-human</FONT></FONT> clinical trials. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Table 5. In Vitro Therapeutic Window of IMA401 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="19%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Normal Tissue Type</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Therapeutic&nbsp;Window&nbsp;(x-fold)</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">iPSC-derived Astrocytes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&gt;10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">iPSC-derived GABA neurons</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&gt;10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">iPSC-derived cardiomyocytes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&gt;10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Osteoblasts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pulmonary Fibroblasts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&gt;10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dermal Microvascular Endothelial Cells</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mesenchymal Stem Cells from Bone Marrow</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tracheal Smooth Muscle Cells</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&gt;10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Epidermal keratinocytes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&gt;10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Renal Cortical Epithelial Cells</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&gt;10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adrenal Cortical Cells</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cardiac Microvascular Endothelial Cells</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&gt;10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chondrocytes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&gt;10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Coronary Artery Endothelial Cells</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&gt;10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nasal Epithelial Cells</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&gt;10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pulmonary Artery Smooth Muscle Cells</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&gt;10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Specificity assessment for IMA401 TCER on normal tissue cells. iPSC: induced pluripotent stem cells. Therapeutic window: fold
difference in IMA401 dose mediating killing by T cells in <FONT STYLE="white-space:nowrap">co-culture</FONT> with indicated normal tissue cell types compared to tumor cell line Hs695T. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">88 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Terminal half-life of <FONT STYLE="white-space:nowrap">10-11</FONT> days observed,
supporting weekly dosing of IMA401.</I><B> </B><I>In vivo</I> half-life of the IMA401 molecule was assessed in mice by quantification of functional TCER molecules in blood. The pharmacokinetics assessment of the IMA401 molecule indicates a <FONT
STYLE="white-space:nowrap">10&#150;11-day</FONT> terminal half-life (<B>Figure 16</B>). We believe the extended stability in vivo supports a weekly dosing regimen for
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-human</FONT></FONT> clinical trials, without the need for continuous infusion of the compound. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Figure 16. Terminal Half-life of IMA401 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g149615g89j31.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Terminal half-life of IMA401 in mice as assessed by two independent pharmacokinetics assays. Levels of IMA401 are assessed
in the plasma of mice infused by a single injection of 2mg/kg IMA401. The pHLA specific TCR domain or the TCER Fc domain in mouse plasma are measured at various time points. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Given the preclinical data, and, what we view as favorable CMC characteristics in terms of purity and stability and the production yields of
&gt;2g/liter, we plan to submit a clinical trial application for IMA401 by the end of 2021. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>IMA402 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IMA402 is directed against an undisclosed cancer target, prevalent in a variety of solid tumors. Based on the prevalence of the cancer target,
we believe IMA402 could address a broad patient population across major tumor indications such as uterine carcinoma, melanoma, ovarian carcinoma, sq NSCLC, cholangiocarcinoma, breast carcinoma, HNSCC, and several subtypes of sarcoma in which the
target is expressed by a proportion of patients ranging between 25% and 100%. Lead candidates for the IMA402 program have been generated. <FONT STYLE="white-space:nowrap">IND-enabling</FONT> studies, including cell line development for cGMP
manufacturing activities, are planned to start in first half of 2021. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Technology Platforms </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To characterize our proprietary and partnered product candidates and to identify and develop future
<FONT STYLE="white-space:nowrap">TCR-based</FONT> product candidates, we established two proprietary target and TCR discovery platforms: XPRESIDENT and XCEPTOR. We believe that for the development of safe and effective
<FONT STYLE="white-space:nowrap">TCR-based</FONT> immunotherapeutics, two fundamental steps are required (<B>Figure 17</B>): (i) picking a true cancer target that is naturally and at significant levels expressed specifically on the tumor, and
(ii)&nbsp;generating the right, potent TCR that specifically recognizes the selected target with no or minimized cross-reactivity with healthy tissues. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">89 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Figure 17. True Targets&nbsp;&amp; Right TCRs Building the Foundation of Our Product
Candidates </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g149615g90l65.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>XPRESIDENT Discovers True Targets for Cancer Immunotherapy </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">XPRESIDENT integrates a high-throughput, ultra-sensitive mass spectrometry&nbsp;coupled with a proprietary workflow and an immunoinformatics
platform. It builds on a primary tissue database of thousands of tissues. From these specimens, a multitude of data is being gathered, including genome, proteome and <FONT STYLE="white-space:nowrap">in-depth</FONT> transcriptome. The core of the
database is its quantitative immunopeptidome data set, which enables the selection of true cancer targets. To our knowledge, this is the largest collection of pHLA target information derived both from cancer and healthy tissues (<B>Figure 18</B>).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Utilizing this foundation, we believe that XPRESIDENT identifies &#147;true target&#148; peptides for
<FONT STYLE="white-space:nowrap">TCR-based</FONT> immunotherapies that are proven to be displayed on patient tumors and that are not present, or present to a far lesser extent, on normal tissues. We utilize the natural mechanisms of the immune
system, by leveraging on the TCR&#150; pHLA interaction, to access intra- and extracellular cancer targets that are invisible to classical antibody or <FONT STYLE="white-space:nowrap">CAR-T</FONT> therapies. By picking our targets from the full
immunopeptidome, a target space increased by 300% as compared to the membrane-bound or extracellular peptidome, we developed a pool of more than 200 prioritized cancer targets across different target classes. These targets originate from well-known
parent proteins, widely uncharacterized proteins and novel target spaces including <FONT STYLE="white-space:nowrap">non-classical</FONT> neoantigens, <FONT STYLE="white-space:nowrap">RNA-edited</FONT> or post-translationally modified epitopes, which
we call &#147;crypto targets&#148;. Our prioritized targets, that have been filed in numerous patent applications, add value to our current pipeline and form a powerful source for future product candidates. We select cancer targets not only based on
their prevalence and specificity to a given tumor indication, but also based on their presentation level per tumor cell. Target presentation at sufficient density per tumor cell is a key component required for mounting an efficient anti-tumor
response, especially for TCR Bispecifics but also for ACT. To our knowledge, the absolute quantitation of the target (&#147;AbsQuant&#148;) on the tumor cell is a unique capability solely available through XPRESIDENT. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By investigating dozens of tissues for each cancer indication, XPRESIDENT is not limited by an individual tumor of a specific cancer type, but
instead analyzes a broad cross-section of the cancer patient population. It has been designed to both select targets that are not only naturally presented by a given tumor at high target density and also to analyze the prevalence of target
presentation among all analyzed tissues. Before entering clinical development, only targets relevant for a significant percentage of patients of a given cancer type are moved forward and are thoroughly characterized prior to or in parallel to TCR
identification.</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">90 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Figure 18. Target Pool of More Than 200 Prioritized pHLA Targets </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g149615g91m18.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">XPRESIDENT&#146;s extensive pHLA database is based on more than 2,000 primary tissue samples from 40 healthy organ types and
20 major cancer indications. Following an analysis of over 400,000,000 MS/MS spectra and an initial long-list of 8,000 tumor-associated pHLA targets, we have prioritized over 200 mass spectrometry validated pHLA targets covering all target classes:
1) peptides of well-known and characterized cancer target proteins; 2) unknown or poorly characterized proteins and 3) crypto targets/neoantigens. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Target expression on cancer tissue with high target levels per tumor cell but not or to a far lesser extent on
normal tissues. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">XPRESIDENT has identified and characterized cancer targets for all of our clinical and preclinical
programs across our entire individual and partnered pipeline. Each of our pipeline programs is currently <FONT STYLE="white-space:nowrap">targeting&nbsp;HLA-A*02,&nbsp;which</FONT> is found in
<FONT STYLE="white-space:nowrap">approximately&nbsp;40-45%&nbsp;of</FONT> individuals in North America, Europe, China and Japan and is one of the most common HLA types worldwide. While all of our current pipeline targets are binding to <FONT
STYLE="white-space:nowrap">HLA-A*02,</FONT> XPRESIDENT is not restricted to <FONT STYLE="white-space:nowrap">HLA-A*02</FONT> and has identified a large set of cancer targets across many different HLA alleles. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>XCEPTOR Identifies, Optimizes and Characterizes Right TCRs for ACT and TCR Bispecifics </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">XCEPTOR is our proprietary, TCR identification platform enabling the discovery and engineering of TCRs with high affinity and specificity
(<B>Figure 19</B>). Apart from the fast, efficient and highly sensitive TCR identification and characterization, XCEPTOR also comprises a protein engineering module to optimize (e.g., chain pairing enhancement, engineering towards CD8 independency)
and affinity-enhance TCRs prior to sourcing our product candidates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">91 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Figure 19. Key Principles of Our Proprietary XCEPTOR Platform for Development of the Right
TCR </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g149615g92n34.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">XCEPTOR picks and optionally engineers the most suitable TCRs for ACT or Bispecific product candidates
(<B>Figure 20</B>): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In the case of ACT, XCEPTOR either picks high-affinity TCRs from the natural repertoire or modestly enhances
these TCRs, aiming for single-digit micromolar affinities mirroring naturally occurring TCR affinities in viral infections. Additionally, we could pursue engineering TCRs to address alpha/beta chain pairing and/or CD8 independency.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In the case of TCR Bispecifics, affinity of the target TCR is required to be much higher to achieve functional
activity, thus the naturally occurring, specific TCRs need to be strongly affinity maturated using yeast display. Stable, high-affinity single-chain TCR variable fragments (scTvs) are serving as building blocks for the generation of the TCER
compound. </P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Figure 20. Target Affinities Differ Depending on the Therapeutic Modality. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g149615g93p54.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">92 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Irrespective of whether a TCR will be used for ACT or TCR Bispecific, we start the TCR
discovery process with a variety of TCR sources for a specific cancer target. In the first step, we identify a variety of TCRs, characterize the receptors and select the TCRs with the most desirable affinity, potency, specificity, and safety
characteristics. During the characterization process, we not only determine the binding motif of the TCRs and ensure functional efficacy at physiological cancer target levels, but also evaluate the TCRs&#146; ability to avoid similar peptides that
are presented on healthy tissues. We also test for potential reactivity against a broad panel of healthy tissues covering critical organs, multiple different cell types and organ-specific cell types. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The entire TCR selection and characterization process is guided by the XPRESIDENT peptide target database. The extensive information available
on the HLA peptidome in <U>normal</U> tissues is specifically useful for determining&nbsp;potential <FONT STYLE="white-space:nowrap">on-</FONT> <FONT STYLE="white-space:nowrap">and&nbsp;off-target&nbsp;toxicities,</FONT> i.e. potential recognition
by a TCR of target peptides and/or similar peptides that are presented on healthy tissues (=XPRESIDENT-guided <FONT STYLE="white-space:nowrap">on-</FONT> and <FONT STYLE="white-space:nowrap">off-target</FONT> toxicity screening). Also, during TCR
maturation the information on similar peptides presented on healthy tissues is helpful to counter-screen for cross-reactive TCRs (=XPRESIDENT-guided similar peptide screening). TCRs recognizing healthy tissues would be a potential threat for the
wellbeing of patients and therefore are <FONT STYLE="white-space:nowrap">de-selected</FONT> early during preclinical development and allow us to focus on the most specific and promising TCRs as early as possible in the development process. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Manufacturing&nbsp;&amp;&nbsp;Supply </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>ACTengine </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All
clinical T cell products are manufactured by Immatics employees through a multi-year collaboration with the Evelyn H. Griffin Stem Cell Therapeutics Research Laboratory at UTHealth (&#147;UTH&#148;) McGovern Medical School in Houston, Texas that
provides us exclusive access to several cGMP manufacturing suites. This cGMP facility is part of the Cellular Therapy Core (&#147;CTC&#148;) at UTHealth and is an 1,850 square <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">foot&nbsp;state-of-the-art&nbsp;multiple</FONT></FONT></FONT> ISO 7 class 10,000 Human Cell Processing cGMP Facility. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
UTHealth facility is <FONT STYLE="white-space:nowrap">FDA-registered</FONT> to manufacture cells and tissues for clinical applications in compliance with cGMP and has received accreditation by the Foundation for Accreditation of Cellular Therapy
(&#147;FACT&#148;) in January 2016, which accreditation was renewed in 2019. The facility was also College of American Pathologists (CAP)-accredited in 2020 and certified by Clinical Laboratory Improvement Amendment (CLIA) and Centers for
Medicare&nbsp;&amp; Medicaid Services (CMS), also in 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have exclusive and dedicated access to three cGMP suites and support areas
for the manufacturing of various ACT products. Facility operation/maintenance, supply procurement/release <FONT STYLE="white-space:nowrap">and&nbsp;co-release&nbsp;of</FONT> final drug product are performed by UTHealth, while our trained personnel
carry out the manufacturing <FONT STYLE="white-space:nowrap">and&nbsp;in-process&nbsp;controls.</FONT> In addition, we have contractual agreements in place with two suppliers of lentiviral vector which is the most critical raw material for the
manufacturing of genetically modified T cells products. The current setup provides a maximum capacity of &gt;500 manufacturing slots/year. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>TCER </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our TCR
Bispecifics (TCER) are expressed in mammalian cells. We have established a laboratory-scale production process to generate R&amp;D material suitable for compound characterization and early preclinical assessments. In the course of preclinical
development, the manufacturing process is turned over to CMOs that are experienced in cGMP manufacturing of biologics and regulatory compliance. The <FONT STYLE="white-space:nowrap">IND-enabling</FONT> studies (e.g.,<I></I><I>&nbsp;in
vitro</I>&nbsp;toxicology studies) are performed with material that we receive from CMOs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The manufacturing phase at our CMOs includes
cell line development, establishment of master- and working cell banks, upstream and downstream process development, formulation development, development of suitable analytical methods for testing and release, cGMP manufacturing, fill and finish,
drug substance and drug product release testing, storage and stability testing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">93 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">An&nbsp;in-house&nbsp;chemistry,</FONT> manufacturing and
control (&#147;CMC&#148;) team guides and manages the processes at our CMOs through the different stages. Before and during the cooperation with a CMO, we conduct audits to control compliance with the mutually agreed process descriptions and to cGMP
regulations. Our CMOs themselves are subject to their&nbsp;own quality assurance functions and are inspected and certified by regulatory agencies, including European national agencies and the FDA. During the development of TCER candidates, our CMOs
may need to modify or scale the manufacturing process to suitable size. Potentially, the drug formulation or other parameters may be changed. Such modifications may require a renewed qualification of the manufacturing process with the relevant
authorities. In addition to the currently contracted CMOs, we expect to engage with additional third-party manufacturers and suppliers to support potential pivotal trials and potential commercial supplies. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Marketing&nbsp;and&nbsp;Sales </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
currently do not have our own marketing, sales or distribution capabilities. We intend to maximize the commercial potential of any approved product candidates by developing a sales and marketing infrastructure or by pursuing strategic collaborations
with commercialization partners. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Competition </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Immunotherapy and the companies and academic groups <FONT STYLE="white-space:nowrap">using&nbsp;TCR-based&nbsp;approaches</FONT> against cancer
are rapidly evolving. While we believe that our technology platforms, therapeutic modalities and scientific knowledge provide us with a competitive advantage, we also face significant competition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other pharmaceutical and biotechnology companies are active in the field of TCR therapies, intending to target solid tumors following the
success <FONT STYLE="white-space:nowrap">of&nbsp;CAR-T&nbsp;therapies</FONT> in hematology. Companies developing other immunotherapies such <FONT STYLE="white-space:nowrap">as&nbsp;CAR-T,&nbsp;bispecific</FONT> antibodies, or immune checkpoint
inhibitors may show that their products demonstrate significant improvement in efficacy and compete with our approach and product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any product candidates that we successfully develop and commercialize will compete with currently approved therapies and new therapies that
may become available in the future. Our competitors fall primarily into the following groups, depending on their treatment approach: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Companies such as Adaptimmune, Gritstone, Immunocore, Adaptive Biotechnologies, pureMHC, BioNTech, and Genentech
are also seeking to identify HLA targets. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Companies such as Adaptimmune, Kite Pharma (a Gilead company), Tmunity, Juno Therapeutics (a BMS company), GSK,
Bluebird Bio, Medigene, PACT Pharma, Ziopharm are investigating novel autologous <FONT STYLE="white-space:nowrap">TCR-T</FONT> therapeutics. Their <FONT STYLE="white-space:nowrap">TCR-T</FONT> programs are partially directed against peptide targets
derived from the same proteins but not necessarily against the same peptide target as used by us. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Companies such as Immunocore, Amgen, Genmab, Eureka Therapeutics, Molecular Partners and Roche are developing TCR
Bispecific compounds or TCR mimetic antibodies. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Many of the companies against which we may compete have significantly
greater financial resources and expertise in research and development, manufacturing, preclinical testing, conducting clinical trials, obtaining regulatory approvals and marketing approved products than us. Smaller or early-stage companies may also
prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These competitors also compete in recruiting and retaining qualified scientific and management personnel and establishing
clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Intellectual Property </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our intellectual
property portfolio includes patents in many commercially significant jurisdictions worldwide. Our patent portfolio is a strategically important asset. As of February&nbsp;1, 2021, the portfolio contains
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">94 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
over 3,500 active worldwide patent applications and more than 100 active patent families. Our patent application portfolio covers a large number of cancer antigen targets, T cell receptors,
antibodies, bispecific molecules, and antigen discovery platforms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of February&nbsp;1, 2021, we own over 1,550 worldwide patents,
including 400 issued U.S. patents. Of the 400 issued U.S. patents, a total of over 350 U.S. patents have been issued since 2017. We plan to continue to expand our U.S. patent portfolio by filing new patent applications as well as filing continuation
and divisional applications of pending U.S. patent applications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We recognize the need for a global intellectual property strategy in
order to protect future products and assets around the world. As a result, we file patent applications with an aim of protecting our technology throughout many commercially relevant jurisdictions, such as Europe, the United States, Canada, Brazil,
China, Japan, South Korea, Argentina, Russia, Australia, New Zealand, Singapore, Vietnam, Thailand, Indonesia, Mexico, Taiwan and the Gulf states. For patent applications deemed to be of highest commercial importance to us, filing may take place in
more than 50 countries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of February&nbsp;1, 2021, patent coverage for our product candidates, encompassing proprietary cancer
antigens, TCRs, TCER and antibodies, includes the following owned patents and patent applications: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Three issued patents in the U.S., two issued foreign patents in Morocco and Colombia, 30 pending patent
applications in Argentina, Australia, Brazil, Canada, Chile, China, Costa Rica, Algeria, Eurasia, Egypt, Europe, Hong Kong, Indonesia, Israel, India, Japan, South Korea, Mexico, Malaysia, New Zealand, Peru, Philippines, Singapore, Thailand, Taiwan,
the Ukraine, the U.S., Vietnam and South Africa relating to IMA201 (MAGEA4/8). These patents and patent applications, if issued, are expected to expire in 2037, in each case without taking into account any possible patent term adjustment or
extensions and assuming payment of all appropriate maintenance, renewal, annuity or other governmental fees. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">One issued patent in the U.S., one issued patent in Germany, 33 pending patent applications in Argentina,
Australia, Brazil, Canada, Chile, China, Columbia, Costa Rica, Algeria, Eurasia, Egypt, Europe, Gulf Cooperation Council, Hong Kong, Indonesia, Israel, India, Japan, South Korea, Mexico, Malaysia, New Zealand, Peru, Philippines, Singapore, Thailand,
Taiwan, the Ukraine, the U.S., Vietnam and South Africa relating to IMA202 (MAGEA1). These patents and patent applications, if issued, are expected to expire between 2036 and 2037, in each case without taking into account any possible patent term
adjustment or extensions and assuming payment of all appropriate maintenance, renewal, annuity or other governmental fees. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">34 pending patent applications in Argentina, Australia, Brazil, Canada, Chile, China, Columbia, Costa Rica,
Germany, Algeria, Eurasia, Egypt, Europe, Gulf Cooperation Council, Hong Kong, Indonesia, Israel, India, Japan, South Korea, Mexico, Malaysia, New Zealand, Peru, Philippines, Singapore, Thailand, Taiwan, the Ukraine, the U.S., Vietnam and South
Africa relating to IMA203 (PRAME). These patents and patent applications, if issued, are expected to expire between 2037 and 2038, in each case without taking into account any possible patent term adjustment or extensions and assuming payment of all
appropriate maintenance, renewal, annuity or other governmental fees. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Four issued patents in the U.S., two issued foreign patents in Germany and Australia, 63 pending patent
applications in Argentina, Australia, Brazil, Canada, Chile, China, Columbia, Costa Rica, Germany, Algeria, Eurasia, Egypt, Europe, Gulf Cooperation Council, Hong Kong, Indonesia, Israel, India, Japan, South Korea , Mexico, Malaysia, New Zealand,
Peru, Philippines, Singapore, Thailand, Taiwan, the Ukraine, the U.S., Vietnam and South Africa relating to IMA204 (COL6A3 exon 6). These patents and patent applications, if issued, are expected to expire between 2036 and 2039, in each case without
taking into account any possible patent term adjustment or extensions and assuming payment of all appropriate maintenance, renewal, annuity or other governmental fees. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">95 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Three issued patents in the U.S., two issued foreign patents in Morocco and Colombia, 37 pending patent
applications in Argentina, Australia, Brazil, Canada, Chile, China, Costa Rica, Algeria, Eurasia, Egypt, Europe, Gulf Cooperation Council, Hong Kong, Indonesia, Israel, India, Japan, South Korea, Mexico, Malaysia, New Zealand, Peru, Philippines,
Singapore, Thailand, Taiwan, the Ukraine, the U.S., Vietnam and South Africa and one pending PCT patent applications relating to IMA401 (MAGEA4/8). These patents and patent applications, if issued, are expected to expire between 2037 and 2040, in
each case without taking into account any possible patent term adjustment or extensions and assuming payment of all appropriate maintenance, renewal, annuity or other governmental fees. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We are currently devising a patent application covering the clinical candidates for IMA402.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to patent coverage for our proprietary cancer antigens, TCRs, TCER and antibodies, we seek protection for
aspects of our ACT protocols via patent filings. To this end, our subsidiary, Immatics US, has filed and owns eleven patent families. These patents and patent applications are predominantly focused on ACT methods, cell populations, and other
immunotherapy methodologies. These patents and pending patent applications, if issued, are expected to expire between 2036 and 2040, in each case without taking into account any possible patent term adjustment or extensions and assuming payment of
all appropriate maintenance, renewal, annuity or other governmental fees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We also place an emphasis on protecting our expanding brand
recognition by filing and registering trademark applications throughout the world. We own 23 different trademarks most of which are registered or have been allowed, in multiple countries and classes. Prominent trademarks are, for example,
XPRESIDENT, TCER, ACTallo, ACTengine and Immatics. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Collaborations and Other Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have forged strategic collaborations with biotech and pharmaceutical companies as well as academic research institutions. Key collaborations
include: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>MD Anderson Cancer Center </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In August 2015, we and The University of Texas M.D. Anderson Cancer Center (&#147;MD Anderson&#148;) announced the launch of Immatics US to
develop multiple T cell and <FONT STYLE="white-space:nowrap">TCR-based</FONT> adoptive cellular therapies. Immatics US secured over $60&nbsp;million in total funding &#150; more than $40.0&nbsp;million from the parent company Immatics OpCo and a
$19.7&nbsp;million grant from the Cancer Prevention and Research Institute of Texas (&#147;CPRIT&#148;) and entered into several agreements, including a restricted stock purchase agreement, several license agreements and a collaboration and license
agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the collaboration and license agreement (the &#147;MD Anderson Collaboration Agreement&#148;), MD Anderson and Immatics
US conduct work pursuant to agreed research plans to develop (i)&nbsp;IMA101 and (ii)&nbsp;ACTengine IMA201, 202, 203 product candidates in certain cancer indications. Immatics US funds all activities by MD Anderson under the research plans. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of the MD Anderson Collaboration Agreement, MD Anderson granted Immatics US a fully
<FONT STYLE="white-space:nowrap">paid-up,</FONT> royalty-free, <FONT STYLE="white-space:nowrap">non-exclusive,</FONT> sublicensable license under certain technology, patent rights and <FONT STYLE="white-space:nowrap">know-how</FONT> controlled by MD
Anderson relating to the development and manufacturing of <FONT STYLE="white-space:nowrap">T-cell</FONT> based therapies to perform activities under the MD Anderson Collaboration Agreement. Immatics US granted MD Anderson a fully <FONT
STYLE="white-space:nowrap">paid-up,</FONT> royalty-free, <FONT STYLE="white-space:nowrap">non-exclusive,</FONT> sublicensable license under certain technology, patent rights and <FONT STYLE="white-space:nowrap">know-how</FONT> controlled by Immatics
US, including intellectual property created under the MD Anderson Collaboration Agreement, to perform activities under the MD Anderson Collaboration Agreement and a fully <FONT STYLE="white-space:nowrap">paid-up,</FONT> royalty-free, <FONT
STYLE="white-space:nowrap">non-exclusive,</FONT> sublicensable license under technology, patent rights and <FONT STYLE="white-space:nowrap">know-how</FONT> created under the MD Anderson Collaboration Agreement for research purposes during the term
of the MD Anderson </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">96 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Collaboration Agreement. Immatics US owns all intellectual property resulting from or directly related to the work conducted under the research plans, provided such ownership does not result in
any violation of law or adversely impact the University of Texas system&#146;s tax exempt status. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The MD Anderson Collaboration Agreement
will continue until the completion of all research activities contemplated by applicable research plans, unless terminated earlier. MD Anderson has the right to terminate the MD Anderson Collaboration Agreement for Immatics US&#146;s material breach
following a certain cure period. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>GlaxoSmithKline </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In December 2019, we entered into a strategic collaboration agreement with GlaxoSmithKline (&#147;GSK&#148;) to develop novel adoptive cell
therapies targeting multiple cancer indications with a focus on solid tumors. Under the agreement, we and GSK are collaborating on the identification, research and development of next-generation TCR therapeutics and will initially develop autologous
T cell therapies with GSK having an option to add allogeneic cell therapies using our ACTallo approach. We will utilize proprietary TCRs identified by our XCEPTOR and directed against two proprietary targets discovered by XPRESIDENT. Under the
strategic collaboration agreement, we have primary responsibility for the development and validation of the TCR therapeutics up to designation of a clinical candidate. GSK will then assume sole responsibility for further worldwide development,
manufacturing and commercialization of the TCR therapeutics with the possibility for us to <FONT STYLE="white-space:nowrap">co-develop</FONT> one or more TCR therapeutics including the conduct of the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">first-in-human</FONT></FONT> clinical trial upon GSK&#146;s request. GSK also obtained an option to select additional target programs to include in the collaboration. For each additional program, we are entitled to
predetermined option, milestone and royalty payments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the terms of the agreement, we received an upfront payment of
&#128;45&nbsp;million for two initial programs and are eligible to receive additional development, regulatory and sales milestones up to &#128;575&nbsp;million, respectively, as well as additional royalties on net sales for each licensed product.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Bristol-Myers Squibb </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We and Celgene Corporation, a Bristol-Myers Squibb Company (&#147;BMS&#148;), entered into a strategic collaboration and license agreement in
August 2019 to develop novel adoptive cell therapies targeting multiple cancers. Under the agreement, we may develop <FONT STYLE="white-space:nowrap">TCR-T</FONT> programs against solid tumor targets discovered by our XPRESIDENT technology. We will
utilize proprietary TCRs identified by our XCEPTOR TCR discovery and engineering platform. We will be responsible for the development of these programs through the lead candidate stage, at which time BMS may exercise its option to exclusively
license one or more programs, thereby assuming sole responsibility for further worldwide development, manufacturing and commercialization of the <FONT STYLE="white-space:nowrap">TCR-T</FONT> cell therapies. We retain certain early stage <FONT
STYLE="white-space:nowrap">co-development</FONT> and <FONT STYLE="white-space:nowrap">co-funding</FONT> rights for selected <FONT STYLE="white-space:nowrap">TCR-T</FONT> cell therapies arising from the collaboration. BMS has the option to
exclusively license up to two additional targets to expand the collaboration at predetermined economics. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the terms of the
agreement, we received an upfront payment of $75&nbsp;million for three programs and are eligible to receive additional regulatory and sales milestones in aggregate amounts of up to $190&nbsp;million, and $300&nbsp;million, respectively, as well as
tiered royalties based on net sales for each licensed product at percentages ranging from high single digits to teens, subject to customary reductions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Genmab </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In July
2018, we and Genmab entered into a research collaboration and license agreement to develop next-generation, T cell engaging bispecific immunotherapies targeting multiple cancer indications. Under the agreement, we are conducting joint research,
funded by Genmab, and combining XPRESIDENT, XCEPTOR and TCER technology platforms with Genmab&#146;s proprietary antibody technologies to develop multiple bispecific immunotherapies in oncology. Both we and Genmab are exclusively discovering and
developing </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">97 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
immunotherapies directed against three proprietary targets, discovered and developed by our XPRESIDENT platform. Genmab is responsible for development, manufacturing and worldwide
commercialization. We retain an option to contribute certain promotion efforts at predetermined levels in selected countries in the EU. Genmab has the option to exclusively license up to two additional targets to expand the collaboration at
predetermined economics. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the terms of the agreement, we received an upfront fee of $54&nbsp;million and is eligible to receive
additional development, regulatory and commercial milestone payments, totaling $550&nbsp;million, for each licensed product resulting from the collaboration. In addition, we are eligible to receive tiered royalties on net sales for each licensed
product at up to double-digit percentages. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Amgen </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since December 2016, Amgen and us have been developing next-generation, T cell engaging bispecific immunotherapies targeting multiple cancers
under the research collaboration and exclusive license agreement. The collaboration combines our XPRESIDENT and XCEPTOR technology platforms with Amgen&#146;s validated BiTE (Bispecific T cell Engager) technology. Amgen is responsible for the
clinical development, manufacturing and commercialization worldwide. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the terms of the agreement, we received a <FONT
STYLE="white-space:nowrap">non-refundable,</FONT> <FONT STYLE="white-space:nowrap">non-creditable</FONT> upfront fee of $30&nbsp;million and are eligible to receive additional development, regulatory and commercial milestone payments in aggregate
amounts of up to $525&nbsp;million, respectively, as well as tiered royalties on net sales for each licensed product at percentages ranging from high-single digits to low teens subject to customary reductions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Other Agreements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We entered into a number of collaborations that are important for our ability to manufacture, supply and offer our adoptive cell therapies and
TCR Bispecifics. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>UTHealth </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We entered into a multi-year collaboration agreement to secure exclusive access to three UTHealth cGMP suites to manufacture various ACT
products within the Griffin Research Laboratory. Under the agreement, general facility operations, maintenance, supply and reagents for cGMP manufacture, and <FONT STYLE="white-space:nowrap">co-release</FONT> of product is provided by UTHealth.
Under the agreement, we perform all manufacturing and <FONT STYLE="white-space:nowrap">in-process</FONT> controls. The UTHealth facility is FDA registered to produce cells and tissues for clinical applications in compliance with cGMP and has
received accreditation by the FACT in January 2016, which was renewed in 2019. In August 2020 UTHealth and Immatics extended the collaboration until end of 2024 providing Immatics exclusive access to cGMP manufacturing infrastructure at The Evelyn
H. Griffin Stem Cell Therapeutics Research Laboratory. The extended collaboration ensures continued clinical batch supply for all of Immatics&#146; ongoing and future ACT clinical trials in the United States and Europe. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Other Manufacturing Agreements </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We use several third-party contract manufacturers acting in accordance with FDA&#146;s good laboratory practice (&#147;GLP&#148;) or cGMP, as
applicable, practices for the manufacture of viral vectors and cell bank development. We generally apply second-supplier strategies to mitigate supply risks and to secure access to manufacturing innovation and competitive supply costs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For pivotal trial supply of ACT products, we plan on entering into one or more relationships with large CMOs with dedicated access to multiple
cGMP suites and trained personnel, as well as into commercial supply agreements with raw material vendors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">98 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For manufacturing and supply of TCR Bispecifics, we have contracted third party
manufacturers and may enter into additional CMO relationships in the future. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Government Regulation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Government authorities in the United States, at the federal, state, and local level, and in other countries and jurisdictions, including the
EU, extensively regulate, among other things, the research, development, testing, manufacture, quality control, approval, packaging, storage, recordkeeping, labeling, advertising, promotion, distribution, marketing, post-approval monitoring and
reporting, as well as import and export of biological products. Some jurisdictions also regulate the pricing of medicinal products. The processes for obtaining marketing approvals in the United States and in foreign countries and jurisdictions,
along with compliance with applicable statutes and regulations, require the expenditure of substantial time and financial resources. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Licensure and Regulation of Biologics in the United States </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the United States, biological products, including gene therapy products, are regulated under the Public Health Service Act
(&#147;PHSA&#148;) and the Federal Food, Drug, and Cosmetic Act (&#147;FDCA&#148;), and their implementing regulations as well as other federal, state and local statutes and regulations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The failure of an applicant to comply with the applicable regulatory requirements at any time during the product development process,
including during testing, the approval process or post-approval process, may result in delays to the conduct of a study, regulatory review and approval, and/or administrative or judicial sanctions. Failure to comply with regulatory requirements may
result in the FDA&#146;s refusal to allow an applicant to proceed with clinical trials, refusal to approve pending applications, license suspension or revocation, withdrawal of an approval, warning letters, product recalls, product seizures, total
or partial suspension of production or distribution, injunctions, fines, and civil or criminal investigations and penalties brought by the FDA or Department of Justice (&#147;DOJ&#148;), or other government entities, including state agencies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An applicant seeking to market and distribute a new biologic in the United States generally must satisfactorily complete each of the following
steps before the product candidate will be licensed by the FDA: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">preclinical testing including laboratory tests, animal studies, and formulation studies, which must be performed
in accordance with the FDA&#146;s GLP regulations, as applicable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">submission to the FDA of an IND for human clinical testing, which must become effective before human clinical
trials may begin; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approval by an IRB representing each clinical site before each clinical trial may be initiated;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">performance of adequate and well-controlled human clinical trials to establish the safety, and efficacy of the
product candidate for each proposed indication, in accordance with current GCP; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">preparation and submission to the FDA of a BLA for a biological product; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">FDA acceptance and substantive review of the BLA; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">review of the product candidate by an FDA advisory committee, where appropriate or if applicable;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">satisfactory completion of an FDA inspection of the manufacturing facility or facilities, including those of
third parties, at which the product candidate or components thereof are manufactured to assess compliance with cGMP requirements and to assure that the facilities, methods, and controls are adequate to preserve the product&#146;s identity, strength,
quality, and purity; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">satisfactory completion of any FDA audits of clinical trial sites to assure compliance with GCP and the integrity
of clinical data in support of the BLA; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">securing FDA approval of the BLA to allow marketing of the new biological product. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">99 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Preclinical Studies and Investigational New Drug Application </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Before an applicant begins testing a product candidate with potential therapeutic value in humans, the product candidate enters preclinical
testing. Preclinical studies include studies to evaluate, among other things, the toxicity of the product candidate. The conduct of the preclinical tests must comply with federal regulations and requirements, as applicable, including GLP
regulations. Some long-term preclinical testing, such as animal tests of reproductive adverse events and carcinogenicity, and long-term toxicity studies, may continue after the IND is submitted. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>The IND and IRB Processes </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An IND is an exemption from the FDCA that allows an unapproved product candidate to be shipped in interstate commerce for use in an
investigational clinical trial and a request for FDA authorization to administer such investigational product to humans. In support of a request for an IND, applicants must submit a protocol for each clinical trial and any subsequent protocol
amendments must be submitted to the FDA as part of the IND. In addition, the results of the preclinical tests, together with manufacturing information, analytical data, any available clinical data or literature and plans for clinical trials, among
other things, must be submitted to the FDA as part of an IND. The FDA requires <FONT STYLE="white-space:nowrap">a&nbsp;30-day&nbsp;waiting</FONT> period after the filing of each IND before clinical trials may begin. This waiting period is designed
to allow the FDA to review the IND to determine whether human research subjects will be exposed to unreasonable health risks. At any time during <FONT STYLE="white-space:nowrap">this&nbsp;30-day&nbsp;period</FONT> the FDA may raise concerns or
questions about the conduct of the trials as outlined in the IND and impose a clinical hold or partial clinical hold. A clinical hold is an order issued by the FDA to the sponsor to delay a proposed clinical investigation or to suspend an ongoing
investigation. A partial clinical hold is a delay or suspension of only part of the clinical work requested under the IND. In this case, the IND sponsor and the FDA must resolve any outstanding concerns before clinical trials can begin. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following commencement of a clinical trial, the FDA may also place a clinical hold or partial clinical hold on that trial. No more than 30
days after imposition of a clinical hold or partial clinical hold, the FDA will provide the sponsor a written explanation of the basis for the hold. Following issuance of a clinical hold or partial clinical hold, an investigation may only resume
after the FDA has notified the sponsor that the investigation may proceed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A sponsor may choose, but is not required, to conduct a
foreign clinical trial under an IND. When a foreign clinical trial is conducted under an IND, all FDA IND requirements must be met unless waived. When a foreign clinical trial is not conducted under an IND, the sponsor must ensure that the study
complies with certain regulatory requirements of the FDA in order to use the study as support for an IND or application for marketing approval or licensing. In particular, such studies must be conducted in accordance with cGCP, including review and
approval by an independent ethics committee (&#147;IEC&#148;) and obtaining informed consent from subjects. The FDA must be able to validate the data through an onsite inspection, if deemed necessary by the FDA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An IRB representing each institution participating in the clinical trial must review and approve among other things, the study protocol and
informed consent information to be provided to study subjects before it commences at that institution, and the IRB must conduct continuing review and reapprove the study at least annually. An IRB can suspend or terminate approval of a clinical trial
at its institution, or an institution it represents, if the clinical trial is not being conducted in accordance with the IRB&#146;s requirements or if the product candidate has been associated with unexpected serious harm to patients. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Clinical trials including the use of an investigational device sometimes require submission of an application for an Investigational Device
Exemption (&#147;IDE&#148;), to the FDA. The IDE application must be supported by appropriate data, such as animal and laboratory testing results, showing that it is safe to test the device in humans and that the investigational protocol is
scientifically sound. The IDE application must be approved in advance by the FDA, unless the product is deemed <FONT STYLE="white-space:nowrap">a&nbsp;non-significant&nbsp;risk</FONT> device and eligible for more abbreviated IDE
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">100 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
requirements. Clinical trials for a significant risk device may begin once the IDE application is approved by the FDA as well as the appropriate IRBs at the clinical trial sites, and the informed
consent of the patients participating in the clinical trial is obtained. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Progress reports detailing the results of the clinical trials
must be submitted at least annually to the FDA. In addition, IND safety reports must be submitted to the FDA for any of the following: serious and unexpected suspected adverse reactions; findings from other studies or animal or&nbsp;in
vitro&nbsp;testing that suggest a significant risk in humans exposed to the product; and any clinically important increase in the case of a serious suspected adverse reaction over that listed in the protocol or investigator brochure. Phase 1, Phase
2 and Phase 3 clinical trials may not be completed successfully within any specified period, or at all. The FDA will typically inspect one or more clinical sites to assure compliance with cGCP and the integrity of the clinical data submitted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the NIH Guidelines, supervision of human gene transfer trials includes evaluation and assessment by an IBC, a local institutional
committee that reviews and oversees research utilizing recombinant or synthetic nucleic acid molecules at that institution. The IBC assesses the safety of the research and identifies any potential risk to public health or the environment, and such
review may result in some delay before initiation of a clinical trial. While the NIH Guidelines are not mandatory unless the research in question being conducted at or sponsored by institutions receiving NIH funding of recombinant or synthetic
nucleic acid molecule research, many companies and other institutions not otherwise subject to the NIH Guidelines voluntarily follow them. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Clinical Trials in Support of a BLA </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Clinical trials involve the administration of the investigational product candidate to human subjects under the supervision of a qualified
investigator in accordance with GCP requirements which include, among other things, the requirement that all research subjects provide their informed consent in writing before their participation in any clinical trial. Clinical trials are conducted
under written clinical trial protocols detailing, among other things, the objectives of the study, inclusion and exclusion criteria, the parameters to be used in monitoring safety, and the effectiveness and safety criteria to be evaluated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Human clinical trials are typically conducted in three sequential phases, but the phases may overlap or be combined. Additional studies may
also be required after licensing. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Phase 1 clinical trials are initially conducted in a limited population to test the product candidate for safety,
including adverse effects, dose tolerance, absorption, metabolism, distribution, excretion, and pharmacodynamics in healthy humans or in patients. During Phase 1 clinical trials, information about the investigational biological product&#146;s
pharmacokinetics and pharmacological effects may be obtained to permit the design of well-controlled and scientifically valid Phase 2 clinical trials. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Phase 2 clinical trials are generally conducted in a limited patient population to identify possible adverse
effects and safety risks, evaluate the efficacy of the product candidate for specific targeted indications, and determine dose tolerance and optimal dosage. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Phase 3 clinical trials are undertaken within an expanded patient population to further evaluate dosage, provide
substantial evidence of clinical efficacy, and further test for safety. A well-controlled, statistically robust Phase 3 trial may be designed to deliver the data that regulatory authorities will use to decide whether or not to license, and, if
licensed, how to appropriately label a biologic. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While the FDA requires in most cases two adequate and well-controlled
pivotal clinical trials to demonstrate the efficacy of a product candidate, a single trial with strong confirmatory evidence may be sufficient in instances where the trial is a large multicenter trial demonstrating internal consistency and a
statistically very persuasive finding of a clinically meaningful effect on mortality, irreversible morbidity or prevention of a disease with a potentially serious outcome and confirmation of the result in a second trial would be practically or
ethically impossible. In rare cancer indications with very limited treatment options a large and/or controlled trial are often not feasible and thus data from smaller and even uncontrolled trials may be sufficient for regulatory approval. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">101 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In some cases, the FDA may approve a BLA for a product candidate but require the sponsor to
conduct additional clinical trials to further assess the product candidate&#146;s safety and effectiveness after approval. Such post-approval trials are typically referred to as Phase 4 clinical trials. These studies are used to gain additional
experience from the treatment of a larger number of patients in the intended treatment group and to further document a clinical benefit in the case of biologics licensed under Accelerated Approval regulations. Failure to exhibit due diligence with
regard to conducting Phase 4 clinical trials could result in withdrawal of approval for products. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Review and Approval of a BLA
</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to obtain approval to market a biological product in the United States, a biologics license application must be submitted to
the FDA that provides sufficient data establishing the safety, purity and potency of the proposed biological product for its intended indication. The BLA includes all relevant data available from pertinent preclinical studies and clinical trials,
including negative or ambiguous results as well as positive findings, together with detailed information relating to the product&#146;s chemistry, manufacturing, controls and proposed labeling, among other things. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under federal law, the submission of most BLAs is subject to an application user fee, which for federal fiscal year 2021 is $2,875,842 for an
application requiring clinical data. The sponsor of an approved BLA is also subject to an annual program fee, which for fiscal year 2021 is $336,432. Certain exceptions and waivers are available for some of these fees, such as an exception from the
application fee for products with orphan designation and a waiver for certain small businesses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following submission of a BLA, the FDA
conducts a preliminary review of the application generally within 60 calendar days of its receipt and strives to inform the sponsor by the 74th day after the FDA&#146;s receipt of the submission whether the application is sufficiently complete to
permit substantive review. The FDA may request additional information rather than accept the application for filing. In this event, the application must be resubmitted with the additional information. The resubmitted application is also subject to
review before the FDA accepts it for filing. Once the submission is accepted for filing, the FDA begins an <FONT STYLE="white-space:nowrap">in-depth</FONT> substantive review. The FDA has agreed to specified performance goals in the review process
of the BLAs. Under that agreement, 90% of original BLA submissions are meant to be reviewed within ten months of the <FONT STYLE="white-space:nowrap">60-day</FONT> filing date, and 90% of original BLAs that have been designated for &#147;priority
review&#148; are meant to be reviewed within six months of the <FONT STYLE="white-space:nowrap">60-day</FONT> filing date. The review process may be extended once per review cycle by the FDA for three additional months to consider new information or
clarification provided by the applicant to address an outstanding deficiency identified by the FDA following the original submission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Before approving an application, the FDA will typically audit the preclinical study and clinical trial sites that generated the data in
support of the BLA. Additionally, the FDA typically will inspect the facility or facilities where the product is or will be manufactured. These <FONT STYLE="white-space:nowrap">pre-approval</FONT> inspections may cover all facilities associated with
a BLA submission, including component manufacturing, finished product manufacturing and control testing laboratories. The FDA will not approve an application unless it determines that the manufacturing processes and facilities are in compliance with
cGMP requirements and adequate to assure consistent production of the product within required specifications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a condition of approval,
the FDA may require an applicant to develop a Risk Evaluation Mitigation Strategy (&#147;REMS&#148;). REMS use risk minimization strategies beyond the professional labeling to ensure that the benefits of the product outweigh the potential risks. To
determine whether a REMS is needed, the FDA will consider the size of the population likely to use the product, seriousness of the disease, expected benefit of the product, expected duration of treatment, seriousness of known or potential adverse
events and whether the product is a new molecular entity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">102 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FDA will refer an application for a novel product to an advisory committee or explain
why such referral was not made. Typically, an advisory committee is a panel of independent experts, including clinicians and other scientific experts, that reviews, evaluates and provides a recommendation as to whether the application should be
approved and under what conditions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Fast Track, Breakthrough Therapy, Priority Review and Regenerative Advanced Therapy Designations </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FDA is authorized to designate certain products for expedited review if they are intended to address an unmet medical need in the treatment
of a serious or life-threatening disease or condition. These programs are referred to as Fast Track designation, Breakthrough Therapy designation, Priority Review designation and Regenerative Advanced Therapy designation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Specifically, the FDA may designate a product for Fast Track designation if it is intended, whether alone or in combination with one or more
other products, for the treatment of a serious or life-threatening disease or condition, and it demonstrates the potential to address unmet medical needs for such a disease or condition. For Fast Track products, sponsors may have greater
interactions with the FDA and the FDA may initiate review of sections of a Fast Track product&#146;s application before the application is complete. This rolling review may be available if the FDA determines, after preliminary evaluation of clinical
data submitted by the sponsor, that a Fast Track product may be effective. The sponsor must also provide, and the FDA must approve, a schedule for the submission of the remaining information and the sponsor must pay applicable user fees. However,
the FDA&#146;s time period goal for reviewing a Fast Track application does not begin until the last section of the application is submitted. In addition, the Fast Track designation may be withdrawn by the FDA if the FDA believes that the
designation is no longer supported by data emerging in the clinical trial process. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Second, a product may be designated as a Breakthrough
Therapy if it is intended, either alone or in combination with one or more other products, to treat a serious or life-threatening disease or condition and preliminary clinical evidence indicates that the product may demonstrate substantial
improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. The FDA may take certain actions with respect to Breakthrough Therapies, including
holding meetings with the sponsor throughout the development process; providing timely advice to the product sponsor regarding development and approval; involving more senior staff in the review process; assigning a cross-disciplinary project lead
for the review team; and taking other steps to design the clinical trials in an efficient manner. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Third, the FDA may designate a product
for Priority Review if it is a product that treats a serious condition and, if licensed, would provide a significant improvement in safety or effectiveness. The FDA determines, on a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">case-by-case</FONT></FONT> basis, whether the proposed product represents a significant improvement when compared with other available therapies. Significant improvement may be
illustrated by evidence of increased effectiveness in the treatment of a condition, elimination or substantial reduction of a treatment-limiting product reaction, documented enhancement of patient compliance that may lead to improvement in serious
outcomes, and evidence of safety and effectiveness in a new subpopulation. A priority designation is intended to direct overall attention and resources to the evaluation of such applications, and to shorten the FDA&#146;s goal for taking action on a
marketing application from ten months to six months. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FDA can accelerate review and approval of products designated as regenerative
advanced therapies. A product is eligible for this designation if it is a regenerative medicine therapy that is intended to treat, modify, reverse or cure a serious or life-threatening disease or condition and preliminary clinical evidence indicates
that the product has the potential to address unmet medical needs for such disease or condition. The benefits of a regenerative advanced therapy designation include early interactions with FDA to expedite development and review, benefits available
to breakthrough therapies, potential eligibility for Priority Review and Accelerated Approval based on surrogate or intermediate endpoints. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">103 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Accelerated Approval Pathway </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FDA may grant Accelerated Approval to a product for a serious or life-threatening condition that provides meaningful therapeutic advantage
to patients over existing treatments, based upon a determination that the product has an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit. The FDA may also grant Accelerated Approval for such a condition when the
product has an effect on an intermediate clinical endpoint that can be measured earlier than an effect on irreversible morbidity or mortality (&#147;IMM&#148;) and that is reasonably likely to predict an effect on IMM or other clinical benefit,
taking into account the severity, rarity, or prevalence of the condition and the availability or lack of alternative treatments. Products granted Accelerated Approval must meet the same statutory standards for safety and effectiveness as those
granted traditional approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the purposes of Accelerated Approval, a surrogate endpoint is a marker, such as a laboratory
measurement, radiographic image, physical sign, or other measure that is thought to predict clinical benefit but is not itself a measure of clinical benefit. Surrogate endpoints can often be measured more easily or more rapidly than clinical
endpoints. An intermediate clinical endpoint is a measurement of a therapeutic effect that is considered reasonably likely to predict the clinical benefit of a drug, such as an effect on IMM. The FDA has limited experience with Accelerated Approvals
based on intermediate clinical endpoints but has indicated that such endpoints generally may support Accelerated Approval where the therapeutic effect measured by the endpoint is not itself a clinical benefit and basis for traditional approval, if
there is a basis for concluding that the therapeutic effect is reasonably likely to predict the ultimate clinical benefit of a product. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Accelerated Approval pathway is most often used in settings in which the course of a disease is long and an extended period of time is
required to measure the intended clinical benefit of a product, even if the effect on the surrogate or intermediate clinical endpoint occurs rapidly. Thus, Accelerated Approval has been used extensively in the development and approval of products
for treatment of a variety of cancers in which the goal of therapy is generally to improve survival or decrease morbidity and the duration of the typical disease course requires lengthy and sometimes large trials to demonstrate a clinical or
survival benefit. Thus, the benefit of Accelerated Approval derives from the potential to receive approval based on surrogate endpoints sooner than possible for trials with clinical or survival endpoints, rather than deriving from any explicit
shortening of the FDA approval timeline, as is the case with Priority Review. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Accelerated Approval pathway is usually contingent on a
sponsor&#146;s agreement to conduct, in a diligent manner, additional post-approval confirmatory studies to verify and describe the product&#146;s clinical benefit. As a result, a product candidate licensed on this basis is subject to rigorous
post-marketing compliance requirements, including the completion of Phase 4 or post-approval clinical trials to confirm the effect on the clinical endpoint. Failure to conduct required post-approval studies, or confirm a clinical benefit during
post-marketing studies, would allow the FDA to initiate expedited proceedings to withdraw approval of the product. All promotional materials for product candidates licensed under accelerated regulations are subject to prior review by the FDA. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>The FDA&#146;s Decision on a BLA </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the basis of the FDA&#146;s evaluation of the application and accompanying information, including the results of the inspection of the
manufacturing facilities, the FDA may issue an approval letter or a complete response letter. An approval letter authorizes commercial marketing of the product with specific prescribing information for specific indications. A complete response
letter generally outlines the deficiencies in the submission and may require substantial additional testing or information in order for the FDA to reconsider the application. If those deficiencies have been addressed to the FDA&#146;s satisfaction
in a resubmission of the BLA, the FDA will issue an approval letter. The FDA has committed to reviewing such resubmissions in two or six months depending on the type of information included. Even with submission of this additional information, the
FDA ultimately may decide that the application does not satisfy the regulatory criteria for licensing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">104 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the FDA licenses a new product, it may limit the licensed indications for use of the
product. The agency may also require testing and surveillance programs to monitor the product after commercialization, or impose other conditions, including distribution restrictions or other risk management mechanisms, including REMS, to help
ensure that the benefits of the product outweigh the potential risks. REMS can include medication guides, communication plans for healthcare professionals, and elements to assure safe use (&#147;ETASU&#148;). ETASU can include, but are not limited
to, special training or certification for prescribing or dispensing, dispensing only under certain circumstances, special monitoring and the use of patient registries. The FDA may prevent or limit further marketing of a product based on the results
of post-market studies or surveillance programs. After licensing, many types of changes to the licensed product, such as adding new indications, manufacturing changes and additional labeling claims, are subject to further testing requirements and
FDA review and approval. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Post-Licensing Regulation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If regulatory licensing for marketing of a product or new indication for an existing product is obtained, the sponsor will be required to
comply with all regular post-licensing regulatory requirements as well as any post-licensing requirements that the FDA may have imposed as part of the licensing process. The sponsor will be required to report, among other things, certain adverse
reactions and manufacturing problems to the FDA, provide updated safety and potency or efficacy information and comply with requirements concerning advertising and promotional labeling requirements. Manufacturers and certain of their subcontractors
are required to register their facilities with the FDA and certain state agencies, and are subject to periodic unannounced inspections by the FDA and certain state agencies for compliance with ongoing regulatory requirements, including cGMP
regulations, which impose certain procedural and documentation requirements upon manufacturers. Changes to the manufacturing processes are strictly regulated and often require prior FDA approval before being implemented. Accordingly, the sponsor and
its third-party manufacturers must continue to expend time, money, and effort in the areas of production and quality control to maintain compliance with cGMP regulations and other regulatory requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As part of the manufacturing process, the manufacturer is required to perform certain tests on each lot of the product before it is released
for distribution. After a BLA is approved for a biological product, the product may also be subject to official lot release, meaning that the manufacturer is required to perform certain tests on each lot of the product before it is released for
distribution. If the product is subject to official release, the manufacturer must submit samples of each lot, together with a release protocol showing a summary of the history of manufacture of the lot and the results of all of the
manufacturer&#146;s tests performed on the lot, to the FDA. The FDA may in addition perform certain confirmatory tests on lots of some products before releasing the lots for distribution. In addition, the FDA conducts laboratory research related to
the regulatory standards on the safety, purity, potency, and effectiveness of biological products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Once a license is granted, the FDA may
suspend or revoke the license if compliance with regulatory requirements is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with a product, including adverse events of
unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the labeling to add new safety information; imposition of post-market studies or clinical trials to
assess safety risks; or imposition of distribution or other restrictions under a REMS program. Other potential consequences include, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">restrictions on the marketing or manufacturing of the product, complete withdrawal of the product from the
market, or product recalls; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">fines, warning letters, or holds on post-licensing clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">refusal of the FDA to approve pending applications or supplements to licensed applications, or suspension or
revocation of product licenses; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">product seizure or detention, or refusal to permit the import or export of products; or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">105 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">injunctions or the imposition of civil or criminal penalties. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FDA strictly regulates the marketing, labeling, advertising and promotion of prescription drug products placed on the market. This
regulation includes, among other things, standards and regulations for <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">direct-to-consumer</FONT></FONT> advertising, communications regarding unapproved uses, industry-sponsored
scientific and educational activities, and promotional activities involving the Internet and social media. After licensing, a drug product generally may not be promoted for uses that are not licensed by the FDA, as reflected in the product&#146;s
prescribing information. In the United States, healthcare professionals are generally permitted to prescribe drugs for such uses not described in the drug&#146;s labeling, known as <FONT STYLE="white-space:nowrap">off-label</FONT> uses, because the
FDA does not regulate the practice of medicine. However, FDA regulations impose rigorous restrictions on manufacturers&#146; communications, prohibiting the promotion of <FONT STYLE="white-space:nowrap">off-label</FONT> uses. It may be permissible,
under very specific, narrow conditions, for a manufacturer to engage in nonpromotional, <FONT STYLE="white-space:nowrap">non-misleading</FONT> communication regarding <FONT STYLE="white-space:nowrap">off-label</FONT> information, such as
distributing scientific or medical journal information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a company is found to have promoted
<FONT STYLE="white-space:nowrap">off-label</FONT> uses, it may become subject to adverse public relations and administrative and judicial enforcement by the FDA, the Department of Justice, or the Office of the Inspector General of the HHS, as well
as state authorities. This could subject a company to a range of penalties that could have a significant commercial impact, including civil and criminal fines and agreements that materially restrict the manner in which a company promotes or
distributes drug products. The federal government has levied large civil and criminal fines against companies for alleged improper promotion and has also requested that companies enter into consent decrees or permanent injunctions under which
specified promotional conduct is changed or curtailed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the distribution of prescription pharmaceutical products is subject
to the Prescription Drug Marketing Act (&#147;PDMA&#148;) and its implementing regulations as well as the Drug Supply Chain Security Act (&#147;DSCA&#148;), which regulate the distribution and tracing of prescription drug samples at the federal
level and set minimum standards for the regulation of distributors by the states. The PDMA, its implementing regulations and state laws limit the distribution of prescription pharmaceutical product samples, and the DSCA imposes requirements to
ensure accountability in distribution and to identify and remove counterfeit and other illegitimate products from the market. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Pediatric Studies and Exclusivity </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Pediatric Research Equity Act, a BLA or supplement thereto for a biological product with a new active ingredient, indication, dosage
form, dosing regimen or route of administration must contain data that are adequate to assess the safety and effectiveness of the product for the claimed indications in all relevant pediatric subpopulations, and to support dosing and administration
for each pediatric subpopulation for which the product is safe and effective. Sponsors must also submit pediatric study plans prior to the assessment data. Those plans must contain an outline of the proposed pediatric study or studies the applicant
plans to conduct, including study objectives and design, any deferral or waiver requests and other information required by regulation. The applicant, the FDA, and the FDA&#146;s internal review committee must then review the information submitted,
consult with each other and agree upon a final plan. The FDA or the applicant may request an amendment to the plan at any time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For
products intended to treat a serious or life-threatening disease or condition, the FDA must, upon the request of an applicant, meet to discuss preparation of the initial pediatric study plan or to discuss deferral or waiver of pediatric assessments.
In addition, FDA will meet early in the development process to discuss pediatric study plans with sponsors and FDA must meet with sponsors by no later than the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">end-of-Phase</FONT></FONT> 1 meeting for serious or life-threatening diseases and by no later than ninety (90)&nbsp;days after FDA&#146;s receipt of the study plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FDA may, on its own initiative or at the request of the applicant, grant deferrals for submission of some or all pediatric data until
after licensing of the product for use in adults, or full or partial waivers from the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">106 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
pediatric data requirements. Generally, the pediatric data requirements do not apply to products with orphan designation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FDA Reauthorization Act of 2017 established new requirements to govern certain molecularly targeted cancer indications. Any company that
submits a BLA three years after the date of enactment of that statute must submit pediatric assessments with the BLA if the biologic is intended for the treatment of an adult cancer and is directed at a molecular target that FDA determines to be
substantially relevant to the growth or progression of a pediatric cancer. The investigation must be designed to yield clinically meaningful pediatric study data regarding the dosing, safety and preliminary potency to inform pediatric labeling for
the product. Deferrals and waivers as described above are also available. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pediatric exclusivity is another type of <FONT
STYLE="white-space:nowrap">non-patent</FONT> marketing exclusivity in the United States and, if granted, provides for the attachment of an additional six months of marketing protection to the term of any existing regulatory exclusivity, including
the <FONT STYLE="white-space:nowrap">non-patent</FONT> and orphan exclusivity. This <FONT STYLE="white-space:nowrap">six-month</FONT> exclusivity may be granted if a BLA sponsor submits pediatric data that fairly respond to a written request from
the FDA for such data. The data do not need to show the product to be effective in the pediatric population studied. If reports of requested pediatric studies are submitted to and accepted by the FDA within the statutory time limits, whatever
statutory or regulatory periods of exclusivity or patent protection cover the product are extended by six months. This is not a patent term extension, but it effectively extends the regulatory period during which the FDA cannot license another
application. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Orphan Drug Designations and Exclusivity </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Orphan Drug Act, the FDA may designate a biological product as an &#147;orphan drug&#148; if it is intended to treat a rare disease
or condition, generally meaning that it affects fewer than 200,000 individuals in the United States, or more in cases in which there is no reasonable expectation that the cost of developing and making a product available in the United States for
treatment of disease or condition will be recovered from sales of the product. A company must seek orphan drug designation before submitting a BLA for the candidate product. If the request is granted, the FDA will disclose the identity of the
therapeutic agent and its potential use. Orphan drug designation does not shorten the PDUFA goal dates for the regulatory review and licensing process, although it does convey certain advantages such as tax benefits and exemption from the PDUFA
application fee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a product with orphan designation receives the first FDA approval for the disease or condition for which it has such
designation or for a select indication or use within the rare disease or condition for which it was designated, the product generally will receive orphan drug exclusivity. Orphan drug exclusivity means that the FDA may not license another
sponsor&#146;s marketing application for the same drug for the same condition for seven years, except in certain limited circumstances. Orphan exclusivity does not block the licensing of a different product for the same rare disease or condition,
nor does it block the licensing of the same product for different conditions. If a biologic designated as an orphan drug ultimately receives marketing licensing for an indication broader than what was designated in its orphan drug application, it
may not be entitled to exclusivity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Orphan drug exclusivity will not bar licensing of another product under certain circumstances,
including if a subsequent product with the same biologic for the same condition is shown to be clinically superior to the licensed product on the basis of greater effectiveness, safety in a substantial portion of the target populations, or providing
a major contribution to patient care, or if the company with orphan drug exclusivity is not able to meet market demand. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Biosimilars
and Regulatory Exclusivity </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2010 Patient Protection and Affordable Care Act, which was signed into law on March&nbsp;23, 2010,
included a subtitle called the Biologics Price Competition and Innovation Act of 2009 (&#147;BPCIA&#148;). The BPCIA established a regulatory scheme authorizing the FDA to license biosimilars and interchangeable biosimilars. The
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">107 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
FDA has licensed several biosimilar products for use in the United States. The FDA has issued several guidance documents outlining an approach to review and licensing of biosimilars. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the BPCIA, a manufacturer may apply for licensure of a biological product that is &#147;biosimilar to&#148; or &#147;interchangeable
with&#148; a previously licensed biological product or &#147;reference product.&#148; In order for the FDA to license a biosimilar product, it must find, among other things, that the product is &#147;highly similar&#148; to the reference product
notwithstanding minor differences in clinically inactive components and that there are no clinically meaningful differences between the reference product and proposed biosimilar product in terms of safety, purity, and potency. For the FDA to license
a biosimilar product as interchangeable with a reference product, the agency must find that the biosimilar product can be expected to produce the same clinical results as the reference product, and, for products administered multiple times, that the
biologic and the reference biologic may be switched after one has been previously administered without increasing safety risks or risks of diminished potency relative to exclusive use of the reference biologic. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the BPCIA, an application for a biosimilar or interchangeable biological product may not be submitted to the FDA until four years
following the date of licensing of the reference product. The FDA may not license a biosimilar or interchangeable biological product until 12 years from the date on which the reference product was licensed. Even if a product is considered to be a
reference product eligible for exclusivity, another company could market a competing version of that product if the FDA licenses a full BLA for such product containing the sponsor&#146;s own preclinical data and data from adequate and
well-controlled clinical trials to demonstrate the safety, purity, and potency of their product. The BPCIA also created certain exclusivity periods for biosimilars licensed as interchangeable products. At this juncture, it is unclear whether
products deemed &#147;interchangeable&#148; by the FDA will, in fact, be readily substituted by pharmacies, which are governed by state pharmacy law. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Patent Term Restoration and Extension </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The term of individual patents depends upon the legal term of the patents in the countries in which they are obtained. In most countries in
which we file, including the United States, the patent term is 20 years from the earliest date of filing of a <FONT STYLE="white-space:nowrap">non-provisional</FONT> patent application. In the United States, a patent claiming a new <FONT
STYLE="white-space:nowrap">FDA-approved</FONT> biological product may be eligible for a limited patent term extension under the Hatch-Waxman Act, which permits a patent restoration of up to five years for patent term lost during product development
and FDA regulatory review. The restoration period granted on a patent covering a product is typically <FONT STYLE="white-space:nowrap">one-half</FONT> the time between the effective date of an IND and the submission date of a marketing application
(such as a BLA), plus the time between the submission date of a marketing application and the ultimate licensing date. Patent term restoration cannot be used to extend the remaining term of a patent past a total of 14 years from the product&#146;s
licensing date. Only one patent applicable to a licensed product is eligible for the extension, only those claims covering the approved product, a method for using it, or a method for manufacturing it may be extended and the application for the
extension must be submitted prior to the expiration of the patent in question and within 60 days after approval of the relevant marketing application. A patent that covers multiple products for which licensing is sought can only be extended in
connection with one of the licenses. The USPTO reviews and licenses the application for any patent term extension or restoration in consultation with the FDA. Similar provisions are available in Europe and other foreign jurisdictions to extend the
term of a patent that covers an approved drug. In the future, if and when our products receive FDA approval, we expect to apply for patent term extensions on patents covering those products. We plan to seek patent term extensions to any of our
issued patents in any jurisdiction where these are available, however there is no guarantee that the applicable authorities, including the FDA in the United States, will agree with our assessment of whether such extensions should be granted, and if
granted, the length of such extensions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Regulation of Companion Diagnostics </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The success of certain of our product candidates may depend, in part, on the development and commercialization of a companion diagnostic.
Companion diagnostics identify patients who are most likely to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">108 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
benefit from a particular therapeutic product; identify patients likely to be at increased risk for serious side effects as a result of treatment with a particular therapeutic product; or monitor
response to treatment with a particular therapeutic product for the purpose of adjusting treatment to achieve improved safety or effectiveness. Companion diagnostics are regulated as medical devices by the FDA. In the United States, the FDCA and its
implementing regulations, and other federal and state statutes and regulations govern, among other things, medical device design and development, preclinical and clinical testing, premarket clearance or approval, registration and listing,
manufacturing, labeling, storage, advertising and promotion, sales and distribution, export and import, and post-market surveillance. Unless an exemption or FDA exercise of enforcement discretion applies, diagnostic tests generally require marketing
clearance or approval from the FDA prior to commercialization. The two primary types of FDA marketing authorization applicable to a medical device are premarket notification, also called 510(k) clearance, and approval of a premarket approval
(&#147;PMA&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To obtain 510(k) clearance for a medical device, or for certain modifications to devices that have received 510(k)
clearance, a manufacturer must submit a premarket notification demonstrating that the proposed device is substantially equivalent to a previously cleared 510(k) device or to a preamendment device that was in commercial distribution before
May&nbsp;28, 1976, or a predicate device, for which the FDA has not yet called for the submission of a PMA. In making a determination that the device is substantially equivalent to a predicate device, the FDA compares the proposed device to the
predicate device or predicate devices and assesses whether the subject device is comparable to the predicate device or predicate devices with respect to intended use, technology, design and other features which could affect safety and effectiveness.
If the FDA determines that the subject device is substantially equivalent to the predicate device or predicate devices, the subject device may be cleared for marketing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">PMA applications must be supported by valid scientific evidence, which typically requires extensive data, including technical, preclinical,
clinical and manufacturing data, to demonstrate to the FDA&#146;s satisfaction the safety and effectiveness of the device. For diagnostic tests, a PMA application typically includes data regarding analytical and clinical validation studies. As part
of its review of the PMA, the FDA will conduct a <FONT STYLE="white-space:nowrap">pre-approval</FONT> inspection of the manufacturing facility or facilities to ensure compliance with the Quality System Regulation (&#147;QSR&#148;), which requires
manufacturers to follow design, testing, control, documentation and other quality assurance procedures. If the FDA evaluations of both the PMA application and the manufacturing facilities are favorable, the FDA will either issue an approval letter
or an approvable letter, which usually contains a number of conditions that must be met in order to secure the final approval of the PMA. If the FDA&#146;s evaluation of the PMA or manufacturing facilities is not favorable, the FDA will deny the
approval of the PMA or issue a not approvable letter. A not approvable letter will outline the deficiencies in the application and, where practical, will identify what is necessary to make the PMA approvable. Once granted, PMA approval may be
withdrawn by the FDA if compliance with post-approval requirements, conditions of approval or other regulatory standards is not maintained or problems are identified following initial marketing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&nbsp;31, 2014, the FDA issued a final guidance document addressing the development and approval process for &#147;<I>In Vitro</I>
Companion Diagnostic Devices.&#148; According to the guidance document, for novel therapeutic products that depend on the use of a diagnostic test and where the diagnostic device could be essential for the safe and effective use of the corresponding
therapeutic product, the premarket application for the companion diagnostic device should be developed and approved or cleared contemporaneously with the therapeutic, although the FDA recognizes that there may be cases when contemporaneous
development may not be possible. However, in cases where a drug cannot be used safely or effectively without the companion diagnostic, the FDA&#146;s guidance indicates it will generally not approve the drug without the approval or clearance of the
diagnostic device. The FDA also issued a draft guidance in July 2016 setting forth the principles for <FONT STYLE="white-space:nowrap">co-development</FONT> of an<I> in vitro</I> companion diagnostic device with a therapeutic product. The draft
guidance describes principles to guide the development and contemporaneous marketing authorization for the therapeutic product and its corresponding<I> in vitro</I> companion diagnostic. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Once cleared or approved, the companion diagnostic device must adhere to post-marketing requirements including the requirements of FDA&#146;s
quality system regulation, adverse event reporting, recalls and corrections </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">109 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
along with product marketing requirements and limitations. Like drug and biologic makers, companion diagnostic makers are subject to unannounced FDA inspections at any time during which the FDA
will conduct an audit of the product(s) and the company&#146;s facilities for compliance with its authorities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Healthcare Law and
Regulation </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See &#147;Item 3. Key Information&#151;D. Risk Factors&#151;Risks Related to Our Business and Industry.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Review and Approval of Medicinal Products in the EU </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to market any product outside of the United States, a company must also comply with numerous and varying regulatory requirements of
other countries and jurisdictions regarding quality, safety and efficacy and governing, among other things, clinical trials, marketing authorization, commercial sales and distribution of products. Whether or not it obtains FDA licensing for a
product, an applicant will need to obtain the necessary approvals by the comparable <FONT STYLE="white-space:nowrap">non-U.S.</FONT> regulatory authorities before it can commence clinical trials or marketing of the product in those countries or
jurisdictions. Specifically, the process governing approval of medicinal products in the EU generally follows similar lines as in the United States. It entails satisfactory completion of preclinical studies and adequate and well-controlled clinical
trials to establish the safety and efficacy of the product for each proposed indication. It also requires the submission to the relevant competent authorities of a MAA, and granting of a marketing authorization by these authorities before the
product can be marketed and sold in the EU. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Clinical Trial Approval in the EU </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Clinical Trials Directive 2001/20/EC, the Directive 2005/28/EC on GCP and the related national implementing provisions of the individual EU
Member States govern the system for the approval of clinical trials in the EU. Under this system, an applicant must obtain prior approval from the competent national authority of the EU Member States in which the clinical trial is to be conducted.
Furthermore, the applicant may only start a clinical trial at a specific study site after the lead ethics committee has issued a favorable opinion. The clinical trial application must be accompanied by, among other documents, an investigational
medicinal product dossier (the Common Technical Document) with supporting information prescribed by Directive 2001/20/EC, Directive 2005/28/EC, where relevant the implementing national provisions of the individual EU Member States and further
detailed in applicable guidance documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In April 2014, the EU adopted a new Clinical Trials Regulation (EU) No 536/2014, which is set
to replace the current Clinical Trials Directive 2001/20/EC. It is expected that the new Clinical Trials Regulation (EU) No 536/2014 will apply following confirmation of full functionality of the Clinical Trials Information System
(&#147;CTIS&#148;), the centralized EU portal and database for clinical trials foreseen by the regulation, through an independent audit. The regulation becomes applicable six months after the European Commission publishes notice of this
confirmation. It will overhaul the current system of approvals for clinical studies in the EU. Specifically, the new regulation, which will be directly applicable in all member states, aims at simplifying and streamlining the approval of clinical
studies in the EU. For instance, the new Clinical Trials Regulation provides for a streamlined application procedure via a single point and strictly defined deadlines for the assessment of clinical study applications. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>PRIME Designation in the EU </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In March
2016, the EMA launched an initiative to facilitate development of product candidates in indications, often rare, for which few or no therapies currently exist. The PRIority MEdicines (&#147;PRIME&#148;) scheme is intended to encourage drug
development in areas of unmet medical need and provides accelerated assessment of products representing substantial innovation reviewed under the centralized procedure. Products from small and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">110 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<FONT STYLE="white-space:nowrap">medium-sized</FONT> enterprises may qualify for earlier entry into the PRIME scheme than products from larger companies. Many benefits accrue to sponsors of
product candidates with PRIME designation, including but not limited to, early and proactive regulatory dialogue with the EMA, frequent discussions on clinical trial designs and other development program elements, and accelerated marketing
authorization application assessment once a dossier has been submitted. Importantly, a dedicated agency contact and a rapporteur from the Committee for Human Medicinal Products (&#147;CHMP&#148;) or Committee for Advanced Therapies are appointed
early in the PRIME scheme facilitating increased understanding of the product at EMA&#146;s Committee level. A <FONT STYLE="white-space:nowrap">kick-off</FONT> meeting initiates these relationships and includes a team of multidisciplinary experts at
the EMA to provide guidance on the overall development and regulatory strategies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Marketing Authorization in the EU </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To obtain a marketing authorization for a product under EU regulatory systems, an applicant must submit an MAA, either under a centralized
procedure administered by the EMA or one of the procedures administered by competent authorities in EU Member States (decentralized procedure, national procedure, or mutual recognition procedure). A marketing authorization may be granted only to an
applicant established in the EU. Regulation (EC) No.&nbsp;1901/2006 provides that prior to obtaining a marketing authorization in the EU, applicants must demonstrate compliance with all measures included in an
<FONT STYLE="white-space:nowrap">EMA-approved</FONT> Pediatric Investigation Plan (&#147;PIP&#148;) covering all subsets of the pediatric population, unless the EMA has granted a product-specific waiver, class waiver, or a deferral for one or more
of the measures included in the PIP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The centralized procedure provides for the grant of a single marketing authorization by the European
Commission that is valid across the European Economic Area. Pursuant to Regulation (EC) No.&nbsp;726/2004, the centralized procedure is compulsory for specific products, including for medicines produced by certain biotechnological processes,
products designated as orphan medicinal products, ATMPs and products with a new active substance indicated for the treatment of certain diseases, including products for the treatment of cancer. For products with a new active substance indicated for
the treatment of other diseases and products that are highly innovative or for which a centralized process is in the interest of patients, the centralized procedure may be optional. The centralized procedure may at the request of the applicant also
be used in certain other cases. We anticipate that the centralized procedure will be mandatory for the product candidates we are developing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the centralized procedure, the CHMP is also responsible for several post-authorization and maintenance activities, such as the
assessment of modifications or extensions to an existing marketing authorization. Under the centralized procedure in the EU, the maximum timeframe for the evaluation of an MAA is 210 days, excluding clock stops when additional information or written
or oral explanation is to be provided by the applicant in response to questions of the CHMP. Accelerated evaluation may be granted by the CHMP in exceptional cases and under PRIME designation, when a medicinal product is of major interest from the
point of view of public health and, in particular, from the viewpoint of therapeutic innovation. If the CHMP accepts such a request, the time limit of 210 days will be reduced to 150 days, but it is possible that the CHMP may revert to the standard
time limit for the centralized procedure if it determines that it is no longer appropriate to conduct an accelerated assessment. At the end of this period, the CHMP provides a scientific opinion on whether or not a marketing authorization should be
granted in relation to a medicinal product. Within 15 calendar days of receipt of a final opinion from the CHMP, the European Commission must prepare a draft decision concerning an application for marketing authorization. This draft decision must
take the opinion and any relevant provisions of EU law into account. Before arriving at a final decision on an application for centralized authorization of a medicinal product the European Commission must consult the Standing Committee on Medicinal
Products for Human Use. The Standing Committee is composed of representatives of the EU Member States and chaired by a <FONT STYLE="white-space:nowrap">non-voting</FONT> European Commission representative. The European Parliament also has a related
&#147;<I>droit de regard</I>.&#148; The European Parliament&#146;s role is to ensure that the European Commission has not exceeded its powers in deciding to grant or refuse to grant a marketing authorization. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">111 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The European Commission may grant a <FONT STYLE="white-space:nowrap">so-called</FONT>
&#147;marketing authorization under exceptional circumstances.&#148; Such authorization is intended for products for which the applicant can demonstrate that it is unable to provide comprehensive data on the efficacy and safety under normal
conditions of use, because the indications for which the product in question is intended are encountered so rarely that the applicant cannot reasonably be expected to provide comprehensive evidence, or in the present state of scientific knowledge,
comprehensive information cannot be provided, or it would be contrary to generally accepted principles of medical ethics to collect such information. Consequently, marketing authorization under exceptional circumstances may be granted subject to
certain specific obligations, which may include the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the applicant must complete an identified program of studies within a time period specified by the competent
authority, the results of which form the basis of a reassessment of the benefit/risk profile; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the medicinal product in question may be supplied on medical prescription only and may in certain cases be
administered only under strict medical supervision, possibly in a hospital and in the case of a radiopharmaceutical, by an authorized person; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the package leaflet and any medical information must draw the attention of the medical practitioner to the fact
that the particulars available concerning the medicinal product in question are as yet inadequate in certain specified respects. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A marketing authorization under exceptional circumstances is subject to annual review to reassess the risk-benefit balance in an annual
reassessment procedure. Continuation of the authorization is linked to the annual reassessment and a negative assessment could potentially result in the marketing authorization being suspended or revoked. The renewal of a marketing authorization of
a medicinal product under exceptional circumstances, however, follows the same rules as a &#147;normal&#148; marketing authorization. Thus, a marketing authorization under exceptional circumstances is granted for an initial five years, after which
the authorization will become valid indefinitely, unless the EMA decides that safety grounds merit one additional five-year renewal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
European Commission may also grant a <FONT STYLE="white-space:nowrap">so-called</FONT> &#147;conditional marketing authorization&#148; prior to obtaining the comprehensive clinical data required for an application for a full marketing authorization.
Such conditional marketing authorizations may be granted for product candidates (including medicines designated as orphan medicinal products), if (i)&nbsp;the risk-benefit balance of the product candidate is positive, (ii)&nbsp;it is likely that the
applicant will be in a position to provide the required comprehensive clinical trial data, (iii)&nbsp;the product fulfills an unmet medical need and (iv)&nbsp;the benefit to public health of the immediate availability on the market of the medicinal
product concerned outweighs the risk inherent in the fact that additional data are still required. A conditional marketing authorization may contain specific obligations to be fulfilled by the marketing authorization holder, including obligations
with respect to the completion of ongoing or new studies, and with respect to the collection of pharmacovigilance data. Conditional marketing authorizations are valid for one year, and may be renewed annually, if the risk-benefit balance remains
positive, and after an assessment of the need for additional or modified conditions and/or specific obligations. The timelines for the centralized procedure described above also apply with respect to the review by the CHMP of applications for a
conditional marketing authorization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The EU medicines rules expressly permit the EU Member States to adopt national legislation
prohibiting or restricting the sale, supply or use of any medicinal product containing, consisting of or derived from a specific type of human or animal cell, such as embryonic stem cells. While the product candidates we have in development do not
make use of embryonic stem cells, it is possible that the national laws in certain EU Member States may prohibit or restrict us from commercializing our product candidates, even if they have been granted an EU marketing authorization. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Regulatory Data Protection in the EU </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the EU, innovative medicinal products approved on the basis of a complete independent data package qualify for eight years of data
exclusivity upon marketing authorization and an additional two years of market </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">112 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
exclusivity pursuant to Directive 2001/83/EC. Regulation (EC) No.&nbsp;726/2004 repeats the entitlement for medicinal products authorized in accordance with the centralized authorization
procedure. Data exclusivity prevents applicants for authorization of generics of these innovative products from referencing the innovator&#146;s data to assess a generic (abridged) application for a period of eight years. During the additional <FONT
STYLE="white-space:nowrap">two-year</FONT> period of market exclusivity, a generic marketing authorization application can be submitted and authorized, and the innovator&#146;s data may be referenced, but no generic medicinal product can be placed
on the EU market until the expiration of the market exclusivity. The overall <FONT STYLE="white-space:nowrap">ten-year</FONT> period will be extended to a maximum of 11 years if, during the first eight years of those ten years, the marketing
authorization holder obtains an authorization for one or more new therapeutic indications which, during the scientific evaluation prior to their authorization, are held to bring a significant clinical benefit in comparison with existing therapies.
Even if a compound is considered to be a new chemical entity so that the innovator gains the prescribed period of data exclusivity, another company may market another version of the product if such company obtained marketing authorization based on
an MAA with a complete independent data package of pharmaceutical tests, <FONT STYLE="white-space:nowrap">non-clinical</FONT> tests and clinical trials. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Periods of Authorization and Renewals </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A marketing authorization has an initial validity for five years in principle. The marketing authorization may be renewed after five years on
the basis of a reevaluation of the risk-benefit balance by the EMA or by the competent authority of the EU Member State. To this end, the marketing authorization holder must provide the EMA or the competent authority with a consolidated version of
the file in respect of quality, safety, and efficacy, including all variations introduced since the marketing authorization was granted, at least six months before the marketing authorization ceases to be valid. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The European Commission or the competent authorities of the EU Member States may decide, on justified grounds relating to pharmacovigilance,
to proceed with one further five-year period of marketing authorization. Once subsequently definitively renewed, the marketing authorization shall be valid for an unlimited period. Any authorization which is not followed by the actual placing of the
medicinal product on the EU market (in case of centralized procedure) or on the market of the authorizing EU Member State within three years after authorization ceases to be valid (the <FONT STYLE="white-space:nowrap">so-called</FONT> sunset
clause). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Orphan Drug Designation and Exclusivity </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Regulation (EC) No.&nbsp;141/2000, as implemented by Regulation (EC) No.&nbsp;847/2000 provides that a drug can be designated as an orphan drug
by the European Commission if its sponsor can establish: that the product is intended for the diagnosis, prevention or treatment of (1)&nbsp;a life-threatening or chronically debilitating condition affecting not more than five in ten thousand
persons in the EU when the application is made, or (2)&nbsp;a life-threatening, seriously debilitating or serious and chronic condition in the EU and that without incentives it is unlikely that the marketing of the drug in the EU would generate
sufficient return to justify the necessary investment. For either of these conditions, the applicant must demonstrate that there exists no satisfactory method of diagnosis, prevention or treatment of the condition in question that has been
authorized in the EU or, if such method exists, the drug will be of significant benefit to those affected by that condition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Once
authorized, orphan medicinal products are entitled to 10 years of market exclusivity in all EU Member States and, in addition, a range of other benefits during the development and regulatory review process including scientific assistance for study
protocols, authorization through the centralized marketing authorization procedure covering all member countries and a reduction or elimination of registration and marketing authorization fees. However, marketing authorization may be granted to a
similar medicinal product with the same orphan indication during the <FONT STYLE="white-space:nowrap">10-year</FONT> period with the consent of the marketing authorization holder for the original orphan medicinal product or if the manufacturer of
the original orphan medicinal product is unable to supply sufficient quantities. Marketing authorization may also be granted to a similar medicinal product with the same orphan indication if this product is safer, more effective or otherwise
clinically superior to the original orphan medicinal </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">113 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
product. The period of market exclusivity may, in addition, be reduced to six years if it can be demonstrated on the basis of available evidence that the original orphan medicinal product is
sufficiently profitable not to justify maintenance of market exclusivity. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Regulatory Requirements After a Marketing Authorization Has
Been Obtained </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In case an authorization for a medicinal product in the EU is obtained, the holder of the marketing authorization is
required to comply with a range of requirements applicable to the manufacturing, marketing, promotion and sale of medicinal products. These include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">compliance with the European Union&#146;s stringent pharmacovigilance or safety reporting rules must be ensured.
These rules can impose post-authorization studies and additional monitoring obligations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the manufacturing of authorized medicinal products, for which a separate manufacturer&#146;s license is
mandatory, must also be conducted in strict compliance with the applicable EU laws, regulations and guidance, including Directive 2001/83/EC, Directive 2003/94/EC, Regulation (EC) No 726/2004 and the European Commission Guidelines for Good
Manufacturing Practice. These requirements include compliance with EU cGMP standards when manufacturing medicinal products and active pharmaceutical ingredients, including the manufacture of active pharmaceutical ingredients outside of the EU with
the intention to import the active pharmaceutical ingredients into the EU; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the marketing and promotion of authorized drugs, including industry-sponsored continuing medical education and
advertising directed toward the prescribers of drugs and/or the general public, are strictly regulated in the EU notably under Directive 2001/83EC, as amended, and EU Member State laws.
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Direct-to-consumer</FONT></FONT> advertising of prescription medicines is prohibited across the EU. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_16"></A>C. Organizational Structure </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2020, we had two subsidiaries. The following table set out for each of our principal subsidiaries, the countries of
incorporation, and the percentage ownership and voting interest held by us (directly or indirectly through subsidiaries). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Company</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Jurisdiction&nbsp;of<BR>Incorporation</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage<BR>Ownership&nbsp;and<BR>Voting Interest</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Immatics Biotechnologies GmbH</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Germany</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Immatics US, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Delaware, United&nbsp;States</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_17"></A>D. Property, Plant and Equipment </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Immatics OpCo has three locations in Germany: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The corporate headquarters are located at Paul-Ehrlich-Stra&szlig;e 15 in 72076 T&uuml;bingen. It comprises
approximately 1,600 square meters of office space as well as research and laboratory space. It houses Operations, Immunology, TCR Discovery and Validation, TCR Engineering&nbsp;&amp; Bispecifics, Immunomonitoring, Discovery, Companion Diagnostics
and CMC. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our operations facility is approximately 700 square meters and is located at Aischbachstra&szlig;e 1 in 72070
T&uuml;bingen. It houses Operations, HR, IT, Finance, Translational Development, Regulatory Affairs and Clinical Development. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our third facility is approximately 380 square meters and is located in Machtlfinger Stra&szlig;e 11 in 81379
Munich. It houses Intellectual Property, IT, Communications and Business Development. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">114 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Immatics US has two locations, an administrative office, which is a direct lease, and the
research and laboratory facility, which is subleased from MD Anderson: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The administrative office is a 6,690 square foot facility located at 2201 West Holcombe, Houston, TX 77030, and
houses Operations, Human Resources, Finance, Clinical Operations, Regulatory, Bioinformatics and Program Management. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The research and laboratory facility is a 15,694 square foot facility located in the Life Science Plaza building
at 2130 West Holcombe, Suite 1100, Houston, Texas 77030. The research and laboratory facility is comprised primarily of laboratory space, with limited office seating that houses CMC, Immunology, Biomarkers, Quality Assurance and Quality Control. Our
sublease on the space will expire in August 2023. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">T cell products are manufactured at the UTHealth Evelyn H. Griffin
Stem Cell Therapeutics Research Laboratory in a 1,850 square <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">foot&nbsp;state-of-the-art&nbsp;cGMP</FONT></FONT></FONT> facility exclusively used by us
in Houston, Texas. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that our office, research and laboratory facilities are sufficient to meet our current needs. However, in
anticipation of future demand, we are negotiating for a new lease for a larger office facility in Germany and also pursuing options for a laboratory facility at both locations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are not aware of any environmental issues or other constraints that would materially impact the intended use of our facilities. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="rom149615_18"></A>ITEM&nbsp;4A.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>UNRESOLVED STAFF COMMENTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="rom149615_19"></A>ITEM&nbsp;5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>OPERATING AND FINANCIAL REVIEW AND PROSPECTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should read the following discussion and analysis of our financial condition and results of operations together with the information under
&#147;Item 3. Key Information&#151;A. Selected Financial Data&#148; and our consolidated financial statements, including the notes thereto, included in this Annual Report. Our consolidated financial statements are presented in euros and have been
prepared in accordance with IFRS. The following discussion includes forward-looking statements that involve risks, uncertainties and assumptions. Our actual results may differ materially from those anticipated in these forward-looking statements as
a result of many factors, including but not limited to those described under &#147;Item 3. Key Information&#151;D. Risk Factors&#148; and elsewhere in this Annual Report. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For a discussion of our consolidated statements of operations for the years ended December&nbsp;31, 2019 and December&nbsp;31, 2018 and our
cash flows for the year ended December&nbsp;31, 2018, see the section &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; in our Registration Statement on Form
<FONT STYLE="white-space:nowrap">F-1</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-240260)</FONT> filed with the SEC on July&nbsp;31, 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_20"></A>A. Operating Results </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a clinical-stage
biotechnology company dedicated to the development of T cell receptor (&#147;TCR&#148;)-based immunotherapies for the treatment of cancer. Our focus is the generation of novel therapeutic options for solid tumor patients. Solid tumors constitute the
majority of all malignancies, and relapsed and/or refractory solid tumor patients have an unmet medical need. We believe that by identifying true cancer targets and the right TCRs, we will be well positioned to transform current solid tumor
treatment paradigms by delivering cellular and bispecific product candidates that have the potential to improve the lives of cancer patients. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">115 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">One of the challenges of effectively treating solid tumors is the lack of cancer-specific
targets. By utilizing <FONT STYLE="white-space:nowrap">TCR-based</FONT> therapeutics, we are capable of directing T cells not only to targets on the surface of the cancer cell, but also to intracellular cancer targets that are not accessible through
classical antibody-based or <FONT STYLE="white-space:nowrap">CAR-T</FONT> therapies. We have developed a suite of proprietary technologies to identify what we refer to as &#147;true targets&#148; and &#147;right TCRs.&#148; True targets are
(i)&nbsp;naturally occurring at significant levels on native tumor tissue, and (ii)&nbsp;highly specific to cancer cells. Right TCRs are (i)&nbsp;high-affinity TCRs, and (ii)&nbsp;highly specific to the respective cancer target, with no or minimized
cross-reactivities to healthy tissues. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that the elucidation of these targets provides us the opportunity to develop a pipeline
of <FONT STYLE="white-space:nowrap">novel&nbsp;TCR-based&nbsp;product</FONT> candidates that generate a meaningful therapeutic impact on the lives of cancer patients by going beyond an incremental clinical benefit. We are developing our targeted
immunotherapy product candidates through two distinct treatment modalities: Adoptive Cell Therapies (&#147;ACT&#148;) and antibody-like Bispecifics. Each is designed with distinct attributes to produce the desired therapeutic effect for patients at
different disease stages and with different types of tumors. Our current proprietary pipeline comprises seven therapeutic programs, three of which are being evaluated in clinical trials. In addition, we are collaborating with world-leading partners,
including Amgen, Genmab, Bristol-Myers Squibb and GlaxoSmithKline, to develop ten additional therapeutic programs covering ACT and Bispecifics. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since our inception, we have focused on developing our technologies and executing our preclinical and clinical research programs with the aim
to deliver the power of T cells to cancer patients. We do not have any products approved for sale. We have funded our operations primarily through equity financing and, to a lesser extent, through upfront payments from our collaborators. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since our inception, we have incurred net losses, which have been significant in recent periods. We expect to continue to incur significant
expenses and increasing net losses for the foreseeable future as we continue our research and development efforts and seek to obtain regulatory approval for and commercialize our product candidates. Our future profitability will be dependent upon
the successful development, approval and commercialization of our product candidates and achieving a level of revenues adequate to support our cost structure. We may never achieve profitability and, unless and until we do, we will continue to need
to raise additional capital. Our net losses may fluctuate significantly from period to period and year to year. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recent Developments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Impact of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> Pandemic </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic has negatively impacted the economies of countries around the world. Our
operations, similar to those of other life sciences companies, have been impacted by the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic. As the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic continues to evolve, we believe the
extent of the impact to our operations, operating results, cash flows, liquidity and financial condition will be primarily driven by the severity and duration of the pandemic, the pandemic&#146;s impact on the U.S. and global economies and the
timing, scope and effectiveness of national and local governmental responses to the pandemic, especially in areas where the conditions have recently worsened. Those primary drivers are beyond our knowledge and control, and as a result, at this time
the ultimate impact on our results of operations, cash flows and financial position in 2021 and thereafter cannot be reasonably predicted. We are continuously assessing and adapting our working practices and business operations to ensure compliance
with official guidance and containment measures related to the pandemic, and we are working proactively with our partners and other stakeholders to take steps to mitigate and minimize any negative impact of the
<FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic on our research and development programs, clinical trials, regulatory submissions, commercialization preparations and other business operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We continue to monitor the situation and enacted significant measures to protect our supply chain, employees, and the execution of clinical
trials. To date, the pandemic has resulted in a slowdown in activities related to our laboratory operations and at some of its suppliers. Due to <FONT STYLE="white-space:nowrap">COVID-19,</FONT> we also experienced delays
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">116 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in research activities performed under our collaboration agreements. Consequently, we recognized less revenue under these agreements during 2020 than we previously planned. We believe the
declines in revenue associated with the delay in research activities are largely temporary, as the revenue is primarily associated with <FONT STYLE="white-space:nowrap">non-refundable</FONT> upfront payments recognized on a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">cost-to-cost</FONT></FONT> basis. <FONT STYLE="white-space:nowrap">COVID-19</FONT> may continue to impact the timing and amount of revenue recognized under these agreements in the future.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Completion of ARYA Merger </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&nbsp;1, 2020, we completed the Business Combination and the PIPE Financing. See &#147;Item 7. Major Shareholders and Related Party
Transactions&#151;B. Related Party Transactions.&#148;<B> </B>Upon consummation of the transactions, Immatics N.V. became publicly traded on Nasdaq, with ordinary shares trading under the ticker symbol &#147;IMTX&#148; and warrants trading under the
ticker symbol &#147;IMTXW.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Components of Operating Results </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Revenue from Collaboration Agreements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To date, we have not generated any revenue from the sale of pharmaceutical products. Our revenue has been solely derived from our collaboration
agreements with Amgen, Genmab, BMS and GSK. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our revenue from collaboration agreements consists of upfront payments as well as
reimbursement of research and development expenses. Upfront payments are initially recorded on our statement of financial position as deferred revenue and are subsequently recognized as revenue on a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">cost-to-cost</FONT></FONT> measurement basis, in accordance with our accounting policy as described further under &#147;&#151;Critical Accounting Policies and Significant Judgments and Estimates.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As part of the collaboration arrangements, we grant exclusive licensing rights for the development and commercialization of future product
candidates, developed for specified targets defined in the respective collaboration agreement. We carry out our research activities, including screening for <FONT STYLE="white-space:nowrap">off-target</FONT> recognition of lead candidates, using our
proprietary technology and <FONT STYLE="white-space:nowrap">know-how,</FONT> participate in joint steering committees, and prepare data packages. In each of our collaboration agreements, these commitments represent one combined performance
obligation, because the research activities are mutually dependent and the collaborator is unable to derive significant benefit from our access to these targets without our research activities, which are highly specialized and cannot be performed by
other organizations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The collaboration agreements resulted in &#128;186.6&nbsp;million of upfront cash payments, intended to fund the
research and development activities under each contract. As part of the agreements, we contribute our XPRESIDENT and other technologies, as well as commit to participating in joint research activities. In addition, we agree to license certain target
rights and the potential product candidates developed under the collaboration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under each of our collaboration agreements, we are
entitled to receive payments for certain development and commercial milestone events, in addition to royalty payments upon successful commercialization of a product. The uncertainty of achieving these milestones significantly impacts on our ability
to generate revenue. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our ability to generate revenue from sales of pharmaceutical products and to become profitable depends on the
successful commercialization of product candidates by us or by our collaboration partners. In the foreseeable future, we do not expect revenue from product sales. To the extent that existing or potential future collaborations generate revenue, our
revenue may vary due to many uncertainties in the development of our product candidates and other factors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">117 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Research and Development Expenses </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Research and development expenses consist primarily of personnel-related costs (including share-based compensation) for the various research
and development departments, intellectual property (&#147;IP&#148;) expenses, facility-related costs and amortization as well as direct expenses for clinical and preclinical programs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our core business is focused on the following initiatives with the goal of providing novel immuno-oncology therapies to cancer patients: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">advancing the proprietary pipeline of product candidates focusing on ACTengine and TCR Bispecifics;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">enhancing ACT manufacturing capabilities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Disrupting the tumor microenvironment through combination therapies, next-generation technologies and novel
target classes; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developing novel personalized
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">multi-TCR-T</FONT></FONT> therapeutic options; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">maintaining and enhance the competitive edge of our target and TCR technology platforms; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">leveraging existing collaborations with Amgen, Genmab, BMS and GSK; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expanding our intellectual property portfolio. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Research expenses are defined as costs incurred for current or planned investigations undertaken with the prospect of gaining new scientific
or technical knowledge and understanding. All research and development costs are expensed as incurred due to scientific uncertainty. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
expect our research and development expenses to increase substantially in the future as we advance existing and future proprietary product candidates into and through clinical studies and pursue regulatory approval. The process of conducting the
necessary clinical studies to obtain regulatory approval is costly and time-consuming. We are increasing our headcount to support our continued research activities and development of our product candidates. Clinical studies generally become larger
and more costly to conduct as they advance into later stages and, in the future, we will be required to make estimates for expense accruals related to clinical study expenses. At this time, we cannot reasonably estimate or know the nature, timing
and estimated costs of the efforts that will be necessary to complete the development of any product candidates that we develop from our programs. Our research and development programs are at an early stage. We must demonstrate our products&#146;
safety and efficacy in humans through extensive clinical testing. We may experience numerous unforeseen events during, or as a result of, the testing process that could delay or prevent commercialization of our products, including but not limited to
the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">after reviewing trial results, we or our collaborators may abandon projects previously believed to be promising;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we, our collaborators, or regulators may suspend or terminate clinical trials if the participating subjects or
patients are being exposed to unacceptable health risks; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our potential products may not achieve the desired effects or may include undesirable side effects or other
characteristics that preclude regulatory approval or limit their commercial use if approved; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">manufacturers may not meet the necessary standards for the production of the product candidates or may not be
able to supply the product candidates in a sufficient quantity; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulatory authorities may find that our clinical trial design or conduct does not meet the applicable approval
requirements; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">safety and efficacy results in various human clinical trials reported in scientific and medical literature may
not be indicative of results we obtain in our clinical trials. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">118 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Clinical testing is very expensive, can take many years, and the outcome is uncertain. It
could take several years before we learn the results from any clinical trial using ACT or TCR Bispecifics. The data collected from our clinical trials may not be sufficient to support approval by the FDA, the EMA or comparable regulatory authorities
of our <FONT STYLE="white-space:nowrap">ACT-</FONT> or TCR Bispecifics-based product candidates for the treatment of solid tumors. The clinical trials for our products under development may not be completed on schedule and the FDA, EMA or regulatory
authorities in other countries may not ultimately approve any of our product candidates for commercial sale. If we fail to adequately demonstrate the safety and effectiveness of any product candidate under development, we may not receive regulatory
approval for those product candidates, which would prevent us from generating revenues or achieving profitability. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>General and
Administrative Expenses </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">General and administrative expenses consist primarily of personnel-related costs (including share-based
compensation) for finance, legal, human resources, business development and other administrative and operational functions, professional fees, accounting and legal services, information technology and facility-related costs. These costs relate to
the operation of the business, unrelated to the research and development function or any individual program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Due to our planned
substantial increase in research and development expenses, as explained above, we also expect that our general and administrative expenses will increase significantly. We expect to incur increased accounting, audit, legal, regulatory, compliance,
director and officer insurance costs as well as investor and public relations expenses associated with being a public company. Additionally, if and when a regulatory approval of a product candidate appears likely, we anticipate an increase in
payroll and expenses as a result of our preparation for commercial operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Other Income </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We receive income through government grants for specific research and development projects. We recognize grant income as we perform research
and development activities, specified by the grant agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other components of other income have historically been immaterial. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Financial Result </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Financial result consists of both financial income and financial expense. Financial income results primarily from interest income on cash and
foreign exchange gains. Our financial expense consists of interest expense related to lease liabilities and foreign exchange losses. Additionally, the ARYA Merger led to a significant <FONT STYLE="white-space:nowrap">one-time</FONT> <FONT
STYLE="white-space:nowrap">non-cash</FONT> expense, recognized as a Share listing expense, based on the excess of the fair value of the equity instruments issued to ARYA, over the fair value of the identified net assets received. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">119 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Results of Operations </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Comparison of the Years Ended December&nbsp;31, 2020 and December&nbsp;31, 2019 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes our consolidated statements of operations for each period presented: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(euros&nbsp;in&nbsp;thousands,&nbsp;except&nbsp;share&nbsp;and&nbsp;per&nbsp;share&nbsp;data)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue from collaboration agreements</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 31,253</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 18,449</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(67,085</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(40,091</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(34,186</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(11,756</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">303</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">385</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Operating result</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(69,715</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(33,013</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financial income</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,949</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">790</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financial expenses</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(10,063</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(264</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share listing expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(152,787</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Financial result</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(159,901</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>526</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Loss before taxes</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(229,616</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(32,487</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxes on income</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net loss</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(229,616</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(32,487</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net loss per share &#150; basic and diluted</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(4.77</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(0.95</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average shares outstanding &#150; basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48,001,228</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33,093,838</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Revenue from Collaboration Agreements </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes our collaboration revenue for the periods indicated: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Revenue from collaboration agreements:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amgen</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,865</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,197</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Genmab</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,204</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,191</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BMS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,489</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,061</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">GSK</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,695</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>Total revenue from collaboration agreements</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><B>&#128;&nbsp;31,253</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><B>&#128;&nbsp;18,449</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Revenue from collaboration agreements increased from &#128;18.5&nbsp;million for the year ended December&nbsp;31, 2019 to
&#128;31.3&nbsp;million for the year ended December&nbsp;31, 2020. The increase resulted from the new collaboration agreement with GSK consummated in December 2019, which resulted in additional revenue of &#128;3.7&nbsp;million, as well as an
increase in revenue of &#128;10.4&nbsp;million from the collaboration with BMS which was consummated in August 2019 and was therefore in the <FONT STYLE="white-space:nowrap">ramp-up</FONT> phase. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Due to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, we experienced delays in research activities performed under the Amgen
and Genmab collaboration agreements. As we recognize revenue under these contracts on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">cost-to-cost</FONT></FONT> model based on research activities, we recognized less revenue under
the Amgen and Genmab agreements in the year 2020 than previously planned. Consequently, revenue recognized under the Amgen agreement decreased by &#128;1.3&nbsp;million and revenue recognized under the Genmab agreement was stable. We believe that
any decline in revenue associated with delayed research activities is largely temporary, because the revenue is primarily associated with <FONT STYLE="white-space:nowrap">non-refundable</FONT> upfront payments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We did not achieve any milestones or receive any royalty payments in connection with our collaboration agreements during the presented
periods. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">120 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Research and Development Expenses </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes our research and development expenses for the periods indicated: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">External research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 34,638</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 25,018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Personnel related (excluding stock-based compensation)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17,901</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,518</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,546</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,556</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total research and development expenses</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&#128;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&nbsp;67,085</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&#128;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&nbsp;40,092</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our research and development expenses increased from &#128;40.1&nbsp;million for the year ended
December&nbsp;31, 2019 to &#128;67.1&nbsp;million for the year ended December&nbsp;31, 2020. External research and development expenses increased from &#128;25.0&nbsp;million for the year ended December&nbsp;31, 2019 to &#128;34.6&nbsp;million for
the year ended December&nbsp;31, 2020. The increase resulted from higher preclinical and clinical work performed, resulting in an increase in ACT expenses, mainly due to the <FONT STYLE="white-space:nowrap">ramp-up</FONT> of additional clinical
trial sites in the United States and in Europe. Furthermore, the direct research and development cost for TCR Bispecifics increased due to the start of process development and optimization for GMP manufacturing of our TCER lead candidate, IMA401, in
2020. Expenses related to collaboration agreements increased due to the start of the new collaborations with BMS and GSK that were signed in 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Personnel related research and development expenses, excluding share-based compensation, increased from &#128;13.5&nbsp;million for the year
ended December&nbsp;31, 2019 to &#128;17.9&nbsp;million for the year ended December&nbsp;31, 2020. The increase mainly resulted from increased research and development headcount. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Share-based compensation expenses increased from &#128;1.6&nbsp;million for the year ended December&nbsp;31, 2019 to &#128;14.5&nbsp;million
for the year ended December&nbsp;31, 2020. The increase resulted from the modification of previous awards as part of the ARYA merger and share-based awards issued under the 2020 Equity Plan. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>General and Administrative Expenses </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes our general and administrative expenses for the periods indicated: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;10,973</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 460</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Personnel related (excluding stock-based compensation)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,983</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,324</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Professional and consulting fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,918</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,113</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other external general and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,312</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total general and administrative expenses</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&#128;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B> 34,186</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&#128;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&nbsp;11,755</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">General and administrative expenses increased from &#128;11.8&nbsp;million for the year ended
December&nbsp;31, 2019 to &#128;34.2&nbsp;million for the year ended December&nbsp;31, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Share-based compensation expenses increased
from &#128;0.5&nbsp;million for the year ended December&nbsp;31, 2019 to &#128;11&nbsp;million for the year ended December&nbsp;31, 2020. The increase resulted from the modification of previous awards as part of the ARYA merger and share-based
awards issued under the 2020 Equity Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Personnel related general and administrative expenses, excluding share-based compensation,
increased from &#128;4.3&nbsp;million for the year ended December&nbsp;31, 2019 to &#128;8.0&nbsp;million for the year ended December&nbsp;31, 2020. The increase mainly resulted from an increased headcount in our finance, human resources and
communications functions, as well as a payment to the former Executive Chairman as part of the ARYA Merger. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">121 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Professional and consulting fees increased from &#128;3.1&nbsp;million for the year ended
December&nbsp;31, 2019 to &#128;9.9&nbsp;million for the year ended December&nbsp;31, 2020. The increase in professional and consulting fees resulted mainly from an increase in accounting, audit and legal fees. The increase is due to both <FONT
STYLE="white-space:nowrap">one-time</FONT> expenses associated with the ARYA Merger and PIPE Financing as well as our efforts to operate as a public company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other external expenses increased from &#128;3.9&nbsp;million for the year ended December&nbsp;31, 2019 to &#128;5.3&nbsp;million for the year
ended December&nbsp;31, 2020. The increase in other expenses mainly resulted from increased insurance payments, depreciation, and expenses for office equipment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Other Income </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other
income decreased from &#128;0.4&nbsp;million for the year ended December&nbsp;31, 2019 to &#128;0.3&nbsp;million for the year ended December&nbsp;31, 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Financial Income and Financial Expense </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Financial income increased from &#128;0.8&nbsp;million for the year ended December&nbsp;31, 2019 to &#128;2.9&nbsp;million for the year ended
December&nbsp;31, 2020. The increase mainly resulted from interest and income from financial instruments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Financial expenses increased
from &#128;0.3&nbsp;million for the year ended December&nbsp;31, 2019 to &#128;10.1&nbsp;million for the year ended December&nbsp;31, 2020. The increase mainly resulted from unrealized exchange rate differences due to the development of the <FONT
STYLE="white-space:nowrap">EUR-USD</FONT> exchange rate. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Share Listing Expense </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As part of the ARYA Merger, we recognized a <FONT STYLE="white-space:nowrap">one-time,</FONT> <FONT STYLE="white-space:nowrap">non-cash</FONT>
share listing expense in accordance with IFRS 2, amounting to &#128;152.8&nbsp;million within our financial result. This is a technical accounting treatment in accordance with IFRS 2, that represents the difference between the fair value of the
shares and warrants transferred to ARYA shareholders and the fair value of the identifiable net assets acquired. The difference was mainly driven by the share price increase of ARYA between signing and closing of the Business Combination Agreement.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Comparison of the Years Ended December&nbsp;31, 2019 and December&nbsp;31, 2018 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For a discussion of our consolidated statements of operations for the years ended December&nbsp;31, 2019 and December&nbsp;31, 2018, see the
section &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#151;Results of Operations&#148; in our Registration Statement on Form <FONT STYLE="white-space:nowrap">F-1</FONT> (File <FONT
STYLE="white-space:nowrap">No.&nbsp;333-240260)</FONT> filed with the SEC on July&nbsp;31, 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Critical Accounting Policies and Significant
Judgments and Estimates </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our consolidated financial statements of Immatics for the fiscal year ending December&nbsp;31, 2020 have been
prepared in accordance with IFRS and the interpretations of the International Financial Reporting Standards Interpretations Committee and applicable on the balance sheet date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The preparation of the consolidated financial statements for the fiscal year ended December&nbsp;31, 2020 in accordance with IFRS required the
use of estimates and assumptions by the management that affect the value of assets and liabilities&#151;as well as contingent assets and liabilities&#151;as reported on the balance sheet date, and revenues and expenses arising during the fiscal
year. The main areas in which assumptions, estimates and the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">122 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
exercising of a degree of discretion are appropriate relate to the determination of revenue recognition, research and development expenses, and share-based compensations as well as income taxes.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our estimates are based on historical experience and other assumptions that are considered appropriate in the circumstances, and
parameters available when the consolidated financial statements were prepared. Existing circumstances and assumptions about future developments, however, may change due to market changes or circumstances arising that are beyond our control. Hence,
our estimates may vary from the actual values. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While our significant accounting policies are more fully discussed in our consolidated
financial statements included in this Annual Report, we believe that the following accounting policies are critical to the process of making significant judgments and estimates in the preparation of our consolidated financial statements. We have
reviewed these critical accounting policies and estimates with the Audit Committee of our Supervisory Board. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Revenue Recognition
for Collaboration Agreements </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We recognize revenue through collaboration and license agreements and reimbursement for research and
development costs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under our collaboration and license agreements, we may receive upfront licensing payments, milestone payments and
reimbursement of research and development expenses. Such collaboration agreements also include licenses of certain of our intellectual property to the respective collaborators. As these agreements comprise several commitments, it must be assessed
whether these commitments are capable of being distinct within the context of the contract. For each of our four collaboration agreements, we determined that the commitments included in each agreement represented single combined performance
obligations, with a single measure of progress. The performance obligation is accounted for as a performance obligation satisfied over time on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">cost-to-cost</FONT></FONT> basis, as
our customer simultaneously receives and consumes the benefit from our performance. Upfront licensing payments and reimbursement for development expenses are initially deferred on our statement of financial position and subsequently recognized as
revenue over time as costs are incurred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Milestone payments are generally included in the transaction price at the amount stipulated in
the respective agreement and recognized to the extent that it is highly probable that a significant reversal in the amount of cumulative revenue recognized will not occur. To date, no milestone payment has been included in the transaction price and
recognized into revenue. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We provide development and manufacturing services to our customers and recognize revenue over time using an
input-based method to measure progress toward complete satisfaction of the service, because the customer simultaneously receives and consumes the benefits provided. Forecast values are used for the calculation of expected future revenue for the
remaining term of the contract. These costs estimated as part of the budgeting process must be reviewed and approved before the we can use them for recognition purposes. Significant management judgment is required to determine the level of effort
required under an arrangement, and the period over which we expect to complete our performance obligations under the arrangement which includes total internal personnel costs and external costs to be incurred. Changes in these estimates can have a
material effect on revenue recognized. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Share-Based Compensation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Immatics GmbH had share-based compensation plans, which issue SARs and tandem awards (consisting of either a SAR or a stock option) to
employees. The SARs and tandem awards were converted as part of the ARYA Merger. The conversion is accounted for as a modification in accordance with IFRS 2. As part of the ARYA merger, we also introduced a new share-based compensation plan that
includes PSUs and service options. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">123 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The costs of equity-settled transactions are determined by the fair value at grant date,
using an appropriate valuation model. Share-based expenses for the respective vesting periods, are recognized in research and development expenses and general and administrative expenses, reflecting a corresponding increase in equity. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Income Taxes </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Uncertainties exist with respect to the interpretation of complex tax regulations, changes in tax laws, and the amount and timing of future
taxable income. Given the wide range and complexity of existing contractual agreements, differences arising between the actual results and the assumptions made, or future changes to such assumptions, could necessitate future adjustments to tax
income and expense already recorded. Deferred tax assets are recognized for unused tax losses to the extent, that it is probable that taxable profit will be available which can be utilized against the losses. Significant management judgement is
required to determine the amount of deferred tax assets that can be recognized, based upon the likely timing and the level of future taxable profits together with future tax planning strategies. Due to our history of loss-making over the last
several years as well as our plans for the foreseeable future, we have not recognized any deferred tax assets on tax losses carried forward. Changes in the estimation of our potential to use of tax losses carried forward can have a material effect
on our net income. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recently Issued and Adopted Accounting Pronouncement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For information on the standards applied for the first time as of January&nbsp;1, 2020 and 2019 please refer to our consolidated financial
statements as of December&nbsp;31, 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_21"></A>B. Liquidity and Capital Resources </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sources of Liquidity </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have funded our
operations primarily from private placements of our ordinary shares, proceeds from collaborators, and the net proceeds generated from the ARYA Merger and PIPE Financing that closed on July&nbsp;1, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents increased from &#128;103.4&nbsp;million for the year ended December&nbsp;31, 2019 to &#128;207.5 for the year ended
December&nbsp;31, 2020. Cash and cash equivalents are invested in accordance with our investment policy, primarily with a view to liquidity and capital preservation, and consist primarily of cash in banks and money market accounts. Additionally, we
invest funds in short-term deposits with an original maturity between three and nine months. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cash Flows </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes our cash flows for each period presented: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net cash provided by / (used in):</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(85,610</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70,967</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,684</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(15,949</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(5,059</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(13,514</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">207,883</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,862</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23,648</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total cash flow</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&#128;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>106,324</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&#128;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>64,046</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&#128;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>30,818</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Operating Activities </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We primarily derive cash from our collaboration agreements. Our cash used in operating activities is significantly influenced by our use of
cash for operating expenses and working capital to support the business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">124 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We experienced a net cash inflow for the years ended December&nbsp;31, 2019 and 2018, and a
net cash outflow from operating activities for the year ended December&nbsp;31, 2020, primarily resulting from differences in the net loss for the periods and working capital changes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our net cash outflow from operating activities for the year ended December&nbsp;31, 2020 was &#128;85.6&nbsp;million. This comprised of a net
loss of &#128;229.6&nbsp;million; a decrease in working capital of &#128;31.6&nbsp;million; a <FONT STYLE="white-space:nowrap">one-time</FONT> cash payment totaling &#128;4.3&nbsp;million, with no corresponding expense due to the modification of our
share-based compensation as part of the ARYA Merger; and a partial offset of &#128;180.2&nbsp;million by <FONT STYLE="white-space:nowrap">non-cash</FONT> charges, mainly from the share listing expense of &#128;152.8&nbsp;million and equity-settled
share-based compensation expenses for employees. The decrease in working capital mainly resulted from a decrease in deferred revenue of &#128;29.3&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the year ended December&nbsp;31, 2019, our net cash inflow from operating activities was &#128;71.0&nbsp;million. This resulted from a
&#128;98.7&nbsp;million increase in working capital, <FONT STYLE="white-space:nowrap">non-cash</FONT> charges of &#128;4.7&nbsp;million, and was partially offset by the net loss of &#128;32.5&nbsp;million for the year. This increase in working
capital mainly resulted from an increase in accounts payable, and other current and <FONT STYLE="white-space:nowrap">non-current</FONT> liabilities of &#128;100.5&nbsp;million, primarily related to deferred revenue from the upfront payments received
from our collaborations with BMS and GSK. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the year ended December&nbsp;31, 2018, our net cash inflow from operating activities was
&#128;20.7&nbsp;million. This resulted from a &#128;49.7&nbsp;million increase in working capital, <FONT STYLE="white-space:nowrap">non-cash</FONT> charges of &#128;3.9&nbsp;million, and was partially offset by the net loss of
&#128;32.4&nbsp;million for the year. This increase in working capital mainly resulted from an increase in accounts payable, and other current and <FONT STYLE="white-space:nowrap">non-current</FONT> liabilities of &#128;43.7&nbsp;million, primarily
related to deferred revenue from the upfront payments received from our collaborations with Genmab. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Investing Activities </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our net use of cash for investing activities for the year ended December&nbsp;31, 2020 was &#128;15.9&nbsp;million. This consisted of a
&#128;7.4&nbsp;million payment for new equipment; our new laboratory space, computers, office, and other laboratory equipment; as well as a &#128;8.4&nbsp;million decrease in cash paid for investments that are classified as other financial assets
and held with financial institutions to finance the company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities for the year ended December&nbsp;31,
2019 was &#128;5.1&nbsp;million. This related to a decrease in cash from the investments in investments classified as other financial assets of around &#128;2.9&nbsp;million, and held with institutions to finance the company, combined with a
&#128;2.1&nbsp;million resulting from the acquisition of new laboratory and computer equipment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities for
the year ended December&nbsp;31, 2018 was &#128;13.5&nbsp;million. This related to a decrease in cash from the investments in investments classified as other financial assets of around &#128;13.1&nbsp;million, and held with institutions to finance
the company, combined with a &#128;0.4&nbsp;million resulting from the acquisition of new laboratory and computer equipment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The increase
in investing activities, other than cash flows from investments in financial assets, reflects the increase in our research and development activities. We intend to use the additional lab space and acquired equipment to expand our research and
development efforts, especially with regard to our clinical pipeline candidates in ACTengine as well as our preclinical pipeline candidates in TCER Bispecifics. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Financing Activities </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2020, net cash received from financing activities amounted to &#128;207.9&nbsp;million. This was mainly
driven by the net proceeds received in exchange for issuance of new shares as part of the ARYA Merger and the PIPE Financing. It was partially offset by the principal portion of payments in connection with lease contracts in the amount of
&#128;2.1&nbsp;million. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">125 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2019, net cash used in financing activities was
&#128;1.9&nbsp;million, resulting from the payment of the principal portion of lease liabilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31,
2018, cash inflow from financing activities of &#128;23.6&nbsp;million was generated from the share premium proceeds received relating to the issuance of shares in 2017. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Operation and Funding Requirements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Historically, we have incurred significant losses due to our substantial research and development expenses. We have an accumulated deficit of
&#128;462.3&nbsp;million as of December&nbsp;31, 2020. We expect our expenses to increase in connection with our ongoing activities, particularly as we continue the research and development of, continue or commence clinical trials of, and seek
regulatory approval for, our product candidates. We believe that we have sufficient financial resources available to fund our projected operating requirements for at least the next twelve months. Because the outcome of our current and planned
clinical trials is highly uncertain, we cannot reasonably estimate the actual amounts necessary to successfully complete the development and commercialization of our product candidates. For example, our costs will increase if we experience any
delays in our current and planned clinical trials. Our future funding requirements will depend on many factors, including, but not limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">progress, timing, scope and costs of our clinical trials, including the ability to timely initiate clinical
sites, enroll subjects and manufacture ACT and TCR Bispecific product candidates for our ongoing, planned and potential future clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">time and cost to conduct <FONT STYLE="white-space:nowrap">IND-</FONT> or
<FONT STYLE="white-space:nowrap">CTA-enabling</FONT> studies for our preclinical programs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">time and costs required to perform research and development to identify and characterize new product candidates
from our research programs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">time and cost necessary to obtain regulatory authorizations and approvals that may be required by regulatory
authorities to execute clinical trials or commercialize our products; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to successfully commercialize our product candidates, if approved; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to have clinical and commercial products successfully manufactured consistent with FDA, the EMA and
comparable regulatory authorities&#146; regulations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">amount of sales and other revenues from product candidates that we may commercialize, if any, including the
selling prices for such potential products and the availability of adequate third-party coverage and reimbursement for patients; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">sales and marketing costs associated with commercializing our products, if approved, including the cost and
timing of building our marketing and sales capabilities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">cost of building, staffing and validating our manufacturing processes, which may include capital expenditure;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">terms and timing of our current and any potential future collaborations, licensing or other arrangements that we
have established or may establish; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">cash requirements of any future acquisitions or the development of other product candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">costs of operating as a public company; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">time and cost necessary to respond to technological, regulatory, political and market developments;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights;
and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">costs associated with any potential business or product acquisitions, strategic collaborations, licensing
agreements or other arrangements that we may establish. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Identifying potential product candidates and conducting
preclinical studies and clinical trials is a time-consuming, expensive and uncertain process that takes many years to complete, and we may never generate the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">126 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
necessary data or results required to obtain regulatory approval and commercialize our product candidates. In addition, our product candidates, if approved, may not achieve commercial success.
Our commercial revenues, if any, will be derived from sales of products that we do not expect to be commercially available for many years, if at all. Accordingly, we will need to continue to rely on additional financing to achieve our business
objectives. Adequate additional financing may not be available to us on acceptable terms, or at all. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless and until we can generate
sufficient revenue to finance our cash requirements, which may never happen, we may seek additional capital through a variety of means, including through public and private equity offerings and debt financings, credit and loan facilities and
additional collaborations. If we raise additional capital through the sale of equity or convertible debt securities, our existing shareholders&#146; ownership interest will be diluted, and the terms of such equity or convertible debt securities may
include liquidation or other preferences that are senior to or otherwise adversely affect the rights of our existing shareholders. If we raise additional capital through the sale of debt securities or through entering into credit or loan facilities,
we may be restricted in our ability to take certain actions, such as incurring additional debt, making capital expenditures, acquiring or licensing intellectual property rights, declaring dividends or encumbering our assets to secure future
indebtedness. Such restrictions could adversely impact our ability to conduct our operations and execute our business plan. If we raise additional capital through collaborations with third parties, we may be required to relinquish valuable rights to
our intellectual property or product candidates or we may be required to grant licenses for our intellectual property or product candidates on unfavorable terms. If we are unable to raise additional capital when needed, we may be required to delay,
limit, reduce or terminate our product development efforts or we may be required to grant rights to third parties to develop and market our product candidates that we would otherwise prefer to develop and market ourselves. For more information as to
the risks associated with our future funding needs, see &#147;Risk Factors&#151;Risks Related to Our Financial Position.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_22"></A>C. Research and Development, Patents and Licenses, etc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See &#147;Item 4. Information on the Company&#151;B. Business Overview&#148; and &#147;Item 5. Operating and Financial Review and
Prospects&#151;A. Operating Results.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_23"></A>D. Trend Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See &#147;Item 5. Operating and Financial Review and Prospects&#151;A. Operating Results.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_24"></A>E. <FONT STYLE="white-space:nowrap">Off-Balance</FONT> Sheet Arrangements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We did not have, during the periods presented in this Annual Report, and we do not currently have, any
<FONT STYLE="white-space:nowrap">off-balance</FONT> sheet arrangements or commitments. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>F. Tabular Disclosure of Contractual Obligations </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes our contractual obligations as of December&nbsp;31, 2020 and the effects that such obligations are expected to
have on our liquidity and cash flows in future periods: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Payments due by period</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Less&nbsp;than<BR>1&nbsp;year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>1&nbsp;&#150;&nbsp;3&nbsp;years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>3&nbsp;&#150;&nbsp;5&nbsp;years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>More&nbsp;than<BR>5&nbsp;years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center"><B>(euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease liabilities(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,453</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,157</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">150</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other lease obligations(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">97</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">185</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">185</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">513</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">In-license</FONT> agreements(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">249</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">249</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contract research organization agreements(4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,704</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">220</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,924</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total contractual obligations</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&#128;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,153</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,858</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,342</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>196</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&#128;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>9,549</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents our future minimum commitments under <FONT STYLE="white-space:nowrap">non-cancelable</FONT> lease
liabilities reflected on the balance sheet in our audited consolidated financial statements included elsewhere in this Annual Report. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">127 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents our future minimum commitments under <FONT STYLE="white-space:nowrap">non-cancelable</FONT> leasing
arrangements, which are not capitalized under IFRS 16. These arrangements include short-term, <FONT STYLE="white-space:nowrap">low-value</FONT> leases, as well as further lease agreements which are not reflected on our balance sheet that we
committed for in 2020 and will be effective from the year 2021. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents obligations of <FONT STYLE="white-space:nowrap">non-cancelable</FONT> terms of license agreements.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents obligations from contract research organization agreements. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have lease agreements for land and buildings in our locations in T&uuml;bingen and Munich, Germany, and Houston, Texas, which will expire
between 2020 and 2026, respectively. In addition, we have various leases for equipment and cars, which will expire in 2022. The amounts in the table above represent our fixed contractual lease obligations and do not include the optional extensions.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2020 and 2019, we are potentially liable to pay &#128;1.6&nbsp;million ($2 million) to a third-party upon
successful completing the milestone of the first clinical lead selection in connection with Immatics&#146; collaboration agreements. We do not recognize a liability for these contingent payments due to the scientific uncertainty of achieving the
related milestones. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the above obligations, we enter into a variety of agreements and financial commitments in the normal
course of business. The terms generally provide us with the option to cancel, reschedule, and adjust our requirements based on our business needs prior to the delivery of goods or performance of services. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_25"></A>G. Safe Harbor </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See &#147;Cautionary Note Regarding Forward-Looking Statements.&#148; </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B><A NAME="rom149615_26"></A>ITEM&nbsp;6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_27"></A>A. Directors and Senior Management </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Management Board consists of one managing director, our Executive Committee consists of seven executive officers, and our Supervisory Board
(as defined below) consists of seven supervisory directors. The following table lists the names, ages as of February&nbsp;1, 2021 and positions of the individuals who are serving as managing director, executive officers and supervisory directors.
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="46%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Age</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Position</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Executive Committee</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Harpreet Singh, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">46</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Executive Officer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Arnd Christ</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">54</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Financial Officer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cedrik Britten, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">46</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Medical Officer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Carsten Reinhardt, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">53</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Development Officer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Toni Weinschenk, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">48</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Innovation Officer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rainer Kramer, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">57</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Business Officer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steffen Walter, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">44</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Technology Officer</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Management Board</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Harpreet Singh, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">46</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Managing Director</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Supervisory Board</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Peter Chambr&eacute;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">65</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chairman of the Supervisory Board</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael G. Atieh</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">67</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Supervisory Director</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Paul R. Carter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">60</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Supervisory Director</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Eliot Forster, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">54</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Supervisory Director</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christof Hettich, L.L.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">61</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Supervisory Director</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Heather L. Mason</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">60</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Supervisory Director</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adam Stone</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">41</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Supervisory Director</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">128 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Officers </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Harpreet Singh, Ph.D.</I> Dr.&nbsp;Singh <FONT STYLE="white-space:nowrap">co-founded</FONT> Immatics OpCo in 2000 and has served as Chief
Executive Officer of Immatics OpCo since 2019 and as President and Chief Executive Officer of Immatics US. Prior to that, Dr.&nbsp;Singh served as our managing director and Chief Scientific Officer. Prior to
<FONT STYLE="white-space:nowrap">co-founding</FONT> Immatics OpCo, Dr.&nbsp;Singh completed a post-doctoral research fellowship with Prof. Hans-Georg Rammensee at the University of T&uuml;bingen. Dr.&nbsp;Singh has played a leadership role in
raising more than $200&nbsp;million of venture capital funding over several financing rounds as well $30&nbsp;million of public grants. Dr.&nbsp;Singh is the inventor of numerous granted patents and patent applications and <FONT
STYLE="white-space:nowrap">co-author</FONT> of numerous scientific papers published by peer-reviewed journals, including <I>Nature</I>, <I>Nature Medicine</I>, <I>Nature Biotechnology</I>, <I>Journal of Experimental Medicine</I>, <I>Brain</I> and
<I>Lancet Oncology</I>. Dr.&nbsp;Singh holds a Ph.D. in immunology from the University of T&uuml;bingen. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Arnd Christ</I>.
Mr.&nbsp;Christ has served as Chief Financial Officer of Immatics OpCo since 2020. From 2015 to 2020, Mr.&nbsp;Christ served as Chief Financial Officer of InflaRx N.V., where he contributed to the successful listing of the company on Nasdaq. Prior
to that, Mr.&nbsp;Christ served as Chief Financial Officer of Proteros Biostructure GmbH, as Chief Financial Officer of MediGene AG, as Chief Financial Officer of NovImmune SA, as Chief Financial Officer of Probiodrug AG, as Chief Financial Officer
of EleGene AG, as Finance Director of Avery Dennison GmbH and as Finance Director of Herberts Industrial Coatings Ltd. Mr.&nbsp;Christ holds a diploma in business economics from the University of W&uuml;rzburg, Germany. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Cedrik M. Britten, M.D.</I> Dr.&nbsp;Britten has served as Chief Medical Officer of Immatics OpCo since 2020, assuming leadership for the
management and global clinical development of our adoptive cell therapy and TCR Bispecifics pipeline from first testing in humans to registration trials, including managing regulatory affairs. From 2015 to 2020, Dr.&nbsp;Britten served as Vice
President and Head of the Oncology Cell Therapy Research Unit of GlaxoSmithKline plc and was responsible for building the Oncology Cell Therapy Unit and driving the strategy and establishing the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">end-to-end</FONT></FONT> capabilities required to research and develop innovative cell therapies in oncology. Prior to that, Dr.&nbsp;Britten served as Vice President of Research and Development of BioNTech RNA
Pharmaceuticals GmbH. Dr.&nbsp;Britten holds an M.D. from the University Medical Center of the Johannes-Gutenberg University. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Carsten
Reinhardt, M.D., Ph.D.</I> Dr.&nbsp;Reinhardt has served as Chief Development Officer of Immatics OpCo since 2020. From 2009 to 2020, Dr.&nbsp;Reinhardt has served as Chief Medical Officer of Immatics OpCo. Dr.&nbsp;Reinhardt leads our Product
Development Strategy and our TCR Bispecifics platform and pipeline as well as the Immunology and Translational Development functions. Prior to joining us, Dr.&nbsp;Reinhardt served as Chief Medical Officer of Micromet Inc., where he was leading the
development of the Bispecific T cell Engager (BiTE) platform and was instrumental in the company becoming public on Nasdaq and in various deals and transactions finally leading to the acquisition by Amgen. Prior to this, Dr.&nbsp;Reinhardt was
International Medical Leader at <FONT STYLE="white-space:nowrap">Hoffmann-La</FONT> Roche and Head of Clinical Development of Fresenius Biotech GmbH and held various academic medical positions and worked at the University of T&uuml;bingen and Max
Planck Institute, Munich to complete his curriculum in Neurology. Dr.&nbsp;Reinhardt is a Visiting Professor for Pharmaceutical Medicine at the University of Basel. Dr.&nbsp;Reinhardt has <FONT STYLE="white-space:nowrap">co-authored</FONT> more than
40 publications in peer-reviewed journals, including <I>Nature</I>, <I>Science</I>, <I>Nature Medicine</I>, <I>Lancet</I>, <I>Journal of Clinical Oncology</I>, <I>Cancer Research</I> and <I>Journal of Experimental Medicine</I>. Dr.&nbsp;Reinhardt
holds an M.D. from the University of Munich and a Ph.D. in cellular immunology from the Institute of Immunology in Munich. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Toni
Weinschenk, Ph.D.</I> Dr.&nbsp;Weinschenk <FONT STYLE="white-space:nowrap">co-founded</FONT> Immatics OpCo in 2000 and has served as Chief Innovation Officer of Immatics OpCo since 2020. From 2002 to 2020, Dr.&nbsp;Weinschenk served in various
executive-level positions with Immatics OpCo, including as Chief Technology Officer, as Vice President Discovery and as Head of Discovery. Dr.&nbsp;Weinschenk is the inventor of our proprietary XPRESIDENT technology platform and leads the discovery
and validation of novel and innovative I/O targets. pHLA targets discovered by his XPRESIDENT platform have been utilized for all of our drug candidates and for the collaboration with leading players in the field. Dr.&nbsp;Weinschenk is an inventor
who holds many patents and has </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">129 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<FONT STYLE="white-space:nowrap">co-authored</FONT> numerous publications in the cancer immunology field in peer-reviewed journals, including <I>Nature</I>, <I>Nature Medicine</I>, <I>Nature
Immunology</I>, <I>Immunological Reviews</I> and <I>Cell Report</I>. Dr.&nbsp;Weinschenk holds a diploma in biochemistry and a Ph.D. in immunology from the University of T&uuml;bingen. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Rainer Kramer, Ph.D.</I> Dr.&nbsp;Kramer has served as Chief Business Officer of Immatics OpCo since 2012. Prior to that, Dr.&nbsp;Kramer
served as a member of the Management Board and Chief Business Officer of Signature Diagnostics AG, as Vice President of Business Development of Jerini AG and as Head of Business Development of MorphoSys AG. During his career, he has delivered
numerous strategic partnerships and license deals encompassing technology and product deals as well as equity transactions with an aggregate value of more than $3&nbsp;billion. Dr.&nbsp;Kramer holds a diploma in molecular biology from the University
of Regensburg and a Ph.D. in neurobiology from the <FONT STYLE="white-space:nowrap">Max-Planck-Institute,</FONT> Martinsried, Germany. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Steffen Walter, Ph.D</I>. Dr.&nbsp;Walter has served as Chief Technology Officer of Immatics OpCo since 2020. From 2005 to 2020,
Dr.&nbsp;Walter served in various executive-level positions with Immatics OpCo, including as Chief Scientific Officer, as Vice President Immunology and as Director and Head of Immunology. Dr.&nbsp;Walter established operations of Immatics US in
Houston, Texas and contributed significantly to its fundraising, including a $20&nbsp;million Cancer Prevention and Research grant by the State of Texas. Dr.&nbsp;Walter leads our Cell Therapy platform and pipeline, including manufacturing and
process development, and our Quality Management. In addition to supporting the development of the XPRESIDENT technology platform, under his initial leadership, we developed our powerful XCEPTOR platforms to support the generation of <FONT
STYLE="white-space:nowrap">TCR-based</FONT> therapeutic modalities. Dr.&nbsp;Walter is a leader in human T cell biology. Dr.&nbsp;Walter is an inventor on numerous patents and patent applications and has
<FONT STYLE="white-space:nowrap">co-authored</FONT> more than 30 publications in prestigious peer-reviewed journals, including <I>Nature</I> <I>Medicine</I>, <I>Cell Reports</I>, <I>Lancet</I> <I>Oncology</I>, <I>Brain</I> and <I>Blood</I>.
Dr.&nbsp;Walter holds a diploma in biochemistry and a Ph.D. in immunology from the University of T&uuml;bingen. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Managing Director </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Harpreet Singh, Ph.D., our Chief Executive Officer, serves as the sole managing director. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Supervisory Directors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Peter
Chambr&eacute;</I>. Mr.&nbsp;Chambr&eacute; has served as the Chairman of our Supervisory Board since 2012. From 2002 to its acquisition in 2006, Mr.&nbsp;Chambr&eacute; served as Chief Executive Officer of Cambridge Antibody Technology Group plc.
Prior to that, Mr.&nbsp;Chambr&eacute; served as Chief Operating Officer of Celera Genomics Group and as Chief Executive Officer of Bespak plc. In addition to our Supervisory Board, Mr.&nbsp;Chambr&eacute; serves on the board of directors of UDG
Healthcare plc, Cancer Research UK (trustee) and 7TM Holding ApS and has previously served as the chairman of the board of directors of OneMed AB, Xellia Pharmaceuticals AS and ApaTech Ltd. and has previously served on the board of directors of
Touchstone Innovations plc, Spectris plc and BTG plc. Mr.&nbsp;Chambr&eacute; holds a B.Sc. in food science from the University of Reading. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Michael G. Atieh</I>. Mr.&nbsp;Atieh has served as a member of our Supervisory Board since 2020. From 2014 until his retirement in 2016,
Mr.&nbsp;Atieh served as Executive Vice President, Chief Financial and Business Officer of Ophthotech Inc. Prior to that, he served as Executive Chairman of Eyetech Inc., as Executive Vice President and Chief Financial Officer of OSI
Pharmaceuticals, as Group President &#150; Global Business Unit and as Senior Vice President and Chief Financial Officer of Cegedim Inc., and in various executive-level positions over a <FONT STYLE="white-space:nowrap">19-year</FONT> period at Merck
and Co., Inc., including as Vice President &#150; U.S. Human Health, Senior Vice President- Merck Medco Managed Care, Vice President - Public Affairs, Vice President &#150; Government Relations, and Treasurer. In addition to our Supervisory Board,
Mr.&nbsp;Atieh serves on the board of directors of Chubb Limited, electroCore, Inc. and Oyster Point Pharma, Inc. and has previously served on the board of directors of Theravance BioPharma, Eyetech Inc. and OSI Pharmaceuticals. Mr.&nbsp;Atieh holds
a B.A. in accounting from Upsala College. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">130 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Paul R. Carter, FCMA.</I> Mr.&nbsp;Carter has served as a member of our Supervisory Board
since 2020. From 2014 to 2016, Mr.&nbsp;Carter served as Executive Vice President, Commercial Operations of Gilead Sciences, Inc. Prior to that, Mr.&nbsp;Carter served as Senior Vice President and Head, International Commercial Operations of Gilead
Sciences, Inc. and in various senior positions over a <FONT STYLE="white-space:nowrap">10-year</FONT> period at GlaxoSmithKline plc, including as Regional Vice President, China&nbsp;&amp; Hong Kong, Vice President and General Manager,
Pharmaceutical&nbsp;&amp; Consumer Health, Hong Kong&nbsp;&amp; South China, and General Manager, SmithKline Beecham Consumer Health, Russia&nbsp;&amp; CIS. In addition to our Supervisory Board, Mr.&nbsp;Carter serves on the board of directors of
Evox Therapeutics Ltd, Mallinckrodt PLC and Hutchison China MediTech Ltd. and has previously served on the board of directors of Alder Biopharmaceuticals Inc. Mr.&nbsp;Carter also serves as an advisor to Astorg Partners SAS, ZambonGroup, Indegene
Inc. and GLG Institute. Mr.&nbsp;Carter holds a B.A. in business studies from the University of West London. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Eliot Forster, Ph.D.</I>
Dr.&nbsp;Forster has served as an interim member of our Supervisory Board since 2020. Since 2018, Dr.&nbsp;Forster has served as the Chief Executive Officer of <FONT STYLE="white-space:nowrap">F-star</FONT> Therapeutics Ltd. From 2015 to 2018,
Dr.&nbsp;Forster served as the Chief Executive Officer of Immunocore Limited. Prior to that, Dr.&nbsp;Forster served as the Chief Executive Officer of Creabilis SA, as the Chief Executive Officer of Solace Pharmaceuticals Inc., as Head of
Development and Operations for the EU and Asia at Pfizer Inc. Dr.&nbsp;Forster is an honorary visiting Professor of Molecular and Clinical Cancer Medicine at the University of Liverpool and an honorary international visiting Professor at the
University of Pavia. In addition to our Supervisory Board, Dr.&nbsp;Forster serves on the board of directors of <FONT STYLE="white-space:nowrap">F-star</FONT> Therapeutics Ltd, Avacta Group plc and OSCHR (Office for Strategic Coordination of Health
Research) and the National Genomics Board and has previously served on the board of directors of MedCity Ltd., Spinifex Pty Ltd, Oxford BioTherapeutics and Atlantic Healthcare (UK) Ltd. Dr.&nbsp;Forster holds a B.Sc. in physiology from the Unversity
of Liverpool, an M.B.A. from Henley Business School and a Ph.D. in neurophysiology from the University of Liverpool. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Christof Hettich,
L.L.D.</I> Dr. Hettich has served as a member of our Supervisory Board since 2006. Since 2015, Dr. Hettich has served as the Chief Executive Officer of SRH Holding (SdbR). Dr. Hettich is an attorney and partner of RITTERSHAUS Rechtsanwaelte in
Mannheim/Frankfurt, Germany, and is a founding partner and managing director of dievini Hopp BioTech holding GmbH &amp; Co. KG. In addition to our Supervisory Board, Dr. Hettich serves on the board of directors of various companies, including
Molecular Health GmbH and Heidelberg Pharma AG, and has previously served on the board of directors of PROMETHERA Biosciences, S.A., Agennix AG, LTS Lohmann Therapie-Systeme AG, Sygnis Pharma AG, AC Immune AG and PARK &amp; Bellheimer AG. Dr.
Hettich was nominated Honorary Professor at the University of Applied Sciences (FH) in Heidelberg, Germany. Dr.&nbsp;Hettich holds a law degree from the University of Freiburg and a L.L.D. from the University of W&uuml;rzburg. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Heather L. Mason.</I> Ms.&nbsp;Mason has served as a member of our Supervisory Board since 2020. From 1990 to 2017, Ms.&nbsp;Mason served
in various leadership positions at Abbott Laboratories, Inc., including as Executive Vice President, Corporate Officer of Abbott Nutrition and as Senior Vice President, Corporate Officer of Abbott Diabetes Care. In addition to our Supervisory Board,
Ms.&nbsp;Mason serves on the board of directors of Assertio Therapeutics, Inc. ConvaTec Group plc, Pendulum Therapeutics, Inc. and SCA Pharmaceuticals, LLC. Ms.&nbsp;Mason holds a B.S.E. from the University of Michigan, Ann Arbor and an M.B.A. from
the University of Chicago. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Adam Stone</I>. Mr.&nbsp;Stone has served as a member of our Supervisory Board since 2020. Since 2012,
Mr.&nbsp;Stone has served as Chief Investment Officer of Perceptive Advisors, which he joined in 2006, and is a member of the internal investment committees of Perceptive Advisors&#146; credit opportunities and venture funds. Prior to joining
Perceptive Advisors, Mr.&nbsp;Stone was a Senior Analyst at Ursus Capital, where he focused on biotechnology and specialty pharmaceuticals. In addition to our Supervisory Board, Mr.&nbsp;Stone serves on the board of directors of Solid Biosciences
Inc., Renovia Inc., Xontogeny LLC, PROMETHERA Biosciences S.A./N.V., ARYA Sciences Acquisition Corp. II and ARYA Sciences Acquisition Corp. III. Mr.&nbsp;Stone holds a B.A. in molecular biology from Princeton University. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">131 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Family Relationships </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are no family relationships among any of our executive officers or directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Arrangements and Understandings </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain
members of our Supervisory Board were designated pursuant to agreements relating to the Business Combination. Specifically, each of Michael G. Atieh and Adam Stone is a designee of ARYA Sponsor and the pre-Business Combination independent directors
of ARYA and each of Paul R. Carter and Christof Hettich is a designee of dievini Hopp BioTech holding GmbH &amp; Co. KG. Pursuant to the Investor Rights and Lock-Up Agreement, certain of our shareholder continue to have director nomination rights.
See &#147;Item 7. Major Shareholders and Related Party Transactions&#151;Related Party Transactions.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_28"></A>B. Compensation
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Immatics OpCo became our wholly owned subsidiary upon the closing of the Business Combination on July&nbsp;1, 2020, and its senior
management became our senior management. The following summarizes the compensation earned by the executive officers of Immatics OpCo for the fiscal year ended December&nbsp;31, 2020. This section also discusses the material elements of the executive
compensation policies and decisions of Immatics OpCo and important factors relevant to an analysis of such policies and decisions. It provides qualitative information regarding the manner and context in which compensation is awarded to and earned by
our executive officers and is intended to place in perspective the information presented in the following tables and the corresponding narrative. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The bonus scheme for the managing directors provides that the annual cash bonus payable to managing directors may not exceed 100% of the
annual base gross salary and will be based upon the achievement of set financial and operating goals for the period. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation of Executive
Officers </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The amount of compensation, including benefits in kind, accrued or paid to the executive officers of Immatics with respect to
the year ended December&nbsp;31, 2020 is described in the table below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>(Euros in thousands)<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Harpreet&nbsp;Singh,&nbsp;Ph.D.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All&nbsp;other&nbsp;executives</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Periodically-paid remuneration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">420</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,240</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bonuses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">265</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">621</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,807</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,034</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total compensation</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&#128;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>4,492</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&#128;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>12,895</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amounts paid in U.S. dollars have been converted to Euros using an annual exchange rate for 2020 of 1.1439 to
one U.S. dollar. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation of Supervisory Board </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The amount of compensation, including benefits in kind, accrued or paid to the Supervisory Directors with respect to the year ended
December&nbsp;31, 2020 is described in the table below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="40%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Peter<BR>Chambr&eacute;</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Michael&nbsp;G.<BR>Atieh</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Paul<BR>Carter</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Heather&nbsp;L.<BR>Mason</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Adam<BR>Stone</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Christoph<BR>Hettich</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Eliot<BR>Forster</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>


<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt"></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Supervisory board compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">140</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>266</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Travel expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment Exit arrangement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,394</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,394</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,046</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,436</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total cash compensation</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,584</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>98</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>96</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>90</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>90</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>90</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>52</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,100</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">132 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2020 Stock Option and Incentive Plan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has established the<B> </B>Immatics N.V. 2020 Stock Option and Incentive Plan (the &#147;Plan&#148;). The Plan was adopted by the
Management Board on June&nbsp;30, 2020 and approved by the Company&#146;s shareholders and Supervisory Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Authorized Shares</I>.
Stock options and awards based on the ordinary shares of the Company may be issued under the Plan for a maximum of 10,006,230 shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Certain Adjustments.</I> If there is a change in the Company&#146;s capital structure, such as a stock dividend, stock split, reverse stock
split, recapitalization, reorganization, reclassification or other similar event, the Administrator will appropriately adjust the number and kind (and the exercise or purchase price, if applicable) of ordinary shares of the Company remaining
available for issuance under the Plan or subject to outstanding awards. In addition, any share limitations with respect to the Plan will be adjusted appropriately by the Administrator. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Plan Administration. </I>The Plan is administered by the Supervisory Board or the Compensation Committee of the Company until July&nbsp;1,
2021 and, after that date, the board of directors of the Company (the &#147;Administrator&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Corporate Transaction; Liquidity
Event</I>. In the event of a merger, consolidation, substantial asset sale, or similar event affecting the Company in which the owners of the Company&#146;s outstanding voting power prior to such event do not own at least a majority of the voting
power of the successor or surviving entity (in each case, a &#147;Transaction&#148;), the parties thereto may cause the assumption or continuation of awards theretofore granted by the successor entity, or the substitution of such awards with new
awards of the successor or parent entity, with appropriate adjustment as to the number and kind of shares and, if appropriate, the per share exercise prices, as such parties may agree. To the extent the parties to the Transaction do not provide for
the assumption, continuation or substitution of awards, then upon the effective time of the Transaction, then, except as otherwise provided in the applicable award agreement, (i)&nbsp;all options and stock appreciation rights that are not
exercisable will become fully exercisable at the time of the Transaction, (ii)&nbsp;awards with time-based vesting conditions or restrictions will become fully vested at the time of the Transaction, and (iii)&nbsp;all awards with conditions and
restrictions relating to the attainment of performance goals may become vested in connection with the Transaction in the Administrator&#146;s discretion or to the extent specified in the applicable award agreement. In the event of such a
Transaction, each holder of an outstanding stock option or stock appreciation right may receive a cash payment from the Company equal to the excess of the consideration payable per share in the Transaction over the applicable exercise price per
share, multiplied by the number of ordinary shares of the Company covered by the stock option or stock appreciation right (to the extent then exercisable) or be permitted to exercise their stock option or stock appreciation right (to the extent then
exercisable) for a period of time prior to the termination of the Plan, as determined by the Administrator. The Company may also make or provide payment, in case or in kind, to the holders of other awards in an amount equal to the consideration
payable per share in the Transaction multiplied by the number of vested ordinary shares of Company underlying such awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Amendment; Termination.
</I>The Administrator may amend or discontinue the Plan at any time. However, the Administrator cannot amend the Plan to increase the number of ordinary shares of the Company available for issuance under the Plan or to change the Plan in certain
other ways without shareholder approval. The Plan cannot be amended if the amendment would materially and adversely affect any rights that an award holder has under outstanding awards, without the participant&#146;s consent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Consistent with market practice in the United States, the trading jurisdiction of our ordinary shares, and in order to further support our ability to attract
and retain the right highly qualified candidates for our board of directors, we also granted share option to Supervisory Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Until
December&nbsp;31, 2020, no options granted to directors and executive officers were exercised. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">133 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The directors and executive officers of Immatics OpCo held the options (both vested and unvested) as of
March&nbsp;31, 2021: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="29%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Beneficiary</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Type of options</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Grant date</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Vesting
date<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number&nbsp;of<BR>options<BR>outstanding</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Strike<BR>price&nbsp;in<BR>USD</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Expiration date</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Harpreet Singh, Ph.D.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Performance-based options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30,&nbsp;2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1,598,000 options will vest quarterly until the options are fully vested if the performance condition shall be deemed satisfied in
three equal tranches as follows:</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">a) One third (1/3) of the Option Shares shall
satisfy the Performance Condition upon the Company&#146;s achievement of market capitalization equal to $1.5&nbsp;billion prior to the Expiration Date, subject to the Optionee&#146;s continuous Service Relationship through such date</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">b) One third (1/3) of the Option Shares shall satisfy the Performance Condition upon the
Company&#146;s achievement of market capitalization equal to $2.0&nbsp;billion prior to the Expiration Date, subject to the Optionee&#146;s continuous Service Relationship through such date</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">c) One third (1/3) of the Option Shares shall satisfy the Performance Condition upon the
Company&#146;s achievement of market capitalization equal to $3.0&nbsp;billion prior to the Expiration Date, subject to the Optionee&#146;s continuous Service Relationship through such date</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>1,598,000</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>10.00</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30,&nbsp;2030</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Service options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>168,000 options will vest quarterly until the options are fully vested</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>168,000</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>10.00</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2030</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Matching Stock options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>264,624 options will vest entirely on July&nbsp;31, 2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>264,624</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>10.00</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2030</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Converted Stock options III</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>5,157 options vested as of March&nbsp;31, 2021, and an additional 25,782 will vest quarterly thereafter until the options are fully vested</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>30,939</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>1.06</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>July&nbsp;1, 2027</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Converted Stock options IV</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>24,229 options vested as of March&nbsp;31, 2021, and an additional 121,142 will vest quarterly thereafter until the options are fully vested</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>145,371</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>1.17</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>January&nbsp;1, 2028</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">134 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="29%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Beneficiary</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Type of options</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Grant date</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Vesting
date<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number&nbsp;of<BR>options<BR>outstanding</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Strike<BR>price&nbsp;in<BR>USD</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Expiration date</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Service options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>December&nbsp;17, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>168,000 options will vest quarterly until the options are fully vested</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>168,000</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>9.70</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>December&nbsp;17, 2030</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Arnd Christ</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Performance-based options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>September&nbsp;14, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">255,000 options will vest quarterly until the options are fully vested if the performance condition shall be deemed satisfied in three
equal tranches as follows:</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">a) One third (1/3) of the Option Shares shall satisfy the
Performance Condition upon the Company&#146;s achievement of market capitalization equal to $1.5&nbsp;billion prior to the Expiration Date, subject to the Optionee&#146;s continuous Service Relationship through such date</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">b) One third (1/3) of the Option Shares shall satisfy the Performance Condition upon the
Company&#146;s achievement of market capitalization equal to $2.0&nbsp;billion prior to the Expiration Date, subject to the Optionee&#146;s continuous Service Relationship through such date</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">c) One third (1/3) of the Option Shares shall satisfy the Performance Condition upon the
Company&#146;s achievement of market capitalization equal to $3.0&nbsp;billion prior to the Expiration Date, subject to the Optionee&#146;s continuous Service Relationship through such date</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>255,000</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>10.00</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>September&nbsp;14, 2030</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Service options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>September&nbsp;14, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>49,000 options will vest quarterly until the options are fully vested</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>49,000</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>10.00</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>September&nbsp;14, 2030</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Service options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>December&nbsp;17, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>49,000 options will vest quarterly until the options are fully vested</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>49,000</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>9.70</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>December&nbsp;17, 2030</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Cedrik Britten, M.D.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Performance-based options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">255,000 options will vest quarterly until the options are fully vested if the performance condition shall be deemed satisfied in three
equal tranches as follows:</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">a) One third (1/3) of the Option Shares shall satisfy the
Performance Condition upon the Company&#146;s achievement of market capitalization equal to $1.5&nbsp;billion prior to the</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>255,000</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>10.00</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2030</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">135 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="29%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Beneficiary</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Type of options</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Grant date</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Vesting
date<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number&nbsp;of<BR>options<BR>outstanding</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Strike<BR>price&nbsp;in<BR>USD</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Expiration date</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Expiration Date, subject to the Optionee&#146;s continuous Service Relationship through such date</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">b) One third (1/3) of the Option Shares shall satisfy the Performance Condition upon the
Company&#146;s achievement of market capitalization equal to $2.0&nbsp;billion prior to the Expiration Date, subject to the Optionee&#146;s continuous Service Relationship through such date</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">c) One third (1/3) of the Option Shares shall satisfy the Performance Condition upon the
Company&#146;s achievement of market capitalization equal to $3.0&nbsp;billion prior to the Expiration Date, subject to the Optionee&#146;s continuous Service Relationship through such date</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Converted Stock options VI</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>15,722 options vested as of March&nbsp;31, 2021, and an additional 78,607 will vest quarterly thereafter until the options are fully vested</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>94,329</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>10.00</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;1, 2030</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Service options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>December&nbsp;17, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>49,000 options will vest quarterly until the options are fully vested</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>49,000</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>9.70</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>December&nbsp;17, 2030</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Carsten Reinhardt, M.D., Ph.D.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Performance-based options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">255,000 options will vest quarterly until the options are fully vested if the performance condition shall be deemed satisfied in three
equal tranches as follows:</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">a) One third (1/3) of the Option Shares shall satisfy the
Performance Condition upon the Company&#146;s achievement of market capitalization equal to $1.5&nbsp;billion prior to the Expiration Date, subject to the Optionee&#146;s continuous Service Relationship through such date</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">b) One third (1/3) of the Option Shares shall satisfy the Performance Condition upon the
Company&#146;s achievement of market capitalization equal to $2.0&nbsp;billion prior to the Expiration Date, subject to the Optionee&#146;s continuous Service Relationship through such date</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>255,000</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>10.00</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2030</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">136 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="29%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Beneficiary</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Type of options</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Grant date</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Vesting
date<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number&nbsp;of<BR>options<BR>outstanding</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Strike<BR>price&nbsp;in<BR>USD</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Expiration date</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">c) One third (1/3) of the Option Shares shall satisfy the
Performance Condition upon the Company&#146;s achievement of market capitalization equal to $3.0&nbsp;billion prior to the Expiration Date, subject to the Optionee&#146;s continuous Service Relationship through such date</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Service options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>49,000 options will vest quarterly until the options are fully vested</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>49,000</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>10.00</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2030</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Matching Stock options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>165,748 options will vest entirely on July&nbsp;31, 2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>165,748</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>10.00</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2030</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Converted Stock options III</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>3,126 options vested as of March&nbsp;31, 2021, and an additional 15,627 will vest quarterly thereafter until the options are fully vested</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>18,753</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>1.06</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>July&nbsp;1, 2027</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Service options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>December&nbsp;17, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>49,000 options will vest quarterly until the options are fully vested</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>49,000</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>9.70</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>December&nbsp;17, 2030</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Rainer Kramer, Ph.D.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Performance-based options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">255,000 options will vest quarterly until the options are fully vested if the performance condition shall be deemed satisfied in three
equal tranches as follows:</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">a) One third (1/3) of the Option Shares shall satisfy the
Performance Condition upon the Company&#146;s achievement of market capitalization equal to $1.5&nbsp;billion prior to the Expiration Date, subject to the Optionee&#146;s continuous Service Relationship through such date</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">b) One third (1/3) of the Option Shares shall satisfy the Performance Condition upon the
Company&#146;s achievement of market capitalization equal to $2.0&nbsp;billion prior to the Expiration Date, subject to the Optionee&#146;s continuous Service Relationship through such date</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">c) One third (1/3) of the Option Shares shall satisfy the Performance Condition upon the
Company&#146;s achievement of market capitalization equal to $3.0&nbsp;billion prior to the Expiration Date, subject to the</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>255,000</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>10.00</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2030</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">137 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="29%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Beneficiary</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Type of options</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Grant date</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Vesting
date<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number&nbsp;of<BR>options<BR>outstanding</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Strike<BR>price&nbsp;in<BR>USD</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Expiration date</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Optionee&#146;s continuous Service Relationship through such date</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Service options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>49,000 options will vest quarterly until the options are fully vested</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>49,000</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>10.00</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2030</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Matching Stock options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>120,676 options will vest entirely on July&nbsp;31, 2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>120,676</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>10.00</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2030</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Converted Stock options III</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>3,812 options vested as of March&nbsp;31, 2021, and an additional 19,056 will vest quarterly thereafter until the options are fully vested</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>22,868</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>1.06</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>July&nbsp;1, 2027</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Service options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>December&nbsp;17, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>49,000 options will vest quarterly until the options are fully vested</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>49,000</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>9.70</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>December&nbsp;17, 2030</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Toni Weinschenk, Ph.D.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Performance-based options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">255,000 options will vest quarterly until the options are fully vested if the performance condition shall be deemed satisfied in three
equal tranches as follows:</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">a) One third (1/3) of the Option Shares shall satisfy the
Performance Condition upon the Company&#146;s achievement of market capitalization equal to $1.5&nbsp;billion prior to the Expiration Date, subject to the Optionee&#146;s continuous Service Relationship through such date</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">b) One third (1/3) of the Option Shares shall satisfy the Performance Condition upon the
Company&#146;s achievement of market capitalization equal to $2.0&nbsp;billion prior to the Expiration Date, subject to the Optionee&#146;s continuous Service Relationship through such date</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">c) One third (1/3) of the Option Shares shall satisfy the Performance Condition upon the
Company&#146;s achievement of market capitalization equal to $3.0&nbsp;billion prior to the Expiration Date, subject to the Optionee&#146;s continuous Service Relationship through such date</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>255,000</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>10.00</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2030</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Service options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>49,000 options will vest quarterly until the options are fully vested</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>49,000</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>10.00</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2030</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">138 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="29%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Beneficiary</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Type of options</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Grant date</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Vesting
date<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number&nbsp;of<BR>options<BR>outstanding</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Strike<BR>price&nbsp;in<BR>USD</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Expiration date</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Matching Stock options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>68,070 options will vest entirely on July&nbsp;31, 2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>68,070</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>10.00</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2030</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Converted Stock options III</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>1,308 options vested as of March&nbsp;31, 2021, and an additional 6,542 will vest quarterly thereafter until the options are fully vested</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>7,850</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>1.06</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>July&nbsp;1, 2027</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Service options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>December&nbsp;17, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>49,000 options will vest quarterly until the options are fully vested</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>49,000</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>9.70</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>December&nbsp;17, 2030</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Steffen Walter, Ph.D.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Performance-based options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">255,000 options will vest quarterly until the options are fully vested if the performance condition shall be deemed satisfied in three
equal tranches as follows:</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">a) One third (1/3) of the Option Shares shall satisfy the
Performance Condition upon the Company&#146;s achievement of market capitalization equal to $1.5&nbsp;billion prior to the Expiration Date, subject to the Optionee&#146;s continuous Service Relationship through such date</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">b) One third (1/3) of the Option Shares shall satisfy the Performance Condition upon the
Company&#146;s achievement of market capitalization equal to $2.0&nbsp;billion prior to the Expiration Date, subject to the Optionee&#146;s continuous Service Relationship through such date</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">c) One third (1/3) of the Option Shares shall satisfy the Performance Condition upon the
Company&#146;s achievement of market capitalization equal to $3.0&nbsp;billion prior to the Expiration Date, subject to the Optionee&#146;s continuous Service Relationship through such date</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>255,000</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>10.00</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2030</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Service options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>49,000 options will vest quarterly until the options are fully vested</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>49,000</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>10.00</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2030</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Matching Stock options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>76,604 options will vest entirely July&nbsp;31, 2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>76,604</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>10.00</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2030</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">139 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="29%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Beneficiary</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Type of options</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Grant date</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Vesting
date<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number&nbsp;of<BR>options<BR>outstanding</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Strike<BR>price&nbsp;in<BR>USD</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Expiration date</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Converted Stock options III</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>1,493 options vested as of March&nbsp;31, 2021, and an additional 7,462 will vest quarterly thereafter until the options are fully vested</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>8,955</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>1.06</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>July&nbsp;1, 2027</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Service options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>December&nbsp;17, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>49,000 options will vest quarterly until the options are fully vested</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>49,000</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>9.70</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>December&nbsp;17, 2030</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Peter Chambr&eacute;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Service options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>25,000 options will vest quarterly until the options are fully vested</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>25,000</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>10.00</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June&nbsp;30,</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">2030</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Matching Stock options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>211,974 options will vest entirely on July&nbsp;31, 2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>211,974</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>10.00</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June&nbsp;30,</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">2030</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Adam Stone</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Service options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>25,000 options will vest quarterly until the options are fully vested</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>25,000</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>10.00</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2030</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Christoph Hettich</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Service options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>25,000 options will vest quarterly until the options are fully vested</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>25,000</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>10.00</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2030</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Heather L. Mason</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Service options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>25,000 options will vest quarterly until the options are fully vested</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>25,000</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>10.00</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2030</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Michael G. Atieh</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Service options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>25,000 options will vest quarterly until the options are fully vested</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>25,000</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>10.00</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2030</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Paul Carter</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Service options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>25,000 options will vest quarterly until the options are fully vested</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>25,000</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>10.00</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;30, 2030</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Eliot Forster</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Service options</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>September&nbsp;14, 2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>25,000 options will vest quarterly until the options are fully vested</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>25,000</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP>9.16</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September&nbsp;13,</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">2020</P></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_29"></A>C. Board Practices </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Structure </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a Dutch public
limited liability company (<I>naamloze vennootschap</I>) with a <FONT STYLE="white-space:nowrap">two-tier</FONT> board structure that consists of a management board (<I>bestuur</I>) (the &#147;Management Board&#148;) and a supervisory board (<I>raad
van commissarissen</I>) (the &#147;Supervisory Board&#148;). The Management Board and the Supervisory Board are separate boards and no individual may simultaneously be a member of both boards. We also have an executive committee (the &#147;Executive
Committee&#148;) consisting of a sole managing director and executive officers appointed by the Management Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under Dutch law, the
Management Board is responsible for our management, strategy, policy and operations. The Supervisory Board is responsible for supervising the conduct of and providing advice to our Management Board and for supervising the business generally.
Furthermore, each member of the Management Board and Supervisory Board has a duty to act in the corporate interest of the company and the business connected with it. Under Dutch law, the corporate interest extends to the interests of all corporate
stakeholders, such as shareholders, creditors, employees, customers and suppliers. The duty to act in the corporate interest of the company also applies in the event of a proposed sale or <FONT STYLE="white-space:nowrap">break-up</FONT> of the
company, whereby the circumstances generally dictate how such duty is to be applied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&nbsp;1, 2021, and pursuant to our articles
of association, our <FONT STYLE="white-space:nowrap">two-tier</FONT> board structure will automatically convert into a <FONT STYLE="white-space:nowrap">one-tier</FONT> board structure. There will be one board of directors that will consist of
executive </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">140 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
directors and <FONT STYLE="white-space:nowrap">non-executive</FONT> directors. In the <FONT STYLE="white-space:nowrap">one-tier</FONT> board structure, the Executive Committee will consist of all
executive directors and all executive officers. As used herein, the term &#147;Board&#148; refers to the Management Board and the Supervisory Board collectively through July&nbsp;1, 2021, and to the <FONT STYLE="white-space:nowrap">one-tier</FONT>
board of directors after such date. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Management Board </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Harpreet Singh, Ph.D., our Chief Executive Officer, serves as the sole managing director. The Management Board consists of such number of
managing directors as the Supervisory Board may determine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to our articles of association, the Management Board is charged with
the management of the company. In fulfilling their duties, managing directors serve the interest of the company and the business connected therewith. Resolutions of our Management Board that result in an important change in the identity or character
of the company or the business connected with it (for example, transfer of the entire business to a third party) require approval of the general meeting. Additionally, resolutions of our Management Board that relate to significant corporate action
(for example, listing on Nasdaq, capital expenditures or debt incurrence of over $500,000 and related party transactions) require prior approval by the Supervisory Board. A resolution taken by our Management Board in violation of our articles of
association will be void or voidable. The Management Board has the power to represent the company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to our articles of
association, managing directors are elected by the general meeting upon a binding nomination. The Supervisory Board is authorized to nominate a director candidate for appointment at the general meeting. Shareholders who individually or jointly
represent at least <FONT STYLE="white-space:nowrap">one-tenth</FONT> of the issued share capital have the same right to nominate a director candidate for appointment at the general meeting. The general meeting may at any time suspend and dismiss a
managing director. The general meeting may only adopt a resolution to suspend or dismiss a managing director by a majority of at least two thirds of the votes cast, representing more than half of the issued share capital, unless the resolution is
adopted on the basis of a proposal of the Supervisory Board; in that case, the resolution may be adopted by an absolute majority of the votes cast, representing more than half of the issued share capital. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Management Board is required to provide the Supervisory Board with the information it needs to carry out its duties. In addition, at least
once a year, the Management Board must inform the Supervisory Board in writing of the strategic policy, the general and financial risks and the management and control system of the company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our articles of association provide that if one or more managing directors have a direct or indirect personal interest that conflicts with the
interest of the company and the business connected with it, they will not be authorized to participate in the discussion and the decision-making process. In the event that all managing directors have, or the only managing director has, a direct or
indirect personal interest that conflicts with the interest of the company and the business connected with it, the resolution will be adopted by the Supervisory Board. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Supervisory Board </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Supervisory Board consists of seven supervisory directors. The Supervisory Board may consist of such number of supervisory directors as the
Supervisory Board may determine, but not less than three. The Supervisory Board is divided into three classes, with each class as nearly equal in number as possible. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The role of the Supervisory Board is the supervision of the policies of the Management Board and of the general course of affairs of the
company and the business connected with it. In doing so, the Supervisory Board also focuses on the effectiveness of our internal risk management and control systems and the integrity and quality of our financial reporting. In fulfilling their
duties, the supervisory directors must serve the interests of the company and the business connected with it. This supervision includes the power to intervene whenever </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">141 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
necessary and to take corrective actions as may be required in the interest of the company, subject to Dutch law and our articles of association. Our articles of association provide the
Supervisory Board with the authority to approve or reject Management Board resolutions that relate to significant corporate action (for example, listing on Nasdaq, capital expenditures or debt incurrence of over $500,000 and related party
transactions). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to our articles of association, the supervisory directors are appointed by the general meeting upon a binding
nomination. The Supervisory Board is authorized to nominate a director candidate for appointment at the general meeting. Shareholders who individually or jointly represent at least <FONT STYLE="white-space:nowrap">one-tenth</FONT> of the issued
share capital have the same right to nominate a director candidate for appointment at the general meeting. The general meeting may at all times overrule the binding nature of each nomination by a resolution adopted by a majority of at least two
thirds of the votes cast, representing more than half of the issued share capital. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The general meeting may at any time suspend and
dismiss a supervisory director. The general meeting may only adopt a resolution to suspend or dismiss a supervisory director by a majority of at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the votes cast, representing more than half
of the issued share capital, unless the resolution is adopted on the basis of a proposal of the Supervisory Board; in that case, the resolution may be adopted by an absolute majority of the votes cast representing more than half of the issued share
capital. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Board of Directors </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&nbsp;1, 2021, and pursuant to our articles of association, our <FONT STYLE="white-space:nowrap">two-tier</FONT> board structure will
automatically convert into a <FONT STYLE="white-space:nowrap">one-tier</FONT> board structure. There will be one Board that will consist of executive directors and <FONT STYLE="white-space:nowrap">non-executive</FONT> directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to our articles of association, the Board will be charged with the management of the company. In fulfilling their duties, our
directors will serve the interest of the company and the business connected with it. The executive directors and the Executive Committee are charged with the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT>
management of the company. Supervision of the fulfilment of duties by the executive directors and of the general course of the company&#146;s affairs and the business connected with it will primarily be carried out by the <FONT
STYLE="white-space:nowrap">non-executive</FONT> directors. The executive directors must in due time provide the <FONT STYLE="white-space:nowrap">non-executive</FONT> directors with the information they need to carry out their duties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board consists of one or more executive directors and three or more <FONT STYLE="white-space:nowrap">non-executive</FONT> directors. The
majority of the Board, however, consists of <FONT STYLE="white-space:nowrap">non-executive</FONT> directors. The number of executive directors and <FONT STYLE="white-space:nowrap">non-executive</FONT> directors is determined by the Board. The Board
will be divided into three classes with each class as nearly equal in number as possible. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After July&nbsp;1, 2021, our directors will be
elected by the general meeting upon a binding nomination. The Board will be authorized to nominate a director candidate for appointment at the general meeting. Shareholders who individually or jointly represent at least <FONT
STYLE="white-space:nowrap">one-tenth</FONT> of the issued share capital will have the same right to nominate a director candidate for appointment at the general meeting. The general meeting may at all times overrule the binding nature of each
nomination by a resolution adopted by a majority of at least two thirds of the votes cast, representing more than half of the issued share capital. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The general meeting may at any time suspend and dismiss a <FONT STYLE="white-space:nowrap">non-executive</FONT> director or executive
director. The general meeting may only adopt a resolution to suspend or dismiss a <FONT STYLE="white-space:nowrap">non-executive</FONT> director or executive director by a majority of at least two thirds of the votes cast, representing more than
half of the issued share capital, unless the resolution is adopted on the basis of a proposal of the Board; in that case, the resolution may be adopted by an absolute majority of the votes cast, representing more than half of the issued share
capital. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">142 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Committee </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the Management Board and the Supervisory Board, or the Board after July&nbsp;1, 2021, we have an Executive Committee. Pursuant
to our articles of association, the Executive Committee consists of all managing directors and executive officers. Executive officers who are not managing directors are appointed by the Management Board, or the Board after July&nbsp;1, 2021. The
Management Board, or the Board after July&nbsp;1, 2021, may at any time suspend or dismiss an executive officer who is not a managing director. A resolution of the Management Board to appoint, suspend or dismiss an executive officer requires the
prior approval of the Supervisory Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Executive Committee is charged with the matters concerning the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> management of the company determined by the Management Board. Two executive officers acting jointly have the power to represent the company. The Management Board
may, whether or not by rule, determine the duties with which each executive officer will be particularly charged, such resolution requires the prior approval of the Supervisory Board. After July&nbsp;1, 2021, the Board may, whether or not by rule,
determine the duties with which each executive officer will be particularly charged, </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director and Officer Qualifications </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have not established any specific, minimum qualifications that must be met by each of our officers. However, we generally evaluate the
following qualities: educational background, diversity of professional experience, knowledge of our business, integrity, professional reputation, independence, wisdom, and ability to represent the best interests of our shareholders. The Nominating
Committee of the Supervisory Board has prepared policies regarding director qualification requirements and the process for identifying and evaluating director candidates for adoption by the Supervisory Board. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Composition </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Management Board
consists of one managing director and the Supervisory Board consists of seven supervisory directors: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the managing director is Harpreet Singh; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Class&nbsp;I supervisory directors are Michael G. Atieh, a designee of the ARYA Sponsor and the <FONT
STYLE="white-space:nowrap">pre-Business</FONT> Combination independent directors of ARYA (collectively, the &#147;ARYA Initial shareholders&#148;) and Paul R. Carter, a designee of dievini, and their terms will expire at the annual meeting of
shareholders in 2021; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Class&nbsp;II supervisory directors are Peter Chambr&eacute; and Heather L. Mason, and their terms will
expire at the annual meeting of shareholders in 2022; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Class&nbsp;III supervisory directors are Adam Stone, a designee of the ARYA Initial shareholders, and Christof
Hettich, a designee of dievini, and their terms will expire at the annual meeting of shareholders in 2023; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">interim supervisory director is Eliot Forster and his interim term will expire at the annual meeting of
shareholders in 2021. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&nbsp;1, 2021, and pursuant to our articles of association, our <FONT
STYLE="white-space:nowrap">two-tier</FONT> board structure will automatically convert into a <FONT STYLE="white-space:nowrap">one-tier</FONT> board structure which will consist of an eight-member staggered board divided into three classes. The
supervisory directors will retain their designated class upon the transition to the <FONT STYLE="white-space:nowrap">one-tier</FONT> board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result of the staggered board, only one class of directors will be elected at each annual meeting of shareholders, with the other classes
continuing for the remainder of their respective terms. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">143 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Committees of the Supervisory Board </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Supervisory Board has established three standing committees: Audit Committee, Compensation Committee and Nominating&nbsp;&amp; Corporate
Governance Committee. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Audit Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Audit Committee members include Michael G. Atieh (chair), Paul R. Carter and Heather L. Mason. Each member of the Audit Committee satisfies the
&#147;independence&#148; requirements set forth in Rule <FONT STYLE="white-space:nowrap">10A-3</FONT> under the Exchange Act and is financially literate and each of Michael G. Atieh and Paul R. Carter qualifies as an &#147;audit committee financial
expert&#148; as defined in applicable SEC rules. The Supervisory Board has adopted Audit Committee rules, which detail the principal functions of the Audit Committee, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">monitoring the independence of our independent registered public accounting firm; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">assuring the rotation of the audit partners (including the lead and concurring partners) as required by law;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">pre-approving</FONT> all audit services and permitted <FONT
STYLE="white-space:nowrap">non-audit</FONT> services to be performed by our independent registered public accounting firm; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">making recommendations regarding the appointment or replacement of our independent registered public accounting
firm; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">determining the compensation and oversight of the work of our independent registered public accounting firm
(including resolution of disagreements between the Executive Committee and the independent auditors regarding financial reporting) for the purpose of preparing or issuing an audit report or related work; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and discussing with the independent auditors and the Executive Officers our annual financial statements
and related disclosures as well as critical accounting policies and practices used by us; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing all related person transactions for potential conflict of interest situations and voting with respect
to all such transactions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">supervising the integrity of our financial reporting and the effectiveness of our internal risk management and
control systems; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing procedures for the receipt, retention and treatment of complaints received by the company regarding
accounting, internal accounting controls or auditing matters. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Compensation Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Compensation Committee members include Paul R. Carter (chair), Adam Stone and Heather L. Mason. The Supervisory Board has adopted Compensation
Committee rules, which detail the principal functions of the Compensation Committee, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving the corporate goals and objectives relevant to the compensation of our Chief Executive
Officer; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evaluating the performance of our Chief Executive Officer in light of such goals and objectives and determining
and approving the compensation of the Chief Executive Officer based on such evaluation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving the compensation of all other executive officers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and making recommendations to the Supervisory Board regarding policies and procedures for the grant of
equity-based awards; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">administering our incentive-based and equity-based compensation plans; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">144 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">retaining or obtaining the advice of outside compensation consultants, legal counsel or other advisers;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and discussing with management which executive compensation information should be included in our
annual proxy statement; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and, where appropriate, making recommendations with regard to the compensation of directors.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, legal
counsel or other adviser and is directly responsible for the appointment, compensation and oversight of the work of any such adviser. However, before engaging or receiving advice from a compensation consultant, external legal counsel or any other
adviser, the Compensation Committee will consider the independence of each such adviser, including the factors required by Nasdaq and the SEC. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Nominating and Corporate Governance Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Nominating and Corporate Governance Committee members include Peter Chambr&eacute; (chair), Christof Hettich and Adam Stone. The Supervisory
Board has adopted Nominating and Corporate Governance Committee rules, which detail the principal functions of the Nominating and Corporate Governance Committee, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">recommending criteria for Management Board, Supervisory Board and committee membership; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">assessing the performance of individual managing directors, supervisory directors and Supervisory Board committee
members and reporting findings to the Supervisory Board; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developing a plan for the succession of managing directors and supervisory directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">supervising selection criteria and appointment procedures for executive officers other than the Chief Executive
Officer; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developing and recommending to the Supervisory Board a set of corporate governance guidelines and periodically
reviewing and reassessing the adequacy of such guidelines; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and discussing with management disclosure of the company&#146;s corporate governance practices.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_30"></A>D. Employees </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2020, Immatics OpCo has a headcount of 198 employees and 142 full-time employees of whom 63 hold a doctorate degree. Of
these full-time employees, 97 are employed in positions relating to research and development positions (including Immunology, Target Research, Companion Diagnostics, CMC Biologics, CMC Peptides, Translational Development, Bioinformatics), 5 are
employed in Clinical, 3 are employed in Business Development, 4 are employed in Intellectual Property and 27 are employed in administrative functions (including Administration&nbsp;&amp; PA, Finance, IT, Quality Management, Human Resources,
Communications, Facility Management) and 6 in senior management positions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2020, Immatics US employed 85
full-time employees of which 21 hold doctorate degrees, 1 has the credentials of JD, and 3 have the credentials of M.D. Of these employees, 58 are employed in positions relating to research and development (including CMC, Target-based Biomarkers,
Immunology, Quality Assurance and Control, Quality Systems and Bioinformatics), 14 are employed in positions relating to Clinical Operations/Development, Regulatory, Strategic Operations and Program Management, 11 are employed in administrative
functions (including Finance, IT, Legal, Corporate Strategy&nbsp;&amp; Investor Relations, Operations and Human Resources), and 2 were employed in senior management positions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have never had a work stoppage, are not covered under any collective bargaining agreements nor are any of our employees represented by a
labor union or works council. We believe we have good employee relations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">145 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_31"></A>E. Share Ownership </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See &#147;Item 7. Major Shareholders and Related Party Transactions&#151;A. Major Shareholders.&#148; </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="rom149615_32"></A>ITEM&nbsp;7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_33"></A>A. Major Shareholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information relating to the beneficial ownership of our ordinary shares as of February&nbsp;1, 2021 by: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each person, or group of affiliated persons, known by us to beneficially own more than 5% of outstanding ordinary
shares; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each of our directors and executive officers; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all of our directors and executive officers as a group. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The number of ordinary shares beneficially owned by each entity, person, executive officer or director is determined in accordance with the
rules of the SEC, and the information is not necessarily indicative of beneficial ownership for any other purpose. Under such rules, beneficial ownership includes any ordinary shares over which the individual has sole or shared voting power or
investment power as well as any ordinary shares that the individual has the right to acquire within 60 days from February&nbsp;1, 2021 through the exercise of any option, warrant or other right. Except as otherwise indicated, and subject to
applicable community property laws, we believe that the persons named in the table have sole voting and investment power with respect to all ordinary shares held by that person based on information provided to us by such person. This table is based
on information supplied by our directors and officers and by Schedules 13D and Schedules 13G, if any, filed with the SEC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The percentage
of outstanding ordinary shares beneficially owned is computed based on 62,908,617 ordinary shares outstanding as of February&nbsp;1, 2021. Ordinary shares that a person has the right to acquire within 60 days are deemed outstanding for purposes of
computing the percentage ownership of the person holding such rights, but are not deemed outstanding for purposes of computing the percentage ownership of any other person. Unless otherwise indicated below, the business address for each beneficial
owner is Immatics N.V., Paul-Ehrlich-Stra&szlig;e 15, 72076 T&uuml;bingen, Federal Republic of Germany. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">146 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Beneficial Owner</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>Ordinary&nbsp;Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage&nbsp;of<BR>Ordinary&nbsp;Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Directors, Executive Officers and Persons Nominated to Serve in Such Positions</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Harpreet Singh, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">296,627</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Arnd Christ</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cedrik Britten, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,722</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Carsten Reinhardt, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">110,907</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Toni Weinschenk, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">72,906</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rainer Kramer, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64,150</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steffen Walter, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39,795</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Peter Chambr&eacute;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">105,987</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael G. Atieh</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Paul R. Carter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Eliot Forster, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christof Hettich, L.L.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Heather L. Mason</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adam Stone(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All directors and executive officers and persons nominated to serve in such positions as a group
(14 persons)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">706,094</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>5% or Greater Shareholders</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARYA Sciences Holdings(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,503,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">dievini Hopp BioTech holding GmbH&nbsp;&amp; Co. KG(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,476,073</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Indicates beneficial ownership of less than 1% of total outstanding ordinary shares. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Does not include any ordinary shares indirectly owned by Adam Stone as a result of his membership interest in
ARYA Sciences Holdings. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This information is based on a Schedule 13G filed with the SEC on February&nbsp;16, 2021 by ARYA Sciences
Holdings, which reported shared voting and dispositive power over 3,503,750 ordinary shares. ARYA Sciences Holdings is governed by a board of directors, consisting of three individuals, each of whom has one vote. A majority of the board of directors
is required to make voting and dispositive decisions regarding the ordinary shares. As such, none of the members of the board of directors of the ARYA Sciences Holdings is deemed to be a beneficial owner of the ordinary shares. The principal
business address of ARYA Sciences Holdings is 51 Astor Place, 10th Floor, New York, NY 10003. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This information is based on a Schedule 13G filed with the SEC on February&nbsp;12, 2021 by dievini Hopp
BioTech holding GmbH&nbsp;&amp; Co. KG (&#147;dievini&#148;), <FONT STYLE="white-space:nowrap">DH-Capital</FONT> GmbH&nbsp;&amp; Co. KG <FONT STYLE="white-space:nowrap">(&#147;DH-Capital&#148;),</FONT> OH Beteiligungen GmbH&nbsp;&amp; Co. KG
(&#147;OH Beteiligungen&#148;), Dietmar Hopp, Oliver Hopp, Daniel Hopp, Prof. Dr.&nbsp;Friedrich von Bohlen und Halbach (&#147;Dr.&nbsp;von Bohlen&#148;), Prof. Dr.&nbsp;Christof Hettich (&#147;Dr.&nbsp;Hettich&#148;), Dr.&nbsp;Mathias Hothum
(&#147;Dr.&nbsp;Hothum&#148;), which reported shared voting and dispositive power over 16,476,073 ordinary shares. The ordinary shares are held by dievini. <FONT STYLE="white-space:nowrap">DH-Capital,</FONT> OH Beteiligungen, Dr.&nbsp;von Bohlen and
Dr.&nbsp;Hettich are collectively the holders of 100% of the limited partner interest in dievini. <FONT STYLE="white-space:nowrap">DH-Capital</FONT> and OH Beteiligungen each hold a 40% limited partner interest in dievini and therefore, control the
voting and dispositive decisions of dievini together and may be deemed to beneficially own the shares held by dievini. Dietmar Hopp, Daniel Hopp and Oliver Hopp are the ultimate controlling persons of dievini,
<FONT STYLE="white-space:nowrap">DH-Capital</FONT> and OH Beteiligungen, and control the voting and investment decisions of the ultimate parent company of dievini and therefore, may be deemed to beneficially own the shares held by dievini by virtue
of their status as controlling persons of dievini. The sole general partner of dievini with the authorization to represent is dievini Verwaltungs GmbH; however, 100% of the shares of dievini Verwaltungs GmbH are held by dievini so dievini
Verwaltungs GmbH is not considered to have control over dievini. The managing directors of dievini Verwaltungs GmbH are Dietmar Hopp, Dr.&nbsp;von Bohlen, Dr.&nbsp;Hettich and Dr.&nbsp;Hothum. Voting and dispositive decisions made within dievini
Verwaltungs GmbH regarding the securities held by dievini are made by at least two managing directors acting together; however, Dietmar Hopp is entitled to </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">147 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
represent dievini Verwaltungs GmbH solely. Therefore, in their capacity as managing directors, Dietmar Hopp, Dr.&nbsp;von Bohlen, Dr.&nbsp;Hettich and Dr.&nbsp;Hothum share voting and dispositive
power over the shares held by dievini, and may be deemed to beneficially own such shares held by dievini; however, each of Dietmar Hopp, Dr.&nbsp;von Bohlen, Dr.&nbsp;Hettich and Dr.&nbsp;Hothum disclaims beneficial ownership of the shares held by
dievini except to the extent of their pecuniary interests therein. The principal business address of dievini, Dietmar Hopp, Dr.&nbsp;von Bohlen, Dr.&nbsp;Hettich and Dr.&nbsp;Hothum is c/o dievini Hopp BioTech holding GmbH&nbsp;&amp; Co. KG,
Johann-Jakob-Astor Stra&szlig;e 57, 69190 Walldorf, Germany. The principal business address of <FONT STYLE="white-space:nowrap">DH-Capital</FONT> GmbH&nbsp;&amp; Co. KG and OH Beteiligungen GmbH&nbsp;&amp; Co. KG is Opelstra&szlig;e 28, 68789 St. <FONT
STYLE="white-space:nowrap">Leon-Rot,</FONT> Germany. The principal business address of Oliver Hopp and Daniel Hopp is Johann-Jakob-Astor-Stra&szlig;e 59, 69190 Walldorf, Germany. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Holders </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of February&nbsp;1, 2021, we
had approximately 96 shareholders of record of our ordinary shares. We estimate that as of February&nbsp;1 2021, approximately 64.7% of our outstanding ordinary shares are held by 61 U.S. record holders. The actual number of shareholders is greater
than this number of record holders and includes shareholders who are beneficial owners but whose shares are held in street name by brokers and other nominees. This number of holders of record also does not include shareholders whose shares may be
held in trust or by other entities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Significant Changes in Ownership by Major Shareholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have experienced significant changes in the percentage ownership held by major shareholders as a result of our Business Combination. Prior
to our Business Combination, our principal shareholders were dievini Hopp BioTech holding GmbH&nbsp;&amp; Co. KG, Wellington Partners and AT Impf GmbH, which held ordinary shares representing 39.79%, 13.19% and 13.13% of our outstanding ordinary
shares prior to our Business Combination. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_34"></A>B. Related Party Transactions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a description of certain related party transactions we have entered into since January&nbsp;1, 2020 with any of our executive
officers, directors or their affiliates and holders of more than 10% of any class of our voting securities in the aggregate, which we refer to as related parties, other than compensation arrangements which are described under &#147;Item 6.
Directors, Senior Management and Employees.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Business Combination </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&nbsp;1, 2020, we closed the Business Combination, pursuant to which the following transactions occurred: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">shareholders of Immatics OpCo exchanged their equity interests in Immatics OpCo for an aggregate of 33,791,269
ordinary shares (including (A)&nbsp;holders of vested Immatics OpCo stock appreciation rights that received cash proceeds in exchange for the cancellation of such stock appreciation rights and subsequently invested portions of such cash proceeds in
our company in exchange for ordinary shares, and (B)&nbsp;holders of unvested Immatics OpCo stock appreciation rights that received options to purchase ordinary shares in exchange for the cancellation of such rights). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ARYA Merger Sub 1, a Cayman Islands exempted company, merged with and into ARYA (the &#147;First Merger&#148;),
with ARYA as the surviving company (the &#147;First Surviving Company&#148;), and, after giving effect to the First Merger, becoming our wholly owned subsidiary. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In connection with the First Merger, each issued and outstanding ordinary share of ARYA was converted into one
ordinary share of the First Surviving Company and, immediately thereafter, each of the resulting ordinary shares of the First Surviving Company was automatically exchanged for one ordinary share, for an aggregate of 17,968,750 ordinary shares.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">148 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Each outstanding warrant to purchase a Class&nbsp;A ordinary share of ARYA was, by its terms, converted into a
warrant to purchase one ordinary share, for an aggregate of 7,187,500 public warrants, other than the warrants held by ARYA Sponsor, which were forfeited. The public warrants entitle the holder to purchase one ordinary share at an exercise price of
$11.50 per share and become exercisable 30 days after the Closing Date. The public warrants expire five years after the Closing Date or earlier upon redemption or liquidation in accordance with their terms. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The First Surviving Company merged with and into Immatics Merger Sub 2, a Cayman Islands exempted company
(&#147;IB Merger Sub&#148;), with IB Merger Sub as the surviving company in the merger, and each issued and outstanding First Surviving Company share was automatically converted into one ordinary share of IB Merger Sub. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Business Combination Agreement, dated as of March&nbsp;17, 2020, as amended by Amendment No.&nbsp;1, dated June&nbsp;7, 2020 (as amended,
the &#147;Business Combination Agreement&#148;), by and among Immatics, Immatics OpCo, ARYA, Immatics Merger Sub 1 and Immatics Merger Sub 2 contained customary representations and warranties and <FONT STYLE="white-space:nowrap">pre-</FONT> and
post-closing covenants of each party and customary closing conditions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PIPE Financing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;17, 2020, concurrently with the execution of the Business Combination Agreement, Immatics OpCo and ARYA entered into Subscription
Agreements with certain investors (the &#147;PIPE Investors&#148;), pursuant to which the PIPE Investors agreed to subscribe for and purchase, and the Company agreed to issue and sell to such PIPE Investors, an aggregate of 10,415,000 ordinary
shares at a price of $10.00 per share, for gross proceeds of approximately $104.2&nbsp;million on the Closing Date, $25.0&nbsp;million of which was funded by an affiliate of the ARYA Sponsor. The PIPE Financing closed concurrently with the Business
Combination. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Nomination and Registration Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the Business Combination and the PIPE Financing, we granted certain registration rights to certain securityholders under the
Investor Rights Agreement entered into as of the closing of the Business Combination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Investor Rights Agreements, until
the firth anniversary of the closing of the Business Combination, at each annual or special meeting of shareholders, (i) Perceptive Life Sciences Master Fund, Ltd, Dr. David Hung, Dr. Todd Wider and Kevin Conroy (collectively, the &#147;ARYA
Investors&#148;) have the right, but not the obligation, to designate for election as a director two individuals to serve on our Supervisory Board or Board, as applicable (one Class I director and one Class III director), and (ii) dievini Hopp
BioTech holding GmbH &amp; Co. KG (&#147;dievini&#148;) has the right, but not the obligation, to designate for election as a director two individuals to serve on our Supervisory Board or Board, as applicable (one Class I director and one Class III
director), provided that ARYA Investors&#146; nomination rights will terminate if at any time ARYA Investors collectively own less than 5% of our then-outstanding ordinary shares and that dievini&#146;s nomination rights will terminate if at any
time dievini own less than 5% of our then-outstanding ordinary shares. Once nominated by these shareholders, our Supervisory Board or Board, as applicable, is obligated to recommend such individuals for election and to include such recommendation in
any proxy statement or similar document provided to our shareholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Investor Rights Agreement, we agreed to file,
subject to customary exceptions, a Registration Statement covering all ordinary shares issued in connection with the First Merger, the Exchange and the PIPE Financing. The Investor Rights Agreement also provides the parties with demand and
&#147;piggy-back&#148; registration rights, subject to certain minimum requirements and customary conditions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Indemnification Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our articles of association provide for certain indemnification rights for our directors and executive officers, and we entered into an
indemnification agreement with each of our executive officers and directors providing for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">149 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
procedures for indemnification and advancements by us of certain expenses and costs relating to claims, suits or proceedings arising from his or her service to us or, at our request, service to
other entities, as officers or directors to the maximum extent permitted by Dutch law. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_35"></A>C. Interests of Experts and Counsel
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="rom149615_36"></A>ITEM&nbsp;8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>FINANCIAL INFORMATION </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_37"></A>A. Consolidated Statements and Other Financial Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Financial Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See &#147;Item 18.
Financial Statements,&#148; which contains our financial statements prepared in accordance with IFRS. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Legal Proceedings </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From time to time, we may be subject to various legal proceedings and claims that arise in the ordinary course of our business activities. For
example, in September 2020, we filed an opposition against Immunocore Limited which challenges its IMMTAX U.S. trademark registration. In November 2020, Immunocore Limited filed counterclaims against three of our U.S. registered trademarks for
IMMATICS. The results of litigation and claims cannot be predicted with certainty. As of the date of this Annual Report, we do not believe that we are party to any claim or litigation, the outcome of which would, individually or in the aggregate, be
reasonably expected to have a material adverse effect on our business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dividends and Dividend Policy </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have never declared or paid any cash dividends and have no plan to declare or pay any dividends on our ordinary shares in the foreseeable
future. We currently intend to retain any earnings for future operations and expansion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will be able to make distributions to our
shareholders only to the extent that our equity exceeds the aggregate amount of issued share capital and reserves that must be maintained pursuant to Dutch law or under our articles of association. We may not make any distribution of profits on
shares held as treasury shares and such treasury shares will not be taken into account when determining the profit entitlement of our shareholders. Our articles of association prescribe that profits in any financial year will be distributed first to
holders of our financing preferred shares, if any are outstanding. Any remaining profits may be reserved by our Management Board, subject to the approval of our Supervisory Board or, after July&nbsp;1, 2021, our Board. Any profits remaining
thereafter and reserves may be distributed as dividends to the holders of our ordinary shares, subject to the appropriate record date. The general meeting is authorized to declare distributions upon the proposal of our Management Board, which
proposal requires the prior approval of our Supervisory Board or, after July&nbsp;1, 2021, our Board. Our Management Board or, after July&nbsp;1, 2021, our Board determines whether and how much of the profits shown in the adopted annual accounts
will be reserved and the manner and date of any dividend. In addition, our Management Board is permitted, subject to Supervisory Board approval and certain requirements, to declare interim dividends without the approval of our shareholders. We may
reclaim any distributions, whether interim or not interim, made in contravention of certain restrictions of Dutch law from shareholders that knew or should have known that such distribution was not permissible. In addition, on the basis of Dutch
case law, if after a distribution we are not able to pay our due and collectable debts, then our shareholders or directors who at the time of the distribution knew or reasonably should have foreseen that result may be liable to our creditors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since we are a holding company, our ability to pay dividends will be dependent upon the financial condition, liquidity and results of
operations of, and the receipt of dividends, loans or other funds from, our </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">150 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
subsidiaries. Our subsidiaries are separate and distinct legal entities and have no obligation to make funds available to us. In addition, there are various statutory, regulatory and contractual
limitations and business considerations on the extent, if any, to which our subsidiaries may pay dividends, make loans or otherwise provide funds to us. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_38"></A>B. Significant Changes </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A discussion of the significant changes in our business can be found under &#147;Item 4. Information on the Company&#151;A. History and
Development of the Company&#148; and &#147;Item 4. Information on the Company&#151;B. Business Overview.&#148; </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="rom149615_39"></A>ITEM&nbsp;9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>THE OFFER AND LISTING </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_40"></A>A. Offering and Listing Details </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See &#147;&#151;C. Markets.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_41">
</A>B. Plan of Distribution </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_42"></A>C. Markets </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our ordinary shares and warrants are listed on Nasdaq under the symbols &#147;IMTX&#148; and &#147;IMTXW,&#148; respectively. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_43"></A>D. Selling Shareholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_44"></A>E. Dilution </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_45"></A>F. Expenses of the Issue </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="rom149615_46"></A>ITEM&nbsp;10.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ADDITIONAL INFORMATION </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_47"></A>A. Share Capital </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_48"></A>B. Memorandum and Articles of Association </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We were incorporated on March&nbsp;10, 2020 as a private limited liability company (<I>besloten vennootschap met beperkte aansprakelijkheid)
under Dutch law, and upon the consummation of the Business Combination, we converted into a Dutch public limited liability company (naamloze vennootschap). </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are registered in the Commercial Register of the Chamber of Commerce (<I>Kamer van Koophandel</I>) in the Netherlands under number
77595726. We have our corporate seat is in Amsterdam, the Netherlands and our registered office is at Paul-Ehrlich-Stra&szlig;e 15, 72076 T&uuml;bingen, Federal Republic of Germany. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">151 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&nbsp;1, 2021, and pursuant to our articles of association, our current <FONT
STYLE="white-space:nowrap">two-tier</FONT> board structure will automatically convert into a <FONT STYLE="white-space:nowrap">one-tier</FONT> board structure, which will consist of a nine-member staggered board divided into three classes. In the <FONT
STYLE="white-space:nowrap">one-tier</FONT> board structure, we will also have an Executive Committee consisting of all our executive directors and other executive officers. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Share Capital </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Authorized Share
Capital </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our authorized share capital consists of 285,000,000 ordinary shares, nominal value of &#128;0.01 per share, and
15,000,000 financing preferred shares. The financing preferred shares are divided into five series, each consisting of 3,000,000 financing preferred shares. As of December&nbsp;31, 2020, there were 62,908,617 ordinary shares outstanding and no
financing preferred shares outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The financing preferred shares may, at the request of the holder, be converted into ordinary
shares pursuant to a resolution of our Management Board or, after July&nbsp;1, 2021, our Board. The conditions for conversion and the further terms and conditions related to the financing preferred shares will be determined by our Management Board
subject to the prior approval of our Supervisory Board or, after July&nbsp;1, 2021, our Board, our general meeting and the meeting of holders of the series of financing preferred shares concerned, if such series of financing preferred shares has
been issued and are held by persons other than us. The preceding sentence applies by analogy to any adjustment to the conditions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Issuance of Ordinary Shares </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under Dutch law, shares are issued and rights to subscribe for shares are granted pursuant to a resolution of our general meeting. Our articles
of association provide that the general meeting may only resolve to issue shares upon the proposal of our Management Board, which proposal requires the prior approval of our Supervisory Board. The general meeting may authorize the Management Board
to issue new ordinary shares or grant rights to subscribe for ordinary shares, subject to the approval of our Supervisory Board. The authorization can be granted and extended, in each case for a period not exceeding five years. For as long as, and
to the extent, that such authorization is effective, our general meeting will not have the power to issue ordinary shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to a
resolution of the general meeting dated June&nbsp;30, 2020, our Management Board is irrevocably authorized to for a period of five years from July&nbsp;1, 2020, to issue ordinary shares or financing preferred shares up to the amount of the
authorized share capital (from time to time). On July&nbsp;1, 2021, the powers of our Management Board will vest in our Board. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Preemptive Rights </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to restrictions in our articles of association, holders of ordinary shares have preemptive rights in relation to newly issued ordinary
shares under Dutch law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under our articles of association, the preemptive rights in respect of newly issued ordinary shares may be
restricted or excluded by a resolution of our general meeting, which resolution requires a <FONT STYLE="white-space:nowrap">two-thirds</FONT> majority of the votes cast if less than half of the issued share capital is present or represented at the
meeting. The general meeting may authorize our Management Board, subject to the prior approval of our Supervisory Board or, after July&nbsp;1, 2021, our Board to limit or exclude the preemptive rights in respect of newly issued ordinary shares. Such
authorization for our Management Board, subject to the prior approval of our Supervisory Board or, after July&nbsp;1, 2021, our Board can be granted and extended, in each case for a period not exceeding five years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to a resolution of the general meeting dated June&nbsp;30, 2020, our Management Board is irrevocably authorized for a period of five
years from July&nbsp;1, 2020 to limit or exclude preemptive rights on ordinary shares up to 100% of the number of ordinary shares in our authorized share capital (from time to time). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">152 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Preemptive rights do not exist with respect (a)&nbsp;to the issue of ordinary shares or
grant of rights to subscribe for ordinary shares to our employees or a &#147;group&#148; company of ours, and (b)&nbsp;the issue of ordinary shares against a contribution in kind. Preemptive rights do not exist with respect to the issue of financing
preferred shares and holders of financing preferred shares have no preemptive right to acquire newly issued ordinary shares. On July&nbsp;1, 2021, the powers of our Management Board will vest in our Board. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Transfer of Ordinary Shares </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under Dutch law, transfers of ordinary shares (other than in book-entry form) require a written deed of transfer and, unless the company is a
party to the deed of transfer, and acknowledgement by or proper service upon the company to be effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under our articles of
association, if one or more ordinary shares are admitted to trading on Nasdaq or any other regulated foreign stock exchange located in the United States, we may, by resolution of our Management Board, determine that the laws of the State of New York
will apply to the property law aspects of the ordinary shares included in the part of the register of shareholders kept by the relevant transfer agent. Such resolution, as well as the revocation thereof, will be made public as required by law and
will be made available for inspection at our office and the Dutch trade register. Our management has adopted such resolution effective as of the Closing Date. On July&nbsp;1, 2021, the powers of our Management Board will vest in our Board. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Form of Ordinary Shares </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to our articles of association, the ordinary shares are registered shares. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Purchase and Repurchase of Ordinary Shares </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under Dutch law, we may not subscribe for newly issued ordinary shares. We may acquire ordinary shares, subject to applicable provisions and
restrictions of Dutch law and our articles of association, to the extent that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">such ordinary shares are fully paid up; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">such repurchase would not cause our shareholders&#146; equity to fall below an amount equal to the sum of the <FONT
STYLE="white-space:nowrap">paid-up</FONT> and <FONT STYLE="white-space:nowrap">called-up</FONT> part of the issued share capital and the reserves we are required to maintain pursuant to Dutch law or our articles of association; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">immediately after the acquisition of such ordinary shares, we and our subsidiaries would not hold, or would not
hold as pledgees, shares having an aggregate nominal value that exceeds 50% of our issued share capital. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other than
ordinary shares acquired for no valuable consideration or under universal title of succession (<I>onder algemene titel</I>) (e.g., through a merger or <FONT STYLE="white-space:nowrap">spin-off)</FONT> under statutory Dutch or other law, we may
acquire ordinary shares only if our general meeting has authorized our Management Board to do so, subject to prior approval of our Supervisory Board or, after July&nbsp;1, 2021, our Board. An authorization by our general meeting for the acquisition
of ordinary shares can be granted for a maximum period of 18 months. Such authorization must specify the number of ordinary shares that may be acquired, the manner in which these shares may be acquired and the price range within which the shares may
be acquired. No authorization of our general meeting is required if ordinary shares are acquired by us on Nasdaq with the intention of transferring such ordinary shares to our employees or employees of a group company pursuant to an arrangement
applicable to them. For each annual general meeting, we expect that our Management Board, or, after July&nbsp;1, 2021, our Board will place on the agenda a proposal to reauthorize our Management Board, or, after July&nbsp;1, 2021, our Board to
repurchase shares for a period of 18 months from the date of the resolution. We cannot derive any right to any distribution from ordinary shares, or voting rights attached to ordinary shares acquired by it. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">153 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to a resolution of the general meeting dated June&nbsp;30, 2020, the our Management
Board is irrevocably authorized for a period of 18 months to resolve for us to acquire fully <FONT STYLE="white-space:nowrap">paid-up</FONT> ordinary shares up to the maximum number of ordinary shares permitted pursuant to the law and our articles
of association from time to time, through privately negotiated repurchases, in self-tender offers, or through accelerated repurchase arrangements, at prices ranging from the nominal value of the ordinary shares up to one hundred and ten percent
(110%) of the market price of ordinary shares, provided that (i)&nbsp;for open market or privately negotiated repurchases, the market price will be the price for ordinary shares Nasdaq at the time of the transaction, (ii)&nbsp;for self-tender
offers, the market price will be the volume weighted average price for the ordinary shares on Nasdaq during a period, determined by the Management Board, of no less than one and no more than five consecutive trading days immediately prior to the
expiration of the tender offer, and (iii)&nbsp;for accelerated repurchase arrangements, the market price will be the volume weighted average price of the ordinary shares on the NYSE over the term of the arrangement. The volume weighted average price
for any number of trading days will be calculated as the arithmetic average of the daily volume weighted average price on those trading days. On July&nbsp;1, 2021, the powers of our Management Board will vest in our Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to a resolution of the general meeting dated June&nbsp;30, 2020, our Management Board is furthermore irrevocably authorized for a
period of 18 months from July&nbsp;1, 2020 to resolve for us to acquire fully paid up financing preferred shares up to the maximum number of financing preferred shares permitted pursuant to the law and our articles of association from time to time
and that financing preferred shares may be acquired through privately negotiated repurchases, in self-tender offers, or through accelerated repurchase arrangements, at prices ranging from the nominal value of the financing preferred shares up to the
amount that would be paid by us upon cancellation of such financing preferred shares in accordance with the relevant provisions of our articles of association. On July&nbsp;1, 2021, the powers of our Management Board will vest in our Board. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Capital Reduction </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At a general meeting, our shareholders may resolve on the proposal of our Management Board, which proposal will require the prior approval of
our Supervisory Board to reduce our issued share capital by (i)&nbsp;cancelling ordinary shares or (ii)&nbsp;reducing the nominal value of the ordinary shares by amending our articles of association. In either case, this reduction would be subject
to applicable statutory provisions. A resolution to cancel ordinary shares may only relate to (i)&nbsp;ordinary shares held by us or in respect of which we hold the depository receipts, or (ii)&nbsp;all financing preferred shares of a class if
approved by the holders of all shares of that class. In order to be approved by our general meeting, a resolution to reduce the capital requires approval of a majority of the votes cast at a general meeting if at least 50% of the issued share
capital is represented at such meeting or at least 66 2/3% of the votes cast at a general meeting if less than 50% of the issued share capital is represented at such meeting. On July&nbsp;1, 2021, the powers of our Management Board will vest in our
Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A reduction of the nominal value of ordinary shares without repayment and without release from the obligation to pay up the
ordinary shares must be effectuated proportionally on shares of the same class (unless all affected shareholders agree to a disproportional reduction). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A resolution that would result in a reduction of capital requires approval by a majority of the votes cast of each group of shareholders of
the same class whose rights are prejudiced by the reduction. In addition, a reduction of capital involves a <FONT STYLE="white-space:nowrap">two-month</FONT> waiting period during which creditors have the right to object to a reduction of capital
under specified circumstances. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General Meeting of Shareholders and Voting Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>General Meeting of Shareholders </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">General meetings are held in Amsterdam, Rotterdam, The Hague, Arnhem, Utrecht, or in the municipality of Haarlemmermeer (Schiphol Airport), the
Netherlands. All of our shareholders and others entitled to attend our general meetings are authorized to address the meeting and, in so far as they have such right, to vote, either in person or by proxy. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">154 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">However, due to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic several
restrictions have been implied in the Netherlands. It is possible that we will deviate from our articles of association and/or the Dutch Civil Code, as permitted under the emergency bill Temporary Measures in the Field of the Ministry of Justice and
Security in connection with the Outbreak of <FONT STYLE="white-space:nowrap">COVID-19</FONT> (<I>Tijdelijke Wet <FONT STYLE="white-space:nowrap">COVID-19</FONT> Justitie</I><I></I><I>&nbsp;&amp; Veiligheid</I>) as extended or amended from time to
time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will hold at least one general meeting each year, to be held within six months after the end of its financial year. A general
meeting will also be held within three months after our Board has determined it to be likely that our equity has decreased to an amount equal to or lower than half of its <FONT STYLE="white-space:nowrap">paid-up</FONT> and <FONT
STYLE="white-space:nowrap">called-up</FONT> capital, in order to discuss the measures to be taken if so required. If our Board fails to hold such general meeting in a timely manner, each shareholder and other person entitled to attend our general
meeting may be authorized by the Dutch court to convene our general meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Management Board or our Supervisory Board or, after
July&nbsp;1, 2021, our Board may convene additional extraordinary general meetings of shareholders at its discretion, subject to the notice requirements described below. Pursuant to Dutch law, one or more shareholders and/or others entitled to
attend general meetings of shareholders, alone or jointly representing at least 10% of our issued share capital, may on their application be authorized by the Dutch court to convene a general meeting. The Dutch court will disallow the application if
(i)&nbsp;the applicants have not previously requested in writing that our Management Board or our Supervisory Board or, after July&nbsp;1, 2021, our Board convenes a shareholders&#146; meeting or (ii)&nbsp;our Management Board or our Supervisory
Board or, after July&nbsp;1, 2021, Board convenes a shareholders&#146; meeting or (ii)&nbsp;our Board has not taken the necessary steps so that the shareholders&#146; meeting could be held within six weeks after such request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The general meeting is convened by a notice, which includes an agenda stating the items to be discussed and the location and time of our
general meeting. For the annual general meeting the agenda will include, among other things, the adoption of our annual accounts, the appropriation of its profits or losses and proposals relating to the composition of and filling of any vacancies on
our Management Board, our Supervisory Board or, after July&nbsp;1, 2021, our Board. In addition, the agenda for a general meeting includes such additional items as determined by our Management Board, our Supervisory Board or, after July&nbsp;1,
2021, our Board. Pursuant to Dutch law, one or more shareholders and/or others entitled to attend general meetings of shareholders, alone or jointly representing at least 3% of the issued share capital, have the right to request the inclusion of
additional items on the agenda of shareholders&#146; meetings. Such requests must be made in writing, and may include a proposal for a shareholder resolution, and must be received by us no later than on the sixtieth (60<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP>) day before the day the relevant shareholders&#146; meeting is held. No resolutions will be adopted on items other than those which have been included in the agenda. Under our articles of
association, certain items can only be put on the agenda as a voting item by our Management Board or our Supervisory Board, after July&nbsp;1, 2021 our Board. Shareholders meeting the relevant requirements may still request the inclusion of such
items on the agenda as a discussion item. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will give notice of each general meeting by publication on its website and, to the extent
required by applicable law, in a Dutch daily newspaper with national distribution, and in any other manner that we may be required to follow in order to comply with Dutch law and applicable stock exchange and SEC requirements. We will observe the
statutory minimum convening notice period for a general meeting. Holders of registered shares may further be provided notice of the meeting in writing at their addresses as stated in its shareholders&#146; register. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to our articles of association and Dutch law, our Management Board, or, after July&nbsp;1, 2021, our Board may determine a record
date (<I>registratiedatum</I>) of 28 calendar days prior to a general meeting to establish which shareholders and others with meeting rights are entitled to attend and, if applicable, vote at our general meeting. The record date, if any, and the
manner in which shareholders can register and exercise their rights will be set out in the notice of our general meeting. Our articles of association provide that a shareholder must notify us in writing of his or her identity and his or her
intention to attend (or be represented at) our general meeting, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">155 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such notice to be received by us on the date set by our Management Board, or, after July&nbsp;1, 2021, our Board in accordance with our articles of association and as set forth in the convening
notice. If this requirement is not complied with or if upon request no proper identification is provided by any person wishing to enter our general meeting, the chairman of our general meeting may, in his or her sole discretion, refuse entry to the
shareholder or his or her proxy holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to our articles of association, our general meeting is chaired by the Chairman of our
Supervisory Board, who, nevertheless, may charge another person to preside over the meeting in his place even if he himself is present at the meeting. If the chairman of our Supervisory Board is absent and he has not charged another person to
preside over the meeting in his place, our general meeting will be presided over by the vice-chairman of our Supervisory Board. If both the chairman and the vice-chairman are absent, our Supervisory Directors present at the meeting will appoint one
of them to be chairman. In the absence of all Supervisory Directors, our general meeting will be presided over by the chief executive officer. If all Supervisory Directors and the chief executive officer are absent, our Managing Directors present at
the meeting will appoint one of them as chairman. If all Supervisory Directors and all Managing Directors are absent, our general meeting will appoint its chairman. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After July&nbsp;1, 2021, our general meeting will be presided over by the chairman of our Board, who, nevertheless, may charge another person
to preside over the meeting in his place even if he himself is present at the meeting. If the chairman of our Board is absent and he has not charged another person to preside over the meeting in his place, the directors present at the meeting will
appoint one of them to be chairman. In the absence of all directors, our general meeting will appoint its chairman. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Voting Rights
and Quorum </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with Dutch law and our articles of association, each ordinary share, irrespective of which class it
concerns, confers the right on the holder thereof to cast one vote at our general meeting. The voting rights attached to any ordinary shares held by us or our direct or indirect subsidiaries are suspended, unless the ordinary shares were encumbered
with a right of usufruct or a pledge in favor of a party other than us or a direct or indirect subsidiary before such ordinary shares were acquired by us or such a subsidiary, in which case, the other party may be entitled to exercise the voting
rights on the ordinary shares. We may not exercise voting rights for ordinary shares in respect of which we or a direct or indirect subsidiary has a right of usufruct or a pledge. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Voting rights may be exercised by shareholders or by a duly appointed proxy holder (the written proxy being acceptable to the chairman of our
general meeting) of a shareholder, which proxy holder need not be a shareholder. The holder of a usufruct or pledge on shares will have the voting rights attached thereto if so provided for when the usufruct or pledge was created. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under our articles of association, blank votes (votes where no choice has been made), abstentions and invalid votes will not be counted as
votes cast. However, shares in respect of which a blank vote or invalid vote has been cast and shares in respect of which the person with meeting rights who is present or represented at the meeting has abstained from voting are counted when
determining the part of the issued share capital that is present or represented at a general meeting. The chairman of our general meeting will determine the manner of voting and whether voting may take place by acclamation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Resolutions of the shareholders are adopted at a general meeting by a majority of votes cast, except where Dutch law or our articles of
association provide for a special majority in relation to specified resolutions. Our articles of association do not provide for a quorum requirement, subject to any provision of mandatory Dutch law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain restrictions in our articles of association, the determination during our general meeting made by the chairman of that
general meeting with regard to the results of a vote will be decisive. Our Board will keep a record of the resolutions passed at each general meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">156 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Amendment of Articles of Association </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At a general meeting, at the proposal of our Management Board, which proposals requires the prior approval of our Supervisory Board, our
general meeting may resolve to amend the articles of association. A resolution by the shareholders to amend the articles of association requires a majority of the votes cast. On July&nbsp;1, 2021, the powers of our Management Board will vest in our
Board. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Merger, Demerger and Dissolution </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the proposal of our Management Board, which proposal requires the prior approval of our Supervisory Board, our general meeting may resolve
with a majority of the votes cast (subject to certain exceptions) or with at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the votes cast if less than half of the issued capital is present or represented at our general meeting, to
legally merge or demerge the company within the meaning of Title 7, Book 2 of the Dutch Civil Code. On July&nbsp;1, 2021, the powers of our Management Board will vest in our Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our shareholders may at a general meeting, based on a proposal by our Management Board which proposal requires the prior approval of our
Supervisory Board, by means of a resolution passed by a majority of the votes cast resolve that the company will be dissolved. In the event of dissolution of the company, the liquidation will be effected by our Managing Directors, under the
supervision of our Supervisory Board unless our general meeting decides otherwise. After July&nbsp;1, 2021, the liquidation will be effected by our Executive Directors, under the supervision of our
<FONT STYLE="white-space:nowrap">Non-Executive</FONT> Directors, unless our general meeting decides otherwise. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I><FONT
STYLE="white-space:nowrap">Squeeze-Out</FONT> </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A shareholder who for its own account (or together with its group companies) holds
at least 95% of our issued share capital may institute proceedings against the other shareholders jointly for the transfer of their shares to the shareholder who holds such 95% majority. The proceedings are held before the Enterprise Chamber of the
Amsterdam Court of Appeal (<I>Ondernemingskamer van het Gerechtshof Amsterdam</I>) (the &#147;<I>Enterprise Chamber</I>&#148;) and can be instituted by means of a writ of summons served upon each of the minority shareholders in accordance with the
provisions of the Dutch Code of Civil Procedure (<I>Wetboek van Burgerlijke Rechtsvordering</I>). The Enterprise Chamber may grant the claim for <FONT STYLE="white-space:nowrap">squeeze-out</FONT> in relation to all minority shareholders and will
determine the price to be paid for the shares, if necessary after appointment of one or three experts who will offer an opinion to the Enterprise Chamber on the value of the shares of the minority shareholders. Once the order to transfer by the
Enterprise Chamber becomes final and irrevocable, the majority shareholder that instituted the <FONT STYLE="white-space:nowrap">squeeze-out</FONT> proceedings will give written notice of the date and place of payment and the price to the holders of
the shares to be acquired whose addresses are known to the majority shareholder. Unless the addresses of all minority shareholders are known to the majority shareholder acquiring the shares, the majority shareholder is required to publish the same
in a newspaper with a national circulation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A shareholder that holds a majority of our issued share capital, but less than the 95%
required to institute the <FONT STYLE="white-space:nowrap">squeeze-out</FONT> proceedings described above, may seek to propose and implement one or more restructuring transactions with the objective of obtaining at least 95% of our issued share
capital so the shareholder may initiate <FONT STYLE="white-space:nowrap">squeeze-out</FONT> proceedings. Those restructuring transactions could, among other things, include a merger or demerger involving the company, a contribution of cash and/or
assets against issuance of ordinary shares, the issue of new ordinary shares to the majority shareholder without preemptive rights for minority shareholders or an asset sale transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Depending on the circumstances, an asset sale of a Dutch public limited liability company (<I>naamloze vennootschap</I>) is sometimes used as
a way to squeeze out minority shareholders, for example, after a successful tender offer through which a third party acquires a supermajority, but less than all, of the company&#146;s shares. In such a scenario, the business of the target company is
sold to a third party or a special purpose vehicle, followed by the liquidation of the target company. The purchase price is distributed to all shareholders in proportion to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">157 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
their respective shareholding as liquidation proceeds, thus separating the business from the company in which minority shareholders had an interest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any sale or transfer of all of our assets and our dissolution or liquidation is subject to approval by a majority of the votes cast in its
general meeting. Our articles of association provide that our general meeting may only adopt such resolution upon a proposal of our Management Board, which proposal requires the prior approval of our Supervisory Board. On July&nbsp;1, 2021, the
powers of our Management Board will vest in our Board. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Certain Other Major Transactions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our articles of association and Dutch law provide that resolutions of our Management Board, or, after July&nbsp;1, 2021, our Board concerning a
material change in our identity, character or business are subject to the approval of our general meeting. Such changes include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a transfer of all or materially all of its business to a third party; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the entry into or termination of a long-lasting alliance of the company or of a subsidiary either with another
entity or company, or as a fully liable partner of a limited partnership or partnership, if this alliance or termination is of significant importance to the company; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the acquisition or disposition of an interest in the capital of a company by the company or by its subsidiary
with a value of at least <FONT STYLE="white-space:nowrap">one-third</FONT> of the value of our assets, according to the balance sheet with explanatory notes or, if the company prepares a consolidated balance sheet, according to the consolidated
balance sheet with explanatory notes in our most recently adopted annual accounts. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dividends and Other Distributions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may only make distributions to our shareholders if our equity exceeds the aggregate amount of the issued share capital and the reserves
which must be maintained pursuant to Dutch law or by our articles of association. Under our articles of association, any profits or distributable reserves must first be applied to pay a dividend on the financing preferred shares, if outstanding.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any remaining profits may be reserved by the Management Board subject to the approval of the Supervisory Board or, after July&nbsp;1,
2021, the Board. After reservation by our Management Board of any distributable profits, our general meeting will be authorized to declare distributions on the proposal of our Management Board which proposal will require the prior approval of our
Supervisory Board. Our Management Board is permitted, subject to approval of our Supervisory Board and certain requirements, to declare interim dividends without the approval of the shareholders. Interim dividends may be declared as provided in our
articles of association and may be distributed to the extent that the shareholders&#146; equity, based on interim financial statements, exceeds the <FONT STYLE="white-space:nowrap">paid-up</FONT> and <FONT STYLE="white-space:nowrap">called-up</FONT>
share capital and the reserves that must be maintained under Dutch law or our articles of association. We may reclaim any distributions, whether interim or not interim, made in contravention of certain restrictions of Dutch law from shareholders
that knew or should have known that such distribution was not permissible. In addition, on the basis of Dutch case law, if after a distribution we are not able to pay its due and collectable debts, then our shareholders or directors who at the time
of the distribution knew or reasonably should have foreseen that result may be liable to its creditors. On July&nbsp;1, 2021, the powers of our Management Board will vest in our Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon proposal of the Management Board, the general meeting may determine that distributions will be made in whole or in part in a currency
other than the Euro. We shall announce any proposal for a distribution and the date when and the place where the distribution will be payable to all shareholders by electronic means of communication with due observance of the applicable law and
stock exchange rules. Claims for payment of dividends and other distributions not made within five years from the date that such dividends or distributions </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">158 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
became payable will lapse, and any such amounts will be considered to have been forfeited to the company (<I>verjaring).</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not anticipate paying any dividends on ordinary shares for the foreseeable future. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Warrants </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2020,
there were 7,187,500 warrants outstanding. The warrants entitle the holder to purchase one ordinary share at an exercise price of $11.50 per share. The warrants will expire five years after the completion of the Business Combination or earlier upon
redemption or liquidation in accordance with their terms. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notices </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will give notice of each general meeting by publication on its website and, to the extent required by applicable law, in a Dutch daily
newspaper with national distribution, and in any other manner that we may be required to follow in order to comply with Dutch law and applicable stock exchange and SEC requirements. Holders of registered shares may further be provided notice of the
meeting in writing at their addresses as stated in its shareholders&#146; register. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_49"></A>C. Material Contracts </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise disclosed in this Annual Report (including the exhibits thereto), we are not currently, and have not been in the last two
years, party to any material contract, other than contracts entered into in the ordinary course of business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_50"></A>D. Exchange
Controls </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under Dutch law, there are no exchange controls applicable to the transfer to persons outside of the Netherlands of dividends
or other distributions with respect to, or of the proceeds from the sale of, shares of a Dutch company, subject to applicable restrictions under sanctions and measures, including those concerning export control, pursuant to applicable resolutions
adopted by the United Nations, regulations of the European Union, the Sanctions Act 1977 (<I>Sanctiewet 1977</I>), national emergency legislation, or other legislation, applicable anti-boycott regulations and similar rules. Pursuant to the Dutch
Foreign Financial Relations Act 1994 (<I>Wet financi&euml;le betrekkingen buitenland 1994</I>) entities could be obliged to provide certain financial information to the Dutch Central Bank for statistical purposes only. The European Directive
Mandatory Disclosure Rules (2011/16/EU) in relation to cross-border tax arrangements can provide for future notification requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under German law, there are no exchange controls restricting the transfer of funds between Germany and other countries or individuals subject
to applicable restrictions concerning import or export control or sanctions and measures against certain persons, entities and countries subject to embargoes in accordance with German law and applicable resolutions adopted by the United Nations and
the European Union. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under German foreign trade regulation, with certain exceptions, every corporation or individual residing in Germany
must report to the German Central Bank on any payment received from or made to a <FONT STYLE="white-space:nowrap">non-resident</FONT> corporation or individual if the payment exceeds &#128;12,500 (or the equivalent in a foreign currency).
Additionally, corporations and individuals residing in Germany must report to the German Central Bank on any claims of a resident against, or liabilities payable to, a <FONT STYLE="white-space:nowrap">non-resident</FONT> corporation or individual
exceeding an aggregate of &#128;5&nbsp;million (or the equivalent in a foreign currency) at the end of any calendar month. Resident corporations and individuals are also required to report annually to the German Central Bank on any stakes of 10% or
more they hold in the equity of <FONT STYLE="white-space:nowrap">non-resident</FONT> corporations with total assets of more than &#128;3&nbsp;million. Corporations residing in Germany with assets in excess of &#128;3&nbsp;million must report
annually to the German Central Bank on any stake of 10% or more in the company held by an individual or a corporation located outside Germany. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">159 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_51"></A>E. Taxation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Material U.S. Federal Income Tax Considerations for U.S. Holders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a description of the material U.S. federal income tax consequences to the U.S. Holders (as defined below) described below of
owning and disposing of our ordinary shares or warrants. It is not a comprehensive description of all tax considerations that may be relevant to a particular person&#146;s decision to acquire ordinary shares or warrants. This discussion does not
address consequences from a fundamental change (as described in the warrant terms) to a U.S. Holder of warrants. This discussion applies only to a U.S. Holder that is an initial purchaser of ordinary shares or warrants and that holds our ordinary
shares or warrants as a capital asset for tax purposes (generally, property held for investment). In addition, it does not describe all of the tax consequences that may be relevant in light of a U.S. Holder&#146;s particular circumstances, including
state and local tax consequences, estate tax consequences, alternative minimum tax consequences, the potential application of the Medicare contribution tax, and tax consequences applicable to U.S. Holders subject to special rules, such as: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain financial institutions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">mutual funds and pension plans; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">U.S. expatriates and certain former citizens or long-term residents of the United States; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">dealers or traders in securities who use a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-market</FONT></FONT> method of tax accounting; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons holding ordinary shares or warrants as part of a hedging transaction, &#147;straddle,&#148;
&#147;hedge,&#148; &#147;conversion,&#148; &#147;synthetic security,&#148; &#147;constructive ownership transaction,&#148; &#147;constructive sale&#148; or other integrated transaction for U.S. federal income tax purposes; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons whose &#147;functional currency&#148; for U.S. federal income tax purposes is not the U.S. dollar;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">tax-exempt</FONT> entities (including private foundations) or government
organizations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">S corporations, partnerships, or other entities or arrangements classified as partnerships for U.S. federal
income tax purposes; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulated investment companies or real estate investment trusts; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">trusts and estates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons who acquired our ordinary shares or warrants pursuant to the exercise of any employee stock option or
otherwise as compensation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons holding our ordinary shares or warrants in connection with a trade or business, permanent establishment,
or fixed base outside the United States; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons who own (directly or through attribution) 10% or more (by vote or value) of our outstanding ordinary
shares. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an entity that is classified as a partnership for U.S. federal income tax purposes holds ordinary shares or
warrants, the U.S. federal income tax treatment of a partner will generally depend on the status of the partner and the activities of the partnership. Partnerships holding ordinary shares or warrants and partners in such partnerships are encouraged
to consult their tax advisors as to the particular U.S. federal income tax consequences of holding and disposing of ordinary shares or warrants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This discussion is based on the Internal Revenue Code of 1986, as amended (the &#147;Code&#148;), administrative pronouncements, judicial
decisions, final, temporary and proposed Treasury Regulations, all as of the date hereof, changes to any of which may affect the tax consequences described herein&#151;possibly with retroactive effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">160 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A &#147;U.S. Holder&#148; is a person who, for U.S. federal income tax purposes, is a
beneficial owner of ordinary shares and is: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) An individual who is a citizen or individual resident of the United States; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) a corporation, or other entity taxable as a corporation, created or organized in or under the laws of the United States, any state
therein or the District of Columbia; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) an estate the income of which is subject to U.S. federal income taxation regardless of its
source; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) a trust if (1)&nbsp;a U.S. court is able to exercise primary supervision over the administration of the trust and one or
more U.S. persons have authority to control all substantial decisions of the trust or (2)&nbsp;the trust has a valid election to be treated as a U.S. person under applicable U.S. Treasury Regulations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">PERSONS CONSIDERING AN INVESTMENT IN ORDINARY SHARES OR WARRANTS SHOULD CONSULT THEIR OWN TAX ADVISORS AS TO THE PARTICULAR TAX CONSEQUENCES
APPLICABLE TO THEM RELATING TO THE ACQUISITION, OWNERSHIP AND DISPOSITION OF THE ORDINARY SHARES, INCLUDING THE APPLICABILITY OF U.S. FEDERAL, STATE AND LOCAL TAX LAWS. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Taxation of Distributions on Ordinary Shares </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the discussion below under &#147;Passive Foreign Investment Company Rules,&#148; distributions paid on ordinary shares, other than
certain pro rata distributions of ordinary shares or rights to acquire ordinary shares, will generally be treated as dividends to the extent paid out of our current or accumulated earnings and profits (as determined under U.S. federal income tax
principles). Distributions in excess of our current and accumulated earnings and profits will constitute a return of capital that will be applied against and reduce (but not below zero) the U.S. Holder&#146;s adjusted tax basis in its ordinary
shares. Any remaining excess will be treated as gain realized on the sale or other disposition of the ordinary shares and will be treated as described below under &#147;Sale or Other Taxable Disposition of Ordinary Shares.&#148; Subject to
applicable limitations, amounts treated as dividend income to certain <FONT STYLE="white-space:nowrap">non-corporate</FONT> U.S. Holders may be taxable at preferential rates applicable to &#147;qualified dividend income&#148; if we are a
&#147;qualified foreign corporation&#148; and certain other requirements are met. However, the qualified dividend income treatment will not apply if we are treated as a PFIC (as defined below) with respect to the U.S. Holder or if we are a PFIC for
the taxable year in which the dividend is paid or the preceding taxable year. The amount of any such distribution will include any amounts withheld by us (or another applicable withholding agent), which, as described below under the heading
&#147;&#151;Material German Tax Considerations&#151;Taxation of Dividends,&#148; is expected to be in respect of German, and not Dutch, income taxes. The amount of the dividend will be treated as foreign-source dividend income to U.S. Holders and
will not be eligible for the dividends-received deduction generally available to U.S. corporations under the Code. Dividends will generally be included in a U.S. Holder&#146;s income on the date of the U.S. Holder&#146;s receipt of the dividend. The
amount of any dividend income paid in foreign currency will be the U.S. dollar amount calculated by reference to the exchange rate in effect on the date of actual or constructive receipt, regardless of whether the payment is in fact converted into
U.S. dollars. If the dividend is converted into U.S. dollars on the date of receipt, a U.S. Holder should not be required to recognize foreign currency gain or loss in respect of the dividend income. A U.S. Holder may have foreign currency gain or
loss if the dividend is converted into U.S. dollars after the date of receipt. Such gain or loss would generally be treated as U.S.-source ordinary income or loss. The amount of any distribution of property other than cash (and other than certain
pro rata distributions of ordinary shares or rights to acquire ordinary shares) will be the fair market value of such property on the date of distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For foreign tax credit limitation purposes, our dividends will generally be treated as passive category income. The rules governing foreign
tax credits are complex and U.S. Holders should therefore consult their tax advisors regarding the effect of the receipt of dividends for foreign tax credit limitation purposes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">161 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to applicable limitations, German income taxes withheld from dividends on common
shares at a rate not exceeding the rate provided by the income tax treaty between Germany and the United States will be eligible for credit against the U.S. Holder&#146;s federal income tax liability. German taxes withheld in excess of the rate
applicable under such treaty will not be eligible for credit against a U.S. Holder&#146;s federal income tax liability. The rules governing foreign tax credits are complex and U.S. Holders are urged to consult their tax advisors regarding the
creditability of foreign taxes in their particular circumstances. In lieu of claiming a foreign tax credit, a U.S. Holder may deduct foreign taxes, including any German income tax, in computing their taxable income, subject to generally applicable
limitations under U.S. law. An election to deduct foreign taxes instead of claiming foreign tax credits applies to all foreign taxes paid or accrued in the taxable year. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Sale or Other Taxable Disposition of Ordinary Shares </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the discussion below under &#147;Passive Foreign Investment Company Rules,&#148; gain or loss realized on the sale or other taxable
disposition of ordinary shares will be capital gain or loss, and will be long-term capital gain or loss if the U.S. Holder held the ordinary shares for more than one year at the time of sale or other taxable disposition. The amount of the gain or
loss will equal the difference between the U.S. Holder&#146;s tax basis in the ordinary shares disposed of and the amount realized on the disposition. This gain or loss will generally be U.S.-source gain or loss for foreign tax credit purposes.
Subject to the PFIC rules described below, long-term capital gains recognized by certain <FONT STYLE="white-space:nowrap">non-corporate</FONT> U.S. Holders (including individuals) will generally be subject to reduced rates of U.S. federal income
tax. The deductibility of capital losses is subject to limitations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Sale or Other Taxable Disposition, Exercise or Expiration of
Warrants </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the discussion below under &#147;Passive Foreign Investment Company Rules,&#148; gain or loss realized on the
sale or other taxable disposition of warrants (other than by way of exercise) will be capital gain or loss and will be long-term capital gain or loss if the U.S. Holder held the warrants for more than one year at the time of the sale or disposition.
The amount of the gain or loss will equal the difference between the U.S. Holder&#146;s tax basis in the warrants disposed of and the amount realized on the disposition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In general, a U.S. Holder will not be required to recognize income, gain or loss upon the exercise of warrants by payment of the exercise
price in cash. A U.S. Holder&#146;s tax basis in the ordinary share received upon exercise of a warrant will be equal to the sum of (1)&nbsp;the U.S. Holder&#146;s tax basis in the warrant and (2)&nbsp;the exercise price of the warrant. It is
unclear under current law whether a U.S. Holder&#146;s holding period in the ordinary share received upon exercise will commence on the day the warrant is exercised or the day after the warrant is exercised, but in any case, it will not include the
period during which the U.S. Holder held the warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although there is no direct legal authority as to the U.S. federal income tax
treatment of an exercise of a warrant on a cashless basis, we believe that it is reasonable to take the position that such exercise will not be taxable (except with respect to cash received in lieu of a fractional ordinary share), either because the
exercise is not a gain realization event or because it qualifies as a <FONT STYLE="white-space:nowrap">tax-free</FONT> recapitalization. In the former case, subject to the discussion below under &#147;Passive Foreign Investment Company Rules,&#148;
the holding period of the ordinary shares would commence either on the day the warrant is exercised or the day after the warrant is exercised. In the latter case, the holding period of the ordinary shares would include the holding period of the
exercised warrants. In either case, the U.S. Holder&#146;s tax basis in the ordinary shares (including any fractional ordinary share) received generally would equal the U.S. Holder&#146;s tax basis in the warrants. However, such position regarding
the treatment of a cashless exercise is not binding on the Internal Revenue Service, or the IRS, and the IRS may treat a cashless exercise of a warrant as a taxable exchange. U.S. Holders are urged to consult their tax advisers as to the
consequences of an exercise of a warrant on a cashless basis. The receipt of cash in lieu of a fractional ordinary share should result in a capital gain or loss equal to the difference between the cash received and the U.S. Holder&#146;s tax basis
in the ordinary shares allocable to the fractional share. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">162 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a warrant expires without being exercised, a U.S. Holder will recognize a capital loss in
an amount equal to such U.S. Holder&#146;s tax basis in the warrant. This loss will be long-term capital loss if, at the time of the expiration, the U.S. Holder&#146;s holding period in the warrant is more than one year. The deductibility of capital
losses is subject to limitations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Possible Constructive Distributions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The terms of each warrant provide for an adjustment to the exercise price of the warrant in certain events (including the payment of certain
dividends and distributions to holders of ordinary shares). An adjustment which has the effect of preventing dilution generally is not taxable. The U.S. Holders of the warrants would, however, be treated as receiving a constructive distribution from
us if, for example, the adjustment to the number of such shares or to such exercise price increases the warrant holders&#146; proportionate interest in our assets or earnings and profits (e.g., through a decrease in the exercise price of the
warrant) as a result of a distribution of cash or other property, such as other securities, to the holders of shares of our ordinary shares, or as a result of the issuance of a stock dividend to holders of shares of our ordinary shares, in each case
which is taxable to the U.S. Holders of such shares as a distribution. Such constructive distribution would be subject to tax in the same manner as if the U.S. Holders of the warrants received a cash distribution from us equal to the fair market
value of such increased interest resulting from the adjustment. Generally, a U.S. Holder&#146;s adjusted tax basis in its warrant would be increased to the extent any such constructive distribution is treated as a dividend. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Passive Foreign Investment Company Rules </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not believe that we should be treated as a PFIC for the year ended December&nbsp;31, 2020 and 2019. Because the determination of our PFIC
status is made annually based on the factual tests described below, however, we cannot provide any assurances regarding our PFIC status for the current or future taxable years or that the IRS will agree with our conclusion regarding our PFIC status.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we are classified as a passive foreign investment company under Section&nbsp;1297 of the Code (a &#147;PFIC&#148;) in any taxable
year, a U.S. Holder will be subject to special rules generally intended to reduce or eliminate any benefits from the deferral of U.S. federal income tax that a U.S. Holder could derive from investing in a
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> company that does not distribute all of its earnings on a current basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> corporation will be classified as a PFIC for any taxable year in which, after applying certain look-through rules, either: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at least 75% of its gross income is passive income (such as income from dividends, interest, rent, royalties and
certain gains) (the &#147;Income Test&#148;); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at least 50% of its gross assets (determined on the basis of a quarterly average) is attributable to assets that
produce passive income or are held for the production of passive income (the &#147;Asset Test&#148;). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is uncertain
whether we or any of our subsidiaries, including Immatics OpCo, will be treated as a PFIC for U.S. federal income tax purposes for 2020 or for the current or any subsequent taxable year. The determination of whether we are a PFIC is a fact-intensive
determination made on an annual basis applying principles and methodologies that in some circumstances are unclear and subject to varying interpretation. Under the Income Test, our status as a PFIC depends on the composition of our income which will
depend on the transactions we enter into in the future and our corporate structure. The composition of our income and assets is also affected by our market capitalization value (which depends on the market price of our ordinary shares and may be
volatile) and by the spending of the cash we raise in any offering, including this offering. Because PFIC status is based on our income, assets, and activities for the entire taxable year, it is not possible to determine whether we will be
characterized as a PFIC for any taxable year until after the close of the relevant taxable year. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">163 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we are classified as a PFIC in any year with respect to which a U.S. Holder owns the
ordinary shares (or, under proposed Treasury regulations that apply retroactively, warrants), we will continue to be treated as a PFIC with respect to such U.S. Holder in all succeeding years during which the U.S. Holder owns the ordinary shares
(or, under proposed Treasury regulations, warrants), regardless of whether we continue to meet the tests described above unless (i)&nbsp;we cease to be a PFIC and the U.S. Holder has made a &#147;deemed sale&#148; election under the PFIC rules, or
(ii)&nbsp;the U.S. Holder makes a QEF Election (as defined below) with respect to all taxable years during such U.S. Holder&#146;s holding period in which we are a PFIC. If the &#147;deemed sale&#148; election is made, a U.S. Holder will be deemed
to have sold the ordinary shares (or, under proposed Treasury regulations, warrants) the U.S. Holder holds at their fair market value and any gain from such deemed sale would be subject to the rules described below. After the deemed sale election,
so long as we do not become a PFIC in a subsequent taxable year, the U.S. Holder&#146;s ordinary shares (or, under proposed Treasury regulations, warrants) with respect to which such election was made will not be treated as shares in a PFIC and the
U.S. Holder will not be subject to the rules described below with respect to any &#147;excess distribution&#148; the U.S. Holder receives from us or any gain from an actual sale or other disposition of the ordinary shares (or, under proposed
Treasury regulations, warrants). U.S. Holders should consult their tax advisors as to the possibility and consequences of making a deemed sale election if we cease to be a PFIC and such election becomes available. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For each taxable year we are treated as a PFIC with respect to U.S. Holders, U.S. Holders will be subject to special tax rules with respect to
any &#147;excess distribution&#148; such U.S. Holder receives and any gain such U.S. Holder recognizes from a sale or other disposition (including, under certain circumstances, a pledge) of ordinary shares, unless (i)&nbsp;such U.S. Holder makes a
QEF Election (as defined below) (which is generally not available with respect to warrants) or (ii)&nbsp;our ordinary shares constitute &#147;marketable&#148; securities, and such U.S. Holder makes a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">mark-to-market</FONT></FONT> election as discussed below (which is also generally not available to warrants). Distributions a U.S. Holder receives in a taxable year that are greater than 125% of the average annual
distributions a U.S. Holder received during the shorter of the three preceding taxable years or the U.S. Holder&#146;s holding period for the ordinary shares (or, under proposed Treasury regulations, warrants) will be treated as an excess
distribution. Under these special tax rules: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the excess distribution or gain will be allocated ratably over a U.S. Holder&#146;s holding period for ordinary
shares (or, under proposed Treasury regulations, warrants); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the amount allocated to the taxable year of disposition, and any taxable year prior to the first taxable year in
which we became a PFIC, will be treated as ordinary income; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the amount allocated to each other year will be subject to the highest tax rate in effect for that year for
individuals or corporations, as appropriate, and the interest charge generally applicable to underpayments of tax will be imposed on the resulting tax attributable to each such year. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The tax liability for amounts allocated to years prior to the year of disposition or &#147;excess distribution&#148; cannot be offset by any
net operating losses for such years, and gains (but not losses) realized on the sale of the ordinary shares or warrants cannot be treated as capital, even if a U.S. Holder holds the ordinary shares or warrants as capital assets. Under proposed
Treasury regulations, if we were a PFIC during any taxable year during which a U.S. Holder held our warrants, the holding period for the ordinary shares received upon exercise of such warrants would include the holding period of the warrants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we are a PFIC, a U.S. Holder will generally be subject to similar rules with respect to distributions we receive from, and our dispositions
of the stock of, any of our direct or indirect subsidiaries that also are PFICs, as if such distributions were indirectly received by, and/or dispositions were indirectly carried out by, such U.S. Holder. U.S. Holders should consult their tax
advisors regarding the application of the PFIC rules to our subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain elections exist that may alleviate some of the adverse
consequences of PFIC status and would result in an alternative treatment of the ordinary shares. A U.S. Holder may avoid the general tax treatment for PFICs </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">164 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
described above by electing to treat us as a &#147;qualified electing fund&#148; under Section&nbsp;1295 of the Code (a &#147;QEF,&#148; and such election, a &#147;QEF Election&#148;) for each of
the taxable years during the U.S. Holder&#146;s holding period that we are a PFIC. If a QEF Election is not in effect for the first taxable year in the U.S. Holder&#146;s holding period in which we are a PFIC, a QEF Election generally can only be
made if the U.S. Holder elects to make an applicable deemed sale or deemed dividend election on the first day of its taxable year in which the PFIC becomes a QEF pursuant to the QEF Election. The deemed gain or deemed dividend recognized with
respect to such an election would be subject to the general tax treatment of PFICs discussed above. In order to comply with the requirements of a QEF Election, a U.S. Holder must receive a PFIC Annual Information Statement from us. We intend to
provide the information necessary for U.S. Holders to make or maintain a QEF Election, including information necessary to determine the appropriate income inclusion amounts for purposes of the QEF Election. However, there is also no assurance that
we will have timely knowledge of our status as a PFIC in the future or of the required information to be provided. A QEF Election cannot be made with respect to the warrants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a U.S. Holder makes a QEF Election with respect to a PFIC, it will be taxed currently on its pro rata share of the PFIC&#146;s ordinary
earnings and net capital gain (at ordinary income and capital gain rates, respectively) for each taxable year that the entity is a PFIC, even if no distributions were received. Any distributions we make out of our earnings and profits that were
previously included in such a U.S. Holder&#146;s income under the QEF Election would not be taxable to such U.S. Holder. Such U.S. Holder&#146;s tax basis in its ordinary shares would be increased by an amount equal to any income included under the
QEF Election and decreased by any amount distributed on the ordinary shares that is not included in its income. In addition, a U.S. Holder will recognize capital gain or loss on the disposition of its ordinary shares in an amount equal to the
difference between the amount realized and its adjusted tax basis in the ordinary shares, each as determined in U.S. dollars. Once made, a QEF Election remains in effect unless invalidated or terminated by the IRS or revoked by the shareholder. A
QEF Election can be revoked only with the consent of the IRS. A U.S. Holder will not be currently taxed on the ordinary income and net capital gain of a PFIC with respect to which a QEF Election was made for any taxable year of the <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> corporation that such corporation does not satisfy the Income Test or Asset Test. Each U.S. Holder should consult its tax advisor regarding the availability of, and procedure for making, any deemed gain,
deemed dividend or QEF Election. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Alternatively, U.S. Holders can avoid the interest charge on excess distributions or gain relating to
the ordinary shares by making a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-market</FONT></FONT> election with respect to the ordinary shares, provided that the ordinary shares constitute &#147;marketable stock.&#148;
&#147;Marketable stock&#148; is, generally, stock that is &#147;regularly traded&#148; on certain U.S. stock exchanges or on a foreign stock exchange that meets certain conditions. For these purposes, the ordinary shares will be considered regularly
traded during any calendar year during which they are traded, other than in de minimis quantities, on at least 15 days during each calendar quarter. Any trades that have as their principal purpose meeting this requirement will be disregarded. Our
ordinary shares are listed on Nasdaq, which is a qualified exchange for these purposes. Consequently, if our ordinary shares remain listed on Nasdaq and are regularly traded (as to which there can be no assurance), and you are a U.S. Holder of
ordinary shares, we expect the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-market</FONT></FONT> election would be available to you if we are a classified as a PFIC. Each U.S. Holder should consult its tax advisor as to
the whether a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-market</FONT></FONT> election is available or advisable with respect to the ordinary shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A U.S. Holder that makes a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-market</FONT></FONT> election must
include in ordinary income for each year an amount equal to the excess, if any, of the fair market value of the ordinary shares at the close of the taxable year over the U.S. Holder&#146;s adjusted tax basis in the ordinary shares. An electing
holder may also claim an ordinary loss deduction for the excess, if any, of the U.S. Holder&#146;s adjusted basis in the ordinary shares over the fair market value of the ordinary shares at the close of the taxable year, but this deduction is
allowable only to the extent of any net <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-market</FONT></FONT> gains for prior years. Gains from an actual sale or other disposition of the ordinary shares will be treated as
ordinary income, and any losses incurred on a sale or other disposition of the shares will be treated as an ordinary loss to the extent of any net <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-market</FONT></FONT> gains
for prior years. Once made, the election cannot be revoked without the consent of the IRS, unless the ordinary shares cease to be marketable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">165 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">However, a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-market</FONT></FONT> election generally cannot be made for equity interests in any lower-tier PFICs that we own, unless shares of such lower-tier PFIC are themselves
&#147;marketable.&#148; As a result, even if a U.S. Holder validly makes a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-market</FONT></FONT> election with respect to our ordinary shares, the U.S. Holder may continue to
be subject to the PFIC rules (described above) with respect to its indirect interest in any of our investments that are treated as an equity interest in a PFIC for U.S. federal income tax purposes. In addition, under current law, a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-market</FONT></FONT> election is not available with respect to the warrants. U.S. Holders should consult their tax advisors to determine whether any of these elections would be
available and if so, what the consequences of the alternative treatments would be in their particular circumstances. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise
provided by the IRS, each U.S. Holder who owns shares and/or warrants in a PFIC is required to file an annual report containing such information as the IRS may require. A U.S. Holder&#146;s failure to file the annual report will cause the statute of
limitations for such U.S. Holder&#146;s U.S. federal income tax return to remain open with regard to the items required to be included in such report until three years after the U.S. Holder files the annual report, and, unless such failure is due to
reasonable cause and not willful neglect, the statute of limitations for the U.S. Holder&#146;s entire U.S. federal income tax return will remain open during such period. U.S. Holders should consult their tax advisors regarding the requirements of
filing such information returns under these rules. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WE STRONGLY URGE YOU TO CONSULT YOUR TAX ADVISOR REGARDING THE IMPACT OF OUR PFIC
STATUS ON YOUR INVESTMENT IN THE ORDINARY SHARES AS WELL AS THE APPLICATION OF THE PFIC RULES TO YOUR INVESTMENT IN THE ORDINARY SHARES. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Information Reporting and Backup Withholding </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payments of dividends and sales proceeds that are made within the United States or through certain U.S.-related financial intermediaries
generally are subject to information reporting, and may be subject to backup withholding, unless (i)&nbsp;the U.S. Holder is a corporation or other exempt recipient or (ii)&nbsp;in the case of backup withholding, the U.S. Holder provides a correct
taxpayer identification number and certifies that it is not subject to backup withholding on a duly executed IRS Form <FONT STYLE="white-space:nowrap">W-9</FONT> or otherwise establishes an exemption. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Backup withholding is not a separate tax. The amount of any backup withholding from a payment to a U.S. Holder may be allowed as a credit
against the U.S. Holder&#146;s U.S. federal income tax liability and may entitle the U.S. Holder to a refund, provided that the required information is timely furnished to the IRS. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Information with Respect to Foreign Financial Assets </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain U.S. Holders who are individuals (and, under regulations, certain entities) may be required to report information relating to the
ordinary shares or warrants, subject to certain exceptions (including an exception for assets held in accounts maintained by certain U.S. financial institutions), by filing IRS Form 8938 (Statement of Specified Foreign Financial Assets) with their
federal income tax return. Such U.S. Holders who fail to timely furnish the required information may be subject to a penalty. Additionally, if a U.S. Holder does not file the required information, the statute of limitations with respect to tax
returns of the U.S. Holder to which the information relates may not close until three years after such information is filed. U.S. Holders should consult their tax advisors regarding their reporting obligations with respect to their ownership and
disposition of the ordinary shares or warrants. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Material Dutch Tax Considerations </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Taxation in the Netherlands </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This section outlines the principal Dutch tax consequences of the acquisition, holding, settlement, redemption and disposal of ordinary shares.
It does not purport to present a comprehensive or complete </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">166 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
description of all aspects of Dutch tax law which could be of relevance to a holder of ordinary shares in the capital of Immatics, which we refer to as a shareholder. For Dutch tax purposes, a
shareholder may include an individual who, or an entity that, does not hold the legal title to the ordinary shares, but to whom, or to which, nevertheless the ordinary shares or the income thereof, are attributed based either on such individual or
entity owning a beneficial interest in the ordinary shares or based on specific statutory provisions. These include statutory provisions pursuant to which ordinary shares are attributed to an individual who is, or who has directly or indirectly
inherited from a person who was, the settlor, grantor or similar originator of a trust, foundation or similar entity that holds the ordinary shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This section is intended as general information only. A prospective shareholder should consult his own tax adviser regarding the tax
consequences of any acquisition, holding, redemption and disposal of ordinary shares. Except as otherwise provided, this section is based on Dutch tax law as applied and interpreted by Dutch tax courts and as published and in effect on the date of
this proxy statement/prospectus, including, for the avoidance of doubt, the tax rates applicable on the date hereof, without prejudice to any amendments introduced at a later date and implemented with or without retroactive effect. On this basis,
the statements included in this section are the opinion of CMS Derks Star Busmann N.V., Dutch counsel to Immatics. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any reference in this
section made to Dutch taxes, Dutch tax or Dutch tax law must be construed as a reference to any taxes of any nature levied by or on behalf of the Netherlands or any of its subdivisions or taxing authorities or to the law governing such taxes,
respectively. The Netherlands means the part of the Kingdom of the Netherlands located in Europe. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any reference hereafter made to a
treaty for the avoidance of double taxation concluded by the Netherlands includes the Tax Regulation for the Kingdom of the Netherlands (<I>Belastingregeling voor het Koninkrijk</I>), the Tax Regulations for the Netherlands and Curacao
(<I>Belastingregeling Nederland Cura&ccedil;ao</I>), the Tax Regulations for the Netherlands and Sint Maarten (<I>Belastingregeling Nederland Sint Maarten</I>), the Tax Regulation for the State of the Netherlands (<I>Belastingregeling voor het land
Nederland</I>) and the Agreement between the Taipei Representative Office in the Netherlands and the Netherlands Trade and Investment Office in Taipei for the avoidance of double taxation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This section does not describe any Dutch tax considerations or consequences that may be relevant to a shareholder: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) who is an individual and for whom the income or capital gains derived from the ordinary shares are attributable to employment activities,
the income from which is taxable in the Netherlands; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) who has, or that has, a substantial interest (<I>aanmerkelijk belang</I>) or a
fictitious substantial interest (<I>fictief aanmerkelijk belang</I>) in Immatics within the meaning of chapter 4 of the Dutch Income Tax Act 2001 (<I>Wet inkomstenbelasting 2001</I>). Generally, a shareholder has a substantial interest in Immatics
if such shareholder, alone or &#151; in case of an individual &#151; together with a partner for Dutch tax purposes, or any relative by blood or by marriage in the ascending or descending line (including foster-children) of either of them, directly
or indirectly: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. owns, or holds, or is deemed to own or hold, certain rights to shares representing 5% or more of the
total issued capital of Immatics, or of the issued and outstanding capital of any class of shares of Immatics; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. holds,
or is deemed to hold, rights to, directly or indirectly, acquire shares, whether or not already issued, representing 5% or more of the total issued capital of Immatics, or of the issued capital of any class of shares of Immatics; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. owns, or holds, or is deemed to own or hold, certain rights on profit participating certificates (<I>winstbewijzen</I>) that
relate to 5% or more of the annual profit of Immatics or to 5% or more of the liquidation proceeds of Immatics. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">167 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A shareholder who is an individual will also have a substantial interest if a partner for
Dutch tax purposes or any relative by blood or by marriage in the ascending or descending line (including foster-children) of either of them has a substantial interest in Immatics: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) that is an entity which is, pursuant to the Dutch Corporate Income Tax Act 1969 (<I>Wet op de vennootschapsbelasting 1969</I>) (the
&#147;<I>CITA</I>&#148;), not subject to Dutch corporate income tax or is in full or in part exempt from Dutch corporate income tax (such as a qualifying pension fund); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) that is an investment institution (<I>beleggingsinstelling</I>) as described in clause 6a or 28 CITA; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) that is required to apply the participation exemption (<I>deelnemingsvrijstelling</I>) with respect to the ordinary shares, or a
combination thereof (as defined in clause 13 CITA). Generally, a holding of ordinary shares is considered to qualify as a participation for the participation exemption if it represents a holding of, or right to acquire, an interest of 5% or more of
the nominal <FONT STYLE="white-space:nowrap">paid-up</FONT> share capital in Immatics. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Withholding Tax on Dividend Payments
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A shareholder is generally subject to Dutch dividend withholding tax at a rate of 15% on dividends distributed by Immatics.
Generally, Immatics is responsible for the withholding of such dividend withholding tax at source. However, a shareholder will not be subject to Dutch dividend withholding tax on dividends distributed by Immatics if, and for as long as, Immatics is
resident solely in Germany for purposes of the convention between Germany and the Netherlands for the avoidance of double taxation and the prevention of fiscal evasion with respect to taxes on income (the &#147;<I>German-Dutch tax treaty</I>&#148;),
unless: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the shareholder is a Dutch Individual (as defined below) or a Dutch Corporate Entity (as defined below); or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) the shareholder is a <FONT STYLE="white-space:nowrap">Non-Dutch</FONT> Individual (as defined below) or a
<FONT STYLE="white-space:nowrap">Non-Dutch</FONT> Corporate Entity (as defined below) and derives profits from an enterprise, which enterprise is, in whole or in part, carried on through a permanent establishment (<I>vaste inrichting</I>) or a
permanent representative (<I>vaste vertegenwoordiger</I>) in the Netherlands, to which the ordinary shares are attributable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The current
German-Dutch tax treaty stipulates that if a company is treated as tax resident of both the Netherlands and Germany it shall be treated as resident of the country in which it has its place of effective management for purposes of the treaty. It is
currently envisaged that Immatics shall have its place of effective management in Germany. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is currently uncertain what evidence,
information and documentation will be required by the Dutch tax authorities for purposes of accepting application of the German-Dutch tax treaty as described above, either at source or through a refund request by a shareholder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dividends distributed by Immatics include, but are not limited to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) distributions of profits in cash or in kind, whatever they be named or in whatever form; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) proceeds from the liquidation of Immatics or proceeds from the repurchase of ordinary shares by Immatics, other than as a temporary
portfolio investment (<I>tijdelijke belegging</I>), in excess of the average <FONT STYLE="white-space:nowrap">paid-in</FONT> capital recognized for Dutch dividend withholding tax purposes; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">168 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) the nominal value of ordinary shares issued to a shareholder or an increase in the
nominal value of ordinary shares, to the extent that no related contribution, recognized for Dutch dividend withholding tax purposes, has been made or will be made; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) partial repayment of <FONT STYLE="white-space:nowrap">paid-in</FONT> capital, that is not recognized for Dutch dividend withholding tax
purposes, or if recognized for Dutch dividend withholding tax purposes, to the extent that Immatics has &#147;net profits&#148;(<I>zuivere winst</I>), unless: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">a. the general meeting has resolved in advance to make such repayment; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">b. the nominal value of the ordinary shares concerned has been reduced with an equal amount by way of an amendment to the
articles of association of Immatics. The term &#147;net profits&#148; includes anticipated profits that have yet to be realized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a
shareholder is resident or deemed to be resident in the Netherlands, such shareholder is generally entitled to an exemption or a credit for any Dutch dividend withholding tax against his Dutch (corporate) income tax liability and to a refund of any
residual Dutch dividend withholding tax. Depending on his specific circumstances, a shareholder resident in a country other than the Netherlands, may be entitled to exemptions from, reduction of, or full or partial refund of, Dutch dividend
withholding tax pursuant to Dutch law, EU law or treaties for avoidance of double taxation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A shareholder that is resident (i)&nbsp;in an
EU member state, or (ii)&nbsp;in a state that is a party to the Agreement on the European Economic Area (&#147;EEA&#148;; Iceland, Liechtenstein or Norway), or (iii)&nbsp;in a designated third state with which the Netherlands has agreed to an
arrangement for the exchange of information on tax matters, is entitled to a full or partial refund of Dutch dividend withholding tax incurred in respect of ordinary shares if the final tax burden in respect of the dividends distributed by Immatics
of a comparable Dutch resident shareholder is lower than the withholding tax incurred by the <FONT STYLE="white-space:nowrap">non-Dutch</FONT> resident shareholder. The refund is granted upon request, and is subject to conditions and limitations. No
entitlement to a refund exists if the disadvantage for the <FONT STYLE="white-space:nowrap">non-Dutch</FONT> resident shareholder is entirely compensated in his state of residence under the provisions of a treaty for the avoidance of double taxation
concluded between this state of residence and the Netherlands. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">According to Dutch domestic anti-dividend stripping rules, no credit
against Dutch (corporate) income tax, exemption from, reduction in or refund of, Dutch dividend withholding tax will be granted if the recipient of the dividends paid by Immatics is not considered to be the beneficial owner (<I>uiteindelijk
gerechtigde</I>) of such dividends. The DWTA provides for a <FONT STYLE="white-space:nowrap">non-exhaustive</FONT> negative description of a beneficial owner. According to the DWTA, a shareholder will not be considered the beneficial owner of the
dividends if as a consequence of a combination of transactions: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">i. a person other than the shareholder wholly or partly, directly or
indirectly, benefits from the dividends; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ii. whereby this other person retains or acquires, directly or indirectly, an interest similar
to that in the ordinary shares on which the dividends were paid; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">iii. that other person is entitled to a credit, reduction or refund
of Dutch dividend withholding tax that is less than that of the shareholder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">169 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Taxes on Income and Capital Gains </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Residents of the Netherlands </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The description of certain Dutch tax consequences in this paragraph is only intended for the following shareholders: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) individuals who are resident or deemed to be resident in the Netherlands for Dutch income tax purposes (&#147;<I>Dutch
Individuals</I>&#148;); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) entities or enterprises that are subject to the CITA and are resident or deemed to be resident in the
Netherlands for corporate income tax purposes (&#147;<I>Dutch Corporate Entities</I>&#148;) </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Dutch Individuals Engaged or Deemed to Be
Engaged in an Enterprise or in Miscellaneous Activities </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dutch Individuals engaged or deemed to be engaged in an enterprise or who
derive income from miscellaneous activities (<I>resultaat uit overige werkzaamheden</I>) are generally subject to income tax at statutory progressive rates with a maximum of 49.5% on any benefits derived or deemed to be derived from the ordinary
shares, that are either attributable to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) an enterprise from which a Dutch Individual derives profits, whether as an entrepreneur
(<I>ondernemer</I>) or pursuant to a <FONT STYLE="white-space:nowrap">co-entitlement</FONT> (<I>medegerechtigde</I>) to the net worth of such enterprise other than as an entrepreneur or a shareholder; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) the benefits of which are attributable to miscellaneous activities, including, without limitation, activities which are beyond the scope
of active portfolio investment activities (<I>meer dan normaal vermogensbeheer</I>). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Dutch Individuals Not Engaged or Deemed to Be
Engaged in an Enterprise or in Miscellaneous Activities </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Generally, the ordinary shares held by a Dutch Individual who is not engaged
or deemed to be engaged in an enterprise or miscellaneous activities, or who is so engaged or deemed to be engaged but the ordinary shares are not attributable to that enterprise or miscellaneous activities, will be subject to annual income tax
imposed on a fictitious yield on the ordinary shares under the regime for savings and investments (<I>inkomen uit sparen en beleggen</I>). Irrespective of the actual income and capital gains realized the annual taxable benefit of all the assets and
liabilities of a Dutch Individual that are taxed under this regime, including the ordinary shares, is set at a percentage of the positive balance of the fair market value of these assets, including the ordinary shares and the fair market value of
these liabilities. The percentage, which is annually indexed, increases: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) from 1.898% over the first &#128;50,000; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) to 4.501% over &#128;50,000 up to and including &#128;950,000; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) to a maximum of 5.69% over &#128;950,000 or higher. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No taxation occurs if this positive balance does not exceed a certain threshold (<I>heffingvrij vermogen</I>), which is &#128;50,000 in 2021.
The fair market value of assets, including the ordinary shares and liabilities that are taxed under this regime is measured once in each calendar year on January 1. The tax rate under the regime for savings and investments is a flat rate of 31%.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Dutch Corporate Entities </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dutch Corporate Entities are generally subject to corporate income tax at statutory rates up to 25% on any benefits derived or deemed to be
derived from the ordinary shares. A reduced rate of 15% applies to the first &#128;&nbsp;245,000 of taxable profits. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">170 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">Non-residents</FONT> of the Netherlands </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The description of certain Dutch tax consequences in this paragraph is only intended for the following shareholders: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">individuals not resident and not deemed to be resident in the Netherlands for Dutch income tax purposes
(&#147;<I><FONT STYLE="white-space:nowrap">Non-Dutch</FONT> Individuals</I>&#148;); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">entities not resident and not deemed to be resident in the Netherlands for Dutch corporate income tax purposes
(&#147;<I><FONT STYLE="white-space:nowrap">Non-Dutch</FONT> Corporate Entities</I>&#148;). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A <FONT
STYLE="white-space:nowrap">Non-Dutch</FONT> Individual or a <FONT STYLE="white-space:nowrap">Non-Dutch</FONT> Corporate Entity will not be subject to any Dutch taxes on income or capital gains in respect of the acquisition, holding, redemption and
disposal of ordinary shares, other than withholding tax as described above, except if: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the
<FONT STYLE="white-space:nowrap">Non-Dutch</FONT> Individual or the <FONT STYLE="white-space:nowrap">Non-Dutch</FONT> Corporate Entity derives profits from an enterprise, whether as entrepreneur or pursuant to a
<FONT STYLE="white-space:nowrap">co-entitlement</FONT> to the net worth of such enterprise other than as an entrepreneur or a shareholder, which enterprise is, in whole or in part, carried on through a permanent establishment (<I>vaste
inrichting</I>) or a permanent representative (<I>vaste vertegenwoordiger</I>) in the Netherlands, to which the ordinary shares are attributable; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) the <FONT STYLE="white-space:nowrap">Non-Dutch</FONT> Individual derives benefits from miscellaneous activities carried out in the
Netherlands in respect of the ordinary shares, including (without limitation) activities which are beyond the scope of active portfolio investment activities; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) the <FONT STYLE="white-space:nowrap">Non-Dutch</FONT> Corporate Entity is entitled to a share in the profits of an enterprise or a <FONT
STYLE="white-space:nowrap">co-entitlement</FONT> to the net worth of an enterprise, other than by way of securities, which enterprise is effectively managed in the Netherlands and to which enterprise the ordinary shares are attributable; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) the <FONT STYLE="white-space:nowrap">Non-Dutch</FONT> Individual is entitled to a share in the profits of an enterprise, other than by
way of securities, which enterprise is effectively managed in the Netherlands and to which enterprise the ordinary shares are attributable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under certain specific circumstances, Dutch taxation rights may be restricted for <FONT STYLE="white-space:nowrap">Non-Dutch</FONT>
Individuals and <FONT STYLE="white-space:nowrap">Non-Dutch</FONT> Corporate Entities pursuant to treaties for the avoidance of double taxation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Dutch Gift Tax or Inheritance Tax </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No Dutch gift tax or inheritance tax is due in respect of any gift of the ordinary shares by, or inheritance of the ordinary shares on the
death of, a shareholder, except if: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at the time of the gift or death of the shareholder, the shareholder is resident, or is deemed to be resident, in
the Netherlands; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the shareholder passes away within 180 days after the date of the gift of the ordinary shares and is not, or not
deemed to be, at the time of the gift, but is, or deemed to be resident in the Netherlands at the time of his death; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the gift of the ordinary shares is made under a condition precedent and the shareholder is resident, or is deemed
to be resident, in the Netherlands at the time the condition is fulfilled. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of Dutch gift tax or
inheritance tax, an individual who is of Dutch nationality will be deemed to be resident in the Netherlands if such individual has been resident in the Netherlands at any time during the 10 years preceding the date of the gift or his death. For
purposes of Dutch gift tax, any individual, irrespective of his </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">171 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
nationality, be deemed to be resident in the Netherlands if such individual has been resident in the Netherlands at any time during the 12 months preceding the date of the gift. Applicable tax
treaties may override deemed residency. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Value Added Tax (VAT) </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No Dutch VAT will be payable by a shareholder in respect of any purchase, ownership and disposal of the ordinary shares. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Other Taxes and Duties </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No other Dutch taxes, including taxes of a documentary nature, such as capital tax, stamp or registration tax or duty, are payable by or on
behalf of the shareholder by reason only of the purchase, ownership and disposal of the ordinary shares </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Residency </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A shareholder will not become resident, or deemed resident, in the Netherlands for tax purposes by reason only of holding the ordinary shares.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Material German Tax Considerations </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following section is a description of the material German tax considerations that become relevant when acquiring, owning and transferring
Immatics&#146; ordinary shares. It is based on the German tax law applicable as of the date of this Annual Report without prejudice to any amendments introduced at a later date and implemented with or without retroactive effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This section is intended as general information only and does not purport to be a comprehensive or complete description of all potential
German tax effects of the acquisition, ownership or transfer of ordinary shares and does not set forth all German tax considerations that may be relevant to a particular person&#146;s decision to acquire ordinary shares. It does not constitute
particular German tax advice and potential purchasers of Immatics&#146; ordinary shares are urged to consult their own tax advisors regarding the tax consequences of the acquisition, ownership and transfer of ordinary shares in light of their
particular circumstances with regard to the application of German tax law to their particular situations, in particular with respect to the procedure to be complied with to obtain a relief of withholding tax on dividends and on capital gains
(<I>Kapitalertragsteuer</I>) and with respect to the influence of double tax treaty provisions, as well as any tax consequences arising under the laws of any state, local or other <FONT STYLE="white-space:nowrap">non-German</FONT> jurisdiction. For
German tax purposes, a shareholder may include an individual who or an entity that does not have the legal title to the ordinary shares, but to whom nevertheless the ordinary shares are attributed, based either on such individual or entity owning a
beneficial interest in the ordinary shares or based on specific statutory provisions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All of the following is subject to change. Such
changes could apply retroactively and could affect the consequences set forth below. This section does not refer to any foreign account tax compliance act (FATCA) aspects. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Immatics&#146; Tax Residency Status </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Immatics has its statutory seat in the Netherlands and its sole place of management in Germany and is therefore tax resident in Germany (for
purposes of the German-Dutch tax treaty). Thus, Immatics qualifies as a corporation subject to German unlimited liability for corporate income tax purposes. However, because Immatics&#146; tax residency depends on future facts regarding its place of
management the German unlimited liability for corporate income tax purposes may change in the future. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">172 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Taxation of Dividends </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Withholding Tax on Dividend Payments </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dividends distributed from Immatics to its shareholders are generally subject to German withholding tax, conditionally upon certain exemptions
(for example, repayments of capital from the tax contribution account (<I>steuerliches Einlagekonto</I>)), as further described. The withholding tax rate is 25% plus a 5.5% solidarity surcharge (<I>Solidarit&auml;tszuschlag</I>) thereon totaling
26.375% of the gross dividend amount. Withholding tax is to be withheld and passed on for the account of the shareholders by a domestic branch of a domestic or foreign credit or financial services institution (<I>Kredit</I>- <I>und</I>
<I>Finanzdienstleistungsinstitut</I>), by the domestic securities trading company (<I>inl&auml;ndisches</I> <I>Wertpapierhandelsunternehmen</I>) or a domestic securities trading bank (<I>inl&auml;ndische Wertpapierhandelsbank</I>) which keeps and
administers the ordinary shares and disburses or credits the dividends or disburses the dividends to a foreign agent, or by the securities custodian bank (<I>Wertpapiersammelbank</I>) to which the ordinary shares were entrusted for collective
custody if the dividends are distributed to a foreign agent by such securities custodian bank (which is referred to as the &#147;Dividend Paying Agent&#148;). In case the ordinary shares are not held in collective deposit with a Dividend Paying
Agent, Immatics is responsible for withholding and remitting the tax to the competent tax office. Such withholding tax is levied and withheld irrespective of whether and to what extent the dividend distribution is taxable at the level of the
shareholder and whether the shareholder is a person residing in Germany or in a foreign country. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the case of dividends distributed to
a company within the meaning of Art. 2 of the amended EU Directive 2011/96/EU of the Council of November&nbsp;30, 2011 (the &#147;EU Parent Subsidiary Directive&#148;) domiciled in another Member State of the European Union, withholding tax is
effectively reduced to zero. This also applies to dividends distributed to a permanent establishment located in another Member State of the European Union of such a parent company or of a parent company tax resident in Germany if the participation
in Immatics is effectively connected with this permanent establishment. The key prerequisite for the application of the EU Parent Subsidiary Directive is that the shareholder has held a direct participation in the share capital of Immatics of at
least 10% for at an uninterrupted period of least one year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The withholding tax on dividends distributed to other foreign resident
shareholders is reduced in accordance with an applicable double tax treaty (to 15%, 5% or 0% depending on certain prerequisites) if Germany has concluded such double tax treaty with the country of residence of the shareholder and if the shareholder
does not hold his ordinary shares either as part of the assets of a permanent establishment or a fixed place of business in Germany or as business assets for which a permanent representative has been appointed in Germany. Further, the foreign
resident shareholder must be eligible for treaty purposes and no limitation of benefits provision in a double tax treaty and&#151;both in relation to a reduction pursuant to the EU Parent Subsidiary Directive and an applicable tax treaty&#151;no
German anti-directive/treaty shopping provision of Section&nbsp;50d paragraph 3 of the German Income Tax Act (<I>Einkommensteuergesetz</I>) must be applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">However, the deduction of withholding taxes will generally apply irrespective of a possible reduction pursuant to the EU Parent Subsidiary
Directive or applicable double tax treaty except for the case that the recipient of the dividends has been granted an exemption from the German Federal Central Tax Office (<I>Bundeszentralamt f&uuml;r Steuern</I>) upon formal application by the
recipient of the dividends (<I>Freistellung im Steuerabzugsverfahren</I>). In case of deducted withholding taxes, the reduction of the withholding tax pursuant to both the EU Parent Subsidiary Directive and an applicable double tax treaty is
procedurally granted in such a manner that the difference between the total amount withheld, including the solidarity surcharge, and the tax liability determined on the basis of the EU Parent Subsidiary Directive (0%) or on the basis of the tax rate
set forth in the applicable double tax treaty (15% unless further qualifications are met) is upon request refunded by the German Federal Central Tax Office (<I>Bundeszentralamt f&uuml;r Steuern</I>). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the case of dividends received by corporations who are not tax resident in Germany, <FONT STYLE="white-space:nowrap">two-fifths</FONT> of
the withholding tax deducted and remitted are refunded without the need to fulfill all prerequisites required for such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">173 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
refund under the EU Parent Subsidiary Directive or under a double tax treaty or if no double tax treaty has been concluded between the state of residence of the shareholder, however, likewise
subject to the conditions of the German anti-directive/treaty shopping provision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to receive a refund pursuant to a double tax
treaty or the aforementioned option for foreign corporations, the shareholder has to submit a completed form for refund (available at the website of the Federal Central Tax Office (http://www.bzst.de) as well as at the German embassies and
consulates) together with a withholding tax certificate (<I>Kapitalertragsteuerbescheinigung</I>) issued by the institution that deducted the respective withholding tax. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The aforementioned reductions of (or exemptions from) withholding tax are further restricted if (i)&nbsp;the applicable double tax treaty
provides for a tax reduction resulting in an applicable tax rate of less than 15% and (ii)&nbsp;the shareholder is not a corporation that directly holds at least 10% in the equity capital of Immatics and is subject to tax on its income and profits
in its state of residence without being exempt. In this case, the reduction of (or exemption from) withholding tax is subject to the following three cumulative prerequisites: (i)&nbsp;the shareholder must qualify as beneficial owner of the shares in
a company for a minimum holding period of 45 consecutive days occurring within a period of 45 days prior and 45 days after the due date of the dividends, (ii)&nbsp;the shareholder has to bear at least 70&nbsp;% of the change in value risk related to
the shares in a company during the minimum holding period without being directly or indirectly hedged, and (iii)&nbsp;the shareholder must not be required to fully or largely compensate directly or indirectly the dividends to third parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the absence of the fulfillment of all of the three prerequisites, three-fifths of the withholding tax imposed on the dividends must not be
credited against the shareholder&#146;s (corporate) income tax liability, but may, upon application, be deducted from the shareholder&#146;s tax base for the relevant assessment period. Furthermore, a shareholder that has received gross dividends
without any deduction of withholding tax due to a tax exemption without qualifying for such a full tax credit has (i)&nbsp;to notify the competent local tax office accordingly, (ii)&nbsp;to declare according to the officially prescribed form and
(iii)&nbsp;has to make a payment in the amount of the omitted withholding tax deduction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">However, these special rules on the restriction
of withholding tax credit do not apply to a shareholder whose overall dividend earnings within an assessment period do not exceed &#128;20,000 or that has been the beneficial owner of the shares in a company for at least one uninterrupted year upon
receipt of the dividends. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For individual or corporate shareholders tax resident outside Germany not holding the ordinary shares through a
permanent establishment (<I>Betriebsst&auml;tte</I>) in Germany or as business assets (<I>Betriebsverm&ouml;gen</I>) for which a permanent representative (<I>st&auml;ndiger</I> <I>Vertreter</I>) has been appointed in Germany, the remaining and paid
withholding tax (if any) is then final (i.e., not refundable) and settles the shareholder&#146;s limited tax liability in Germany. For individual or corporate shareholders tax resident in Germany (for example, those shareholders whose residence,
domicile, registered office or place of management is located in Germany) holding their ordinary shares as business assets, as well as for shareholders tax resident outside of Germany holding their ordinary shares through a permanent establishment
in Germany or as business assets for which a permanent representative has been appointed in Germany, the withholding tax withheld (including solidarity surcharge) can be credited against the shareholder&#146;s personal income tax or corporate income
tax liability in Germany. Any withholding tax (including solidarity surcharge) in excess of such tax liability is refunded. For individual shareholders tax resident in Germany holding Immatics&#146; ordinary shares as private assets, the withholding
tax is a final tax (<I>Abgeltungsteuer</I>), subject to the exceptions described in the following section. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Taxation of Dividend Income
of Shareholders Tax Resident in Germany Holding Immatics&#146; Ordinary Shares as Private Assets (Private Individuals) </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For individual
shareholders (individuals) resident in Germany holding Immatics&#146; ordinary shares as private assets, dividends are subject to a flat rate tax which is satisfied by the withholding tax actually withheld
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">174 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(<I>Abgeltungsteuer</I>). Accordingly, dividend income will be taxed at a flat tax rate of 25% plus 5.5% solidarity surcharge thereon totaling 26.375% and church tax (<I>Kirchensteuer</I>) in
case the shareholder is subject to church tax because of his personal circumstances. An automatic procedure for deduction of church tax by way of withholding will apply to shareholders being subject to church tax unless the shareholder has filed a
blocking notice (<I>Sperrvermerk</I>) with the German Federal Tax Office (details related to the computation of the specific tax rate including church tax are to be discussed with the individual tax advisor of the relevant shareholder). Except for
an annual lump sum savings allowance (<I>Sparer-Pauschbetrag</I>) of up to &#128;801 (for individual filers) or up to &#128;1,602 (for married couples and for partners in accordance with the registered partnership law (<I>Gesetz &uuml;ber die
Eingetragene Lebenspartnerschaft</I>) filing jointly), private individual shareholders will not be entitled to deduct expenses incurred in connection with the capital investment from their dividend income. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The income tax owed for the dividend income is satisfied by the withholding tax withheld by the Dividend Paying Agent. However, if the flat
tax results in a higher tax burden as opposed to the private individual shareholder&#146;s personal income tax rate, the private individual shareholder can opt for taxation at his personal income tax rate. In that case, the final withholding tax
will be credited against the income tax. The option can be exercised only for all capital income from capital investments received in the relevant assessment period uniformly and married couples as well as partners in accordance with the registered
partnership law filing jointly may only jointly exercise the option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Exceptions from the flat rate tax (satisfied by withholding the tax
at source, <I>Abgeltungswirkung</I>) may apply&#151;that is, only upon application&#151;for shareholders who have a shareholding of at least 25% in Immatics and for shareholders who have a shareholding of at least 1% in Immatics and work for a
company in a professional capacity. In such a case, the same rules apply as for sole proprietors holding the ordinary shares as business assets (see below &#147;Taxation of Dividend Income of Shareholders Tax Resident in Germany Holding the
Company&#146;s Ordinary Shares as Business Assets&#151;Sole Proprietors&#148;). Further, the flat rate tax does not apply if and to the extent dividends reduced Immatics taxable income. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Taxation of Dividend Income of Shareholders Tax Resident in Germany Holding Immatics&#146; Ordinary Shares as Business Assets </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a shareholder holds the Immatics&#146; ordinary shares as business assets, the taxation of the dividend income depends on whether the
respective shareholder is a corporation, a sole proprietor or a partnership. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Corporations </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dividend income of corporate shareholders is exempt from corporate income tax, provided that the corporation holds a direct participation of at
least 10% in the share capital of a company at the beginning of the calendar year in which the dividends are paid (participation exemption). The acquisition of a participation of at least 10% in the course of a calendar year is deemed to have
occurred at the beginning of such calendar year. Participations in the share capital of the company which a corporate shareholder holds through a partnership, including <FONT STYLE="white-space:nowrap">co-entrepreneurships</FONT>
(<I>Mitunternehmerschaften</I>), are attributable to such corporate shareholder only on a pro rata basis at the ratio of the interest share of the corporate shareholder in the assets of the relevant partnership. However, 5% of the <FONT
STYLE="white-space:nowrap">tax-exempt</FONT> dividends are deemed to be <FONT STYLE="white-space:nowrap">non-deductible</FONT> business expenses for tax purposes and therefore are effectively subject to corporate income tax (plus solidarity
surcharge) and trade tax; i.e., tax exemption of 95%. Business expenses incurred in connection with the dividends received are entirely tax deductible. The participation exemption does not apply if and to the extent dividends reduced Immatics
taxable income. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For trade tax purposes the entire dividend income is subject to trade tax (i.e., the
<FONT STYLE="white-space:nowrap">tax-exempt</FONT> dividends must be added back when determining the trade taxable income), unless the corporation shareholder holds at least 15% of the company&#146;s registered share capital at the beginning of the
relevant tax assessment period (<I>Erhebungszeitraum</I>). In case of an indirect participation via a partnership please refer to the section &#147;Partnerships&#148; below. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">175 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the shareholding is below 10% in the share capital, dividends are taxable at the applicable corporate
income tax rate of 15%, plus 5.5% solidarity surcharge thereon and trade tax (the rate of which depends on the applicably municipality levy rate determined by the municipality the corporate shareholder has its place of management and permanent
establishments respectively). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Special regulations apply which abolish the 95% tax exemption, if the company&#146;s ordinary shares are
held as trading portfolio assets in the meaning of Section&nbsp;340e of the German Commercial Code (<I>Handelsgesetzbuch</I>) by (i)&nbsp;a credit institution (<I>Kreditinstitut</I>), (ii) a financial service institution
(<I>Finanzdienstleistungsinstitut</I>) or (iii)&nbsp;a financial enterprise within the meaning of the German Banking Act (<I>Kreditwesengesetz</I>), in case more than 50% of the shares of such financial enterprise are held directly or indirectly by
a credit institution or a financial service institution, as well as by a life insurance company, a health insurance company or a pension fund in case the shares are attributable to the capital investments, resulting in fully taxable income. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Sole Proprietors </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For
sole proprietors (individuals) resident in Germany holding ordinary shares as business assets dividends are subject to the partial income rule (<I>Teileink&uuml;nfteverfahren</I>). Accordingly, only (i) 60% of the dividend income will be taxed at
his/her personal income tax rate plus 5.5% solidarity surcharge thereon and church tax (if applicable) and (ii) 60% of the business expenses related to the dividend income are deductible for tax purposes. In addition, the dividend income is entirely
subject to trade tax if the ordinary shares are held as business assets of a permanent establishment in Germany within the meaning of the German Trade Tax Act (<I>Gewerbesteuergesetz</I>), unless the shareholder holds at least 15% of the
company&#146;s registered share capital at the beginning of the relevant assessment period. The trade tax levied will be eligible for credit against the shareholder&#146;s personal income tax liability based on the applicable municipal trade tax
rate and the individual tax situation of the shareholder limited to currently 4.0 times the trade tax measurement amount (<I>Gewerbesteuer-Messbetrag</I>). As from 2021 onwards the solidarity surcharge likely will be abolished in case a certain
income threshold is not exceeded. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Partnerships </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In case ordinary shares are held by a partnership, the partnership itself is not subject to corporate income tax or personal income tax. In
this regard, corporate income tax or personal income tax (and church tax, if applicable) as well as solidarity surcharge are levied only at the level of the partner with respect to their relevant part of the partnership&#146;s taxable income and
depending on their individual circumstances: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if the partner is a corporation, the dividend income will be subject to corporate income tax plus solidarity
surcharge (see &#147;Corporations&#148; above); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if the partner is a sole proprietor, the dividend income will be subject to the partial income rule (see
&#147;Sole Proprietors&#148; above); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if the partner is a private individual, the dividend income will be subject to the flat tax rate (see
&#147;Private Individuals&#148; above). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In case the partnership is a (operative or deemed) commercial partnership with
its place of management in Germany the dividend income is subject to German trade tax at the level of the partnership, unless the partnership holds at least 15% of a company&#146;s registered share capital at the beginning of the relevant assessment
period, in which case the dividend income is exempt from trade tax. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Taxation of Dividend Income of Shareholders Tax Resident Outside
of Germany </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For foreign individual or corporate shareholders tax resident outside of Germany not holding the ordinary shares through a
permanent establishment in Germany or as business assets for which a permanent representative </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">176 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
has been appointed in Germany, the deducted withholding tax (possibly reduced by way of a tax relief under a double tax treaty or domestic tax law, such as in connection with the EU Parent
Subsidiary Directive) is final (that is, not refundable) and settles the shareholder&#146;s limited tax liability in Germany, unless the shareholder is entitled to apply for a withholding tax refund or exemption. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In contrast, individual or corporate shareholders tax resident outside of Germany holding the company&#146;s ordinary shares through a
permanent establishment in Germany or as business assets for which a permanent representative has been appointed in Germany are subject to the same rules as applicable (and described above) to shareholders resident in Germany holding the ordinary
shares as business assets. The withholding tax withheld (including solidarity surcharge) is credited against the shareholder&#146;s personal income tax or corporate income tax liability in Germany. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Taxation of Capital Gains </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Withholding Tax on Capital Gains </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Capital gains realized on the disposal of ordinary shares are only subject to withholding tax if (i)&nbsp;a permanent establishment in Germany
of a German or foreign credit or financial institution, (ii)&nbsp;a German securities trading company or (iii)&nbsp;a German securities trading bank stores or administrates or carries out the disposal of the ordinary shares and pays or credits the
capital gains. In those cases, the institution (and not the company) is required to deduct the withholding tax at the time of payment for the account of the shareholder and has to pay the withholding tax to the competent tax authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In case the ordinary shares in the company are held (i)&nbsp;as business assets by a sole proprietor, a partnership or a corporation and such
shares are attributable to a German business or (ii)&nbsp;in case of a corporation being subject to unlimited corporate income tax liability in Germany, the capital gains are not subject to withholding tax. In case of the aforementioned exemption
under (i)&nbsp;above, the withholding tax exemption is subject to the condition that the paying agent has been notified by the beneficiary (<I>Gl&auml;ubiger</I>) that the capital gains are exempt from withholding tax. The respective notification
has to be filed by using the officially prescribed form. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Taxation of Capital Gains Realized by Shareholders Tax Resident in Germany
Holding Immatics&#146; Ordinary Shares as Private Assets (Private Individuals) </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For individual shareholders (individuals) resident in
Germany holding ordinary shares as private assets, capital gains realized on the disposal of ordinary shares are subject to final withholding tax (<I>Abgeltungsteuer</I>). Accordingly, capital gains will be taxed at a flat tax rate of 25%, plus 5.5%
solidarity surcharge thereon totaling 26.375% and church tax, in case the shareholder is subject to church tax because of his personal circumstances. An automatic procedure for deduction of church tax by way of withholding will apply to shareholders
being subject to church tax unless the shareholder has filed a blocking notice (<I>Sperrvermerk</I>) with the German Federal Central Tax Office (details related to the computation of the specific tax rate including church tax are to be discussed
with the personal tax advisor of the relevant shareholder). The taxable capital gain is calculated by deducting the acquisition costs of the ordinary shares and the expenses directly and materially related to the disposal from the proceeds of the
disposal. Apart from that, except for an annual lump sum savings allowance (<I>Sparer-Pauschbetrag</I>) of up to &#128;801 (for individual filers) or up to &#128;1,602 (for married couples and for partners in accordance with the registered
partnership law (<I>Gesetz &uuml;ber die Eingetragene Lebenspartnerschaft</I>) filing jointly), private individual shareholders will not be entitled to deduct expenses incurred in connection with the capital investment from their capital gain. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In case the flat tax results in a higher tax burden as opposed to the private individual shareholder&#146;s personal income tax rate, the
private individual shareholder can opt for taxation at his personal income tax rate. In that case, the withholding tax (including solidarity surcharge) withheld will be credited against the income tax. The option can be exercised only for all
capital income from capital investments received in the relevant assessment </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">177 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
period uniformly and married couples as well as for partners in accordance with the registered partnership law filing jointly may only jointly exercise the option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Capital losses arising from the disposal of the ordinary shares can only be offset against other capital gains resulting from the disposition
of the ordinary shares or shares in other stock corporations during the same calendar year. Offsetting of overall losses with other income (such as business or rental income) and other capital income is not possible. Such losses are to be carried
forward and to be offset against positive capital gains deriving from the disposal of ordinary shares in stock corporations in future years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The final withholding tax (<I>Abgeltungsteuer</I>) will not apply if the seller of the ordinary shares or in case of gratuitous transfer, its
legal predecessor has held, directly or indirectly, at least 1% of the company&#146;s registered share capital at any time during the five years prior to the disposal. In that case capital gains are subject to the partial income rule
(<I>Teileink&uuml;nfteverfahren</I>). Accordingly, only (i) 60% of the capital gains will be taxed at his/her personal income tax rate, plus 5.5% solidarity surcharge thereon and church tax (if applicable) and (ii) 60% of the business expenses
related to the capital gains are deductible for tax purposes. The withholding tax withheld (including solidarity surcharge) will be credited against the shareholder&#146;s personal income tax liability in Germany. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Taxation of Capital Gains Realized by Shareholders Tax Resident in Germany Holding Immatics&#146; Ordinary Shares as Business Assets
</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a shareholder holds ordinary shares as business assets, the taxation of capital gains realized on the disposal of such shares
depends on whether the respective shareholder is a corporation, a sole proprietor or a partnership: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Corporations </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Capital gains realized on the disposal of ordinary shares by a corporate shareholder are generally exempt from corporate income tax and trade
tax. However, 5% of the <FONT STYLE="white-space:nowrap">tax-exempt</FONT> capital gains are deemed to be <FONT STYLE="white-space:nowrap">non-deductible</FONT> business expenses for tax purposes and therefore are effectively subject to corporate
income tax (plus solidarity surcharge) and trade tax; i.e., tax exemption of 95%. Business expenses incurred in connection with the capital gains are entirely tax deductible. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Capital losses incurred upon the disposal of ordinary shares or other impairments of the share value are not tax deductible. A reduction of
profit is also defined as any losses incurred in connection with a loan or security in the event the loan or the security is granted by a shareholder or by a related party thereto or by a third person with the right of recourse against the before
mentioned persons and the shareholder holds directly or indirectly more than 25% of the company&#146;s registered share capital. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Special
regulations apply, if the ordinary shares are held as trading portfolio assets by a credit institution, a financial service institution or a financial enterprise within the meaning of the German Banking Act (<I>Kreditwesengesetz</I>) as well as by a
life insurance company, a health insurance company or a pension fund (see &#147;Corporations&#148;). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Sole Proprietors </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the ordinary shares are held by a sole proprietor, capital gains realized on the disposal of the ordinary shares are subject to the partial
income rule (<I>Teileink&uuml;nfteverfahren</I>). Accordingly, only (i) 60% of the capital gains will be taxed at his /her personal income tax rate plus 5.5% solidarity surcharge thereon and church tax (if applicable) and (ii) 60% of the business
expenses related to the dividend income are deductible for tax purposes. In addition, 60% of the capital gains are subject to trade tax if the ordinary shares are held as business assets of a permanent establishment in Germany within the meaning of
the German Trade Tax Act (<I>Gewerbesteuergesetz</I>). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">178 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
The trade tax levied, depending on the applicable municipal trade tax rate and the individual tax situation, is partly or entirely be credited against the shareholder&#146;s personal income tax
liability. As from 2021 onwards the solidarity surcharge likely will be abolished in case a certain income threshold is not exceeded. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Partnerships </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In case the
ordinary shares are held by a partnership, the partnership itself is not subject to corporate income tax or personal income tax as well as solidarity surcharge (and church tax) since partnerships qualify as transparent for German income tax
purposes. In this regard, corporate income tax or personal income tax as well as solidarity surcharge (and church tax, if applicable) are levied only at the level of the partner with respect to their relevant part of the partnership&#146;s taxable
income and depending on their individual circumstances: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If the partner is a corporation, the capital gains will be subject to corporate income tax plus solidarity
surcharge (see above &#147;Corporations&#148;). Trade tax will be levied additionally at the level of the partner insofar as the relevant profit of the partnership is not subject to trade tax at the level of the partnership. However, with respect to
both corporate income and trade tax, the 95%-exemption rule as described above applies. With regard to corporate partners, special regulations apply if they are held as trading portfolio assets by credit institutions, financial service institutions
or financial enterprises within the meaning of the German Banking Act or life insurance companies, health insurance companies or pension funds, as described above. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If the partner is a sole proprietor (individual), the capital gains are subject to the partial income rule (see
above &#147;Sole proprietors&#148;). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, if the partnership is liable to German trade tax, 60% of the capital
gains are subject to trade tax at the level of the partnership, to the extent the partners are individuals, and 5% of the capital gains are subject to trade tax, to the extent the partners are corporations. However, if a partner is a private
individual the trade tax paid at the level of the is credited against the partner&#146;s personal income tax liability at up to 4.0 times of the trade tax measurement amount (<I>Gewerbesteuer-Messbetrag</I>) depending on the applicable municipal
trade tax levy rate and the personal tax situation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Taxation of Capital Gains Realized by Shareholders Tax Resident Outside of Germany
</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Capital gains realized on the disposal of the ordinary shares by a shareholder tax resident outside of Germany are subject to German
taxation provided that (i)&nbsp;the company&#146;s ordinary shares are held as business assets of a permanent establishment or as business assets for which a permanent representative has been appointed in Germany, or (ii)&nbsp;the shareholder or, in
case of a gratuitous transfer, its legal predecessor has held, directly or indirectly at least 1% of the company&#146;s shares capital at any time during a five-year period prior to the disposal. In these cases, capital gains are generally subject
to the same rules as described above for shareholders resident in Germany. However, except for the cases referred to in (i)&nbsp;above, most double tax treaties concluded by Germany provide for a full exemption from German taxation except that that
the company is considered a real estate holding entity for treaty purposes. Further, in case of <FONT STYLE="white-space:nowrap">non-German</FONT> corporation, the participation exemption applies in full resulting in a tax exemption of 100% (i.e.,
no deemed <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">non-tax-deductible</FONT></FONT> business expenses). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Inheritance and Gift Tax </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The transfer of Immatics&#146; ordinary shares to another person by way of succession or donation is subject to German inheritance and gift tax
(<I>Erbschaft- und Schenkungsteuer</I>) if: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the decedent, the donor, the heir, the donee or any other beneficiary has his /her /its
residence, domicile, registered office or place of management in Germany at the time of the transfer, or is a German citizen who has not stayed abroad for more than five consecutive years without having a residence in Germany; or </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">179 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) (irrespective of the personal circumstances) the ordinary shares are held by the
decedent or donor as business assets for which a permanent establishment in Germany is maintained or a permanent representative is appointed in Germany; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) (irrespective of the personal circumstances) at least 10% of the ordinary shares are held directly or indirectly by the decedent or
person making the gift, himself or together with a related party in terms of Section&nbsp;6 Foreign Tax Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Special regulations apply to
qualified German citizens who maintain neither a residence nor their domicile in Germany but in a low tax jurisdiction and to former German citizens, also resulting in inheritance and gift tax. The few double tax treaties on inheritance and gift tax
which Germany has entered into provide that German inheritance and gift tax is levied only in case of (i)&nbsp;and, with certain restrictions, in case of (ii). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Value Added Tax (VAT) </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No German value added tax (<I>Umsatzsteuer</I>) will be payable by a shareholder in respect of any purchase, ownership and disposal of the
ordinary shares except for a valid option to waive VAT exemption requiring a sale between entrepreneurs for VAT purposes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Transfer
Taxes </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No German capital transfer tax (<I>Kapitalverkehrsteuer</I>) or stamp duty (<I>Stempelgeb&uuml;hr</I>) or similar taxes are
levied when acquiring, owning or transferring the company&#146;s ordinary shares. Net wealth tax (<I>Verm&ouml;gensteuer</I>) is currently not levied in Germany. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January&nbsp;22, 2013, the Council of the European Union approved the resolution of the ministers of finance from eleven EU member states
(including Germany) to introduce a financial transaction tax (&#147;FTT&#148;) within the framework of enhanced cooperation. On February&nbsp;14, 2013, the European Commission accepted the proposal for a Council Directive implementing enhanced
cooperation in the area of FTT. The plan focuses on levying a financial tax of 0.1% (0.01% for derivates) on the purchase and sale of financial instruments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A joint statement issued by ten of the eleven participating EU Member States in October 2016 reaffirmed the intention to introduce a FTT. However, at the
moment not many details are available. Thus, it is not known to what extent the elements of the European Commission&#146;s proposal outlined in the preceding paragraph will be followed in relation to the taxation of shares. The FTT proposal remains
subject to negotiation between the participating EU Member States and is subject to political discussion. It may therefore be altered prior to the implementation, the timing of which remains unclear. With the EU Council&#146;s conclusion of <FONT
STYLE="white-space:nowrap">COVID-19</FONT> financial support and the German Presidency starting in July 2020 the agreement on a FTT becomes more realistic as one of the measures to fund the EU&#146;s response to the
<FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic. Additional EU Member States may decide to participate. If an <FONT STYLE="white-space:nowrap">EU-wide</FONT> FTT (see above) fails, representatives of the IfW (Institute for the World
Economy) intend to advocate the introduction of a comprehensive version of the tax in Germany after the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic. Prospective holders of the ordinary shares are advised to seek their own professional
advice in relation to FTT. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_52"></A>F. Dividends and Paying Agents </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_53"></A>G. Statement by Experts </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">180 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_54"></A>H. Documents on Display </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are subject to the informational requirements of the Exchange Act. Accordingly, we are required to file reports and other information with
the SEC, including annual reports on Form <FONT STYLE="white-space:nowrap">20-F</FONT> and reports on Form <FONT STYLE="white-space:nowrap">6-K.</FONT> The SEC maintains an Internet site at <I>www.sec.gov</I> that contains reports, proxy and
information statements and other information we have filed electronically with the SEC. As a foreign private issuer, we are exempt under the Exchange Act from, among other things, the rules prescribing the furnishing and content of proxy statements,
and our executive officers, directors and principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained in Section&nbsp;16 of the Exchange Act. In addition, we are not required under the Exchange Act to
file periodic reports and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We also make available on our website, free of charge, our Annual Report and the text of our reports on Form
<FONT STYLE="white-space:nowrap">6-K,</FONT> including any amendments to these reports, as well as certain other SEC filings, as soon as reasonably practicable after they are electronically filed with or furnished to the SEC. Our website address is
<I>www.immatics.com</I>. The reference to our website is an inactive textual reference only, and information contained therein or connected thereto is not incorporated into this Annual Report. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_55"></A>I. Subsidiary Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="rom149615_56"></A>ITEM&nbsp;11.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are exposed to various risks in relation to financial instruments. Our principal financial instruments comprise cash, cash equivalents and
fixed-term deposits. The main purpose of these financial instruments is to invest the proceeds of capital contributions and upfront payments from collaboration agreements. We have various other financial instruments such as other receivables and
trade accounts payable, which arise directly from our operations. We do not engage in the trading of financial assets for speculative purposes. The main risks arising from our financial instruments are interest rate risk, liquidity risk and currency
exchange risk. The Management Board reviews and agrees to policies for managing these risks as summarized below. We also monitor the market price risk arising from all financial instruments. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Interest Rate Risk </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our exposure to
changes in interest rates relates to investments in deposits and to changes in the interest for overnight deposits. Changes in the general level of interest rates may lead to an increase or decrease in the fair value of these investments. Regarding
the liabilities shown in the statement of financial position, we are currently not subject to interest rate risks. We do not believe that an increase or decrease of 100 basis points in interest rates would have a material effect on our business,
financial condition or results of operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Credit Risk </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject us to concentrations of credit and liquidity risk consist primarily of cash, cash equivalents,
deposits and accounts receivable. Our cash, cash equivalents and deposits are denominated in euros and U.S. dollars. Cash, cash equivalents and deposits securities are maintained with two high-quality financial institutions in Germany and one in the
United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We continually monitor our positions with, and the credit quality of, the financial institutions and corporations that are
counterparts to our financial instruments and we are not currently anticipating <FONT STYLE="white-space:nowrap">non-performance.</FONT> The maximum default risk corresponds to the carrying amount of the financial assets shown in the statement of
financial position. We monitor the risk of a liquidity shortage. The main factors considered here are the maturities of financial assets, as well as expected cash flows from equity measures. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">181 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Currency Risk </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Currency risk shows the risk that the value of a financial instrument will fluctuate due to changes in foreign exchange rates. In particular,
it poses a threat if the value of the currency in which liabilities are priced appreciates relative to the currency of the assets. The way we manage our currency risks is governed by our Investment and Exchange Risk Policy, which is overseen by the
Board of Directors and executed by the finance department. Our business transactions are generally conducted in euros and U.S. dollars. We aim to match U.S. dollar cash inflows with U.S. dollar cash outflows where possible. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our cash and cash equivalents were &#128;207.5&nbsp;million as of December&nbsp;31, 2020. Approximately 70% of our cash and cash equivalents
were held in Germany, of which approximately 46% were denominated in euros and 24% were denominated in U.S. dollars. The remainder of our cash and cash equivalents are held in the United States and denominated in U.S. dollars. Additionally, we have
short-term deposits classified as financial assets denominated in U.S. dollars in the amount of &#128;24.4&nbsp;million as of December&nbsp;31, 2020. We believe we do not have a material exposure to foreign currency risk. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="rom149615_57"></A>ITEM&nbsp;12.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_58"></A>A. Debt Securities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_59"></A>B. Warrants and Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_60"></A>C. Other Securities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_61"></A>D. American Depositary Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable<B>.</B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">182 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART II </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="rom149615_62"></A>ITEM&nbsp;13.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_63"></A>A. Defaults </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_64"></A>B. Arrears
and Delinquencies </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="rom149615_65"></A>ITEM&nbsp;14.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="rom149615_66"></A>ITEM&nbsp;15.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>CONTROLS AND PROCEDURES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_67"></A>A. Disclosure Controls and Procedures </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As required by Rule <FONT STYLE="white-space:nowrap">13a-15</FONT> under the Exchange Act, management, including our chief executive officer
and our chief financial officer, has evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Disclosure controls and procedures refer to controls and other procedures designed to
ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC. Disclosure controls and
procedures include, without limitations, controls and procedures designed to ensure that information required to be disclosed by us in our reports that we file or submit under the Exchange Act is accumulated and communicated to management, including
our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding our required disclosures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on the foregoing, our chief executive officer and our chief financial officer have concluded that, as of December&nbsp;31, 2020, our
disclosure controls and procedures were not effective due to the material weaknesses in our internal control over financial reporting primarily related to (i)&nbsp;clearly defined control processes, roles and segregation of duties within our
business processes to ensure appropriate financial reporting, and (ii)&nbsp;the design and operating effectiveness of IT general controls for information systems that are significant to the preparation of our consolidated financial statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have developed a remediation plan designed to address these material weaknesses and other existing deficiencies. We have <FONT
STYLE="white-space:nowrap">re-designed</FONT> the key processes and included significant measures to ensure an effective internal control over financial reporting. We are currently implementing these processes to ensure operating effectiveness. In
doing so, we rely on the assistance of external advisors with expertise in these matters. Additionally, we have and continue to train our accounting and finance staff and hired financial reporting personnel, to develop and implement appropriate
internal controls and reporting procedures. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_68"></A>B. Management&#146;s Annual Report on Internal Control over Financial Reporting
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Annual Report does not include a report of management&#146;s assessment regarding internal control over financial reporting due
to a transition period established by rules of the SEC for newly public companies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_69"></A>C. Attestation Report of the Registered
Public Accounting Firm </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Annual Report does not include an attestation report of the company&#146;s registered public accounting
firm due to a transition period established by rules of the SEC for newly public companies and because we are an emerging growth company under the JOBS Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">183 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom149615_70"></A>D. Changes in Internal Control Over Financial Reporting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Annual Report does not include disclosure of changes in control over financial reporting due to a transition period established by rules
of the SEC for newly public companies. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="rom149615_71"></A>ITEM&nbsp;16A.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>AUDIT COMMITTEE FINANCIAL EXPERTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Audit Committee members include Michael G. Atieh (chair), Paul R. Carter and Heather L. Mason. Each member of the Audit Committee satisfies the
&#147;independence&#148; requirements set forth in Rule <FONT STYLE="white-space:nowrap">10A-3</FONT> under the Exchange Act and is financially literate and each of Michael G. Atieh and Paul R. Carter qualifies as an &#147;audit committee financial
expert&#148; as defined in applicable SEC rules. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="rom149615_72"></A>ITEM&nbsp;16B.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>CODE OF ETHICS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have adopted a Code of Business Conduct and Ethics that applies to all of our employees, officers and directors, including those officers
responsible for financial reporting. Our Code of Business Conduct and Ethics is available on our website. We intend to disclose any amendment to the code, or any waivers of its requirements, in our Annual Report on Form <FONT
STYLE="white-space:nowrap">20-F.</FONT> For the year ended December&nbsp;31, 2020, we did not grant any waivers of the Code of Business Conduct and Ethics. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="rom149615_73"></A>ITEM&nbsp;16C.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>PRINCIPAL ACCOUNTANT FEES AND SERVICES </B></P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>For&nbsp;the&nbsp;Years&nbsp;Ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(euro&nbsp;in&nbsp;thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,042</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">688</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit-Related Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All Other Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,042</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">688</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the years ended December&nbsp;31, 2020 and 2019, PricewaterhouseCoopers GmbH
Wirtschaftspr&uuml;fungsgesellschaft was the Company&#146;s auditor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Audit fees include the standard audit work performed each fiscal
year necessary to allow the auditor to issue an opinion on our financial statements and to issue an opinion on the local statutory financial statements. Audit fees also include services such as reviews of quarterly financial results and review of
securities offering documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Audit-related fees consisted of fees billed for assurance and related services that were reasonably
related to the performance of the audit or review of our financial statements or for services that were traditionally performed by the external auditor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Tax fees are fees billed for professional services for tax compliance, tax advice and tax planning. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee evaluates the qualifications, independence and performance of the independent auditor as well as <FONT
STYLE="white-space:nowrap">pre-approves</FONT> and reviews the audit and <FONT STYLE="white-space:nowrap">non-audit</FONT> services to be performed by the independent auditor. In accordance with this policy, all services performed by and fees paid
to PricewaterhouseCoopers GmbH Wirtschaftspr&uuml;fungsgesellschaft were approved by the Audit Committee. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="rom149615_74"></A>ITEM&nbsp;16D.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">184 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="rom149615_75"></A>ITEM&nbsp;16E.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>PURCHASES&nbsp;OF&nbsp;EQUITY&nbsp;SECURITIES&nbsp;BY&nbsp;THE&nbsp;ISSUER&nbsp;AND&nbsp;AFFILIATED
PURCHASERS </B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2020, no purchases of our equity securities were made by or on
behalf of us or any affiliated purchaser. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="rom149615_76"></A>ITEM&nbsp;16F.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>CHANGE IN REGISTRANT&#146;S CERTIFYING ACCOUNTANT </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="rom149615_77"></A>ITEM&nbsp;16G.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>CORPORATE GOVERNANCE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a &#147;foreign private issuer,&#148; as defined by the SEC, we are permitted to follow home country corporate governance practices, instead
of certain corporate governance standards required by the Nasdaq for U.S. companies. Accordingly, we follow Dutch corporate governance rules in lieu of certain of the Nasdaq&#146;s corporate governance requirements. The significant differences
between our Dutch corporate governance rules and the Nasdaq&#146;s corporate governance requirements are set forth below: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Quorum Requirements</I>. In accordance with Dutch law and generally accepted business practices, our Articles
of Association do not provide quorum requirements generally applicable to general meetings of shareholders in the United States. To this extent, our practice varies from the requirement of Nasdaq Listing Rule 5620(c), which requires an issuer to
provide in its bylaws for a generally applicable quorum, and that such quorum may not be less than <FONT STYLE="white-space:nowrap">one-third</FONT> of the outstanding voting stock. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Solicitation of Proxies</I>. Although we must provide shareholders with an agenda and other relevant documents
for the general meeting of shareholders, Dutch law does not have a regulatory regime for the solicitation of proxies and the solicitation of proxies is not a generally accepted business practice in the Netherlands, thus our practice will vary from
the requirement of Nasdaq Listing Rule 5620(b). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Compensation Committee</I>. As permitted by the listing requirements of Nasdaq, we have also opted out of the
requirements of Nasdaq Listing Rule 5605(d), which requires an issuer to have a compensation committee that, inter alia, consists entirely of independent directors. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Nominating and Corporate Governance Committee</I>. As permitted by the listing requirements of Nasdaq, we have
also opted out of the requirements of Nasdaq Listing Rule 5605(e), which requires an issuer to have independent director oversight of director nominations. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Director Compensation</I>. As permitted by the listing requirements of Nasdaq, we have also opted out of the
requirements of Nasdaq Listing Rule 5250(b)(3), which requires an issuer to disclose information regarding third party compensation of its directors or director nominees. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Shareholder Approval</I>. We have opted out of shareholder approval requirements for the issuance of
securities in connection with certain events such as the acquisition of stock or assets of another company, the establishment of or amendments to equity-based compensation plans for employees, a change of control of us and certain private
placements. To this extent, our practice varies from the requirements of Nasdaq Rule 5635, which generally requires an issuer to obtain shareholder approval for the issuance of securities in connection with such events. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="rom149615_78"></A>ITEM&nbsp;16H.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>MINE SAFETY DISCLOSURE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">185 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART III </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="rom149615_79"></A>ITEM&nbsp;17.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>FINANCIAL STATEMENTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have responded to Item 18 in lieu of this item. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="rom149615_80"></A>ITEM&nbsp;18.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>FINANCIAL STATEMENTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Financial statements are filed as part of this Annual Report beginning on page <FONT STYLE="white-space:nowrap">F-1.</FONT> </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="rom149615_81"></A>ITEM&nbsp;19.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>EXHIBITS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following documents are filed as part of this Annual Report or incorporated by reference herein: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="54%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exhibit<BR>Number</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="13" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Incorporation by Reference</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Form</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>File&nbsp;Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exhibit<BR>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Filing&nbsp;Date</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1809196/000119312520206488/d96389dex31.htm">Deed of Conversion of Immatics B.V. and Articles of Association of Immatics N.V. </A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">F-1</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">333-240260</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.1</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">July&nbsp;31,&nbsp;2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">2.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1809196/000119312520162185/d865842dex41.htm">Amended and Restated Warrant Agreement, between Continental Stock Transfer&nbsp;
&amp; Trust Company, Immatics B.V. and ARYA Sciences Acquisition Corp.</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">F-4</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">333-237702</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">4.1</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">June&nbsp;5, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">2.2*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d149615dex22.htm">Description of Securities Registered Pursuant to Section&nbsp;12 of the Securities Exchange Act of 1934 </A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1809196/000119312520206488/d96389dex101.htm">Investor Rights and <FONT STYLE="white-space:nowrap">Lock-up</FONT> Agreement</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">F-1</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">333-240260</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">10.1</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">July&nbsp;31, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4.2#</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1809196/000119312520162185/d865842dex104.htm">Form of Indemnification Agreement (Executive Officers and Directors)</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">F-4</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">333-237702</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">10.4</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">June&nbsp;5, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4.3&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1809196/000119312520108419/d865842dex105.htm">Collaboration&nbsp;&amp; License Agreement, dated as of August&nbsp;
14, 2015, by and between Immatics US, Inc. and The University of Texas M.D. Anderson Center</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">F-4</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">333-237702</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">10.5</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">April&nbsp;16, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4.4&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1809196/000119312520108419/d865842dex106.htm">License Royalty Adjustment Agreement, dated as of January&nbsp;
5, 2016, by and between Immatics US, Inc. and The Board of Regents of The University of Texas System on behalf of the University of Texas M.D. Anderson Cancer Center</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">F-4</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">333-237702</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">10.6</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">April&nbsp;16, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4.5&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1809196/000119312520108419/d865842dex107.htm">Master Clinical Trial Agreement, dated as of December&nbsp;
1, 2016, by and between Immatics US, Inc. and The University of Texas MD Anderson Center</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">F-4</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">333-237702</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">10.7</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">April&nbsp;16,&nbsp;2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4.6&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1809196/000119312520108419/d865842dex108.htm">Restricted Stock Acquisition Agreement, dated as of August&nbsp;
14, 2015, by and between Immatics US, Inc. and The University of Texas M.D. Anderson Cancer Center </A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">F-4</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">333-237702</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">10.8</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">April&nbsp;16, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4.7&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1809196/000119312520108419/d865842dex109.htm"><FONT STYLE="white-space:nowrap">Non-Exclusive</FONT> License Agreement, dated as of August&nbsp;
3, 2015, by and between Immatics Biotechnologies GmbH and Stichting Sanquin Bloedvoorziening</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">F-4</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">333-237702</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">10.9</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">April&nbsp;16, 2020</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">186 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="52%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exhibit<BR>Number</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="13" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Incorporation by Reference</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Form</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>File&nbsp;Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exhibit<BR>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Filing&nbsp;Date</B></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4.8&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1809196/000119312520108419/d865842dex1010.htm">Facilities/Equipment Use and Services Agreement, dated as of September&nbsp;
1, 2015, by and between Immatics US, Inc. and The University of Texas Health Science Center at Houston</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">F-4</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">333-237702</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">10.10</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">April&nbsp;16, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4.9&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1809196/000119312520108419/d865842dex1011.htm">Amendment Number 1 &#151; Facilities/Equipment Use and Services Agreement, dated as of February&nbsp;
1, 2016, by and between Immatics US, Inc. and The University of Texas Health Science Center at Houston</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">F-4</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">333-237702</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">10.11</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">April&nbsp;16, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4.10&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1809196/000119312520108419/d865842dex1012.htm">Amendment Number 2 &#151; Facilities/Equipment Use and Services Agreement, dated as of August&nbsp;
10, 2016, by and between Immatics US, Inc. and The University of Texas Health Science Center at Houston</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">F-4</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">333-237702</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">10.12</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">April&nbsp;16, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4.11&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1809196/000119312520108419/d865842dex1013.htm">Amendment Number 3 &#151; Facilities/Equipment Use and Services Agreement, dated as of October 1, 2016, by and between Immatics US, Inc. and
 The University of Texas Health Science Center at Houston</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">F-4</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">333-237702</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">10.13</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">April&nbsp;16, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4.12&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1809196/000119312520108419/d865842dex1014.htm">Amendment Number 4 &#151; Facilities/Equipment Use and Services Agreement, dated as of April 1, 2017, by and between Immatics US, Inc. and The
 University of Texas Health Science Center at Houston</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">F-4</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">333-237702</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">10.14</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">April&nbsp;16, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4.13&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1809196/000119312520108419/d865842dex1015.htm">Amendment Number 5 &#151; Facilities/Equipment Use and Services Agreement, dated as of July 1, 2018, by and between Immatics US, Inc. and The
University of Texas Health Science Center at Houston</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">F-4</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">333-237702</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">10.15</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">April&nbsp;16, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4.14&#134;*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d149615dex414.htm">Amendment Number 6 &#151; Facilities/Equipment Use and Services Agreement, dated as of June&nbsp;1, 2020, by and between Immatics US, Inc. and The University of Texas Health Science Center at Houston
</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4.15#</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1809196/000119312520163109/d865842dex1016.htm">2020 Stock Option and Incentive Plan and forms of award agreements thereunder </A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">F-4</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">333-237702</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">10.16</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">June&nbsp;8, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">8.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d149615dex81.htm">Subsidiaries</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">12.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d149615dex121.htm">Certification of Principal Executive Officer Pursuant to Rules <FONT STYLE="white-space:nowrap">13a-14(a)</FONT> and <FONT STYLE="white-space:nowrap">15d-14(a)</FONT> under the Securities Exchange Act of 1934,
 as Adopted Pursuant to Section&nbsp;302 of the Sarbanes-Oxley Act of 2002 </A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">187 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exhibit<BR>Number</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="13" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Incorporation by Reference</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Form</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>File&nbsp;Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exhibit<BR>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Filing&nbsp;Date</B></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">12.2*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d149615dex122.htm">Certification of Principal Financial Officer Pursuant to Rules <FONT STYLE="white-space:nowrap">13a-14(a)</FONT> and <FONT STYLE="white-space:nowrap">15d-14(a)</FONT> under the Securities Exchange Act of 1934,
 as Adopted Pursuant to Section&nbsp;302 of the Sarbanes-Oxley Act of 2002</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">13.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d149615dex131.htm">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section&nbsp;1350, as Adopted Pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">13.2*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d149615dex132.htm">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section&nbsp;1350, as Adopted Pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">15.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d149615dex151.htm">Consent of PricewaterhouseCoopers GmbH Wirtschaftspr&uuml;fungsgesellschaft </A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">101.INS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">XBRL Instance Document</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">101.SCH</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">XBRL Taxonomy Extension Schema Document</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">101.CAL</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">XBRL Taxonomy Extension Calculation Linkbase Document</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">101.DEF</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">XBRL Taxonomy Extension Definition Linkbase Document</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">101.LAB</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">XBRL Taxonomy Extension Label Linkbase Document</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">101.PRE</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">XBRL Taxonomy Extension Presentation Linkbase Document</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Filed herewith. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">#</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Indicates a management contract or any compensatory plan, contract or arrangement. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#134;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Portions of this exhibit have been redacted in compliance with Regulation
<FONT STYLE="white-space:nowrap">S-K</FONT> Item 601(a)(6) and Item 601(b)(10). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">188 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>INDEX TO FINANCIAL STATEMENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="96%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#fin149615_1a">Report of Independent Registered Public Accounting Firm
</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>F-2</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#fin149615_1">Consolidated Statement of Financial Position of Immatics
N.V.</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B><FONT STYLE="white-space:nowrap">F-3</FONT></B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#fin149615_2">Consolidated Statement of Loss of Immatics N.V.</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B><FONT STYLE="white-space:nowrap">F-4</FONT></B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#fin149615_3">Consolidated Statement of Comprehensive Loss of Immatics
N.V.</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B><FONT STYLE="white-space:nowrap">F-5</FONT></B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#fin149615_4">Consolidated Statement of Cash Flows</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B><FONT STYLE="white-space:nowrap">F-6</FONT></B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#fin149615_5">Consolidated Statement of Changes in Shareholders&#146; equity (deficit) of
Immatics N.V.</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B><FONT STYLE="white-space:nowrap">F-7</FONT></B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#fin149615_6">Notes to the Consolidated Financial Statements of Immatics
N.V.</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B><FONT STYLE="white-space:nowrap">F-8</FONT></B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><A NAME="fin149615_1a"></A>Report of Independent Registered Public Accounting Firm </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the Shareholders and Management Board of IMMATICS N.V. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Opinion on the Financial Statements </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have
audited the accompanying consolidated statements of financial position of IMMATICS N.V. and its subsidiaries (the &#147;Company&#148;) as of December 31, 2020 and 2019, and the related consolidated statements of loss, comprehensive loss, changes in
shareholders&#146; equity (deficit) and cash flows for each of the three years in the period ended December 31, 2020, including the related notes (collectively referred to as the &#147;consolidated financial statements&#148;). In our opinion, the
consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2020 and 2019, and the results of its operations and its cash flows for each of the three years in the period ended
December 31, 2020 in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Change
in Accounting Principle </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As discussed in Note 5.8 to the consolidated financial statements, the Company changed the manner in which it accounts for
leases in 2019. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Basis for Opinion </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These
consolidated financial statements are the responsibility of the Company&#146;s management. Our responsibility is to express an opinion on the Company&#146;s consolidated financial statements based on our audits. We are a public accounting firm
registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the
Securities and Exchange Commission and the PCAOB. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We conducted our audits of these consolidated financial statements in accordance with the standards of
the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or
fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the
accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stuttgart, Germany </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March 30, 2021 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PricewaterhouseCoopers GmbH </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Wirtschaftspr&#252;fungsgesellschaft </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="73%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ Dietmar Eglauer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>/s/ ppa. Andreas Schuster</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Wirtschaftspr&#252;fer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Wirtschaftspr&#252;fer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(German Public Auditor)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>(German Public Auditor)</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have served as the Company&#146;s auditor since 2019. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="fin149615_1"></A>Consolidated Statement of Financial Position of Immatics N.V. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Notes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,&nbsp;2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,&nbsp;2019*</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Current assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">207,530</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">103,353</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other financial assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24,448</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">957</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,763</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total current assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>238,991</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>124,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-current</FONT> assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property, plant and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,868</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,720</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">914</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,008</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT>
assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,149</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,287</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other <FONT STYLE="white-space:nowrap">non-current</FONT> assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">724</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,262</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total <FONT STYLE="white-space:nowrap">non-current</FONT> assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>15,655</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>10,277</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>254,646</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>134,277</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Liabilities and shareholders&#146; deficit</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Current liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Provisions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,082</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">59,465</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,881</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,411</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,288</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total current liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>60,609</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>69,296</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-current</FONT> liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">85,475</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">101,909</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,306</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,823</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other <FONT STYLE="white-space:nowrap">non-current</FONT> liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,084</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total <FONT STYLE="white-space:nowrap">non-current</FONT> liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>89,781</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>105,816</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Shareholders&#146; equity (deficit)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">629</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,164</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share premium</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">573,339</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">190,945</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(462,253</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(233,194</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other reserves</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(7,459</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(770</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total equity (deficit) attributable to shareholders of the parent</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>104,256</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(41,855</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-controlling</FONT> interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total shareholders&#146; equity (deficit)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>104,256</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(40,835</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total liabilities and shareholders&#146; equity (deficit)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>254,646</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>134,277</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">See Note 2 for details regarding the change in presentation of Other financial assets </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-3 </P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these consolidated financial statements. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="fin149615_2"></A>Consolidated Statement of Loss of Immatics N.V. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Notes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(Euros in thousands, except share and per<BR>share data)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue from collaboration agreements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31,253</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18,449</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,770</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(67,085</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(40,091</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(33,971</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(34,186</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(11,756</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(7,666</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">303</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">385</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,458</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Operating result</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(69,715</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(33,013</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(34,409</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financial income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,949</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">790</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,215</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financial expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(10,063</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(264</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(161</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share listing expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(152,787</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Financial result</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(159,901</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>526</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,054</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Loss before taxes</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(229,616</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(32,487</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(32,355</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxes on income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net loss</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(229,616</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(32,487</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(32,355</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Attributable to:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity holders of the parent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(229,059</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(31,571</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(31,444</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-controlling</FONT> interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(557</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(916</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(911</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net loss</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(229,616</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(32,487</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(32,355</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net loss per share - basic and diluted</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(4.77</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(0.95</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(0.95</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average shares outstanding - basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48,001,228</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33,093,838</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33,093,838</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-4 </P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these consolidated financial statements. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="fin149615_3"></A>Consolidated Statement of Comprehensive Loss of Immatics N.V. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Notes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net Loss</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(229,616</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(32,487</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(32,355</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Other comprehensive loss</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Items that may be reclassified subsequently to profit or loss, net of tax</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Currency translation differences from foreign operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(6,689</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(29</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">313</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total comprehensive loss for the period</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(236,305</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(32,516</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(32,042</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Attributable to:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity holders of the parent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(235,748</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(31,600</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(31,131</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:9.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-controlling</FONT> interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(557</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(916</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(911</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total comprehensive loss for the period</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(236,305</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(32,516</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(32,042</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-5 </P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these consolidated financial statements. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="fin149615_4"></A>Consolidated Statement of Cash Flows </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019*</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash flows from operating activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Loss before taxation</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(229,616</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(32,487</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(32,355</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Adjustments for:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(850</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(790</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(507</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,424</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,176</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">289</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">170</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share listing expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">152,787</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity settled share-based payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22,908</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">152</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">118</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MD Anderson compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(Decrease) Increase in other liabilities resulting from share appreciation rights</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,036</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,864</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">220</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment related to share-based compensation awards previously classified as
equity-settled</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4,322</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net foreign exchange differences</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4,477</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Changes in working capital</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increase in accounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(294</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(563</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(175</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increase (decrease) in other assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,600</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,497</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,608</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(Increase) decrease in accounts payable and other current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(23,387</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">98,937</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43,732</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest received</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">808</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">790</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">507</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest paid</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(289</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(170</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(16</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net cash provided by/(used in) operating activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(85,610</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>70,967</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>20,684</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash flows from investing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payments for property, plant and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(7,420</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,143</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(429</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash paid for investments in Other financial assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(82,930</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(20,473</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(13,101</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash received from maturity of investments classified in Other financial assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">74,505</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17,551</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payments for intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(104</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(91</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(78</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from disposal of property, plant and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">97</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net cash provided by/(used in) investing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(15,949</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(5,059</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(13,514</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash flows from financing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from issuance of shares to equity holders of the parent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">217,918</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23,648</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transaction cost deducted from equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(7,939</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payments for leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,096</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,862</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net cash provided by/(used in) financing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>207,883</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,862</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>23,648</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net increase in cash and cash equivalents</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>106,324</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>64,046</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>30,818</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash and cash equivalents at beginning of period</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>103,353</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>39,367</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>8,415</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effects of exchange rate changes on cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,147</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(60</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">134</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash and cash equivalents at end of period</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>207,530</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>103,353</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>39,367</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">See Note 2 for details regarding the revision as a result of a correction in classification of Other financial
assets </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-6 </P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these consolidated financial statements. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="fin149615_5"></A>Consolidated Statement of Changes in Shareholders&#146; equity (deficit) of
Immatics N.V. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Notes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Share<BR>capital</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Share<BR>premium</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated<BR>deficit</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Other<BR>reserves</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total equity<BR>attributable<BR>to<BR>shareholders<BR>of the parent</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Non-</FONT></B><br><B>controlling<BR>interest</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>share-<BR>holders&#146;<BR>equity<BR>(deficit)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance as of January&nbsp;1, 2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,164</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>167,027</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(170,179</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,054</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(3,042</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>787</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(2,255</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">313</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">313</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">313</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(31,444</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(31,444</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(911</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(32,355</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Comprehensive loss for the year</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(31,444</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>313</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(31,131</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(911</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(32,042</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity-settled tandem awards</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">118</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">118</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">118</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of ordinary shares</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23,648</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23,648</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23,648</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MD Anderson compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance as of December&nbsp;31, 2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,164</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>190,793</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(201,623</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(741</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(10,407</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,236</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(9,171</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance as of January&nbsp;1, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,164</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>190,793</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(201,623</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(741</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(10,407</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,236</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(9,171</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(29</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(29</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(29</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(31,571</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(31,571</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(916</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(32,487</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Comprehensive loss for the year</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(31,571</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(29</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(31,600</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(916</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(32,516</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity-settled tandem awards</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">152</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>152</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>152</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MD Anderson compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance as of December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,164</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>190,945</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(233,194</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(770</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(41,855</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,020</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(40,835</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance as of January&nbsp;1, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,164</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>190,945</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(233,194</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(770</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(41,855</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,020</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(40,835</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,689</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,689</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,689</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(229,059</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(229,059</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(557</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(229,616</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Comprehensive loss for the year</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(229,059</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(6,689</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(235,748</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(557</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(236,305</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reorganization</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(833</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">833</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Issue of share capital</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MD Anderson Share Exchange</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">501</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(508</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PIPE Financing, net of transaction costs</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3, 19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">104</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">89,973</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90,077</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90,077</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARYA Merger, net of transaction costs</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,19,<BR>17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">180</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">272,508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">272,688</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">272,688</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SAR conversion</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(7</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total issuance of share capital</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>298</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>362,975</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>363,273</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(508</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>362,765</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity-settled share-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,908</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,908</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,908</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment related to share-based compensation awards previously classified as
equity-settled</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4,322</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4,322</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4,322</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MD Anderson compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance as of December&nbsp;31, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>629</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>573,339</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(462,253</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(7,459</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>104,256</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>104,256</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-7 </P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these consolidated financial statements. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="fin149615_6"></A>Notes to the Consolidated Financial Statements of Immatics N.V. </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Group information </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Immatics N.V, together with its German subsidiary Immatics Biotechnologies GmbH and its U.S. subsidiary, Immatics US Inc., (&#147;Immatics&#148; or &#147;the
Group&#148;) is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer patients. Immatics N.V., a Dutch public limited liability company, was converted on
July&nbsp;1, 2020 from Immatics B.V., a Dutch company with limited liability. Immatics Biotechnologies GmbH and Immatics US Inc. became subsidiaries of Immatics N.V. as part of the ARYA Merger (defined below) on July&nbsp;1, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Immatics N.V is registered with the commercial register at the Netherlands Chamber of Commerce under RSIN 861058926 with a corporate seat in Amsterdam and is
located at Paul-Ehrlich Str. 15 in 72076 T&uuml;bingen, Germany. Prior to July&nbsp;1, 2020, Immatics N.V. was a shell company with no active trade or business or subsidiaries and all relevant assets and liabilities as well as income and expenses
were borne by Immatics Biotechnologies GmbH and its U.S. subsidiary Immatics US, Inc. Therefore, the comparable consolidated financial statements as of December&nbsp;31, 2019 and for the years ended December&nbsp;31, 2019 and December&nbsp;31, 2018
represent consolidated financial statements of Immatics Biotechnologies GmbH. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These annual consolidated financial statements of the Group for the year
ended December&nbsp;31, 2020 were authorized for issue by the Management Board of Immatics N.V. on March&nbsp;30, 2021. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Basis of presentation </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of the Group have been prepared in accordance with International Financial Reporting Standards (&#147;IFRS&#148;) as
issued by the International Accounting Standards Board (&#147;IASB&#148;), taking into account the recommendations of the International Financial Reporting Standards Interpretations Committee (&#147;IFRS IC&#148;). The consolidated financial
statements are presented in Euro. Amounts are stated in thousands of Euros, unless otherwise indicated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group had a
<FONT STYLE="white-space:nowrap">non-controlling</FONT> interest, representing approximately 3.96% of the Group&#146;s Immatics US, Inc. subsidiary as of December&nbsp;31, 2019 and 2018. On July&nbsp;1, 2020 and as part of the ARYA Merger, the <FONT
STYLE="white-space:nowrap">non-controlling</FONT> interest of MD Anderson in Immatics US, Inc. was exchanged for ordinary shares in Immatics N.V. See note 3 for further details. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Short-term deposits, which have an original maturity between three and nine months, were previously classified within Other current assets and have been
retrospectively presented as a separate line item, Other financial assets, within the Statement of Financial Position. This change resulted in a reclassification of &#128;16.0&nbsp;million as of December&nbsp;31, 2019. This change in presentation
was made after review of the Group&#146;s financial statements subsequent to the ARYA Merger to ensure better comparability of the financial statements with peer companies and provide more relevant presentation within the Group&#146;s financial
statements. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.1</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Going concern </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since inception, the Group&#146;s activities have consisted primarily of raising capital and performing research and development activities to advance its
technologies. The Group is still in the development phase and has not yet marketed any products commercially. Immatics&#146; ongoing success depends on the successful development and regulatory approval of its products and its ability to finance
operations. The Group will seek additional funding to reach its development and commercialization objectives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group plans to seek funds through
further private or public equity financings, debt financings, collaboration agreements and marketing, distribution or licensing arrangements. The Group may not be able to obtain financing or enter into collaboration or other arrangements on
acceptable terms. If the Group is unable to obtain funding, it could be forced to delay, reduce or eliminate some or all of its research and development programs, product portfolio expansion or commercialization efforts, which could adversely affect
its business prospects. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
However, Immatics&#146; cash and cash equivalents as well as short-term deposits will be sufficient to fund operating expenses and capital expenditure requirements for at least twelve months from
the issuance date and expect a cash reach for at least twelve months. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accompanying consolidated financial statements have been prepared on a going
concern basis. This contemplates the Group will continue in operation for the foreseeable future and will be able to realize its assets and discharge its liabilities in the normal course of operations. The consolidated financial statements do not
reflect any adjustments relating to the recoverability and classification of assets or the amounts and classification of liabilities that would be necessary, was the Group unable to continue as a going concern. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.2</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Correction of classification of Statement of Cash Flows </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the third quarter of 2020, the Group identified and corrected the classification of short-term deposits with an original maturity dates between three
and nine months within the Statement of Cash Flows which resulted in a misclassification within the Statement of Cash Flows since 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has
evaluated the effect of this misclassification, both qualitatively and quantitatively, and concluded that the correction did not have a material impact on, nor require amendment of, any previously filed financial statements. In the Statement of Cash
Flows, the changes in short-term deposits were previously classified as (Increase) decrease in other assets within operating activities and has been retrospectively corrected and presented as separate line items within investing activities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This correction of classification resulted in the following impact to the Statement of Cash Flows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year ended December&nbsp;31, 2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year ended December&nbsp;31, 2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As<BR>reported</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Adjustment</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As<BR>revised</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As reported</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Adjustment</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As<BR>revised</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(Increase) decrease in other assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4,419</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,922</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,497</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(7,493</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,101</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,608</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net cash provided by operating activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68,045</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,922</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70,967</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,583</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,101</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,684</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash paid for investments classified in Other financial assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(20,473</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(20,473</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(13,101</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(13,101</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash received from maturity of investments classified in Other financial assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17,551</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17,551</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net cash used in investing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,137</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,922</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(5,059</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(413</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(13,101</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(13,514</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>Total effect on Cash Flow</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="12"></TD>
<TD HEIGHT="16" COLSPAN="12"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Three&nbsp;months&nbsp;ended&nbsp;March&nbsp;31,&nbsp;2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Six months ended June&nbsp;30, 2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As<BR>reported</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Adjustment</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As<BR>revised</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As&nbsp;reported</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Adjustment</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As<BR>revised</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(Increase) decrease in other assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(17,209</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,836</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(373</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,917</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(16,023</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,106</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net cash provided by/ (used in) operating activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(28,286</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,836</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(11,450</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(11,716</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(16,023</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(27,739</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash paid for investments classified in Other financial assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(32,859</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(32,859</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(32,859</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(32,859</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash received from maturity of investments classified in Other financial assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48,882</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48,882</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net cash provided by/ (used in) investing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,387</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(16,836</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(19,223</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4,550</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,473</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>Total effect on Cash Flow</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is no impact on the Group&#146;s Consolidated Statement of Financial Position, Consolidated Statement
of Changes in Shareholders&#146; Deficit, Consolidated Statement of Loss, Net loss per share, Consolidated Statement of Comprehensive Loss, and no impact to financing cash flows for the any of the periods presented. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.3</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><FONT STYLE="white-space:nowrap">COVID-19</FONT> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2019, a novel strain of coronavirus <FONT STYLE="white-space:nowrap">(&#147;COVID-19&#148;)</FONT> emerged. On January&nbsp;30, 2020, the World
Health Organization declared the outbreak a pandemic and a global emergency. In response, many countries and businesses instituted travel restrictions, quarantines, and office closures that are still in place. The extent of the pandemic and
governmental responses may impact our ability to obtain raw materials and equipment used for research and development, obtain sufficient additional funds to finance our operations, and conduct clinical trials, any of which could materially and
adversely affect our business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Management continues to monitor the situation and enacted significant measures to protect the Group&#146;s supply chain,
employees, and the execution of clinical trials. To date, the pandemic has resulted in a slowdown in activities related to the Group&#146;s laboratory operations and at some of its suppliers. The ongoing spread of
<FONT STYLE="white-space:nowrap">COVID-19</FONT> may also negatively impact the Group&#146;s ability to conduct clinical trials, including potential delays and restrictions on the Group&#146;s ability to recruit and retain patients, principal
investigators and healthcare employees. <FONT STYLE="white-space:nowrap">COVID-19</FONT> could also affect the operations of contract research organizations, which may also result in delays or disruptions in the supply of product candidates.
Immatics continues to expand its clinical programs with additional clinical trial sites opening in the U.S. and in Europe. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Due to <FONT
STYLE="white-space:nowrap">COVID-19,</FONT> the Group has also experienced delays in research activities performed under its collaboration agreements. Consequently, the Group recognized less revenue under these agreements in 2020 than previously
planned. Management believes the declines in revenue associated with the delay in research activities are largely temporary, as the revenue is primarily associated with <FONT STYLE="white-space:nowrap">non-refundable</FONT> upfront payments
recognized on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">cost-to-cost</FONT></FONT> basis. <FONT STYLE="white-space:nowrap">COVID-19</FONT> may continue to impact the timing and amount of revenue recognized under these
agreements in the future. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ARYA Merger </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;17, 2020, Immatics entered into a definitive merger agreement with ARYA Sciences Acquisition Corp. (&#147;ARYA&#148;), a special purpose
acquisition company sponsored by Perceptive Advisors. The transaction closed on July&nbsp;1, 2020. The merger (&#147;ARYA Merger&#148;) was effectuated as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The shareholders of Immatics Biotechnologies GmbH exchanged their interest for ordinary shares in the share
capital of Immatics B.V. (&#147;the Reorganization&#148;). The Reorganization is accounted for as a recapitalization, with Immatics Biotechnologies GmbH being the accounting predecessor. The Reorganization resulted in a &#128;0.8&nbsp;million
decrease in share capital and an offsetting increase in share premium. Subsequent to the Reorganization, Immatics B.V. was converted into Immatics N.V., after the share exchange of Immatics shareholders. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">As part of the Reorganization, the minority shareholder in Immatics US, Inc., MD Anderson Cancer Center (&#147;MD Anderson&#148;) exchanged its
interest in Immatics US, Inc. for ordinary shares in the share capital of Immatics N.V. (&#147;MD Anderson Share Exchange&#148;). This resulted in a decrease to <FONT STYLE="white-space:nowrap">non-controlling</FONT> interest of
&#128;0.5&nbsp;million, with corresponding increases to share capital and share premium. (See note 20). </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ARYA merged into Immatics N.V., with former ARYA shareholders receiving one ordinary share of Immatics N.V. for
each issued and outstanding ordinary share of ARYA and one warrant to purchase ordinary shares in Immatics N.V., for each issued and outstanding warrant to acquire ordinary shares in ARYA. The merger of ARYA constituted transaction by Immatics N.V.,
which is accounted for within the scope of IFRS 2. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">As part of the transaction, former shareholders of ARYA received
17,968,750 shares of Immatics N.V. and 7,187,500 warrants (&#147;Immatics Warrants&#148;) to purchase ordinary shares of Immatics N.V. In </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
exchange, Immatics received the net assets held by ARYA, which had a fair value of &#128;124.9&nbsp;million upon closing of the transaction on July&nbsp;1, 2020. The net assets included
&#128;128.8&nbsp;million of cash and cash equivalents held in ARYA&#146;s trust account and current liabilities of &#128;3.9&nbsp;million. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">In accordance with IFRS 2, the difference between the fair value of the net assets contributed by ARYA and the fair value of equity instruments
provided to former ARYA shareholders is treated as an expense, resulting in a &#128;152.8&nbsp;million Share listing expense classified within the Financial result (See Note 17) and an increase in equity. The 7,187,500 Immatics Warrants give the
holder the right, but not the obligation, to subscribe to Immatics&#146; shares at a fixed or determinable price for a specified period of time subject to the provision of the Warrant Agreement. Those instruments were considered equity instruments
according to IFRS 2 when they vested immediately on July 1, 2020. Management accounted for those instruments as equity instruments under IFRS 2 after the vesting date and has not applied the provisions of debt and equity classification under IAS 32.
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Immatics N.V. raised an additional net &#128;90.1&nbsp;million in net equity proceeds through a private placement
of ordinary shares with existing shareholders of Immatics, ARYA and other new investors (&#147;PIPE Financing&#148;). The PIPE Financing is treated as a capital contribution, which resulted in increases of &#128;0.1&nbsp;million and
&#128;90.0&nbsp;million to share capital and share premium, respectively. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Both the ARYA Merger and PIPE Financing closed as of
July&nbsp;1, 2020. Upon consummation of the transactions, Immatics N.V. became a publicly traded corporation at the Nasdaq Capital Market under the ticker IMTX. The Immatics Warrants are traded under the ticker IMTXW. Immatics incurred incremental
transaction costs directly attributable to the issuance of new shares to ARYA shareholders and the PIPE Financing of &#128;7.9&nbsp;million, which it netted against the equity proceeds as a reduction in share premium. As part of the <FONT
STYLE="white-space:nowrap">year-end</FONT> closing, we adjusted the transaction cost netted against the equity proceeds by &#128;0.6&nbsp;million. The adjustment was immaterial for our financial statements. The adjustment was due to a revised
allocation of cost, both attributable to the issuance of new shares as well as listing of existing shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Immatics also amended existing share-based
compensation agreements held by employees of Immatics GmbH prior to the ARYA Merger (See Note 18), in addition to making additional cash and share-based payments to key management personnel (See Note 26). </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Application of new and revised international financial reporting standards </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.1</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Application of new standards </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accounting policies adopted in the preparation of the consolidated financial statements are consistent with those followed in the preparation of the
Group&#146;s annual consolidated financial statements for the year ended December&nbsp;31, 2019, except for the adoption of new standards and interpretations effective as of January&nbsp;1, 2020. The Group has not early adopted any standard,
interpretation or amendment that has been issued but is not yet effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New standards and interpretations applied for the first time: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Standard/interpretation</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Effective&nbsp;date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amendments to IFRS 3, &#147;Business combinations&#148;, - Definition of a business</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">January&nbsp;1,&nbsp;2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Amendments to IAS 1, &#147;Presentation of financial statements&#148;, and IAS 8, &#147;Accounting policies, changes in accounting estimates and errors&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">January&nbsp;1, 2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amendment to IFRS 9, IAS 39 and IFRS 17: - Interest rate benchmark reform</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">January&nbsp;1, 2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amendment to the Conceptual framework</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">January&nbsp;1, 2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Those amendments on standards and interpretations had no effect on the consolidated financial statements of the Group. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.2</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Assessment of potential impact of future standards, amendments to existing standards and interpretations
</B></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following standards and interpretations have been issued by the IASB, but were not yet mandatory for the year ended
December&nbsp;31, 2020: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Standard/interpretation</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Effective&nbsp;date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Material&nbsp;effect&nbsp;expected<BR>on Immatics financial<BR>statements</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">IFRS 16
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">COVID-19-Related</FONT></FONT> Rent Concessions Amendment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">January&nbsp;1,&nbsp;2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">No</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amendments to IAS 1,&#148; Presentation of financial statements&#148;, on classification of
liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">January&nbsp;1, 2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">No</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">IFRS 17 Insurance contracts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">January&nbsp;1, 2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">No</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Summary of accounting policies applied by the Group for the annual reporting period ending December&nbsp;31,
2020 </B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following are the significant accounting policies applied by the Group in preparing its consolidated financial statements:
</P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.1</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Segment information </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group manages its operations as a single segment for the purposes of assessing performance and making operating decisions. The Group&#146;s focus is on the
research and development of T cell redirecting immunotherapies for the treatment of cancer. The Chief Executive Officer is the chief operating decision maker who regularly reviews the consolidated operating results and makes decisions about the
allocation of the Group&#146;s resources. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.2</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Cash and cash equivalents </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents in the Consolidated Statement of Financial Position is comprised of cash held at banks (including money market funds) and short-term
deposits with an original maturity of three months or less. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.3</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Financial assets </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Initial recognition and measurement </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial assets
within the scope of IFRS 9 include cash and cash equivalents, loans, short-term deposits and receivables. Immatics determines the classification of its financial assets at initial recognition. All financial assets are recognized initially at fair
value plus transaction costs. Purchases and sales of financial assets are recognized on their trade date, on which the Group commits to purchase or sell the asset. The subsequent measurement of financial assets depends on their classification as
described below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Short-term deposits </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Immatics has
short-term deposits with original maturities between three and nine months, which are classified as Other financial assets. Short-term deposits with an original maturity of three months or less are classified as cash and cash equivalents. Under IFRS
9 short-term deposits are classified within financial assets at fair value. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Receivables </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group has receivables from collaboration agreements. A receivable must be capitalized at the point in time at which the Group has become a contractual
partner and a claim to cash and cash equivalents has arisen. In subsequent reporting periods, a receivable is measured at amortized cost using the effective interest method. Since the receivables are short-term receivables without a fixed interest
rate, these receivables are capitalized at the original invoice or contract amount. Receivable balances are classified as current assets, because all of the Group&#146;s receivables have an expected maturity of less than 12 months. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Interest and other finance income </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial instruments include money market funds and short-term deposits measured at fair value. Interest income is recorded using the effective interest rate
(EIR). EIR is the rate that discounts the estimated future cash payments or receipts over the expected life of the financial instrument or a shorter period, where appropriate, to the net carrying amount of the financial asset or liability. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2020, Immatics is a counterparty in foreign exchange forward contracts. The contracts do not meet the criteria to apply hedge
accounting and are therefore separately accounted for and measured at fair value. Any change in the fair value is accounted for within the Consolidated Statement of Loss. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.4</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Property, plant and equipment </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Property, plant and equipment is stated at cost, net of accumulated depreciation and accumulated impairment losses, if any. All repair and maintenance costs
are recognized as expense when incurred. Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets. The estimated useful lives are generally within the following ranges: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Category</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Estimated&nbsp;useful&nbsp;life</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Computer equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">1&nbsp;&#150;&nbsp;10&nbsp;years</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Laboratory equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">1 &#150; 15 years</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Office equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">2 &#150; 20 years</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.5</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Intangible assets </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Acquired intangible assets are initially recognized at cost. Following initial recognition, intangible assets are carried at cost less accumulated amortization
and accumulated impairment losses, if any. Intangible assets with finite lives are amortized over their useful economic lives and assessed for impairment, whenever there is an indication that the intangible asset may be impaired. The amortization
period and the amortization method for an intangible asset with a finite useful life, is reviewed at least at the end of each reporting period. Immatics does not have any internally developed intangible assets or intangible assets with indefinite
useful lives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amortization is calculated on a straight-line basis over the estimated useful lives of the assets as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Category</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Estimated&nbsp;useful&nbsp;life</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Licenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">5&nbsp;&#150;&nbsp;30&nbsp;years</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Software</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">1 &#150; 5 years</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.6</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Research and development </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Research expenses are defined as costs incurred for current or planned investigations undertaken with the prospect of gaining new scientific or technical
knowledge and understanding. All Research costs are expensed as incurred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An intangible asset arising from development expenditure on an individual
project is recognized only when the Group can demonstrate the technical feasibility of completing the intangible asset so that it will be available for use or sale, its intention to complete and its ability to use or sell the asset, how the asset
will generate future economic benefits, the availability of resources to complete and the ability to measure reliably the expenditure during the development. The Group did not recognize any intangible assets from development expenditures in 2020,
2019 and 2018 due to the existing uncertainties in connection with its development activities. Research and development expenses include the following types of costs: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">salaries, benefits and other related costs, including stock-based compensation, for personnel engaged in
research and development functions; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">expenses incurred in connection with the preclinical development of our programs and clinical trials of our
product candidates, including under agreements with third parties, such as consultants, contractors, academic institutions and contract research organizations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the cost of manufacturing product candidates for use in clinical trials, including under agreements with third
parties, such as, consultants and contractors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">laboratory costs; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">leased facility costs, equipment depreciation and other expenses, which include direct and allocated expenses;
and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">intellectual property costs incurred in connection with filing and prosecuting patent applications as well as
third-party license fees. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.7</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Financial liabilities: Initial recognition and measurement </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial liabilities within the scope of IFRS 9 are classified as financial liabilities at fair value through profit or loss or at amortized cost, as
appropriate. The Group determines the classification of its financial liabilities at initial recognition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All financial liabilities are recognized
initially at fair value and, in the case of loans and borrowings, carried at amortized cost. This includes directly attributable transaction costs. Immatics only recognized accounts payable as other financial liabilities at amortized costs. The
Group has not designated any financial liabilities upon initial recognition as fair value through profit or loss. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group does not engage in hedging
transactions that meet the criteria to apply hedge accounting. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.8</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Leases </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Application of IAS 17 (&#147;Leases&#148;) until December&nbsp;31, 2018 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to 2019, the Group applied IAS 17 when accounting for leases. As a lessee under IAS 17, leases for which substantially all the risks and rewards of
ownership transferred to the Group were classified as finance leases. Finance leases were capitalized at the lease&#146;s inception at the fair value of the leased property or, if lower, the present value of the minimum lease payments. The
corresponding rental obligations, net of finance charges, were included in other current liabilities and other <FONT STYLE="white-space:nowrap">non-current</FONT> liabilities. Each lease payment was allocated between the liability and finance cost.
The finance cost was charged as an expense over the lease period so as to produce a constant periodic rate of interest on the remaining balance of the liability for each period. The assets associated with the finance leases are depreciated over the
shorter of the asset&#146;s useful life or the lease term if there is no reasonable certainty that the Group will obtain ownership at the end of the lease term. Leases in which a significant portion of the risks and rewards of ownership were not
transferred to the Group as lessee were classified as operating leases. Payments made under operating leases (net of any incentives received from the lessor) were charged as an expense on a straight-line basis over the period of the lease. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Application of IFRS 16 (&#147;Leases&#148;) effective January&nbsp;1, 2019 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group adopted IFRS 16 (&#147;Leases&#148;) effective January&nbsp;1, 2019. The Group leases various offices, equipment and vehicles. Rental contracts are
typically made for fixed periods of two to seven years but may have extension options as described in below. Contracts may contain both lease and <FONT STYLE="white-space:nowrap">non-lease</FONT> components. The Group has elected not to separate
lease and <FONT STYLE="white-space:nowrap">non-lease</FONT> components and instead accounts for these as a single lease component. Lease terms are negotiated on an individual basis. The lease agreements do not impose any covenants other than the
security interests in the leased assets that are held by the lessor. Leased assets may not be used as security for borrowing purposes. Under IFRS 16, leases are recognized as a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset with a corresponding liability on the date at which the leased asset is available for use by the Group. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Assets and liabilities arising from a lease are initially measured on a present value basis. Lease liabilities include the net present value of the following
lease payments: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">fixed payments (including <FONT STYLE="white-space:nowrap">in-substance</FONT> fixed payments), less any lease
incentives received. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">amounts expected to be payable by the Group under residual value guarantees. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the exercise price of a purchase option if the Group is reasonably certain to exercise that option; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">payments of penalties for terminating the lease, if the lease term reflects the Group exercising that option.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Lease payments to be made under reasonably certain extension options are also included in the measurement of the liability. The lease
payments are discounted using the interest rate implicit in the lease. If that rate cannot be readily determined, which is generally the case for the Group&#146;s leases, the lessee&#146;s incremental borrowing rate is used. The incremental
borrowing rate is the rate that the individual lessee would have to pay to borrow the funds, necessary to obtain an asset of similar value to the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset in a
similar economic environment with similar terms, security and conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To determine the incremental borrowing rate, the Group: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">uses a <FONT STYLE="white-space:nowrap">build-up</FONT> approach that starts with a risk-free interest rate
adjusted for credit risk for leases held by Immatics, and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">makes adjustments specific to the lease, including lease term, country, currency and security
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT> assets are measured at cost comprising the
following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the amount of the initial measurement of lease liability </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any lease payments made at or before the commencement date less any lease incentives received
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any initial direct costs, and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">restoration costs. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT> assets are generally depreciated over the shorter of the
asset&#146;s useful life or the lease term on a straight-line basis. If the Group is reasonably certain to exercise a purchase option, the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset is
depreciated over the underlying asset&#146;s useful life. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payments associated with short-term leases of equipment and vehicles and all leases of <FONT
STYLE="white-space:nowrap">low-value</FONT> assets are recognized on a straight-line basis as an expense. Short-term leases are leases with a lease term of 12 months or less. <FONT STYLE="white-space:nowrap">Low-value</FONT> assets have a value of
less than &#128;5&nbsp;thousand. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Extension and termination options are included in a number of property and equipment leases across the Group. These are
used to maximize operational flexibility in terms of managing the assets used in the Group&#146;s operations. The extension and termination options held are exercisable only by the Group and not by the respective lessor. For relevant leases which
include an extension option, Immatics performed an assessment as of December&nbsp;31, 2020 to determine whether option extensions are reasonably certain. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.9</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Revenue from collaboration agreements </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. As of December&nbsp;31, 2020,
the Group had four strategic collaboration agreements in place with Amgen Inc., Thousand Oaks/CA/USA (&#147;Amgen&#148;), Genmab A/S, Copenhagen/Denmark (&#147;Genmab&#148;), Celgene Switzerland LLC (&#147;BMS&#148;) and GlaxoSmithKline Intellectual
Property Development Limited (&#147;GSK&#148;). Each of the Group&#146;s four strategic collaboration agreements are in the <FONT STYLE="white-space:nowrap">pre-clinical</FONT> stage. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To determine the recognition of revenue from arrangements that fall within the scope of IFRS 15, the Group performs the following five steps: </P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">identify the contract(s) with a customer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">identify the performance obligations in the contract; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">determine the transaction price; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">allocate the transaction price to the performance obligations in the contract; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">recognize revenue when (or as) the Group satisfies a performance obligation. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the terms of these agreements, Immatics agrees to collaborate in the development, manufacture, and commercialization of cancer immunotherapy treatments
for specified targets identified through the use of Immatics XPRESIDENT technology. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As part of the collaboration arrangements, Immatics grants exclusive
licensing rights for the development and commercialization of future product candidates, developed for targets defined in the collaboration agreements. Additionally, Immatics agrees to perform certain research activities under the collaboration
agreements, including screening of highly specific molecules for reactivity with the specified targets and <FONT STYLE="white-space:nowrap">off-targets</FONT> using Immatics&#146; proprietary technology and
<FONT STYLE="white-space:nowrap">know-how,</FONT> participation on steering committees, and preparation of data packages. The research activities are the predominant item in each of the Group&#146;s collaboration agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group performs an analysis to identify the performance obligations under the contract, including licenses and rights to future intellectual property
developed under the contract and research activities. As these agreements comprise several promises, it must be assessed whether these promises are capable of being distinct and distinct within the context of the contract. <FONT
STYLE="white-space:nowrap">Up-front</FONT> licensing payments and reimbursement for research and development expenses are initially deferred on our Consolidated Statement of Financial Position and subsequently recognized as costs are incurred using
a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">cost-to-cost</FONT></FONT> method. Milestone payments are generally included in the transaction price at the amount stipulated in the respective agreement and recognized to the
extent that it is highly probable that a&nbsp;significant reversal&nbsp;in the amount of cumulative revenue recognized will not occur. To date, no milestone has been included in the transaction price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As stated above, the licenses contributed under the collaboration agreements currently in place do not represent distinct performance obligations, because the
Group&#146;s collaboration partners would likely be unable to derive significant benefits from their access to these targets without Immatics&#146; research activities. Identification of a viable product candidate that will bind to the targets
specified in the agreements requires use of the Group&#146;s XPRESIDENT technology and database of target and <FONT STYLE="white-space:nowrap">off-target</FONT> data. These agreements include a <FONT STYLE="white-space:nowrap">non-refundable</FONT>
upfront payment, payments for research and development activities in certain circumstances, and payments based upon the achievement of defined milestones. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under IFRS 15, the Group applies significant judgement when evaluating whether the obligations under these agreements represent one or more combined
performance obligations, the allocation of the transaction price to identified performance obligations, and the determination of whether milestone payments should be included in the transaction price. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Upfront payment </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each of the Group&#146;s strategic
collaboration agreements included a <FONT STYLE="white-space:nowrap">non-refundable</FONT> upfront payment, meant to subsidize research activities. The Group recorded these payments as deferred revenue, which it allocated to the combined performance
obligations for each agreement. Such amounts are recognized as revenue over the performance period of the research activities on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">cost-to-cost</FONT></FONT> basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">cost-to-cost</FONT></FONT> basis using direct costs and directly attributable personal
costs was considered the best measure of progress in which control of the combined performance obligations transfers to the Group&#146;s collaboration partners, due to the nature of the work being performed. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Reimbursement for services </I></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the collaboration
agreement with Genmab, the Group receives reimbursement for employee research and development costs. These employee costs are presented as research and development expenses, while </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
reimbursements of those costs, which is based on an FTE rate defined in the contract, are presented as revenue and not deducted from expenses. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Development and Commercial Milestones </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The collaboration
agreements include contingent payments related to development and commercial milestone events. These milestone payments represent variable consideration that are not initially recognized within the transaction price, due to the scientific
uncertainties and the required commitment from the collaboration partners to develop and commercialize a product candidate. The Group assesses the probability of significant reversals for any amounts that become likely to be realized prior to
recognizing the variable consideration, associated with these payments within the transaction price. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Sales-based milestones and royalty payments
</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The collaboration agreements also include sales-based royalty payments upon successful commercialization of a licensed product. In accordance with
IFRS 15.B63, the Group recognizes revenue from sales-based milestone and royalty payments at the later of (i)&nbsp;the occurrence of the subsequent sale; or (ii)&nbsp;the performance obligation to which some or all of the sales-based milestone, or
royalty payments has been allocated has been satisfied. The Group anticipates recognizing these milestones and royalty payments, when subsequent sales are generated from a licensed product by the collaboration partner. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Cost to fulfill contracts </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group incurs costs for
personnel, supplies and other costs related to its laboratory operations as well as fees from third parties and license expenses in connection with its research and development obligations under the collaboration and licensing agreement. These costs
are recognized as research and development expenses over the period in which services are performed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Cost to obtain a contract </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For some collaboration agreements, the Group incurs incremental costs of obtaining a contract with a customer. The Group capitalizes those incremental costs if
the costs are expected to be recovered. The recognized asset is amortized consistent with the method used to determine the pattern of revenue recognition of the underlying contract. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.10</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Share-based payment </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group&#146;s Employees as well as others providing similar services to the Group, receive remuneration in the form of share-based payments, which are
equity-settled transactions. The Group`s equity-settled option plans include Matching Stock Options, Converted Stock Options, Service Options and PSUs and are described in detail in Note 18. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The costs of equity-settled transactions are determined by the fair value at grant date, using an appropriate valuation model. Share-based expenses for the
respective vesting periods, are recognized in research and development expenses and general and administrative expenses, reflecting a corresponding increase in equity. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.11</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Other income </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group primarily earns other income from government research grants. Government grants are recognized as income when there is reasonable assurance that the
grant will be received and all required conditions have been complied with. Grants from governmental agencies for the support of specific research and development projects are recorded as other income to the extent the related expenses have been
incurred. Grant agreements include a budget that specifies the amount and nature of expenses allowed during the entire grant term. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Expenses incurred
under the grants are calculated according to agreed-upon terms on a quarterly basis, filed with the governmental agencies, and recorded as income. The governmental agencies make payments to the Group
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
based on these calculations of expenses incurred under the grants. If these estimated calculations change, the Group will then adjust grant income in the subsequent period. The Group believes
that its calculations are based on the agreed-upon terms as stated in the grant agreements. The governmental agencies generally have the right to audit the Group&#146;s calculations. If the governmental agencies disagree with the Group&#146;s
calculations the amount of grant income recognized could change. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>5.12</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Foreign currency </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transactions and balances in Germany and in the USA </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
consolidated financial statements are presented in Euro, which is the parents&#146;, Immatics N.V. functional and presentation currency. Assets and liabilities of foreign operations are translated into Euros at the rate of exchange prevailing at the
reporting. The Consolidated Statement of Loss is translated at average exchange rates. The currency translation differences are recognized in other comprehensive loss. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Transactions in foreign currencies are initially recorded by the Group&#146;s entities at their respective functional currency spot rates, at the date the
transaction first qualifies for recognition. The Group used the following exchange rates to convert the financial statements of its U.S. subsidiary: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Year-end</FONT><BR>rate</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Average<BR>rate</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Year-end</FONT><BR>rate</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Average<BR>rate</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Year-end</FONT><BR>rate</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Average<BR>rate</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Euros per U.S.&nbsp;Dollar</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.8149</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.8762</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.8902</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.8932</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.8738</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.8468</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.13</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Fair value of financial instruments </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the
measurement date. The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the principal market for the asset or liability or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the absence of a principal market, in the most advantageous market for the asset or liability that is
accessible by the Group. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of an asset or a liability is measured using the assumptions that market participants would use
when pricing the asset or liability, assuming that market participants act in their economic best interest. The Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair
value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs. All assets and liabilities for which fair value is measured or disclosed in the consolidated financial statements are categorized within the fair
value hierarchy, described as follows, based on the lowest level input that is significant to the fair value measurement as a whole: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Level&nbsp;1 &#151; Quoted (unadjusted) market prices in active markets for identical assets or liabilities.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Level&nbsp;2 &#151; Valuation techniques, for which the lowest level input that is significant to the fair
value measurement is directly or indirectly observable. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Level&nbsp;3 &#151; Valuation techniques, for which the lowest level input that is significant to the fair
value measurement is unobservable. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For assets and liabilities that are recognized in the consolidated financial statements at fair
value on a recurring basis, the Group determines whether transfers have occurred between levels in the hierarchy by <FONT STYLE="white-space:nowrap">re-assessing</FONT> categorization (based on the lowest level input that is significant to the fair
value measurement as a whole), at the end of each reporting period. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.14</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Provisions </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Provisions are recognized when the Group has a present obligation (legal or constructive) as a result of a past event, it is probable that an outflow of
resources embodying economic benefits will be required to settle the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
obligation and a reliable estimate can be made of the amount of the obligation. Where the Group expects some or all of a provision to be reimbursed, for example under an insurance contract, the
reimbursement is recognized as a separate asset but only when the reimbursement is virtually certain. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the effect of the time value of money is
material, provisions are discounted using a current <FONT STYLE="white-space:nowrap">pre-tax</FONT> rate that reflects, when appropriate, the risks specific to the liability. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.15</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Income Tax </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Deferred income tax results from temporary differences between the carrying amount of an asset or a liability and its tax base. Deferred income tax is provided
in full using the liability method on temporary differences. In accordance with IAS 12 (&#147;Income Taxes&#148;), the deferred tax assets and liabilities reflect all temporary valuation and accounting differences between financial statements
prepared for tax purposes and our consolidated financial statements. Tax losses carried forward are considered in deferred tax assets calculation. The Group offsets tax assets and liabilities if and only if it has a legally enforceable right to set
off current tax assets, current tax liabilities, deferred tax assets and deferred tax liabilities which relate to income taxes levied by the same tax authority. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Significant accounting judgements, estimates and assumptions </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of the Group&#146;s consolidated financial statements requires management to make judgements, estimates and assumptions that affect the
reported amounts of revenue, expenses, assets and liabilities, income taxes and the accompanying disclosures. Uncertainty about these assumptions and estimates could result in outcomes that require a material adjustment to the carrying amount of the
asset or liability affected in future periods. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Estimates &#150; Taxes </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Uncertainties exist with respect to the interpretation of complex tax regulations, changes in tax laws, and the amount and timing of future taxable income.
Given the wide range and complexity of existing contractual agreements, differences arising between the actual results and the assumptions made, or future changes to such assumptions, could necessitate future adjustments to tax income and expense
already recorded. Deferred tax assets are recognized for unused tax losses to the extent, that it is probable that taxable profit will be available which can be utilized against the losses. Significant management judgement is required to determine
the amount of deferred tax assets that can be recognized, based upon the likely timing and the level of future taxable profits together with future tax planning strategies. Due to the Group&#146;s history of loss-making over the last several years
as well as the plans for the foreseeable future, the Group has not recognized any deferred tax assets on tax losses carried forward. Changes in the estimation of our potential to use tax losses carried forward can have a material effect on the
Group`s net income. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Revenue recognition from collaboration agreements </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As the collaboration agreements comprise several promises, it must be assessed whether these promises are capable of being distinct within the context of the
contract. For the four collaboration agreements the Group assessed that these promises are not capable of being distinct within the context of the contract, which results in accounting for all goods and services promised as a single performance
obligation with a single measure of progress. The performance obligation is accounted for as a performance obligation, satisfied over time using a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">cost-to-cost</FONT></FONT> method as
the customer simultaneously receives and consumes the benefits from Immatics&#146; performance. <FONT STYLE="white-space:nowrap">Up-front</FONT> licensing payments are initially deferred on our Consolidated Statement of Financial Position and
subsequently recognized as revenue over time as costs are incurred. Milestone payments are generally included in the transaction price at the amount stipulated in the respective agreement and recognized as revenue to the extent that it is highly
probable that a&nbsp;significant reversal&nbsp;in the amount of cumulative revenue </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
recognized will not occur. To date, no milestone has been included in the transaction price. Changes in this estimate can have a material effect on revenue recognized. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Immatics provides development and manufacturing services to customers and recognizes revenue over time using an input-based method to measure progress toward
complete satisfaction of the service, because the customer simultaneously receives and consumes the benefits provided. Forecast values are used for the calculation of expected future revenue for the remaining term of the contract. These costs
estimated as part of the budgeting process must be reviewed and approved before the Group can use them for recognition purposes. Significant management judgment is </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">required to determine the level of effort required under an arrangement, and the period over which the Company expects to complete its performance obligations
under the arrangement which includes total internal personnel costs and external costs to be incurred. Changes in these estimates can have a material effect on revenue recognized. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Share-based payments </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Determining the fair value of
share-based payment transactions requires the most appropriate valuation for the specific program, which depends on the underlying terms and conditions. This estimate also requires the determination of the most appropriate inputs to the valuation
model, including the fair value of the share option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Management determined the value of share-based awards with the assistance of a third-party valuation
specialist using certain assumptions, such as share price volatility, the determination of an appropriate risk-free interest rate, expected dividends and the probability of reaching certain exercisability criteria. Changes in these estimates can
have a material effect on share-based expenses recognized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For 2018 and 2019, the vested SARs under the 2010 Plan could only be exercised in an event
that more than 50% of the shareholdings in the Company will be acquired by a third person (&#147;Change of control&#148;) and the vested SARs of the 2016 Plan might only be exercised upon the occurrence of a change in control or expiration of the
applicable <FONT STYLE="white-space:nowrap">lock-up</FONT> period following completion of an initial public offering (&#147;IPO&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair values
of these awards were discounted based on the probability of the awards becoming exercisable. It is necessary to look at different scenarios under which the award would be expected to be realized. Therefore, it was necessary to estimate the
probability of each such scenario. The present value of the probability-weighted fair value under all scenarios represents the value of the awards. The difficulty in applying this method is the estimation of the different possible outcomes and the
probabilities associated with such outcomes. Management&#146;s assessment is updated at each valuation date. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Classification of Warrants </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As described in Note 3 AYA Merger Immatics Warrants give the holder the right, but not the obligation, to subscribe to Immatics&#146; shares at a fixed or
determinable price for a specified period of time subject to the provision of the Warrant Agreement. Those instruments were considered equity instruments according to IFRS 2 when they vested immediately on July 1, 2020. Management accounted for
those instruments as equity instruments under IFRS 2 after the vesting date and has not applied the provisions of debt and equity classification under IAS 32. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Accounts receivable </B></P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Receivables from collaboration agreements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;957</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Accounts receivable</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,250</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>957</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2020, and 2019, no receivables were considered impaired. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Other current and <FONT STYLE="white-space:nowrap">non-current</FONT> assets </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other current assets </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Grant receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">998</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2,389</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,236</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Positive market value forward contract</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">914</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Value added tax receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">798</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">768</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Capitalized transaction costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">787</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">617</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Other current assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,763</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,667</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group recognizes receivables for government grants when it is reasonably assured that the grant will be received, and all
contractual conditions have been complied with. As of December&nbsp;31, 2020, and 2019, no receivables were considered impaired. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prepaid expenses include
prepaid insurance expenses of &#128;1.0&nbsp;million and &#128;0.1&nbsp;million as of December&nbsp;31, 2020 and 2019, respectively. The Group paid &#128;0.5&nbsp;million and &#128;0.6&nbsp;million of incremental cost for the successful arrangement
of the Celgene Switzerland LLC (&#147;BMS&#148;) and Genmab A/S (&#147;Genmab&#148;) collaboration agreements as of December&nbsp;31, 2020 and 2019, respectively. Additionally, prepaid expenses include expenses for licenses and software of
&#128;0.6&nbsp;million and &#128;0.2&nbsp;million as of December&nbsp;31, 2020 and 2019, respectively. The remaining amount is related to prepaid maintenance expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other assets include receivables from capital gains tax of &#128;0.4&nbsp;million and &#128;0.3&nbsp;million as of December&nbsp;31, 2020 and 2019,
respectively. The remaining amount is related to prepaid deposit expenses. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other <FONT STYLE="white-space:nowrap">non-current</FONT> assets </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;724</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;937</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other <FONT STYLE="white-space:nowrap">non-current</FONT> assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total <FONT STYLE="white-space:nowrap">non-current</FONT> assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>724</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,262</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prepaid expenses consist of &#128;0.7&nbsp;million and &#128;0.9&nbsp;million of incremental cost paid for the successful
arrangement of the BMS and Genmab collaboration agreements as of December&nbsp;31, 2020 and 2019, respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Property, plant and equipment </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Changes to property, plant and equipment during 2020 and 2019 consisted of the following: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="3"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Laboratory<BR>equipment</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Computer<BR>equipment</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Office<BR>equipment</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; "></TR>
<TR STYLE="font-size:1px; "></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cost as of January&nbsp;1, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>11,222</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,439</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,455</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>15,116</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Impact of IFRS 16 adoption</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(441</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(441</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cost as of January&nbsp;1, 2019, adjusted</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>10,781</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,439</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,455</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>14,675</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,204</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">515</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">297</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Disposals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(314</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(316</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Currency translation differences</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cost as of December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>12,723</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,956</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,753</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>17,432</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Accumulated depreciation as of January&nbsp;1,&nbsp;2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>8,279</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,793</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,037</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>11,109</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,219</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">256</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">322</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,797</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Disposals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(218</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(219</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Currency translation differences</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Accumulated depreciation as of December&nbsp;31,&nbsp;2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>9,303</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,050</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,359</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>12,712</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net book value as of December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,420</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>906</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>394</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,720</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cost as of January&nbsp;1, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>12,723</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,956</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,753</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>17,432</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,545</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">406</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,427</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,379</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Disposals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Currency translation differences</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">299</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">367</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cost as of December&nbsp;31, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>15,968</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,322</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,146</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>22,437</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Accumulated depreciation as of January&nbsp;1,&nbsp;2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>9,303</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,050</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,359</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>12,712</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,384</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">404</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">315</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,102</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Disposals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Currency translation differences</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">210</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">239</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Accumulated depreciation as of December&nbsp;31,&nbsp;2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>10,476</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,428</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,665</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>14,568</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net book value as of December&nbsp;31, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,493</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>894</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,481</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7,868</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Depreciation expense is included in the following line items of the Consolidated Statement of Loss: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,315</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,757</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">482</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">301</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,103</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,797</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,058</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>10.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Intangible assets </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Changes to intangible assets during 2020 and 2019 consisted of the following: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Patents<BR>and<BR>licenses</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Software<BR>licenses</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cost as of January&nbsp;1, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>&nbsp;&nbsp;1,201</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;551</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,752</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Currency translation differences</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cost as of December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,220</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>643</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,863</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Accumulated amortization as of January&nbsp;1, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>314</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>399</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>713</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">111</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Currency translation differences</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Accumulated amortization as of December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>369</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>486</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>855</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net book value as of December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>851</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>157</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,008</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cost as of January&nbsp;1, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,220</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>643</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,863</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">104</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">104</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Currency translation differences</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(88</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(97</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cost as of December&nbsp;31, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,132</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>738</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,870</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Accumulated amortization as of January&nbsp;1, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>369</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>486</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>855</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">126</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Currency translation differences</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(22</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(25</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Accumulated amortization as of December&nbsp;31, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>403</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>554</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>956</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net book value as of December&nbsp;31, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>730</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>184</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>914</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amortization expense is classified as follows within the Consolidated Statement of Loss: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="69%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;109</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>126</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>111</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>118</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>11.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Leases </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Right-of</FONT> use assets consist of the following: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Buildings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5,760</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2,799</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">IT and telecommunication</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">258</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">349</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vehicles</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6,149</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,287</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Lease liabilities consist of the following: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease liability &#150; current</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,881</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,411</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease liability &#150; <FONT STYLE="white-space:nowrap">non-current</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,306</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,823</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6,187</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,234</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additions to the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets were
&#128;5.1&nbsp;million and &#128;0.3&nbsp;million as of December&nbsp;31, 2020 and 2019, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Currency translation differences included in <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets were &#128;0.3&nbsp;million and &#128;0.05&nbsp;million as of December&nbsp;31, 2020 and 2019, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Expenses related to <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets and lease liabilities consist of the
following: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Depreciation charges of <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(Euros&nbsp;in&nbsp;thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Buildings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,036</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,804</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">IT and telecommunication</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">101</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">101</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vehicles</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,195</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,950</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Interest expenses form leases</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">170</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Expense relating to short-term leases and <FONT STYLE="white-space:nowrap">low-value</FONT>
assets (included in administrative expenses)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The total cash payments for leases were &#128;2.4&nbsp;million and &#128;2.1&nbsp;million as of December&nbsp;31, 2020 and
2019, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2020, the Group has committed lease payments of &#128;6.9&nbsp;million, of which &#128;2.1&nbsp;million will
occur in the next 12 months. The remaining lease payments will occur between January&nbsp;1, 2022 and December&nbsp;31, 2026. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>12.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Accounts payable </B></P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,554</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,866</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,498</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,216</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total accounts payable</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>10,052</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7,082</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other accrued liabilities classified within accounts payable mainly relate to outstanding invoices totaling
&#128;7&nbsp;million and &#128;2&nbsp;million as of December&nbsp;31, 2020 and 2019, respectively. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>13.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Revenue from collaboration agreements </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group earns revenue through strategic collaboration agreements with third party pharmaceutical and biotechnology companies. As of December&nbsp;31, 2020,
the Group had four strategic collaboration agreements in place. All collaboration agreements are still at <FONT STYLE="white-space:nowrap">pre-clinical</FONT> stage. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As part of these collaboration arrangement, Immatics grants exclusive licensing rights or options thereto
for the development and commercialization of future product candidates, developed for several targets defined in the respective collaboration agreements, in addition to research activities, including screening of highly specific molecules for
reactivity with the specified targets and <FONT STYLE="white-space:nowrap">off-targets</FONT> using Immatics&#146; proprietary technology and <FONT STYLE="white-space:nowrap">know-how,</FONT> participation on a joint steering committee, and
preparation of data packages. For each collaboration agreement, these promises represent one combined performance obligation, because the research activities are mutually dependent and the respective collaboration partner is unable to derive
significant benefits from their access to these targets without Immatics&#146; research activities, which are highly specialized and cannot be performed by other organizations. Under each agreement, research activities were determined to be the
predominant item under the contract. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Amgen Collaboration Agreement </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2016, Immatics Biotechnologies GmbH entered into a research collaboration and license agreement with Amgen Inc. (&#147;Amgen&#148;) to develop
next-generation, T cell engaging bispecific immunotherapies targeting multiple cancers. Under the terms of the agreement, Immatics contributed its XPRESIDENT target discovery and T cell receptor (TCR) capabilities to the <FONT
STYLE="white-space:nowrap">pre-clinical</FONT> development of product candidates. Amgen Inc. contributed its validated Bispecific T cell Engager (BiTE<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>) technology and will be responsible for
the clinical development, manufacturing and commercialization worldwide. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the collaboration agreement with Amgen development milestone payments and
commercial milestone payments amount to a maximum up to $525&nbsp;million for each program and tiered royalties up to a double-digit percentage of net sales. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group received a <FONT STYLE="white-space:nowrap">non-refundable</FONT> upfront payment of $30&nbsp;million (&#128;28 million) upon signing of the Amgen
agreement. The Group classified the initial receipt of the upfront payment as deferred revenue, which recognizes into revenue as on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">cost-to-cost</FONT></FONT> basis using forecasted
costs. A <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">cost-to-cost</FONT></FONT> basis was determined most representative of the transfer of benefits to Amgen. The Group recognized approximately &#128;4.9&nbsp;million,
&#128;6.2&nbsp;million and &#128;1.5&nbsp;million of revenue associated with the upfront payment during the years ended December&nbsp;31, 2020, 2019 and 2018, respectively. Total deferred revenue under the agreement was &#128;10&nbsp;million and
&#128;15&nbsp;million as of December&nbsp;31, 2020 and 2019, respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Genmab Collaboration Agreement </I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In July 2018, Immatics Biotechnologies GmbH entered into a research collaboration and license agreement with Genmab A/S (&#147;Genmab&#148;) to develop
next-generation, T cell engaging bispecific immunotherapies targeting multiple cancer indications. Under the agreement, Immatics and Genmab conduct joint research to combine Immatics&#146; XPRESIDENT and Bispecific TCR technology platforms with
Genmab&#146;s proprietary antibody technologies to develop multiple bispecific immunotherapies in oncology. The two companies plan to develop immunotherapies directed against three proprietary targets. Genmab will be responsible for development,
manufacturing and worldwide commercialization. Immatics will have an option to contribute certain promotion efforts at predetermined levels in selected countries in the EU. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Genmab collaboration agreement contains a maximum of $550&nbsp;million of milestone payments for each licensed product resulting from the collaboration.
In addition, Immatics is entitled to receive royalty payments. Royalty rates are based on aggregate net sales of a licensed product. The agreement provides for higher royalty rates as annual net sales of a licensed product increases. Under the
agreement, the royalty rates begin in the high single-digits, increasing to the low tens as a percentage of aggregate annual net sales of a licensed product. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group received a <FONT STYLE="white-space:nowrap">non-refundable</FONT> upfront payment of $54&nbsp;million (&#128;46 million) upon signing of the
agreement. The Group classified the initial receipt of the upfront payment as deferred revenue. The Group recognized approximately &#128;11.2&nbsp;million, &#128;11.2&nbsp;million and &#128;2.3&nbsp;million of revenue associated with the upfront
payment and with reimbursements for research and development costs performed, during the years ended December&nbsp;31, 2020, 2019 and 2018, respectively. Revenue for the Genmab collaboration agreement is
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
recognized on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">cost-to-cost</FONT></FONT> basis using forecasted costs. A <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">cost-to-cost</FONT></FONT> basis was determined most representative of the transfer of benefits to Genmab. Total deferred revenue under the agreement was &#128;26&nbsp;million and &#128;35&nbsp;million as of
December&nbsp;31, 2020 and 2019, respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>BMS Collaboration Agreement </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In August 2019, Immatics Biotechnologies GmbH and BMS entered into a collaboration and option agreement to develop novel adoptive cell therapies targeting
multiple cancers. Under the agreement, Immatics may develop T Cell Receptor Engineered T Cell Therapy <FONT STYLE="white-space:nowrap">(TCR-T)</FONT> programs against solid tumor targets discovered with Immatics&#146; XPRESIDENT technology. Programs
would utilize proprietary T Cell Receptors (TCRs) identified by Immatics&#146; XCEPTOR TCR discovery and engineering platform. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If Immatics develops
programs against the <FONT STYLE="white-space:nowrap">TCR-T</FONT> targets, Immatics will be responsible for the development and validation of these programs through lead candidate stage, at which time BMS may exercise
<FONT STYLE="white-space:nowrap">opt-in</FONT> rights and assume sole responsibility for further worldwide development, manufacturing and commercialization of the <FONT STYLE="white-space:nowrap">TCR-T</FONT> cell therapies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Immatics would have certain early stage <FONT STYLE="white-space:nowrap">co-development</FONT> rights or <FONT STYLE="white-space:nowrap">co-funding</FONT>
rights for selected <FONT STYLE="white-space:nowrap">TCR-T</FONT> cell therapies arising from the collaboration. With respect to this collaboration agreement with BMS, Immatics may be eligible to receive up to $505&nbsp;million for each licensed
product in option exercise payments, development, regulatory and commercial milestone payments as well as tiered royalties on net sales. In addition, Immatics is entitled to royalty payments. Royalty rates are based on aggregate net sales of a
licensed product resulting from the collaboration. The agreement provides for higher royalty rates as annual net sales of a licensed product increases. Under each contract, the royalty rates begin in the
<FONT STYLE="white-space:nowrap">mid-single-digits,</FONT> increasing to the low teen-digits as a percentage of aggregate annual net sales of a licensed product. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group received a <FONT STYLE="white-space:nowrap">non-refundable</FONT> upfront payment of $75&nbsp;million (&#128;68 million) upon signing of the
agreement. The Group classified the initial receipt of the upfront payment as deferred revenue. The Group recognized &#128;11.5&nbsp;million and &#128;1.1&nbsp;million of revenue associated with the upfront payment as of December&nbsp;31, 2020 and
2019, respectively. Revenue for the BMS collaboration agreement is recognized on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">cost-to-cost</FONT></FONT> basis using forecasted costs. A <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">cost-to-cost</FONT></FONT> basis was determined most representative of the transfer of benefits to BMS. Total deferred revenue under the agreement was &#128;55&nbsp;million and &#128;66.5&nbsp;million as of
December&nbsp;31, 2020 and 2019, respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>GSK </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2019, Immatics entered into a collaboration agreement with GSK to develop novel adoptive cell therapies targeting multiple cancer indications.
Immatics and GSK plan to collaborate on the identification, research and development of next-generation TCR Therapeutics focusing on solid tumors. The collaboration will initially focus on the development of autologous T cell therapies and GSK has
an option to develop allogeneic T cell therapies using Immatics ACTallo approach. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Immatics and GSK intend to utilize proprietary TCRs identified by
Immatics TCR discovery platform XCEPTOR which are planned to be directed against two proprietary targets. Those proprietary targets were discovered and validated by the respective XPRESIDENT technology. Immatics will be mainly responsible for the
development and validation of the <FONT STYLE="white-space:nowrap">TCR-T</FONT> up to designation of a clinical candidate. GSK will then assume sole responsibility for further development, manufacturing and commercialization of the <FONT
STYLE="white-space:nowrap">TCR-T</FONT> with the option for Immatics to <FONT STYLE="white-space:nowrap">co-develop</FONT> one or more <FONT STYLE="white-space:nowrap">TCR-Ts</FONT> upon GSK&acute;s request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group received a <FONT STYLE="white-space:nowrap">non-refundable</FONT> upfront payment of &#128;45&nbsp;million for two initial programs upon signing of
the GSK agreement and is eligible to receive up to &#128;575&nbsp;million of milestone payments per program. In addition, Immatics is entitled to royalty payments. Royalty rates are based on aggregate net sales of a licensed product resulting from
the collaboration. The agreement provides for higher royalty rates as annual net sales of a licensed product increases. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group classified the initial receipt of the upfront payment as deferred revenue. The Group recognized
&#128;3.7&nbsp;million of revenue associated with the upfront payment as of December&nbsp;31, 2020 and recognized no revenue associated with the upfront payment during 2019. Total deferred revenue under the agreement was &#128;41&nbsp;million and
&#128;45&nbsp;million as of December&nbsp;31, 2020 and 2019, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group has not recognized any royalty or milestone revenue under the
collaboration agreements, due to the scientific uncertainty of achieving the milestones or the successful commercialization of a product. As of December&nbsp;31, 2020, Immatics had not received any milestone or royalty payments in connection with
the collaboration agreements. The Group plans to recognize the remaining deferred revenue balance into revenue as it performs the related performance obligations under each contract. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Deferred revenue related to the collaboration agreements consists of the following: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">59,465</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-current</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">85,475</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">101,909</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>132,075</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>161,374</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Cost to obtain a contract </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group incurs costs from a third party, who assists in identifying collaboration partners. The Group recognizes an asset to the extent these costs are
incremental and directly related to a specific contract. The Group then amortizes the asset consistently with the pattern of revenue recognition for the related contracts. Total assets, net of amortization, for these capitalized costs of obtaining a
contract were &#128;1.2&nbsp;million and &#128;1.5&nbsp;million as of December&nbsp;31, 2020 and 2019, respectively, which are classified in other current assets and other <FONT STYLE="white-space:nowrap">non-current</FONT> assets. The Group
recognized expenses related to the amortization of capitalized cost of obtaining a contract of &#128;0.3&nbsp;million, &#128;0.2&nbsp;million and &#128;0.04&nbsp;million as of December&nbsp;31, 2020, 2019 and 2018, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2020, the Group is potentially liable to pay &#128;1.6&nbsp;million ($2 million) to a third-party upon successful completing the
milestone of the first clinical lead selection in connection with Immatics&#146; collaboration agreements. The Group does not recognize a liability for these contingent payments due to the scientific uncertainty of achieving the related milestones.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each of the Group&#146;s strategic collaboration agreements included a <FONT STYLE="white-space:nowrap">non-refundable</FONT> upfront payment, meant to
subsidize research activities, recognized as deferred revenue. For all collaboration agreements these upfront payments exceeded the Group&#146;s right to consideration for services performed under each collaboration agreement. Therefore, only
deferred revenue net of contract assets is presented as of December&nbsp;31, 2020, December&nbsp;31, 2019 and December&nbsp;31, 2018, respectively. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>14. Other income </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other income includes grant income, in
addition immaterial amounts from other sources. The Group receives income through government grants for specific research and development projects. The Group recognizes grant income as it performs research and development activities specified by the
grant agreements. Total grant income was &#128;0.2&nbsp;million, &#128;0.03&nbsp;million, and &#128;2.9&nbsp;million during the years ended December&nbsp;31, 2020, 2019 and 2018, respectively. There are no unfulfilled conditions or contingencies
attached to these grants. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group had the following deferred income and receivable balances under these agreements: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Receivables</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;998</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">164</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>875</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,162</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group classifies receivables under these agreements within other current assets, while it presents deferred income within
other current liabilities. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>15.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Other current liabilities </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The components of other current liabilities are: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payroll tax</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,185</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;727</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrual for vacation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">525</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">330</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred grant income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">164</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued bonuses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">154</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,025</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,288</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other current liabilities are <FONT STYLE="white-space:nowrap">non-interest-bearing</FONT> and are due within one year. The
carrying amounts of other current liabilities represents fair value due to their short-term nature. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>16.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Financial income and expenses </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial income and financial expenses consist of the following: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income from short-term deposits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">850</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">790</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">507</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign currency gains</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,708</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on other financial instruments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Financial income</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,949</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>790</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,215</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expenses form leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(289</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(170</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(16</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign currency losses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(9,774</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(94</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(145</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Financial expenses</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(10,063</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(264</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(161</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Foreign currency losses mainly consist of unrealized losses in connection with our USD holdings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gain on other financial instruments includes an unrealized gain of 0.9&nbsp;million and a realized gain of 1.2&nbsp;million from foreign currency forward
contracts for the year ended December&nbsp;31, 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>17. Share listing expense </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As described in Note 3, the ARYA Merger led to a share listing expense. Immatics issued shares and warrants with a fair value of &#128;277.7&nbsp;million to
ARYA shareholders, comprised of the fair value of Immatics shares, that </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
were issued to ARYA shareholders of &#128;13.53 per share, as well as a fair value of Immatics Warrants of &#128;4.82 per share (price of ARYA shares at Closing of the ARYA Merger). In exchange,
Immatics received the identifiable net assets held by ARYA, which had a fair value of upon closing of &#128;124.9&nbsp;million. The excess of the fair value of the equity instruments issued over the fair value of the identified net assets
contributed, represents a <FONT STYLE="white-space:nowrap">non-cash</FONT> expense in accordance with IFRS 2. This <FONT STYLE="white-space:nowrap">one-time</FONT> expense as a result of the ARYA Merger, in the amount of &#128;152.8&nbsp;million, is
recognized as Share listing expense presented as part of the Financial result within the Consolidated Statement of Loss. Details of the calculation of the Share listing expense are as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(Euros in thousands, except share and per share data) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>shares/warrants</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(a) ARYA Ordinary Shares</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17,968,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(b) Closing price of ARYA Ordinary Shares on Nasdaq as of July&nbsp;1,&nbsp;2020</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13.53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(c) Fair value of TopCo Shares issued to ARYA shareholders <B>(a * b)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">243,071</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(d) Outstanding ARYA Public Warrants</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,187,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(e) Closing price of ARYA Public Warrants on Nasdaq as of July&nbsp;1,&nbsp;2020</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(f) Fair value of outstanding ARYA Public Warrants (d * e)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34,644</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total fair value of ARYA Ordinary Shares and ARYA Public
Warrants&nbsp;(c&nbsp;+&nbsp;f)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&#128;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>277,715</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARYA&#146;s identifiable net assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">124,927</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">IFRS 2 Expense on the closing date</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&#128;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>152,787</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>18. Share-based payments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Immatics Biotechnologies GmbH previously issued share-based awards to employees under two different plans. Under the Immatics Biotechnologies GmbH Stock
Appreciation Program 2010 (the &#147;2010 Plan&#148;), the Company issued stock appreciation rights (&#147;SARs&#148;), which the Group accounted for as cash-settled awards. Under the Immatics Biotechnologies 2016 Equity Incentive Plan (&#147;2016
Plan&#148;), the Company issued tandem awards, which allowed employees to exercise their awards as either a SAR or a stock option. In 2020, prior to the ARYA Merger, Immatics N.V. established the new equity incentive plan (&#147;2020 Equity
Plan&#148;). As part of the ARYA Merger, the 2010 Plan and the 2016 Plan were converted and were superseded by the 2020 Equity Plan as described below. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Share appreciation rights (&#147;the 2010 Plan&#148;) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Effective January&nbsp;1, 2005, in addition to performance-related compensation, certain Immatics employees became eligible to participate in a Stock
Appreciation Rights (SAR) Program as part of a long-term equity incentive scheme. The aim of this program was to give employees a long-term stake in the success of the Company. The SAR program was adopted by resolutions by the supervisory board in
January 2005 and was subsequently amended on February&nbsp;6, 2007 and September&nbsp;7, 2010. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the 2010 Plan, the beneficiaries received SAR
awards, which did not require any cash investment into the company. SARs granted under this program carried no dividend or voting rights. The award holders had the right to execute the vested SARs only in a defined exit event. An exit event was
defined as the acquisition of more than 50.00% of the outstanding shares by a third party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SARs granted under the 2010 Plan vested based on the
satisfaction of service requirements (time-based vesting). These awards generally had a five-year graded vesting period. Employees leaving the Group were able to retain any vested awards as of their termination date, unless they were terminated for
cause. Per the terms of the SAR agreements, employees were not entitled to subscribe to shares in the Group. Therefore, SARs granted under the 2010 Plan might be settled in cash only. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As awards issued under the 2010 Plan were cash settled, the Group applied liability accounting and revalued
the outstanding awards at each reporting date. The Group applied a Black Scholes pricing model to estimate the fair value of the SARs as of December&nbsp;31, 2019 and 2018 based on a company value of $350,000&nbsp;thousand and
$160,000&nbsp;thousand, respectively. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP><B>Amounts in USD</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercise price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 1.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 1.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underlying share price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67.87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Time period (years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk free rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.59</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.77</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dividend yield</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Combined probability of exit events</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">80.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Expected volatility was determined by calculating the historic volatility in share prices of peer companies within the
biotechnology industry. The expected life in the model has been adjusted, based on management&#146;s best estimate, for the effects of <FONT STYLE="white-space:nowrap">non-transferability</FONT> and exercise restrictions. Furthermore, the fair value
of SARs issued under the 2010 Plan were discounted based on the probability of the awards becoming exercisable due to either a change in control or an IPO, as management expected to settle these awards also in case of an IPO. The Black Scholes model
considered for an IPO event a time period of one year and for a trade sale event a time period of five years. Awards issued under the 2010 Plan did not expire. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Set out below are summaries of SARs issued during 2019 and 2018: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="52%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted&nbsp;average<BR>exercise&nbsp;price&nbsp;in&nbsp;USD</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted&nbsp;average<BR>exercise&nbsp;price&nbsp;in&nbsp;USD</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SARs outstanding at January&nbsp;1,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43,675</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43,978</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SARs granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SARs forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">220</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">303</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SARs outstanding at December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43,455</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43,675</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SARs vested</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">117</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">169</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SARs exercisable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There were no awards issued under the 2010 Plan as of December&nbsp;31, 2020, 2019 or 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Resulting from these awards Immatics had other <FONT STYLE="white-space:nowrap">non-current</FONT> liabilities of &#128;2.1&nbsp;million and
&#128;0.2&nbsp;million as of December&nbsp;31, 2019, and 2018, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As the 2010 Plan was converted in 2020, there were no SARs outstanding as of
December&nbsp;31, 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2016 Equity Incentive Plan (&#147;the 2016 Plan&#148;) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On February&nbsp;8, 2017, the Company established the &#147;2016 Equity Incentive Plan&#148; to provide employees and consultants of the Group the ability to
share in the Company&#146;s future success. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Awards issued under the 2016 Plan were tandem awards, which consisted of an option to acquire a stated the
number of shares at a stated exercise price, or alternatively, the right to receive any appreciation in the value of the stated number of shares (&#147;SAR portion&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Generally, the tandem awards issued under the 2016 Plan had a five-year vesting period. The first annual
tranche vested on the first anniversary of the grant date. Following the first anniversary, the awards continued to vest on a monthly basis. Vesting was contingent on the recipient&#146;s continued service to the Group. Employees which left the
Group were able to retain any awards vested as of their termination date, unless they were terminated for cause. Former employees forfeited their awards, if they remained unexercised more than three months after an IPO or change in control. In the
event of a change in control, the unvested portion of the Tandem Award should immediately vest. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Tandem Award (to the extent vested) might only be
exercised after the contribution of all Immatics shares to a holding company for purposes of an indirect IPO, a change in control, or the expiration of a certain <FONT STYLE="white-space:nowrap">lock-up</FONT> period following the completion of a
direct IPO. A change in control was defined as the acquisition of more than 50% of the outstanding shares by a third party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the terms of the 2016
Plan, options had to be settled in equity shares of the Group, while SAR portions might be settled in either equity shares or cash, at the Group&#146;s discretion. While the Group did not have a policy or prior history of settling these awards, it
intended to settle outstanding awards in equity shares. As a result, the Group was treating awards issued under the 2016 plan as equity-settled. Subsequent settlements of SARs in cash, to the extent they occurred, would be recorded via an adjustment
to equity. Each option or SAR issued under the plan might be settled for one common share of the Group in the event it is exercisable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Set out below are
summaries of tandem awards issued during 2019 and 2018: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="53%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted&nbsp;average<BR>exercise&nbsp;price&nbsp;in&nbsp;USD</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted&nbsp;average<BR>exercise&nbsp;price&nbsp;in&nbsp;USD</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tandem Awards outstanding at January&nbsp;1,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">74,401</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31,880</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tandem awards granted in June to September</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26,557</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43,964</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tandem awards granted in December</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23.82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,447</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tandem awards forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.81</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,936</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,443</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tandem awards outstanding at December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">103,469</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">74,401</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tandem awards vested</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,238</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,350</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tandem awards exercisable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average remaining contract life (years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" NOWRAP ALIGN="center">8.56</TD>
<TD VALIGN="bottom" NOWRAP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" NOWRAP ALIGN="center">9.12</TD>
<TD VALIGN="bottom" NOWRAP>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average fair value of options granted in USD till September</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" NOWRAP ALIGN="center">10.27</TD>
<TD VALIGN="bottom" NOWRAP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" NOWRAP ALIGN="center">4.51</TD>
<TD VALIGN="bottom" NOWRAP>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average fair value of options granted in USD for December</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" NOWRAP ALIGN="center">53.41</TD>
<TD VALIGN="bottom" NOWRAP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" NOWRAP ALIGN="center">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group used a Black Scholes pricing model to estimate the fair value of equity settled tandem awards issued during 2019
until September 2019, based on a company valuation of $160&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of tandem awards issued in December 2019 was based on a company
valuation of $350&nbsp;million. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="52%"></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP><B>Amounts in USD</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">June&nbsp;2019&nbsp;-&nbsp;September&nbsp;2019</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercise price in USD</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23.82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underlying share price in USD</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67.87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">78</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Time period (years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk free rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.59</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.04</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.77</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dividend yield</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Combined probability of exit events</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">80.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Expected volatility was determined by calculating the historic volatility in share prices of peer companies
within the biotechnology industry. The expected life in the model has been adjusted, based on management&#146;s best estimate, for the effects of <FONT STYLE="white-space:nowrap">non-transferability</FONT> and exercise restrictions. Furthermore, the
fair value of awards issued under the 2016 Plan were discounted based on the probability of the awards becoming exercisable due to either a change in control or an IPO. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Conversion of 2010 Plan and 2016 Plan in connection with ARYA Merger </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As part of the ARYA Merger, all outstanding awards under the 2010 Plan and 2016 Plan were replaced by a combination of cash payments and share-based awards
under the 2020 Equity Plan in Immatics N.V. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Cash Payments </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In accordance with the employee award agreements, holders of vested awards under the 2010 Plan and 2016 Plan (including any awards scheduled to vest prior to
2021), agreed to receive a cash payment of $10.00 per award, less the applicable exercise price (&#147;Award Cash Proceeds&#148;). Per the terms of the employee award agreements, active employees were required to
<FONT STYLE="white-space:nowrap">re-invest</FONT> <FONT STYLE="white-space:nowrap">25%-50%</FONT> of the Award Cash Proceeds, net of taxes, with management members required to <FONT STYLE="white-space:nowrap">re-invest</FONT> 50%. In total,
employees elected to receive &#128;8.9&nbsp;million in net Award Cash Proceeds before taxes, which were paid during the third quarter. These proceeds mainly covered wage tax obligations by the employees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These cash payments represent a modification of awards previously issued under the 2010 Plan and 2016 Plan. The Group recognized &#128;2.6&nbsp;million in
operating expense related to the modification of awards issued under the 2010 Plan and previously accounted for as a liability. The Group also recognized &#128;4.3&nbsp;million as a reduction in share premium, associated with the modification from
previously equity-settled tandem awards, which were settled in cash as part of the modification. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Share-based Awards </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The share-based awards, that were received by employees as part of the conversion, consisted of Re-investment Shares, Matching Stock Options and Converted
Stock Options as described below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In accordance with the employee <FONT STYLE="white-space:nowrap">re-investment</FONT> elections, employees received
733,598 shares in Immatics N.V. <FONT STYLE="white-space:nowrap">(&#147;Re-investment</FONT> Shares&#148;), which had a fair value of &#128;8.5&nbsp;million based on the ARYA share price of $15.15, as of the merger on July&nbsp;1, 2020. The
Re-investment Shares issued represented a modification of awards previously granted under the 2010 Plan and the 2016 Plan. This modification resulted in additional operating expense of &#128;4.1&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For each ordinary Re-investment Share received, active employees and management members also received two stock options (&#147;Matching Stock Options&#148;)
to acquire shares in Immatics N.V. The Matching Stock Options have an exercise price of $10.00 and vest in full on July&nbsp;31, 2021. The award recipient must remain employed by Immatics or one of its affiliates through the vesting date, to receive
the option. The awards have a <FONT STYLE="white-space:nowrap">ten-year</FONT> contract life. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Matching Stock Options award agreements had a service
commencement date in June 2020. However, the grant date criteria for these awards, as specified in IFRS 2 and the underlying award agreements, were not met until July&nbsp;1, 2020. Based on the July&nbsp;1, 2020 grant date the Group assigned a fair
value of $10.59. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Immatics applied a Black Scholes pricing model to estimate the fair value of the Matching Stock Options, which the Group records as an
expense over the four-year graded vesting period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As&nbsp;of&nbsp;June&nbsp;30,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercise price in USD</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underlying share price in USD</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Time period (years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk free rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.29</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dividend yield</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Set out below are summaries of Matching Stock Options issued during 2020: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted&nbsp;average<BR>exercise&nbsp;price&nbsp;in&nbsp;USD</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matching Stock Options outstanding on January&nbsp;1,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matching Stock Options granted in June</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,430,818</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matching Stock Options forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,262</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matching Stock Options outstanding at December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,422,556</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matching Stock Options vested</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average remaining contract life (years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" NOWRAP ALIGN="center">9.50</TD>
<TD VALIGN="bottom" NOWRAP>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average fair value of options granted in USD for June</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" NOWRAP ALIGN="center">10.59</TD>
<TD VALIGN="bottom" NOWRAP>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For any outstanding 2016 Plan and 2010 Plan awards scheduled to vest on or after January&nbsp;1, 2021, employees received
replacement stock options (&#147;Converted Options&#148;) to acquire shares in Immatics N.V. The Converted Options have comparable terms as the previous awards, with revised exercise prices reflecting the reorganized capital structure of Immatics.
The options granted under the 2020 Equity Plan that gives employees the right to acquire shares in Immatics N.V., are accounted for as a modification under IFRS 2, with the incremental fair value expensed over the remaining vesting period. The
incremental fair value is the difference between the fair value of the options to purchase ordinary shares under the 2020 Equity Plan to acquire shares in Immatics N.V., and the fair value of the exchanged unvested SAR (both measured at the date on
which the replacement award is issued). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based on the terms of the Converted Options award agreements, the awards had a service commencement date in June
2020. However, the grant date criteria for these awards, as specified in IFRS 2 and the underlying award agreements, were not met until July&nbsp;1, 2020. Based on the July&nbsp;1, 2020 grant date the Group assigned an average fair value of $13.79.
The incremental average fair value of the Converted Options compared to the share-based awards under the 2010 Plan and 2016 Plan was $4.83. Immatics applied a Black Scholes pricing model to estimate the fair value of the Converted Options. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of<BR>June&nbsp;30,&nbsp;2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Average exercise price in USD</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underlying share price in USD</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Time period (years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk free rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.29</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dividend yield</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Set out below are summaries of Converted Options issued during 2020: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted&nbsp;average<BR>exercise&nbsp;price&nbsp;in&nbsp;USD</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Converted Options outstanding on January&nbsp;1,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Converted Options granted in June</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">632,384</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Converted Options forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37,540</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Converted Options outstanding on December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">594,844</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Converted Options vested</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">53,856</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average remaining contract life (years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" NOWRAP ALIGN="center">7.01</TD>
<TD VALIGN="bottom" NOWRAP>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average fair value of options granted in USD for June</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" NOWRAP ALIGN="center">4.83</TD>
<TD VALIGN="bottom" NOWRAP>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Additional grants under the 2020 Equity Plan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Service Options </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to the ARYA Merger, Immatics N.V.
established the 2020 Equity Plan. After closing the ARYA Merger, employees, directors and officers received 1,087,242 employee stock options under the 2020 Equity Plan with a service requirement (&#147;Service Options&#148;), to acquire shares of
Immatics N.V. The service-based options will vest solely on a four-year time-based vesting schedule. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The total amount of the Service options granted were
accounted for by considering a fair value of $11.29, $9.25, and $6.73, as of grant date June&nbsp;30, 2020, September&nbsp;14, 2020, and December&nbsp;17, 2020, respectively. Immatics applied a Black Scholes pricing model to estimate the fair value
of the Service Options. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of<BR>June&nbsp;30,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of<BR>September&nbsp;14,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of<BR>December&nbsp;17,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercise price in USD</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underlying share price in USD</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 9.16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">84</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Time period (years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk free rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.29</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.37</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.49</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dividend yield</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A total of 1,963,566 Service Options have been granted as of December&nbsp;31, 2020. Set out below are summaries of Service
Options issued during 2020:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted&nbsp;average<BR>exercise&nbsp;price&nbsp;in&nbsp;USD</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Service Options outstanding on January&nbsp;1,</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Service Options granted in June</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,087,417</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Service Options granted in September</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">74,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Service Options granted in December</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">802,149</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Service Options forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">53,384</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Service Options outstanding on December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,910,182</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Service Options vested</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average remaining contract life (years)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" NOWRAP ALIGN="center">9.72</TD>
<TD VALIGN="bottom" NOWRAP>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average fair value of options granted in USD for June</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" NOWRAP ALIGN="center">11.29</TD>
<TD VALIGN="bottom" NOWRAP>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average fair value of options granted in USD for September</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" NOWRAP ALIGN="center">9.25</TD>
<TD VALIGN="bottom" NOWRAP>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average fair value of options granted in USD for December</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" NOWRAP ALIGN="center">6.73</TD>
<TD VALIGN="bottom" NOWRAP>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Performance-Based Options (&#147;PSUs&#148;) </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, after the closing of the ARYA Merger certain executive officers and key personnel of the Group received under the 2020 Equity Plan PSUs, vesting
based both on achievement of market capitalization milestones and satisfaction of a four-year time-based vesting schedule. The PSUs are split into three equal tranches. The performance criteria for each of the three respective tranches requires
Immatics to achieve a market capitalization of at least $1.5 billion, $2&nbsp;billion and $3&nbsp;billion, respectively. The amount of 3,644,000 of the PSUs granted on June&nbsp;30, 2020, were accounted for by considering a fair value of $11.10.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The remaining amount of 255,000 PSUs granted on September&nbsp;14, 2020, were accounted for by considering a fair value of $6.41. A Monte-Carlo
simulation model has been used to measure each fair value at grant date of the PSUs. The model incorporates the impact of the performance criteria regarding market capitalization described above in the calculation of the award&#146;s fair value at
grant date. In addition to the probability of achieving the market capitalization performance criteria, the inputs used in the measurements of the fair value at grant date of the PSUs were as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="16%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As&nbsp;of&nbsp;June&nbsp;30,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As&nbsp;of&nbsp;September&nbsp;14,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercise price in USD</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underlying share price in USD</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 9.16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">78</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Time period (years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk free rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.66</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.67</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dividend yield</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A total of 3,644,000 PSUs have been granted as of December&nbsp;31, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Set out below are summaries of PSUs issued during 2020: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted&nbsp;average<BR>exercise&nbsp;price&nbsp;in&nbsp;USD</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSUs outstanding on January&nbsp;1,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSUs granted in June</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,644,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSUs granted in September</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">255,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSUs forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">255,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSUs outstanding on December&nbsp;31,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,644,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSUs vested</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average remaining contract life (years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" NOWRAP ALIGN="center">9.60</TD>
<TD VALIGN="bottom" NOWRAP>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average fair value of options granted in USD for June</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" NOWRAP ALIGN="center">11.10</TD>
<TD VALIGN="bottom" NOWRAP>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average fair value of options granted in USD for September</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" NOWRAP ALIGN="center">6.41</TD>
<TD VALIGN="bottom" NOWRAP>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group recognized total employee-related share-based compensation expense from all plans for the years ended
December&nbsp;31, 2020, 2019 and 2018 as set out below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,546</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,556</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">238</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,973</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">460</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total share-based compensation</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>25,519</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,016</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>338</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>19.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Shareholders&#146; equity (deficit) </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As described in Note 1 and Note 3, Immatics N.V. was founded in 2020 with a share capital of &#128;0.01 after the Reorganization. On July&nbsp;1, 2020, upon
closing of the ARYA Merger, Immatics N.V. had 62,908,617 outstanding ordinary shares with a par value of &#128;0.01, resulting in a share capital of &#128;629&nbsp;thousand. In 2020, the ARYA Merger and PIPE Financing led to an increase in share
premium by &#128;362,5&nbsp;million. As of December&nbsp;31, 2020, the total number of ordinary shares of Immatics N.V. outstanding is 62,908,617 with a par value of &#128;0.01. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2019, the total number of ordinary shares of Immatics Biotechnologies GmbH outstanding is 1,163,625 with a par value of &#128;1.00.
Adjusted for the effect of the Reorganization as discussed in Note 3, which is applied retrospectively to all prior periods presented, the total number of ordinary shares outstanding as of December&nbsp;31, 2019 was 33,093,838 with a par value of
&#128;0.01. In 2019, there was no capital increase and, hence, no change in share capital or share premium. In 2018, &#128;23.6 million were paid into share premium by the shareholders based on the Series E financing round, which closed in 2017. The
related Series E share capital was previously paid in full in 2017. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other reserves are related to accumulated foreign currency translation amounts
associated with the Group&#146;s US operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2020, there were 7,187,500 Immatics Warrants outstanding. The warrants entitle
the holder to purchase one ordinary share of Immatics N.V. at an exercise price of $11.50 per share. Until warrant holders acquire the Groups ordinary shares upon exercise of such warrants, they will have no rights with respect to the Groups
ordinary shares. The warrants will expire on July&nbsp;1, 2025, five years after the ARYA Merger close date, or earlier upon redemption or liquidation in accordance with their terms. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>20.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><FONT STYLE="white-space:nowrap">Non-controlling</FONT> interests </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-controlling</FONT> interests related to those shares in Immatics US Inc. which have been provided to The University of
Texas M.D. Anderson Cancer Center, Houston/Texas/USA, (&#147;MD Anderson&#148;) based on the restricted stock acquisition agreement described below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Until June&nbsp;30, 2020, Immatics and MD Anderson were partners in a Restricted Stock Acquisition Agreement (the &#147;RSAA&#148;). Under the terms of the
RSAA, MD Anderson was entitled to additional restricted shares in Immatics US, Inc. based on performance of certain work orders between August&nbsp;14, 2018 and August&nbsp;14, 2020. MD Anderson performed services in connection with our clinical
trials in our ACT platform. The RSAA was canceled as part of the ARYA Merger (See Note 3). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&nbsp;1, 2020 MD Anderson exchanged all of its 379,420
shares in Immatics US, Inc., that they acquired under the RSAA for 697,431 shares in Immatics N.V. The shares of Immatics N.V. had a fair value at the date of the exchange of $15.15 per share. Immediately prior to the exchange, the carrying amount
of the existing 5.14% <FONT STYLE="white-space:nowrap">non-controlling</FONT> interest in Immatics US Inc. was &#128;0.5&nbsp;million. The exchange resulted in a decrease of <FONT STYLE="white-space:nowrap">non-controlling</FONT> interest of
&#128;0.5&nbsp;million and a corresponding increase of share capital and net increase to share premium for the issuance of shares and derecognition of the <FONT STYLE="white-space:nowrap">non-controlling</FONT> interest. The RSAA was also canceled
as of July&nbsp;1, 2020. Any future services rendered by MD Anderson will be paid in cash. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Loss allocated to the
<FONT STYLE="white-space:nowrap">non-controlling</FONT> interest amounted to &#128;0.6&nbsp;million in 2020, &#128;0.9&nbsp;million in 2019 and &#128;0.9&nbsp;million in 2018, respectively. <FONT STYLE="white-space:nowrap">Non-controlling</FONT>
interests on equity amounted to &#128;1&nbsp;million as of December&nbsp;31, 2019 and &#128;1.2&nbsp;million as of December&nbsp;31, 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In total, the
Group recognized expenses in relation to MD Anderson&#146;s performance under the RSAA of &#128;0.04&nbsp;million, &#128;0.7&nbsp;million and &#128;0.8&nbsp;million as of December&nbsp;31, 2020, 2019 and 2018, respectively. A corresponding increase
in equity was recognized with an amount of &#128;0.7&nbsp;million and &#128;0.8&nbsp;million as of December&nbsp;31, 2019 and 2018, respectively for vested shares under the agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>21.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Personnel expenses </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group recognized the following personnel expenses: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Wages and salaries</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,277</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,635</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,485</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,968</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,596</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total Wages and salaries</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>22,245</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>15,231</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>12,718</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Other employee benefits</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,624</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,035</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,920</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">728</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">607</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total other employee benefits</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,639</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,763</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,527</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Share-based compensation expense</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,546</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,556</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">238</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,973</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">460</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total share-based compensation expense</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>25,519</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,016</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>338</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>51,403</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>20,010</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>15,583</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other employee benefit expenses include employee retirement fund contributions, health insurance, and statutory social
expenses. Immatics US Inc. sponsors a defined contribution retirement plan for employees in the United States. During 2020, 2019 and 2018, total Group contributions to the defined contribution plan amounted to &#128;0.2&nbsp;million,
&#128;0.1&nbsp;million and &#128;0.1&nbsp;million, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the year ended December&nbsp;31, 2020, 2019 and 2018, other employee benefits also
include employee health insurance costs amounting to &#128;0.4&nbsp;million, &#128;0.3&nbsp;million and &#128;0.4&nbsp;million for Immatics US Inc., statutory social expenses amounting to &#128;1.7&nbsp;million, &#128;1.3&nbsp;million and
&#128;1.0&nbsp;million for our German operations and other miscellaneous expenses amounting to &#128;0.1&nbsp;million, &#128;0.07&nbsp;million and &#128;0.2&nbsp;million, respectively. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>22.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Income Tax </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the year ended December&nbsp;31, 2020, 2019 and 2018, the Group generated losses in both Germany and the U.S. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During 2020, 2019 and 2018, the Group&#146;s German operations were subject to a statutory tax rate of 29.1%. In the U.S., the Group was subject to a corporate
income tax rate of 21% for the year ended December&nbsp;31, 2020, 2019 and 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2020, 2019 and 2018, no deferred tax assets have
been recognized in respect of these losses, due to the uncertainty of the Group&#146;s ability to generate taxable profits in the foreseeable future. The current assessment regarding the usability of deferred tax assets may change, depending on the
Group&#146;s taxable income in future years. This may result in higher or lower deferred tax assets related to tax losses carried forward. Due to the ARYA Merger described in Note 3, there are certain limitations on tax losses carried forward for
net operating losses incurred by Immatics US, Inc., under Section&nbsp;382 of the U.S. Internal Revenue Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A reconciliation between taxes on income reflected on the Consolidated Statement of Loss and the expected
income tax benefit, based on the Group&#146;s German statutory tax rate, for the years ended December&nbsp;31, 2020, 2019 and 2018 is as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss before tax</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(229,616</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(32,487</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(32,355</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected tax benefit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66,818</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,415</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Effects</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Difference in tax rates</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,582</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,875</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,373</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Non-deductible&nbsp;
tax-expenses</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(599</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(61</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(70</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Government grants exempted from taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">853</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Permanent Differences</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(44,461</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-recognition&nbsp;of</FONT> deferred taxes on tax losses and
temporary differences</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(19,221</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(7,526</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(8,825</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>Taxes on income</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right"><B>&#151;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right"><B>&#151;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right"><B>&#151;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The main permanent difference relates to the Share listing expense of &#128;153&nbsp;million, which does not have a
corresponding taxable expense. Other permanent differences include transaction cost directly attributable and incremental to capital raises and expenses for equity-settled share-based compensation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Deferred tax assets consist of the following: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31, 2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31, 2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Deferred<BR>tax<BR>assets</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Deferred<BR>tax<BR>liabilities</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Deferred<BR>tax<BR>assets</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Deferred<BR>tax<BR>liabilities</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,770</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,064</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT>
asset</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,713</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(854</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">180</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">358</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">607</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,776</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">886</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Recognized</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,729</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,713</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,929</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(854</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Netting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,713</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,713</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(854</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">854</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-recognition</FONT> due to history of losses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,016</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3,075</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>Net tax</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2020, and 2019, the Group had accumulated tax losses of &#128;288&nbsp;million and
&#128;219&nbsp;million, respectively, that may be offset against future taxable profits of the Group subject to certain limitations. As of December&nbsp;31, 2020, &#128;26&nbsp;million of total tax losses is subject to a twenty-year carryforward
period. All other tax losses have an indefinite carryforward period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group has limited taxable temporary differences and no tax planning
opportunities available that could partly support the recognition of these losses as deferred tax assets. On this basis, the Group has determined that it cannot recognize deferred tax assets on the tax losses carried forward as well as on temporary
differences. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Limitation on tax loss carryforwards in the US Inc. is 80.00% starting with losses generated after January&nbsp;1, 2018. These have an
indefinite carryforward period, but no carryback option. Any losses generated prior to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
January&nbsp;1, 2018 still can be utilized at 100.00% and are subject to a twenty-year carry forward expiration period. Due to the ARYA Merger described in Note 3, there are certain limitations
on tax losses carried forward for net operating losses incurred by Immatics US, Inc., under Section&nbsp;382 of the U.S. Internal Revenue Code. For Immatics Biotechnologies GmbH, we believe that the ARYA Merger did not lead to a forfeiture of tax
losses carried forward in accordance with &#167; 8c KStG. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Deferred tax assets have not been recognized in respect of these losses due to the uncertainty
of the Group&#146;s ability to generate taxable profits in the foreseeable future. The current assessment regarding the usability of deferred tax assets may change depending on the income situation of future years and may result in higher deferred
tax assets on net tax losses carried forward. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>23.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Financial Risk Management Objectives and Policies </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group&#146;s principal financial instruments comprise cash, cash equivalents and short-term deposits. The main purpose of these financial instruments is to
invest the proceeds of capital contributions and upfront payments from collaboration agreements. The Group has various other financial instruments such as other receivables and trade accounts payable, which arise directly from its operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The main risks arising from the Group&#146;s financial instruments are market risk and liquidity risk. The Board of Management reviews and agrees on policies
for managing these risks as summarized below. The Group also monitors the market price risk arising from all financial instruments. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Interest rate risk
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The exposure of the Group to changes in interest rates relates to investments in deposits and to changes in the interest for overnight deposits.
Changes in the general level of interest rates may lead to an increase or decrease in the fair value of these investments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Regarding the liabilities
shown in the Consolidated Statement of Financial Position, the Group is currently not subject to interest rate risks. The Group is subject to a limited risk resulting from negative interest rates on financial instruments, especially on cash and cash
equivalents and Other financial assets. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Credit risk </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Group to concentrations of credit and liquidity risk consist primarily of cash and cash equivalents and
short-term deposits. The Group&#146;s cash and cash equivalents are denominated in Euros and US Dollars and maintained with two high-quality financial institutions in Germany and two in the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The maximum default risk is &#128;232&nbsp;million and &#128;119&nbsp;million as of December&nbsp;31, 2020 and 2019, respectively. These amounts consist of
&#128;208&nbsp;million and &#128;103&nbsp;million cash and cash equivalents as well as &#128;24&nbsp;million and &#128;16&nbsp;million Other financial assets as of December&nbsp;31, 2020 and 2019, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The cash and cash equivalents are held with banks, which are rated BBB+ to Aa3 by S&amp;P and Moody`s. Short-term deposits are graded within the investment
category from P1 to P2 by the rating agency Moody`s. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group continually monitors its positions with, and the credit quality of, the financial
institutions and corporation, which are counterparts to its financial instruments and does not anticipate <FONT STYLE="white-space:nowrap">non-performance.</FONT> The Group monitors the risk of a liquidity shortage. The main factors considered here
are the maturities of financial assets as well as expected cash flows from equity measures<B>.</B> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Currency risk </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Currency risk shows the risk that the value of a financial instrument will fluctuate due to changes in foreign exchange rates. In particular it poses a threat
if the value of the currency in which liabilities are priced </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
appreciates relative to the currency of the assets. The business transactions of the Group are generally conducted in Euros and U.S. dollars. The Group aims to match EUR cash inflows with EUR
cash outflows and U.S. dollar cash inflows with U.S.&nbsp;Dollar cash outflows where possible. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The objective of currency risk management is to identify,
manage and control currency risk exposures within acceptable parameters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Due to the initial public offering in 2020, the Group has a significant U.S.
dollar amount on its statements of financial position. In 2020 the Group recognized significant foreign exchange losses as Immatics N.V.`s and Immatics GmbH&acute;s functional currency is Euro, but both entities hold significant U.S. dollar amounts.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cash, cash equivalents and financial assets balances denominated in U.S. dollars held by entities with functional currency of EUR are as follows: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cash, cash equivalents and financial assets Immatics N.V. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,528</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financial assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total assets exposed to the risk</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>42,528</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Conversion rate EUR/USD as reporting date 1/1.2271 </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cash, cash equivalents and financial assets Immatics GmbH </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52,015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financial assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24,448</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total assets exposed to the risk</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>76,463</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Conversion rate EUR/USD as reporting date 1/1.2271 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since the Group is primarily exposed to changes in U.S. dollars/euro exchange rates, the sensitivity of profit or loss to changes in the exchange rates,
results mainly from U.S. dollar financial instruments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2020, if the euro had weakened/strengthened by 10% against U.S. dollars by considering that all
other variables held constant, the Group`s loss would have been &#128;10.9&nbsp;million higher/&#128;13.2&nbsp;million lower, resulting from foreign exchange on translation of U.S. dollar assets of Immatics N.V. and Immatics GmbH. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sensitivity analysis Immatics N.V.: </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Conversion<BR>rate</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Profit/(loss)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Carrying<BR>amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Euro weakens by 1% against U.S. dollars</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.2394</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(421</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,107</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Euro strengths by 1% against U.S. dollars</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.2148</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">430</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,958</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Euro weakens by 5% against U.S. dollars</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.2885</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,025</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40,503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Euro strengths by 5% against U.S. dollars</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1657</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,238</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44,766</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Euro weakens by 10% against U.S. dollars</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.3498</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3,866</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38,662</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Euro strengths by 10% against U.S. dollars</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1044</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,725</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47,253</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sensitivity analysis Immatics GmbH: </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Conversion<BR>rate</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Profit/(loss)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Carrying<BR>amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Euro weakens by 1% against U.S. dollars</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.2394</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(757</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75,706</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Euro strengths by 1% against U.S. dollars</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.2148</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">772</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">77,235</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Euro weakens by 5% against U.S. dollars</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.2885</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3,641</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">72,822</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Euro strengths by 5% against U.S. dollars</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1657</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">80,487</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Euro weakens by 10% against U.S. dollars</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.3498</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(6,951</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69,512</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Euro strengths by 10% against U.S. dollars</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1044</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,496</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">84,959</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Liquidity risk </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group
continuously monitors its risk to a shortage of funds. The Group&#146;s objective is to maintain a balance between continuity of funding and flexibility through the use of capital raises. All financial liabilities are due within six months. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2020, and 2019, the Group held the following funds which are expected to generate cash inflows in time, to counteract liquidity risk.
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Euros in thousands) </B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">207,530</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">103,353</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Short-term deposits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24,448</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total funds available</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>231,978</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>119,376</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>24.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Financial Instruments </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Set out below are the carrying amounts and fair values of the Group&#146;s financial instruments that are carried in the consolidated financial statements.
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Euros in thousands</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Carrying amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B>IFRS 9</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Financial assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Short-term deposits*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">At fair value through profit or loss (FVTPL)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24,448</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24,448</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Positive market value</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">forward contracts*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">At fair value through profit or loss (FVTPL)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">914</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">914</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">other financial assets at amortized cost</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">957</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">957</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other <FONT STYLE="white-space:nowrap">current/non-current</FONT> assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">other financial assets at amortized cost</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,586</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,710</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,586</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,710</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total financial assets**</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>28,198</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>18,690</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>28,198</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>18,690</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Financial liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">other financial liabilities at amortized cost</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,082</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,082</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">other financial liabilities at amortized cost</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,288</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,288</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total financial liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>12,077</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>8,370</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>12,077</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>8,370</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Short-term deposits&#148; are classified within Other financial assets. &#147;Positive market value forward
contract&#148; are classified in other current assets. &#147;Negative market value forward contracts&#148; are classified in other current liabilities. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">**</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Financial assets, other than cash and cash equivalents. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The carrying value of financial instruments, such as cash and cash equivalents, deposits, accounts receivable and accounts payable approximate their fair
value based on the short-term maturities of these instruments. The fair values of the financial assets and liabilities are included at the amount at which the instrument could be exchanged in a current transaction between willing parties, other than
in a forced or liquidation sale. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following methods and assumptions were used to estimate the fair values: All financial assets, except for
derivatives, which are categorized Level&nbsp;2, are categorized Level&nbsp;1 and therefore are valued using quoted (unadjusted) market prices. Except for derivatives, which are categorized Level&nbsp;2, all other financial liabilities are also
categorized Level&nbsp;1. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>25.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Commitments and contingencies </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes contractual obligations as of December&nbsp;31, 2020: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Payments due by period</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">(Euros in thousands)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Less&nbsp;than<BR>1&nbsp;year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>1 - 3<BR>years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>3 - 5<BR>years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>More&nbsp;than<BR>5&nbsp;years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,453</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,157</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">150</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other lease obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">97</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">185</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">185</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">513</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">In-license</FONT> agreements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">249</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">249</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contract research organization agreements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,704</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">220</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,924</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total contractual cash obligation</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,153</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,858</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,342</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>196</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>9,549</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes contractual obligations as of December&nbsp;31, 2019: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Payments due by period</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">(Euros in thousands)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Less&nbsp;than<BR>1&nbsp;year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>1 - 3<BR>years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>3 - 5<BR>years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>More&nbsp;than<BR>5&nbsp;years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,482</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,823</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,352</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other lease obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">172</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">324</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,096</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">In-license</FONT> agreements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">455</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">655</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contract research organization agreements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,131</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,466</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,597</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total contractual cash obligation</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,240</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,813</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>347</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>300</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7,700</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2020, and 2019 the Group is potentially liable to pay &#128;1.6&nbsp;million to a third-party upon
successful completing the milestone of the first clinical lead selection in connection with Immatics&#146; collaboration agreements. The Group does not recognize a liability for these contingent payments due to the scientific uncertainty of
achieving the related milestones. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>26.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Related party disclosures </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Key management personnel have been defined as the members of the Executive Committee of Immatics N.V. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation of key management personnel: </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fixed</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,660</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,202</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,088</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Variable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">886</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">521</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">433</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,841</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">697</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">119</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total key management compensation</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>17,387</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,420</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,640</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fixed and variable key management compensation represent short-term employee benefits. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2020, and 2019, amounts of &#128;0.0&nbsp;million and &#128;0.7&nbsp;million were accrued for key management compensation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The members of the Supervisory Board of the Group received a fixed fee as well as reimbursed travel expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total compensation for the Supervisory Board amounted to &#128;2.7&nbsp;million in 2020: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Peter<BR>Chambr&eacute;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Harald&nbsp;F.<BR>Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Michael&nbsp;G.<BR>Atieh</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Paul<BR>Carter</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Heather&nbsp;L.<BR>Mason</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Adam<BR>Stone</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Christoph<BR>Hettich</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Eliot<BR>Forster</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Supervisory board compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">140</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>282</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Travel expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment Exit arrangement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,394</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,394</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,046</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,436</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total cash compensation</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,584</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>16</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>98</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>96</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>90</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>90</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>90</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>52</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,116</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Harald F. Stock and Peter Chambr&eacute; were members of the Supervisory Board of Immatics in 2019 and in 2018. They received
a fixed fee as Supervisory Board members and reimbursement for travel expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total compensation for the Supervisory Board amounted to
&#128;0.4&nbsp;million in 2019: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Peter<BR>Chambr&eacute;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Harald<BR>F.&nbsp;Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Supervisory board fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>309</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Travel expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>107</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>387</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>29</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>416</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total compensation for the Supervisory Board amounted to &#128;0.5&nbsp;million in 2018: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Peter<BR>Chambr&eacute;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Harald<BR>F.&nbsp;Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>(Euros in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Supervisory board fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>410</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Travel expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>68</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>452</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>26</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>478</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to the ARYA Merger, Immatics N.V. established the 2020 Incentive Plan. Immatics N.V. granted certain
service-based options out of the 2020 Incentive Plan to its management and directors and in addition, performance-based options to its management upon closing of the ARYA Merger. The service-based options will vest based upon satisfaction of a
four-year time-based vesting schedule, which provides for 25% vesting on the first anniversary of the vesting commencement date and quarterly vesting thereafter. The performance-based options will vest based both on achievement of certain market
capitalization milestones and satisfaction of a four-year time-based vesting schedule, which provides for 25% vesting on the first anniversary of the vesting commencement date and quarterly vesting thereafter. The following options were granted to
Immatics&#146; Managing Director and Supervisory Directors: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="21%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="16%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Type of options</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Grant date</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Strike<BR>Price&nbsp;in<BR>USD</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Expiration date</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Managing Director</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Harpreet Singh</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Performance-based options</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,598,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">June&nbsp;30, 2030</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Harpreet Singh</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Service options</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">168,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">June&nbsp;30, 2030</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Harpreet Singh</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Matching Stock options</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">264,624</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">June&nbsp;30, 2030</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Harpreet Singh</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Converted options</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,939</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.06</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">July&nbsp;1, 2027</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Harpreet Singh</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Converted options</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">145,371</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">January&nbsp;1,&nbsp;2028</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Harpreet Singh</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Service options</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">December&nbsp;17,&nbsp;2020</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">168,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">December&nbsp;17,&nbsp;2030</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Supervisory Directors</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Peter Chambr&eacute;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Service options</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">June&nbsp;30, 2030</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Peter Chambr&eacute;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Matching Stock options</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">211,974</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">June&nbsp;30, 2030</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adam Stone</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Service options</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">June&nbsp;30, 2030</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christoph Hettich</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Service options</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">June&nbsp;30, 2030</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Heather L. Mason</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Service options</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">June&nbsp;30, 2030</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael G. Atieh</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Service options</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">June&nbsp;30, 2030</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Paul Carter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Service options</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">June&nbsp;30, 2020</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">June&nbsp;30, 2030</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Eliot Forster</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Service options</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">September&nbsp;14,&nbsp;2020</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">September&nbsp;13,&nbsp;2030</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An additional aggregate of 1,680,000 performance-based options and 539,000 service options to purchase ordinary shares, were
granted to other Immatics&#146; key management personnel, who are members of the Executive Committee but not Directors. Certain key management personnel were also participants in the share-based compensation plans of Immatics GmbH (2010 Plan and
2016 Plan). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As part of the replacement awards issued in connection with the ARYA Merger (See Note 18), these key management personnel received cash
payments before taxes of &#128;3.4&nbsp;million, 417,415 converted options in Immatics N.V. and 750,076 matching stock options in Immatics N.V. The cash payments mainly covered wage tax obligations of the employees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Group did not enter into transactions with related entities in 2020, 2019 and 2018 other than the mentioned compensation contracts. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>27.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Net loss per share </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Basic net loss per share is computed by dividing net loss by the weighted average number of common shares outstanding during the period, excluding common stock
equivalents, adjusted for the effect of the corporate </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
reorganization as discussed in Note 3 and applied retrospectively to all prior periods presented. The diluted net loss per share reflects the basic net loss per share, since the effects of
potentially dilutive securities are antidilutive given the net loss for each period presented. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the periods included in these financial statements the
Group was loss-making in all periods, therefore, anti-dilutive instruments are excluded in the calculation of diluted weighted average number of ordinary shares outstanding, including the outstanding equity awards during the periods and the
7,187,500 Immatics Warrants issued in 2020 and outstanding as of December&nbsp;31, 2020. These warrants and options could potentially dilute basic earnings per share in the future. See Note 18 for details of outstanding share options. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>28.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Events occurring after the reporting period </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company evaluated subsequent events for recognition or disclosure through March&nbsp;30, 2021 and did not identify material subsequent events. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registrant hereby certifies that it meets all of the requirements for filing on Form <FONT STYLE="white-space:nowrap">20-F</FONT> and that
it has duly caused and authorized the undersigned to sign this report on its behalf. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Date: March&nbsp;30, 2021 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="74%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Immatics N.V.</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By:&nbsp;&nbsp;</P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Harpreet Singh</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Harpreet Singh</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer and Managing Director</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.2
<SEQUENCE>2
<FILENAME>d149615dex22.htm
<DESCRIPTION>EX-2.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-2.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 2.2 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DESCRIPTION OF THE REGISTRANT&#146;S SECURITIES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXCHANGE ACT OF 1934 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>As of
December&nbsp;31, 2020, Immatics N.V. (the &#147;Company&#148;, &#147;we&#148; &#147;us&#148;) had two class of securities registered under Section&nbsp;12 of the Securities Exchange Act of 1934, as amended: (a)&nbsp;ordinary shares, nominal value
&#128;0.01 per share, and (b)&nbsp;warrants to purchase ordinary shares. </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The following descriptions do not purport to be complete and are subject
to the Company&#146;s articles of association and the amended and restated warrant agreement relating to the warrants, copies of which have been filed as exhibits to the Company&#146;s Annual Report on Form
<FONT STYLE="white-space:nowrap">20-F</FONT> of which this Exhibit 2.2 is a part, and are subject to provisions of applicable Dutch law. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We were incorporated on March&nbsp;10, 2020 as a private limited liability company (<I>besloten</I> <I>vennootschap</I> <I>met</I>
<I>beperkte</I> <I>aansprakelijkheid</I>) under Dutch law, and upon the consummation of the Business Combination, we converted into a Dutch public limited liability company (<I>naamloze</I> <I>vennootschap</I>). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are registered in the Commercial Register of the Chamber of Commerce (<I>Kamer van Koophandel</I>) in the Netherlands under number
77595726. We have our corporate seat is in Amsterdam, the Netherlands and our registered office is at Paul-Ehrlich-Stra&szlig;e 15, 72076 T&uuml;bingen, Federal Republic of Germany. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&nbsp;1, 2021, and pursuant to our articles of association, our current <FONT STYLE="white-space:nowrap">two-tier</FONT> board
structure will automatically convert into a <FONT STYLE="white-space:nowrap">one-tier</FONT> board structure, which will consist of a nine-member staggered board divided into three classes. In the <FONT STYLE="white-space:nowrap">one-tier</FONT>
board structure, we will also have an Executive Committee consisting of all our executive directors and other executive officers. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Share Capital
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Authorized Share Capital </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our authorized share capital consists of 285,000,000 ordinary shares, nominal value of &#128;0.01 per share, and 15,000,000 financing preferred
shares. The financing preferred shares are divided into five series, each consisting of 3,000,000 financing preferred shares. As of December&nbsp;31, 2020, there were 62,908,617 ordinary shares outstanding and no financing preferred shares
outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The financing preferred shares may, at the request of the holder, be converted into ordinary shares pursuant to a resolution
of our Management Board or, after July&nbsp;1, 2021, our Board. The conditions for conversion and the further terms and conditions related to the financing preferred shares will be determined by our Management Board subject to the prior approval of
our Supervisory Board or, after July&nbsp;1, 2021, our Board, our general meeting and the meeting of holders of the series of financing preferred shares concerned, if such series of financing preferred shares has been issued and are held by persons
other than us. The preceding sentence applies by analogy to any adjustment to the conditions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Issuance of Ordinary Shares
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under Dutch law, shares are issued and rights to subscribe for shares are granted pursuant to a resolution of our general meeting.
Our articles of association provide that the general meeting may only resolve to issue shares upon the proposal of our Management Board, which proposal requires the prior approval of our Supervisory Board. The general meeting may authorize the
Management Board to issue new ordinary shares or grant rights to subscribe for ordinary shares, subject to the approval of our Supervisory Board. The authorization can be granted and extended, in each case for a period not exceeding five years. For
as long as, and to the extent, that such authorization is effective, our general meeting will not have the power to issue ordinary shares. </P> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to a resolution of the general meeting dated June&nbsp;30, 2020, our Management
Board is irrevocably authorized to for a period of five years from July&nbsp;1, 2020, to issue ordinary shares or financing preferred shares up to the amount of the authorized share capital (from time to time). On July&nbsp;1, 2021, the powers of
our Management Board will vest in our Board. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Preemptive Rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to restrictions in our articles of association, holders of ordinary shares have preemptive rights in relation to newly issued ordinary
shares under Dutch law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under our articles of association, the preemptive rights in respect of newly issued ordinary shares may be
restricted or excluded by a resolution of our general meeting, which resolution requires a <FONT STYLE="white-space:nowrap">two-thirds</FONT> majority of the votes cast if less than half of the issued share capital is present or represented at the
meeting. The general meeting may authorize our Management Board, subject to the prior approval of our Supervisory Board or, after July&nbsp;1, 2021, our Board to limit or exclude the preemptive rights in respect of newly issued ordinary shares. Such
authorization for our Management Board, subject to the prior approval of our Supervisory Board or, after July&nbsp;1, 2021, our Board can be granted and extended, in each case for a period not exceeding five years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to a resolution of the general meeting dated June&nbsp;30, 2020, our Management Board is irrevocably authorized for a period of five
years from July&nbsp;1, 2020 to limit or exclude preemptive rights on ordinary shares up to 100% of the number of ordinary shares in our authorized share capital (from time to time). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Preemptive rights do not exist with respect (a)&nbsp;to the issue of ordinary shares or grant of rights to subscribe for ordinary shares to
our employees or a &#147;group&#148; company of ours, and (b)&nbsp;the issue of ordinary shares against a contribution in kind. Preemptive rights do not exist with respect to the issue of financing preferred shares and holders of financing preferred
shares have no preemptive right to acquire newly issued ordinary shares. On July&nbsp;1, 2021, the powers of our Management Board will vest in our Board. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Transfer of Ordinary Shares </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under Dutch law, transfers of ordinary shares (other than in book-entry form) require a written deed of transfer and, unless the company is a
party to the deed of transfer, and acknowledgement by or proper service upon the company to be effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under our articles of
association, if one or more ordinary shares are admitted to trading on Nasdaq or any other regulated foreign stock exchange located in the United States, we may, by resolution of our Management Board, determine that the laws of the State of New York
will apply to the property law aspects of the ordinary shares included in the part of the register of shareholders kept by the relevant transfer agent. Such resolution, as well as the revocation thereof, will be made public as required by law and
will be made available for inspection at our office and the Dutch trade register. Our management has adopted such resolution effective as of the Closing Date. On July&nbsp;1, 2021, the powers of our Management Board will vest in our Board. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Form of Ordinary Shares </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to our articles of association, the ordinary shares are registered shares. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Purchase and Repurchase of Ordinary Shares </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under Dutch law, we may not subscribe for newly issued ordinary shares. We may acquire ordinary shares, subject to applicable provisions and
restrictions of Dutch law and our articles of association, to the extent that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">such ordinary shares are fully paid up; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">such repurchase would not cause our shareholders&#146; equity to fall below an amount equal to the sum of the <FONT
STYLE="white-space:nowrap">paid-up</FONT> and <FONT STYLE="white-space:nowrap">called-up</FONT> part of the issued share capital and the reserves we are required to maintain pursuant to Dutch law or our articles of association; and
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">immediately after the acquisition of such ordinary shares, we and our subsidiaries would not hold, or would not
hold as pledgees, shares having an aggregate nominal value that exceeds 50% of our issued share capital. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other than
ordinary shares acquired for no valuable consideration or under universal title of succession (<I>onder algemene titel</I>) (e.g., through a merger or <FONT STYLE="white-space:nowrap">spin-off)</FONT> under statutory Dutch or other law, we may
acquire ordinary shares only if our general meeting has authorized our Management Board to do so, subject to prior approval of our Supervisory Board or, after July&nbsp;1, 2021, our Board. An authorization by our general meeting for the acquisition
of ordinary shares can be granted for a maximum period of 18 months. Such authorization must specify the number of ordinary shares that may be acquired, the manner in which these shares may be acquired and the price range within which the shares may
be acquired. No authorization of our general meeting is required if ordinary shares are acquired by us on Nasdaq with the intention of transferring such ordinary shares to our employees or employees of a group company pursuant to an arrangement
applicable to them. For each annual general meeting, we expect that our Management Board, or, after July&nbsp;1, 2021, our Board will place on the agenda a proposal to reauthorize our Management Board, or, after July&nbsp;1, 2021, our Board to
repurchase shares for a period of 18 months from the date of the resolution. We cannot derive any right to any distribution from ordinary shares, or voting rights attached to ordinary shares acquired by it. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to a resolution of the general meeting dated June&nbsp;30, 2020, the our Management Board is irrevocably authorized for a period of
18 months to resolve for us to acquire fully <FONT STYLE="white-space:nowrap">paid-up</FONT> ordinary shares up to the maximum number of ordinary shares permitted pursuant to the law and our articles of association from time to time, through
privately negotiated repurchases, in self-tender offers, or through accelerated repurchase arrangements, at prices ranging from the nominal value of the ordinary shares up to one hundred and ten percent (110%) of the market price of ordinary shares,
provided that (i)&nbsp;for open market or privately negotiated repurchases, the market price will be the price for ordinary shares Nasdaq at the time of the transaction, (ii)&nbsp;for self-tender offers, the market price will be the volume weighted
average price for the ordinary shares on Nasdaq during a period, determined by the Management Board, of no less than one and no more than five consecutive trading days immediately prior to the expiration of the tender offer, and (iii)&nbsp;for
accelerated repurchase arrangements, the market price will be the volume weighted average price of the ordinary shares on the NYSE over the term of the arrangement. The volume weighted average price for any number of trading days will be calculated
as the arithmetic average of the daily volume weighted average price on those trading days. On July&nbsp;1, 2021, the powers of our Management Board will vest in our Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to a resolution of the general meeting dated June&nbsp;30, 2020, our Management Board is furthermore irrevocably authorized for a
period of 18 months from July&nbsp;1, 2020 to resolve for us to acquire fully paid up financing preferred shares up to the maximum number of financing preferred shares permitted pursuant to the law and our articles of association from time to time
and that financing preferred shares may be acquired through privately negotiated repurchases, in self-tender offers, or through accelerated repurchase arrangements, at prices ranging from the nominal value of the financing preferred shares up to the
amount that would be paid by us upon cancellation of such financing preferred shares in accordance with the relevant provisions of our articles of association. On July&nbsp;1, 2021, the powers of our Management Board will vest in our Board. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Capital Reduction </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At a general meeting, our shareholders may resolve on the proposal of our Management Board, which proposal will require the prior approval of
our Supervisory Board to reduce our issued share capital by (i)&nbsp;cancelling ordinary shares or (ii)&nbsp;reducing the nominal value of the ordinary shares by amending our articles of association. In either case, this reduction would be subject
to applicable statutory provisions. A resolution to cancel ordinary shares may only relate to (i)&nbsp;ordinary shares held by us or in respect of which we hold the depository receipts, or (ii)&nbsp;all financing preferred shares of a class if
approved by the holders of all shares of that class. In order to be approved by our general meeting, a resolution to reduce the capital requires approval of a majority of the votes cast at a general meeting if at least 50% of the issued share
capital is represented at such meeting or at least 66 2/3% of the votes cast at a general meeting if less than 50% of the issued share capital is represented at such meeting. On July&nbsp;1, 2021, the powers of our Management Board will vest in our
Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A reduction of the nominal value of ordinary shares without repayment and without release from the obligation to pay up the
ordinary shares must be effectuated proportionally on shares of the same class (unless all affected shareholders agree to a disproportional reduction). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A resolution that would result in a reduction of capital requires approval by a majority of
the votes cast of each group of shareholders of the same class whose rights are prejudiced by the reduction. In addition, a reduction of capital involves a <FONT STYLE="white-space:nowrap">two-month</FONT> waiting period during which creditors have
the right to object to a reduction of capital under specified circumstances. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General Meeting of Shareholders and Voting Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>General Meeting of Shareholders </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">General meetings are held in Amsterdam, Rotterdam, The Hague, Arnhem, Utrecht, or in the municipality of Haarlemmermeer (Schiphol Airport), the
Netherlands. All of our shareholders and others entitled to attend our general meetings are authorized to address the meeting and, in so far as they have such right, to vote, either in person or by proxy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">However, due to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic several restrictions have been implied in the Netherlands. It is
possible that we will deviate from our articles of association and/or the Dutch Civil Code, as permitted under the emergency bill Temporary Measures in the Field of the Ministry of Justice and Security in connection with the Outbreak of <FONT
STYLE="white-space:nowrap">COVID-19</FONT> (<I>Tijdelijke Wet <FONT STYLE="white-space:nowrap">COVID-19</FONT> Justitie</I><I></I><I>&nbsp;&amp; Veiligheid</I>) as extended or amended from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will hold at least one general meeting each year, to be held within six months after the end of its financial year. A general meeting will
also be held within three months after our Board has determined it to be likely that our equity has decreased to an amount equal to or lower than half of its <FONT STYLE="white-space:nowrap">paid-up</FONT> and
<FONT STYLE="white-space:nowrap">called-up</FONT> capital, in order to discuss the measures to be taken if so required. If our Board fails to hold such general meeting in a timely manner, each shareholder and other person entitled to attend our
general meeting may be authorized by the Dutch court to convene our general meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Management Board or our Supervisory Board or,
after July&nbsp;1, 2021, our Board may convene additional extraordinary general meetings of shareholders at its discretion, subject to the notice requirements described below. Pursuant to Dutch law, one or more shareholders and/or others entitled to
attend general meetings of shareholders, alone or jointly representing at least 10% of our issued share capital, may on their application be authorized by the Dutch court to convene a general meeting. The Dutch court will disallow the application if
(i)&nbsp;the applicants have not previously requested in writing that our Management Board or our Supervisory Board or, after July&nbsp;1, 2021, our Board convenes a shareholders&#146; meeting or (ii)&nbsp;our Management Board or our Supervisory
Board or, after July&nbsp;1, 2021, Board convenes a shareholders&#146; meeting or (ii)&nbsp;our Board has not taken the necessary steps so that the shareholders&#146; meeting could be held within six weeks after such request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The general meeting is convened by a notice, which includes an agenda stating the items to be discussed and the location and time of our
general meeting. For the annual general meeting the agenda will include, among other things, the adoption of our annual accounts, the appropriation of its profits or losses and proposals relating to the composition of and filling of any vacancies on
our Management Board, our Supervisory Board or, after July&nbsp;1, 2021, our Board. In addition, the agenda for a general meeting includes such additional items as determined by our Management Board, our Supervisory Board or, after July&nbsp;1,
2021, our Board. Pursuant to Dutch law, one or more shareholders and/or others entitled to attend general meetings of shareholders, alone or jointly representing at least 3% of the issued share capital, have the right to request the inclusion of
additional items on the agenda of shareholders&#146; meetings. Such requests must be made in writing, and may include a proposal for a shareholder resolution, and must be received by us no later than on the sixtieth (60<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP>) day before the day the relevant shareholders&#146; meeting is held. No resolutions will be adopted on items other than those which have been included in the agenda. Under our articles of
association, certain items can only be put on the agenda as a voting item by our Management Board or our Supervisory Board, after July&nbsp;1, 2021 our Board. Shareholders meeting the relevant requirements may still request the inclusion of such
items on the agenda as a discussion item. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will give notice of each general meeting by publication on its website and, to the extent
required by applicable law, in a Dutch daily newspaper with national distribution, and in any other manner that we may be required to follow in order to comply with Dutch law and applicable stock exchange and SEC requirements. We will observe the
statutory minimum convening notice period for a general meeting. Holders of registered shares may further be provided notice of the meeting in writing at their addresses as stated in its shareholders&#146; register. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to our articles of association and Dutch law, our Management Board, or, after
July&nbsp;1, 2021, our Board may determine a record date (<I>registratiedatum</I>) of 28 calendar days prior to a general meeting to establish which shareholders and others with meeting rights are entitled to attend and, if applicable, vote at our
general meeting. The record date, if any, and the manner in which shareholders can register and exercise their rights will be set out in the notice of our general meeting. Our articles of association provide that a shareholder must notify us in
writing of his or her identity and his or her intention to attend (or be represented at) our general meeting, such notice to be received by us on the date set by our Management Board, or, after July&nbsp;1, 2021, our Board in accordance with our
articles of association and as set forth in the convening notice. If this requirement is not complied with or if upon request no proper identification is provided by any person wishing to enter our general meeting, the chairman of our general
meeting may, in his or her sole discretion, refuse entry to the shareholder or his or her proxy holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to our articles of
association, our general meeting is chaired by the Chairman of our Supervisory Board, who, nevertheless, may charge another person to preside over the meeting in his place even if he himself is present at the meeting. If the chairman of our
Supervisory Board is absent and he has not charged another person to preside over the meeting in his place, our general meeting will be presided over by the vice-chairman of our Supervisory Board. If both the chairman and the vice-chairman are
absent, our Supervisory Directors present at the meeting will appoint one of them to be chairman. In the absence of all Supervisory Directors, our general meeting will be presided over by the chief executive officer. If all Supervisory Directors and
the chief executive officer are absent, our Managing Directors present at the meeting will appoint one of them as chairman. If all Supervisory Directors and all Managing Directors are absent, our general meeting will appoint its chairman. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After July&nbsp;1, 2021, our general meeting will be presided over by the chairman of our Board, who, nevertheless, may charge another person
to preside over the meeting in his place even if he himself is present at the meeting. If the chairman of our Board is absent and he has not charged another person to preside over the meeting in his place, the directors present at the meeting will
appoint one of them to be chairman. In the absence of all directors, our general meeting will appoint its chairman. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Voting Rights
and Quorum </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with Dutch law and our articles of association, each ordinary share, irrespective of which class it
concerns, confers the right on the holder thereof to cast one vote at our general meeting. The voting rights attached to any ordinary shares held by us or our direct or indirect subsidiaries are suspended, unless the ordinary shares were encumbered
with a right of usufruct or a pledge in favor of a party other than us or a direct or indirect subsidiary before such ordinary shares were acquired by us or such a subsidiary, in which case, the other party may be entitled to exercise the voting
rights on the ordinary shares. We may not exercise voting rights for ordinary shares in respect of which we or a direct or indirect subsidiary has a right of usufruct or a pledge. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Voting rights may be exercised by shareholders or by a duly appointed proxy holder (the written proxy being acceptable to the chairman of our
general meeting) of a shareholder, which proxy holder need not be a shareholder. The holder of a usufruct or pledge on shares will have the voting rights attached thereto if so provided for when the usufruct or pledge was created. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under our articles of association, blank votes (votes where no choice has been made), abstentions and invalid votes will not be counted as
votes cast. However, shares in respect of which a blank vote or invalid vote has been cast and shares in respect of which the person with meeting rights who is present or represented at the meeting has abstained from voting are counted when
determining the part of the issued share capital that is present or represented at a general meeting. The chairman of our general meeting will determine the manner of voting and whether voting may take place by acclamation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Resolutions of the shareholders are adopted at a general meeting by a majority of votes cast, except where Dutch law or our articles of
association provide for a special majority in relation to specified resolutions. Our articles of association do not provide for a quorum requirement, subject to any provision of mandatory Dutch law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain restrictions in our articles of association, the determination during our general meeting made by the chairman of that
general meeting with regard to the results of a vote will be decisive. Our Board will keep a record of the resolutions passed at each general meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Amendment of Articles of Association </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At a general meeting, at the proposal of our Management Board, which proposals requires the prior approval of our Supervisory Board, our
general meeting may resolve to amend the articles of association. A resolution by the shareholders to amend the articles of association requires a majority of the votes cast. On July&nbsp;1, 2021, the powers of our Management Board will vest in our
Board. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Merger, Demerger and Dissolution </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the proposal of our Management Board, which proposal requires the prior approval of our Supervisory Board, our general meeting may resolve
with a majority of the votes cast (subject to certain exceptions) or with at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the votes cast if less than half of the issued capital is present or represented at our general meeting, to
legally merge or demerge the company within the meaning of Title 7, Book 2 of the Dutch Civil Code. On July&nbsp;1, 2021, the powers of our Management Board will vest in our Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our shareholders may at a general meeting, based on a proposal by our Management Board which proposal requires the prior approval of our
Supervisory Board, by means of a resolution passed by a majority of the votes cast resolve that the company will be dissolved. In the event of dissolution of the company, the liquidation will be effected by our Managing Directors, under the
supervision of our Supervisory Board unless our general meeting decides otherwise. After July&nbsp;1, 2021, the liquidation will be effected by our Executive Directors, under the supervision of our
<FONT STYLE="white-space:nowrap">Non-Executive</FONT> Directors, unless our general meeting decides otherwise. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I><FONT
STYLE="white-space:nowrap">Squeeze-Out</FONT> </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A shareholder who for its own account (or together with its group companies) holds
at least 95% of our issued share capital may institute proceedings against the other shareholders jointly for the transfer of their shares to the shareholder who holds such 95% majority. The proceedings are held before the Enterprise Chamber of the
Amsterdam Court of Appeal (<I>Ondernemingskamer van het Gerechtshof Amsterdam</I>) (the &#147;<I>Enterprise Chamber</I>&#148;) and can be instituted by means of a writ of summons served upon each of the minority shareholders in accordance with the
provisions of the Dutch Code of Civil Procedure (<I>Wetboek van Burgerlijke Rechtsvordering</I>). The Enterprise Chamber may grant the claim for <FONT STYLE="white-space:nowrap">squeeze-out</FONT> in relation to all minority shareholders and will
determine the price to be paid for the shares, if necessary after appointment of one or three experts who will offer an opinion to the Enterprise Chamber on the value of the shares of the minority shareholders. Once the order to transfer by the
Enterprise Chamber becomes final and irrevocable, the majority shareholder that instituted the <FONT STYLE="white-space:nowrap">squeeze-out</FONT> proceedings will give written notice of the date and place of payment and the price to the holders of
the shares to be acquired whose addresses are known to the majority shareholder. Unless the addresses of all minority shareholders are known to the majority shareholder acquiring the shares, the majority shareholder is required to publish the same
in a newspaper with a national circulation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A shareholder that holds a majority of our issued share capital, but less than the 95%
required to institute the <FONT STYLE="white-space:nowrap">squeeze-out</FONT> proceedings described above, may seek to propose and implement one or more restructuring transactions with the objective of obtaining at least 95% of our issued share
capital so the shareholder may initiate <FONT STYLE="white-space:nowrap">squeeze-out</FONT> proceedings. Those restructuring transactions could, among other things, include a merger or demerger involving the company, a contribution of cash and/or
assets against issuance of ordinary shares, the issue of new ordinary shares to the majority shareholder without preemptive rights for minority shareholders or an asset sale transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Depending on the circumstances, an asset sale of a Dutch public limited liability company (<I>naamloze vennootschap</I>) is sometimes used as
a way to squeeze out minority shareholders, for example, after a successful tender offer through which a third party acquires a supermajority, but less than all, of the company&#146;s shares. In such a scenario, the business of the target company is
sold to a third party or a special purpose vehicle, followed by the liquidation of the target company. The purchase price is distributed to all shareholders in proportion to their respective shareholding as liquidation proceeds, thus separating the
business from the company in which minority shareholders had an interest. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any sale or transfer of all of our assets and our dissolution or liquidation is subject to
approval by a majority of the votes cast in its general meeting. Our articles of association provide that our general meeting may only adopt such resolution upon a proposal of our Management Board, which proposal requires the prior approval of our
Supervisory Board. On July&nbsp;1, 2021, the powers of our Management Board will vest in our Board. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Certain Other Major
Transactions </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our articles of association and Dutch law provide that resolutions of our Management Board, or, after July&nbsp;1,
2021, our Board concerning a material change in our identity, character or business are subject to the approval of our general meeting. Such changes include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a transfer of all or materially all of its business to a third party; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the entry into or termination of a long-lasting alliance of the company or of a subsidiary either with another
entity or company, or as a fully liable partner of a limited partnership or partnership, if this alliance or termination is of significant importance to the company; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the acquisition or disposition of an interest in the capital of a company by the company or by its subsidiary
with a value of at least <FONT STYLE="white-space:nowrap">one-third</FONT> of the value of our assets, according to the balance sheet with explanatory notes or, if the company prepares a consolidated balance sheet, according to the consolidated
balance sheet with explanatory notes in our most recently adopted annual accounts. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dividends and Other Distributions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may only make distributions to our shareholders if our equity exceeds the aggregate amount of the issued share capital and the reserves
which must be maintained pursuant to Dutch law or by our articles of association. Under our articles of association, any profits or distributable reserves must first be applied to pay a dividend on the financing preferred shares, if outstanding.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any remaining profits may be reserved by the Management Board subject to the approval of the Supervisory Board or, after July&nbsp;1,
2021, the Board. After reservation by our Management Board of any distributable profits, our general meeting will be authorized to declare distributions on the proposal of our Management Board which proposal will require the prior approval of our
Supervisory Board. Our Management Board is permitted, subject to approval of our Supervisory Board and certain requirements, to declare interim dividends without the approval of the shareholders. Interim dividends may be declared as provided in our
articles of association and may be distributed to the extent that the shareholders&#146; equity, based on interim financial statements, exceeds the <FONT STYLE="white-space:nowrap">paid-up</FONT> and <FONT STYLE="white-space:nowrap">called-up</FONT>
share capital and the reserves that must be maintained under Dutch law or our articles of association. We may reclaim any distributions, whether interim or not interim, made in contravention of certain restrictions of Dutch law from shareholders
that knew or should have known that such distribution was not permissible. In addition, on the basis of Dutch case law, if after a distribution we are not able to pay its due and collectable debts, then our shareholders or directors who at the time
of the distribution knew or reasonably should have foreseen that result may be liable to its creditors. On July&nbsp;1, 2021, the powers of our Management Board will vest in our Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon proposal of the Management Board, the general meeting may determine that distributions will be made in whole or in part in a currency
other than the Euro. We shall announce any proposal for a distribution and the date when and the place where the distribution will be payable to all shareholders by electronic means of communication with due observance of the applicable law and
stock exchange rules. Claims for payment of dividends and other distributions not made within five years from the date that such dividends or distributions became payable will lapse, and any such amounts will be considered to have been forfeited to
the company (<I>verjaring).</I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not anticipate paying any dividends on ordinary shares for the foreseeable future. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Warrants </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2020,
there were 7,187,500 warrants outstanding. Our warrants are issued in registered (book-entry) form under the amended and restated warrant agreement (the &#147;Warrant Agreement&#148;) by and between us and Continental Stock Transfer&nbsp;&amp; Trust
Company, as warrant agent. The following summary of certain provisions relating to our warrants does not purport to be complete and is subject to, and is qualified in its entirety by reference to the warrant agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>General </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each whole warrant entitles the holder to purchase one ordinary share for $11.50 per share, subject to certain adjustments (the &#147;Exercise
Price&#148;). The warrants will expire at the earliest to occur of (i) 5:00 p.m., New York City time on July&nbsp;1, 2025 and (ii) 5:00 p.m., New York City time on the redemption date, if any, that we may fix in accordance with the Warrant
Agreement. The private warrants are not subject to redemption by us, and therefore will expire at 5:00 p.m., New York City time on October&nbsp;25, 2024. We may extend the duration of the warrants so long as we provide at least 20 days&#146; prior
written notice to all registered holders. Any such extension must be identical among all of the warrants. Any warrant not exercised prior to its expiration will become void. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Exercise and Expiration </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A warrant may be exercised by delivering to the Warrant Agent (i)&nbsp;the warrant, (ii)&nbsp;an election to purchase form, and (iii)&nbsp;the
payment in full of the Exercise Price and any and all applicable taxes due in connection with the exercise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As soon as practicable after
the exercise of any warrant we will issue a book-entry position or certificate, as applicable, for the ordinary shares. All ordinary shares issued upon the proper exercise of a warrant in conformity with the Warrant Agreement will be validly issued,
fully paid and <FONT STYLE="white-space:nowrap">non-assessable.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A warrant holder may notify us in writing of the holder&#146;s
election to be subject to a provision of the Warrant Agreement preventing the holder from exercising a warrant, to the extent that, after giving effect to such exercise, the holder (together with its affiliates), to the Warrant Agent&#146;s actual
knowledge, would beneficially own in excess of 4.9% or 9.8%, as specified by the holder (the &#147;Maximum Percentage&#148;) of our outstanding ordinary shares immediately after giving effect to such exercise. By written notice to us, a warrant
holder may increase or decrease the Maximum Percentage to any other percentage specified in such notice; provided, however, that any such increase will not be effective until the sixty-first (61st) day after such notice is delivered to us. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Cashless Exercise </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have agreed to use our reasonable best efforts to file with the Securities and Exchange Commission (the &#147;Commission&#148;) as soon as
practicable a registration statement for the registration, under the Securities Act, of the ordinary shares issuable upon exercise of the warrants. We are obligated to use our reasonable best efforts to cause the same to become effective and to
maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants. Warrant holders have the right, until such registration statement is declared effective by the Commission,
and during any other period that we may fail to have maintained an effective registration statement covering the ordinary shares issuable upon exercise of the warrants, to exercise such warrants on a &#147;cashless basis.&#148; In a cashless
exercise, holders may exchange their warrants for a number of ordinary shares equal to the quotient obtained by dividing (x)&nbsp;the product of (i)&nbsp;the number of ordinary shares underlying the warrants and (ii)&nbsp;the excess of the
&#147;fair market value&#148; of our ordinary shares over the Exercise Price by (y)&nbsp;the &#147;fair market value&#148; of our ordinary shares. In this scenario, the &#147;fair market value&#148; means the average reported last sale price of our
ordinary shares for the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">10-trading-day</FONT></FONT> period ending on the trading day prior to the date that notice of exercise is received by the Warrant Agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, by reason of any exercise of warrants on a &#147;cashless basis&#148;, the holder of any warrant would be entitled, upon the exercise of
such warrant, to receive a fractional interest in an ordinary shares, we will round down to the nearest whole number, the number of ordinary shares to be issued to such holder. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Redemption and Notice </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have the right to redeem the warrants, at any time while they are exercisable and prior to their expiration, at the price of $0.01 per
warrant (the &#147;Redemption Price&#148;). If we choose to redeem all outstanding warrants, we are required to (i)&nbsp;fix a date for the redemption and (ii)&nbsp;provide notice to the registered holders of the warrants at least 30 days prior to
the redemption date. We will mail any such notice of redemption by first class mail, postage prepaid, not less than 30 days prior to the redemption date to registered warrant holders. The notice will be sent to each registered holder&#146;s last
address as it appears on the registration books. Any notice so mailed will be conclusively presumed to have been duly given, whether or not the registered holder actually receives such notice. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may only redeem the warrants if (i)&nbsp;the last reported sale price of our ordinary
shares has been at least $18.00 per share (subject to certain adjustments), on 20 trading days within the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">30-trading-day</FONT></FONT> period ending on the third business day prior to
the date on which notice of the redemption is given and (ii)&nbsp;there is an effective registration statement covering the ordinary shares issuable upon exercise of the warrants, and a current prospectus relating thereto, available throughout the
30 days prior to the redemption date. If there is no effective registration statement and current prospectus available, we may, at the election of our board, nonetheless require holders to exercise their warrants on a &#147;cashless basis,&#148;
provided that the conditions set forth in clause (i)&nbsp;above are satisfied. If we require holders to exercise their warrants on a &#147;cashless basis&#148; in such a scenario, holders of the warrants will be required to surrender the warrants
for a number of ordinary shares equal to the quotient obtained by dividing (x)&nbsp;the product of (i)&nbsp;the number of ordinary shares underlying the warrants and (ii)&nbsp;the excess of the &#147;fair market value&#148; of our ordinary shares
over the Exercise Price by (y)&nbsp;the &#147;fair market value&#148; of our ordinary shares. In this scenario, the &#147;fair market value&#148; means the average last sale price of our ordinary shares for the 10 trading days ending on the third
trading day prior to the date that notice of redemption is sent to the holders of the warrants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The warrants may be exercised for cash or
on a &#147;cashless basis&#148;, as applicable, at any time after we send a notice of redemption and prior to the redemption date. If we require all warrant holders to exercise their warrants on a &#147;cashless basis,&#148; the notice of redemption
will contain the information necessary to calculate the number of ordinary shares to be received upon exercise of the warrants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On and
after the redemption date, the record holder of the warrants will have no further rights except to receive, upon surrender of the warrants, the Redemption Price. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Adjustments </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
number of ordinary shares issuable upon the exercise of the warrants is subject to customary adjustments in certain circumstances, such as a share split, dividend or reclassification of our ordinary shares, as described in the Warrant Agreement. In
the event the number of ordinary shares purchasable upon the exercise of the warrants is adjusted, the Exercise Price will be adjusted (to the nearest cent) by multiplying the Exercise Price immediately prior to such adjustment, by a fraction
(x)&nbsp;the numerator of which shall be the number of ordinary shares purchasable upon the exercise of the warrants immediately prior to such adjustment, and (y)&nbsp;the denominator of which shall be the number of ordinary shares so purchasable
immediately thereafter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, by reason of any adjustment made pursuant to the events described above (each, an &#147;Adjustment&#148;),
the holder of any warrant would be entitled, upon the exercise of such warrant, to receive a fractional interest in a share, we will, upon such exercise, round down to the nearest whole number the number of ordinary shares to be issued to such
holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Warrant holders also have replacement rights in the case of certain reorganization, merger, consolidation or sale transactions
involving our company or substantially all of our assets (each a &#147;Replacement Event&#148;). Upon the occurrence of any Replacement Event, warrant holders will have the right to purchase and receive (in lieu of our ordinary shares) the kind and
amount of stock or other securities or property (including cash) receivable upon such Replacement Event that the holder would have received if the warrants were exercised immediately prior to such event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon any adjustment of the Exercise Price or the number of shares issuable upon exercise of a warrant, we will provide written notice of such
adjustment to the Warrant Agent stating the Exercise Price resulting from such adjustment and the increase or decrease, if any, in the number of shares purchasable at such price upon the exercise of a warrant. We will also provide notice of any
adjustment described above to each warrant holder at the last address set forth in the warrant register stating the date of the event. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Transfers and Exchanges </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Warrants may be exchanged or transferred upon surrender of the warrant to the Warrant Agent, together with a written request for exchange or
transfer. Upon any transfer, a new warrant representing an equal aggregate number of warrants will be issued and the old warrant will be cancelled by the Warrant Agent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Book-entry warrants may be transferred only in whole and warrants bearing a restrictive
legend may transferred or exchanged only if the Transfer Agent has received an opinion of counsel stating that such transfer may be made and indicating whether the new warrants must also bear a restrictive legend. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>No Rights as a Shareholder </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A warrant does not entitle the holder to any of the rights of a shareholder of our company, including, without limitation, the right to receive
dividends, the right to vote or the right to receive notice as shareholders in respect of the meetings of shareholders or the election of directors of our company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notices </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will give notice of each
general meeting by publication on its website and, to the extent required by applicable law, in a Dutch daily newspaper with national distribution, and in any other manner that we may be required to follow in order to comply with Dutch law and
applicable stock exchange and SEC requirements. Holders of registered shares may further be provided notice of the meeting in writing at their addresses as stated in its shareholders&#146; register. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stock Exchange Listing </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our ordinary
shares are listed on Nasdaq under the symbol &#147;IMTX.&#148; Our warrants are listed on Nasdaq under the symbol &#147;IMTXW.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.14
<SEQUENCE>3
<FILENAME>d149615dex414.htm
<DESCRIPTION>EX-4.14
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.14</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.14 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Certain confidential information contained in this document, marked by [**], has been omitted because Immatics N.V. (IMTX) has determined
that the information (i)&nbsp;is not material and (ii)&nbsp;is the type that IMTX customarily and actually treats as private or confidential. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMMATICS US, INC.
</B></P> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENT NUMBER <FONT STYLE="white-space:nowrap">6-</FONT> FACILITIES/EQUIPMENT USE AND SERVICES AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Amendment Number 6 (&#147;Amendment&#148;) to the Facilities/Equipment Use and Services Agreement (&#147;Agreement&#148;) is entered into
effective the 1<SUP STYLE="font-size:85%; vertical-align:top">st</SUP> day of June 2020, by and between The University of Texas Health Science Center at Houston, (&#147;UTHealth&#148;) and lmmatics US, Inc. (&#147;lmmatics&#148;). UTHealth and
lmmatics shall be known collectively as &#147;the Parties&#148; and singularly as &#147;a Party&#148; or &#147;the Party.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS,
the Parties previously entered into an Agreement effective September&nbsp;1, 2015, as previously amended, whereby UTHealth makes available certain facilities, equipment, and personnel in support of projects; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Parties now desire to amend the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, the Parties agree as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Section&nbsp;1.1. a shall be deleted in its entirety and replaced with the following: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Production Suites/Administrative Space</U>. An exclusive license to use certain production suites and administrative space located in
the Facility, described as Rooms BBS 6310, BBS 6312, BBS 6314, and a cubicle in BBS 6102 (the &#147;Premises&#148;). The use of Room BBS 6310 shall be for the period February&nbsp;1, 2017 through December&nbsp;31, 2024, BBS 6312 shall be for the
period September&nbsp;1, 2015 through December&nbsp;31 , 2024 and the use of Room BBS 6314 shall be for the period February&nbsp;1, 2016 through December&nbsp;31, 2024.&#148; </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Section&nbsp;5.1 shall be deleted in its entirety and replaced with the following: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;This Agreement shall commence as of September&nbsp;1, 2015, and shall continue until December&nbsp;31, 2024 (&#147;Term&#148;), unless
the term is otherwise limited as set forth in Section&nbsp;1.1a or Section&nbsp;5.2.&#148; </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Section&nbsp;9 shall be deleted in its entirety and replaced with the following: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Compensation</U>. In consideration for the license herein granted for the use of the Licensed Facilities and the other services
provided by UTHealth pursuant to this Agreement, lmmatics shall compensate UTHealth as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the period June&nbsp;1, 2020 through
December&nbsp;31, 2021: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a comprehensive monthly fee of [**] per production suite (i.e., BBS 6310, BBS 6312, and BBS 6314) inclusive of a
[**] administrative fee and calculated in accordance with the budget set forth in <B><U>Exhibit <FONT STYLE="white-space:nowrap">E-2</FONT></U> </B>for the applicable term set forth in section 1.1a. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a monthly fee of [**] for the exclusive use of a Biosafe Sepax 2 RM automated cell processing system for the same
term set forth in section 5.1. This fee is inclusive of a [**] administrative fee and covers the maintenance of the instrument. In case of breakdown, during the downtime of the instrument the samples may be processed on an identical system located
in The Judith R. Hoffberger Cellular Therapeutics Laboratory and such service will be invoiced separately. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Process
specific reagents and other supplies are not included in the cost set forth above and shall be procured by UTHealth and invoiced to lmmatics as a separate line item charge. Additionally, individual extra-ordinary services as set forth in
<B><U>Exhibit F</U> </B>shall be invoiced to lmmatics as a separate line item charge. The invoices for reagents, other supplies, and extra-ordinary services shall also include a [**] administrative fee. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Certain confidential information contained in this document, marked by [**], has been
omitted because Immatics N.V. (IMTX) has determined that the information (i)&nbsp;is not material and (ii)&nbsp;is the type that IMTX customarily and actually treats as private or confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">All payments shall be made within [**] days after receipt of the invoice and mailed to the
address below or sent by electronic funds transfer: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The University of Texas Health Science Center at Houston </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">6431 Fannin Street, MSB 5.248 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Houston, TX 77030 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Attn: Diane
Harnden </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the period January&nbsp;1, 2022 through December&nbsp;31, 2024: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">a comprehensive monthly fee of [**] per production suite (i.e., BBS 6310, BBS 6312, and BBS 6314) inclusive of a [**] administrative fee and
calculated in accordance with the budget set forth in <B><U>Exhibit <FONT STYLE="white-space:nowrap">E-2</FONT></U> </B>for the applicable term set forth in section 1.1a. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a monthly fee of [**] for the exclusive use of a Biosafe Sepax 2 RM automated cell processing system for the same
term set forth in section 5.1. This fee is inclusive of a [**] administrative fee and covers the maintenance of the instrument. In case of breakdown, during the downtime of the instrument the samples may be processed on an identical system located
in The Judith R. Hoffberger Cellular Therapeutics Laboratory and such service will be invoiced separately. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Process
specific reagents and other supplies are not included in the cost set forth above and shall be procured by UTHealth and invoiced to lmmatics as a separate line item charge. Additionally, individual extra-ordinary services as set forth in
<B><U>Exhibit F</U> </B>shall be invoiced to lmmatics as a separate line item charge. The invoices for reagents, other supplies, and extra-ordinary services shall also include a [**] administrative fee. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">All payments shall be made within [**] days after receipt of the invoice and mailed to the address below or sent by electronic funds transfer:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The University of Texas Health Science Center at Houston </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">6431 Fannin Street, MSB 5.248 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Houston, TX 77030 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Attn: Diane
Harnden&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. Exhibit E2 shall be deleted in its entirety and replaced with the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the period June&nbsp;1, 2020 thorugh December&nbsp;31, 2021 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[**] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the period January&nbsp;1, 2022 thorugh
December&nbsp;31, 2024 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Certain confidential information contained in this document, marked by [**], has been
omitted because Immatics N.V. (IMTX) has determined that the information (i)&nbsp;is not material and (ii)&nbsp;is the type that IMTX customarily and actually treats as private or confidential. </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[**] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as provided for herein, all other terms and conditions of the Agreement effective September 1, 2015, as previously amended, shall
remain in full force and effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Parties have executed this Amendment to be effective as of the first date written above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SIGNED: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="36%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">IMMATICS US, INC.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">THE UNIVERSITY OF TEXAS HEALTH SCIENCE AT HOUSTON</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Steffen Walter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ T. Kevin Dillon</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Steffen Walter</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">T. Kevin Dillon</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Chief Technology Officer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Sr. Executive Vice President, Chief Operating and Financial Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Date: 6/17/2020</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Date: 06/19/2020</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">APPROVED AS TO LEGAL FORM</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">on behalf of UTHealth</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">dsl 6/19/2020</P></TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-8.1
<SEQUENCE>4
<FILENAME>d149615dex81.htm
<DESCRIPTION>EX-8.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-8.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 8.1 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SUBSIDIARIES </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Company</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Jurisdiction of Incorporation</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Immatics Biotechnologies GmbH</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Germany</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Immatics US, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">United States</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>5
<FILENAME>d149615dex121.htm
<DESCRIPTION>EX-12.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-12.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 12.1 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATION PURSUANT TO </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RULES <FONT STYLE="white-space:nowrap">13a-14(a)</FONT> AND <FONT STYLE="white-space:nowrap">15d-14(a)</FONT> UNDER THE SECURITIES EXCHANGE
ACT OF 1934, </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I, Harpreet Singh, certify that: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. I have
reviewed this annual report on Form <FONT STYLE="white-space:nowrap">20-F</FONT> of Immatics N.V.; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. Based on my knowledge, this report
does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered
by this report; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly
present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. The company&#146;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules <FONT STYLE="white-space:nowrap">13a-15(e)</FONT> and <FONT STYLE="white-space:nowrap">15d-15(e))</FONT> for the company and have: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">b. [reserved]; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">c. Evaluated the effectiveness of the company&#146;s disclosure controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">d. Disclosed in this report any change in the company&#146;s internal control over financial reporting that occurred during the
period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company&#146;s internal control over financial reporting; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. The company&#146;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the company&#146;s auditors and the audit committee of the company&#146;s board of directors (or persons performing the equivalent functions): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the company&#146;s ability to record, process, summarize and report financial information; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the
company&#146;s internal control over financial reporting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: March&nbsp;30, 2021 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Harpreet Singh</P>
<P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Harpreet Singh</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer and Managing Director</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>6
<FILENAME>d149615dex122.htm
<DESCRIPTION>EX-12.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-12.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 12.2 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATION PURSUANT TO </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RULES <FONT STYLE="white-space:nowrap">13a-14(a)</FONT> AND <FONT STYLE="white-space:nowrap">15d-14(a)</FONT> UNDER THE SECURITIES EXCHANGE
ACT OF 1934, </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I, Arnd Christ, certify that: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. I have
reviewed this annual report on Form <FONT STYLE="white-space:nowrap">20-F</FONT> of Immatics N.V.; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. Based on my knowledge, this report
does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered
by this report; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly
present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. The company&#146;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules <FONT STYLE="white-space:nowrap">13a-15(e)</FONT> and <FONT STYLE="white-space:nowrap">15d-15(e))</FONT> for the company and have: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">b. [reserved]; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">c. Evaluated the effectiveness of the company&#146;s disclosure controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">d. Disclosed in this report any change in the company&#146;s internal control over financial reporting that occurred during the
period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company&#146;s internal control over financial reporting; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. The company&#146;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the company&#146;s auditors and the audit committee of the company&#146;s board of directors (or persons performing the equivalent functions): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the company&#146;s ability to record, process, summarize and report financial information; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the
company&#146;s internal control over financial reporting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: March&nbsp;30, 2021 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Arnd Christ</P> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Arnd Christ</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Financial Officer</P></TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>7
<FILENAME>d149615dex131.htm
<DESCRIPTION>EX-13.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-13.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 13.1 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATION PURSUANT TO </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The certification set forth below is being submitted in connection with Immatics N.V.&#146;s annual report on Form
<FONT STYLE="white-space:nowrap">20-F</FONT> for the year ended December&nbsp;31, 2020 (the &#147;Report&#148;) for the purpose of complying with Rule <FONT STYLE="white-space:nowrap">13a-14(b)</FONT> or Rule
<FONT STYLE="white-space:nowrap">15d-14(b)</FONT> of the Securities Exchange Act of 1934 (the &#147;Exchange Act&#148;) and Section&nbsp;1350 of Chapter 63 of Title 18 of the United States Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I, Harpreet Singh, the Chief Executive Officer of Immatics N.V., certify that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. the Report fully complies with the requirements of Section&nbsp;13(a) or 15(d) of the Exchange Act; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of
Immatics N.V. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: March&nbsp;30, 2021 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Harpreet Singh</P>
<P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Harpreet Singh</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer and Managing Director</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.2
<SEQUENCE>8
<FILENAME>d149615dex132.htm
<DESCRIPTION>EX-13.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-13.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 13.2 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATION PURSUANT TO </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The certification set forth below is being submitted in connection with Immatics N.V.&#146;s annual report on Form
<FONT STYLE="white-space:nowrap">20-F</FONT> for the year ended December&nbsp;31, 2020 (the &#147;Report&#148;) for the purpose of complying with Rule <FONT STYLE="white-space:nowrap">13a-14(b)</FONT> or Rule
<FONT STYLE="white-space:nowrap">15d-14(b)</FONT> of the Securities Exchange Act of 1934 (the &#147;Exchange Act&#148;) and Section&nbsp;1350 of Chapter 63 of Title 18 of the United States Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I, Arnd Christ, the Chief Financial Officer of Immatics N.V., certify that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. the Report fully complies with the requirements of Section&nbsp;13(a) or 15(d) of the Exchange Act; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of
Immatics N.V. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: March&nbsp;30, 2021 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Arnd Christ</P> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Arnd Christ</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Financial Officer</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15.1
<SEQUENCE>9
<FILENAME>d149615dex151.htm
<DESCRIPTION>EX-15.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-15.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 15.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the incorporation by reference in the Registration Statement on Form<B></B><FONT STYLE="white-space:nowrap">&nbsp;S-8</FONT> (No.<B> </B><FONT
STYLE="white-space:nowrap">333-249408)</FONT> of Immatics N.V.<B> </B>of our report dated March&nbsp;30, 2021 relating to the financial statements, which appears in this Form <FONT STYLE="white-space:nowrap">20-F.</FONT> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stuttgart, Germany </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March&nbsp;30, 2021 </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PricewaterhouseCoopers GmbH </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Wirtschaftspr&uuml;fungsgesellschaft </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="50%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Dietmar Eglauer</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Wirtschaftspr&uuml;fer</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(German Public Auditor)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ ppa. Andreas Schuster</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Wirtschaftspr&uuml;fer</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(German Public Auditor)</P></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>10
<FILENAME>imtx-20201231.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 30-March-2021 [01:58:02] {AM}-->
<xbrli:xbrl xmlns:imtx="http://imtx.com/20201231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full" xmlns:srt="http://fasb.org/srt/2020-01-31">
<link:schemaRef xlink:type="simple" xlink:href="imtx-20201231.xsd" />
<xbrli:context id="PAsOn12_31_2020">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2018To12_31_2018">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-01-01</xbrli:startDate>
<xbrli:endDate>2018-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To03_31_2020">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-03-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To06_30_2020">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P07_01_2020To07_01_2020">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-07-01</xbrli:startDate>
<xbrli:endDate>2020-07-01</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn07_01_2020">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-07-01</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2017">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P06_30_2020To06_30_2020">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-06-30</xbrli:startDate>
<xbrli:endDate>2020-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_ReceivablesFromCapitalGainsTaxMemberIMTXBalanceSheetLocationAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:BalanceSheetLocationAxis">imtx:ReceivablesFromCapitalGainsTaxMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_CelgeneSwitzerlandLlcAndGenmabAsMemberIMTXCollaborationAgreementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:CollaborationAgreementAxis">imtx:CelgeneSwitzerlandLlcAndGenmabAsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_BuildingsMemberifrsfullClassesOfAssetsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_CommunicationAndNetworkEquipmentMemberifrsfullClassesOfAssetsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:CommunicationAndNetworkEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_VehiclesMemberifrsfullClassesOfAssetsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_OtherAssetsMemberifrsfullClassesOfAssetsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_ServiceOptionsMemberIMTXTypeOfVestingAxis_TwentyTwentyIncentivePlanMemberIMTXPlanNameAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:PlanNameAxis">imtx:TwentyTwentyIncentivePlanMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:TypeOfVestingAxis">imtx:ServiceOptionsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_PerformanceBasedOptionsMemberIMTXTypeOfVestingAxis_TwentyTwentyIncentivePlanMemberIMTXPlanNameAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:PlanNameAxis">imtx:TwentyTwentyIncentivePlanMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:TypeOfVestingAxis">imtx:PerformanceBasedOptionsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:TypeOfVestingAxis">imtx:ServiceOptionsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imtx:ImmaticsGmbhMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis_PerformanceBasedOptionsMemberIMTXTypeOfVestingAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:TypeOfVestingAxis">imtx:PerformanceBasedOptionsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imtx:ImmaticsGmbhMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_NotLaterThanOneYearMemberifrsfullMaturityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_LaterThanOneYearAndNotLaterThanThreeYearsMemberifrsfullMaturityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_LaterThanThreeYearsAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_LaterThanFiveYearsMemberifrsfullMaturityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrsfullCategoriesOfFinancialAssetsAxis_PositiveMarketValueForwardContractsMemberifrsfullClassesOfFinancialAssetsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">imtx:PositiveMarketValueForwardContractsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_OtherFinancialAssetsAtAmortizedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_TradeReceivablesMemberifrsfullClassesOfFinancialAssetsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">imtx:OtherFinancialAssetsAtAmortizedCostMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrsfullCategoriesOfFinancialAssetsAxis_ShorttermDepositsMemberifrsfullClassesOfFinancialAssetsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">imtx:ShorttermDepositsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_OtherCurrentAssetMemberifrsfullClassesOfFinancialAssetsAxis_OtherFinancialAssetsAtAmortizedCostMemberifrsfullCategoriesOfFinancialAssetsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">imtx:OtherCurrentAssetMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">imtx:OtherFinancialAssetsAtAmortizedCostMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_AccountsPayableMemberifrsfullClassesOfFinancialAssetsAxis_OtherFinancialAssetsAtAmortizedCostMemberifrsfullCategoriesOfFinancialAssetsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">imtx:AccountsPayableMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">imtx:OtherFinancialAssetsAtAmortizedCostMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_OtherCurrentLiabilitiesMemberifrsfullClassesOfFinancialAssetsAxis_OtherFinancialAssetsAtAmortizedCostMemberifrsfullCategoriesOfFinancialAssetsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">imtx:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">imtx:OtherFinancialAssetsAtAmortizedCostMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_AmgenCollaborationAgreementMemberIMTXAgreementAxis_DevelopmentAndCommercialMilestonePaymentsMemberIMTXMilestoneAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:AgreementAxis">imtx:AmgenCollaborationAgreementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:MilestoneAxis">imtx:DevelopmentAndCommercialMilestonePaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_GenmabCollaborationAgreementMemberIMTXAgreementAxis_MilestonePaymentForLicensedProductMemberIMTXMilestoneAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:AgreementAxis">imtx:GenmabCollaborationAgreementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:MilestoneAxis">imtx:MilestonePaymentForLicensedProductMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_BMSCollaborationAgreementMemberIMTXAgreementAxis_OptionExerciseDevelopmentCommecialAndRegulatoryMilestonePaymentsMemberIMTXMilestoneAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:AgreementAxis">imtx:BMSCollaborationAgreementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:MilestoneAxis">imtx:OptionExerciseDevelopmentCommecialAndRegulatoryMilestonePaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_GSKCollaborationAgreementMemberIMTXAgreementAxis_MilestoneProgramsBasedOnTheProgramMemberIMTXMilestoneAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:AgreementAxis">imtx:GSKCollaborationAgreementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:MilestoneAxis">imtx:MilestoneProgramsBasedOnTheProgramMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_GSKCollaborationAgreementMemberIMTXAgreementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:AgreementAxis">imtx:GSKCollaborationAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_BMSCollaborationAgreementMemberIMTXAgreementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:AgreementAxis">imtx:BMSCollaborationAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_GenmabCollaborationAgreementMemberIMTXAgreementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:AgreementAxis">imtx:GenmabCollaborationAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_AmgenCollaborationAgreementMemberIMTXAgreementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:AgreementAxis">imtx:AmgenCollaborationAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_AryaMergerMemberIMTXShareListingExpenseAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:ShareListingExpenseAxis">imtx:AryaMergerMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_AryaMemberifrsfullBusinessCombinationsAxis_OrdinarySharesMemberifrsfullClassesOfShareCapitalAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imtx:AryaMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_AryaMemberifrsfullBusinessCombinationsAxis_WarrantsMemberifrsfullClassesOfFinancialInstrumentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imtx:AryaMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imtx:WarrantsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_AryaMemberifrsfullBusinessCombinationsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imtx:AryaMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_IntangibleAssetsMemberifrsfullAssetsAndLiabilitiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">imtx:IntangibleAssetsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_DeferredRevenueMemberifrsfullAssetsAndLiabilitiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">imtx:DeferredRevenueMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_LeaseLiabilityMemberifrsfullAssetsAndLiabilitiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">imtx:LeaseLiabilityMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_DeferredExpensesMemberifrsfullAssetsAndLiabilitiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">imtx:DeferredExpensesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_DeferredAssetRecognisedMemberifrsfullAssetsAndLiabilitiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">imtx:DeferredAssetRecognisedMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_DeferredTaxLiabilitiesDeferredExpensesMemberifrsfullAssetsAndLiabilitiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">imtx:DeferredTaxLiabilitiesDeferredExpensesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_DeferredTaxLiabilitiesRightOfUseAssetMemberifrsfullAssetsAndLiabilitiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">imtx:DeferredTaxLiabilitiesRightOfUseAssetMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_CurrencyRiskMemberifrsfullTypesOfRisksAxis_ImmaticsNvMembersrtOwnershipAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:OwnershipAxis">imtx:ImmaticsNvMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_CurrencyRiskMemberifrsfullTypesOfRisksAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imtx:ImmaticsGmbhMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_EuroWeakensBy1AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="srt:OwnershipAxis">imtx:ImmaticsNvMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:SensitiveAnalaysisOfCurrencyAxis">imtx:EuroWeakensBy1AgainstUsDollarsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_EuroStrengthsBy1AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="srt:OwnershipAxis">imtx:ImmaticsNvMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:SensitiveAnalaysisOfCurrencyAxis">imtx:EuroStrengthsBy1AgainstUsDollarsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_EuroWeakensBy5AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="srt:OwnershipAxis">imtx:ImmaticsNvMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:SensitiveAnalaysisOfCurrencyAxis">imtx:EuroWeakensBy5AgainstUsDollarsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_EuroStrengthsBy5AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="srt:OwnershipAxis">imtx:ImmaticsNvMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:SensitiveAnalaysisOfCurrencyAxis">imtx:EuroStrengthsBy5AgainstUsDollarsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_EuroWeakensBy10AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="srt:OwnershipAxis">imtx:ImmaticsNvMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:SensitiveAnalaysisOfCurrencyAxis">imtx:EuroWeakensBy10AgainstUsDollarsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_EuroStrengthsBy10AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="srt:OwnershipAxis">imtx:ImmaticsNvMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:SensitiveAnalaysisOfCurrencyAxis">imtx:EuroStrengthsBy10AgainstUsDollarsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_EuroWeakensBy1AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imtx:ImmaticsGmbhMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:SensitiveAnalaysisOfCurrencyAxis">imtx:EuroWeakensBy1AgainstUsDollarsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_EuroStrengthsBy1AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imtx:ImmaticsGmbhMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:SensitiveAnalaysisOfCurrencyAxis">imtx:EuroStrengthsBy1AgainstUsDollarsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_EuroWeakensBy10AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imtx:ImmaticsGmbhMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:SensitiveAnalaysisOfCurrencyAxis">imtx:EuroWeakensBy10AgainstUsDollarsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_EuroWeakensBy5AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imtx:ImmaticsGmbhMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:SensitiveAnalaysisOfCurrencyAxis">imtx:EuroWeakensBy5AgainstUsDollarsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_EuroStrengthsBy5AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imtx:ImmaticsGmbhMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:SensitiveAnalaysisOfCurrencyAxis">imtx:EuroStrengthsBy5AgainstUsDollarsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_EuroStrengthsBy10AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imtx:ImmaticsGmbhMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:SensitiveAnalaysisOfCurrencyAxis">imtx:EuroStrengthsBy10AgainstUsDollarsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_CashAndCashEquivalentsMemberifrsfullClassesOfFinancialAssetsAxis_LiquidityRiskMemberifrsfullTypesOfRisksAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">imtx:CashAndCashEquivalentsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_LiquidityRiskMemberifrsfullTypesOfRisksAxis_ShorttermDepositsMemberifrsfullClassesOfFinancialAssetsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">imtx:ShorttermDepositsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_LiquidityRiskMemberifrsfullTypesOfRisksAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_CreditRiskMemberifrsfullTypesOfRisksAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_CurrencyRiskMemberifrsfullTypesOfRisksAxis_USDsrtCurrencyAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_CurrencyRiskMemberifrsfullTypesOfRisksAxis_EURsrtCurrencyAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_ConvertedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:ConvertedOptionsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_ShareAppreciationRightsTwoThousandAndTenPlanMemberIMTXPlanAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:PlanAxis">imtx:ShareAppreciationRightsTwoThousandAndTenPlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMemberIMTXPlanAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:PlanAxis">imtx:ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_ModificationOfTwoThousandAndSixteenPlanMemberIMTXPlanAxis_ShareReinvestmentMemberIMTXSchemeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:SchemeAxis">imtx:ShareReinvestmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:PlanAxis">imtx:ModificationOfTwoThousandAndSixteenPlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_TrancheOneMemberIMTXTrancheAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:TrancheAxis">imtx:TrancheOneMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:PerformanceBasedOptionsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_TrancheTwoMemberIMTXTrancheAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:TrancheAxis">imtx:TrancheTwoMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:PerformanceBasedOptionsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_TrancheThreeMemberIMTXTrancheAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:TrancheAxis">imtx:TrancheThreeMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:PerformanceBasedOptionsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_CollaborationAgreementsMemberIMTXAgreementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:AgreementAxis">imtx:CollaborationAgreementsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_ImmaticsUsIncMemberifrsfullSignificantInvestmentsInSubsidiariesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imtx:ImmaticsUsIncMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_ReceivablesFromCapitalGainsTaxMemberIMTXBalanceSheetLocationAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:BalanceSheetLocationAxis">imtx:ReceivablesFromCapitalGainsTaxMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_CelgeneSwitzerlandLlcAndGenmabAsMemberIMTXCollaborationAgreementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:CollaborationAgreementAxis">imtx:CelgeneSwitzerlandLlcAndGenmabAsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_BuildingsMemberifrsfullClassesOfAssetsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_CommunicationAndNetworkEquipmentMemberifrsfullClassesOfAssetsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:CommunicationAndNetworkEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_VehiclesMemberifrsfullClassesOfAssetsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_OtherAssetsMemberifrsfullClassesOfAssetsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_NotLaterThanOneYearMemberifrsfullMaturityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_LaterThanOneYearAndNotLaterThanThreeYearsMemberifrsfullMaturityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_LaterThanThreeYearsAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_LaterThanFiveYearsMemberifrsfullMaturityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrsfullCategoriesOfFinancialAssetsAxis_PositiveMarketValueForwardContractsMemberifrsfullClassesOfFinancialAssetsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">imtx:PositiveMarketValueForwardContractsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_OtherFinancialAssetsAtAmortizedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_TradeReceivablesMemberifrsfullClassesOfFinancialAssetsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">imtx:OtherFinancialAssetsAtAmortizedCostMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrsfullCategoriesOfFinancialAssetsAxis_ShorttermDepositsMemberifrsfullClassesOfFinancialAssetsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">imtx:ShorttermDepositsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_OtherCurrentAssetMemberifrsfullClassesOfFinancialAssetsAxis_OtherFinancialAssetsAtAmortizedCostMemberifrsfullCategoriesOfFinancialAssetsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">imtx:OtherCurrentAssetMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">imtx:OtherFinancialAssetsAtAmortizedCostMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_AccountsPayableMemberifrsfullClassesOfFinancialAssetsAxis_OtherFinancialAssetsAtAmortizedCostMemberifrsfullCategoriesOfFinancialAssetsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">imtx:AccountsPayableMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">imtx:OtherFinancialAssetsAtAmortizedCostMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_OtherCurrentLiabilitiesMemberifrsfullClassesOfFinancialAssetsAxis_OtherFinancialAssetsAtAmortizedCostMemberifrsfullCategoriesOfFinancialAssetsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">imtx:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">imtx:OtherFinancialAssetsAtAmortizedCostMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_GSKCollaborationAgreementMemberIMTXAgreementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:AgreementAxis">imtx:GSKCollaborationAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_GenmabCollaborationAgreementMemberIMTXAgreementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:AgreementAxis">imtx:GenmabCollaborationAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_AmgenCollaborationAgreementMemberIMTXAgreementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:AgreementAxis">imtx:AmgenCollaborationAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_BMSCollaborationAgreementMemberIMTXAgreementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:AgreementAxis">imtx:BMSCollaborationAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_ImmaticsBiotechnologiesGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imtx:ImmaticsBiotechnologiesGmbhMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_ReorganizationMemberIMTXEventAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:EventAxis">imtx:ReorganizationMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_IntangibleAssetsMemberifrsfullAssetsAndLiabilitiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">imtx:IntangibleAssetsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_DeferredRevenueMemberifrsfullAssetsAndLiabilitiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">imtx:DeferredRevenueMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_OtherLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">imtx:OtherLiabilitiesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_LeaseLiabilityMemberifrsfullAssetsAndLiabilitiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">imtx:LeaseLiabilityMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_DeferredExpensesMemberifrsfullAssetsAndLiabilitiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">imtx:DeferredExpensesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_DeferredAssetRecognisedMemberifrsfullAssetsAndLiabilitiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">imtx:DeferredAssetRecognisedMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_DeferredTaxLiabilitiesDeferredExpensesMemberifrsfullAssetsAndLiabilitiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">imtx:DeferredTaxLiabilitiesDeferredExpensesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_DeferredTaxLiabilitiesRightOfUseAssetMemberifrsfullAssetsAndLiabilitiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">imtx:DeferredTaxLiabilitiesRightOfUseAssetMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_CashAndCashEquivalentsMemberifrsfullClassesOfFinancialAssetsAxis_LiquidityRiskMemberifrsfullTypesOfRisksAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">imtx:CashAndCashEquivalentsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_LiquidityRiskMemberifrsfullTypesOfRisksAxis_ShorttermDepositsMemberifrsfullClassesOfFinancialAssetsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">imtx:ShorttermDepositsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_LiquidityRiskMemberifrsfullTypesOfRisksAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_CreditRiskMemberifrsfullTypesOfRisksAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:ShareAppreciationRightsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_ShareAppreciationRightsTwoThousandAndTenPlanMemberIMTXPlanAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:PlanAxis">imtx:ShareAppreciationRightsTwoThousandAndTenPlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:PlanAxis">imtx:TwoThousandAndSixteenTandemAwardsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_CollaborationAgreementsMemberIMTXAgreementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:AgreementAxis">imtx:CollaborationAgreementsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_OtherReservesMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_TotalEquityAttributableToShareholdersOfParentMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">imtx:TotalEquityAttributableToShareholdersOfParentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_RetainedEarningsMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_SharePremiumMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_IssuedCapitalMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_AmendmentsToIfrsThreeMemberifrsfullNewIFRSsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:NewIFRSsAxis">imtx:AmendmentsToIfrsThreeMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_AmendmentsToIasOneAndIasEightMemberifrsfullNewIFRSsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:NewIFRSsAxis">imtx:AmendmentsToIasOneAndIasEightMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_AmendmentsToIfrsNineIasThirtyNineAndIfrsSeventeenMemberifrsfullNewIFRSsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:NewIFRSsAxis">imtx:AmendmentsToIfrsNineIasThirtyNineAndIfrsSeventeenMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_AmendmentsToConceptualFrameworkMemberifrsfullNewIFRSsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:NewIFRSsAxis">imtx:AmendmentsToConceptualFrameworkMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_AmendmentsToIasOneMemberifrsfullNewIFRSsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:NewIFRSsAxis">imtx:AmendmentsToIasOneMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_IfrsSeventeenMemberifrsfullNewIFRSsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:NewIFRSsAxis">imtx:IfrsSeventeenMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_IfrsSixteenMemberifrsfullNewIFRSsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:NewIFRSsAxis">imtx:IfrsSixteenMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_ResearchAndDevelopmentExpenseMemberIMTXIncomeStatementLocationAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:IncomeStatementLocationAxis">imtx:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_GeneralAndAdministrativeExpenseMemberIMTXIncomeStatementLocationAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:IncomeStatementLocationAxis">imtx:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_BottomOfRangeMemberifrsfullRangeAxis_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis_TopOfRangeMemberifrsfullRangeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_BottomOfRangeMemberifrsfullRangeAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imtx:LaboratoryEquipmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis_TopOfRangeMemberifrsfullRangeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imtx:LaboratoryEquipmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_BottomOfRangeMemberifrsfullRangeAxis_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis_TopOfRangeMemberifrsfullRangeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_BottomOfRangeMemberifrsfullRangeAxis_LicencesMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_LicencesMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_TopOfRangeMemberifrsfullRangeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_BottomOfRangeMemberifrsfullRangeAxis_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_TopOfRangeMemberifrsfullRangeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_TopOfRangeMemberifrsfullRangeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_BottomOfRangeMemberifrsfullRangeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_CelgeneSwitzerlandLlcAndGenmabAsMemberIMTXCollaborationAgreementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:CollaborationAgreementAxis">imtx:CelgeneSwitzerlandLlcAndGenmabAsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imtx:LaboratoryEquipmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imtx:LaboratoryEquipmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_PatentAndLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">imtx:PatentAndLicensesMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_SoftwareLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">imtx:SoftwareLicensesMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_SoftwareLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">imtx:SoftwareLicensesMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_PatentAndLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">imtx:PatentAndLicensesMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_BuildingsMemberifrsfullClassesOfAssetsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_CommunicationAndNetworkEquipmentMemberifrsfullClassesOfAssetsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:CommunicationAndNetworkEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_VehiclesMemberifrsfullClassesOfAssetsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_OtherAssetsMemberifrsfullClassesOfAssetsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_PeterChambreMemberifrsfullCategoriesOfRelatedPartiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imtx:PeterChambreMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_HaraldFstockMemberifrsfullCategoriesOfRelatedPartiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imtx:HaraldFstockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_MichaelGAtiehMemberifrsfullCategoriesOfRelatedPartiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imtx:MichaelGAtiehMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_PaulCarterMemberifrsfullCategoriesOfRelatedPartiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imtx:PaulCarterMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_HeatherLMasonMemberifrsfullCategoriesOfRelatedPartiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imtx:HeatherLMasonMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_AdamStoneMemberifrsfullCategoriesOfRelatedPartiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imtx:AdamStoneMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_ChristophHettichMemberifrsfullCategoriesOfRelatedPartiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imtx:ChristophHettichMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_EliotForsterMemberifrsfullCategoriesOfRelatedPartiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imtx:EliotForsterMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis_PerformanceBasedOptionsMemberIMTXTypeOfVestingAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:TypeOfVestingAxis">imtx:PerformanceBasedOptionsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imtx:HarpreetSinghMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imtx:HarpreetSinghMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:TypeOfVestingAxis">imtx:ServiceOptionsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis_MatchingStockOptionsMemberIMTXTypeOfVestingAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imtx:HarpreetSinghMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:TypeOfVestingAxis">imtx:MatchingStockOptionsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_ConvertedOptionsMemberIMTXTypeOfVestingAxis_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imtx:HarpreetSinghMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:TypeOfVestingAxis">imtx:ConvertedOptionsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_ConvertedOptionsOneMemberIMTXTypeOfVestingAxis_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:TypeOfVestingAxis">imtx:ConvertedOptionsOneMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imtx:HarpreetSinghMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsOneMemberIMTXTypeOfVestingAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imtx:HarpreetSinghMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:TypeOfVestingAxis">imtx:ServiceOptionsOneMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_PeterChambreMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imtx:PeterChambreMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:TypeOfVestingAxis">imtx:ServiceOptionsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_MatchingStockOptionsMemberIMTXTypeOfVestingAxis_PeterChambreMemberifrsfullCategoriesOfRelatedPartiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imtx:PeterChambreMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:TypeOfVestingAxis">imtx:MatchingStockOptionsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_AdamStoneMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:TypeOfVestingAxis">imtx:ServiceOptionsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imtx:AdamStoneMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_ChristophHettichMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:TypeOfVestingAxis">imtx:ServiceOptionsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imtx:ChristophHettichMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_HeatherLMasonMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:TypeOfVestingAxis">imtx:ServiceOptionsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imtx:HeatherLMasonMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_MichaelGAtiehMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:TypeOfVestingAxis">imtx:ServiceOptionsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imtx:MichaelGAtiehMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_PaulCarterMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:TypeOfVestingAxis">imtx:ServiceOptionsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imtx:PaulCarterMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_EliotForsterMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:TypeOfVestingAxis">imtx:ServiceOptionsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imtx:EliotForsterMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_KeyManagementPersonnelOfEntityOrParentMemberifrsfullCategoriesOfRelatedPartiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_AryaMemberifrsfullBusinessCombinationsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imtx:AryaMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_BMSCollaborationAgreementMemberIMTXAgreementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:AgreementAxis">imtx:BMSCollaborationAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_GenmabCollaborationAgreementMemberIMTXAgreementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:AgreementAxis">imtx:GenmabCollaborationAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_AmgenCollaborationAgreementMemberIMTXAgreementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:AgreementAxis">imtx:AmgenCollaborationAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_GSKCollaborationAgreementMemberIMTXAgreementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:AgreementAxis">imtx:GSKCollaborationAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_NonInterestBearingLiabilityMemberifrsfullBorrowingsByNameAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">imtx:NonInterestBearingLiabilityMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_IndefiniteTaxLossesCarryforwardMemberifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">imtx:IndefiniteTaxLossesCarryforwardMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_TwentySixYearTaxLossesCarryforwardMemberifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">imtx:TwentySixYearTaxLossesCarryforwardMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_EuroStrengthsBy10AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imtx:ImmaticsGmbhMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:SensitiveAnalaysisOfCurrencyAxis">imtx:EuroStrengthsBy10AgainstUsDollarsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_EuroStrengthsBy5AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imtx:ImmaticsGmbhMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:SensitiveAnalaysisOfCurrencyAxis">imtx:EuroStrengthsBy5AgainstUsDollarsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_EuroWeakensBy5AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imtx:ImmaticsGmbhMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:SensitiveAnalaysisOfCurrencyAxis">imtx:EuroWeakensBy5AgainstUsDollarsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_EuroWeakensBy10AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imtx:ImmaticsGmbhMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:SensitiveAnalaysisOfCurrencyAxis">imtx:EuroWeakensBy10AgainstUsDollarsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_EuroStrengthsBy1AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imtx:ImmaticsGmbhMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:SensitiveAnalaysisOfCurrencyAxis">imtx:EuroStrengthsBy1AgainstUsDollarsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_EuroWeakensBy1AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imtx:ImmaticsGmbhMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:SensitiveAnalaysisOfCurrencyAxis">imtx:EuroWeakensBy1AgainstUsDollarsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_EuroStrengthsBy10AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="srt:OwnershipAxis">imtx:ImmaticsNvMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:SensitiveAnalaysisOfCurrencyAxis">imtx:EuroStrengthsBy10AgainstUsDollarsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_EuroWeakensBy10AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="srt:OwnershipAxis">imtx:ImmaticsNvMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:SensitiveAnalaysisOfCurrencyAxis">imtx:EuroWeakensBy10AgainstUsDollarsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_EuroStrengthsBy5AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="srt:OwnershipAxis">imtx:ImmaticsNvMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:SensitiveAnalaysisOfCurrencyAxis">imtx:EuroStrengthsBy5AgainstUsDollarsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_EuroWeakensBy5AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="srt:OwnershipAxis">imtx:ImmaticsNvMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:SensitiveAnalaysisOfCurrencyAxis">imtx:EuroWeakensBy5AgainstUsDollarsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_EuroStrengthsBy1AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="srt:OwnershipAxis">imtx:ImmaticsNvMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:SensitiveAnalaysisOfCurrencyAxis">imtx:EuroStrengthsBy1AgainstUsDollarsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_EuroWeakensBy1AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="srt:OwnershipAxis">imtx:ImmaticsNvMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:SensitiveAnalaysisOfCurrencyAxis">imtx:EuroWeakensBy1AgainstUsDollarsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_CurrencyRiskMemberifrsfullTypesOfRisksAxis_TopOfRangeMemberifrsfullRangeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_BottomOfRangeMemberifrsfullRangeAxis_CurrencyRiskMemberifrsfullTypesOfRisksAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:ShareAppreciationRightsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_ConvertedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:ConvertedOptionsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:AdditionalGrantsUnderTwoThousandAndTwentyPlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:PerformanceBasedOptionsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_TwoThousandAndSixteenTandemAwardsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:TwoThousandAndSixteenTandemAwardsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_MatchingStockOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:MatchingStockOptionsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_GrantedOnSeptemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:DateOfGrantAxis">imtx:GrantedOnSeptemberTwoThousandAndTwentyMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:PerformanceBasedOptionsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_GrantedOnJuneTwoThousandAndTwentyMemberIMTXDateOfGrantAxis_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:DateOfGrantAxis">imtx:GrantedOnJuneTwoThousandAndTwentyMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:PerformanceBasedOptionsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_GrantedOnJuneTwoThousandAndTwentyMemberIMTXDateOfGrantAxis_MatchingStockOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:MatchingStockOptionsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:DateOfGrantAxis">imtx:GrantedOnJuneTwoThousandAndTwentyMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_GrantedOnDecemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:DateOfGrantAxis">imtx:GrantedOnDecemberTwoThousandAndTwentyMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:AdditionalGrantsUnderTwoThousandAndTwentyPlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_GrantedOnSeptemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:DateOfGrantAxis">imtx:GrantedOnSeptemberTwoThousandAndTwentyMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:AdditionalGrantsUnderTwoThousandAndTwentyPlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_ConvertedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_GrantedOnJuneTwoThousandAndTwentyMemberIMTXDateOfGrantAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:ConvertedOptionsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:DateOfGrantAxis">imtx:GrantedOnJuneTwoThousandAndTwentyMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_GrantedOnJuneTwoThousandAndTwentyMemberIMTXDateOfGrantAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:DateOfGrantAxis">imtx:GrantedOnJuneTwoThousandAndTwentyMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:AdditionalGrantsUnderTwoThousandAndTwentyPlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_AryaMergerMemberIMTXShareListingExpenseAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:ShareListingExpenseAxis">imtx:AryaMergerMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_ActiveEmployeesMemberIMTXCategoryOfEmployeesAxis_BottomOfRangeMemberifrsfullRangeAxis_ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMemberIMTXPlanAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:PlanAxis">imtx:ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:CategoryOfEmployeesAxis">imtx:ActiveEmployeesMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_ActiveEmployeesMemberIMTXCategoryOfEmployeesAxis_ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMemberIMTXPlanAxis_TopOfRangeMemberifrsfullRangeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:PlanAxis">imtx:ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:CategoryOfEmployeesAxis">imtx:ActiveEmployeesMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_ManagementMembersMemberIMTXCategoryOfEmployeesAxis_ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMemberIMTXPlanAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:PlanAxis">imtx:ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:CategoryOfEmployeesAxis">imtx:ManagementMembersMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMemberIMTXPlanAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:PlanAxis">imtx:ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_ModificationOfTwoThousandAndTenPlanMemberIMTXPlanAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:PlanAxis">imtx:ModificationOfTwoThousandAndTenPlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_ModificationOfTwoThousandAndSixteenPlanMemberIMTXPlanAxis_ShareReinvestmentMemberIMTXSchemeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:SchemeAxis">imtx:ShareReinvestmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:PlanAxis">imtx:ModificationOfTwoThousandAndSixteenPlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_ModificationOfTwoThousandAndSixteenPlanMemberIMTXPlanAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:PlanAxis">imtx:ModificationOfTwoThousandAndSixteenPlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_AryaMemberifrsfullBusinessCombinationsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:AdditionalGrantsUnderTwoThousandAndTwentyPlanMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imtx:AryaMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_MatchingStockOptionsMemberIMTXShareReinvestmentSchemeAxis_ModificationOfTwoThousandAndSixteenPlanMemberIMTXPlanAxis_ShareReinvestmentMemberIMTXSchemeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:SchemeAxis">imtx:ShareReinvestmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:ShareReinvestmentSchemeAxis">imtx:MatchingStockOptionsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:PlanAxis">imtx:ModificationOfTwoThousandAndSixteenPlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_LaterThanFourYearsAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_LaterThanOneYearMemberifrsfullMaturityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_OrdinaryShareMemberdeiDocumentInformationDocumentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="dei:DocumentInformationDocumentAxis">imtx:OrdinaryShareMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_WarrantsMemberdeiDocumentInformationDocumentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="dei:DocumentInformationDocumentAxis">imtx:WarrantsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_OtherReservesMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_TotalEquityAttributableToShareholdersOfParentMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">imtx:TotalEquityAttributableToShareholdersOfParentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_RetainedEarningsMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_SharePremiumMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_PreviouslyStatedMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:PreviouslyStatedMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_ImmaticsUsIncMemberifrsfullSignificantInvestmentsInSubsidiariesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imtx:ImmaticsUsIncMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_ResearchAndDevelopmentExpenseMemberIMTXIncomeStatementLocationAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:IncomeStatementLocationAxis">imtx:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_GeneralAndAdministrativeExpenseMemberIMTXIncomeStatementLocationAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:IncomeStatementLocationAxis">imtx:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_CelgeneSwitzerlandLlcAndGenmabAsMemberIMTXCollaborationAgreementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:CollaborationAgreementAxis">imtx:CelgeneSwitzerlandLlcAndGenmabAsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imtx:LaboratoryEquipmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imtx:LaboratoryEquipmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_PatentAndLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">imtx:PatentAndLicensesMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_SoftwareLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">imtx:SoftwareLicensesMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_SoftwareLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">imtx:SoftwareLicensesMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_PatentAndLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">imtx:PatentAndLicensesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_PatentAndLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">imtx:PatentAndLicensesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_BuildingsMemberifrsfullClassesOfAssetsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_CommunicationAndNetworkEquipmentMemberifrsfullClassesOfAssetsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:CommunicationAndNetworkEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_VehiclesMemberifrsfullClassesOfAssetsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_OtherAssetsMemberifrsfullClassesOfAssetsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_PeterChambreMemberifrsfullCategoriesOfRelatedPartiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imtx:PeterChambreMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_HaraldFstockMemberifrsfullCategoriesOfRelatedPartiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imtx:HaraldFstockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_AmgenCollaborationAgreementMemberIMTXAgreementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:AgreementAxis">imtx:AmgenCollaborationAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_GenmabCollaborationAgreementMemberIMTXAgreementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:AgreementAxis">imtx:GenmabCollaborationAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_BMSCollaborationAgreementMemberIMTXAgreementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:AgreementAxis">imtx:BMSCollaborationAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_GSKCollaborationAgreementMemberIMTXAgreementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:AgreementAxis">imtx:GSKCollaborationAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_IndefiniteTaxLossesCarryforwardMemberifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">imtx:IndefiniteTaxLossesCarryforwardMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:ShareAppreciationRightsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:PlanAxis">imtx:TwoThousandAndSixteenTandemAwardsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_GrantedOnJuneToSeptemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:DateOfGrantAxis">imtx:GrantedOnJuneToSeptemberTwoThousandAndTwentyMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_GrantedOnDecemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:DateOfGrantAxis">imtx:GrantedOnDecemberTwoThousandAndTwentyMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_GrantedOnSeptemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:DateOfGrantAxis">imtx:GrantedOnSeptemberTwoThousandAndTwentyMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2018To12_31_2018_OtherReservesMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-01-01</xbrli:startDate>
<xbrli:endDate>2018-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2018To12_31_2018_TotalEquityAttributableToShareholdersOfParentMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">imtx:TotalEquityAttributableToShareholdersOfParentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-01-01</xbrli:startDate>
<xbrli:endDate>2018-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2018To12_31_2018_RetainedEarningsMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-01-01</xbrli:startDate>
<xbrli:endDate>2018-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2018To12_31_2018_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-01-01</xbrli:startDate>
<xbrli:endDate>2018-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2018To12_31_2018_SharePremiumMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-01-01</xbrli:startDate>
<xbrli:endDate>2018-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2018To12_31_2018_PreviouslyStatedMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:PreviouslyStatedMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-01-01</xbrli:startDate>
<xbrli:endDate>2018-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2018To12_31_2018_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-01-01</xbrli:startDate>
<xbrli:endDate>2018-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2018To12_31_2018_ImmaticsUsIncMemberifrsfullSignificantInvestmentsInSubsidiariesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imtx:ImmaticsUsIncMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-01-01</xbrli:startDate>
<xbrli:endDate>2018-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2018To12_31_2018_ResearchAndDevelopmentExpenseMemberIMTXIncomeStatementLocationAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:IncomeStatementLocationAxis">imtx:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-01-01</xbrli:startDate>
<xbrli:endDate>2018-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2018To12_31_2018_GeneralAndAdministrativeExpenseMemberIMTXIncomeStatementLocationAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:IncomeStatementLocationAxis">imtx:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-01-01</xbrli:startDate>
<xbrli:endDate>2018-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2018To12_31_2018_PeterChambreMemberifrsfullCategoriesOfRelatedPartiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imtx:PeterChambreMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-01-01</xbrli:startDate>
<xbrli:endDate>2018-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2018To12_31_2018_HaraldFstockMemberifrsfullCategoriesOfRelatedPartiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imtx:HaraldFstockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-01-01</xbrli:startDate>
<xbrli:endDate>2018-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2018To12_31_2018_AmgenCollaborationAgreementMemberIMTXAgreementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:AgreementAxis">imtx:AmgenCollaborationAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-01-01</xbrli:startDate>
<xbrli:endDate>2018-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2018To12_31_2018_GenmabCollaborationAgreementMemberIMTXAgreementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:AgreementAxis">imtx:GenmabCollaborationAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-01-01</xbrli:startDate>
<xbrli:endDate>2018-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2018To12_31_2018_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:ShareAppreciationRightsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-01-01</xbrli:startDate>
<xbrli:endDate>2018-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2018To12_31_2018_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:PlanAxis">imtx:TwoThousandAndSixteenTandemAwardsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-01-01</xbrli:startDate>
<xbrli:endDate>2018-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2018To12_31_2018_GrantedOnJuneToSeptemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:DateOfGrantAxis">imtx:GrantedOnJuneToSeptemberTwoThousandAndTwentyMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-01-01</xbrli:startDate>
<xbrli:endDate>2018-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2018To12_31_2018_GrantedOnSeptemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:DateOfGrantAxis">imtx:GrantedOnSeptemberTwoThousandAndTwentyMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-01-01</xbrli:startDate>
<xbrli:endDate>2018-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P03_30_2021To03_30_2021_AuthorizationOfFinancialStatementsMemberifrsfullNonadjustingEventsAfterReportingPeriodAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">imtx:AuthorizationOfFinancialStatementsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2021-03-30</xbrli:startDate>
<xbrli:endDate>2021-03-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To03_31_2020_PreviouslyStatedMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:PreviouslyStatedMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-03-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To03_31_2020_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-03-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To06_30_2020_PreviouslyStatedMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:PreviouslyStatedMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To06_30_2020_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn07_01_2020_AryaMemberifrsfullBusinessCombinationsAxis_OrdinarySharesMemberifrsfullClassesOfShareCapitalAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imtx:AryaMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-07-01</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn07_01_2020_AryaMemberifrsfullBusinessCombinationsAxis_WarrantsMemberifrsfullClassesOfFinancialInstrumentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imtx:AryaMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">imtx:WarrantsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-07-01</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn07_01_2020_AryaMemberifrsfullBusinessCombinationsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imtx:AryaMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-07-01</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn07_01_2020_OrdinarySharesMemberifrsfullClassesOfShareCapitalAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-07-01</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn07_01_2020_AryaMergerMemberIMTXShareListingExpenseAxis_PipeFinancingMemberifrsfullBorrowingsByNameAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">imtx:PipeFinancingMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:ShareListingExpenseAxis">imtx:AryaMergerMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-07-01</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P07_01_2020To07_01_2020_AryaMemberifrsfullBusinessCombinationsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imtx:AryaMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-07-01</xbrli:startDate>
<xbrli:endDate>2020-07-01</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P07_01_2020To07_01_2020_PipeFinancingMemberifrsfullClassesOfOrdinarySharesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">imtx:PipeFinancingMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-07-01</xbrli:startDate>
<xbrli:endDate>2020-07-01</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P07_01_2020To07_01_2020_IssuedCapitalMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-07-01</xbrli:startDate>
<xbrli:endDate>2020-07-01</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P07_01_2020To07_01_2020_SharePremiumMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-07-01</xbrli:startDate>
<xbrli:endDate>2020-07-01</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P07_01_2020To07_01_2020_MdAndersonMemberifrsfullCategoriesOfRelatedPartiesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">imtx:MdAndersonMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-07-01</xbrli:startDate>
<xbrli:endDate>2020-07-01</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P07_01_2020To07_01_2020_RestrictedStockAcquisitionAgreementMemberifrsfullBusinessCombinationsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">imtx:RestrictedStockAcquisitionAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-07-01</xbrli:startDate>
<xbrli:endDate>2020-07-01</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_ImmaticsBiotechnologiesGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis_SeriesEShareCapitalMemberifrsfullClassesOfShareCapitalAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">imtx:SeriesEShareCapitalMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">imtx:ImmaticsBiotechnologiesGmbhMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:ShareAppreciationRightsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_ShareAppreciationRightsTwoThousandAndTenPlanMemberIMTXPlanAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:PlanAxis">imtx:ShareAppreciationRightsTwoThousandAndTenPlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P02_01_2017To12_31_2020_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:PlanAxis">imtx:TwoThousandAndSixteenTandemAwardsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2017-02-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2017_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:PlanAxis">imtx:TwoThousandAndSixteenTandemAwardsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn09_30_2020_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:PlanAxis">imtx:TwoThousandAndSixteenTandemAwardsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-09-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P09_14_2020To09_14_2020_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:PerformanceBasedOptionsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-09-14</xbrli:startDate>
<xbrli:endDate>2020-09-14</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P09_14_2020To09_14_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:AdditionalGrantsUnderTwoThousandAndTwentyPlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-09-14</xbrli:startDate>
<xbrli:endDate>2020-09-14</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P09_14_2020To09_14_2020_GrantedOnSeptemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:PerformanceBasedOptionsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:DateOfGrantAxis">imtx:GrantedOnSeptemberTwoThousandAndTwentyMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-09-14</xbrli:startDate>
<xbrli:endDate>2020-09-14</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P09_14_2020To09_14_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_GrantedOnSeptemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:AdditionalGrantsUnderTwoThousandAndTwentyPlanMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:DateOfGrantAxis">imtx:GrantedOnSeptemberTwoThousandAndTwentyMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-09-14</xbrli:startDate>
<xbrli:endDate>2020-09-14</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P06_30_2020To06_30_2020_MatchingStockOptionsMemberIMTXPlanAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:PlanAxis">imtx:MatchingStockOptionsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-06-30</xbrli:startDate>
<xbrli:endDate>2020-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P06_30_2020To06_30_2020_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:PerformanceBasedOptionsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-06-30</xbrli:startDate>
<xbrli:endDate>2020-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P06_30_2020To06_30_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:AdditionalGrantsUnderTwoThousandAndTwentyPlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-06-30</xbrli:startDate>
<xbrli:endDate>2020-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P06_30_2020To06_30_2020_ConvertedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:ConvertedOptionsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-06-30</xbrli:startDate>
<xbrli:endDate>2020-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P06_30_2020To06_30_2020_GrantedOnJuneTwoThousandAndTwentyMemberIMTXDateOfGrantAxis_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:PerformanceBasedOptionsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:DateOfGrantAxis">imtx:GrantedOnJuneTwoThousandAndTwentyMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-06-30</xbrli:startDate>
<xbrli:endDate>2020-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P06_30_2020To06_30_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_GrantedOnJuneTwoThousandAndTwentyMemberIMTXDateOfGrantAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:DateOfGrantAxis">imtx:GrantedOnJuneTwoThousandAndTwentyMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:AdditionalGrantsUnderTwoThousandAndTwentyPlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-06-30</xbrli:startDate>
<xbrli:endDate>2020-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P12_17_2020To12_17_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:AdditionalGrantsUnderTwoThousandAndTwentyPlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-12-17</xbrli:startDate>
<xbrli:endDate>2020-12-17</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P12_17_2020To12_17_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_GrantedOnDecemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:AdditionalGrantsUnderTwoThousandAndTwentyPlanMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="imtx:DateOfGrantAxis">imtx:GrantedOnDecemberTwoThousandAndTwentyMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-12-17</xbrli:startDate>
<xbrli:endDate>2020-12-17</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P06_01_2019To09_30_2019_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:PlanAxis">imtx:TwoThousandAndSixteenTandemAwardsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-06-01</xbrli:startDate>
<xbrli:endDate>2019-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_IssuedCapitalMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_SharePremiumMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_RetainedEarningsMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_OtherReservesMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_TotalEquityAttributableToShareholdersOfParentMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">imtx:TotalEquityAttributableToShareholdersOfParentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_IssuedCapitalMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_SharePremiumMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_RetainedEarningsMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_OtherReservesMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_TotalEquityAttributableToShareholdersOfParentMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">imtx:TotalEquityAttributableToShareholdersOfParentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imtx:LaboratoryEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imtx:LaboratoryEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_PatentAndLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">imtx:PatentAndLicensesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_SoftwareLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">imtx:SoftwareLicensesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_PatentAndLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">imtx:PatentAndLicensesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_SoftwareLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">imtx:SoftwareLicensesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_PatentAndLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">imtx:PatentAndLicensesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_SoftwareLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">imtx:SoftwareLicensesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_PatentAndLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">imtx:PatentAndLicensesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_SoftwareLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">imtx:SoftwareLicensesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_PatentAndLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">imtx:PatentAndLicensesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_SoftwareLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">imtx:SoftwareLicensesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:AdditionalGrantsUnderTwoThousandAndTwentyPlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_MatchingStockOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:MatchingStockOptionsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:PerformanceBasedOptionsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imtx:LaboratoryEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imtx:LaboratoryEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imtx:LaboratoryEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_IssuedCapitalMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_SharePremiumMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_RetainedEarningsMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_OtherReservesMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_TotalEquityAttributableToShareholdersOfParentMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">imtx:TotalEquityAttributableToShareholdersOfParentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imtx:LaboratoryEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis_PreviouslyStatedMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:PreviouslyStatedMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imtx:LaboratoryEquipmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_PreviouslyStatedMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:PreviouslyStatedMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis_PreviouslyStatedMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:PreviouslyStatedMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_PreviouslyStatedMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:PreviouslyStatedMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imtx:LaboratoryEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_AdjustmentOnAdoptionIfrsSixteenMemberIMTXTypeOfAdoptionsAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:TypeOfAdoptionsAxis">imtx:AdjustmentOnAdoptionIfrsSixteenMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imtx:LaboratoryEquipmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_AdjustmentOnAdoptionIfrsSixteenMemberIMTXTypeOfAdoptionsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="imtx:TypeOfAdoptionsAxis">imtx:AdjustmentOnAdoptionIfrsSixteenMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_PatentAndLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">imtx:PatentAndLicensesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_SoftwareLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">imtx:SoftwareLicensesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_PatentAndLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">imtx:PatentAndLicensesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_SoftwareLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">imtx:SoftwareLicensesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_PatentAndLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">imtx:PatentAndLicensesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_SoftwareLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">imtx:SoftwareLicensesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">imtx:LaboratoryEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2017_IssuedCapitalMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2017_SharePremiumMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2017_RetainedEarningsMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2017_OtherReservesMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2017_TotalEquityAttributableToShareholdersOfParentMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">imtx:TotalEquityAttributableToShareholdersOfParentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2017_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2017_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001809196</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">imtx:ShareAppreciationRightsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<ifrs-full:CashAndCashEquivalents id="Factid_19489537" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">207530000</ifrs-full:CashAndCashEquivalents>
<ifrs-full:CashAndCashEquivalents id="Factid_19489538" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">103353000</ifrs-full:CashAndCashEquivalents>
<ifrs-full:OtherCurrentFinancialAssets id="Factid_19489539" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">24448000</ifrs-full:OtherCurrentFinancialAssets>
<ifrs-full:OtherCurrentFinancialAssets id="Factid_19489540" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">16023000</ifrs-full:OtherCurrentFinancialAssets>
<ifrs-full:CurrentTradeReceivables id="Factid_19489541" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">1250000</ifrs-full:CurrentTradeReceivables>
<ifrs-full:CurrentTradeReceivables id="Factid_19489542" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">957000</ifrs-full:CurrentTradeReceivables>
<ifrs-full:OtherCurrentAssets id="Factid_19489543" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">5763000</ifrs-full:OtherCurrentAssets>
<ifrs-full:OtherCurrentAssets id="Factid_19489544" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">3667000</ifrs-full:OtherCurrentAssets>
<ifrs-full:CurrentAssets id="Factid_19489545" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">238991000</ifrs-full:CurrentAssets>
<ifrs-full:CurrentAssets id="Factid_19489546" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">124000000</ifrs-full:CurrentAssets>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19489547" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">7868000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19489548" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">4720000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:IntangibleAssetsOtherThanGoodwill id="Factid_19489549" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">914000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
<ifrs-full:IntangibleAssetsOtherThanGoodwill id="Factid_19489550" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">1008000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
<ifrs-full:RightofuseAssets id="Factid_19489551" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">6149000</ifrs-full:RightofuseAssets>
<ifrs-full:RightofuseAssets id="Factid_19489552" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">3287000</ifrs-full:RightofuseAssets>
<ifrs-full:OtherNoncurrentAssets id="Factid_19489553" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">724000</ifrs-full:OtherNoncurrentAssets>
<ifrs-full:OtherNoncurrentAssets id="Factid_19489554" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">1262000</ifrs-full:OtherNoncurrentAssets>
<ifrs-full:NoncurrentAssets id="Factid_19489555" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">15655000</ifrs-full:NoncurrentAssets>
<ifrs-full:NoncurrentAssets id="Factid_19489556" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">10277000</ifrs-full:NoncurrentAssets>
<ifrs-full:Assets id="Factid_19489557" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">254646000</ifrs-full:Assets>
<ifrs-full:Assets id="Factid_19489558" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">134277000</ifrs-full:Assets>
<ifrs-full:CurrentProvisions id="Factid_19489559" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">51000</ifrs-full:CurrentProvisions>
<ifrs-full:CurrentProvisions id="Factid_19489560" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">50000</ifrs-full:CurrentProvisions>
<ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers id="Factid_19489561" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">10052000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
<ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers id="Factid_19489562" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">7082000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
<ifrs-full:CurrentContractLiabilities id="Factid_19489563" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">46600000</ifrs-full:CurrentContractLiabilities>
<ifrs-full:CurrentContractLiabilities id="Factid_19489564" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">59465000</ifrs-full:CurrentContractLiabilities>
<ifrs-full:CurrentLeaseLiabilities id="Factid_19489565" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">1881000</ifrs-full:CurrentLeaseLiabilities>
<ifrs-full:CurrentLeaseLiabilities id="Factid_19489566" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">1411000</ifrs-full:CurrentLeaseLiabilities>
<ifrs-full:OtherCurrentLiabilities id="Factid_19489567" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">2025000</ifrs-full:OtherCurrentLiabilities>
<ifrs-full:OtherCurrentLiabilities id="Factid_19489568" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">1288000</ifrs-full:OtherCurrentLiabilities>
<ifrs-full:CurrentLiabilities id="Factid_19489569" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">60609000</ifrs-full:CurrentLiabilities>
<ifrs-full:CurrentLiabilities id="Factid_19489570" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">69296000</ifrs-full:CurrentLiabilities>
<ifrs-full:NoncurrentContractLiabilities id="Factid_19489571" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">85475000</ifrs-full:NoncurrentContractLiabilities>
<ifrs-full:NoncurrentContractLiabilities id="Factid_19489572" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">101909000</ifrs-full:NoncurrentContractLiabilities>
<ifrs-full:NoncurrentLeaseLiabilities id="Factid_19489573" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">4306000</ifrs-full:NoncurrentLeaseLiabilities>
<ifrs-full:NoncurrentLeaseLiabilities id="Factid_19489574" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">1823000</ifrs-full:NoncurrentLeaseLiabilities>
<ifrs-full:OtherNoncurrentLiabilities id="Factid_19489575" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">2084000</ifrs-full:OtherNoncurrentLiabilities>
<ifrs-full:NoncurrentLiabilities id="Factid_19489576" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">89781000</ifrs-full:NoncurrentLiabilities>
<ifrs-full:NoncurrentLiabilities id="Factid_19489577" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">105816000</ifrs-full:NoncurrentLiabilities>
<ifrs-full:IssuedCapital id="Factid_19489578" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">629000</ifrs-full:IssuedCapital>
<ifrs-full:IssuedCapital id="Factid_19489579" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">1164000</ifrs-full:IssuedCapital>
<ifrs-full:SharePremium id="Factid_19489580" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">573339000</ifrs-full:SharePremium>
<ifrs-full:SharePremium id="Factid_19489581" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">190945000</ifrs-full:SharePremium>
<ifrs-full:RetainedEarnings id="Factid_19489582" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">-462253000</ifrs-full:RetainedEarnings>
<ifrs-full:RetainedEarnings id="Factid_19489583" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">-233194000</ifrs-full:RetainedEarnings>
<ifrs-full:OtherReserves id="Factid_19489584" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">-7459000</ifrs-full:OtherReserves>
<ifrs-full:OtherReserves id="Factid_19489585" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">-770000</ifrs-full:OtherReserves>
<ifrs-full:EquityAttributableToOwnersOfParent id="Factid_19489586" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">104256000</ifrs-full:EquityAttributableToOwnersOfParent>
<ifrs-full:EquityAttributableToOwnersOfParent id="Factid_19489587" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">-41855000</ifrs-full:EquityAttributableToOwnersOfParent>
<ifrs-full:NoncontrollingInterests id="Factid_19489588" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">1020000</ifrs-full:NoncontrollingInterests>
<ifrs-full:Equity id="Factid_19489589" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">104256000</ifrs-full:Equity>
<ifrs-full:Equity id="Factid_19489590" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">-40835000</ifrs-full:Equity>
<ifrs-full:EquityAndLiabilities id="Factid_19489591" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">254646000</ifrs-full:EquityAndLiabilities>
<ifrs-full:EquityAndLiabilities id="Factid_19489592" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">134277000</ifrs-full:EquityAndLiabilities>
<imtx:RevenueFromCollaborationAgreements id="Factid_19489593" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">31253000</imtx:RevenueFromCollaborationAgreements>
<imtx:RevenueFromCollaborationAgreements id="Factid_19489594" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">18449000</imtx:RevenueFromCollaborationAgreements>
<imtx:RevenueFromCollaborationAgreements id="Factid_19489595" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">3770000</imtx:RevenueFromCollaborationAgreements>
<ifrs-full:ResearchAndDevelopmentExpense id="Factid_19489596" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">67085000</ifrs-full:ResearchAndDevelopmentExpense>
<ifrs-full:ResearchAndDevelopmentExpense id="Factid_19489597" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">40091000</ifrs-full:ResearchAndDevelopmentExpense>
<ifrs-full:ResearchAndDevelopmentExpense id="Factid_19489598" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">33971000</ifrs-full:ResearchAndDevelopmentExpense>
<ifrs-full:GeneralAndAdministrativeExpense id="Factid_19489599" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">34186000</ifrs-full:GeneralAndAdministrativeExpense>
<ifrs-full:GeneralAndAdministrativeExpense id="Factid_19489600" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">11756000</ifrs-full:GeneralAndAdministrativeExpense>
<ifrs-full:GeneralAndAdministrativeExpense id="Factid_19489601" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">7666000</ifrs-full:GeneralAndAdministrativeExpense>
<ifrs-full:OtherIncome id="Factid_19489602" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">303000</ifrs-full:OtherIncome>
<ifrs-full:OtherIncome id="Factid_19489603" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">385000</ifrs-full:OtherIncome>
<ifrs-full:OtherIncome id="Factid_19489604" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">3458000</ifrs-full:OtherIncome>
<ifrs-full:ProfitLossFromOperatingActivities id="Factid_19489605" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">-69715000</ifrs-full:ProfitLossFromOperatingActivities>
<ifrs-full:ProfitLossFromOperatingActivities id="Factid_19489606" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">-33013000</ifrs-full:ProfitLossFromOperatingActivities>
<ifrs-full:ProfitLossFromOperatingActivities id="Factid_19489607" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">-34409000</ifrs-full:ProfitLossFromOperatingActivities>
<ifrs-full:FinanceIncome id="Factid_19489608" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">2949000</ifrs-full:FinanceIncome>
<ifrs-full:FinanceIncome id="Factid_19489609" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">790000</ifrs-full:FinanceIncome>
<ifrs-full:FinanceIncome id="Factid_19489610" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">2215000</ifrs-full:FinanceIncome>
<ifrs-full:FinanceCosts id="Factid_19489611" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">10063000</ifrs-full:FinanceCosts>
<ifrs-full:FinanceCosts id="Factid_19489612" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">264000</ifrs-full:FinanceCosts>
<ifrs-full:FinanceCosts id="Factid_19489613" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">161000</ifrs-full:FinanceCosts>
<imtx:ShareListingExpense id="Factid_19489614" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">152787000</imtx:ShareListingExpense>
<ifrs-full:FinanceIncomeCost id="Factid_19489615" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">-159901000</ifrs-full:FinanceIncomeCost>
<ifrs-full:FinanceIncomeCost id="Factid_19489616" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">526000</ifrs-full:FinanceIncomeCost>
<ifrs-full:FinanceIncomeCost id="Factid_19489617" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">2054000</ifrs-full:FinanceIncomeCost>
<ifrs-full:ProfitLossBeforeTax id="Factid_19489618" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">-229616000</ifrs-full:ProfitLossBeforeTax>
<ifrs-full:ProfitLossBeforeTax id="Factid_19489620" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">-32355000</ifrs-full:ProfitLossBeforeTax>
<ifrs-full:ProfitLoss id="Factid_19489621" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">-229616000</ifrs-full:ProfitLoss>
<ifrs-full:ProfitLoss id="Factid_19489622" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">-32487000</ifrs-full:ProfitLoss>
<ifrs-full:ProfitLoss id="Factid_19489623" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">-32355000</ifrs-full:ProfitLoss>
<ifrs-full:ProfitLossAttributableToOwnersOfParent id="Factid_19489624" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">-229059000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
<ifrs-full:ProfitLossAttributableToOwnersOfParent id="Factid_19489625" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">-31571000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
<ifrs-full:ProfitLossAttributableToOwnersOfParent id="Factid_19489626" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">-31444000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
<ifrs-full:ProfitLossAttributableToNoncontrollingInterests id="Factid_19489627" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">-557000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
<ifrs-full:ProfitLossAttributableToNoncontrollingInterests id="Factid_19489628" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">-916000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
<ifrs-full:ProfitLossAttributableToNoncontrollingInterests id="Factid_19489629" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">-911000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
<ifrs-full:BasicAndDilutedEarningsLossPerShare id="Factid_19489633" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR_per_Share" decimals="INF">-4.77</ifrs-full:BasicAndDilutedEarningsLossPerShare>
<ifrs-full:BasicAndDilutedEarningsLossPerShare id="Factid_19489634" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR_per_Share" decimals="INF">-0.95</ifrs-full:BasicAndDilutedEarningsLossPerShare>
<ifrs-full:BasicAndDilutedEarningsLossPerShare id="Factid_19489635" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR_per_Share" decimals="INF">-0.95</ifrs-full:BasicAndDilutedEarningsLossPerShare>
<ifrs-full:WeightedAverageShares id="Factid_19489636" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_shares" decimals="INF">48001228</ifrs-full:WeightedAverageShares>
<ifrs-full:WeightedAverageShares id="Factid_19489637" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_shares" decimals="INF">33093838</ifrs-full:WeightedAverageShares>
<ifrs-full:WeightedAverageShares id="Factid_19489638" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_shares" decimals="INF">33093838</ifrs-full:WeightedAverageShares>
<ifrs-full:IncomeTaxExpenseContinuingOperations id="Factid_19489639" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">0</ifrs-full:IncomeTaxExpenseContinuingOperations>
<ifrs-full:IncomeTaxExpenseContinuingOperations id="Factid_19489640" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">0</ifrs-full:IncomeTaxExpenseContinuingOperations>
<ifrs-full:IncomeTaxExpenseContinuingOperations id="Factid_19489641" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">0</ifrs-full:IncomeTaxExpenseContinuingOperations>
<ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax id="Factid_19489645" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">-6689000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax>
<ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax id="Factid_19489646" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">-29000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax>
<ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax id="Factid_19489647" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">313000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax>
<ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent id="Factid_19489651" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">-235748000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
<ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent id="Factid_19489652" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">-31600000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
<ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent id="Factid_19489653" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">-31131000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
<ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests id="Factid_19489654" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">-557000</ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests>
<ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests id="Factid_19489655" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">-916000</ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests>
<ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests id="Factid_19489656" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">-911000</ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests>
<ifrs-full:ProfitLossBeforeTax id="Factid_19489661" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">-32487000</ifrs-full:ProfitLossBeforeTax>
<ifrs-full:AdjustmentsForInterestIncome id="Factid_19489663" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">850000</ifrs-full:AdjustmentsForInterestIncome>
<ifrs-full:AdjustmentsForInterestIncome id="Factid_19489664" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">790000</ifrs-full:AdjustmentsForInterestIncome>
<ifrs-full:AdjustmentsForInterestIncome id="Factid_19489665" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">507000</ifrs-full:AdjustmentsForInterestIncome>
<ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense id="Factid_19489666" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">4424000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
<ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense id="Factid_19489667" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">3858000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
<ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense id="Factid_19489668" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">2176000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
<ifrs-full:AdjustmentsForInterestExpense id="Factid_19489669" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">289000</ifrs-full:AdjustmentsForInterestExpense>
<ifrs-full:AdjustmentsForInterestExpense id="Factid_19489670" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">170000</ifrs-full:AdjustmentsForInterestExpense>
<ifrs-full:AdjustmentsForInterestExpense id="Factid_19489671" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">16000</ifrs-full:AdjustmentsForInterestExpense>
<imtx:AdjustmentsForShareListingExpense id="Factid_19489672" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">152787000</imtx:AdjustmentsForShareListingExpense>
<imtx:AdjustmentForEquitySettledSharebasedPayment id="Factid_19489675" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">22908000</imtx:AdjustmentForEquitySettledSharebasedPayment>
<imtx:AdjustmentForEquitySettledSharebasedPayment id="Factid_19489676" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">152000</imtx:AdjustmentForEquitySettledSharebasedPayment>
<imtx:AdjustmentForEquitySettledSharebasedPayment id="Factid_19489677" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">118000</imtx:AdjustmentForEquitySettledSharebasedPayment>
<ifrs-full:AdjustmentsForSharebasedPayments id="Factid_19489678" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">45000</ifrs-full:AdjustmentsForSharebasedPayments>
<ifrs-full:AdjustmentsForSharebasedPayments id="Factid_19489679" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">700000</ifrs-full:AdjustmentsForSharebasedPayments>
<ifrs-full:AdjustmentsForSharebasedPayments id="Factid_19489680" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">1360000</ifrs-full:AdjustmentsForSharebasedPayments>
<ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities id="Factid_19489681" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">-2036000</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities>
<ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities id="Factid_19489682" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">1864000</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities>
<ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities id="Factid_19489683" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">220000</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities>
<imtx:PaymentsForShareBasedCompensation id="Factid_19489684" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">4322000</imtx:PaymentsForShareBasedCompensation>
<ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable id="Factid_19489687" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">-294000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
<ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable id="Factid_19489688" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">-563000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
<ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable id="Factid_19489689" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">-175000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
<ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets id="Factid_19489690" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">-1600000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
<ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets id="Factid_19489691" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">-1497000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
<ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets id="Factid_19489692" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">5608000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
<ifrs-full:InterestReceivedClassifiedAsOperatingActivities id="Factid_19489693" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">808000</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
<ifrs-full:InterestReceivedClassifiedAsOperatingActivities id="Factid_19489694" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">790000</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
<ifrs-full:InterestReceivedClassifiedAsOperatingActivities id="Factid_19489695" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">507000</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
<ifrs-full:InterestPaidClassifiedAsOperatingActivities id="Factid_19489696" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">289000</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
<ifrs-full:InterestPaidClassifiedAsOperatingActivities id="Factid_19489697" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">170000</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
<ifrs-full:InterestPaidClassifiedAsOperatingActivities id="Factid_19489698" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">16000</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
<ifrs-full:CashFlowsFromUsedInOperatingActivities id="Factid_19489699" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">-85610000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
<ifrs-full:CashFlowsFromUsedInOperatingActivities id="Factid_19489700" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">70967000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
<ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities id="Factid_19489702" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">7420000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
<ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities id="Factid_19489703" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">2143000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
<ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities id="Factid_19489704" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">429000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
<ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod id="Factid_19489705" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">82930000</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
<ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod id="Factid_19489706" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">20473000</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
<ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod id="Factid_19489707" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">13101000</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
<ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod id="Factid_19489708" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">74505000</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
<ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod id="Factid_19489709" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">17551000</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
<ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities id="Factid_19489711" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">104000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
<ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities id="Factid_19489712" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">91000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
<ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities id="Factid_19489713" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">78000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
<ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities id="Factid_19489715" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">97000</ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
<ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities id="Factid_19489716" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">94000</ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
<ifrs-full:CashFlowsFromUsedInInvestingActivities id="Factid_19489717" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">-15949000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
<ifrs-full:CashFlowsFromUsedInInvestingActivities id="Factid_19489718" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">-5059000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
<ifrs-full:CashFlowsFromUsedInInvestingActivities id="Factid_19489719" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">-13514000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
<ifrs-full:ProceedsFromIssuingShares id="Factid_19489720" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">217918000</ifrs-full:ProceedsFromIssuingShares>
<ifrs-full:ProceedsFromIssuingShares id="Factid_19489722" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">23648000</ifrs-full:ProceedsFromIssuingShares>
<ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities id="Factid_19489723" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">2096000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
<ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities id="Factid_19489724" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">1862000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
<ifrs-full:CashFlowsFromUsedInFinancingActivities id="Factid_19489726" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">207883000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
<ifrs-full:CashFlowsFromUsedInFinancingActivities id="Factid_19489727" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">-1862000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
<ifrs-full:CashFlowsFromUsedInFinancingActivities id="Factid_19489728" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">23648000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
<ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges id="Factid_19489729" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">106324000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
<ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges id="Factid_19489730" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">64046000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
<ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges id="Factid_19489731" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">30818000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
<ifrs-full:CashAndCashEquivalents id="Factid_19489733" contextRef="PAsOn12_31_2018" unitRef="Unit_EUR" decimals="-3">39367000</ifrs-full:CashAndCashEquivalents>
<ifrs-full:CashAndCashEquivalents id="Factid_19489734" contextRef="PAsOn12_31_2017" unitRef="Unit_EUR" decimals="-3">8415000</ifrs-full:CashAndCashEquivalents>
<ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents id="Factid_19489735" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">-2147000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
<ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents id="Factid_19489736" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">-60000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
<ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents id="Factid_19489737" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">134000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
<ifrs-full:Equity id="Factid_19489741" contextRef="PAsOn12_31_2017_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">1164000</ifrs-full:Equity>
<ifrs-full:Equity id="Factid_19489742" contextRef="PAsOn12_31_2017_SharePremiumMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">167027000</ifrs-full:Equity>
<ifrs-full:Equity id="Factid_19489743" contextRef="PAsOn12_31_2017_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-170179000</ifrs-full:Equity>
<ifrs-full:Equity id="Factid_19489744" contextRef="PAsOn12_31_2017_OtherReservesMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-1054000</ifrs-full:Equity>
<ifrs-full:Equity id="Factid_19489745" contextRef="PAsOn12_31_2017_TotalEquityAttributableToShareholdersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-3042000</ifrs-full:Equity>
<ifrs-full:Equity id="Factid_19489746" contextRef="PAsOn12_31_2017_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">787000</ifrs-full:Equity>
<ifrs-full:Equity id="Factid_19489747" contextRef="PAsOn12_31_2017" unitRef="Unit_EUR" decimals="-3">-2255000</ifrs-full:Equity>
<ifrs-full:OtherComprehensiveIncome id="Factid_19489748" contextRef="P01_01_2018To12_31_2018_OtherReservesMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">313000</ifrs-full:OtherComprehensiveIncome>
<ifrs-full:OtherComprehensiveIncome id="Factid_19489749" contextRef="P01_01_2018To12_31_2018_TotalEquityAttributableToShareholdersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">313000</ifrs-full:OtherComprehensiveIncome>
<ifrs-full:OtherComprehensiveIncome id="Factid_19489750" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">313000</ifrs-full:OtherComprehensiveIncome>
<ifrs-full:ProfitLoss id="Factid_19489751" contextRef="P01_01_2018To12_31_2018_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-31444000</ifrs-full:ProfitLoss>
<ifrs-full:ProfitLoss id="Factid_19489752" contextRef="P01_01_2018To12_31_2018_TotalEquityAttributableToShareholdersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-31444000</ifrs-full:ProfitLoss>
<ifrs-full:ProfitLoss id="Factid_19489753" contextRef="P01_01_2018To12_31_2018_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-911000</ifrs-full:ProfitLoss>
<ifrs-full:ComprehensiveIncome id="Factid_19489755" contextRef="P01_01_2018To12_31_2018_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-31444000</ifrs-full:ComprehensiveIncome>
<ifrs-full:ComprehensiveIncome id="Factid_19489756" contextRef="P01_01_2018To12_31_2018_OtherReservesMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">313000</ifrs-full:ComprehensiveIncome>
<ifrs-full:ComprehensiveIncome id="Factid_19489757" contextRef="P01_01_2018To12_31_2018_TotalEquityAttributableToShareholdersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-31131000</ifrs-full:ComprehensiveIncome>
<ifrs-full:ComprehensiveIncome id="Factid_19489758" contextRef="P01_01_2018To12_31_2018_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-911000</ifrs-full:ComprehensiveIncome>
<ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions id="Factid_19489760" contextRef="P01_01_2018To12_31_2018_SharePremiumMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">118000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
<ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions id="Factid_19489761" contextRef="P01_01_2018To12_31_2018_TotalEquityAttributableToShareholdersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">118000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
<ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions id="Factid_19489762" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">118000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
<ifrs-full:IssueOfEquity id="Factid_19489763" contextRef="P01_01_2018To12_31_2018_SharePremiumMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">23648000</ifrs-full:IssueOfEquity>
<ifrs-full:IssueOfEquity id="Factid_19489764" contextRef="P01_01_2018To12_31_2018_TotalEquityAttributableToShareholdersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">23648000</ifrs-full:IssueOfEquity>
<ifrs-full:IssueOfEquity id="Factid_19489765" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">23648000</ifrs-full:IssueOfEquity>
<imtx:IncreasedecreaseThroughCompensationExpense id="Factid_19489766" contextRef="P01_01_2018To12_31_2018_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">1360000</imtx:IncreasedecreaseThroughCompensationExpense>
<imtx:IncreasedecreaseThroughCompensationExpense id="Factid_19489767" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">1360000</imtx:IncreasedecreaseThroughCompensationExpense>
<ifrs-full:Equity id="Factid_19489775" contextRef="PAsOn12_31_2018_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">1164000</ifrs-full:Equity>
<ifrs-full:Equity id="Factid_19489776" contextRef="PAsOn12_31_2018_SharePremiumMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">190793000</ifrs-full:Equity>
<ifrs-full:Equity id="Factid_19489777" contextRef="PAsOn12_31_2018_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-201623000</ifrs-full:Equity>
<ifrs-full:Equity id="Factid_19489778" contextRef="PAsOn12_31_2018_OtherReservesMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-741000</ifrs-full:Equity>
<ifrs-full:Equity id="Factid_19489779" contextRef="PAsOn12_31_2018_TotalEquityAttributableToShareholdersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-10407000</ifrs-full:Equity>
<ifrs-full:Equity id="Factid_19489780" contextRef="PAsOn12_31_2018_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">1236000</ifrs-full:Equity>
<ifrs-full:Equity id="Factid_19489781" contextRef="PAsOn12_31_2018" unitRef="Unit_EUR" decimals="-3">-9171000</ifrs-full:Equity>
<ifrs-full:OtherComprehensiveIncome id="Factid_19489782" contextRef="P01_01_2019To12_31_2019_OtherReservesMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-29000</ifrs-full:OtherComprehensiveIncome>
<ifrs-full:OtherComprehensiveIncome id="Factid_19489783" contextRef="P01_01_2019To12_31_2019_TotalEquityAttributableToShareholdersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-29000</ifrs-full:OtherComprehensiveIncome>
<ifrs-full:OtherComprehensiveIncome id="Factid_19489784" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">-29000</ifrs-full:OtherComprehensiveIncome>
<ifrs-full:ProfitLoss id="Factid_19489785" contextRef="P01_01_2019To12_31_2019_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-31571000</ifrs-full:ProfitLoss>
<ifrs-full:ProfitLoss id="Factid_19489786" contextRef="P01_01_2019To12_31_2019_TotalEquityAttributableToShareholdersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-31571000</ifrs-full:ProfitLoss>
<ifrs-full:ProfitLoss id="Factid_19489787" contextRef="P01_01_2019To12_31_2019_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-916000</ifrs-full:ProfitLoss>
<ifrs-full:ComprehensiveIncome id="Factid_19489789" contextRef="P01_01_2019To12_31_2019_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-31571000</ifrs-full:ComprehensiveIncome>
<ifrs-full:ComprehensiveIncome id="Factid_19489790" contextRef="P01_01_2019To12_31_2019_OtherReservesMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-29000</ifrs-full:ComprehensiveIncome>
<ifrs-full:ComprehensiveIncome id="Factid_19489791" contextRef="P01_01_2019To12_31_2019_TotalEquityAttributableToShareholdersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-31600000</ifrs-full:ComprehensiveIncome>
<ifrs-full:ComprehensiveIncome id="Factid_19489792" contextRef="P01_01_2019To12_31_2019_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-916000</ifrs-full:ComprehensiveIncome>
<ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions id="Factid_19489794" contextRef="P01_01_2019To12_31_2019_SharePremiumMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">152000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
<ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions id="Factid_19489795" contextRef="P01_01_2019To12_31_2019_TotalEquityAttributableToShareholdersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">152000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
<ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions id="Factid_19489796" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">152000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
<imtx:IncreasedecreaseThroughCompensationExpense id="Factid_19489797" contextRef="P01_01_2019To12_31_2019_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">700000</imtx:IncreasedecreaseThroughCompensationExpense>
<imtx:IncreasedecreaseThroughCompensationExpense id="Factid_19489798" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">700000</imtx:IncreasedecreaseThroughCompensationExpense>
<ifrs-full:Equity id="Factid_19489806" contextRef="PAsOn12_31_2019_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">1164000</ifrs-full:Equity>
<ifrs-full:Equity id="Factid_19489807" contextRef="PAsOn12_31_2019_SharePremiumMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">190945000</ifrs-full:Equity>
<ifrs-full:Equity id="Factid_19489808" contextRef="PAsOn12_31_2019_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-233194000</ifrs-full:Equity>
<ifrs-full:Equity id="Factid_19489809" contextRef="PAsOn12_31_2019_OtherReservesMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-770000</ifrs-full:Equity>
<ifrs-full:Equity id="Factid_19489810" contextRef="PAsOn12_31_2019_TotalEquityAttributableToShareholdersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-41855000</ifrs-full:Equity>
<ifrs-full:Equity id="Factid_19489811" contextRef="PAsOn12_31_2019_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">1020000</ifrs-full:Equity>
<ifrs-full:OtherComprehensiveIncome id="Factid_19489813" contextRef="P01_01_2020To12_31_2020_OtherReservesMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-6689000</ifrs-full:OtherComprehensiveIncome>
<ifrs-full:OtherComprehensiveIncome id="Factid_19489814" contextRef="P01_01_2020To12_31_2020_TotalEquityAttributableToShareholdersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-6689000</ifrs-full:OtherComprehensiveIncome>
<ifrs-full:OtherComprehensiveIncome id="Factid_19489815" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">-6689000</ifrs-full:OtherComprehensiveIncome>
<ifrs-full:ProfitLoss id="Factid_19489816" contextRef="P01_01_2020To12_31_2020_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-229059000</ifrs-full:ProfitLoss>
<ifrs-full:ProfitLoss id="Factid_19489817" contextRef="P01_01_2020To12_31_2020_TotalEquityAttributableToShareholdersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-229059000</ifrs-full:ProfitLoss>
<ifrs-full:ProfitLoss id="Factid_19489818" contextRef="P01_01_2020To12_31_2020_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-557000</ifrs-full:ProfitLoss>
<ifrs-full:ComprehensiveIncome id="Factid_19489820" contextRef="P01_01_2020To12_31_2020_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-229059000</ifrs-full:ComprehensiveIncome>
<ifrs-full:ComprehensiveIncome id="Factid_19489821" contextRef="P01_01_2020To12_31_2020_OtherReservesMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-6689000</ifrs-full:ComprehensiveIncome>
<ifrs-full:ComprehensiveIncome id="Factid_19489822" contextRef="P01_01_2020To12_31_2020_TotalEquityAttributableToShareholdersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-235748000</ifrs-full:ComprehensiveIncome>
<ifrs-full:ComprehensiveIncome id="Factid_19489823" contextRef="P01_01_2020To12_31_2020_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-557000</ifrs-full:ComprehensiveIncome>
<imtx:IncreaseDecreaseThroughReorganizationEquity id="Factid_19489825" contextRef="P01_01_2020To12_31_2020_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-833000</imtx:IncreaseDecreaseThroughReorganizationEquity>
<imtx:IncreaseDecreaseThroughReorganizationEquity id="Factid_19489826" contextRef="P01_01_2020To12_31_2020_SharePremiumMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">833000</imtx:IncreaseDecreaseThroughReorganizationEquity>
<imtx:IncreasedecreaseThroughChangesInNoncontrollingInterest id="Factid_19489827" contextRef="P01_01_2020To12_31_2020_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">7000</imtx:IncreasedecreaseThroughChangesInNoncontrollingInterest>
<imtx:IncreasedecreaseThroughChangesInNoncontrollingInterest id="Factid_19489828" contextRef="P01_01_2020To12_31_2020_SharePremiumMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">501000</imtx:IncreasedecreaseThroughChangesInNoncontrollingInterest>
<imtx:IncreasedecreaseThroughChangesInNoncontrollingInterest id="Factid_19489829" contextRef="P01_01_2020To12_31_2020_TotalEquityAttributableToShareholdersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">508000</imtx:IncreasedecreaseThroughChangesInNoncontrollingInterest>
<imtx:IncreasedecreaseThroughChangesInNoncontrollingInterest id="Factid_19489830" contextRef="P01_01_2020To12_31_2020_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-508000</imtx:IncreasedecreaseThroughChangesInNoncontrollingInterest>
<ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners id="Factid_19489831" contextRef="P01_01_2020To12_31_2020_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">104000</ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners>
<ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners id="Factid_19489832" contextRef="P01_01_2020To12_31_2020_SharePremiumMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">89973000</ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners>
<ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners id="Factid_19489833" contextRef="P01_01_2020To12_31_2020_TotalEquityAttributableToShareholdersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">90077000</ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners>
<ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners id="Factid_19489834" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">90077000</ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners>
<imtx:IncreaseThroughARYAMerger id="Factid_19489835" contextRef="P01_01_2020To12_31_2020_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">180000</imtx:IncreaseThroughARYAMerger>
<imtx:IncreaseThroughARYAMerger id="Factid_19489836" contextRef="P01_01_2020To12_31_2020_SharePremiumMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">272508000</imtx:IncreaseThroughARYAMerger>
<imtx:IncreaseThroughARYAMerger id="Factid_19489837" contextRef="P01_01_2020To12_31_2020_TotalEquityAttributableToShareholdersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">272688000</imtx:IncreaseThroughARYAMerger>
<imtx:IncreaseThroughARYAMerger id="Factid_19489838" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">272688000</imtx:IncreaseThroughARYAMerger>
<imtx:SARConversion id="Factid_19489839" contextRef="P01_01_2020To12_31_2020_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">7000</imtx:SARConversion>
<imtx:SARConversion id="Factid_19489840" contextRef="P01_01_2020To12_31_2020_SharePremiumMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-7000</imtx:SARConversion>
<imtx:IncreasedecreaseThroughIssuanceOfEquity id="Factid_19489841" contextRef="P01_01_2020To12_31_2020_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">298000</imtx:IncreasedecreaseThroughIssuanceOfEquity>
<imtx:IncreasedecreaseThroughIssuanceOfEquity id="Factid_19489842" contextRef="P01_01_2020To12_31_2020_SharePremiumMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">362975000</imtx:IncreasedecreaseThroughIssuanceOfEquity>
<imtx:IncreasedecreaseThroughIssuanceOfEquity id="Factid_19489843" contextRef="P01_01_2020To12_31_2020_TotalEquityAttributableToShareholdersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">363273000</imtx:IncreasedecreaseThroughIssuanceOfEquity>
<imtx:IncreasedecreaseThroughIssuanceOfEquity id="Factid_19489844" contextRef="P01_01_2020To12_31_2020_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-508000</imtx:IncreasedecreaseThroughIssuanceOfEquity>
<imtx:IncreasedecreaseThroughIssuanceOfEquity id="Factid_19489845" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">362765000</imtx:IncreasedecreaseThroughIssuanceOfEquity>
<ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions id="Factid_19489846" contextRef="P01_01_2020To12_31_2020_SharePremiumMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">22908000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
<ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions id="Factid_19489847" contextRef="P01_01_2020To12_31_2020_TotalEquityAttributableToShareholdersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">22908000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
<ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions id="Factid_19489848" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">22908000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
<imtx:IncreasedecreaseThroughShareBasedCompensationPreviouslyClassifiesAsEquitySettled id="Factid_19489849" contextRef="P01_01_2020To12_31_2020_SharePremiumMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-4322000</imtx:IncreasedecreaseThroughShareBasedCompensationPreviouslyClassifiesAsEquitySettled>
<imtx:IncreasedecreaseThroughShareBasedCompensationPreviouslyClassifiesAsEquitySettled id="Factid_19489850" contextRef="P01_01_2020To12_31_2020_TotalEquityAttributableToShareholdersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-4322000</imtx:IncreasedecreaseThroughShareBasedCompensationPreviouslyClassifiesAsEquitySettled>
<imtx:IncreasedecreaseThroughShareBasedCompensationPreviouslyClassifiesAsEquitySettled id="Factid_19489851" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">-4322000</imtx:IncreasedecreaseThroughShareBasedCompensationPreviouslyClassifiesAsEquitySettled>
<imtx:IncreasedecreaseThroughCompensationExpense id="Factid_19489852" contextRef="P01_01_2020To12_31_2020_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">45000</imtx:IncreasedecreaseThroughCompensationExpense>
<imtx:IncreasedecreaseThroughCompensationExpense id="Factid_19489853" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">45000</imtx:IncreasedecreaseThroughCompensationExpense>
<ifrs-full:Equity id="Factid_19489854" contextRef="PAsOn12_31_2020_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">629000</ifrs-full:Equity>
<ifrs-full:Equity id="Factid_19489855" contextRef="PAsOn12_31_2020_SharePremiumMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">573339000</ifrs-full:Equity>
<ifrs-full:Equity id="Factid_19489856" contextRef="PAsOn12_31_2020_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-462253000</ifrs-full:Equity>
<ifrs-full:Equity id="Factid_19489857" contextRef="PAsOn12_31_2020_OtherReservesMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">-7459000</ifrs-full:Equity>
<ifrs-full:Equity id="Factid_19489858" contextRef="PAsOn12_31_2020_TotalEquityAttributableToShareholdersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-3">104256000</ifrs-full:Equity>
<ifrs-full:DisclosureOfCompositionOfGroupExplanatory id="Factid_19489860" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1.&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Group information &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Immatics N.V, together with its German subsidiary Immatics Biotechnologies GmbH and its U.S. subsidiary, Immatics US Inc., (&amp;#8220;Immatics&amp;#8221; or &amp;#8220;the Group&amp;#8221;) is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer patients. Immatics N.V., a Dutch public limited liability company, was converted on July&amp;#160;1, 2020 from Immatics B.V., a Dutch company with limited liability. Immatics Biotechnologies GmbH and Immatics US Inc. became subsidiaries of Immatics N.V. as part of the ARYA Merger (defined below) on July&amp;#160;1, 2020. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Immatics N.V is registered with the commercial register at the Netherlands Chamber of Commerce under RSIN 861058926 with a corporate seat in Amsterdam and is located at Paul-Ehrlich Str. 15 in 72076 T&amp;#252;bingen, Germany. Prior to July&amp;#160;1, 2020, Immatics N.V. was a shell company with no active trade or business or subsidiaries and all relevant assets and liabilities as well as income and expenses were borne by Immatics Biotechnologies GmbH and its U.S. subsidiary Immatics US, Inc. Therefore, the comparable consolidated financial statements as of &lt;/div&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;December&amp;#160;31, 2019 &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;and for the years ended December&amp;#160;31, 2019 and December&amp;#160;31, 2018 represent consolidated financial statements of Immatics Biotechnologies GmbH. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;These annual consolidated financial statements of the Group for the year ended December&amp;#160;31, 2020 were authorized for issue by the Management Board of Immatics N.V. on March&amp;#160;30, 2021. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfCompositionOfGroupExplanatory>
<ifrs-full:DateOfEndOfReportingPeriod2013 id="Factid_19489861" contextRef="P01_01_2020To12_31_2020">2020-12-31</ifrs-full:DateOfEndOfReportingPeriod2013>
<ifrs-full:DateOfAuthorisationForIssueOfFinancialStatements2013 id="Factid_19489862" contextRef="P03_30_2021To03_30_2021_AuthorizationOfFinancialStatementsMemberifrsfullNonadjustingEventsAfterReportingPeriodAxis">2021-03-30</ifrs-full:DateOfAuthorisationForIssueOfFinancialStatements2013>
<ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory id="Factid_19489863" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2.&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Basis of presentation &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The consolidated financial statements of the Group have been prepared in accordance with International Financial Reporting Standards (&amp;#8220;IFRS&amp;#8221;) as issued by the International Accounting Standards Board (&amp;#8220;IASB&amp;#8221;), taking into account the recommendations of the International Financial Reporting Standards Interpretations Committee (&amp;#8220;IFRS IC&amp;#8221;). The consolidated financial statements are presented in Euro. Amounts are stated in thousands of Euros, unless otherwise indicated. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;The Group had a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-controlling&lt;/div&gt; interest, representing approximately 3.96% of the Group&amp;#8217;s Immatics US, Inc. subsidiary as of December&amp;#160;31, 2019 and 2018. On July&amp;#160;1, 2020 and as part of the ARYA Merger, the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-controlling&lt;/div&gt; interest of MD Anderson in Immatics US, Inc. was exchanged for ordinary shares in Immatics N.V. See note 3 for further details. &lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Short-term deposits, which have an original maturity between three and nine months, were previously classified within Other current assets and have been retrospectively presented as a separate line item, Other financial assets, within the Statement of Financial Position. This change resulted in a reclassification of &amp;#8364;16.0&amp;#160;million as of December&amp;#160;31, 2019. This change in presentation was made after review of the Group&amp;#8217;s financial statements subsequent to the ARYA Merger to ensure better comparability of the financial statements with peer companies and provide more relevant presentation within the Group&amp;#8217;s financial statements. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2.1&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Going concern &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Since inception, the Group&amp;#8217;s activities have consisted primarily of raising capital and performing research and development activities to advance its technologies. The Group is still in the development phase and has not yet marketed any products commercially. Immatics&amp;#8217; ongoing success depends on the successful development and regulatory approval of its products and its ability to finance operations. The Group will seek additional funding to reach its development and commercialization objectives. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Group plans to seek funds through further private or public equity financings, debt financings, collaboration agreements and marketing, distribution or licensing arrangements. The Group may not be able to obtain financing or enter into collaboration or other arrangements on acceptable terms. If the Group is unable to obtain funding, it could be forced to delay, reduce or eliminate some or all of its research and development programs, product portfolio expansion or commercialization efforts, which could adversely affect its business prospects. However, Immatics&amp;#8217; cash and cash equivalents as well as short-term deposits will be sufficient to fund operating expenses and capital expenditure requirements for at least twelve months from the issuance date and expect a cash reach for at least twelve months. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The accompanying consolidated financial statements have been prepared on a going concern basis. This contemplates the Group will continue in operation for the foreseeable future and will be able to realize its assets and discharge its liabilities in the normal course of operations. The consolidated financial statements do not reflect any adjustments relating to the recoverability and classification of assets or the amounts and classification of liabilities that would be necessary, was the Group unable to continue as a going concern. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;  &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2.2&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Correction of classification of Statement of Cash Flows &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;During the third quarter of 2020, the Group identified and corrected the classification of short-term deposits with an original maturity dates between three and nine months within the Statement of Cash Flows which resulted in a misclassification within the Statement of Cash Flows since 2018. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company has evaluated the effect of this misclassification, both qualitatively and quantitatively, and concluded that the correction did not have a material impact on, nor require amendment of, any previously filed financial statements. In the Statement of Cash Flows, the changes in short-term deposits were previously classified as (Increase) decrease in other assets within operating activities and has been retrospectively corrected and presented as separate line items within investing activities. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;This correction of classification resulted in the following impact to the Statement of Cash Flows: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 60%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year ended December&amp;#160;31, 2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year ended December&amp;#160;31, 2018&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&lt;br/&gt;reported&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Adjustment&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&lt;br/&gt;revised&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&lt;br/&gt;reported&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Adjustment&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&lt;br/&gt;revised&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;(Increase) decrease in other assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(4,419&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2,922&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(1,497&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(7,493&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;13,101&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;5,608&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net cash provided by operating activities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;68,045&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2,922&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;70,967&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;7,583&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;13,101&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;20,684&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Cash paid for investments classified in Other financial assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(20,473&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(20,473&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(13,101&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(13,101&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cash received from maturity of investments classified in Other financial assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;17,551&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;17,551&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net cash used in investing activities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(2,137&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(2,922&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(5,059&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(413&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(13,101&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(13,514&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 60%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total effect on Cash Flow&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="width: 60%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 58%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Three&amp;#160;months&amp;#160;ended&amp;#160;March&amp;#160;31,&amp;#160;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Six months ended June&amp;#160;30, 2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&lt;br/&gt;reported&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Adjustment&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&lt;br/&gt;revised&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&lt;br/&gt;reported&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Adjustment&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&lt;br/&gt;revised&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 58%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;(Increase) decrease in other assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(17,209&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;16,836&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(373&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;14,917&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(16,023&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(1,106&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 58%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net cash provided by/ (used in) operating activities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(28,286&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,836&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(11,450&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(11,716&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(16,023&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(27,739&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 58%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Cash paid for investments classified in Other financial assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(32,859&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(32,859&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(32,859&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(32,859&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 58%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cash received from maturity of investments classified in Other financial assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,023&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,023&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;48,882&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;48,882&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 58%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net cash provided by/ (used in) investing activities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(2,387&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(16,836&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(19,223&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(4,550&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;16,023&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;11,473&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 58%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total effect on Cash Flow&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="width: 58%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;There is no impact on the Group&amp;#8217;s Consolidated Statement of Financial Position, Consolidated Statement of Changes in Shareholders&amp;#8217; Deficit, Consolidated Statement of Loss, Net loss per share, Consolidated Statement of Comprehensive Loss, and no impact to financing cash flows for the any of the periods presented. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;  &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2.3&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;COVID-19&lt;/div&gt; &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;In December 2019, a novel strain of coronavirus &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(&amp;#8220;COVID-19&amp;#8221;)&lt;/div&gt; emerged. On January&amp;#160;30, 2020, the World Health Organization declared the outbreak a pandemic and a global emergency. In response, many countries and businesses instituted travel restrictions, quarantines, and office closures that are still in place. The extent of the pandemic and governmental responses may impact our ability to obtain raw materials and equipment used for research and development, obtain sufficient additional funds to finance our operations, and conduct clinical trials, any of which could materially and adversely affect our business. &lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"&gt;Management continues to monitor the situation and enacted significant measures to protect the Group&amp;#8217;s supply chain, employees, and the execution of clinical trials. To date, the pandemic has resulted in a slowdown in activities related to the Group&amp;#8217;s laboratory operations and at some of its suppliers. The ongoing spread of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;COVID-19&lt;/div&gt; may also negatively impact the Group&amp;#8217;s ability to conduct clinical trials, including potential delays and restrictions on the Group&amp;#8217;s ability to recruit and retain patients, principal investigators and healthcare employees. &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;COVID-19&lt;/div&gt; could also affect the operations of contract research organizations, which may also result in delays or disruptions in the supply of product candidates. Immatics continues to expand its clinical programs with additional clinical trial sites opening in the U.S. and in Europe. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;Due to &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;COVID-19,&lt;/div&gt; the Group has also experienced delays in research activities performed under its collaboration agreements. Consequently, the Group recognized less revenue under these agreements in 2020 than previously planned. Management believes the declines in revenue associated with the delay in research activities are largely temporary, as the revenue is primarily associated with &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-refundable&lt;/div&gt; upfront payments recognized on a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;cost-to-cost&lt;/div&gt;&lt;/div&gt; basis. &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;COVID-19&lt;/div&gt; may continue to impact the timing and amount of revenue recognized under these agreements in the future. &lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory>
<imtx:DisclosureOfReconciliationOfChangesInCashFlowStatementTextBlock id="Factid_19489867" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;This correction of classification resulted in the following impact to the Statement of Cash Flows: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 60%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year ended December&amp;#160;31, 2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year ended December&amp;#160;31, 2018&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&lt;br/&gt;reported&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Adjustment&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&lt;br/&gt;revised&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&lt;br/&gt;reported&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Adjustment&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&lt;br/&gt;revised&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;(Increase) decrease in other assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(4,419&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2,922&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(1,497&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(7,493&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;13,101&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;5,608&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net cash provided by operating activities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;68,045&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2,922&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;70,967&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;7,583&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;13,101&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;20,684&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Cash paid for investments classified in Other financial assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(20,473&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(20,473&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(13,101&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(13,101&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cash received from maturity of investments classified in Other financial assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;17,551&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;17,551&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net cash used in investing activities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(2,137&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(2,922&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(5,059&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(413&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(13,101&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(13,514&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 60%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total effect on Cash Flow&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="width: 60%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 58%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Three&amp;#160;months&amp;#160;ended&amp;#160;March&amp;#160;31,&amp;#160;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Six months ended June&amp;#160;30, 2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&lt;br/&gt;reported&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Adjustment&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&lt;br/&gt;revised&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&lt;br/&gt;reported&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Adjustment&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&lt;br/&gt;revised&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 58%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;(Increase) decrease in other assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(17,209&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;16,836&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(373&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;14,917&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(16,023&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(1,106&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 58%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net cash provided by/ (used in) operating activities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(28,286&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,836&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(11,450&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(11,716&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(16,023&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(27,739&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 58%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Cash paid for investments classified in Other financial assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(32,859&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(32,859&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(32,859&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(32,859&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 58%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cash received from maturity of investments classified in Other financial assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,023&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,023&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;48,882&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;48,882&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 58%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net cash provided by/ (used in) investing activities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(2,387&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(16,836&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(19,223&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(4,550&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;16,023&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;11,473&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 58%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total effect on Cash Flow&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="width: 58%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DisclosureOfReconciliationOfChangesInCashFlowStatementTextBlock>
<ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets id="Factid_19489868" contextRef="P01_01_2019To12_31_2019_PreviouslyStatedMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">-4419000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
<ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets id="Factid_19489869" contextRef="P01_01_2019To12_31_2019_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">2922000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
<ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets id="Factid_19489871" contextRef="P01_01_2018To12_31_2018_PreviouslyStatedMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">-7493000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
<ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets id="Factid_19489872" contextRef="P01_01_2018To12_31_2018_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">13101000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
<ifrs-full:CashFlowsFromUsedInOperatingActivities id="Factid_19489874" contextRef="P01_01_2019To12_31_2019_PreviouslyStatedMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">68045000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
<ifrs-full:CashFlowsFromUsedInOperatingActivities id="Factid_19489875" contextRef="P01_01_2019To12_31_2019_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">2922000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
<ifrs-full:CashFlowsFromUsedInOperatingActivities id="Factid_19489877" contextRef="P01_01_2018To12_31_2018_PreviouslyStatedMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">7583000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
<ifrs-full:CashFlowsFromUsedInOperatingActivities id="Factid_19489878" contextRef="P01_01_2018To12_31_2018_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">13101000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
<ifrs-full:CashFlowsFromUsedInOperatingActivities id="Factid_19489879" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">20684000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
<ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod id="Factid_19489880" contextRef="P01_01_2019To12_31_2019_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">20473000</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
<ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod id="Factid_19489882" contextRef="P01_01_2018To12_31_2018_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">13101000</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
<ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod id="Factid_19489884" contextRef="P01_01_2019To12_31_2019_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">17551000</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
<ifrs-full:CashFlowsFromUsedInInvestingActivities id="Factid_19489886" contextRef="P01_01_2019To12_31_2019_PreviouslyStatedMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">-2137000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
<ifrs-full:CashFlowsFromUsedInInvestingActivities id="Factid_19489887" contextRef="P01_01_2019To12_31_2019_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">-2922000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
<ifrs-full:CashFlowsFromUsedInInvestingActivities id="Factid_19489889" contextRef="P01_01_2018To12_31_2018_PreviouslyStatedMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">-413000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
<ifrs-full:CashFlowsFromUsedInInvestingActivities id="Factid_19489890" contextRef="P01_01_2018To12_31_2018_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">-13101000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
<ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets id="Factid_19489892" contextRef="P01_01_2020To03_31_2020_PreviouslyStatedMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">-17209000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
<ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets id="Factid_19489893" contextRef="P01_01_2020To03_31_2020_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">16836000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
<ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets id="Factid_19489894" contextRef="P01_01_2020To03_31_2020" unitRef="Unit_EUR" decimals="-3">-373000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
<ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets id="Factid_19489895" contextRef="P01_01_2020To06_30_2020_PreviouslyStatedMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">14917000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
<ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets id="Factid_19489896" contextRef="P01_01_2020To06_30_2020_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">-16023000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
<ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets id="Factid_19489897" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3">-1106000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
<ifrs-full:CashFlowsFromUsedInOperatingActivities id="Factid_19489898" contextRef="P01_01_2020To03_31_2020_PreviouslyStatedMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">-28286000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
<ifrs-full:CashFlowsFromUsedInOperatingActivities id="Factid_19489899" contextRef="P01_01_2020To03_31_2020_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">16836000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
<ifrs-full:CashFlowsFromUsedInOperatingActivities id="Factid_19489900" contextRef="P01_01_2020To03_31_2020" unitRef="Unit_EUR" decimals="-3">-11450000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
<ifrs-full:CashFlowsFromUsedInOperatingActivities id="Factid_19489901" contextRef="P01_01_2020To06_30_2020_PreviouslyStatedMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">-11716000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
<ifrs-full:CashFlowsFromUsedInOperatingActivities id="Factid_19489902" contextRef="P01_01_2020To06_30_2020_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">-16023000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
<ifrs-full:CashFlowsFromUsedInOperatingActivities id="Factid_19489903" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3">-27739000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
<ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod id="Factid_19489904" contextRef="P01_01_2020To03_31_2020_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">32859000</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
<ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod id="Factid_19489905" contextRef="P01_01_2020To03_31_2020" unitRef="Unit_EUR" decimals="-3">32859000</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
<ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod id="Factid_19489906" contextRef="P01_01_2020To06_30_2020_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">32859000</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
<ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod id="Factid_19489907" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3">32859000</ifrs-full:PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
<ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod id="Factid_19489908" contextRef="P01_01_2020To03_31_2020_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">16023000</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
<ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod id="Factid_19489909" contextRef="P01_01_2020To03_31_2020" unitRef="Unit_EUR" decimals="-3">16023000</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
<ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod id="Factid_19489910" contextRef="P01_01_2020To06_30_2020_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">48882000</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
<ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod id="Factid_19489911" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3">48882000</ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod>
<ifrs-full:CashFlowsFromUsedInInvestingActivities id="Factid_19489912" contextRef="P01_01_2020To03_31_2020_PreviouslyStatedMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">-2387000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
<ifrs-full:CashFlowsFromUsedInInvestingActivities id="Factid_19489913" contextRef="P01_01_2020To03_31_2020_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">-16836000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
<ifrs-full:CashFlowsFromUsedInInvestingActivities id="Factid_19489914" contextRef="P01_01_2020To03_31_2020" unitRef="Unit_EUR" decimals="-3">-19223000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
<ifrs-full:CashFlowsFromUsedInInvestingActivities id="Factid_19489915" contextRef="P01_01_2020To06_30_2020_PreviouslyStatedMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">-4550000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
<ifrs-full:CashFlowsFromUsedInInvestingActivities id="Factid_19489916" contextRef="P01_01_2020To06_30_2020_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">16023000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
<ifrs-full:CashFlowsFromUsedInInvestingActivities id="Factid_19489917" contextRef="P01_01_2020To06_30_2020" unitRef="Unit_EUR" decimals="-3">11473000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
<ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests id="Factid_19489918" contextRef="P01_01_2019To12_31_2019_ImmaticsUsIncMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_pure" decimals="4">0.0396</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
<ifrs-full:OtherCurrentFinancialAssets id="Factid_19489919" contextRef="PAsOn12_31_2019_ImmaticsUsIncMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_EUR" decimals="-5">16000000</ifrs-full:OtherCurrentFinancialAssets>
<imtx:IncreaseDecreaseThroughReorganizationEquity id="Factid_19489921" contextRef="P07_01_2020To07_01_2020_AryaMemberifrsfullBusinessCombinationsAxis" unitRef="Unit_EUR" decimals="-5">800000</imtx:IncreaseDecreaseThroughReorganizationEquity>
<imtx:IncreasedecreaseThroughChangesInNoncontrollingInterest id="Factid_19489922" contextRef="P07_01_2020To07_01_2020_AryaMemberifrsfullBusinessCombinationsAxis" unitRef="Unit_EUR" decimals="-5">500000</imtx:IncreasedecreaseThroughChangesInNoncontrollingInterest>
<ifrs-full:DescriptionOfHowAcquirerObtainedControlOfAcquiree id="Factid_19489923" contextRef="P07_01_2020To07_01_2020_AryaMemberifrsfullBusinessCombinationsAxis">one ordinary share of Immatics N.V. for each issued and outstanding ordinary share of ARYA and one warrant to purchase ordinary shares in Immatics N.V., for each issued and outstanding warrant to acquire ordinary shares</ifrs-full:DescriptionOfHowAcquirerObtainedControlOfAcquiree>
<ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed id="Factid_19489924" contextRef="PAsOn07_01_2020_AryaMemberifrsfullBusinessCombinationsAxis" unitRef="Unit_EUR" decimals="-5">124900000</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
<ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable id="Factid_19489925" contextRef="PAsOn07_01_2020_AryaMemberifrsfullBusinessCombinationsAxis_OrdinarySharesMemberifrsfullClassesOfShareCapitalAxis" unitRef="Unit_shares" decimals="0">17968750</ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable>
<ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable id="Factid_19489926" contextRef="PAsOn07_01_2020_AryaMemberifrsfullBusinessCombinationsAxis_WarrantsMemberifrsfullClassesOfFinancialInstrumentsAxis" unitRef="Unit_Warrants" decimals="0">7187500</ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable>
<ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate id="Factid_19489927" contextRef="PAsOn07_01_2020_AryaMemberifrsfullBusinessCombinationsAxis" unitRef="Unit_EUR" decimals="-5">128800000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
<ifrs-full:CurrentLiabilitiesRecognisedAsOfAcquisitionDate id="Factid_19489928" contextRef="PAsOn07_01_2020_AryaMemberifrsfullBusinessCombinationsAxis" unitRef="Unit_EUR" decimals="-5">3900000</ifrs-full:CurrentLiabilitiesRecognisedAsOfAcquisitionDate>
<imtx:ShareListingExpense id="Factid_19489929" contextRef="P07_01_2020To07_01_2020_AryaMemberifrsfullBusinessCombinationsAxis" unitRef="Unit_EUR" decimals="-5">152800000</imtx:ShareListingExpense>
<ifrs-full:ShareIssueRelatedCost id="Factid_19489930" contextRef="P07_01_2020To07_01_2020" unitRef="Unit_EUR" decimals="-5">7900000</ifrs-full:ShareIssueRelatedCost>
<ifrs-full:ProceedsFromIssueOfOrdinaryShares id="Factid_19489931" contextRef="P07_01_2020To07_01_2020_PipeFinancingMemberifrsfullClassesOfOrdinarySharesAxis" unitRef="Unit_EUR" decimals="-5">90100000</ifrs-full:ProceedsFromIssueOfOrdinaryShares>
<ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners id="Factid_19489932" contextRef="P07_01_2020To07_01_2020_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-5">100000</ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners>
<ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners id="Factid_19489933" contextRef="P07_01_2020To07_01_2020_SharePremiumMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-5">90000000</ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners>
<ifrs-full:DisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatory id="Factid_19489934" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4.&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Application of new and revised international financial reporting standards &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4.1&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Application of new standards &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The accounting policies adopted in the preparation of the consolidated financial statements are consistent with those followed in the preparation of the Group&amp;#8217;s annual consolidated financial statements for the year ended December&amp;#160;31, 2019, except for the adoption of new standards and interpretations effective as of January&amp;#160;1, 2020. The Group has not early adopted any standard, interpretation or amendment that has been issued but is not yet effective. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;New standards and interpretations applied for the first time: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;width:87%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Standard/interpretation&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Effective&amp;#160;date&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Amendments to IFRS 3, &amp;#8220;Business combinations&amp;#8221;, - Definition of a business&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;January&amp;#160;1,&amp;#160;2020&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Amendments to IAS 1, &amp;#8220;Presentation of financial statements&amp;#8221;, and IAS 8, &amp;#8220;Accounting policies, changes in accounting estimates and errors&amp;#8221;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;"&gt;January&amp;#160;1, 2020&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Amendment to IFRS 9, IAS 39 and IFRS 17: - Interest rate benchmark reform&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;January&amp;#160;1, 2020&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Amendment to the Conceptual framework&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;"&gt;January&amp;#160;1, 2020&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Those amendments on standards and interpretations had no effect on the consolidated financial statements of the Group. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4.2&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Assessment of potential impact of future standards, amendments to existing standards and interpretations &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following standards a&lt;div style="display:inline;"&gt;n&lt;/div&gt;d interpretations have been issued by the IASB, but were not yet mandatory for the year ended December&amp;#160;31, 2020: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;width:72%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:7%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:7%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Standard/interpretation&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Effective&amp;#160;date&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Material effect expected&lt;br/&gt; on Immatics financial&lt;br/&gt; statements&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;IFRS 16 &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;COVID-19-Related&lt;/div&gt;&lt;/div&gt; Rent Concessions Amendment&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;January&amp;#160;1,&amp;#160;2021&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;No&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Amendments to IAS 1,&amp;#8221; Presentation of financial statements&amp;#8221;, on classification of liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;"&gt;January&amp;#160;1, 2022&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;"&gt;No&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;IFRS 17 Insurance contracts&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;January&amp;#160;1, 2023&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;No&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatory>
<ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations id="Factid_19489935" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;New standards and interpretations applied for the first time: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;width:87%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Standard/interpretation&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Effective&amp;#160;date&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Amendments to IFRS 3, &amp;#8220;Business combinations&amp;#8221;, - Definition of a business&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;January&amp;#160;1,&amp;#160;2020&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Amendments to IAS 1, &amp;#8220;Presentation of financial statements&amp;#8221;, and IAS 8, &amp;#8220;Accounting policies, changes in accounting estimates and errors&amp;#8221;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;"&gt;January&amp;#160;1, 2020&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Amendment to IFRS 9, IAS 39 and IFRS 17: - Interest rate benchmark reform&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;January&amp;#160;1, 2020&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Amendment to the Conceptual framework&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;"&gt;January&amp;#160;1, 2020&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations>
<imtx:DisclosureOfNonMandatoryStandardsAndInterpretationsIssuedByTheIasbTableTextBlock id="Factid_19489936" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following standards a&lt;div style="display:inline;"&gt;n&lt;/div&gt;d interpretations have been issued by the IASB, but were not yet mandatory for the year ended December&amp;#160;31, 2020: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;width:72%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:7%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:7%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Standard/interpretation&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Effective&amp;#160;date&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Material effect expected&lt;br/&gt; on Immatics financial&lt;br/&gt; statements&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;IFRS 16 &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;COVID-19-Related&lt;/div&gt;&lt;/div&gt; Rent Concessions Amendment&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;January&amp;#160;1,&amp;#160;2021&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;No&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Amendments to IAS 1,&amp;#8221; Presentation of financial statements&amp;#8221;, on classification of liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;"&gt;January&amp;#160;1, 2022&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;"&gt;No&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;IFRS 17 Insurance contracts&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;January&amp;#160;1, 2023&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;No&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DisclosureOfNonMandatoryStandardsAndInterpretationsIssuedByTheIasbTableTextBlock>
<ifrs-full:TitleOfNewIFRS id="Factid_19489937" contextRef="P01_01_2020To12_31_2020_AmendmentsToIfrsThreeMemberifrsfullNewIFRSsAxis">Amendments to IFRS 3, &amp;#8220;Business combinations&amp;#8221;, - Definition of a business</ifrs-full:TitleOfNewIFRS>
<ifrs-full:TitleOfNewIFRS id="Factid_19489938" contextRef="P01_01_2020To12_31_2020_AmendmentsToIasOneAndIasEightMemberifrsfullNewIFRSsAxis">Amendments to IAS 1, &amp;#8220;Presentation of financial statements&amp;#8221;, and IAS 8, &amp;#8220;Accounting policies, changes in accounting estimates and errors&amp;#8221;</ifrs-full:TitleOfNewIFRS>
<ifrs-full:TitleOfNewIFRS id="Factid_19489939" contextRef="P01_01_2020To12_31_2020_AmendmentsToIfrsNineIasThirtyNineAndIfrsSeventeenMemberifrsfullNewIFRSsAxis">Amendment to IFRS 9, IAS 39 and IFRS 17: - Interest rate benchmark reform</ifrs-full:TitleOfNewIFRS>
<ifrs-full:TitleOfNewIFRS id="Factid_19489940" contextRef="P01_01_2020To12_31_2020_AmendmentsToConceptualFrameworkMemberifrsfullNewIFRSsAxis">Amendment to the Conceptual framework</ifrs-full:TitleOfNewIFRS>
<ifrs-full:DateByWhichApplicationOfNewIFRSIsRequired id="Factid_19489941" contextRef="P01_01_2020To12_31_2020_AmendmentsToIfrsThreeMemberifrsfullNewIFRSsAxis">2020-01-01</ifrs-full:DateByWhichApplicationOfNewIFRSIsRequired>
<ifrs-full:DateByWhichApplicationOfNewIFRSIsRequired id="Factid_19489942" contextRef="P01_01_2020To12_31_2020_AmendmentsToIasOneAndIasEightMemberifrsfullNewIFRSsAxis">2020-01-01</ifrs-full:DateByWhichApplicationOfNewIFRSIsRequired>
<ifrs-full:DateByWhichApplicationOfNewIFRSIsRequired id="Factid_19489943" contextRef="P01_01_2020To12_31_2020_AmendmentsToIfrsNineIasThirtyNineAndIfrsSeventeenMemberifrsfullNewIFRSsAxis">2020-01-01</ifrs-full:DateByWhichApplicationOfNewIFRSIsRequired>
<ifrs-full:DateByWhichApplicationOfNewIFRSIsRequired id="Factid_19489944" contextRef="P01_01_2020To12_31_2020_AmendmentsToConceptualFrameworkMemberifrsfullNewIFRSsAxis">2020-01-01</ifrs-full:DateByWhichApplicationOfNewIFRSIsRequired>
<ifrs-full:TitleOfNewIFRS id="Factid_19489945" contextRef="P01_01_2020To12_31_2020_AmendmentsToIasOneMemberifrsfullNewIFRSsAxis">Amendments to IAS 1,&amp;#8221; Presentation of financial statements&amp;#8221;, on classification of liabilities</ifrs-full:TitleOfNewIFRS>
<ifrs-full:TitleOfNewIFRS id="Factid_19489946" contextRef="P01_01_2020To12_31_2020_IfrsSeventeenMemberifrsfullNewIFRSsAxis">IFRS 17 Insurance contracts</ifrs-full:TitleOfNewIFRS>
<ifrs-full:DateByWhichApplicationOfNewIFRSIsRequired id="Factid_19489947" contextRef="P01_01_2020To12_31_2020_IfrsSixteenMemberifrsfullNewIFRSsAxis">2021-01-01</ifrs-full:DateByWhichApplicationOfNewIFRSIsRequired>
<ifrs-full:DateByWhichApplicationOfNewIFRSIsRequired id="Factid_19489948" contextRef="P01_01_2020To12_31_2020_AmendmentsToIasOneMemberifrsfullNewIFRSsAxis">2022-01-01</ifrs-full:DateByWhichApplicationOfNewIFRSIsRequired>
<ifrs-full:DateByWhichApplicationOfNewIFRSIsRequired id="Factid_19489949" contextRef="P01_01_2020To12_31_2020_IfrsSeventeenMemberifrsfullNewIFRSsAxis">2023-01-01</ifrs-full:DateByWhichApplicationOfNewIFRSIsRequired>
<imtx:DisclosureOfAccountReceivableExplanatoryTextBlock id="Factid_19489951" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;7.&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Accounts receivable &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;  &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 65%;"&gt;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; border-bottom: 0.75pt solid black;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); padding-bottom: 0.75pt; width: 65%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Receivables from collaboration agreements&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); padding-bottom: 0.75pt; width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"&gt;1,250&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"&gt;957&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 65%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 65%;;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Accounts receivable&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,250&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;957&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 65%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December&amp;#160;31, 2020, and 2019, no receivables were considered impaired. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DisclosureOfAccountReceivableExplanatoryTextBlock>
<imtx:DisclosureOfTradeAndOtherReceivableExplanatoryTableTextBlock id="Factid_19489952" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 65%;"&gt;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; border-bottom: 0.75pt solid black;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); padding-bottom: 0.75pt; width: 65%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Receivables from collaboration agreements&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); padding-bottom: 0.75pt; width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"&gt;1,250&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"&gt;957&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 65%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 65%;;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Accounts receivable&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,250&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;957&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 65%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DisclosureOfTradeAndOtherReceivableExplanatoryTableTextBlock>
<imtx:ReceivablesFromCollaborationAgreements id="Factid_19489953" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">1250000</imtx:ReceivablesFromCollaborationAgreements>
<imtx:ReceivablesFromCollaborationAgreements id="Factid_19489954" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">957000</imtx:ReceivablesFromCollaborationAgreements>
<ifrs-full:TradeReceivables id="Factid_19489957" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">0</ifrs-full:TradeReceivables>
<ifrs-full:TradeReceivables id="Factid_19489958" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">0</ifrs-full:TradeReceivables>
<ifrs-full:DisclosureOfOtherAssetsExplanatory id="Factid_19489959" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;8.&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Other current and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-current&lt;/div&gt; assets &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Other current assets &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;  &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 64%;"&gt;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 64%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Grant receivable&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;875&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;998&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 64%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Prepaid expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2,389&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,236&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 64%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Positive market value forward contract&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;914&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 64%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Value added tax receivable&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;798&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;768&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 64%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Capitalized transaction costs&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;48&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 64%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;787&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;617&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 64%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 64%;;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Other current assets&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5,763&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,667&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 64%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Group recognizes receivables for government grants when it is reasonably assured that the grant will be received, and all contractual conditions have been complied with. As of December&amp;#160;31, 2020, and 2019, no receivables were considered impaired. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Prepaid expenses include prepaid insurance expenses of &amp;#8364;1.0&amp;#160;million and &amp;#8364;0.1&amp;#160;million as of December&amp;#160;31, 2020 and 2019, respectively. The Group paid &amp;#8364;0.5&amp;#160;million and &amp;#8364;0.6&amp;#160;million of incremental cost for the successful arrangement of the Celgene Switzerland LLC (&amp;#8220;BMS&amp;#8221;) and Genmab A/S (&amp;#8220;Genmab&amp;#8221;) collaboration agreements as of December&amp;#160;31, 2020 and 2019, respectively. Additionally, prepaid expenses include expenses for licenses and software of &amp;#8364;0.6&amp;#160;million and &amp;#8364;0.2&amp;#160;million as of December&amp;#160;31, 2020 and 2019, respectively. The remaining amount is related to prepaid maintenance expenses. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other assets include receivables from capital gains tax of &amp;#8364;0.4&amp;#160;million and &amp;#8364;0.3 million as of December&amp;#160;31, 2020 and 2019, respectively. The remaining amount is related to prepaid deposit expenses. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Other &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-current&lt;/div&gt; assets &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; font-size: 8pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:65%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:13%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:13%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="break-inside: avoid; font-family: 'times new roman'; font-size: 8pt;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="break-inside: avoid; font-family: 'times new roman'; font-size: 8pt;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="break-inside: avoid; font-family: 'times new roman'; font-size: 10pt;"&gt;&lt;td style="background-color: rgb(204, 238, 255); font-size: 10pt;;vertical-align:top;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;times new roman&amp;quot;; line-height: normal;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Prepaid expenses&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;724&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;937&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="break-inside: avoid; font-family: 'times new roman'; font-size: 10pt;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;times new roman&amp;quot;; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-current&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;325&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="break-inside: avoid; font-family: 'times new roman'; font-size: 10pt;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;times new roman&amp;quot;; line-height: normal;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;div style="letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;non-current&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&amp;#160;&lt;/div&gt;assets&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;724&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,262&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Prepaid expenses consist of &amp;#8364;0.7&amp;#160;million and &amp;#8364;0.9&amp;#160;million of incremental cost paid for the successful arrangement of the BMS and Genmab collaboration agreements as of December&amp;#160;31, 2020 and 2019, respectively. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfOtherAssetsExplanatory>
<ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory id="Factid_19489960" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 64%;"&gt;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 64%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Grant receivable&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;875&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;998&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 64%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Prepaid expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2,389&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,236&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 64%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Positive market value forward contract&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;914&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 64%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Value added tax receivable&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;798&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;768&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 64%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Capitalized transaction costs&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;48&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 64%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;787&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;617&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 64%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 64%;;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Other current assets&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5,763&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,667&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 64%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 13%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory>
<ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory id="Factid_19489963" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Changes to property, plant and equipment during 2020 and 2019 consisted of the following: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:92%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:65%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" rowspan="3" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Laboratory&lt;br/&gt; equipment&lt;/div&gt;&lt;/td&gt;&lt;td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" rowspan="3" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Computer&lt;br/&gt; equipment&lt;/div&gt;&lt;/td&gt;&lt;td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" rowspan="3" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Office&lt;br/&gt; equipment&lt;/div&gt;&lt;/td&gt;&lt;td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" rowspan="3" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/td&gt;&lt;td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td colspan="17"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td colspan="17" style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost as of January&amp;#160;1, 2019&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11,222&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,439&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,455&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;15,116&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Impact of IFRS 16 adoption&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(441&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(441&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost as of January&amp;#160;1, 2019, adjusted&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;10,781&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,439&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,455&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;14,675&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Additions&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2,204&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;515&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;297&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;3,016&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Disposals&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(314&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(2&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(316&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Currency translation differences&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;52&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;4&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;57&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost as of December&amp;#160;31, 2019&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12,723&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,956&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,753&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;17,432&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1pt;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;Accumulated depreciation as of January 1, 2019&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;8,279&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,793&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,037&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11,109&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Additions&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,219&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;256&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;322&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,797&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Disposals&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(218&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(1&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(219&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Currency translation differences&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;23&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;25&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;Accumulated depreciation as of December 31, 2019&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;9,303&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,050&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,359&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12,712&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net book value as of December&amp;#160;31, 2019&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,420&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;906&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;394&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,720&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost as of January&amp;#160;1, 2020&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12,723&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,956&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,753&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;17,432&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Additions&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;3,545&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;406&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,427&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;5,379&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Disposals&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;6&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;7&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Currency translation differences&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;299&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;40&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;28&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;367&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost as of December&amp;#160;31, 2020&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;15,968&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,322&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,146&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;22,437&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1pt;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;Accumulated depreciation as of January 1, 2020&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;9,303&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,050&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,359&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12,712&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Additions&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,384&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;404&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;315&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2,102&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Disposals&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;6&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;7&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Currency translation differences&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;210&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;26&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;3&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;239&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;Accumulated depreciation as of December 31, 2020&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;10,476&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,428&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,665&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;14,568&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net book value as of December&amp;#160;31, 2020&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5,493&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;894&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,481&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;7,868&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory>
<imtx:DisclosureOfDepreciationExpensesTableTextBlock id="Factid_19489964" contextRef="P01_01_2020To12_31_2020">Depreciation expense is included in the following line items of the Consolidated Statement of Loss:&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:79%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year ended December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Research and development expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,503&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,315&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,757&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;General and administrative expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;600&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;482&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;301&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,103&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,797&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,058&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DisclosureOfDepreciationExpensesTableTextBlock>
<ifrs-full:DepreciationPropertyPlantAndEquipment id="Factid_19489965" contextRef="P01_01_2020To12_31_2020_ResearchAndDevelopmentExpenseMemberIMTXIncomeStatementLocationAxis" unitRef="Unit_EUR" decimals="-3">1503000</ifrs-full:DepreciationPropertyPlantAndEquipment>
<ifrs-full:DepreciationPropertyPlantAndEquipment id="Factid_19489966" contextRef="P01_01_2019To12_31_2019_ResearchAndDevelopmentExpenseMemberIMTXIncomeStatementLocationAxis" unitRef="Unit_EUR" decimals="-3">1315000</ifrs-full:DepreciationPropertyPlantAndEquipment>
<ifrs-full:DepreciationPropertyPlantAndEquipment id="Factid_19489967" contextRef="P01_01_2018To12_31_2018_ResearchAndDevelopmentExpenseMemberIMTXIncomeStatementLocationAxis" unitRef="Unit_EUR" decimals="-3">1757000</ifrs-full:DepreciationPropertyPlantAndEquipment>
<ifrs-full:DepreciationPropertyPlantAndEquipment id="Factid_19489968" contextRef="P01_01_2020To12_31_2020_GeneralAndAdministrativeExpenseMemberIMTXIncomeStatementLocationAxis" unitRef="Unit_EUR" decimals="-3">600000</ifrs-full:DepreciationPropertyPlantAndEquipment>
<ifrs-full:DepreciationPropertyPlantAndEquipment id="Factid_19489969" contextRef="P01_01_2019To12_31_2019_GeneralAndAdministrativeExpenseMemberIMTXIncomeStatementLocationAxis" unitRef="Unit_EUR" decimals="-3">482000</ifrs-full:DepreciationPropertyPlantAndEquipment>
<ifrs-full:DepreciationPropertyPlantAndEquipment id="Factid_19489970" contextRef="P01_01_2018To12_31_2018_GeneralAndAdministrativeExpenseMemberIMTXIncomeStatementLocationAxis" unitRef="Unit_EUR" decimals="-3">301000</ifrs-full:DepreciationPropertyPlantAndEquipment>
<ifrs-full:DepreciationPropertyPlantAndEquipment id="Factid_19489971" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">2103000</ifrs-full:DepreciationPropertyPlantAndEquipment>
<ifrs-full:DepreciationPropertyPlantAndEquipment id="Factid_19489972" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">1797000</ifrs-full:DepreciationPropertyPlantAndEquipment>
<ifrs-full:DepreciationPropertyPlantAndEquipment id="Factid_19489973" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">2058000</ifrs-full:DepreciationPropertyPlantAndEquipment>
<ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables id="Factid_19489974" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">-23387000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
<ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables id="Factid_19489975" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">98937000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
<ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables id="Factid_19489976" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">43732000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
<ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory id="Factid_19489977" contextRef="P01_01_2020To12_31_2020"> &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Summary of accounting policies applied by the Group for the annual reporting period ending December&amp;#160;31, 2020&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following are the significant accounting policies applied by the Group in preparing its consolidated financial statements: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;  &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.1&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Segment information &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Group manages its operations as a single segment for the purposes of assessing performance and making operating decisions. The Group&amp;#8217;s focus is on the research and development of T cell redirecting immunotherapies for the treatment of cancer. The Chief Executive Officer is the chief operating decision maker who regularly reviews the consolidated operating results and makes decisions about the allocation of the Group&amp;#8217;s resources. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-size: 1px; margin-top: 18px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;  &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.2&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cash and cash equivalents &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cash and cash equivalents in the Consolidated Statement of Financial Position &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;is comprised&lt;/div&gt; of cash held at banks (including money market funds) and short-term deposits with an original maturity of three months or less. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.3&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Financial assets &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Initial recognition and measurement &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Financial assets within the scope of IFRS 9 include cash and cash equivalents, loans, short-term deposits and receivables. Immatics determines the classification of its financial assets at initial recognition. All financial assets are recognized initially at fair value plus transaction costs. Purchases and sales of financial assets are recognized on their trade date, on which the Group commits to purchase or sell the asset. The subsequent measurement of financial assets depends on their classification as described below. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Short-term deposits &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Immatics has short-term deposits with original maturities between three and nine months, which are classified as Other financial assets. Short-term deposits with an original maturity of three months or less are classified as cash and cash equivalents. Under IFRS 9 short-term deposits are classified within financial assets at fair value. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Receivables &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Group has receivables from collaboration agreements. A receivable must be capitalized at the point in time at which the Group has become a contractual partner and a claim to cash and cash equivalents has arisen. In subsequent reporting periods, a receivable is measured at amortized cost using the effective interest method. Since the receivables are short-term receivables without a fixed interest rate, these receivables are capitalized at the original invoice or contract amount. Receivable balances are classified as current assets, because all of the Group&amp;#8217;s receivables have an expected maturity of less than 12 months. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Interest and other finance income &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Financial instruments include money market funds and short-term deposits measured at fair value. Interest income is recorded using the effective interest rate (EIR). EIR is the rate that discounts the estimated future cash payments or receipts over the expected life of the financial instrument or a shorter period, where appropriate, to the net carrying amount of the financial asset or liability. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December&amp;#160;31, 2020, Immatics is a counterparty in foreign exchange forward contracts. The contracts do not meet the criteria to apply hedge accounting and are therefore separately accounted for and measured at fair value. Any change in the fair value is accounted for within the Consolidated Statement of Loss. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;br/&gt;&lt;/div&gt;  &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.4&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Property, plant and equipment &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Property, plant and equipment is stated at cost, net of accumulated depreciation and accumulated impairment losses, if any. All repair and maintenance costs are recognized as expense when incurred. Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets. The estimated useful lives are generally within the following ranges: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;  &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 79%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 8%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt; width: 79%;;vertical-align:bottom;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Category&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Estimated&amp;#160;useful&amp;#160;life&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 79%;;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Computer equipment&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:center;;vertical-align:bottom;"&gt;1&amp;#160;&amp;#8211;&amp;#160;10&amp;#160;years&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgba(255, 255, 255, 0); width: 79%;;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Laboratory equipment&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0); width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;text-align:center;;vertical-align:bottom;"&gt;1 &amp;#8211;&amp;#160;15&amp;#160;years&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 79%;;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Office equipment&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:center;;vertical-align:bottom;"&gt;2 &amp;#8211;&amp;#160;20&amp;#160;years&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.5&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Intangible assets &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Acquired intangible assets are initially recognized at cost. Following initial recognition, intangible assets are carried at cost less accumulated amortization and accumulated impairment losses, if any. Intangible assets with finite lives are amortized over their useful economic lives and assessed for impairment, whenever there is an indication that the intangible asset may be impaired. The amortization period and the amortization method for an intangible asset with a finite useful life, is reviewed at least at the end of each reporting period. Immatics does not have any internally developed intangible assets or intangible assets with indefinite useful lives. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Amortization is calculated on a straight-line basis over the estimated useful lives of the assets as follows: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;width:79%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:8%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Category&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Estimated&amp;#160;useful&amp;#160;life&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Licenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:center;;vertical-align:bottom;"&gt;5&amp;#160;&amp;#8211;&amp;#160;30&amp;#160;years&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Software&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;text-align:center;;vertical-align:bottom;"&gt;1 &amp;#8211; 5&amp;#160;years&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.6&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Research and development &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Research expenses are defined as costs incurred for current or planned investigations undertaken with the prospect of gaining new scientific or technical knowledge and understanding. All Research costs are expensed as incurred. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;An intangible asset arising from development expenditure on an individual project is recognized only when the Group can demonstrate the technical feasibility of completing the intangible asset so that it will be available for use or sale, its intention to complete and its ability to use or sell the asset, how the asset will generate future economic benefits, the availability of resources to complete and the ability to measure reliably the expenditure during the development. The Group did not recognize any intangible assets from development expenditures in 2020, 2019 and 2018 due to the existing uncertainties in connection with its development activities. Research and development expenses include the following types of costs: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;1.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;salaries, benefits and other related costs, including stock-based compensation, for personnel engaged in research and development functions; &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;2.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;expenses incurred in connection with the preclinical development of our programs and clinical trials of our product candidates, including under agreements with third parties, such as consultants, contractors, academic institutions and contract research organizations; &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;3.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;the cost of manufacturing product candidates for use in clinical trials, including under agreements with third parties, such as, consultants and contractors; &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;4.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;laboratory costs; &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;5.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;leased facility costs, equipment depreciation and other expenses, which include direct and allocated expenses; and &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;6.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;intellectual property costs incurred in connection with filing and prosecuting patent applications as well as third-party license fees. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.7&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Financial liabilities: Initial recognition and measurement &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Financial liabilities within the scope of IFRS 9 are classified as financial liabilities at fair value through profit or loss or at amortized cost, as appropriate. The Group determines the classification of its financial liabilities at initial recognition. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;All financial liabilities are recognized initially at fair value and, in the case of loans and borrowings, carried at amortized cost. This includes directly attributable transaction costs. Immatics only recognized accounts payable as other financial liabilities at amortized costs. The Group has not designated any financial liabilities upon initial recognition as fair value through profit or loss. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Group does not engage in hedging transactions that meet the criteria to apply hedge accounting. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.8&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Leases &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Application of IAS 17 (&amp;#8220;Leases&amp;#8221;) until December&amp;#160;31, 2018 &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;Prior to 2019, the Group applied IAS 17 when accounting for leases. As a lessee under IAS 17, leases for which substantially all the risks and rewards of ownership transferred to the Group were classified as finance leases. Finance leases were capitalized at the lease&amp;#8217;s inception at the fair value of the leased property or, if lower, the present value of the minimum lease payments. The corresponding rental obligations, net of finance charges, were included in other current liabilities and other &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-current&lt;/div&gt; liabilities. Each lease payment was allocated between the liability and finance cost. The finance cost was charged as an expense over the lease period so as to produce a constant periodic rate of interest on the remaining balance of the liability for each period. The assets associated with the finance leases are depreciated over the shorter of the asset&amp;#8217;s useful life or the lease term if there is no reasonable certainty that the Group will obtain ownership at the end of the lease term. Leases in which a significant portion of the risks and rewards of ownership were not transferred to the Group as lessee were classified as operating leases. Payments made under operating leases (net of any incentives received from the lessor) were charged as an expense on a straight-line basis over the period of the lease. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Application of IFRS 16 (&amp;#8220;Leases&amp;#8221;) effective January&amp;#160;1, 2019 &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;The Group adopted IFRS 16 (&amp;#8220;Leases&amp;#8221;) effective January&amp;#160;1, 2019. The Group leases various offices, equipment and vehicles. Rental contracts are typically made for fixed periods of two to seven years but may have extension options as described in below. Contracts may contain both lease and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-lease&lt;/div&gt; components. The Group has elected not to separate lease and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-lease&lt;/div&gt; components and instead accounts for these as a single lease component. Lease terms are negotiated on an individual basis. The lease agreements do not impose any covenants other than the security interests in the leased assets that are held by the lessor. Leased assets may not be used as security for borrowing purposes. Under IFRS 16, leases are recognized as a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; asset with a corresponding liability on the date at which the leased asset is available for use by the Group. &lt;/div&gt; &lt;div style="font-family: times new roman;font-size: 10pt;margin-top: 0pt;margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Assets and liabilities arising from a lease are initially measured on a present value basis. Lease liabilities include the net present value of the following lease payments: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;1.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;fixed payments (including &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;in-substance&lt;/div&gt; fixed payments), less any lease incentives received. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;2.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;amounts expected to be payable by the Group under residual value guarantees. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;3.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;the exercise price of a purchase option if the Group is reasonably certain to exercise that option; and &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;4.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;payments of penalties for terminating the lease, if the lease term reflects the Group exercising that option. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;Lease payments to be made under reasonably certain extension options are also included in the measurement of the liability. The lease payments are discounted using the interest rate implicit in the lease. If that rate cannot be readily determined, which is generally the case for the Group&amp;#8217;s leases, the lessee&amp;#8217;s incremental borrowing rate is used. The incremental borrowing rate is the rate that the individual lessee would have to pay to borrow the funds, necessary to obtain an asset of similar value to the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; asset in a similar economic environment with similar terms, security and conditions. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;To determine the incremental borrowing rate, the Group: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;1.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;uses a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;build-up&lt;/div&gt; approach that starts with a risk-free interest rate adjusted for credit risk for leases held by Immatics, and &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;2.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;makes adjustments specific to the lease, including lease term, country, currency and security &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Right-of-use&lt;/div&gt;&lt;/div&gt; assets are measured at cost comprising the following: &lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;1.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;the amount of the initial measurement of lease liability &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;2.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;any lease payments made at or before the commencement date less any lease incentives received &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;3.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;any initial direct costs, and &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;4.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;restoration costs. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Right-of-use&lt;/div&gt;&lt;/div&gt; assets are generally depreciated over the shorter of the asset&amp;#8217;s useful life or the lease term on a straight-line basis. If the Group is reasonably certain to exercise a purchase option, the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; asset is depreciated over the underlying asset&amp;#8217;s useful life. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;Payments associated with short-term leases of equipment and vehicles and all leases of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;low-value&lt;/div&gt; assets are recognized on a straight-line basis as an expense. Short-term leases are leases with a lease term of 12 months or less. &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Low-value&lt;/div&gt; assets have a value of less than &amp;#8364;5&amp;#160;thousand. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Extension and termination options are included in a number of property and equipment leases across the Group. These are used to maximize operational flexibility in terms of managing the assets used in the Group&amp;#8217;s operations. The extension and termination options held are exercisable only by the Group and not by the respective lessor. For relevant leases which include an extension option, Immatics performed an assessment as of December&amp;#160;31, 2020 to determine whether option extensions are reasonably certain. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.9&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Revenue from collaboration agreements &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;The Group earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. As of December&amp;#160;31, 2020, the Group had four strategic collaboration agreements in place with Amgen Inc., Thousand Oaks/CA/USA (&amp;#8220;Amgen&amp;#8221;), Genmab A/S, Copenhagen/Denmark (&amp;#8220;Genmab&amp;#8221;), Celgene Switzerland LLC (&amp;#8220;BMS&amp;#8221;) and GlaxoSmithKline Intellectual Property Development Limited (&amp;#8220;GSK&amp;#8221;). Each of the Group&amp;#8217;s four strategic collaboration agreements are in the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;pre-clinical&lt;/div&gt; stage. &lt;/div&gt; &lt;div style="font-family: times new roman;font-size: 10pt;margin-top: 0pt;margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;To determine the recognition of revenue from arrangements that fall within the scope of IFRS 15, the Group performs the following five steps: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;(i)&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;identify the contract(s) with a customer; &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;(ii)&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;identify the performance obligations in the contract; &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;(iii)&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;determine the transaction price; &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;(iv)&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;allocate the transaction price to the performance obligations in the contract; and &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;(v)&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;recognize revenue when (or as) the Group satisfies a performance obligation. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Under the terms of these agreements, Immatics agrees to collaborate in the development, manufacture, and commercialization of cancer immunotherapy treatments for specified targets identified through the use of Immatics XPRESIDENT technology. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;As part of the collaboration arrangements, Immatics grants exclusive licensing rights for the development and commercialization of future product candidates, developed for targets defined in the collaboration agreements. Additionally, Immatics agrees to perform certain research activities under the collaboration agreements, including screening of highly specific molecules for reactivity with the specified targets and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;off-targets&lt;/div&gt; using Immatics&amp;#8217; proprietary technology and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;know-how,&lt;/div&gt; participation on steering committees, and preparation of data packages. The research activities are the predominant item in each of the Group&amp;#8217;s collaboration agreements. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;The Group performs an analysis to identify the performance obligations under the contract, including licenses and rights to future intellectual property developed under the contract and research activities. As these agreements comprise several promises, it must be assessed whether these promises are capable of being distinct and distinct within the context of the contract. &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Up-front&lt;/div&gt; licensing payments and reimbursement for research and development expenses are initially deferred on our Consolidated Statement of Financial Position and subsequently recognized as costs are incurred using a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;cost-to-cost&lt;/div&gt;&lt;/div&gt; method. Milestone payments are generally included in the transaction price at the amount stipulated in the respective agreement and recognized to the extent that it is highly probable that a&amp;#160;significant reversal&amp;#160;in the amount of cumulative revenue recognized will not occur. To date, no milestone has been included in the transaction price. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;As stated above, the licenses contributed under the collaboration agreements currently in place&amp;#160;do not represent distinct performance obligations, because the Group&amp;#8217;s collaboration partners would likely be unable to derive significant benefits from their access to these targets without Immatics&amp;#8217; research activities. Identification of a viable product candidate that will bind to the targets specified in the agreements requires use of the Group&amp;#8217;s XPRESIDENT technology and database of target and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;off-target&lt;/div&gt; data. These agreements include a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-refundable&lt;/div&gt; upfront payment, payments for research and development activities in certain circumstances, and payments based upon the achievement of defined milestones. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Under IFRS 15, the Group applies significant judgement when evaluating whether the obligations under these agreements represent one or more combined performance obligations, the allocation of the transaction price to identified performance obligations, and the determination of whether milestone payments should be included in the transaction price. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Upfront payment &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;Each of the Group&amp;#8217;s strategic collaboration agreements included a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-refundable&lt;/div&gt; upfront payment, meant to subsidize research activities. The Group recorded these payments as deferred revenue, which it allocated to the combined performance obligations for each agreement. Such amounts are recognized as revenue over the performance period of the research activities on a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;cost-to-cost&lt;/div&gt;&lt;/div&gt; basis. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;The &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;cost-to-cost&lt;/div&gt;&lt;/div&gt; basis using direct costs and directly attributable personal costs was considered the best measure of progress in which control of the combined performance obligations transfers to the Group&amp;#8217;s collaboration partners, due to the nature of the work being performed. &lt;/div&gt; &lt;div style="font-size: 1px; margin-top: 18px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Reimbursement for services&lt;/div&gt; Under the collaboration agreement with Genmab, the Group receives reimbursement for employee research and development costs. These employee costs are presented as research and development expenses, while reimbursements of those costs, which is based on an FTE rate defined in the contract, are presented as revenue and not deducted from expenses. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Development and Commercial Milestones &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The collaboration agreements include contingent payments related to development and commercial milestone events. These milestone payments represent variable consideration that are not initially recognized within the transaction price, due to the scientific uncertainties and the required commitment from the collaboration partners to develop and commercialize a product candidate. The Group assesses the probability of significant reversals for any amounts that become likely to be realized prior to recognizing the variable consideration, associated with these payments within the transaction price. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Sales-based milestones and royalty payments &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The collaboration agreements also include sales-based royalty payments upon successful commercialization of a licensed product. In accordance with IFRS 15.B63, the Group recognizes revenue from sales-based milestone and royalty payments at the later of (i)&amp;#160;the occurrence of the subsequent sale; or (ii)&amp;#160;the performance obligation to which some or all of the sales-based milestone, or royalty payments has been allocated has been satisfied. The Group anticipates recognizing these milestones and royalty payments, when subsequent sales are generated from a licensed product by the collaboration partner. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Cost to fulfill contracts &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Group incurs costs for personnel, supplies and other costs related to its laboratory operations as well as fees from third parties and license expenses in connection with its research and development obligations under the collaboration and licensing agreement. These costs are recognized as research and development expenses over the period in which services are performed. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Cost to obtain a contract &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;For some collaboration agreements, the Group incurs incremental costs of obtaining a contract with a customer. The Group capitalizes those incremental costs if the costs are expected to be recovered. The recognized asset is amortized consistent with the method used to determine the pattern of revenue recognition of the underlying contract. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.10&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Share-based payment &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Group&amp;#8217;s Employees as well as others providing similar services to the Group, receive remuneration in the form of share-based payments, which are equity-settled transactions. The Group`s equity-settled option plans include Matching Stock Options, Converted Stock Options, Service Options and PSUs and are described in detail in Note 18. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The costs of equity-settled transactions are determined by the fair value at grant date, using an appropriate valuation model. Share-based expenses for the respective vesting periods, are recognized in research and development expenses and general and administrative expenses, reflecting a corresponding increase in equity. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.11&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Other income &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Group primarily earns other income from government research grants. Government grants are recognized as income when there is reasonable assurance that the grant will be received and all required conditions have been complied with. Grants from governmental agencies for the support of specific research and development projects are recorded as other income to the extent the related expenses have been incurred. Grant agreements include a budget that specifies the amount and nature of expenses allowed during the entire grant term. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman;font-size: 10pt;margin-top: 0pt;margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Expenses incurred under the grants are calculated according to agreed-upon terms on a quarterly basis, filed with the governmental agencies, and recorded as income. The governmental agencies make payments to the Group based on these calculations of expenses incurred under the grants. If these estimated calculations change, the Group will then adjust grant income in the subsequent period. The Group believes that its calculations are based on the agreed-upon terms as stated in the grant agreements. The governmental agencies generally have the right to audit the Group&amp;#8217;s calculations. If the governmental agencies disagree with the Group&amp;#8217;s calculations the amount of grant income recognized could change. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.12&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Foreign currency &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Transactions and balances in Germany and in the USA &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The consolidated financial statements are presented in Euro, which is the parents&amp;#8217;, Immatics N.V. functional and presentation currency. Assets and liabilities of foreign operations are translated into Euros at the rate of exchange prevailing at the reporting. The Consolidated Statement of Loss is translated at average exchange rates. The currency translation differences are recognized in other comprehensive loss. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Transactions in foreign currencies are initially recorded by the Group&amp;#8217;s entities at their respective functional currency spot rates, at the date the transaction first qualifies for recognition. The Group used the following exchange rates to convert the financial statements of its U.S. subsidiary: &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:64%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Year-end&lt;/div&gt;&lt;br/&gt; rate&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;Average&lt;br/&gt; rate&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Year-end&lt;/div&gt;&lt;br/&gt; rate&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;Average&lt;br/&gt; rate&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Year-end&lt;/div&gt;&lt;br/&gt; rate&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;Average&lt;br/&gt; rate&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Euros per U.S.&amp;#160;Dollar&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.8149&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.8762&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.8902&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.8932&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.8738&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.8468&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.13&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair value of financial instruments &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&amp;#160;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&amp;#160;&lt;/div&gt; &lt;div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;&lt;div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#8226;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-size: 10pt;;text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;in the principal market for the asset or liability or &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&lt;div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;&lt;div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#8226;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-size: 10pt;;text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;in the absence of a principal market, in the most advantageous market for the asset or liability that is accessible by the Group. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest. The Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs. All assets and liabilities for which fair value is measured or disclosed in the consolidated financial statements are categorized within the fair value hierarchy, described as follows, based on the lowest level input that is significant to the fair value measurement as a whole: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&lt;div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;&lt;div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#8226;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-size: 10pt;;text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Level&amp;#160;1 &amp;#8212; Quoted (unadjusted) market prices in active markets for identical assets or liabilities. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&lt;div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;&lt;div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#8226;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-size: 10pt;;text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Level&amp;#160;2 &amp;#8212; Valuation techniques, for which the lowest level input that is significant to the fair value measurement is directly or indirectly observable. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&lt;div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;&lt;div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#8226;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-size: 10pt;;text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Level&amp;#160;3 &amp;#8212; Valuation techniques, for which the lowest level input that is significant to the fair value measurement is unobservable. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;br/&gt; For assets and liabilities that are recognized in the consolidated financial statements at fair value on a recurring basis, the Group determines whether transfers have occurred between levels in the hierarchy by &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;re-assessing&lt;/div&gt; categorization (based on the lowest level input that is significant to the fair value measurement as a whole), at the end of each reporting period. &lt;/div&gt;  &lt;div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.14&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Provisions &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Provisions are recognized when the Group has a present obligation (legal or constructive) as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation and a reliable estimate can be made of the amount of the obligation. Where the Group expects some or all of a provision to be reimbursed, for example under an insurance contract, the reimbursement is recognized as a separate asset but only when the reimbursement is virtually certain. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;If the effect of the time value of money is material, provisions are discounted using a current &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;pre-tax&lt;/div&gt; rate that reflects, when appropriate, the risks specific to the liability. &lt;/div&gt;  &lt;div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.15&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Income Tax &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred income tax results from temporary differences between the carrying amount of an asset or a liability and its tax base. Deferred income tax is provided in full using the liability method on temporary differences. In accordance with IAS 12 (&amp;#8220;Income Taxes&amp;#8221;), the deferred tax assets and liabilities reflect all temporary valuation and accounting differences between financial statements prepared for tax purposes and our consolidated financial statements. Tax losses carried forward are considered in deferred tax assets calculation. The Group offsets tax assets and liabilities if and only if it has a legally enforceable right to set off current tax assets, current tax liabilities, deferred tax assets and deferred tax liabilities which relate to income taxes levied by the same tax authority. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory>
<ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory id="Factid_19489978" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.1&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Segment information &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Group manages its operations as a single segment for the purposes of assessing performance and making operating decisions. The Group&amp;#8217;s focus is on the research and development of T cell redirecting immunotherapies for the treatment of cancer. The Chief Executive Officer is the chief operating decision maker who regularly reviews the consolidated operating results and makes decisions about the allocation of the Group&amp;#8217;s resources. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory>
<ifrs-full:DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory id="Factid_19489979" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.2&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cash and cash equivalents &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cash and cash equivalents in the Consolidated Statement of Financial Position &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;is comprised&lt;/div&gt; of cash held at banks (including money market funds) and short-term deposits with an original maturity of three months or less. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory>
<ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory id="Factid_19489980" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.3&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Financial assets &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Initial recognition and measurement &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Financial assets within the scope of IFRS 9 include cash and cash equivalents, loans, short-term deposits and receivables. Immatics determines the classification of its financial assets at initial recognition. All financial assets are recognized initially at fair value plus transaction costs. Purchases and sales of financial assets are recognized on their trade date, on which the Group commits to purchase or sell the asset. The subsequent measurement of financial assets depends on their classification as described below. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Short-term deposits &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Immatics has short-term deposits with original maturities between three and nine months, which are classified as Other financial assets. Short-term deposits with an original maturity of three months or less are classified as cash and cash equivalents. Under IFRS 9 short-term deposits are classified within financial assets at fair value. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Receivables &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Group has receivables from collaboration agreements. A receivable must be capitalized at the point in time at which the Group has become a contractual partner and a claim to cash and cash equivalents has arisen. In subsequent reporting periods, a receivable is measured at amortized cost using the effective interest method. Since the receivables are short-term receivables without a fixed interest rate, these receivables are capitalized at the original invoice or contract amount. Receivable balances are classified as current assets, because all of the Group&amp;#8217;s receivables have an expected maturity of less than 12 months. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Interest and other finance income &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Financial instruments include money market funds and short-term deposits measured at fair value. Interest income is recorded using the effective interest rate (EIR). EIR is the rate that discounts the estimated future cash payments or receipts over the expected life of the financial instrument or a shorter period, where appropriate, to the net carrying amount of the financial asset or liability. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December&amp;#160;31, 2020, Immatics is a counterparty in foreign exchange forward contracts. The contracts do not meet the criteria to apply hedge accounting and are therefore separately accounted for and measured at fair value. Any change in the fair value is accounted for within the Consolidated Statement of Loss. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;br/&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory>
<ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory id="Factid_19489982" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.5&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Intangible assets &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Acquired intangible assets are initially recognized at cost. Following initial recognition, intangible assets are carried at cost less accumulated amortization and accumulated impairment losses, if any. Intangible assets with finite lives are amortized over their useful economic lives and assessed for impairment, whenever there is an indication that the intangible asset may be impaired. The amortization period and the amortization method for an intangible asset with a finite useful life, is reviewed at least at the end of each reporting period. Immatics does not have any internally developed intangible assets or intangible assets with indefinite useful lives. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Amortization is calculated on a straight-line basis over the estimated useful lives of the assets as follows: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;width:79%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:8%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Category&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Estimated&amp;#160;useful&amp;#160;life&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Licenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:center;;vertical-align:bottom;"&gt;5&amp;#160;&amp;#8211;&amp;#160;30&amp;#160;years&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Software&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;text-align:center;;vertical-align:bottom;"&gt;1 &amp;#8211; 5&amp;#160;years&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory>
<ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory id="Factid_19489983" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.6&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Research and development &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Research expenses are defined as costs incurred for current or planned investigations undertaken with the prospect of gaining new scientific or technical knowledge and understanding. All Research costs are expensed as incurred. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;An intangible asset arising from development expenditure on an individual project is recognized only when the Group can demonstrate the technical feasibility of completing the intangible asset so that it will be available for use or sale, its intention to complete and its ability to use or sell the asset, how the asset will generate future economic benefits, the availability of resources to complete and the ability to measure reliably the expenditure during the development. The Group did not recognize any intangible assets from development expenditures in 2020, 2019 and 2018 due to the existing uncertainties in connection with its development activities. Research and development expenses include the following types of costs: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;1.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;salaries, benefits and other related costs, including stock-based compensation, for personnel engaged in research and development functions; &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;2.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;expenses incurred in connection with the preclinical development of our programs and clinical trials of our product candidates, including under agreements with third parties, such as consultants, contractors, academic institutions and contract research organizations; &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;3.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;the cost of manufacturing product candidates for use in clinical trials, including under agreements with third parties, such as, consultants and contractors; &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;4.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;laboratory costs; &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;5.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;leased facility costs, equipment depreciation and other expenses, which include direct and allocated expenses; and &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;6.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;intellectual property costs incurred in connection with filing and prosecuting patent applications as well as third-party license fees. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory>
<ifrs-full:DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory id="Factid_19489984" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.7&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Financial liabilities: Initial recognition and measurement &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Financial liabilities within the scope of IFRS 9 are classified as financial liabilities at fair value through profit or loss or at amortized cost, as appropriate. The Group determines the classification of its financial liabilities at initial recognition. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;All financial liabilities are recognized initially at fair value and, in the case of loans and borrowings, carried at amortized cost. This includes directly attributable transaction costs. Immatics only recognized accounts payable as other financial liabilities at amortized costs. The Group has not designated any financial liabilities upon initial recognition as fair value through profit or loss. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Group does not engage in hedging transactions that meet the criteria to apply hedge accounting. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory>
<ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory id="Factid_19489985" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.8&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Leases &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Application of IAS 17 (&amp;#8220;Leases&amp;#8221;) until December&amp;#160;31, 2018 &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;Prior to 2019, the Group applied IAS 17 when accounting for leases. As a lessee under IAS 17, leases for which substantially all the risks and rewards of ownership transferred to the Group were classified as finance leases. Finance leases were capitalized at the lease&amp;#8217;s inception at the fair value of the leased property or, if lower, the present value of the minimum lease payments. The corresponding rental obligations, net of finance charges, were included in other current liabilities and other &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-current&lt;/div&gt; liabilities. Each lease payment was allocated between the liability and finance cost. The finance cost was charged as an expense over the lease period so as to produce a constant periodic rate of interest on the remaining balance of the liability for each period. The assets associated with the finance leases are depreciated over the shorter of the asset&amp;#8217;s useful life or the lease term if there is no reasonable certainty that the Group will obtain ownership at the end of the lease term. Leases in which a significant portion of the risks and rewards of ownership were not transferred to the Group as lessee were classified as operating leases. Payments made under operating leases (net of any incentives received from the lessor) were charged as an expense on a straight-line basis over the period of the lease. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Application of IFRS 16 (&amp;#8220;Leases&amp;#8221;) effective January&amp;#160;1, 2019 &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;The Group adopted IFRS 16 (&amp;#8220;Leases&amp;#8221;) effective January&amp;#160;1, 2019. The Group leases various offices, equipment and vehicles. Rental contracts are typically made for fixed periods of two to seven years but may have extension options as described in below. Contracts may contain both lease and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-lease&lt;/div&gt; components. The Group has elected not to separate lease and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-lease&lt;/div&gt; components and instead accounts for these as a single lease component. Lease terms are negotiated on an individual basis. The lease agreements do not impose any covenants other than the security interests in the leased assets that are held by the lessor. Leased assets may not be used as security for borrowing purposes. Under IFRS 16, leases are recognized as a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; asset with a corresponding liability on the date at which the leased asset is available for use by the Group. &lt;/div&gt; &lt;div style="font-family: times new roman;font-size: 10pt;margin-top: 0pt;margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Assets and liabilities arising from a lease are initially measured on a present value basis. Lease liabilities include the net present value of the following lease payments: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;1.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;fixed payments (including &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;in-substance&lt;/div&gt; fixed payments), less any lease incentives received. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;2.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;amounts expected to be payable by the Group under residual value guarantees. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;3.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;the exercise price of a purchase option if the Group is reasonably certain to exercise that option; and &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;4.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;payments of penalties for terminating the lease, if the lease term reflects the Group exercising that option. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;Lease payments to be made under reasonably certain extension options are also included in the measurement of the liability. The lease payments are discounted using the interest rate implicit in the lease. If that rate cannot be readily determined, which is generally the case for the Group&amp;#8217;s leases, the lessee&amp;#8217;s incremental borrowing rate is used. The incremental borrowing rate is the rate that the individual lessee would have to pay to borrow the funds, necessary to obtain an asset of similar value to the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; asset in a similar economic environment with similar terms, security and conditions. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;To determine the incremental borrowing rate, the Group: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;1.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;uses a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;build-up&lt;/div&gt; approach that starts with a risk-free interest rate adjusted for credit risk for leases held by Immatics, and &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;2.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;makes adjustments specific to the lease, including lease term, country, currency and security &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Right-of-use&lt;/div&gt;&lt;/div&gt; assets are measured at cost comprising the following: &lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;1.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;the amount of the initial measurement of lease liability &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;2.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;any lease payments made at or before the commencement date less any lease incentives received &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;3.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;any initial direct costs, and &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;4.&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;restoration costs. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Right-of-use&lt;/div&gt;&lt;/div&gt; assets are generally depreciated over the shorter of the asset&amp;#8217;s useful life or the lease term on a straight-line basis. If the Group is reasonably certain to exercise a purchase option, the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; asset is depreciated over the underlying asset&amp;#8217;s useful life. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;Payments associated with short-term leases of equipment and vehicles and all leases of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;low-value&lt;/div&gt; assets are recognized on a straight-line basis as an expense. Short-term leases are leases with a lease term of 12 months or less. &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Low-value&lt;/div&gt; assets have a value of less than &amp;#8364;5&amp;#160;thousand. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Extension and termination options are included in a number of property and equipment leases across the Group. These are used to maximize operational flexibility in terms of managing the assets used in the Group&amp;#8217;s operations. The extension and termination options held are exercisable only by the Group and not by the respective lessor. For relevant leases which include an extension option, Immatics performed an assessment as of December&amp;#160;31, 2020 to determine whether option extensions are reasonably certain. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory>
<ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue id="Factid_19489986" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.9&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Revenue from collaboration agreements &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;The Group earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. As of December&amp;#160;31, 2020, the Group had four strategic collaboration agreements in place with Amgen Inc., Thousand Oaks/CA/USA (&amp;#8220;Amgen&amp;#8221;), Genmab A/S, Copenhagen/Denmark (&amp;#8220;Genmab&amp;#8221;), Celgene Switzerland LLC (&amp;#8220;BMS&amp;#8221;) and GlaxoSmithKline Intellectual Property Development Limited (&amp;#8220;GSK&amp;#8221;). Each of the Group&amp;#8217;s four strategic collaboration agreements are in the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;pre-clinical&lt;/div&gt; stage. &lt;/div&gt; &lt;div style="font-family: times new roman;font-size: 10pt;margin-top: 0pt;margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;To determine the recognition of revenue from arrangements that fall within the scope of IFRS 15, the Group performs the following five steps: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;(i)&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;identify the contract(s) with a customer; &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;(ii)&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;identify the performance obligations in the contract; &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;(iii)&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;determine the transaction price; &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;(iv)&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;allocate the transaction price to the performance obligations in the contract; and &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;(v)&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;recognize revenue when (or as) the Group satisfies a performance obligation. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Under the terms of these agreements, Immatics agrees to collaborate in the development, manufacture, and commercialization of cancer immunotherapy treatments for specified targets identified through the use of Immatics XPRESIDENT technology. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;As part of the collaboration arrangements, Immatics grants exclusive licensing rights for the development and commercialization of future product candidates, developed for targets defined in the collaboration agreements. Additionally, Immatics agrees to perform certain research activities under the collaboration agreements, including screening of highly specific molecules for reactivity with the specified targets and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;off-targets&lt;/div&gt; using Immatics&amp;#8217; proprietary technology and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;know-how,&lt;/div&gt; participation on steering committees, and preparation of data packages. The research activities are the predominant item in each of the Group&amp;#8217;s collaboration agreements. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;The Group performs an analysis to identify the performance obligations under the contract, including licenses and rights to future intellectual property developed under the contract and research activities. As these agreements comprise several promises, it must be assessed whether these promises are capable of being distinct and distinct within the context of the contract. &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Up-front&lt;/div&gt; licensing payments and reimbursement for research and development expenses are initially deferred on our Consolidated Statement of Financial Position and subsequently recognized as costs are incurred using a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;cost-to-cost&lt;/div&gt;&lt;/div&gt; method. Milestone payments are generally included in the transaction price at the amount stipulated in the respective agreement and recognized to the extent that it is highly probable that a&amp;#160;significant reversal&amp;#160;in the amount of cumulative revenue recognized will not occur. To date, no milestone has been included in the transaction price. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;As stated above, the licenses contributed under the collaboration agreements currently in place&amp;#160;do not represent distinct performance obligations, because the Group&amp;#8217;s collaboration partners would likely be unable to derive significant benefits from their access to these targets without Immatics&amp;#8217; research activities. Identification of a viable product candidate that will bind to the targets specified in the agreements requires use of the Group&amp;#8217;s XPRESIDENT technology and database of target and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;off-target&lt;/div&gt; data. These agreements include a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-refundable&lt;/div&gt; upfront payment, payments for research and development activities in certain circumstances, and payments based upon the achievement of defined milestones. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Under IFRS 15, the Group applies significant judgement when evaluating whether the obligations under these agreements represent one or more combined performance obligations, the allocation of the transaction price to identified performance obligations, and the determination of whether milestone payments should be included in the transaction price. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Upfront payment &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;Each of the Group&amp;#8217;s strategic collaboration agreements included a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-refundable&lt;/div&gt; upfront payment, meant to subsidize research activities. The Group recorded these payments as deferred revenue, which it allocated to the combined performance obligations for each agreement. Such amounts are recognized as revenue over the performance period of the research activities on a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;cost-to-cost&lt;/div&gt;&lt;/div&gt; basis. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;The &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;cost-to-cost&lt;/div&gt;&lt;/div&gt; basis using direct costs and directly attributable personal costs was considered the best measure of progress in which control of the combined performance obligations transfers to the Group&amp;#8217;s collaboration partners, due to the nature of the work being performed. &lt;/div&gt; &lt;div style="font-size: 1px; margin-top: 18px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Reimbursement for services&lt;/div&gt; Under the collaboration agreement with Genmab, the Group receives reimbursement for employee research and development costs. These employee costs are presented as research and development expenses, while reimbursements of those costs, which is based on an FTE rate defined in the contract, are presented as revenue and not deducted from expenses. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Development and Commercial Milestones &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The collaboration agreements include contingent payments related to development and commercial milestone events. These milestone payments represent variable consideration that are not initially recognized within the transaction price, due to the scientific uncertainties and the required commitment from the collaboration partners to develop and commercialize a product candidate. The Group assesses the probability of significant reversals for any amounts that become likely to be realized prior to recognizing the variable consideration, associated with these payments within the transaction price. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Sales-based milestones and royalty payments &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The collaboration agreements also include sales-based royalty payments upon successful commercialization of a licensed product. In accordance with IFRS 15.B63, the Group recognizes revenue from sales-based milestone and royalty payments at the later of (i)&amp;#160;the occurrence of the subsequent sale; or (ii)&amp;#160;the performance obligation to which some or all of the sales-based milestone, or royalty payments has been allocated has been satisfied. The Group anticipates recognizing these milestones and royalty payments, when subsequent sales are generated from a licensed product by the collaboration partner. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Cost to fulfill contracts &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Group incurs costs for personnel, supplies and other costs related to its laboratory operations as well as fees from third parties and license expenses in connection with its research and development obligations under the collaboration and licensing agreement. These costs are recognized as research and development expenses over the period in which services are performed. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Cost to obtain a contract &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;For some collaboration agreements, the Group incurs incremental costs of obtaining a contract with a customer. The Group capitalizes those incremental costs if the costs are expected to be recovered. The recognized asset is amortized consistent with the method used to determine the pattern of revenue recognition of the underlying contract. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue>
<ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory id="Factid_19489987" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.10&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Share-based payment &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Group&amp;#8217;s Employees as well as others providing similar services to the Group, receive remuneration in the form of share-based payments, which are equity-settled transactions. The Group`s equity-settled option plans include Matching Stock Options, Converted Stock Options, Service Options and PSUs and are described in detail in Note 18. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The costs of equity-settled transactions are determined by the fair value at grant date, using an appropriate valuation model. Share-based expenses for the respective vesting periods, are recognized in research and development expenses and general and administrative expenses, reflecting a corresponding increase in equity. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory>
<imtx:DescriptionOfAccountingPolicyForOtherIncomePolicyTextBlock id="Factid_19489988" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.11&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Other income &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Group primarily earns other income from government research grants. Government grants are recognized as income when there is reasonable assurance that the grant will be received and all required conditions have been complied with. Grants from governmental agencies for the support of specific research and development projects are recorded as other income to the extent the related expenses have been incurred. Grant agreements include a budget that specifies the amount and nature of expenses allowed during the entire grant term. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman;font-size: 10pt;margin-top: 0pt;margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Expenses incurred under the grants are calculated according to agreed-upon terms on a quarterly basis, filed with the governmental agencies, and recorded as income. The governmental agencies make payments to the Group based on these calculations of expenses incurred under the grants. If these estimated calculations change, the Group will then adjust grant income in the subsequent period. The Group believes that its calculations are based on the agreed-upon terms as stated in the grant agreements. The governmental agencies generally have the right to audit the Group&amp;#8217;s calculations. If the governmental agencies disagree with the Group&amp;#8217;s calculations the amount of grant income recognized could change. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DescriptionOfAccountingPolicyForOtherIncomePolicyTextBlock>
<ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory id="Factid_19489989" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.12&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Foreign currency &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Transactions and balances in Germany and in the USA &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The consolidated financial statements are presented in Euro, which is the parents&amp;#8217;, Immatics N.V. functional and presentation currency. Assets and liabilities of foreign operations are translated into Euros at the rate of exchange prevailing at the reporting. The Consolidated Statement of Loss is translated at average exchange rates. The currency translation differences are recognized in other comprehensive loss. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Transactions in foreign currencies are initially recorded by the Group&amp;#8217;s entities at their respective functional currency spot rates, at the date the transaction first qualifies for recognition. The Group used the following exchange rates to convert the financial statements of its U.S. subsidiary: &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:64%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Year-end&lt;/div&gt;&lt;br/&gt; rate&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;Average&lt;br/&gt; rate&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Year-end&lt;/div&gt;&lt;br/&gt; rate&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;Average&lt;br/&gt; rate&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Year-end&lt;/div&gt;&lt;br/&gt; rate&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;Average&lt;br/&gt; rate&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Euros per U.S.&amp;#160;Dollar&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.8149&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.8762&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.8902&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.8932&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.8738&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.8468&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory>
<ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory id="Factid_19489991" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.14&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Provisions &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Provisions are recognized when the Group has a present obligation (legal or constructive) as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation and a reliable estimate can be made of the amount of the obligation. Where the Group expects some or all of a provision to be reimbursed, for example under an insurance contract, the reimbursement is recognized as a separate asset but only when the reimbursement is virtually certain. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;If the effect of the time value of money is material, provisions are discounted using a current &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;pre-tax&lt;/div&gt; rate that reflects, when appropriate, the risks specific to the liability. &lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory>
<ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory id="Factid_19489992" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.15&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Income Tax &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred income tax results from temporary differences between the carrying amount of an asset or a liability and its tax base. Deferred income tax is provided in full using the liability method on temporary differences. In accordance with IAS 12 (&amp;#8220;Income Taxes&amp;#8221;), the deferred tax assets and liabilities reflect all temporary valuation and accounting differences between financial statements prepared for tax purposes and our consolidated financial statements. Tax losses carried forward are considered in deferred tax assets calculation. The Group offsets tax assets and liabilities if and only if it has a legally enforceable right to set off current tax assets, current tax liabilities, deferred tax assets and deferred tax liabilities which relate to income taxes levied by the same tax authority. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory>
<imtx:DisclosureOfDetailedInformationAboutForeignExchangeRatesExplanatoryTableTextBlock id="Factid_19489993" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;The Group used the following exchange rates to convert the financial statements of its U.S. subsidiary:&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:64%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Year-end&lt;/div&gt;&lt;br/&gt; rate&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;Average&lt;br/&gt; rate&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Year-end&lt;/div&gt;&lt;br/&gt; rate&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;Average&lt;br/&gt; rate&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Year-end&lt;/div&gt;&lt;br/&gt; rate&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;Average&lt;br/&gt; rate&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Euros per U.S.&amp;#160;Dollar&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.8149&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.8762&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.8902&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.8932&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.8738&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.8468&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DisclosureOfDetailedInformationAboutForeignExchangeRatesExplanatoryTableTextBlock>
<imtx:DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesExplanatoryTableTextBlock id="Factid_19489994" contextRef="P01_01_2020To12_31_2020">The estimated useful lives are generally within the following ranges:&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 79%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 8%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt; width: 79%;;vertical-align:bottom;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Category&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Estimated&amp;#160;useful&amp;#160;life&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 79%;;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Computer equipment&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:center;;vertical-align:bottom;"&gt;1&amp;#160;&amp;#8211;&amp;#160;10&amp;#160;years&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgba(255, 255, 255, 0); width: 79%;;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Laboratory equipment&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0); width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;text-align:center;;vertical-align:bottom;"&gt;1 &amp;#8211;&amp;#160;15&amp;#160;years&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 79%;;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Office equipment&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:center;;vertical-align:bottom;"&gt;2 &amp;#8211;&amp;#160;20&amp;#160;years&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesExplanatoryTableTextBlock>
<imtx:DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillExplanatoryTableTextBlock id="Factid_19489995" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Amortization is calculated on a straight-line basis over the estimated useful lives of the assets as follows: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;width:79%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:8%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Category&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Estimated&amp;#160;useful&amp;#160;life&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Licenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:center;;vertical-align:bottom;"&gt;5&amp;#160;&amp;#8211;&amp;#160;30&amp;#160;years&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Software&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;text-align:center;;vertical-align:bottom;"&gt;1 &amp;#8211; 5&amp;#160;years&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillExplanatoryTableTextBlock>
<ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory id="Factid_19489996" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; font-size: 8pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:65%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:13%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:13%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="break-inside: avoid; font-family: 'times new roman'; font-size: 8pt;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="break-inside: avoid; font-family: 'times new roman'; font-size: 8pt;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="break-inside: avoid; font-family: 'times new roman'; font-size: 10pt;"&gt;&lt;td style="background-color: rgb(204, 238, 255); font-size: 10pt;;vertical-align:top;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;times new roman&amp;quot;; line-height: normal;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Prepaid expenses&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;724&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;937&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="break-inside: avoid; font-family: 'times new roman'; font-size: 10pt;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;times new roman&amp;quot;; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-current&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;325&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="break-inside: avoid; font-family: 'times new roman'; font-size: 10pt;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;times new roman&amp;quot;; line-height: normal;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;div style="letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;non-current&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&amp;#160;&lt;/div&gt;assets&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;724&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,262&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory>
<ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment id="Factid_19489997" contextRef="P01_01_2020To12_31_2020_BottomOfRangeMemberifrsfullRangeAxis_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">P1Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
<ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment id="Factid_19489998" contextRef="P01_01_2020To12_31_2020_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis_TopOfRangeMemberifrsfullRangeAxis">P10Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
<ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment id="Factid_19489999" contextRef="P01_01_2020To12_31_2020_BottomOfRangeMemberifrsfullRangeAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">P1Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
<ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment id="Factid_19490000" contextRef="P01_01_2020To12_31_2020_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis_TopOfRangeMemberifrsfullRangeAxis">P15Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
<ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment id="Factid_19490001" contextRef="P01_01_2020To12_31_2020_BottomOfRangeMemberifrsfullRangeAxis_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">P2Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
<ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment id="Factid_19490002" contextRef="P01_01_2020To12_31_2020_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis_TopOfRangeMemberifrsfullRangeAxis">P20Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
<ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill id="Factid_19490003" contextRef="P01_01_2020To12_31_2020_BottomOfRangeMemberifrsfullRangeAxis_LicencesMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
<ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill id="Factid_19490004" contextRef="P01_01_2020To12_31_2020_LicencesMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_TopOfRangeMemberifrsfullRangeAxis">P30Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
<ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill id="Factid_19490005" contextRef="P01_01_2020To12_31_2020_BottomOfRangeMemberifrsfullRangeAxis_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis">P1Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
<ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill id="Factid_19490006" contextRef="P01_01_2020To12_31_2020_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_TopOfRangeMemberifrsfullRangeAxis">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
<ifrs-full:ClosingForeignExchangeRate id="Factid_19490007" contextRef="PAsOn12_31_2020" unitRef="Unit_pure" decimals="4">0.8149</ifrs-full:ClosingForeignExchangeRate>
<ifrs-full:AverageForeignExchangeRate id="Factid_19490008" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_pure" decimals="4">0.8762</ifrs-full:AverageForeignExchangeRate>
<ifrs-full:ClosingForeignExchangeRate id="Factid_19490009" contextRef="PAsOn12_31_2019" unitRef="Unit_pure" decimals="4">0.8902</ifrs-full:ClosingForeignExchangeRate>
<ifrs-full:AverageForeignExchangeRate id="Factid_19490010" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_pure" decimals="4">0.8932</ifrs-full:AverageForeignExchangeRate>
<ifrs-full:ClosingForeignExchangeRate id="Factid_19490011" contextRef="PAsOn12_31_2018" unitRef="Unit_pure" decimals="4">0.8738</ifrs-full:ClosingForeignExchangeRate>
<ifrs-full:AverageForeignExchangeRate id="Factid_19490012" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_pure" decimals="4">0.8468</ifrs-full:AverageForeignExchangeRate>
<imtx:RentalContractTerm id="Factid_19490014" contextRef="P01_01_2020To12_31_2020_TopOfRangeMemberifrsfullRangeAxis">seven</imtx:RentalContractTerm>
<ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory id="Factid_19490015" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;6.&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Significant accounting judgements, estimates and assumptions &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The preparation of the Group&amp;#8217;s consolidated financial statements requires management to make judgements, estimates and assumptions that affect the reported amounts of revenue, expenses, assets and liabilities, income taxes and the accompanying disclosures. Uncertainty about these assumptions and estimates could result in outcomes that require a material adjustment to the carrying amount of the asset or liability affected in future periods. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Estimates &amp;#8211; Taxes &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Uncertainties exist with respect to the interpretation of complex tax regulations, changes in tax laws, and the amount and timing of future taxable income. Given the wide range and complexity of existing contractual agreements, differences arising between the actual results and the assumptions made, or future changes to such assumptions, could necessitate future adjustments to tax income and expense already recorded. Deferred tax assets are recognized for unused tax losses to the extent, that it is probable that taxable profit will be available which can be utilized against the losses. Significant management judgement is required to determine the amount of deferred tax assets that can be recognized, based upon the likely timing and the level of future taxable profits together with future tax planning strategies. Due to the Group&amp;#8217;s history of loss-making over the last several years as well as the plans for the foreseeable future, the Group has not recognized any deferred tax assets on tax losses carried forward. Changes in the estimation of our potential to use tax losses carried forward can have a material effect on the Group`s net income. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 1px; margin-top: 18px; margin-bottom: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Revenue recognition from collaboration agreements &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;As the collaboration agreements comprise several promises, it must be assessed whether these promises are capable of being distinct within the context of the contract. For the four collaboration agreements the Group assessed that these promises are not capable of being distinct within the context of the contract, which results in accounting for all goods and services promised as a single performance obligation with a single measure of progress. The performance obligation is accounted for as a performance obligation, satisfied over time using a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;cost-to-cost&lt;/div&gt;&lt;/div&gt; method as the customer simultaneously receives and consumes the benefits from Immatics&amp;#8217; performance. &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Up-front&lt;/div&gt; licensing payments are initially deferred on our Consolidated Statement of Financial Position and subsequently recognized as revenue over time as costs are incurred. Milestone payments are generally included in the transaction price at the amount stipulated in the respective agreement and recognized as revenue to the extent that it is highly probable that a&amp;#160;significant reversal&amp;#160;in the amount of cumulative revenue recognized will not occur. To date, no milestone has been included in the transaction price. Changes in this estimate can have a material effect on revenue recognized. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Immatics provides development and manufacturing services to customers and recognizes revenue over time using an input-based method to measure progress toward complete satisfaction of the service, because the customer simultaneously receives and consumes the benefits provided. Forecast values are used for the calculation of expected future revenue for the remaining term of the contract. These costs estimated as part of the budgeting process must be reviewed and approved before the Group can use them for recognition purposes. Significant management judgment is &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;required to determine the level of effort required under an arrangement, and the period over which the Company expects to complete its performance obligations under the arrangement which includes total internal personnel costs and external costs to be incurred. Changes in these estimates can have a material effect on revenue recognized. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Share-based payments &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Determining the fair value of share-based payment transactions requires the most appropriate valuation for the specific program, which depends on the underlying terms and conditions. This estimate also requires the determination of the most appropriate inputs to the valuation model, including the fair value of the share option. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Management determined the value of share-based awards with the assistance of a third-party valuation specialist using certain assumptions, such as share price volatility, the determination of an appropriate risk-free interest rate, expected dividends and the probability of reaching certain exercisability criteria. Changes in these estimates can have a material effect on share-based expenses recognized. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;For 2018 and 2019, the vested SARs under the 2010 Plan could only be exercised in an event that more than 50% of the shareholdings in the Company will be acquired by a third person (&amp;#8220;Change of control&amp;#8221;) and the vested SARs of the 2016 Plan might only be exercised upon the occurrence of a change in control or expiration of the applicable &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;lock-up&lt;/div&gt; period following completion of an initial public offering (&amp;#8220;IPO&amp;#8221;). &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The fair values of these awards were discounted based on the probability of the awards becoming exercisable. It is necessary to look at different scenarios under which the award would be expected to be realized. Therefore, it was necessary to estimate the probability of each such scenario. The present value of the probability-weighted fair value under all scenarios represents the value of the awards. The difficulty in applying this method is the estimation of the different possible outcomes and the probabilities associated with such outcomes. Management&amp;#8217;s assessment is updated at each &lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;valuation date. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Classification of Warrants &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As described in Note 3 AYA Merger Immatics Warrants give the holder the right, but not the obligation, to subscribe to Immatics&amp;#8217; shares at a fixed or determinable price for a specified period of time subject to the provision of the Warrant Agreement. Those instruments were considered equity instruments according to IFRS 2 when they vested immediately on July 1, 2020. Management accounted for those instruments as equity instruments under IFRS 2 after the vesting date and has not applied the provisions of debt and equity classification under IAS 32.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory>
<imtx:CurrentGrantReceivable id="Factid_19490018" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">875000</imtx:CurrentGrantReceivable>
<imtx:CurrentGrantReceivable id="Factid_19490019" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">998000</imtx:CurrentGrantReceivable>
<ifrs-full:CurrentPrepaidExpenses id="Factid_19490020" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">2389000</ifrs-full:CurrentPrepaidExpenses>
<ifrs-full:CurrentPrepaidExpenses id="Factid_19490021" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">1236000</ifrs-full:CurrentPrepaidExpenses>
<imtx:PositiveMarketValueForwardContract id="Factid_19490022" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">914000</imtx:PositiveMarketValueForwardContract>
<ifrs-full:CurrentValueAddedTaxReceivables id="Factid_19490023" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">798000</ifrs-full:CurrentValueAddedTaxReceivables>
<ifrs-full:CurrentValueAddedTaxReceivables id="Factid_19490024" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">768000</ifrs-full:CurrentValueAddedTaxReceivables>
<imtx:CapitalizedTransactionCosts id="Factid_19490025" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">48000</imtx:CapitalizedTransactionCosts>
<ifrs-full:OtherAssets id="Factid_19490026" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">787000</ifrs-full:OtherAssets>
<ifrs-full:OtherAssets id="Factid_19490027" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">617000</ifrs-full:OtherAssets>
<ifrs-full:NoncurrentPrepayments id="Factid_19490030" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">724000</ifrs-full:NoncurrentPrepayments>
<ifrs-full:NoncurrentPrepayments id="Factid_19490031" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">937000</ifrs-full:NoncurrentPrepayments>
<imtx:OtherNonCurrentAsset id="Factid_19490032" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">325000</imtx:OtherNonCurrentAsset>
<imtx:CurrentPrepaidInsurance id="Factid_19490035" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-5">1000000</imtx:CurrentPrepaidInsurance>
<imtx:CurrentPrepaidInsurance id="Factid_19490036" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-5">100000</imtx:CurrentPrepaidInsurance>
<imtx:CurrentIncrementalCostForCollaborationAgreement id="Factid_19490037" contextRef="P01_01_2020To12_31_2020_CelgeneSwitzerlandLlcAndGenmabAsMemberIMTXCollaborationAgreementAxis" unitRef="Unit_EUR" decimals="-5">500000</imtx:CurrentIncrementalCostForCollaborationAgreement>
<imtx:CurrentIncrementalCostForCollaborationAgreement id="Factid_19490038" contextRef="P01_01_2019To12_31_2019_CelgeneSwitzerlandLlcAndGenmabAsMemberIMTXCollaborationAgreementAxis" unitRef="Unit_EUR" decimals="-5">600000</imtx:CurrentIncrementalCostForCollaborationAgreement>
<imtx:PrepaidExpensesOfLicensesAndSoftware id="Factid_19490039" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-5">600000</imtx:PrepaidExpensesOfLicensesAndSoftware>
<imtx:PrepaidExpensesOfLicensesAndSoftware id="Factid_19490040" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-5">200000</imtx:PrepaidExpensesOfLicensesAndSoftware>
<ifrs-full:OtherAssets id="Factid_19490041" contextRef="PAsOn12_31_2020_ReceivablesFromCapitalGainsTaxMemberIMTXBalanceSheetLocationAxis" unitRef="Unit_EUR" decimals="-5">400000</ifrs-full:OtherAssets>
<ifrs-full:OtherAssets id="Factid_19490042" contextRef="PAsOn12_31_2019_ReceivablesFromCapitalGainsTaxMemberIMTXBalanceSheetLocationAxis" unitRef="Unit_EUR" decimals="-5">300000</ifrs-full:OtherAssets>
<ifrs-full:NoncurrentPrepayments id="Factid_19490043" contextRef="PAsOn12_31_2020_CelgeneSwitzerlandLlcAndGenmabAsMemberIMTXCollaborationAgreementAxis" unitRef="Unit_EUR" decimals="-5">700000</ifrs-full:NoncurrentPrepayments>
<ifrs-full:NoncurrentPrepayments id="Factid_19490044" contextRef="PAsOn12_31_2019_CelgeneSwitzerlandLlcAndGenmabAsMemberIMTXCollaborationAgreementAxis" unitRef="Unit_EUR" decimals="-5">900000</ifrs-full:NoncurrentPrepayments>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490046" contextRef="PAsOn12_31_2018_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">11222000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490047" contextRef="PAsOn12_31_2018_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">2439000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490048" contextRef="PAsOn12_31_2018_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">1455000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490049" contextRef="PAsOn12_31_2018_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">15116000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490050" contextRef="PAsOn12_31_2018_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis_PreviouslyStatedMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">10781000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490051" contextRef="PAsOn12_31_2018_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_PreviouslyStatedMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">2439000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490052" contextRef="PAsOn12_31_2018_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis_PreviouslyStatedMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">1455000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490053" contextRef="PAsOn12_31_2018_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_PreviouslyStatedMemberifrsfullRetrospectiveApplicationAndRetrospectiveRestatementAxis" unitRef="Unit_EUR" decimals="-3">14675000</ifrs-full:PropertyPlantAndEquipment>
<imtx:AdditionsOtherPropertyPlantAndEquipment id="Factid_19490054" contextRef="P01_01_2019To12_31_2019_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">2204000</imtx:AdditionsOtherPropertyPlantAndEquipment>
<imtx:AdditionsOtherPropertyPlantAndEquipment id="Factid_19490055" contextRef="P01_01_2019To12_31_2019_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">515000</imtx:AdditionsOtherPropertyPlantAndEquipment>
<imtx:AdditionsOtherPropertyPlantAndEquipment id="Factid_19490056" contextRef="P01_01_2019To12_31_2019_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">297000</imtx:AdditionsOtherPropertyPlantAndEquipment>
<imtx:AdditionsOtherPropertyPlantAndEquipment id="Factid_19490057" contextRef="P01_01_2019To12_31_2019_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">3016000</imtx:AdditionsOtherPropertyPlantAndEquipment>
<imtx:DisposalsOfPropertyPlantAndEquipment id="Factid_19490058" contextRef="P01_01_2019To12_31_2019_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">314000</imtx:DisposalsOfPropertyPlantAndEquipment>
<imtx:DisposalsOfPropertyPlantAndEquipment id="Factid_19490059" contextRef="P01_01_2019To12_31_2019_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">2000</imtx:DisposalsOfPropertyPlantAndEquipment>
<imtx:DisposalsOfPropertyPlantAndEquipment id="Factid_19490060" contextRef="P01_01_2019To12_31_2019_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">316000</imtx:DisposalsOfPropertyPlantAndEquipment>
<imtx:CurrencyTranslationDifferences id="Factid_19490061" contextRef="P01_01_2019To12_31_2019_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">52000</imtx:CurrencyTranslationDifferences>
<imtx:CurrencyTranslationDifferences id="Factid_19490062" contextRef="P01_01_2019To12_31_2019_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">4000</imtx:CurrencyTranslationDifferences>
<imtx:CurrencyTranslationDifferences id="Factid_19490063" contextRef="P01_01_2019To12_31_2019_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">1000</imtx:CurrencyTranslationDifferences>
<imtx:CurrencyTranslationDifferences id="Factid_19490064" contextRef="P01_01_2019To12_31_2019_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">57000</imtx:CurrencyTranslationDifferences>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490069" contextRef="PAsOn12_31_2018_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">-8279000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490070" contextRef="PAsOn12_31_2018_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">-1793000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490071" contextRef="PAsOn12_31_2018_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">-1037000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490072" contextRef="PAsOn12_31_2018_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">-11109000</ifrs-full:PropertyPlantAndEquipment>
<imtx:AdditionsOtherPropertyPlantAndEquipment id="Factid_19490073" contextRef="P01_01_2019To12_31_2019_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">1219000</imtx:AdditionsOtherPropertyPlantAndEquipment>
<imtx:AdditionsOtherPropertyPlantAndEquipment id="Factid_19490074" contextRef="P01_01_2019To12_31_2019_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">256000</imtx:AdditionsOtherPropertyPlantAndEquipment>
<imtx:AdditionsOtherPropertyPlantAndEquipment id="Factid_19490075" contextRef="P01_01_2019To12_31_2019_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">322000</imtx:AdditionsOtherPropertyPlantAndEquipment>
<imtx:AdditionsOtherPropertyPlantAndEquipment id="Factid_19490076" contextRef="P01_01_2019To12_31_2019_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">1797000</imtx:AdditionsOtherPropertyPlantAndEquipment>
<imtx:DisposalsOfPropertyPlantAndEquipment id="Factid_19490077" contextRef="P01_01_2019To12_31_2019_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">218000</imtx:DisposalsOfPropertyPlantAndEquipment>
<imtx:DisposalsOfPropertyPlantAndEquipment id="Factid_19490078" contextRef="P01_01_2019To12_31_2019_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">1000</imtx:DisposalsOfPropertyPlantAndEquipment>
<imtx:DisposalsOfPropertyPlantAndEquipment id="Factid_19490079" contextRef="P01_01_2019To12_31_2019_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">219000</imtx:DisposalsOfPropertyPlantAndEquipment>
<imtx:CurrencyTranslationDifferences id="Factid_19490080" contextRef="P01_01_2019To12_31_2019_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">23000</imtx:CurrencyTranslationDifferences>
<imtx:CurrencyTranslationDifferences id="Factid_19490081" contextRef="P01_01_2019To12_31_2019_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">2000</imtx:CurrencyTranslationDifferences>
<imtx:CurrencyTranslationDifferences id="Factid_19490082" contextRef="P01_01_2019To12_31_2019_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">25000</imtx:CurrencyTranslationDifferences>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490087" contextRef="PAsOn12_31_2019_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">3420000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490088" contextRef="PAsOn12_31_2019_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">906000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490089" contextRef="PAsOn12_31_2019_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">394000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490091" contextRef="PAsOn12_31_2018_AdjustmentOnAdoptionIfrsSixteenMemberIMTXTypeOfAdoptionsAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">-441000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490092" contextRef="PAsOn12_31_2018_AdjustmentOnAdoptionIfrsSixteenMemberIMTXTypeOfAdoptionsAxis" unitRef="Unit_EUR" decimals="-3">-441000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490093" contextRef="PAsOn12_31_2019_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">12723000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490094" contextRef="PAsOn12_31_2019_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">2956000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490095" contextRef="PAsOn12_31_2019_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">1753000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490096" contextRef="PAsOn12_31_2019_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">17432000</ifrs-full:PropertyPlantAndEquipment>
<imtx:AdditionsOtherPropertyPlantAndEquipment id="Factid_19490097" contextRef="P01_01_2020To12_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">3545000</imtx:AdditionsOtherPropertyPlantAndEquipment>
<imtx:AdditionsOtherPropertyPlantAndEquipment id="Factid_19490098" contextRef="P01_01_2020To12_31_2020_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">406000</imtx:AdditionsOtherPropertyPlantAndEquipment>
<imtx:AdditionsOtherPropertyPlantAndEquipment id="Factid_19490099" contextRef="P01_01_2020To12_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">1427000</imtx:AdditionsOtherPropertyPlantAndEquipment>
<imtx:AdditionsOtherPropertyPlantAndEquipment id="Factid_19490100" contextRef="P01_01_2020To12_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">5379000</imtx:AdditionsOtherPropertyPlantAndEquipment>
<imtx:DisposalsOfPropertyPlantAndEquipment id="Factid_19490101" contextRef="P01_01_2020To12_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">-1000</imtx:DisposalsOfPropertyPlantAndEquipment>
<imtx:DisposalsOfPropertyPlantAndEquipment id="Factid_19490102" contextRef="P01_01_2020To12_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">-6000</imtx:DisposalsOfPropertyPlantAndEquipment>
<imtx:DisposalsOfPropertyPlantAndEquipment id="Factid_19490103" contextRef="P01_01_2020To12_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">-7000</imtx:DisposalsOfPropertyPlantAndEquipment>
<imtx:CurrencyTranslationDifferences id="Factid_19490104" contextRef="P01_01_2020To12_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">299000</imtx:CurrencyTranslationDifferences>
<imtx:CurrencyTranslationDifferences id="Factid_19490105" contextRef="P01_01_2020To12_31_2020_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">40000</imtx:CurrencyTranslationDifferences>
<imtx:CurrencyTranslationDifferences id="Factid_19490106" contextRef="P01_01_2020To12_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">28000</imtx:CurrencyTranslationDifferences>
<imtx:CurrencyTranslationDifferences id="Factid_19490107" contextRef="P01_01_2020To12_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">367000</imtx:CurrencyTranslationDifferences>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490108" contextRef="PAsOn12_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">15968000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490109" contextRef="PAsOn12_31_2020_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">3322000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490110" contextRef="PAsOn12_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">3146000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490111" contextRef="PAsOn12_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">22437000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490112" contextRef="PAsOn12_31_2019_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">-9303000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490113" contextRef="PAsOn12_31_2019_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">-2050000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490114" contextRef="PAsOn12_31_2019_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">-1359000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490115" contextRef="PAsOn12_31_2019_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">-12712000</ifrs-full:PropertyPlantAndEquipment>
<imtx:AdditionsOtherPropertyPlantAndEquipment id="Factid_19490116" contextRef="P01_01_2020To12_31_2020_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">1384000</imtx:AdditionsOtherPropertyPlantAndEquipment>
<imtx:AdditionsOtherPropertyPlantAndEquipment id="Factid_19490117" contextRef="P01_01_2020To12_31_2020_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">404000</imtx:AdditionsOtherPropertyPlantAndEquipment>
<imtx:AdditionsOtherPropertyPlantAndEquipment id="Factid_19490118" contextRef="P01_01_2020To12_31_2020_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">315000</imtx:AdditionsOtherPropertyPlantAndEquipment>
<imtx:AdditionsOtherPropertyPlantAndEquipment id="Factid_19490119" contextRef="P01_01_2020To12_31_2020_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">2102000</imtx:AdditionsOtherPropertyPlantAndEquipment>
<imtx:DisposalsOfPropertyPlantAndEquipment id="Factid_19490120" contextRef="P01_01_2020To12_31_2020_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">-1000</imtx:DisposalsOfPropertyPlantAndEquipment>
<imtx:DisposalsOfPropertyPlantAndEquipment id="Factid_19490121" contextRef="P01_01_2020To12_31_2020_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">-6000</imtx:DisposalsOfPropertyPlantAndEquipment>
<imtx:DisposalsOfPropertyPlantAndEquipment id="Factid_19490122" contextRef="P01_01_2020To12_31_2020_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">-7000</imtx:DisposalsOfPropertyPlantAndEquipment>
<imtx:CurrencyTranslationDifferences id="Factid_19490123" contextRef="P01_01_2020To12_31_2020_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">210000</imtx:CurrencyTranslationDifferences>
<imtx:CurrencyTranslationDifferences id="Factid_19490124" contextRef="P01_01_2020To12_31_2020_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">26000</imtx:CurrencyTranslationDifferences>
<imtx:CurrencyTranslationDifferences id="Factid_19490125" contextRef="P01_01_2020To12_31_2020_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">3000</imtx:CurrencyTranslationDifferences>
<imtx:CurrencyTranslationDifferences id="Factid_19490126" contextRef="P01_01_2020To12_31_2020_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">239000</imtx:CurrencyTranslationDifferences>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490127" contextRef="PAsOn12_31_2020_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">-10476000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490128" contextRef="PAsOn12_31_2020_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">-2428000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490129" contextRef="PAsOn12_31_2020_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">-1665000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490130" contextRef="PAsOn12_31_2020_AccumulatedDepreciationAndAmortisationMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">-14568000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490131" contextRef="PAsOn12_31_2020_LaboratoryEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">5493000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490132" contextRef="PAsOn12_31_2020_ComputerEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">894000</ifrs-full:PropertyPlantAndEquipment>
<ifrs-full:PropertyPlantAndEquipment id="Factid_19490133" contextRef="PAsOn12_31_2020_OfficeEquipmentMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-3">1481000</ifrs-full:PropertyPlantAndEquipment>
<imtx:DisclosureOfAmortizationExpensesTableTextBlock id="Factid_19490137" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Amortization expense is classified as follows within the Consolidated Statement of Loss: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:82%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&amp;#160;ended&amp;#160;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Research and development expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;31&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;28&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;9&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;General and administrative expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;95&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;83&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;109&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;126&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;111&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;118&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DisclosureOfAmortizationExpensesTableTextBlock>
<ifrs-full:IntangibleAssetsAndGoodwill id="Factid_19490138" contextRef="PAsOn12_31_2018_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_PatentAndLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis" unitRef="Unit_EUR" decimals="-3">1201000</ifrs-full:IntangibleAssetsAndGoodwill>
<ifrs-full:IntangibleAssetsAndGoodwill id="Factid_19490139" contextRef="PAsOn12_31_2018_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_SoftwareLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis" unitRef="Unit_EUR" decimals="-3">551000</ifrs-full:IntangibleAssetsAndGoodwill>
<ifrs-full:IntangibleAssetsAndGoodwill id="Factid_19490140" contextRef="PAsOn12_31_2018_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">1752000</ifrs-full:IntangibleAssetsAndGoodwill>
<ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill id="Factid_19490141" contextRef="P01_01_2019To12_31_2019_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_SoftwareLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis" unitRef="Unit_EUR" decimals="-3">91000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
<ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill id="Factid_19490142" contextRef="P01_01_2019To12_31_2019_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">91000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
<ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill id="Factid_19490143" contextRef="P01_01_2019To12_31_2019_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_PatentAndLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis" unitRef="Unit_EUR" decimals="-3">19000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
<ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill id="Factid_19490144" contextRef="P01_01_2019To12_31_2019_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_SoftwareLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis" unitRef="Unit_EUR" decimals="-3">1000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
<ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill id="Factid_19490145" contextRef="P01_01_2019To12_31_2019_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">20000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
<ifrs-full:IntangibleAssetsAndGoodwill id="Factid_19490149" contextRef="PAsOn12_31_2018_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_PatentAndLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis" unitRef="Unit_EUR" decimals="-3">-314000</ifrs-full:IntangibleAssetsAndGoodwill>
<ifrs-full:IntangibleAssetsAndGoodwill id="Factid_19490150" contextRef="PAsOn12_31_2018_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_SoftwareLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis" unitRef="Unit_EUR" decimals="-3">-399000</ifrs-full:IntangibleAssetsAndGoodwill>
<ifrs-full:IntangibleAssetsAndGoodwill id="Factid_19490151" contextRef="PAsOn12_31_2018_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">-713000</ifrs-full:IntangibleAssetsAndGoodwill>
<ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill id="Factid_19490152" contextRef="P01_01_2019To12_31_2019_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_PatentAndLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis" unitRef="Unit_EUR" decimals="-3">24000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
<ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill id="Factid_19490153" contextRef="P01_01_2019To12_31_2019_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_SoftwareLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis" unitRef="Unit_EUR" decimals="-3">87000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
<ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill id="Factid_19490154" contextRef="P01_01_2019To12_31_2019_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">111000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
<ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill id="Factid_19490155" contextRef="P01_01_2019To12_31_2019_PatentAndLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis" unitRef="Unit_EUR" decimals="-3">31000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
<ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill id="Factid_19490156" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">31000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
<ifrs-full:IntangibleAssetsAndGoodwill id="Factid_19490160" contextRef="PAsOn12_31_2019_PatentAndLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis" unitRef="Unit_EUR" decimals="-3">851000</ifrs-full:IntangibleAssetsAndGoodwill>
<ifrs-full:IntangibleAssetsAndGoodwill id="Factid_19490161" contextRef="PAsOn12_31_2019_SoftwareLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis" unitRef="Unit_EUR" decimals="-3">157000</ifrs-full:IntangibleAssetsAndGoodwill>
<ifrs-full:IntangibleAssetsAndGoodwill id="Factid_19490162" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">1008000</ifrs-full:IntangibleAssetsAndGoodwill>
<ifrs-full:IntangibleAssetsAndGoodwill id="Factid_19490163" contextRef="PAsOn12_31_2019_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_PatentAndLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis" unitRef="Unit_EUR" decimals="-3">1220000</ifrs-full:IntangibleAssetsAndGoodwill>
<ifrs-full:IntangibleAssetsAndGoodwill id="Factid_19490164" contextRef="PAsOn12_31_2019_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_SoftwareLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis" unitRef="Unit_EUR" decimals="-3">643000</ifrs-full:IntangibleAssetsAndGoodwill>
<ifrs-full:IntangibleAssetsAndGoodwill id="Factid_19490165" contextRef="PAsOn12_31_2019_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">1863000</ifrs-full:IntangibleAssetsAndGoodwill>
<ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill id="Factid_19490166" contextRef="P01_01_2020To12_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_SoftwareLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis" unitRef="Unit_EUR" decimals="-3">104000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
<ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill id="Factid_19490167" contextRef="P01_01_2020To12_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">104000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
<ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill id="Factid_19490168" contextRef="P01_01_2020To12_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_PatentAndLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis" unitRef="Unit_EUR" decimals="-3">-88000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
<ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill id="Factid_19490169" contextRef="P01_01_2020To12_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_SoftwareLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis" unitRef="Unit_EUR" decimals="-3">-9000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
<ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill id="Factid_19490170" contextRef="P01_01_2020To12_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">-97000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
<ifrs-full:IntangibleAssetsAndGoodwill id="Factid_19490171" contextRef="PAsOn12_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_PatentAndLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis" unitRef="Unit_EUR" decimals="-3">1132000</ifrs-full:IntangibleAssetsAndGoodwill>
<ifrs-full:IntangibleAssetsAndGoodwill id="Factid_19490172" contextRef="PAsOn12_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_SoftwareLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis" unitRef="Unit_EUR" decimals="-3">738000</ifrs-full:IntangibleAssetsAndGoodwill>
<ifrs-full:IntangibleAssetsAndGoodwill id="Factid_19490173" contextRef="PAsOn12_31_2020_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">1870000</ifrs-full:IntangibleAssetsAndGoodwill>
<ifrs-full:IntangibleAssetsAndGoodwill id="Factid_19490174" contextRef="PAsOn12_31_2019_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_PatentAndLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis" unitRef="Unit_EUR" decimals="-3">-369000</ifrs-full:IntangibleAssetsAndGoodwill>
<ifrs-full:IntangibleAssetsAndGoodwill id="Factid_19490175" contextRef="PAsOn12_31_2019_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_SoftwareLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis" unitRef="Unit_EUR" decimals="-3">-486000</ifrs-full:IntangibleAssetsAndGoodwill>
<ifrs-full:IntangibleAssetsAndGoodwill id="Factid_19490176" contextRef="PAsOn12_31_2019_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">-855000</ifrs-full:IntangibleAssetsAndGoodwill>
<ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill id="Factid_19490177" contextRef="P01_01_2020To12_31_2020_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_PatentAndLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis" unitRef="Unit_EUR" decimals="-3">56000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
<ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill id="Factid_19490178" contextRef="P01_01_2020To12_31_2020_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_SoftwareLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis" unitRef="Unit_EUR" decimals="-3">71000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
<ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill id="Factid_19490179" contextRef="P01_01_2020To12_31_2020_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">126000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
<ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill id="Factid_19490180" contextRef="P01_01_2020To12_31_2020_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_PatentAndLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis" unitRef="Unit_EUR" decimals="-3">-22000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
<ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill id="Factid_19490181" contextRef="P01_01_2020To12_31_2020_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_SoftwareLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis" unitRef="Unit_EUR" decimals="-3">-3000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
<ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill id="Factid_19490182" contextRef="P01_01_2020To12_31_2020_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">-25000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
<ifrs-full:IntangibleAssetsAndGoodwill id="Factid_19490183" contextRef="PAsOn12_31_2020_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_PatentAndLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis" unitRef="Unit_EUR" decimals="-3">-403000</ifrs-full:IntangibleAssetsAndGoodwill>
<ifrs-full:IntangibleAssetsAndGoodwill id="Factid_19490184" contextRef="PAsOn12_31_2020_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_SoftwareLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis" unitRef="Unit_EUR" decimals="-3">-554000</ifrs-full:IntangibleAssetsAndGoodwill>
<ifrs-full:IntangibleAssetsAndGoodwill id="Factid_19490185" contextRef="PAsOn12_31_2020_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-3">-956000</ifrs-full:IntangibleAssetsAndGoodwill>
<ifrs-full:IntangibleAssetsAndGoodwill id="Factid_19490186" contextRef="PAsOn12_31_2020_PatentAndLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis" unitRef="Unit_EUR" decimals="-3">730000</ifrs-full:IntangibleAssetsAndGoodwill>
<ifrs-full:IntangibleAssetsAndGoodwill id="Factid_19490187" contextRef="PAsOn12_31_2020_SoftwareLicensesMemberifrsfullClassesOfIntangibleAssetsAndGoodwillAxis" unitRef="Unit_EUR" decimals="-3">184000</ifrs-full:IntangibleAssetsAndGoodwill>
<ifrs-full:IntangibleAssetsAndGoodwill id="Factid_19490188" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">914000</ifrs-full:IntangibleAssetsAndGoodwill>
<ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill id="Factid_19490189" contextRef="P01_01_2020To12_31_2020_ResearchAndDevelopmentExpenseMemberIMTXIncomeStatementLocationAxis" unitRef="Unit_EUR" decimals="-3">31000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
<ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill id="Factid_19490190" contextRef="P01_01_2019To12_31_2019_ResearchAndDevelopmentExpenseMemberIMTXIncomeStatementLocationAxis" unitRef="Unit_EUR" decimals="-3">28000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
<ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill id="Factid_19490191" contextRef="P01_01_2018To12_31_2018_ResearchAndDevelopmentExpenseMemberIMTXIncomeStatementLocationAxis" unitRef="Unit_EUR" decimals="-3">9000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
<ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill id="Factid_19490192" contextRef="P01_01_2020To12_31_2020_GeneralAndAdministrativeExpenseMemberIMTXIncomeStatementLocationAxis" unitRef="Unit_EUR" decimals="-3">95000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
<ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill id="Factid_19490193" contextRef="P01_01_2019To12_31_2019_GeneralAndAdministrativeExpenseMemberIMTXIncomeStatementLocationAxis" unitRef="Unit_EUR" decimals="-3">83000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
<ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill id="Factid_19490194" contextRef="P01_01_2018To12_31_2018_GeneralAndAdministrativeExpenseMemberIMTXIncomeStatementLocationAxis" unitRef="Unit_EUR" decimals="-3">109000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
<ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill id="Factid_19490195" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">126000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
<ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill id="Factid_19490196" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">111000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
<ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill id="Factid_19490197" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">118000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
<ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory id="Factid_19490198" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;28.&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Events occurring after the reporting period &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company evaluated subsequent events for recognition or disclosure through March&amp;#160;30, 2021 and did not identify material subsequent events.&lt;/div&gt;&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory>
<imtx:DilutiveEffectOfShareOptionsOnNumberOfWarrants id="Factid_19490200" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_shares" decimals="0">7187500</imtx:DilutiveEffectOfShareOptionsOnNumberOfWarrants>
<ifrs-full:DisclosureOfLeasesExplanatory id="Factid_19490201" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11.&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Leases &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;  &lt;div style="font-family: times new roman;font-size: 10pt;margin-top: 12pt;margin-bottom: 0pt;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Right-of&lt;/div&gt; use assets consist of the following: &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:74%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:8%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:8%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt; 2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt; 2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Buildings&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;5,760&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2,799&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;IT and telecommunication&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;258&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;349&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Vehicles&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;90&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;90&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;41&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;49&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;6,149&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,287&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Lease liabilities consist of the following: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:74%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:8%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:8%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt; 2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt; 2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Lease liability &amp;#8211; current&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,881&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,411&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Lease liability &amp;#8211; &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-current&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;4,306&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,823&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;6,187&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,234&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;Additions to the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; assets were &amp;#8364;5.1&amp;#160;million and &amp;#8364;0.3&amp;#160;million as of December&amp;#160;31, 2020 and 2019, respectively. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;Currency translation differences included in &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; assets were &amp;#8364;0.3&amp;#160;million and &amp;#8364;0.05&amp;#160;million as of December&amp;#160;31, 2020 and 2019, respectively. &lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;Expenses related to &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; assets and lease liabilities consist of the following: &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:82%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&amp;#160;ended&amp;#160;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&lt;div style="text-decoration:underline;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Depreciation charges of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Buildings&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2,036&lt;/td&gt;&lt;td style="white-space: nowrap; font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,804&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;IT and telecommunication&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;101&lt;/td&gt;&lt;td style="white-space: nowrap; font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;101&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Vehicles&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;50&lt;/td&gt;&lt;td style="white-space: nowrap; font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;37&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;8&lt;/td&gt;&lt;td style="white-space: nowrap; font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;8&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,195&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,950&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1pt;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Interest expenses form leases&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;260&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;170&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Expense relating to short-term leases and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;low-value&lt;/div&gt; assets (included in administrative expenses)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;51&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;27&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The total cash payments for leases were &amp;#8364;2.4&amp;#160;million and &amp;#8364;2.1&amp;#160;million as of December&amp;#160;31, 2020 and 2019, respectively. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December&amp;#160;31, 2020, the Group has committed lease payments of &amp;#8364;6.9&amp;#160;million, of which &amp;#8364;2.1&amp;#160;million will occur in the next 12 months. The remaining lease payments will occur between January&amp;#160;1, 2022 and December&amp;#160;31, 202&lt;div style="display:inline;"&gt;6&lt;/div&gt;. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfLeasesExplanatory>
<ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory id="Factid_19490202" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman;font-size: 10pt;margin-top: 12pt;margin-bottom: 0pt;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Right-of&lt;/div&gt; use assets consist of the following: &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:74%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:8%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:8%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt; 2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt; 2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Buildings&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;5,760&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2,799&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;IT and telecommunication&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;258&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;349&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Vehicles&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;90&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;90&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;41&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;49&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;6,149&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,287&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory>
<imtx:DisclosureOfLeaseLiabilitiesTableTextBlock id="Factid_19490203" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Lease liabilities consist of the following: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:74%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:8%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:8%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt; 2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt; 2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Lease liability &amp;#8211; current&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,881&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,411&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Lease liability &amp;#8211; &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-current&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;4,306&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,823&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;6,187&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,234&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DisclosureOfLeaseLiabilitiesTableTextBlock>
<imtx:DisclosureOfExpensesRelatedToRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock id="Factid_19490204" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;Expenses related to &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; assets and lease liabilities consist of the following: &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:82%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&amp;#160;ended&amp;#160;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&lt;div style="text-decoration:underline;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Depreciation charges of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Buildings&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2,036&lt;/td&gt;&lt;td style="white-space: nowrap; font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,804&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;IT and telecommunication&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;101&lt;/td&gt;&lt;td style="white-space: nowrap; font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;101&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Vehicles&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;50&lt;/td&gt;&lt;td style="white-space: nowrap; font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;37&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;8&lt;/td&gt;&lt;td style="white-space: nowrap; font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;8&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,195&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,950&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1pt;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Interest expenses form leases&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;260&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;170&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Expense relating to short-term leases and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;low-value&lt;/div&gt; assets (included in administrative expenses)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;51&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;27&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DisclosureOfExpensesRelatedToRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock>
<ifrs-full:RightofuseAssets id="Factid_19490205" contextRef="PAsOn12_31_2020_BuildingsMemberifrsfullClassesOfAssetsAxis" unitRef="Unit_EUR" decimals="-3">5760000</ifrs-full:RightofuseAssets>
<ifrs-full:RightofuseAssets id="Factid_19490206" contextRef="PAsOn12_31_2019_BuildingsMemberifrsfullClassesOfAssetsAxis" unitRef="Unit_EUR" decimals="-3">2799000</ifrs-full:RightofuseAssets>
<ifrs-full:RightofuseAssets id="Factid_19490207" contextRef="PAsOn12_31_2020_CommunicationAndNetworkEquipmentMemberifrsfullClassesOfAssetsAxis" unitRef="Unit_EUR" decimals="-3">258000</ifrs-full:RightofuseAssets>
<ifrs-full:RightofuseAssets id="Factid_19490208" contextRef="PAsOn12_31_2019_CommunicationAndNetworkEquipmentMemberifrsfullClassesOfAssetsAxis" unitRef="Unit_EUR" decimals="-3">349000</ifrs-full:RightofuseAssets>
<ifrs-full:RightofuseAssets id="Factid_19490209" contextRef="PAsOn12_31_2020_VehiclesMemberifrsfullClassesOfAssetsAxis" unitRef="Unit_EUR" decimals="-3">90000</ifrs-full:RightofuseAssets>
<ifrs-full:RightofuseAssets id="Factid_19490210" contextRef="PAsOn12_31_2019_VehiclesMemberifrsfullClassesOfAssetsAxis" unitRef="Unit_EUR" decimals="-3">90000</ifrs-full:RightofuseAssets>
<ifrs-full:RightofuseAssets id="Factid_19490211" contextRef="PAsOn12_31_2020_OtherAssetsMemberifrsfullClassesOfAssetsAxis" unitRef="Unit_EUR" decimals="-3">41000</ifrs-full:RightofuseAssets>
<ifrs-full:RightofuseAssets id="Factid_19490212" contextRef="PAsOn12_31_2019_OtherAssetsMemberifrsfullClassesOfAssetsAxis" unitRef="Unit_EUR" decimals="-3">49000</ifrs-full:RightofuseAssets>
<ifrs-full:LeaseLiabilities id="Factid_19490219" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">6187000</ifrs-full:LeaseLiabilities>
<ifrs-full:LeaseLiabilities id="Factid_19490220" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">3234000</ifrs-full:LeaseLiabilities>
<imtx:DisclosureOfCompensationOfKeyManagementPersonnelTableTextBlock id="Factid_19490222" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Compensation of key management personnel: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 100%;;margin : 0px auto;;text-align:left;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 78%;"&gt;&lt;/td&gt;&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year ended December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 78%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Fixed&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2,660&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,202&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,088&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 78%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Variable&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;886&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;521&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;433&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 78%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Share-based compensation expense&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;13,841&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;697&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;119&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 78%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 78%;;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total key management compensation&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;17,387&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,420&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,640&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 78%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DisclosureOfCompensationOfKeyManagementPersonnelTableTextBlock>
<imtx:DisclosureOfCompensationManagingDirectorsAndSupervisoryBoardTextBlock id="Factid_19490224" contextRef="P01_01_2020To12_31_2020">The following options were granted to Immatics&amp;#8217; Managing Director&amp;#160;and Supervisory Directors:&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;width:35%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;width:20%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;width:15%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Type of options&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Grant date&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number of&lt;br/&gt; Options&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Strike&lt;br/&gt; Price&amp;#160;in&lt;br/&gt; USD&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Expiration date&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Managing Director&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Harpreet Singh&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;Performance-based&amp;#160;options&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2020&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;1,598,000&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;10&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2030&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Harpreet Singh&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;Service options&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2020&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;168,000&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2030&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Harpreet Singh&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;Matching Stock options&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2020&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;264,624&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;10&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2030&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Harpreet Singh&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;Converted options&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2020&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;30,939&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.06&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;July&amp;#160;1, 2027&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Harpreet Singh&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;Converted options&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2020&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;145,371&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;1.17&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;January&amp;#160;1, 2028&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Harpreet Singh&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;Service options&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;December&amp;#160;17,&amp;#160;2020&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;168,000&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;9.70&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;December&amp;#160;17,&amp;#160;2030&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Supervisory Directors&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Peter Chambr&amp;#233;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;Service options&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2020&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;25,000&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2030&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Peter Chambr&amp;#233;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;Matching Stock options&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2020&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;211,974&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;10&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2030&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Adam Stone&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;Service options&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2020&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;25,000&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2030&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Christoph Hettich&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;Service options&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2020&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;25,000&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;10&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2030&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Heather L. Mason&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;Service options&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2020&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;25,000&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2030&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Michael G. Atieh&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;Service options&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2020&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;25,000&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;10&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2030&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Paul Carter&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;Service options&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2020&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;25,000&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2030&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Eliot Forster&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;Service options&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;September&amp;#160;14,&amp;#160;2020&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;25,000&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;9.16&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;September&amp;#160;13,&amp;#160;2030&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DisclosureOfCompensationManagingDirectorsAndSupervisoryBoardTextBlock>
<ifrs-full:DepreciationRightofuseAssets id="Factid_19490225" contextRef="P01_01_2020To12_31_2020_BuildingsMemberifrsfullClassesOfAssetsAxis" unitRef="Unit_EUR" decimals="-3">2036000</ifrs-full:DepreciationRightofuseAssets>
<ifrs-full:DepreciationRightofuseAssets id="Factid_19490226" contextRef="P01_01_2019To12_31_2019_BuildingsMemberifrsfullClassesOfAssetsAxis" unitRef="Unit_EUR" decimals="-3">1804000</ifrs-full:DepreciationRightofuseAssets>
<ifrs-full:DepreciationRightofuseAssets id="Factid_19490227" contextRef="P01_01_2020To12_31_2020_CommunicationAndNetworkEquipmentMemberifrsfullClassesOfAssetsAxis" unitRef="Unit_EUR" decimals="-3">101000</ifrs-full:DepreciationRightofuseAssets>
<ifrs-full:DepreciationRightofuseAssets id="Factid_19490228" contextRef="P01_01_2019To12_31_2019_CommunicationAndNetworkEquipmentMemberifrsfullClassesOfAssetsAxis" unitRef="Unit_EUR" decimals="-3">101000</ifrs-full:DepreciationRightofuseAssets>
<ifrs-full:DepreciationRightofuseAssets id="Factid_19490229" contextRef="P01_01_2020To12_31_2020_VehiclesMemberifrsfullClassesOfAssetsAxis" unitRef="Unit_EUR" decimals="-3">50000</ifrs-full:DepreciationRightofuseAssets>
<ifrs-full:DepreciationRightofuseAssets id="Factid_19490230" contextRef="P01_01_2019To12_31_2019_VehiclesMemberifrsfullClassesOfAssetsAxis" unitRef="Unit_EUR" decimals="-3">37000</ifrs-full:DepreciationRightofuseAssets>
<ifrs-full:DepreciationRightofuseAssets id="Factid_19490231" contextRef="P01_01_2020To12_31_2020_OtherAssetsMemberifrsfullClassesOfAssetsAxis" unitRef="Unit_EUR" decimals="-3">8000</ifrs-full:DepreciationRightofuseAssets>
<ifrs-full:DepreciationRightofuseAssets id="Factid_19490232" contextRef="P01_01_2019To12_31_2019_OtherAssetsMemberifrsfullClassesOfAssetsAxis" unitRef="Unit_EUR" decimals="-3">8000</ifrs-full:DepreciationRightofuseAssets>
<ifrs-full:DepreciationRightofuseAssets id="Factid_19490233" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">2195000</ifrs-full:DepreciationRightofuseAssets>
<ifrs-full:DepreciationRightofuseAssets id="Factid_19490234" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">1950000</ifrs-full:DepreciationRightofuseAssets>
<imtx:InterestExpenseOnLease id="Factid_19490235" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">260000</imtx:InterestExpenseOnLease>
<imtx:InterestExpenseOnLease id="Factid_19490236" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">170000</imtx:InterestExpenseOnLease>
<ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed id="Factid_19490237" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">51000</ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed>
<ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed id="Factid_19490238" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">27000</ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed>
<imtx:KeyManagementPersonnelCompensationFixed id="Factid_19490239" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">2660000</imtx:KeyManagementPersonnelCompensationFixed>
<imtx:KeyManagementPersonnelCompensationFixed id="Factid_19490240" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">1202000</imtx:KeyManagementPersonnelCompensationFixed>
<imtx:KeyManagementPersonnelCompensationFixed id="Factid_19490241" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">1088000</imtx:KeyManagementPersonnelCompensationFixed>
<ifrs-full:KeyManagementPersonnelCompensationOtherLongtermBenefits id="Factid_19490242" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">886000</ifrs-full:KeyManagementPersonnelCompensationOtherLongtermBenefits>
<ifrs-full:KeyManagementPersonnelCompensationOtherLongtermBenefits id="Factid_19490243" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">521000</ifrs-full:KeyManagementPersonnelCompensationOtherLongtermBenefits>
<ifrs-full:KeyManagementPersonnelCompensationOtherLongtermBenefits id="Factid_19490244" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">433000</ifrs-full:KeyManagementPersonnelCompensationOtherLongtermBenefits>
<ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment id="Factid_19490245" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">13841000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
<ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment id="Factid_19490246" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">697000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
<ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment id="Factid_19490247" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">119000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
<ifrs-full:KeyManagementPersonnelCompensation id="Factid_19490248" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">17387000</ifrs-full:KeyManagementPersonnelCompensation>
<ifrs-full:KeyManagementPersonnelCompensation id="Factid_19490249" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">2420000</ifrs-full:KeyManagementPersonnelCompensation>
<ifrs-full:KeyManagementPersonnelCompensation id="Factid_19490250" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">1640000</ifrs-full:KeyManagementPersonnelCompensation>
<ifrs-full:AdditionsToRightofuseAssets id="Factid_19490251" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-5">5100000</ifrs-full:AdditionsToRightofuseAssets>
<ifrs-full:AdditionsToRightofuseAssets id="Factid_19490252" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-5">300000</ifrs-full:AdditionsToRightofuseAssets>
<imtx:TranslationDifferenceOnRightOfUseAsset id="Factid_19490253" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-5">300000</imtx:TranslationDifferenceOnRightOfUseAsset>
<imtx:TranslationDifferenceOnRightOfUseAsset id="Factid_19490254" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-4">50000</imtx:TranslationDifferenceOnRightOfUseAsset>
<ifrs-full:CashOutflowForLeases id="Factid_19490255" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-5">2400000</ifrs-full:CashOutflowForLeases>
<ifrs-full:CashOutflowForLeases id="Factid_19490256" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-5">2100000</ifrs-full:CashOutflowForLeases>
<ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities id="Factid_19490257" contextRef="P01_01_2020To12_31_2020_LaterThanFourYearsAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-5">6900000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
<ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities id="Factid_19490258" contextRef="P01_01_2020To12_31_2020_LaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-5">2100000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
<imtx:KeyManagementPersonnelCompensationSupervisoryBoardCompensation id="Factid_19490259" contextRef="P01_01_2020To12_31_2020_PeterChambreMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">140000</imtx:KeyManagementPersonnelCompensationSupervisoryBoardCompensation>
<imtx:KeyManagementPersonnelCompensationSupervisoryBoardCompensation id="Factid_19490260" contextRef="P01_01_2020To12_31_2020_HaraldFstockMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">16000</imtx:KeyManagementPersonnelCompensationSupervisoryBoardCompensation>
<imtx:KeyManagementPersonnelCompensationSupervisoryBoardCompensation id="Factid_19490261" contextRef="P01_01_2020To12_31_2020_MichaelGAtiehMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">28000</imtx:KeyManagementPersonnelCompensationSupervisoryBoardCompensation>
<imtx:KeyManagementPersonnelCompensationSupervisoryBoardCompensation id="Factid_19490262" contextRef="P01_01_2020To12_31_2020_PaulCarterMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">26000</imtx:KeyManagementPersonnelCompensationSupervisoryBoardCompensation>
<imtx:KeyManagementPersonnelCompensationSupervisoryBoardCompensation id="Factid_19490263" contextRef="P01_01_2020To12_31_2020_HeatherLMasonMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">20000</imtx:KeyManagementPersonnelCompensationSupervisoryBoardCompensation>
<imtx:KeyManagementPersonnelCompensationSupervisoryBoardCompensation id="Factid_19490264" contextRef="P01_01_2020To12_31_2020_AdamStoneMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">20000</imtx:KeyManagementPersonnelCompensationSupervisoryBoardCompensation>
<imtx:KeyManagementPersonnelCompensationSupervisoryBoardCompensation id="Factid_19490265" contextRef="P01_01_2020To12_31_2020_ChristophHettichMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">20000</imtx:KeyManagementPersonnelCompensationSupervisoryBoardCompensation>
<imtx:KeyManagementPersonnelCompensationSupervisoryBoardCompensation id="Factid_19490266" contextRef="P01_01_2020To12_31_2020_EliotForsterMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">12000</imtx:KeyManagementPersonnelCompensationSupervisoryBoardCompensation>
<imtx:KeyManagementPersonnelCompensationSupervisoryBoardCompensation id="Factid_19490267" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">282000</imtx:KeyManagementPersonnelCompensationSupervisoryBoardCompensation>
<imtx:KeyManagementPersonnelCompensationTravellingExpenses id="Factid_19490268" contextRef="P01_01_2020To12_31_2020_PeterChambreMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">4000</imtx:KeyManagementPersonnelCompensationTravellingExpenses>
<imtx:KeyManagementPersonnelCompensationTravellingExpenses id="Factid_19490276" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">4000</imtx:KeyManagementPersonnelCompensationTravellingExpenses>
<imtx:KeyManagementPersonnelCompensationShareBasedCompensationExpense id="Factid_19490277" contextRef="P01_01_2020To12_31_2020_PeterChambreMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">1046000</imtx:KeyManagementPersonnelCompensationShareBasedCompensationExpense>
<imtx:KeyManagementPersonnelCompensationShareBasedCompensationExpense id="Factid_19490285" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">1436000</imtx:KeyManagementPersonnelCompensationShareBasedCompensationExpense>
<imtx:KeyManagementPersonnelCompensations id="Factid_19490286" contextRef="P01_01_2020To12_31_2020_PeterChambreMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">3584000</imtx:KeyManagementPersonnelCompensations>
<imtx:KeyManagementPersonnelCompensations id="Factid_19490287" contextRef="P01_01_2020To12_31_2020_HaraldFstockMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">16000</imtx:KeyManagementPersonnelCompensations>
<imtx:KeyManagementPersonnelCompensations id="Factid_19490288" contextRef="P01_01_2020To12_31_2020_MichaelGAtiehMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">98000</imtx:KeyManagementPersonnelCompensations>
<imtx:KeyManagementPersonnelCompensations id="Factid_19490289" contextRef="P01_01_2020To12_31_2020_PaulCarterMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">96000</imtx:KeyManagementPersonnelCompensations>
<imtx:KeyManagementPersonnelCompensations id="Factid_19490290" contextRef="P01_01_2020To12_31_2020_HeatherLMasonMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">90000</imtx:KeyManagementPersonnelCompensations>
<imtx:KeyManagementPersonnelCompensations id="Factid_19490291" contextRef="P01_01_2020To12_31_2020_AdamStoneMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">90000</imtx:KeyManagementPersonnelCompensations>
<imtx:KeyManagementPersonnelCompensations id="Factid_19490292" contextRef="P01_01_2020To12_31_2020_ChristophHettichMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">90000</imtx:KeyManagementPersonnelCompensations>
<imtx:KeyManagementPersonnelCompensations id="Factid_19490293" contextRef="P01_01_2020To12_31_2020_EliotForsterMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">52000</imtx:KeyManagementPersonnelCompensations>
<imtx:KeyManagementPersonnelCompensations id="Factid_19490294" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">4116000</imtx:KeyManagementPersonnelCompensations>
<imtx:KeyManagementPersonnelCompensationSupervisoryBoardCompensation id="Factid_19490295" contextRef="P01_01_2019To12_31_2019_PeterChambreMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">300000</imtx:KeyManagementPersonnelCompensationSupervisoryBoardCompensation>
<imtx:KeyManagementPersonnelCompensationSupervisoryBoardCompensation id="Factid_19490296" contextRef="P01_01_2019To12_31_2019_HaraldFstockMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">9000</imtx:KeyManagementPersonnelCompensationSupervisoryBoardCompensation>
<imtx:KeyManagementPersonnelCompensationSupervisoryBoardCompensation id="Factid_19490297" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">309000</imtx:KeyManagementPersonnelCompensationSupervisoryBoardCompensation>
<imtx:KeyManagementPersonnelCompensationTravellingExpenses id="Factid_19490298" contextRef="P01_01_2019To12_31_2019_PeterChambreMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">87000</imtx:KeyManagementPersonnelCompensationTravellingExpenses>
<imtx:KeyManagementPersonnelCompensationTravellingExpenses id="Factid_19490299" contextRef="P01_01_2019To12_31_2019_HaraldFstockMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">20000</imtx:KeyManagementPersonnelCompensationTravellingExpenses>
<imtx:KeyManagementPersonnelCompensationTravellingExpenses id="Factid_19490300" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">107000</imtx:KeyManagementPersonnelCompensationTravellingExpenses>
<imtx:KeyManagementPersonnelCompensations id="Factid_19490301" contextRef="P01_01_2019To12_31_2019_PeterChambreMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">387000</imtx:KeyManagementPersonnelCompensations>
<imtx:KeyManagementPersonnelCompensations id="Factid_19490302" contextRef="P01_01_2019To12_31_2019_HaraldFstockMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">29000</imtx:KeyManagementPersonnelCompensations>
<imtx:KeyManagementPersonnelCompensations id="Factid_19490303" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">416000</imtx:KeyManagementPersonnelCompensations>
<imtx:KeyManagementPersonnelCompensationSupervisoryBoardCompensation id="Factid_19490304" contextRef="P01_01_2018To12_31_2018_PeterChambreMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">400000</imtx:KeyManagementPersonnelCompensationSupervisoryBoardCompensation>
<imtx:KeyManagementPersonnelCompensationSupervisoryBoardCompensation id="Factid_19490305" contextRef="P01_01_2018To12_31_2018_HaraldFstockMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">10000</imtx:KeyManagementPersonnelCompensationSupervisoryBoardCompensation>
<imtx:KeyManagementPersonnelCompensationSupervisoryBoardCompensation id="Factid_19490306" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">410000</imtx:KeyManagementPersonnelCompensationSupervisoryBoardCompensation>
<imtx:KeyManagementPersonnelCompensationTravellingExpenses id="Factid_19490307" contextRef="P01_01_2018To12_31_2018_PeterChambreMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">52000</imtx:KeyManagementPersonnelCompensationTravellingExpenses>
<imtx:KeyManagementPersonnelCompensationTravellingExpenses id="Factid_19490308" contextRef="P01_01_2018To12_31_2018_HaraldFstockMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">16000</imtx:KeyManagementPersonnelCompensationTravellingExpenses>
<imtx:KeyManagementPersonnelCompensationTravellingExpenses id="Factid_19490309" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">68000</imtx:KeyManagementPersonnelCompensationTravellingExpenses>
<imtx:KeyManagementPersonnelCompensations id="Factid_19490310" contextRef="P01_01_2018To12_31_2018_PeterChambreMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">452000</imtx:KeyManagementPersonnelCompensations>
<imtx:KeyManagementPersonnelCompensations id="Factid_19490311" contextRef="P01_01_2018To12_31_2018_HaraldFstockMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">26000</imtx:KeyManagementPersonnelCompensations>
<imtx:KeyManagementPersonnelCompensations id="Factid_19490312" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">478000</imtx:KeyManagementPersonnelCompensations>
<ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement id="Factid_19490313" contextRef="P01_01_2020To12_31_2020_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis_PerformanceBasedOptionsMemberIMTXTypeOfVestingAxis" unitRef="Unit_shares" decimals="0">1598000</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
<ifrs-full:ExercisePriceShareOptionsGranted2019 id="Factid_19490314" contextRef="P01_01_2020To12_31_2020_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis_PerformanceBasedOptionsMemberIMTXTypeOfVestingAxis" unitRef="Unit_USD_per_Share" decimals="0">10</ifrs-full:ExercisePriceShareOptionsGranted2019>
<ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement id="Factid_19490315" contextRef="P01_01_2020To12_31_2020_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis" unitRef="Unit_shares" decimals="0">168000</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
<ifrs-full:ExercisePriceShareOptionsGranted2019 id="Factid_19490316" contextRef="P01_01_2020To12_31_2020_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis" unitRef="Unit_USD_per_Share" decimals="0">10</ifrs-full:ExercisePriceShareOptionsGranted2019>
<ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement id="Factid_19490317" contextRef="P01_01_2020To12_31_2020_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis_MatchingStockOptionsMemberIMTXTypeOfVestingAxis" unitRef="Unit_shares" decimals="0">264624</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
<ifrs-full:ExercisePriceShareOptionsGranted2019 id="Factid_19490318" contextRef="P01_01_2020To12_31_2020_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis_MatchingStockOptionsMemberIMTXTypeOfVestingAxis" unitRef="Unit_USD_per_Share" decimals="0">10</ifrs-full:ExercisePriceShareOptionsGranted2019>
<ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement id="Factid_19490319" contextRef="P01_01_2020To12_31_2020_ConvertedOptionsMemberIMTXTypeOfVestingAxis_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_shares" decimals="0">30939</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
<ifrs-full:ExercisePriceShareOptionsGranted2019 id="Factid_19490320" contextRef="P01_01_2020To12_31_2020_ConvertedOptionsMemberIMTXTypeOfVestingAxis_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_USD_per_Share" decimals="2">1.06</ifrs-full:ExercisePriceShareOptionsGranted2019>
<ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement id="Factid_19490321" contextRef="P01_01_2020To12_31_2020_ConvertedOptionsOneMemberIMTXTypeOfVestingAxis_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_shares" decimals="0">145371</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
<ifrs-full:ExercisePriceShareOptionsGranted2019 id="Factid_19490322" contextRef="P01_01_2020To12_31_2020_ConvertedOptionsOneMemberIMTXTypeOfVestingAxis_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_USD_per_Share" decimals="2">1.17</ifrs-full:ExercisePriceShareOptionsGranted2019>
<ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement id="Factid_19490323" contextRef="P01_01_2020To12_31_2020_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsOneMemberIMTXTypeOfVestingAxis" unitRef="Unit_shares" decimals="0">168000</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
<ifrs-full:ExercisePriceShareOptionsGranted2019 id="Factid_19490324" contextRef="P01_01_2020To12_31_2020_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsOneMemberIMTXTypeOfVestingAxis" unitRef="Unit_USD_per_Share" decimals="2">9.70</ifrs-full:ExercisePriceShareOptionsGranted2019>
<ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement id="Factid_19490326" contextRef="P01_01_2020To12_31_2020_PeterChambreMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis" unitRef="Unit_shares" decimals="0">25000</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
<ifrs-full:ExercisePriceShareOptionsGranted2019 id="Factid_19490327" contextRef="P01_01_2020To12_31_2020_PeterChambreMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis" unitRef="Unit_USD_per_Share" decimals="0">10</ifrs-full:ExercisePriceShareOptionsGranted2019>
<ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement id="Factid_19490328" contextRef="P01_01_2020To12_31_2020_MatchingStockOptionsMemberIMTXTypeOfVestingAxis_PeterChambreMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_shares" decimals="0">211974</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
<ifrs-full:ExercisePriceShareOptionsGranted2019 id="Factid_19490329" contextRef="P01_01_2020To12_31_2020_MatchingStockOptionsMemberIMTXTypeOfVestingAxis_PeterChambreMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_USD_per_Share" decimals="0">10</ifrs-full:ExercisePriceShareOptionsGranted2019>
<ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement id="Factid_19490330" contextRef="P01_01_2020To12_31_2020_AdamStoneMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis" unitRef="Unit_shares" decimals="0">25000</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
<ifrs-full:ExercisePriceShareOptionsGranted2019 id="Factid_19490331" contextRef="P01_01_2020To12_31_2020_AdamStoneMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis" unitRef="Unit_USD_per_Share" decimals="0">10</ifrs-full:ExercisePriceShareOptionsGranted2019>
<ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement id="Factid_19490332" contextRef="P01_01_2020To12_31_2020_ChristophHettichMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis" unitRef="Unit_shares" decimals="0">25000</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
<ifrs-full:ExercisePriceShareOptionsGranted2019 id="Factid_19490333" contextRef="P01_01_2020To12_31_2020_ChristophHettichMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis" unitRef="Unit_USD_per_Share" decimals="0">10</ifrs-full:ExercisePriceShareOptionsGranted2019>
<ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement id="Factid_19490334" contextRef="P01_01_2020To12_31_2020_HeatherLMasonMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis" unitRef="Unit_shares" decimals="0">25000</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
<ifrs-full:ExercisePriceShareOptionsGranted2019 id="Factid_19490335" contextRef="P01_01_2020To12_31_2020_HeatherLMasonMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis" unitRef="Unit_USD_per_Share" decimals="0">10</ifrs-full:ExercisePriceShareOptionsGranted2019>
<ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement id="Factid_19490336" contextRef="P01_01_2020To12_31_2020_MichaelGAtiehMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis" unitRef="Unit_shares" decimals="0">25000</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
<ifrs-full:ExercisePriceShareOptionsGranted2019 id="Factid_19490337" contextRef="P01_01_2020To12_31_2020_MichaelGAtiehMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis" unitRef="Unit_USD_per_Share" decimals="0">10</ifrs-full:ExercisePriceShareOptionsGranted2019>
<ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement id="Factid_19490338" contextRef="P01_01_2020To12_31_2020_PaulCarterMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis" unitRef="Unit_shares" decimals="0">25000</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
<ifrs-full:ExercisePriceShareOptionsGranted2019 id="Factid_19490339" contextRef="P01_01_2020To12_31_2020_PaulCarterMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis" unitRef="Unit_USD_per_Share" decimals="0">10</ifrs-full:ExercisePriceShareOptionsGranted2019>
<ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement id="Factid_19490340" contextRef="P01_01_2020To12_31_2020_EliotForsterMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis" unitRef="Unit_shares" decimals="0">25000</ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement>
<ifrs-full:ExercisePriceShareOptionsGranted2019 id="Factid_19490341" contextRef="P01_01_2020To12_31_2020_EliotForsterMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis" unitRef="Unit_USD_per_Share" decimals="2">9.16</ifrs-full:ExercisePriceShareOptionsGranted2019>
<ifrs-full:DateOfGrantOfSharebasedPaymentArrangement id="Factid_19490342" contextRef="P01_01_2020To12_31_2020_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis_PerformanceBasedOptionsMemberIMTXTypeOfVestingAxis">June 30, 2020</ifrs-full:DateOfGrantOfSharebasedPaymentArrangement>
<ifrs-full:DateOfGrantOfSharebasedPaymentArrangement id="Factid_19490343" contextRef="P01_01_2020To12_31_2020_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">June 30, 2020</ifrs-full:DateOfGrantOfSharebasedPaymentArrangement>
<ifrs-full:DateOfGrantOfSharebasedPaymentArrangement id="Factid_19490344" contextRef="P01_01_2020To12_31_2020_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis_MatchingStockOptionsMemberIMTXTypeOfVestingAxis">June 30, 2020</ifrs-full:DateOfGrantOfSharebasedPaymentArrangement>
<ifrs-full:DateOfGrantOfSharebasedPaymentArrangement id="Factid_19490345" contextRef="P01_01_2020To12_31_2020_ConvertedOptionsMemberIMTXTypeOfVestingAxis_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis">June 30, 2020</ifrs-full:DateOfGrantOfSharebasedPaymentArrangement>
<ifrs-full:DateOfGrantOfSharebasedPaymentArrangement id="Factid_19490346" contextRef="P01_01_2020To12_31_2020_ConvertedOptionsOneMemberIMTXTypeOfVestingAxis_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis">June 30, 2020</ifrs-full:DateOfGrantOfSharebasedPaymentArrangement>
<ifrs-full:DateOfGrantOfSharebasedPaymentArrangement id="Factid_19490347" contextRef="P01_01_2020To12_31_2020_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsOneMemberIMTXTypeOfVestingAxis">December 17, 2020</ifrs-full:DateOfGrantOfSharebasedPaymentArrangement>
<ifrs-full:DateOfGrantOfSharebasedPaymentArrangement id="Factid_19490348" contextRef="P01_01_2020To12_31_2020_PeterChambreMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">June 30, 2020</ifrs-full:DateOfGrantOfSharebasedPaymentArrangement>
<ifrs-full:DateOfGrantOfSharebasedPaymentArrangement id="Factid_19490349" contextRef="P01_01_2020To12_31_2020_MatchingStockOptionsMemberIMTXTypeOfVestingAxis_PeterChambreMemberifrsfullCategoriesOfRelatedPartiesAxis">June 30, 2020</ifrs-full:DateOfGrantOfSharebasedPaymentArrangement>
<ifrs-full:DateOfGrantOfSharebasedPaymentArrangement id="Factid_19490350" contextRef="P01_01_2020To12_31_2020_AdamStoneMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">June 30, 2020</ifrs-full:DateOfGrantOfSharebasedPaymentArrangement>
<ifrs-full:DateOfGrantOfSharebasedPaymentArrangement id="Factid_19490351" contextRef="P01_01_2020To12_31_2020_ChristophHettichMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">June 30, 2020</ifrs-full:DateOfGrantOfSharebasedPaymentArrangement>
<ifrs-full:DateOfGrantOfSharebasedPaymentArrangement id="Factid_19490352" contextRef="P01_01_2020To12_31_2020_HeatherLMasonMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">June 30, 2020</ifrs-full:DateOfGrantOfSharebasedPaymentArrangement>
<ifrs-full:DateOfGrantOfSharebasedPaymentArrangement id="Factid_19490353" contextRef="P01_01_2020To12_31_2020_MichaelGAtiehMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">June 30, 2020</ifrs-full:DateOfGrantOfSharebasedPaymentArrangement>
<ifrs-full:DateOfGrantOfSharebasedPaymentArrangement id="Factid_19490354" contextRef="P01_01_2020To12_31_2020_PaulCarterMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">June 30, 2020</ifrs-full:DateOfGrantOfSharebasedPaymentArrangement>
<ifrs-full:DateOfGrantOfSharebasedPaymentArrangement id="Factid_19490355" contextRef="P01_01_2020To12_31_2020_EliotForsterMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">September 14, 2020</ifrs-full:DateOfGrantOfSharebasedPaymentArrangement>
<ifrs-full:DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement id="Factid_19490356" contextRef="P01_01_2020To12_31_2020_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis_PerformanceBasedOptionsMemberIMTXTypeOfVestingAxis">Performance-based options</ifrs-full:DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement>
<ifrs-full:DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement id="Factid_19490357" contextRef="P01_01_2020To12_31_2020_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">Service options</ifrs-full:DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement>
<ifrs-full:DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement id="Factid_19490358" contextRef="P01_01_2020To12_31_2020_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis_MatchingStockOptionsMemberIMTXTypeOfVestingAxis">Matching Stock options</ifrs-full:DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement>
<ifrs-full:DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement id="Factid_19490359" contextRef="P01_01_2020To12_31_2020_ConvertedOptionsMemberIMTXTypeOfVestingAxis_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis">Converted options</ifrs-full:DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement>
<ifrs-full:DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement id="Factid_19490360" contextRef="P01_01_2020To12_31_2020_ConvertedOptionsOneMemberIMTXTypeOfVestingAxis_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis">Converted options</ifrs-full:DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement>
<ifrs-full:DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement id="Factid_19490361" contextRef="P01_01_2020To12_31_2020_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsOneMemberIMTXTypeOfVestingAxis">Service options</ifrs-full:DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement>
<ifrs-full:DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement id="Factid_19490362" contextRef="P01_01_2020To12_31_2020_PeterChambreMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">Service options</ifrs-full:DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement>
<ifrs-full:DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement id="Factid_19490363" contextRef="P01_01_2020To12_31_2020_MatchingStockOptionsMemberIMTXTypeOfVestingAxis_PeterChambreMemberifrsfullCategoriesOfRelatedPartiesAxis">Matching Stock options</ifrs-full:DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement>
<ifrs-full:DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement id="Factid_19490364" contextRef="P01_01_2020To12_31_2020_AdamStoneMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">Service options</ifrs-full:DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement>
<ifrs-full:DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement id="Factid_19490365" contextRef="P01_01_2020To12_31_2020_ChristophHettichMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">Service options</ifrs-full:DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement>
<ifrs-full:DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement id="Factid_19490366" contextRef="P01_01_2020To12_31_2020_HeatherLMasonMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">Service options</ifrs-full:DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement>
<ifrs-full:DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement id="Factid_19490367" contextRef="P01_01_2020To12_31_2020_MichaelGAtiehMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">Service options</ifrs-full:DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement>
<ifrs-full:DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement id="Factid_19490368" contextRef="P01_01_2020To12_31_2020_PaulCarterMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">Service options</ifrs-full:DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement>
<ifrs-full:DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement id="Factid_19490369" contextRef="P01_01_2020To12_31_2020_EliotForsterMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">Service options</ifrs-full:DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement>
<ifrs-full:DescriptionOfTransactionsWithRelatedParty id="Factid_19490370" contextRef="P01_01_2020To12_31_2020_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis_PerformanceBasedOptionsMemberIMTXTypeOfVestingAxis">Harpreet Singh</ifrs-full:DescriptionOfTransactionsWithRelatedParty>
<ifrs-full:DescriptionOfTransactionsWithRelatedParty id="Factid_19490371" contextRef="P01_01_2020To12_31_2020_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">Harpreet Singh</ifrs-full:DescriptionOfTransactionsWithRelatedParty>
<ifrs-full:DescriptionOfTransactionsWithRelatedParty id="Factid_19490372" contextRef="P01_01_2020To12_31_2020_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis_MatchingStockOptionsMemberIMTXTypeOfVestingAxis">Harpreet Singh</ifrs-full:DescriptionOfTransactionsWithRelatedParty>
<ifrs-full:DescriptionOfTransactionsWithRelatedParty id="Factid_19490373" contextRef="P01_01_2020To12_31_2020_ConvertedOptionsMemberIMTXTypeOfVestingAxis_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis">Harpreet Singh</ifrs-full:DescriptionOfTransactionsWithRelatedParty>
<ifrs-full:DescriptionOfTransactionsWithRelatedParty id="Factid_19490374" contextRef="P01_01_2020To12_31_2020_ConvertedOptionsOneMemberIMTXTypeOfVestingAxis_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis">Harpreet Singh</ifrs-full:DescriptionOfTransactionsWithRelatedParty>
<ifrs-full:DescriptionOfTransactionsWithRelatedParty id="Factid_19490375" contextRef="P01_01_2020To12_31_2020_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsOneMemberIMTXTypeOfVestingAxis">Harpreet Singh</ifrs-full:DescriptionOfTransactionsWithRelatedParty>
<ifrs-full:DescriptionOfTransactionsWithRelatedParty id="Factid_19490376" contextRef="P01_01_2020To12_31_2020_PeterChambreMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">Peter Chambr&amp;#233;</ifrs-full:DescriptionOfTransactionsWithRelatedParty>
<ifrs-full:DescriptionOfTransactionsWithRelatedParty id="Factid_19490377" contextRef="P01_01_2020To12_31_2020_MatchingStockOptionsMemberIMTXTypeOfVestingAxis_PeterChambreMemberifrsfullCategoriesOfRelatedPartiesAxis">Peter Chambr&amp;#233;</ifrs-full:DescriptionOfTransactionsWithRelatedParty>
<ifrs-full:DescriptionOfTransactionsWithRelatedParty id="Factid_19490378" contextRef="P01_01_2020To12_31_2020_AdamStoneMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">Adam Stone</ifrs-full:DescriptionOfTransactionsWithRelatedParty>
<ifrs-full:DescriptionOfTransactionsWithRelatedParty id="Factid_19490379" contextRef="P01_01_2020To12_31_2020_ChristophHettichMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">Christoph Hettich</ifrs-full:DescriptionOfTransactionsWithRelatedParty>
<ifrs-full:DescriptionOfTransactionsWithRelatedParty id="Factid_19490380" contextRef="P01_01_2020To12_31_2020_HeatherLMasonMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">Heather L. Mason</ifrs-full:DescriptionOfTransactionsWithRelatedParty>
<ifrs-full:DescriptionOfTransactionsWithRelatedParty id="Factid_19490381" contextRef="P01_01_2020To12_31_2020_MichaelGAtiehMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">Michael G. Atieh</ifrs-full:DescriptionOfTransactionsWithRelatedParty>
<ifrs-full:DescriptionOfTransactionsWithRelatedParty id="Factid_19490382" contextRef="P01_01_2020To12_31_2020_PaulCarterMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">Paul Carter</ifrs-full:DescriptionOfTransactionsWithRelatedParty>
<ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits id="Factid_19490384" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-5">2700000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
<ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits id="Factid_19490385" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-5">400000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
<ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits id="Factid_19490386" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-5">500000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
<imtx:AccruedOfKeyManagementCompensation id="Factid_19490387" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-5">0</imtx:AccruedOfKeyManagementCompensation>
<imtx:AccruedOfKeyManagementCompensation id="Factid_19490388" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-5">700000</imtx:AccruedOfKeyManagementCompensation>
<imtx:PercentageOfStockVestedOverThePeriodOfFourYearTimeBasedVestingSchedule id="Factid_19490389" contextRef="PAsOn12_31_2020_ServiceOptionsMemberIMTXTypeOfVestingAxis_TwentyTwentyIncentivePlanMemberIMTXPlanNameAxis" unitRef="Unit_pure" decimals="2">0.25</imtx:PercentageOfStockVestedOverThePeriodOfFourYearTimeBasedVestingSchedule>
<imtx:PercentageOfStockVestedOverThePeriodOfFourYearTimeBasedVestingSchedule id="Factid_19490390" contextRef="PAsOn12_31_2020_PerformanceBasedOptionsMemberIMTXTypeOfVestingAxis_TwentyTwentyIncentivePlanMemberIMTXPlanNameAxis" unitRef="Unit_pure" decimals="2">0.25</imtx:PercentageOfStockVestedOverThePeriodOfFourYearTimeBasedVestingSchedule>
<ifrs-full:NumberOfOutstandingShareOptions id="Factid_19490391" contextRef="PAsOn12_31_2020_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis" unitRef="Unit_shares" decimals="0">1680000</ifrs-full:NumberOfOutstandingShareOptions>
<ifrs-full:NumberOfOutstandingShareOptions id="Factid_19490392" contextRef="PAsOn12_31_2020_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis_PerformanceBasedOptionsMemberIMTXTypeOfVestingAxis" unitRef="Unit_shares" decimals="0">539000</ifrs-full:NumberOfOutstandingShareOptions>
<imtx:PaymentOfPayrollTaxOfTheEmployees id="Factid_19490393" contextRef="P01_01_2020To12_31_2020_KeyManagementPersonnelOfEntityOrParentMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-5">3400000</imtx:PaymentOfPayrollTaxOfTheEmployees>
<imtx:NumberOfConvertedStockOptionsInTheEntity id="Factid_19490394" contextRef="P01_01_2020To12_31_2020_AryaMemberifrsfullBusinessCombinationsAxis" unitRef="Unit_shares" decimals="0">417415</imtx:NumberOfConvertedStockOptionsInTheEntity>
<imtx:NumberOfMatchingStockOptionInTheEntity id="Factid_19490395" contextRef="P01_01_2020To12_31_2020_AryaMemberifrsfullBusinessCombinationsAxis" unitRef="Unit_shares" decimals="0">750076</imtx:NumberOfMatchingStockOptionInTheEntity>
<imtx:DisclosureOfContractualObligationsTableTextBlock id="Factid_19490397" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table summarizes contractual obligations as of December&amp;#160;31, 2020: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:66%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="18" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Payments due by period&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;(Euros in thousands)&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-top: 0.75pt solid black; border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Less&amp;#160;than&lt;br/&gt;1&amp;#160;year&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-top: 0.75pt solid black; border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;1&amp;#160;-&amp;#160;3&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;years&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-top: 0.75pt solid black; border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;3&amp;#160;-&amp;#160;5&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;years&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-top: 0.75pt solid black; border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;More&amp;#160;than&lt;br/&gt; 5 years&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-top: 0.75pt solid black; border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Lease liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2,103&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;3,453&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,157&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;150&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;6,863&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other lease obligations&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;97&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;185&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;185&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;46&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;513&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;In-license&lt;/div&gt; agreements&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;249&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;249&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Contract research organization agreements&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,704&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;220&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,924&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total contractual cash obligation&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,153&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,858&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,342&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;196&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;9,549&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table summarizes contractual obligations as of December&amp;#160;31, 2019: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:67%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="18" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Payments due by period&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;(Euros in thousands)&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="padding-bottom: 0.75pt; border-bottom: 0.75pt solid black; border-top: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Less&amp;#160;than&lt;br/&gt;1&amp;#160;year&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt; border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt; border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black; border-top: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;1&amp;#160;-&amp;#160;3&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;years&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom: 0.75pt solid black; border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt; border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black; border-top: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;3&amp;#160;-&amp;#160;5&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;years&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt; border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt; border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="padding-bottom: 0.75pt; border-bottom: 0.75pt solid black; border-top: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;More&amp;#160;than&amp;#160;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;years&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt; border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt; border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="padding-bottom: 0.75pt; border-bottom: 0.75pt solid black; border-top: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Lease liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,482&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,823&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;47&lt;/td&gt;&lt;td style="white-space: nowrap; font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;3,352&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other lease obligations&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;172&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;324&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;300&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;300&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,096&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;In-license&lt;/div&gt; agreements&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;455&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;200&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;655&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Contract research organization agreements&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,131&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,466&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2,597&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total contractual cash obligation&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,240&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,813&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;347&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;300&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;7,700&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DisclosureOfContractualObligationsTableTextBlock>
<imtx:ContractualObligationOfLeaseLiabilities id="Factid_19490398" contextRef="PAsOn12_31_2020_NotLaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">2103000</imtx:ContractualObligationOfLeaseLiabilities>
<imtx:ContractualObligationOfLeaseLiabilities id="Factid_19490399" contextRef="PAsOn12_31_2020_LaterThanOneYearAndNotLaterThanThreeYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">3453000</imtx:ContractualObligationOfLeaseLiabilities>
<imtx:ContractualObligationOfLeaseLiabilities id="Factid_19490400" contextRef="PAsOn12_31_2020_LaterThanThreeYearsAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">1157000</imtx:ContractualObligationOfLeaseLiabilities>
<imtx:ContractualObligationOfLeaseLiabilities id="Factid_19490401" contextRef="PAsOn12_31_2020_LaterThanFiveYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">150000</imtx:ContractualObligationOfLeaseLiabilities>
<imtx:ContractualObligationOfLeaseLiabilities id="Factid_19490402" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">6863000</imtx:ContractualObligationOfLeaseLiabilities>
<imtx:OtherLeaseObligations id="Factid_19490403" contextRef="PAsOn12_31_2020_NotLaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">97000</imtx:OtherLeaseObligations>
<imtx:OtherLeaseObligations id="Factid_19490404" contextRef="PAsOn12_31_2020_LaterThanOneYearAndNotLaterThanThreeYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">185000</imtx:OtherLeaseObligations>
<imtx:OtherLeaseObligations id="Factid_19490405" contextRef="PAsOn12_31_2020_LaterThanThreeYearsAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">185000</imtx:OtherLeaseObligations>
<imtx:OtherLeaseObligations id="Factid_19490406" contextRef="PAsOn12_31_2020_LaterThanFiveYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">46000</imtx:OtherLeaseObligations>
<imtx:OtherLeaseObligations id="Factid_19490407" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">513000</imtx:OtherLeaseObligations>
<imtx:ContractualObligationOfInLicenseAgreements id="Factid_19490408" contextRef="PAsOn12_31_2020_NotLaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">249000</imtx:ContractualObligationOfInLicenseAgreements>
<imtx:ContractualObligationOfInLicenseAgreements id="Factid_19490409" contextRef="PAsOn12_31_2020_LaterThanOneYearAndNotLaterThanThreeYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">0</imtx:ContractualObligationOfInLicenseAgreements>
<imtx:ContractualObligationOfInLicenseAgreements id="Factid_19490410" contextRef="PAsOn12_31_2020_LaterThanThreeYearsAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">0</imtx:ContractualObligationOfInLicenseAgreements>
<imtx:ContractualObligationOfInLicenseAgreements id="Factid_19490411" contextRef="PAsOn12_31_2020_LaterThanFiveYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">0</imtx:ContractualObligationOfInLicenseAgreements>
<imtx:ContractualObligationOfInLicenseAgreements id="Factid_19490412" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">249000</imtx:ContractualObligationOfInLicenseAgreements>
<imtx:ContractResearchOrganizationAgreements id="Factid_19490413" contextRef="PAsOn12_31_2020_NotLaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">1704000</imtx:ContractResearchOrganizationAgreements>
<imtx:ContractResearchOrganizationAgreements id="Factid_19490414" contextRef="PAsOn12_31_2020_LaterThanOneYearAndNotLaterThanThreeYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">220000</imtx:ContractResearchOrganizationAgreements>
<imtx:ContractResearchOrganizationAgreements id="Factid_19490415" contextRef="PAsOn12_31_2020_LaterThanThreeYearsAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">0</imtx:ContractResearchOrganizationAgreements>
<imtx:ContractResearchOrganizationAgreements id="Factid_19490416" contextRef="PAsOn12_31_2020_LaterThanFiveYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">0</imtx:ContractResearchOrganizationAgreements>
<imtx:ContractResearchOrganizationAgreements id="Factid_19490417" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">1924000</imtx:ContractResearchOrganizationAgreements>
<imtx:ContractualCashObligation id="Factid_19490418" contextRef="PAsOn12_31_2020_NotLaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">4153000</imtx:ContractualCashObligation>
<imtx:ContractualCashObligation id="Factid_19490419" contextRef="PAsOn12_31_2020_LaterThanOneYearAndNotLaterThanThreeYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">3858000</imtx:ContractualCashObligation>
<imtx:ContractualCashObligation id="Factid_19490420" contextRef="PAsOn12_31_2020_LaterThanThreeYearsAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">1342000</imtx:ContractualCashObligation>
<imtx:ContractualCashObligation id="Factid_19490421" contextRef="PAsOn12_31_2020_LaterThanFiveYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">196000</imtx:ContractualCashObligation>
<imtx:ContractualCashObligation id="Factid_19490422" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">9549000</imtx:ContractualCashObligation>
<imtx:ContractualObligationOfLeaseLiabilities id="Factid_19490423" contextRef="PAsOn12_31_2019_NotLaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">1482000</imtx:ContractualObligationOfLeaseLiabilities>
<imtx:ContractualObligationOfLeaseLiabilities id="Factid_19490424" contextRef="PAsOn12_31_2019_LaterThanOneYearAndNotLaterThanThreeYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">1823000</imtx:ContractualObligationOfLeaseLiabilities>
<imtx:ContractualObligationOfLeaseLiabilities id="Factid_19490425" contextRef="PAsOn12_31_2019_LaterThanThreeYearsAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">47000</imtx:ContractualObligationOfLeaseLiabilities>
<imtx:ContractualObligationOfLeaseLiabilities id="Factid_19490426" contextRef="PAsOn12_31_2019_LaterThanFiveYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">0</imtx:ContractualObligationOfLeaseLiabilities>
<imtx:ContractualObligationOfLeaseLiabilities id="Factid_19490427" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">3352000</imtx:ContractualObligationOfLeaseLiabilities>
<imtx:OtherLeaseObligations id="Factid_19490428" contextRef="PAsOn12_31_2019_NotLaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">172000</imtx:OtherLeaseObligations>
<imtx:OtherLeaseObligations id="Factid_19490429" contextRef="PAsOn12_31_2019_LaterThanOneYearAndNotLaterThanThreeYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">324000</imtx:OtherLeaseObligations>
<imtx:OtherLeaseObligations id="Factid_19490430" contextRef="PAsOn12_31_2019_LaterThanThreeYearsAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">300000</imtx:OtherLeaseObligations>
<imtx:OtherLeaseObligations id="Factid_19490431" contextRef="PAsOn12_31_2019_LaterThanFiveYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">300000</imtx:OtherLeaseObligations>
<imtx:OtherLeaseObligations id="Factid_19490432" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">1096000</imtx:OtherLeaseObligations>
<imtx:ContractualObligationOfInLicenseAgreements id="Factid_19490433" contextRef="PAsOn12_31_2019_NotLaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">455000</imtx:ContractualObligationOfInLicenseAgreements>
<imtx:ContractualObligationOfInLicenseAgreements id="Factid_19490434" contextRef="PAsOn12_31_2019_LaterThanOneYearAndNotLaterThanThreeYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">200000</imtx:ContractualObligationOfInLicenseAgreements>
<imtx:ContractualObligationOfInLicenseAgreements id="Factid_19490435" contextRef="PAsOn12_31_2019_LaterThanThreeYearsAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">0</imtx:ContractualObligationOfInLicenseAgreements>
<imtx:ContractualObligationOfInLicenseAgreements id="Factid_19490436" contextRef="PAsOn12_31_2019_LaterThanFiveYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">0</imtx:ContractualObligationOfInLicenseAgreements>
<imtx:ContractualObligationOfInLicenseAgreements id="Factid_19490437" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">655000</imtx:ContractualObligationOfInLicenseAgreements>
<imtx:ContractResearchOrganizationAgreements id="Factid_19490438" contextRef="PAsOn12_31_2019_NotLaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">1131000</imtx:ContractResearchOrganizationAgreements>
<imtx:ContractResearchOrganizationAgreements id="Factid_19490439" contextRef="PAsOn12_31_2019_LaterThanOneYearAndNotLaterThanThreeYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">1466000</imtx:ContractResearchOrganizationAgreements>
<imtx:ContractResearchOrganizationAgreements id="Factid_19490440" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">2597000</imtx:ContractResearchOrganizationAgreements>
<imtx:ContractualCashObligation id="Factid_19490441" contextRef="PAsOn12_31_2019_NotLaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">3240000</imtx:ContractualCashObligation>
<imtx:ContractualCashObligation id="Factid_19490442" contextRef="PAsOn12_31_2019_LaterThanOneYearAndNotLaterThanThreeYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">3813000</imtx:ContractualCashObligation>
<imtx:ContractualCashObligation id="Factid_19490443" contextRef="PAsOn12_31_2019_LaterThanThreeYearsAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">347000</imtx:ContractualCashObligation>
<imtx:ContractualCashObligation id="Factid_19490444" contextRef="PAsOn12_31_2019_LaterThanFiveYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-3">300000</imtx:ContractualCashObligation>
<imtx:ContractualCashObligation id="Factid_19490445" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">7700000</imtx:ContractualCashObligation>
<imtx:KeyManagementPersonnelCompensationTravellingExpenses id="Factid_19490446" contextRef="P01_01_2020To12_31_2020_HaraldFstockMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">0</imtx:KeyManagementPersonnelCompensationTravellingExpenses>
<imtx:KeyManagementPersonnelCompensationTravellingExpenses id="Factid_19490447" contextRef="P01_01_2020To12_31_2020_MichaelGAtiehMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">0</imtx:KeyManagementPersonnelCompensationTravellingExpenses>
<imtx:KeyManagementPersonnelCompensationTravellingExpenses id="Factid_19490448" contextRef="P01_01_2020To12_31_2020_PaulCarterMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">0</imtx:KeyManagementPersonnelCompensationTravellingExpenses>
<imtx:KeyManagementPersonnelCompensationTravellingExpenses id="Factid_19490449" contextRef="P01_01_2020To12_31_2020_HeatherLMasonMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">0</imtx:KeyManagementPersonnelCompensationTravellingExpenses>
<imtx:KeyManagementPersonnelCompensationTravellingExpenses id="Factid_19490450" contextRef="P01_01_2020To12_31_2020_AdamStoneMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">0</imtx:KeyManagementPersonnelCompensationTravellingExpenses>
<imtx:KeyManagementPersonnelCompensationTravellingExpenses id="Factid_19490451" contextRef="P01_01_2020To12_31_2020_ChristophHettichMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">0</imtx:KeyManagementPersonnelCompensationTravellingExpenses>
<imtx:KeyManagementPersonnelCompensationTravellingExpenses id="Factid_19490452" contextRef="P01_01_2020To12_31_2020_EliotForsterMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">0</imtx:KeyManagementPersonnelCompensationTravellingExpenses>
<imtx:KeyManagementPersonnelCompensationShareBasedCompensationExpense id="Factid_19490453" contextRef="P01_01_2020To12_31_2020_HaraldFstockMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">0</imtx:KeyManagementPersonnelCompensationShareBasedCompensationExpense>
<imtx:KeyManagementPersonnelCompensationShareBasedCompensationExpense id="Factid_19490454" contextRef="P01_01_2020To12_31_2020_MichaelGAtiehMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">70000</imtx:KeyManagementPersonnelCompensationShareBasedCompensationExpense>
<imtx:KeyManagementPersonnelCompensationShareBasedCompensationExpense id="Factid_19490455" contextRef="P01_01_2020To12_31_2020_PaulCarterMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">70000</imtx:KeyManagementPersonnelCompensationShareBasedCompensationExpense>
<imtx:KeyManagementPersonnelCompensationShareBasedCompensationExpense id="Factid_19490456" contextRef="P01_01_2020To12_31_2020_HeatherLMasonMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">70000</imtx:KeyManagementPersonnelCompensationShareBasedCompensationExpense>
<imtx:KeyManagementPersonnelCompensationShareBasedCompensationExpense id="Factid_19490457" contextRef="P01_01_2020To12_31_2020_AdamStoneMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">70000</imtx:KeyManagementPersonnelCompensationShareBasedCompensationExpense>
<imtx:KeyManagementPersonnelCompensationShareBasedCompensationExpense id="Factid_19490458" contextRef="P01_01_2020To12_31_2020_ChristophHettichMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">70000</imtx:KeyManagementPersonnelCompensationShareBasedCompensationExpense>
<imtx:KeyManagementPersonnelCompensationShareBasedCompensationExpense id="Factid_19490459" contextRef="P01_01_2020To12_31_2020_EliotForsterMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">40000</imtx:KeyManagementPersonnelCompensationShareBasedCompensationExpense>
<ifrs-full:FinancialAssets id="Factid_19490470" contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrsfullCategoriesOfFinancialAssetsAxis_ShorttermDepositsMemberifrsfullClassesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3">24448000</ifrs-full:FinancialAssets>
<ifrs-full:FinancialAssets id="Factid_19490471" contextRef="PAsOn12_31_2019_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrsfullCategoriesOfFinancialAssetsAxis_ShorttermDepositsMemberifrsfullClassesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3">16023000</ifrs-full:FinancialAssets>
<ifrs-full:FinancialAssetsAtFairValue id="Factid_19490472" contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrsfullCategoriesOfFinancialAssetsAxis_ShorttermDepositsMemberifrsfullClassesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3">24448000</ifrs-full:FinancialAssetsAtFairValue>
<ifrs-full:FinancialAssetsAtFairValue id="Factid_19490473" contextRef="PAsOn12_31_2019_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrsfullCategoriesOfFinancialAssetsAxis_ShorttermDepositsMemberifrsfullClassesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3">16023000</ifrs-full:FinancialAssetsAtFairValue>
<ifrs-full:FinancialAssets id="Factid_19490474" contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrsfullCategoriesOfFinancialAssetsAxis_PositiveMarketValueForwardContractsMemberifrsfullClassesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3">914000</ifrs-full:FinancialAssets>
<ifrs-full:FinancialAssets id="Factid_19490475" contextRef="PAsOn12_31_2019_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrsfullCategoriesOfFinancialAssetsAxis_PositiveMarketValueForwardContractsMemberifrsfullClassesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3">0</ifrs-full:FinancialAssets>
<ifrs-full:FinancialAssetsAtFairValue id="Factid_19490476" contextRef="PAsOn12_31_2020_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrsfullCategoriesOfFinancialAssetsAxis_PositiveMarketValueForwardContractsMemberifrsfullClassesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3">914000</ifrs-full:FinancialAssetsAtFairValue>
<ifrs-full:FinancialAssetsAtFairValue id="Factid_19490477" contextRef="PAsOn12_31_2019_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrsfullCategoriesOfFinancialAssetsAxis_PositiveMarketValueForwardContractsMemberifrsfullClassesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3">0</ifrs-full:FinancialAssetsAtFairValue>
<ifrs-full:FinancialAssets id="Factid_19490478" contextRef="PAsOn12_31_2020_OtherFinancialAssetsAtAmortizedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_TradeReceivablesMemberifrsfullClassesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3">1250000</ifrs-full:FinancialAssets>
<ifrs-full:FinancialAssets id="Factid_19490479" contextRef="PAsOn12_31_2019_OtherFinancialAssetsAtAmortizedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_TradeReceivablesMemberifrsfullClassesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3">957000</ifrs-full:FinancialAssets>
<ifrs-full:FinancialAssetsAtFairValue id="Factid_19490480" contextRef="PAsOn12_31_2020_OtherFinancialAssetsAtAmortizedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_TradeReceivablesMemberifrsfullClassesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3">1250000</ifrs-full:FinancialAssetsAtFairValue>
<ifrs-full:FinancialAssetsAtFairValue id="Factid_19490481" contextRef="PAsOn12_31_2019_OtherFinancialAssetsAtAmortizedCostMemberifrsfullCategoriesOfFinancialAssetsAxis_TradeReceivablesMemberifrsfullClassesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3">957000</ifrs-full:FinancialAssetsAtFairValue>
<ifrs-full:FinancialAssets id="Factid_19490482" contextRef="PAsOn12_31_2020_OtherCurrentAssetMemberifrsfullClassesOfFinancialAssetsAxis_OtherFinancialAssetsAtAmortizedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3">1586000</ifrs-full:FinancialAssets>
<ifrs-full:FinancialAssets id="Factid_19490483" contextRef="PAsOn12_31_2019_OtherCurrentAssetMemberifrsfullClassesOfFinancialAssetsAxis_OtherFinancialAssetsAtAmortizedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3">1710000</ifrs-full:FinancialAssets>
<ifrs-full:FinancialAssetsAtFairValue id="Factid_19490484" contextRef="PAsOn12_31_2020_OtherCurrentAssetMemberifrsfullClassesOfFinancialAssetsAxis_OtherFinancialAssetsAtAmortizedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3">1586000</ifrs-full:FinancialAssetsAtFairValue>
<ifrs-full:FinancialAssetsAtFairValue id="Factid_19490485" contextRef="PAsOn12_31_2019_OtherCurrentAssetMemberifrsfullClassesOfFinancialAssetsAxis_OtherFinancialAssetsAtAmortizedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3">1710000</ifrs-full:FinancialAssetsAtFairValue>
<ifrs-full:FinancialAssets id="Factid_19490486" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">28198000</ifrs-full:FinancialAssets>
<ifrs-full:FinancialAssets id="Factid_19490487" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">18690000</ifrs-full:FinancialAssets>
<ifrs-full:FinancialAssetsAtFairValue id="Factid_19490488" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">28198000</ifrs-full:FinancialAssetsAtFairValue>
<ifrs-full:FinancialAssetsAtFairValue id="Factid_19490489" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">18690000</ifrs-full:FinancialAssetsAtFairValue>
<ifrs-full:FinancialLiabilities id="Factid_19490490" contextRef="PAsOn12_31_2020_AccountsPayableMemberifrsfullClassesOfFinancialAssetsAxis_OtherFinancialAssetsAtAmortizedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3">10052000</ifrs-full:FinancialLiabilities>
<ifrs-full:FinancialLiabilities id="Factid_19490491" contextRef="PAsOn12_31_2019_AccountsPayableMemberifrsfullClassesOfFinancialAssetsAxis_OtherFinancialAssetsAtAmortizedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3">7082000</ifrs-full:FinancialLiabilities>
<ifrs-full:FinancialLiabilitiesAtFairValue id="Factid_19490492" contextRef="PAsOn12_31_2020_AccountsPayableMemberifrsfullClassesOfFinancialAssetsAxis_OtherFinancialAssetsAtAmortizedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3">10052000</ifrs-full:FinancialLiabilitiesAtFairValue>
<ifrs-full:FinancialLiabilitiesAtFairValue id="Factid_19490493" contextRef="PAsOn12_31_2019_AccountsPayableMemberifrsfullClassesOfFinancialAssetsAxis_OtherFinancialAssetsAtAmortizedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3">7082000</ifrs-full:FinancialLiabilitiesAtFairValue>
<ifrs-full:FinancialLiabilities id="Factid_19490494" contextRef="PAsOn12_31_2020_OtherCurrentLiabilitiesMemberifrsfullClassesOfFinancialAssetsAxis_OtherFinancialAssetsAtAmortizedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3">2025000</ifrs-full:FinancialLiabilities>
<ifrs-full:FinancialLiabilities id="Factid_19490495" contextRef="PAsOn12_31_2019_OtherCurrentLiabilitiesMemberifrsfullClassesOfFinancialAssetsAxis_OtherFinancialAssetsAtAmortizedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3">1288000</ifrs-full:FinancialLiabilities>
<ifrs-full:FinancialLiabilitiesAtFairValue id="Factid_19490496" contextRef="PAsOn12_31_2020_OtherCurrentLiabilitiesMemberifrsfullClassesOfFinancialAssetsAxis_OtherFinancialAssetsAtAmortizedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3">2025000</ifrs-full:FinancialLiabilitiesAtFairValue>
<ifrs-full:FinancialLiabilitiesAtFairValue id="Factid_19490497" contextRef="PAsOn12_31_2019_OtherCurrentLiabilitiesMemberifrsfullClassesOfFinancialAssetsAxis_OtherFinancialAssetsAtAmortizedCostMemberifrsfullCategoriesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3">1288000</ifrs-full:FinancialLiabilitiesAtFairValue>
<ifrs-full:FinancialLiabilities id="Factid_19490498" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">12077000</ifrs-full:FinancialLiabilities>
<ifrs-full:FinancialLiabilities id="Factid_19490499" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">8370000</ifrs-full:FinancialLiabilities>
<ifrs-full:FinancialLiabilitiesAtFairValue id="Factid_19490500" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">12077000</ifrs-full:FinancialLiabilitiesAtFairValue>
<ifrs-full:FinancialLiabilitiesAtFairValue id="Factid_19490501" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">8370000</ifrs-full:FinancialLiabilitiesAtFairValue>
<imtx:DateOfExpiryOfShareOptionsGranted id="Factid_19490512" contextRef="P01_01_2020To12_31_2020_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis_PerformanceBasedOptionsMemberIMTXTypeOfVestingAxis">2030-06-30</imtx:DateOfExpiryOfShareOptionsGranted>
<imtx:DateOfExpiryOfShareOptionsGranted id="Factid_19490513" contextRef="P01_01_2020To12_31_2020_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">2030-06-30</imtx:DateOfExpiryOfShareOptionsGranted>
<imtx:DateOfExpiryOfShareOptionsGranted id="Factid_19490514" contextRef="P01_01_2020To12_31_2020_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis_MatchingStockOptionsMemberIMTXTypeOfVestingAxis">2030-06-30</imtx:DateOfExpiryOfShareOptionsGranted>
<imtx:DateOfExpiryOfShareOptionsGranted id="Factid_19490515" contextRef="P01_01_2020To12_31_2020_ConvertedOptionsMemberIMTXTypeOfVestingAxis_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis">2027-07-01</imtx:DateOfExpiryOfShareOptionsGranted>
<imtx:DateOfExpiryOfShareOptionsGranted id="Factid_19490516" contextRef="P01_01_2020To12_31_2020_ConvertedOptionsOneMemberIMTXTypeOfVestingAxis_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis">2028-01-01</imtx:DateOfExpiryOfShareOptionsGranted>
<imtx:DateOfExpiryOfShareOptionsGranted id="Factid_19490517" contextRef="P01_01_2020To12_31_2020_HarpreetSinghMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsOneMemberIMTXTypeOfVestingAxis">2030-12-17</imtx:DateOfExpiryOfShareOptionsGranted>
<imtx:DateOfExpiryOfShareOptionsGranted id="Factid_19490518" contextRef="P01_01_2020To12_31_2020_PeterChambreMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">2030-06-30</imtx:DateOfExpiryOfShareOptionsGranted>
<imtx:DateOfExpiryOfShareOptionsGranted id="Factid_19490519" contextRef="P01_01_2020To12_31_2020_MatchingStockOptionsMemberIMTXTypeOfVestingAxis_PeterChambreMemberifrsfullCategoriesOfRelatedPartiesAxis">2030-06-30</imtx:DateOfExpiryOfShareOptionsGranted>
<imtx:DateOfExpiryOfShareOptionsGranted id="Factid_19490520" contextRef="P01_01_2020To12_31_2020_AdamStoneMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">2030-06-30</imtx:DateOfExpiryOfShareOptionsGranted>
<imtx:DateOfExpiryOfShareOptionsGranted id="Factid_19490521" contextRef="P01_01_2020To12_31_2020_ChristophHettichMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">2030-06-30</imtx:DateOfExpiryOfShareOptionsGranted>
<imtx:DateOfExpiryOfShareOptionsGranted id="Factid_19490522" contextRef="P01_01_2020To12_31_2020_HeatherLMasonMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">2030-06-30</imtx:DateOfExpiryOfShareOptionsGranted>
<imtx:DateOfExpiryOfShareOptionsGranted id="Factid_19490523" contextRef="P01_01_2020To12_31_2020_MichaelGAtiehMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">2030-06-30</imtx:DateOfExpiryOfShareOptionsGranted>
<imtx:DateOfExpiryOfShareOptionsGranted id="Factid_19490524" contextRef="P01_01_2020To12_31_2020_PaulCarterMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">2030-06-30</imtx:DateOfExpiryOfShareOptionsGranted>
<imtx:DateOfExpiryOfShareOptionsGranted id="Factid_19490525" contextRef="P01_01_2020To12_31_2020_EliotForsterMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">2030-09-13</imtx:DateOfExpiryOfShareOptionsGranted>
<ifrs-full:DescriptionOfTransactionsWithRelatedParty id="Factid_19490526" contextRef="P01_01_2020To12_31_2020_EliotForsterMemberifrsfullCategoriesOfRelatedPartiesAxis_ServiceOptionsMemberIMTXTypeOfVestingAxis">Eliot Forster</ifrs-full:DescriptionOfTransactionsWithRelatedParty>
<ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory id="Factid_19490527" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;13.&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Revenue from collaboration agreements &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;The Group earns revenue through strategic collaboration agreements with third party pharmaceutical and biotechnology companies. As of December&amp;#160;31, 2020, the Group had four strategic collaboration agreements in place. All collaboration agreements are still at &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;pre-clinical&lt;/div&gt; stage. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;As part of these collaboration arrangement, Immatics grants exclusive licensing rights or options thereto for the development and commercialization of future product candidates, developed for several targets defined in the respective collaboration agreements, in addition to research activities, including screening of highly specific molecules for reactivity with the specified targets and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;off-targets&lt;/div&gt; using Immatics&amp;#8217; proprietary technology and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;know-how,&lt;/div&gt; participation on a joint steering committee, and preparation of data packages. For each collaboration agreement, these promises represent one combined performance obligation, because the research activities are mutually dependent and the respective collaboration partner is unable to derive significant benefits from their access to these targets without Immatics&amp;#8217; research activities, which are highly specialized and cannot be performed by other organizations. Under each agreement, research activities were determined to be the predominant item under the contract. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Amgen Collaboration Agreement &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;In December 2016, Immatics Biotechnologies GmbH entered into a research collaboration and license agreement with Amgen Inc. (&amp;#8220;Amgen&amp;#8221;) to develop next-generation, T cell engaging bispecific immunotherapies targeting multiple cancers. Under the terms of the agreement, Immatics contributed its XPRESIDENT target discovery and T cell receptor (TCR) capabilities to the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;pre-clinical&lt;/div&gt; development of product candidates. Amgen Inc. contributed its validated Bispecific T cell Engager (BiTE&lt;div style="font-size: 85%; vertical-align: top;;vertical-align: super;font-size: smaller;display:inline;"&gt;&amp;#174;&lt;/div&gt;) technology and will be responsible for the clinical development, manufacturing and commercialization worldwide. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;In the collaboration agreement with Amgen development milestone payments and commercial milestone payments amount to a maximum &lt;div style="display:inline;"&gt;up to&lt;/div&gt; $525&amp;#160;million for each program and tiered royalties up to a double-digit percentage of net sales. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;The Group received a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-refundable&lt;/div&gt; upfront payment of $30&amp;#160;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;million (&amp;#8364;28 million) upon signing of the Amgen agreement. The Group classified the initial receipt of the upfront payment as deferred revenue, which recognizes into revenue as on a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;cost-to-cost&lt;/div&gt;&lt;/div&gt; basis using forecasted costs. A &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;cost-to-cost&lt;/div&gt;&lt;/div&gt; basis was determined most representative of the transfer of benefits to Amgen. The Group recognized approximately &lt;/div&gt;&amp;#8364;4.9&amp;#160;million, &amp;#8364;6.2&amp;#160;million and &amp;#8364;1.5&amp;#160;million of revenue associated with the upfront payment during the years ended December&amp;#160;31, 2020, 2019 and 2018, respectively. Total deferred revenue under the agreement was &amp;#8364;10&amp;#160;million and &amp;#8364;15&amp;#160;million as of December&amp;#160;31, 2020 and 2019, respectively. &lt;/div&gt; &lt;div style="font-size: 1px; margin-top: 18px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Genmab Collaboration Agreement &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;In July 2018, Immatics Biotechnologies GmbH entered into a research collaboration and license agreement with Genmab A/S (&amp;#8220;Genmab&amp;#8221;) to develop next-generation, T cell engaging bispecific immunotherapies targeting multiple cancer indications. Under the agreement, Immatics and Genmab conduct joint research to combine Immatics&amp;#8217; XPRESIDENT and Bispecific TCR technology platforms with Genmab&amp;#8217;s proprietary antibody technologies to develop multiple bispecific immunotherapies in oncology. The two companies plan to develop immunotherapies directed against three proprietary targets. Genmab will be responsible for development, manufacturing and worldwide commercialization. Immatics will have an option to contribute certain promotion efforts at predetermined levels in selected countries in the EU. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Genmab collaboration agreement contains a maximum of $550&amp;#160;million of milestone payments for each licensed product resulting from the collaboration. In addition, Immatics is entitled to receive royalty payments. Royalty rates are based on aggregate net sales of a licensed product. The agreement provides for higher royalty rates as annual net sales of a licensed product increases. Under the agreement, the royalty rates begin in the high single-digits, increasing to the low tens as a percentage of aggregate annual net sales of a licensed product. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;The Group received a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-refundable&lt;/div&gt; upfront payment of $54&amp;#160;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;million (&amp;#8364;46 million) upon signing of the agreement. The Group classified the initial receipt of the upfront payment as deferred revenue. The Group recognized &lt;/div&gt;approximately &amp;#8364;11.2&amp;#160;million, &amp;#8364;11.2&amp;#160;million and &amp;#8364;2.3&amp;#160;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;million of revenue associated with the upfront payment and with reimbursements for research and development costs performed, during the years ended December&amp;#160;31, 2020, 2019 and 2018, respectively. Revenue for the Genmab collaboration agreement is recognized on a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;cost-to-cost&lt;/div&gt;&lt;/div&gt; basis using forecasted costs. A &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;cost-to-cost&lt;/div&gt;&lt;/div&gt; basis was determined most representative of the transfer of benefits to Genmab. Total deferred revenue under the agreement was &lt;/div&gt;&amp;#8364;26&amp;#160;million and &amp;#8364;35&amp;#160;million as of December&amp;#160;31, 2020 and 2019, respectively. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;BMS Collaboration Agreement &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;In August 2019, Immatics Biotechnologies GmbH and BMS entered into a collaboration and option agreement to develop novel adoptive cell therapies targeting multiple cancers. Under the agreement, Immatics may develop T Cell Receptor Engineered T Cell Therapy &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(TCR-T)&lt;/div&gt; programs against solid tumor targets discovered with Immatics&amp;#8217; XPRESIDENT technology. Programs would utilize proprietary T Cell Receptors (TCRs) identified by Immatics&amp;#8217; XCEPTOR TCR discovery and engineering platform. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;If Immatics develops programs against the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;TCR-T&lt;/div&gt; targets, Immatics will be responsible for the development and validation of these programs through lead candidate stage, at which time BMS may exercise &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;opt-in&lt;/div&gt; rights and assume sole responsibility for further worldwide development, manufacturing and commercialization of the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;TCR-T&lt;/div&gt; cell therapies. &lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"&gt;Immatics would have certain early stage &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;co-development&lt;/div&gt; rights or &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;co-funding&lt;/div&gt; rights for selected &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;TCR-T&lt;/div&gt; cell therapies arising from the collaboration. With respect to this collaboration agreement with BMS, Immatics may be eligible to receive up to $505&amp;#160;million for each licensed product in option exercise payments, development, regulatory and commercial milestone payments as well as tiered royalties on net sales. In addition, Immatics is entitled to royalty payments. Royalty rates are based on aggregate net sales of a licensed product resulting from the collaboration. The agreement provides for higher royalty rates as annual net sales of a licensed product increases. Under each contract, the royalty rates begin in the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;mid-single-digits,&lt;/div&gt; increasing to the low teen-digits as a percentage of aggregate annual net sales of a licensed product. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;The Group received a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-refundable&lt;/div&gt; upfront payment of $75&amp;#160;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;million (&amp;#8364;68 million) upon signing of the agreement. The Group classified the initial receipt of the upfront payment as deferred revenue. The Group recognized &lt;/div&gt;&lt;/div&gt;&amp;#8364;11.5&amp;#160;million and &amp;#8364;1.1&amp;#160;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;million of revenue associated with the upfront payment as of December&amp;#160;31, 2020 and 2019, respectively. Revenue for the BMS collaboration agreement is recognized on a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;cost-to-cost&lt;/div&gt;&lt;/div&gt; basis using forecasted costs. A &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;cost-to-cost&lt;/div&gt;&lt;/div&gt; basis was determined most representative of the transfer of benefits to BMS. Total deferred revenue under the agreement was &lt;/div&gt;&amp;#8364;55&amp;#160;million and &amp;#8364;66.5&amp;#160;million as of December&amp;#160;31, 2020 and 2019, respectively. &lt;/div&gt; &lt;div style="font-size: 1px; margin-top: 18px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;GSK &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;In December 2019, Immatics entered into a collaboration agreement with GSK to develop novel adoptive cell therapies targeting multiple cancer indications. Immatics and GSK plan to collaborate on the identification, research and development of next-generation TCR Therapeutics focusing on solid tumors. The collaboration will initially focus on the development of autologous T cell therapies and GSK has an option to develop allogeneic T cell therapies using Immatics ACTallo approach. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;Immatics and GSK intend to utilize proprietary TCRs identified by Immatics TCR discovery platform XCEPTOR which are planned to be directed against two proprietary targets. Those proprietary targets were discovered and validated by the respective XPRESIDENT technology. Immatics will be mainly responsible for the development and validation of the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;TCR-T&lt;/div&gt; up to designation of a clinical candidate. GSK will then assume sole responsibility for further development, manufacturing and commercialization of the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;TCR-T&lt;/div&gt; with the option for Immatics to &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;co-develop&lt;/div&gt; one or more &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;TCR-Ts&lt;/div&gt; upon GSK&amp;#180;s request. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;The Group received a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-refundable&lt;/div&gt; upfront payment of &amp;#8364;45&amp;#160;million for two initial programs upon signing of the GSK agreement and is eligible to receive &lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;up to &amp;#8364;&lt;/div&gt;&lt;/div&gt;575&amp;#160;million of milestone payments per program. In addition, Immatics is entitled to royalty payments. Royalty rates are based on aggregate net sales of a licensed product resulting from the collaboration. The agreement provides for higher royalty rates as annual net sales of a licensed product increases. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Group classified the initial receipt of the upfront payment as deferred revenue. The Group recognized &amp;#8364;3.7&amp;#160;million of revenue associated with the upfront payment as of December&amp;#160;31, 2020 and recognized no revenue associated with the upfront payment during 2019. Total deferred revenue under the agreement was &amp;#8364;41&amp;#160;million and &amp;#8364;45&amp;#160;million as of December&amp;#160;31, 2020 and 2019, respectively. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Group has not recognized any royalty or milestone revenue under the collaboration agreements, due to the scientific uncertainty of achieving the milestones or the successful commercialization of a product. As of December 31, 2020, Immatics had not received any milestone or royalty payments in connection with the collaboration agreements. The Group plans to recognize the remaining deferred revenue balance into revenue as it performs the related performance obligations under each contract. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred revenue related to the collaboration agreements consists of the following: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:74%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Current&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;46,600&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;59,465&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Non-current&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;85,475&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;101,909&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;132,075&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;161,374&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Cost to obtain a contract &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;The Group incurs costs from a third party, who assists in identifying collaboration partners. The Group recognizes an asset to the extent these costs are incremental and directly related to a specific contract. The Group then amortizes the asset consistently with the pattern of revenue recognition for the related contracts. Total assets, net of amortization, for these capitalized costs of obtaining a contract were &amp;#8364;1.2&amp;#160;million and &amp;#8364;1.5&amp;#160;million as of December&amp;#160;31, 2020 and 2019, respectively, which are classified in other current assets and other &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-current&lt;/div&gt; assets. The Group recognized expenses related to the amortization of capitalized cost of obtaining a contract of &amp;#8364;0.3&amp;#160;million, &amp;#8364;0.2&amp;#160;million and &amp;#8364;0.04&amp;#160;million as of December&amp;#160;31, 2020, 2019 and 2018, respectively. &lt;/div&gt; &lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December&amp;#160;31, 2020, the Group is potentially liable to pay &amp;#8364;1.6&amp;#160;million (&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;$2&amp;#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;million) to a third-party upon successful completing the milestone of the first clinical lead selection in connection with Immatics&amp;#8217; collaboration agreements. The Group does not recognize a liability for these contingent payments due to the scientific uncertainty of achieving the related milestones. &lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;Each of the Group&amp;#8217;s strategic collaboration agreements included a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-refundable&lt;/div&gt; upfront payment, meant to subsidize research activities, recognized as deferred revenue. For all collaboration agreements these upfront payments exceeded the Group&amp;#8217;s right to consideration for services performed under each collaboration agreement. Therefore, only deferred revenue net of contract assets is presented as of December&amp;#160;31, 2020, December&amp;#160;31, 2019 and December&amp;#160;31, 2018, respectively. &lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory>
<imtx:DisclosureOfContractLiabilitiesTextBlock id="Factid_19490528" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred revenue related to the collaboration agreements consists of the following: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:74%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Current&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;46,600&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;59,465&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Non-current&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;85,475&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;101,909&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;132,075&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;161,374&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DisclosureOfContractLiabilitiesTextBlock>
<ifrs-full:ContractLiabilities id="Factid_19490531" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">132075000</ifrs-full:ContractLiabilities>
<ifrs-full:ContractLiabilities id="Factid_19490532" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">161374000</ifrs-full:ContractLiabilities>
<ifrs-full:DisclosureOfOtherCurrentLiabilitiesExplanatory id="Factid_19490535" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;15.&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Other current liabilities &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;   &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The components of other curre&lt;div style="background-color:#ffffff;;display:inline;"&gt;n&lt;/div&gt;&lt;div style="display:inline;"&gt;&lt;div style="background-color:#ffffff;;display:inline;"&gt;t&lt;/div&gt;&lt;/div&gt;&amp;#160;liabilities are: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:74%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:8%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:8%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Payroll tax&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,185&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;727&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Accrual for vacation&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;525&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;330&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Deferred grant income&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;164&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Accrued bonuses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;154&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;52&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Other&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;161&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;15&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,025&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,288&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;Other current liabilities are &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-interest-bearing&lt;/div&gt; and are due within one year. The carrying amounts of other current liabilities represents fair value due to their short-term nature. &lt;/div&gt; &lt;div style="font-size: 1px; margin-top: 18px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfOtherCurrentLiabilitiesExplanatory>
<imtx:DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTextBlock id="Factid_19490537" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The components of other curre&lt;div style="background-color:#ffffff;;display:inline;"&gt;n&lt;/div&gt;&lt;div style="display:inline;"&gt;&lt;div style="background-color:#ffffff;;display:inline;"&gt;t&lt;/div&gt;&lt;/div&gt;&amp;#160;liabilities are: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:74%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:8%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:8%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Payroll tax&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,185&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;727&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Accrual for vacation&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;525&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;330&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Deferred grant income&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;164&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Accrued bonuses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;154&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;52&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Other&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;161&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;15&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,025&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,288&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTextBlock>
<imtx:MilestonePaymentReceivable id="Factid_19490538" contextRef="PAsOn12_31_2020_AmgenCollaborationAgreementMemberIMTXAgreementAxis_DevelopmentAndCommercialMilestonePaymentsMemberIMTXMilestoneAxis" unitRef="Unit_USD" decimals="-6">525000000</imtx:MilestonePaymentReceivable>
<imtx:UpfrontPaymentReceived id="Factid_19490539" contextRef="P01_01_2020To12_31_2020_AmgenCollaborationAgreementMemberIMTXAgreementAxis" unitRef="Unit_USD" decimals="-6">30000000</imtx:UpfrontPaymentReceived>
<ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod id="Factid_19490541" contextRef="P01_01_2020To12_31_2020_AmgenCollaborationAgreementMemberIMTXAgreementAxis" unitRef="Unit_EUR" decimals="-5">4900000</ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod>
<ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod id="Factid_19490542" contextRef="P01_01_2019To12_31_2019_AmgenCollaborationAgreementMemberIMTXAgreementAxis" unitRef="Unit_EUR" decimals="-5">6200000</ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod>
<ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod id="Factid_19490543" contextRef="P01_01_2018To12_31_2018_AmgenCollaborationAgreementMemberIMTXAgreementAxis" unitRef="Unit_EUR" decimals="-5">1500000</ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod>
<ifrs-full:ContractLiabilities id="Factid_19490544" contextRef="PAsOn12_31_2020_AmgenCollaborationAgreementMemberIMTXAgreementAxis" unitRef="Unit_EUR" decimals="-6">10000000</ifrs-full:ContractLiabilities>
<ifrs-full:ContractLiabilities id="Factid_19490545" contextRef="PAsOn12_31_2019_AmgenCollaborationAgreementMemberIMTXAgreementAxis" unitRef="Unit_EUR" decimals="-6">15000000</ifrs-full:ContractLiabilities>
<imtx:MilestonePaymentReceivable id="Factid_19490546" contextRef="PAsOn12_31_2020_GenmabCollaborationAgreementMemberIMTXAgreementAxis_MilestonePaymentForLicensedProductMemberIMTXMilestoneAxis" unitRef="Unit_USD" decimals="-6">550000000</imtx:MilestonePaymentReceivable>
<imtx:UpfrontPaymentReceived id="Factid_19490547" contextRef="P01_01_2020To12_31_2020_GenmabCollaborationAgreementMemberIMTXAgreementAxis" unitRef="Unit_USD" decimals="-6">54000000</imtx:UpfrontPaymentReceived>
<ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod id="Factid_19490548" contextRef="P01_01_2020To12_31_2020_GenmabCollaborationAgreementMemberIMTXAgreementAxis" unitRef="Unit_EUR" decimals="-5">11200000</ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod>
<ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod id="Factid_19490549" contextRef="P01_01_2019To12_31_2019_GenmabCollaborationAgreementMemberIMTXAgreementAxis" unitRef="Unit_EUR" decimals="-5">11200000</ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod>
<ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod id="Factid_19490550" contextRef="P01_01_2018To12_31_2018_GenmabCollaborationAgreementMemberIMTXAgreementAxis" unitRef="Unit_EUR" decimals="-5">2300000</ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod>
<ifrs-full:ContractLiabilities id="Factid_19490552" contextRef="PAsOn12_31_2020_GenmabCollaborationAgreementMemberIMTXAgreementAxis" unitRef="Unit_EUR" decimals="-6">26000000</ifrs-full:ContractLiabilities>
<ifrs-full:ContractLiabilities id="Factid_19490553" contextRef="PAsOn12_31_2019_GenmabCollaborationAgreementMemberIMTXAgreementAxis" unitRef="Unit_EUR" decimals="-6">35000000</ifrs-full:ContractLiabilities>
<imtx:MilestonePaymentReceivable id="Factid_19490555" contextRef="PAsOn12_31_2020_BMSCollaborationAgreementMemberIMTXAgreementAxis_OptionExerciseDevelopmentCommecialAndRegulatoryMilestonePaymentsMemberIMTXMilestoneAxis" unitRef="Unit_USD" decimals="-6">505000000</imtx:MilestonePaymentReceivable>
<imtx:UpfrontPaymentReceived id="Factid_19490556" contextRef="P01_01_2020To12_31_2020_BMSCollaborationAgreementMemberIMTXAgreementAxis" unitRef="Unit_USD" decimals="-6">75000000</imtx:UpfrontPaymentReceived>
<ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod id="Factid_19490557" contextRef="P01_01_2020To12_31_2020_BMSCollaborationAgreementMemberIMTXAgreementAxis" unitRef="Unit_EUR" decimals="-5">11500000</ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod>
<ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod id="Factid_19490558" contextRef="P01_01_2019To12_31_2019_BMSCollaborationAgreementMemberIMTXAgreementAxis" unitRef="Unit_EUR" decimals="-5">1100000</ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod>
<ifrs-full:ContractLiabilities id="Factid_19490559" contextRef="PAsOn12_31_2020_BMSCollaborationAgreementMemberIMTXAgreementAxis" unitRef="Unit_EUR" decimals="-6">55000000</ifrs-full:ContractLiabilities>
<imtx:UpfrontPaymentReceived id="Factid_19490561" contextRef="P01_01_2020To12_31_2020_GSKCollaborationAgreementMemberIMTXAgreementAxis" unitRef="Unit_USD" decimals="-6">45000000</imtx:UpfrontPaymentReceived>
<imtx:MilestonePaymentReceivable id="Factid_19490562" contextRef="PAsOn12_31_2020_GSKCollaborationAgreementMemberIMTXAgreementAxis_MilestoneProgramsBasedOnTheProgramMemberIMTXMilestoneAxis" unitRef="Unit_USD" decimals="-6">575000000</imtx:MilestonePaymentReceivable>
<ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod id="Factid_19490563" contextRef="P01_01_2020To12_31_2020_GSKCollaborationAgreementMemberIMTXAgreementAxis" unitRef="Unit_EUR" decimals="-5">3700000</ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod>
<ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod id="Factid_19490564" contextRef="P01_01_2019To12_31_2019_GSKCollaborationAgreementMemberIMTXAgreementAxis" unitRef="Unit_EUR" decimals="-6">0</ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod>
<ifrs-full:ContractLiabilities id="Factid_19490565" contextRef="PAsOn12_31_2020_GSKCollaborationAgreementMemberIMTXAgreementAxis" unitRef="Unit_EUR" decimals="-6">41000000</ifrs-full:ContractLiabilities>
<ifrs-full:ContractLiabilities id="Factid_19490566" contextRef="PAsOn12_31_2019_GSKCollaborationAgreementMemberIMTXAgreementAxis" unitRef="Unit_EUR" decimals="-6">45000000</ifrs-full:ContractLiabilities>
<ifrs-full:CurrentTaxLiabilitiesCurrent id="Factid_19490567" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">1185000</ifrs-full:CurrentTaxLiabilitiesCurrent>
<ifrs-full:CurrentTaxLiabilitiesCurrent id="Factid_19490568" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">727000</ifrs-full:CurrentTaxLiabilitiesCurrent>
<ifrs-full:AccrualsClassifiedAsCurrent id="Factid_19490569" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">525000</ifrs-full:AccrualsClassifiedAsCurrent>
<ifrs-full:AccrualsClassifiedAsCurrent id="Factid_19490570" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">330000</ifrs-full:AccrualsClassifiedAsCurrent>
<imtx:DeferredGrantIncomeCurrent id="Factid_19490571" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">164000</imtx:DeferredGrantIncomeCurrent>
<ifrs-full:CurrentProvisionsForEmployeeBenefits id="Factid_19490572" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">154000</ifrs-full:CurrentProvisionsForEmployeeBenefits>
<ifrs-full:CurrentProvisionsForEmployeeBenefits id="Factid_19490573" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">52000</ifrs-full:CurrentProvisionsForEmployeeBenefits>
<imtx:OtherCurrent id="Factid_19490574" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">161000</imtx:OtherCurrent>
<imtx:OtherCurrent id="Factid_19490575" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">15000</imtx:OtherCurrent>
<ifrs-full:AssetsRecognisedFromCostsToObtainOrFulfilContractsWithCustomers id="Factid_19490578" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-5">1200000</ifrs-full:AssetsRecognisedFromCostsToObtainOrFulfilContractsWithCustomers>
<ifrs-full:AssetsRecognisedFromCostsToObtainOrFulfilContractsWithCustomers id="Factid_19490579" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-5">1500000</ifrs-full:AssetsRecognisedFromCostsToObtainOrFulfilContractsWithCustomers>
<ifrs-full:AmortisationAssetsRecognisedFromCostsIncurredToObtainOrFulfilContractsWithCustomers id="Factid_19490580" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-5">300000</ifrs-full:AmortisationAssetsRecognisedFromCostsIncurredToObtainOrFulfilContractsWithCustomers>
<ifrs-full:AmortisationAssetsRecognisedFromCostsIncurredToObtainOrFulfilContractsWithCustomers id="Factid_19490581" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-5">200000</ifrs-full:AmortisationAssetsRecognisedFromCostsIncurredToObtainOrFulfilContractsWithCustomers>
<ifrs-full:AmortisationAssetsRecognisedFromCostsIncurredToObtainOrFulfilContractsWithCustomers id="Factid_19490582" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-4">40000</ifrs-full:AmortisationAssetsRecognisedFromCostsIncurredToObtainOrFulfilContractsWithCustomers>
<imtx:PotentialMilestonePaymentPayable id="Factid_19490583" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-6">2000000</imtx:PotentialMilestonePaymentPayable>
<ifrs-full:BorrowingsMaturity id="Factid_19490584" contextRef="P01_01_2020To12_31_2020_NonInterestBearingLiabilityMemberifrsfullBorrowingsByNameAxis">one year</ifrs-full:BorrowingsMaturity>
<ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory id="Factid_19490585" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="background-color:#ffffff;;display:inline;"&gt;14. Other income &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other income includes grant income, in addition immaterial amounts from other sources. The Group receives income through government grants for specific research and development projects. The Group recognizes grant income as it performs research and development activities specified by the grant agreements. Total grant income &lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;was &amp;#8364;0.2&amp;#160;million, &amp;#8364;0.03&amp;#160;million, and &amp;#8364;2.9&amp;#160;million during the years ended December&amp;#160;31, 2020, 2019 and 2018, respectively. There are no unfulfilled conditions or contingencies attached to these grants. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Group had the following deferred income and receivable balances under these agreements: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:73%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:9%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:9%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Receivables&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;875&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;998&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred income&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;164&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;875&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,162&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Group classifies receivables under these agreements within other current assets, while it presents deferred income within other current liabilities. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory>
<imtx:DisclosureOfOtherIncomeExplanatoryTextBlock id="Factid_19490586" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Group had the following deferred income and receivable balances under these agreements: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:73%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:9%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:9%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Receivables&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;875&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;998&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred income&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;164&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;875&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,162&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DisclosureOfOtherIncomeExplanatoryTextBlock>
<ifrs-full:NumberOfSharesOutstanding id="Factid_19490587" contextRef="PAsOn07_01_2020_OrdinarySharesMemberifrsfullClassesOfShareCapitalAxis" unitRef="Unit_shares" decimals="INF">62908617</ifrs-full:NumberOfSharesOutstanding>
<ifrs-full:ParValuePerShare id="Factid_19490588" contextRef="PAsOn07_01_2020_OrdinarySharesMemberifrsfullClassesOfShareCapitalAxis" unitRef="Unit_EUR_per_Share" decimals="INF">0.01</ifrs-full:ParValuePerShare>
<ifrs-full:CurrentTaxExpenseIncome id="Factid_19490592" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">66818000</ifrs-full:CurrentTaxExpenseIncome>
<ifrs-full:CurrentTaxExpenseIncome id="Factid_19490593" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">9454000</ifrs-full:CurrentTaxExpenseIncome>
<ifrs-full:CurrentTaxExpenseIncome id="Factid_19490594" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">9415000</ifrs-full:CurrentTaxExpenseIncome>
<ifrs-full:TaxEffectFromChangeInTaxRate id="Factid_19490595" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">2582000</ifrs-full:TaxEffectFromChangeInTaxRate>
<ifrs-full:TaxEffectFromChangeInTaxRate id="Factid_19490596" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">1875000</ifrs-full:TaxEffectFromChangeInTaxRate>
<ifrs-full:TaxEffectFromChangeInTaxRate id="Factid_19490597" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">1373000</ifrs-full:TaxEffectFromChangeInTaxRate>
<ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss id="Factid_19490598" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">599000</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
<ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss id="Factid_19490599" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">61000</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
<ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss id="Factid_19490600" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">70000</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
<imtx:TaxEffectOfGovernmentGrantsExemptedFromTaxes id="Factid_19490601" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">45000</imtx:TaxEffectOfGovernmentGrantsExemptedFromTaxes>
<imtx:TaxEffectOfGovernmentGrantsExemptedFromTaxes id="Factid_19490602" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">8000</imtx:TaxEffectOfGovernmentGrantsExemptedFromTaxes>
<imtx:TaxEffectOfGovernmentGrantsExemptedFromTaxes id="Factid_19490603" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">853000</imtx:TaxEffectOfGovernmentGrantsExemptedFromTaxes>
<imtx:NonRecognitionOfDeferredTaxesOnTaxLossesAndTemporaryDifferences id="Factid_19490604" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">-19221000</imtx:NonRecognitionOfDeferredTaxesOnTaxLossesAndTemporaryDifferences>
<imtx:NonRecognitionOfDeferredTaxesOnTaxLossesAndTemporaryDifferences id="Factid_19490605" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">-7526000</imtx:NonRecognitionOfDeferredTaxesOnTaxLossesAndTemporaryDifferences>
<imtx:NonRecognitionOfDeferredTaxesOnTaxLossesAndTemporaryDifferences id="Factid_19490606" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">-8825000</imtx:NonRecognitionOfDeferredTaxesOnTaxLossesAndTemporaryDifferences>
<imtx:GovernmentGrantReceivable id="Factid_19490610" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">875000</imtx:GovernmentGrantReceivable>
<imtx:GovernmentGrantReceivable id="Factid_19490611" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">998000</imtx:GovernmentGrantReceivable>
<imtx:DeferredIncomeCurrent id="Factid_19490612" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">0</imtx:DeferredIncomeCurrent>
<imtx:DeferredIncomeCurrent id="Factid_19490613" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">164000</imtx:DeferredIncomeCurrent>
<imtx:TotalDeferredIncome id="Factid_19490614" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">875000</imtx:TotalDeferredIncome>
<imtx:TotalDeferredIncome id="Factid_19490615" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">1162000</imtx:TotalDeferredIncome>
<ifrs-full:IssuedCapital id="Factid_19490616" contextRef="PAsOn07_01_2020" unitRef="Unit_EUR" decimals="-3">629000</ifrs-full:IssuedCapital>
<ifrs-full:RevenueFromGovernmentGrants id="Factid_19490617" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-5">200000</ifrs-full:RevenueFromGovernmentGrants>
<ifrs-full:RevenueFromGovernmentGrants id="Factid_19490618" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-4">30000</ifrs-full:RevenueFromGovernmentGrants>
<ifrs-full:RevenueFromGovernmentGrants id="Factid_19490619" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-5">2900000</ifrs-full:RevenueFromGovernmentGrants>
<imtx:ContingenciesRelatedToGrant id="Factid_19490620" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-6">0</imtx:ContingenciesRelatedToGrant>
<imtx:DisclosureOfShareListingExpenseTextBlock id="Factid_19490622" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;17. Share listing expense &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;As described in Note 3, the ARYA Merger led to a share listing expense. Immatics issued shares and warrants with a fair value of &amp;#8364;277.7&amp;#160;million to ARYA shareholders, comprised of the fair value of Immatics shares, that were issued to ARYA shareholders of &amp;#8364;13.53 per share, as well as a fair value of Immatics Warrants of &amp;#8364;4.82 per share (price of ARYA shares at Closing of the ARYA Merger). In exchange, Immatics received the identifiable net assets held by ARYA, which had a fair value of upon closing of &amp;#8364;124.9&amp;#160;million. The excess of the fair value of the equity instruments issued over the fair value of the identified net assets contributed, represents a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-cash&lt;/div&gt; expense in accordance with IFRS 2. This &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;one-time&lt;/div&gt; expense as a result of the ARYA Merger, in the amount of &amp;#8364;152.8&amp;#160;million, is recognized as Share listing expense presented as part of the Financial result within the Consolidated Statement of Loss. Details of the calculation of the Share listing expense are as follows: &lt;/div&gt; &lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;  &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:73%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(Euros in thousands, except share and per share data)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="white-space: nowrap; padding-bottom: 0.45pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Description&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.45pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Amount&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.45pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.45pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="padding-bottom: 0.75pt; border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:center;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Number of&lt;br/&gt; shares/warrants&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.45pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;(a) ARYA Ordinary Shares&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;17,968,750&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(b) Closing price of ARYA Ordinary Shares on Nasdaq as of July&amp;#160;1, 2020&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#8364;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;13.53&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;(c) Fair value of TopCo Shares issued to ARYA shareholders &lt;div style="font-weight:bold;display:inline;width:100%;"&gt;(a * b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:bottom;"&gt;&amp;#8364;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;243,071&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255);;display:inline;"&gt;&amp;#8212;&amp;#160;&lt;/div&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(d) Outstanding ARYA Public Warrants&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;7,187,500&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;(e) Closing price of ARYA Public Warrants on Nasdaq as of July&amp;#160;1, 2020&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#8364;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;4.82&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(f) Fair value of outstanding ARYA Public Warrants (d * e)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#8364;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;34,644&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Total fair value of ARYA Ordinary Shares and ARYA Public Warrants (c + f)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8364;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;277,715&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;ARYA&amp;#8217;s identifiable net assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#8364;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;124,927&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;IFRS 2 Expense on the closing date&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8364;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;152,787&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DisclosureOfShareListingExpenseTextBlock>
<ifrs-full:NumberOfSharesOutstanding id="Factid_19490623" contextRef="PAsOn12_31_2020" unitRef="Unit_shares" decimals="INF">62908617</ifrs-full:NumberOfSharesOutstanding>
<ifrs-full:ParValuePerShare id="Factid_19490624" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR_per_Share" decimals="INF">0.01</ifrs-full:ParValuePerShare>
<ifrs-full:NumberOfSharesOutstanding id="Factid_19490625" contextRef="PAsOn12_31_2019_ImmaticsBiotechnologiesGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_shares" decimals="INF">1163625</ifrs-full:NumberOfSharesOutstanding>
<ifrs-full:ParValuePerShare id="Factid_19490626" contextRef="PAsOn12_31_2019_ImmaticsBiotechnologiesGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_EUR_per_Share" decimals="INF">1.00</ifrs-full:ParValuePerShare>
<imtx:DisclosureOfDetailedInformationAboutShareListingExpensesTextBlock id="Factid_19490627" contextRef="P01_01_2020To12_31_2020">Details of the calculation of the Share listing expense are as follows:&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:73%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(Euros in thousands, except share and per share data)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="white-space: nowrap; padding-bottom: 0.45pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Description&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.45pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Amount&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.45pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.45pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="padding-bottom: 0.75pt; border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:center;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Number of&lt;br/&gt; shares/warrants&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.45pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;(a) ARYA Ordinary Shares&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;17,968,750&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(b) Closing price of ARYA Ordinary Shares on Nasdaq as of July&amp;#160;1, 2020&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#8364;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;13.53&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;(c) Fair value of TopCo Shares issued to ARYA shareholders &lt;div style="font-weight:bold;display:inline;width:100%;"&gt;(a * b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:bottom;"&gt;&amp;#8364;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;243,071&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255);;display:inline;"&gt;&amp;#8212;&amp;#160;&lt;/div&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(d) Outstanding ARYA Public Warrants&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;7,187,500&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;(e) Closing price of ARYA Public Warrants on Nasdaq as of July&amp;#160;1, 2020&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#8364;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;4.82&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(f) Fair value of outstanding ARYA Public Warrants (d * e)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#8364;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;34,644&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Total fair value of ARYA Ordinary Shares and ARYA Public Warrants (c + f)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8364;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;277,715&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;ARYA&amp;#8217;s identifiable net assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#8364;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;124,927&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;IFRS 2 Expense on the closing date&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8364;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;152,787&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DisclosureOfDetailedInformationAboutShareListingExpensesTextBlock>
<ifrs-full:SharePremium id="Factid_19490628" contextRef="PAsOn12_31_2018_ImmaticsBiotechnologiesGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis_SeriesEShareCapitalMemberifrsfullClassesOfShareCapitalAxis" unitRef="Unit_EUR" decimals="-5">23600000</ifrs-full:SharePremium>
<imtx:NumberOfWarrantsOutsatnding id="Factid_19490629" contextRef="PAsOn12_31_2020_AryaMergerMemberIMTXShareListingExpenseAxis" unitRef="Unit_shares" decimals="0">7187500</imtx:NumberOfWarrantsOutsatnding>
<imtx:ExercisePriceOfWarrants id="Factid_19490630" contextRef="PAsOn12_31_2020_AryaMergerMemberIMTXShareListingExpenseAxis" unitRef="Unit_USD_per_Share" decimals="2">11.50</imtx:ExercisePriceOfWarrants>
<imtx:ClassOfWarrantOrRightTermPeriod id="Factid_19490631" contextRef="P01_01_2020To12_31_2020_AryaMergerMemberIMTXShareListingExpenseAxis">P5Y</imtx:ClassOfWarrantOrRightTermPeriod>
<ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable id="Factid_19490633" contextRef="PAsOn12_31_2020_AryaMemberifrsfullBusinessCombinationsAxis_OrdinarySharesMemberifrsfullClassesOfShareCapitalAxis" unitRef="Unit_shares" decimals="0">17968750</ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable>
<ifrs-full:ParValuePerShare id="Factid_19490634" contextRef="PAsOn12_31_2020_AryaMemberifrsfullBusinessCombinationsAxis_OrdinarySharesMemberifrsfullClassesOfShareCapitalAxis" unitRef="Unit_EUR_per_Share" decimals="2">13.53</ifrs-full:ParValuePerShare>
<ifrs-full:EquityInterestsOfAcquirer id="Factid_19490636" contextRef="PAsOn12_31_2020_AryaMemberifrsfullBusinessCombinationsAxis_OrdinarySharesMemberifrsfullClassesOfShareCapitalAxis" unitRef="Unit_EUR" decimals="-3">243071000</ifrs-full:EquityInterestsOfAcquirer>
<ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable id="Factid_19490639" contextRef="PAsOn12_31_2020_AryaMemberifrsfullBusinessCombinationsAxis_WarrantsMemberifrsfullClassesOfFinancialInstrumentsAxis" unitRef="Unit_Warrants" decimals="0">7187500</ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable>
<imtx:WarrantsIssuedPricePerWarrant id="Factid_19490640" contextRef="PAsOn12_31_2020_AryaMemberifrsfullBusinessCombinationsAxis_WarrantsMemberifrsfullClassesOfFinancialInstrumentsAxis" unitRef="Unit_EUR_per_Share" decimals="2">4.82</imtx:WarrantsIssuedPricePerWarrant>
<ifrs-full:EquityInterestsOfAcquirer id="Factid_19490642" contextRef="PAsOn12_31_2020_AryaMemberifrsfullBusinessCombinationsAxis_WarrantsMemberifrsfullClassesOfFinancialInstrumentsAxis" unitRef="Unit_EUR" decimals="-3">34644000</ifrs-full:EquityInterestsOfAcquirer>
<ifrs-full:EquityInterestsOfAcquirer id="Factid_19490644" contextRef="PAsOn12_31_2020_AryaMemberifrsfullBusinessCombinationsAxis" unitRef="Unit_EUR" decimals="-3">277715000</ifrs-full:EquityInterestsOfAcquirer>
<ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed id="Factid_19490646" contextRef="PAsOn12_31_2020_AryaMemberifrsfullBusinessCombinationsAxis" unitRef="Unit_EUR" decimals="-3">124927000</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
<imtx:AdjustmentsForShareListingExpense id="Factid_19490648" contextRef="P01_01_2020To12_31_2020_AryaMemberifrsfullBusinessCombinationsAxis" unitRef="Unit_EUR" decimals="-3">152787000</imtx:AdjustmentsForShareListingExpense>
<ifrs-full:DeferredTaxAssets id="Factid_19490650" contextRef="PAsOn12_31_2020_IntangibleAssetsMemberifrsfullAssetsAndLiabilitiesAxis" unitRef="Unit_EUR" decimals="-3">1770000</ifrs-full:DeferredTaxAssets>
<ifrs-full:DeferredTaxAssets id="Factid_19490651" contextRef="PAsOn12_31_2019_IntangibleAssetsMemberifrsfullAssetsAndLiabilitiesAxis" unitRef="Unit_EUR" decimals="-3">2064000</ifrs-full:DeferredTaxAssets>
<ifrs-full:DeferredTaxLiabilities id="Factid_19490652" contextRef="PAsOn12_31_2020_DeferredTaxLiabilitiesRightOfUseAssetMemberifrsfullAssetsAndLiabilitiesAxis" unitRef="Unit_EUR" decimals="-3">1713000</ifrs-full:DeferredTaxLiabilities>
<ifrs-full:DeferredTaxLiabilities id="Factid_19490653" contextRef="PAsOn12_31_2019_DeferredTaxLiabilitiesRightOfUseAssetMemberifrsfullAssetsAndLiabilitiesAxis" unitRef="Unit_EUR" decimals="-3">854000</ifrs-full:DeferredTaxLiabilities>
<ifrs-full:DeferredTaxAssets id="Factid_19490654" contextRef="PAsOn12_31_2020_DeferredRevenueMemberifrsfullAssetsAndLiabilitiesAxis" unitRef="Unit_EUR" decimals="-3">180000</ifrs-full:DeferredTaxAssets>
<ifrs-full:DeferredTaxAssets id="Factid_19490655" contextRef="PAsOn12_31_2019_DeferredRevenueMemberifrsfullAssetsAndLiabilitiesAxis" unitRef="Unit_EUR" decimals="-3">358000</ifrs-full:DeferredTaxAssets>
<ifrs-full:DeferredTaxAssets id="Factid_19490656" contextRef="PAsOn12_31_2019_OtherLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis" unitRef="Unit_EUR" decimals="-3">607000</ifrs-full:DeferredTaxAssets>
<ifrs-full:DeferredTaxAssets id="Factid_19490657" contextRef="PAsOn12_31_2020_LeaseLiabilityMemberifrsfullAssetsAndLiabilitiesAxis" unitRef="Unit_EUR" decimals="-3">1776000</ifrs-full:DeferredTaxAssets>
<ifrs-full:DeferredTaxAssets id="Factid_19490658" contextRef="PAsOn12_31_2019_LeaseLiabilityMemberifrsfullAssetsAndLiabilitiesAxis" unitRef="Unit_EUR" decimals="-3">886000</ifrs-full:DeferredTaxAssets>
<ifrs-full:DeferredTaxAssets id="Factid_19490659" contextRef="PAsOn12_31_2020_DeferredExpensesMemberifrsfullAssetsAndLiabilitiesAxis" unitRef="Unit_EUR" decimals="-3">3000</ifrs-full:DeferredTaxAssets>
<ifrs-full:DeferredTaxAssets id="Factid_19490660" contextRef="PAsOn12_31_2019_DeferredExpensesMemberifrsfullAssetsAndLiabilitiesAxis" unitRef="Unit_EUR" decimals="-3">14000</ifrs-full:DeferredTaxAssets>
<ifrs-full:DeferredTaxAssets id="Factid_19490661" contextRef="PAsOn12_31_2020_DeferredAssetRecognisedMemberifrsfullAssetsAndLiabilitiesAxis" unitRef="Unit_EUR" decimals="-3">3729000</ifrs-full:DeferredTaxAssets>
<ifrs-full:DeferredTaxLiabilities id="Factid_19490662" contextRef="PAsOn12_31_2020_DeferredTaxLiabilitiesDeferredExpensesMemberifrsfullAssetsAndLiabilitiesAxis" unitRef="Unit_EUR" decimals="-3">1713000</ifrs-full:DeferredTaxLiabilities>
<ifrs-full:DeferredTaxAssets id="Factid_19490663" contextRef="PAsOn12_31_2019_DeferredAssetRecognisedMemberifrsfullAssetsAndLiabilitiesAxis" unitRef="Unit_EUR" decimals="-3">3929000</ifrs-full:DeferredTaxAssets>
<ifrs-full:DeferredTaxLiabilities id="Factid_19490664" contextRef="PAsOn12_31_2019_DeferredTaxLiabilitiesDeferredExpensesMemberifrsfullAssetsAndLiabilitiesAxis" unitRef="Unit_EUR" decimals="-3">854000</ifrs-full:DeferredTaxLiabilities>
<imtx:DeferredTaxAssetsOffset id="Factid_19490665" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">-1713000</imtx:DeferredTaxAssetsOffset>
<imtx:DeferredTaxLiabilitiesOffSet id="Factid_19490666" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">1713000</imtx:DeferredTaxLiabilitiesOffSet>
<imtx:DeferredTaxAssetsOffset id="Factid_19490667" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">-854000</imtx:DeferredTaxAssetsOffset>
<imtx:DeferredTaxLiabilitiesOffSet id="Factid_19490668" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">854000</imtx:DeferredTaxLiabilitiesOffSet>
<imtx:DeferredTaxAssetsNonrecognition id="Factid_19490669" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">-2016000</imtx:DeferredTaxAssetsNonrecognition>
<imtx:DeferredTaxAssetsNonrecognition id="Factid_19490670" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">-3075000</imtx:DeferredTaxAssetsNonrecognition>
<ifrs-full:DeferredTaxAssets id="Factid_19490671" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">0</ifrs-full:DeferredTaxAssets>
<ifrs-full:DeferredTaxLiabilities id="Factid_19490672" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">0</ifrs-full:DeferredTaxLiabilities>
<ifrs-full:DeferredTaxAssets id="Factid_19490673" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">0</ifrs-full:DeferredTaxAssets>
<ifrs-full:DeferredTaxLiabilities id="Factid_19490674" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">0</ifrs-full:DeferredTaxLiabilities>
<imtx:PercentageOnLimitationOnTaxLossCarryforwardsAfterPriorPeriod id="Factid_19490675" contextRef="PAsOn12_31_2020" unitRef="Unit_pure" decimals="4">0.8000</imtx:PercentageOnLimitationOnTaxLossCarryforwardsAfterPriorPeriod>
<imtx:PercentageOnLimitationOnTaxLossCarryforwardsBeforePriorPeriod id="Factid_19490676" contextRef="PAsOn12_31_2017" unitRef="Unit_pure" decimals="4">1.0000</imtx:PercentageOnLimitationOnTaxLossCarryforwardsBeforePriorPeriod>
<ifrs-full:TaxEffectOfTaxLosses id="Factid_19490677" contextRef="P01_01_2020To12_31_2020_IndefiniteTaxLossesCarryforwardMemberifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" unitRef="Unit_EUR" decimals="-6">288000000</ifrs-full:TaxEffectOfTaxLosses>
<ifrs-full:TaxEffectOfTaxLosses id="Factid_19490678" contextRef="P01_01_2019To12_31_2019_IndefiniteTaxLossesCarryforwardMemberifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" unitRef="Unit_EUR" decimals="-6">219000000</ifrs-full:TaxEffectOfTaxLosses>
<ifrs-full:TaxEffectOfTaxLosses id="Factid_19490679" contextRef="P01_01_2020To12_31_2020_TwentySixYearTaxLossesCarryforwardMemberifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" unitRef="Unit_EUR" decimals="-6">26000000</ifrs-full:TaxEffectOfTaxLosses>
<ifrs-full:ApplicableTaxRate id="Factid_19490680" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_pure" decimals="3">0.291</ifrs-full:ApplicableTaxRate>
<ifrs-full:ApplicableTaxRate id="Factid_19490681" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_pure" decimals="3">0.291</ifrs-full:ApplicableTaxRate>
<ifrs-full:ApplicableTaxRate id="Factid_19490682" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_pure" decimals="3">0.291</ifrs-full:ApplicableTaxRate>
<imtx:CorporateIncomeTaxRate id="Factid_19490683" contextRef="PAsOn12_31_2020" unitRef="Unit_pure" decimals="2">0.21</imtx:CorporateIncomeTaxRate>
<imtx:CorporateIncomeTaxRate id="Factid_19490684" contextRef="PAsOn12_31_2019" unitRef="Unit_pure" decimals="2">0.21</imtx:CorporateIncomeTaxRate>
<imtx:CorporateIncomeTaxRate id="Factid_19490685" contextRef="PAsOn12_31_2018" unitRef="Unit_pure" decimals="2">0.21</imtx:CorporateIncomeTaxRate>
<ifrs-full:WagesAndSalaries id="Factid_19490688" contextRef="P01_01_2020To12_31_2020_ResearchAndDevelopmentExpenseMemberIMTXIncomeStatementLocationAxis" unitRef="Unit_EUR" decimals="-3">15277000</ifrs-full:WagesAndSalaries>
<ifrs-full:WagesAndSalaries id="Factid_19490689" contextRef="P01_01_2019To12_31_2019_ResearchAndDevelopmentExpenseMemberIMTXIncomeStatementLocationAxis" unitRef="Unit_EUR" decimals="-3">11635000</ifrs-full:WagesAndSalaries>
<ifrs-full:WagesAndSalaries id="Factid_19490690" contextRef="P01_01_2018To12_31_2018_ResearchAndDevelopmentExpenseMemberIMTXIncomeStatementLocationAxis" unitRef="Unit_EUR" decimals="-3">10485000</ifrs-full:WagesAndSalaries>
<ifrs-full:WagesAndSalaries id="Factid_19490691" contextRef="P01_01_2020To12_31_2020_GeneralAndAdministrativeExpenseMemberIMTXIncomeStatementLocationAxis" unitRef="Unit_EUR" decimals="-3">6968000</ifrs-full:WagesAndSalaries>
<ifrs-full:WagesAndSalaries id="Factid_19490692" contextRef="P01_01_2019To12_31_2019_GeneralAndAdministrativeExpenseMemberIMTXIncomeStatementLocationAxis" unitRef="Unit_EUR" decimals="-3">3596000</ifrs-full:WagesAndSalaries>
<ifrs-full:WagesAndSalaries id="Factid_19490693" contextRef="P01_01_2018To12_31_2018_GeneralAndAdministrativeExpenseMemberIMTXIncomeStatementLocationAxis" unitRef="Unit_EUR" decimals="-3">2233000</ifrs-full:WagesAndSalaries>
<ifrs-full:WagesAndSalaries id="Factid_19490694" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">22245000</ifrs-full:WagesAndSalaries>
<ifrs-full:WagesAndSalaries id="Factid_19490695" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">15231000</ifrs-full:WagesAndSalaries>
<ifrs-full:WagesAndSalaries id="Factid_19490696" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">12718000</ifrs-full:WagesAndSalaries>
<ifrs-full:OtherShorttermEmployeeBenefits id="Factid_19490697" contextRef="P01_01_2020To12_31_2020_ResearchAndDevelopmentExpenseMemberIMTXIncomeStatementLocationAxis" unitRef="Unit_EUR" decimals="-3">2624000</ifrs-full:OtherShorttermEmployeeBenefits>
<ifrs-full:OtherShorttermEmployeeBenefits id="Factid_19490698" contextRef="P01_01_2019To12_31_2019_ResearchAndDevelopmentExpenseMemberIMTXIncomeStatementLocationAxis" unitRef="Unit_EUR" decimals="-3">2035000</ifrs-full:OtherShorttermEmployeeBenefits>
<ifrs-full:OtherShorttermEmployeeBenefits id="Factid_19490699" contextRef="P01_01_2018To12_31_2018_ResearchAndDevelopmentExpenseMemberIMTXIncomeStatementLocationAxis" unitRef="Unit_EUR" decimals="-3">1920000</ifrs-full:OtherShorttermEmployeeBenefits>
<ifrs-full:OtherShorttermEmployeeBenefits id="Factid_19490700" contextRef="P01_01_2020To12_31_2020_GeneralAndAdministrativeExpenseMemberIMTXIncomeStatementLocationAxis" unitRef="Unit_EUR" decimals="-3">1015000</ifrs-full:OtherShorttermEmployeeBenefits>
<ifrs-full:OtherShorttermEmployeeBenefits id="Factid_19490701" contextRef="P01_01_2019To12_31_2019_GeneralAndAdministrativeExpenseMemberIMTXIncomeStatementLocationAxis" unitRef="Unit_EUR" decimals="-3">728000</ifrs-full:OtherShorttermEmployeeBenefits>
<ifrs-full:OtherShorttermEmployeeBenefits id="Factid_19490702" contextRef="P01_01_2018To12_31_2018_GeneralAndAdministrativeExpenseMemberIMTXIncomeStatementLocationAxis" unitRef="Unit_EUR" decimals="-3">607000</ifrs-full:OtherShorttermEmployeeBenefits>
<ifrs-full:ShorttermEmployeeBenefitsExpense id="Factid_19490703" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">3639000</ifrs-full:ShorttermEmployeeBenefitsExpense>
<ifrs-full:ShorttermEmployeeBenefitsExpense id="Factid_19490704" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">2763000</ifrs-full:ShorttermEmployeeBenefitsExpense>
<ifrs-full:ShorttermEmployeeBenefitsExpense id="Factid_19490705" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">2527000</ifrs-full:ShorttermEmployeeBenefitsExpense>
<ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees id="Factid_19490706" contextRef="P01_01_2020To12_31_2020_ResearchAndDevelopmentExpenseMemberIMTXIncomeStatementLocationAxis" unitRef="Unit_EUR" decimals="-3">14546000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
<ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees id="Factid_19490707" contextRef="P01_01_2019To12_31_2019_ResearchAndDevelopmentExpenseMemberIMTXIncomeStatementLocationAxis" unitRef="Unit_EUR" decimals="-3">1556000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
<ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees id="Factid_19490708" contextRef="P01_01_2018To12_31_2018_ResearchAndDevelopmentExpenseMemberIMTXIncomeStatementLocationAxis" unitRef="Unit_EUR" decimals="-3">238000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
<ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees id="Factid_19490709" contextRef="P01_01_2020To12_31_2020_GeneralAndAdministrativeExpenseMemberIMTXIncomeStatementLocationAxis" unitRef="Unit_EUR" decimals="-3">10973000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
<ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees id="Factid_19490710" contextRef="P01_01_2019To12_31_2019_GeneralAndAdministrativeExpenseMemberIMTXIncomeStatementLocationAxis" unitRef="Unit_EUR" decimals="-3">460000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
<ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees id="Factid_19490711" contextRef="P01_01_2018To12_31_2018_GeneralAndAdministrativeExpenseMemberIMTXIncomeStatementLocationAxis" unitRef="Unit_EUR" decimals="-3">100000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
<ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees id="Factid_19490712" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">25519000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
<ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees id="Factid_19490713" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">2016000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
<ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees id="Factid_19490714" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">338000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
<ifrs-full:EmployeeBenefitsExpense id="Factid_19490715" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">51403000</ifrs-full:EmployeeBenefitsExpense>
<ifrs-full:EmployeeBenefitsExpense id="Factid_19490716" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">20010000</ifrs-full:EmployeeBenefitsExpense>
<ifrs-full:EmployeeBenefitsExpense id="Factid_19490717" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">15583000</ifrs-full:EmployeeBenefitsExpense>
<ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans id="Factid_19490718" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-5">200000</ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans>
<ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans id="Factid_19490719" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-5">100000</ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans>
<ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans id="Factid_19490720" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-5">100000</ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans>
<imtx:EmployeeHealthInsuranceCost id="Factid_19490721" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-5">400000</imtx:EmployeeHealthInsuranceCost>
<imtx:EmployeeHealthInsuranceCost id="Factid_19490722" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-5">300000</imtx:EmployeeHealthInsuranceCost>
<imtx:EmployeeHealthInsuranceCost id="Factid_19490723" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-5">400000</imtx:EmployeeHealthInsuranceCost>
<ifrs-full:SocialSecurityContributions id="Factid_19490724" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-5">1700000</ifrs-full:SocialSecurityContributions>
<ifrs-full:SocialSecurityContributions id="Factid_19490725" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-5">1300000</ifrs-full:SocialSecurityContributions>
<ifrs-full:SocialSecurityContributions id="Factid_19490726" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-5">1000000</ifrs-full:SocialSecurityContributions>
<ifrs-full:OtherEmployeeExpense id="Factid_19490727" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-5">100000</ifrs-full:OtherEmployeeExpense>
<ifrs-full:OtherEmployeeExpense id="Factid_19490728" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-4">70000</ifrs-full:OtherEmployeeExpense>
<ifrs-full:OtherEmployeeExpense id="Factid_19490729" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-5">200000</ifrs-full:OtherEmployeeExpense>
<ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory id="Factid_19490730" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;20.&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Non-controlling&lt;/div&gt; interests &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Non-controlling&lt;/div&gt; interests related to those shares in Immatics US Inc. which have been provided to The University of Texas M.D. Anderson Cancer Center, Houston/Texas/USA, (&amp;#8220;MD Anderson&amp;#8221;) based on the restricted stock acquisition agreement described below. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;Until June&amp;#160;30, 2020, Immatics and MD Anderson were partners in a Restricted Stock Acquisition Agreement (the &amp;#8220;RSAA&amp;#8221;). Under the terms of the RSAA, MD Anderson was entitled to additional restricted shares in Immatics US, Inc. based on performance of certain work orders between August&amp;#160;14, 2018 and August&amp;#160;14, 2020. MD Anderson performed services in connection with our clinical trials in our ACT platform. The RSAA was canceled as part of the ARYA Merger (See Note 3).&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;On July&amp;#160;1, 2020 MD Anderson exchanged all of its 379,420 shares in Immatics US, Inc., that they acquired under the RSAA for 697,431 shares in Immatics N.V. The shares of Immatics N.V. had a fair value at the date of the exchange of $15.15 per share. Immediately prior to the exchange, the carrying amount of the existing 5.14% &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-controlling&lt;/div&gt; interest in Immatics US Inc. was &amp;#8364;0.5&amp;#160;million. The exchange resulted in a decrease of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-controlling&lt;/div&gt; interest of &amp;#8364;0.5&amp;#160;million and a corresponding increase of share capital and net increase to share premium for the issuance of shares and derecognition of the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-controlling&lt;/div&gt; interest. The RSAA was also canceled as of July&amp;#160;1, 2020. Any future services rendered by MD Anderson will be paid in cash. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Loss allocated to the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-controlling&lt;/div&gt; interest amounted to &lt;/div&gt;&amp;#8364;0.6&amp;#160;million in 2020, &amp;#8364;0.9&amp;#160;million in 2019 and &amp;#8364;0.9&amp;#160;million in 2018, respectively. &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Non-controlling&lt;/div&gt; interests on equity amounted to &amp;#8364;1&amp;#160;million as of December&amp;#160;31, 2019 and &amp;#8364;1.2&amp;#160;million as of December&amp;#160;31, 2018. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;In total, the Group recognized expenses in relation to MD Anderson&amp;#8217;s performance under the RSAA of &amp;#8364;0.04&amp;#160;million, &amp;#8364;0.7&amp;#160;million and &amp;#8364;0.8&amp;#160;million as of December&amp;#160;31, 2020, 2019 and 2018, respectively. A corresponding increase in equity was recognized with an amount of &amp;#8364;0.7&amp;#160;million and &amp;#8364;0.8&amp;#160;million as of December&amp;#160;31, 2019 and 2018, respectively for vested shares under the agreement. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory>
<imtx:LossOnNoncontrollingInterest id="Factid_19490742" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-5">600000</imtx:LossOnNoncontrollingInterest>
<imtx:LossOnNoncontrollingInterest id="Factid_19490743" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-5">900000</imtx:LossOnNoncontrollingInterest>
<imtx:LossOnNoncontrollingInterest id="Factid_19490744" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-5">900000</imtx:LossOnNoncontrollingInterest>
<ifrs-full:NoncontrollingInterests id="Factid_19490746" contextRef="PAsOn12_31_2018" unitRef="Unit_EUR" decimals="-5">1200000</ifrs-full:NoncontrollingInterests>
<imtx:DisclosureOfCurrencyRiskExposureExplanatoryTableTextBlock id="Factid_19490748" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cash, cash equivalents and financial assets Immatics N.V. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:74%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:19%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&amp;#160;ended&amp;#160;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Cash and cash equivalents&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;42,528&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Financial assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total assets exposed to the risk&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;42,528&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="margin-bottom: 0px; margin-top: 0px;"&gt;&amp;#160;&lt;/div&gt; &lt;div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Conversion rate EUR/USD as reporting date 1/1.2271&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-bottom: 0px; margin-top: 0px;"&gt;&amp;#160;&lt;/div&gt; &lt;div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cash, cash equivalents and financial assets Immatics GmbH&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &amp;#160;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:74%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:19%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&amp;#160;ended&amp;#160;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Cash and cash equivalents&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;52,015&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Financial assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;24,448&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total assets exposed to the risk&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;76,463&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DisclosureOfCurrencyRiskExposureExplanatoryTableTextBlock>
<ifrs-full:SensitivityAnalysisForEachTypeOfMarketRisk id="Factid_19490749" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-size: 1px; margin-top: 18px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Sensitivity analysis Immatics N.V.: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:71%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Conversion&lt;br/&gt; rate&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); white-space: nowrap;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Profit/(loss)&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Carrying&lt;br/&gt; amount&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Euro weakens by 1% against U.S. dollars&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.2394&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(421&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;42,107&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Euro strengths by 1% against U.S. dollars&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1.2148&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;430&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;42,958&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Euro weakens by 5% against U.S. dollars&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.2885&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(2,025&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;40,503&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Euro strengths by 5% against U.S. dollars&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1.1657&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2,238&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;44,766&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Euro weakens by 10% against U.S. dollars&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.3498&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(3,866&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;38,662&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Euro strengths by 10% against U.S. dollars&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1.1044&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;4,725&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;47,253&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Sensitivity analysis Immatics GmbH: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:71%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Conversion&lt;br/&gt; rate&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); white-space: nowrap;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Profit/(loss)&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Carrying&lt;br/&gt; amount&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Euro weakens by 1% against U.S. dollars&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.2394&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(757&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;75,706&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Euro strengths by 1% against U.S. dollars&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1.2148&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;772&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;77,235&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Euro weakens by 5% against U.S. dollars&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.2885&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(3,641&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;72,822&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Euro strengths by 5% against U.S. dollars&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1.1657&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;4,024&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;80,487&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Euro weakens by 10% against U.S. dollars&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.3498&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(6,951&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;69,512&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Euro strengths by 10% against U.S. dollars&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1.1044&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;8,496&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;84,959&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:SensitivityAnalysisForEachTypeOfMarketRisk>
<ifrs-full:DescriptionOfManagingLiquidityRisk id="Factid_19490750" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December&amp;#160;31, 2020, and 2019, the Group held the following funds which are expected to generate cash inflows in time, to counteract liquidity risk. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:80%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&amp;#160;ended&amp;#160;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Cash and cash equivalents&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;207,530&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;103,353&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Short-term deposits&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;24,448&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,023&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total funds available&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;231,978&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;119,376&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DescriptionOfManagingLiquidityRisk>
<ifrs-full:CashAndCashEquivalents id="Factid_19490751" contextRef="PAsOn12_31_2020_CurrencyRiskMemberifrsfullTypesOfRisksAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_EUR" decimals="-3">42528000</ifrs-full:CashAndCashEquivalents>
<ifrs-full:FinancialAssets id="Factid_19490752" contextRef="PAsOn12_31_2020_CurrencyRiskMemberifrsfullTypesOfRisksAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_EUR" decimals="-3">0</ifrs-full:FinancialAssets>
<imtx:MaximumExposedToCurrencyRisk id="Factid_19490753" contextRef="PAsOn12_31_2020_CurrencyRiskMemberifrsfullTypesOfRisksAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_EUR" decimals="-3">42528000</imtx:MaximumExposedToCurrencyRisk>
<ifrs-full:CashAndCashEquivalents id="Factid_19490754" contextRef="PAsOn12_31_2020_CurrencyRiskMemberifrsfullTypesOfRisksAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_EUR" decimals="-3">52015000</ifrs-full:CashAndCashEquivalents>
<ifrs-full:FinancialAssets id="Factid_19490755" contextRef="PAsOn12_31_2020_CurrencyRiskMemberifrsfullTypesOfRisksAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_EUR" decimals="-3">24448000</ifrs-full:FinancialAssets>
<imtx:MaximumExposedToCurrencyRisk id="Factid_19490756" contextRef="PAsOn12_31_2020_CurrencyRiskMemberifrsfullTypesOfRisksAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_EUR" decimals="-3">76463000</imtx:MaximumExposedToCurrencyRisk>
<ifrs-full:ClosingForeignExchangeRate id="Factid_19490759" contextRef="PAsOn12_31_2020_EuroWeakensBy1AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_pure" decimals="4">1.2394</ifrs-full:ClosingForeignExchangeRate>
<imtx:IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints id="Factid_19490760" contextRef="P01_01_2020To12_31_2020_EuroWeakensBy1AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_EUR" decimals="-3">-421000</imtx:IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints>
<ifrs-full:ValueAtRisk id="Factid_19490761" contextRef="PAsOn12_31_2020_EuroWeakensBy1AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_EUR" decimals="-3">42107000</ifrs-full:ValueAtRisk>
<ifrs-full:ClosingForeignExchangeRate id="Factid_19490762" contextRef="PAsOn12_31_2020_EuroStrengthsBy1AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_pure" decimals="4">1.2148</ifrs-full:ClosingForeignExchangeRate>
<imtx:IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints id="Factid_19490763" contextRef="P01_01_2020To12_31_2020_EuroStrengthsBy1AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_EUR" decimals="-3">430000</imtx:IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints>
<ifrs-full:ValueAtRisk id="Factid_19490764" contextRef="PAsOn12_31_2020_EuroStrengthsBy1AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_EUR" decimals="-3">42958000</ifrs-full:ValueAtRisk>
<ifrs-full:ClosingForeignExchangeRate id="Factid_19490765" contextRef="PAsOn12_31_2020_EuroWeakensBy5AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_pure" decimals="4">1.2885</ifrs-full:ClosingForeignExchangeRate>
<imtx:IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints id="Factid_19490766" contextRef="P01_01_2020To12_31_2020_EuroWeakensBy5AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_EUR" decimals="-3">-2025000</imtx:IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints>
<ifrs-full:ValueAtRisk id="Factid_19490767" contextRef="PAsOn12_31_2020_EuroWeakensBy5AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_EUR" decimals="-3">40503000</ifrs-full:ValueAtRisk>
<ifrs-full:ClosingForeignExchangeRate id="Factid_19490768" contextRef="PAsOn12_31_2020_EuroStrengthsBy5AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_pure" decimals="4">1.1657</ifrs-full:ClosingForeignExchangeRate>
<imtx:IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints id="Factid_19490769" contextRef="P01_01_2020To12_31_2020_EuroStrengthsBy5AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_EUR" decimals="-3">2238000</imtx:IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints>
<ifrs-full:ValueAtRisk id="Factid_19490770" contextRef="PAsOn12_31_2020_EuroStrengthsBy5AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_EUR" decimals="-3">44766000</ifrs-full:ValueAtRisk>
<ifrs-full:ClosingForeignExchangeRate id="Factid_19490771" contextRef="PAsOn12_31_2020_EuroWeakensBy10AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_pure" decimals="4">1.3498</ifrs-full:ClosingForeignExchangeRate>
<imtx:IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints id="Factid_19490772" contextRef="P01_01_2020To12_31_2020_EuroWeakensBy10AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_EUR" decimals="-3">-3866000</imtx:IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints>
<ifrs-full:ValueAtRisk id="Factid_19490773" contextRef="PAsOn12_31_2020_EuroWeakensBy10AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_EUR" decimals="-3">38662000</ifrs-full:ValueAtRisk>
<ifrs-full:ClosingForeignExchangeRate id="Factid_19490774" contextRef="PAsOn12_31_2020_EuroStrengthsBy10AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_pure" decimals="4">1.1044</ifrs-full:ClosingForeignExchangeRate>
<imtx:IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints id="Factid_19490775" contextRef="P01_01_2020To12_31_2020_EuroStrengthsBy10AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_EUR" decimals="-3">4725000</imtx:IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints>
<ifrs-full:ValueAtRisk id="Factid_19490776" contextRef="PAsOn12_31_2020_EuroStrengthsBy10AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_EUR" decimals="-3">47253000</ifrs-full:ValueAtRisk>
<ifrs-full:ClosingForeignExchangeRate id="Factid_19490777" contextRef="PAsOn12_31_2020_EuroWeakensBy1AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_pure" decimals="4">1.2394</ifrs-full:ClosingForeignExchangeRate>
<imtx:IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints id="Factid_19490778" contextRef="P01_01_2020To12_31_2020_EuroWeakensBy1AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_EUR" decimals="-3">-757000</imtx:IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints>
<ifrs-full:ValueAtRisk id="Factid_19490779" contextRef="PAsOn12_31_2020_EuroWeakensBy1AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_EUR" decimals="-3">75706000</ifrs-full:ValueAtRisk>
<ifrs-full:ClosingForeignExchangeRate id="Factid_19490780" contextRef="PAsOn12_31_2020_EuroStrengthsBy1AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_pure" decimals="4">1.2148</ifrs-full:ClosingForeignExchangeRate>
<imtx:IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints id="Factid_19490781" contextRef="P01_01_2020To12_31_2020_EuroStrengthsBy1AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_EUR" decimals="-3">772000</imtx:IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints>
<ifrs-full:ValueAtRisk id="Factid_19490782" contextRef="PAsOn12_31_2020_EuroStrengthsBy1AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_EUR" decimals="-3">77235000</ifrs-full:ValueAtRisk>
<ifrs-full:ClosingForeignExchangeRate id="Factid_19490783" contextRef="PAsOn12_31_2020_EuroWeakensBy5AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_pure" decimals="4">1.2885</ifrs-full:ClosingForeignExchangeRate>
<imtx:IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints id="Factid_19490784" contextRef="P01_01_2020To12_31_2020_EuroWeakensBy5AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_EUR" decimals="-3">-3641000</imtx:IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints>
<ifrs-full:ValueAtRisk id="Factid_19490785" contextRef="PAsOn12_31_2020_EuroWeakensBy5AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_EUR" decimals="-3">72822000</ifrs-full:ValueAtRisk>
<ifrs-full:ClosingForeignExchangeRate id="Factid_19490786" contextRef="PAsOn12_31_2020_EuroStrengthsBy5AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_pure" decimals="4">1.1657</ifrs-full:ClosingForeignExchangeRate>
<imtx:IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints id="Factid_19490787" contextRef="P01_01_2020To12_31_2020_EuroStrengthsBy5AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_EUR" decimals="-3">4024000</imtx:IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints>
<ifrs-full:ValueAtRisk id="Factid_19490788" contextRef="PAsOn12_31_2020_EuroStrengthsBy5AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_EUR" decimals="-3">80487000</ifrs-full:ValueAtRisk>
<ifrs-full:ClosingForeignExchangeRate id="Factid_19490789" contextRef="PAsOn12_31_2020_EuroWeakensBy10AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_pure" decimals="4">1.3498</ifrs-full:ClosingForeignExchangeRate>
<imtx:IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints id="Factid_19490790" contextRef="P01_01_2020To12_31_2020_EuroWeakensBy10AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_EUR" decimals="-3">-6951000</imtx:IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints>
<ifrs-full:ValueAtRisk id="Factid_19490791" contextRef="PAsOn12_31_2020_EuroWeakensBy10AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_EUR" decimals="-3">69512000</ifrs-full:ValueAtRisk>
<ifrs-full:ClosingForeignExchangeRate id="Factid_19490792" contextRef="PAsOn12_31_2020_EuroStrengthsBy10AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_pure" decimals="4">1.1044</ifrs-full:ClosingForeignExchangeRate>
<imtx:IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints id="Factid_19490793" contextRef="P01_01_2020To12_31_2020_EuroStrengthsBy10AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_EUR" decimals="-3">8496000</imtx:IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints>
<ifrs-full:ValueAtRisk id="Factid_19490794" contextRef="PAsOn12_31_2020_EuroStrengthsBy10AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_EUR" decimals="-3">84959000</ifrs-full:ValueAtRisk>
<imtx:PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk id="Factid_19490795" contextRef="PAsOn12_31_2020_EuroWeakensBy1AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_pure" decimals="2">0.01</imtx:PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk>
<imtx:PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk id="Factid_19490796" contextRef="PAsOn12_31_2020_EuroStrengthsBy1AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_pure" decimals="2">0.01</imtx:PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk>
<imtx:PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk id="Factid_19490797" contextRef="PAsOn12_31_2020_EuroWeakensBy5AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_pure" decimals="2">0.05</imtx:PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk>
<imtx:PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk id="Factid_19490798" contextRef="PAsOn12_31_2020_EuroStrengthsBy5AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_pure" decimals="2">0.05</imtx:PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk>
<imtx:PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk id="Factid_19490799" contextRef="PAsOn12_31_2020_EuroWeakensBy10AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_pure" decimals="2">0.10</imtx:PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk>
<imtx:PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk id="Factid_19490800" contextRef="PAsOn12_31_2020_EuroStrengthsBy10AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_pure" decimals="2">0.10</imtx:PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk>
<imtx:PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk id="Factid_19490801" contextRef="PAsOn12_31_2020_EuroWeakensBy1AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_pure" decimals="2">0.01</imtx:PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk>
<imtx:PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk id="Factid_19490802" contextRef="PAsOn12_31_2020_EuroStrengthsBy1AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_pure" decimals="2">0.01</imtx:PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk>
<imtx:PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk id="Factid_19490803" contextRef="PAsOn12_31_2020_EuroWeakensBy5AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_pure" decimals="2">0.05</imtx:PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk>
<imtx:PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk id="Factid_19490804" contextRef="PAsOn12_31_2020_EuroStrengthsBy5AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_pure" decimals="2">0.05</imtx:PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk>
<imtx:PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk id="Factid_19490805" contextRef="PAsOn12_31_2020_EuroWeakensBy10AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_pure" decimals="2">0.10</imtx:PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk>
<imtx:PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk id="Factid_19490806" contextRef="PAsOn12_31_2020_EuroStrengthsBy10AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsNvMembersrtOwnershipAxis" unitRef="Unit_pure" decimals="2">0.10</imtx:PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk>
<imtx:PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk id="Factid_19490807" contextRef="PAsOn12_31_2020_EuroWeakensBy1AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_pure" decimals="2">0.01</imtx:PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk>
<imtx:PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk id="Factid_19490808" contextRef="PAsOn12_31_2020_EuroStrengthsBy1AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_pure" decimals="2">0.01</imtx:PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk>
<imtx:PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk id="Factid_19490809" contextRef="PAsOn12_31_2020_EuroWeakensBy5AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_pure" decimals="2">0.05</imtx:PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk>
<imtx:PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk id="Factid_19490810" contextRef="PAsOn12_31_2020_EuroStrengthsBy5AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_pure" decimals="2">0.05</imtx:PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk>
<imtx:PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk id="Factid_19490811" contextRef="PAsOn12_31_2020_EuroWeakensBy10AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_pure" decimals="2">0.10</imtx:PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk>
<imtx:PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk id="Factid_19490812" contextRef="PAsOn12_31_2020_EuroStrengthsBy10AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_pure" decimals="2">0.10</imtx:PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk>
<imtx:PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk id="Factid_19490813" contextRef="PAsOn12_31_2020_EuroWeakensBy1AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_pure" decimals="2">0.01</imtx:PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk>
<imtx:PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk id="Factid_19490814" contextRef="PAsOn12_31_2020_EuroStrengthsBy1AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_pure" decimals="2">0.01</imtx:PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk>
<imtx:PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk id="Factid_19490815" contextRef="PAsOn12_31_2020_EuroWeakensBy5AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_pure" decimals="2">0.05</imtx:PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk>
<imtx:PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk id="Factid_19490816" contextRef="PAsOn12_31_2020_EuroStrengthsBy5AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_pure" decimals="2">0.05</imtx:PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk>
<imtx:PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk id="Factid_19490817" contextRef="PAsOn12_31_2020_EuroWeakensBy10AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_pure" decimals="2">0.10</imtx:PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk>
<imtx:PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk id="Factid_19490818" contextRef="PAsOn12_31_2020_EuroStrengthsBy10AgainstUsDollarsMemberIMTXSensitiveAnalaysisOfCurrencyAxis_ImmaticsGmbhMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_pure" decimals="2">0.10</imtx:PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk>
<ifrs-full:FinancialAssetsHeldForManagingLiquidityRisk id="Factid_19490819" contextRef="PAsOn12_31_2020_CashAndCashEquivalentsMemberifrsfullClassesOfFinancialAssetsAxis_LiquidityRiskMemberifrsfullTypesOfRisksAxis" unitRef="Unit_EUR" decimals="-3">207530000</ifrs-full:FinancialAssetsHeldForManagingLiquidityRisk>
<ifrs-full:FinancialAssetsHeldForManagingLiquidityRisk id="Factid_19490820" contextRef="PAsOn12_31_2019_CashAndCashEquivalentsMemberifrsfullClassesOfFinancialAssetsAxis_LiquidityRiskMemberifrsfullTypesOfRisksAxis" unitRef="Unit_EUR" decimals="-3">103353000</ifrs-full:FinancialAssetsHeldForManagingLiquidityRisk>
<ifrs-full:FinancialAssetsHeldForManagingLiquidityRisk id="Factid_19490821" contextRef="PAsOn12_31_2020_LiquidityRiskMemberifrsfullTypesOfRisksAxis_ShorttermDepositsMemberifrsfullClassesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3">24448000</ifrs-full:FinancialAssetsHeldForManagingLiquidityRisk>
<ifrs-full:FinancialAssetsHeldForManagingLiquidityRisk id="Factid_19490822" contextRef="PAsOn12_31_2019_LiquidityRiskMemberifrsfullTypesOfRisksAxis_ShorttermDepositsMemberifrsfullClassesOfFinancialAssetsAxis" unitRef="Unit_EUR" decimals="-3">16023000</ifrs-full:FinancialAssetsHeldForManagingLiquidityRisk>
<ifrs-full:FinancialAssetsHeldForManagingLiquidityRisk id="Factid_19490823" contextRef="PAsOn12_31_2020_LiquidityRiskMemberifrsfullTypesOfRisksAxis" unitRef="Unit_EUR" decimals="-3">231978000</ifrs-full:FinancialAssetsHeldForManagingLiquidityRisk>
<ifrs-full:FinancialAssetsHeldForManagingLiquidityRisk id="Factid_19490824" contextRef="PAsOn12_31_2019_LiquidityRiskMemberifrsfullTypesOfRisksAxis" unitRef="Unit_EUR" decimals="-3">119376000</ifrs-full:FinancialAssetsHeldForManagingLiquidityRisk>
<ifrs-full:MaximumExposureToCreditRisk id="Factid_19490825" contextRef="PAsOn12_31_2020_CreditRiskMemberifrsfullTypesOfRisksAxis" unitRef="Unit_EUR" decimals="-6">232000000</ifrs-full:MaximumExposureToCreditRisk>
<ifrs-full:MaximumExposureToCreditRisk id="Factid_19490826" contextRef="PAsOn12_31_2019_CreditRiskMemberifrsfullTypesOfRisksAxis" unitRef="Unit_EUR" decimals="-6">119000000</ifrs-full:MaximumExposureToCreditRisk>
<ifrs-full:CashAndCashEquivalents id="Factid_19490827" contextRef="PAsOn12_31_2020_CreditRiskMemberifrsfullTypesOfRisksAxis" unitRef="Unit_EUR" decimals="-6">208000000</ifrs-full:CashAndCashEquivalents>
<ifrs-full:CashAndCashEquivalents id="Factid_19490828" contextRef="PAsOn12_31_2019_CreditRiskMemberifrsfullTypesOfRisksAxis" unitRef="Unit_EUR" decimals="-6">103000000</ifrs-full:CashAndCashEquivalents>
<ifrs-full:OtherFinancialAssets id="Factid_19490829" contextRef="PAsOn12_31_2020_CreditRiskMemberifrsfullTypesOfRisksAxis" unitRef="Unit_EUR" decimals="-6">24000000</ifrs-full:OtherFinancialAssets>
<ifrs-full:OtherFinancialAssets id="Factid_19490830" contextRef="PAsOn12_31_2019_CreditRiskMemberifrsfullTypesOfRisksAxis" unitRef="Unit_EUR" decimals="-6">16000000</ifrs-full:OtherFinancialAssets>
<imtx:PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk id="Factid_19490831" contextRef="PAsOn12_31_2020_CurrencyRiskMemberifrsfullTypesOfRisksAxis_USDsrtCurrencyAxis" unitRef="Unit_pure" decimals="2">0.10</imtx:PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk>
<imtx:PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk id="Factid_19490832" contextRef="PAsOn12_31_2020_CurrencyRiskMemberifrsfullTypesOfRisksAxis_EURsrtCurrencyAxis" unitRef="Unit_pure" decimals="2">0.10</imtx:PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk>
<ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss id="Factid_19490833" contextRef="P01_01_2020To12_31_2020_CurrencyRiskMemberifrsfullTypesOfRisksAxis_TopOfRangeMemberifrsfullRangeAxis" unitRef="Unit_EUR" decimals="-5">10900000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
<ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss id="Factid_19490834" contextRef="P01_01_2020To12_31_2020_BottomOfRangeMemberifrsfullRangeAxis_CurrencyRiskMemberifrsfullTypesOfRisksAxis" unitRef="Unit_EUR" decimals="-5">13200000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
<ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory id="Factid_19490835" contextRef="P01_01_2020To12_31_2020">&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;18.&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Share-based payments &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Immatics Biotechnologies GmbH previously issued share-based awards to employees under two different plans. Under the Immatics Biotechnologies GmbH Stock Appreciation Program 2010 (the &amp;#8220;2010 Plan&amp;#8221;), the Company issued stock appreciation rights (&amp;#8220;SARs&amp;#8221;), which the Group accounted for as cash-settled awards. Under the Immatics Biotechnologies 2016 Equity Incentive Plan (&amp;#8220;2016 Plan&amp;#8221;), the Company issued tandem awards, which allowed employees to exercise their awards as either a SAR or a stock option. In 2020, prior to the ARYA Merger, Immatics N.V. established the new equity incentive plan (&amp;#8220;2020 Equity Plan&amp;#8221;). As part of the ARYA Merger, the 2010 Plan and the 2016 Plan were converted and were superseded by the 2020 Equity Plan as described below. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Share appreciation rights (&amp;#8220;the 2010 Plan&amp;#8221;) &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Effective January&amp;#160;1, 2005, in addition to performance-related compensation, certain Immatics employees became eligible to participate in a Stock Appreciation Rights (SAR) Program as part of a long-term equity incentive scheme. The aim of this program was to give employees a long-term stake in the success of the Company. The SAR program was adopted by resolutions by the supervisory board in January 2005 and was subsequently amended on February&amp;#160;6, 2007 and September&amp;#160;7, 2010. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Under the 2010 Plan, the beneficiaries received SAR awards, which did not require any cash investment into the company. SARs granted under this program carried no dividend or voting rights. The award holders had the right to execute the vested SARs only in a defined exit event. An exit event was defined as the acquisition of more than 50.00% of the outstanding shares by a third party. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;SARs granted under the 2010 Plan vested based on the satisfaction of service requirements (time-based vesting). These awards generally had a five-year graded vesting period. Employees leaving the Group were able to retain any vested awards as of their termination date, unless they were terminated for cause. Per the terms of the SAR agreements, employees were not entitled to subscribe to shares in the Group. Therefore, SARs granted under the 2010 Plan might be settled in cash only. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As awards issued under the 2010 Plan were cash settled, the Group applied liability accounting and revalued the outstanding awards at each reporting date. The Group applied a Black Scholes pricing model to estimate the fair value of the SARs as of December&amp;#160;31, 2019 and 2018 based on a company value of $350,000&amp;#160;thousand and $160,000&amp;#160;thousand, respectively. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:83%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Amounts in USD&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Exercise price&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.12&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.12&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Underlying share price&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;67.87&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;27.21&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Volatility&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;73&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;64&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Time period (years)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1.25&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;5.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Risk free rate&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.59&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2.77&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Dividend yield&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;0.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;0.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Combined probability of exit events&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;80.00&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;25.00&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;Expected volatility was determined by calculating the historic volatility in share prices of peer companies within the biotechnology industry. The expected life in the model has been adjusted, based on management&amp;#8217;s best estimate, for the effects of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-transferability&lt;/div&gt; and exercise restrictions. Furthermore, the fair value of SARs issued under the 2010 Plan were discounted based on the probability of the awards becoming exercisable due to either a change in control or an IPO, as management expected to settle these awards also in case of an IPO. The Black Scholes model considered for an IPO event a time period of one year and for a trade sale event a time period of five years. Awards issued under the 2010 Plan did not expire. &lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Set out below are summaries of SARs issued during 2019 and 2018: &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:92%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:68%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price in&lt;br/&gt;USD&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price in&lt;br/&gt;USD&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;SARs outstanding at January&amp;#160;1,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.12&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;43,675&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.12&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;43,978&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;SARs granted&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;SARs forfeited&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.12&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;220&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.12&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;303&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;SARs outstanding at December&amp;#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1.12&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;43,455&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1.12&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;43,675&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;SARs vested&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.12&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;117&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.12&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;169&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;SARs exercisable&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;There were no awards issued under the 2010 Plan as of December&amp;#160;31, 2020, 2019 or 2018. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;Resulting from these awards Immatics had other &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-current&lt;/div&gt; liabilities of &amp;#8364;2.1&amp;#160;million and &amp;#8364;0.2&amp;#160;million as of December&amp;#160;31, 2019, and 2018, respectively. &lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As the 2010 Plan was converted in 2020, there were no SARs outstanding as of December&amp;#160;31, 2020. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2016 Equity Incentive Plan (&amp;#8220;the 2016 Plan&amp;#8221;) &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;On February&amp;#160;8, 2017, the Company established the &amp;#8220;2016 Equity Incentive Plan&amp;#8221; to provide employees and consultants of the Group the ability to share in the Company&amp;#8217;s future success. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Awards issued under the 2016 Plan were tandem awards, which consisted of an option to acquire a stated the number of shares at a stated exercise price, or alternatively, the right to receive any appreciation in the value of the stated number of shares (&amp;#8220;SAR portion&amp;#8221;). &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Generally, the tandem awards issued under the 2016 Plan had a five-year vesting period. The first annual tranche vested on the first anniversary of the grant date. Following the first anniversary, the awards continued to vest on a monthly basis. Vesting was contingent on the recipient&amp;#8217;s continued service to the Group. Employees which left the Group were able to retain any awards vested as of their termination date, unless they were terminated for cause. Former employees forfeited their awards, if they remained unexercised more than three months after an IPO or change in control. In the event of a change in control, the unvested portion of the Tandem Award should immediately vest. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;The Tandem Award (to the extent vested) might only be exercised after the contribution of all Immatics shares to a holding company for purposes of an indirect IPO, a change in control, or the expiration of a certain &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;lock-up&lt;/div&gt; period following the completion of a direct IPO. A change in control was defined as the acquisition of more than 50% of the outstanding shares by a third party. &lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Under the terms of the 2016 Plan, options had to be settled in equity shares of the Group, while SAR portions might be settled in either equity shares or cash, at the Group&amp;#8217;s discretion. While the Group did not have a policy or prior history of settling these awards, it intended to settle outstanding awards in equity shares. As a result, the Group was treating awards issued under the 2016 plan as equity-settled. Subsequent settlements of SARs in cash, to the extent they occurred, would be recorded via an adjustment to equity. Each option or SAR issued under the plan might be settled for one common share of the Group in the event it is exercisable. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Set out below are summaries of tandem awards issued during 2019 and 2018: &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:65%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&amp;#160;average&lt;br/&gt;exercise price in&lt;br/&gt;USD&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&lt;br/&gt;average&amp;#160;exercise&lt;br/&gt;price in USD&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Tandem Awards outstanding at January&amp;#160;1,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;16.65&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;74,401&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;16.65&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;31,880&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Tandem awards granted in June to September&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;18.30&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;26,557&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16.65&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;43,964&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Tandem awards granted in December&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;23.82&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;5,447&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Tandem awards forfeited&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16.81&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2,936&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16.65&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,443&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Tandem awards outstanding at December&amp;#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;17.45&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;103,469&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;16.65&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;74,401&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Tandem awards vested&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16.76&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,238&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16.65&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;14,350&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Tandem awards exercisable&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Weighted average remaining contract life (years)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;8.56&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;9.12&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Weighted average fair value of options granted in USD till September&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10.27&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;4.51&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Weighted average fair value of options granted in USD for December&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;53.41&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Group used a Black Scholes pricing model to estimate the fair value of equity settled tandem awards issued during 2019 until September 2019, based on a company valuation of $160&amp;#160;million. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The fair value of tandem awards issued in December 2019 was based on a company valuation of $350&amp;#160;million. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:61%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:9%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:9%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:9%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Amounts in USD&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;June&amp;#160;2019&amp;#160;-&amp;#160;September&amp;#160;2019&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;2018&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Exercise price in USD&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#160;23.82&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#160;18.30&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#160;16.65&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Underlying share price in USD&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;67.87&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16.94&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;27.21&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Volatility&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;73&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;78&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;64&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Time period (years)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1.25&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2.10&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;5.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Risk free rate&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.59&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2.04&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2.77&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Dividend yield&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;0.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;0.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;0.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Combined probability of exit events&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;80.00&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;60.00&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;25.00&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;Expected volatility was determined by calculating the historic volatility in share prices of peer companies within the biotechnology industry. The expected life in the model has been adjusted, based on management&amp;#8217;s best estimate, for the effects of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-transferability&lt;/div&gt; and exercise restrictions. Furthermore, the fair value of awards issued under the 2016 Plan were discounted based on the probability of the awards becoming exercisable due to either a change in control or an IPO. &lt;br/&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-block: 0em;"&gt;&amp;#160;&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Conversion of 2010 Plan and 2016 Plan in connection with ARYA Merger &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As part of the ARYA Merger, all outstanding awards under the 2010 Plan and 2016 Plan were replaced by a combination of cash payments and share-based awards under the 2020 Equity Plan in Immatics N.V. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Cash Payments &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;In accordance with the employee award agreements, holders of vested awards under the 2010 Plan and 2016 Plan (including any awards scheduled to vest prior to 2021), agreed to receive a cash payment of $10.00 per award, less the applicable exercise price (&amp;#8220;Award Cash Proceeds&amp;#8221;). Per the terms of the employee award agreements, active employees were required to &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;re-invest&lt;/div&gt; &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;25%-50%&lt;/div&gt; of the Award Cash Proceeds, net of taxes, with management members required to &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;re-invest&lt;/div&gt; 50%. In total, employees elected to receive &amp;#8364;8.9&amp;#160;million in net Award Cash Proceeds before taxes, which were paid during the third quarter. These proceeds mainly covered wage tax obligations by the employees.&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0px; margin-bottom: 0px;"&gt;&amp;#160;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;These cash payments represent a modification of awards previously issued under the 2010 Plan and 2016 Plan. The Group recognized &amp;#8364;2.6&amp;#160;million in operating expense related to the modification of awards issued under the 2010 Plan and previously accounted for as a liability. The Group also recognized &amp;#8364;4.3&amp;#160;million as a reduction in share premium, associated with the modification from previously equity-settled tandem awards, which were settled in cash as part of the modification. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Share-based Awards &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The share-based awards, that were received by employees as part of the conversion, consisted of Re-investment Shares, Matching Stock Options and Converted Stock Options as described below. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;In accordance with the employee &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;re-investment&lt;/div&gt; elections, employees received 733,598 shares in Immatics N.V. &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(&amp;#8220;Re-investment&lt;/div&gt; Shares&amp;#8221;), which had a fair value of &amp;#8364;8.5&amp;#160;million based on the ARYA share price of $15.15, as of the merger on July&amp;#160;1, 2020. The Re-investment Shares issued represented a modification of awards previously granted under the 2010 Plan and the 2016 Plan. This modification resulted in additional operating expense of &amp;#8364;4.1&amp;#160;million. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;For each ordinary Re-investment Share received, active employees and management members also received two stock options (&amp;#8220;Matching Stock Options&amp;#8221;) to acquire shares in Immatics N.V. The Matching Stock Options have an exercise price of $10.00 and vest in full on July&amp;#160;31, 2021. The award recipient must remain employed by Immatics or one of its affiliates through the vesting date, to receive the option. The awards have a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;ten-year&lt;/div&gt; contract life. &lt;/div&gt; &lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Matching Stock Options award agreements had a service commencement date in June 2020. However, the grant date criteria for these awards, as specified in IFRS 2 and the underlying award agreements, were not met until July&amp;#160;1, 2020. Based on the July&amp;#160;1, 2020 grant date the Group assigned a fair value of $10.59. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Immatics applied a Black Scholes pricing model to estimate the fair value of the Matching Stock Options, which the Group records as an expense over the four-year graded vesting period. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:84%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:12%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&amp;#160;of&amp;#160;June&amp;#160;30,&lt;/div&gt;&lt;br/&gt; &lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Exercise price in USD&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10.00&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Underlying share price in USD&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;15.15&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Volatility&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;75&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Time period (years)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;5.5&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Risk free rate&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.29&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Dividend yield&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;0.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Set out below are summaries of Matching Stock Options issued during 2020: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;  &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:71%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:7%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:7%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&amp;#160;average&lt;br/&gt; exercise price in&lt;br/&gt; USD&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Matching Stock Options outstanding on January&amp;#160;1,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Matching Stock Options granted in June&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,430,818&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Matching Stock Options forfeited&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10.00&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;8,262&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Matching Stock Options outstanding at December&amp;#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,422,556&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Matching Stock Options vested&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Weighted average remaining contract life (years)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;9.50&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Weighted average fair value of options granted in USD for June&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10.59&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;For any outstanding 2016 Plan and 2010 Plan awards scheduled to vest on or after January&amp;#160;1, 2021, employees received replacement stock options (&amp;#8220;Converted Options&amp;#8221;) to acquire shares in Immatics N.V. The Converted Options have comparable terms as the previous awards, with revised exercise prices reflecting the reorganized capital structure of Immatics. The options granted under the 2020 Equity Plan that gives employees the right to acquire shares in Immatics N.V., are accounted for as a modification under IFRS 2, with the incremental fair value expensed over the remaining vesting period. The incremental fair value is the difference between the fair value of the options to purchase ordinary shares under the 2020 Equity Plan to acquire shares in Immatics N.V., and the fair value of the exchanged unvested SAR (both measured at the date on which the replacement award is issued). &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Based on the terms of the Converted Options award agreements, the awards had a service commencement date in June 2020. However, the grant date criteria for these awards, as specified in IFRS 2 and the underlying award agreements, were not met until July&amp;#160;1, 2020. Based on the July&amp;#160;1, 2020 grant date the Group assigned an average fair value of $13.79. The incremental average fair value of the Converted Options compared to the share-based awards under the 2010 Plan and 2016 Plan was $4.83. Immatics applied a Black Scholes pricing model to estimate the fair value of the Converted Options. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;  &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:90%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:6%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of&lt;br/&gt; June&amp;#160;30,&lt;br/&gt; 2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Average exercise price in USD&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2.47&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Underlying share price in USD&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;15.15&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Volatility&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;75&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Time period (years)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;5.6&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Risk free rate&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.29&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Dividend yield&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;0.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Set out below are summaries of Converted Options issued during 2020: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:72%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:8%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:8%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&amp;#160;average&lt;br/&gt; exercise price in&lt;br/&gt; USD&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Converted Options outstanding on January&amp;#160;1,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Converted Options granted in June&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2.49&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;632,384&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Converted Options forfeited&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.08&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;37,540&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Converted Options outstanding on December&amp;#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2.58&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;594,844&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Converted Options vested&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#160;2.45&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;53,856&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Weighted average remaining contract life (years)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;7.01&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Weighted average fair value of options granted in USD for June&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;4.83&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Additional grants under the 2020 Equity Plan &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Service Options &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Prior to the ARYA Merger, Immatics N.V. established the 2020 Equity Plan. After closing the ARYA Merger, employees, directors and officers received 1,087,242 employee stock options under the 2020 Equity Plan with a service requirement (&amp;#8220;Service Options&amp;#8221;), to acquire shares of Immatics N.V. The service-based options will vest solely on a four-year time-based vesting schedule. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The total amount of the Service options granted were accounted for by considering a fair value of $11.29, $9.25, and $6.73, as of grant date June&amp;#160;30, 2020, September&amp;#160;14, 2020, and December&amp;#160;17, 2020, respectively. &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Immatics applied a Black Scholes pricing model to estimate the fair value of the Service Options.&lt;/div&gt; &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;  &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:68%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:7%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:7%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:7%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&amp;#160;of&amp;#160;June&amp;#160;30,&lt;br/&gt; 2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&amp;#160;of&amp;#160;September&amp;#160;14,&lt;br/&gt; 2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&amp;#160;of&lt;br/&gt; December&amp;#160;17,&lt;br/&gt; 2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Exercise price in USD&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#160;10.00&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#160;10.00&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#160;9.70&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Underlying share price in USD&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;15.15&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;9.16&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;9.70&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Volatility&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;75&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;79&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;84&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Time period (years)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;7.0&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;6.2&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;6.0&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Risk free rate&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.29&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.37&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.49&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Dividend yield&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;0.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;0.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;0.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A total of 1,963,566 Service Options have been granted as of December&amp;#160;31, 2020. Set out below are summaries of Service Options issued during 2020:&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;  &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:73%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:6%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:6%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&lt;br/&gt; average&amp;#160;exercise&lt;br/&gt; price in USD&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Service Options outstanding on January&amp;#160;1,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Service Options granted in June&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,087,417&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Service Options granted in September&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;9.72&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;74,000&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Service Options granted in December&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;9.70&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;802,149&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Service Options forfeited&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10.00&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;53,384&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Service Options outstanding on December&amp;#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;9.87&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,910,182&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Service Options vested&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Weighted average remaining contract life (years)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;9.72&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Weighted average fair value of options granted in USD for June&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;11.29&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Weighted average fair value of options granted in USD for September&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;9.25&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Weighted average fair value of options granted in USD for December&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;6.73&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Performance-Based Options (&amp;#8220;PSUs&amp;#8221;) &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;In addition, after the closing of the ARYA Merger certain executive officers and key personnel of the Group received under the 2020 Equity Plan PSUs, vesting based both on achievement of market capitalization milestones and satisfaction of a four-year time-based vesting schedule. The PSUs are split into three equal tranches. The performance criteria for each of the three respective tranches requires Immatics to achieve a market capitalization of at least $1.5&amp;#160;billion, $2&amp;#160;billion and $3&amp;#160;billion, respectively. The amount of 3,644,000 of the PSUs granted on June&amp;#160;30, 2020, were accounted for by considering a fair value of $11.10. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The remaining amount of 255,000 PSUs granted on September&amp;#160;14, 2020, were accounted for by considering a fair value of $6.41. &lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A Monte-Carlo simulation model has been used to measure each fair value at grant date of the PSUs. The model incorporates the impact of the performance criteria regarding market capitalization described above in the calculation of the award&amp;#8217;s fair value at grant &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;date. In addition to the probability of achieving the market capitalization performance criteria, the inputs used in the measurements of the fair value at grant date of the PSUs were as follows: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;  &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:73%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:10%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:9%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&amp;#160;of&amp;#160;June&amp;#160;30,&lt;br/&gt; 2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of&lt;br/&gt; September&amp;#160;14,&lt;br/&gt; 2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Exercise price in USD&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#160;10.00&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#160;10.00&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Underlying share price in USD&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;15.15&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;9.16&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Volatility&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;79&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;78&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Time period (years)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;7.0&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;6.7&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Risk free rate&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.66&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.67&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Dividend yield&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;0.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;0.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A total of 3,644,000 PSUs have been granted as of December&amp;#160;31, 2020. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Set out below are summaries of PSUs issued during 2020: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:73%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:6%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:6%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&lt;br/&gt; average&amp;#160;exercise&lt;br/&gt; price in USD&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;PSUs outstanding on January&amp;#160;1,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;PSUs granted in June&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;3,644,000&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;PSUs granted in September&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10.00&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;255,000&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;PSUs forfeited&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;255,000&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;PSUs outstanding on December&amp;#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10.00&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;3,644,000&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;PSUs vested&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Weighted average remaining contract life (years)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;9.60&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Weighted average fair value of options granted in USD for June&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;11.10&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Weighted average fair value of options granted in USD for September&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;6.41&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman;font-size: 10pt;margin-top: 12pt;margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Group recognized total employee-related share-based compensation expense from all plans for the years ended December&amp;#160;31, 2020, 2019 and 2018 as set out below: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:80%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&amp;#160;ended&amp;#160;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Research and development expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;14,546&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,556&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;238&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;General and administrative expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10,973&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;460&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;100&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total share-based compensation&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;25,519&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,016&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;338&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; </ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory>
<ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory id="Factid_19490836" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;16.&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Financial income and expenses &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;   &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Financial income and financial expenses consist of the following: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:80%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year ended December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Interest income from short-term deposits&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;850&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;790&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;507&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Foreign currency gains&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,708&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Gain on other financial instruments&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2,099&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Financial income&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,949&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;790&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,215&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1pt;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Interest expenses form leases&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(289&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(170&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(16&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Foreign currency losses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(9,774&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(94&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(145&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Financial expenses&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(10,063&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(264&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(161&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Foreign currency losses mainly consist of unrealized losses in connection with our USD holdings. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman;font-size: 10pt;margin-top: 0pt;margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Gain on other financial instruments includes an unrealized gain of 0.9&amp;#160;million and a realized gain of 1.2&amp;#160;million from foreign currency forward contracts for the year ended December&amp;#160;31, 2020. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory>
<ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory id="Factid_19490838" contextRef="P01_01_2020To12_31_2020_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">&lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:83%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Amounts in USD&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Exercise price&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.12&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.12&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Underlying share price&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;67.87&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;27.21&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Volatility&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;73&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;64&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Time period (years)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1.25&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;5.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Risk free rate&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.59&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2.77&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Dividend yield&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;0.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;0.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Combined probability of exit events&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;80.00&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;25.00&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory>
<ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory id="Factid_19490839" contextRef="P01_01_2020To12_31_2020_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Set out below are summaries of SARs issued during 2019 and 2018: &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:92%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:68%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price in&lt;br/&gt;USD&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price in&lt;br/&gt;USD&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;SARs outstanding at January&amp;#160;1,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.12&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;43,675&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.12&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;43,978&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;SARs granted&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;SARs forfeited&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.12&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;220&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.12&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;303&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;SARs outstanding at December&amp;#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1.12&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;43,455&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1.12&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;43,675&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;SARs vested&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.12&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;117&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.12&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;169&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;SARs exercisable&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory>
<imtx:DisclosureDetailsOfActivitiesUnderShareBasedPaymentArrangementTextBlock id="Factid_19490840" contextRef="P01_01_2020To12_31_2020_TwoThousandAndSixteenTandemAwardsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Set out below are summaries of tandem awards issued during 2019 and 2018: &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:65%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&amp;#160;average&lt;br/&gt;exercise price in&lt;br/&gt;USD&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&lt;br/&gt;average&amp;#160;exercise&lt;br/&gt;price in USD&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Tandem Awards outstanding at January&amp;#160;1,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;16.65&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;74,401&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;16.65&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;31,880&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Tandem awards granted in June to September&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;18.30&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;26,557&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16.65&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;43,964&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Tandem awards granted in December&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;23.82&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;5,447&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Tandem awards forfeited&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16.81&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2,936&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16.65&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,443&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Tandem awards outstanding at December&amp;#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;17.45&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;103,469&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;16.65&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;74,401&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Tandem awards vested&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16.76&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,238&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16.65&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;14,350&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Tandem awards exercisable&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Weighted average remaining contract life (years)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;8.56&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;9.12&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Weighted average fair value of options granted in USD till September&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10.27&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;4.51&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Weighted average fair value of options granted in USD for December&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;53.41&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DisclosureDetailsOfActivitiesUnderShareBasedPaymentArrangementTextBlock>
<ifrs-full:InterestIncomeOnDeposits id="Factid_19490844" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">850000</ifrs-full:InterestIncomeOnDeposits>
<ifrs-full:InterestIncomeOnDeposits id="Factid_19490845" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">790000</ifrs-full:InterestIncomeOnDeposits>
<ifrs-full:InterestIncomeOnDeposits id="Factid_19490846" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">507000</ifrs-full:InterestIncomeOnDeposits>
<ifrs-full:NetForeignExchangeGain id="Factid_19490847" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">1708000</ifrs-full:NetForeignExchangeGain>
<ifrs-full:GainLossRecognisedOnFinancialInstrumentsWhoseFairValuePreviouslyCouldNotBeReliablyMeasured id="Factid_19490848" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">2099000</ifrs-full:GainLossRecognisedOnFinancialInstrumentsWhoseFairValuePreviouslyCouldNotBeReliablyMeasured>
<ifrs-full:InterestExpenseOnLeaseLiabilities id="Factid_19490852" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">289000</ifrs-full:InterestExpenseOnLeaseLiabilities>
<ifrs-full:InterestExpenseOnLeaseLiabilities id="Factid_19490853" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">170000</ifrs-full:InterestExpenseOnLeaseLiabilities>
<ifrs-full:InterestExpenseOnLeaseLiabilities id="Factid_19490854" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">16000</ifrs-full:InterestExpenseOnLeaseLiabilities>
<ifrs-full:NetForeignExchangeLoss id="Factid_19490855" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">9774000</ifrs-full:NetForeignExchangeLoss>
<ifrs-full:NetForeignExchangeLoss id="Factid_19490856" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">94000</ifrs-full:NetForeignExchangeLoss>
<ifrs-full:NetForeignExchangeLoss id="Factid_19490857" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">145000</ifrs-full:NetForeignExchangeLoss>
<ifrs-full:ExercisePriceShareOptionsGranted2019 id="Factid_19490861" contextRef="P01_01_2019To12_31_2019_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">1.12</ifrs-full:ExercisePriceShareOptionsGranted2019>
<ifrs-full:ExercisePriceShareOptionsGranted2019 id="Factid_19490862" contextRef="P01_01_2018To12_31_2018_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">1.12</ifrs-full:ExercisePriceShareOptionsGranted2019>
<ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 id="Factid_19490863" contextRef="P01_01_2019To12_31_2019_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">67.87</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
<ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 id="Factid_19490864" contextRef="P01_01_2018To12_31_2018_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">27.21</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
<ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted id="Factid_19490865" contextRef="P01_01_2019To12_31_2019_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="2">0.73</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
<ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted id="Factid_19490866" contextRef="P01_01_2018To12_31_2018_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="2">0.64</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
<ifrs-full:DescriptionOfOptionLifeShareOptionsGranted id="Factid_19490867" contextRef="P01_01_2019To12_31_2019_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_Y" decimals="2">1.25</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
<ifrs-full:DescriptionOfOptionLifeShareOptionsGranted id="Factid_19490868" contextRef="P01_01_2018To12_31_2018_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_Y" decimals="2">5.00</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
<ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted id="Factid_19490869" contextRef="P01_01_2019To12_31_2019_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="4">0.0159</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
<ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted id="Factid_19490870" contextRef="P01_01_2018To12_31_2018_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="4">0.0277</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
<ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted id="Factid_19490871" contextRef="P01_01_2019To12_31_2019_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="4">0.0000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
<ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted id="Factid_19490872" contextRef="P01_01_2018To12_31_2018_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="4">0.0000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
<imtx:CombinedProbabilityOfExitEventsShareOptionsGranted id="Factid_19490873" contextRef="P01_01_2019To12_31_2019_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="2">80.00</imtx:CombinedProbabilityOfExitEventsShareOptionsGranted>
<imtx:CombinedProbabilityOfExitEventsShareOptionsGranted id="Factid_19490874" contextRef="P01_01_2018To12_31_2018_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="2">25.00</imtx:CombinedProbabilityOfExitEventsShareOptionsGranted>
<ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 id="Factid_19490880" contextRef="PAsOn12_31_2018_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">1.12</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
<ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 id="Factid_19490881" contextRef="PAsOn12_31_2017_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">1.12</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
<ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019 id="Factid_19490882" contextRef="P01_01_2019To12_31_2019_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">1.12</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
<ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019 id="Factid_19490883" contextRef="P01_01_2018To12_31_2018_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">1.12</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
<ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 id="Factid_19490884" contextRef="PAsOn12_31_2019_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">1.12</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
<imtx:WeightedAverageExercisePriceOfShareOptionsVestedInSharebasedPaymentArrangement2019 id="Factid_19490886" contextRef="PAsOn12_31_2019_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">1.12</imtx:WeightedAverageExercisePriceOfShareOptionsVestedInSharebasedPaymentArrangement2019>
<imtx:WeightedAverageExercisePriceOfShareOptionsVestedInSharebasedPaymentArrangement2019 id="Factid_19490887" contextRef="PAsOn12_31_2018_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">1.12</imtx:WeightedAverageExercisePriceOfShareOptionsVestedInSharebasedPaymentArrangement2019>
<ifrs-full:NumberOfOutstandingShareOptions id="Factid_19490888" contextRef="PAsOn12_31_2018_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="0">43675</ifrs-full:NumberOfOutstandingShareOptions>
<ifrs-full:NumberOfOutstandingShareOptions id="Factid_19490889" contextRef="PAsOn12_31_2017_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="0">43978</ifrs-full:NumberOfOutstandingShareOptions>
<ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement id="Factid_19490892" contextRef="P01_01_2019To12_31_2019_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="0">220</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
<ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement id="Factid_19490893" contextRef="P01_01_2018To12_31_2018_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="0">303</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
<ifrs-full:NumberOfOutstandingShareOptions id="Factid_19490894" contextRef="PAsOn12_31_2019_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="0">43455</ifrs-full:NumberOfOutstandingShareOptions>
<imtx:NumberOfShareOptionsVestedInSharebasedPaymentArrangement id="Factid_19490896" contextRef="PAsOn12_31_2019_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="0">117</imtx:NumberOfShareOptionsVestedInSharebasedPaymentArrangement>
<imtx:NumberOfShareOptionsVestedInSharebasedPaymentArrangement id="Factid_19490897" contextRef="PAsOn12_31_2018_ShareAppreciationRightsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="0">169</imtx:NumberOfShareOptionsVestedInSharebasedPaymentArrangement>
<imtx:UnrealisedGainLossFromForeignCurrencyForwardContracts id="Factid_19490900" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-5">900000</imtx:UnrealisedGainLossFromForeignCurrencyForwardContracts>
<imtx:RealisedGainLossFromForeignCurrencyForwardContracts id="Factid_19490901" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-5">1200000</imtx:RealisedGainLossFromForeignCurrencyForwardContracts>
<imtx:StockIssuedDuringPeriodValueNewIssues id="Factid_19490902" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="2">0.01</imtx:StockIssuedDuringPeriodValueNewIssues>
<ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory id="Factid_19490903" contextRef="P01_01_2020To12_31_2020_MatchingStockOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Set out below are summaries of Matching Stock Options issued during 2020: &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:71%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:7%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:7%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&amp;#160;average&lt;br/&gt;exercise price in&lt;br/&gt;USD&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Matching Stock Options outstanding on January&amp;#160;1,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Matching Stock Options granted in June&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,430,818&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Matching Stock Options forfeited&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10.00&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;8,262&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Matching Stock Options outstanding at December&amp;#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,422,556&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Matching Stock Options vested&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Weighted average remaining contract life (years)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;9.50&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Weighted average fair value of options granted in USD for June&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10.59&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory>
<ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory id="Factid_19490904" contextRef="P01_01_2020To12_31_2020_ConvertedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt; Immatics applied a Black Scholes pricing model to estimate the fair value of the Converted Options.&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:90%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:6%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of&lt;br/&gt;June&amp;#160;30,&lt;br/&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Average exercise price in USD&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2.47&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Underlying share price in USD&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;15.15&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Volatility&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;75&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Time period (years)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;5.6&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Risk free rate&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.29&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Dividend yield&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;0.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory>
<ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory id="Factid_19490905" contextRef="P01_01_2020To12_31_2020_ConvertedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Set out below are summaries of Converted Options issued during 2020: &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:73%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:7%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:7%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&amp;#160;average&lt;br/&gt;exercise price in&lt;br/&gt;USD&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Converted Options outstanding on January&amp;#160;1,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Converted Options granted in June&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2.49&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;632,384&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Converted Options forfeited&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.08&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;37,540&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Converted Options outstanding on December&amp;#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2.58&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;594,844&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Converted Options vested&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#160;2.45&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;53,856&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Weighted average remaining contract life (years)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;7.01&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Weighted average fair value of options granted in USD for June&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;4.83&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory>
<ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory id="Factid_19490906" contextRef="P01_01_2020To12_31_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="display:inline;"&gt;Immatics applied a Black Scholes pricing model to estimate the fair value of the Service Options.&lt;/div&gt;&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:71%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:6%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:6%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:6%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&amp;#160;of&amp;#160;June&amp;#160;30,&lt;br/&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&amp;#160;of&amp;#160;September&lt;/div&gt;&lt;br/&gt;&lt;div style="font-weight:bold;display:inline;"&gt;14, 2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&amp;#160;of&lt;/div&gt;&lt;br/&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;17,&lt;br/&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Exercise price in USD&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#160;10.00&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#160;10.00&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#160;9.70&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Underlying share price in USD&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;15.15&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;9.16&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;9.70&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Volatility&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;75&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;79&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;84&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Time period (years)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;7.0&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;6.2&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;6.0&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Risk free rate&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.29&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.37&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.49&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Dividend yield&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;0.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;0.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;0.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory>
<ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory id="Factid_19490907" contextRef="P01_01_2020To12_31_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;Set out below are summaries of Service Options issued during 2020:&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:73%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:6%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:6%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&lt;br/&gt;average&amp;#160;exercise&lt;br/&gt;price in USD&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Service Options outstanding on January&amp;#160;1,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Service Options granted in June&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,087,417&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Service Options granted in September&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;9.72&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;74,000&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Service Options granted in December&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;9.70&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;802,149&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Service Options forfeited&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10.00&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;53,384&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Service Options outstanding on December&amp;#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;9.87&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,910,182&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Service Options vested&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Weighted average remaining contract life (years)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;9.72&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Weighted average fair value of options granted in USD for June&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;11.29&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Weighted average fair value of options granted in USD for September&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;9.25&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Weighted average fair value of options granted in USD for December&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;6.73&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory>
<ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory id="Factid_19490908" contextRef="P01_01_2020To12_31_2020_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;In addition to the probability of achieving the market capitalization performance criteria, the inputs used in the measurements of the fair value at grant date of the PSUs were as follows:&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:73%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:9%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:8%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&amp;#160;of&amp;#160;June&amp;#160;30,&lt;br/&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of&lt;br/&gt;September&amp;#160;14,&lt;br/&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Exercise price in USD&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#160;10.00&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#160;10.00&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Underlying share price in USD&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;15.15&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;9.16&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Volatility&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;79&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;78&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Time period (years)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;7.0&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;6.7&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Risk free rate&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.66&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.67&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Dividend yield&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;0.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;0.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory>
<ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory id="Factid_19490909" contextRef="P01_01_2020To12_31_2020_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Set out below are summaries of PSUs issued during 2020: &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:73%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:6%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:6%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&lt;br/&gt;average&amp;#160;exercise&lt;br/&gt;price in USD&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;PSUs outstanding on January&amp;#160;1,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;PSUs granted in June&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;3,644,000&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;PSUs granted in September&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10.00&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;255,000&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;PSUs forfeited&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;255,000&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;PSUs outstanding on December&amp;#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10.00&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;3,644,000&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;PSUs vested&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Weighted average remaining contract life (years)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;9.60&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Weighted average fair value of options granted in USD for June&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;11.10&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Weighted average fair value of options granted in USD for September&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;6.41&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory>
<imtx:DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTextBlock id="Factid_19490910" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Group recognized total employee-related share-based compensation expense from all plans for the years ended December&amp;#160;31, 2020, 2019 and 2018 as set out below: &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:80%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&amp;#160;ended&amp;#160;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Research and development expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;14,546&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,556&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;238&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;General and administrative expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10,973&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;460&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;100&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total share-based compensation&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;25,519&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,016&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;338&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTextBlock>
<imtx:PercentageOfOutstandingSharesToBePurchasedByThirdParty id="Factid_19490911" contextRef="PAsOn12_31_2020_ShareAppreciationRightsTwoThousandAndTenPlanMemberIMTXPlanAxis" unitRef="Unit_pure" decimals="2">0.50</imtx:PercentageOfOutstandingSharesToBePurchasedByThirdParty>
<ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted id="Factid_19490912" contextRef="PAsOn12_31_2019_ShareAppreciationRightsTwoThousandAndTenPlanMemberIMTXPlanAxis" unitRef="Unit_USD" decimals="-3">350000000</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
<ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted id="Factid_19490913" contextRef="PAsOn12_31_2018_ShareAppreciationRightsTwoThousandAndTenPlanMemberIMTXPlanAxis" unitRef="Unit_USD" decimals="-3">160000000</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
<ifrs-full:LiabilitiesFromSharebasedPaymentTransactions2011 id="Factid_19490914" contextRef="PAsOn12_31_2019_ShareAppreciationRightsTwoThousandAndTenPlanMemberIMTXPlanAxis" unitRef="Unit_EUR" decimals="-5">2100000</ifrs-full:LiabilitiesFromSharebasedPaymentTransactions2011>
<ifrs-full:LiabilitiesFromSharebasedPaymentTransactions2011 id="Factid_19490915" contextRef="PAsOn12_31_2018_ShareAppreciationRightsTwoThousandAndTenPlanMemberIMTXPlanAxis" unitRef="Unit_EUR" decimals="-5">200000</ifrs-full:LiabilitiesFromSharebasedPaymentTransactions2011>
<ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement id="Factid_19490916" contextRef="P02_01_2017To12_31_2020_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis">five</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
<imtx:PercentageOfOutstandingSharesToBePurchasedByThirdParty id="Factid_19490917" contextRef="PAsOn12_31_2017_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis" unitRef="Unit_pure" decimals="2">0.50</imtx:PercentageOfOutstandingSharesToBePurchasedByThirdParty>
<ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted id="Factid_19490918" contextRef="PAsOn09_30_2020_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis" unitRef="Unit_USD" decimals="-6">160000000</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
<ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted id="Factid_19490919" contextRef="PAsOn12_31_2019_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis" unitRef="Unit_USD" decimals="-6">350000000</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
<imtx:CashPaymentAwardPerSharePayable id="Factid_19490920" contextRef="PAsOn12_31_2020_ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMemberIMTXPlanAxis" unitRef="Unit_pure" decimals="2">0.10</imtx:CashPaymentAwardPerSharePayable>
<imtx:PercentageOfCashProceedsToBeBeReinvested id="Factid_19490921" contextRef="P01_01_2020To12_31_2020_ActiveEmployeesMemberIMTXCategoryOfEmployeesAxis_BottomOfRangeMemberifrsfullRangeAxis_ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMemberIMTXPlanAxis" unitRef="Unit_pure" decimals="INF">0.25</imtx:PercentageOfCashProceedsToBeBeReinvested>
<imtx:PercentageOfCashProceedsToBeBeReinvested id="Factid_19490922" contextRef="P01_01_2020To12_31_2020_ActiveEmployeesMemberIMTXCategoryOfEmployeesAxis_ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMemberIMTXPlanAxis_TopOfRangeMemberifrsfullRangeAxis" unitRef="Unit_pure" decimals="INF">0.50</imtx:PercentageOfCashProceedsToBeBeReinvested>
<imtx:PercentageOfCashProceedsToBeBeReinvested id="Factid_19490923" contextRef="P01_01_2020To12_31_2020_ManagementMembersMemberIMTXCategoryOfEmployeesAxis_ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMemberIMTXPlanAxis" unitRef="Unit_pure" decimals="INF">0.50</imtx:PercentageOfCashProceedsToBeBeReinvested>
<ifrs-full:PaymentsToAndOnBehalfOfEmployees id="Factid_19490924" contextRef="P01_01_2020To12_31_2020_ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMemberIMTXPlanAxis" unitRef="Unit_EUR" decimals="-5">8900000</ifrs-full:PaymentsToAndOnBehalfOfEmployees>
<imtx:ExpenseFromTheModificationOfShareBasedAwards id="Factid_19490925" contextRef="P01_01_2020To12_31_2020_ModificationOfTwoThousandAndTenPlanMemberIMTXPlanAxis" unitRef="Unit_EUR" decimals="-5">2600000</imtx:ExpenseFromTheModificationOfShareBasedAwards>
<ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets id="Factid_19490926" contextRef="P01_01_2020To12_31_2020_ModificationOfTwoThousandAndSixteenPlanMemberIMTXPlanAxis" unitRef="Unit_EUR" decimals="-5">4300000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
<ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement id="Factid_19490927" contextRef="P01_01_2020To12_31_2020_ModificationOfTwoThousandAndSixteenPlanMemberIMTXPlanAxis_ShareReinvestmentMemberIMTXSchemeAxis" unitRef="Unit_shares" decimals="0">733598</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
<ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted id="Factid_19490928" contextRef="PAsOn12_31_2020_ModificationOfTwoThousandAndSixteenPlanMemberIMTXPlanAxis_ShareReinvestmentMemberIMTXSchemeAxis" unitRef="Unit_EUR" decimals="-5">8500000</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
<ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 id="Factid_19490929" contextRef="P01_01_2020To12_31_2020_ModificationOfTwoThousandAndSixteenPlanMemberIMTXPlanAxis_ShareReinvestmentMemberIMTXSchemeAxis" unitRef="Unit_USD_per_Share" decimals="INF">15.15</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
<imtx:ExpenseFromTheModificationOfShareBasedAwards id="Factid_19490930" contextRef="P01_01_2020To12_31_2020_ModificationOfTwoThousandAndSixteenPlanMemberIMTXPlanAxis_ShareReinvestmentMemberIMTXSchemeAxis" unitRef="Unit_EUR" decimals="-5">4100000</imtx:ExpenseFromTheModificationOfShareBasedAwards>
<ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 id="Factid_19490932" contextRef="P01_01_2020To12_31_2020_MatchingStockOptionsMemberIMTXShareReinvestmentSchemeAxis_ModificationOfTwoThousandAndSixteenPlanMemberIMTXPlanAxis_ShareReinvestmentMemberIMTXSchemeAxis" unitRef="Unit_USD_per_Share" decimals="0">10</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
<imtx:DateOfVestingOfStockOptions id="Factid_19490933" contextRef="P01_01_2020To12_31_2020_MatchingStockOptionsMemberIMTXShareReinvestmentSchemeAxis_ModificationOfTwoThousandAndSixteenPlanMemberIMTXPlanAxis_ShareReinvestmentMemberIMTXSchemeAxis">2021-07-31</imtx:DateOfVestingOfStockOptions>
<ifrs-full:DateOfGrantOfSharebasedPaymentArrangement id="Factid_19490935" contextRef="P01_01_2020To12_31_2020_MatchingStockOptionsMemberIMTXShareReinvestmentSchemeAxis_ModificationOfTwoThousandAndSixteenPlanMemberIMTXPlanAxis_ShareReinvestmentMemberIMTXSchemeAxis">July 1, 2020</ifrs-full:DateOfGrantOfSharebasedPaymentArrangement>
<imtx:ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare id="Factid_19490936" contextRef="P01_01_2020To12_31_2020_MatchingStockOptionsMemberIMTXShareReinvestmentSchemeAxis_ModificationOfTwoThousandAndSixteenPlanMemberIMTXPlanAxis_ShareReinvestmentMemberIMTXSchemeAxis" unitRef="Unit_USD_per_Share" decimals="INF">10.59</imtx:ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare>
<ifrs-full:ExercisePriceShareOptionsGranted2019 id="Factid_19490937" contextRef="P01_01_2019To12_31_2019_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis" unitRef="Unit_USD_per_Share" decimals="INF">23.82</ifrs-full:ExercisePriceShareOptionsGranted2019>
<ifrs-full:ExercisePriceShareOptionsGranted2019 id="Factid_19490938" contextRef="P06_01_2019To09_30_2019_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis" unitRef="Unit_USD_per_Share" decimals="INF">18.30</ifrs-full:ExercisePriceShareOptionsGranted2019>
<ifrs-full:ExercisePriceShareOptionsGranted2019 id="Factid_19490939" contextRef="P01_01_2018To12_31_2018_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis" unitRef="Unit_USD_per_Share" decimals="INF">16.65</ifrs-full:ExercisePriceShareOptionsGranted2019>
<ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 id="Factid_19490940" contextRef="P01_01_2019To12_31_2019_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis" unitRef="Unit_USD_per_Share" decimals="INF">67.87</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
<ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 id="Factid_19490941" contextRef="P06_01_2019To09_30_2019_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis" unitRef="Unit_USD_per_Share" decimals="INF">16.94</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
<ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 id="Factid_19490942" contextRef="P01_01_2018To12_31_2018_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis" unitRef="Unit_USD_per_Share" decimals="INF">27.21</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
<ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted id="Factid_19490943" contextRef="P01_01_2019To12_31_2019_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis" unitRef="Unit_pure" decimals="2">0.73</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
<ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted id="Factid_19490944" contextRef="P06_01_2019To09_30_2019_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis" unitRef="Unit_pure" decimals="2">0.78</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
<ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted id="Factid_19490945" contextRef="P01_01_2018To12_31_2018_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis" unitRef="Unit_pure" decimals="2">0.64</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
<ifrs-full:DescriptionOfOptionLifeShareOptionsGranted id="Factid_19490946" contextRef="P01_01_2019To12_31_2019_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis" unitRef="Unit_Y" decimals="2">1.25</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
<ifrs-full:DescriptionOfOptionLifeShareOptionsGranted id="Factid_19490947" contextRef="P06_01_2019To09_30_2019_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis" unitRef="Unit_Y" decimals="2">2.10</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
<ifrs-full:DescriptionOfOptionLifeShareOptionsGranted id="Factid_19490948" contextRef="P01_01_2018To12_31_2018_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis" unitRef="Unit_Y" decimals="2">5.00</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
<ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted id="Factid_19490949" contextRef="P01_01_2019To12_31_2019_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis" unitRef="Unit_pure" decimals="4">0.0159</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
<ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted id="Factid_19490950" contextRef="P06_01_2019To09_30_2019_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis" unitRef="Unit_pure" decimals="4">0.0204</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
<ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted id="Factid_19490951" contextRef="P01_01_2018To12_31_2018_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis" unitRef="Unit_pure" decimals="4">0.0277</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
<ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted id="Factid_19490952" contextRef="P01_01_2019To12_31_2019_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis" unitRef="Unit_pure" decimals="4">0.0000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
<ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted id="Factid_19490953" contextRef="P06_01_2019To09_30_2019_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis" unitRef="Unit_pure" decimals="4">0.0000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
<ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted id="Factid_19490954" contextRef="P01_01_2018To12_31_2018_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis" unitRef="Unit_pure" decimals="4">0.0000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
<imtx:CombinedProbabilityOfExitEventsShareOptionsGranted id="Factid_19490955" contextRef="P01_01_2019To12_31_2019_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis" unitRef="Unit_pure" decimals="2">80.00</imtx:CombinedProbabilityOfExitEventsShareOptionsGranted>
<imtx:CombinedProbabilityOfExitEventsShareOptionsGranted id="Factid_19490956" contextRef="P06_01_2019To09_30_2019_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis" unitRef="Unit_pure" decimals="2">60.00</imtx:CombinedProbabilityOfExitEventsShareOptionsGranted>
<imtx:CombinedProbabilityOfExitEventsShareOptionsGranted id="Factid_19490957" contextRef="P01_01_2018To12_31_2018_TwoThousandAndSixteenTandemAwardsMemberIMTXPlanAxis" unitRef="Unit_pure" decimals="2">25.00</imtx:CombinedProbabilityOfExitEventsShareOptionsGranted>
<ifrs-full:ExercisePriceShareOptionsGranted2019 id="Factid_19490958" contextRef="P06_30_2020To06_30_2020_MatchingStockOptionsMemberIMTXPlanAxis" unitRef="Unit_USD_per_Share" decimals="INF">10.00</ifrs-full:ExercisePriceShareOptionsGranted2019>
<ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 id="Factid_19490959" contextRef="P06_30_2020To06_30_2020_MatchingStockOptionsMemberIMTXPlanAxis" unitRef="Unit_USD_per_Share" decimals="INF">15.15</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
<ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted id="Factid_19490960" contextRef="P06_30_2020To06_30_2020_MatchingStockOptionsMemberIMTXPlanAxis" unitRef="Unit_pure" decimals="2">0.75</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
<ifrs-full:DescriptionOfOptionLifeShareOptionsGranted id="Factid_19490961" contextRef="P06_30_2020To06_30_2020_MatchingStockOptionsMemberIMTXPlanAxis" unitRef="Unit_Y" decimals="1">5.5</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
<ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted id="Factid_19490962" contextRef="P06_30_2020To06_30_2020_MatchingStockOptionsMemberIMTXPlanAxis" unitRef="Unit_pure" decimals="4">0.0029</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
<ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted id="Factid_19490963" contextRef="P06_30_2020To06_30_2020_MatchingStockOptionsMemberIMTXPlanAxis" unitRef="Unit_pure" decimals="4">0.0000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
<ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement id="Factid_19490966" contextRef="P09_14_2020To09_14_2020_GrantedOnSeptemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="0">255000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
<imtx:ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare id="Factid_19490967" contextRef="P09_14_2020To09_14_2020_GrantedOnSeptemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="INF">6.41</imtx:ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare>
<ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 id="Factid_19490968" contextRef="PAsOn12_31_2018" unitRef="Unit_USD_per_Share" decimals="2">16.65</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
<ifrs-full:NumberOfOutstandingShareOptions id="Factid_19490969" contextRef="PAsOn12_31_2018" unitRef="Unit_shares" decimals="0">74401</ifrs-full:NumberOfOutstandingShareOptions>
<ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 id="Factid_19490970" contextRef="PAsOn12_31_2017" unitRef="Unit_USD_per_Share" decimals="2">16.65</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
<ifrs-full:NumberOfOutstandingShareOptions id="Factid_19490971" contextRef="PAsOn12_31_2017" unitRef="Unit_shares" decimals="0">31880</ifrs-full:NumberOfOutstandingShareOptions>
<ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 id="Factid_19490972" contextRef="P01_01_2019To12_31_2019_GrantedOnJuneToSeptemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis" unitRef="Unit_USD_per_Share" decimals="2">18.30</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
<ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement id="Factid_19490973" contextRef="P01_01_2019To12_31_2019_GrantedOnJuneToSeptemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis" unitRef="Unit_shares" decimals="0">26557</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
<ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 id="Factid_19490974" contextRef="P01_01_2018To12_31_2018_GrantedOnJuneToSeptemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis" unitRef="Unit_USD_per_Share" decimals="2">16.65</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
<ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement id="Factid_19490975" contextRef="P01_01_2018To12_31_2018_GrantedOnJuneToSeptemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis" unitRef="Unit_shares" decimals="0">43964</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
<ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 id="Factid_19490976" contextRef="P01_01_2019To12_31_2019_GrantedOnDecemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis" unitRef="Unit_USD_per_Share" decimals="2">23.82</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
<ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement id="Factid_19490977" contextRef="P01_01_2019To12_31_2019_GrantedOnDecemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis" unitRef="Unit_shares" decimals="0">5447</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
<ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019 id="Factid_19490978" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD_per_Share" decimals="2">16.81</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
<ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement id="Factid_19490979" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_shares" decimals="0">2936</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
<ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019 id="Factid_19490980" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_USD_per_Share" decimals="2">16.65</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
<ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement id="Factid_19490981" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_shares" decimals="0">1443</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
<ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 id="Factid_19490982" contextRef="PAsOn12_31_2019" unitRef="Unit_USD_per_Share" decimals="2">17.45</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
<ifrs-full:NumberOfOutstandingShareOptions id="Factid_19490983" contextRef="PAsOn12_31_2019" unitRef="Unit_shares" decimals="0">103469</ifrs-full:NumberOfOutstandingShareOptions>
<imtx:WeightedAverageExercisePriceOfShareOptionsVestedDuringThePeriod id="Factid_19490986" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD_per_Share" decimals="2">16.76</imtx:WeightedAverageExercisePriceOfShareOptionsVestedDuringThePeriod>
<imtx:NumberOfShareOptionsVestedDuringThePeriod id="Factid_19490987" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_shares" decimals="0">16238</imtx:NumberOfShareOptionsVestedDuringThePeriod>
<imtx:WeightedAverageExercisePriceOfShareOptionsVestedDuringThePeriod id="Factid_19490988" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_USD_per_Share" decimals="2">16.65</imtx:WeightedAverageExercisePriceOfShareOptionsVestedDuringThePeriod>
<imtx:NumberOfShareOptionsVestedDuringThePeriod id="Factid_19490989" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_shares" decimals="0">14350</imtx:NumberOfShareOptionsVestedDuringThePeriod>
<ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 id="Factid_19490992" contextRef="P01_01_2019To12_31_2019">P8Y6M21D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
<ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 id="Factid_19490993" contextRef="P01_01_2018To12_31_2018">P9Y1M13D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
<ifrs-full:WeightedAverageSharePrice2019 id="Factid_19490994" contextRef="P01_01_2019To12_31_2019_GrantedOnSeptemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis" unitRef="Unit_USD_per_Share" decimals="2">10.27</ifrs-full:WeightedAverageSharePrice2019>
<ifrs-full:WeightedAverageSharePrice2019 id="Factid_19490995" contextRef="P01_01_2018To12_31_2018_GrantedOnSeptemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis" unitRef="Unit_USD_per_Share" decimals="2">4.51</ifrs-full:WeightedAverageSharePrice2019>
<ifrs-full:WeightedAverageSharePrice2019 id="Factid_19490996" contextRef="P01_01_2019To12_31_2019_GrantedOnDecemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis" unitRef="Unit_USD_per_Share" decimals="2">53.41</ifrs-full:WeightedAverageSharePrice2019>
<imtx:MinimumMarketCapitalization id="Factid_19490998" contextRef="PAsOn12_31_2020_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_TrancheOneMemberIMTXTrancheAxis" unitRef="Unit_USD" decimals="-8">1500000000</imtx:MinimumMarketCapitalization>
<imtx:MinimumMarketCapitalization id="Factid_19490999" contextRef="PAsOn12_31_2020_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_TrancheTwoMemberIMTXTrancheAxis" unitRef="Unit_USD" decimals="-9">2000000000</imtx:MinimumMarketCapitalization>
<imtx:MinimumMarketCapitalization id="Factid_19491000" contextRef="PAsOn12_31_2020_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_TrancheThreeMemberIMTXTrancheAxis" unitRef="Unit_USD" decimals="-9">3000000000</imtx:MinimumMarketCapitalization>
<ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement id="Factid_19491001" contextRef="P01_01_2020To12_31_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_AryaMemberifrsfullBusinessCombinationsAxis" unitRef="Unit_shares" decimals="0">1087242</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
<ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement id="Factid_19491002" contextRef="P01_01_2020To12_31_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="0">1963566</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
<imtx:ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare id="Factid_19491003" contextRef="P06_30_2020To06_30_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_GrantedOnJuneTwoThousandAndTwentyMemberIMTXDateOfGrantAxis" unitRef="Unit_USD_per_Share" decimals="2">11.29</imtx:ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare>
<imtx:ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare id="Factid_19491004" contextRef="P09_14_2020To09_14_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_GrantedOnSeptemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis" unitRef="Unit_USD_per_Share" decimals="2">9.25</imtx:ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare>
<imtx:ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare id="Factid_19491005" contextRef="P12_17_2020To12_17_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_GrantedOnDecemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis" unitRef="Unit_USD_per_Share" decimals="2">6.73</imtx:ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare>
<imtx:ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare id="Factid_19491006" contextRef="P07_01_2020To07_01_2020" unitRef="Unit_USD_per_Share" decimals="2">13.79</imtx:ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare>
<imtx:ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare id="Factid_19491007" contextRef="P01_01_2020To12_31_2020_ConvertedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">4.83</imtx:ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare>
<ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement id="Factid_19491017" contextRef="P06_30_2020To06_30_2020_GrantedOnJuneTwoThousandAndTwentyMemberIMTXDateOfGrantAxis_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="0">3644000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
<imtx:ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare id="Factid_19491018" contextRef="P06_30_2020To06_30_2020_GrantedOnJuneTwoThousandAndTwentyMemberIMTXDateOfGrantAxis_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">11.10</imtx:ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare>
<ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 id="Factid_19491031" contextRef="P01_01_2020To12_31_2020_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">P9Y7M6D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
<imtx:ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare id="Factid_19491032" contextRef="P01_01_2020To12_31_2020_GrantedOnJuneTwoThousandAndTwentyMemberIMTXDateOfGrantAxis_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">11.10</imtx:ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare>
<imtx:ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare id="Factid_19491033" contextRef="P01_01_2020To12_31_2020_GrantedOnSeptemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">6.41</imtx:ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare>
<ifrs-full:ExercisePriceShareOptionsGranted2019 id="Factid_19491044" contextRef="P06_30_2020To06_30_2020_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">10.00</ifrs-full:ExercisePriceShareOptionsGranted2019>
<ifrs-full:ExercisePriceShareOptionsGranted2019 id="Factid_19491045" contextRef="P09_14_2020To09_14_2020_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">10.00</ifrs-full:ExercisePriceShareOptionsGranted2019>
<ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 id="Factid_19491046" contextRef="P06_30_2020To06_30_2020_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">15.15</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
<ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 id="Factid_19491047" contextRef="P09_14_2020To09_14_2020_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">9.16</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
<ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted id="Factid_19491048" contextRef="P06_30_2020To06_30_2020_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="2">0.79</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
<ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted id="Factid_19491049" contextRef="P09_14_2020To09_14_2020_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="2">0.78</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
<ifrs-full:DescriptionOfOptionLifeShareOptionsGranted id="Factid_19491050" contextRef="P06_30_2020To06_30_2020_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_Y" decimals="1">7.0</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
<ifrs-full:DescriptionOfOptionLifeShareOptionsGranted id="Factid_19491051" contextRef="P09_14_2020To09_14_2020_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_Y" decimals="1">6.7</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
<ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted id="Factid_19491052" contextRef="P06_30_2020To06_30_2020_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="4">0.0066</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
<ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted id="Factid_19491053" contextRef="P09_14_2020To09_14_2020_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="4">0.0067</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
<ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted id="Factid_19491054" contextRef="P06_30_2020To06_30_2020_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="4">0.0000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
<ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted id="Factid_19491055" contextRef="P09_14_2020To09_14_2020_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="4">0.0000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
<ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 id="Factid_19491061" contextRef="P01_01_2020To12_31_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_GrantedOnJuneTwoThousandAndTwentyMemberIMTXDateOfGrantAxis" unitRef="Unit_USD_per_Share" decimals="2">10.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
<ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement id="Factid_19491062" contextRef="P01_01_2020To12_31_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_GrantedOnJuneTwoThousandAndTwentyMemberIMTXDateOfGrantAxis" unitRef="Unit_shares" decimals="0">1087417</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
<ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 id="Factid_19491063" contextRef="P01_01_2020To12_31_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_GrantedOnSeptemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis" unitRef="Unit_USD_per_Share" decimals="2">9.72</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
<ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement id="Factid_19491064" contextRef="P01_01_2020To12_31_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_GrantedOnSeptemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis" unitRef="Unit_shares" decimals="0">74000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
<ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 id="Factid_19491065" contextRef="P01_01_2020To12_31_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_GrantedOnDecemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis" unitRef="Unit_USD_per_Share" decimals="2">9.70</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
<ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement id="Factid_19491066" contextRef="P01_01_2020To12_31_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_GrantedOnDecemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis" unitRef="Unit_shares" decimals="0">802149</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
<ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019 id="Factid_19491067" contextRef="P01_01_2020To12_31_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">10.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
<ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement id="Factid_19491068" contextRef="P01_01_2020To12_31_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="0">53384</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
<ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 id="Factid_19491069" contextRef="PAsOn12_31_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">9.87</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
<ifrs-full:NumberOfOutstandingShareOptions id="Factid_19491070" contextRef="PAsOn12_31_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="0">1910182</ifrs-full:NumberOfOutstandingShareOptions>
<ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 id="Factid_19491073" contextRef="P01_01_2020To12_31_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">P9Y8M19D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
<imtx:ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare id="Factid_19491074" contextRef="P01_01_2020To12_31_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_GrantedOnJuneTwoThousandAndTwentyMemberIMTXDateOfGrantAxis" unitRef="Unit_USD_per_Share" decimals="2">11.29</imtx:ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare>
<imtx:ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare id="Factid_19491075" contextRef="P01_01_2020To12_31_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_GrantedOnSeptemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis" unitRef="Unit_USD_per_Share" decimals="2">9.25</imtx:ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare>
<imtx:ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare id="Factid_19491076" contextRef="P01_01_2020To12_31_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_GrantedOnDecemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis" unitRef="Unit_USD_per_Share" decimals="2">6.73</imtx:ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare>
<ifrs-full:ExercisePriceShareOptionsGranted2019 id="Factid_19491094" contextRef="P06_30_2020To06_30_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">10.00</ifrs-full:ExercisePriceShareOptionsGranted2019>
<ifrs-full:ExercisePriceShareOptionsGranted2019 id="Factid_19491095" contextRef="P09_14_2020To09_14_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">10.00</ifrs-full:ExercisePriceShareOptionsGranted2019>
<ifrs-full:ExercisePriceShareOptionsGranted2019 id="Factid_19491096" contextRef="P12_17_2020To12_17_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">9.70</ifrs-full:ExercisePriceShareOptionsGranted2019>
<ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 id="Factid_19491097" contextRef="P06_30_2020To06_30_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">15.15</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
<ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 id="Factid_19491098" contextRef="P09_14_2020To09_14_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">9.16</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
<ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 id="Factid_19491099" contextRef="P12_17_2020To12_17_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">9.70</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
<ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted id="Factid_19491100" contextRef="P06_30_2020To06_30_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="2">0.75</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
<ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted id="Factid_19491101" contextRef="P09_14_2020To09_14_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="2">0.79</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
<ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted id="Factid_19491102" contextRef="P12_17_2020To12_17_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="2">0.84</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
<ifrs-full:DescriptionOfOptionLifeShareOptionsGranted id="Factid_19491103" contextRef="P06_30_2020To06_30_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_Y" decimals="1">7.0</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
<ifrs-full:DescriptionOfOptionLifeShareOptionsGranted id="Factid_19491104" contextRef="P09_14_2020To09_14_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_Y" decimals="1">6.2</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
<ifrs-full:DescriptionOfOptionLifeShareOptionsGranted id="Factid_19491105" contextRef="P12_17_2020To12_17_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_Y" decimals="1">6.0</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
<ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted id="Factid_19491106" contextRef="P06_30_2020To06_30_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="4">0.0029</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
<ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted id="Factid_19491107" contextRef="P09_14_2020To09_14_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="4">0.0037</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
<ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted id="Factid_19491108" contextRef="P12_17_2020To12_17_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="4">0.0049</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
<ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted id="Factid_19491109" contextRef="P06_30_2020To06_30_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="4">0.0000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
<ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted id="Factid_19491110" contextRef="P09_14_2020To09_14_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="4">0.0000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
<ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted id="Factid_19491111" contextRef="P12_17_2020To12_17_2020_AdditionalGrantsUnderTwoThousandAndTwentyPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="4">0.0000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
<ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 id="Factid_19491114" contextRef="P01_01_2020To12_31_2020_ConvertedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_GrantedOnJuneTwoThousandAndTwentyMemberIMTXDateOfGrantAxis" unitRef="Unit_USD_per_Share" decimals="2">2.49</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
<ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement id="Factid_19491115" contextRef="P01_01_2020To12_31_2020_ConvertedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_GrantedOnJuneTwoThousandAndTwentyMemberIMTXDateOfGrantAxis" unitRef="Unit_shares" decimals="0">632384</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
<ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019 id="Factid_19491116" contextRef="P01_01_2020To12_31_2020_ConvertedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">1.08</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
<ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement id="Factid_19491117" contextRef="P01_01_2020To12_31_2020_ConvertedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="0">37540</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
<ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 id="Factid_19491118" contextRef="PAsOn12_31_2020_ConvertedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">2.58</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
<ifrs-full:NumberOfOutstandingShareOptions id="Factid_19491119" contextRef="PAsOn12_31_2020_ConvertedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="0">594844</ifrs-full:NumberOfOutstandingShareOptions>
<imtx:WeightedAverageExercisePriceOfShareOptionsVestedInSharebasedPaymentArrangement2019 id="Factid_19491120" contextRef="PAsOn12_31_2020_ConvertedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">2.45</imtx:WeightedAverageExercisePriceOfShareOptionsVestedInSharebasedPaymentArrangement2019>
<imtx:NumberOfShareOptionsVestedInSharebasedPaymentArrangement id="Factid_19491121" contextRef="PAsOn12_31_2020_ConvertedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="0">53856</imtx:NumberOfShareOptionsVestedInSharebasedPaymentArrangement>
<ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 id="Factid_19491122" contextRef="P01_01_2020To12_31_2020_ConvertedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">P7Y3D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
<ifrs-full:ExercisePriceShareOptionsGranted2019 id="Factid_19491124" contextRef="P06_30_2020To06_30_2020_ConvertedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">2.47</ifrs-full:ExercisePriceShareOptionsGranted2019>
<ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 id="Factid_19491125" contextRef="P06_30_2020To06_30_2020_ConvertedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">15.15</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
<ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted id="Factid_19491126" contextRef="P06_30_2020To06_30_2020_ConvertedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="2">0.75</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
<ifrs-full:DescriptionOfOptionLifeShareOptionsGranted id="Factid_19491127" contextRef="P06_30_2020To06_30_2020_ConvertedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_Y" decimals="1">5.6</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
<ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted id="Factid_19491128" contextRef="P06_30_2020To06_30_2020_ConvertedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="4">0.0029</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
<ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted id="Factid_19491129" contextRef="P06_30_2020To06_30_2020_ConvertedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_pure" decimals="4">0.0000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
<ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 id="Factid_19491132" contextRef="P01_01_2020To12_31_2020_GrantedOnJuneTwoThousandAndTwentyMemberIMTXDateOfGrantAxis_MatchingStockOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">10.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
<ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement id="Factid_19491133" contextRef="P01_01_2020To12_31_2020_GrantedOnJuneTwoThousandAndTwentyMemberIMTXDateOfGrantAxis_MatchingStockOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="0">1430818</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
<ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019 id="Factid_19491134" contextRef="P01_01_2020To12_31_2020_MatchingStockOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">10.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
<ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement id="Factid_19491135" contextRef="P01_01_2020To12_31_2020_MatchingStockOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="0">8262</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
<ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 id="Factid_19491136" contextRef="PAsOn12_31_2020_MatchingStockOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">10.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
<ifrs-full:NumberOfOutstandingShareOptions id="Factid_19491137" contextRef="PAsOn12_31_2020_MatchingStockOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="0">1422556</ifrs-full:NumberOfOutstandingShareOptions>
<ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 id="Factid_19491140" contextRef="P01_01_2020To12_31_2020_MatchingStockOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">P9Y6M</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
<imtx:ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare id="Factid_19491141" contextRef="P01_01_2020To12_31_2020_GrantedOnJuneTwoThousandAndTwentyMemberIMTXDateOfGrantAxis_MatchingStockOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">10.59</imtx:ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare>
<ifrs-full:OtherNoncurrentLiabilities id="Factid_19491144" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" xsi:nil="true" />
<imtx:DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock id="Factid_19491145" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2.1&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Going concern &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Since inception, the Group&amp;#8217;s activities have consisted primarily of raising capital and performing research and development activities to advance its technologies. The Group is still in the development phase and has not yet marketed any products commercially. Immatics&amp;#8217; ongoing success depends on the successful development and regulatory approval of its products and its ability to finance operations. The Group will seek additional funding to reach its development and commercialization objectives. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Group plans to seek funds through further private or public equity financings, debt financings, collaboration agreements and marketing, distribution or licensing arrangements. The Group may not be able to obtain financing or enter into collaboration or other arrangements on acceptable terms. If the Group is unable to obtain funding, it could be forced to delay, reduce or eliminate some or all of its research and development programs, product portfolio expansion or commercialization efforts, which could adversely affect its business prospects. However, Immatics&amp;#8217; cash and cash equivalents as well as short-term deposits will be sufficient to fund operating expenses and capital expenditure requirements for at least twelve months from the issuance date and expect a cash reach for at least twelve months. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The accompanying consolidated financial statements have been prepared on a going concern basis. This contemplates the Group will continue in operation for the foreseeable future and will be able to realize its assets and discharge its liabilities in the normal course of operations. The consolidated financial statements do not reflect any adjustments relating to the recoverability and classification of assets or the amounts and classification of liabilities that would be necessary, was the Group unable to continue as a going concern. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock>
<ifrs-full:DescriptionOfAccountingPolicyForCashFlowsExplanatory id="Factid_19491146" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2.2&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Correction of classification of Statement of Cash Flows &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;During the third quarter of 2020, the Group identified and corrected the classification of short-term deposits with an original maturity dates between three and nine months within the Statement of Cash Flows which resulted in a misclassification within the Statement of Cash Flows since 2018. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company has evaluated the effect of this misclassification, both qualitatively and quantitatively, and concluded that the correction did not have a material impact on, nor require amendment of, any previously filed financial statements. In the Statement of Cash Flows, the changes in short-term deposits were previously classified as (Increase) decrease in other assets within operating activities and has been retrospectively corrected and presented as separate line items within investing activities. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;This correction of classification resulted in the following impact to the Statement of Cash Flows: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 60%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year ended December&amp;#160;31, 2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year ended December&amp;#160;31, 2018&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&lt;br/&gt;reported&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Adjustment&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&lt;br/&gt;revised&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&lt;br/&gt;reported&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Adjustment&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&lt;br/&gt;revised&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;(Increase) decrease in other assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(4,419&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2,922&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(1,497&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(7,493&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;13,101&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;5,608&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net cash provided by operating activities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;68,045&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2,922&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;70,967&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;7,583&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;13,101&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;20,684&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Cash paid for investments classified in Other financial assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(20,473&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(20,473&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(13,101&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(13,101&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cash received from maturity of investments classified in Other financial assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;17,551&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;17,551&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net cash used in investing activities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(2,137&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(2,922&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(5,059&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(413&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(13,101&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(13,514&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 60%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total effect on Cash Flow&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="width: 60%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 58%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Three&amp;#160;months&amp;#160;ended&amp;#160;March&amp;#160;31,&amp;#160;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Six months ended June&amp;#160;30, 2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&lt;br/&gt;reported&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Adjustment&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&lt;br/&gt;revised&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&lt;br/&gt;reported&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Adjustment&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&lt;br/&gt;revised&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 58%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;(Increase) decrease in other assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(17,209&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;16,836&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(373&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;14,917&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(16,023&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(1,106&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 58%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net cash provided by/ (used in) operating activities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(28,286&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,836&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(11,450&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(11,716&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(16,023&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(27,739&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 58%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Cash paid for investments classified in Other financial assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(32,859&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(32,859&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(32,859&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(32,859&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 58%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cash received from maturity of investments classified in Other financial assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,023&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,023&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;48,882&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;48,882&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 58%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net cash provided by/ (used in) investing activities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(2,387&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(16,836&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(19,223&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(4,550&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;16,023&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;11,473&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 58%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total effect on Cash Flow&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="width: 58%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;There is no impact on the Group&amp;#8217;s Consolidated Statement of Financial Position, Consolidated Statement of Changes in Shareholders&amp;#8217; Deficit, Consolidated Statement of Loss, Net loss per share, Consolidated Statement of Comprehensive Loss, and no impact to financing cash flows for the any of the periods presented. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DescriptionOfAccountingPolicyForCashFlowsExplanatory>
<imtx:DescriptionOfAccountingPolicyForCovidNineteenPolicyTextBlock id="Factid_19491147" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2.3&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;COVID-19&lt;/div&gt; &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;In December 2019, a novel strain of coronavirus &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(&amp;#8220;COVID-19&amp;#8221;)&lt;/div&gt; emerged. On January&amp;#160;30, 2020, the World Health Organization declared the outbreak a pandemic and a global emergency. In response, many countries and businesses instituted travel restrictions, quarantines, and office closures that are still in place. The extent of the pandemic and governmental responses may impact our ability to obtain raw materials and equipment used for research and development, obtain sufficient additional funds to finance our operations, and conduct clinical trials, any of which could materially and adversely affect our business. &lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"&gt;Management continues to monitor the situation and enacted significant measures to protect the Group&amp;#8217;s supply chain, employees, and the execution of clinical trials. To date, the pandemic has resulted in a slowdown in activities related to the Group&amp;#8217;s laboratory operations and at some of its suppliers. The ongoing spread of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;COVID-19&lt;/div&gt; may also negatively impact the Group&amp;#8217;s ability to conduct clinical trials, including potential delays and restrictions on the Group&amp;#8217;s ability to recruit and retain patients, principal investigators and healthcare employees. &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;COVID-19&lt;/div&gt; could also affect the operations of contract research organizations, which may also result in delays or disruptions in the supply of product candidates. Immatics continues to expand its clinical programs with additional clinical trial sites opening in the U.S. and in Europe. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;Due to &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;COVID-19,&lt;/div&gt; the Group has also experienced delays in research activities performed under its collaboration agreements. Consequently, the Group recognized less revenue under these agreements in 2020 than previously planned. Management believes the declines in revenue associated with the delay in research activities are largely temporary, as the revenue is primarily associated with &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-refundable&lt;/div&gt; upfront payments recognized on a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;cost-to-cost&lt;/div&gt;&lt;/div&gt; basis. &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;COVID-19&lt;/div&gt; may continue to impact the timing and amount of revenue recognized under these agreements in the future. &lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DescriptionOfAccountingPolicyForCovidNineteenPolicyTextBlock>
<ifrs-full:TitleOfNewIFRS id="Factid_19491148" contextRef="P01_01_2020To12_31_2020_IfrsSixteenMemberifrsfullNewIFRSsAxis">IFRS 16 COVID-19-Related Rent Concessions Amendment</ifrs-full:TitleOfNewIFRS>
<imtx:DisclosureOfDetailedInformationAboutFinanceIncomeExpenseExplanatoryTextBlock id="Factid_19491149" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Financial income and financial expenses consist of the following: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:80%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year ended December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Interest income from short-term deposits&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;850&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;790&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;507&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Foreign currency gains&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,708&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Gain on other financial instruments&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2,099&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Financial income&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,949&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;790&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,215&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1pt;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Interest expenses form leases&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(289&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(170&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(16&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Foreign currency losses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(9,774&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(94&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(145&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Financial expenses&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(10,063&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(264&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(161&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DisclosureOfDetailedInformationAboutFinanceIncomeExpenseExplanatoryTextBlock>
<ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory id="Factid_19491150" contextRef="P01_01_2020To12_31_2020_TwoThousandAndSixteenTandemAwardsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The fair value of tandem awards issued in December 2019 was based on a company valuation of $350&amp;#160;million. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:61%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:9%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:9%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:9%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Amounts in USD&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;June&amp;#160;2019&amp;#160;-&amp;#160;September&amp;#160;2019&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;2018&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Exercise price in USD&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#160;23.82&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#160;18.30&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#160;16.65&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Underlying share price in USD&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;67.87&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16.94&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;27.21&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Volatility&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;73&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;78&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;64&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Time period (years)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1.25&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2.10&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;5.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Risk free rate&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.59&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2.04&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2.77&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Dividend yield&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;0.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;0.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;0.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Combined probability of exit events&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;80.00&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;60.00&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;25.00&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory>
<ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory id="Factid_19491151" contextRef="P01_01_2020To12_31_2020_MatchingStockOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Immatics applied a Black Scholes pricing model to estimate the fair value of the Matching Stock Options, which the Group records as an expense over the four-year graded vesting period. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:84%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:12%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&amp;#160;of&amp;#160;June&amp;#160;30,&lt;/div&gt;&lt;br/&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Exercise price in USD&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10.00&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Underlying share price in USD&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;15.15&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Volatility&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;75&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Time period (years)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;5.5&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Risk free rate&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.29&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Dividend yield&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;0.00&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory>
<ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 id="Factid_19491154" contextRef="P01_01_2020To12_31_2020_GrantedOnJuneTwoThousandAndTwentyMemberIMTXDateOfGrantAxis_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">10.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
<ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement id="Factid_19491155" contextRef="P01_01_2020To12_31_2020_GrantedOnJuneTwoThousandAndTwentyMemberIMTXDateOfGrantAxis_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="0">3644000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
<ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 id="Factid_19491156" contextRef="P01_01_2020To12_31_2020_GrantedOnSeptemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">10.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
<ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement id="Factid_19491157" contextRef="P01_01_2020To12_31_2020_GrantedOnSeptemberTwoThousandAndTwentyMemberIMTXDateOfGrantAxis_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="0">255000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
<ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019 id="Factid_19491158" contextRef="P01_01_2020To12_31_2020_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">10.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
<ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement id="Factid_19491159" contextRef="P01_01_2020To12_31_2020_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="0">255000</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
<ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 id="Factid_19491160" contextRef="PAsOn12_31_2020_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_USD_per_Share" decimals="2">10.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
<ifrs-full:NumberOfOutstandingShareOptions id="Factid_19491161" contextRef="PAsOn12_31_2020_PerformanceBasedOptionsMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="0">3644000</ifrs-full:NumberOfOutstandingShareOptions>
<ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement id="Factid_19491162" contextRef="P01_01_2020To12_31_2020_MatchingStockOptionsMemberIMTXShareReinvestmentSchemeAxis_ModificationOfTwoThousandAndSixteenPlanMemberIMTXPlanAxis_ShareReinvestmentMemberIMTXSchemeAxis">ten-year</ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement>
<ifrs-full:ComprehensiveIncome id="Factid_19491163" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">-236305000</ifrs-full:ComprehensiveIncome>
<ifrs-full:ComprehensiveIncome id="Factid_19491164" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">-32516000</ifrs-full:ComprehensiveIncome>
<ifrs-full:ComprehensiveIncome id="Factid_19491165" contextRef="P01_01_2018To12_31_2018" unitRef="Unit_EUR" decimals="-3">-32042000</ifrs-full:ComprehensiveIncome>
<imtx:RentalContractTerm id="Factid_19491166" contextRef="P01_01_2020To12_31_2020_BottomOfRangeMemberifrsfullRangeAxis">two</imtx:RentalContractTerm>
<ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests id="Factid_19705572" contextRef="P01_01_2018To12_31_2018_ImmaticsUsIncMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_pure" decimals="4">0.0396</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
<imtx:PotentialMilestonePaymentPayable id="Factid_19708930" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-5">1600000</imtx:PotentialMilestonePaymentPayable>
<ifrs-full:NoncontrollingInterests id="Factid_19723206" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">0</ifrs-full:NoncontrollingInterests>
<dei:DocumentType id="Factid_19723671" contextRef="P01_01_2020To12_31_2020">20-F</dei:DocumentType>
<dei:AmendmentFlag id="Factid_19723672" contextRef="P01_01_2020To12_31_2020">false</dei:AmendmentFlag>
<dei:DocumentPeriodEndDate id="Factid_19723675" contextRef="P01_01_2020To12_31_2020">2020-12-31</dei:DocumentPeriodEndDate>
<dei:DocumentFiscalYearFocus id="Factid_19723679" contextRef="P01_01_2020To12_31_2020">2020</dei:DocumentFiscalYearFocus>
<dei:DocumentFiscalPeriodFocus id="Factid_19723680" contextRef="P01_01_2020To12_31_2020">FY</dei:DocumentFiscalPeriodFocus>
<dei:EntityRegistrantName id="Factid_19723683" contextRef="P01_01_2020To12_31_2020">Immatics N.V.</dei:EntityRegistrantName>
<dei:EntityCentralIndexKey id="Factid_19723686" contextRef="P01_01_2020To12_31_2020">0001809196</dei:EntityCentralIndexKey>
<dei:CurrentFiscalYearEndDate id="Factid_19723690" contextRef="P01_01_2020To12_31_2020">--12-31</dei:CurrentFiscalYearEndDate>
<dei:EntityIncorporationStateCountryCode id="Factid_19723694" contextRef="P01_01_2020To12_31_2020">P7</dei:EntityIncorporationStateCountryCode>
<dei:EntityWellKnownSeasonedIssuer id="Factid_19723701" contextRef="P01_01_2020To12_31_2020">No</dei:EntityWellKnownSeasonedIssuer>
<dei:EntityVoluntaryFilers id="Factid_19723703" contextRef="P01_01_2020To12_31_2020">No</dei:EntityVoluntaryFilers>
<dei:EntityCurrentReportingStatus id="Factid_19723710" contextRef="P01_01_2020To12_31_2020">Yes</dei:EntityCurrentReportingStatus>
<dei:EntityInteractiveDataCurrent id="Factid_19723712" contextRef="P01_01_2020To12_31_2020">Yes</dei:EntityInteractiveDataCurrent>
<dei:EntityFileNumber id="Factid_19723728" contextRef="P01_01_2020To12_31_2020">001-39363</dei:EntityFileNumber>
<dei:Security12bTitle id="Factid_19723866" contextRef="P01_01_2020To12_31_2020_OrdinaryShareMemberdeiDocumentInformationDocumentAxis">Ordinary shares, nominal value &amp;#8364;0.01 per share</dei:Security12bTitle>
<dei:Security12bTitle id="Factid_19723867" contextRef="P01_01_2020To12_31_2020_WarrantsMemberdeiDocumentInformationDocumentAxis">Warrants to purchase ordinary shares</dei:Security12bTitle>
<dei:TradingSymbol id="Factid_19723868" contextRef="P01_01_2020To12_31_2020_OrdinaryShareMemberdeiDocumentInformationDocumentAxis">IMTX</dei:TradingSymbol>
<dei:TradingSymbol id="Factid_19723869" contextRef="P01_01_2020To12_31_2020_WarrantsMemberdeiDocumentInformationDocumentAxis">IMTXW</dei:TradingSymbol>
<dei:ContactPersonnelName id="Factid_19723880" contextRef="P01_01_2020To12_31_2020_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">Edward A. Sturchio</dei:ContactPersonnelName>
<dei:EntityAddressAddressLine1 id="Factid_19724027" contextRef="P01_01_2020To12_31_2020_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">2130 W. Holcombe Blvd., Suite 900</dei:EntityAddressAddressLine1>
<dei:EntityAddressCityOrTown id="Factid_19724030" contextRef="P01_01_2020To12_31_2020_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">Houston</dei:EntityAddressCityOrTown>
<dei:CityAreaCode id="Factid_19724034" contextRef="P01_01_2020To12_31_2020_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">281</dei:CityAreaCode>
<dei:LocalPhoneNumber id="Factid_19724035" contextRef="P01_01_2020To12_31_2020_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">810-7545</dei:LocalPhoneNumber>
<ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains id="Factid_19724265" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">-4477000</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
<ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains id="Factid_19724266" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_EUR" decimals="-3">3000</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
<ifrs-full:PaymentsForShareIssueCosts id="Factid_19724267" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">7939000</ifrs-full:PaymentsForShareIssueCosts>
<imtx:UpfrontPaymentReceived id="Factid_19724340" contextRef="P01_01_2020To12_31_2020_AmgenCollaborationAgreementMemberIMTXAgreementAxis" unitRef="Unit_EUR" decimals="-6">28000000</imtx:UpfrontPaymentReceived>
<imtx:UpfrontPaymentReceived id="Factid_19724342" contextRef="P01_01_2020To12_31_2020_GenmabCollaborationAgreementMemberIMTXAgreementAxis" unitRef="Unit_EUR" decimals="-6">46000000</imtx:UpfrontPaymentReceived>
<ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory id="Factid_19724431" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;19.&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Shareholders&amp;#8217; equity (deficit) &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As described in Note 1 and Note 3, Immatics N.V. was founded in 2020 with a share capital of &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#8364;0.01&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;after the Reorganization. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;On July&amp;#160;1, 2020, upon closing of the ARYA Merger, Immatics N.V. had 62,908,617 outstanding ordinary shares with a par value of &amp;#8364;0.01, resulting in a share capital of &amp;#8364;629&amp;#160;thousand. In 2020, the ARYA Merger and PIPE Financing led to an increase in share premium by &amp;#8364;362,5&amp;#160;million. As of December&amp;#160;31, 2020, the total number of ordinary shares of Immatics N.V. outstanding is 62,908,617 with a par value of &amp;#8364;0.01. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December&amp;#160;31, 2019, the total number of ordinary shares of Immatics Biotechnologies GmbH outstanding is 1,163,625 with a par value of &amp;#8364;1.00. &lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Adjusted for the effect of the Reorganization as discussed in Note 3, which is applied retrospectively to all prior periods presented, the total number of ordinary shares outstanding as of December&amp;#160;31, 2019 was 33,093,838 with a par value of &amp;#8364;0.01. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;In 2019, there was no capital increase and, hence, no change in share capital or share premium. In 2018, &amp;#8364;23.6&amp;#160;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;million&lt;/div&gt; were paid into share premium by the shareholders based on the Series E financing round, which closed in 2017. The related Series E share capital was previously paid in full in 2017. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other reserves are related to accumulated foreign currency translation amounts associated with the Group&amp;#8217;s US operations. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December&amp;#160;31, 2020, there were 7,187,500 &lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Immatics Warrants outstanding. The warrants entitle the holder to purchase one ordinary share of Immatics N.V. at an exercise price of &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;$11.50 per share. &lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Until warrant holders acquire the Groups ordinary shares upon exercise of such warrants, they will have no rights with respect to the Groups ordinary shares. The warrants will expire on July&amp;#160;1, 2025, &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;five &lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;years after the ARYA Merger close date, or earlier upon redemption or liquidation in accordance with their terms. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory>
<ifrs-full:NumberOfSharesOutstanding id="Factid_19724477" contextRef="PAsOn12_31_2019_ReorganizationMemberIMTXEventAxis" unitRef="Unit_shares" decimals="INF">33093838</ifrs-full:NumberOfSharesOutstanding>
<ifrs-full:ParValuePerShare id="Factid_19724478" contextRef="PAsOn12_31_2019_ReorganizationMemberIMTXEventAxis" unitRef="Unit_USD_per_Share" decimals="INF">0.01</ifrs-full:ParValuePerShare>
<imtx:NumberOfSharesExchangedInSubsidiaries id="Factid_19724481" contextRef="P07_01_2020To07_01_2020_MdAndersonMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_shares" decimals="0">379420</imtx:NumberOfSharesExchangedInSubsidiaries>
<imtx:StockIssuedDuringPeriodSharesAcquisitions id="Factid_19724482" contextRef="P07_01_2020To07_01_2020_RestrictedStockAcquisitionAgreementMemberifrsfullBusinessCombinationsAxis" unitRef="Unit_shares" decimals="0">697431</imtx:StockIssuedDuringPeriodSharesAcquisitions>
<ifrs-full:ParValuePerShare id="Factid_19724483" contextRef="PAsOn07_01_2020_AryaMemberifrsfullBusinessCombinationsAxis" unitRef="Unit_USD_per_Share" decimals="2">15.15</ifrs-full:ParValuePerShare>
<ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests id="Factid_19724489" contextRef="P06_30_2020To06_30_2020" unitRef="Unit_pure" decimals="4">0.0514</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
<imtx:StockIssuedDuringPeriodValueNewIssues id="Factid_19724490" contextRef="P06_30_2020To06_30_2020" unitRef="Unit_EUR" decimals="-5">500000</imtx:StockIssuedDuringPeriodValueNewIssues>
<imtx:IncreasedecreaseThroughChangesInNoncontrollingInterest id="Factid_19724491" contextRef="P06_30_2020To06_30_2020" unitRef="Unit_EUR" decimals="-5">500000</imtx:IncreasedecreaseThroughChangesInNoncontrollingInterest>
<imtx:TaxEffectOfPermanentDifferences id="Factid_19724597" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">-44461000</imtx:TaxEffectOfPermanentDifferences>
<imtx:EffectiveIncomeTaxReconciliationPermanentEffectShareListingExpense id="Factid_19724703" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-6">153000000</imtx:EffectiveIncomeTaxReconciliationPermanentEffectShareListingExpense>
<imtx:UnrecordedContingentLiability id="Factid_19725243" contextRef="PAsOn12_31_2020_CollaborationAgreementsMemberIMTXAgreementAxis" unitRef="Unit_EUR" decimals="-5">1600000</imtx:UnrecordedContingentLiability>
<imtx:UnrecordedContingentLiability id="Factid_19725244" contextRef="PAsOn12_31_2019_CollaborationAgreementsMemberIMTXAgreementAxis" unitRef="Unit_EUR" decimals="-5">1600000</imtx:UnrecordedContingentLiability>
<dei:EntityCommonStockSharesOutstanding id="Factid_19725311" contextRef="PAsOn12_31_2020" unitRef="Unit_shares" decimals="INF">62908617</dei:EntityCommonStockSharesOutstanding>
<dei:DocumentAccountingStandard id="Factid_19725331" contextRef="P01_01_2020To12_31_2020">International Financial Reporting Standards</dei:DocumentAccountingStandard>
<dei:EntityShellCompany id="Factid_19735939" contextRef="P01_01_2020To12_31_2020">false</dei:EntityShellCompany>
<dei:EntityFilerCategory id="Factid_19736066" contextRef="P01_01_2020To12_31_2020">Non-accelerated Filer</dei:EntityFilerCategory>
<dei:EntityEmergingGrowthCompany id="Factid_19736080" contextRef="P01_01_2020To12_31_2020">true</dei:EntityEmergingGrowthCompany>
<dei:EntityExTransitionPeriod id="Factid_19736204" contextRef="P01_01_2020To12_31_2020">false</dei:EntityExTransitionPeriod>
<dei:SecurityExchangeName id="Factid_19736215" contextRef="P01_01_2020To12_31_2020_OrdinaryShareMemberdeiDocumentInformationDocumentAxis">NASDAQ</dei:SecurityExchangeName>
<dei:SecurityExchangeName id="Factid_19736228" contextRef="P01_01_2020To12_31_2020_WarrantsMemberdeiDocumentInformationDocumentAxis">NASDAQ</dei:SecurityExchangeName>
<dei:IcfrAuditorAttestationFlag id="Factid_19736390" contextRef="P01_01_2020To12_31_2020">false</dei:IcfrAuditorAttestationFlag>
<dei:DocumentAnnualReport id="Factid_19736442" contextRef="P01_01_2020To12_31_2020">true</dei:DocumentAnnualReport>
<dei:DocumentRegistrationStatement id="Factid_19736447" contextRef="P01_01_2020To12_31_2020">false</dei:DocumentRegistrationStatement>
<dei:DocumentShellCompanyReport id="Factid_19736449" contextRef="P01_01_2020To12_31_2020">false</dei:DocumentShellCompanyReport>
<dei:DocumentTransitionReport id="Factid_19736465" contextRef="P01_01_2020To12_31_2020">false</dei:DocumentTransitionReport>
<dei:EntityAddressAddressLine1 id="Factid_19749871" contextRef="P01_01_2020To12_31_2020">Paul-Ehrlich-Stra&amp;#223;e 15</dei:EntityAddressAddressLine1>
<dei:EntityAddressCityOrTown id="Factid_19749878" contextRef="P01_01_2020To12_31_2020">T&amp;#252;bingen</dei:EntityAddressCityOrTown>
<dei:EntityAddressPostalZipCode id="Factid_19749884" contextRef="P01_01_2020To12_31_2020">77030</dei:EntityAddressPostalZipCode>
<imtx:UpfrontPaymentReceived id="Factid_19753656" contextRef="P01_01_2020To12_31_2020_BMSCollaborationAgreementMemberIMTXAgreementAxis" unitRef="Unit_EUR" decimals="-6">68000000</imtx:UpfrontPaymentReceived>
<imtx:DeferredGrantIncomeCurrent id="Factid_19757360" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">0</imtx:DeferredGrantIncomeCurrent>
<ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory id="Factid_19768728" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;25.&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Commitments and contingencies &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table summarizes contractual obligations as of December&amp;#160;31, 2020: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:66%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="18" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Payments due by period&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;(Euros in thousands)&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-top: 0.75pt solid black; border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Less&amp;#160;than&lt;br/&gt;1&amp;#160;year&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-top: 0.75pt solid black; border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;1&amp;#160;-&amp;#160;3&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;years&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-top: 0.75pt solid black; border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;3&amp;#160;-&amp;#160;5&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;years&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-top: 0.75pt solid black; border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;More&amp;#160;than&lt;br/&gt; 5 years&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-top: 0.75pt solid black; border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Lease liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2,103&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;3,453&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,157&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;150&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;6,863&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other lease obligations&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;97&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;185&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;185&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;46&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;513&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;In-license&lt;/div&gt; agreements&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;249&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;249&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Contract research organization agreements&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,704&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;220&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,924&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total contractual cash obligation&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,153&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,858&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,342&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;196&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;9,549&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table summarizes contractual obligations as of December&amp;#160;31, 2019: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:67%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="18" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Payments due by period&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;(Euros in thousands)&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="padding-bottom: 0.75pt; border-bottom: 0.75pt solid black; border-top: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Less&amp;#160;than&lt;br/&gt;1&amp;#160;year&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt; border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt; border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black; border-top: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;1&amp;#160;-&amp;#160;3&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;years&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom: 0.75pt solid black; border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt; border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black; border-top: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;3&amp;#160;-&amp;#160;5&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;years&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt; border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt; border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="padding-bottom: 0.75pt; border-bottom: 0.75pt solid black; border-top: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;More&amp;#160;than&amp;#160;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;years&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt; border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt; border-top: 0.75pt solid black;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="padding-bottom: 0.75pt; border-bottom: 0.75pt solid black; border-top: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Lease liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,482&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,823&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;47&lt;/td&gt;&lt;td style="white-space: nowrap; font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;3,352&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other lease obligations&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;172&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;324&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;300&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;300&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,096&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;In-license&lt;/div&gt; agreements&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;455&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;200&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;655&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Contract research organization agreements&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,131&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,466&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2,597&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total contractual cash obligation&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,240&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,813&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;347&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;300&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;7,700&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December&amp;#160;31, 2020, and 2019 the Group is potentially liable to pay &amp;#8364;1.6&amp;#160;million to a third-party upon successful completing the milestone of the first clinical lead selection in connection with Immatics&amp;#8217; collaboration agreements. The Group does not recognize a liability for these contingent payments due to the scientific uncertainty of achieving the related milestones. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory>
<dei:EntityAddressCountry id="Factid_19779879" contextRef="P01_01_2020To12_31_2020">DE</dei:EntityAddressCountry>
<dei:EntityAddressStateOrProvince id="Factid_19779921" contextRef="P01_01_2020To12_31_2020">TX</dei:EntityAddressStateOrProvince>
<imtx:AryaMergerTransactionExplanatory id="Factid_19828553" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3.&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;ARYA Merger &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;On March&amp;#160;17, 2020, Immatics entered into a definitive merger agreement with ARYA Sciences Acquisition Corp. (&amp;#8220;ARYA&amp;#8221;), a special purpose acquisition company sponsored by Perceptive Advisors. The transaction closed on July&amp;#160;1, 2020. The merger (&amp;#8220;ARYA Merger&amp;#8221;) was effectuated as follows: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:5%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:3%;"&gt;&amp;#8226;&lt;/td&gt;&lt;td style="vertical-align:top;;width:1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The shareholders of Immatics Biotechnologies GmbH exchanged their interest for ordinary shares in the share capital of Immatics B.V. (&amp;#8220;the Reorganization&amp;#8221;). The Reorganization is accounted for as a recapitalization, with Immatics Biotechnologies GmbH being the accounting predecessor. The Reorganization resulted in a &amp;#8364;0.8&amp;#160;million decrease in share capital and an offsetting increase in share premium. Subsequent to the Reorganization, Immatics B.V. was converted into Immatics N.V., after the share exchange of Immatics shareholders. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 9%;"&gt;As part of the Reorganization, the minority shareholder in Immatics US, Inc., MD Anderson Cancer Center (&amp;#8220;MD Anderson&amp;#8221;) exchanged its interest in Immatics US, Inc. for ordinary shares in the share capital of Immatics N.V. (&amp;#8220;MD Anderson Share Exchange&amp;#8221;). This resulted in a decrease to &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-controlling&lt;/div&gt; interest of &amp;#8364;0.5&amp;#160;million, with corresponding increases to share capital and share premium. (See note 20). &lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:5%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:3%;"&gt;&amp;#8226;&lt;/td&gt;&lt;td style="vertical-align:top;;width:1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;ARYA merged into Immatics N.V., with former ARYA shareholders receiving one ordinary share of Immatics N.V. for each issued and outstanding ordinary share of ARYA and one warrant to purchase ordinary shares in Immatics N.V., for each issued and outstanding warrant to acquire ordinary shares in ARYA. The merger of ARYA constituted transaction by Immatics N.V., which is accounted for within the scope of IFRS 2. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 9%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As part of the transaction, former shareholders of ARYA received 17,968,750 shares of Immatics N.V. and 7,187,500 warrants (&amp;#8220;Immatics Warrants&amp;#8221;) to purchase ordinary shares of Immatics N.V. In exchange, Immatics received the net assets held by ARYA, which had a fair value of &amp;#8364;124.9&amp;#160;million upon closing of the transaction on July&amp;#160;1, 2020. The net assets included &amp;#8364;128.8&amp;#160;million of cash and cash equivalents held in ARYA&amp;#8217;s trust account and current liabilities of &amp;#8364;3.9&amp;#160;million. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 9%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;In accordance with IFRS 2, the difference between the fair value of the net assets contributed by ARYA and the fair value of equity instruments provided to former ARYA shareholders is treated as an expense, resulting in a &amp;#8364;152.8&amp;#160;million Share listing expense classified within the Financial result (See Note 17&lt;/div&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;) and an increase in equity. The 7,187,500 Immatics Warrants give the holder the right, but not the obligation, to subscribe to Immatics&amp;#8217; shares at a fixed or determinable price for a specified period of time subject to the provision of the Warrant Agreement. Those instruments were considered equity instruments according to IFRS 2 when they vested immediately on July 1, 2020. Management accounted for those instruments as equity instruments under IFRS 2 after the vesting date and has not applied the provisions of debt and equity classification under IAS 32. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:5%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:3%;"&gt;&amp;#8226;&lt;/td&gt;&lt;td style="vertical-align:top;;width:1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Immatics N.V. raised an additional net &amp;#8364;90.1&amp;#160;million in net equity proceeds through a private placement of ordinary shares with existing shareholders of Immatics, ARYA and other new investors (&amp;#8220;PIPE Financing&amp;#8221;). The PIPE Financing is treated as a capital contribution, which resulted in increases of &amp;#8364;0.1&amp;#160;million and &amp;#8364;90.0&amp;#160;million to share capital and share premium, respectively. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Both the ARYA Merger and PIPE Financing closed as of July&amp;#160;1, 2020. &lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Upon consummation of the transactions, Immatics N.V. became a publicly traded corporation at the Nasdaq Capital Market under the ticker IMTX. The Immatics Warrants are traded under the ticker IMTXW. Immatics incurred incremental transaction costs directly attributable to the issuance of new shares to ARYA shareholders and the PIPE Financing &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;of &amp;#8364;7.9&amp;#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;million, which it netted against the equity proceeds as a reduction in share premium. As part of the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;year-end&lt;/div&gt; closing, we adjusted the transaction cost netted against the equity proceeds by &amp;#8364;0.6&amp;#160;million. The adjustment was immaterial for our financial statements. The adjustment was due to a revised allocation of cost, both attributable to the issuance of new shares as well as listing of existing shares. &lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Immatics also amended existing share-based compensation agreements held by employees of Immatics GmbH prior to the ARYA Merger (See Note 18), in addition to making additional cash and share-based payments to key management personnel (See Note 26). &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:AryaMergerTransactionExplanatory>
<ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory id="Factid_19828554" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;9.&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Property, plant and equipment &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Changes to property, plant and equipment during 2020 and 2019 consisted of the following: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:92%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:65%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" rowspan="3" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Laboratory&lt;br/&gt; equipment&lt;/div&gt;&lt;/td&gt;&lt;td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" rowspan="3" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Computer&lt;br/&gt; equipment&lt;/div&gt;&lt;/td&gt;&lt;td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" rowspan="3" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Office&lt;br/&gt; equipment&lt;/div&gt;&lt;/td&gt;&lt;td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" rowspan="3" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/td&gt;&lt;td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td colspan="17"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td colspan="17" style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost as of January&amp;#160;1, 2019&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11,222&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,439&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,455&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;15,116&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Impact of IFRS 16 adoption&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(441&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(441&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost as of January&amp;#160;1, 2019, adjusted&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;10,781&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,439&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,455&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;14,675&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Additions&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2,204&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;515&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;297&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;3,016&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Disposals&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(314&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(2&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(316&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Currency translation differences&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;52&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;4&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;57&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost as of December&amp;#160;31, 2019&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12,723&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,956&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,753&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;17,432&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1pt;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;Accumulated depreciation as of January 1, 2019&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;8,279&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,793&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,037&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11,109&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Additions&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,219&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;256&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;322&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,797&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Disposals&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(218&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(1&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(219&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Currency translation differences&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;23&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;25&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;Accumulated depreciation as of December 31, 2019&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;9,303&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,050&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,359&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12,712&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net book value as of December&amp;#160;31, 2019&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,420&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;906&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;394&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,720&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost as of January&amp;#160;1, 2020&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12,723&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,956&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,753&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;17,432&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Additions&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;3,545&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;406&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,427&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;5,379&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Disposals&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;6&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;7&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Currency translation differences&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;299&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;40&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;28&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;367&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost as of December&amp;#160;31, 2020&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;15,968&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,322&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,146&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;22,437&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1pt;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;Accumulated depreciation as of January 1, 2020&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;9,303&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,050&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,359&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12,712&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Additions&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,384&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;404&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;315&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2,102&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Disposals&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;6&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;7&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Currency translation differences&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;210&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;26&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;3&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;239&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;Accumulated depreciation as of December 31, 2020&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;10,476&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,428&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,665&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;14,568&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net book value as of December&amp;#160;31, 2020&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5,493&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;894&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,481&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;7,868&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Depreciation expense is included in the following line items of the Consolidated Statement of Loss: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;  &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:79%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year ended December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Research and development expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,503&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,315&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,757&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;General and administrative expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;600&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;482&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;301&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,103&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,797&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,058&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory>
<ifrs-full:DisclosureOfIntangibleAssetsExplanatory id="Factid_19828557" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;10.&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Intangible assets &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="font-family: times new roman;font-size: 10pt;margin-top: 12pt;margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Changes to intangible assets during 2020 and 2019 consisted of the following: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:75%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Patents&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;and&lt;br/&gt; licenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Software&lt;br/&gt; licenses&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost as of January&amp;#160;1, 2019&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,201&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;551&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,752&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Additions&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;91&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;91&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Currency translation differences&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;19&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;20&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost as of December&amp;#160;31, 2019&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,220&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;643&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,863&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1pt;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Accumulated amortization as of January&amp;#160;1, 2019&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;314&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;399&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;713&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Additions&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;24&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;87&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;111&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Currency translation differences&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;31&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;31&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Accumulated amortization as of December&amp;#160;31, 2019&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;369&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;486&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;855&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net book value as of December&amp;#160;31, 2019&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;851&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;157&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,008&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1pt;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost as of January&amp;#160;1, 2020&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,220&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;643&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,863&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Additions&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;104&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;104&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Currency translation differences&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(88&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(9&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(97&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost as of December&amp;#160;31, 2020&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,132&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;738&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,870&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Accumulated amortization as of January&amp;#160;1, 2020&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;369&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;486&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;855&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Additions&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;56&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;71&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;126&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Currency translation differences&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(22&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(3&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(25&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Accumulated amortization as of December&amp;#160;31, 2020&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;403&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;554&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;956&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net book value as of December&amp;#160;31, 2020&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;730&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;184&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;914&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Amortization expense is classified as follows within the Consolidated Statement of Loss: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:82%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&amp;#160;ended&amp;#160;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Research and development expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;31&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;28&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;9&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;General and administrative expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;95&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;83&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;109&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;126&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;111&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;118&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfIntangibleAssetsExplanatory>
<ifrs-full:DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory id="Factid_19828558" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman;font-size: 10pt;margin-top: 12pt;margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Changes to intangible assets during 2020 and 2019 consisted of the following: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:75%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Patents&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;and&lt;br/&gt; licenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Software&lt;br/&gt; licenses&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost as of January&amp;#160;1, 2019&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,201&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;551&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,752&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Additions&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;91&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;91&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Currency translation differences&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;19&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;20&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost as of December&amp;#160;31, 2019&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,220&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;643&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,863&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1pt;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Accumulated amortization as of January&amp;#160;1, 2019&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;314&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;399&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;713&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Additions&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;24&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;87&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;111&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Currency translation differences&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;31&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;31&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Accumulated amortization as of December&amp;#160;31, 2019&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;369&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;486&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;855&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net book value as of December&amp;#160;31, 2019&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;851&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;157&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,008&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1pt;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:8;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost as of January&amp;#160;1, 2020&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,220&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;643&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,863&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Additions&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;104&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;104&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Currency translation differences&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(88&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(9&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(97&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost as of December&amp;#160;31, 2020&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,132&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;738&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,870&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Accumulated amortization as of January&amp;#160;1, 2020&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;369&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;486&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;855&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Additions&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;56&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;71&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;126&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Currency translation differences&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(22&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(3&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(25&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Accumulated amortization as of December&amp;#160;31, 2020&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;403&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;554&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;956&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net book value as of December&amp;#160;31, 2020&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;730&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;184&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;914&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory>
<imtx:DisclosureOfPersonnelExpensesExplanatoryTextBlock id="Factid_19828577" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;21.&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Personnel expenses &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Group recognized the following personnel expenses: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:76%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year ended December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Wages and salaries&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Research and development expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;15,277&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;11,635&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10,485&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;General and administrative expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;6,968&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;3,596&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2,233&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total Wages and salaries&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;22,245&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;15,231&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12,718&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Other employee benefits&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Research and development expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2,624&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2,035&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,920&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;General and administrative expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,015&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;728&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;607&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total other employee benefits&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,639&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,763&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,527&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Share-based compensation expense&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Research and development expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;14,546&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,556&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;238&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;General and administrative expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10,973&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;460&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;100&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total share-based compensation expense&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;25,519&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,016&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;338&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;51,403&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;20,010&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;15,583&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other employee benefit expenses include employee retirement fund contributions, health insurance, and statutory social expenses. Immatics US Inc. sponsors a defined contribution retirement plan for employees in the United States. During 2020, 2019 and 2018, total Group contributions to the defined contribution plan amounted to &amp;#8364;0.2&amp;#160;million, &amp;#8364;0.1&amp;#160;million and &amp;#8364;0.1&amp;#160;million, respectively. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;For the year ended December&amp;#160;31, 2020, 2019 and 2018, other employee benefits also include employee health insurance costs amounting to &amp;#8364;0.4&amp;#160;million, &amp;#8364;0.3&amp;#160;million and &amp;#8364;0.4&amp;#160;million for Immatics US Inc., statutory social expenses amounting to &amp;#8364;1.7&amp;#160;million, &amp;#8364;1.3&amp;#160;million and &amp;#8364;1.0&amp;#160;million for our German operations and other miscellaneous expenses amounting to &amp;#8364;0.1&amp;#160;million, &amp;#8364;0.07&amp;#160;million and &amp;#8364;0.2&amp;#160;million, respectively. &lt;/div&gt;&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DisclosureOfPersonnelExpensesExplanatoryTextBlock>
<imtx:DisclosureOfPersonnelExpenesTextBlock id="Factid_19828581" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Group recognized the following personnel expenses: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:76%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year ended December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Wages and salaries&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Research and development expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;15,277&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;11,635&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10,485&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;General and administrative expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;6,968&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;3,596&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2,233&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total Wages and salaries&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;22,245&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;15,231&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12,718&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Other employee benefits&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Research and development expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2,624&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2,035&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,920&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;General and administrative expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,015&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;728&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;607&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total other employee benefits&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,639&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,763&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,527&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Share-based compensation expense&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Research and development expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;14,546&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,556&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;238&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;General and administrative expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10,973&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;460&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;100&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total share-based compensation expense&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;25,519&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,016&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;338&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;51,403&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;20,010&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;15,583&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DisclosureOfPersonnelExpenesTextBlock>
<ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory id="Factid_19828587" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12.&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Accounts payable &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:66%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Accounts payable&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2,554&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;4,866&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other accrued liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;7,498&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2,216&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total accounts payable&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;10,052&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;7,082&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other accrued liabilities classified within accounts payable mainly relate to outstanding invoices totaling &amp;#8364;7&amp;#160;million and &amp;#8364;2&amp;#160;million as of December&amp;#160;31, 2020 and 2019, respectively. &lt;/div&gt;&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory>
<imtx:DisclosureOfAccountsPayableExplanatoryTableTextBlock id="Factid_19828588" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:66%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Accounts payable&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2,554&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;4,866&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other accrued liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;7,498&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2,216&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total accounts payable&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;10,052&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;7,082&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DisclosureOfAccountsPayableExplanatoryTableTextBlock>
<ifrs-full:TradeAndOtherPayablesToTradeSuppliers id="Factid_19828589" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">2554000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
<ifrs-full:TradeAndOtherPayablesToTradeSuppliers id="Factid_19828590" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">4866000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
<imtx:OtherAccruedLiabilities id="Factid_19828591" contextRef="PAsOn12_31_2020" unitRef="Unit_EUR" decimals="-3">7498000</imtx:OtherAccruedLiabilities>
<imtx:OtherAccruedLiabilities id="Factid_19828592" contextRef="PAsOn12_31_2019" unitRef="Unit_EUR" decimals="-3">2216000</imtx:OtherAccruedLiabilities>
<ifrs-full:DisclosureOfIncomeTaxExplanatory id="Factid_19828600" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;22.&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Income Tax &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;For the year ended December&amp;#160;31, 2020, 2019 and 2018, the Group generated losses in both Germany and the U.S.&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;During 2020, 2019 and 2018, the Group&amp;#8217;s German operations were subject to a statutory tax rate of 29.1%. In the U.S., the Group was subject to a corporate income tax rate of 21% for the year ended December&amp;#160;31, 2020, 2019 and 2018. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&amp;#160;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December&amp;#160;31, 2020, 2019 and 2018, no deferred tax assets have been recognized in respect of these losses, due to the uncertainty of the Group&amp;#8217;s ability to generate taxable profits in the foreseeable future. The current assessment regarding the usability of deferred tax assets may change, depending on the Group&amp;#8217;s taxable income in future years. This may result in higher or lower deferred tax assets related to tax losses carried forward. Due to the ARYA Merger described in Note 3, there are certain limitations on tax losses carried forward for net operating losses incurred by Immatics US, Inc., under Section&amp;#160;382 of the U.S. Internal Revenue Code. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A reconciliation between taxes on income reflected on the Consolidated Statement of Loss and the expected income tax benefit, based on the Group&amp;#8217;s German statutory tax rate, for the years ended December&amp;#160;31, 2020, 2019 and 2018 is as follows: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:74%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year ended December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Loss before tax&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(229,616&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(32,487&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(32,355&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Expected tax benefit&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;66,818&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;9,454&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;9,415&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Effects&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Difference in tax rates&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(2,582&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(1,875&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(1,373&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Non-deductible&amp;#160; tax-expenses&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(599&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(61&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(70&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Government grants exempted from taxes&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;45&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;8&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;853&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Permanent Differences&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(44,461&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="padding:0in 0in 0in 0in;vertical-align:top;"&gt;&lt;div style="margin-top:0in; margin-right:0in; margin-bottom:.0001pt; margin-left:60.0pt; text-indent:-12.0pt; line-height:normal; font-family:calibri,sans-serif"&gt;&lt;div style="font-size: 10pt; font-family: &amp;quot;times new roman&amp;quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Non-recognition&amp;#160;of deferred taxes on tax losses and temporary differences&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:0in 0in 0in 0in;vertical-align:bottom;"&gt;&lt;div style="margin:0in 0in 0.0001pt; line-height:normal; font-family:calibri,sans-serif"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;"&gt;(19,221&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;"&gt;(7,526&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;"&gt;(8,825&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Taxes on income&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The main permanent difference relates to the Share listing expense of &amp;#8364;153&amp;#160;million, which does not have a corresponding taxable expense. Other permanent differences include transaction cost directly attributable and incremental to capital raises and expenses for equity-settled share-based compensation. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred tax assets consist of the following: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:70%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="14" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31, 2020&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31, 2019&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="14" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred&lt;br/&gt; tax&lt;br/&gt; assets&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred&lt;br/&gt; tax&lt;br/&gt; liabilities&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred&lt;br/&gt; tax&lt;br/&gt; assets&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred&lt;br/&gt; tax&lt;br/&gt; liabilities&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 60%;"&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Intangible assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,770&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2,064&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Right-of-use&lt;/div&gt;&lt;/div&gt; asset&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(1,713&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(854&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Deferred revenue&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;180&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;358&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;607&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Lease liability&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,776&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;886&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;3&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;14&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Recognized&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;3,729&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(1,713&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;3,929&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(854&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Netting&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(1,713&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,713&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(854&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;854&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Non-recognition&lt;/div&gt; due to history of losses&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(2,016&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(3,075&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 60%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net tax&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="width: 60%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;   &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;  &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman;font-size: 10pt;margin-top: 0pt;margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December&amp;#160;31, 2020, and 2019, the Group had accumulated tax losses of &amp;#8364;288&amp;#160;million and &amp;#8364;219&amp;#160;million, &lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;respectively, that may be offset against future taxable profits of the Group subject to certain limitations. &lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December&amp;#160;31, 2020, &amp;#8364;26&amp;#160;million of total tax losses is subject to a twenty-year carryforward period. All other tax losses have an indefinite carryforward period. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman;font-size: 0pt;margin-top: 12pt;margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Group has limited taxable temporary differences and no tax planning opportunities available that could partly support the recognition of these losses as deferred tax assets. On this basis, the Group has determined that it cannot recognize deferred tax assets on the tax losses carried forward as well as on temporary differences. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Limitation on tax loss carryforwards in the US Inc. is 80.00% starting with losses generated after January&amp;#160;1, 2018. These have an indefinite carryforward period, but no carryback option. Any losses generated prior to January&amp;#160;1, 2018 still can be utilized at 100.00% &lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;and are subject to a twenty-year carry forward expiration period. Due to the ARYA Merger described in Note 3, there are certain limitations on tax losses carried forward for net operating losses incurred by Immatics US, Inc., under Section&amp;#160;382 of the U.S. Internal Revenue Code. For Immatics Biotechnologies GmbH, we believe that the ARYA Merger did not lead to a forfeiture of tax losses carried forward in accordance with &amp;#167; 8c KStG. &lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred tax assets have not been recognized in respect of these losses due to the uncertainty of the Group&amp;#8217;s ability to generate taxable profits in the foreseeable future. The current assessment regarding the usability of deferred tax assets may change depending on the income situation of future years and may result in higher deferred tax assets on net tax losses carried forward. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfIncomeTaxExplanatory>
<imtx:DisclosureOfReconciliationBetweenTaxesOnIncomeAndExpectedIncomeTaxBenefitTableTextBlock id="Factid_19828602" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A reconciliation between taxes on income reflected on the Consolidated Statement of Loss and the expected income tax benefit, based on the Group&amp;#8217;s German statutory tax rate, for the years ended December&amp;#160;31, 2020, 2019 and 2018 is as follows: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:74%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year ended December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Loss before tax&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(229,616&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(32,487&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(32,355&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Expected tax benefit&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;66,818&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;9,454&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;9,415&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Effects&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Difference in tax rates&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(2,582&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(1,875&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(1,373&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Non-deductible&amp;#160; tax-expenses&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(599&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(61&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(70&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Government grants exempted from taxes&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;45&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;8&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;853&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Permanent Differences&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(44,461&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="padding:0in 0in 0in 0in;vertical-align:top;"&gt;&lt;div style="margin-top:0in; margin-right:0in; margin-bottom:.0001pt; margin-left:60.0pt; text-indent:-12.0pt; line-height:normal; font-family:calibri,sans-serif"&gt;&lt;div style="font-size: 10pt; font-family: &amp;quot;times new roman&amp;quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Non-recognition&amp;#160;of deferred taxes on tax losses and temporary differences&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:0in 0in 0in 0in;vertical-align:bottom;"&gt;&lt;div style="margin:0in 0in 0.0001pt; line-height:normal; font-family:calibri,sans-serif"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;"&gt;(19,221&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;"&gt;(7,526&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;"&gt;(8,825&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Taxes on income&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DisclosureOfReconciliationBetweenTaxesOnIncomeAndExpectedIncomeTaxBenefitTableTextBlock>
<imtx:DisclosureOfDeferredTaxAssetsAndLiabilitiesTableTextBlock id="Factid_19828603" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred tax assets consist of the following: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:70%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="14" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31, 2020&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31, 2019&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="14" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred&lt;br/&gt; tax&lt;br/&gt; assets&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred&lt;br/&gt; tax&lt;br/&gt; liabilities&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred&lt;br/&gt; tax&lt;br/&gt; assets&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred&lt;br/&gt; tax&lt;br/&gt; liabilities&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 60%;"&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Intangible assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,770&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2,064&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Right-of-use&lt;/div&gt;&lt;/div&gt; asset&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(1,713&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(854&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Deferred revenue&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;180&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;358&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;607&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Lease liability&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,776&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;886&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;3&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;14&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Recognized&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;3,729&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(1,713&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;3,929&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(854&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Netting&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(1,713&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,713&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(854&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;854&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Non-recognition&lt;/div&gt; due to history of losses&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(2,016&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(3,075&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 60%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net tax&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="width: 60%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DisclosureOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
<ifrs-full:DisclosureOfFinancialRiskManagementExplanatory id="Factid_19828604" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;23.&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Financial Risk Management Objectives and Policies &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Group&amp;#8217;s principal financial instruments comprise cash, cash equivalents and short-term deposits. The main purpose of these financial instruments is to invest the proceeds of capital contributions and upfront payments from collaboration agreements. The Group has various other financial instruments such as other receivables and trade accounts payable, which arise directly from its operations. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The main risks arising from the Group&amp;#8217;s financial instruments are market risk and liquidity risk. The Board of Management reviews and agrees &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;on &lt;/div&gt;policies for managing these risks as summarized below. The Group also monitors the market price risk arising from all financial instruments. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Interest rate risk &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The exposure of the Group to changes in interest rates relates to investments in deposits and to changes in the interest for overnight deposits. Changes in the general level of interest rates may lead to an increase or decrease in the fair value of these investments. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Regarding the liabilities shown in the Consolidated Statement of Financial Position, the Group is currently not subject to interest rate risks. The Group is subject to a limited risk resulting from negative interest rates on financial instruments, especially on cash and cash equivalents and Other &lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;financial assets. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Credit risk &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Financial instruments that potentially subject the Group to concentrations of credit and liquidity risk consist primarily of cash and cash equivalents and short-term deposits. The Group&amp;#8217;s cash and cash equivalents are denominated in Euros and US Dollars and maintained with two high-quality financial institutions in Germany and two in the United States. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The maximum default risk is &amp;#8364;232&amp;#160;million and &amp;#8364;119&amp;#160;million as of December&amp;#160;31, 2020 and 2019, respectively. These amounts consist of &amp;#8364;208&amp;#160;million and &amp;#8364;103&amp;#160;million cash and cash equivalents as well as &amp;#8364;24&amp;#160;million and &amp;#8364;16&amp;#160;million Other financial assets as of December&amp;#160;31, 2020 and 2019, respectively. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The cash and cash equivalents are held with banks, which are rated BBB+ to Aa3 &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;by&lt;/div&gt; S&amp;amp;P and Moody`s. Short-term deposits are graded within the investment category from P1 to P2 by the rating agency Moody`s. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;The Group continually monitors its positions with, and the credit quality of, the financial institutions and corporation, which are counterparts to its financial instruments and does not anticipate &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-performance.&lt;/div&gt; The Group monitors the risk of a liquidity shortage. The main factors considered here are the maturities of financial assets as well as expected cash flows from equity measures&lt;div style="font-weight:bold;display:inline;"&gt;.&lt;/div&gt; &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Currency risk &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Currency risk shows the risk that the value of a financial instrument will fluctuate due to changes in foreign exchange rates. In particular it poses a threat if the value of the currency in which liabilities are priced appreciates relative to the currency of the assets. The business transactions of the Group are generally conducted in Euros and U.S. dollars. The Group aims to match EUR cash inflows with EUR cash outflows and U.S. dollar cash inflows with U.S.&amp;#160;Dollar cash outflows where possible.&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The objective of currency risk management is to identify, manage and control currency risk exposures within acceptable parameters. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Due to the initial public offering in 2020, the Group has a significant U.S. dollar amount on its statements of financial position. In 2020 the Group recognized significant foreign exchange losses as Immatics N.V.`s and Immatics GmbH&amp;#180;s functional currency is Euro, but both entities hold significant U.S. dollar amounts.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cash, cash equivalents and financial assets balances denominated in U.S. dollars held by entities with functional currency of EUR are as follows: &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cash, cash equivalents and financial assets Immatics N.V. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:74%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:19%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&amp;#160;ended&amp;#160;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Cash and cash equivalents&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;42,528&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Financial assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total assets exposed to the risk&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;42,528&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="margin-bottom: 0px; margin-top: 0px;"&gt;&amp;#160;&lt;/div&gt; &lt;div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Conversion rate EUR/USD as reporting date 1/1.2271&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-bottom: 0px; margin-top: 0px;"&gt;&amp;#160;&lt;/div&gt; &lt;div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cash, cash equivalents and financial assets Immatics GmbH&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &amp;#160;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:74%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:19%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&amp;#160;ended&amp;#160;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Cash and cash equivalents&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;52,015&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Financial assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;24,448&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total assets exposed to the risk&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;76,463&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Conversion rate EUR/USD as reporting date 1/1.2271 &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Since the Group is primarily exposed to changes in U.S. dollars/euro exchange rates, the sensitivity of profit or loss to changes in the exchange rates, results mainly from U.S. dollar financial instruments. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;In 2020, if the euro had weakened/strengthened by 10% against U.S. dollars by considering that all other variables held constant, the Group`s loss would have been &amp;#8364;10.9&amp;#160;million higher/&amp;#8364;13.2&amp;#160;million lower, resulting from foreign exchange on translation of U.S. dollar assets of Immatics N.V. and Immatics GmbH. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-size: 1px; margin-top: 18px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Sensitivity analysis Immatics N.V.: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:71%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Conversion&lt;br/&gt; rate&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); white-space: nowrap;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Profit/(loss)&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Carrying&lt;br/&gt; amount&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Euro weakens by 1% against U.S. dollars&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.2394&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(421&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;42,107&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Euro strengths by 1% against U.S. dollars&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1.2148&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;430&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;42,958&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Euro weakens by 5% against U.S. dollars&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.2885&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(2,025&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;40,503&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Euro strengths by 5% against U.S. dollars&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1.1657&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2,238&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;44,766&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Euro weakens by 10% against U.S. dollars&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.3498&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(3,866&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;38,662&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Euro strengths by 10% against U.S. dollars&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1.1044&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;4,725&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;47,253&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Sensitivity analysis Immatics GmbH: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:71%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Conversion&lt;br/&gt; rate&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); white-space: nowrap;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Profit/(loss)&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Carrying&lt;br/&gt; amount&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Euro weakens by 1% against U.S. dollars&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.2394&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(757&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;75,706&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Euro strengths by 1% against U.S. dollars&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1.2148&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;772&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;77,235&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Euro weakens by 5% against U.S. dollars&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.2885&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(3,641&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;72,822&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Euro strengths by 5% against U.S. dollars&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1.1657&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;4,024&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;80,487&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Euro weakens by 10% against U.S. dollars&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.3498&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(6,951&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;69,512&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Euro strengths by 10% against U.S. dollars&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1.1044&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;8,496&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;84,959&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Liquidity risk &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Group continuously monitors its risk to a shortage of funds. The Group&amp;#8217;s objective is to maintain a balance between continuity of funding and flexibility through the use of capital raises. All financial liabilities are due within six months. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December&amp;#160;31, 2020, and 2019, the Group held the following funds which are expected to generate cash inflows in time, to counteract liquidity risk. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:80%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&amp;#160;ended&amp;#160;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Cash and cash equivalents&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;207,530&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;103,353&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Short-term deposits&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;24,448&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,023&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total funds available&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;231,978&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;119,376&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfFinancialRiskManagementExplanatory>
<ifrs-full:DisclosureOfFinancialInstrumentsExplanatory id="Factid_19828605" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;24.&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Financial Instruments &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="font-family: times new roman;font-size: 10pt;margin-top: 6pt;margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Set out below are the carrying amounts and fair values of the Group&amp;#8217;s financial instruments that are carried in the consolidated financial statements. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:47%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td style="width:18%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td rowspan="2" style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Euros in thousands&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Carrying amount&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;IFRS 9&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt; 2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt; 2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt; 2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt; 2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Financial assets&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Short-term deposits*&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;At fair value through profit or loss (FVTPL)&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;24,448&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,023&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;24,448&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,023&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Positive market value&lt;/div&gt;&lt;/div&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;forward contracts*&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;At fair value through profit or loss (FVTPL)&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;914&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;914&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Accounts receivable&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;other&amp;#160;financial&amp;#160;assets&amp;#160;at amortized cost&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,250&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;957&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,250&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;957&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Other &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;current/non-current&lt;/div&gt; assets&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;other financial assets at amortized cost&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,586&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,710&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,586&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,710&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total financial assets**&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;28,198&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;18,690&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;28,198&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;18,690&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Financial liabilities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Accounts payable&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;other&amp;#160;financial&amp;#160;liabilities at amortized cost&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10,052&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;7,082&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10,052&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;7,082&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Other current liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;other financial liabilities at amortized cost&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2,025&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,288&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2,025&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,288&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total financial liabilities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12,077&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;8,370&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12,077&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;8,370&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:2%;"&gt;*&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Short-term deposits&amp;#8221; are classified within Other financial assets. &amp;#8220;Positive market value forward contract&amp;#8221; are classified in other current assets. &amp;#8220;Negative market value forward contracts&amp;#8221; are classified in other current liabilities. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:2%;"&gt;**&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Financial assets, other than cash and cash equivalents. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The carrying value of financial instruments, such as cash and cash equivalents, deposits, accounts receivable and accounts payable approximate their fair value based on the short-term maturities of these instruments. The fair values of the financial assets and liabilities are included at the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced or liquidation sale. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following methods and assumptions were used to estimate the fair values: All financial assets, except for derivatives, which are categorized Level&amp;#160;2, are categorized Level&amp;#160;1 and therefore are valued using quoted (unadjusted) market prices. Except for derivatives, which are categorized Level&amp;#160;2, all other financial liabilities are also categorized Level&amp;#160;1. &lt;/div&gt;&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfFinancialInstrumentsExplanatory>
<ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory id="Factid_19828606" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman;font-size: 10pt;margin-top: 6pt;margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Set out below are the carrying amounts and fair values of the Group&amp;#8217;s financial instruments that are carried in the consolidated financial statements. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:47%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td style="width:18%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td rowspan="2" style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Euros in thousands&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Carrying amount&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;IFRS 9&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt; 2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt; 2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt; 2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;br/&gt; 2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Financial assets&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Short-term deposits*&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;At fair value through profit or loss (FVTPL)&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;24,448&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,023&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;24,448&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,023&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Positive market value&lt;/div&gt;&lt;/div&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;forward contracts*&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;At fair value through profit or loss (FVTPL)&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;914&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;914&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Accounts receivable&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;other&amp;#160;financial&amp;#160;assets&amp;#160;at amortized cost&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,250&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;957&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,250&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;957&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Other &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;current/non-current&lt;/div&gt; assets&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;other financial assets at amortized cost&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,586&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,710&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,586&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,710&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total financial assets**&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;28,198&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;18,690&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;28,198&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;18,690&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Financial liabilities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Accounts payable&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;other&amp;#160;financial&amp;#160;liabilities at amortized cost&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10,052&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;7,082&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10,052&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;7,082&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Other current liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;other financial liabilities at amortized cost&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2,025&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,288&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2,025&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,288&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total financial liabilities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12,077&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;8,370&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12,077&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;8,370&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:2%;"&gt;*&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Short-term deposits&amp;#8221; are classified within Other financial assets. &amp;#8220;Positive market value forward contract&amp;#8221; are classified in other current assets. &amp;#8220;Negative market value forward contracts&amp;#8221; are classified in other current liabilities. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:2%;"&gt;**&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Financial assets, other than cash and cash equivalents. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory>
<ifrs-full:DisclosureOfRelatedPartyExplanatory id="Factid_19828607" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;26.&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Related party disclosures &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Key management personnel have been defined as the members of the Executive Committee of Immatics N.V.&lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Compensation of key management personnel: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 100%;;margin : 0px auto;;text-align:left;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 78%;"&gt;&lt;/td&gt;&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year ended December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="10" style="text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 78%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Fixed&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2,660&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,202&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,088&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 78%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Variable&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;886&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;521&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;433&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 78%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Share-based compensation expense&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;13,841&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;697&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;119&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 78%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 78%;;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total key management compensation&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;17,387&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,420&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,640&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 78%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Fixed and variable key management compensation represent short-term employee benefits. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December&amp;#160;31, 2020, and 2019, amounts of &amp;#8364;0.0&amp;#160;million and &amp;#8364;0.7&amp;#160;million were accrued for key management compensation. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The members of the Supervisory Board of the Group received a fixed fee as well as reimbursed travel expenses. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total compensation for the Supervisory Board amounted to &amp;#8364;2.7&amp;#160;million in 2020: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:53%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Peter&lt;br/&gt; Chambr&amp;#233;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Harald&amp;#160;F.&lt;br/&gt; Stock&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Michael&lt;br/&gt; G.&amp;#160;Atieh&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Paul&lt;br/&gt; Carter&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Heather&lt;br/&gt; L.&amp;#160;Mason&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Adam&lt;br/&gt; Stone&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Christoph&lt;br/&gt; Hettich&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Eliot&lt;br/&gt; Forster&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Supervisory board compensation&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;140&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;16&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;28&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;26&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;20&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;20&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;20&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;12&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;282&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Travel expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;4&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Payment Exit arrangement&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;2,394&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: right;"&gt;&amp;#8212;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: right;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#8212;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: right;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#8212;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: right;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#8212;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: right;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#8212;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: right;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#8212;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: right;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#8212;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="line-height: normal; text-align: right;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="line-height: normal; text-align: right;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;2,394&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="line-height: normal; text-align: right;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Share-based compensation expense&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,046 &lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"&gt;70&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"&gt;70&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;70&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;70&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;70&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;40&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,436&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;Total cash compensation&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,584&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;16&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;98&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;96&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;90&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;90&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;90&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;52&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,116&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;   &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Harald F. Stock and Peter Chambr&amp;#233; were members of the Supervisory Board of Immatics in 2019 and in 2018. They received a fixed fee as Supervisory Board members and reimbursement for travel expenses. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total compensation for the Supervisory Board amounted to &amp;#8364;0.4&amp;#160;million in 2019: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:77%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Peter&lt;br/&gt; Chambr&amp;#233;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Harald&lt;br/&gt; F.&amp;#160;Stock&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Supervisory board fee&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;300&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;9&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;309&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Travel expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;87&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;20&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;107&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;387&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;29&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;416&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total compensation for the Supervisory Board amounted to &amp;#8364;0.5&amp;#160;million in 2018: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:77%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Peter&lt;br/&gt; Chambr&amp;#233;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Harald&lt;br/&gt; F.&amp;#160;Stock&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Supervisory board fee&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;400&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;410&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Travel expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;52&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;16&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;68&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;452&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;26&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;478&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;   &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Prior to the ARYA Merger, Immatics N.V. established the 2020 Incentive Plan. Immatics N.V. granted certain service-based options out of the 2020 Incentive Plan to its management and directors and in addition, performance-based options to its management upon closing of the ARYA Merger. The service-based options will vest based upon satisfaction of a four-year time-based vesting schedule, which provides for 25% vesting on the first anniversary of the vesting commencement date and quarterly vesting thereafter. The performance-based options will vest based both on achievement of certain market capitalization milestones and satisfaction of a four-year time-based vesting schedule, which provides for 25% vesting on the first anniversary of the vesting commencement date and quarterly vesting thereafter. The following options were granted to Immatics&amp;#8217; Managing Director&amp;#160;and Supervisory Directors: &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;width:35%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;width:20%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:1%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;width:15%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Type of options&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Grant date&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number of&lt;br/&gt; Options&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Strike&lt;br/&gt; Price&amp;#160;in&lt;br/&gt; USD&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Expiration date&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Managing Director&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Harpreet Singh&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;Performance-based&amp;#160;options&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2020&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;1,598,000&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;10&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2030&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Harpreet Singh&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;Service options&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2020&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;168,000&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2030&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Harpreet Singh&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;Matching Stock options&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2020&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;264,624&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;10&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2030&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Harpreet Singh&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;Converted options&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2020&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;30,939&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.06&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;July&amp;#160;1, 2027&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Harpreet Singh&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;Converted options&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2020&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;145,371&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;1.17&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;January&amp;#160;1, 2028&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Harpreet Singh&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;Service options&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;December&amp;#160;17,&amp;#160;2020&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;168,000&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;9.70&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;December&amp;#160;17,&amp;#160;2030&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Supervisory Directors&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Peter Chambr&amp;#233;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;Service options&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2020&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;25,000&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2030&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Peter Chambr&amp;#233;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;Matching Stock options&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2020&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;211,974&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;10&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2030&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Adam Stone&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;Service options&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2020&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;25,000&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2030&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Christoph Hettich&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;Service options&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2020&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;25,000&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;10&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2030&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Heather L. Mason&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;Service options&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2020&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;25,000&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2030&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Michael G. Atieh&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;Service options&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2020&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;25,000&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;10&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2030&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Paul Carter&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;Service options&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2020&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;25,000&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;"&gt;June&amp;#160;30, 2030&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Eliot Forster&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;Service options&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;September&amp;#160;14,&amp;#160;2020&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;25,000&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;9.16&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:top;"&gt;September&amp;#160;13,&amp;#160;2030&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;An additional aggregate of 1,680,000 performance-based options and 539,000 &lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;service options to purchase ordinary shares, were granted to other Immatics&amp;#8217; key management personnel, who are members of the Executive Committee but not Directors. Certain key management personnel were also participants in the share-based compensation plans of Immatics &lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;GmbH (2010 Plan and 2016 Plan). &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As part of the replacement awards issued in connection with the ARYA Merger (See Note 18), &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;these&lt;/div&gt; key management personnel received cash payments before taxes of &amp;#8364;3.4&amp;#160;million, 417,415 converted options in Immatics N.V. and 750,076 matching stock options in Immatics N.V. The cash payments mainly covered wage tax obligations of the employees. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Group did not enter into transactions with related entities in 2020, 2019 and 2018 other than the mentioned compensation contracts. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfRelatedPartyExplanatory>
<imtx:DisclosureOfCompensationSupervisoryBoardTextBlock id="Factid_19828622" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total compensation for the Supervisory Board amounted to &amp;#8364;2.7&amp;#160;million in 2020: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:53%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:2%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Peter&lt;br/&gt; Chambr&amp;#233;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Harald&amp;#160;F.&lt;br/&gt; Stock&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Michael&lt;br/&gt; G.&amp;#160;Atieh&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Paul&lt;br/&gt; Carter&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Heather&lt;br/&gt; L.&amp;#160;Mason&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Adam&lt;br/&gt; Stone&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Christoph&lt;br/&gt; Hettich&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Eliot&lt;br/&gt; Forster&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Supervisory board compensation&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;140&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;16&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;28&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;26&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;20&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;20&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;20&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;12&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;282&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Travel expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;4&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Payment Exit arrangement&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;2,394&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: right;"&gt;&amp;#8212;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: right;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#8212;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: right;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#8212;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: right;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#8212;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: right;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#8212;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: right;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#8212;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: right;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#8212;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="line-height: normal; text-align: right;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="line-height: normal; text-align: right;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;2,394&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="line-height: normal; text-align: right;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Share-based compensation expense&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,046 &lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"&gt;70&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;"&gt;70&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;70&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;70&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;70&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;40&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,436&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;Total cash compensation&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,584&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;16&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;98&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;96&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;90&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;90&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;90&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;52&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,116&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total compensation for the Supervisory Board amounted to &amp;#8364;0.4&amp;#160;million in 2019: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:77%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Peter&lt;br/&gt; Chambr&amp;#233;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Harald&lt;br/&gt; F.&amp;#160;Stock&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Supervisory board fee&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;300&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;9&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;309&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Travel expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;87&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;20&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;107&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;387&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;29&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;416&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total compensation for the Supervisory Board amounted to &amp;#8364;0.5&amp;#160;million in 2018: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:77%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Euros in thousands)&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Peter&lt;br/&gt; Chambr&amp;#233;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Harald&lt;br/&gt; F.&amp;#160;Stock&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Supervisory board fee&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;400&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;410&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Travel expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;52&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;16&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;68&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;452&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;26&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;478&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</imtx:DisclosureOfCompensationSupervisoryBoardTextBlock>
<imtx:KeyManagementPersonnelCompensationPaymentExitArrangement id="Factid_19828673" contextRef="P01_01_2020To12_31_2020_PeterChambreMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">2394000</imtx:KeyManagementPersonnelCompensationPaymentExitArrangement>
<imtx:KeyManagementPersonnelCompensationPaymentExitArrangement id="Factid_19828674" contextRef="P01_01_2020To12_31_2020_HaraldFstockMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">0</imtx:KeyManagementPersonnelCompensationPaymentExitArrangement>
<imtx:KeyManagementPersonnelCompensationPaymentExitArrangement id="Factid_19828675" contextRef="P01_01_2020To12_31_2020_MichaelGAtiehMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">0</imtx:KeyManagementPersonnelCompensationPaymentExitArrangement>
<imtx:KeyManagementPersonnelCompensationPaymentExitArrangement id="Factid_19828676" contextRef="P01_01_2020To12_31_2020_PaulCarterMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">0</imtx:KeyManagementPersonnelCompensationPaymentExitArrangement>
<imtx:KeyManagementPersonnelCompensationPaymentExitArrangement id="Factid_19828677" contextRef="P01_01_2020To12_31_2020_HeatherLMasonMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">0</imtx:KeyManagementPersonnelCompensationPaymentExitArrangement>
<imtx:KeyManagementPersonnelCompensationPaymentExitArrangement id="Factid_19828678" contextRef="P01_01_2020To12_31_2020_AdamStoneMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">0</imtx:KeyManagementPersonnelCompensationPaymentExitArrangement>
<imtx:KeyManagementPersonnelCompensationPaymentExitArrangement id="Factid_19828679" contextRef="P01_01_2020To12_31_2020_ChristophHettichMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">0</imtx:KeyManagementPersonnelCompensationPaymentExitArrangement>
<imtx:KeyManagementPersonnelCompensationPaymentExitArrangement id="Factid_19828680" contextRef="P01_01_2020To12_31_2020_EliotForsterMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-3">0</imtx:KeyManagementPersonnelCompensationPaymentExitArrangement>
<imtx:KeyManagementPersonnelCompensationPaymentExitArrangement id="Factid_19828681" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_EUR" decimals="-3">2394000</imtx:KeyManagementPersonnelCompensationPaymentExitArrangement>
<ifrs-full:DisclosureOfEarningsPerShareExplanatory id="Factid_19828682" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;27.&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net loss per share &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Basic net loss per share is computed by dividing net loss by the weighted average number of common shares outstanding during the period, excluding common stock equivalents, adjusted for the effect of the corporate reorganization as discussed in Note 3 and applied retrospectively to all prior periods presented. The diluted net loss per share reflects the basic net loss per share, since the effects of potentially dilutive securities are antidilutive given the net loss for each period presented. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;For the periods included in these financial statements the Group was loss-making in all periods, therefore, anti-dilutive instruments are excluded in the calculation of diluted weighted average number of ordinary shares outstanding, including the outstanding equity awards during the periods and &lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;the 7,187,500 &lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Immatics Warrants issued in 2020 and outstanding as of December&amp;#160;31, 2020. These warrants and options could potentially dilute basic earnings per share in the future. See Note 18 for details of outstanding share options. &lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfEarningsPerShareExplanatory>
<ifrs-full:ContractLiabilities id="Factid_19854562" contextRef="PAsOn12_31_2019_BMSCollaborationAgreementMemberIMTXAgreementAxis" unitRef="Unit_EUR" decimals="-5">66500000</ifrs-full:ContractLiabilities>
<ifrs-full:SharePremium id="Factid_19922274" contextRef="PAsOn07_01_2020_AryaMergerMemberIMTXShareListingExpenseAxis_PipeFinancingMemberifrsfullBorrowingsByNameAxis" unitRef="Unit_EUR" decimals="-6">3625000000</ifrs-full:SharePremium>
<ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory id="Factid_19922771" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.4&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Property, plant and equipment &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Property, plant and equipment is stated at cost, net of accumulated depreciation and accumulated impairment losses, if any. All repair and maintenance costs are recognized as expense when incurred. Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets. The estimated useful lives are generally within the following ranges: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;  &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 79%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 8%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="white-space: nowrap; padding-bottom: 1pt; width: 79%;;vertical-align:bottom;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Category&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Estimated&amp;#160;useful&amp;#160;life&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 79%;;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Computer equipment&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:center;;vertical-align:bottom;"&gt;1&amp;#160;&amp;#8211;&amp;#160;10&amp;#160;years&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgba(255, 255, 255, 0); width: 79%;;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Laboratory equipment&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0); width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgba(255, 255, 255, 0);;text-align:center;;vertical-align:bottom;"&gt;1 &amp;#8211;&amp;#160;15&amp;#160;years&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 79%;;vertical-align:bottom;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Office equipment&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;text-align:center;;vertical-align:bottom;"&gt;2 &amp;#8211;&amp;#160;20&amp;#160;years&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory>
<ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory id="Factid_19922773" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.13&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair value of financial instruments &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either: &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;&amp;#8226;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;in the principal market for the asset or liability or &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt;&lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;&amp;#8226;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;in the absence of a principal market, in the most advantageous market for the asset or liability that is accessible by the Group. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest. The Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs. All assets and liabilities for which fair value is measured or disclosed in the consolidated financial statements are categorized within the fair value hierarchy, described as follows, based on the lowest level input that is significant to the fair value measurement as a whole: &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;&amp;#8226;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Level&amp;#160;1 &amp;#8212; Quoted (unadjusted) market prices in active markets for identical assets or liabilities. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt;&lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;&amp;#8226;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Level&amp;#160;2 &amp;#8212; Valuation techniques, for which the lowest level input that is significant to the fair value measurement is directly or indirectly observable. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt;&lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:5%;"&gt;&amp;#8226;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Level&amp;#160;3 &amp;#8212; Valuation techniques, for which the lowest level input that is significant to the fair value measurement is unobservable. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;For assets and liabilities that are recognized in the consolidated financial statements at fair value on a recurring basis, the Group determines whether transfers have occurred between levels in the hierarchy by &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;re-assessing&lt;/div&gt; categorization (based on the lowest level input that is significant to the fair value measurement as a whole), at the end of each reporting period. &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory>
<xbrli:unit id="Unit_EUR">
<xbrli:measure>iso4217:EUR</xbrli:measure>
</xbrli:unit>
<xbrli:unit id="Unit_pure">
<xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit>
<xbrli:unit id="Unit_shares">
<xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit>
<xbrli:unit id="Unit_USD">
<xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit>
<xbrli:unit id="Unit_EUR_per_Share">
<xbrli:divide>
<xbrli:unitNumerator>
<xbrli:measure>iso4217:EUR</xbrli:measure>
</xbrli:unitNumerator>
<xbrli:unitDenominator>
<xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unitDenominator>
</xbrli:divide>
</xbrli:unit>
<xbrli:unit id="Unit_Warrants">
<xbrli:measure>imtx:Warrants</xbrli:measure>
</xbrli:unit>
<xbrli:unit id="Unit_USD_per_Share">
<xbrli:divide>
<xbrli:unitNumerator>
<xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unitNumerator>
<xbrli:unitDenominator>
<xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unitDenominator>
</xbrli:divide>
</xbrli:unit>
<xbrli:unit id="Unit_Y">
<xbrli:measure>utr:Y</xbrli:measure>
</xbrli:unit>
<link:footnoteLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="#Factid_19489538" xlink:type="locator" xlink:label="loc_1" />
<link:footnote xlink:role="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US" xlink:type="resource" xlink:label="FN_69575">See Note 2 for details regarding the change in presentation of Other financial assets</link:footnote>
<link:footnoteArc xlink:type="arc" xlink:to="FN_69575" order="1" xlink:from="loc_1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489540" xlink:type="locator" xlink:label="loc_2" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_69575" order="1" xlink:from="loc_2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489542" xlink:type="locator" xlink:label="loc_3" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_69575" order="1" xlink:from="loc_3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489544" xlink:type="locator" xlink:label="loc_4" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_69575" order="1" xlink:from="loc_4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489546" xlink:type="locator" xlink:label="loc_5" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_69575" order="1" xlink:from="loc_5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489548" xlink:type="locator" xlink:label="loc_6" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_69575" order="1" xlink:from="loc_6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489550" xlink:type="locator" xlink:label="loc_7" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_69575" order="1" xlink:from="loc_7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489552" xlink:type="locator" xlink:label="loc_8" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_69575" order="1" xlink:from="loc_8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489554" xlink:type="locator" xlink:label="loc_9" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_69575" order="1" xlink:from="loc_9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489556" xlink:type="locator" xlink:label="loc_10" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_69575" order="1" xlink:from="loc_10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489558" xlink:type="locator" xlink:label="loc_11" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_69575" order="1" xlink:from="loc_11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489560" xlink:type="locator" xlink:label="loc_12" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_69575" order="1" xlink:from="loc_12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489562" xlink:type="locator" xlink:label="loc_13" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_69575" order="1" xlink:from="loc_13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489564" xlink:type="locator" xlink:label="loc_14" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_69575" order="1" xlink:from="loc_14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489566" xlink:type="locator" xlink:label="loc_15" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_69575" order="1" xlink:from="loc_15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489568" xlink:type="locator" xlink:label="loc_16" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_69575" order="1" xlink:from="loc_16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489570" xlink:type="locator" xlink:label="loc_17" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_69575" order="1" xlink:from="loc_17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489572" xlink:type="locator" xlink:label="loc_18" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_69575" order="1" xlink:from="loc_18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489574" xlink:type="locator" xlink:label="loc_19" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_69575" order="1" xlink:from="loc_19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489575" xlink:type="locator" xlink:label="loc_20" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_69575" order="1" xlink:from="loc_20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489577" xlink:type="locator" xlink:label="loc_21" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_69575" order="1" xlink:from="loc_21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489579" xlink:type="locator" xlink:label="loc_22" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_69575" order="1" xlink:from="loc_22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489581" xlink:type="locator" xlink:label="loc_23" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_69575" order="1" xlink:from="loc_23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489583" xlink:type="locator" xlink:label="loc_24" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_69575" order="1" xlink:from="loc_24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489585" xlink:type="locator" xlink:label="loc_25" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_69575" order="1" xlink:from="loc_25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489587" xlink:type="locator" xlink:label="loc_26" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_69575" order="1" xlink:from="loc_26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489588" xlink:type="locator" xlink:label="loc_27" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_69575" order="1" xlink:from="loc_27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489590" xlink:type="locator" xlink:label="loc_28" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_69575" order="1" xlink:from="loc_28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489592" xlink:type="locator" xlink:label="loc_29" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_69575" order="1" xlink:from="loc_29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489661" xlink:type="locator" xlink:label="loc_30" />
<link:footnote xlink:role="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US" xlink:type="resource" xlink:label="FN_70982">See Note 2 for details regarding the revision as a result of a correction in classification of Other financial assets</link:footnote>
<link:footnoteArc xlink:type="arc" xlink:to="FN_70982" order="1" xlink:from="loc_30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489664" xlink:type="locator" xlink:label="loc_31" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_70982" order="1" xlink:from="loc_31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489667" xlink:type="locator" xlink:label="loc_32" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_70982" order="1" xlink:from="loc_32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489670" xlink:type="locator" xlink:label="loc_33" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_70982" order="1" xlink:from="loc_33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489676" xlink:type="locator" xlink:label="loc_34" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_70982" order="1" xlink:from="loc_34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489679" xlink:type="locator" xlink:label="loc_35" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_70982" order="1" xlink:from="loc_35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489682" xlink:type="locator" xlink:label="loc_36" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_70982" order="1" xlink:from="loc_36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489688" xlink:type="locator" xlink:label="loc_37" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_70982" order="1" xlink:from="loc_37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489691" xlink:type="locator" xlink:label="loc_38" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_70982" order="1" xlink:from="loc_38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489694" xlink:type="locator" xlink:label="loc_39" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_70982" order="1" xlink:from="loc_39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489697" xlink:type="locator" xlink:label="loc_40" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_70982" order="1" xlink:from="loc_40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489700" xlink:type="locator" xlink:label="loc_41" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_70982" order="1" xlink:from="loc_41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489703" xlink:type="locator" xlink:label="loc_42" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_70982" order="1" xlink:from="loc_42" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489706" xlink:type="locator" xlink:label="loc_43" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_70982" order="1" xlink:from="loc_43" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489709" xlink:type="locator" xlink:label="loc_44" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_70982" order="1" xlink:from="loc_44" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489712" xlink:type="locator" xlink:label="loc_45" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_70982" order="1" xlink:from="loc_45" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489715" xlink:type="locator" xlink:label="loc_46" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_70982" order="1" xlink:from="loc_46" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489718" xlink:type="locator" xlink:label="loc_47" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_70982" order="1" xlink:from="loc_47" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489724" xlink:type="locator" xlink:label="loc_48" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_70982" order="1" xlink:from="loc_48" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489727" xlink:type="locator" xlink:label="loc_49" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_70982" order="1" xlink:from="loc_49" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489730" xlink:type="locator" xlink:label="loc_50" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_70982" order="1" xlink:from="loc_50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489733" xlink:type="locator" xlink:label="loc_51" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_70982" order="1" xlink:from="loc_51" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489736" xlink:type="locator" xlink:label="loc_52" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_70982" order="1" xlink:from="loc_52" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19489975" xlink:type="locator" xlink:label="loc_53" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_70982" order="1" xlink:from="loc_53" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
<link:loc xlink:href="#Factid_19724266" xlink:type="locator" xlink:label="loc_54" />
<link:footnoteArc xlink:type="arc" xlink:to="FN_70982" order="1" xlink:from="loc_54" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" />
</link:footnoteLink>
</xbrli:xbrl>

</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>imtx-20201231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 30-March-2021 [01:58:01] {AM}-->
<schema targetNamespace="http://imtx.com/20201231" elementFormDefault="qualified" xmlns:imtx="http://imtx.com/20201231" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:us-types="http://fasb.org/us-types/2020-01-31">
<annotation>
<appinfo>
<link:roleType roleURI="http://imtx.com/role/CoverPage" id="CoverPage">
<link:definition>1001 - Document - Cover Page</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/ConsolidatedStatementOfFinancialPositionOfImmaticsNV" id="ConsolidatedStatementOfFinancialPositionOfImmaticsNV">
<link:definition>1002 - Statement - Consolidated Statement of Financial Position of Immatics N.V.</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/ConsolidatedStatementOfLossOfImmaticsNV" id="ConsolidatedStatementOfLossOfImmaticsNV">
<link:definition>1003 - Statement - Consolidated Statement of Loss of Immatics N.V.</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/ConsolidatedStatementOfComprehensiveLossOfImmaticsNV" id="ConsolidatedStatementOfComprehensiveLossOfImmaticsNV">
<link:definition>1004 - Statement - Consolidated Statement of Comprehensive Loss of Immatics N.V.</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/ConsolidatedStatementOfCashFlows" id="ConsolidatedStatementOfCashFlows">
<link:definition>1005 - Statement - Consolidated Statement of Cash Flows</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/ConsolidatedStatementOfChangesInShareholdersEquityDeficitOfImmaticsNV" id="ConsolidatedStatementOfChangesInShareholdersEquityDeficitOfImmaticsNV">
<link:definition>1006 - Statement - Consolidated Statement of Changes in Shareholders' equity (deficit) of Immatics N.V.</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/GroupInformation" id="GroupInformation">
<link:definition>1007 - Disclosure - Group information</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/BasisOfPresentation" id="BasisOfPresentation">
<link:definition>1008 - Disclosure - Basis of presentation</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/AryaMerger" id="AryaMerger">
<link:definition>1009 - Disclosure - ARYA Merger</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/ApplicationOfNewAndRevisedInternationalFinancialReportingStandards" id="ApplicationOfNewAndRevisedInternationalFinancialReportingStandards">
<link:definition>1010 - Disclosure - Application of new and revised international financial reporting standards</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020" id="SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020">
<link:definition>1011 - Disclosure - Summary of accounting policies applied by the Group for the annual reporting period ending December 31, 2020</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/SignificantAccountingJudgmentsEstimatesAndAssumptions" id="SignificantAccountingJudgmentsEstimatesAndAssumptions">
<link:definition>1012 - Disclosure - Significant accounting judgments, estimates and assumptions</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/AccountsReceivable" id="AccountsReceivable">
<link:definition>1013 - Disclosure - Accounts receivable</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/OtherCurrentAndNonCurrentAssets" id="OtherCurrentAndNonCurrentAssets">
<link:definition>1014 - Disclosure - Other current and non-current assets</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/PropertyPlantAndEquipment" id="PropertyPlantAndEquipment">
<link:definition>1015 - Disclosure - Property, plant and equipment</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/IntangibleAssets" id="IntangibleAssets">
<link:definition>1016 - Disclosure - Intangible assets</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/Leases" id="Leases">
<link:definition>1017 - Disclosure - Leases</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/AccountsPayable" id="AccountsPayable">
<link:definition>1018 - Disclosure - Accounts payable</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/RevenueFromCollaborationAgreements" id="RevenueFromCollaborationAgreements">
<link:definition>1019 - Disclosure - Revenue from collaboration agreements</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/OtherIncome" id="OtherIncome">
<link:definition>1020 - Disclosure - Other income</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/OtherCurrentLiabilities" id="OtherCurrentLiabilities">
<link:definition>1021 - Disclosure - Other current liabilities</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/FinancialIncomeAndExpenses" id="FinancialIncomeAndExpenses">
<link:definition>1022 - Disclosure - Financial income and expenses</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/ShareListingExpenses" id="ShareListingExpenses">
<link:definition>1023 - Disclosure - Share listing expenses</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/ShareBasedPayments" id="ShareBasedPayments">
<link:definition>1024 - Disclosure - Share-based payments</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/ShareholdersEquityDeficit" id="ShareholdersEquityDeficit">
<link:definition>1025 - Disclosure - Shareholders' equity (deficit)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/NonControllingInterests" id="NonControllingInterests">
<link:definition>1026 - Disclosure - Non-controlling interests</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/PersonnelExpenses" id="PersonnelExpenses">
<link:definition>1027 - Disclosure - Personnel expenses</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/IncomeTax" id="IncomeTax">
<link:definition>1028 - Disclosure - Income Tax</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/FinancialRiskManagementObjectivesAndPolicies" id="FinancialRiskManagementObjectivesAndPolicies">
<link:definition>1029 - Disclosure - Financial Risk Management Objectives and Policies</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/FinancialInstruments" id="FinancialInstruments">
<link:definition>1030 - Disclosure - Financial Instruments</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
<link:definition>1031 - Disclosure - Commitments and contingencies</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/RelatedPartyDisclosures" id="RelatedPartyDisclosures">
<link:definition>1032 - Disclosure - Related party disclosures</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/NetLossPerShare" id="NetLossPerShare">
<link:definition>1033 - Disclosure - Net loss per share</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/EventsOccurringAfterTheReportingPeriod" id="EventsOccurringAfterTheReportingPeriod">
<link:definition>1034 - Disclosure - Events occurring after the reporting period</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020Policies" id="SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020Policies">
<link:definition>1035 - Disclosure - Summary of accounting policies applied by the Group for the annual reporting period ending December 31, 2020 (Policies)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/BasisOfPresentationTables" id="BasisOfPresentationTables">
<link:definition>1036 - Disclosure - Basis of presentation (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/ApplicationOfNewAndRevisedInternationalFinancialReportingStandardsTables" id="ApplicationOfNewAndRevisedInternationalFinancialReportingStandardsTables">
<link:definition>1037 - Disclosure - Application of new and revised international financial reporting standards (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020Tables" id="SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020Tables">
<link:definition>1038 - Disclosure - Summary of accounting policies applied by the Group for the annual reporting period ending December 31, 2020 (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/AccountsReceivableTables" id="AccountsReceivableTables">
<link:definition>1039 - Disclosure - Accounts receivable (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/OtherCurrentAndNonCurrentAssetsTables" id="OtherCurrentAndNonCurrentAssetsTables">
<link:definition>1040 - Disclosure - Other current and non-current assets  (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/PropertyPlantAndEquipmentTables" id="PropertyPlantAndEquipmentTables">
<link:definition>1041 - Disclosure - Property, plant and equipment (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/IntangibleAssetsTables" id="IntangibleAssetsTables">
<link:definition>1042 - Disclosure - Intangible assets (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/LeasesTables" id="LeasesTables">
<link:definition>1043 - Disclosure - Leases (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/AccountsPayableTables" id="AccountsPayableTables">
<link:definition>1044 - Disclosure - Accounts payable (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/RevenueFromCollaborationAgreementsTables" id="RevenueFromCollaborationAgreementsTables">
<link:definition>1045 - Disclosure - Revenue from collaboration agreements (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/OtherIncomeTables" id="OtherIncomeTables">
<link:definition>1046 - Disclosure - Other income (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/OtherCurrentLiabilitiesTables" id="OtherCurrentLiabilitiesTables">
<link:definition>1047 - Disclosure - Other current liabilities (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/FinancialIncomeAndExpensesTables" id="FinancialIncomeAndExpensesTables">
<link:definition>1048 - Disclosure - Financial income and expenses (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/ShareListingExpensesTables" id="ShareListingExpensesTables">
<link:definition>1049 - Disclosure - Share listing expenses (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/ShareBasedPaymentsTables" id="ShareBasedPaymentsTables">
<link:definition>1050 - Disclosure - Share-based payments (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/PersonnelExpensesTables" id="PersonnelExpensesTables">
<link:definition>1051 - Disclosure - Personnel expenses (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/IncomeTaxTables" id="IncomeTaxTables">
<link:definition>1052 - Disclosure - Income Tax (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesTables" id="FinancialRiskManagementObjectivesAndPoliciesTables">
<link:definition>1053 - Disclosure - Financial Risk Management Objectives and Policies (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/FinancialInstrumentsTables" id="FinancialInstrumentsTables">
<link:definition>1054 - Disclosure - Financial Instruments (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/CommitmentsAndContingenciesTables" id="CommitmentsAndContingenciesTables">
<link:definition>1055 - Disclosure - Commitments and contingencies (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/RelatedPartyDisclosuresTables" id="RelatedPartyDisclosuresTables">
<link:definition>1056 - Disclosure - Related party disclosures (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/GroupInformationAdditionalInformationDetail" id="GroupInformationAdditionalInformationDetail">
<link:definition>1057 - Disclosure - Group information - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/BasisOfPresentationSummaryOfReconciliationOfChangesInCashFlowStatementDetail" id="BasisOfPresentationSummaryOfReconciliationOfChangesInCashFlowStatementDetail">
<link:definition>1058 - Disclosure - Basis of presentation - Summary of Reconciliation Of Changes In Cash Flow Statement (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/BasisOfPresentationAdditionalInformationDetail" id="BasisOfPresentationAdditionalInformationDetail">
<link:definition>1059 - Disclosure - Basis of presentation - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/AryaMergerAdditionalInformationDetail" id="AryaMergerAdditionalInformationDetail">
<link:definition>1060 - Disclosure - ARYA Merger - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/ApplicationOfNewAndRevisedInternationalFinancialReportingStandardsSummaryOfApplicationOfNewStandardsDetail" id="ApplicationOfNewAndRevisedInternationalFinancialReportingStandardsSummaryOfApplicationOfNewStandardsDetail">
<link:definition>1061 - Disclosure - Application of new and revised international financial reporting standards - Summary of Application of new standards  (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/ApplicationOfNewAndRevisedInternationalFinancialReportingStandardsSummaryOfNonMandatoryStandardsAndInterpretationsIssuedByIasbDetail" id="ApplicationOfNewAndRevisedInternationalFinancialReportingStandardsSummaryOfNonMandatoryStandardsAndInterpretationsIssuedByIasbDetail">
<link:definition>1062 - Disclosure - Application of new and revised international financial reporting standards - Summary of Non Mandatory  standards and interpretations issued by  IASB (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail" id="SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail">
<link:definition>1063 - Disclosure - Summary of accounting policies applied by the Group for the annual reporting period ending December 31, 2020 - Summary of estimated Useful Lives of Property, Plant and Equipment (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020SummaryOfUsefulLifeOfIntangibleAssetsOtherThanGoodwillDetail" id="SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020SummaryOfUsefulLifeOfIntangibleAssetsOtherThanGoodwillDetail">
<link:definition>1064 - Disclosure - Summary of accounting policies applied by the Group for the annual reporting period ending December 31, 2020 - Summary of useful life of intangible assets other than goodwill (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020SummaryOfForeignExchangeRatesDetail" id="SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020SummaryOfForeignExchangeRatesDetail">
<link:definition>1065 - Disclosure - Summary of accounting policies applied by the Group for the annual reporting period ending December 31, 2020 - Summary of foreign exchange rates (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020AdditionalInformationDetail" id="SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020AdditionalInformationDetail">
<link:definition>1066 - Disclosure - Summary of accounting policies applied by the Group for the annual reporting period ending December 31, 2020 - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/AccountsReceivableSummaryOfTradeReceivablesDetail" id="AccountsReceivableSummaryOfTradeReceivablesDetail">
<link:definition>1067 - Disclosure - Accounts receivable - Summary of Trade receivables (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/AccountsReceivableAdditionalInformationDetail" id="AccountsReceivableAdditionalInformationDetail">
<link:definition>1068 - Disclosure - Accounts receivable - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/OtherCurrentAndNonCurrentAssetsSummaryOfOtherCurrentAssetsDetail" id="OtherCurrentAndNonCurrentAssetsSummaryOfOtherCurrentAssetsDetail">
<link:definition>1069 - Disclosure - Other current and non-current assets -Summary of Other current assets (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/OtherCurrentAndNonCurrentAssetsAdditionalInformationDetails" id="OtherCurrentAndNonCurrentAssetsAdditionalInformationDetails">
<link:definition>1070 - Disclosure - Other current and non-current assets - Additional Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/OtherCurrentAndNonCurrentAssetsSummaryOfOtherNonCurrentAssetsDetail" id="OtherCurrentAndNonCurrentAssetsSummaryOfOtherNonCurrentAssetsDetail">
<link:definition>1071 - Disclosure - Other current and non-current assets - Summary of Other&amp;#160;non-current&amp;#160;assets (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/PropertyPlantAndEquipmentSummaryOfChangesToPropertyPlantAndEquipmentDetail" id="PropertyPlantAndEquipmentSummaryOfChangesToPropertyPlantAndEquipmentDetail">
<link:definition>1072 - Disclosure - Property, plant and equipment - Summary of Changes to property, plant and equipment (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/PropertyPlantAndEquipmentSummaryOfDepreciationExpenseDetail" id="PropertyPlantAndEquipmentSummaryOfDepreciationExpenseDetail">
<link:definition>1073 - Disclosure - Property, plant and equipment - Summary of Depreciation expense (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/IntangibleAssetsSummaryOfChangesToIntangibleAssetsDetail" id="IntangibleAssetsSummaryOfChangesToIntangibleAssetsDetail">
<link:definition>1074 - Disclosure - Intangible assets - Summary of Changes to intangible assets (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/IntangibleAssetsSummaryOfAmortizationExpenseDetail" id="IntangibleAssetsSummaryOfAmortizationExpenseDetail">
<link:definition>1075 - Disclosure - Intangible assets - Summary of Amortization expense (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/LeasesSummaryOfRightOfUseAssetsDetail" id="LeasesSummaryOfRightOfUseAssetsDetail">
<link:definition>1076 - Disclosure - Leases - Summary of Right-of&amp;#160;use assets (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/LeasesDetailsOfLeaseLiabilitiesDetail" id="LeasesDetailsOfLeaseLiabilitiesDetail">
<link:definition>1077 - Disclosure - Leases - Details of Lease liabilities (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/LeasesSummaryOfExpensesRelatedToRightOfUseAssetsAndLeaseLiabilitiesDetail" id="LeasesSummaryOfExpensesRelatedToRightOfUseAssetsAndLeaseLiabilitiesDetail">
<link:definition>1078 - Disclosure - Leases - Summary of expenses related to&amp;#160;right-of-use&amp;#160;assets and lease liabilities (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/LeasesAdditionalInformationDetail" id="LeasesAdditionalInformationDetail">
<link:definition>1079 - Disclosure - Leases - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/AccountsPayableSummaryOfAccountsPayableDetail" id="AccountsPayableSummaryOfAccountsPayableDetail">
<link:definition>1080 - Disclosure - Accounts payable - Summary of Accounts Payable (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/AccountsPayableAdditionalInformationDetail" id="AccountsPayableAdditionalInformationDetail">
<link:definition>1081 - Disclosure - Accounts payable - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/RevenueFromCollaborationAgreementsAdditionalInformationDetail" id="RevenueFromCollaborationAgreementsAdditionalInformationDetail">
<link:definition>1082 - Disclosure - Revenue from collaboration agreements - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/RevenueFromCollaborationAgreementsSummaryOfDeferredRevenueRelatedToTheCollaborationAgreementsDetail" id="RevenueFromCollaborationAgreementsSummaryOfDeferredRevenueRelatedToTheCollaborationAgreementsDetail">
<link:definition>1083 - Disclosure - Revenue from collaboration agreements - Summary of Deferred revenue related to the collaboration agreements (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/OtherIncomeSummaryOfOtherIncomeDetail" id="OtherIncomeSummaryOfOtherIncomeDetail">
<link:definition>1084 - Disclosure - Other income - Summary of other income (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/OtherIncomeAdditionalInformationDetail" id="OtherIncomeAdditionalInformationDetail">
<link:definition>1085 - Disclosure - Other income - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/OtherCurrentLiabilitiesSummaryOfOtherCurrentLiabilitiesDetail" id="OtherCurrentLiabilitiesSummaryOfOtherCurrentLiabilitiesDetail">
<link:definition>1086 - Disclosure - Other current liabilities - Summary of other current liabilities (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/OtherCurrentLiabilitiesAdditionalInformationDetail" id="OtherCurrentLiabilitiesAdditionalInformationDetail">
<link:definition>1087 - Disclosure - Other current liabilities - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/FinancialIncomeAndExpensesSummaryOfFinanceIncomeAndCostsDetail" id="FinancialIncomeAndExpensesSummaryOfFinanceIncomeAndCostsDetail">
<link:definition>1088 - Disclosure - Financial income and expenses - Summary of finance income and costs (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/FinancialIncomeAndExpensesAdditionalInformationDetail" id="FinancialIncomeAndExpensesAdditionalInformationDetail">
<link:definition>1089 - Disclosure - Financial income and expenses - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/ShareListingExpenseAdditionalInformationDetail" id="ShareListingExpenseAdditionalInformationDetail">
<link:definition>1090 - Disclosure - Share listing expense - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/ShareListingExpensesSummaryOfCalculationOfTheShareListingExpenseDetail" id="ShareListingExpensesSummaryOfCalculationOfTheShareListingExpenseDetail">
<link:definition>1091 - Disclosure - Share listing expenses - Summary of Calculation of the Share listing expense (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/ShareBasedPaymentsSummaryOfOptionsGrantedPricedUsingBlackScholesForSarsTandemAwardsConvertedOptionsMatchingStockOptionsAndMonteCarloOptionPricingModelDetail" id="ShareBasedPaymentsSummaryOfOptionsGrantedPricedUsingBlackScholesForSarsTandemAwardsConvertedOptionsMatchingStockOptionsAndMonteCarloOptionPricingModelDetail">
<link:definition>1092 - Disclosure - Share-based payments - Summary of Options Granted Priced Using Black Scholes for SARs, Tandem Awards, Converted Options, Matching Stock Options and Monte Carlo Option Pricing Model (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/ShareBasedPaymentsSummaryOfEmployeeShareOptionsDetail" id="ShareBasedPaymentsSummaryOfEmployeeShareOptionsDetail">
<link:definition>1093 - Disclosure - Share-based payments - Summary of Employee Share Options (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/ShareBasedPaymentsSummaryOfActivitiesUnderShareBasedPaymentArrangementDetail" id="ShareBasedPaymentsSummaryOfActivitiesUnderShareBasedPaymentArrangementDetail">
<link:definition>1094 - Disclosure - Share-based payments - Summary of Activities Under Share Based Payment Arrangement (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/ShareBasedPaymentsAdditionalInformationDetail" id="ShareBasedPaymentsAdditionalInformationDetail">
<link:definition>1095 - Disclosure - Share-based payments - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/ShareBasedPaymentsSummaryOfEmployeeRelatedShareBasedCompensationExpenseDetail" id="ShareBasedPaymentsSummaryOfEmployeeRelatedShareBasedCompensationExpenseDetail">
<link:definition>1096 - Disclosure - Share-based payments - Summary of Employee Related Share Based Compensation Expense (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/ShareholdersEquityDeficitAdditionalInformationDetail" id="ShareholdersEquityDeficitAdditionalInformationDetail">
<link:definition>1097 - Disclosure - Shareholders' equity (deficit) - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/NonControllingInterestsAdditionalInformationDetail" id="NonControllingInterestsAdditionalInformationDetail">
<link:definition>1098 - Disclosure - Non-controlling interests - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/PersonnelExpensesSummaryOfPersonnelExpensesDetail" id="PersonnelExpensesSummaryOfPersonnelExpensesDetail">
<link:definition>1099 - Disclosure - Personnel expenses - Summary of Personnel Expenses (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/PersonnelExpensesAdditionalInformationDetail" id="PersonnelExpensesAdditionalInformationDetail">
<link:definition>1100 - Disclosure - Personnel expenses - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/IncomeTaxSummaryOfReconciliationBetweenTaxesOnIncomeAndExpectedIncomeTaxBenefitDetail" id="IncomeTaxSummaryOfReconciliationBetweenTaxesOnIncomeAndExpectedIncomeTaxBenefitDetail">
<link:definition>1101 - Disclosure - Income Tax - Summary of Reconciliation Between Taxes On Income And Expected Income Tax Benefit (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/IncomeTaxSummaryOfDeferredTaxAssetsDetail" id="IncomeTaxSummaryOfDeferredTaxAssetsDetail">
<link:definition>1102 - Disclosure - Income Tax - Summary of Deferred Tax Assets (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/IncomeTaxAdditionalInformationDetail" id="IncomeTaxAdditionalInformationDetail">
<link:definition>1103 - Disclosure - Income Tax - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesSummaryOfCurrencyRiskExposureDetail" id="FinancialRiskManagementObjectivesAndPoliciesSummaryOfCurrencyRiskExposureDetail">
<link:definition>1104 - Disclosure - Financial Risk Management Objectives and Policies - Summary of Currency Risk Exposure (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesSummaryOfSensitivityAnalysisOfForeignCurrencyRiskDetail" id="FinancialRiskManagementObjectivesAndPoliciesSummaryOfSensitivityAnalysisOfForeignCurrencyRiskDetail">
<link:definition>1105 - Disclosure - Financial Risk Management Objectives and Policies - Summary of Sensitivity Analysis of Foreign Currency Risk (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesSummaryOfSensitivityAnalysisOfForeignCurrencyRiskParentheticalDetail" id="FinancialRiskManagementObjectivesAndPoliciesSummaryOfSensitivityAnalysisOfForeignCurrencyRiskParentheticalDetail">
<link:definition>1106 - Disclosure - Financial Risk Management Objectives and Policies - Summary of Sensitivity Analysis of Foreign Currency Risk (Parenthetical) (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesSummaryOfLiquidityRiskDetail" id="FinancialRiskManagementObjectivesAndPoliciesSummaryOfLiquidityRiskDetail">
<link:definition>1107 - Disclosure - Financial Risk Management Objectives and Policies - Summary of Liquidity Risk (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesAdditionalInformationDetail" id="FinancialRiskManagementObjectivesAndPoliciesAdditionalInformationDetail">
<link:definition>1108 - Disclosure - Financial Risk Management Objectives and Policies - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/FinancialInstrumentsSummaryOfCarryingAmountsAndFairValuesOfGroupsFinancialInstrumentsDetail" id="FinancialInstrumentsSummaryOfCarryingAmountsAndFairValuesOfGroupsFinancialInstrumentsDetail">
<link:definition>1109 - Disclosure - Financial Instruments - Summary of Carrying Amounts and Fair values of Group's Financial Instruments (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/CommitmentsAndContingenciesSummaryOfContractualObligationsDetail" id="CommitmentsAndContingenciesSummaryOfContractualObligationsDetail">
<link:definition>1110 - Disclosure - Commitments and contingencies - Summary of Contractual Obligations (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" id="CommitmentsAndContingenciesAdditionalInformationDetail">
<link:definition>1111 - Disclosure - Commitments and contingencies - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/RelatedPartyDisclosuresSummaryOfCompensationOfKeyManagementPersonnelDetail" id="RelatedPartyDisclosuresSummaryOfCompensationOfKeyManagementPersonnelDetail">
<link:definition>1112 - Disclosure - Related party disclosures - Summary of Compensation of Key Management Personnel (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/RelatedPartyDisclosuresSummaryOfCompensationForTheSupervisoryBoardDetail" id="RelatedPartyDisclosuresSummaryOfCompensationForTheSupervisoryBoardDetail">
<link:definition>1113 - Disclosure - Related party disclosures - Summary of Compensation for the Supervisory Board (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/RelatedPartyDisclosuresSummaryOfOptionsGrantedToManagingDirectorAndSupervisoryDirectorsDetail" id="RelatedPartyDisclosuresSummaryOfOptionsGrantedToManagingDirectorAndSupervisoryDirectorsDetail">
<link:definition>1114 - Disclosure - Related party disclosures - Summary of Options Granted to Managing Director and Supervisory Directors (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/RelatedPartyDisclosuresSummaryOfCompensationForTheSupervisoryBoardParentheticalDetail" id="RelatedPartyDisclosuresSummaryOfCompensationForTheSupervisoryBoardParentheticalDetail">
<link:definition>1115 - Disclosure - Related party disclosures - Summary of Compensation for the Supervisory Board (Parenthetical) (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/RelatedPartyDisclosuresAdditionalInformationDetail" id="RelatedPartyDisclosuresAdditionalInformationDetail">
<link:definition>1116 - Disclosure - Related party disclosures - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/NetLossPerShareAdditionalInformationDetail" id="NetLossPerShareAdditionalInformationDetail">
<link:definition>1117 - Disclosure - Net loss per share - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://imtx.com/role/ConsolidatedStatementOfLossOfImmaticsNVAlternate1" id="ConsolidatedStatementOfLossOfImmaticsNVAlternate1">
<link:definition>1118 - Statement - Consolidated Statement of Loss of Immatics N.V. Alternate 1</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="imtx-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="imtx-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="imtx-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="imtx-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
<import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/currency/2020-01-31" schemaLocation="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/exch/2020-01-31" schemaLocation="https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/sic/2020-01-31" schemaLocation="https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
<import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
<import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" />
<import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
<import namespace="http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full" schemaLocation="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd" />
<import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
<import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
<import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
<element name="OrdinaryShareMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_OrdinaryShareMember" substitutionGroup="xbrli:item" />
<element name="WarrantsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_WarrantsMember" substitutionGroup="xbrli:item" />
<element name="ShareListingExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_ShareListingExpense" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="RevenueFromCollaborationAgreements" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_RevenueFromCollaborationAgreements" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="AdjustmentsForShareListingExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_AdjustmentsForShareListingExpense" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="AdjustmentForEquitySettledSharebasedPayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_AdjustmentForEquitySettledSharebasedPayment" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="PaymentsForShareBasedCompensation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_PaymentsForShareBasedCompensation" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ChangesInWorkingCapitalAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_ChangesInWorkingCapitalAbstract" substitutionGroup="xbrli:item" />
<element name="TotalEquityAttributableToShareholdersOfParentMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_TotalEquityAttributableToShareholdersOfParentMember" substitutionGroup="xbrli:item" />
<element name="IncreasedecreaseThroughCompensationExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_IncreasedecreaseThroughCompensationExpense" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="IncreaseDecreaseThroughReorganizationEquity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_IncreaseDecreaseThroughReorganizationEquity" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="IncreasedecreaseThroughChangesInNoncontrollingInterest" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="IncreaseThroughARYAMerger" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_IncreaseThroughARYAMerger" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="SARConversion" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_SARConversion" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="IncreasedecreaseThroughIssuanceOfEquity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_IncreasedecreaseThroughIssuanceOfEquity" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="IncreasedecreaseThroughShareBasedCompensationPreviouslyClassifiesAsEquitySettled" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_IncreasedecreaseThroughShareBasedCompensationPreviouslyClassifiesAsEquitySettled" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="TextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_TextBlockAbstract" substitutionGroup="xbrli:item" />
<element name="AryaMergerTransactionExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_AryaMergerTransactionExplanatory" substitutionGroup="xbrli:item" />
<element name="DisclosureOfAccountReceivableExplanatoryTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfAccountReceivableExplanatoryTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfShareListingExpenseTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfShareListingExpenseTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfPersonnelExpensesExplanatoryTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfPersonnelExpensesExplanatoryTextBlock" substitutionGroup="xbrli:item" />
<element name="DescriptionOfAccountingPolicyForOtherIncomePolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DescriptionOfAccountingPolicyForOtherIncomePolicyTextBlock" substitutionGroup="xbrli:item" />
<element name="DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock" substitutionGroup="xbrli:item" />
<element name="DescriptionOfAccountingPolicyForCovidNineteenPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DescriptionOfAccountingPolicyForCovidNineteenPolicyTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfReconciliationOfChangesInCashFlowStatementTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfNonMandatoryStandardsAndInterpretationsIssuedByTheIasbTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfNonMandatoryStandardsAndInterpretationsIssuedByTheIasbTableTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesExplanatoryTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesExplanatoryTableTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillExplanatoryTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillExplanatoryTableTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfDetailedInformationAboutForeignExchangeRatesExplanatoryTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesExplanatoryTableTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfTradeAndOtherReceivableExplanatoryTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfTradeAndOtherReceivableExplanatoryTableTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfDepreciationExpensesTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfDepreciationExpensesTableTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfAmortizationExpensesTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfAmortizationExpensesTableTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfLeaseLiabilitiesTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfLeaseLiabilitiesTableTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfExpensesRelatedToRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfExpensesRelatedToRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfAccountsPayableExplanatoryTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfAccountsPayableExplanatoryTableTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfContractLiabilitiesTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfContractLiabilitiesTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfOtherIncomeExplanatoryTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfOtherIncomeExplanatoryTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfDetailedInformationAboutFinanceIncomeExpenseExplanatoryTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseExplanatoryTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfDetailedInformationAboutShareListingExpensesTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfDetailedInformationAboutShareListingExpensesTextBlock" substitutionGroup="xbrli:item" />
<element name="StatementsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_StatementsTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="StatementsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_StatementsLineItems" substitutionGroup="xbrli:item" />
<element name="DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureDetailsOfActivitiesUnderShareBasedPaymentArrangementTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureDetailsOfActivitiesUnderShareBasedPaymentArrangementTextBlock" substitutionGroup="xbrli:item" />
<element name="ShareAppreciationRightsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_ShareAppreciationRightsMember" substitutionGroup="xbrli:item" />
<element name="MatchingStockOptionsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_MatchingStockOptionsMember" substitutionGroup="xbrli:item" />
<element name="ConvertedOptionsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_ConvertedOptionsMember" substitutionGroup="xbrli:item" />
<element name="AdditionalGrantsUnderTwoThousandAndTwentyPlanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember" substitutionGroup="xbrli:item" />
<element name="PerformanceBasedOptionsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_PerformanceBasedOptionsMember" substitutionGroup="xbrli:item" />
<element name="TwoThousandAndSixteenTandemAwardsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_TwoThousandAndSixteenTandemAwardsMember" substitutionGroup="xbrli:item" />
<element name="DisclosureOfPersonnelExpenesTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfPersonnelExpenesTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfReconciliationBetweenTaxesOnIncomeAndExpectedIncomeTaxBenefitTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfReconciliationBetweenTaxesOnIncomeAndExpectedIncomeTaxBenefitTableTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfCurrencyRiskExposureExplanatoryTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfCurrencyRiskExposureExplanatoryTableTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfContractualObligationsTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfContractualObligationsTableTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfCompensationOfKeyManagementPersonnelTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfCompensationOfKeyManagementPersonnelTableTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfCompensationSupervisoryBoardTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfCompensationSupervisoryBoardTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfCompensationManagingDirectorsAndSupervisoryBoardTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfCompensationManagingDirectorsAndSupervisoryBoardTextBlock" substitutionGroup="xbrli:item" />
<element name="AuthorizationOfFinancialStatementsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_AuthorizationOfFinancialStatementsMember" substitutionGroup="xbrli:item" />
<element name="DisclosureOfReconciliationOfChangesInCashFlowStatementAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementAbstract" substitutionGroup="xbrli:item" />
<element name="DisclosureOfReconciliationOfChangesInCashFlowStatementTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="DisclosureOfReconciliationOfChangesInCashFlowStatementLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementLineItems" substitutionGroup="xbrli:item" />
<element name="ImmaticsUsIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_ImmaticsUsIncMember" substitutionGroup="xbrli:item" />
<element name="AryaMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_AryaMember" substitutionGroup="xbrli:item" />
<element name="PipeFinancingMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_PipeFinancingMember" substitutionGroup="xbrli:item" />
<element name="AmendmentsToIfrsThreeMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_AmendmentsToIfrsThreeMember" substitutionGroup="xbrli:item" />
<element name="AmendmentsToIasOneAndIasEightMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_AmendmentsToIasOneAndIasEightMember" substitutionGroup="xbrli:item" />
<element name="AmendmentsToConceptualFrameworkMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_AmendmentsToConceptualFrameworkMember" substitutionGroup="xbrli:item" />
<element name="AmendmentsToIfrsNineIasThirtyNineAndIfrsSeventeenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_AmendmentsToIfrsNineIasThirtyNineAndIfrsSeventeenMember" substitutionGroup="xbrli:item" />
<element name="AmendmentsToIasOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_AmendmentsToIasOneMember" substitutionGroup="xbrli:item" />
<element name="IfrsSeventeenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_IfrsSeventeenMember" substitutionGroup="xbrli:item" />
<element name="IfrsSixteenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_IfrsSixteenMember" substitutionGroup="xbrli:item" />
<element name="DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesAbstract" substitutionGroup="xbrli:item" />
<element name="DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="LaboratoryEquipmentMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_LaboratoryEquipmentMember" substitutionGroup="xbrli:item" />
<element name="DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesLineItems" substitutionGroup="xbrli:item" />
<element name="DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillAbstract" substitutionGroup="xbrli:item" />
<element name="DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillLineItems" substitutionGroup="xbrli:item" />
<element name="DisclosureOfDetailedInformationAboutForeignExchangeRatesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="DisclosureOfDetailedInformationAboutForeignExchangeRatesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesLineItems" substitutionGroup="xbrli:item" />
<element name="RentalContractTerm" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_RentalContractTerm" substitutionGroup="xbrli:item" />
<element name="ReceivablesFromCollaborationAgreements" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_ReceivablesFromCollaborationAgreements" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="CurrentGrantReceivable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_CurrentGrantReceivable" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="PositiveMarketValueForwardContract" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_PositiveMarketValueForwardContract" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="CapitalizedTransactionCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_CapitalizedTransactionCosts" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="CollaborationAgreementAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_CollaborationAgreementAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="CollaborationAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_CollaborationAgreementMember" substitutionGroup="xbrli:item" />
<element name="CelgeneSwitzerlandLlcAndGenmabAsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_CelgeneSwitzerlandLlcAndGenmabAsMember" substitutionGroup="xbrli:item" />
<element name="CurrentPrepaidInsurance" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_CurrentPrepaidInsurance" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="CurrentIncrementalCostForCollaborationAgreement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_CurrentIncrementalCostForCollaborationAgreement" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="PrepaidExpensesOfLicensesAndSoftware" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_PrepaidExpensesOfLicensesAndSoftware" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="BalanceSheetLocationAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_BalanceSheetLocationAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="BalanceSheetLocationDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_BalanceSheetLocationDomain" substitutionGroup="xbrli:item" />
<element name="ReceivablesFromCapitalGainsTaxMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_ReceivablesFromCapitalGainsTaxMember" substitutionGroup="xbrli:item" />
<element name="OtherNonCurrentAsset" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_OtherNonCurrentAsset" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="TypeOfAdoptionsAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_TypeOfAdoptionsAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="TypeOfAdoptionsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_TypeOfAdoptionsMember" substitutionGroup="xbrli:item" />
<element name="AdjustmentOnAdoptionIfrsSixteenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_AdjustmentOnAdoptionIfrsSixteenMember" substitutionGroup="xbrli:item" />
<element name="AdditionsOtherPropertyPlantAndEquipment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_AdditionsOtherPropertyPlantAndEquipment" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="DisposalsOfPropertyPlantAndEquipment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DisposalsOfPropertyPlantAndEquipment" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="CurrencyTranslationDifferences" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_CurrencyTranslationDifferences" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="DisclosureOfDepreciationExpensesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfDepreciationExpensesAbstract" substitutionGroup="xbrli:item" />
<element name="IncomeStatementLocationAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_IncomeStatementLocationAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="IncomeStatementLocationMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_IncomeStatementLocationMember" substitutionGroup="xbrli:item" />
<element name="ResearchAndDevelopmentExpenseMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_ResearchAndDevelopmentExpenseMember" substitutionGroup="xbrli:item" />
<element name="GeneralAndAdministrativeExpenseMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_GeneralAndAdministrativeExpenseMember" substitutionGroup="xbrli:item" />
<element name="PatentAndLicensesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_PatentAndLicensesMember" substitutionGroup="xbrli:item" />
<element name="SoftwareLicensesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_SoftwareLicensesMember" substitutionGroup="xbrli:item" />
<element name="DisclosureOfAmortizationExpensesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfAmortizationExpensesAbstract" substitutionGroup="xbrli:item" />
<element name="DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesAbstract" substitutionGroup="xbrli:item" />
<element name="DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesLineItems" substitutionGroup="xbrli:item" />
<element name="InterestExpenseOnLease" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_InterestExpenseOnLease" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="TranslationDifferenceOnRightOfUseAsset" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_TranslationDifferenceOnRightOfUseAsset" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="OtherAccruedLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_OtherAccruedLiabilities" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="DisclosureOfRevenueFromContractWithCustomersTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfRevenueFromContractWithCustomersTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="AgreementAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_AgreementAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="AgreementDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_AgreementDomain" substitutionGroup="xbrli:item" />
<element name="AmgenCollaborationAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_AmgenCollaborationAgreementMember" substitutionGroup="xbrli:item" />
<element name="GenmabCollaborationAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_GenmabCollaborationAgreementMember" substitutionGroup="xbrli:item" />
<element name="BMSCollaborationAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_BMSCollaborationAgreementMember" substitutionGroup="xbrli:item" />
<element name="GSKCollaborationAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_GSKCollaborationAgreementMember" substitutionGroup="xbrli:item" />
<element name="MilestoneAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_MilestoneAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="MilestoneDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_MilestoneDomain" substitutionGroup="xbrli:item" />
<element name="DevelopmentAndCommercialMilestonePaymentsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DevelopmentAndCommercialMilestonePaymentsMember" substitutionGroup="xbrli:item" />
<element name="MilestonePaymentForLicensedProductMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_MilestonePaymentForLicensedProductMember" substitutionGroup="xbrli:item" />
<element name="MilestoneProgramsBasedOnTheProgramMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_MilestoneProgramsBasedOnTheProgramMember" substitutionGroup="xbrli:item" />
<element name="OptionExerciseDevelopmentCommecialAndRegulatoryMilestonePaymentsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_OptionExerciseDevelopmentCommecialAndRegulatoryMilestonePaymentsMember" substitutionGroup="xbrli:item" />
<element name="DisclosureOfRevenueFromContractWithCustomersLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfRevenueFromContractWithCustomersLineItems" substitutionGroup="xbrli:item" />
<element name="MilestonePaymentReceivable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_MilestonePaymentReceivable" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="UpfrontPaymentReceived" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_UpfrontPaymentReceived" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="PotentialMilestonePaymentPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_PotentialMilestonePaymentPayable" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="DisclosureOfOtherIncomeAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfOtherIncomeAbstract" substitutionGroup="xbrli:item" />
<element name="GovernmentGrantReceivable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_GovernmentGrantReceivable" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="DeferredIncomeCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DeferredIncomeCurrent" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="TotalDeferredIncome" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_TotalDeferredIncome" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ContingenciesRelatedToGrant" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_ContingenciesRelatedToGrant" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesAbstract" substitutionGroup="xbrli:item" />
<element name="DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems" substitutionGroup="xbrli:item" />
<element name="DeferredGrantIncomeCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_DeferredGrantIncomeCurrent" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="OtherCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_OtherCurrent" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="NonInterestBearingLiabilityMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_NonInterestBearingLiabilityMember" substitutionGroup="xbrli:item" />
<element name="DisclosureOfDetailedInformationAboutFinanceIncomeExpenseAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseAbstract" substitutionGroup="xbrli:item" />
<element name="RealisedGainLossFromForeignCurrencyForwardContracts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_RealisedGainLossFromForeignCurrencyForwardContracts" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="UnrealisedGainLossFromForeignCurrencyForwardContracts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_UnrealisedGainLossFromForeignCurrencyForwardContracts" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="DisclosureOfShareListingExpenseLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfShareListingExpenseLineItems" substitutionGroup="xbrli:item" />
<element name="WarrantsIssuedPricePerWarrant" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_WarrantsIssuedPricePerWarrant" substitutionGroup="xbrli:item" />
<element name="DisclosureOfDetailedInformationAboutShareListingExpenseLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems" substitutionGroup="xbrli:item" />
<element name="CombinedProbabilityOfExitEventsShareOptionsGranted" type="xbrli:pureItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_CombinedProbabilityOfExitEventsShareOptionsGranted" substitutionGroup="xbrli:item" />
<element name="PlanAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_PlanAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="PlanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_PlanMember" substitutionGroup="xbrli:item" />
<element name="WeightedAverageExercisePriceOfShareOptionsVestedInSharebasedPaymentArrangement2019" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_WeightedAverageExercisePriceOfShareOptionsVestedInSharebasedPaymentArrangement2019" substitutionGroup="xbrli:item" />
<element name="NumberOfShareOptionsVestedInSharebasedPaymentArrangement" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_NumberOfShareOptionsVestedInSharebasedPaymentArrangement" substitutionGroup="xbrli:item" />
<element name="ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare" substitutionGroup="xbrli:item" />
<element name="DateOfGrantAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DateOfGrantAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="DateOfGrantMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DateOfGrantMember" substitutionGroup="xbrli:item" />
<element name="GrantedOnJuneTwoThousandAndTwentyMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_GrantedOnJuneTwoThousandAndTwentyMember" substitutionGroup="xbrli:item" />
<element name="GrantedOnSeptemberTwoThousandAndTwentyMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_GrantedOnSeptemberTwoThousandAndTwentyMember" substitutionGroup="xbrli:item" />
<element name="GrantedOnDecemberTwoThousandAndTwentyMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_GrantedOnDecemberTwoThousandAndTwentyMember" substitutionGroup="xbrli:item" />
<element name="WeightedAverageExercisePriceOfShareOptionsVestedDuringThePeriod" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_WeightedAverageExercisePriceOfShareOptionsVestedDuringThePeriod" substitutionGroup="xbrli:item" />
<element name="NumberOfShareOptionsVestedDuringThePeriod" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_NumberOfShareOptionsVestedDuringThePeriod" substitutionGroup="xbrli:item" />
<element name="GrantedOnJuneToSeptemberTwoThousandAndTwentyMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_GrantedOnJuneToSeptemberTwoThousandAndTwentyMember" substitutionGroup="xbrli:item" />
<element name="ShareAppreciationRightsTwoThousandAndTenPlanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_ShareAppreciationRightsTwoThousandAndTenPlanMember" substitutionGroup="xbrli:item" />
<element name="ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMember" substitutionGroup="xbrli:item" />
<element name="ModificationOfTwoThousandAndTenPlanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_ModificationOfTwoThousandAndTenPlanMember" substitutionGroup="xbrli:item" />
<element name="ModificationOfTwoThousandAndSixteenPlanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_ModificationOfTwoThousandAndSixteenPlanMember" substitutionGroup="xbrli:item" />
<element name="CategoryOfEmployeesAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_CategoryOfEmployeesAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="CategoryOfEmployeesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_CategoryOfEmployeesMember" substitutionGroup="xbrli:item" />
<element name="ActiveEmployeesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_ActiveEmployeesMember" substitutionGroup="xbrli:item" />
<element name="ManagementMembersMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_ManagementMembersMember" substitutionGroup="xbrli:item" />
<element name="SchemeAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_SchemeAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="SchemeMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_SchemeMember" substitutionGroup="xbrli:item" />
<element name="ShareReinvestmentMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_ShareReinvestmentMember" substitutionGroup="xbrli:item" />
<element name="ShareReinvestmentSchemeAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_ShareReinvestmentSchemeAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="ShareReinvestmentSchemeMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_ShareReinvestmentSchemeMember" substitutionGroup="xbrli:item" />
<element name="PercentageOfOutstandingSharesToBePurchasedByThirdParty" type="num:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_PercentageOfOutstandingSharesToBePurchasedByThirdParty" substitutionGroup="xbrli:item" />
<element name="CashPaymentAwardPerSharePayable" type="num:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_CashPaymentAwardPerSharePayable" substitutionGroup="xbrli:item" />
<element name="PercentageOfCashProceedsToBeBeReinvested" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_PercentageOfCashProceedsToBeBeReinvested" substitutionGroup="xbrli:item" />
<element name="ExpenseFromTheModificationOfShareBasedAwards" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_ExpenseFromTheModificationOfShareBasedAwards" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="DateOfVestingOfStockOptions" type="xbrli:dateItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DateOfVestingOfStockOptions" substitutionGroup="xbrli:item" />
<element name="MinimumMarketCapitalization" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_MinimumMarketCapitalization" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="TrancheAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_TrancheAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="TrancheMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_TrancheMember" substitutionGroup="xbrli:item" />
<element name="TrancheOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_TrancheOneMember" substitutionGroup="xbrli:item" />
<element name="TrancheTwoMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_TrancheTwoMember" substitutionGroup="xbrli:item" />
<element name="TrancheThreeMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_TrancheThreeMember" substitutionGroup="xbrli:item" />
<element name="DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseAbstract" substitutionGroup="xbrli:item" />
<element name="DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseLineItems" substitutionGroup="xbrli:item" />
<element name="SeriesEShareCapitalMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_SeriesEShareCapitalMember" substitutionGroup="xbrli:item" />
<element name="ImmaticsBiotechnologiesGmbhMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_ImmaticsBiotechnologiesGmbhMember" substitutionGroup="xbrli:item" />
<element name="NumberOfWarrantsOutsatnding" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_NumberOfWarrantsOutsatnding" substitutionGroup="xbrli:item" />
<element name="ExercisePriceOfWarrants" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_ExercisePriceOfWarrants" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantOrRightTermPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_ClassOfWarrantOrRightTermPeriod" substitutionGroup="xbrli:item" />
<element name="StockIssuedDuringPeriodValueNewIssues" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_StockIssuedDuringPeriodValueNewIssues" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ShareListingExpenseAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_ShareListingExpenseAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="ShareListingExpenseDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_ShareListingExpenseDomain" substitutionGroup="xbrli:item" />
<element name="AryaMergerMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_AryaMergerMember" substitutionGroup="xbrli:item" />
<element name="EventAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_EventAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="EventDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_EventDomain" substitutionGroup="xbrli:item" />
<element name="ReorganizationMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_ReorganizationMember" substitutionGroup="xbrli:item" />
<element name="NumberOfSharesExchangedInSubsidiaries" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_NumberOfSharesExchangedInSubsidiaries" substitutionGroup="xbrli:item" />
<element name="StockIssuedDuringPeriodSharesAcquisitions" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_StockIssuedDuringPeriodSharesAcquisitions" substitutionGroup="xbrli:item" />
<element name="LossOnNoncontrollingInterest" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_LossOnNoncontrollingInterest" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="MdAndersonMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_MdAndersonMember" substitutionGroup="xbrli:item" />
<element name="RestrictedStockAcquisitionAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_RestrictedStockAcquisitionAgreementMember" substitutionGroup="xbrli:item" />
<element name="EmployeeHealthInsuranceCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_EmployeeHealthInsuranceCost" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="TaxEffectOfGovernmentGrantsExemptedFromTaxes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_TaxEffectOfGovernmentGrantsExemptedFromTaxes" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="NonRecognitionOfDeferredTaxesOnTaxLossesAndTemporaryDifferences" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_NonRecognitionOfDeferredTaxesOnTaxLossesAndTemporaryDifferences" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="TaxEffectOfPermanentDifferences" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_TaxEffectOfPermanentDifferences" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="DeferredTaxAssetsNonrecognition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_DeferredTaxAssetsNonrecognition" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="DeferredTaxAssetsOffset" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_DeferredTaxAssetsOffset" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="DeferredTaxLiabilitiesOffSet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_DeferredTaxLiabilitiesOffSet" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="IntangibleAssetsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_IntangibleAssetsMember" substitutionGroup="xbrli:item" />
<element name="DeferredRevenueMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DeferredRevenueMember" substitutionGroup="xbrli:item" />
<element name="LeaseLiabilityMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_LeaseLiabilityMember" substitutionGroup="xbrli:item" />
<element name="DeferredExpensesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DeferredExpensesMember" substitutionGroup="xbrli:item" />
<element name="DeferredAssetRecognisedMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DeferredAssetRecognisedMember" substitutionGroup="xbrli:item" />
<element name="DeferredTaxLiabilitiesRightOfUseAssetMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DeferredTaxLiabilitiesRightOfUseAssetMember" substitutionGroup="xbrli:item" />
<element name="DeferredTaxLiabilitiesDeferredExpensesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DeferredTaxLiabilitiesDeferredExpensesMember" substitutionGroup="xbrli:item" />
<element name="OtherLiabilitiesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_OtherLiabilitiesMember" substitutionGroup="xbrli:item" />
<element name="CorporateIncomeTaxRate" type="num:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_CorporateIncomeTaxRate" substitutionGroup="xbrli:item" />
<element name="PercentageOnLimitationOnTaxLossCarryforwardsAfterPriorPeriod" type="num:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_PercentageOnLimitationOnTaxLossCarryforwardsAfterPriorPeriod" substitutionGroup="xbrli:item" />
<element name="PercentageOnLimitationOnTaxLossCarryforwardsBeforePriorPeriod" type="num:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_PercentageOnLimitationOnTaxLossCarryforwardsBeforePriorPeriod" substitutionGroup="xbrli:item" />
<element name="EffectiveIncomeTaxReconciliationPermanentEffectShareListingExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_EffectiveIncomeTaxReconciliationPermanentEffectShareListingExpense" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="IndefiniteTaxLossesCarryforwardMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_IndefiniteTaxLossesCarryforwardMember" substitutionGroup="xbrli:item" />
<element name="TwentySixYearTaxLossesCarryforwardMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_TwentySixYearTaxLossesCarryforwardMember" substitutionGroup="xbrli:item" />
<element name="DisclosureOfCurrencyRiskExposureAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfCurrencyRiskExposureAbstract" substitutionGroup="xbrli:item" />
<element name="DisclosureOfCurrencyRiskExposureTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfCurrencyRiskExposureTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="DisclosureOfCurrencyRiskExposureLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfCurrencyRiskExposureLineItems" substitutionGroup="xbrli:item" />
<element name="MaximumExposedToCurrencyRisk" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_MaximumExposedToCurrencyRisk" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="ImmaticsNvMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_ImmaticsNvMember" substitutionGroup="xbrli:item" />
<element name="ImmaticsGmbhMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_ImmaticsGmbhMember" substitutionGroup="xbrli:item" />
<element name="DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems" substitutionGroup="xbrli:item" />
<element name="IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="SensitiveAnalaysisOfCurrencyAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_SensitiveAnalaysisOfCurrencyAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="SensitiveAnalaysisOfCurrencyDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_SensitiveAnalaysisOfCurrencyDomain" substitutionGroup="xbrli:item" />
<element name="EuroWeakensBy1AgainstUsDollarsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_EuroWeakensBy1AgainstUsDollarsMember" substitutionGroup="xbrli:item" />
<element name="EuroStrengthsBy1AgainstUsDollarsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_EuroStrengthsBy1AgainstUsDollarsMember" substitutionGroup="xbrli:item" />
<element name="EuroWeakensBy5AgainstUsDollarsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_EuroWeakensBy5AgainstUsDollarsMember" substitutionGroup="xbrli:item" />
<element name="EuroStrengthsBy5AgainstUsDollarsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_EuroStrengthsBy5AgainstUsDollarsMember" substitutionGroup="xbrli:item" />
<element name="EuroWeakensBy10AgainstUsDollarsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_EuroWeakensBy10AgainstUsDollarsMember" substitutionGroup="xbrli:item" />
<element name="EuroStrengthsBy10AgainstUsDollarsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_EuroStrengthsBy10AgainstUsDollarsMember" substitutionGroup="xbrli:item" />
<element name="PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk" type="num:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk" substitutionGroup="xbrli:item" />
<element name="PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk" type="num:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk" substitutionGroup="xbrli:item" />
<element name="DescriptionOfManagingLiquidityRiskAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DescriptionOfManagingLiquidityRiskAbstract" substitutionGroup="xbrli:item" />
<element name="ShorttermDepositsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_ShorttermDepositsMember" substitutionGroup="xbrli:item" />
<element name="CashAndCashEquivalentsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_CashAndCashEquivalentsMember" substitutionGroup="xbrli:item" />
<element name="OtherFinancialAssetsAtAmortizedCostMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_OtherFinancialAssetsAtAmortizedCostMember" substitutionGroup="xbrli:item" />
<element name="PositiveMarketValueForwardContractsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_PositiveMarketValueForwardContractsMember" substitutionGroup="xbrli:item" />
<element name="OtherCurrentAssetMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_OtherCurrentAssetMember" substitutionGroup="xbrli:item" />
<element name="AccountsPayableMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_AccountsPayableMember" substitutionGroup="xbrli:item" />
<element name="OtherCurrentLiabilitiesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_OtherCurrentLiabilitiesMember" substitutionGroup="xbrli:item" />
<element name="DisclosureOfContractualObligationsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfContractualObligationsAbstract" substitutionGroup="xbrli:item" />
<element name="DisclosureOfContractualObligationsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfContractualObligationsTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="DisclosureOfContractualObligationsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfContractualObligationsLineItems" substitutionGroup="xbrli:item" />
<element name="ContractualObligationOfLeaseLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_ContractualObligationOfLeaseLiabilities" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="OtherLeaseObligations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_OtherLeaseObligations" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ContractualObligationOfInLicenseAgreements" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_ContractualObligationOfInLicenseAgreements" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ContractResearchOrganizationAgreements" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_ContractResearchOrganizationAgreements" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ContractualCashObligation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_ContractualCashObligation" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="UnrecordedContingentLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_UnrecordedContingentLiability" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="CollaborationAgreementsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_CollaborationAgreementsMember" substitutionGroup="xbrli:item" />
<element name="DisclosureOfCompensationOfKeyManagementPersonnelAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_DisclosureOfCompensationOfKeyManagementPersonnelAbstract" substitutionGroup="xbrli:item" />
<element name="KeyManagementPersonnelCompensationFixed" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_KeyManagementPersonnelCompensationFixed" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="MichaelGAtiehMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_MichaelGAtiehMember" substitutionGroup="xbrli:item" />
<element name="PaulCarterMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_PaulCarterMember" substitutionGroup="xbrli:item" />
<element name="HeatherLMasonMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_HeatherLMasonMember" substitutionGroup="xbrli:item" />
<element name="AdamStoneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_AdamStoneMember" substitutionGroup="xbrli:item" />
<element name="ChristophHettichMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_ChristophHettichMember" substitutionGroup="xbrli:item" />
<element name="EliotForsterMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_EliotForsterMember" substitutionGroup="xbrli:item" />
<element name="PeterChambreMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_PeterChambreMember" substitutionGroup="xbrli:item" />
<element name="HaraldFstockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_HaraldFstockMember" substitutionGroup="xbrli:item" />
<element name="KeyManagementPersonnelCompensationSupervisoryBoardCompensation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_KeyManagementPersonnelCompensationSupervisoryBoardCompensation" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="KeyManagementPersonnelCompensationTravellingExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_KeyManagementPersonnelCompensationTravellingExpenses" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="KeyManagementPersonnelCompensationShareBasedCompensationExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_KeyManagementPersonnelCompensationShareBasedCompensationExpense" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="KeyManagementPersonnelCompensations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_KeyManagementPersonnelCompensations" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="KeyManagementPersonnelCompensationPaymentExitArrangement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_KeyManagementPersonnelCompensationPaymentExitArrangement" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="TypeOfVestingAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_TypeOfVestingAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="TypeOfVestingDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_TypeOfVestingDomain" substitutionGroup="xbrli:item" />
<element name="ServiceOptionsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_ServiceOptionsMember" substitutionGroup="xbrli:item" />
<element name="ConvertedOptionsOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_ConvertedOptionsOneMember" substitutionGroup="xbrli:item" />
<element name="ServiceOptionsOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_ServiceOptionsOneMember" substitutionGroup="xbrli:item" />
<element name="HarpreetSinghMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_HarpreetSinghMember" substitutionGroup="xbrli:item" />
<element name="DateOfExpiryOfShareOptionsGranted" type="xbrli:dateItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DateOfExpiryOfShareOptionsGranted" substitutionGroup="xbrli:item" />
<element name="PlanNameAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_PlanNameAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="PlanNameDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_PlanNameDomain" substitutionGroup="xbrli:item" />
<element name="TwentyTwentyIncentivePlanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="imtx_TwentyTwentyIncentivePlanMember" substitutionGroup="xbrli:item" />
<element name="AccruedOfKeyManagementCompensation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_AccruedOfKeyManagementCompensation" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="PercentageOfStockVestedOverThePeriodOfFourYearTimeBasedVestingSchedule" type="num:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="imtx_PercentageOfStockVestedOverThePeriodOfFourYearTimeBasedVestingSchedule" substitutionGroup="xbrli:item" />
<element name="PaymentOfPayrollTaxOfTheEmployees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_PaymentOfPayrollTaxOfTheEmployees" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="NumberOfConvertedStockOptionsInTheEntity" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_NumberOfConvertedStockOptionsInTheEntity" substitutionGroup="xbrli:item" />
<element name="NumberOfMatchingStockOptionInTheEntity" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_NumberOfMatchingStockOptionInTheEntity" substitutionGroup="xbrli:item" />
<element name="DilutiveEffectOfShareOptionsOnNumberOfWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="imtx_DilutiveEffectOfShareOptionsOnNumberOfWarrants" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>12
<FILENAME>imtx-20201231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 30-March-2021 [01:58:01] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ConsolidatedStatementOfFinancialPositionOfImmaticsNV" roleURI="http://imtx.com/role/ConsolidatedStatementOfFinancialPositionOfImmaticsNV" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ConsolidatedStatementOfLossOfImmaticsNV" roleURI="http://imtx.com/role/ConsolidatedStatementOfLossOfImmaticsNV" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ConsolidatedStatementOfComprehensiveLossOfImmaticsNV" roleURI="http://imtx.com/role/ConsolidatedStatementOfComprehensiveLossOfImmaticsNV" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ConsolidatedStatementOfCashFlows" roleURI="http://imtx.com/role/ConsolidatedStatementOfCashFlows" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ConsolidatedStatementOfChangesInShareholdersEquityDeficitOfImmaticsNV" roleURI="http://imtx.com/role/ConsolidatedStatementOfChangesInShareholdersEquityDeficitOfImmaticsNV" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#OtherCurrentAndNonCurrentAssetsSummaryOfOtherCurrentAssetsDetail" roleURI="http://imtx.com/role/OtherCurrentAndNonCurrentAssetsSummaryOfOtherCurrentAssetsDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#OtherCurrentAndNonCurrentAssetsSummaryOfOtherNonCurrentAssetsDetail" roleURI="http://imtx.com/role/OtherCurrentAndNonCurrentAssetsSummaryOfOtherNonCurrentAssetsDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#RevenueFromCollaborationAgreementsSummaryOfDeferredRevenueRelatedToTheCollaborationAgreementsDetail" roleURI="http://imtx.com/role/RevenueFromCollaborationAgreementsSummaryOfDeferredRevenueRelatedToTheCollaborationAgreementsDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#OtherIncomeSummaryOfOtherIncomeDetail" roleURI="http://imtx.com/role/OtherIncomeSummaryOfOtherIncomeDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#OtherCurrentLiabilitiesSummaryOfOtherCurrentLiabilitiesDetail" roleURI="http://imtx.com/role/OtherCurrentLiabilitiesSummaryOfOtherCurrentLiabilitiesDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#FinancialIncomeAndExpensesSummaryOfFinanceIncomeAndCostsDetail" roleURI="http://imtx.com/role/FinancialIncomeAndExpensesSummaryOfFinanceIncomeAndCostsDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ConsolidatedStatementOfLossOfImmaticsNVAlternate1" roleURI="http://imtx.com/role/ConsolidatedStatementOfLossOfImmaticsNVAlternate1" />
<calculationLink xlink:type="extended" xlink:role="http://imtx.com/role/ConsolidatedStatementOfFinancialPositionOfImmaticsNV">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets" xlink:to="loc_ifrs-full_CurrentAssets" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets" xlink:to="loc_ifrs-full_CashAndCashEquivalents" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherCurrentFinancialAssets" xlink:label="loc_ifrs-full_OtherCurrentFinancialAssets" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets" xlink:to="loc_ifrs-full_OtherCurrentFinancialAssets" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets" xlink:to="loc_ifrs-full_CurrentTradeReceivables" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherCurrentAssets" xlink:label="loc_ifrs-full_OtherCurrentAssets" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets" xlink:to="loc_ifrs-full_OtherCurrentAssets" use="optional" order="5" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets" xlink:to="loc_ifrs-full_NoncurrentAssets" use="optional" order="6" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment" use="optional" order="7" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill" use="optional" order="8" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets" xlink:to="loc_ifrs-full_RightofuseAssets" use="optional" order="9" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="loc_ifrs-full_OtherNoncurrentAssets" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets" xlink:to="loc_ifrs-full_OtherNoncurrentAssets" use="optional" order="10" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://imtx.com/role/ConsolidatedStatementOfFinancialPositionOfImmaticsNV">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities" xlink:to="loc_ifrs-full_CurrentLiabilities" use="optional" order="11" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentProvisions" xlink:label="loc_ifrs-full_CurrentProvisions" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities" xlink:to="loc_ifrs-full_CurrentProvisions" use="optional" order="12" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" use="optional" order="13" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentContractLiabilities" xlink:label="loc_ifrs-full_CurrentContractLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities" xlink:to="loc_ifrs-full_CurrentContractLiabilities" use="optional" order="14" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities" use="optional" order="15" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherCurrentLiabilities" xlink:label="loc_ifrs-full_OtherCurrentLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities" xlink:to="loc_ifrs-full_OtherCurrentLiabilities" use="optional" order="16" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities" xlink:to="loc_ifrs-full_NoncurrentLiabilities" use="optional" order="17" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentContractLiabilities" xlink:label="loc_ifrs-full_NoncurrentContractLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities" xlink:to="loc_ifrs-full_NoncurrentContractLiabilities" use="optional" order="18" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities" use="optional" order="19" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherNoncurrentLiabilities" xlink:label="loc_ifrs-full_OtherNoncurrentLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities" xlink:to="loc_ifrs-full_OtherNoncurrentLiabilities" use="optional" order="20" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities" xlink:to="loc_ifrs-full_Equity" use="optional" order="21" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity" xlink:to="loc_ifrs-full_EquityAttributableToOwnersOfParent" use="optional" order="22" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="loc_ifrs-full_IssuedCapital" use="optional" order="23" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharePremium" xlink:label="loc_ifrs-full_SharePremium" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="loc_ifrs-full_SharePremium" use="optional" order="24" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="loc_ifrs-full_RetainedEarnings" use="optional" order="25" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherReserves" xlink:label="loc_ifrs-full_OtherReserves" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="loc_ifrs-full_OtherReserves" use="optional" order="26" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncontrollingInterests" xlink:label="loc_ifrs-full_NoncontrollingInterests" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity" xlink:to="loc_ifrs-full_NoncontrollingInterests" use="optional" order="27" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://imtx.com/role/ConsolidatedStatementOfLossOfImmaticsNV">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss" xlink:to="loc_ifrs-full_ProfitLossBeforeTax" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinanceIncomeCost" xlink:label="loc_ifrs-full_FinanceIncomeCost" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax" xlink:to="loc_ifrs-full_FinanceIncomeCost" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncomeCost" xlink:to="loc_ifrs-full_FinanceIncome" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncomeCost" xlink:to="loc_ifrs-full_FinanceCosts" use="optional" order="4" weight="-1" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShareListingExpense" xlink:label="loc_IMTX_ShareListingExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncomeCost" xlink:to="loc_IMTX_ShareListingExpense" use="optional" order="5" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities" use="optional" order="6" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense" use="optional" order="7" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities" xlink:to="loc_ifrs-full_GeneralAndAdministrativeExpense" use="optional" order="8" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-full_OtherIncome" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities" xlink:to="loc_ifrs-full_OtherIncome" use="optional" order="9" weight="1" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_RevenueFromCollaborationAgreements" xlink:label="loc_IMTX_RevenueFromCollaborationAgreements" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities" xlink:to="loc_IMTX_RevenueFromCollaborationAgreements" use="optional" order="10" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations" use="optional" order="11" weight="-1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://imtx.com/role/ConsolidatedStatementOfLossOfImmaticsNVAlternate1">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss" xlink:to="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent" use="optional" order="12" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss" xlink:to="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" use="optional" order="13" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://imtx.com/role/ConsolidatedStatementOfCashFlows">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" use="optional" order="2" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" use="optional" order="3" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" use="optional" order="5" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" use="optional" order="6" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities" use="optional" order="7" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares" use="optional" order="8" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" use="optional" order="9" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="loc_ifrs-full_PaymentsForShareIssueCosts" use="optional" order="10" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" use="optional" order="11" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForInterestIncome" xlink:label="loc_ifrs-full_AdjustmentsForInterestIncome" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-full_AdjustmentsForInterestIncome" use="optional" order="12" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" use="optional" order="13" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForInterestExpense" xlink:label="loc_ifrs-full_AdjustmentsForInterestExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-full_AdjustmentsForInterestExpense" use="optional" order="14" weight="1" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AdjustmentsForShareListingExpense" xlink:label="loc_IMTX_AdjustmentsForShareListingExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="loc_IMTX_AdjustmentsForShareListingExpense" use="optional" order="15" weight="1" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AdjustmentForEquitySettledSharebasedPayment" xlink:label="loc_IMTX_AdjustmentForEquitySettledSharebasedPayment" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="loc_IMTX_AdjustmentForEquitySettledSharebasedPayment" use="optional" order="16" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments" use="optional" order="17" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" use="optional" order="18" weight="1" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PaymentsForShareBasedCompensation" xlink:label="loc_IMTX_PaymentsForShareBasedCompensation" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="loc_IMTX_PaymentsForShareBasedCompensation" use="optional" order="19" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:label="loc_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" use="optional" order="20" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" use="optional" order="21" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" use="optional" order="22" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities" use="optional" order="23" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities" use="optional" order="24" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" use="optional" order="25" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-full_ProfitLossBeforeTax" use="optional" order="26" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://imtx.com/role/OtherCurrentAndNonCurrentAssetsSummaryOfOtherCurrentAssetsDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherCurrentAssets" xlink:label="loc_ifrs-full_OtherCurrentAssets" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CurrentGrantReceivable" xlink:label="loc_IMTX_CurrentGrantReceivable" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentAssets" xlink:to="loc_IMTX_CurrentGrantReceivable" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentAssets" xlink:to="loc_ifrs-full_CurrentPrepaidExpenses" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PositiveMarketValueForwardContract" xlink:label="loc_IMTX_PositiveMarketValueForwardContract" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentAssets" xlink:to="loc_IMTX_PositiveMarketValueForwardContract" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentValueAddedTaxReceivables" xlink:label="loc_ifrs-full_CurrentValueAddedTaxReceivables" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentAssets" xlink:to="loc_ifrs-full_CurrentValueAddedTaxReceivables" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CapitalizedTransactionCosts" xlink:label="loc_IMTX_CapitalizedTransactionCosts" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentAssets" xlink:to="loc_IMTX_CapitalizedTransactionCosts" use="optional" order="5" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherAssets" xlink:label="loc_ifrs-full_OtherAssets" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentAssets" xlink:to="loc_ifrs-full_OtherAssets" use="optional" order="6" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://imtx.com/role/OtherCurrentAndNonCurrentAssetsSummaryOfOtherNonCurrentAssetsDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="loc_ifrs-full_OtherNoncurrentAssets" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentPrepayments" xlink:label="loc_ifrs-full_NoncurrentPrepayments" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherNoncurrentAssets" xlink:to="loc_ifrs-full_NoncurrentPrepayments" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_OtherNonCurrentAsset" xlink:label="loc_IMTX_OtherNonCurrentAsset" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherNoncurrentAssets" xlink:to="loc_IMTX_OtherNonCurrentAsset" use="optional" order="2" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://imtx.com/role/RevenueFromCollaborationAgreementsSummaryOfDeferredRevenueRelatedToTheCollaborationAgreementsDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ContractLiabilities" xlink:label="loc_ifrs-full_ContractLiabilities" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentContractLiabilities" xlink:label="loc_ifrs-full_CurrentContractLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ContractLiabilities" xlink:to="loc_ifrs-full_CurrentContractLiabilities" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentContractLiabilities" xlink:label="loc_ifrs-full_NoncurrentContractLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ContractLiabilities" xlink:to="loc_ifrs-full_NoncurrentContractLiabilities" use="optional" order="2" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://imtx.com/role/OtherIncomeSummaryOfOtherIncomeDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TotalDeferredIncome" xlink:label="loc_IMTX_TotalDeferredIncome" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GovernmentGrantReceivable" xlink:label="loc_IMTX_GovernmentGrantReceivable" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMTX_TotalDeferredIncome" xlink:to="loc_IMTX_GovernmentGrantReceivable" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DeferredIncomeCurrent" xlink:label="loc_IMTX_DeferredIncomeCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMTX_TotalDeferredIncome" xlink:to="loc_IMTX_DeferredIncomeCurrent" use="optional" order="2" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://imtx.com/role/OtherCurrentLiabilitiesSummaryOfOtherCurrentLiabilitiesDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherCurrentLiabilities" xlink:label="loc_ifrs-full_OtherCurrentLiabilities" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="loc_ifrs-full_CurrentTaxLiabilitiesCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentLiabilities" xlink:to="loc_ifrs-full_CurrentTaxLiabilitiesCurrent" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AccrualsClassifiedAsCurrent" xlink:label="loc_ifrs-full_AccrualsClassifiedAsCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentLiabilities" xlink:to="loc_ifrs-full_AccrualsClassifiedAsCurrent" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DeferredGrantIncomeCurrent" xlink:label="loc_IMTX_DeferredGrantIncomeCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentLiabilities" xlink:to="loc_IMTX_DeferredGrantIncomeCurrent" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:label="loc_ifrs-full_CurrentProvisionsForEmployeeBenefits" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentLiabilities" xlink:to="loc_ifrs-full_CurrentProvisionsForEmployeeBenefits" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_OtherCurrent" xlink:label="loc_IMTX_OtherCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherCurrentLiabilities" xlink:to="loc_IMTX_OtherCurrent" use="optional" order="5" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://imtx.com/role/FinancialIncomeAndExpensesSummaryOfFinanceIncomeAndCostsDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InterestIncomeOnDeposits" xlink:label="loc_ifrs-full_InterestIncomeOnDeposits" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncome" xlink:to="loc_ifrs-full_InterestIncomeOnDeposits" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NetForeignExchangeGain" xlink:label="loc_ifrs-full_NetForeignExchangeGain" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncome" xlink:to="loc_ifrs-full_NetForeignExchangeGain" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GainLossRecognisedOnFinancialInstrumentsWhoseFairValuePreviouslyCouldNotBeReliablyMeasured" xlink:label="loc_ifrs-full_GainLossRecognisedOnFinancialInstrumentsWhoseFairValuePreviouslyCouldNotBeReliablyMeasured" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncome" xlink:to="loc_ifrs-full_GainLossRecognisedOnFinancialInstrumentsWhoseFairValuePreviouslyCouldNotBeReliablyMeasured" use="optional" order="3" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://imtx.com/role/FinancialIncomeAndExpensesSummaryOfFinanceIncomeAndCostsDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceCosts" xlink:to="loc_ifrs-full_InterestExpenseOnLeaseLiabilities" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NetForeignExchangeLoss" xlink:label="loc_ifrs-full_NetForeignExchangeLoss" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceCosts" xlink:to="loc_ifrs-full_NetForeignExchangeLoss" use="optional" order="5" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://imtx.com/role/ConsolidatedStatementOfComprehensiveLossOfImmaticsNV">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome" xlink:to="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome" xlink:to="loc_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" use="optional" order="2" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://imtx.com/role/ConsolidatedStatementOfChangesInShareholdersEquityDeficitOfImmaticsNV">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncreasedecreaseThroughIssuanceOfEquity" xlink:label="loc_IMTX_IncreasedecreaseThroughIssuanceOfEquity" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest" xlink:label="loc_IMTX_IncreasedecreaseThroughChangesInNoncontrollingInterest" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMTX_IncreasedecreaseThroughIssuanceOfEquity" xlink:to="loc_IMTX_IncreasedecreaseThroughChangesInNoncontrollingInterest" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMTX_IncreasedecreaseThroughIssuanceOfEquity" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncreaseThroughARYAMerger" xlink:label="loc_IMTX_IncreaseThroughARYAMerger" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMTX_IncreasedecreaseThroughIssuanceOfEquity" xlink:to="loc_IMTX_IncreaseThroughARYAMerger" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_SARConversion" xlink:label="loc_IMTX_SARConversion" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMTX_IncreasedecreaseThroughIssuanceOfEquity" xlink:to="loc_IMTX_SARConversion" use="optional" order="4" weight="1" />
</calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>13
<FILENAME>imtx-20201231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 30-March-2021 [01:58:01] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#CoverPage" roleURI="http://imtx.com/role/CoverPage" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ConsolidatedStatementOfChangesInShareholdersEquityDeficitOfImmaticsNV" roleURI="http://imtx.com/role/ConsolidatedStatementOfChangesInShareholdersEquityDeficitOfImmaticsNV" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ShareBasedPaymentsTables" roleURI="http://imtx.com/role/ShareBasedPaymentsTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#GroupInformationAdditionalInformationDetail" roleURI="http://imtx.com/role/GroupInformationAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#BasisOfPresentationSummaryOfReconciliationOfChangesInCashFlowStatementDetail" roleURI="http://imtx.com/role/BasisOfPresentationSummaryOfReconciliationOfChangesInCashFlowStatementDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#BasisOfPresentationAdditionalInformationDetail" roleURI="http://imtx.com/role/BasisOfPresentationAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#AryaMergerAdditionalInformationDetail" roleURI="http://imtx.com/role/AryaMergerAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ApplicationOfNewAndRevisedInternationalFinancialReportingStandardsSummaryOfApplicationOfNewStandardsDetail" roleURI="http://imtx.com/role/ApplicationOfNewAndRevisedInternationalFinancialReportingStandardsSummaryOfApplicationOfNewStandardsDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ApplicationOfNewAndRevisedInternationalFinancialReportingStandardsSummaryOfNonMandatoryStandardsAndInterpretationsIssuedByIasbDetail" roleURI="http://imtx.com/role/ApplicationOfNewAndRevisedInternationalFinancialReportingStandardsSummaryOfNonMandatoryStandardsAndInterpretationsIssuedByIasbDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail" roleURI="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020SummaryOfUsefulLifeOfIntangibleAssetsOtherThanGoodwillDetail" roleURI="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020SummaryOfUsefulLifeOfIntangibleAssetsOtherThanGoodwillDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020SummaryOfForeignExchangeRatesDetail" roleURI="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020SummaryOfForeignExchangeRatesDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020AdditionalInformationDetail" roleURI="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020AdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#OtherCurrentAndNonCurrentAssetsAdditionalInformationDetails" roleURI="http://imtx.com/role/OtherCurrentAndNonCurrentAssetsAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#PropertyPlantAndEquipmentSummaryOfChangesToPropertyPlantAndEquipmentDetail" roleURI="http://imtx.com/role/PropertyPlantAndEquipmentSummaryOfChangesToPropertyPlantAndEquipmentDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#PropertyPlantAndEquipmentSummaryOfDepreciationExpenseDetail" roleURI="http://imtx.com/role/PropertyPlantAndEquipmentSummaryOfDepreciationExpenseDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#IntangibleAssetsSummaryOfChangesToIntangibleAssetsDetail" roleURI="http://imtx.com/role/IntangibleAssetsSummaryOfChangesToIntangibleAssetsDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#IntangibleAssetsSummaryOfAmortizationExpenseDetail" roleURI="http://imtx.com/role/IntangibleAssetsSummaryOfAmortizationExpenseDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#LeasesSummaryOfRightOfUseAssetsDetail" roleURI="http://imtx.com/role/LeasesSummaryOfRightOfUseAssetsDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#LeasesSummaryOfExpensesRelatedToRightOfUseAssetsAndLeaseLiabilitiesDetail" roleURI="http://imtx.com/role/LeasesSummaryOfExpensesRelatedToRightOfUseAssetsAndLeaseLiabilitiesDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#LeasesAdditionalInformationDetail" roleURI="http://imtx.com/role/LeasesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#RevenueFromCollaborationAgreementsAdditionalInformationDetail" roleURI="http://imtx.com/role/RevenueFromCollaborationAgreementsAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#OtherCurrentLiabilitiesSummaryOfOtherCurrentLiabilitiesDetail" roleURI="http://imtx.com/role/OtherCurrentLiabilitiesSummaryOfOtherCurrentLiabilitiesDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#OtherCurrentLiabilitiesAdditionalInformationDetail" roleURI="http://imtx.com/role/OtherCurrentLiabilitiesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ShareListingExpenseAdditionalInformationDetail" roleURI="http://imtx.com/role/ShareListingExpenseAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ShareListingExpensesSummaryOfCalculationOfTheShareListingExpenseDetail" roleURI="http://imtx.com/role/ShareListingExpensesSummaryOfCalculationOfTheShareListingExpenseDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ShareBasedPaymentsSummaryOfOptionsGrantedPricedUsingBlackScholesForSarsTandemAwardsConvertedOptionsMatchingStockOptionsAndMonteCarloOptionPricingModelDetail" roleURI="http://imtx.com/role/ShareBasedPaymentsSummaryOfOptionsGrantedPricedUsingBlackScholesForSarsTandemAwardsConvertedOptionsMatchingStockOptionsAndMonteCarloOptionPricingModelDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ShareBasedPaymentsSummaryOfEmployeeShareOptionsDetail" roleURI="http://imtx.com/role/ShareBasedPaymentsSummaryOfEmployeeShareOptionsDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ShareBasedPaymentsSummaryOfActivitiesUnderShareBasedPaymentArrangementDetail" roleURI="http://imtx.com/role/ShareBasedPaymentsSummaryOfActivitiesUnderShareBasedPaymentArrangementDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ShareBasedPaymentsAdditionalInformationDetail" roleURI="http://imtx.com/role/ShareBasedPaymentsAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ShareBasedPaymentsSummaryOfEmployeeRelatedShareBasedCompensationExpenseDetail" roleURI="http://imtx.com/role/ShareBasedPaymentsSummaryOfEmployeeRelatedShareBasedCompensationExpenseDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ShareholdersEquityDeficitAdditionalInformationDetail" roleURI="http://imtx.com/role/ShareholdersEquityDeficitAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#NonControllingInterestsAdditionalInformationDetail" roleURI="http://imtx.com/role/NonControllingInterestsAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#PersonnelExpensesSummaryOfPersonnelExpensesDetail" roleURI="http://imtx.com/role/PersonnelExpensesSummaryOfPersonnelExpensesDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#IncomeTaxSummaryOfDeferredTaxAssetsDetail" roleURI="http://imtx.com/role/IncomeTaxSummaryOfDeferredTaxAssetsDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#IncomeTaxAdditionalInformationDetail" roleURI="http://imtx.com/role/IncomeTaxAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#FinancialRiskManagementObjectivesAndPoliciesSummaryOfCurrencyRiskExposureDetail" roleURI="http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesSummaryOfCurrencyRiskExposureDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#FinancialRiskManagementObjectivesAndPoliciesSummaryOfSensitivityAnalysisOfForeignCurrencyRiskDetail" roleURI="http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesSummaryOfSensitivityAnalysisOfForeignCurrencyRiskDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#FinancialRiskManagementObjectivesAndPoliciesSummaryOfSensitivityAnalysisOfForeignCurrencyRiskParentheticalDetail" roleURI="http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesSummaryOfSensitivityAnalysisOfForeignCurrencyRiskParentheticalDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#FinancialRiskManagementObjectivesAndPoliciesSummaryOfLiquidityRiskDetail" roleURI="http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesSummaryOfLiquidityRiskDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#FinancialRiskManagementObjectivesAndPoliciesAdditionalInformationDetail" roleURI="http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#FinancialInstrumentsSummaryOfCarryingAmountsAndFairValuesOfGroupsFinancialInstrumentsDetail" roleURI="http://imtx.com/role/FinancialInstrumentsSummaryOfCarryingAmountsAndFairValuesOfGroupsFinancialInstrumentsDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#CommitmentsAndContingenciesSummaryOfContractualObligationsDetail" roleURI="http://imtx.com/role/CommitmentsAndContingenciesSummaryOfContractualObligationsDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#CommitmentsAndContingenciesAdditionalInformationDetail" roleURI="http://imtx.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#RelatedPartyDisclosuresSummaryOfCompensationForTheSupervisoryBoardDetail" roleURI="http://imtx.com/role/RelatedPartyDisclosuresSummaryOfCompensationForTheSupervisoryBoardDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#RelatedPartyDisclosuresSummaryOfOptionsGrantedToManagingDirectorAndSupervisoryDirectorsDetail" roleURI="http://imtx.com/role/RelatedPartyDisclosuresSummaryOfOptionsGrantedToManagingDirectorAndSupervisoryDirectorsDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#RelatedPartyDisclosuresAdditionalInformationDetail" roleURI="http://imtx.com/role/RelatedPartyDisclosuresAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ConsolidatedStatementOfFinancialPositionOfImmaticsNV" roleURI="http://imtx.com/role/ConsolidatedStatementOfFinancialPositionOfImmaticsNV" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ConsolidatedStatementOfLossOfImmaticsNV" roleURI="http://imtx.com/role/ConsolidatedStatementOfLossOfImmaticsNV" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ConsolidatedStatementOfComprehensiveLossOfImmaticsNV" roleURI="http://imtx.com/role/ConsolidatedStatementOfComprehensiveLossOfImmaticsNV" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ConsolidatedStatementOfCashFlows" roleURI="http://imtx.com/role/ConsolidatedStatementOfCashFlows" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#GroupInformation" roleURI="http://imtx.com/role/GroupInformation" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#BasisOfPresentation" roleURI="http://imtx.com/role/BasisOfPresentation" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ApplicationOfNewAndRevisedInternationalFinancialReportingStandards" roleURI="http://imtx.com/role/ApplicationOfNewAndRevisedInternationalFinancialReportingStandards" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ApplicationOfNewAndRevisedInternationalFinancialReportingStandardsTables" roleURI="http://imtx.com/role/ApplicationOfNewAndRevisedInternationalFinancialReportingStandardsTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#AccountsReceivable" roleURI="http://imtx.com/role/AccountsReceivable" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#AccountsReceivableTables" roleURI="http://imtx.com/role/AccountsReceivableTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#AccountsReceivableSummaryOfTradeReceivablesDetail" roleURI="http://imtx.com/role/AccountsReceivableSummaryOfTradeReceivablesDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#AccountsReceivableAdditionalInformationDetail" roleURI="http://imtx.com/role/AccountsReceivableAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#OtherCurrentAndNonCurrentAssets" roleURI="http://imtx.com/role/OtherCurrentAndNonCurrentAssets" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#OtherCurrentAndNonCurrentAssetsTables" roleURI="http://imtx.com/role/OtherCurrentAndNonCurrentAssetsTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#PropertyPlantAndEquipment" roleURI="http://imtx.com/role/PropertyPlantAndEquipment" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#PropertyPlantAndEquipmentTables" roleURI="http://imtx.com/role/PropertyPlantAndEquipmentTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020" roleURI="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020Policies" roleURI="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020Policies" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020Tables" roleURI="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020Tables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#SignificantAccountingJudgmentsEstimatesAndAssumptions" roleURI="http://imtx.com/role/SignificantAccountingJudgmentsEstimatesAndAssumptions" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#OtherCurrentAndNonCurrentAssetsSummaryOfOtherCurrentAssetsDetail" roleURI="http://imtx.com/role/OtherCurrentAndNonCurrentAssetsSummaryOfOtherCurrentAssetsDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#OtherCurrentAndNonCurrentAssetsSummaryOfOtherNonCurrentAssetsDetail" roleURI="http://imtx.com/role/OtherCurrentAndNonCurrentAssetsSummaryOfOtherNonCurrentAssetsDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#IntangibleAssets" roleURI="http://imtx.com/role/IntangibleAssets" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#IntangibleAssetsTables" roleURI="http://imtx.com/role/IntangibleAssetsTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#EventsOccurringAfterTheReportingPeriod" roleURI="http://imtx.com/role/EventsOccurringAfterTheReportingPeriod" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#NetLossPerShare" roleURI="http://imtx.com/role/NetLossPerShare" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#Leases" roleURI="http://imtx.com/role/Leases" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#LeasesTables" roleURI="http://imtx.com/role/LeasesTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#LeasesDetailsOfLeaseLiabilitiesDetail" roleURI="http://imtx.com/role/LeasesDetailsOfLeaseLiabilitiesDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#RelatedPartyDisclosures" roleURI="http://imtx.com/role/RelatedPartyDisclosures" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#RelatedPartyDisclosuresTables" roleURI="http://imtx.com/role/RelatedPartyDisclosuresTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#RelatedPartyDisclosuresSummaryOfCompensationOfKeyManagementPersonnelDetail" roleURI="http://imtx.com/role/RelatedPartyDisclosuresSummaryOfCompensationOfKeyManagementPersonnelDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#RelatedPartyDisclosuresSummaryOfCompensationForTheSupervisoryBoardParentheticalDetail" roleURI="http://imtx.com/role/RelatedPartyDisclosuresSummaryOfCompensationForTheSupervisoryBoardParentheticalDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#CommitmentsAndContingencies" roleURI="http://imtx.com/role/CommitmentsAndContingencies" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#CommitmentsAndContingenciesTables" roleURI="http://imtx.com/role/CommitmentsAndContingenciesTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#FinancialInstruments" roleURI="http://imtx.com/role/FinancialInstruments" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#FinancialInstrumentsTables" roleURI="http://imtx.com/role/FinancialInstrumentsTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#AccountsPayable" roleURI="http://imtx.com/role/AccountsPayable" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#AccountsPayableTables" roleURI="http://imtx.com/role/AccountsPayableTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#AccountsPayableSummaryOfAccountsPayableDetail" roleURI="http://imtx.com/role/AccountsPayableSummaryOfAccountsPayableDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#RevenueFromCollaborationAgreements" roleURI="http://imtx.com/role/RevenueFromCollaborationAgreements" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#RevenueFromCollaborationAgreementsSummaryOfDeferredRevenueRelatedToTheCollaborationAgreementsDetail" roleURI="http://imtx.com/role/RevenueFromCollaborationAgreementsSummaryOfDeferredRevenueRelatedToTheCollaborationAgreementsDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#OtherCurrentLiabilities" roleURI="http://imtx.com/role/OtherCurrentLiabilities" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ShareholdersEquityDeficit" roleURI="http://imtx.com/role/ShareholdersEquityDeficit" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#OtherCurrentLiabilitiesTables" roleURI="http://imtx.com/role/OtherCurrentLiabilitiesTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#IncomeTax" roleURI="http://imtx.com/role/IncomeTax" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#IncomeTaxTables" roleURI="http://imtx.com/role/IncomeTaxTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#IncomeTaxSummaryOfReconciliationBetweenTaxesOnIncomeAndExpectedIncomeTaxBenefitDetail" roleURI="http://imtx.com/role/IncomeTaxSummaryOfReconciliationBetweenTaxesOnIncomeAndExpectedIncomeTaxBenefitDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#OtherIncome" roleURI="http://imtx.com/role/OtherIncome" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#OtherIncomeSummaryOfOtherIncomeDetail" roleURI="http://imtx.com/role/OtherIncomeSummaryOfOtherIncomeDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#OtherIncomeAdditionalInformationDetail" roleURI="http://imtx.com/role/OtherIncomeAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ShareListingExpenses" roleURI="http://imtx.com/role/ShareListingExpenses" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ShareListingExpensesTables" roleURI="http://imtx.com/role/ShareListingExpensesTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#PersonnelExpenses" roleURI="http://imtx.com/role/PersonnelExpenses" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#PersonnelExpensesAdditionalInformationDetail" roleURI="http://imtx.com/role/PersonnelExpensesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#NonControllingInterests" roleURI="http://imtx.com/role/NonControllingInterests" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#FinancialRiskManagementObjectivesAndPolicies" roleURI="http://imtx.com/role/FinancialRiskManagementObjectivesAndPolicies" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#FinancialRiskManagementObjectivesAndPoliciesTables" roleURI="http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ShareBasedPayments" roleURI="http://imtx.com/role/ShareBasedPayments" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#FinancialIncomeAndExpenses" roleURI="http://imtx.com/role/FinancialIncomeAndExpenses" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#FinancialIncomeAndExpensesSummaryOfFinanceIncomeAndCostsDetail" roleURI="http://imtx.com/role/FinancialIncomeAndExpensesSummaryOfFinanceIncomeAndCostsDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#FinancialIncomeAndExpensesAdditionalInformationDetail" roleURI="http://imtx.com/role/FinancialIncomeAndExpensesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#BasisOfPresentationTables" roleURI="http://imtx.com/role/BasisOfPresentationTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#AccountsPayableAdditionalInformationDetail" roleURI="http://imtx.com/role/AccountsPayableAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#RevenueFromCollaborationAgreementsTables" roleURI="http://imtx.com/role/RevenueFromCollaborationAgreementsTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#OtherIncomeTables" roleURI="http://imtx.com/role/OtherIncomeTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#FinancialIncomeAndExpensesTables" roleURI="http://imtx.com/role/FinancialIncomeAndExpensesTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#PersonnelExpensesTables" roleURI="http://imtx.com/role/PersonnelExpensesTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#NetLossPerShareAdditionalInformationDetail" roleURI="http://imtx.com/role/NetLossPerShareAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#AryaMerger" roleURI="http://imtx.com/role/AryaMerger" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" />
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/CoverPage">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems_876586" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_868818" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_DocumentType_868818" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_868819" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_AmendmentFlag_868819" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_868820" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_DocumentPeriodEndDate_868820" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_868821" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_DocumentFiscalYearFocus_868821" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_868822" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_DocumentFiscalPeriodFocus_868822" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_868823" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityRegistrantName_868823" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_868824" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityCentralIndexKey_868824" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_868825" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_CurrentFiscalYearEndDate_868825" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_868827" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_868827" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_868828" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityCurrentReportingStatus_868828" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_868829" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityFilerCategory_868829" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_868830" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_868830" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_868831" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityVoluntaryFilers_868831" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_868833" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityShellCompany_868833" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_868834" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityEmergingGrowthCompany_868834" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_868835" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_DocumentAnnualReport_868835" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_868836" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityInteractiveDataCurrent_868836" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_dei_IcfrAuditorAttestationFlag_868838" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_IcfrAuditorAttestationFlag_868838" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_dei_DocumentAccountingStandard_868839" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_DocumentAccountingStandard_868839" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_868899" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityIncorporationStateCountryCode_868899" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_876569" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityFileNumber_876569" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_876597" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_TradingSymbol_876597" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_876601" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_Security12bTitle_876601" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_ContactPersonnelName" xlink:label="loc_dei_ContactPersonnelName_876609" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_ContactPersonnelName_876609" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_876613" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityAddressAddressLine1_876613" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_876614" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityAddressCityOrTown_876614" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_876615" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityAddressStateOrProvince_876615" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_876616" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityAddressCountry_876616" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_876617" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityAddressPostalZipCode_876617" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_876624" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_CityAreaCode_876624" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_876625" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_LocalPhoneNumber_876625" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_dei_DocumentRegistrationStatement_876636" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_DocumentRegistrationStatement_876636" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_dei_DocumentShellCompanyReport_876638" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_DocumentShellCompanyReport_876638" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_876639" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_DocumentTransitionReport_876639" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable_876580" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_DocumentInformationTable_876580" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_876605" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_876580" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_876605" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_876606" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_876605" xlink:to="loc_dei_AddressTypeDomain_876606" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_876606_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_876605" xlink:to="loc_dei_AddressTypeDomain_876606_default" use="optional" order="38" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_BusinessContactMember" xlink:label="loc_dei_BusinessContactMember_876607" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_AddressTypeDomain_876606" xlink:to="loc_dei_BusinessContactMember_876607" use="optional" order="39" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentInformationDocumentAxis" xlink:label="loc_dei_DocumentInformationDocumentAxis_876582" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_876580" xlink:to="loc_dei_DocumentInformationDocumentAxis_876582" use="optional" order="40" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentDomain" xlink:label="loc_dei_DocumentDomain_876583" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_DocumentInformationDocumentAxis_876582" xlink:to="loc_dei_DocumentDomain_876583" use="optional" order="41" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentDomain" xlink:label="loc_dei_DocumentDomain_876583_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_DocumentInformationDocumentAxis_876582" xlink:to="loc_dei_DocumentDomain_876583_default" use="optional" order="42" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_OrdinaryShareMember" xlink:label="loc_imtx_OrdinaryShareMember_876587" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentDomain_876583" xlink:to="loc_imtx_OrdinaryShareMember_876587" use="optional" order="43" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_WarrantsMember" xlink:label="loc_imtx_WarrantsMember_876593" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentDomain_876583" xlink:to="loc_imtx_WarrantsMember_876593" use="optional" order="44" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_876596" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_SecurityExchangeName_876596" use="optional" order="45" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_877955" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityExTransitionPeriod_877955" use="optional" order="46" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/ConsolidatedStatementOfChangesInShareholdersEquityDeficitOfImmaticsNV">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_864826" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_864826" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_864827" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_864826" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_864827" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_864828" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_864827" xlink:to="loc_ifrs-full_EquityMember_864828" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_864828_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_864827" xlink:to="loc_ifrs-full_EquityMember_864828_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_864829" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_864828" xlink:to="loc_ifrs-full_IssuedCapitalMember_864829" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharePremiumMember" xlink:label="loc_ifrs-full_SharePremiumMember_864831" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_864828" xlink:to="loc_ifrs-full_SharePremiumMember_864831" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember_864832" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_864828" xlink:to="loc_ifrs-full_RetainedEarningsMember_864832" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherReservesMember" xlink:label="loc_ifrs-full_OtherReservesMember_864833" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_864828" xlink:to="loc_ifrs-full_OtherReservesMember_864833" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TotalEquityAttributableToShareholdersOfParentMember" xlink:label="loc_imtx_TotalEquityAttributableToShareholdersOfParentMember_864834" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_864828" xlink:to="loc_imtx_TotalEquityAttributableToShareholdersOfParentMember_864834" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncontrollingInterestsMember" xlink:label="loc_ifrs-full_NoncontrollingInterestsMember_864835" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_864828" xlink:to="loc_ifrs-full_NoncontrollingInterestsMember_864835" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_864837" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" xlink:to="loc_ifrs-full_Equity_864837" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_864838" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_864838" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_864839" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" xlink:to="loc_ifrs-full_ProfitLoss_864839" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_864840" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" xlink:to="loc_ifrs-full_ComprehensiveIncome_864840" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_864841" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_864841" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_864842" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" xlink:to="loc_ifrs-full_IssueOfEquity_864842" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncreasedecreaseThroughCompensationExpense" xlink:label="loc_imtx_IncreasedecreaseThroughCompensationExpense_864843" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" xlink:to="loc_imtx_IncreasedecreaseThroughCompensationExpense_864843" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncreaseDecreaseThroughReorganizationEquity" xlink:label="loc_imtx_IncreaseDecreaseThroughReorganizationEquity_864845" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" xlink:to="loc_imtx_IncreaseDecreaseThroughReorganizationEquity_864845" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest" xlink:label="loc_imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest_864846" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" xlink:to="loc_imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest_864846" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners_864847" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners_864847" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncreaseThroughARYAMerger" xlink:label="loc_imtx_IncreaseThroughARYAMerger_864848" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" xlink:to="loc_imtx_IncreaseThroughARYAMerger_864848" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_SARConversion" xlink:label="loc_imtx_SARConversion_864849" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" xlink:to="loc_imtx_SARConversion_864849" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncreasedecreaseThroughIssuanceOfEquity" xlink:label="loc_imtx_IncreasedecreaseThroughIssuanceOfEquity_864850" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" xlink:to="loc_imtx_IncreasedecreaseThroughIssuanceOfEquity_864850" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncreasedecreaseThroughShareBasedCompensationPreviouslyClassifiesAsEquitySettled" xlink:label="loc_imtx_IncreasedecreaseThroughShareBasedCompensationPreviouslyClassifiesAsEquitySettled_864852" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" xlink:to="loc_imtx_IncreasedecreaseThroughShareBasedCompensationPreviouslyClassifiesAsEquitySettled_864852" use="optional" order="24" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/ShareBasedPaymentsTables">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsLineItems" xlink:label="loc_imtx_StatementsLineItems_867239" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_867234" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867239" xlink:to="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_867234" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsTable" xlink:label="loc_imtx_StatementsTable_867236" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imtx_StatementsLineItems_867239" xlink:to="loc_imtx_StatementsTable_867236" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_867240" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_StatementsTable_867236" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_867240" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_867241" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_867240" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_867241" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_867241_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_867240" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_867241_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShareAppreciationRightsMember" xlink:label="loc_imtx_ShareAppreciationRightsMember_867242" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_867241" xlink:to="loc_imtx_ShareAppreciationRightsMember_867242" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MatchingStockOptionsMember" xlink:label="loc_imtx_MatchingStockOptionsMember_867427" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_867241" xlink:to="loc_imtx_MatchingStockOptionsMember_867427" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ConvertedOptionsMember" xlink:label="loc_imtx_ConvertedOptionsMember_867429" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_867241" xlink:to="loc_imtx_ConvertedOptionsMember_867429" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember" xlink:label="loc_imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember_867431" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_867241" xlink:to="loc_imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember_867431" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PerformanceBasedOptionsMember" xlink:label="loc_imtx_PerformanceBasedOptionsMember_867434" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_867241" xlink:to="loc_imtx_PerformanceBasedOptionsMember_867434" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TwoThousandAndSixteenTandemAwardsMember" xlink:label="loc_imtx_TwoThousandAndSixteenTandemAwardsMember_870738" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_867241" xlink:to="loc_imtx_TwoThousandAndSixteenTandemAwardsMember_870738" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory_867251" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867239" xlink:to="loc_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory_867251" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTextBlock" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTextBlock_870758" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867239" xlink:to="loc_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTextBlock_870758" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureDetailsOfActivitiesUnderShareBasedPaymentArrangementTextBlock" xlink:label="loc_imtx_DisclosureDetailsOfActivitiesUnderShareBasedPaymentArrangementTextBlock_870759" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867239" xlink:to="loc_imtx_DisclosureDetailsOfActivitiesUnderShareBasedPaymentArrangementTextBlock_870759" use="optional" order="14" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/GroupInformationAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_864862" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_864858" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_864862" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_864858" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_864859" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_864858" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_864859" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_864860" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_864859" xlink:to="loc_ifrs-full_NonadjustingEventsMember_864860" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_864860_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_864859" xlink:to="loc_ifrs-full_NonadjustingEventsMember_864860_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AuthorizationOfFinancialStatementsMember" xlink:label="loc_imtx_AuthorizationOfFinancialStatementsMember_864861" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsMember_864860" xlink:to="loc_imtx_AuthorizationOfFinancialStatementsMember_864861" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DateOfAuthorisationForIssueOfFinancialStatements2013" xlink:label="loc_ifrs-full_DateOfAuthorisationForIssueOfFinancialStatements2013_864863" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_864862" xlink:to="loc_ifrs-full_DateOfAuthorisationForIssueOfFinancialStatements2013_864863" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DateOfEndOfReportingPeriod2013" xlink:label="loc_ifrs-full_DateOfEndOfReportingPeriod2013_864864" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_864862" xlink:to="loc_ifrs-full_DateOfEndOfReportingPeriod2013_864864" use="optional" order="7" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/BasisOfPresentationSummaryOfReconciliationOfChangesInCashFlowStatementDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementLineItems" xlink:label="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementLineItems_864885" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementTable" xlink:label="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementTable_864878" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementLineItems_864885" xlink:to="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementTable_864878" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:label="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_864879" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementTable_864878" xlink:to="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_864879" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RestatedMember" xlink:label="loc_ifrs-full_RestatedMember_864880" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_864879" xlink:to="loc_ifrs-full_RestatedMember_864880" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RestatedMember" xlink:label="loc_ifrs-full_RestatedMember_864880_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_864879" xlink:to="loc_ifrs-full_RestatedMember_864880_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PreviouslyStatedMember" xlink:label="loc_ifrs-full_PreviouslyStatedMember_864881" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RestatedMember_864880" xlink:to="loc_ifrs-full_PreviouslyStatedMember_864881" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:label="loc_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember_864884" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RestatedMember_864880" xlink:to="loc_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember_864884" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_864886" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementLineItems_864885" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_864886" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_864887" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementLineItems_864885" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_864887" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_864888" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementLineItems_864885" xlink:to="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_864888" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_864889" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementLineItems_864885" xlink:to="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_864889" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_864890" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementLineItems_864885" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_864890" use="optional" order="11" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/BasisOfPresentationAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_864901" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_864895" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_864901" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_864895" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_864898" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_864895" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_864898" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_864899" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_864898" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_864899" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_864899_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_864898" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_864899_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ImmaticsUsIncMember" xlink:label="loc_imtx_ImmaticsUsIncMember_864900" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_864899" xlink:to="loc_imtx_ImmaticsUsIncMember_864900" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_864902" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_864901" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_864902" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherCurrentFinancialAssets" xlink:label="loc_ifrs-full_OtherCurrentFinancialAssets_864903" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_864901" xlink:to="loc_ifrs-full_OtherCurrentFinancialAssets_864903" use="optional" order="7" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/AryaMergerAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_864926" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_864909" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_864926" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_864909" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_864910" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_864909" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_864910" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_864911" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_864910" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_864911" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_864911_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_864910" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_864911_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AryaMember" xlink:label="loc_imtx_AryaMember_864912" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_864911" xlink:to="loc_imtx_AryaMember_864912" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfOrdinarySharesAxis" xlink:label="loc_ifrs-full_ClassesOfOrdinarySharesAxis_864913" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_864909" xlink:to="loc_ifrs-full_ClassesOfOrdinarySharesAxis_864913" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_864922" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_864921" xlink:to="loc_ifrs-full_OrdinarySharesMember_864922" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_864914" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfOrdinarySharesAxis_864913" xlink:to="loc_ifrs-full_OrdinarySharesMember_864914" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_864914_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfOrdinarySharesAxis_864913" xlink:to="loc_ifrs-full_OrdinarySharesMember_864914_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PipeFinancingMember" xlink:label="loc_imtx_PipeFinancingMember_864915" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_OrdinarySharesMember_864914" xlink:to="loc_imtx_PipeFinancingMember_864915" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_864916" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_864909" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_864916" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_864917" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_864916" xlink:to="loc_ifrs-full_EquityMember_864917" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_864917_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_864916" xlink:to="loc_ifrs-full_EquityMember_864917_default" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_864918" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_864917" xlink:to="loc_ifrs-full_IssuedCapitalMember_864918" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharePremiumMember" xlink:label="loc_ifrs-full_SharePremiumMember_864919" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_864917" xlink:to="loc_ifrs-full_SharePremiumMember_864919" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_864920" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_864909" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_864920" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_864921" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_864920" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_864921" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_864921_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_864920" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_864921_default" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_864923" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_864909" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_864923" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_864924" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_864923" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_864924" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_864924_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_864923" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_864924_default" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_WarrantsMember" xlink:label="loc_imtx_WarrantsMember_864925" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_864924" xlink:to="loc_imtx_WarrantsMember_864925" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncreaseDecreaseThroughReorganizationEquity" xlink:label="loc_imtx_IncreaseDecreaseThroughReorganizationEquity_864928" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_864926" xlink:to="loc_imtx_IncreaseDecreaseThroughReorganizationEquity_864928" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest" xlink:label="loc_imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest_864929" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_864926" xlink:to="loc_imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest_864929" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfHowAcquirerObtainedControlOfAcquiree" xlink:label="loc_ifrs-full_DescriptionOfHowAcquirerObtainedControlOfAcquiree_864930" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_864926" xlink:to="loc_ifrs-full_DescriptionOfHowAcquirerObtainedControlOfAcquiree_864930" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable" xlink:label="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_864931" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_864926" xlink:to="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_864931" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_864932" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_864926" xlink:to="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_864932" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_864933" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_864926" xlink:to="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_864933" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate_864934" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_864926" xlink:to="loc_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate_864934" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShareListingExpense" xlink:label="loc_imtx_ShareListingExpense_864935" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_864926" xlink:to="loc_imtx_ShareListingExpense_864935" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_864936" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_864926" xlink:to="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_864936" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners_864937" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_864926" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners_864937" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_864938" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_864926" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_864938" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts_876651" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_864926" xlink:to="loc_ifrs-full_PaymentsForShareIssueCosts_876651" use="optional" order="34" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/ApplicationOfNewAndRevisedInternationalFinancialReportingStandardsSummaryOfApplicationOfNewStandardsDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems_864957" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTable" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTable_864950" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems_864957" xlink:to="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTable_864950" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NewIFRSsAxis" xlink:label="loc_ifrs-full_NewIFRSsAxis_864951" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTable_864950" xlink:to="loc_ifrs-full_NewIFRSsAxis_864951" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NewIFRSsMember" xlink:label="loc_ifrs-full_NewIFRSsMember_864952" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NewIFRSsAxis_864951" xlink:to="loc_ifrs-full_NewIFRSsMember_864952" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NewIFRSsMember" xlink:label="loc_ifrs-full_NewIFRSsMember_864952_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NewIFRSsAxis_864951" xlink:to="loc_ifrs-full_NewIFRSsMember_864952_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AmendmentsToIfrsThreeMember" xlink:label="loc_imtx_AmendmentsToIfrsThreeMember_864953" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NewIFRSsMember_864952" xlink:to="loc_imtx_AmendmentsToIfrsThreeMember_864953" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AmendmentsToIasOneAndIasEightMember" xlink:label="loc_imtx_AmendmentsToIasOneAndIasEightMember_864954" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NewIFRSsMember_864952" xlink:to="loc_imtx_AmendmentsToIasOneAndIasEightMember_864954" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AmendmentsToConceptualFrameworkMember" xlink:label="loc_imtx_AmendmentsToConceptualFrameworkMember_864956" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NewIFRSsMember_864952" xlink:to="loc_imtx_AmendmentsToConceptualFrameworkMember_864956" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AmendmentsToIfrsNineIasThirtyNineAndIfrsSeventeenMember" xlink:label="loc_imtx_AmendmentsToIfrsNineIasThirtyNineAndIfrsSeventeenMember_864955" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NewIFRSsMember_864952" xlink:to="loc_imtx_AmendmentsToIfrsNineIasThirtyNineAndIfrsSeventeenMember_864955" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DateByWhichApplicationOfNewIFRSIsRequired" xlink:label="loc_ifrs-full_DateByWhichApplicationOfNewIFRSIsRequired_864959" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems_864957" xlink:to="loc_ifrs-full_DateByWhichApplicationOfNewIFRSIsRequired_864959" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TitleOfNewIFRS" xlink:label="loc_ifrs-full_TitleOfNewIFRS_864958" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems_864957" xlink:to="loc_ifrs-full_TitleOfNewIFRS_864958" use="optional" order="10" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/ApplicationOfNewAndRevisedInternationalFinancialReportingStandardsSummaryOfNonMandatoryStandardsAndInterpretationsIssuedByIasbDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems_864968" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TitleOfNewIFRS" xlink:label="loc_ifrs-full_TitleOfNewIFRS_864969" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems_864968" xlink:to="loc_ifrs-full_TitleOfNewIFRS_864969" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DateByWhichApplicationOfNewIFRSIsRequired" xlink:label="loc_ifrs-full_DateByWhichApplicationOfNewIFRSIsRequired_864970" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems_864968" xlink:to="loc_ifrs-full_DateByWhichApplicationOfNewIFRSIsRequired_864970" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTable" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTable_864962" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems_864968" xlink:to="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTable_864962" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NewIFRSsAxis" xlink:label="loc_ifrs-full_NewIFRSsAxis_864963" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTable_864962" xlink:to="loc_ifrs-full_NewIFRSsAxis_864963" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NewIFRSsMember" xlink:label="loc_ifrs-full_NewIFRSsMember_864964" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NewIFRSsAxis_864963" xlink:to="loc_ifrs-full_NewIFRSsMember_864964" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NewIFRSsMember" xlink:label="loc_ifrs-full_NewIFRSsMember_864964_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NewIFRSsAxis_864963" xlink:to="loc_ifrs-full_NewIFRSsMember_864964_default" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AmendmentsToIasOneMember" xlink:label="loc_imtx_AmendmentsToIasOneMember_864966" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NewIFRSsMember_864964" xlink:to="loc_imtx_AmendmentsToIasOneMember_864966" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IfrsSeventeenMember" xlink:label="loc_imtx_IfrsSeventeenMember_864967" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NewIFRSsMember_864964" xlink:to="loc_imtx_IfrsSeventeenMember_864967" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IfrsSixteenMember" xlink:label="loc_imtx_IfrsSixteenMember_870158" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NewIFRSsMember_864964" xlink:to="loc_imtx_IfrsSixteenMember_870158" use="optional" order="9" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesLineItems" xlink:label="loc_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesLineItems_866253" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesTable" xlink:label="loc_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesTable_866243" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesLineItems_866253" xlink:to="loc_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesTable_866243" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_866244" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesTable_866243" xlink:to="loc_ifrs-full_RangeAxis_866244" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_866245" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_866244" xlink:to="loc_ifrs-full_RangesMember_866245" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_866245_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_866244" xlink:to="loc_ifrs-full_RangesMember_866245_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_866246" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_866245" xlink:to="loc_ifrs-full_BottomOfRangeMember_866246" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_866247" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_866245" xlink:to="loc_ifrs-full_TopOfRangeMember_866247" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_866248" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesTable_866243" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_866248" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_866249" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_866248" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_866249" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_866249_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_866248" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_866249_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_866250" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_866249" xlink:to="loc_ifrs-full_ComputerEquipmentMember_866250" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_LaboratoryEquipmentMember" xlink:label="loc_imtx_LaboratoryEquipmentMember_866251" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_866249" xlink:to="loc_imtx_LaboratoryEquipmentMember_866251" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="loc_ifrs-full_OfficeEquipmentMember_866252" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_866249" xlink:to="loc_ifrs-full_OfficeEquipmentMember_866252" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_866257" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesLineItems_866253" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_866257" use="optional" order="13" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020SummaryOfUsefulLifeOfIntangibleAssetsOtherThanGoodwillDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillLineItems" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillLineItems_866271" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillTable" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillTable_866262" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillLineItems_866271" xlink:to="loc_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillTable_866262" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_866263" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillTable_866262" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_866263" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_866264" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_866263" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_866264" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_866264_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_866263" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_866264_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LicencesMember" xlink:label="loc_ifrs-full_LicencesMember_866265" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_866264" xlink:to="loc_ifrs-full_LicencesMember_866265" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComputerSoftwareMember" xlink:label="loc_ifrs-full_ComputerSoftwareMember_866266" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_866264" xlink:to="loc_ifrs-full_ComputerSoftwareMember_866266" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_866267" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillTable_866262" xlink:to="loc_ifrs-full_RangeAxis_866267" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_866268" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_866267" xlink:to="loc_ifrs-full_RangesMember_866268" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_866268_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_866267" xlink:to="loc_ifrs-full_RangesMember_866268_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_866269" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_866268" xlink:to="loc_ifrs-full_BottomOfRangeMember_866269" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_866270" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_866268" xlink:to="loc_ifrs-full_TopOfRangeMember_866270" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_866272" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillLineItems_866271" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_866272" use="optional" order="12" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020SummaryOfForeignExchangeRatesDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesLineItems" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesLineItems_866276" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesTable" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesTable_866275" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesLineItems_866276" xlink:to="loc_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesTable_866275" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClosingForeignExchangeRate" xlink:label="loc_ifrs-full_ClosingForeignExchangeRate_866279" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesLineItems_866276" xlink:to="loc_ifrs-full_ClosingForeignExchangeRate_866279" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AverageForeignExchangeRate" xlink:label="loc_ifrs-full_AverageForeignExchangeRate_866280" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesLineItems_866276" xlink:to="loc_ifrs-full_AverageForeignExchangeRate_866280" use="optional" order="3" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020AdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsLineItems" xlink:label="loc_imtx_StatementsLineItems_866289" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsTable" xlink:label="loc_imtx_StatementsTable_866284" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imtx_StatementsLineItems_866289" xlink:to="loc_imtx_StatementsTable_866284" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_870942" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_StatementsTable_866284" xlink:to="loc_ifrs-full_RangeAxis_870942" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_870943" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_870942" xlink:to="loc_ifrs-full_RangesMember_870943" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_870943_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_870942" xlink:to="loc_ifrs-full_RangesMember_870943_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_870944" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_870943" xlink:to="loc_ifrs-full_BottomOfRangeMember_870944" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_870945" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_870943" xlink:to="loc_ifrs-full_TopOfRangeMember_870945" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_RentalContractTerm" xlink:label="loc_imtx_RentalContractTerm_866291" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_866289" xlink:to="loc_imtx_RentalContractTerm_866291" use="optional" order="7" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/OtherCurrentAndNonCurrentAssetsAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_866343" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_866339" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_866343" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_866339" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CollaborationAgreementAxis" xlink:label="loc_imtx_CollaborationAgreementAxis_866340" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_866339" xlink:to="loc_imtx_CollaborationAgreementAxis_866340" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CollaborationAgreementMember" xlink:label="loc_imtx_CollaborationAgreementMember_866341" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imtx_CollaborationAgreementAxis_866340" xlink:to="loc_imtx_CollaborationAgreementMember_866341" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CollaborationAgreementMember" xlink:label="loc_imtx_CollaborationAgreementMember_866341_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imtx_CollaborationAgreementAxis_866340" xlink:to="loc_imtx_CollaborationAgreementMember_866341_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CelgeneSwitzerlandLlcAndGenmabAsMember" xlink:label="loc_imtx_CelgeneSwitzerlandLlcAndGenmabAsMember_866342" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_CollaborationAgreementMember_866341" xlink:to="loc_imtx_CelgeneSwitzerlandLlcAndGenmabAsMember_866342" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_BalanceSheetLocationAxis" xlink:label="loc_imtx_BalanceSheetLocationAxis_870968" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_866339" xlink:to="loc_imtx_BalanceSheetLocationAxis_870968" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_BalanceSheetLocationDomain" xlink:label="loc_imtx_BalanceSheetLocationDomain_870969" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imtx_BalanceSheetLocationAxis_870968" xlink:to="loc_imtx_BalanceSheetLocationDomain_870969" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_BalanceSheetLocationDomain" xlink:label="loc_imtx_BalanceSheetLocationDomain_870969_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imtx_BalanceSheetLocationAxis_870968" xlink:to="loc_imtx_BalanceSheetLocationDomain_870969_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ReceivablesFromCapitalGainsTaxMember" xlink:label="loc_imtx_ReceivablesFromCapitalGainsTaxMember_870970" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_BalanceSheetLocationDomain_870969" xlink:to="loc_imtx_ReceivablesFromCapitalGainsTaxMember_870970" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CurrentPrepaidInsurance" xlink:label="loc_imtx_CurrentPrepaidInsurance_866344" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_866343" xlink:to="loc_imtx_CurrentPrepaidInsurance_866344" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CurrentIncrementalCostForCollaborationAgreement" xlink:label="loc_imtx_CurrentIncrementalCostForCollaborationAgreement_866345" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_866343" xlink:to="loc_imtx_CurrentIncrementalCostForCollaborationAgreement_866345" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PrepaidExpensesOfLicensesAndSoftware" xlink:label="loc_imtx_PrepaidExpensesOfLicensesAndSoftware_866346" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_866343" xlink:to="loc_imtx_PrepaidExpensesOfLicensesAndSoftware_866346" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherAssets" xlink:label="loc_ifrs-full_OtherAssets_866348" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_866343" xlink:to="loc_ifrs-full_OtherAssets_866348" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentPrepayments" xlink:label="loc_ifrs-full_NoncurrentPrepayments_866349" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_866343" xlink:to="loc_ifrs-full_NoncurrentPrepayments_866349" use="optional" order="14" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/PropertyPlantAndEquipmentSummaryOfChangesToPropertyPlantAndEquipmentDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_866365" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_866354" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_866365" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_866354" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_866355" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_866354" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_866355" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_866356" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_866355" xlink:to="loc_ifrs-full_CarryingAmountMember_866356" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_866356_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_866355" xlink:to="loc_ifrs-full_CarryingAmountMember_866356_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_866357" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_866356" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_866357" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_866364" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_866356" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_866364" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TypeOfAdoptionsAxis" xlink:label="loc_imtx_TypeOfAdoptionsAxis_866358" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_866354" xlink:to="loc_imtx_TypeOfAdoptionsAxis_866358" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TypeOfAdoptionsMember" xlink:label="loc_imtx_TypeOfAdoptionsMember_866359" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imtx_TypeOfAdoptionsAxis_866358" xlink:to="loc_imtx_TypeOfAdoptionsMember_866359" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TypeOfAdoptionsMember" xlink:label="loc_imtx_TypeOfAdoptionsMember_866359_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imtx_TypeOfAdoptionsAxis_866358" xlink:to="loc_imtx_TypeOfAdoptionsMember_866359_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AdjustmentOnAdoptionIfrsSixteenMember" xlink:label="loc_imtx_AdjustmentOnAdoptionIfrsSixteenMember_866360" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_TypeOfAdoptionsMember_866359" xlink:to="loc_imtx_AdjustmentOnAdoptionIfrsSixteenMember_866360" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:label="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_866361" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_866354" xlink:to="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_866361" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RestatedMember" xlink:label="loc_ifrs-full_RestatedMember_866362" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_866361" xlink:to="loc_ifrs-full_RestatedMember_866362" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RestatedMember" xlink:label="loc_ifrs-full_RestatedMember_866362_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_866361" xlink:to="loc_ifrs-full_RestatedMember_866362_default" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PreviouslyStatedMember" xlink:label="loc_ifrs-full_PreviouslyStatedMember_866363" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RestatedMember_866362" xlink:to="loc_ifrs-full_PreviouslyStatedMember_866363" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_866367" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_866354" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_866367" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_866368" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_866367" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_866368" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_866368_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_866367" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_866368_default" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_LaboratoryEquipmentMember" xlink:label="loc_imtx_LaboratoryEquipmentMember_866369" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_866368" xlink:to="loc_imtx_LaboratoryEquipmentMember_866369" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_866370" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_866368" xlink:to="loc_ifrs-full_ComputerEquipmentMember_866370" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="loc_ifrs-full_OfficeEquipmentMember_866371" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_866368" xlink:to="loc_ifrs-full_OfficeEquipmentMember_866371" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_866372" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_866365" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_866372" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AdditionsOtherPropertyPlantAndEquipment" xlink:label="loc_imtx_AdditionsOtherPropertyPlantAndEquipment_870282" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_866365" xlink:to="loc_imtx_AdditionsOtherPropertyPlantAndEquipment_870282" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisposalsOfPropertyPlantAndEquipment" xlink:label="loc_imtx_DisposalsOfPropertyPlantAndEquipment_870283" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_866365" xlink:to="loc_imtx_DisposalsOfPropertyPlantAndEquipment_870283" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CurrencyTranslationDifferences" xlink:label="loc_imtx_CurrencyTranslationDifferences_870289" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_866365" xlink:to="loc_imtx_CurrencyTranslationDifferences_870289" use="optional" order="24" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/PropertyPlantAndEquipmentSummaryOfDepreciationExpenseDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_865037" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_865032" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_865037" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_865032" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncomeStatementLocationAxis" xlink:label="loc_imtx_IncomeStatementLocationAxis_865033" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_865032" xlink:to="loc_imtx_IncomeStatementLocationAxis_865033" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncomeStatementLocationMember" xlink:label="loc_imtx_IncomeStatementLocationMember_865034" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imtx_IncomeStatementLocationAxis_865033" xlink:to="loc_imtx_IncomeStatementLocationMember_865034" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncomeStatementLocationMember" xlink:label="loc_imtx_IncomeStatementLocationMember_865034_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imtx_IncomeStatementLocationAxis_865033" xlink:to="loc_imtx_IncomeStatementLocationMember_865034_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ResearchAndDevelopmentExpenseMember" xlink:label="loc_imtx_ResearchAndDevelopmentExpenseMember_865035" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_IncomeStatementLocationMember_865034" xlink:to="loc_imtx_ResearchAndDevelopmentExpenseMember_865035" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GeneralAndAdministrativeExpenseMember" xlink:label="loc_imtx_GeneralAndAdministrativeExpenseMember_865036" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_IncomeStatementLocationMember_865034" xlink:to="loc_imtx_GeneralAndAdministrativeExpenseMember_865036" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_865038" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_865037" xlink:to="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_865038" use="optional" order="7" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/IntangibleAssetsSummaryOfChangesToIntangibleAssetsDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_866431" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_866422" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_866431" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_866422" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_866424" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_866422" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_866424" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_866425" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_866424" xlink:to="loc_ifrs-full_CarryingAmountMember_866425" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_866425_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_866424" xlink:to="loc_ifrs-full_CarryingAmountMember_866425_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_866427" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_866425" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_866427" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AccumulatedImpairmentMember" xlink:label="loc_ifrs-full_AccumulatedImpairmentMember_866428" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_866425" xlink:to="loc_ifrs-full_AccumulatedImpairmentMember_866428" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_866445" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_866422" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_866445" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_866447" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_866445" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_866447" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_866447_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_866445" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_866447_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PatentAndLicensesMember" xlink:label="loc_imtx_PatentAndLicensesMember_866448" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_866447" xlink:to="loc_imtx_PatentAndLicensesMember_866448" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_SoftwareLicensesMember" xlink:label="loc_imtx_SoftwareLicensesMember_866449" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_866447" xlink:to="loc_imtx_SoftwareLicensesMember_866449" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_866435" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_866431" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwill_866435" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_866437" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_866431" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_866437" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_866439" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_866431" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_866439" use="optional" order="14" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/IntangibleAssetsSummaryOfAmortizationExpenseDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_866457" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_866452" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_866457" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_866452" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncomeStatementLocationAxis" xlink:label="loc_imtx_IncomeStatementLocationAxis_866453" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_866452" xlink:to="loc_imtx_IncomeStatementLocationAxis_866453" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncomeStatementLocationMember" xlink:label="loc_imtx_IncomeStatementLocationMember_866454" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imtx_IncomeStatementLocationAxis_866453" xlink:to="loc_imtx_IncomeStatementLocationMember_866454" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncomeStatementLocationMember" xlink:label="loc_imtx_IncomeStatementLocationMember_866454_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imtx_IncomeStatementLocationAxis_866453" xlink:to="loc_imtx_IncomeStatementLocationMember_866454_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ResearchAndDevelopmentExpenseMember" xlink:label="loc_imtx_ResearchAndDevelopmentExpenseMember_866455" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_IncomeStatementLocationMember_866454" xlink:to="loc_imtx_ResearchAndDevelopmentExpenseMember_866455" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GeneralAndAdministrativeExpenseMember" xlink:label="loc_imtx_GeneralAndAdministrativeExpenseMember_866456" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_IncomeStatementLocationMember_866454" xlink:to="loc_imtx_GeneralAndAdministrativeExpenseMember_866456" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_866458" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_866457" xlink:to="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_866458" use="optional" order="7" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/LeasesSummaryOfRightOfUseAssetsDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_866493" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_866485" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_866493" xlink:to="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_866485" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_866486" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_866485" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_866486" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_866487" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_866486" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_866487" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_866487_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_866486" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_866487_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_866488" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_866487" xlink:to="loc_ifrs-full_BuildingsMember_866488" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CommunicationAndNetworkEquipmentMember" xlink:label="loc_ifrs-full_CommunicationAndNetworkEquipmentMember_866490" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_866487" xlink:to="loc_ifrs-full_CommunicationAndNetworkEquipmentMember_866490" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_VehiclesMember" xlink:label="loc_ifrs-full_VehiclesMember_866491" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_866487" xlink:to="loc_ifrs-full_VehiclesMember_866491" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherAssetsMember" xlink:label="loc_ifrs-full_OtherAssetsMember_866492" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_866487" xlink:to="loc_ifrs-full_OtherAssetsMember_866492" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_866494" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_866493" xlink:to="loc_ifrs-full_RightofuseAssets_866494" use="optional" order="9" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/LeasesSummaryOfExpensesRelatedToRightOfUseAssetsAndLeaseLiabilitiesDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesLineItems" xlink:label="loc_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesLineItems_866517" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesTable" xlink:label="loc_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesTable_866507" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesLineItems_866517" xlink:to="loc_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesTable_866507" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_866508" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesTable_866507" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_866508" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_866509" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_866508" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_866509" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_866509_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_866508" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_866509_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_866511" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_866509" xlink:to="loc_ifrs-full_BuildingsMember_866511" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CommunicationAndNetworkEquipmentMember" xlink:label="loc_ifrs-full_CommunicationAndNetworkEquipmentMember_866512" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_866509" xlink:to="loc_ifrs-full_CommunicationAndNetworkEquipmentMember_866512" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_VehiclesMember" xlink:label="loc_ifrs-full_VehiclesMember_866513" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_866509" xlink:to="loc_ifrs-full_VehiclesMember_866513" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherAssetsMember" xlink:label="loc_ifrs-full_OtherAssetsMember_866515" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_866509" xlink:to="loc_ifrs-full_OtherAssetsMember_866515" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets_866522" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesLineItems_866517" xlink:to="loc_ifrs-full_DepreciationRightofuseAssets_866522" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:label="loc_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_866524" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesLineItems_866517" xlink:to="loc_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_866524" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_InterestExpenseOnLease" xlink:label="loc_imtx_InterestExpenseOnLease_870408" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesLineItems_866517" xlink:to="loc_imtx_InterestExpenseOnLease_870408" use="optional" order="11" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/LeasesAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_866549" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:label="loc_ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable_866542" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_866549" xlink:to="loc_ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable_866542" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_866543" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable_866542" xlink:to="loc_ifrs-full_MaturityAxis_866543" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_866544" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_866543" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_866544" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_866544_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_866543" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_866544_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LaterThanOneYearMember" xlink:label="loc_ifrs-full_LaterThanOneYearMember_866546" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_866544" xlink:to="loc_ifrs-full_LaterThanOneYearMember_866546" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_876339" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_866544" xlink:to="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_876339" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="loc_ifrs-full_AdditionsToRightofuseAssets_866550" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_866549" xlink:to="loc_ifrs-full_AdditionsToRightofuseAssets_866550" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TranslationDifferenceOnRightOfUseAsset" xlink:label="loc_imtx_TranslationDifferenceOnRightOfUseAsset_866551" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_866549" xlink:to="loc_imtx_TranslationDifferenceOnRightOfUseAsset_866551" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashOutflowForLeases" xlink:label="loc_ifrs-full_CashOutflowForLeases_866552" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_866549" xlink:to="loc_ifrs-full_CashOutflowForLeases_866552" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_876337" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_866549" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_876337" use="optional" order="10" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/RevenueFromCollaborationAgreementsAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfRevenueFromContractWithCustomersLineItems" xlink:label="loc_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems_866856" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfRevenueFromContractWithCustomersTable" xlink:label="loc_imtx_DisclosureOfRevenueFromContractWithCustomersTable_866827" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems_866856" xlink:to="loc_imtx_DisclosureOfRevenueFromContractWithCustomersTable_866827" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AgreementAxis" xlink:label="loc_imtx_AgreementAxis_866839" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_DisclosureOfRevenueFromContractWithCustomersTable_866827" xlink:to="loc_imtx_AgreementAxis_866839" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AgreementDomain" xlink:label="loc_imtx_AgreementDomain_866840" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imtx_AgreementAxis_866839" xlink:to="loc_imtx_AgreementDomain_866840" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AgreementDomain" xlink:label="loc_imtx_AgreementDomain_866840_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imtx_AgreementAxis_866839" xlink:to="loc_imtx_AgreementDomain_866840_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AmgenCollaborationAgreementMember" xlink:label="loc_imtx_AmgenCollaborationAgreementMember_866841" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_AgreementDomain_866840" xlink:to="loc_imtx_AmgenCollaborationAgreementMember_866841" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GenmabCollaborationAgreementMember" xlink:label="loc_imtx_GenmabCollaborationAgreementMember_866852" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_AgreementDomain_866840" xlink:to="loc_imtx_GenmabCollaborationAgreementMember_866852" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_BMSCollaborationAgreementMember" xlink:label="loc_imtx_BMSCollaborationAgreementMember_866853" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_AgreementDomain_866840" xlink:to="loc_imtx_BMSCollaborationAgreementMember_866853" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GSKCollaborationAgreementMember" xlink:label="loc_imtx_GSKCollaborationAgreementMember_866889" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_AgreementDomain_866840" xlink:to="loc_imtx_GSKCollaborationAgreementMember_866889" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MilestoneAxis" xlink:label="loc_imtx_MilestoneAxis_866842" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_DisclosureOfRevenueFromContractWithCustomersTable_866827" xlink:to="loc_imtx_MilestoneAxis_866842" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MilestoneDomain" xlink:label="loc_imtx_MilestoneDomain_866843" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imtx_MilestoneAxis_866842" xlink:to="loc_imtx_MilestoneDomain_866843" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MilestoneDomain" xlink:label="loc_imtx_MilestoneDomain_866843_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imtx_MilestoneAxis_866842" xlink:to="loc_imtx_MilestoneDomain_866843_default" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DevelopmentAndCommercialMilestonePaymentsMember" xlink:label="loc_imtx_DevelopmentAndCommercialMilestonePaymentsMember_866844" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_MilestoneDomain_866843" xlink:to="loc_imtx_DevelopmentAndCommercialMilestonePaymentsMember_866844" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MilestonePaymentForLicensedProductMember" xlink:label="loc_imtx_MilestonePaymentForLicensedProductMember_866882" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_MilestoneDomain_866843" xlink:to="loc_imtx_MilestonePaymentForLicensedProductMember_866882" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MilestoneProgramsBasedOnTheProgramMember" xlink:label="loc_imtx_MilestoneProgramsBasedOnTheProgramMember_866895" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_MilestoneDomain_866843" xlink:to="loc_imtx_MilestoneProgramsBasedOnTheProgramMember_866895" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_OptionExerciseDevelopmentCommecialAndRegulatoryMilestonePaymentsMember" xlink:label="loc_imtx_OptionExerciseDevelopmentCommecialAndRegulatoryMilestonePaymentsMember_870580" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_MilestoneDomain_866843" xlink:to="loc_imtx_OptionExerciseDevelopmentCommecialAndRegulatoryMilestonePaymentsMember_870580" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_866845" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_DisclosureOfRevenueFromContractWithCustomersTable_866827" xlink:to="loc_srt_StatementScenarioAxis_866845" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_866847" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_866845" xlink:to="loc_srt_ScenarioUnspecifiedDomain_866847" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_866847_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_866845" xlink:to="loc_srt_ScenarioUnspecifiedDomain_866847_default" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MilestonePaymentReceivable" xlink:label="loc_imtx_MilestonePaymentReceivable_866859" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems_866856" xlink:to="loc_imtx_MilestonePaymentReceivable_866859" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_UpfrontPaymentReceived" xlink:label="loc_imtx_UpfrontPaymentReceived_866860" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems_866856" xlink:to="loc_imtx_UpfrontPaymentReceived_866860" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xlink:label="loc_ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod_866862" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems_866856" xlink:to="loc_ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod_866862" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ContractLiabilities" xlink:label="loc_ifrs-full_ContractLiabilities_866863" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems_866856" xlink:to="loc_ifrs-full_ContractLiabilities_866863" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AssetsRecognisedFromCostsToObtainOrFulfilContractsWithCustomers" xlink:label="loc_ifrs-full_AssetsRecognisedFromCostsToObtainOrFulfilContractsWithCustomers_866865" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems_866856" xlink:to="loc_ifrs-full_AssetsRecognisedFromCostsToObtainOrFulfilContractsWithCustomers_866865" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AmortisationAssetsRecognisedFromCostsIncurredToObtainOrFulfilContractsWithCustomers" xlink:label="loc_ifrs-full_AmortisationAssetsRecognisedFromCostsIncurredToObtainOrFulfilContractsWithCustomers_866867" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems_866856" xlink:to="loc_ifrs-full_AmortisationAssetsRecognisedFromCostsIncurredToObtainOrFulfilContractsWithCustomers_866867" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PotentialMilestonePaymentPayable" xlink:label="loc_imtx_PotentialMilestonePaymentPayable_866870" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems_866856" xlink:to="loc_imtx_PotentialMilestonePaymentPayable_866870" use="optional" order="25" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/OtherCurrentLiabilitiesSummaryOfOtherCurrentLiabilitiesDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems_866857" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTable" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTable_866855" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems_866857" xlink:to="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTable_866855" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="loc_ifrs-full_CurrentTaxLiabilitiesCurrent_866858" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems_866857" xlink:to="loc_ifrs-full_CurrentTaxLiabilitiesCurrent_866858" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AccrualsClassifiedAsCurrent" xlink:label="loc_ifrs-full_AccrualsClassifiedAsCurrent_866861" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems_866857" xlink:to="loc_ifrs-full_AccrualsClassifiedAsCurrent_866861" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DeferredGrantIncomeCurrent" xlink:label="loc_imtx_DeferredGrantIncomeCurrent_866864" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems_866857" xlink:to="loc_imtx_DeferredGrantIncomeCurrent_866864" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:label="loc_ifrs-full_CurrentProvisionsForEmployeeBenefits_866866" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems_866857" xlink:to="loc_ifrs-full_CurrentProvisionsForEmployeeBenefits_866866" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_OtherCurrent" xlink:label="loc_imtx_OtherCurrent_866869" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems_866857" xlink:to="loc_imtx_OtherCurrent_866869" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherCurrentLiabilities" xlink:label="loc_ifrs-full_OtherCurrentLiabilities_866871" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems_866857" xlink:to="loc_ifrs-full_OtherCurrentLiabilities_866871" use="optional" order="7" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/OtherCurrentLiabilitiesAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems_866917" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTable" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTable_866907" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems_866917" xlink:to="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTable_866907" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_866910" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTable_866907" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_866910" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_866911" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_866910" xlink:to="loc_ifrs-full_BorrowingsByNameMember_866911" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_866911_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_866910" xlink:to="loc_ifrs-full_BorrowingsByNameMember_866911_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_NonInterestBearingLiabilityMember" xlink:label="loc_imtx_NonInterestBearingLiabilityMember_866914" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_866911" xlink:to="loc_imtx_NonInterestBearingLiabilityMember_866914" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BorrowingsMaturity" xlink:label="loc_ifrs-full_BorrowingsMaturity_866919" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems_866917" xlink:to="loc_ifrs-full_BorrowingsMaturity_866919" use="optional" order="6" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/ShareListingExpenseAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfShareListingExpenseLineItems" xlink:label="loc_imtx_DisclosureOfShareListingExpenseLineItems_867256" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_867245" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imtx_DisclosureOfShareListingExpenseLineItems_867256" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_867245" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_867246" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_867245" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_867246" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_867247" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_867246" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_867247" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_867247_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_867246" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_867247_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_867248" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_867247" xlink:to="loc_ifrs-full_OrdinarySharesMember_867248" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_867249" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_867245" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_867249" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_867250" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_867249" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_867250" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_867250_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_867249" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_867250_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_WarrantsMember" xlink:label="loc_imtx_WarrantsMember_867252" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_867250" xlink:to="loc_imtx_WarrantsMember_867252" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_867253" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_867245" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_867253" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_867254" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_867253" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_867254" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_867254_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_867253" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_867254_default" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AryaMember" xlink:label="loc_imtx_AryaMember_867255" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_867254" xlink:to="loc_imtx_AryaMember_867255" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_867260" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfShareListingExpenseLineItems_867256" xlink:to="loc_ifrs-full_ParValuePerShare_867260" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_WarrantsIssuedPricePerWarrant" xlink:label="loc_imtx_WarrantsIssuedPricePerWarrant_867275" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfShareListingExpenseLineItems_867256" xlink:to="loc_imtx_WarrantsIssuedPricePerWarrant_867275" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_867276" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfShareListingExpenseLineItems_867256" xlink:to="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_867276" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AdjustmentsForShareListingExpense" xlink:label="loc_imtx_AdjustmentsForShareListingExpense_867277" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfShareListingExpenseLineItems_867256" xlink:to="loc_imtx_AdjustmentsForShareListingExpense_867277" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_867319" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfShareListingExpenseLineItems_867256" xlink:to="loc_ifrs-full_EquityInterestsOfAcquirer_867319" use="optional" order="18" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/ShareListingExpensesSummaryOfCalculationOfTheShareListingExpenseDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems_866987" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_866975" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems_866987" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_866975" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_866976" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_866975" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_866976" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_866977" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_866976" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_866977" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_866977_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_866976" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_866977_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AryaMember" xlink:label="loc_imtx_AryaMember_866978" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_866977" xlink:to="loc_imtx_AryaMember_866978" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_866980" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_866975" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_866980" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_866981" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_866980" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_866981" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_866981_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_866980" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_866981_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_866982" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_866981" xlink:to="loc_ifrs-full_OrdinarySharesMember_866982" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_866983" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_866975" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_866983" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_866984" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_866983" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_866984" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_866984_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_866983" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_866984_default" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_WarrantsMember" xlink:label="loc_imtx_WarrantsMember_866985" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_866984" xlink:to="loc_imtx_WarrantsMember_866985" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable" xlink:label="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_866988" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems_866987" xlink:to="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_866988" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_866989" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems_866987" xlink:to="loc_ifrs-full_ParValuePerShare_866989" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_WarrantsIssuedPricePerWarrant" xlink:label="loc_imtx_WarrantsIssuedPricePerWarrant_866992" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems_866987" xlink:to="loc_imtx_WarrantsIssuedPricePerWarrant_866992" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_866993" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems_866987" xlink:to="loc_ifrs-full_EquityInterestsOfAcquirer_866993" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_866994" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems_866987" xlink:to="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_866994" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AdjustmentsForShareListingExpense" xlink:label="loc_imtx_AdjustmentsForShareListingExpense_866995" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems_866987" xlink:to="loc_imtx_AdjustmentsForShareListingExpense_866995" use="optional" order="19" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/ShareBasedPaymentsSummaryOfOptionsGrantedPricedUsingBlackScholesForSarsTandemAwardsConvertedOptionsMatchingStockOptionsAndMonteCarloOptionPricingModelDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867292" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_867283" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867292" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_867283" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_867285" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_867283" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_867285" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_867286" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_867285" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_867286" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_867286_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_867285" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_867286_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShareAppreciationRightsMember" xlink:label="loc_imtx_ShareAppreciationRightsMember_867290" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_867286" xlink:to="loc_imtx_ShareAppreciationRightsMember_867290" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember" xlink:label="loc_imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember_868840" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_867286" xlink:to="loc_imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember_868840" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PerformanceBasedOptionsMember" xlink:label="loc_imtx_PerformanceBasedOptionsMember_868841" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_867286" xlink:to="loc_imtx_PerformanceBasedOptionsMember_868841" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ConvertedOptionsMember" xlink:label="loc_imtx_ConvertedOptionsMember_868853" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_867286" xlink:to="loc_imtx_ConvertedOptionsMember_868853" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PlanAxis" xlink:label="loc_imtx_PlanAxis_868615" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_867283" xlink:to="loc_imtx_PlanAxis_868615" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PlanMember" xlink:label="loc_imtx_PlanMember_868616" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imtx_PlanAxis_868615" xlink:to="loc_imtx_PlanMember_868616" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PlanMember" xlink:label="loc_imtx_PlanMember_868616_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imtx_PlanAxis_868615" xlink:to="loc_imtx_PlanMember_868616_default" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TwoThousandAndSixteenTandemAwardsMember" xlink:label="loc_imtx_TwoThousandAndSixteenTandemAwardsMember_868617" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_PlanMember_868616" xlink:to="loc_imtx_TwoThousandAndSixteenTandemAwardsMember_868617" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MatchingStockOptionsMember" xlink:label="loc_imtx_MatchingStockOptionsMember_868684" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_PlanMember_868616" xlink:to="loc_imtx_MatchingStockOptionsMember_868684" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_867295" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867292" xlink:to="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_867295" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_867306" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867292" xlink:to="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_867306" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_867308" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867292" xlink:to="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_867308" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_867311" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867292" xlink:to="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_867311" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_867313" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867292" xlink:to="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_867313" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_867314" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867292" xlink:to="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_867314" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CombinedProbabilityOfExitEventsShareOptionsGranted" xlink:label="loc_imtx_CombinedProbabilityOfExitEventsShareOptionsGranted_867317" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867292" xlink:to="loc_imtx_CombinedProbabilityOfExitEventsShareOptionsGranted_867317" use="optional" order="20" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/ShareBasedPaymentsSummaryOfEmployeeShareOptionsDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867324" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_867323" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867324" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_867323" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_867325" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_867323" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_867325" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_867326" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_867325" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_867326" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_867326_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_867325" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_867326_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShareAppreciationRightsMember" xlink:label="loc_imtx_ShareAppreciationRightsMember_867327" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_867326" xlink:to="loc_imtx_ShareAppreciationRightsMember_867327" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PerformanceBasedOptionsMember" xlink:label="loc_imtx_PerformanceBasedOptionsMember_868808" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_867326" xlink:to="loc_imtx_PerformanceBasedOptionsMember_868808" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember" xlink:label="loc_imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember_868826" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_867326" xlink:to="loc_imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember_868826" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ConvertedOptionsMember" xlink:label="loc_imtx_ConvertedOptionsMember_868843" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_867326" xlink:to="loc_imtx_ConvertedOptionsMember_868843" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MatchingStockOptionsMember" xlink:label="loc_imtx_MatchingStockOptionsMember_868854" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_867326" xlink:to="loc_imtx_MatchingStockOptionsMember_868854" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DateOfGrantAxis" xlink:label="loc_imtx_DateOfGrantAxis_868809" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_867323" xlink:to="loc_imtx_DateOfGrantAxis_868809" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DateOfGrantMember" xlink:label="loc_imtx_DateOfGrantMember_868810" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imtx_DateOfGrantAxis_868809" xlink:to="loc_imtx_DateOfGrantMember_868810" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DateOfGrantMember" xlink:label="loc_imtx_DateOfGrantMember_868810_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imtx_DateOfGrantAxis_868809" xlink:to="loc_imtx_DateOfGrantMember_868810_default" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GrantedOnJuneTwoThousandAndTwentyMember" xlink:label="loc_imtx_GrantedOnJuneTwoThousandAndTwentyMember_868811" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DateOfGrantMember_868810" xlink:to="loc_imtx_GrantedOnJuneTwoThousandAndTwentyMember_868811" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GrantedOnSeptemberTwoThousandAndTwentyMember" xlink:label="loc_imtx_GrantedOnSeptemberTwoThousandAndTwentyMember_868814" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DateOfGrantMember_868810" xlink:to="loc_imtx_GrantedOnSeptemberTwoThousandAndTwentyMember_868814" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GrantedOnDecemberTwoThousandAndTwentyMember" xlink:label="loc_imtx_GrantedOnDecemberTwoThousandAndTwentyMember_868832" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DateOfGrantMember_868810" xlink:to="loc_imtx_GrantedOnDecemberTwoThousandAndTwentyMember_868832" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_867328" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867324" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_867328" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_867330" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867324" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_867330" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_867331" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867324" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_867331" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_WeightedAverageExercisePriceOfShareOptionsVestedInSharebasedPaymentArrangement2019" xlink:label="loc_imtx_WeightedAverageExercisePriceOfShareOptionsVestedInSharebasedPaymentArrangement2019_867332" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867324" xlink:to="loc_imtx_WeightedAverageExercisePriceOfShareOptionsVestedInSharebasedPaymentArrangement2019_867332" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_867341" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867324" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_867341" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_867343" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867324" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_867343" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_867344" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867324" xlink:to="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_867344" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_NumberOfShareOptionsVestedInSharebasedPaymentArrangement" xlink:label="loc_imtx_NumberOfShareOptionsVestedInSharebasedPaymentArrangement_867347" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867324" xlink:to="loc_imtx_NumberOfShareOptionsVestedInSharebasedPaymentArrangement_867347" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_868812" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867324" xlink:to="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_868812" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare" xlink:label="loc_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare_868813" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867324" xlink:to="loc_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare_868813" use="optional" order="25" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/ShareBasedPaymentsSummaryOfActivitiesUnderShareBasedPaymentArrangementDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsLineItems" xlink:label="loc_imtx_StatementsLineItems_867379" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsTable" xlink:label="loc_imtx_StatementsTable_867376" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imtx_StatementsLineItems_867379" xlink:to="loc_imtx_StatementsTable_867376" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DateOfGrantAxis" xlink:label="loc_imtx_DateOfGrantAxis_868766" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_StatementsTable_867376" xlink:to="loc_imtx_DateOfGrantAxis_868766" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DateOfGrantMember" xlink:label="loc_imtx_DateOfGrantMember_868767" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imtx_DateOfGrantAxis_868766" xlink:to="loc_imtx_DateOfGrantMember_868767" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DateOfGrantMember" xlink:label="loc_imtx_DateOfGrantMember_868767_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imtx_DateOfGrantAxis_868766" xlink:to="loc_imtx_DateOfGrantMember_868767_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GrantedOnJuneToSeptemberTwoThousandAndTwentyMember" xlink:label="loc_imtx_GrantedOnJuneToSeptemberTwoThousandAndTwentyMember_868769" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DateOfGrantMember_868767" xlink:to="loc_imtx_GrantedOnJuneToSeptemberTwoThousandAndTwentyMember_868769" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GrantedOnDecemberTwoThousandAndTwentyMember" xlink:label="loc_imtx_GrantedOnDecemberTwoThousandAndTwentyMember_868774" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DateOfGrantMember_868767" xlink:to="loc_imtx_GrantedOnDecemberTwoThousandAndTwentyMember_868774" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GrantedOnSeptemberTwoThousandAndTwentyMember" xlink:label="loc_imtx_GrantedOnSeptemberTwoThousandAndTwentyMember_868776" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DateOfGrantMember_868767" xlink:to="loc_imtx_GrantedOnSeptemberTwoThousandAndTwentyMember_868776" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PlanAxis" xlink:label="loc_imtx_PlanAxis_869271" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_StatementsTable_867376" xlink:to="loc_imtx_PlanAxis_869271" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PlanMember" xlink:label="loc_imtx_PlanMember_869272" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imtx_PlanAxis_869271" xlink:to="loc_imtx_PlanMember_869272" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PlanMember" xlink:label="loc_imtx_PlanMember_869272_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imtx_PlanAxis_869271" xlink:to="loc_imtx_PlanMember_869272_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_867383" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867379" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_867383" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_867385" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867379" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_867385" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_868746" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867379" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_868746" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_WeightedAverageExercisePriceOfShareOptionsVestedDuringThePeriod" xlink:label="loc_imtx_WeightedAverageExercisePriceOfShareOptionsVestedDuringThePeriod_868750" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867379" xlink:to="loc_imtx_WeightedAverageExercisePriceOfShareOptionsVestedDuringThePeriod_868750" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_868754" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867379" xlink:to="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_868754" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageSharePrice2019" xlink:label="loc_ifrs-full_WeightedAverageSharePrice2019_868756" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867379" xlink:to="loc_ifrs-full_WeightedAverageSharePrice2019_868756" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_868759" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867379" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_868759" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_868760" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867379" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_868760" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_868761" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867379" xlink:to="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_868761" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_NumberOfShareOptionsVestedDuringThePeriod" xlink:label="loc_imtx_NumberOfShareOptionsVestedDuringThePeriod_868763" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867379" xlink:to="loc_imtx_NumberOfShareOptionsVestedDuringThePeriod_868763" use="optional" order="20" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/ShareBasedPaymentsAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_868359" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_868359" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PlanAxis" xlink:label="loc_imtx_PlanAxis_868360" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_868359" xlink:to="loc_imtx_PlanAxis_868360" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PlanMember" xlink:label="loc_imtx_PlanMember_868362" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imtx_PlanAxis_868360" xlink:to="loc_imtx_PlanMember_868362" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PlanMember" xlink:label="loc_imtx_PlanMember_868362_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imtx_PlanAxis_868360" xlink:to="loc_imtx_PlanMember_868362_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShareAppreciationRightsTwoThousandAndTenPlanMember" xlink:label="loc_imtx_ShareAppreciationRightsTwoThousandAndTenPlanMember_868363" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_PlanMember_868362" xlink:to="loc_imtx_ShareAppreciationRightsTwoThousandAndTenPlanMember_868363" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TwoThousandAndSixteenTandemAwardsMember" xlink:label="loc_imtx_TwoThousandAndSixteenTandemAwardsMember_868365" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_PlanMember_868362" xlink:to="loc_imtx_TwoThousandAndSixteenTandemAwardsMember_868365" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMember" xlink:label="loc_imtx_ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMember_868366" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_PlanMember_868362" xlink:to="loc_imtx_ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMember_868366" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ModificationOfTwoThousandAndTenPlanMember" xlink:label="loc_imtx_ModificationOfTwoThousandAndTenPlanMember_868532" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_PlanMember_868362" xlink:to="loc_imtx_ModificationOfTwoThousandAndTenPlanMember_868532" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ModificationOfTwoThousandAndSixteenPlanMember" xlink:label="loc_imtx_ModificationOfTwoThousandAndSixteenPlanMember_868533" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_PlanMember_868362" xlink:to="loc_imtx_ModificationOfTwoThousandAndSixteenPlanMember_868533" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CategoryOfEmployeesAxis" xlink:label="loc_imtx_CategoryOfEmployeesAxis_868367" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_868359" xlink:to="loc_imtx_CategoryOfEmployeesAxis_868367" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CategoryOfEmployeesMember" xlink:label="loc_imtx_CategoryOfEmployeesMember_868368" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imtx_CategoryOfEmployeesAxis_868367" xlink:to="loc_imtx_CategoryOfEmployeesMember_868368" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CategoryOfEmployeesMember" xlink:label="loc_imtx_CategoryOfEmployeesMember_868368_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imtx_CategoryOfEmployeesAxis_868367" xlink:to="loc_imtx_CategoryOfEmployeesMember_868368_default" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ActiveEmployeesMember" xlink:label="loc_imtx_ActiveEmployeesMember_868369" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_CategoryOfEmployeesMember_868368" xlink:to="loc_imtx_ActiveEmployeesMember_868369" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ManagementMembersMember" xlink:label="loc_imtx_ManagementMembersMember_868370" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_CategoryOfEmployeesMember_868368" xlink:to="loc_imtx_ManagementMembersMember_868370" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_868371" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_868359" xlink:to="loc_ifrs-full_RangeAxis_868371" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_868372" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_868371" xlink:to="loc_ifrs-full_RangesMember_868372" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_868372_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_868371" xlink:to="loc_ifrs-full_RangesMember_868372_default" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_868373" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_868372" xlink:to="loc_ifrs-full_BottomOfRangeMember_868373" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_868374" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_868372" xlink:to="loc_ifrs-full_TopOfRangeMember_868374" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_SchemeAxis" xlink:label="loc_imtx_SchemeAxis_868375" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_868359" xlink:to="loc_imtx_SchemeAxis_868375" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_SchemeMember" xlink:label="loc_imtx_SchemeMember_868376" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imtx_SchemeAxis_868375" xlink:to="loc_imtx_SchemeMember_868376" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_SchemeMember" xlink:label="loc_imtx_SchemeMember_868376_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imtx_SchemeAxis_868375" xlink:to="loc_imtx_SchemeMember_868376_default" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShareReinvestmentMember" xlink:label="loc_imtx_ShareReinvestmentMember_868377" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_SchemeMember_868376" xlink:to="loc_imtx_ShareReinvestmentMember_868377" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShareReinvestmentSchemeAxis" xlink:label="loc_imtx_ShareReinvestmentSchemeAxis_868378" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_868359" xlink:to="loc_imtx_ShareReinvestmentSchemeAxis_868378" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShareReinvestmentSchemeMember" xlink:label="loc_imtx_ShareReinvestmentSchemeMember_868379" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imtx_ShareReinvestmentSchemeAxis_868378" xlink:to="loc_imtx_ShareReinvestmentSchemeMember_868379" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShareReinvestmentSchemeMember" xlink:label="loc_imtx_ShareReinvestmentSchemeMember_868379_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imtx_ShareReinvestmentSchemeAxis_868378" xlink:to="loc_imtx_ShareReinvestmentSchemeMember_868379_default" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MatchingStockOptionsMember" xlink:label="loc_imtx_MatchingStockOptionsMember_868380" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_ShareReinvestmentSchemeMember_868379" xlink:to="loc_imtx_MatchingStockOptionsMember_868380" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_868654" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_868359" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_868654" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_868656" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_868654" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_868656" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_868656_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_868654" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_868656_default" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PerformanceBasedOptionsMember" xlink:label="loc_imtx_PerformanceBasedOptionsMember_868721" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_868656" xlink:to="loc_imtx_PerformanceBasedOptionsMember_868721" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember" xlink:label="loc_imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember_868786" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_868656" xlink:to="loc_imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember_868786" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ConvertedOptionsMember" xlink:label="loc_imtx_ConvertedOptionsMember_868787" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_868656" xlink:to="loc_imtx_ConvertedOptionsMember_868787" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DateOfGrantAxis" xlink:label="loc_imtx_DateOfGrantAxis_868724" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_868359" xlink:to="loc_imtx_DateOfGrantAxis_868724" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DateOfGrantMember" xlink:label="loc_imtx_DateOfGrantMember_868728" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imtx_DateOfGrantAxis_868724" xlink:to="loc_imtx_DateOfGrantMember_868728" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DateOfGrantMember" xlink:label="loc_imtx_DateOfGrantMember_868728_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imtx_DateOfGrantAxis_868724" xlink:to="loc_imtx_DateOfGrantMember_868728_default" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GrantedOnJuneTwoThousandAndTwentyMember" xlink:label="loc_imtx_GrantedOnJuneTwoThousandAndTwentyMember_868730" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DateOfGrantMember_868728" xlink:to="loc_imtx_GrantedOnJuneTwoThousandAndTwentyMember_868730" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GrantedOnSeptemberTwoThousandAndTwentyMember" xlink:label="loc_imtx_GrantedOnSeptemberTwoThousandAndTwentyMember_868806" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DateOfGrantMember_868728" xlink:to="loc_imtx_GrantedOnSeptemberTwoThousandAndTwentyMember_868806" use="optional" order="38" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GrantedOnDecemberTwoThousandAndTwentyMember" xlink:label="loc_imtx_GrantedOnDecemberTwoThousandAndTwentyMember_868807" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DateOfGrantMember_868728" xlink:to="loc_imtx_GrantedOnDecemberTwoThousandAndTwentyMember_868807" use="optional" order="39" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TrancheAxis" xlink:label="loc_imtx_TrancheAxis_868735" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_868359" xlink:to="loc_imtx_TrancheAxis_868735" use="optional" order="40" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TrancheMember" xlink:label="loc_imtx_TrancheMember_868736" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imtx_TrancheAxis_868735" xlink:to="loc_imtx_TrancheMember_868736" use="optional" order="41" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TrancheMember" xlink:label="loc_imtx_TrancheMember_868736_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imtx_TrancheAxis_868735" xlink:to="loc_imtx_TrancheMember_868736_default" use="optional" order="42" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TrancheOneMember" xlink:label="loc_imtx_TrancheOneMember_868737" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_TrancheMember_868736" xlink:to="loc_imtx_TrancheOneMember_868737" use="optional" order="43" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TrancheTwoMember" xlink:label="loc_imtx_TrancheTwoMember_870914" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_TrancheMember_868736" xlink:to="loc_imtx_TrancheTwoMember_870914" use="optional" order="44" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TrancheThreeMember" xlink:label="loc_imtx_TrancheThreeMember_870916" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_TrancheMember_868736" xlink:to="loc_imtx_TrancheThreeMember_870916" use="optional" order="45" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_868780" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_868359" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_868780" use="optional" order="46" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_868783" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_868780" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_868783" use="optional" order="47" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_868783_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_868780" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_868783_default" use="optional" order="48" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AryaMember" xlink:label="loc_imtx_AryaMember_868785" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_868783" xlink:to="loc_imtx_AryaMember_868785" use="optional" order="49" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PercentageOfOutstandingSharesToBePurchasedByThirdParty" xlink:label="loc_imtx_PercentageOfOutstandingSharesToBePurchasedByThirdParty_868382" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_imtx_PercentageOfOutstandingSharesToBePurchasedByThirdParty_868382" use="optional" order="50" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_868384" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_868384" use="optional" order="51" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011" xlink:label="loc_ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011_868385" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011_868385" use="optional" order="52" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_868386" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_868386" use="optional" order="53" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CashPaymentAwardPerSharePayable" xlink:label="loc_imtx_CashPaymentAwardPerSharePayable_868388" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_imtx_CashPaymentAwardPerSharePayable_868388" use="optional" order="54" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PercentageOfCashProceedsToBeBeReinvested" xlink:label="loc_imtx_PercentageOfCashProceedsToBeBeReinvested_868389" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_imtx_PercentageOfCashProceedsToBeBeReinvested_868389" use="optional" order="55" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PaymentsToAndOnBehalfOfEmployees" xlink:label="loc_ifrs-full_PaymentsToAndOnBehalfOfEmployees_868390" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_ifrs-full_PaymentsToAndOnBehalfOfEmployees_868390" use="optional" order="56" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ExpenseFromTheModificationOfShareBasedAwards" xlink:label="loc_imtx_ExpenseFromTheModificationOfShareBasedAwards_868391" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_imtx_ExpenseFromTheModificationOfShareBasedAwards_868391" use="optional" order="57" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_868392" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_868392" use="optional" order="58" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_868397" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_868397" use="optional" order="59" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_868430" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_868430" use="optional" order="60" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_868462" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_868462" use="optional" order="61" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement_868467" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement_868467" use="optional" order="62" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DateOfVestingOfStockOptions" xlink:label="loc_imtx_DateOfVestingOfStockOptions_868483" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_imtx_DateOfVestingOfStockOptions_868483" use="optional" order="63" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare" xlink:label="loc_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare_868488" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare_868488" use="optional" order="64" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DateOfGrantOfSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement_868491" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement_868491" use="optional" order="65" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MinimumMarketCapitalization" xlink:label="loc_imtx_MinimumMarketCapitalization_868734" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_imtx_MinimumMarketCapitalization_868734" use="optional" order="66" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/ShareBasedPaymentsSummaryOfEmployeeRelatedShareBasedCompensationExpenseDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseLineItems" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseLineItems_868798" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTable" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTable_868793" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseLineItems_868798" xlink:to="loc_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTable_868793" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncomeStatementLocationAxis" xlink:label="loc_imtx_IncomeStatementLocationAxis_868794" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTable_868793" xlink:to="loc_imtx_IncomeStatementLocationAxis_868794" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncomeStatementLocationMember" xlink:label="loc_imtx_IncomeStatementLocationMember_868795" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imtx_IncomeStatementLocationAxis_868794" xlink:to="loc_imtx_IncomeStatementLocationMember_868795" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncomeStatementLocationMember" xlink:label="loc_imtx_IncomeStatementLocationMember_868795_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imtx_IncomeStatementLocationAxis_868794" xlink:to="loc_imtx_IncomeStatementLocationMember_868795_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ResearchAndDevelopmentExpenseMember" xlink:label="loc_imtx_ResearchAndDevelopmentExpenseMember_868796" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_IncomeStatementLocationMember_868795" xlink:to="loc_imtx_ResearchAndDevelopmentExpenseMember_868796" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GeneralAndAdministrativeExpenseMember" xlink:label="loc_imtx_GeneralAndAdministrativeExpenseMember_868805" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_IncomeStatementLocationMember_868795" xlink:to="loc_imtx_GeneralAndAdministrativeExpenseMember_868805" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_868800" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseLineItems_868798" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_868800" use="optional" order="7" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/ShareholdersEquityDeficitAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_866897" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_866868" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_866897" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_866868" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_866874" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_866868" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_866874" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_866875" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_866874" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_866875" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_866875_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_866874" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_866875_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_866876" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_866875" xlink:to="loc_ifrs-full_OrdinarySharesMember_866876" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_SeriesEShareCapitalMember" xlink:label="loc_imtx_SeriesEShareCapitalMember_866974" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_866875" xlink:to="loc_imtx_SeriesEShareCapitalMember_866974" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_866878" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_866868" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_866878" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_866879" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_866878" xlink:to="loc_ifrs-full_BorrowingsByNameMember_866879" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_866879_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_866878" xlink:to="loc_ifrs-full_BorrowingsByNameMember_866879_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PipeFinancingMember" xlink:label="loc_imtx_PipeFinancingMember_866941" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_866879" xlink:to="loc_imtx_PipeFinancingMember_866941" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_866885" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_866868" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_866885" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_866888" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_866885" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_866888" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_866888_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_866885" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_866888_default" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ImmaticsBiotechnologiesGmbhMember" xlink:label="loc_imtx_ImmaticsBiotechnologiesGmbhMember_866891" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_866888" xlink:to="loc_imtx_ImmaticsBiotechnologiesGmbhMember_866891" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_866935" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_866868" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_866935" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_866938" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_866935" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_866938" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_866938_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_866935" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_866938_default" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AryaMergerMember" xlink:label="loc_imtx_AryaMergerMember_876474" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_ShareListingExpenseDomain_876473" xlink:to="loc_imtx_AryaMergerMember_876474" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShareListingExpenseAxis" xlink:label="loc_imtx_ShareListingExpenseAxis_876472" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_866868" xlink:to="loc_imtx_ShareListingExpenseAxis_876472" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShareListingExpenseDomain" xlink:label="loc_imtx_ShareListingExpenseDomain_876473" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imtx_ShareListingExpenseAxis_876472" xlink:to="loc_imtx_ShareListingExpenseDomain_876473" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShareListingExpenseDomain" xlink:label="loc_imtx_ShareListingExpenseDomain_876473_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imtx_ShareListingExpenseAxis_876472" xlink:to="loc_imtx_ShareListingExpenseDomain_876473_default" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EventAxis" xlink:label="loc_imtx_EventAxis_876689" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_866868" xlink:to="loc_imtx_EventAxis_876689" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EventDomain" xlink:label="loc_imtx_EventDomain_876690" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imtx_EventAxis_876689" xlink:to="loc_imtx_EventDomain_876690" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EventDomain" xlink:label="loc_imtx_EventDomain_876690_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imtx_EventAxis_876689" xlink:to="loc_imtx_EventDomain_876690_default" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ReorganizationMember" xlink:label="loc_imtx_ReorganizationMember_876691" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_EventDomain_876690" xlink:to="loc_imtx_ReorganizationMember_876691" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_866899" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_866897" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_866899" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_866900" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_866897" xlink:to="loc_ifrs-full_ParValuePerShare_866900" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_866901" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_866897" xlink:to="loc_ifrs-full_IssuedCapital_866901" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharePremium" xlink:label="loc_ifrs-full_SharePremium_866903" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_866897" xlink:to="loc_ifrs-full_SharePremium_866903" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_NumberOfWarrantsOutsatnding" xlink:label="loc_imtx_NumberOfWarrantsOutsatnding_866913" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_866897" xlink:to="loc_imtx_NumberOfWarrantsOutsatnding_866913" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ExercisePriceOfWarrants" xlink:label="loc_imtx_ExercisePriceOfWarrants_866918" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_866897" xlink:to="loc_imtx_ExercisePriceOfWarrants_866918" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ClassOfWarrantOrRightTermPeriod" xlink:label="loc_imtx_ClassOfWarrantOrRightTermPeriod_866923" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_866897" xlink:to="loc_imtx_ClassOfWarrantOrRightTermPeriod_866923" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_imtx_StockIssuedDuringPeriodValueNewIssues_867389" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_866897" xlink:to="loc_imtx_StockIssuedDuringPeriodValueNewIssues_867389" use="optional" order="33" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/NonControllingInterestsAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsLineItems" xlink:label="loc_imtx_StatementsLineItems_867057" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsTable" xlink:label="loc_imtx_StatementsTable_867054" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imtx_StatementsLineItems_867057" xlink:to="loc_imtx_StatementsTable_867054" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_867058" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_StatementsTable_867054" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_867058" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_867059" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_867058" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_867059" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_867059_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_867058" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_867059_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MdAndersonMember" xlink:label="loc_imtx_MdAndersonMember_867060" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_867059" xlink:to="loc_imtx_MdAndersonMember_867060" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_867061" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_StatementsTable_867054" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_867061" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_867062" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_867061" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_867062" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_867062_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_867061" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_867062_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_RestrictedStockAcquisitionAgreementMember" xlink:label="loc_imtx_RestrictedStockAcquisitionAgreementMember_867063" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_867062" xlink:to="loc_imtx_RestrictedStockAcquisitionAgreementMember_867063" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AryaMember" xlink:label="loc_imtx_AryaMember_867064" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_867062" xlink:to="loc_imtx_AryaMember_867064" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_NumberOfSharesExchangedInSubsidiaries" xlink:label="loc_imtx_NumberOfSharesExchangedInSubsidiaries_867065" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867057" xlink:to="loc_imtx_NumberOfSharesExchangedInSubsidiaries_867065" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_imtx_StockIssuedDuringPeriodSharesAcquisitions_867066" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867057" xlink:to="loc_imtx_StockIssuedDuringPeriodSharesAcquisitions_867066" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_867067" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867057" xlink:to="loc_ifrs-full_ParValuePerShare_867067" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_867068" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867057" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_867068" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_imtx_StockIssuedDuringPeriodValueNewIssues_867069" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867057" xlink:to="loc_imtx_StockIssuedDuringPeriodValueNewIssues_867069" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest" xlink:label="loc_imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest_867070" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867057" xlink:to="loc_imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest_867070" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_LossOnNoncontrollingInterest" xlink:label="loc_imtx_LossOnNoncontrollingInterest_867071" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867057" xlink:to="loc_imtx_LossOnNoncontrollingInterest_867071" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncontrollingInterests" xlink:label="loc_ifrs-full_NoncontrollingInterests_867072" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867057" xlink:to="loc_ifrs-full_NoncontrollingInterests_867072" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncreasedecreaseThroughCompensationExpense" xlink:label="loc_imtx_IncreasedecreaseThroughCompensationExpense_867073" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867057" xlink:to="loc_imtx_IncreasedecreaseThroughCompensationExpense_867073" use="optional" order="19" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/PersonnelExpensesSummaryOfPersonnelExpensesDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsLineItems" xlink:label="loc_imtx_StatementsLineItems_867029" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsTable" xlink:label="loc_imtx_StatementsTable_867026" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imtx_StatementsLineItems_867029" xlink:to="loc_imtx_StatementsTable_867026" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncomeStatementLocationAxis" xlink:label="loc_imtx_IncomeStatementLocationAxis_867030" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_StatementsTable_867026" xlink:to="loc_imtx_IncomeStatementLocationAxis_867030" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncomeStatementLocationMember" xlink:label="loc_imtx_IncomeStatementLocationMember_867031" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imtx_IncomeStatementLocationAxis_867030" xlink:to="loc_imtx_IncomeStatementLocationMember_867031" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncomeStatementLocationMember" xlink:label="loc_imtx_IncomeStatementLocationMember_867031_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imtx_IncomeStatementLocationAxis_867030" xlink:to="loc_imtx_IncomeStatementLocationMember_867031_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ResearchAndDevelopmentExpenseMember" xlink:label="loc_imtx_ResearchAndDevelopmentExpenseMember_867032" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_IncomeStatementLocationMember_867031" xlink:to="loc_imtx_ResearchAndDevelopmentExpenseMember_867032" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GeneralAndAdministrativeExpenseMember" xlink:label="loc_imtx_GeneralAndAdministrativeExpenseMember_867033" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_IncomeStatementLocationMember_867031" xlink:to="loc_imtx_GeneralAndAdministrativeExpenseMember_867033" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WagesAndSalaries" xlink:label="loc_ifrs-full_WagesAndSalaries_867034" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867029" xlink:to="loc_ifrs-full_WagesAndSalaries_867034" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherShorttermEmployeeBenefits" xlink:label="loc_ifrs-full_OtherShorttermEmployeeBenefits_867035" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867029" xlink:to="loc_ifrs-full_OtherShorttermEmployeeBenefits_867035" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:label="loc_ifrs-full_ShorttermEmployeeBenefitsExpense_867036" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867029" xlink:to="loc_ifrs-full_ShorttermEmployeeBenefitsExpense_867036" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_867038" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867029" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_867038" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EmployeeBenefitsExpense" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense_867039" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867029" xlink:to="loc_ifrs-full_EmployeeBenefitsExpense_867039" use="optional" order="11" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/IncomeTaxSummaryOfDeferredTaxAssetsDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsLineItems" xlink:label="loc_imtx_StatementsLineItems_866952" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsTable" xlink:label="loc_imtx_StatementsTable_866949" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imtx_StatementsLineItems_866952" xlink:to="loc_imtx_StatementsTable_866949" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AssetsAndLiabilitiesAxis" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesAxis_866953" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_StatementsTable_866949" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesAxis_866953" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AssetsAndLiabilitiesMember" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesMember_866954" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesAxis_866953" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesMember_866954" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AssetsAndLiabilitiesMember" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesMember_866954_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesAxis_866953" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesMember_866954_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IntangibleAssetsMember" xlink:label="loc_imtx_IntangibleAssetsMember_866956" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesMember_866954" xlink:to="loc_imtx_IntangibleAssetsMember_866956" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DeferredRevenueMember" xlink:label="loc_imtx_DeferredRevenueMember_866958" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesMember_866954" xlink:to="loc_imtx_DeferredRevenueMember_866958" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_LeaseLiabilityMember" xlink:label="loc_imtx_LeaseLiabilityMember_866961" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesMember_866954" xlink:to="loc_imtx_LeaseLiabilityMember_866961" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DeferredExpensesMember" xlink:label="loc_imtx_DeferredExpensesMember_866962" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesMember_866954" xlink:to="loc_imtx_DeferredExpensesMember_866962" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DeferredAssetRecognisedMember" xlink:label="loc_imtx_DeferredAssetRecognisedMember_866966" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesMember_866954" xlink:to="loc_imtx_DeferredAssetRecognisedMember_866966" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DeferredTaxLiabilitiesRightOfUseAssetMember" xlink:label="loc_imtx_DeferredTaxLiabilitiesRightOfUseAssetMember_866986" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesMember_866954" xlink:to="loc_imtx_DeferredTaxLiabilitiesRightOfUseAssetMember_866986" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DeferredTaxLiabilitiesDeferredExpensesMember" xlink:label="loc_imtx_DeferredTaxLiabilitiesDeferredExpensesMember_866997" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesMember_866954" xlink:to="loc_imtx_DeferredTaxLiabilitiesDeferredExpensesMember_866997" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_OtherLiabilitiesMember" xlink:label="loc_imtx_OtherLiabilitiesMember_867004" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesMember_866954" xlink:to="loc_imtx_OtherLiabilitiesMember_867004" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-full_DeferredTaxAssets_867000" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_866952" xlink:to="loc_ifrs-full_DeferredTaxAssets_867000" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_867002" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_866952" xlink:to="loc_ifrs-full_DeferredTaxLiabilities_867002" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DeferredTaxAssetsNonrecognition" xlink:label="loc_imtx_DeferredTaxAssetsNonrecognition_871065" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_866952" xlink:to="loc_imtx_DeferredTaxAssetsNonrecognition_871065" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DeferredTaxAssetsOffset" xlink:label="loc_imtx_DeferredTaxAssetsOffset_871078" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_866952" xlink:to="loc_imtx_DeferredTaxAssetsOffset_871078" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DeferredTaxLiabilitiesOffSet" xlink:label="loc_imtx_DeferredTaxLiabilitiesOffSet_871083" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_866952" xlink:to="loc_imtx_DeferredTaxLiabilitiesOffSet_871083" use="optional" order="17" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/IncomeTaxAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsLineItems" xlink:label="loc_imtx_StatementsLineItems_867011" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsTable" xlink:label="loc_imtx_StatementsTable_867008" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imtx_StatementsLineItems_867011" xlink:to="loc_imtx_StatementsTable_867008" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TypeOfAdoptionsAxis" xlink:label="loc_imtx_TypeOfAdoptionsAxis_867009" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_StatementsTable_867008" xlink:to="loc_imtx_TypeOfAdoptionsAxis_867009" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TypeOfAdoptionsMember" xlink:label="loc_imtx_TypeOfAdoptionsMember_869226" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imtx_TypeOfAdoptionsAxis_867009" xlink:to="loc_imtx_TypeOfAdoptionsMember_869226" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TypeOfAdoptionsMember" xlink:label="loc_imtx_TypeOfAdoptionsMember_869226_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imtx_TypeOfAdoptionsAxis_867009" xlink:to="loc_imtx_TypeOfAdoptionsMember_869226_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_867423" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_StatementsTable_867008" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_867423" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_867424" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_867423" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_867424" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_867424_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_867423" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_867424_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IndefiniteTaxLossesCarryforwardMember" xlink:label="loc_imtx_IndefiniteTaxLossesCarryforwardMember_867425" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_867424" xlink:to="loc_imtx_IndefiniteTaxLossesCarryforwardMember_867425" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TwentySixYearTaxLossesCarryforwardMember" xlink:label="loc_imtx_TwentySixYearTaxLossesCarryforwardMember_867426" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_867424" xlink:to="loc_imtx_TwentySixYearTaxLossesCarryforwardMember_867426" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-full_ApplicableTaxRate_867012" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867011" xlink:to="loc_ifrs-full_ApplicableTaxRate_867012" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CorporateIncomeTaxRate" xlink:label="loc_imtx_CorporateIncomeTaxRate_867013" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867011" xlink:to="loc_imtx_CorporateIncomeTaxRate_867013" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TaxEffectOfTaxLosses" xlink:label="loc_ifrs-full_TaxEffectOfTaxLosses_867014" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867011" xlink:to="loc_ifrs-full_TaxEffectOfTaxLosses_867014" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PercentageOnLimitationOnTaxLossCarryforwardsAfterPriorPeriod" xlink:label="loc_imtx_PercentageOnLimitationOnTaxLossCarryforwardsAfterPriorPeriod_867015" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867011" xlink:to="loc_imtx_PercentageOnLimitationOnTaxLossCarryforwardsAfterPriorPeriod_867015" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PercentageOnLimitationOnTaxLossCarryforwardsBeforePriorPeriod" xlink:label="loc_imtx_PercentageOnLimitationOnTaxLossCarryforwardsBeforePriorPeriod_867016" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867011" xlink:to="loc_imtx_PercentageOnLimitationOnTaxLossCarryforwardsBeforePriorPeriod_867016" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EffectiveIncomeTaxReconciliationPermanentEffectShareListingExpense" xlink:label="loc_imtx_EffectiveIncomeTaxReconciliationPermanentEffectShareListingExpense_876755" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867011" xlink:to="loc_imtx_EffectiveIncomeTaxReconciliationPermanentEffectShareListingExpense_876755" use="optional" order="15" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesSummaryOfCurrencyRiskExposureDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfCurrencyRiskExposureLineItems" xlink:label="loc_imtx_DisclosureOfCurrencyRiskExposureLineItems_867086" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfCurrencyRiskExposureTable" xlink:label="loc_imtx_DisclosureOfCurrencyRiskExposureTable_867085" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imtx_DisclosureOfCurrencyRiskExposureLineItems_867086" xlink:to="loc_imtx_DisclosureOfCurrencyRiskExposureTable_867085" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srt_OwnershipAxis_867087" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_DisclosureOfCurrencyRiskExposureTable_867085" xlink:to="loc_srt_OwnershipAxis_867087" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_867088" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_867087" xlink:to="loc_srt_OwnershipDomain_867088" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_867088_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_867087" xlink:to="loc_srt_OwnershipDomain_867088_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ImmaticsNvMember" xlink:label="loc_imtx_ImmaticsNvMember_867089" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_867088" xlink:to="loc_imtx_ImmaticsNvMember_867089" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-full_TypesOfRisksAxis_867090" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_DisclosureOfCurrencyRiskExposureTable_867085" xlink:to="loc_ifrs-full_TypesOfRisksAxis_867090" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-full_TypesOfRisksMember_867091" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfRisksAxis_867090" xlink:to="loc_ifrs-full_TypesOfRisksMember_867091" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-full_TypesOfRisksMember_867091_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfRisksAxis_867090" xlink:to="loc_ifrs-full_TypesOfRisksMember_867091_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrencyRiskMember" xlink:label="loc_ifrs-full_CurrencyRiskMember_867092" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksMember_867091" xlink:to="loc_ifrs-full_CurrencyRiskMember_867092" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_867093" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_DisclosureOfCurrencyRiskExposureTable_867085" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_867093" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_867094" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_867093" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_867094" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_867094_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_867093" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_867094_default" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ImmaticsGmbhMember" xlink:label="loc_imtx_ImmaticsGmbhMember_867095" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_867094" xlink:to="loc_imtx_ImmaticsGmbhMember_867095" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_867096" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfCurrencyRiskExposureLineItems_867086" xlink:to="loc_ifrs-full_CashAndCashEquivalents_867096" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssets" xlink:label="loc_ifrs-full_FinancialAssets_867097" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfCurrencyRiskExposureLineItems_867086" xlink:to="loc_ifrs-full_FinancialAssets_867097" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MaximumExposedToCurrencyRisk" xlink:label="loc_imtx_MaximumExposedToCurrencyRisk_867099" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfCurrencyRiskExposureLineItems_867086" xlink:to="loc_imtx_MaximumExposedToCurrencyRisk_867099" use="optional" order="16" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesSummaryOfSensitivityAnalysisOfForeignCurrencyRiskDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems" xlink:label="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems_867104" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable" xlink:label="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable_867103" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems_867104" xlink:to="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable_867103" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_SensitiveAnalaysisOfCurrencyAxis" xlink:label="loc_imtx_SensitiveAnalaysisOfCurrencyAxis_867105" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable_867103" xlink:to="loc_imtx_SensitiveAnalaysisOfCurrencyAxis_867105" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_SensitiveAnalaysisOfCurrencyDomain" xlink:label="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_867106" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyAxis_867105" xlink:to="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_867106" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_SensitiveAnalaysisOfCurrencyDomain" xlink:label="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_867106_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyAxis_867105" xlink:to="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_867106_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EuroWeakensBy1AgainstUsDollarsMember" xlink:label="loc_imtx_EuroWeakensBy1AgainstUsDollarsMember_867108" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_867106" xlink:to="loc_imtx_EuroWeakensBy1AgainstUsDollarsMember_867108" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EuroStrengthsBy1AgainstUsDollarsMember" xlink:label="loc_imtx_EuroStrengthsBy1AgainstUsDollarsMember_867109" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_867106" xlink:to="loc_imtx_EuroStrengthsBy1AgainstUsDollarsMember_867109" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EuroWeakensBy5AgainstUsDollarsMember" xlink:label="loc_imtx_EuroWeakensBy5AgainstUsDollarsMember_867110" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_867106" xlink:to="loc_imtx_EuroWeakensBy5AgainstUsDollarsMember_867110" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EuroStrengthsBy5AgainstUsDollarsMember" xlink:label="loc_imtx_EuroStrengthsBy5AgainstUsDollarsMember_867111" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_867106" xlink:to="loc_imtx_EuroStrengthsBy5AgainstUsDollarsMember_867111" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EuroWeakensBy10AgainstUsDollarsMember" xlink:label="loc_imtx_EuroWeakensBy10AgainstUsDollarsMember_867112" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_867106" xlink:to="loc_imtx_EuroWeakensBy10AgainstUsDollarsMember_867112" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EuroStrengthsBy10AgainstUsDollarsMember" xlink:label="loc_imtx_EuroStrengthsBy10AgainstUsDollarsMember_867113" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_867106" xlink:to="loc_imtx_EuroStrengthsBy10AgainstUsDollarsMember_867113" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srt_OwnershipAxis_867114" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable_867103" xlink:to="loc_srt_OwnershipAxis_867114" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_867115" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_867114" xlink:to="loc_srt_OwnershipDomain_867115" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_867115_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_867114" xlink:to="loc_srt_OwnershipDomain_867115_default" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ImmaticsNvMember" xlink:label="loc_imtx_ImmaticsNvMember_867116" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_867115" xlink:to="loc_imtx_ImmaticsNvMember_867116" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_867117" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable_867103" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_867117" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_867118" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_867117" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_867118" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_867118_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_867117" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_867118_default" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ImmaticsGmbhMember" xlink:label="loc_imtx_ImmaticsGmbhMember_867119" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_867118" xlink:to="loc_imtx_ImmaticsGmbhMember_867119" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClosingForeignExchangeRate" xlink:label="loc_ifrs-full_ClosingForeignExchangeRate_867120" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems_867104" xlink:to="loc_ifrs-full_ClosingForeignExchangeRate_867120" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints" xlink:label="loc_imtx_IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints_867121" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems_867104" xlink:to="loc_imtx_IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints_867121" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ValueAtRisk" xlink:label="loc_ifrs-full_ValueAtRisk_867122" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems_867104" xlink:to="loc_ifrs-full_ValueAtRisk_867122" use="optional" order="21" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesSummaryOfSensitivityAnalysisOfForeignCurrencyRiskParentheticalDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems" xlink:label="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems_867128" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable" xlink:label="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable_867127" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems_867128" xlink:to="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable_867127" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_867130" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable_867127" xlink:to="loc_srt_CurrencyAxis_867130" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_867131" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_867130" xlink:to="loc_currency_AllCurrenciesDomain_867131" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_867131_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_867130" xlink:to="loc_currency_AllCurrenciesDomain_867131_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srt_OwnershipAxis_867150" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable_867127" xlink:to="loc_srt_OwnershipAxis_867150" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_867151" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_867150" xlink:to="loc_srt_OwnershipDomain_867151" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_867151_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_867150" xlink:to="loc_srt_OwnershipDomain_867151_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ImmaticsNvMember" xlink:label="loc_imtx_ImmaticsNvMember_867152" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_867151" xlink:to="loc_imtx_ImmaticsNvMember_867152" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_867153" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable_867127" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_867153" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_867154" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_867153" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_867154" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_867154_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_867153" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_867154_default" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ImmaticsGmbhMember" xlink:label="loc_imtx_ImmaticsGmbhMember_867155" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_867154" xlink:to="loc_imtx_ImmaticsGmbhMember_867155" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_SensitiveAnalaysisOfCurrencyAxis" xlink:label="loc_imtx_SensitiveAnalaysisOfCurrencyAxis_870425" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable_867127" xlink:to="loc_imtx_SensitiveAnalaysisOfCurrencyAxis_870425" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_SensitiveAnalaysisOfCurrencyDomain" xlink:label="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_870427" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyAxis_870425" xlink:to="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_870427" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_SensitiveAnalaysisOfCurrencyDomain" xlink:label="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_870427_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyAxis_870425" xlink:to="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_870427_default" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EuroWeakensBy1AgainstUsDollarsMember" xlink:label="loc_imtx_EuroWeakensBy1AgainstUsDollarsMember_870428" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_870427" xlink:to="loc_imtx_EuroWeakensBy1AgainstUsDollarsMember_870428" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EuroStrengthsBy1AgainstUsDollarsMember" xlink:label="loc_imtx_EuroStrengthsBy1AgainstUsDollarsMember_870429" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_870427" xlink:to="loc_imtx_EuroStrengthsBy1AgainstUsDollarsMember_870429" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EuroWeakensBy5AgainstUsDollarsMember" xlink:label="loc_imtx_EuroWeakensBy5AgainstUsDollarsMember_870432" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_870427" xlink:to="loc_imtx_EuroWeakensBy5AgainstUsDollarsMember_870432" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EuroStrengthsBy5AgainstUsDollarsMember" xlink:label="loc_imtx_EuroStrengthsBy5AgainstUsDollarsMember_870433" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_870427" xlink:to="loc_imtx_EuroStrengthsBy5AgainstUsDollarsMember_870433" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EuroWeakensBy10AgainstUsDollarsMember" xlink:label="loc_imtx_EuroWeakensBy10AgainstUsDollarsMember_870434" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_870427" xlink:to="loc_imtx_EuroWeakensBy10AgainstUsDollarsMember_870434" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EuroStrengthsBy10AgainstUsDollarsMember" xlink:label="loc_imtx_EuroStrengthsBy10AgainstUsDollarsMember_870439" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_870427" xlink:to="loc_imtx_EuroStrengthsBy10AgainstUsDollarsMember_870439" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk" xlink:label="loc_imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk_867140" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems_867128" xlink:to="loc_imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk_867140" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk" xlink:label="loc_imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk_867141" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems_867128" xlink:to="loc_imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk_867141" use="optional" order="23" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesSummaryOfLiquidityRiskDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsLineItems" xlink:label="loc_imtx_StatementsLineItems_867168" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsTable" xlink:label="loc_imtx_StatementsTable_867165" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imtx_StatementsLineItems_867168" xlink:to="loc_imtx_StatementsTable_867165" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_867169" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_StatementsTable_867165" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_867169" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-full_FinancialAssetsMember_867170" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_867169" xlink:to="loc_ifrs-full_FinancialAssetsMember_867170" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-full_FinancialAssetsMember_867170_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_867169" xlink:to="loc_ifrs-full_FinancialAssetsMember_867170_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShorttermDepositsMember" xlink:label="loc_imtx_ShorttermDepositsMember_867172" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsMember_867170" xlink:to="loc_imtx_ShorttermDepositsMember_867172" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CashAndCashEquivalentsMember" xlink:label="loc_imtx_CashAndCashEquivalentsMember_876761" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsMember_867170" xlink:to="loc_imtx_CashAndCashEquivalentsMember_876761" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-full_TypesOfRisksAxis_867173" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_StatementsTable_867165" xlink:to="loc_ifrs-full_TypesOfRisksAxis_867173" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-full_TypesOfRisksMember_867174" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfRisksAxis_867173" xlink:to="loc_ifrs-full_TypesOfRisksMember_867174" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-full_TypesOfRisksMember_867174_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfRisksAxis_867173" xlink:to="loc_ifrs-full_TypesOfRisksMember_867174_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LiquidityRiskMember" xlink:label="loc_ifrs-full_LiquidityRiskMember_867175" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksMember_867174" xlink:to="loc_ifrs-full_LiquidityRiskMember_867175" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk" xlink:label="loc_ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk_867176" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867168" xlink:to="loc_ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk_867176" use="optional" order="11" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsLineItems" xlink:label="loc_imtx_StatementsLineItems_867185" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsTable" xlink:label="loc_imtx_StatementsTable_867182" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imtx_StatementsLineItems_867185" xlink:to="loc_imtx_StatementsTable_867182" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-full_TypesOfRisksAxis_867188" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_StatementsTable_867182" xlink:to="loc_ifrs-full_TypesOfRisksAxis_867188" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-full_TypesOfRisksMember_867189" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfRisksAxis_867188" xlink:to="loc_ifrs-full_TypesOfRisksMember_867189" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-full_TypesOfRisksMember_867189_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfRisksAxis_867188" xlink:to="loc_ifrs-full_TypesOfRisksMember_867189_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CreditRiskMember" xlink:label="loc_ifrs-full_CreditRiskMember_867190" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksMember_867189" xlink:to="loc_ifrs-full_CreditRiskMember_867190" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrencyRiskMember" xlink:label="loc_ifrs-full_CurrencyRiskMember_867202" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksMember_867189" xlink:to="loc_ifrs-full_CurrencyRiskMember_867202" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_867192" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_StatementsTable_867182" xlink:to="loc_srt_CurrencyAxis_867192" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_867193" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_867192" xlink:to="loc_currency_AllCurrenciesDomain_867193" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_867193_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_867192" xlink:to="loc_currency_AllCurrenciesDomain_867193_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_EUR" xlink:label="loc_currency_EUR_867194" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_867193" xlink:to="loc_currency_EUR_867194" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_USD" xlink:label="loc_currency_USD_867195" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_867193" xlink:to="loc_currency_USD_867195" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_867204" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_StatementsTable_867182" xlink:to="loc_ifrs-full_RangeAxis_867204" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_867205" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_867204" xlink:to="loc_ifrs-full_RangesMember_867205" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_867205_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_867204" xlink:to="loc_ifrs-full_RangesMember_867205_default" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_867207" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_867205" xlink:to="loc_ifrs-full_TopOfRangeMember_867207" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_867208" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_867205" xlink:to="loc_ifrs-full_BottomOfRangeMember_867208" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_MaximumExposureToCreditRisk" xlink:label="loc_ifrs-full_MaximumExposureToCreditRisk_867210" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867185" xlink:to="loc_ifrs-full_MaximumExposureToCreditRisk_867210" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_867212" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867185" xlink:to="loc_ifrs-full_CashAndCashEquivalents_867212" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherFinancialAssets" xlink:label="loc_ifrs-full_OtherFinancialAssets_867214" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867185" xlink:to="loc_ifrs-full_OtherFinancialAssets_867214" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk" xlink:label="loc_imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk_867217" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867185" xlink:to="loc_imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk_867217" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk" xlink:label="loc_imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk_867218" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867185" xlink:to="loc_imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk_867218" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_867221" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_867185" xlink:to="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_867221" use="optional" order="22" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/FinancialInstrumentsSummaryOfCarryingAmountsAndFairValuesOfGroupsFinancialInstrumentsDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_866768" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_866753" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_866768" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_866753" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_866754" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_866753" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_866754" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsCategoryMember" xlink:label="loc_ifrs-full_FinancialAssetsCategoryMember_866755" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_866754" xlink:to="loc_ifrs-full_FinancialAssetsCategoryMember_866755" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsCategoryMember" xlink:label="loc_ifrs-full_FinancialAssetsCategoryMember_866755_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_866754" xlink:to="loc_ifrs-full_FinancialAssetsCategoryMember_866755_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_866756" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_866755" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_866756" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_OtherFinancialAssetsAtAmortizedCostMember" xlink:label="loc_imtx_OtherFinancialAssetsAtAmortizedCostMember_866757" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_866755" xlink:to="loc_imtx_OtherFinancialAssetsAtAmortizedCostMember_866757" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_866758" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_866753" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_866758" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-full_FinancialAssetsMember_866759" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_866758" xlink:to="loc_ifrs-full_FinancialAssetsMember_866759" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-full_FinancialAssetsMember_866759_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_866758" xlink:to="loc_ifrs-full_FinancialAssetsMember_866759_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShorttermDepositsMember" xlink:label="loc_imtx_ShorttermDepositsMember_866762" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsMember_866759" xlink:to="loc_imtx_ShorttermDepositsMember_866762" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PositiveMarketValueForwardContractsMember" xlink:label="loc_imtx_PositiveMarketValueForwardContractsMember_866763" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsMember_866759" xlink:to="loc_imtx_PositiveMarketValueForwardContractsMember_866763" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TradeReceivablesMember" xlink:label="loc_ifrs-full_TradeReceivablesMember_866764" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsMember_866759" xlink:to="loc_ifrs-full_TradeReceivablesMember_866764" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_OtherCurrentAssetMember" xlink:label="loc_imtx_OtherCurrentAssetMember_866765" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsMember_866759" xlink:to="loc_imtx_OtherCurrentAssetMember_866765" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AccountsPayableMember" xlink:label="loc_imtx_AccountsPayableMember_866766" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsMember_866759" xlink:to="loc_imtx_AccountsPayableMember_866766" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_OtherCurrentLiabilitiesMember" xlink:label="loc_imtx_OtherCurrentLiabilitiesMember_866767" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FinancialAssetsMember_866759" xlink:to="loc_imtx_OtherCurrentLiabilitiesMember_866767" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssets" xlink:label="loc_ifrs-full_FinancialAssets_866769" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_866768" xlink:to="loc_ifrs-full_FinancialAssets_866769" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialLiabilities" xlink:label="loc_ifrs-full_FinancialLiabilities_866770" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_866768" xlink:to="loc_ifrs-full_FinancialLiabilities_866770" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsAtFairValue" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValue_866771" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_866768" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValue_866771" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialLiabilitiesAtFairValue" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValue_866772" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_866768" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValue_866772" use="optional" order="19" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/CommitmentsAndContingenciesSummaryOfContractualObligationsDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfContractualObligationsLineItems" xlink:label="loc_imtx_DisclosureOfContractualObligationsLineItems_866739" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ContractualObligationOfLeaseLiabilities" xlink:label="loc_imtx_ContractualObligationOfLeaseLiabilities_866724" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfContractualObligationsLineItems_866739" xlink:to="loc_imtx_ContractualObligationOfLeaseLiabilities_866724" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_OtherLeaseObligations" xlink:label="loc_imtx_OtherLeaseObligations_866725" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfContractualObligationsLineItems_866739" xlink:to="loc_imtx_OtherLeaseObligations_866725" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ContractualObligationOfInLicenseAgreements" xlink:label="loc_imtx_ContractualObligationOfInLicenseAgreements_866727" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfContractualObligationsLineItems_866739" xlink:to="loc_imtx_ContractualObligationOfInLicenseAgreements_866727" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ContractResearchOrganizationAgreements" xlink:label="loc_imtx_ContractResearchOrganizationAgreements_866728" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfContractualObligationsLineItems_866739" xlink:to="loc_imtx_ContractResearchOrganizationAgreements_866728" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ContractualCashObligation" xlink:label="loc_imtx_ContractualCashObligation_866729" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_DisclosureOfContractualObligationsLineItems_866739" xlink:to="loc_imtx_ContractualCashObligation_866729" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfContractualObligationsTable" xlink:label="loc_imtx_DisclosureOfContractualObligationsTable_866732" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imtx_DisclosureOfContractualObligationsLineItems_866739" xlink:to="loc_imtx_DisclosureOfContractualObligationsTable_866732" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_866733" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_DisclosureOfContractualObligationsTable_866732" xlink:to="loc_ifrs-full_MaturityAxis_866733" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_866734" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_866733" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_866734" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_866734_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_866733" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_866734_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_866735" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_866734" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_866735" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_866736" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_866734" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_866736" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_866737" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_866734" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_866737" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_866738" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_866734" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_866738" use="optional" order="13" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/CommitmentsAndContingenciesAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsLineItems" xlink:label="loc_imtx_StatementsLineItems_876792" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsTable" xlink:label="loc_imtx_StatementsTable_876791" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_imtx_StatementsLineItems_876792" xlink:to="loc_imtx_StatementsTable_876791" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AgreementAxis" xlink:label="loc_imtx_AgreementAxis_876793" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_imtx_StatementsTable_876791" xlink:to="loc_imtx_AgreementAxis_876793" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AgreementDomain" xlink:label="loc_imtx_AgreementDomain_876794" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imtx_AgreementAxis_876793" xlink:to="loc_imtx_AgreementDomain_876794" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AgreementDomain" xlink:label="loc_imtx_AgreementDomain_876794_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imtx_AgreementAxis_876793" xlink:to="loc_imtx_AgreementDomain_876794_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CollaborationAgreementsMember" xlink:label="loc_imtx_CollaborationAgreementsMember_876795" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_AgreementDomain_876794" xlink:to="loc_imtx_CollaborationAgreementsMember_876795" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_UnrecordedContingentLiability" xlink:label="loc_imtx_UnrecordedContingentLiability_876798" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_StatementsLineItems_876792" xlink:to="loc_imtx_UnrecordedContingentLiability_876798" use="optional" order="6" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/RelatedPartyDisclosuresSummaryOfCompensationForTheSupervisoryBoardDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems_866572" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_KeyManagementPersonnelCompensationSupervisoryBoardCompensation" xlink:label="loc_imtx_KeyManagementPersonnelCompensationSupervisoryBoardCompensation_866537" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems_866572" xlink:to="loc_imtx_KeyManagementPersonnelCompensationSupervisoryBoardCompensation_866537" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_KeyManagementPersonnelCompensationTravellingExpenses" xlink:label="loc_imtx_KeyManagementPersonnelCompensationTravellingExpenses_866553" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems_866572" xlink:to="loc_imtx_KeyManagementPersonnelCompensationTravellingExpenses_866553" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_KeyManagementPersonnelCompensationShareBasedCompensationExpense" xlink:label="loc_imtx_KeyManagementPersonnelCompensationShareBasedCompensationExpense_866555" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems_866572" xlink:to="loc_imtx_KeyManagementPersonnelCompensationShareBasedCompensationExpense_866555" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_KeyManagementPersonnelCompensations" xlink:label="loc_imtx_KeyManagementPersonnelCompensations_866556" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems_866572" xlink:to="loc_imtx_KeyManagementPersonnelCompensations_866556" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesTable" xlink:label="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesTable_866562" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems_866572" xlink:to="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesTable_866562" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_866563" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesTable_866562" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_866563" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866565" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_866563" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866565" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866565_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_866563" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866565_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MichaelGAtiehMember" xlink:label="loc_imtx_MichaelGAtiehMember_866566" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866565" xlink:to="loc_imtx_MichaelGAtiehMember_866566" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PaulCarterMember" xlink:label="loc_imtx_PaulCarterMember_866567" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866565" xlink:to="loc_imtx_PaulCarterMember_866567" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_HeatherLMasonMember" xlink:label="loc_imtx_HeatherLMasonMember_866568" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866565" xlink:to="loc_imtx_HeatherLMasonMember_866568" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AdamStoneMember" xlink:label="loc_imtx_AdamStoneMember_866569" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866565" xlink:to="loc_imtx_AdamStoneMember_866569" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ChristophHettichMember" xlink:label="loc_imtx_ChristophHettichMember_866570" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866565" xlink:to="loc_imtx_ChristophHettichMember_866570" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EliotForsterMember" xlink:label="loc_imtx_EliotForsterMember_866571" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866565" xlink:to="loc_imtx_EliotForsterMember_866571" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PeterChambreMember" xlink:label="loc_imtx_PeterChambreMember_866573" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866565" xlink:to="loc_imtx_PeterChambreMember_866573" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_HaraldFstockMember" xlink:label="loc_imtx_HaraldFstockMember_866574" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866565" xlink:to="loc_imtx_HaraldFstockMember_866574" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_KeyManagementPersonnelCompensationPaymentExitArrangement" xlink:label="loc_imtx_KeyManagementPersonnelCompensationPaymentExitArrangement_880588" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems_866572" xlink:to="loc_imtx_KeyManagementPersonnelCompensationPaymentExitArrangement_880588" use="optional" order="17" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/RelatedPartyDisclosuresSummaryOfOptionsGrantedToManagingDirectorAndSupervisoryDirectorsDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866608" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_866581" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866608" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_866581" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TypeOfVestingAxis" xlink:label="loc_imtx_TypeOfVestingAxis_866584" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_866581" xlink:to="loc_imtx_TypeOfVestingAxis_866584" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TypeOfVestingDomain" xlink:label="loc_imtx_TypeOfVestingDomain_866586" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imtx_TypeOfVestingAxis_866584" xlink:to="loc_imtx_TypeOfVestingDomain_866586" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TypeOfVestingDomain" xlink:label="loc_imtx_TypeOfVestingDomain_866586_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imtx_TypeOfVestingAxis_866584" xlink:to="loc_imtx_TypeOfVestingDomain_866586_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PerformanceBasedOptionsMember" xlink:label="loc_imtx_PerformanceBasedOptionsMember_866587" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_TypeOfVestingDomain_866586" xlink:to="loc_imtx_PerformanceBasedOptionsMember_866587" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ServiceOptionsMember" xlink:label="loc_imtx_ServiceOptionsMember_866588" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_TypeOfVestingDomain_866586" xlink:to="loc_imtx_ServiceOptionsMember_866588" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MatchingStockOptionsMember" xlink:label="loc_imtx_MatchingStockOptionsMember_866589" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_TypeOfVestingDomain_866586" xlink:to="loc_imtx_MatchingStockOptionsMember_866589" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ConvertedOptionsMember" xlink:label="loc_imtx_ConvertedOptionsMember_866591" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_TypeOfVestingDomain_866586" xlink:to="loc_imtx_ConvertedOptionsMember_866591" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ConvertedOptionsOneMember" xlink:label="loc_imtx_ConvertedOptionsOneMember_870321" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_TypeOfVestingDomain_866586" xlink:to="loc_imtx_ConvertedOptionsOneMember_870321" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ServiceOptionsOneMember" xlink:label="loc_imtx_ServiceOptionsOneMember_870324" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_TypeOfVestingDomain_866586" xlink:to="loc_imtx_ServiceOptionsOneMember_870324" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_866593" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_866581" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_866593" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866594" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_866593" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866594" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866594_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_866593" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866594_default" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_HarpreetSinghMember" xlink:label="loc_imtx_HarpreetSinghMember_866595" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866594" xlink:to="loc_imtx_HarpreetSinghMember_866595" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PeterChambreMember" xlink:label="loc_imtx_PeterChambreMember_866596" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866594" xlink:to="loc_imtx_PeterChambreMember_866596" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AdamStoneMember" xlink:label="loc_imtx_AdamStoneMember_866597" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866594" xlink:to="loc_imtx_AdamStoneMember_866597" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ChristophHettichMember" xlink:label="loc_imtx_ChristophHettichMember_866598" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866594" xlink:to="loc_imtx_ChristophHettichMember_866598" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_HeatherLMasonMember" xlink:label="loc_imtx_HeatherLMasonMember_866602" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866594" xlink:to="loc_imtx_HeatherLMasonMember_866602" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MichaelGAtiehMember" xlink:label="loc_imtx_MichaelGAtiehMember_866604" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866594" xlink:to="loc_imtx_MichaelGAtiehMember_866604" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PaulCarterMember" xlink:label="loc_imtx_PaulCarterMember_866605" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866594" xlink:to="loc_imtx_PaulCarterMember_866605" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EliotForsterMember" xlink:label="loc_imtx_EliotForsterMember_866606" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866594" xlink:to="loc_imtx_EliotForsterMember_866606" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfTransactionsWithRelatedParty" xlink:label="loc_ifrs-full_DescriptionOfTransactionsWithRelatedParty_866609" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866608" xlink:to="loc_ifrs-full_DescriptionOfTransactionsWithRelatedParty_866609" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement_866610" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866608" xlink:to="loc_ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement_866610" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DateOfGrantOfSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement_866611" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866608" xlink:to="loc_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement_866611" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_866612" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866608" xlink:to="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_866612" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_866613" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866608" xlink:to="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_866613" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DateOfExpiryOfShareOptionsGranted" xlink:label="loc_imtx_DateOfExpiryOfShareOptionsGranted_866805" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866608" xlink:to="loc_imtx_DateOfExpiryOfShareOptionsGranted_866805" use="optional" order="27" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://imtx.com/role/RelatedPartyDisclosuresAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866680" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_866654" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866680" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_866654" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_866655" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_866654" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_866655" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866656" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_866655" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866656" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866656_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_866655" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866656_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_866657" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866656" xlink:to="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_866657" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PlanNameAxis" xlink:label="loc_imtx_PlanNameAxis_866658" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_866654" xlink:to="loc_imtx_PlanNameAxis_866658" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PlanNameDomain" xlink:label="loc_imtx_PlanNameDomain_866659" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imtx_PlanNameAxis_866658" xlink:to="loc_imtx_PlanNameDomain_866659" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PlanNameDomain" xlink:label="loc_imtx_PlanNameDomain_866659_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imtx_PlanNameAxis_866658" xlink:to="loc_imtx_PlanNameDomain_866659_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TwentyTwentyIncentivePlanMember" xlink:label="loc_imtx_TwentyTwentyIncentivePlanMember_866662" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_PlanNameDomain_866659" xlink:to="loc_imtx_TwentyTwentyIncentivePlanMember_866662" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TypeOfVestingAxis" xlink:label="loc_imtx_TypeOfVestingAxis_866666" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_866654" xlink:to="loc_imtx_TypeOfVestingAxis_866666" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TypeOfVestingDomain" xlink:label="loc_imtx_TypeOfVestingDomain_866667" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_imtx_TypeOfVestingAxis_866666" xlink:to="loc_imtx_TypeOfVestingDomain_866667" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TypeOfVestingDomain" xlink:label="loc_imtx_TypeOfVestingDomain_866667_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_imtx_TypeOfVestingAxis_866666" xlink:to="loc_imtx_TypeOfVestingDomain_866667_default" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ServiceOptionsMember" xlink:label="loc_imtx_ServiceOptionsMember_866668" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_TypeOfVestingDomain_866667" xlink:to="loc_imtx_ServiceOptionsMember_866668" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PerformanceBasedOptionsMember" xlink:label="loc_imtx_PerformanceBasedOptionsMember_866669" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_imtx_TypeOfVestingDomain_866667" xlink:to="loc_imtx_PerformanceBasedOptionsMember_866669" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_866671" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_866654" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_866671" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_866673" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_866671" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_866673" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_866673_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_866671" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_866673_default" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AryaMember" xlink:label="loc_imtx_AryaMember_866674" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_866673" xlink:to="loc_imtx_AryaMember_866674" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_866675" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_866654" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_866675" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_866677" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_866675" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_866677" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_866677_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_866675" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_866677_default" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ImmaticsGmbhMember" xlink:label="loc_imtx_ImmaticsGmbhMember_866678" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_866677" xlink:to="loc_imtx_ImmaticsGmbhMember_866678" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AccruedOfKeyManagementCompensation" xlink:label="loc_imtx_AccruedOfKeyManagementCompensation_866682" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866680" xlink:to="loc_imtx_AccruedOfKeyManagementCompensation_866682" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PercentageOfStockVestedOverThePeriodOfFourYearTimeBasedVestingSchedule" xlink:label="loc_imtx_PercentageOfStockVestedOverThePeriodOfFourYearTimeBasedVestingSchedule_866684" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866680" xlink:to="loc_imtx_PercentageOfStockVestedOverThePeriodOfFourYearTimeBasedVestingSchedule_866684" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_866686" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866680" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_866686" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PaymentOfPayrollTaxOfTheEmployees" xlink:label="loc_imtx_PaymentOfPayrollTaxOfTheEmployees_866692" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866680" xlink:to="loc_imtx_PaymentOfPayrollTaxOfTheEmployees_866692" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_NumberOfConvertedStockOptionsInTheEntity" xlink:label="loc_imtx_NumberOfConvertedStockOptionsInTheEntity_866698" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866680" xlink:to="loc_imtx_NumberOfConvertedStockOptionsInTheEntity_866698" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_NumberOfMatchingStockOptionInTheEntity" xlink:label="loc_imtx_NumberOfMatchingStockOptionInTheEntity_866701" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866680" xlink:to="loc_imtx_NumberOfMatchingStockOptionInTheEntity_866701" use="optional" order="28" />
</definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>14
<FILENAME>imtx-20201231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no" ?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 30-March-2021 [01:58:01] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
  <roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
  <labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract" xlink:type="locator"/>
    <label xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable" xlink:type="locator"/>
    <label xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_dei_EntityAddressesAddressTypeAxis" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Addresses, Address Type [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesAddressTypeAxis" xlink:to="lab_dei_EntityAddressesAddressTypeAxis" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain" xlink:type="locator"/>
    <label xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Address Type [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AddressTypeDomain" xlink:to="lab_dei_AddressTypeDomain" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_BusinessContactMember" xlink:label="loc_dei_BusinessContactMember" xlink:type="locator"/>
    <label xlink:label="lab_dei_BusinessContactMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Contact [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_BusinessContactMember" xlink:to="lab_dei_BusinessContactMember" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentInformationDocumentAxis" xlink:label="loc_dei_DocumentInformationDocumentAxis" xlink:type="locator"/>
    <label xlink:label="lab_dei_DocumentInformationDocumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information, Document [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationDocumentAxis" xlink:to="lab_dei_DocumentInformationDocumentAxis" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentDomain" xlink:label="loc_dei_DocumentDomain" xlink:type="locator"/>
    <label xlink:label="lab_dei_DocumentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentDomain" xlink:to="lab_dei_DocumentDomain" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_OrdinaryShareMember" xlink:label="loc_imtx_OrdinaryShareMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_OrdinaryShareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ordinary Share [Member]</label>
    <label xlink:label="lab_imtx_OrdinaryShareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Shares [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_OrdinaryShareMember" xlink:to="lab_imtx_OrdinaryShareMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_WarrantsMember" xlink:label="loc_imtx_WarrantsMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_WarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants [Member]</label>
    <label xlink:label="lab_imtx_WarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_WarrantsMember" xlink:to="lab_imtx_WarrantsMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_WarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrants.</label>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems" xlink:type="locator"/>
    <label xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType" xlink:type="locator"/>
    <label xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag" xlink:type="locator"/>
    <label xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:type="locator"/>
    <label xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:type="locator"/>
    <label xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:type="locator"/>
    <label xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:type="locator"/>
    <label xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport" xlink:type="locator"/>
    <label xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Annual Report</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:type="locator"/>
    <label xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_dei_DocumentAccountingStandard" xlink:type="locator"/>
    <label xlink:label="lab_dei_DocumentAccountingStandard" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Accounting Standard</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAccountingStandard" xlink:to="lab_dei_DocumentAccountingStandard" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol" xlink:type="locator"/>
    <label xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle" xlink:type="locator"/>
    <label xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_ContactPersonnelName" xlink:label="loc_dei_ContactPersonnelName" xlink:type="locator"/>
    <label xlink:label="lab_dei_ContactPersonnelName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contact Personnel Name</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelName" xlink:to="lab_dei_ContactPersonnelName" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Country</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode" xlink:type="locator"/>
    <label xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber" xlink:type="locator"/>
    <label xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_dei_DocumentRegistrationStatement" xlink:type="locator"/>
    <label xlink:label="lab_dei_DocumentRegistrationStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Registration Statement</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentRegistrationStatement" xlink:to="lab_dei_DocumentRegistrationStatement" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_dei_DocumentShellCompanyReport" xlink:type="locator"/>
    <label xlink:label="lab_dei_DocumentShellCompanyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Shell Company Report</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentShellCompanyReport" xlink:to="lab_dei_DocumentShellCompanyReport" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport" xlink:type="locator"/>
    <label xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName" xlink:type="locator"/>
    <label xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of financial position [abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="lab_ifrs-full_StatementOfFinancialPositionAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="loc_ifrs-full_EquityAndLiabilitiesAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_EquityAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity and liabilities [abstract]</label>
    <label xlink:label="lab_ifrs-full_EquityAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and shareholders' deficit</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract" xlink:to="lab_ifrs-full_EquityAndLiabilitiesAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_NoncurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current liabilities [abstract]</label>
    <label xlink:label="lab_ifrs-full_NoncurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current liabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="lab_ifrs-full_NoncurrentLiabilitiesAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_NoncurrentLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current lease liabilities</label>
    <label xlink:label="lab_ifrs-full_NoncurrentLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities</label>
    <label xlink:label="lab_ifrs-full_NoncurrentLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liability &#x2013; non-current</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLeaseLiabilities" xlink:to="lab_ifrs-full_NoncurrentLeaseLiabilities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherNoncurrentLiabilities" xlink:label="loc_ifrs-full_OtherNoncurrentLiabilities" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_OtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other non-current liabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentLiabilities" xlink:to="lab_ifrs-full_OtherNoncurrentLiabilities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_NoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current liabilities</label>
    <label xlink:label="lab_ifrs-full_NoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total non-current liabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilities" xlink:to="lab_ifrs-full_NoncurrentLiabilities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentContractLiabilities" xlink:label="loc_ifrs-full_NoncurrentContractLiabilities" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_NoncurrentContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current contract liabilities</label>
    <label xlink:label="lab_ifrs-full_NoncurrentContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</label>
    <label xlink:label="lab_ifrs-full_NoncurrentContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentContractLiabilities" xlink:to="lab_ifrs-full_NoncurrentContractLiabilities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-full_EquityAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [abstract]</label>
    <label xlink:label="lab_ifrs-full_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shareholders' equity (deficit)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAbstract" xlink:to="lab_ifrs-full_EquityAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_IssuedCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issued capital</label>
    <label xlink:label="lab_ifrs-full_IssuedCapital" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share capital</label>
    <label xlink:label="lab_ifrs-full_IssuedCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares value outstanding</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapital" xlink:to="lab_ifrs-full_IssuedCapital" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharePremium" xlink:label="loc_ifrs-full_SharePremium" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_SharePremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share premium</label>
    <label xlink:label="lab_ifrs-full_SharePremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share premium</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SharePremium" xlink:to="lab_ifrs-full_SharePremium" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_RetainedEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained earnings</label>
    <label xlink:label="lab_ifrs-full_RetainedEarnings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarnings" xlink:to="lab_ifrs-full_RetainedEarnings" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherReserves" xlink:label="loc_ifrs-full_OtherReserves" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_OtherReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other reserves</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherReserves" xlink:to="lab_ifrs-full_OtherReserves" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParent" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_EquityAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity attributable to owners of parent</label>
    <label xlink:label="lab_ifrs-full_EquityAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total equity (deficit) attributable to shareholders of the parent</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="lab_ifrs-full_EquityAttributableToOwnersOfParent" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncontrollingInterests" xlink:label="loc_ifrs-full_NoncontrollingInterests" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_NoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-controlling interests</label>
    <label xlink:label="lab_ifrs-full_NoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Non-controlling interest</label>
    <label xlink:label="lab_ifrs-full_NoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-controlling interests</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncontrollingInterests" xlink:to="lab_ifrs-full_NoncontrollingInterests" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_Equity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity</label>
    <label xlink:label="lab_ifrs-full_Equity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total shareholders' equity (deficit)</label>
    <label xlink:label="lab_ifrs-full_Equity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning Balance</label>
    <label xlink:label="lab_ifrs-full_Equity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending Balance</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity" xlink:to="lab_ifrs-full_Equity" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_CurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current liabilities [abstract]</label>
    <label xlink:label="lab_ifrs-full_CurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract" xlink:to="lab_ifrs-full_CurrentLiabilitiesAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current trade payables</label>
    <label xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</label>
    <label xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total accounts payable</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentContractLiabilities" xlink:label="loc_ifrs-full_CurrentContractLiabilities" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_CurrentContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current contract liabilities</label>
    <label xlink:label="lab_ifrs-full_CurrentContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</label>
    <label xlink:label="lab_ifrs-full_CurrentContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentContractLiabilities" xlink:to="lab_ifrs-full_CurrentContractLiabilities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_CurrentLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current lease liabilities</label>
    <label xlink:label="lab_ifrs-full_CurrentLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities</label>
    <label xlink:label="lab_ifrs-full_CurrentLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liability &#x2013; current</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLeaseLiabilities" xlink:to="lab_ifrs-full_CurrentLeaseLiabilities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherCurrentLiabilities" xlink:label="loc_ifrs-full_OtherCurrentLiabilities" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_OtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other current liabilities</label>
    <label xlink:label="lab_ifrs-full_OtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCurrentLiabilities" xlink:to="lab_ifrs-full_OtherCurrentLiabilities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_CurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current liabilities</label>
    <label xlink:label="lab_ifrs-full_CurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilities" xlink:to="lab_ifrs-full_CurrentLiabilities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentProvisions" xlink:label="loc_ifrs-full_CurrentProvisions" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_CurrentProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current provisions</label>
    <label xlink:label="lab_ifrs-full_CurrentProvisions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Provisions</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentProvisions" xlink:to="lab_ifrs-full_CurrentProvisions" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_EquityAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity and liabilities</label>
    <label xlink:label="lab_ifrs-full_EquityAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and shareholders' equity (deficit)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilities" xlink:to="lab_ifrs-full_EquityAndLiabilities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AssetsAbstract" xlink:label="loc_ifrs-full_AssetsAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [abstract]</label>
    <label xlink:label="lab_ifrs-full_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsAbstract" xlink:to="lab_ifrs-full_AssetsAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</label>
    <label xlink:label="lab_ifrs-full_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Assets" xlink:to="lab_ifrs-full_Assets" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_NoncurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current assets [abstract]</label>
    <label xlink:label="lab_ifrs-full_NoncurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract" xlink:to="lab_ifrs-full_NoncurrentAssetsAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current assets</label>
    <label xlink:label="lab_ifrs-full_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total non-current assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssets" xlink:to="lab_ifrs-full_NoncurrentAssets" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="loc_ifrs-full_OtherNoncurrentAssets" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_OtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other non-current assets</label>
    <label xlink:label="lab_ifrs-full_OtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total non-current assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentAssets" xlink:to="lab_ifrs-full_OtherNoncurrentAssets" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_RightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-use assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssets" xlink:to="lab_ifrs-full_RightofuseAssets" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible assets other than goodwill</label>
    <label xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_PropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</label>
    <label xlink:label="lab_ifrs-full_PropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning Cost</label>
    <label xlink:label="lab_ifrs-full_PropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending Cost</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="loc_ifrs-full_CurrentAssetsAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_CurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current assets [abstract]</label>
    <label xlink:label="lab_ifrs-full_CurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsAbstract" xlink:to="lab_ifrs-full_CurrentAssetsAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_CurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current assets</label>
    <label xlink:label="lab_ifrs-full_CurrentAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssets" xlink:to="lab_ifrs-full_CurrentAssets" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherCurrentAssets" xlink:label="loc_ifrs-full_OtherCurrentAssets" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_OtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other current assets</label>
    <label xlink:label="lab_ifrs-full_OtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other current assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCurrentAssets" xlink:to="lab_ifrs-full_OtherCurrentAssets" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_CurrentTradeReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current trade receivables</label>
    <label xlink:label="lab_ifrs-full_CurrentTradeReceivables" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTradeReceivables" xlink:to="lab_ifrs-full_CurrentTradeReceivables" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherCurrentFinancialAssets" xlink:label="loc_ifrs-full_OtherCurrentFinancialAssets" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_OtherCurrentFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other current financial assets</label>
    <label xlink:label="lab_ifrs-full_OtherCurrentFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other financial assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCurrentFinancialAssets" xlink:to="lab_ifrs-full_OtherCurrentFinancialAssets" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_CashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:label="lab_ifrs-full_CashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents at beginning of period</label>
    <label xlink:label="lab_ifrs-full_CashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents at end of period</label>
    <label xlink:label="lab_ifrs-full_CashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents" xlink:to="lab_ifrs-full_CashAndCashEquivalents" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="loc_ifrs-full_IncomeStatementAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit or loss [abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeStatementAbstract" xlink:to="lab_ifrs-full_IncomeStatementAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and development expense</label>
    <label xlink:label="lab_ifrs-full_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Research and development expenses</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ResearchAndDevelopmentExpense" xlink:to="lab_ifrs-full_ResearchAndDevelopmentExpense" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and administrative expense</label>
    <label xlink:label="lab_ifrs-full_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">General and administrative expenses</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeneralAndAdministrativeExpense" xlink:to="lab_ifrs-full_GeneralAndAdministrativeExpense" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-full_OtherIncome" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other income</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIncome" xlink:to="lab_ifrs-full_OtherIncome" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit (loss) from operating activities</label>
    <label xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating result</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities" xlink:to="lab_ifrs-full_ProfitLossFromOperatingActivities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_FinanceIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance income</label>
    <label xlink:label="lab_ifrs-full_FinanceIncome" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Financial income</label>
    <label xlink:label="lab_ifrs-full_FinanceIncome" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Financial income</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceIncome" xlink:to="lab_ifrs-full_FinanceIncome" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_FinanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance costs</label>
    <label xlink:label="lab_ifrs-full_FinanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Financial expenses</label>
    <label xlink:label="lab_ifrs-full_FinanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Financial expenses</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceCosts" xlink:to="lab_ifrs-full_FinanceCosts" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_ShareListingExpense" xlink:label="loc_imtx_ShareListingExpense" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ShareListingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share listing expense</label>
    <label xlink:label="lab_imtx_ShareListingExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Share listing expense</label>
    <label xlink:label="lab_imtx_ShareListingExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share listing expense</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ShareListingExpense" xlink:to="lab_imtx_ShareListingExpense" xlink:type="arc"/>
    <label xlink:label="lab_imtx_ShareListingExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share listing expense.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinanceIncomeCost" xlink:label="loc_ifrs-full_FinanceIncomeCost" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_FinanceIncomeCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance income (cost)</label>
    <label xlink:label="lab_ifrs-full_FinanceIncomeCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Financial result</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceIncomeCost" xlink:to="lab_ifrs-full_FinanceIncomeCost" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ProfitLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit (loss) before tax</label>
    <label xlink:label="lab_ifrs-full_ProfitLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss before taxes</label>
    <label xlink:label="lab_ifrs-full_ProfitLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Loss before taxation</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossBeforeTax" xlink:to="lab_ifrs-full_ProfitLossBeforeTax" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax expense (income)</label>
    <label xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Taxes on income</label>
    <label xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Taxes on income</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit (loss)</label>
    <label xlink:label="lab_ifrs-full_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss</label>
    <label xlink:label="lab_ifrs-full_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net Loss</label>
    <label xlink:label="lab_ifrs-full_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss before tax</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss" xlink:to="lab_ifrs-full_ProfitLoss" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossAttributableToAbstract" xlink:label="loc_ifrs-full_ProfitLossAttributableToAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ProfitLossAttributableToAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit (loss), attributable to [abstract]</label>
    <label xlink:label="lab_ifrs-full_ProfitLossAttributableToAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Attributable to:</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToAbstract" xlink:to="lab_ifrs-full_ProfitLossAttributableToAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit (loss), attributable to owners of parent</label>
    <label xlink:label="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Equity holders of the parent</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:to="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit (loss), attributable to non-controlling interests</label>
    <label xlink:label="lab_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Non-controlling interest</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:to="lab_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BasicAndDilutedEarningsLossPerShare" xlink:label="loc_ifrs-full_BasicAndDilutedEarningsLossPerShare" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_BasicAndDilutedEarningsLossPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basic and diluted earnings (loss) per share</label>
    <label xlink:label="lab_ifrs-full_BasicAndDilutedEarningsLossPerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share&#x2014;basic and diluted</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicAndDilutedEarningsLossPerShare" xlink:to="lab_ifrs-full_BasicAndDilutedEarningsLossPerShare" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_WeightedAverageShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average number of ordinary shares outstanding</label>
    <label xlink:label="lab_ifrs-full_WeightedAverageShares" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average shares outstanding&#x2014;basic and diluted</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageShares" xlink:to="lab_ifrs-full_WeightedAverageShares" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_RevenueFromCollaborationAgreements" xlink:label="loc_imtx_RevenueFromCollaborationAgreements" xlink:type="locator"/>
    <label xlink:label="lab_imtx_RevenueFromCollaborationAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from collaboration agreements</label>
    <label xlink:label="lab_imtx_RevenueFromCollaborationAgreements" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Revenue from collaboration agreements</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_RevenueFromCollaborationAgreements" xlink:to="lab_imtx_RevenueFromCollaborationAgreements" xlink:type="arc"/>
    <label xlink:label="lab_imtx_RevenueFromCollaborationAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue from collaboration agreements</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:label="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of comprehensive income [abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:to="lab_ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherComprehensiveIncomeAbstract" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_OtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income [abstract]</label>
    <label xlink:label="lab_ifrs-full_OtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive loss</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:label="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]</label>
    <label xlink:label="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Items that may be reclassified subsequently to profit or loss, net of tax</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gains (losses) on exchange differences on translation, net of tax</label>
    <label xlink:label="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Currency translation differences from foreign operations</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:to="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive income</label>
    <label xlink:label="lab_ifrs-full_ComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total comprehensive loss for the period</label>
    <label xlink:label="lab_ifrs-full_ComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total comprehensive loss for the period</label>
    <label xlink:label="lab_ifrs-full_ComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Comprehensive loss for the year</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome" xlink:to="lab_ifrs-full_ComprehensiveIncome" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncomeAttributableToAbstract" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive income attributable to [abstract]</label>
    <label xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Attributable to:</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToAbstract" xlink:to="lab_ifrs-full_ComprehensiveIncomeAttributableToAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive income, attributable to owners of parent</label>
    <label xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Equity holders of the parent</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:to="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive income, attributable to non-controlling interests</label>
    <label xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Non-controlling interest</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:to="lab_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of cash flows [abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract" xlink:to="lab_ifrs-full_StatementOfCashFlowsAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) operating activities [abstract]</label>
    <label xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile profit (loss) [abstract]</label>
    <label xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Adjustments for:</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForInterestIncome" xlink:label="loc_ifrs-full_AdjustmentsForInterestIncome" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_AdjustmentsForInterestIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for interest income</label>
    <label xlink:label="lab_ifrs-full_AdjustmentsForInterestIncome" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Interest income</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForInterestIncome" xlink:to="lab_ifrs-full_AdjustmentsForInterestIncome" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for depreciation and amortisation expense</label>
    <label xlink:label="lab_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:to="lab_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForInterestExpense" xlink:label="loc_ifrs-full_AdjustmentsForInterestExpense" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_AdjustmentsForInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for interest expense</label>
    <label xlink:label="lab_ifrs-full_AdjustmentsForInterestExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForInterestExpense" xlink:to="lab_ifrs-full_AdjustmentsForInterestExpense" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_AdjustmentsForShareListingExpense" xlink:label="loc_imtx_AdjustmentsForShareListingExpense" xlink:type="locator"/>
    <label xlink:label="lab_imtx_AdjustmentsForShareListingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments For Share Listing Expense</label>
    <label xlink:label="lab_imtx_AdjustmentsForShareListingExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share listing expense</label>
    <label xlink:label="lab_imtx_AdjustmentsForShareListingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expense on the closing date</label>
    <label xlink:label="lab_imtx_AdjustmentsForShareListingExpense" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:type="resource" xml:lang="en-US">IFRS 2 Expense on the closing date</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_AdjustmentsForShareListingExpense" xlink:to="lab_imtx_AdjustmentsForShareListingExpense" xlink:type="arc"/>
    <label xlink:label="lab_imtx_AdjustmentsForShareListingExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustments for share listing expense.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_AdjustmentForEquitySettledSharebasedPayment" xlink:label="loc_imtx_AdjustmentForEquitySettledSharebasedPayment" xlink:type="locator"/>
    <label xlink:label="lab_imtx_AdjustmentForEquitySettledSharebasedPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment for equity settled sharebased payment</label>
    <label xlink:label="lab_imtx_AdjustmentForEquitySettledSharebasedPayment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Equity settled share-based payment</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_AdjustmentForEquitySettledSharebasedPayment" xlink:to="lab_imtx_AdjustmentForEquitySettledSharebasedPayment" xlink:type="arc"/>
    <label xlink:label="lab_imtx_AdjustmentForEquitySettledSharebasedPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustment for equity settled share-based payment.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for share-based payments</label>
    <label xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">MD Anderson compensation expense</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForSharebasedPayments" xlink:to="lab_ifrs-full_AdjustmentsForSharebasedPayments" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for increase (decrease) in other liabilities</label>
    <label xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">(Decrease) Increase in other liabilities resulting from share appreciation rights</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_PaymentsForShareBasedCompensation" xlink:label="loc_imtx_PaymentsForShareBasedCompensation" xlink:type="locator"/>
    <label xlink:label="lab_imtx_PaymentsForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments For Share Based Compensation</label>
    <label xlink:label="lab_imtx_PaymentsForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Payment related to share-based compensation awards previously classified as equity-settled</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_PaymentsForShareBasedCompensation" xlink:to="lab_imtx_PaymentsForShareBasedCompensation" xlink:type="arc"/>
    <label xlink:label="lab_imtx_PaymentsForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments for share based compensation.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:label="loc_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for unrealised foreign exchange losses (gains)</label>
    <label xlink:label="lab_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net foreign exchange differences</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:to="lab_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_ChangesInWorkingCapitalAbstract" xlink:label="loc_imtx_ChangesInWorkingCapitalAbstract" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ChangesInWorkingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changes In Working Capital [Abstract]</label>
    <label xlink:label="lab_imtx_ChangesInWorkingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Changes in working capital</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ChangesInWorkingCapitalAbstract" xlink:to="lab_imtx_ChangesInWorkingCapitalAbstract" xlink:type="arc"/>
    <label xlink:label="lab_imtx_ChangesInWorkingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Changes in working capital [Abstract].</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for decrease (increase) in trade accounts receivable</label>
    <label xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Increase in accounts receivable</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for decrease (increase) in other assets</label>
    <label xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) in other assets</label>
    <label xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">(Increase) decrease in other assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest received, classified as operating activities</label>
    <label xlink:label="lab_ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Interest received</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:to="lab_ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest paid, classified as operating activities</label>
    <label xlink:label="lab_ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Interest paid</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:to="lab_ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) operating activities</label>
    <label xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by/(used in) operating activities</label>
    <label xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by/ (used in) operating activities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for increase (decrease) in trade and other payables</label>
    <label xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">(Increase) decrease in accounts payable and other current liabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) investing activities [abstract]</label>
    <label xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase of property, plant and equipment, classified as investing activities</label>
    <label xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Payments for property, plant and equipment</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase of investments other than investments accounted for using equity method</label>
    <label xlink:label="lab_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Cash paid for investments in Other financial assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:to="lab_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from sales of investments other than investments accounted for using equity method</label>
    <label xlink:label="lab_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash received from maturity of investments classified in Other financial assets</label>
    <label xlink:label="lab_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash received from maturity of investments classified in Other financial assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:to="lab_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase of intangible assets, classified as investing activities</label>
    <label xlink:label="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Payments for intangible assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:to="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from sales of property, plant and equipment, classified as investing activities</label>
    <label xlink:label="lab_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from disposal of property, plant and equipment</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="lab_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) investing activities</label>
    <label xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by/(used in) investing activities</label>
    <label xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by/ (used in) investing activities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) financing activities [abstract]</label>
    <label xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ProceedsFromIssuingShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from issuing shares</label>
    <label xlink:label="lab_ifrs-full_ProceedsFromIssuingShares" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of shares to equity holders of the parent</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingShares" xlink:to="lab_ifrs-full_ProceedsFromIssuingShares" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of lease liabilities, classified as financing activities</label>
    <label xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Payments for leases</label>
    <label xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments for leases</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:to="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) financing activities</label>
    <label xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by/(used in) financing activities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_PaymentsForShareIssueCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for share issue costs</label>
    <label xlink:label="lab_ifrs-full_PaymentsForShareIssueCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Transaction cost deducted from equity</label>
    <label xlink:label="lab_ifrs-full_PaymentsForShareIssueCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Payment for share issuance costs</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsForShareIssueCosts" xlink:to="lab_ifrs-full_PaymentsForShareIssueCosts" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in cash and cash equivalents before effect of exchange rate changes</label>
    <label xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net increase in cash and cash equivalents</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:to="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</label>
    <label xlink:label="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Effects of exchange rate changes on cash and cash equivalents</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:to="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_StatementOfChangesInEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of changes in equity [abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract" xlink:to="lab_ifrs-full_StatementOfChangesInEquityAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_StatementOfChangesInEquityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of changes in equity [table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable" xlink:to="lab_ifrs-full_StatementOfChangesInEquityTable" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ComponentsOfEquityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of equity [axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis" xlink:to="lab_ifrs-full_ComponentsOfEquityAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_EquityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityMember" xlink:to="lab_ifrs-full_EquityMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_IssuedCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issued capital [member]</label>
    <label xlink:label="lab_ifrs-full_IssuedCapitalMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share capital [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapitalMember" xlink:to="lab_ifrs-full_IssuedCapitalMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharePremiumMember" xlink:label="loc_ifrs-full_SharePremiumMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_SharePremiumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share premium [member]</label>
    <label xlink:label="lab_ifrs-full_SharePremiumMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share premium [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SharePremiumMember" xlink:to="lab_ifrs-full_SharePremiumMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained earnings [member]</label>
    <label xlink:label="lab_ifrs-full_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarningsMember" xlink:to="lab_ifrs-full_RetainedEarningsMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherReservesMember" xlink:label="loc_ifrs-full_OtherReservesMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_OtherReservesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other reserves [member]</label>
    <label xlink:label="lab_ifrs-full_OtherReservesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other reserves [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherReservesMember" xlink:to="lab_ifrs-full_OtherReservesMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_TotalEquityAttributableToShareholdersOfParentMember" xlink:label="loc_imtx_TotalEquityAttributableToShareholdersOfParentMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_TotalEquityAttributableToShareholdersOfParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Equity Attributable To Shareholders Of Parent [Member]</label>
    <label xlink:label="lab_imtx_TotalEquityAttributableToShareholdersOfParentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total equity attributable to shareholders of the parent [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_TotalEquityAttributableToShareholdersOfParentMember" xlink:to="lab_imtx_TotalEquityAttributableToShareholdersOfParentMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncontrollingInterestsMember" xlink:label="loc_ifrs-full_NoncontrollingInterestsMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_NoncontrollingInterestsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-controlling interests [member]</label>
    <label xlink:label="lab_ifrs-full_NoncontrollingInterestsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Non-controlling interests [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncontrollingInterestsMember" xlink:to="lab_ifrs-full_NoncontrollingInterestsMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_StatementOfChangesInEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of changes in equity [line items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="lab_ifrs-full_StatementOfChangesInEquityLineItems" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_OtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income</label>
    <label xlink:label="lab_ifrs-full_OtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive loss</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncome" xlink:to="lab_ifrs-full_OtherComprehensiveIncome" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through share-based payment transactions, equity</label>
    <label xlink:label="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity-settled share-based compensation</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_IssueOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issue of equity</label>
    <label xlink:label="lab_ifrs-full_IssueOfEquity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Issuance of ordinary shares</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssueOfEquity" xlink:to="lab_ifrs-full_IssueOfEquity" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_IncreasedecreaseThroughCompensationExpense" xlink:label="loc_imtx_IncreasedecreaseThroughCompensationExpense" xlink:type="locator"/>
    <label xlink:label="lab_imtx_IncreasedecreaseThroughCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase Decrease Through Compensation Expense</label>
    <label xlink:label="lab_imtx_IncreasedecreaseThroughCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">MD Anderson compensation expense</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_IncreasedecreaseThroughCompensationExpense" xlink:to="lab_imtx_IncreasedecreaseThroughCompensationExpense" xlink:type="arc"/>
    <label xlink:label="lab_imtx_IncreasedecreaseThroughCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (decrease) through compensation expense.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_IncreaseDecreaseThroughReorganizationEquity" xlink:label="loc_imtx_IncreaseDecreaseThroughReorganizationEquity" xlink:type="locator"/>
    <label xlink:label="lab_imtx_IncreaseDecreaseThroughReorganizationEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase Decrease Through Reorganization Equity</label>
    <label xlink:label="lab_imtx_IncreaseDecreaseThroughReorganizationEquity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Reorganization</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_IncreaseDecreaseThroughReorganizationEquity" xlink:to="lab_imtx_IncreaseDecreaseThroughReorganizationEquity" xlink:type="arc"/>
    <label xlink:label="lab_imtx_IncreaseDecreaseThroughReorganizationEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (decrease) through reorganization, equity.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest" xlink:label="loc_imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest" xlink:type="locator"/>
    <label xlink:label="lab_imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase decrease through Changes in Noncontrolling Interest</label>
    <label xlink:label="lab_imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">MD Anderson Share Exchange</label>
    <label xlink:label="lab_imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/disclosureGuidance" xlink:type="resource" xml:lang="en-US">Increase (decrease) through changes in noncontrolling interest</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest" xlink:to="lab_imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest" xlink:type="arc"/>
    <label xlink:label="lab_imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (decrease) through changes in noncontrolling interest.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase through other contributions by owners, equity</label>
    <label xlink:label="lab_ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">PIPE Financing, net of transaction costs</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_IncreaseThroughARYAMerger" xlink:label="loc_imtx_IncreaseThroughARYAMerger" xlink:type="locator"/>
    <label xlink:label="lab_imtx_IncreaseThroughARYAMerger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase Through A R Y A Merger</label>
    <label xlink:label="lab_imtx_IncreaseThroughARYAMerger" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">ARYA Merger, net of transaction costs</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_IncreaseThroughARYAMerger" xlink:to="lab_imtx_IncreaseThroughARYAMerger" xlink:type="arc"/>
    <label xlink:label="lab_imtx_IncreaseThroughARYAMerger" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase through ARYA Merger.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_SARConversion" xlink:label="loc_imtx_SARConversion" xlink:type="locator"/>
    <label xlink:label="lab_imtx_SARConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">S A R conversion</label>
    <label xlink:label="lab_imtx_SARConversion" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">SAR conversion</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_SARConversion" xlink:to="lab_imtx_SARConversion" xlink:type="arc"/>
    <label xlink:label="lab_imtx_SARConversion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">SAR conversion.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_IncreasedecreaseThroughIssuanceOfEquity" xlink:label="loc_imtx_IncreasedecreaseThroughIssuanceOfEquity" xlink:type="locator"/>
    <label xlink:label="lab_imtx_IncreasedecreaseThroughIssuanceOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase Decrease Through Issuance Of Equity</label>
    <label xlink:label="lab_imtx_IncreasedecreaseThroughIssuanceOfEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total issuance of share capital</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_IncreasedecreaseThroughIssuanceOfEquity" xlink:to="lab_imtx_IncreasedecreaseThroughIssuanceOfEquity" xlink:type="arc"/>
    <label xlink:label="lab_imtx_IncreasedecreaseThroughIssuanceOfEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (decrease) through issuance of equity.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_IncreasedecreaseThroughShareBasedCompensationPreviouslyClassifiesAsEquitySettled" xlink:label="loc_imtx_IncreasedecreaseThroughShareBasedCompensationPreviouslyClassifiesAsEquitySettled" xlink:type="locator"/>
    <label xlink:label="lab_imtx_IncreasedecreaseThroughShareBasedCompensationPreviouslyClassifiesAsEquitySettled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase Decrease Through Share Based Compensation Previously Classifies As Equity Settled</label>
    <label xlink:label="lab_imtx_IncreasedecreaseThroughShareBasedCompensationPreviouslyClassifiesAsEquitySettled" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Payment related to share-based compensation awards previously classified as equity-settled</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_IncreasedecreaseThroughShareBasedCompensationPreviouslyClassifiesAsEquitySettled" xlink:to="lab_imtx_IncreasedecreaseThroughShareBasedCompensationPreviouslyClassifiesAsEquitySettled" xlink:type="arc"/>
    <label xlink:label="lab_imtx_IncreasedecreaseThroughShareBasedCompensationPreviouslyClassifiesAsEquitySettled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (decrease) through share based compensation previously classifies as equity settled.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract" xlink:type="locator"/>
    <label xlink:label="lab_imtx_TextBlockAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Text Block [Abstract]</label>
    <label xlink:label="lab_imtx_TextBlockAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Text Block [Abstract]</label>
    <label xlink:label="lab_imtx_TextBlockAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Text block [abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_TextBlockAbstract" xlink:to="lab_imtx_TextBlockAbstract" xlink:type="arc"/>
    <label xlink:label="lab_imtx_TextBlockAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Text block.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfCompositionOfGroupExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCompositionOfGroupExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfCompositionOfGroupExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of composition of group [text block]</label>
    <label xlink:label="lab_ifrs-full_DisclosureOfCompositionOfGroupExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Group information</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCompositionOfGroupExplanatory" xlink:to="lab_ifrs-full_DisclosureOfCompositionOfGroupExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of basis of preparation of financial statements [text block]</label>
    <label xlink:label="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of presentation</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_AryaMergerTransactionExplanatory" xlink:label="loc_imtx_AryaMergerTransactionExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_imtx_AryaMergerTransactionExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ARYA Merger transaction Explanatory</label>
    <label xlink:label="lab_imtx_AryaMergerTransactionExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ARYA Merger</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_AryaMergerTransactionExplanatory" xlink:to="lab_imtx_AryaMergerTransactionExplanatory" xlink:type="arc"/>
    <label xlink:label="lab_imtx_AryaMergerTransactionExplanatory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The entire disclosure of ARYA Merger transaction explanatory.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of changes in accounting policies, accounting estimates and errors [text block]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of significant accounting policies [text block]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of accounting judgements and estimates [text block]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfAccountReceivableExplanatoryTextBlock" xlink:label="loc_imtx_DisclosureOfAccountReceivableExplanatoryTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfAccountReceivableExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Account Receivable Explanatory [Text Block]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfAccountReceivableExplanatoryTextBlock" xlink:to="lab_imtx_DisclosureOfAccountReceivableExplanatoryTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfAccountReceivableExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of account receivable Explanatory.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfOtherAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOtherAssetsExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfOtherAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of other assets [text block]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherAssetsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfOtherAssetsExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of property, plant and equipment [text block]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of intangible assets [text block]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:label="loc_ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Presentation of leases for lessee [abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="lab_ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfLeasesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfLeasesExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfLeasesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of leases [text block]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfLeasesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfLeasesExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of trade and other payables [text block]</label>
    <label xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of revenue from contracts with customers [text block]</label>
    <label xlink:label="lab_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from collaboration agreements</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:to="lab_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of other operating income [text block]</label>
    <label xlink:label="lab_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory" xlink:to="lab_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfOtherCurrentLiabilitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOtherCurrentLiabilitiesExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfOtherCurrentLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of other current liabilities [text block]</label>
    <label xlink:label="lab_ifrs-full_DisclosureOfOtherCurrentLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other current liabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherCurrentLiabilitiesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfOtherCurrentLiabilitiesExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of finance income (cost) [text block]</label>
    <label xlink:label="lab_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial income and expenses</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:to="lab_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfShareListingExpenseTextBlock" xlink:label="loc_imtx_DisclosureOfShareListingExpenseTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfShareListingExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Share Listing Expense [Text Block]</label>
    <label xlink:label="lab_imtx_DisclosureOfShareListingExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share listing expense</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfShareListingExpenseTextBlock" xlink:to="lab_imtx_DisclosureOfShareListingExpenseTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfShareListingExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of share listing expense.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of share-based payment arrangements [text block]</label>
    <label xlink:label="lab_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based payments</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:label="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of share capital, reserves and other equity interest [text block]</label>
    <label xlink:label="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shareholders' equity (deficit)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:to="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of non-controlling interests [text block]</label>
    <label xlink:label="lab_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-controlling&#xA0;interests</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfPersonnelExpensesExplanatoryTextBlock" xlink:label="loc_imtx_DisclosureOfPersonnelExpensesExplanatoryTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfPersonnelExpensesExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Personnel Expenses Explanatory [Text Block]</label>
    <label xlink:label="lab_imtx_DisclosureOfPersonnelExpensesExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Personnel expenses</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfPersonnelExpensesExplanatoryTextBlock" xlink:to="lab_imtx_DisclosureOfPersonnelExpensesExplanatoryTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfPersonnelExpensesExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Personnel Expenses Explanatory.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of income tax [text block]</label>
    <label xlink:label="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:to="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of financial risk management [text block]</label>
    <label xlink:label="lab_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Risk Management Objectives and Policies</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:to="lab_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of financial instruments [text block]</label>
    <label xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of commitments and contingent liabilities [text block]</label>
    <label xlink:label="lab_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of related party [text block]</label>
    <label xlink:label="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related party disclosures</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:to="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of earnings per share [text block]</label>
    <label xlink:label="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:to="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of events after reporting period [text block]</label>
    <label xlink:label="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Events occurring after the reporting period</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:to="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for segment reporting [text block]</label>
    <label xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Segment information</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for restricted cash and cash equivalents [text block]</label>
    <label xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for financial assets [text block]</label>
    <label xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Financial assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for property, plant and equipment [text block]</label>
    <label xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for intangible assets other than goodwill [text block]</label>
    <label xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for research and development expense [text block]</label>
    <label xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Research and development</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for financial liabilities [text block]</label>
    <label xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Financial liabilities: Initial recognition and measurement</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for leases [text block]</label>
    <label xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Leases</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for recognition of revenue [text block]</label>
    <label xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Revenue from collaboration agreements</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for share-based payment transactions [text block]</label>
    <label xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-based payment</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DescriptionOfAccountingPolicyForOtherIncomePolicyTextBlock" xlink:label="loc_imtx_DescriptionOfAccountingPolicyForOtherIncomePolicyTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DescriptionOfAccountingPolicyForOtherIncomePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description Of Accounting Policy For Other Income [Policy Text Block]</label>
    <label xlink:label="lab_imtx_DescriptionOfAccountingPolicyForOtherIncomePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other income</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DescriptionOfAccountingPolicyForOtherIncomePolicyTextBlock" xlink:to="lab_imtx_DescriptionOfAccountingPolicyForOtherIncomePolicyTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DescriptionOfAccountingPolicyForOtherIncomePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Description of accounting policy for other income.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for foreign currency translation [text block]</label>
    <label xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for financial instruments at fair value through profit or loss [text block]</label>
    <label xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair value of financial instruments</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for provisions [text block]</label>
    <label xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Provisions</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for income tax [text block]</label>
    <label xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income Tax</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock" xlink:label="loc_imtx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description Of Accounting Policy For Going concern [Policy Text Block]</label>
    <label xlink:label="lab_imtx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Going concern</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock" xlink:to="lab_imtx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Description of accounting policy for going concern.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DescriptionOfAccountingPolicyForCovidNineteenPolicyTextBlock" xlink:label="loc_imtx_DescriptionOfAccountingPolicyForCovidNineteenPolicyTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DescriptionOfAccountingPolicyForCovidNineteenPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description Of Accounting Policy For Covid 19 [Policy Text Block]</label>
    <label xlink:label="lab_imtx_DescriptionOfAccountingPolicyForCovidNineteenPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Covid-19</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DescriptionOfAccountingPolicyForCovidNineteenPolicyTextBlock" xlink:to="lab_imtx_DescriptionOfAccountingPolicyForCovidNineteenPolicyTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DescriptionOfAccountingPolicyForCovidNineteenPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Description of accounting policy for covid nineteen.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfAccountingPolicyForCashFlowsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForCashFlowsExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForCashFlowsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for cash flows [text block]</label>
    <label xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForCashFlowsExplanatory" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Correction of classification of Statement of Cash Flows</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForCashFlowsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForCashFlowsExplanatory" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementTextBlock" xlink:label="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Reconciliation Of Changes In Cash Flow Statement [Text Block]</label>
    <label xlink:label="lab_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Reconciliation Of Changes In Cash Flow Statement</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementTextBlock" xlink:to="lab_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of changes in cash flow statement.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of expected impact of initial application of new standards or interpretations [text block]</label>
    <label xlink:label="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of Application of new standards</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:to="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfNonMandatoryStandardsAndInterpretationsIssuedByTheIasbTableTextBlock" xlink:label="loc_imtx_DisclosureOfNonMandatoryStandardsAndInterpretationsIssuedByTheIasbTableTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfNonMandatoryStandardsAndInterpretationsIssuedByTheIasbTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Non Mandatory Standards And Interpretations Issued By The IASB [Table Text Block]</label>
    <label xlink:label="lab_imtx_DisclosureOfNonMandatoryStandardsAndInterpretationsIssuedByTheIasbTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of Non Mandatory standards and interpretations issued by IASB</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfNonMandatoryStandardsAndInterpretationsIssuedByTheIasbTableTextBlock" xlink:to="lab_imtx_DisclosureOfNonMandatoryStandardsAndInterpretationsIssuedByTheIasbTableTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfNonMandatoryStandardsAndInterpretationsIssuedByTheIasbTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of non mandatory standards and interpretations issued by the IASB.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesExplanatoryTableTextBlock" xlink:label="loc_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesExplanatoryTableTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Property Plant And Equipment Estimated Useful Lives Explanatory [Table Text Block]</label>
    <label xlink:label="lab_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of estimated Useful Lives of Property, Plant and Equipment</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesExplanatoryTableTextBlock" xlink:to="lab_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesExplanatoryTableTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of property plant and equipment estimated useful lives explanatory.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillExplanatoryTableTextBlock" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillExplanatoryTableTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Useful Life Measured As Period Of Time Intangible Assets Other Than Goodwill Explanatory [Table Text Block]</label>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of useful life of intangible assets other than goodwill</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillExplanatoryTableTextBlock" xlink:to="lab_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillExplanatoryTableTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about useful life measured as period of time intangible assets other than goodwill explanatory.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesExplanatoryTableTextBlock" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesExplanatoryTableTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Foreign Exchange Rates Explanatory [Table Text Block]</label>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of foreign exchange rates</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesExplanatoryTableTextBlock" xlink:to="lab_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesExplanatoryTableTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about foreign exchange rates explanatory.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfTradeAndOtherReceivableExplanatoryTableTextBlock" xlink:label="loc_imtx_DisclosureOfTradeAndOtherReceivableExplanatoryTableTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfTradeAndOtherReceivableExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Trade And Other Receivable Explanatory [Table Text Block]</label>
    <label xlink:label="lab_imtx_DisclosureOfTradeAndOtherReceivableExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of Trade receivables</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfTradeAndOtherReceivableExplanatoryTableTextBlock" xlink:to="lab_imtx_DisclosureOfTradeAndOtherReceivableExplanatoryTableTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfTradeAndOtherReceivableExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of trade and other receivable explanatory.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of other current assets [text block]</label>
    <label xlink:label="lab_ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of Other current assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of other non-current assets [text block]</label>
    <label xlink:label="lab_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of Other&#xA0;non-current&#xA0;assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [text block]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDepreciationExpensesTableTextBlock" xlink:label="loc_imtx_DisclosureOfDepreciationExpensesTableTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfDepreciationExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Depreciation Expenses [Table Text Block]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfDepreciationExpensesTableTextBlock" xlink:to="lab_imtx_DisclosureOfDepreciationExpensesTableTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfDepreciationExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of depreciation expenses.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of changes in intangible assets and goodwill [text block]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfAmortizationExpensesTableTextBlock" xlink:label="loc_imtx_DisclosureOfAmortizationExpensesTableTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfAmortizationExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Amortization Expenses [Table Text Block]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfAmortizationExpensesTableTextBlock" xlink:to="lab_imtx_DisclosureOfAmortizationExpensesTableTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfAmortizationExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of amortization expenses.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [text block]</label>
    <label xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of Right-of&#xA0;use assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfLeaseLiabilitiesTableTextBlock" xlink:label="loc_imtx_DisclosureOfLeaseLiabilitiesTableTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfLeaseLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Lease Liabilities [Table Text Block]</label>
    <label xlink:label="lab_imtx_DisclosureOfLeaseLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Details of Lease liabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfLeaseLiabilitiesTableTextBlock" xlink:to="lab_imtx_DisclosureOfLeaseLiabilitiesTableTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfLeaseLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of lease liabilities.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfExpensesRelatedToRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock" xlink:label="loc_imtx_DisclosureOfExpensesRelatedToRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfExpensesRelatedToRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Expenses Related To Right Of Use Assets And Lease Liabilities [Table Text Block]</label>
    <label xlink:label="lab_imtx_DisclosureOfExpensesRelatedToRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of expenses related to&#xA0;right-of-use&#xA0;assets and lease liabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfExpensesRelatedToRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock" xlink:to="lab_imtx_DisclosureOfExpensesRelatedToRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfExpensesRelatedToRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of expenses related to right of use assets and lease liabilities.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfAccountsPayableExplanatoryTableTextBlock" xlink:label="loc_imtx_DisclosureOfAccountsPayableExplanatoryTableTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfAccountsPayableExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Accounts Payable Explanatory [Table Text Block]</label>
    <label xlink:label="lab_imtx_DisclosureOfAccountsPayableExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Accounts Payable</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfAccountsPayableExplanatoryTableTextBlock" xlink:to="lab_imtx_DisclosureOfAccountsPayableExplanatoryTableTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfAccountsPayableExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounts payable explanatory.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfContractLiabilitiesTextBlock" xlink:label="loc_imtx_DisclosureOfContractLiabilitiesTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfContractLiabilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Contract Liabilities [Text Block]</label>
    <label xlink:label="lab_imtx_DisclosureOfContractLiabilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Deferred revenue related to the collaboration agreements</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfContractLiabilitiesTextBlock" xlink:to="lab_imtx_DisclosureOfContractLiabilitiesTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfContractLiabilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of contract liabilities.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfOtherIncomeExplanatoryTextBlock" xlink:label="loc_imtx_DisclosureOfOtherIncomeExplanatoryTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfOtherIncomeExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Other income Explanatory [Text Block]</label>
    <label xlink:label="lab_imtx_DisclosureOfOtherIncomeExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of other income</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfOtherIncomeExplanatoryTextBlock" xlink:to="lab_imtx_DisclosureOfOtherIncomeExplanatoryTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfOtherIncomeExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of other income explanatory.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTextBlock" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about other current liabilities [Text Block]</label>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of other current liabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTextBlock" xlink:to="lab_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about other current liabilities abstract.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseExplanatoryTextBlock" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseExplanatoryTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Finance Income Expense Explanatory [Text Block]</label>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of finance income and costs</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseExplanatoryTextBlock" xlink:to="lab_imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseExplanatoryTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about finance income expense explanatory.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutShareListingExpensesTextBlock" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutShareListingExpensesTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutShareListingExpensesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">disclosure of detailed information about Share listing expenses [Text Block]</label>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutShareListingExpensesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Calculation of the Share listing expense</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutShareListingExpensesTextBlock" xlink:to="lab_imtx_DisclosureOfDetailedInformationAboutShareListingExpensesTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutShareListingExpensesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about Share listing expenses [text block].</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_StatementsTable" xlink:label="loc_imtx_StatementsTable" xlink:type="locator"/>
    <label xlink:label="lab_imtx_StatementsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statements [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_StatementsTable" xlink:to="lab_imtx_StatementsTable" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_StatementsLineItems" xlink:label="loc_imtx_StatementsLineItems" xlink:type="locator"/>
    <label xlink:label="lab_imtx_StatementsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statements [Line Items]</label>
    <label xlink:label="lab_imtx_StatementsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statements [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_StatementsLineItems" xlink:to="lab_imtx_StatementsLineItems" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block]</label>
    <label xlink:label="lab_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Options Granted Priced Using Black Scholes for SARs, Tandem Awards, Converted Options, Matching Stock Options and Monte Carlo Option Pricing Model</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:to="lab_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of range of exercise prices of outstanding share options [text block]</label>
    <label xlink:label="lab_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Employee Share Options</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTextBlock" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Share Based Compensation Expense [Text Block]</label>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Employee Related Share Based Compensation Expense</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTextBlock" xlink:to="lab_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about share based compensation expense.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureDetailsOfActivitiesUnderShareBasedPaymentArrangementTextBlock" xlink:label="loc_imtx_DisclosureDetailsOfActivitiesUnderShareBasedPaymentArrangementTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureDetailsOfActivitiesUnderShareBasedPaymentArrangementTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Details Of Activities Under Share Based Payment Arrangement [Text Block]</label>
    <label xlink:label="lab_imtx_DisclosureDetailsOfActivitiesUnderShareBasedPaymentArrangementTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Activities Under Share Based Payment Arrangement</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureDetailsOfActivitiesUnderShareBasedPaymentArrangementTextBlock" xlink:to="lab_imtx_DisclosureDetailsOfActivitiesUnderShareBasedPaymentArrangementTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureDetailsOfActivitiesUnderShareBasedPaymentArrangementTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure details of activities under share based payment arrangement.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Types of share-based payment arrangements [axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_SharebasedPaymentArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based payment arrangements [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="lab_ifrs-full_SharebasedPaymentArrangementsMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_ShareAppreciationRightsMember" xlink:label="loc_imtx_ShareAppreciationRightsMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ShareAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Appreciation Rights [Member]</label>
    <label xlink:label="lab_imtx_ShareAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share Appreciation Rights [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ShareAppreciationRightsMember" xlink:to="lab_imtx_ShareAppreciationRightsMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_ShareAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share appreciation rights.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_MatchingStockOptionsMember" xlink:label="loc_imtx_MatchingStockOptionsMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_MatchingStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Matching Stock Options [Member]</label>
    <label xlink:label="lab_imtx_MatchingStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Matching Stock Options [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_MatchingStockOptionsMember" xlink:to="lab_imtx_MatchingStockOptionsMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_ConvertedOptionsMember" xlink:label="loc_imtx_ConvertedOptionsMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ConvertedOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Converted Options [Member]</label>
    <label xlink:label="lab_imtx_ConvertedOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Converted Options [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ConvertedOptionsMember" xlink:to="lab_imtx_ConvertedOptionsMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember" xlink:label="loc_imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Grants Under Two Thousand And Twenty Plan [Member]</label>
    <label xlink:label="lab_imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Grants Under 2020 Plan [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember" xlink:to="lab_imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_PerformanceBasedOptionsMember" xlink:label="loc_imtx_PerformanceBasedOptionsMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_PerformanceBasedOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance Based Options [Member]</label>
    <label xlink:label="lab_imtx_PerformanceBasedOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance Based Options [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_PerformanceBasedOptionsMember" xlink:to="lab_imtx_PerformanceBasedOptionsMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_PerformanceBasedOptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Performance based options [Member].</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_TwoThousandAndSixteenTandemAwardsMember" xlink:label="loc_imtx_TwoThousandAndSixteenTandemAwardsMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_TwoThousandAndSixteenTandemAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Thousand And Sixteen Tandem Awards [Member]</label>
    <label xlink:label="lab_imtx_TwoThousandAndSixteenTandemAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2016 Tandem Awards [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_TwoThousandAndSixteenTandemAwardsMember" xlink:to="lab_imtx_TwoThousandAndSixteenTandemAwardsMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_TwoThousandAndSixteenTandemAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two thousand and sixteen tandem awards [Member].</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfPersonnelExpenesTextBlock" xlink:label="loc_imtx_DisclosureOfPersonnelExpenesTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfPersonnelExpenesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Personnel Expenes [Text Block]</label>
    <label xlink:label="lab_imtx_DisclosureOfPersonnelExpenesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Personnel Expenses</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfPersonnelExpenesTextBlock" xlink:to="lab_imtx_DisclosureOfPersonnelExpenesTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfPersonnelExpenesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Personnel Expenses [Text Block]</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfReconciliationBetweenTaxesOnIncomeAndExpectedIncomeTaxBenefitTableTextBlock" xlink:label="loc_imtx_DisclosureOfReconciliationBetweenTaxesOnIncomeAndExpectedIncomeTaxBenefitTableTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfReconciliationBetweenTaxesOnIncomeAndExpectedIncomeTaxBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation between taxes on income and expected income tax benefit [Table Text Block]</label>
    <label xlink:label="lab_imtx_DisclosureOfReconciliationBetweenTaxesOnIncomeAndExpectedIncomeTaxBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Reconciliation Between Taxes On Income And Expected Income Tax Benefit</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfReconciliationBetweenTaxesOnIncomeAndExpectedIncomeTaxBenefitTableTextBlock" xlink:to="lab_imtx_DisclosureOfReconciliationBetweenTaxesOnIncomeAndExpectedIncomeTaxBenefitTableTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfReconciliationBetweenTaxesOnIncomeAndExpectedIncomeTaxBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation between taxes on income and expected income tax benefit[Text Block].</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_imtx_DisclosureOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Deferred Tax Assets And Liabilities [Table Text Block]</label>
    <label xlink:label="lab_imtx_DisclosureOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Deferred Tax Assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_imtx_DisclosureOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of deferred tax assets and liabilities.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfCurrencyRiskExposureExplanatoryTableTextBlock" xlink:label="loc_imtx_DisclosureOfCurrencyRiskExposureExplanatoryTableTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfCurrencyRiskExposureExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Currency Risk Exposure Explanatory [Table Text Block]</label>
    <label xlink:label="lab_imtx_DisclosureOfCurrencyRiskExposureExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Currency Risk Exposure</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfCurrencyRiskExposureExplanatoryTableTextBlock" xlink:to="lab_imtx_DisclosureOfCurrencyRiskExposureExplanatoryTableTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfCurrencyRiskExposureExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Currency Risk Exposure Explanatory.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk" xlink:label="loc_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sensitivity analysis for types of market risk [text block]</label>
    <label xlink:label="lab_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Sensitivity Analysis of Foreign Currency Risk</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk" xlink:to="lab_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfManagingLiquidityRisk" xlink:label="loc_ifrs-full_DescriptionOfManagingLiquidityRisk" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DescriptionOfManagingLiquidityRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of how entity manages liquidity risk [text block]</label>
    <label xlink:label="lab_ifrs-full_DescriptionOfManagingLiquidityRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Liquidity Risk</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfManagingLiquidityRisk" xlink:to="lab_ifrs-full_DescriptionOfManagingLiquidityRisk" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about financial instruments [text block]</label>
    <label xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Carrying Amounts and Fair values of Group's Financial Instruments</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfContractualObligationsTableTextBlock" xlink:label="loc_imtx_DisclosureOfContractualObligationsTableTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfContractualObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Contractual Obligations [Table Text Block]</label>
    <label xlink:label="lab_imtx_DisclosureOfContractualObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Contractual Obligations</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfContractualObligationsTableTextBlock" xlink:to="lab_imtx_DisclosureOfContractualObligationsTableTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfContractualObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of contractual obligations.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfCompensationOfKeyManagementPersonnelTableTextBlock" xlink:label="loc_imtx_DisclosureOfCompensationOfKeyManagementPersonnelTableTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfCompensationOfKeyManagementPersonnelTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Compensation Of Key Management Personnel [Table Text Block]</label>
    <label xlink:label="lab_imtx_DisclosureOfCompensationOfKeyManagementPersonnelTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Compensation of Key Management Personnel</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfCompensationOfKeyManagementPersonnelTableTextBlock" xlink:to="lab_imtx_DisclosureOfCompensationOfKeyManagementPersonnelTableTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfCompensationOfKeyManagementPersonnelTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of compensation of key management personnel.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfCompensationSupervisoryBoardTextBlock" xlink:label="loc_imtx_DisclosureOfCompensationSupervisoryBoardTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfCompensationSupervisoryBoardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">disclosure of compensation supervisory board [Text Block]</label>
    <label xlink:label="lab_imtx_DisclosureOfCompensationSupervisoryBoardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Compensation for the Supervisory Board</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfCompensationSupervisoryBoardTextBlock" xlink:to="lab_imtx_DisclosureOfCompensationSupervisoryBoardTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfCompensationSupervisoryBoardTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of compensation supervisory board.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfCompensationManagingDirectorsAndSupervisoryBoardTextBlock" xlink:label="loc_imtx_DisclosureOfCompensationManagingDirectorsAndSupervisoryBoardTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfCompensationManagingDirectorsAndSupervisoryBoardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of compensation Managing directors and supervisory board [Text Block]</label>
    <label xlink:label="lab_imtx_DisclosureOfCompensationManagingDirectorsAndSupervisoryBoardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Options Granted to Managing Director and Supervisory Directors</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfCompensationManagingDirectorsAndSupervisoryBoardTextBlock" xlink:to="lab_imtx_DisclosureOfCompensationManagingDirectorsAndSupervisoryBoardTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfCompensationManagingDirectorsAndSupervisoryBoardTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of compensation Managing directors and supervisory board.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-adjusting events after reporting period [axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_NonadjustingEventsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-adjusting events after reporting period [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonadjustingEventsMember" xlink:to="lab_ifrs-full_NonadjustingEventsMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_AuthorizationOfFinancialStatementsMember" xlink:label="loc_imtx_AuthorizationOfFinancialStatementsMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_AuthorizationOfFinancialStatementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Authorization Of Financial Statements [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_AuthorizationOfFinancialStatementsMember" xlink:to="lab_imtx_AuthorizationOfFinancialStatementsMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_AuthorizationOfFinancialStatementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Authorization of financial statements.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [line items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DateOfAuthorisationForIssueOfFinancialStatements2013" xlink:label="loc_ifrs-full_DateOfAuthorisationForIssueOfFinancialStatements2013" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DateOfAuthorisationForIssueOfFinancialStatements2013" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Date of authorisation for issue of financial statements</label>
    <label xlink:label="lab_ifrs-full_DateOfAuthorisationForIssueOfFinancialStatements2013" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Date of authorisation for issue of financial statements</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DateOfAuthorisationForIssueOfFinancialStatements2013" xlink:to="lab_ifrs-full_DateOfAuthorisationForIssueOfFinancialStatements2013" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DateOfEndOfReportingPeriod2013" xlink:label="loc_ifrs-full_DateOfEndOfReportingPeriod2013" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DateOfEndOfReportingPeriod2013" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Date of end of reporting period</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DateOfEndOfReportingPeriod2013" xlink:to="lab_ifrs-full_DateOfEndOfReportingPeriod2013" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementAbstract" xlink:label="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementAbstract" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Reconciliation Of Changes In Cash Flow Statement [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementAbstract" xlink:to="lab_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementAbstract" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of changes in cash flow statement.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementTable" xlink:label="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementTable" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Reconciliation Of Changes In Cash Flow Statement [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementTable" xlink:to="lab_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementTable" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of changes in cash flow statement.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:label="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retrospective application and retrospective restatement [axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:to="lab_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RestatedMember" xlink:label="loc_ifrs-full_RestatedMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_RestatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currently stated [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RestatedMember" xlink:to="lab_ifrs-full_RestatedMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PreviouslyStatedMember" xlink:label="loc_ifrs-full_PreviouslyStatedMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_PreviouslyStatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Previously stated [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PreviouslyStatedMember" xlink:to="lab_ifrs-full_PreviouslyStatedMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:label="loc_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) due to changes in accounting policy and corrections of prior period errors [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:to="lab_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementLineItems" xlink:label="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementLineItems" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Reconciliation Of Changes In Cash Flow Statement [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementLineItems" xlink:to="lab_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementLineItems" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of changes in cash flow statement.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of subsidiaries [table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiaries [axis]</label>
    <label xlink:label="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsidiaries [axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_EntitysTotalForSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity's total for subsidiaries [member]</label>
    <label xlink:label="lab_ifrs-full_EntitysTotalForSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity's total for subsidiaries [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember" xlink:to="lab_ifrs-full_EntitysTotalForSubsidiariesMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_ImmaticsUsIncMember" xlink:label="loc_imtx_ImmaticsUsIncMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ImmaticsUsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Immatics US Inc [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ImmaticsUsIncMember" xlink:to="lab_imtx_ImmaticsUsIncMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_ImmaticsUsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Immatics US, Inc.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of subsidiaries [line items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proportion of ownership interests held by non-controlling interests</label>
    <label xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Ownership interests held by non-controlling interests</label>
    <label xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ownership interests held by non-controlling interests</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:to="lab_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about business combination [table]</label>
    <label xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about business combination [table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_BusinessCombinationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business combinations [axis]</label>
    <label xlink:label="lab_ifrs-full_BusinessCombinationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business combinations [axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BusinessCombinationsAxis" xlink:to="lab_ifrs-full_BusinessCombinationsAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity's total for business combinations [member]</label>
    <label xlink:label="lab_ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity's total for business combinations [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:to="lab_ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_AryaMember" xlink:label="loc_imtx_AryaMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_AryaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ARYA [Member]</label>
    <label xlink:label="lab_imtx_AryaMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">ARYA [member]</label>
    <label xlink:label="lab_imtx_AryaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ARYA [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_AryaMember" xlink:to="lab_imtx_AryaMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_AryaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">ARYA [Member].</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfOrdinarySharesAxis" xlink:label="loc_ifrs-full_ClassesOfOrdinarySharesAxis" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ClassesOfOrdinarySharesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of ordinary shares [axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfOrdinarySharesAxis" xlink:to="lab_ifrs-full_ClassesOfOrdinarySharesAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_OrdinarySharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ordinary shares [member]</label>
    <label xlink:label="lab_ifrs-full_OrdinarySharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ordinary shares [member]</label>
    <label xlink:label="lab_ifrs-full_OrdinarySharesMember" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:type="resource" xml:lang="en-US">Ordinary Shares [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OrdinarySharesMember" xlink:to="lab_ifrs-full_OrdinarySharesMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_PipeFinancingMember" xlink:label="loc_imtx_PipeFinancingMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_PipeFinancingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PIPE Financing [Member]</label>
    <label xlink:label="lab_imtx_PipeFinancingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PIPE Financing [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_PipeFinancingMember" xlink:to="lab_imtx_PipeFinancingMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_PipeFinancingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">PIPE financing.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ClassesOfShareCapitalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of share capital [axis]</label>
    <label xlink:label="lab_ifrs-full_ClassesOfShareCapitalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of share capital [axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis" xlink:to="lab_ifrs-full_ClassesOfShareCapitalAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ClassesOfShareCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share capital [member]</label>
    <label xlink:label="lab_ifrs-full_ClassesOfShareCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share capital [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember" xlink:to="lab_ifrs-full_ClassesOfShareCapitalMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of financial instruments [axis]</label>
    <label xlink:label="lab_ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of financial instruments [axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="lab_ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial instruments, class [member]</label>
    <label xlink:label="lab_ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial instruments, class [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:to="lab_ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about business combination [line items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfHowAcquirerObtainedControlOfAcquiree" xlink:label="loc_ifrs-full_DescriptionOfHowAcquirerObtainedControlOfAcquiree" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DescriptionOfHowAcquirerObtainedControlOfAcquiree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of how acquirer obtained control of acquiree</label>
    <label xlink:label="lab_ifrs-full_DescriptionOfHowAcquirerObtainedControlOfAcquiree" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Description Of How Acquirer Obtained Control Of Acquire</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfHowAcquirerObtainedControlOfAcquiree" xlink:to="lab_ifrs-full_DescriptionOfHowAcquirerObtainedControlOfAcquiree" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable" xlink:label="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of instruments or interests issued or issuable</label>
    <label xlink:label="lab_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Number of instruments issued or issuable</label>
    <label xlink:label="lab_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ARYA Shares</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable" xlink:to="lab_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Identifiable assets acquired (liabilities assumed)</label>
    <label xlink:label="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net Assets Acquired (Liabilities Assumed)</label>
    <label xlink:label="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Identifiable net assets</label>
    <label xlink:label="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:type="resource" xml:lang="en-US">ARYA's identifiable net assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:to="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents recognised as of acquisition date</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:to="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current liabilities recognised as of acquisition date</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:to="lab_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from issue of ordinary shares</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:to="lab_ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ShareIssueRelatedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share issue related cost</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareIssueRelatedCost" xlink:to="lab_ifrs-full_ShareIssueRelatedCost" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsAbstract" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of expected impact of initial application of new standards or interpretations [abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsAbstract" xlink:to="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTable" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTable" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of expected impact of initial application of new standards or interpretations [table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTable" xlink:to="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTable" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NewIFRSsAxis" xlink:label="loc_ifrs-full_NewIFRSsAxis" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_NewIFRSsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New IFRSs [axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NewIFRSsAxis" xlink:to="lab_ifrs-full_NewIFRSsAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NewIFRSsMember" xlink:label="loc_ifrs-full_NewIFRSsMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_NewIFRSsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New IFRSs [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NewIFRSsMember" xlink:to="lab_ifrs-full_NewIFRSsMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_AmendmentsToIfrsThreeMember" xlink:label="loc_imtx_AmendmentsToIfrsThreeMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_AmendmentsToIfrsThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendments To IFRS Three [Member]</label>
    <label xlink:label="lab_imtx_AmendmentsToIfrsThreeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Amendments To IFRS 3</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_AmendmentsToIfrsThreeMember" xlink:to="lab_imtx_AmendmentsToIfrsThreeMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_AmendmentsToIfrsThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amendments to IFRS three.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_AmendmentsToIasOneAndIasEightMember" xlink:label="loc_imtx_AmendmentsToIasOneAndIasEightMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_AmendmentsToIasOneAndIasEightMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendments To IAS One And IAS Eight [Member]</label>
    <label xlink:label="lab_imtx_AmendmentsToIasOneAndIasEightMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Amendments To IAS 1 And IAS 8</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_AmendmentsToIasOneAndIasEightMember" xlink:to="lab_imtx_AmendmentsToIasOneAndIasEightMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_AmendmentsToIasOneAndIasEightMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amendments to IAS one and IAS eight.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_AmendmentsToConceptualFrameworkMember" xlink:label="loc_imtx_AmendmentsToConceptualFrameworkMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_AmendmentsToConceptualFrameworkMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendments To Conceptual Framework [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_AmendmentsToConceptualFrameworkMember" xlink:to="lab_imtx_AmendmentsToConceptualFrameworkMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_AmendmentsToConceptualFrameworkMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amendments to conceptual framework.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_AmendmentsToIfrsNineIasThirtyNineAndIfrsSeventeenMember" xlink:label="loc_imtx_AmendmentsToIfrsNineIasThirtyNineAndIfrsSeventeenMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_AmendmentsToIfrsNineIasThirtyNineAndIfrsSeventeenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendments To IFRS Nine IAS Thirty Nine And IFRS Seventeen [Member]</label>
    <label xlink:label="lab_imtx_AmendmentsToIfrsNineIasThirtyNineAndIfrsSeventeenMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Amendments To IFRS Nine IAS 39 And IFRS 17</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_AmendmentsToIfrsNineIasThirtyNineAndIfrsSeventeenMember" xlink:to="lab_imtx_AmendmentsToIfrsNineIasThirtyNineAndIfrsSeventeenMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_AmendmentsToIfrsNineIasThirtyNineAndIfrsSeventeenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amendments to IFRS nine IAS thirty nine and IFRS seventeen.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of expected impact of initial application of new standards or interpretations [line items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems" xlink:to="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DateByWhichApplicationOfNewIFRSIsRequired" xlink:label="loc_ifrs-full_DateByWhichApplicationOfNewIFRSIsRequired" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DateByWhichApplicationOfNewIFRSIsRequired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Date by which application of new IFRS is required</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DateByWhichApplicationOfNewIFRSIsRequired" xlink:to="lab_ifrs-full_DateByWhichApplicationOfNewIFRSIsRequired" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TitleOfNewIFRS" xlink:label="loc_ifrs-full_TitleOfNewIFRS" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_TitleOfNewIFRS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of new IFRS</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TitleOfNewIFRS" xlink:to="lab_ifrs-full_TitleOfNewIFRS" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_AmendmentsToIasOneMember" xlink:label="loc_imtx_AmendmentsToIasOneMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_AmendmentsToIasOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendments To IAS One [Member]</label>
    <label xlink:label="lab_imtx_AmendmentsToIasOneMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Amendments To IAS 1</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_AmendmentsToIasOneMember" xlink:to="lab_imtx_AmendmentsToIasOneMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_AmendmentsToIasOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amendments to IAS one.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_IfrsSeventeenMember" xlink:label="loc_imtx_IfrsSeventeenMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_IfrsSeventeenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">IFRS Seventeen [Member]</label>
    <label xlink:label="lab_imtx_IfrsSeventeenMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">IFRS 17</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_IfrsSeventeenMember" xlink:to="lab_imtx_IfrsSeventeenMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_IfrsSeventeenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">IFRS seventeen.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_IfrsSixteenMember" xlink:label="loc_imtx_IfrsSixteenMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_IfrsSixteenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">IFRS Sixteen [Member]</label>
    <label xlink:label="lab_imtx_IfrsSixteenMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">IFRS 16</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_IfrsSixteenMember" xlink:to="lab_imtx_IfrsSixteenMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_IfrsSixteenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Ifrs 16</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesAbstract" xlink:label="loc_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesAbstract" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Property Plant And Equipment Estimated Useful Lives [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesAbstract" xlink:to="lab_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesAbstract" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of property plant and equipment estimated useful lives .</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesTable" xlink:label="loc_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesTable" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Property Plant And Equipment Estimated Useful Lives [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesTable" xlink:to="lab_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesTable" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of property plant and equipment estimated useful lives.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Range [axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangeAxis" xlink:to="lab_ifrs-full_RangeAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_RangesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ranges [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangesMember" xlink:to="lab_ifrs-full_RangesMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_BottomOfRangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Bottom of range [member]</label>
    <label xlink:label="lab_ifrs-full_BottomOfRangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Bottom of range [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BottomOfRangeMember" xlink:to="lab_ifrs-full_BottomOfRangeMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_TopOfRangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Top of range [member]</label>
    <label xlink:label="lab_ifrs-full_TopOfRangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Top of range [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TopOfRangeMember" xlink:to="lab_ifrs-full_TopOfRangeMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of property, plant and equipment [axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, plant and equipment [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="lab_ifrs-full_PropertyPlantAndEquipmentMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer equipment [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComputerEquipmentMember" xlink:to="lab_ifrs-full_ComputerEquipmentMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_LaboratoryEquipmentMember" xlink:label="loc_imtx_LaboratoryEquipmentMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Laboratory Equipment [Member]</label>
    <label xlink:label="lab_imtx_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Laboratory equipment [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_LaboratoryEquipmentMember" xlink:to="lab_imtx_LaboratoryEquipmentMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Laboratory equipment.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="loc_ifrs-full_OfficeEquipmentMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Office equipment [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OfficeEquipmentMember" xlink:to="lab_ifrs-full_OfficeEquipmentMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesLineItems" xlink:label="loc_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesLineItems" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Property Plant And Equipment Estimated Useful Lives [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesLineItems" xlink:to="lab_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesLineItems" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of property plant and equipment estimated useful lives.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Useful life measured as period of time, property, plant and equipment</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:to="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillAbstract" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillAbstract" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Useful Life Measured As Period Of Time Intangible Assets Other Than Goodwill [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillAbstract" xlink:to="lab_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillAbstract" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about useful life measured as period of time intangible assets other than goodwill.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillTable" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillTable" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Useful Life Measured As Period Of Time Intangible Assets Other Than Goodwill [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillTable" xlink:to="lab_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillTable" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about useful life measured as period of time intangible assets other than goodwill.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of intangible assets other than goodwill [axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible assets other than goodwill [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LicencesMember" xlink:label="loc_ifrs-full_LicencesMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_LicencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Licences [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LicencesMember" xlink:to="lab_ifrs-full_LicencesMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComputerSoftwareMember" xlink:label="loc_ifrs-full_ComputerSoftwareMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ComputerSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer software [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComputerSoftwareMember" xlink:to="lab_ifrs-full_ComputerSoftwareMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillLineItems" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillLineItems" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Useful Life Measured As Period Of Time Intangible Assets Other Than Goodwill [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillLineItems" xlink:to="lab_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillLineItems" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about useful life measured as period of time intangible assets other than goodwill.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Useful life measured as period of time, intangible assets other than goodwill</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ForeignExchangeRatesAbstract" xlink:label="loc_ifrs-full_ForeignExchangeRatesAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ForeignExchangeRatesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign exchange rates [abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ForeignExchangeRatesAbstract" xlink:to="lab_ifrs-full_ForeignExchangeRatesAbstract" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesTable" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesTable" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Foreign Exchange Rates [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesTable" xlink:to="lab_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesTable" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about foreign exchange rates.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesLineItems" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesLineItems" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Foreign Exchange Rates [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesLineItems" xlink:to="lab_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesLineItems" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about foreign exchange rates.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClosingForeignExchangeRate" xlink:label="loc_ifrs-full_ClosingForeignExchangeRate" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ClosingForeignExchangeRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Closing foreign exchange rate</label>
    <label xlink:label="lab_ifrs-full_ClosingForeignExchangeRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion rate</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClosingForeignExchangeRate" xlink:to="lab_ifrs-full_ClosingForeignExchangeRate" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AverageForeignExchangeRate" xlink:label="loc_ifrs-full_AverageForeignExchangeRate" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_AverageForeignExchangeRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Average foreign exchange rate</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AverageForeignExchangeRate" xlink:to="lab_ifrs-full_AverageForeignExchangeRate" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_RentalContractTerm" xlink:label="loc_imtx_RentalContractTerm" xlink:type="locator"/>
    <label xlink:label="lab_imtx_RentalContractTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rental Contract Term</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_RentalContractTerm" xlink:to="lab_imtx_RentalContractTerm" xlink:type="arc"/>
    <label xlink:label="lab_imtx_RentalContractTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Rental contract term.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade and other current receivables [abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:to="lab_ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_ReceivablesFromCollaborationAgreements" xlink:label="loc_imtx_ReceivablesFromCollaborationAgreements" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ReceivablesFromCollaborationAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivables From Collaboration Agreements</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ReceivablesFromCollaborationAgreements" xlink:to="lab_imtx_ReceivablesFromCollaborationAgreements" xlink:type="arc"/>
    <label xlink:label="lab_imtx_ReceivablesFromCollaborationAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Receivables from collaboration agreements.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TradeReceivables" xlink:label="loc_ifrs-full_TradeReceivables" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_TradeReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade receivables</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeReceivables" xlink:to="lab_ifrs-full_TradeReceivables" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_TradeAndOtherReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade and other receivables [abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract" xlink:to="lab_ifrs-full_TradeAndOtherReceivablesAbstract" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_CurrentGrantReceivable" xlink:label="loc_imtx_CurrentGrantReceivable" xlink:type="locator"/>
    <label xlink:label="lab_imtx_CurrentGrantReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Grant Receivable</label>
    <label xlink:label="lab_imtx_CurrentGrantReceivable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Grant receivable</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_CurrentGrantReceivable" xlink:to="lab_imtx_CurrentGrantReceivable" xlink:type="arc"/>
    <label xlink:label="lab_imtx_CurrentGrantReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Current grant receivable.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_CurrentPrepaidExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current prepaid expenses</label>
    <label xlink:label="lab_ifrs-full_CurrentPrepaidExpenses" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentPrepaidExpenses" xlink:to="lab_ifrs-full_CurrentPrepaidExpenses" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_PositiveMarketValueForwardContract" xlink:label="loc_imtx_PositiveMarketValueForwardContract" xlink:type="locator"/>
    <label xlink:label="lab_imtx_PositiveMarketValueForwardContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Positive market value forward contract</label>
    <label xlink:label="lab_imtx_PositiveMarketValueForwardContract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Positive market value forward contract</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_PositiveMarketValueForwardContract" xlink:to="lab_imtx_PositiveMarketValueForwardContract" xlink:type="arc"/>
    <label xlink:label="lab_imtx_PositiveMarketValueForwardContract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Positive market value forward contract.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentValueAddedTaxReceivables" xlink:label="loc_ifrs-full_CurrentValueAddedTaxReceivables" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_CurrentValueAddedTaxReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current value added tax receivables</label>
    <label xlink:label="lab_ifrs-full_CurrentValueAddedTaxReceivables" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Value added tax receivable</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentValueAddedTaxReceivables" xlink:to="lab_ifrs-full_CurrentValueAddedTaxReceivables" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_CapitalizedTransactionCosts" xlink:label="loc_imtx_CapitalizedTransactionCosts" xlink:type="locator"/>
    <label xlink:label="lab_imtx_CapitalizedTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized Transaction Costs</label>
    <label xlink:label="lab_imtx_CapitalizedTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Capitalized transaction costs</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_CapitalizedTransactionCosts" xlink:to="lab_imtx_CapitalizedTransactionCosts" xlink:type="arc"/>
    <label xlink:label="lab_imtx_CapitalizedTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Capitalized transaction costs.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherAssets" xlink:label="loc_ifrs-full_OtherAssets" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_OtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other assets</label>
    <label xlink:label="lab_ifrs-full_OtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherAssets" xlink:to="lab_ifrs-full_OtherAssets" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_CollaborationAgreementAxis" xlink:label="loc_imtx_CollaborationAgreementAxis" xlink:type="locator"/>
    <label xlink:label="lab_imtx_CollaborationAgreementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaboration Agreement [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_CollaborationAgreementAxis" xlink:to="lab_imtx_CollaborationAgreementAxis" xlink:type="arc"/>
    <label xlink:label="lab_imtx_CollaborationAgreementAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaboration agreement.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_CollaborationAgreementMember" xlink:label="loc_imtx_CollaborationAgreementMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_CollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaboration Agreement [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_CollaborationAgreementMember" xlink:to="lab_imtx_CollaborationAgreementMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_CollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaboration agreement.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_CelgeneSwitzerlandLlcAndGenmabAsMember" xlink:label="loc_imtx_CelgeneSwitzerlandLlcAndGenmabAsMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_CelgeneSwitzerlandLlcAndGenmabAsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Celgene Switzerland LLC And Genmab AS [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_CelgeneSwitzerlandLlcAndGenmabAsMember" xlink:to="lab_imtx_CelgeneSwitzerlandLlcAndGenmabAsMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_CelgeneSwitzerlandLlcAndGenmabAsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Celgene switzerland LLC and genmab A/S.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_CurrentPrepaidInsurance" xlink:label="loc_imtx_CurrentPrepaidInsurance" xlink:type="locator"/>
    <label xlink:label="lab_imtx_CurrentPrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Prepaid insurance</label>
    <label xlink:label="lab_imtx_CurrentPrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Prepaid insurance expenses</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_CurrentPrepaidInsurance" xlink:to="lab_imtx_CurrentPrepaidInsurance" xlink:type="arc"/>
    <label xlink:label="lab_imtx_CurrentPrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Current prepaid insurance.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_CurrentIncrementalCostForCollaborationAgreement" xlink:label="loc_imtx_CurrentIncrementalCostForCollaborationAgreement" xlink:type="locator"/>
    <label xlink:label="lab_imtx_CurrentIncrementalCostForCollaborationAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Incremental Cost For Collaboration Agreement</label>
    <label xlink:label="lab_imtx_CurrentIncrementalCostForCollaborationAgreement" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current Incremental cost for collaboration agreement</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_CurrentIncrementalCostForCollaborationAgreement" xlink:to="lab_imtx_CurrentIncrementalCostForCollaborationAgreement" xlink:type="arc"/>
    <label xlink:label="lab_imtx_CurrentIncrementalCostForCollaborationAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Current incremental cost for collaboration agreement.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_PrepaidExpensesOfLicensesAndSoftware" xlink:label="loc_imtx_PrepaidExpensesOfLicensesAndSoftware" xlink:type="locator"/>
    <label xlink:label="lab_imtx_PrepaidExpensesOfLicensesAndSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expenses Of Licenses And Software</label>
    <label xlink:label="lab_imtx_PrepaidExpensesOfLicensesAndSoftware" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses of licenses and software</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_PrepaidExpensesOfLicensesAndSoftware" xlink:to="lab_imtx_PrepaidExpensesOfLicensesAndSoftware" xlink:type="arc"/>
    <label xlink:label="lab_imtx_PrepaidExpensesOfLicensesAndSoftware" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Prepaid expenses of licenses and software.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentPrepayments" xlink:label="loc_ifrs-full_NoncurrentPrepayments" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_NoncurrentPrepayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current prepayments</label>
    <label xlink:label="lab_ifrs-full_NoncurrentPrepayments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentPrepayments" xlink:to="lab_ifrs-full_NoncurrentPrepayments" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_BalanceSheetLocationAxis" xlink:label="loc_imtx_BalanceSheetLocationAxis" xlink:type="locator"/>
    <label xlink:label="lab_imtx_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_BalanceSheetLocationAxis" xlink:to="lab_imtx_BalanceSheetLocationAxis" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_BalanceSheetLocationDomain" xlink:label="loc_imtx_BalanceSheetLocationDomain" xlink:type="locator"/>
    <label xlink:label="lab_imtx_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_BalanceSheetLocationDomain" xlink:to="lab_imtx_BalanceSheetLocationDomain" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_ReceivablesFromCapitalGainsTaxMember" xlink:label="loc_imtx_ReceivablesFromCapitalGainsTaxMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ReceivablesFromCapitalGainsTaxMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivables From Capital Gains Tax [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ReceivablesFromCapitalGainsTaxMember" xlink:to="lab_imtx_ReceivablesFromCapitalGainsTaxMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentReceivablesAbstract" xlink:label="loc_ifrs-full_NoncurrentReceivablesAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_NoncurrentReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade and other non-current receivables [abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentReceivablesAbstract" xlink:to="lab_ifrs-full_NoncurrentReceivablesAbstract" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_OtherNonCurrentAsset" xlink:label="loc_imtx_OtherNonCurrentAsset" xlink:type="locator"/>
    <label xlink:label="lab_imtx_OtherNonCurrentAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Non Current Asset</label>
    <label xlink:label="lab_imtx_OtherNonCurrentAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other non-current assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_OtherNonCurrentAsset" xlink:to="lab_imtx_OtherNonCurrentAsset" xlink:type="arc"/>
    <label xlink:label="lab_imtx_OtherNonCurrentAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other non current asset.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_CarryingAmountMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Carrying amount [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CarryingAmountMember" xlink:to="lab_ifrs-full_CarryingAmountMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_GrossCarryingAmountMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross carrying amount [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossCarryingAmountMember" xlink:to="lab_ifrs-full_GrossCarryingAmountMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated depreciation and amortisation [member]</label>
    <label xlink:label="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accumulated depreciation [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:to="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_TypeOfAdoptionsAxis" xlink:label="loc_imtx_TypeOfAdoptionsAxis" xlink:type="locator"/>
    <label xlink:label="lab_imtx_TypeOfAdoptionsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Type Of Adoptions [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_TypeOfAdoptionsAxis" xlink:to="lab_imtx_TypeOfAdoptionsAxis" xlink:type="arc"/>
    <label xlink:label="lab_imtx_TypeOfAdoptionsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Type of adoptions.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_TypeOfAdoptionsMember" xlink:label="loc_imtx_TypeOfAdoptionsMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_TypeOfAdoptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Type Of Adoptions [Member]</label>
    <label xlink:label="lab_imtx_TypeOfAdoptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Type Of Adoptions [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_TypeOfAdoptionsMember" xlink:to="lab_imtx_TypeOfAdoptionsMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_TypeOfAdoptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Type of adoptions.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_AdjustmentOnAdoptionIfrsSixteenMember" xlink:label="loc_imtx_AdjustmentOnAdoptionIfrsSixteenMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_AdjustmentOnAdoptionIfrsSixteenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment On Adoption IFRS Sixteen [Member]</label>
    <label xlink:label="lab_imtx_AdjustmentOnAdoptionIfrsSixteenMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Adjustment On Adoption IFRS 16</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_AdjustmentOnAdoptionIfrsSixteenMember" xlink:to="lab_imtx_AdjustmentOnAdoptionIfrsSixteenMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_AdjustmentOnAdoptionIfrsSixteenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustment on adoption IFRS sixteen.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [line items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_AdditionsOtherPropertyPlantAndEquipment" xlink:label="loc_imtx_AdditionsOtherPropertyPlantAndEquipment" xlink:type="locator"/>
    <label xlink:label="lab_imtx_AdditionsOtherPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additions Other Property Plant and Equipment</label>
    <label xlink:label="lab_imtx_AdditionsOtherPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Additions</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_AdditionsOtherPropertyPlantAndEquipment" xlink:to="lab_imtx_AdditionsOtherPropertyPlantAndEquipment" xlink:type="arc"/>
    <label xlink:label="lab_imtx_AdditionsOtherPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Additions other property, plant and equipment.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisposalsOfPropertyPlantAndEquipment" xlink:label="loc_imtx_DisposalsOfPropertyPlantAndEquipment" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisposalsOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposals of Property Plant and Equipment</label>
    <label xlink:label="lab_imtx_DisposalsOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Disposals</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisposalsOfPropertyPlantAndEquipment" xlink:to="lab_imtx_DisposalsOfPropertyPlantAndEquipment" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisposalsOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposals of property, plant and equipment.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_CurrencyTranslationDifferences" xlink:label="loc_imtx_CurrencyTranslationDifferences" xlink:type="locator"/>
    <label xlink:label="lab_imtx_CurrencyTranslationDifferences" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency Translation Differences</label>
    <label xlink:label="lab_imtx_CurrencyTranslationDifferences" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Currency translation differences</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_CurrencyTranslationDifferences" xlink:to="lab_imtx_CurrencyTranslationDifferences" xlink:type="arc"/>
    <label xlink:label="lab_imtx_CurrencyTranslationDifferences" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Currency translation differences.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDepreciationExpensesAbstract" xlink:label="loc_imtx_DisclosureOfDepreciationExpensesAbstract" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfDepreciationExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Depreciation Expenses [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfDepreciationExpensesAbstract" xlink:to="lab_imtx_DisclosureOfDepreciationExpensesAbstract" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfDepreciationExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of depreciation expenses.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_IncomeStatementLocationAxis" xlink:label="loc_imtx_IncomeStatementLocationAxis" xlink:type="locator"/>
    <label xlink:label="lab_imtx_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_IncomeStatementLocationAxis" xlink:to="lab_imtx_IncomeStatementLocationAxis" xlink:type="arc"/>
    <label xlink:label="lab_imtx_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income statement location.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_IncomeStatementLocationMember" xlink:label="loc_imtx_IncomeStatementLocationMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_IncomeStatementLocationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_IncomeStatementLocationMember" xlink:to="lab_imtx_IncomeStatementLocationMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_IncomeStatementLocationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income statement location.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_ResearchAndDevelopmentExpenseMember" xlink:label="loc_imtx_ResearchAndDevelopmentExpenseMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research And Development Expense [Member]</label>
    <label xlink:label="lab_imtx_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Research and development expenses [Member]</label>
    <label xlink:label="lab_imtx_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:type="resource" xml:lang="en-US">Research And Development Expense [Member]</label>
    <label xlink:label="lab_imtx_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development expenses [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ResearchAndDevelopmentExpenseMember" xlink:to="lab_imtx_ResearchAndDevelopmentExpenseMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research and development expense [Member].</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_GeneralAndAdministrativeExpenseMember" xlink:label="loc_imtx_GeneralAndAdministrativeExpenseMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General And Administrative Expense [Member]</label>
    <label xlink:label="lab_imtx_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">General and administrative expenses [Member]</label>
    <label xlink:label="lab_imtx_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:type="resource" xml:lang="en-US">General And Administrative Expense [Member]</label>
    <label xlink:label="lab_imtx_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative expenses [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_GeneralAndAdministrativeExpenseMember" xlink:to="lab_imtx_GeneralAndAdministrativeExpenseMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">General and administrative expense [Member].</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, property, plant and equipment</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:to="lab_ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillAbstract" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of changes in intangible assets and goodwill [abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillAbstract" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of changes in intangible assets and goodwill [table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AccumulatedImpairmentMember" xlink:label="loc_ifrs-full_AccumulatedImpairmentMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_AccumulatedImpairmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated impairment [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedImpairmentMember" xlink:to="lab_ifrs-full_AccumulatedImpairmentMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_IntangibleAssetsAndGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible assets and goodwill</label>
    <label xlink:label="lab_ifrs-full_IntangibleAssetsAndGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning Balance</label>
    <label xlink:label="lab_ifrs-full_IntangibleAssetsAndGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending Balance</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwill" xlink:to="lab_ifrs-full_IntangibleAssetsAndGoodwill" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additions other than through business combinations, intangible assets other than goodwill</label>
    <label xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Additions</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through net exchange differences, intangible assets and goodwill</label>
    <label xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Currency translation differences</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of intangible assets and goodwill [axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="lab_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible assets and goodwill [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:to="lab_ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_PatentAndLicensesMember" xlink:label="loc_imtx_PatentAndLicensesMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_PatentAndLicensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Patent And Licenses [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_PatentAndLicensesMember" xlink:to="lab_imtx_PatentAndLicensesMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_PatentAndLicensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Patent and licenses.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_SoftwareLicensesMember" xlink:label="loc_imtx_SoftwareLicensesMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_SoftwareLicensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Software Licenses [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_SoftwareLicensesMember" xlink:to="lab_imtx_SoftwareLicensesMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_SoftwareLicensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Software licenses.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfAmortizationExpensesAbstract" xlink:label="loc_imtx_DisclosureOfAmortizationExpensesAbstract" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfAmortizationExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Amortization Expenses [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfAmortizationExpensesAbstract" xlink:to="lab_imtx_DisclosureOfAmortizationExpensesAbstract" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfAmortizationExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of amortization expenses.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about intangible assets [table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about intangible assets [line items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortisation, intangible assets other than goodwill</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract" xlink:to="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:to="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ClassesOfAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of assets [axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis" xlink:to="lab_ifrs-full_ClassesOfAssetsAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-full_ClassesOfAssetsMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ClassesOfAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfAssetsMember" xlink:to="lab_ifrs-full_ClassesOfAssetsMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_BuildingsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Buildings [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BuildingsMember" xlink:to="lab_ifrs-full_BuildingsMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CommunicationAndNetworkEquipmentMember" xlink:label="loc_ifrs-full_CommunicationAndNetworkEquipmentMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_CommunicationAndNetworkEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Communication and network equipment [member]</label>
    <label xlink:label="lab_ifrs-full_CommunicationAndNetworkEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">IT and telecommunication</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CommunicationAndNetworkEquipmentMember" xlink:to="lab_ifrs-full_CommunicationAndNetworkEquipmentMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_VehiclesMember" xlink:label="loc_ifrs-full_VehiclesMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vehicles [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_VehiclesMember" xlink:to="lab_ifrs-full_VehiclesMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherAssetsMember" xlink:label="loc_ifrs-full_OtherAssetsMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other assets [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherAssetsMember" xlink:to="lab_ifrs-full_OtherAssetsMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [line items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LeaseLiabilitiesAbstract" xlink:label="loc_ifrs-full_LeaseLiabilitiesAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_LeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease liabilities [abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract" xlink:to="lab_ifrs-full_LeaseLiabilitiesAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_LeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease liabilities</label>
    <label xlink:label="lab_ifrs-full_LeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities" xlink:to="lab_ifrs-full_LeaseLiabilities" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesAbstract" xlink:label="loc_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesAbstract" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Expenses Related ToRightOfUseAssets And Lease Liabilities [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesAbstract" xlink:to="lab_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesAbstract" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of expenses related to&#xA0;right-of-use&#xA0;assets and lease liabilities.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesTable" xlink:label="loc_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesTable" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Expenses Related ToRightOfUseAssets And Lease Liabilities [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesTable" xlink:to="lab_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesTable" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of expenses related to&#xA0;right-of-use&#xA0;assets and lease liabilities.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesLineItems" xlink:label="loc_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesLineItems" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Expenses Related ToRightOfUseAssets And Lease Liabilities [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesLineItems" xlink:to="lab_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesLineItems" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of expenses related to&#xA0;right-of-use&#xA0;assets and lease liabilities.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DepreciationRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, right-of-use assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationRightofuseAssets" xlink:to="lab_ifrs-full_DepreciationRightofuseAssets" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:label="loc_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expense relating to short-term leases for which recognition exemption has been used</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:to="lab_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_InterestExpenseOnLease" xlink:label="loc_imtx_InterestExpenseOnLease" xlink:type="locator"/>
    <label xlink:label="lab_imtx_InterestExpenseOnLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense on Lease</label>
    <label xlink:label="lab_imtx_InterestExpenseOnLease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense form lease</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_InterestExpenseOnLease" xlink:to="lab_imtx_InterestExpenseOnLease" xlink:type="arc"/>
    <label xlink:label="lab_imtx_InterestExpenseOnLease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest expense on lease.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:label="loc_ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="lab_ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_MaturityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maturity [axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaturityAxis" xlink:to="lab_ifrs-full_MaturityAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_AggregatedTimeBandsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregated time bands [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember" xlink:to="lab_ifrs-full_AggregatedTimeBandsMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LaterThanOneYearMember" xlink:label="loc_ifrs-full_LaterThanOneYearMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_LaterThanOneYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than one year [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearMember" xlink:to="lab_ifrs-full_LaterThanOneYearMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than four years and not later than five years [member]</label>
    <label xlink:label="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Until 2025 [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:to="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="loc_ifrs-full_AdditionsToRightofuseAssets" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_AdditionsToRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additions to right-of-use assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsToRightofuseAssets" xlink:to="lab_ifrs-full_AdditionsToRightofuseAssets" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_TranslationDifferenceOnRightOfUseAsset" xlink:label="loc_imtx_TranslationDifferenceOnRightOfUseAsset" xlink:type="locator"/>
    <label xlink:label="lab_imtx_TranslationDifferenceOnRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Translation Difference On Right Of Use Asset</label>
    <label xlink:label="lab_imtx_TranslationDifferenceOnRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Currency translation of &#xA0;right-of-use&#xA0;assets&#xA0;</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_TranslationDifferenceOnRightOfUseAsset" xlink:to="lab_imtx_TranslationDifferenceOnRightOfUseAsset" xlink:type="arc"/>
    <label xlink:label="lab_imtx_TranslationDifferenceOnRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Translation difference on right of use asset.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashOutflowForLeases" xlink:label="loc_ifrs-full_CashOutflowForLeases" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_CashOutflowForLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash outflow for leases</label>
    <label xlink:label="lab_ifrs-full_CashOutflowForLeases" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash payments for leases</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashOutflowForLeases" xlink:to="lab_ifrs-full_CashOutflowForLeases" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade and other current payables [abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:label="loc_ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade payables</label>
    <label xlink:label="lab_ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:to="lab_ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_OtherAccruedLiabilities" xlink:label="loc_imtx_OtherAccruedLiabilities" xlink:type="locator"/>
    <label xlink:label="lab_imtx_OtherAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities</label>
    <label xlink:label="lab_imtx_OtherAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other accrued liabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_OtherAccruedLiabilities" xlink:to="lab_imtx_OtherAccruedLiabilities" xlink:type="arc"/>
    <label xlink:label="lab_imtx_OtherAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other accrued liabilities.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RevenueAbstract" xlink:label="loc_ifrs-full_RevenueAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_RevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue [abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueAbstract" xlink:to="lab_ifrs-full_RevenueAbstract" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfRevenueFromContractWithCustomersTable" xlink:label="loc_imtx_DisclosureOfRevenueFromContractWithCustomersTable" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfRevenueFromContractWithCustomersTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Revenue From Contract With Customers [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfRevenueFromContractWithCustomersTable" xlink:to="lab_imtx_DisclosureOfRevenueFromContractWithCustomersTable" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_AgreementAxis" xlink:label="loc_imtx_AgreementAxis" xlink:type="locator"/>
    <label xlink:label="lab_imtx_AgreementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Agreement [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_AgreementAxis" xlink:to="lab_imtx_AgreementAxis" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_AgreementDomain" xlink:label="loc_imtx_AgreementDomain" xlink:type="locator"/>
    <label xlink:label="lab_imtx_AgreementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Agreement [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_AgreementDomain" xlink:to="lab_imtx_AgreementDomain" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_AmgenCollaborationAgreementMember" xlink:label="loc_imtx_AmgenCollaborationAgreementMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_AmgenCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amgen Collaboration Agreement [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_AmgenCollaborationAgreementMember" xlink:to="lab_imtx_AmgenCollaborationAgreementMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_GenmabCollaborationAgreementMember" xlink:label="loc_imtx_GenmabCollaborationAgreementMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_GenmabCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Genmab Collaboration Agreement [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_GenmabCollaborationAgreementMember" xlink:to="lab_imtx_GenmabCollaborationAgreementMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_BMSCollaborationAgreementMember" xlink:label="loc_imtx_BMSCollaborationAgreementMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_BMSCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">B M S Collaboration Agreement [Member]</label>
    <label xlink:label="lab_imtx_BMSCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BMS Collaboration Agreement [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_BMSCollaborationAgreementMember" xlink:to="lab_imtx_BMSCollaborationAgreementMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_GSKCollaborationAgreementMember" xlink:label="loc_imtx_GSKCollaborationAgreementMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_GSKCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">G S K Collaboration Agreement [Member]</label>
    <label xlink:label="lab_imtx_GSKCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GSK Collaboration Agreement [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_GSKCollaborationAgreementMember" xlink:to="lab_imtx_GSKCollaborationAgreementMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_MilestoneAxis" xlink:label="loc_imtx_MilestoneAxis" xlink:type="locator"/>
    <label xlink:label="lab_imtx_MilestoneAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Milestone [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_MilestoneAxis" xlink:to="lab_imtx_MilestoneAxis" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_MilestoneDomain" xlink:label="loc_imtx_MilestoneDomain" xlink:type="locator"/>
    <label xlink:label="lab_imtx_MilestoneDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Milestone [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_MilestoneDomain" xlink:to="lab_imtx_MilestoneDomain" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DevelopmentAndCommercialMilestonePaymentsMember" xlink:label="loc_imtx_DevelopmentAndCommercialMilestonePaymentsMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DevelopmentAndCommercialMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Development And Commercial Milestone Payments [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DevelopmentAndCommercialMilestonePaymentsMember" xlink:to="lab_imtx_DevelopmentAndCommercialMilestonePaymentsMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_MilestonePaymentForLicensedProductMember" xlink:label="loc_imtx_MilestonePaymentForLicensedProductMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_MilestonePaymentForLicensedProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Milestone Payment For Licensed Product [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_MilestonePaymentForLicensedProductMember" xlink:to="lab_imtx_MilestonePaymentForLicensedProductMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_MilestoneProgramsBasedOnTheProgramMember" xlink:label="loc_imtx_MilestoneProgramsBasedOnTheProgramMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_MilestoneProgramsBasedOnTheProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Milestone Programs Based On The Program [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_MilestoneProgramsBasedOnTheProgramMember" xlink:to="lab_imtx_MilestoneProgramsBasedOnTheProgramMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_OptionExerciseDevelopmentCommecialAndRegulatoryMilestonePaymentsMember" xlink:label="loc_imtx_OptionExerciseDevelopmentCommecialAndRegulatoryMilestonePaymentsMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_OptionExerciseDevelopmentCommecialAndRegulatoryMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Option Exercise Development Commecial And Regulatory Milestone Payments [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_OptionExerciseDevelopmentCommecialAndRegulatoryMilestonePaymentsMember" xlink:to="lab_imtx_OptionExerciseDevelopmentCommecialAndRegulatoryMilestonePaymentsMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis" xlink:type="locator"/>
    <label xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <label xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfRevenueFromContractWithCustomersLineItems" xlink:label="loc_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Revenue From Contract With Customers [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems" xlink:to="lab_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_MilestonePaymentReceivable" xlink:label="loc_imtx_MilestonePaymentReceivable" xlink:type="locator"/>
    <label xlink:label="lab_imtx_MilestonePaymentReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Milestone Payment Receivable</label>
    <label xlink:label="lab_imtx_MilestonePaymentReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Milestone payment receivable</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_MilestonePaymentReceivable" xlink:to="lab_imtx_MilestonePaymentReceivable" xlink:type="arc"/>
    <label xlink:label="lab_imtx_MilestonePaymentReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Milestone payment receivable.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_UpfrontPaymentReceived" xlink:label="loc_imtx_UpfrontPaymentReceived" xlink:type="locator"/>
    <label xlink:label="lab_imtx_UpfrontPaymentReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Upfront Payment Received</label>
    <label xlink:label="lab_imtx_UpfrontPaymentReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Upfront payment received</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_UpfrontPaymentReceived" xlink:to="lab_imtx_UpfrontPaymentReceived" xlink:type="arc"/>
    <label xlink:label="lab_imtx_UpfrontPaymentReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Upfront payment received.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xlink:label="loc_ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue that was included in contract liability balance at beginning of period</label>
    <label xlink:label="lab_ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract with customers liability revenue recognized</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xlink:to="lab_ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ContractLiabilities" xlink:label="loc_ifrs-full_ContractLiabilities" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract liabilities</label>
    <label xlink:label="lab_ifrs-full_ContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract with customers liability</label>
    <label xlink:label="lab_ifrs-full_ContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContractLiabilities" xlink:to="lab_ifrs-full_ContractLiabilities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AssetsRecognisedFromCostsToObtainOrFulfilContractsWithCustomers" xlink:label="loc_ifrs-full_AssetsRecognisedFromCostsToObtainOrFulfilContractsWithCustomers" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_AssetsRecognisedFromCostsToObtainOrFulfilContractsWithCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets recognised from costs to obtain or fulfil contracts with customers</label>
    <label xlink:label="lab_ifrs-full_AssetsRecognisedFromCostsToObtainOrFulfilContractsWithCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalized costs of contract net of amortization</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsRecognisedFromCostsToObtainOrFulfilContractsWithCustomers" xlink:to="lab_ifrs-full_AssetsRecognisedFromCostsToObtainOrFulfilContractsWithCustomers" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AmortisationAssetsRecognisedFromCostsIncurredToObtainOrFulfilContractsWithCustomers" xlink:label="loc_ifrs-full_AmortisationAssetsRecognisedFromCostsIncurredToObtainOrFulfilContractsWithCustomers" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_AmortisationAssetsRecognisedFromCostsIncurredToObtainOrFulfilContractsWithCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortisation, assets recognised from costs incurred to obtain or fulfil contracts with customers</label>
    <label xlink:label="lab_ifrs-full_AmortisationAssetsRecognisedFromCostsIncurredToObtainOrFulfilContractsWithCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of contract costs capitalized</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmortisationAssetsRecognisedFromCostsIncurredToObtainOrFulfilContractsWithCustomers" xlink:to="lab_ifrs-full_AmortisationAssetsRecognisedFromCostsIncurredToObtainOrFulfilContractsWithCustomers" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_PotentialMilestonePaymentPayable" xlink:label="loc_imtx_PotentialMilestonePaymentPayable" xlink:type="locator"/>
    <label xlink:label="lab_imtx_PotentialMilestonePaymentPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Potential Milestone Payment Payable</label>
    <label xlink:label="lab_imtx_PotentialMilestonePaymentPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Potential milestone payment payable</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_PotentialMilestonePaymentPayable" xlink:to="lab_imtx_PotentialMilestonePaymentPayable" xlink:type="arc"/>
    <label xlink:label="lab_imtx_PotentialMilestonePaymentPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Potential milestone payment payable.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfOtherIncomeAbstract" xlink:label="loc_imtx_DisclosureOfOtherIncomeAbstract" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfOtherIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Other income [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfOtherIncomeAbstract" xlink:to="lab_imtx_DisclosureOfOtherIncomeAbstract" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_GovernmentGrantReceivable" xlink:label="loc_imtx_GovernmentGrantReceivable" xlink:type="locator"/>
    <label xlink:label="lab_imtx_GovernmentGrantReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Government Grant Receivable</label>
    <label xlink:label="lab_imtx_GovernmentGrantReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receivables</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_GovernmentGrantReceivable" xlink:to="lab_imtx_GovernmentGrantReceivable" xlink:type="arc"/>
    <label xlink:label="lab_imtx_GovernmentGrantReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Government grant receivable.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DeferredIncomeCurrent" xlink:label="loc_imtx_DeferredIncomeCurrent" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DeferredIncomeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred income current</label>
    <label xlink:label="lab_imtx_DeferredIncomeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DeferredIncomeCurrent" xlink:to="lab_imtx_DeferredIncomeCurrent" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DeferredIncomeCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred income current</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_TotalDeferredIncome" xlink:label="loc_imtx_TotalDeferredIncome" xlink:type="locator"/>
    <label xlink:label="lab_imtx_TotalDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total deferred income</label>
    <label xlink:label="lab_imtx_TotalDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_TotalDeferredIncome" xlink:to="lab_imtx_TotalDeferredIncome" xlink:type="arc"/>
    <label xlink:label="lab_imtx_TotalDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total deferred income.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RevenueFromGovernmentGrants" xlink:label="loc_ifrs-full_RevenueFromGovernmentGrants" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_RevenueFromGovernmentGrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income from government grants</label>
    <label xlink:label="lab_ifrs-full_RevenueFromGovernmentGrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from grants</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromGovernmentGrants" xlink:to="lab_ifrs-full_RevenueFromGovernmentGrants" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_ContingenciesRelatedToGrant" xlink:label="loc_imtx_ContingenciesRelatedToGrant" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ContingenciesRelatedToGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingencies Related To Grant</label>
    <label xlink:label="lab_imtx_ContingenciesRelatedToGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingencies related to grant</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ContingenciesRelatedToGrant" xlink:to="lab_imtx_ContingenciesRelatedToGrant" xlink:type="arc"/>
    <label xlink:label="lab_imtx_ContingenciesRelatedToGrant" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contingencies related to grant.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesAbstract" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesAbstract" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about other current liabilities [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesAbstract" xlink:to="lab_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesAbstract" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about other current liabilities abstract.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTable" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTable" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about other current liabilities [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTable" xlink:to="lab_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTable" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about other current liabilities Table.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about other current liabilities [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems" xlink:to="lab_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about other current liabilities line items.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="loc_ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current tax liabilities, current</label>
    <label xlink:label="lab_ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payroll tax</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:to="lab_ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AccrualsClassifiedAsCurrent" xlink:label="loc_ifrs-full_AccrualsClassifiedAsCurrent" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_AccrualsClassifiedAsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accruals classified as current</label>
    <label xlink:label="lab_ifrs-full_AccrualsClassifiedAsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accrual for vacation</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccrualsClassifiedAsCurrent" xlink:to="lab_ifrs-full_AccrualsClassifiedAsCurrent" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DeferredGrantIncomeCurrent" xlink:label="loc_imtx_DeferredGrantIncomeCurrent" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DeferredGrantIncomeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred grant income current</label>
    <label xlink:label="lab_imtx_DeferredGrantIncomeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred grant income</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DeferredGrantIncomeCurrent" xlink:to="lab_imtx_DeferredGrantIncomeCurrent" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DeferredGrantIncomeCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred grant income current.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:label="loc_ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current provisions for employee benefits</label>
    <label xlink:label="lab_ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued bonuses</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:to="lab_ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_OtherCurrent" xlink:label="loc_imtx_OtherCurrent" xlink:type="locator"/>
    <label xlink:label="lab_imtx_OtherCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Current</label>
    <label xlink:label="lab_imtx_OtherCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_OtherCurrent" xlink:to="lab_imtx_OtherCurrent" xlink:type="arc"/>
    <label xlink:label="lab_imtx_OtherCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other current.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_BorrowingsByNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings by name [axis]</label>
    <label xlink:label="lab_ifrs-full_BorrowingsByNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings by name [axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsByNameAxis" xlink:to="lab_ifrs-full_BorrowingsByNameAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_BorrowingsByNameMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings by name [member]</label>
    <label xlink:label="lab_ifrs-full_BorrowingsByNameMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings by name [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsByNameMember" xlink:to="lab_ifrs-full_BorrowingsByNameMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_NonInterestBearingLiabilityMember" xlink:label="loc_imtx_NonInterestBearingLiabilityMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_NonInterestBearingLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non Interest Bearing Liability [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_NonInterestBearingLiabilityMember" xlink:to="lab_imtx_NonInterestBearingLiabilityMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_NonInterestBearingLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non interest bearing liability.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BorrowingsMaturity" xlink:label="loc_ifrs-full_BorrowingsMaturity" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_BorrowingsMaturity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, maturity</label>
    <label xlink:label="lab_ifrs-full_BorrowingsMaturity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings maturity</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsMaturity" xlink:to="lab_ifrs-full_BorrowingsMaturity" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseAbstract" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseAbstract" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Finance Income Expense [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseAbstract" xlink:to="lab_imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseAbstract" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Finance Income Expense.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InterestIncomeOnDeposits" xlink:label="loc_ifrs-full_InterestIncomeOnDeposits" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_InterestIncomeOnDeposits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest income on deposits</label>
    <label xlink:label="lab_ifrs-full_InterestIncomeOnDeposits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income from short-term deposits</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestIncomeOnDeposits" xlink:to="lab_ifrs-full_InterestIncomeOnDeposits" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NetForeignExchangeGain" xlink:label="loc_ifrs-full_NetForeignExchangeGain" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_NetForeignExchangeGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net foreign exchange gain</label>
    <label xlink:label="lab_ifrs-full_NetForeignExchangeGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency gains</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetForeignExchangeGain" xlink:to="lab_ifrs-full_NetForeignExchangeGain" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GainLossRecognisedOnFinancialInstrumentsWhoseFairValuePreviouslyCouldNotBeReliablyMeasured" xlink:label="loc_ifrs-full_GainLossRecognisedOnFinancialInstrumentsWhoseFairValuePreviouslyCouldNotBeReliablyMeasured" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_GainLossRecognisedOnFinancialInstrumentsWhoseFairValuePreviouslyCouldNotBeReliablyMeasured" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (loss) recognised on derecognition of financial instruments whose fair value previously could not be reliably measured</label>
    <label xlink:label="lab_ifrs-full_GainLossRecognisedOnFinancialInstrumentsWhoseFairValuePreviouslyCouldNotBeReliablyMeasured" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain on other financial instruments</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainLossRecognisedOnFinancialInstrumentsWhoseFairValuePreviouslyCouldNotBeReliablyMeasured" xlink:to="lab_ifrs-full_GainLossRecognisedOnFinancialInstrumentsWhoseFairValuePreviouslyCouldNotBeReliablyMeasured" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest expense on lease liabilities</label>
    <label xlink:label="lab_ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Interest expenses form leases</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:to="lab_ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NetForeignExchangeLoss" xlink:label="loc_ifrs-full_NetForeignExchangeLoss" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_NetForeignExchangeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net foreign exchange loss</label>
    <label xlink:label="lab_ifrs-full_NetForeignExchangeLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Foreign currency losses</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetForeignExchangeLoss" xlink:to="lab_ifrs-full_NetForeignExchangeLoss" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_RealisedGainLossFromForeignCurrencyForwardContracts" xlink:label="loc_imtx_RealisedGainLossFromForeignCurrencyForwardContracts" xlink:type="locator"/>
    <label xlink:label="lab_imtx_RealisedGainLossFromForeignCurrencyForwardContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Realised gain loss from foreign currency forward contracts</label>
    <label xlink:label="lab_imtx_RealisedGainLossFromForeignCurrencyForwardContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Realised gain loss from foreign currency forward contracts</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_RealisedGainLossFromForeignCurrencyForwardContracts" xlink:to="lab_imtx_RealisedGainLossFromForeignCurrencyForwardContracts" xlink:type="arc"/>
    <label xlink:label="lab_imtx_RealisedGainLossFromForeignCurrencyForwardContracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Realised gain loss from foreign currency forward contracts</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_UnrealisedGainLossFromForeignCurrencyForwardContracts" xlink:label="loc_imtx_UnrealisedGainLossFromForeignCurrencyForwardContracts" xlink:type="locator"/>
    <label xlink:label="lab_imtx_UnrealisedGainLossFromForeignCurrencyForwardContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrealised gain loss from foreign currency forward contracts</label>
    <label xlink:label="lab_imtx_UnrealisedGainLossFromForeignCurrencyForwardContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealised gain loss from foreign currency forward contracts</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_UnrealisedGainLossFromForeignCurrencyForwardContracts" xlink:to="lab_imtx_UnrealisedGainLossFromForeignCurrencyForwardContracts" xlink:type="arc"/>
    <label xlink:label="lab_imtx_UnrealisedGainLossFromForeignCurrencyForwardContracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Unrealised gain loss from foreign currency forward contracts.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about business combination [abstract]</label>
    <label xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about business combination [abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfShareListingExpenseLineItems" xlink:label="loc_imtx_DisclosureOfShareListingExpenseLineItems" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfShareListingExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Share Listing Expense [Line Items]</label>
    <label xlink:label="lab_imtx_DisclosureOfShareListingExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of share listing expense [line items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfShareListingExpenseLineItems" xlink:to="lab_imtx_DisclosureOfShareListingExpenseLineItems" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfShareListingExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of share listing expense.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ParValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Par value per share</label>
    <label xlink:label="lab_ifrs-full_ParValuePerShare" xlink:role="http://www.xbrl.org/2003/role/disclosureGuidance" xlink:type="resource" xml:lang="en-US">Closing price of ARYA ordinary shares</label>
    <label xlink:label="lab_ifrs-full_ParValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Closing price of ARYA Ordinary Shares on Nasdaq as of July 1, 2020</label>
    <label xlink:label="lab_ifrs-full_ParValuePerShare" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:type="resource" xml:lang="en-US">Par value per share</label>
    <label xlink:label="lab_ifrs-full_ParValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Par value per share</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ParValuePerShare" xlink:to="lab_ifrs-full_ParValuePerShare" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_WarrantsIssuedPricePerWarrant" xlink:label="loc_imtx_WarrantsIssuedPricePerWarrant" xlink:type="locator"/>
    <label xlink:label="lab_imtx_WarrantsIssuedPricePerWarrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants Issued Price Per Warrant</label>
    <label xlink:label="lab_imtx_WarrantsIssuedPricePerWarrant" xlink:role="http://www.xbrl.org/2003/role/disclosureGuidance" xlink:type="resource" xml:lang="en-US">Closing price of ARYA public warrants</label>
    <label xlink:label="lab_imtx_WarrantsIssuedPricePerWarrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Closing price of ARYA Public Warrants on Nasdaq as of July 1, 2020</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_WarrantsIssuedPricePerWarrant" xlink:to="lab_imtx_WarrantsIssuedPricePerWarrant" xlink:type="arc"/>
    <label xlink:label="lab_imtx_WarrantsIssuedPricePerWarrant" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrants issued price per warrant.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_EquityInterestsOfAcquirer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity interests of acquirer</label>
    <label xlink:label="lab_ifrs-full_EquityInterestsOfAcquirer" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:type="resource" xml:lang="en-US">Fair value of ARYA ordinary shares and warrants</label>
    <label xlink:label="lab_ifrs-full_EquityInterestsOfAcquirer" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair value of outstanding ARYA</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityInterestsOfAcquirer" xlink:to="lab_ifrs-full_EquityInterestsOfAcquirer" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about share listing expense [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems" xlink:to="lab_imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about share listing expense.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [line items]</label>
    <label xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [line items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise price, share options granted</label>
    <label xlink:label="lab_ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Exercise price</label>
    <label xlink:label="lab_ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Strike Price in USD</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:to="lab_ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average share price, share options granted</label>
    <label xlink:label="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying share price</label>
    <label xlink:label="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average share price of share options granted</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:to="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expected volatility, share options granted</label>
    <label xlink:label="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Volatility</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:to="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Option life, share options granted</label>
    <label xlink:label="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Time period (years)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:to="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Risk free interest rate, share options granted</label>
    <label xlink:label="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk free rate</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:to="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expected dividend as percentage, share options granted</label>
    <label xlink:label="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividend yield</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:to="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_CombinedProbabilityOfExitEventsShareOptionsGranted" xlink:label="loc_imtx_CombinedProbabilityOfExitEventsShareOptionsGranted" xlink:type="locator"/>
    <label xlink:label="lab_imtx_CombinedProbabilityOfExitEventsShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Combined probability of exit events Share Options Granted</label>
    <label xlink:label="lab_imtx_CombinedProbabilityOfExitEventsShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Combined probability of exit events</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_CombinedProbabilityOfExitEventsShareOptionsGranted" xlink:to="lab_imtx_CombinedProbabilityOfExitEventsShareOptionsGranted" xlink:type="arc"/>
    <label xlink:label="lab_imtx_CombinedProbabilityOfExitEventsShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Combined probability of exit events share options granted.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_PlanAxis" xlink:label="loc_imtx_PlanAxis" xlink:type="locator"/>
    <label xlink:label="lab_imtx_PlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_PlanAxis" xlink:to="lab_imtx_PlanAxis" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_PlanMember" xlink:label="loc_imtx_PlanMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_PlanMember" xlink:to="lab_imtx_PlanMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Plan [Member].</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of share options outstanding in share-based payment arrangement</label>
    <label xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, Outstanding at January&#xA0;1,</label>
    <label xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, Outstanding at December&#xA0;31,</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of share options granted in share-based payment arrangement</label>
    <label xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SARs granted</label>
    <label xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, Tandem awards granted</label>
    <label xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:type="resource" xml:lang="en-US">Share based compensation by share based payment arrangement exercise price per share granted</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of share options forfeited in share-based payment arrangement</label>
    <label xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SARs forfeited</label>
    <label xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, Tandem awards forfeited</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_WeightedAverageExercisePriceOfShareOptionsVestedInSharebasedPaymentArrangement2019" xlink:label="loc_imtx_WeightedAverageExercisePriceOfShareOptionsVestedInSharebasedPaymentArrangement2019" xlink:type="locator"/>
    <label xlink:label="lab_imtx_WeightedAverageExercisePriceOfShareOptionsVestedInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price Of Share Options Vested In Sharebased Payment Arrangement 2019</label>
    <label xlink:label="lab_imtx_WeightedAverageExercisePriceOfShareOptionsVestedInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SARs vested</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_WeightedAverageExercisePriceOfShareOptionsVestedInSharebasedPaymentArrangement2019" xlink:to="lab_imtx_WeightedAverageExercisePriceOfShareOptionsVestedInSharebasedPaymentArrangement2019" xlink:type="arc"/>
    <label xlink:label="lab_imtx_WeightedAverageExercisePriceOfShareOptionsVestedInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of share options vested in sharebased payment arrangement 2019.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of share options outstanding in share-based payment arrangement</label>
    <label xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Number of share options, outstanding at January&#xA0;1,</label>
    <label xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Number of share options, outstanding at December&#xA0;31,</label>
    <label xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of share options outstanding</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOutstandingShareOptions" xlink:to="lab_ifrs-full_NumberOfOutstandingShareOptions" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of share options granted in share-based payment arrangement</label>
    <label xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SARs granted</label>
    <label xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:type="resource" xml:lang="en-US">Number of share options, Tandem awards granted</label>
    <label xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share based compensation by share based payment arrangement options granted during the period</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of share options forfeited in share-based payment arrangement</label>
    <label xlink:label="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SARs forfeited</label>
    <label xlink:label="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Number of share options, Tandem awards forfeited</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_NumberOfShareOptionsVestedInSharebasedPaymentArrangement" xlink:label="loc_imtx_NumberOfShareOptionsVestedInSharebasedPaymentArrangement" xlink:type="locator"/>
    <label xlink:label="lab_imtx_NumberOfShareOptionsVestedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Share Options Vested In Sharebased Payment Arrangement</label>
    <label xlink:label="lab_imtx_NumberOfShareOptionsVestedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SARs vested</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_NumberOfShareOptionsVestedInSharebasedPaymentArrangement" xlink:to="lab_imtx_NumberOfShareOptionsVestedInSharebasedPaymentArrangement" xlink:type="arc"/>
    <label xlink:label="lab_imtx_NumberOfShareOptionsVestedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of share options vested in sharebased payment arrangement.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average remaining contractual life of outstanding share options</label>
    <label xlink:label="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining contract life (years)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:to="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare" xlink:label="loc_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation By Share Based Payment Arrangement Weighted Average Fair Value Per Share</label>
    <label xlink:label="lab_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average fair value of options granted</label>
    <label xlink:label="lab_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share based compensation by share based payment arrangement fair value per share</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare" xlink:to="lab_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare" xlink:type="arc"/>
    <label xlink:label="lab_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share based compensation by share based payment arrangement weighted average fair value per share.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DateOfGrantAxis" xlink:label="loc_imtx_DateOfGrantAxis" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DateOfGrantAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Date Of Grant [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DateOfGrantAxis" xlink:to="lab_imtx_DateOfGrantAxis" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DateOfGrantAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Date of grant [Axis].</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DateOfGrantMember" xlink:label="loc_imtx_DateOfGrantMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DateOfGrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Date Of Grant [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DateOfGrantMember" xlink:to="lab_imtx_DateOfGrantMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DateOfGrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Date of grant .</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_GrantedOnJuneTwoThousandAndTwentyMember" xlink:label="loc_imtx_GrantedOnJuneTwoThousandAndTwentyMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_GrantedOnJuneTwoThousandAndTwentyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Granted On June Two Thousand And Twenty [Member]</label>
    <label xlink:label="lab_imtx_GrantedOnJuneTwoThousandAndTwentyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted On June 2020 [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_GrantedOnJuneTwoThousandAndTwentyMember" xlink:to="lab_imtx_GrantedOnJuneTwoThousandAndTwentyMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_GrantedOnJuneTwoThousandAndTwentyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Granted on june two thousand and twenty [Member].</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_GrantedOnSeptemberTwoThousandAndTwentyMember" xlink:label="loc_imtx_GrantedOnSeptemberTwoThousandAndTwentyMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_GrantedOnSeptemberTwoThousandAndTwentyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Granted On September Two Thousand And Twenty [Member]</label>
    <label xlink:label="lab_imtx_GrantedOnSeptemberTwoThousandAndTwentyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted On September 2020 [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_GrantedOnSeptemberTwoThousandAndTwentyMember" xlink:to="lab_imtx_GrantedOnSeptemberTwoThousandAndTwentyMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_GrantedOnSeptemberTwoThousandAndTwentyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Granted on september two thousand and twenty [Member].</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_GrantedOnDecemberTwoThousandAndTwentyMember" xlink:label="loc_imtx_GrantedOnDecemberTwoThousandAndTwentyMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_GrantedOnDecemberTwoThousandAndTwentyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Granted On December Two Thousand And Twenty [Member]</label>
    <label xlink:label="lab_imtx_GrantedOnDecemberTwoThousandAndTwentyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted On December 2020 [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_GrantedOnDecemberTwoThousandAndTwentyMember" xlink:to="lab_imtx_GrantedOnDecemberTwoThousandAndTwentyMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_GrantedOnDecemberTwoThousandAndTwentyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Granted on december two thousand and twenty [Member].</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_WeightedAverageExercisePriceOfShareOptionsVestedDuringThePeriod" xlink:label="loc_imtx_WeightedAverageExercisePriceOfShareOptionsVestedDuringThePeriod" xlink:type="locator"/>
    <label xlink:label="lab_imtx_WeightedAverageExercisePriceOfShareOptionsVestedDuringThePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price Of Share Options Vested During The Period</label>
    <label xlink:label="lab_imtx_WeightedAverageExercisePriceOfShareOptionsVestedDuringThePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, Tandem awards vested</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_WeightedAverageExercisePriceOfShareOptionsVestedDuringThePeriod" xlink:to="lab_imtx_WeightedAverageExercisePriceOfShareOptionsVestedDuringThePeriod" xlink:type="arc"/>
    <label xlink:label="lab_imtx_WeightedAverageExercisePriceOfShareOptionsVestedDuringThePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of share options vested during the period.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageSharePrice2019" xlink:label="loc_ifrs-full_WeightedAverageSharePrice2019" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_WeightedAverageSharePrice2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average share price</label>
    <label xlink:label="lab_ifrs-full_WeightedAverageSharePrice2019" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average fair value of options granted</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageSharePrice2019" xlink:to="lab_ifrs-full_WeightedAverageSharePrice2019" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_NumberOfShareOptionsVestedDuringThePeriod" xlink:label="loc_imtx_NumberOfShareOptionsVestedDuringThePeriod" xlink:type="locator"/>
    <label xlink:label="lab_imtx_NumberOfShareOptionsVestedDuringThePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Share Options Vested During The Period</label>
    <label xlink:label="lab_imtx_NumberOfShareOptionsVestedDuringThePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of share options, Tandem awards vested</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_NumberOfShareOptionsVestedDuringThePeriod" xlink:to="lab_imtx_NumberOfShareOptionsVestedDuringThePeriod" xlink:type="arc"/>
    <label xlink:label="lab_imtx_NumberOfShareOptionsVestedDuringThePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of share options vested during the period.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_GrantedOnJuneToSeptemberTwoThousandAndTwentyMember" xlink:label="loc_imtx_GrantedOnJuneToSeptemberTwoThousandAndTwentyMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_GrantedOnJuneToSeptemberTwoThousandAndTwentyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Granted On June To September Two Thousand And Twenty [Member]</label>
    <label xlink:label="lab_imtx_GrantedOnJuneToSeptemberTwoThousandAndTwentyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted On June 2020 [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_GrantedOnJuneToSeptemberTwoThousandAndTwentyMember" xlink:to="lab_imtx_GrantedOnJuneToSeptemberTwoThousandAndTwentyMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_GrantedOnJuneToSeptemberTwoThousandAndTwentyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Granted on june to september two thousand and twenty [Member].</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_ShareAppreciationRightsTwoThousandAndTenPlanMember" xlink:label="loc_imtx_ShareAppreciationRightsTwoThousandAndTenPlanMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ShareAppreciationRightsTwoThousandAndTenPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Appreciation Rights Two Thousand And Ten Plan [Member]</label>
    <label xlink:label="lab_imtx_ShareAppreciationRightsTwoThousandAndTenPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share Appreciation Rights Two Thousand And Ten Plan [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ShareAppreciationRightsTwoThousandAndTenPlanMember" xlink:to="lab_imtx_ShareAppreciationRightsTwoThousandAndTenPlanMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_ShareAppreciationRightsTwoThousandAndTenPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share appreciation rights two thousand and ten plan [Member].</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMember" xlink:label="loc_imtx_ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Modification Of Awards Under Two Thousand Ten And Two Thousand And Sixteen Plan [Member]</label>
    <label xlink:label="lab_imtx_ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Modification Of Awards Under Two Thousand Ten And Two Thousand And Sixteen Plan [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMember" xlink:to="lab_imtx_ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Modification of awards under two thousand ten and two thousand and sixteen plan [Member].</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_ModificationOfTwoThousandAndTenPlanMember" xlink:label="loc_imtx_ModificationOfTwoThousandAndTenPlanMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ModificationOfTwoThousandAndTenPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Modification Of Two Thousand And Ten Plan [Member]</label>
    <label xlink:label="lab_imtx_ModificationOfTwoThousandAndTenPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Modification Of Two Thousand And Ten Plan [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ModificationOfTwoThousandAndTenPlanMember" xlink:to="lab_imtx_ModificationOfTwoThousandAndTenPlanMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_ModificationOfTwoThousandAndTenPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Modification of two thousand and ten plan [Member].</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_ModificationOfTwoThousandAndSixteenPlanMember" xlink:label="loc_imtx_ModificationOfTwoThousandAndSixteenPlanMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ModificationOfTwoThousandAndSixteenPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Modification Of Two Thousand And Sixteen Plan [Member]</label>
    <label xlink:label="lab_imtx_ModificationOfTwoThousandAndSixteenPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Modification Of Two Thousand And Sixteen Plan [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ModificationOfTwoThousandAndSixteenPlanMember" xlink:to="lab_imtx_ModificationOfTwoThousandAndSixteenPlanMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_ModificationOfTwoThousandAndSixteenPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Modification of two thousand and sixteen plan [Member].</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_CategoryOfEmployeesAxis" xlink:label="loc_imtx_CategoryOfEmployeesAxis" xlink:type="locator"/>
    <label xlink:label="lab_imtx_CategoryOfEmployeesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Category Of Employees [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_CategoryOfEmployeesAxis" xlink:to="lab_imtx_CategoryOfEmployeesAxis" xlink:type="arc"/>
    <label xlink:label="lab_imtx_CategoryOfEmployeesAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Category Of employees [Axis].</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_CategoryOfEmployeesMember" xlink:label="loc_imtx_CategoryOfEmployeesMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_CategoryOfEmployeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Category Of Employees [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_CategoryOfEmployeesMember" xlink:to="lab_imtx_CategoryOfEmployeesMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_CategoryOfEmployeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Category of employees [Member].</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_ActiveEmployeesMember" xlink:label="loc_imtx_ActiveEmployeesMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ActiveEmployeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Active Employees [Member]</label>
    <label xlink:label="lab_imtx_ActiveEmployeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Active Employees [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ActiveEmployeesMember" xlink:to="lab_imtx_ActiveEmployeesMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_ActiveEmployeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Active employees [Member].</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_ManagementMembersMember" xlink:label="loc_imtx_ManagementMembersMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ManagementMembersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Management Members [Member]</label>
    <label xlink:label="lab_imtx_ManagementMembersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Management Members [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ManagementMembersMember" xlink:to="lab_imtx_ManagementMembersMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_ManagementMembersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Management members [Member].</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_SchemeAxis" xlink:label="loc_imtx_SchemeAxis" xlink:type="locator"/>
    <label xlink:label="lab_imtx_SchemeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scheme [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_SchemeAxis" xlink:to="lab_imtx_SchemeAxis" xlink:type="arc"/>
    <label xlink:label="lab_imtx_SchemeAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Scheme [Axis].</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_SchemeMember" xlink:label="loc_imtx_SchemeMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_SchemeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scheme [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_SchemeMember" xlink:to="lab_imtx_SchemeMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_SchemeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Scheme [Member].</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_ShareReinvestmentMember" xlink:label="loc_imtx_ShareReinvestmentMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ShareReinvestmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Reinvestment [Member]</label>
    <label xlink:label="lab_imtx_ShareReinvestmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share Reinvestment [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ShareReinvestmentMember" xlink:to="lab_imtx_ShareReinvestmentMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_ShareReinvestmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share reinvestment [Member].</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_ShareReinvestmentSchemeAxis" xlink:label="loc_imtx_ShareReinvestmentSchemeAxis" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ShareReinvestmentSchemeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Reinvestment Scheme [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ShareReinvestmentSchemeAxis" xlink:to="lab_imtx_ShareReinvestmentSchemeAxis" xlink:type="arc"/>
    <label xlink:label="lab_imtx_ShareReinvestmentSchemeAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share reinvestment scheme [Axis].</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_ShareReinvestmentSchemeMember" xlink:label="loc_imtx_ShareReinvestmentSchemeMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ShareReinvestmentSchemeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Reinvestment Scheme [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ShareReinvestmentSchemeMember" xlink:to="lab_imtx_ShareReinvestmentSchemeMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_ShareReinvestmentSchemeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share reinvestment scheme [Member].</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_PercentageOfOutstandingSharesToBePurchasedByThirdParty" xlink:label="loc_imtx_PercentageOfOutstandingSharesToBePurchasedByThirdParty" xlink:type="locator"/>
    <label xlink:label="lab_imtx_PercentageOfOutstandingSharesToBePurchasedByThirdParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage Of Outstanding Shares To Be Purchased By Third Party</label>
    <label xlink:label="lab_imtx_PercentageOfOutstandingSharesToBePurchasedByThirdParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of outstanding shares to be purchased by third party</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_PercentageOfOutstandingSharesToBePurchasedByThirdParty" xlink:to="lab_imtx_PercentageOfOutstandingSharesToBePurchasedByThirdParty" xlink:type="arc"/>
    <label xlink:label="lab_imtx_PercentageOfOutstandingSharesToBePurchasedByThirdParty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage of outstanding shares to be purchased by third party.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average fair value at measurement date, share options granted</label>
    <label xlink:label="lab_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:type="resource" xml:lang="en-US">Fair value of stock appreciation rights</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:to="lab_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011" xlink:label="loc_ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities from share-based payment transactions</label>
    <label xlink:label="lab_ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities arising from share based payment arrangement</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011" xlink:to="lab_ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of vesting requirements for share-based payment arrangement</label>
    <label xlink:label="lab_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share based compensation by share based payment equity instruments other than shares vesting period</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_CashPaymentAwardPerSharePayable" xlink:label="loc_imtx_CashPaymentAwardPerSharePayable" xlink:type="locator"/>
    <label xlink:label="lab_imtx_CashPaymentAwardPerSharePayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Payment Award Per Share Payable</label>
    <label xlink:label="lab_imtx_CashPaymentAwardPerSharePayable" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:type="resource" xml:lang="en-US">Cash payment award per share payable</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_CashPaymentAwardPerSharePayable" xlink:to="lab_imtx_CashPaymentAwardPerSharePayable" xlink:type="arc"/>
    <label xlink:label="lab_imtx_CashPaymentAwardPerSharePayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash payment award per share payable.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_PercentageOfCashProceedsToBeBeReinvested" xlink:label="loc_imtx_PercentageOfCashProceedsToBeBeReinvested" xlink:type="locator"/>
    <label xlink:label="lab_imtx_PercentageOfCashProceedsToBeBeReinvested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage Of Cash Proceeds To Be Be Reinvested</label>
    <label xlink:label="lab_imtx_PercentageOfCashProceedsToBeBeReinvested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of cash proceeds to be reinvested</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_PercentageOfCashProceedsToBeBeReinvested" xlink:to="lab_imtx_PercentageOfCashProceedsToBeBeReinvested" xlink:type="arc"/>
    <label xlink:label="lab_imtx_PercentageOfCashProceedsToBeBeReinvested" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage of cash proceeds to be reinvested.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PaymentsToAndOnBehalfOfEmployees" xlink:label="loc_ifrs-full_PaymentsToAndOnBehalfOfEmployees" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_PaymentsToAndOnBehalfOfEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to and on behalf of employees</label>
    <label xlink:label="lab_ifrs-full_PaymentsToAndOnBehalfOfEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash payment to employees stock based awards</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsToAndOnBehalfOfEmployees" xlink:to="lab_ifrs-full_PaymentsToAndOnBehalfOfEmployees" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_ExpenseFromTheModificationOfShareBasedAwards" xlink:label="loc_imtx_ExpenseFromTheModificationOfShareBasedAwards" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ExpenseFromTheModificationOfShareBasedAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expense From The Modification Of Share Based Awards</label>
    <label xlink:label="lab_imtx_ExpenseFromTheModificationOfShareBasedAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share based compensation expenses modification of awards</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ExpenseFromTheModificationOfShareBasedAwards" xlink:to="lab_imtx_ExpenseFromTheModificationOfShareBasedAwards" xlink:type="arc"/>
    <label xlink:label="lab_imtx_ExpenseFromTheModificationOfShareBasedAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Expense from the modification of share based awards.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expense from equity-settled share-based payment transactions in which goods or services received did not qualify for recognition as assets</label>
    <label xlink:label="lab_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to additional paid in capital due to modification of previously settled equity awards</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:to="lab_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of maximum term of options granted for share-based payment arrangement</label>
    <label xlink:label="lab_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share based compensation by share based payment arrangement term of stock options</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DateOfVestingOfStockOptions" xlink:label="loc_imtx_DateOfVestingOfStockOptions" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DateOfVestingOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Date Of Vesting Of Stock Options</label>
    <label xlink:label="lab_imtx_DateOfVestingOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Date of vesting of stock options</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DateOfVestingOfStockOptions" xlink:to="lab_imtx_DateOfVestingOfStockOptions" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DateOfVestingOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Date of vesting of stock options.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DateOfGrantOfSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Date of grant of share-based payment arrangement</label>
    <label xlink:label="lab_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share based compensation by share based payment arrangement grant date</label>
    <label xlink:label="lab_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grant date</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_MinimumMarketCapitalization" xlink:label="loc_imtx_MinimumMarketCapitalization" xlink:type="locator"/>
    <label xlink:label="lab_imtx_MinimumMarketCapitalization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum Market Capitalization</label>
    <label xlink:label="lab_imtx_MinimumMarketCapitalization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum market capitalization</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_MinimumMarketCapitalization" xlink:to="lab_imtx_MinimumMarketCapitalization" xlink:type="arc"/>
    <label xlink:label="lab_imtx_MinimumMarketCapitalization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Minimum market capitalization.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_TrancheAxis" xlink:label="loc_imtx_TrancheAxis" xlink:type="locator"/>
    <label xlink:label="lab_imtx_TrancheAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tranche [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_TrancheAxis" xlink:to="lab_imtx_TrancheAxis" xlink:type="arc"/>
    <label xlink:label="lab_imtx_TrancheAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tranche [Axis].</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_TrancheMember" xlink:label="loc_imtx_TrancheMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_TrancheMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tranche [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_TrancheMember" xlink:to="lab_imtx_TrancheMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_TrancheMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tranche [Member].</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_TrancheOneMember" xlink:label="loc_imtx_TrancheOneMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_TrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tranche One [Member]</label>
    <label xlink:label="lab_imtx_TrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranche One [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_TrancheOneMember" xlink:to="lab_imtx_TrancheOneMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_TrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tranche One [Member].</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_TrancheTwoMember" xlink:label="loc_imtx_TrancheTwoMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_TrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tranche Two [Member]</label>
    <label xlink:label="lab_imtx_TrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranche Two [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_TrancheTwoMember" xlink:to="lab_imtx_TrancheTwoMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_TrancheThreeMember" xlink:label="loc_imtx_TrancheThreeMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_TrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tranche Three [Member]</label>
    <label xlink:label="lab_imtx_TrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranche Three [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_TrancheThreeMember" xlink:to="lab_imtx_TrancheThreeMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseAbstract" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseAbstract" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Share Based Compensation Expense [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseAbstract" xlink:to="lab_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseAbstract" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about share based compensation expense [Abstract].</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTable" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTable" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Share Based Compensation Expense [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTable" xlink:to="lab_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTable" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about share based compensation expense [Table].</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseLineItems" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseLineItems" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Share Based Compensation Expense [Line Items]</label>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Share Based Compensation Expense [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseLineItems" xlink:to="lab_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseLineItems" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about share based compensation expense [Line Items].</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expense from share-based payment transactions with employees</label>
    <label xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation expense</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:to="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of classes of share capital [table]</label>
    <label xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of classes of share capital [table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_SeriesEShareCapitalMember" xlink:label="loc_imtx_SeriesEShareCapitalMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_SeriesEShareCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series E Share Capital [Member]</label>
    <label xlink:label="lab_imtx_SeriesEShareCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series E Share Capital [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_SeriesEShareCapitalMember" xlink:to="lab_imtx_SeriesEShareCapitalMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_SeriesEShareCapitalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series E share capital.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_ImmaticsBiotechnologiesGmbhMember" xlink:label="loc_imtx_ImmaticsBiotechnologiesGmbhMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ImmaticsBiotechnologiesGmbhMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Immatics Biotechnologies GmbH [Member]</label>
    <label xlink:label="lab_imtx_ImmaticsBiotechnologiesGmbhMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Immatics Biotechnologies GmbH [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ImmaticsBiotechnologiesGmbhMember" xlink:to="lab_imtx_ImmaticsBiotechnologiesGmbhMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_ImmaticsBiotechnologiesGmbhMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Immatics biotechnologies gmbH.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of classes of share capital [line items]</label>
    <label xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of classes of share capital [line items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_NumberOfSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of shares outstanding</label>
    <label xlink:label="lab_ifrs-full_NumberOfSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares outstanding</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesOutstanding" xlink:to="lab_ifrs-full_NumberOfSharesOutstanding" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_NumberOfWarrantsOutsatnding" xlink:label="loc_imtx_NumberOfWarrantsOutsatnding" xlink:type="locator"/>
    <label xlink:label="lab_imtx_NumberOfWarrantsOutsatnding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Warrants Outsatnding</label>
    <label xlink:label="lab_imtx_NumberOfWarrantsOutsatnding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of warrants outsatnding</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_NumberOfWarrantsOutsatnding" xlink:to="lab_imtx_NumberOfWarrantsOutsatnding" xlink:type="arc"/>
    <label xlink:label="lab_imtx_NumberOfWarrantsOutsatnding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of warrants outsatnding.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_ExercisePriceOfWarrants" xlink:label="loc_imtx_ExercisePriceOfWarrants" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ExercisePriceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price Of Warrants</label>
    <label xlink:label="lab_imtx_ExercisePriceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price per share</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ExercisePriceOfWarrants" xlink:to="lab_imtx_ExercisePriceOfWarrants" xlink:type="arc"/>
    <label xlink:label="lab_imtx_ExercisePriceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exercise price of warrants.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_ClassOfWarrantOrRightTermPeriod" xlink:label="loc_imtx_ClassOfWarrantOrRightTermPeriod" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ClassOfWarrantOrRightTermPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right Term Period</label>
    <label xlink:label="lab_imtx_ClassOfWarrantOrRightTermPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of warrant or right, term period</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ClassOfWarrantOrRightTermPeriod" xlink:to="lab_imtx_ClassOfWarrantOrRightTermPeriod" xlink:type="arc"/>
    <label xlink:label="lab_imtx_ClassOfWarrantOrRightTermPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class of warrant or right, term period.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_imtx_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator"/>
    <label xlink:label="lab_imtx_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period Value New Issues</label>
    <label xlink:label="lab_imtx_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stock issued during period, value, new issues</label>
    <label xlink:label="lab_imtx_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock issued during period, value, new issues</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_imtx_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc"/>
    <label xlink:label="lab_imtx_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock issued during period, value, new issues.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_ShareListingExpenseAxis" xlink:label="loc_imtx_ShareListingExpenseAxis" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ShareListingExpenseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share listing expense [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ShareListingExpenseAxis" xlink:to="lab_imtx_ShareListingExpenseAxis" xlink:type="arc"/>
    <label xlink:label="lab_imtx_ShareListingExpenseAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share listing expense</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_ShareListingExpenseDomain" xlink:label="loc_imtx_ShareListingExpenseDomain" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ShareListingExpenseDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share listing expense [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ShareListingExpenseDomain" xlink:to="lab_imtx_ShareListingExpenseDomain" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_AryaMergerMember" xlink:label="loc_imtx_AryaMergerMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_AryaMergerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ARYA Merger [Member]</label>
    <label xlink:label="lab_imtx_AryaMergerMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">ARYA Merger [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_AryaMergerMember" xlink:to="lab_imtx_AryaMergerMember" xlink:type="arc"/>
    <label xlink:label="lab_imtx_AryaMergerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">ARYA merger.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_EventAxis" xlink:label="loc_imtx_EventAxis" xlink:type="locator"/>
    <label xlink:label="lab_imtx_EventAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Event [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_EventAxis" xlink:to="lab_imtx_EventAxis" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_EventDomain" xlink:label="loc_imtx_EventDomain" xlink:type="locator"/>
    <label xlink:label="lab_imtx_EventDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Event [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_EventDomain" xlink:to="lab_imtx_EventDomain" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_ReorganizationMember" xlink:label="loc_imtx_ReorganizationMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ReorganizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reorganization [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ReorganizationMember" xlink:to="lab_imtx_ReorganizationMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_NumberOfSharesExchangedInSubsidiaries" xlink:label="loc_imtx_NumberOfSharesExchangedInSubsidiaries" xlink:type="locator"/>
    <label xlink:label="lab_imtx_NumberOfSharesExchangedInSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of shares exchanged in subsidiaries</label>
    <label xlink:label="lab_imtx_NumberOfSharesExchangedInSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares exchanged in subsidiaries</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_NumberOfSharesExchangedInSubsidiaries" xlink:to="lab_imtx_NumberOfSharesExchangedInSubsidiaries" xlink:type="arc"/>
    <label xlink:label="lab_imtx_NumberOfSharesExchangedInSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of shares exchanged in subsidiaries.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_imtx_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="locator"/>
    <label xlink:label="lab_imtx_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period Shares Acquisitions</label>
    <label xlink:label="lab_imtx_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock issued during period, shares, acquisitions</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_imtx_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc"/>
    <label xlink:label="lab_imtx_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_LossOnNoncontrollingInterest" xlink:label="loc_imtx_LossOnNoncontrollingInterest" xlink:type="locator"/>
    <label xlink:label="lab_imtx_LossOnNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss on noncontrolling interest</label>
    <label xlink:label="lab_imtx_LossOnNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss on non-controlling&#xA0;interest</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_LossOnNoncontrollingInterest" xlink:to="lab_imtx_LossOnNoncontrollingInterest" xlink:type="arc"/>
    <label xlink:label="lab_imtx_LossOnNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss on non-controlling interest.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Categories of related parties [axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="lab_ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity's total for related parties [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="lab_ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_MdAndersonMember" xlink:label="loc_imtx_MdAndersonMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_MdAndersonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MD Anderson [Member]</label>
    <label xlink:label="lab_imtx_MdAndersonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MD Anderson [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_MdAndersonMember" xlink:to="lab_imtx_MdAndersonMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_RestrictedStockAcquisitionAgreementMember" xlink:label="loc_imtx_RestrictedStockAcquisitionAgreementMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_RestrictedStockAcquisitionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Acquisition Agreement [Member]</label>
    <label xlink:label="lab_imtx_RestrictedStockAcquisitionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock Acquisition Agreement [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_RestrictedStockAcquisitionAgreementMember" xlink:to="lab_imtx_RestrictedStockAcquisitionAgreementMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfEmployeeBenefitsExpenseAbstract" xlink:label="loc_ifrs-full_ClassesOfEmployeeBenefitsExpenseAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ClassesOfEmployeeBenefitsExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of employee benefits expense [abstract]</label>
    <label xlink:label="lab_ifrs-full_ClassesOfEmployeeBenefitsExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of employee benefits expense [abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfEmployeeBenefitsExpenseAbstract" xlink:to="lab_ifrs-full_ClassesOfEmployeeBenefitsExpenseAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WagesAndSalaries" xlink:label="loc_ifrs-full_WagesAndSalaries" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_WagesAndSalaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Wages and salaries</label>
    <label xlink:label="lab_ifrs-full_WagesAndSalaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Wages and salaries</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WagesAndSalaries" xlink:to="lab_ifrs-full_WagesAndSalaries" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherShorttermEmployeeBenefits" xlink:label="loc_ifrs-full_OtherShorttermEmployeeBenefits" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_OtherShorttermEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other short-term employee benefits</label>
    <label xlink:label="lab_ifrs-full_OtherShorttermEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other employee benefits</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherShorttermEmployeeBenefits" xlink:to="lab_ifrs-full_OtherShorttermEmployeeBenefits" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:label="loc_ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-term employee benefits expense</label>
    <label xlink:label="lab_ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other employee benefits</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:to="lab_ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EmployeeBenefitsExpense" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_EmployeeBenefitsExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee benefits expense</label>
    <label xlink:label="lab_ifrs-full_EmployeeBenefitsExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EmployeeBenefitsExpense" xlink:to="lab_ifrs-full_EmployeeBenefitsExpense" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Post-employment benefit expense, defined contribution plans</label>
    <label xlink:label="lab_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Post-employment benefit expense, defined contribution plans</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:to="lab_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_EmployeeHealthInsuranceCost" xlink:label="loc_imtx_EmployeeHealthInsuranceCost" xlink:type="locator"/>
    <label xlink:label="lab_imtx_EmployeeHealthInsuranceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Health insurance Cost</label>
    <label xlink:label="lab_imtx_EmployeeHealthInsuranceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee health insurance cost</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_EmployeeHealthInsuranceCost" xlink:to="lab_imtx_EmployeeHealthInsuranceCost" xlink:type="arc"/>
    <label xlink:label="lab_imtx_EmployeeHealthInsuranceCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee health insurance cost.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SocialSecurityContributions" xlink:label="loc_ifrs-full_SocialSecurityContributions" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_SocialSecurityContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Social security contributions</label>
    <label xlink:label="lab_ifrs-full_SocialSecurityContributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Social security contributions</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SocialSecurityContributions" xlink:to="lab_ifrs-full_SocialSecurityContributions" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherEmployeeExpense" xlink:label="loc_ifrs-full_OtherEmployeeExpense" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_OtherEmployeeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other employee expense</label>
    <label xlink:label="lab_ifrs-full_OtherEmployeeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">other miscellaneous expenses</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherEmployeeExpense" xlink:to="lab_ifrs-full_OtherEmployeeExpense" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Major components of tax expense (income) [abstract]</label>
    <label xlink:label="lab_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Major components of tax expense (income) [abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="lab_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentTaxExpenseIncome" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncome" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_CurrentTaxExpenseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current tax expense (income)</label>
    <label xlink:label="lab_ifrs-full_CurrentTaxExpenseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected tax benefit</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncome" xlink:to="lab_ifrs-full_CurrentTaxExpenseIncome" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TaxEffectFromChangeInTaxRate" xlink:label="loc_ifrs-full_TaxEffectFromChangeInTaxRate" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_TaxEffectFromChangeInTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax effect from change in tax rate</label>
    <label xlink:label="lab_ifrs-full_TaxEffectFromChangeInTaxRate" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Difference in tax rates</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxEffectFromChangeInTaxRate" xlink:to="lab_ifrs-full_TaxEffectFromChangeInTaxRate" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:label="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax effect of expense not deductible in determining taxable profit (tax loss)</label>
    <label xlink:label="lab_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Non-deductible&#xA0; tax-expenses</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:to="lab_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_TaxEffectOfGovernmentGrantsExemptedFromTaxes" xlink:label="loc_imtx_TaxEffectOfGovernmentGrantsExemptedFromTaxes" xlink:type="locator"/>
    <label xlink:label="lab_imtx_TaxEffectOfGovernmentGrantsExemptedFromTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Effect of Government Grants Exempted From Taxes</label>
    <label xlink:label="lab_imtx_TaxEffectOfGovernmentGrantsExemptedFromTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Government grants exempted from taxes</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_TaxEffectOfGovernmentGrantsExemptedFromTaxes" xlink:to="lab_imtx_TaxEffectOfGovernmentGrantsExemptedFromTaxes" xlink:type="arc"/>
    <label xlink:label="lab_imtx_TaxEffectOfGovernmentGrantsExemptedFromTaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax effect of government grants exempted from taxes.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_NonRecognitionOfDeferredTaxesOnTaxLossesAndTemporaryDifferences" xlink:label="loc_imtx_NonRecognitionOfDeferredTaxesOnTaxLossesAndTemporaryDifferences" xlink:type="locator"/>
    <label xlink:label="lab_imtx_NonRecognitionOfDeferredTaxesOnTaxLossesAndTemporaryDifferences" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non recognition of deferred taxes on tax losses and temporary differences</label>
    <label xlink:label="lab_imtx_NonRecognitionOfDeferredTaxesOnTaxLossesAndTemporaryDifferences" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-recognition&#xA0;of&#xA0;deferred taxes on tax losses and temporary differences</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_NonRecognitionOfDeferredTaxesOnTaxLossesAndTemporaryDifferences" xlink:to="lab_imtx_NonRecognitionOfDeferredTaxesOnTaxLossesAndTemporaryDifferences" xlink:type="arc"/>
    <label xlink:label="lab_imtx_NonRecognitionOfDeferredTaxesOnTaxLossesAndTemporaryDifferences" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non-recognition&#xA0;of&#xA0;deferred taxes on tax losses and temporary differences.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_TaxEffectOfPermanentDifferences" xlink:label="loc_imtx_TaxEffectOfPermanentDifferences" xlink:type="locator"/>
    <label xlink:label="lab_imtx_TaxEffectOfPermanentDifferences" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Effect Of Permanent Differences</label>
    <label xlink:label="lab_imtx_TaxEffectOfPermanentDifferences" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Permanent Differences</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_TaxEffectOfPermanentDifferences" xlink:to="lab_imtx_TaxEffectOfPermanentDifferences" xlink:type="arc"/>
    <label xlink:label="lab_imtx_TaxEffectOfPermanentDifferences" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax effect of permanent differences.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="loc_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax assets and liabilities [abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="lab_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-full_DeferredTaxAssets" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax assets</label>
    <label xlink:label="lab_ifrs-full_DeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxAssets" xlink:to="lab_ifrs-full_DeferredTaxAssets" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities</label>
    <label xlink:label="lab_ifrs-full_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilities" xlink:to="lab_ifrs-full_DeferredTaxLiabilities" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DeferredTaxAssetsNonrecognition" xlink:label="loc_imtx_DeferredTaxAssetsNonrecognition" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DeferredTaxAssetsNonrecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets Nonrecognition</label>
    <label xlink:label="lab_imtx_DeferredTaxAssetsNonrecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-recognition due to history of losses</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DeferredTaxAssetsNonrecognition" xlink:to="lab_imtx_DeferredTaxAssetsNonrecognition" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DeferredTaxAssetsNonrecognition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred tax assets nonrecognition.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DeferredTaxAssetsOffset" xlink:label="loc_imtx_DeferredTaxAssetsOffset" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DeferredTaxAssetsOffset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets Offset</label>
    <label xlink:label="lab_imtx_DeferredTaxAssetsOffset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets netting</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DeferredTaxAssetsOffset" xlink:to="lab_imtx_DeferredTaxAssetsOffset" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DeferredTaxAssetsOffset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred tax assets offset.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DeferredTaxLiabilitiesOffSet" xlink:label="loc_imtx_DeferredTaxLiabilitiesOffSet" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DeferredTaxLiabilitiesOffSet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities Off set</label>
    <label xlink:label="lab_imtx_DeferredTaxLiabilitiesOffSet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities netting</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DeferredTaxLiabilitiesOffSet" xlink:to="lab_imtx_DeferredTaxLiabilitiesOffSet" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DeferredTaxLiabilitiesOffSet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities off set.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AssetsAndLiabilitiesAxis" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesAxis" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_AssetsAndLiabilitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets and liabilities [axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesAxis" xlink:to="lab_ifrs-full_AssetsAndLiabilitiesAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AssetsAndLiabilitiesMember" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_AssetsAndLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets and liabilities [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesMember" xlink:to="lab_ifrs-full_AssetsAndLiabilitiesMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_IntangibleAssetsMember" xlink:label="loc_imtx_IntangibleAssetsMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_IntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets [Member]</label>
    <label xlink:label="lab_imtx_IntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_IntangibleAssetsMember" xlink:to="lab_imtx_IntangibleAssetsMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DeferredRevenueMember" xlink:label="loc_imtx_DeferredRevenueMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DeferredRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Revenue [Member]</label>
    <label xlink:label="lab_imtx_DeferredRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DeferredRevenueMember" xlink:to="lab_imtx_DeferredRevenueMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_LeaseLiabilityMember" xlink:label="loc_imtx_LeaseLiabilityMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_LeaseLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Liability [Member]</label>
    <label xlink:label="lab_imtx_LeaseLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liability [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_LeaseLiabilityMember" xlink:to="lab_imtx_LeaseLiabilityMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DeferredExpensesMember" xlink:label="loc_imtx_DeferredExpensesMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DeferredExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Expenses [Member]</label>
    <label xlink:label="lab_imtx_DeferredExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred expenses [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DeferredExpensesMember" xlink:to="lab_imtx_DeferredExpensesMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DeferredAssetRecognisedMember" xlink:label="loc_imtx_DeferredAssetRecognisedMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DeferredAssetRecognisedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Asset Recognised [Member]</label>
    <label xlink:label="lab_imtx_DeferredAssetRecognisedMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Recognized [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DeferredAssetRecognisedMember" xlink:to="lab_imtx_DeferredAssetRecognisedMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DeferredTaxLiabilitiesRightOfUseAssetMember" xlink:label="loc_imtx_DeferredTaxLiabilitiesRightOfUseAssetMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DeferredTaxLiabilitiesRightOfUseAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities Right of use asset [Member]</label>
    <label xlink:label="lab_imtx_DeferredTaxLiabilitiesRightOfUseAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use&#xA0;asset [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DeferredTaxLiabilitiesRightOfUseAssetMember" xlink:to="lab_imtx_DeferredTaxLiabilitiesRightOfUseAssetMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DeferredTaxLiabilitiesDeferredExpensesMember" xlink:label="loc_imtx_DeferredTaxLiabilitiesDeferredExpensesMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DeferredTaxLiabilitiesDeferredExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities Deferred expenses [Member]</label>
    <label xlink:label="lab_imtx_DeferredTaxLiabilitiesDeferredExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recognized [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DeferredTaxLiabilitiesDeferredExpensesMember" xlink:to="lab_imtx_DeferredTaxLiabilitiesDeferredExpensesMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_OtherLiabilitiesMember" xlink:label="loc_imtx_OtherLiabilitiesMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities [Member]</label>
    <label xlink:label="lab_imtx_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other liabilities [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_OtherLiabilitiesMember" xlink:to="lab_imtx_OtherLiabilitiesMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-full_ApplicableTaxRate" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ApplicableTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Applicable tax rate</label>
    <label xlink:label="lab_ifrs-full_ApplicableTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">statutory tax rate</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ApplicableTaxRate" xlink:to="lab_ifrs-full_ApplicableTaxRate" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_CorporateIncomeTaxRate" xlink:label="loc_imtx_CorporateIncomeTaxRate" xlink:type="locator"/>
    <label xlink:label="lab_imtx_CorporateIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">corporate income tax rate</label>
    <label xlink:label="lab_imtx_CorporateIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">corporate income tax rate</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_CorporateIncomeTaxRate" xlink:to="lab_imtx_CorporateIncomeTaxRate" xlink:type="arc"/>
    <label xlink:label="lab_imtx_CorporateIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">corporate income tax rate.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TaxEffectOfTaxLosses" xlink:label="loc_ifrs-full_TaxEffectOfTaxLosses" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_TaxEffectOfTaxLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax effect of tax losses</label>
    <label xlink:label="lab_ifrs-full_TaxEffectOfTaxLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax effect of tax losses</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxEffectOfTaxLosses" xlink:to="lab_ifrs-full_TaxEffectOfTaxLosses" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_PercentageOnLimitationOnTaxLossCarryforwardsAfterPriorPeriod" xlink:label="loc_imtx_PercentageOnLimitationOnTaxLossCarryforwardsAfterPriorPeriod" xlink:type="locator"/>
    <label xlink:label="lab_imtx_PercentageOnLimitationOnTaxLossCarryforwardsAfterPriorPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage on Limitation on tax loss carryforwards after prior period</label>
    <label xlink:label="lab_imtx_PercentageOnLimitationOnTaxLossCarryforwardsAfterPriorPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage on limitation on tax loss carryforwards after prior period</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_PercentageOnLimitationOnTaxLossCarryforwardsAfterPriorPeriod" xlink:to="lab_imtx_PercentageOnLimitationOnTaxLossCarryforwardsAfterPriorPeriod" xlink:type="arc"/>
    <label xlink:label="lab_imtx_PercentageOnLimitationOnTaxLossCarryforwardsAfterPriorPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage on limitation on tax loss carryforwards after prior period.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_PercentageOnLimitationOnTaxLossCarryforwardsBeforePriorPeriod" xlink:label="loc_imtx_PercentageOnLimitationOnTaxLossCarryforwardsBeforePriorPeriod" xlink:type="locator"/>
    <label xlink:label="lab_imtx_PercentageOnLimitationOnTaxLossCarryforwardsBeforePriorPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage on Limitation on tax loss carryforwards before prior period</label>
    <label xlink:label="lab_imtx_PercentageOnLimitationOnTaxLossCarryforwardsBeforePriorPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage on limitation on tax loss carryforwards before prior period</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_PercentageOnLimitationOnTaxLossCarryforwardsBeforePriorPeriod" xlink:to="lab_imtx_PercentageOnLimitationOnTaxLossCarryforwardsBeforePriorPeriod" xlink:type="arc"/>
    <label xlink:label="lab_imtx_PercentageOnLimitationOnTaxLossCarryforwardsBeforePriorPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage on limitation on tax loss carryforwards before prior period.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_EffectiveIncomeTaxReconciliationPermanentEffectShareListingExpense" xlink:label="loc_imtx_EffectiveIncomeTaxReconciliationPermanentEffectShareListingExpense" xlink:type="locator"/>
    <label xlink:label="lab_imtx_EffectiveIncomeTaxReconciliationPermanentEffectShareListingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Reconciliation Permanent Effect Share Listing Expense</label>
    <label xlink:label="lab_imtx_EffectiveIncomeTaxReconciliationPermanentEffectShareListingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective income tax reconciliation permanent effect share listing expense</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_EffectiveIncomeTaxReconciliationPermanentEffectShareListingExpense" xlink:to="lab_imtx_EffectiveIncomeTaxReconciliationPermanentEffectShareListingExpense" xlink:type="arc"/>
    <label xlink:label="lab_imtx_EffectiveIncomeTaxReconciliationPermanentEffectShareListingExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective income tax reconciliation permanent effect share listing expense.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:to="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_IndefiniteTaxLossesCarryforwardMember" xlink:label="loc_imtx_IndefiniteTaxLossesCarryforwardMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_IndefiniteTaxLossesCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite Tax Losses carryforward [Member]</label>
    <label xlink:label="lab_imtx_IndefiniteTaxLossesCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite Tax Losses Carryforward [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_IndefiniteTaxLossesCarryforwardMember" xlink:to="lab_imtx_IndefiniteTaxLossesCarryforwardMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_TwentySixYearTaxLossesCarryforwardMember" xlink:label="loc_imtx_TwentySixYearTaxLossesCarryforwardMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_TwentySixYearTaxLossesCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Twenty Six Year Tax Losses carryforward [Member]</label>
    <label xlink:label="lab_imtx_TwentySixYearTaxLossesCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Twenty Six Year Tax Losses Carryforward [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_TwentySixYearTaxLossesCarryforwardMember" xlink:to="lab_imtx_TwentySixYearTaxLossesCarryforwardMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfCurrencyRiskExposureAbstract" xlink:label="loc_imtx_DisclosureOfCurrencyRiskExposureAbstract" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfCurrencyRiskExposureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Currency Risk Exposure [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfCurrencyRiskExposureAbstract" xlink:to="lab_imtx_DisclosureOfCurrencyRiskExposureAbstract" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfCurrencyRiskExposureTable" xlink:label="loc_imtx_DisclosureOfCurrencyRiskExposureTable" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfCurrencyRiskExposureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Currency Risk Exposure [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfCurrencyRiskExposureTable" xlink:to="lab_imtx_DisclosureOfCurrencyRiskExposureTable" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfCurrencyRiskExposureLineItems" xlink:label="loc_imtx_DisclosureOfCurrencyRiskExposureLineItems" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfCurrencyRiskExposureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Currency Risk Exposure [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfCurrencyRiskExposureLineItems" xlink:to="lab_imtx_DisclosureOfCurrencyRiskExposureLineItems" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssets" xlink:label="loc_ifrs-full_FinancialAssets" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_FinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets</label>
    <label xlink:label="lab_ifrs-full_FinancialAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial assets</label>
    <label xlink:label="lab_ifrs-full_FinancialAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Financial assets, Carrying amount</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssets" xlink:to="lab_ifrs-full_FinancialAssets" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_MaximumExposedToCurrencyRisk" xlink:label="loc_imtx_MaximumExposedToCurrencyRisk" xlink:type="locator"/>
    <label xlink:label="lab_imtx_MaximumExposedToCurrencyRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum Exposed to Currency risk</label>
    <label xlink:label="lab_imtx_MaximumExposedToCurrencyRisk" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets exposed to the risk</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_MaximumExposedToCurrencyRisk" xlink:to="lab_imtx_MaximumExposedToCurrencyRisk" xlink:type="arc"/>
    <label xlink:label="lab_imtx_MaximumExposedToCurrencyRisk" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Maximum Exposed to Currency risk.</label>
    <loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srt_OwnershipAxis" xlink:type="locator"/>
    <label xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ownership [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain" xlink:type="locator"/>
    <label xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ownership [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_ImmaticsNvMember" xlink:label="loc_imtx_ImmaticsNvMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ImmaticsNvMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Immatics NV [Member]</label>
    <label xlink:label="lab_imtx_ImmaticsNvMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Immatics N.V. [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ImmaticsNvMember" xlink:to="lab_imtx_ImmaticsNvMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-full_TypesOfRisksAxis" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_TypesOfRisksAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Types of risks [axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfRisksAxis" xlink:to="lab_ifrs-full_TypesOfRisksAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-full_TypesOfRisksMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_TypesOfRisksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Risks [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfRisksMember" xlink:to="lab_ifrs-full_TypesOfRisksMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrencyRiskMember" xlink:label="loc_ifrs-full_CurrencyRiskMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_CurrencyRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency risk [member]</label>
    <label xlink:label="lab_ifrs-full_CurrencyRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency risk [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrencyRiskMember" xlink:to="lab_ifrs-full_CurrencyRiskMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_ImmaticsGmbhMember" xlink:label="loc_imtx_ImmaticsGmbhMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ImmaticsGmbhMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Immatics GmbH [Member]</label>
    <label xlink:label="lab_imtx_ImmaticsGmbhMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Immatics GmbH [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ImmaticsGmbhMember" xlink:to="lab_imtx_ImmaticsGmbhMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about financial instruments [abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable" xlink:label="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Sensitivity Analysis For Each Type Of Market Risk [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable" xlink:to="lab_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems" xlink:label="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Sensitivity Analysis For Each Type Of Market Risk [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems" xlink:to="lab_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints" xlink:label="loc_imtx_IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints" xlink:type="locator"/>
    <label xlink:label="lab_imtx_IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase Decrease In Profit Loss Before Tax On Basis Of Higher Lower Basis Points</label>
    <label xlink:label="lab_imtx_IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Profit/(loss)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints" xlink:to="lab_imtx_IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints" xlink:type="arc"/>
    <label xlink:label="lab_imtx_IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase Decrease In Profit Loss Before Tax On Basis Of Higher Lower Basis Points.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ValueAtRisk" xlink:label="loc_ifrs-full_ValueAtRisk" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ValueAtRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Value at risk</label>
    <label xlink:label="lab_ifrs-full_ValueAtRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying amount</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ValueAtRisk" xlink:to="lab_ifrs-full_ValueAtRisk" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_SensitiveAnalaysisOfCurrencyAxis" xlink:label="loc_imtx_SensitiveAnalaysisOfCurrencyAxis" xlink:type="locator"/>
    <label xlink:label="lab_imtx_SensitiveAnalaysisOfCurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sensitive analaysis of currency [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyAxis" xlink:to="lab_imtx_SensitiveAnalaysisOfCurrencyAxis" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_SensitiveAnalaysisOfCurrencyDomain" xlink:label="loc_imtx_SensitiveAnalaysisOfCurrencyDomain" xlink:type="locator"/>
    <label xlink:label="lab_imtx_SensitiveAnalaysisOfCurrencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sensitive analaysis of currency [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyDomain" xlink:to="lab_imtx_SensitiveAnalaysisOfCurrencyDomain" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_EuroWeakensBy1AgainstUsDollarsMember" xlink:label="loc_imtx_EuroWeakensBy1AgainstUsDollarsMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_EuroWeakensBy1AgainstUsDollarsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Euro weakens by 1 against US dollars [Member]</label>
    <label xlink:label="lab_imtx_EuroWeakensBy1AgainstUsDollarsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Euro weakens by 1% against U.S. dollars [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_EuroWeakensBy1AgainstUsDollarsMember" xlink:to="lab_imtx_EuroWeakensBy1AgainstUsDollarsMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_EuroStrengthsBy1AgainstUsDollarsMember" xlink:label="loc_imtx_EuroStrengthsBy1AgainstUsDollarsMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_EuroStrengthsBy1AgainstUsDollarsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Euro strengths by 1 against US dollars [Member]</label>
    <label xlink:label="lab_imtx_EuroStrengthsBy1AgainstUsDollarsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Euro strengths by 1% against U.S. dollars [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_EuroStrengthsBy1AgainstUsDollarsMember" xlink:to="lab_imtx_EuroStrengthsBy1AgainstUsDollarsMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_EuroWeakensBy5AgainstUsDollarsMember" xlink:label="loc_imtx_EuroWeakensBy5AgainstUsDollarsMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_EuroWeakensBy5AgainstUsDollarsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Euro weakens by 5 against US dollars [Member]</label>
    <label xlink:label="lab_imtx_EuroWeakensBy5AgainstUsDollarsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Euro weakens by 5% against U.S. dollars [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_EuroWeakensBy5AgainstUsDollarsMember" xlink:to="lab_imtx_EuroWeakensBy5AgainstUsDollarsMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_EuroStrengthsBy5AgainstUsDollarsMember" xlink:label="loc_imtx_EuroStrengthsBy5AgainstUsDollarsMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_EuroStrengthsBy5AgainstUsDollarsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Euro strengths by 5 against US dollars [Member]</label>
    <label xlink:label="lab_imtx_EuroStrengthsBy5AgainstUsDollarsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Euro strengths by 5% against U.S. dollars [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_EuroStrengthsBy5AgainstUsDollarsMember" xlink:to="lab_imtx_EuroStrengthsBy5AgainstUsDollarsMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_EuroWeakensBy10AgainstUsDollarsMember" xlink:label="loc_imtx_EuroWeakensBy10AgainstUsDollarsMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_EuroWeakensBy10AgainstUsDollarsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Euro weakens by 10 against US dollars [Member]</label>
    <label xlink:label="lab_imtx_EuroWeakensBy10AgainstUsDollarsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Euro weakens by 10% against U.S. dollars [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_EuroWeakensBy10AgainstUsDollarsMember" xlink:to="lab_imtx_EuroWeakensBy10AgainstUsDollarsMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_EuroStrengthsBy10AgainstUsDollarsMember" xlink:label="loc_imtx_EuroStrengthsBy10AgainstUsDollarsMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_EuroStrengthsBy10AgainstUsDollarsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Euro strengths by 10 against US dollars [Member]</label>
    <label xlink:label="lab_imtx_EuroStrengthsBy10AgainstUsDollarsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Euro strengths by 10% against U.S. dollars [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_EuroStrengthsBy10AgainstUsDollarsMember" xlink:to="lab_imtx_EuroStrengthsBy10AgainstUsDollarsMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk" xlink:label="loc_imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk" xlink:type="locator"/>
    <label xlink:label="lab_imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage Of Reasonably Possible Increase In Foreign Currency Risk</label>
    <label xlink:label="lab_imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage Of Reasonably Possible Increase In Foreign Currency Risk</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk" xlink:to="lab_imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk" xlink:type="arc"/>
    <label xlink:label="lab_imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage Of Reasonably Possible Increase In Foreign Currency Risk.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk" xlink:label="loc_imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk" xlink:type="locator"/>
    <label xlink:label="lab_imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage Of Reasonably Possible Decrease In Foreign Currency Risk</label>
    <label xlink:label="lab_imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage Of Reasonably Possible Decrease In Foreign Currency Risk</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk" xlink:to="lab_imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk" xlink:type="arc"/>
    <label xlink:label="lab_imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage Of Reasonably Possible Decrease In Foreign Currency Risk.</label>
    <loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis" xlink:type="locator"/>
    <label xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis" xlink:to="lab_srt_CurrencyAxis" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain" xlink:type="locator"/>
    <label xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Currencies [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain" xlink:to="lab_currency_AllCurrenciesDomain" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DescriptionOfManagingLiquidityRiskAbstract" xlink:label="loc_imtx_DescriptionOfManagingLiquidityRiskAbstract" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DescriptionOfManagingLiquidityRiskAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description Of Managing Liquidity Risk [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DescriptionOfManagingLiquidityRiskAbstract" xlink:to="lab_imtx_DescriptionOfManagingLiquidityRiskAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk" xlink:label="loc_ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets held for managing liquidity risk</label>
    <label xlink:label="lab_ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial assets held for managing liquidity risk</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk" xlink:to="lab_ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_ClassesOfFinancialAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of financial assets [axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="lab_ifrs-full_ClassesOfFinancialAssetsAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-full_FinancialAssetsMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_FinancialAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets, class [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsMember" xlink:to="lab_ifrs-full_FinancialAssetsMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_ShorttermDepositsMember" xlink:label="loc_imtx_ShorttermDepositsMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ShorttermDepositsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ShortTerm Deposits [Member]</label>
    <label xlink:label="lab_imtx_ShorttermDepositsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-Term Deposits [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ShorttermDepositsMember" xlink:to="lab_imtx_ShorttermDepositsMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_CashAndCashEquivalentsMember" xlink:label="loc_imtx_CashAndCashEquivalentsMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash And Cash Equivalents [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_CashAndCashEquivalentsMember" xlink:to="lab_imtx_CashAndCashEquivalentsMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LiquidityRiskMember" xlink:label="loc_ifrs-full_LiquidityRiskMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_LiquidityRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liquidity risk [member]</label>
    <label xlink:label="lab_ifrs-full_LiquidityRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liquidity risk [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiquidityRiskMember" xlink:to="lab_ifrs-full_LiquidityRiskMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_MaximumExposureToCreditRisk" xlink:label="loc_ifrs-full_MaximumExposureToCreditRisk" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_MaximumExposureToCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum exposure to credit risk</label>
    <label xlink:label="lab_ifrs-full_MaximumExposureToCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum exposure to credit risk</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaximumExposureToCreditRisk" xlink:to="lab_ifrs-full_MaximumExposureToCreditRisk" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherFinancialAssets" xlink:label="loc_ifrs-full_OtherFinancialAssets" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_OtherFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other financial assets</label>
    <label xlink:label="lab_ifrs-full_OtherFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other financial assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherFinancialAssets" xlink:to="lab_ifrs-full_OtherFinancialAssets" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign exchange gain (loss)</label>
    <label xlink:label="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign exchange gain (loss)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:to="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CreditRiskMember" xlink:label="loc_ifrs-full_CreditRiskMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_CreditRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit risk [member]</label>
    <label xlink:label="lab_ifrs-full_CreditRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit risk [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CreditRiskMember" xlink:to="lab_ifrs-full_CreditRiskMember" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_EUR" xlink:label="loc_currency_EUR" xlink:type="locator"/>
    <label xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Euro Member Countries, Euro</label>
    <label xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Euro [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_EUR" xlink:to="lab_currency_EUR" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_USD" xlink:label="loc_currency_USD" xlink:type="locator"/>
    <label xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">United States of America, Dollars</label>
    <label xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">US [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_USD" xlink:to="lab_currency_USD" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about financial instruments [table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Categories of financial assets [axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:to="lab_ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsCategoryMember" xlink:label="loc_ifrs-full_FinancialAssetsCategoryMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_FinancialAssetsCategoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets, category [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember" xlink:to="lab_ifrs-full_FinancialAssetsCategoryMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets at fair value through profit or loss, category [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:to="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_OtherFinancialAssetsAtAmortizedCostMember" xlink:label="loc_imtx_OtherFinancialAssetsAtAmortizedCostMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_OtherFinancialAssetsAtAmortizedCostMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Financial Assets At Amortized Cost [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_OtherFinancialAssetsAtAmortizedCostMember" xlink:to="lab_imtx_OtherFinancialAssetsAtAmortizedCostMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_PositiveMarketValueForwardContractsMember" xlink:label="loc_imtx_PositiveMarketValueForwardContractsMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_PositiveMarketValueForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Positive Market Value Forward Contracts [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_PositiveMarketValueForwardContractsMember" xlink:to="lab_imtx_PositiveMarketValueForwardContractsMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TradeReceivablesMember" xlink:label="loc_ifrs-full_TradeReceivablesMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_TradeReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade receivables [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeReceivablesMember" xlink:to="lab_ifrs-full_TradeReceivablesMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_OtherCurrentAssetMember" xlink:label="loc_imtx_OtherCurrentAssetMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_OtherCurrentAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Current Asset [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_OtherCurrentAssetMember" xlink:to="lab_imtx_OtherCurrentAssetMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_AccountsPayableMember" xlink:label="loc_imtx_AccountsPayableMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_AccountsPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_AccountsPayableMember" xlink:to="lab_imtx_AccountsPayableMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_OtherCurrentLiabilitiesMember" xlink:label="loc_imtx_OtherCurrentLiabilitiesMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Current Liabilities [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_OtherCurrentLiabilitiesMember" xlink:to="lab_imtx_OtherCurrentLiabilitiesMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about financial instruments [line items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialLiabilities" xlink:label="loc_ifrs-full_FinancialLiabilities" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_FinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial liabilities</label>
    <label xlink:label="lab_ifrs-full_FinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial liabilities, Carrying amount</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilities" xlink:to="lab_ifrs-full_FinancialLiabilities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsAtFairValue" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValue" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_FinancialAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets, Fair value</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsAtFairValue" xlink:to="lab_ifrs-full_FinancialAssetsAtFairValue" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialLiabilitiesAtFairValue" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValue" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_FinancialLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial liabilities, at fair value</label>
    <label xlink:label="lab_ifrs-full_FinancialLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial liabilities, Fair value</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilitiesAtFairValue" xlink:to="lab_ifrs-full_FinancialLiabilitiesAtFairValue" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfContractualObligationsAbstract" xlink:label="loc_imtx_DisclosureOfContractualObligationsAbstract" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfContractualObligationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Contractual Obligations [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfContractualObligationsAbstract" xlink:to="lab_imtx_DisclosureOfContractualObligationsAbstract" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfContractualObligationsTable" xlink:label="loc_imtx_DisclosureOfContractualObligationsTable" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfContractualObligationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Contractual Obligations [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfContractualObligationsTable" xlink:to="lab_imtx_DisclosureOfContractualObligationsTable" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_NotLaterThanOneYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Not later than one year [member]</label>
    <label xlink:label="lab_ifrs-full_NotLaterThanOneYearMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less than 1year</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotLaterThanOneYearMember" xlink:to="lab_ifrs-full_NotLaterThanOneYearMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than one year and not later than three years [member]</label>
    <label xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">1 - 3 years</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:to="lab_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than three years and not later than five years [member]</label>
    <label xlink:label="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3 - 5 years</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:to="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_LaterThanFiveYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than five years [member]</label>
    <label xlink:label="lab_ifrs-full_LaterThanFiveYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">More than 5 years</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFiveYearsMember" xlink:to="lab_ifrs-full_LaterThanFiveYearsMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfContractualObligationsLineItems" xlink:label="loc_imtx_DisclosureOfContractualObligationsLineItems" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfContractualObligationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Contractual Obligations [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfContractualObligationsLineItems" xlink:to="lab_imtx_DisclosureOfContractualObligationsLineItems" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_ContractualObligationOfLeaseLiabilities" xlink:label="loc_imtx_ContractualObligationOfLeaseLiabilities" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ContractualObligationOfLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contractual Obligation Of Lease Liabilities</label>
    <label xlink:label="lab_imtx_ContractualObligationOfLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ContractualObligationOfLeaseLiabilities" xlink:to="lab_imtx_ContractualObligationOfLeaseLiabilities" xlink:type="arc"/>
    <label xlink:label="lab_imtx_ContractualObligationOfLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contractual obligation of lease liabilities.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_OtherLeaseObligations" xlink:label="loc_imtx_OtherLeaseObligations" xlink:type="locator"/>
    <label xlink:label="lab_imtx_OtherLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Lease Obligations</label>
    <label xlink:label="lab_imtx_OtherLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Lease Obligations</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_OtherLeaseObligations" xlink:to="lab_imtx_OtherLeaseObligations" xlink:type="arc"/>
    <label xlink:label="lab_imtx_OtherLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other lease obligations.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_ContractualObligationOfInLicenseAgreements" xlink:label="loc_imtx_ContractualObligationOfInLicenseAgreements" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ContractualObligationOfInLicenseAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contractual Obligation Of In License Agreements</label>
    <label xlink:label="lab_imtx_ContractualObligationOfInLicenseAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">In-license agreements</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ContractualObligationOfInLicenseAgreements" xlink:to="lab_imtx_ContractualObligationOfInLicenseAgreements" xlink:type="arc"/>
    <label xlink:label="lab_imtx_ContractualObligationOfInLicenseAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contractual obligation of in license agreements.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_ContractResearchOrganizationAgreements" xlink:label="loc_imtx_ContractResearchOrganizationAgreements" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ContractResearchOrganizationAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract Research Organization Agreements</label>
    <label xlink:label="lab_imtx_ContractResearchOrganizationAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract research organization agreements</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ContractResearchOrganizationAgreements" xlink:to="lab_imtx_ContractResearchOrganizationAgreements" xlink:type="arc"/>
    <label xlink:label="lab_imtx_ContractResearchOrganizationAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contract research organization agreements.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_ContractualCashObligation" xlink:label="loc_imtx_ContractualCashObligation" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ContractualCashObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contractual Cash Obligation</label>
    <label xlink:label="lab_imtx_ContractualCashObligation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total contractual obligation</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ContractualCashObligation" xlink:to="lab_imtx_ContractualCashObligation" xlink:type="arc"/>
    <label xlink:label="lab_imtx_ContractualCashObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contractual cash obligation.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_UnrecordedContingentLiability" xlink:label="loc_imtx_UnrecordedContingentLiability" xlink:type="locator"/>
    <label xlink:label="lab_imtx_UnrecordedContingentLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecorded Contingent Liability</label>
    <label xlink:label="lab_imtx_UnrecordedContingentLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecorded contingent liability</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_UnrecordedContingentLiability" xlink:to="lab_imtx_UnrecordedContingentLiability" xlink:type="arc"/>
    <label xlink:label="lab_imtx_UnrecordedContingentLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Unrecorded contingent liability.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_CollaborationAgreementsMember" xlink:label="loc_imtx_CollaborationAgreementsMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_CollaborationAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaboration Agreements [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_CollaborationAgreementsMember" xlink:to="lab_imtx_CollaborationAgreementsMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DisclosureOfCompensationOfKeyManagementPersonnelAbstract" xlink:label="loc_imtx_DisclosureOfCompensationOfKeyManagementPersonnelAbstract" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DisclosureOfCompensationOfKeyManagementPersonnelAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Compensation Of Key Management Personnel [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DisclosureOfCompensationOfKeyManagementPersonnelAbstract" xlink:to="lab_imtx_DisclosureOfCompensationOfKeyManagementPersonnelAbstract" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_KeyManagementPersonnelCompensationFixed" xlink:label="loc_imtx_KeyManagementPersonnelCompensationFixed" xlink:type="locator"/>
    <label xlink:label="lab_imtx_KeyManagementPersonnelCompensationFixed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key Management Personnel Compensation Fixed</label>
    <label xlink:label="lab_imtx_KeyManagementPersonnelCompensationFixed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fixed</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_KeyManagementPersonnelCompensationFixed" xlink:to="lab_imtx_KeyManagementPersonnelCompensationFixed" xlink:type="arc"/>
    <label xlink:label="lab_imtx_KeyManagementPersonnelCompensationFixed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Key management personnel compensation fixed.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_KeyManagementPersonnelCompensationOtherLongtermBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationOtherLongtermBenefits" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationOtherLongtermBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key management personnel compensation, other long-term employee benefits</label>
    <label xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationOtherLongtermBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationOtherLongtermBenefits" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationOtherLongtermBenefits" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key management personnel compensation, share-based payment</label>
    <label xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation expense</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key management personnel compensation</label>
    <label xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensation" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract" xlink:to="lab_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesTable" xlink:label="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesTable" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesTable" xlink:to="lab_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesTable" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_MichaelGAtiehMember" xlink:label="loc_imtx_MichaelGAtiehMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_MichaelGAtiehMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Michael G Atieh [Member]</label>
    <label xlink:label="lab_imtx_MichaelGAtiehMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Michael G. Atieh</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_MichaelGAtiehMember" xlink:to="lab_imtx_MichaelGAtiehMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_PaulCarterMember" xlink:label="loc_imtx_PaulCarterMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_PaulCarterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Paul Carter [Member]</label>
    <label xlink:label="lab_imtx_PaulCarterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Paul Carter</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_PaulCarterMember" xlink:to="lab_imtx_PaulCarterMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_HeatherLMasonMember" xlink:label="loc_imtx_HeatherLMasonMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_HeatherLMasonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Heather L Mason [Member]</label>
    <label xlink:label="lab_imtx_HeatherLMasonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Heather I. Mason</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_HeatherLMasonMember" xlink:to="lab_imtx_HeatherLMasonMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_AdamStoneMember" xlink:label="loc_imtx_AdamStoneMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_AdamStoneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adam Stone [Member]</label>
    <label xlink:label="lab_imtx_AdamStoneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adam Stone</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_AdamStoneMember" xlink:to="lab_imtx_AdamStoneMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_ChristophHettichMember" xlink:label="loc_imtx_ChristophHettichMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ChristophHettichMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Christoph Hettich [Member]</label>
    <label xlink:label="lab_imtx_ChristophHettichMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Christoph Hettich</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ChristophHettichMember" xlink:to="lab_imtx_ChristophHettichMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_EliotForsterMember" xlink:label="loc_imtx_EliotForsterMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_EliotForsterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Eliot Forster [Member]</label>
    <label xlink:label="lab_imtx_EliotForsterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Eliot Forster</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_EliotForsterMember" xlink:to="lab_imtx_EliotForsterMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_PeterChambreMember" xlink:label="loc_imtx_PeterChambreMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_PeterChambreMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peter Chambre [Member]</label>
    <label xlink:label="lab_imtx_PeterChambreMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peter Chambre</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_PeterChambreMember" xlink:to="lab_imtx_PeterChambreMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_HaraldFstockMember" xlink:label="loc_imtx_HaraldFstockMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_HaraldFstockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Harald FStock [Member]</label>
    <label xlink:label="lab_imtx_HaraldFstockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Harald F.Stock</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_HaraldFstockMember" xlink:to="lab_imtx_HaraldFstockMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [line items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems" xlink:to="lab_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_KeyManagementPersonnelCompensationSupervisoryBoardCompensation" xlink:label="loc_imtx_KeyManagementPersonnelCompensationSupervisoryBoardCompensation" xlink:type="locator"/>
    <label xlink:label="lab_imtx_KeyManagementPersonnelCompensationSupervisoryBoardCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key Management Personnel Compensation Supervisory Board Compensation</label>
    <label xlink:label="lab_imtx_KeyManagementPersonnelCompensationSupervisoryBoardCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Supervisory board compensation</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_KeyManagementPersonnelCompensationSupervisoryBoardCompensation" xlink:to="lab_imtx_KeyManagementPersonnelCompensationSupervisoryBoardCompensation" xlink:type="arc"/>
    <label xlink:label="lab_imtx_KeyManagementPersonnelCompensationSupervisoryBoardCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Key management personnel compensation supervisory board compensation.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_KeyManagementPersonnelCompensationTravellingExpenses" xlink:label="loc_imtx_KeyManagementPersonnelCompensationTravellingExpenses" xlink:type="locator"/>
    <label xlink:label="lab_imtx_KeyManagementPersonnelCompensationTravellingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key Management Personnel Compensation Travelling Expenses</label>
    <label xlink:label="lab_imtx_KeyManagementPersonnelCompensationTravellingExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Travel expenses</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_KeyManagementPersonnelCompensationTravellingExpenses" xlink:to="lab_imtx_KeyManagementPersonnelCompensationTravellingExpenses" xlink:type="arc"/>
    <label xlink:label="lab_imtx_KeyManagementPersonnelCompensationTravellingExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Key management personnel compensation travelling expenses.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_KeyManagementPersonnelCompensationShareBasedCompensationExpense" xlink:label="loc_imtx_KeyManagementPersonnelCompensationShareBasedCompensationExpense" xlink:type="locator"/>
    <label xlink:label="lab_imtx_KeyManagementPersonnelCompensationShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key Management Personnel Compensation Share Based Compensation Expense</label>
    <label xlink:label="lab_imtx_KeyManagementPersonnelCompensationShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation expense</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_KeyManagementPersonnelCompensationShareBasedCompensationExpense" xlink:to="lab_imtx_KeyManagementPersonnelCompensationShareBasedCompensationExpense" xlink:type="arc"/>
    <label xlink:label="lab_imtx_KeyManagementPersonnelCompensationShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Key management personnel compensation share based compensation expense.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_KeyManagementPersonnelCompensations" xlink:label="loc_imtx_KeyManagementPersonnelCompensations" xlink:type="locator"/>
    <label xlink:label="lab_imtx_KeyManagementPersonnelCompensations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key Management Personnel Compensations</label>
    <label xlink:label="lab_imtx_KeyManagementPersonnelCompensations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total cash compensation</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_KeyManagementPersonnelCompensations" xlink:to="lab_imtx_KeyManagementPersonnelCompensations" xlink:type="arc"/>
    <label xlink:label="lab_imtx_KeyManagementPersonnelCompensations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Key management personnel compensations.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_KeyManagementPersonnelCompensationPaymentExitArrangement" xlink:label="loc_imtx_KeyManagementPersonnelCompensationPaymentExitArrangement" xlink:type="locator"/>
    <label xlink:label="lab_imtx_KeyManagementPersonnelCompensationPaymentExitArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key Management Personnel Compensation Payment Exit Arrangement</label>
    <label xlink:label="lab_imtx_KeyManagementPersonnelCompensationPaymentExitArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payment Exit arrangement</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_KeyManagementPersonnelCompensationPaymentExitArrangement" xlink:to="lab_imtx_KeyManagementPersonnelCompensationPaymentExitArrangement" xlink:type="arc"/>
    <label xlink:label="lab_imtx_KeyManagementPersonnelCompensationPaymentExitArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Key management personnel compensation payment exit arrangement.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of transactions between related parties [abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of transactions between related parties [table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_TypeOfVestingAxis" xlink:label="loc_imtx_TypeOfVestingAxis" xlink:type="locator"/>
    <label xlink:label="lab_imtx_TypeOfVestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Type Of Vesting [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_TypeOfVestingAxis" xlink:to="lab_imtx_TypeOfVestingAxis" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_TypeOfVestingDomain" xlink:label="loc_imtx_TypeOfVestingDomain" xlink:type="locator"/>
    <label xlink:label="lab_imtx_TypeOfVestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Type Of Vesting [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_TypeOfVestingDomain" xlink:to="lab_imtx_TypeOfVestingDomain" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_ServiceOptionsMember" xlink:label="loc_imtx_ServiceOptionsMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ServiceOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Service Options [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ServiceOptionsMember" xlink:to="lab_imtx_ServiceOptionsMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_ConvertedOptionsOneMember" xlink:label="loc_imtx_ConvertedOptionsOneMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ConvertedOptionsOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Converted Options One [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ConvertedOptionsOneMember" xlink:to="lab_imtx_ConvertedOptionsOneMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_ServiceOptionsOneMember" xlink:label="loc_imtx_ServiceOptionsOneMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_ServiceOptionsOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Service Options One [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_ServiceOptionsOneMember" xlink:to="lab_imtx_ServiceOptionsOneMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_HarpreetSinghMember" xlink:label="loc_imtx_HarpreetSinghMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_HarpreetSinghMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Harpreet Singh [Member]</label>
    <label xlink:label="lab_imtx_HarpreetSinghMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Harpreet Singh</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_HarpreetSinghMember" xlink:to="lab_imtx_HarpreetSinghMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of transactions between related parties [line items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfTransactionsWithRelatedParty" xlink:label="loc_ifrs-full_DescriptionOfTransactionsWithRelatedParty" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DescriptionOfTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of transactions with related party</label>
    <label xlink:label="lab_ifrs-full_DescriptionOfTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Description of Transactions with related party</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfTransactionsWithRelatedParty" xlink:to="lab_ifrs-full_DescriptionOfTransactionsWithRelatedParty" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of method of settlement for share-based payment arrangement</label>
    <label xlink:label="lab_ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Type of option</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of instruments granted in share-based payment arrangement</label>
    <label xlink:label="lab_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Options</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_DateOfExpiryOfShareOptionsGranted" xlink:label="loc_imtx_DateOfExpiryOfShareOptionsGranted" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DateOfExpiryOfShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Date Of Expiry Of Share Options Granted</label>
    <label xlink:label="lab_imtx_DateOfExpiryOfShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration date</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DateOfExpiryOfShareOptionsGranted" xlink:to="lab_imtx_DateOfExpiryOfShareOptionsGranted" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DateOfExpiryOfShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Date of expiry of share options granted.</label>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key management personnel compensation, short-term employee benefits</label>
    <label xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:type="resource" xml:lang="en-US">Key management personnel compensation, short-term employee benefits</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:type="locator"/>
    <label xlink:label="lab_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key management personnel of entity or parent [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:to="lab_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_PlanNameAxis" xlink:label="loc_imtx_PlanNameAxis" xlink:type="locator"/>
    <label xlink:label="lab_imtx_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_PlanNameAxis" xlink:to="lab_imtx_PlanNameAxis" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_PlanNameDomain" xlink:label="loc_imtx_PlanNameDomain" xlink:type="locator"/>
    <label xlink:label="lab_imtx_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_PlanNameDomain" xlink:to="lab_imtx_PlanNameDomain" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_TwentyTwentyIncentivePlanMember" xlink:label="loc_imtx_TwentyTwentyIncentivePlanMember" xlink:type="locator"/>
    <label xlink:label="lab_imtx_TwentyTwentyIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Twenty Twenty Incentive Plan [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_TwentyTwentyIncentivePlanMember" xlink:to="lab_imtx_TwentyTwentyIncentivePlanMember" xlink:type="arc"/>
    <loc xlink:href="imtx-20201231.xsd#imtx_AccruedOfKeyManagementCompensation" xlink:label="loc_imtx_AccruedOfKeyManagementCompensation" xlink:type="locator"/>
    <label xlink:label="lab_imtx_AccruedOfKeyManagementCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Of Key Management Compensation</label>
    <label xlink:label="lab_imtx_AccruedOfKeyManagementCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued of key management compensation</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_AccruedOfKeyManagementCompensation" xlink:to="lab_imtx_AccruedOfKeyManagementCompensation" xlink:type="arc"/>
    <label xlink:label="lab_imtx_AccruedOfKeyManagementCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued of key management compensation.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_PercentageOfStockVestedOverThePeriodOfFourYearTimeBasedVestingSchedule" xlink:label="loc_imtx_PercentageOfStockVestedOverThePeriodOfFourYearTimeBasedVestingSchedule" xlink:type="locator"/>
    <label xlink:label="lab_imtx_PercentageOfStockVestedOverThePeriodOfFourYearTimeBasedVestingSchedule" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage Of Stock Vested Over The Period Of Four Year Time Based Vesting Schedule</label>
    <label xlink:label="lab_imtx_PercentageOfStockVestedOverThePeriodOfFourYearTimeBasedVestingSchedule" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of stock vested over the period of four-year time-based vesting schedule</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_PercentageOfStockVestedOverThePeriodOfFourYearTimeBasedVestingSchedule" xlink:to="lab_imtx_PercentageOfStockVestedOverThePeriodOfFourYearTimeBasedVestingSchedule" xlink:type="arc"/>
    <label xlink:label="lab_imtx_PercentageOfStockVestedOverThePeriodOfFourYearTimeBasedVestingSchedule" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage of stock vested over the period of four-year time-based vesting schedule.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_PaymentOfPayrollTaxOfTheEmployees" xlink:label="loc_imtx_PaymentOfPayrollTaxOfTheEmployees" xlink:type="locator"/>
    <label xlink:label="lab_imtx_PaymentOfPayrollTaxOfTheEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment Of Payroll Tax Of The Employees</label>
    <label xlink:label="lab_imtx_PaymentOfPayrollTaxOfTheEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payment of Payroll Tax of the employees</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_PaymentOfPayrollTaxOfTheEmployees" xlink:to="lab_imtx_PaymentOfPayrollTaxOfTheEmployees" xlink:type="arc"/>
    <label xlink:label="lab_imtx_PaymentOfPayrollTaxOfTheEmployees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payment of Payroll Tax of the employees.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_NumberOfConvertedStockOptionsInTheEntity" xlink:label="loc_imtx_NumberOfConvertedStockOptionsInTheEntity" xlink:type="locator"/>
    <label xlink:label="lab_imtx_NumberOfConvertedStockOptionsInTheEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Converted Stock Options In The Entity</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_NumberOfConvertedStockOptionsInTheEntity" xlink:to="lab_imtx_NumberOfConvertedStockOptionsInTheEntity" xlink:type="arc"/>
    <label xlink:label="lab_imtx_NumberOfConvertedStockOptionsInTheEntity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Converted stock options in the entity.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_NumberOfMatchingStockOptionInTheEntity" xlink:label="loc_imtx_NumberOfMatchingStockOptionInTheEntity" xlink:type="locator"/>
    <label xlink:label="lab_imtx_NumberOfMatchingStockOptionInTheEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Matching Stock Option In The Entity</label>
    <label xlink:label="lab_imtx_NumberOfMatchingStockOptionInTheEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of matching stock option in the entity</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_NumberOfMatchingStockOptionInTheEntity" xlink:to="lab_imtx_NumberOfMatchingStockOptionInTheEntity" xlink:type="arc"/>
    <label xlink:label="lab_imtx_NumberOfMatchingStockOptionInTheEntity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of matching stock option in the entity.</label>
    <loc xlink:href="imtx-20201231.xsd#imtx_DilutiveEffectOfShareOptionsOnNumberOfWarrants" xlink:label="loc_imtx_DilutiveEffectOfShareOptionsOnNumberOfWarrants" xlink:type="locator"/>
    <label xlink:label="lab_imtx_DilutiveEffectOfShareOptionsOnNumberOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dilutive effect of share options on number of warrants</label>
    <label xlink:label="lab_imtx_DilutiveEffectOfShareOptionsOnNumberOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dilutive effect of share options on number of warrants</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_imtx_DilutiveEffectOfShareOptionsOnNumberOfWarrants" xlink:to="lab_imtx_DilutiveEffectOfShareOptionsOnNumberOfWarrants" xlink:type="arc"/>
    <label xlink:label="lab_imtx_DilutiveEffectOfShareOptionsOnNumberOfWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Dilutive effect of share options on number of warrants.</label>
</labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>15
<FILENAME>imtx-20201231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 30-March-2021 [01:58:01] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#CoverPage" roleURI="http://imtx.com/role/CoverPage" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ConsolidatedStatementOfFinancialPositionOfImmaticsNV" roleURI="http://imtx.com/role/ConsolidatedStatementOfFinancialPositionOfImmaticsNV" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ConsolidatedStatementOfLossOfImmaticsNV" roleURI="http://imtx.com/role/ConsolidatedStatementOfLossOfImmaticsNV" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ConsolidatedStatementOfComprehensiveLossOfImmaticsNV" roleURI="http://imtx.com/role/ConsolidatedStatementOfComprehensiveLossOfImmaticsNV" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ConsolidatedStatementOfCashFlows" roleURI="http://imtx.com/role/ConsolidatedStatementOfCashFlows" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ConsolidatedStatementOfChangesInShareholdersEquityDeficitOfImmaticsNV" roleURI="http://imtx.com/role/ConsolidatedStatementOfChangesInShareholdersEquityDeficitOfImmaticsNV" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#GroupInformation" roleURI="http://imtx.com/role/GroupInformation" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#BasisOfPresentation" roleURI="http://imtx.com/role/BasisOfPresentation" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#AryaMerger" roleURI="http://imtx.com/role/AryaMerger" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ApplicationOfNewAndRevisedInternationalFinancialReportingStandards" roleURI="http://imtx.com/role/ApplicationOfNewAndRevisedInternationalFinancialReportingStandards" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020" roleURI="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#SignificantAccountingJudgmentsEstimatesAndAssumptions" roleURI="http://imtx.com/role/SignificantAccountingJudgmentsEstimatesAndAssumptions" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#AccountsReceivable" roleURI="http://imtx.com/role/AccountsReceivable" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#OtherCurrentAndNonCurrentAssets" roleURI="http://imtx.com/role/OtherCurrentAndNonCurrentAssets" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#PropertyPlantAndEquipment" roleURI="http://imtx.com/role/PropertyPlantAndEquipment" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#IntangibleAssets" roleURI="http://imtx.com/role/IntangibleAssets" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#Leases" roleURI="http://imtx.com/role/Leases" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#AccountsPayable" roleURI="http://imtx.com/role/AccountsPayable" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#RevenueFromCollaborationAgreements" roleURI="http://imtx.com/role/RevenueFromCollaborationAgreements" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#OtherIncome" roleURI="http://imtx.com/role/OtherIncome" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#OtherCurrentLiabilities" roleURI="http://imtx.com/role/OtherCurrentLiabilities" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#FinancialIncomeAndExpenses" roleURI="http://imtx.com/role/FinancialIncomeAndExpenses" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ShareListingExpenses" roleURI="http://imtx.com/role/ShareListingExpenses" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ShareBasedPayments" roleURI="http://imtx.com/role/ShareBasedPayments" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ShareholdersEquityDeficit" roleURI="http://imtx.com/role/ShareholdersEquityDeficit" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#NonControllingInterests" roleURI="http://imtx.com/role/NonControllingInterests" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#PersonnelExpenses" roleURI="http://imtx.com/role/PersonnelExpenses" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#IncomeTax" roleURI="http://imtx.com/role/IncomeTax" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#FinancialRiskManagementObjectivesAndPolicies" roleURI="http://imtx.com/role/FinancialRiskManagementObjectivesAndPolicies" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#FinancialInstruments" roleURI="http://imtx.com/role/FinancialInstruments" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#CommitmentsAndContingencies" roleURI="http://imtx.com/role/CommitmentsAndContingencies" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#RelatedPartyDisclosures" roleURI="http://imtx.com/role/RelatedPartyDisclosures" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#NetLossPerShare" roleURI="http://imtx.com/role/NetLossPerShare" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#EventsOccurringAfterTheReportingPeriod" roleURI="http://imtx.com/role/EventsOccurringAfterTheReportingPeriod" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020Policies" roleURI="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020Policies" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#BasisOfPresentationTables" roleURI="http://imtx.com/role/BasisOfPresentationTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ApplicationOfNewAndRevisedInternationalFinancialReportingStandardsTables" roleURI="http://imtx.com/role/ApplicationOfNewAndRevisedInternationalFinancialReportingStandardsTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020Tables" roleURI="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020Tables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#AccountsReceivableTables" roleURI="http://imtx.com/role/AccountsReceivableTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#OtherCurrentAndNonCurrentAssetsTables" roleURI="http://imtx.com/role/OtherCurrentAndNonCurrentAssetsTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#PropertyPlantAndEquipmentTables" roleURI="http://imtx.com/role/PropertyPlantAndEquipmentTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#IntangibleAssetsTables" roleURI="http://imtx.com/role/IntangibleAssetsTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#LeasesTables" roleURI="http://imtx.com/role/LeasesTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#AccountsPayableTables" roleURI="http://imtx.com/role/AccountsPayableTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#RevenueFromCollaborationAgreementsTables" roleURI="http://imtx.com/role/RevenueFromCollaborationAgreementsTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#OtherIncomeTables" roleURI="http://imtx.com/role/OtherIncomeTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#OtherCurrentLiabilitiesTables" roleURI="http://imtx.com/role/OtherCurrentLiabilitiesTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#FinancialIncomeAndExpensesTables" roleURI="http://imtx.com/role/FinancialIncomeAndExpensesTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ShareListingExpensesTables" roleURI="http://imtx.com/role/ShareListingExpensesTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ShareBasedPaymentsTables" roleURI="http://imtx.com/role/ShareBasedPaymentsTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#PersonnelExpensesTables" roleURI="http://imtx.com/role/PersonnelExpensesTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#IncomeTaxTables" roleURI="http://imtx.com/role/IncomeTaxTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#FinancialRiskManagementObjectivesAndPoliciesTables" roleURI="http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#FinancialInstrumentsTables" roleURI="http://imtx.com/role/FinancialInstrumentsTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#CommitmentsAndContingenciesTables" roleURI="http://imtx.com/role/CommitmentsAndContingenciesTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#RelatedPartyDisclosuresTables" roleURI="http://imtx.com/role/RelatedPartyDisclosuresTables" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#GroupInformationAdditionalInformationDetail" roleURI="http://imtx.com/role/GroupInformationAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#BasisOfPresentationSummaryOfReconciliationOfChangesInCashFlowStatementDetail" roleURI="http://imtx.com/role/BasisOfPresentationSummaryOfReconciliationOfChangesInCashFlowStatementDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#BasisOfPresentationAdditionalInformationDetail" roleURI="http://imtx.com/role/BasisOfPresentationAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#AryaMergerAdditionalInformationDetail" roleURI="http://imtx.com/role/AryaMergerAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ApplicationOfNewAndRevisedInternationalFinancialReportingStandardsSummaryOfApplicationOfNewStandardsDetail" roleURI="http://imtx.com/role/ApplicationOfNewAndRevisedInternationalFinancialReportingStandardsSummaryOfApplicationOfNewStandardsDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ApplicationOfNewAndRevisedInternationalFinancialReportingStandardsSummaryOfNonMandatoryStandardsAndInterpretationsIssuedByIasbDetail" roleURI="http://imtx.com/role/ApplicationOfNewAndRevisedInternationalFinancialReportingStandardsSummaryOfNonMandatoryStandardsAndInterpretationsIssuedByIasbDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail" roleURI="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020SummaryOfUsefulLifeOfIntangibleAssetsOtherThanGoodwillDetail" roleURI="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020SummaryOfUsefulLifeOfIntangibleAssetsOtherThanGoodwillDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020SummaryOfForeignExchangeRatesDetail" roleURI="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020SummaryOfForeignExchangeRatesDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020AdditionalInformationDetail" roleURI="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020AdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#AccountsReceivableSummaryOfTradeReceivablesDetail" roleURI="http://imtx.com/role/AccountsReceivableSummaryOfTradeReceivablesDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#AccountsReceivableAdditionalInformationDetail" roleURI="http://imtx.com/role/AccountsReceivableAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#OtherCurrentAndNonCurrentAssetsSummaryOfOtherCurrentAssetsDetail" roleURI="http://imtx.com/role/OtherCurrentAndNonCurrentAssetsSummaryOfOtherCurrentAssetsDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#OtherCurrentAndNonCurrentAssetsAdditionalInformationDetails" roleURI="http://imtx.com/role/OtherCurrentAndNonCurrentAssetsAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#OtherCurrentAndNonCurrentAssetsSummaryOfOtherNonCurrentAssetsDetail" roleURI="http://imtx.com/role/OtherCurrentAndNonCurrentAssetsSummaryOfOtherNonCurrentAssetsDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#PropertyPlantAndEquipmentSummaryOfChangesToPropertyPlantAndEquipmentDetail" roleURI="http://imtx.com/role/PropertyPlantAndEquipmentSummaryOfChangesToPropertyPlantAndEquipmentDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#PropertyPlantAndEquipmentSummaryOfDepreciationExpenseDetail" roleURI="http://imtx.com/role/PropertyPlantAndEquipmentSummaryOfDepreciationExpenseDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#IntangibleAssetsSummaryOfChangesToIntangibleAssetsDetail" roleURI="http://imtx.com/role/IntangibleAssetsSummaryOfChangesToIntangibleAssetsDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#IntangibleAssetsSummaryOfAmortizationExpenseDetail" roleURI="http://imtx.com/role/IntangibleAssetsSummaryOfAmortizationExpenseDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#LeasesSummaryOfRightOfUseAssetsDetail" roleURI="http://imtx.com/role/LeasesSummaryOfRightOfUseAssetsDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#LeasesDetailsOfLeaseLiabilitiesDetail" roleURI="http://imtx.com/role/LeasesDetailsOfLeaseLiabilitiesDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#LeasesSummaryOfExpensesRelatedToRightOfUseAssetsAndLeaseLiabilitiesDetail" roleURI="http://imtx.com/role/LeasesSummaryOfExpensesRelatedToRightOfUseAssetsAndLeaseLiabilitiesDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#LeasesAdditionalInformationDetail" roleURI="http://imtx.com/role/LeasesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#AccountsPayableSummaryOfAccountsPayableDetail" roleURI="http://imtx.com/role/AccountsPayableSummaryOfAccountsPayableDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#AccountsPayableAdditionalInformationDetail" roleURI="http://imtx.com/role/AccountsPayableAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#RevenueFromCollaborationAgreementsAdditionalInformationDetail" roleURI="http://imtx.com/role/RevenueFromCollaborationAgreementsAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#RevenueFromCollaborationAgreementsSummaryOfDeferredRevenueRelatedToTheCollaborationAgreementsDetail" roleURI="http://imtx.com/role/RevenueFromCollaborationAgreementsSummaryOfDeferredRevenueRelatedToTheCollaborationAgreementsDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#OtherIncomeSummaryOfOtherIncomeDetail" roleURI="http://imtx.com/role/OtherIncomeSummaryOfOtherIncomeDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#OtherIncomeAdditionalInformationDetail" roleURI="http://imtx.com/role/OtherIncomeAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#OtherCurrentLiabilitiesSummaryOfOtherCurrentLiabilitiesDetail" roleURI="http://imtx.com/role/OtherCurrentLiabilitiesSummaryOfOtherCurrentLiabilitiesDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#OtherCurrentLiabilitiesAdditionalInformationDetail" roleURI="http://imtx.com/role/OtherCurrentLiabilitiesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#FinancialIncomeAndExpensesSummaryOfFinanceIncomeAndCostsDetail" roleURI="http://imtx.com/role/FinancialIncomeAndExpensesSummaryOfFinanceIncomeAndCostsDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#FinancialIncomeAndExpensesAdditionalInformationDetail" roleURI="http://imtx.com/role/FinancialIncomeAndExpensesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ShareListingExpenseAdditionalInformationDetail" roleURI="http://imtx.com/role/ShareListingExpenseAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ShareListingExpensesSummaryOfCalculationOfTheShareListingExpenseDetail" roleURI="http://imtx.com/role/ShareListingExpensesSummaryOfCalculationOfTheShareListingExpenseDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ShareBasedPaymentsSummaryOfOptionsGrantedPricedUsingBlackScholesForSarsTandemAwardsConvertedOptionsMatchingStockOptionsAndMonteCarloOptionPricingModelDetail" roleURI="http://imtx.com/role/ShareBasedPaymentsSummaryOfOptionsGrantedPricedUsingBlackScholesForSarsTandemAwardsConvertedOptionsMatchingStockOptionsAndMonteCarloOptionPricingModelDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ShareBasedPaymentsSummaryOfEmployeeShareOptionsDetail" roleURI="http://imtx.com/role/ShareBasedPaymentsSummaryOfEmployeeShareOptionsDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ShareBasedPaymentsSummaryOfActivitiesUnderShareBasedPaymentArrangementDetail" roleURI="http://imtx.com/role/ShareBasedPaymentsSummaryOfActivitiesUnderShareBasedPaymentArrangementDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ShareBasedPaymentsAdditionalInformationDetail" roleURI="http://imtx.com/role/ShareBasedPaymentsAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ShareBasedPaymentsSummaryOfEmployeeRelatedShareBasedCompensationExpenseDetail" roleURI="http://imtx.com/role/ShareBasedPaymentsSummaryOfEmployeeRelatedShareBasedCompensationExpenseDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#ShareholdersEquityDeficitAdditionalInformationDetail" roleURI="http://imtx.com/role/ShareholdersEquityDeficitAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#NonControllingInterestsAdditionalInformationDetail" roleURI="http://imtx.com/role/NonControllingInterestsAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#PersonnelExpensesSummaryOfPersonnelExpensesDetail" roleURI="http://imtx.com/role/PersonnelExpensesSummaryOfPersonnelExpensesDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#PersonnelExpensesAdditionalInformationDetail" roleURI="http://imtx.com/role/PersonnelExpensesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#IncomeTaxSummaryOfReconciliationBetweenTaxesOnIncomeAndExpectedIncomeTaxBenefitDetail" roleURI="http://imtx.com/role/IncomeTaxSummaryOfReconciliationBetweenTaxesOnIncomeAndExpectedIncomeTaxBenefitDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#IncomeTaxSummaryOfDeferredTaxAssetsDetail" roleURI="http://imtx.com/role/IncomeTaxSummaryOfDeferredTaxAssetsDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#IncomeTaxAdditionalInformationDetail" roleURI="http://imtx.com/role/IncomeTaxAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#FinancialRiskManagementObjectivesAndPoliciesSummaryOfCurrencyRiskExposureDetail" roleURI="http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesSummaryOfCurrencyRiskExposureDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#FinancialRiskManagementObjectivesAndPoliciesSummaryOfSensitivityAnalysisOfForeignCurrencyRiskDetail" roleURI="http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesSummaryOfSensitivityAnalysisOfForeignCurrencyRiskDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#FinancialRiskManagementObjectivesAndPoliciesSummaryOfSensitivityAnalysisOfForeignCurrencyRiskParentheticalDetail" roleURI="http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesSummaryOfSensitivityAnalysisOfForeignCurrencyRiskParentheticalDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#FinancialRiskManagementObjectivesAndPoliciesSummaryOfLiquidityRiskDetail" roleURI="http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesSummaryOfLiquidityRiskDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#FinancialRiskManagementObjectivesAndPoliciesAdditionalInformationDetail" roleURI="http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#FinancialInstrumentsSummaryOfCarryingAmountsAndFairValuesOfGroupsFinancialInstrumentsDetail" roleURI="http://imtx.com/role/FinancialInstrumentsSummaryOfCarryingAmountsAndFairValuesOfGroupsFinancialInstrumentsDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#CommitmentsAndContingenciesSummaryOfContractualObligationsDetail" roleURI="http://imtx.com/role/CommitmentsAndContingenciesSummaryOfContractualObligationsDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#CommitmentsAndContingenciesAdditionalInformationDetail" roleURI="http://imtx.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#RelatedPartyDisclosuresSummaryOfCompensationOfKeyManagementPersonnelDetail" roleURI="http://imtx.com/role/RelatedPartyDisclosuresSummaryOfCompensationOfKeyManagementPersonnelDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#RelatedPartyDisclosuresSummaryOfCompensationForTheSupervisoryBoardDetail" roleURI="http://imtx.com/role/RelatedPartyDisclosuresSummaryOfCompensationForTheSupervisoryBoardDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#RelatedPartyDisclosuresSummaryOfOptionsGrantedToManagingDirectorAndSupervisoryDirectorsDetail" roleURI="http://imtx.com/role/RelatedPartyDisclosuresSummaryOfOptionsGrantedToManagingDirectorAndSupervisoryDirectorsDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#RelatedPartyDisclosuresSummaryOfCompensationForTheSupervisoryBoardParentheticalDetail" roleURI="http://imtx.com/role/RelatedPartyDisclosuresSummaryOfCompensationForTheSupervisoryBoardParentheticalDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#RelatedPartyDisclosuresAdditionalInformationDetail" roleURI="http://imtx.com/role/RelatedPartyDisclosuresAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="imtx-20201231.xsd#NetLossPerShareAdditionalInformationDetail" roleURI="http://imtx.com/role/NetLossPerShareAdditionalInformationDetail" />
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/CoverPage">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_868817" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable_876580" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_868817" xlink:to="loc_dei_DocumentInformationTable_876580" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentInformationDocumentAxis" xlink:label="loc_dei_DocumentInformationDocumentAxis_876582" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_876580" xlink:to="loc_dei_DocumentInformationDocumentAxis_876582" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentDomain" xlink:label="loc_dei_DocumentDomain_876583" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationDocumentAxis_876582" xlink:to="loc_dei_DocumentDomain_876583" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_OrdinaryShareMember" xlink:label="loc_imtx_OrdinaryShareMember_876587" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentDomain_876583" xlink:to="loc_imtx_OrdinaryShareMember_876587" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_WarrantsMember" xlink:label="loc_imtx_WarrantsMember_876593" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentDomain_876583" xlink:to="loc_imtx_WarrantsMember_876593" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_876605" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_876580" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_876605" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_876606" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_876605" xlink:to="loc_dei_AddressTypeDomain_876606" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_BusinessContactMember" xlink:label="loc_dei_BusinessContactMember_876607" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AddressTypeDomain_876606" xlink:to="loc_dei_BusinessContactMember_876607" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems_876586" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_876580" xlink:to="loc_dei_DocumentInformationLineItems_876586" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_868818" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_DocumentType_868818" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_868819" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_AmendmentFlag_868819" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_868820" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_DocumentPeriodEndDate_868820" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_868821" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_DocumentFiscalYearFocus_868821" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_868822" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_DocumentFiscalPeriodFocus_868822" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_868823" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityRegistrantName_868823" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_868824" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityCentralIndexKey_868824" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_868825" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_CurrentFiscalYearEndDate_868825" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_868827" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_868827" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_868828" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityCurrentReportingStatus_868828" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_868829" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityFilerCategory_868829" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_868830" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_868830" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_868831" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityVoluntaryFilers_868831" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_868833" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityShellCompany_868833" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_868834" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityEmergingGrowthCompany_868834" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_877955" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityExTransitionPeriod_877955" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_868835" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_DocumentAnnualReport_868835" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_868836" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityInteractiveDataCurrent_868836" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_dei_IcfrAuditorAttestationFlag_868838" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_IcfrAuditorAttestationFlag_868838" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_dei_DocumentAccountingStandard_868839" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_DocumentAccountingStandard_868839" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_868899" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityIncorporationStateCountryCode_868899" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_876569" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityFileNumber_876569" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_876601" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_Security12bTitle_876601" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_876596" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_SecurityExchangeName_876596" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_876597" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_TradingSymbol_876597" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_ContactPersonnelName" xlink:label="loc_dei_ContactPersonnelName_876609" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_ContactPersonnelName_876609" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_876613" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityAddressAddressLine1_876613" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_876614" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityAddressCityOrTown_876614" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_876615" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityAddressStateOrProvince_876615" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_876616" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityAddressCountry_876616" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_876617" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_EntityAddressPostalZipCode_876617" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_876624" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_CityAreaCode_876624" use="optional" order="41" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_876625" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_LocalPhoneNumber_876625" use="optional" order="42" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_dei_DocumentRegistrationStatement_876636" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_DocumentRegistrationStatement_876636" use="optional" order="43" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_dei_DocumentShellCompanyReport_876638" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_DocumentShellCompanyReport_876638" use="optional" order="44" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_876639" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_876586" xlink:to="loc_dei_DocumentTransitionReport_876639" use="optional" order="45" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/ConsolidatedStatementOfFinancialPositionOfImmaticsNV">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract_864660" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AssetsAbstract" xlink:label="loc_ifrs-full_AssetsAbstract_864661" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_864660" xlink:to="loc_ifrs-full_AssetsAbstract_864661" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="loc_ifrs-full_CurrentAssetsAbstract_864662" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_864661" xlink:to="loc_ifrs-full_CurrentAssetsAbstract_864662" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_864663" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_864662" xlink:to="loc_ifrs-full_CashAndCashEquivalents_864663" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherCurrentFinancialAssets" xlink:label="loc_ifrs-full_OtherCurrentFinancialAssets_864664" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_864662" xlink:to="loc_ifrs-full_OtherCurrentFinancialAssets_864664" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_864665" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_864662" xlink:to="loc_ifrs-full_CurrentTradeReceivables_864665" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherCurrentAssets" xlink:label="loc_ifrs-full_OtherCurrentAssets_864666" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_864662" xlink:to="loc_ifrs-full_OtherCurrentAssets_864666" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_864667" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_864662" xlink:to="loc_ifrs-full_CurrentAssets_864667" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract_864668" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_864661" xlink:to="loc_ifrs-full_NoncurrentAssetsAbstract_864668" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_864669" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_864668" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_864669" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_864670" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_864668" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_864670" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_864671" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_864668" xlink:to="loc_ifrs-full_RightofuseAssets_864671" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="loc_ifrs-full_OtherNoncurrentAssets_864672" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_864668" xlink:to="loc_ifrs-full_OtherNoncurrentAssets_864672" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets_864673" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_864668" xlink:to="loc_ifrs-full_NoncurrentAssets_864673" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_864674" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_864661" xlink:to="loc_ifrs-full_Assets_864674" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="loc_ifrs-full_EquityAndLiabilitiesAbstract_864675" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_864660" xlink:to="loc_ifrs-full_EquityAndLiabilitiesAbstract_864675" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_864676" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_864675" xlink:to="loc_ifrs-full_CurrentLiabilitiesAbstract_864676" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentProvisions" xlink:label="loc_ifrs-full_CurrentProvisions_864677" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_864676" xlink:to="loc_ifrs-full_CurrentProvisions_864677" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_864678" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_864676" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_864678" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentContractLiabilities" xlink:label="loc_ifrs-full_CurrentContractLiabilities_864679" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_864676" xlink:to="loc_ifrs-full_CurrentContractLiabilities_864679" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_864680" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_864676" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_864680" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherCurrentLiabilities" xlink:label="loc_ifrs-full_OtherCurrentLiabilities_864681" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_864676" xlink:to="loc_ifrs-full_OtherCurrentLiabilities_864681" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_864682" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_864676" xlink:to="loc_ifrs-full_CurrentLiabilities_864682" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract_864683" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_864675" xlink:to="loc_ifrs-full_NoncurrentLiabilitiesAbstract_864683" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentContractLiabilities" xlink:label="loc_ifrs-full_NoncurrentContractLiabilities_864684" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_864683" xlink:to="loc_ifrs-full_NoncurrentContractLiabilities_864684" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_864685" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_864683" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_864685" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherNoncurrentLiabilities" xlink:label="loc_ifrs-full_OtherNoncurrentLiabilities_864686" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_864683" xlink:to="loc_ifrs-full_OtherNoncurrentLiabilities_864686" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities_864687" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_864683" xlink:to="loc_ifrs-full_NoncurrentLiabilities_864687" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-full_EquityAbstract_864688" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_864675" xlink:to="loc_ifrs-full_EquityAbstract_864688" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_864689" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_864688" xlink:to="loc_ifrs-full_IssuedCapital_864689" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharePremium" xlink:label="loc_ifrs-full_SharePremium_864690" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_864688" xlink:to="loc_ifrs-full_SharePremium_864690" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_864691" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_864688" xlink:to="loc_ifrs-full_RetainedEarnings_864691" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherReserves" xlink:label="loc_ifrs-full_OtherReserves_864692" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_864688" xlink:to="loc_ifrs-full_OtherReserves_864692" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParent_864693" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_864688" xlink:to="loc_ifrs-full_EquityAttributableToOwnersOfParent_864693" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncontrollingInterests" xlink:label="loc_ifrs-full_NoncontrollingInterests_864694" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_864688" xlink:to="loc_ifrs-full_NoncontrollingInterests_864694" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_864695" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_864688" xlink:to="loc_ifrs-full_Equity_864695" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_864696" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_864675" xlink:to="loc_ifrs-full_EquityAndLiabilities_864696" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/ConsolidatedStatementOfLossOfImmaticsNV">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="loc_ifrs-full_IncomeStatementAbstract_864698" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_RevenueFromCollaborationAgreements" xlink:label="loc_imtx_RevenueFromCollaborationAgreements_881029" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_864698" xlink:to="loc_imtx_RevenueFromCollaborationAgreements_881029" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_864700" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_864698" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_864700" use="optional" order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_864701" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_864698" xlink:to="loc_ifrs-full_GeneralAndAdministrativeExpense_864701" use="optional" order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-full_OtherIncome_864702" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_864698" xlink:to="loc_ifrs-full_OtherIncome_864702" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_864703" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_864698" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_864703" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_864704" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_864698" xlink:to="loc_ifrs-full_FinanceIncome_864704" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_864705" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_864698" xlink:to="loc_ifrs-full_FinanceCosts_864705" use="optional" order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShareListingExpense" xlink:label="loc_imtx_ShareListingExpense_864706" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_864698" xlink:to="loc_imtx_ShareListingExpense_864706" use="optional" order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinanceIncomeCost" xlink:label="loc_ifrs-full_FinanceIncomeCost_864707" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_864698" xlink:to="loc_ifrs-full_FinanceIncomeCost_864707" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_864708" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_864698" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_864708" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_864709" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_864698" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_864709" use="optional" order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_864710" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_864698" xlink:to="loc_ifrs-full_ProfitLoss_864710" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossAttributableToAbstract" xlink:label="loc_ifrs-full_ProfitLossAttributableToAbstract_864711" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_864698" xlink:to="loc_ifrs-full_ProfitLossAttributableToAbstract_864711" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_864712" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAttributableToAbstract_864711" xlink:to="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_864712" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_864713" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAttributableToAbstract_864711" xlink:to="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_864713" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_864714" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAttributableToAbstract_864711" xlink:to="loc_ifrs-full_ProfitLoss_864714" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BasicAndDilutedEarningsLossPerShare" xlink:label="loc_ifrs-full_BasicAndDilutedEarningsLossPerShare_864715" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_864698" xlink:to="loc_ifrs-full_BasicAndDilutedEarningsLossPerShare_864715" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_864716" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_864698" xlink:to="loc_ifrs-full_WeightedAverageShares_864716" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/ConsolidatedStatementOfComprehensiveLossOfImmaticsNV">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:label="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_864718" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_864719" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_864718" xlink:to="loc_ifrs-full_ProfitLoss_864719" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherComprehensiveIncomeAbstract" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeAbstract_864720" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_864718" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeAbstract_864720" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:label="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_864721" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_864720" xlink:to="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_864721" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax_864722" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_864721" xlink:to="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax_864722" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_864723" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_864718" xlink:to="loc_ifrs-full_ComprehensiveIncome_864723" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncomeAttributableToAbstract" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToAbstract_864724" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_864718" xlink:to="loc_ifrs-full_ComprehensiveIncomeAttributableToAbstract_864724" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_864725" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToAbstract_864724" xlink:to="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_864725" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_864726" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToAbstract_864724" xlink:to="loc_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_864726" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_864727" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToAbstract_864724" xlink:to="loc_ifrs-full_ComprehensiveIncome_864727" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/ConsolidatedStatementOfCashFlows">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract_864729" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_864730" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_864729" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_864730" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_864731" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_864730" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_864731" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_864732" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_864730" xlink:to="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_864732" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForInterestIncome" xlink:label="loc_ifrs-full_AdjustmentsForInterestIncome_864733" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_864732" xlink:to="loc_ifrs-full_AdjustmentsForInterestIncome_864733" use="optional" order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_864734" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_864732" xlink:to="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_864734" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForInterestExpense" xlink:label="loc_ifrs-full_AdjustmentsForInterestExpense_864735" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_864732" xlink:to="loc_ifrs-full_AdjustmentsForInterestExpense_864735" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AdjustmentsForShareListingExpense" xlink:label="loc_imtx_AdjustmentsForShareListingExpense_864736" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_864732" xlink:to="loc_imtx_AdjustmentsForShareListingExpense_864736" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AdjustmentForEquitySettledSharebasedPayment" xlink:label="loc_imtx_AdjustmentForEquitySettledSharebasedPayment_864737" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_864732" xlink:to="loc_imtx_AdjustmentForEquitySettledSharebasedPayment_864737" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_864738" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_864732" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_864738" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities_864739" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_864732" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities_864739" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PaymentsForShareBasedCompensation" xlink:label="loc_imtx_PaymentsForShareBasedCompensation_864740" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_864732" xlink:to="loc_imtx_PaymentsForShareBasedCompensation_864740" use="optional" order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:label="loc_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_876643" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_864732" xlink:to="loc_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_876643" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ChangesInWorkingCapitalAbstract" xlink:label="loc_imtx_ChangesInWorkingCapitalAbstract_864741" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_864730" xlink:to="loc_imtx_ChangesInWorkingCapitalAbstract_864741" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_864742" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_ChangesInWorkingCapitalAbstract_864741" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_864742" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_864743" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_ChangesInWorkingCapitalAbstract_864741" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_864743" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_865040" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_ChangesInWorkingCapitalAbstract_864741" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_865040" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_864806" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_ChangesInWorkingCapitalAbstract_864741" xlink:to="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_864806" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities_864807" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_ChangesInWorkingCapitalAbstract_864741" xlink:to="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities_864807" use="optional" order="18" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_864808" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_ChangesInWorkingCapitalAbstract_864741" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_864808" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_864809" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_864729" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_864809" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_864810" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_864809" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_864810" use="optional" order="21" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_864811" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_864809" xlink:to="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_864811" use="optional" order="22" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_864812" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_864809" xlink:to="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_864812" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_864813" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_864809" xlink:to="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_864813" use="optional" order="24" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_864814" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_864809" xlink:to="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_864814" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_864815" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_864809" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_864815" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_864816" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_864729" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_864816" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_864817" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_864816" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_864817" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts_876644" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_864816" xlink:to="loc_ifrs-full_PaymentsForShareIssueCosts_876644" use="optional" order="29" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_864818" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_864816" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_864818" use="optional" order="30" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_864819" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_864816" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_864819" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_864820" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_864729" xlink:to="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_864820" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_864821" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_864729" xlink:to="loc_ifrs-full_CashAndCashEquivalents_864821" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_864822" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_864729" xlink:to="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_864822" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_864823" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_864729" xlink:to="loc_ifrs-full_CashAndCashEquivalents_864823" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/ConsolidatedStatementOfChangesInShareholdersEquityDeficitOfImmaticsNV">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract_864825" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_864826" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract_864825" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_864826" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_864827" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_864826" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_864827" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_864828" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_864827" xlink:to="loc_ifrs-full_EquityMember_864828" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_864829" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_864828" xlink:to="loc_ifrs-full_IssuedCapitalMember_864829" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharePremiumMember" xlink:label="loc_ifrs-full_SharePremiumMember_864831" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_864828" xlink:to="loc_ifrs-full_SharePremiumMember_864831" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember_864832" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_864828" xlink:to="loc_ifrs-full_RetainedEarningsMember_864832" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherReservesMember" xlink:label="loc_ifrs-full_OtherReservesMember_864833" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_864828" xlink:to="loc_ifrs-full_OtherReservesMember_864833" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TotalEquityAttributableToShareholdersOfParentMember" xlink:label="loc_imtx_TotalEquityAttributableToShareholdersOfParentMember_864834" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_864828" xlink:to="loc_imtx_TotalEquityAttributableToShareholdersOfParentMember_864834" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncontrollingInterestsMember" xlink:label="loc_ifrs-full_NoncontrollingInterestsMember_864835" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_864828" xlink:to="loc_ifrs-full_NoncontrollingInterestsMember_864835" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_864826" xlink:to="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_864837" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" xlink:to="loc_ifrs-full_Equity_864837" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_864838" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_864838" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_864839" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" xlink:to="loc_ifrs-full_ProfitLoss_864839" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_864840" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" xlink:to="loc_ifrs-full_ComprehensiveIncome_864840" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_864841" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_864841" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_864842" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" xlink:to="loc_ifrs-full_IssueOfEquity_864842" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncreaseDecreaseThroughReorganizationEquity" xlink:label="loc_imtx_IncreaseDecreaseThroughReorganizationEquity_864845" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" xlink:to="loc_imtx_IncreaseDecreaseThroughReorganizationEquity_864845" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest" xlink:label="loc_imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest_864846" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" xlink:to="loc_imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest_864846" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners_864847" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners_864847" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncreaseThroughARYAMerger" xlink:label="loc_imtx_IncreaseThroughARYAMerger_864848" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" xlink:to="loc_imtx_IncreaseThroughARYAMerger_864848" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_SARConversion" xlink:label="loc_imtx_SARConversion_864849" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" xlink:to="loc_imtx_SARConversion_864849" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncreasedecreaseThroughIssuanceOfEquity" xlink:label="loc_imtx_IncreasedecreaseThroughIssuanceOfEquity_864850" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" xlink:to="loc_imtx_IncreasedecreaseThroughIssuanceOfEquity_864850" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncreasedecreaseThroughShareBasedCompensationPreviouslyClassifiesAsEquitySettled" xlink:label="loc_imtx_IncreasedecreaseThroughShareBasedCompensationPreviouslyClassifiesAsEquitySettled_864852" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" xlink:to="loc_imtx_IncreasedecreaseThroughShareBasedCompensationPreviouslyClassifiesAsEquitySettled_864852" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncreasedecreaseThroughCompensationExpense" xlink:label="loc_imtx_IncreasedecreaseThroughCompensationExpense_864843" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" xlink:to="loc_imtx_IncreasedecreaseThroughCompensationExpense_864843" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_864844" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_864836" xlink:to="loc_ifrs-full_Equity_864844" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/GroupInformation">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_864854" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfCompositionOfGroupExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCompositionOfGroupExplanatory_864855" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_864854" xlink:to="loc_ifrs-full_DisclosureOfCompositionOfGroupExplanatory_864855" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/BasisOfPresentation">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_864866" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_864867" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_864866" xlink:to="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_864867" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/AryaMerger">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_864905" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AryaMergerTransactionExplanatory" xlink:label="loc_imtx_AryaMergerTransactionExplanatory_876494" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_864905" xlink:to="loc_imtx_AryaMergerTransactionExplanatory_876494" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/ApplicationOfNewAndRevisedInternationalFinancialReportingStandards">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_864942" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatory_864943" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_864942" xlink:to="loc_ifrs-full_DisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatory_864943" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866204" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_866205" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866204" xlink:to="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_866205" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/SignificantAccountingJudgmentsEstimatesAndAssumptions">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866294" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_866295" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866294" xlink:to="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_866295" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/AccountsReceivable">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_864972" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfAccountReceivableExplanatoryTextBlock" xlink:label="loc_imtx_DisclosureOfAccountReceivableExplanatoryTextBlock_864973" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_864972" xlink:to="loc_imtx_DisclosureOfAccountReceivableExplanatoryTextBlock_864973" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/OtherCurrentAndNonCurrentAssets">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_864985" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfOtherAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOtherAssetsExplanatory_864986" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_864985" xlink:to="loc_ifrs-full_DisclosureOfOtherAssetsExplanatory_864986" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/PropertyPlantAndEquipment">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_864992" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_864993" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_864992" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_864993" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/IntangibleAssets">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866410" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_866411" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866410" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_866411" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/Leases">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:label="loc_ifrs-full_PresentationOfLeasesForLesseeAbstract_866471" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfLeasesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfLeasesExplanatory_866472" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PresentationOfLeasesForLesseeAbstract_866471" xlink:to="loc_ifrs-full_DisclosureOfLeasesExplanatory_866472" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/AccountsPayable">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866774" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_866775" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866774" xlink:to="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_866775" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/RevenueFromCollaborationAgreements">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866814" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory_866815" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866814" xlink:to="loc_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory_866815" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/OtherIncome">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866920" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory_866921" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866920" xlink:to="loc_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory_866921" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/OtherCurrentLiabilities">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866832" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfOtherCurrentLiabilitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOtherCurrentLiabilitiesExplanatory_866833" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866832" xlink:to="loc_ifrs-full_DisclosureOfOtherCurrentLiabilitiesExplanatory_866833" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/FinancialIncomeAndExpenses">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_867229" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_867231" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_867229" xlink:to="loc_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_867231" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/ShareListingExpenses">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866960" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfShareListingExpenseTextBlock" xlink:label="loc_imtx_DisclosureOfShareListingExpenseTextBlock_866963" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866960" xlink:to="loc_imtx_DisclosureOfShareListingExpenseTextBlock_866963" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/ShareBasedPayments">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_867228" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_867230" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_867228" xlink:to="loc_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_867230" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/ShareholdersEquityDeficit">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866834" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:label="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_866835" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866834" xlink:to="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_866835" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/NonControllingInterests">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_867049" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory_867050" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_867049" xlink:to="loc_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory_867050" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/PersonnelExpenses">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_867018" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfPersonnelExpensesExplanatoryTextBlock" xlink:label="loc_imtx_DisclosureOfPersonnelExpensesExplanatoryTextBlock_867019" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_867018" xlink:to="loc_imtx_DisclosureOfPersonnelExpensesExplanatoryTextBlock_867019" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/IncomeTax">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866872" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_866873" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866872" xlink:to="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_866873" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/FinancialRiskManagementObjectivesAndPolicies">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_867076" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_867077" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_867076" xlink:to="loc_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_867077" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/FinancialInstruments">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866743" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_866744" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866743" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_866744" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/CommitmentsAndContingencies">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866712" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_866713" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866712" xlink:to="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_866713" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/RelatedPartyDisclosures">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866501" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_866502" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866501" xlink:to="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_866502" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/NetLossPerShare">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866463" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_866464" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866463" xlink:to="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_866464" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/EventsOccurringAfterTheReportingPeriod">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866460" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_866461" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866460" xlink:to="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_866461" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020Policies">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866211" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock" xlink:label="loc_imtx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock_869287" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866211" xlink:to="loc_imtx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock_869287" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfAccountingPolicyForCashFlowsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForCashFlowsExplanatory_869289" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866211" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForCashFlowsExplanatory_869289" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DescriptionOfAccountingPolicyForCovidNineteenPolicyTextBlock" xlink:label="loc_imtx_DescriptionOfAccountingPolicyForCovidNineteenPolicyTextBlock_869288" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866211" xlink:to="loc_imtx_DescriptionOfAccountingPolicyForCovidNineteenPolicyTextBlock_869288" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_866212" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866211" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_866212" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory_866214" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866211" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory_866214" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory_866215" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866211" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory_866215" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_866216" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866211" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_866216" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_866217" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866211" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_866217" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_866218" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866211" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_866218" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_866219" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866211" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_866219" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_866220" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866211" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_866220" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_866221" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866211" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_866221" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_866222" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866211" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_866222" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DescriptionOfAccountingPolicyForOtherIncomePolicyTextBlock" xlink:label="loc_imtx_DescriptionOfAccountingPolicyForOtherIncomePolicyTextBlock_866224" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866211" xlink:to="loc_imtx_DescriptionOfAccountingPolicyForOtherIncomePolicyTextBlock_866224" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_866225" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866211" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_866225" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory_866226" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866211" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory_866226" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_866227" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866211" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_866227" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_866228" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866211" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_866228" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/BasisOfPresentationTables">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_864874" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementTextBlock" xlink:label="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementTextBlock_869290" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_864874" xlink:to="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementTextBlock_869290" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/ApplicationOfNewAndRevisedInternationalFinancialReportingStandardsTables">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_864945" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_864946" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_864945" xlink:to="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_864946" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfNonMandatoryStandardsAndInterpretationsIssuedByTheIasbTableTextBlock" xlink:label="loc_imtx_DisclosureOfNonMandatoryStandardsAndInterpretationsIssuedByTheIasbTableTextBlock_864947" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_864945" xlink:to="loc_imtx_DisclosureOfNonMandatoryStandardsAndInterpretationsIssuedByTheIasbTableTextBlock_864947" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020Tables">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866235" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesExplanatoryTableTextBlock" xlink:label="loc_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesExplanatoryTableTextBlock_866238" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866235" xlink:to="loc_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesExplanatoryTableTextBlock_866238" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillExplanatoryTableTextBlock" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillExplanatoryTableTextBlock_866239" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866235" xlink:to="loc_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillExplanatoryTableTextBlock_866239" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesExplanatoryTableTextBlock" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesExplanatoryTableTextBlock_866240" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866235" xlink:to="loc_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesExplanatoryTableTextBlock_866240" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/AccountsReceivableTables">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_864975" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfTradeAndOtherReceivableExplanatoryTableTextBlock" xlink:label="loc_imtx_DisclosureOfTradeAndOtherReceivableExplanatoryTableTextBlock_864976" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_864975" xlink:to="loc_imtx_DisclosureOfTradeAndOtherReceivableExplanatoryTableTextBlock_864976" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/OtherCurrentAndNonCurrentAssetsTables">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_864988" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory_864989" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_864988" xlink:to="loc_ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory_864989" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory_864990" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_864988" xlink:to="loc_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory_864990" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/PropertyPlantAndEquipmentTables">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_864995" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_864996" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_864995" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_864996" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDepreciationExpensesTableTextBlock" xlink:label="loc_imtx_DisclosureOfDepreciationExpensesTableTextBlock_864997" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_864995" xlink:to="loc_imtx_DisclosureOfDepreciationExpensesTableTextBlock_864997" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/IntangibleAssetsTables">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866413" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory_866414" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866413" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory_866414" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfAmortizationExpensesTableTextBlock" xlink:label="loc_imtx_DisclosureOfAmortizationExpensesTableTextBlock_866417" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866413" xlink:to="loc_imtx_DisclosureOfAmortizationExpensesTableTextBlock_866417" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/LeasesTables">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:label="loc_ifrs-full_PresentationOfLeasesForLesseeAbstract_866474" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_866475" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PresentationOfLeasesForLesseeAbstract_866474" xlink:to="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_866475" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfLeaseLiabilitiesTableTextBlock" xlink:label="loc_imtx_DisclosureOfLeaseLiabilitiesTableTextBlock_866481" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PresentationOfLeasesForLesseeAbstract_866474" xlink:to="loc_imtx_DisclosureOfLeaseLiabilitiesTableTextBlock_866481" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfExpensesRelatedToRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock" xlink:label="loc_imtx_DisclosureOfExpensesRelatedToRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock_866482" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PresentationOfLeasesForLesseeAbstract_866474" xlink:to="loc_imtx_DisclosureOfExpensesRelatedToRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock_866482" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/AccountsPayableTables">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866778" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfAccountsPayableExplanatoryTableTextBlock" xlink:label="loc_imtx_DisclosureOfAccountsPayableExplanatoryTableTextBlock_866781" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866778" xlink:to="loc_imtx_DisclosureOfAccountsPayableExplanatoryTableTextBlock_866781" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/RevenueFromCollaborationAgreementsTables">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866817" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfContractLiabilitiesTextBlock" xlink:label="loc_imtx_DisclosureOfContractLiabilitiesTextBlock_870553" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866817" xlink:to="loc_imtx_DisclosureOfContractLiabilitiesTextBlock_870553" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/OtherIncomeTables">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866925" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfOtherIncomeExplanatoryTextBlock" xlink:label="loc_imtx_DisclosureOfOtherIncomeExplanatoryTextBlock_870613" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866925" xlink:to="loc_imtx_DisclosureOfOtherIncomeExplanatoryTextBlock_870613" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/OtherCurrentLiabilitiesTables">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866846" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTextBlock" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTextBlock_866848" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866846" xlink:to="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTextBlock_866848" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/FinancialIncomeAndExpensesTables">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_867284" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseExplanatoryTextBlock" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseExplanatoryTextBlock_870649" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_867284" xlink:to="loc_imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseExplanatoryTextBlock_870649" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/ShareListingExpensesTables">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866968" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutShareListingExpensesTextBlock" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutShareListingExpensesTextBlock_866969" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866968" xlink:to="loc_imtx_DisclosureOfDetailedInformationAboutShareListingExpensesTextBlock_866969" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/ShareBasedPaymentsTables">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_867233" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsTable" xlink:label="loc_imtx_StatementsTable_867236" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_867233" xlink:to="loc_imtx_StatementsTable_867236" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_867240" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsTable_867236" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_867240" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_867241" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_867240" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_867241" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShareAppreciationRightsMember" xlink:label="loc_imtx_ShareAppreciationRightsMember_867242" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_867241" xlink:to="loc_imtx_ShareAppreciationRightsMember_867242" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TwoThousandAndSixteenTandemAwardsMember" xlink:label="loc_imtx_TwoThousandAndSixteenTandemAwardsMember_870738" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_867241" xlink:to="loc_imtx_TwoThousandAndSixteenTandemAwardsMember_870738" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MatchingStockOptionsMember" xlink:label="loc_imtx_MatchingStockOptionsMember_867427" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_867241" xlink:to="loc_imtx_MatchingStockOptionsMember_867427" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ConvertedOptionsMember" xlink:label="loc_imtx_ConvertedOptionsMember_867429" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_867241" xlink:to="loc_imtx_ConvertedOptionsMember_867429" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember" xlink:label="loc_imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember_867431" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_867241" xlink:to="loc_imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember_867431" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PerformanceBasedOptionsMember" xlink:label="loc_imtx_PerformanceBasedOptionsMember_867434" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_867241" xlink:to="loc_imtx_PerformanceBasedOptionsMember_867434" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsLineItems" xlink:label="loc_imtx_StatementsLineItems_867239" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsTable_867236" xlink:to="loc_imtx_StatementsLineItems_867239" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_867234" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867239" xlink:to="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_867234" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory_867251" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867239" xlink:to="loc_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory_867251" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureDetailsOfActivitiesUnderShareBasedPaymentArrangementTextBlock" xlink:label="loc_imtx_DisclosureDetailsOfActivitiesUnderShareBasedPaymentArrangementTextBlock_870759" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867239" xlink:to="loc_imtx_DisclosureDetailsOfActivitiesUnderShareBasedPaymentArrangementTextBlock_870759" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTextBlock" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTextBlock_870758" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867239" xlink:to="loc_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTextBlock_870758" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/PersonnelExpensesTables">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_867021" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfPersonnelExpenesTextBlock" xlink:label="loc_imtx_DisclosureOfPersonnelExpenesTextBlock_871287" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_867021" xlink:to="loc_imtx_DisclosureOfPersonnelExpenesTextBlock_871287" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/IncomeTaxTables">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866880" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfReconciliationBetweenTaxesOnIncomeAndExpectedIncomeTaxBenefitTableTextBlock" xlink:label="loc_imtx_DisclosureOfReconciliationBetweenTaxesOnIncomeAndExpectedIncomeTaxBenefitTableTextBlock_866881" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866880" xlink:to="loc_imtx_DisclosureOfReconciliationBetweenTaxesOnIncomeAndExpectedIncomeTaxBenefitTableTextBlock_866881" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_imtx_DisclosureOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_866886" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866880" xlink:to="loc_imtx_DisclosureOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_866886" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesTables">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_867079" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfCurrencyRiskExposureExplanatoryTableTextBlock" xlink:label="loc_imtx_DisclosureOfCurrencyRiskExposureExplanatoryTableTextBlock_867080" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_867079" xlink:to="loc_imtx_DisclosureOfCurrencyRiskExposureExplanatoryTableTextBlock_867080" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk" xlink:label="loc_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk_867081" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_867079" xlink:to="loc_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk_867081" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfManagingLiquidityRisk" xlink:label="loc_ifrs-full_DescriptionOfManagingLiquidityRisk_867082" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_867079" xlink:to="loc_ifrs-full_DescriptionOfManagingLiquidityRisk_867082" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/FinancialInstrumentsTables">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866747" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_866748" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866747" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_866748" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/CommitmentsAndContingenciesTables">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866716" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfContractualObligationsTableTextBlock" xlink:label="loc_imtx_DisclosureOfContractualObligationsTableTextBlock_866717" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866716" xlink:to="loc_imtx_DisclosureOfContractualObligationsTableTextBlock_866717" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/RelatedPartyDisclosuresTables">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866504" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfCompensationOfKeyManagementPersonnelTableTextBlock" xlink:label="loc_imtx_DisclosureOfCompensationOfKeyManagementPersonnelTableTextBlock_866510" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866504" xlink:to="loc_imtx_DisclosureOfCompensationOfKeyManagementPersonnelTableTextBlock_866510" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfCompensationSupervisoryBoardTextBlock" xlink:label="loc_imtx_DisclosureOfCompensationSupervisoryBoardTextBlock_866514" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866504" xlink:to="loc_imtx_DisclosureOfCompensationSupervisoryBoardTextBlock_866514" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfCompensationManagingDirectorsAndSupervisoryBoardTextBlock" xlink:label="loc_imtx_DisclosureOfCompensationManagingDirectorsAndSupervisoryBoardTextBlock_866516" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866504" xlink:to="loc_imtx_DisclosureOfCompensationManagingDirectorsAndSupervisoryBoardTextBlock_866516" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/GroupInformationAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_864857" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_864858" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_864857" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_864858" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_864859" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_864858" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_864859" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_864860" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_864859" xlink:to="loc_ifrs-full_NonadjustingEventsMember_864860" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AuthorizationOfFinancialStatementsMember" xlink:label="loc_imtx_AuthorizationOfFinancialStatementsMember_864861" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsMember_864860" xlink:to="loc_imtx_AuthorizationOfFinancialStatementsMember_864861" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_864862" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_864858" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_864862" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DateOfAuthorisationForIssueOfFinancialStatements2013" xlink:label="loc_ifrs-full_DateOfAuthorisationForIssueOfFinancialStatements2013_864863" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_864862" xlink:to="loc_ifrs-full_DateOfAuthorisationForIssueOfFinancialStatements2013_864863" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DateOfEndOfReportingPeriod2013" xlink:label="loc_ifrs-full_DateOfEndOfReportingPeriod2013_864864" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_864862" xlink:to="loc_ifrs-full_DateOfEndOfReportingPeriod2013_864864" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/BasisOfPresentationSummaryOfReconciliationOfChangesInCashFlowStatementDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementAbstract" xlink:label="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementAbstract_864877" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementTable" xlink:label="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementTable_864878" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementAbstract_864877" xlink:to="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementTable_864878" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:label="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_864879" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementTable_864878" xlink:to="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_864879" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RestatedMember" xlink:label="loc_ifrs-full_RestatedMember_864880" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_864879" xlink:to="loc_ifrs-full_RestatedMember_864880" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PreviouslyStatedMember" xlink:label="loc_ifrs-full_PreviouslyStatedMember_864881" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RestatedMember_864880" xlink:to="loc_ifrs-full_PreviouslyStatedMember_864881" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:label="loc_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember_864884" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RestatedMember_864880" xlink:to="loc_ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember_864884" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementLineItems" xlink:label="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementLineItems_864885" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementTable_864878" xlink:to="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementLineItems_864885" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_864886" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementLineItems_864885" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_864886" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_864887" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementLineItems_864885" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_864887" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_864888" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementLineItems_864885" xlink:to="loc_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_864888" use="optional" order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_864889" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementLineItems_864885" xlink:to="loc_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod_864889" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_864890" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementLineItems_864885" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_864890" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/BasisOfPresentationAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_864893" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_864895" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_864893" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_864895" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_864898" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_864895" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_864898" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_864899" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_864898" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_864899" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ImmaticsUsIncMember" xlink:label="loc_imtx_ImmaticsUsIncMember_864900" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_864899" xlink:to="loc_imtx_ImmaticsUsIncMember_864900" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_864901" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_864895" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_864901" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_864902" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_864901" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_864902" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherCurrentFinancialAssets" xlink:label="loc_ifrs-full_OtherCurrentFinancialAssets_864903" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_864901" xlink:to="loc_ifrs-full_OtherCurrentFinancialAssets_864903" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/AryaMergerAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_864908" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_864909" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_864908" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_864909" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_864910" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_864909" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_864910" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_864911" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_864910" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_864911" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AryaMember" xlink:label="loc_imtx_AryaMember_864912" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_864911" xlink:to="loc_imtx_AryaMember_864912" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfOrdinarySharesAxis" xlink:label="loc_ifrs-full_ClassesOfOrdinarySharesAxis_864913" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_864909" xlink:to="loc_ifrs-full_ClassesOfOrdinarySharesAxis_864913" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_864914" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfOrdinarySharesAxis_864913" xlink:to="loc_ifrs-full_OrdinarySharesMember_864914" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PipeFinancingMember" xlink:label="loc_imtx_PipeFinancingMember_864915" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OrdinarySharesMember_864914" xlink:to="loc_imtx_PipeFinancingMember_864915" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_864916" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_864909" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_864916" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_864917" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_864916" xlink:to="loc_ifrs-full_EquityMember_864917" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_864918" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_864917" xlink:to="loc_ifrs-full_IssuedCapitalMember_864918" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharePremiumMember" xlink:label="loc_ifrs-full_SharePremiumMember_864919" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityMember_864917" xlink:to="loc_ifrs-full_SharePremiumMember_864919" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_864920" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_864909" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_864920" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_864921" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_864920" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_864921" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_864922" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_864921" xlink:to="loc_ifrs-full_OrdinarySharesMember_864922" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_864923" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_864909" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_864923" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_864924" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_864923" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_864924" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_WarrantsMember" xlink:label="loc_imtx_WarrantsMember_864925" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_864924" xlink:to="loc_imtx_WarrantsMember_864925" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_864926" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_864909" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_864926" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncreaseDecreaseThroughReorganizationEquity" xlink:label="loc_imtx_IncreaseDecreaseThroughReorganizationEquity_864928" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_864926" xlink:to="loc_imtx_IncreaseDecreaseThroughReorganizationEquity_864928" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest" xlink:label="loc_imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest_864929" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_864926" xlink:to="loc_imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest_864929" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfHowAcquirerObtainedControlOfAcquiree" xlink:label="loc_ifrs-full_DescriptionOfHowAcquirerObtainedControlOfAcquiree_864930" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_864926" xlink:to="loc_ifrs-full_DescriptionOfHowAcquirerObtainedControlOfAcquiree_864930" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable" xlink:label="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_864931" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_864926" xlink:to="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_864931" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_864932" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_864926" xlink:to="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_864932" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_864933" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_864926" xlink:to="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_864933" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate_864934" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_864926" xlink:to="loc_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate_864934" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShareListingExpense" xlink:label="loc_imtx_ShareListingExpense_864935" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_864926" xlink:to="loc_imtx_ShareListingExpense_864935" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_864936" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_864926" xlink:to="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_864936" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners_864937" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_864926" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners_864937" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_864938" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_864926" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_864938" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts_876651" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_864926" xlink:to="loc_ifrs-full_PaymentsForShareIssueCosts_876651" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/ApplicationOfNewAndRevisedInternationalFinancialReportingStandardsSummaryOfApplicationOfNewStandardsDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsAbstract" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsAbstract_864949" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTable" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTable_864950" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsAbstract_864949" xlink:to="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTable_864950" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NewIFRSsAxis" xlink:label="loc_ifrs-full_NewIFRSsAxis_864951" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTable_864950" xlink:to="loc_ifrs-full_NewIFRSsAxis_864951" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NewIFRSsMember" xlink:label="loc_ifrs-full_NewIFRSsMember_864952" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NewIFRSsAxis_864951" xlink:to="loc_ifrs-full_NewIFRSsMember_864952" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AmendmentsToIfrsThreeMember" xlink:label="loc_imtx_AmendmentsToIfrsThreeMember_864953" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NewIFRSsMember_864952" xlink:to="loc_imtx_AmendmentsToIfrsThreeMember_864953" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AmendmentsToIasOneAndIasEightMember" xlink:label="loc_imtx_AmendmentsToIasOneAndIasEightMember_864954" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NewIFRSsMember_864952" xlink:to="loc_imtx_AmendmentsToIasOneAndIasEightMember_864954" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AmendmentsToIfrsNineIasThirtyNineAndIfrsSeventeenMember" xlink:label="loc_imtx_AmendmentsToIfrsNineIasThirtyNineAndIfrsSeventeenMember_864955" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NewIFRSsMember_864952" xlink:to="loc_imtx_AmendmentsToIfrsNineIasThirtyNineAndIfrsSeventeenMember_864955" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AmendmentsToConceptualFrameworkMember" xlink:label="loc_imtx_AmendmentsToConceptualFrameworkMember_864956" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NewIFRSsMember_864952" xlink:to="loc_imtx_AmendmentsToConceptualFrameworkMember_864956" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems_864957" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTable_864950" xlink:to="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems_864957" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TitleOfNewIFRS" xlink:label="loc_ifrs-full_TitleOfNewIFRS_864958" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems_864957" xlink:to="loc_ifrs-full_TitleOfNewIFRS_864958" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DateByWhichApplicationOfNewIFRSIsRequired" xlink:label="loc_ifrs-full_DateByWhichApplicationOfNewIFRSIsRequired_864959" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems_864957" xlink:to="loc_ifrs-full_DateByWhichApplicationOfNewIFRSIsRequired_864959" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/ApplicationOfNewAndRevisedInternationalFinancialReportingStandardsSummaryOfNonMandatoryStandardsAndInterpretationsIssuedByIasbDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsAbstract" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsAbstract_864961" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTable" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTable_864962" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsAbstract_864961" xlink:to="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTable_864962" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NewIFRSsAxis" xlink:label="loc_ifrs-full_NewIFRSsAxis_864963" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTable_864962" xlink:to="loc_ifrs-full_NewIFRSsAxis_864963" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NewIFRSsMember" xlink:label="loc_ifrs-full_NewIFRSsMember_864964" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NewIFRSsAxis_864963" xlink:to="loc_ifrs-full_NewIFRSsMember_864964" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IfrsSixteenMember" xlink:label="loc_imtx_IfrsSixteenMember_870158" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NewIFRSsMember_864964" xlink:to="loc_imtx_IfrsSixteenMember_870158" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AmendmentsToIasOneMember" xlink:label="loc_imtx_AmendmentsToIasOneMember_864966" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NewIFRSsMember_864964" xlink:to="loc_imtx_AmendmentsToIasOneMember_864966" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IfrsSeventeenMember" xlink:label="loc_imtx_IfrsSeventeenMember_864967" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NewIFRSsMember_864964" xlink:to="loc_imtx_IfrsSeventeenMember_864967" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems_864968" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsTable_864962" xlink:to="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems_864968" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TitleOfNewIFRS" xlink:label="loc_ifrs-full_TitleOfNewIFRS_864969" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems_864968" xlink:to="loc_ifrs-full_TitleOfNewIFRS_864969" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DateByWhichApplicationOfNewIFRSIsRequired" xlink:label="loc_ifrs-full_DateByWhichApplicationOfNewIFRSIsRequired_864970" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems_864968" xlink:to="loc_ifrs-full_DateByWhichApplicationOfNewIFRSIsRequired_864970" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesAbstract" xlink:label="loc_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesAbstract_866242" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesTable" xlink:label="loc_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesTable_866243" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesAbstract_866242" xlink:to="loc_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesTable_866243" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_866244" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesTable_866243" xlink:to="loc_ifrs-full_RangeAxis_866244" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_866245" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_866244" xlink:to="loc_ifrs-full_RangesMember_866245" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_866246" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_866245" xlink:to="loc_ifrs-full_BottomOfRangeMember_866246" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_866247" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_866245" xlink:to="loc_ifrs-full_TopOfRangeMember_866247" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_866248" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesTable_866243" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_866248" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_866249" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_866248" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_866249" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_866250" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_866249" xlink:to="loc_ifrs-full_ComputerEquipmentMember_866250" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_LaboratoryEquipmentMember" xlink:label="loc_imtx_LaboratoryEquipmentMember_866251" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_866249" xlink:to="loc_imtx_LaboratoryEquipmentMember_866251" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="loc_ifrs-full_OfficeEquipmentMember_866252" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_866249" xlink:to="loc_ifrs-full_OfficeEquipmentMember_866252" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesLineItems" xlink:label="loc_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesLineItems_866253" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesTable_866243" xlink:to="loc_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesLineItems_866253" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_866257" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesLineItems_866253" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_866257" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020SummaryOfUsefulLifeOfIntangibleAssetsOtherThanGoodwillDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillAbstract" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillAbstract_866260" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillTable" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillTable_866262" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillAbstract_866260" xlink:to="loc_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillTable_866262" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_866263" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillTable_866262" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_866263" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_866264" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_866263" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_866264" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LicencesMember" xlink:label="loc_ifrs-full_LicencesMember_866265" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_866264" xlink:to="loc_ifrs-full_LicencesMember_866265" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComputerSoftwareMember" xlink:label="loc_ifrs-full_ComputerSoftwareMember_866266" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_866264" xlink:to="loc_ifrs-full_ComputerSoftwareMember_866266" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_866267" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillTable_866262" xlink:to="loc_ifrs-full_RangeAxis_866267" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_866268" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_866267" xlink:to="loc_ifrs-full_RangesMember_866268" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_866269" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_866268" xlink:to="loc_ifrs-full_BottomOfRangeMember_866269" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_866270" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_866268" xlink:to="loc_ifrs-full_TopOfRangeMember_866270" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillLineItems" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillLineItems_866271" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillTable_866262" xlink:to="loc_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillLineItems_866271" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_866272" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillLineItems_866271" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_866272" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020SummaryOfForeignExchangeRatesDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ForeignExchangeRatesAbstract" xlink:label="loc_ifrs-full_ForeignExchangeRatesAbstract_866274" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesTable" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesTable_866275" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ForeignExchangeRatesAbstract_866274" xlink:to="loc_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesTable_866275" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesLineItems" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesLineItems_866276" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesTable_866275" xlink:to="loc_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesLineItems_866276" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClosingForeignExchangeRate" xlink:label="loc_ifrs-full_ClosingForeignExchangeRate_866279" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesLineItems_866276" xlink:to="loc_ifrs-full_ClosingForeignExchangeRate_866279" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AverageForeignExchangeRate" xlink:label="loc_ifrs-full_AverageForeignExchangeRate_866280" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesLineItems_866276" xlink:to="loc_ifrs-full_AverageForeignExchangeRate_866280" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020AdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866282" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsTable" xlink:label="loc_imtx_StatementsTable_866284" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866282" xlink:to="loc_imtx_StatementsTable_866284" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_870942" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsTable_866284" xlink:to="loc_ifrs-full_RangeAxis_870942" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_870943" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_870942" xlink:to="loc_ifrs-full_RangesMember_870943" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_870944" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_870943" xlink:to="loc_ifrs-full_BottomOfRangeMember_870944" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_870945" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_870943" xlink:to="loc_ifrs-full_TopOfRangeMember_870945" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsLineItems" xlink:label="loc_imtx_StatementsLineItems_866289" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsTable_866284" xlink:to="loc_imtx_StatementsLineItems_866289" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_RentalContractTerm" xlink:label="loc_imtx_RentalContractTerm_866291" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_866289" xlink:to="loc_imtx_RentalContractTerm_866291" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/AccountsReceivableSummaryOfTradeReceivablesDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_864978" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ReceivablesFromCollaborationAgreements" xlink:label="loc_imtx_ReceivablesFromCollaborationAgreements_864979" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_864978" xlink:to="loc_imtx_ReceivablesFromCollaborationAgreements_864979" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_864980" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_864978" xlink:to="loc_ifrs-full_CurrentTradeReceivables_864980" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/AccountsReceivableAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_864982" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TradeReceivables" xlink:label="loc_ifrs-full_TradeReceivables_864983" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_864982" xlink:to="loc_ifrs-full_TradeReceivables_864983" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/OtherCurrentAndNonCurrentAssetsSummaryOfOtherCurrentAssetsDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract_866312" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CurrentGrantReceivable" xlink:label="loc_imtx_CurrentGrantReceivable_866314" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_866312" xlink:to="loc_imtx_CurrentGrantReceivable_866314" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses_866315" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_866312" xlink:to="loc_ifrs-full_CurrentPrepaidExpenses_866315" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PositiveMarketValueForwardContract" xlink:label="loc_imtx_PositiveMarketValueForwardContract_866316" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_866312" xlink:to="loc_imtx_PositiveMarketValueForwardContract_866316" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentValueAddedTaxReceivables" xlink:label="loc_ifrs-full_CurrentValueAddedTaxReceivables_866317" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_866312" xlink:to="loc_ifrs-full_CurrentValueAddedTaxReceivables_866317" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CapitalizedTransactionCosts" xlink:label="loc_imtx_CapitalizedTransactionCosts_866321" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_866312" xlink:to="loc_imtx_CapitalizedTransactionCosts_866321" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherAssets" xlink:label="loc_ifrs-full_OtherAssets_866322" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_866312" xlink:to="loc_ifrs-full_OtherAssets_866322" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherCurrentAssets" xlink:label="loc_ifrs-full_OtherCurrentAssets_866323" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_866312" xlink:to="loc_ifrs-full_OtherCurrentAssets_866323" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/OtherCurrentAndNonCurrentAssetsAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866337" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_866339" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866337" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_866339" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CollaborationAgreementAxis" xlink:label="loc_imtx_CollaborationAgreementAxis_866340" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_866339" xlink:to="loc_imtx_CollaborationAgreementAxis_866340" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CollaborationAgreementMember" xlink:label="loc_imtx_CollaborationAgreementMember_866341" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_CollaborationAgreementAxis_866340" xlink:to="loc_imtx_CollaborationAgreementMember_866341" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CelgeneSwitzerlandLlcAndGenmabAsMember" xlink:label="loc_imtx_CelgeneSwitzerlandLlcAndGenmabAsMember_866342" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_CollaborationAgreementMember_866341" xlink:to="loc_imtx_CelgeneSwitzerlandLlcAndGenmabAsMember_866342" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_BalanceSheetLocationAxis" xlink:label="loc_imtx_BalanceSheetLocationAxis_870968" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_866339" xlink:to="loc_imtx_BalanceSheetLocationAxis_870968" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_BalanceSheetLocationDomain" xlink:label="loc_imtx_BalanceSheetLocationDomain_870969" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_BalanceSheetLocationAxis_870968" xlink:to="loc_imtx_BalanceSheetLocationDomain_870969" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ReceivablesFromCapitalGainsTaxMember" xlink:label="loc_imtx_ReceivablesFromCapitalGainsTaxMember_870970" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_BalanceSheetLocationDomain_870969" xlink:to="loc_imtx_ReceivablesFromCapitalGainsTaxMember_870970" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_866343" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_866339" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_866343" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CurrentPrepaidInsurance" xlink:label="loc_imtx_CurrentPrepaidInsurance_866344" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_866343" xlink:to="loc_imtx_CurrentPrepaidInsurance_866344" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CurrentIncrementalCostForCollaborationAgreement" xlink:label="loc_imtx_CurrentIncrementalCostForCollaborationAgreement_866345" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_866343" xlink:to="loc_imtx_CurrentIncrementalCostForCollaborationAgreement_866345" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PrepaidExpensesOfLicensesAndSoftware" xlink:label="loc_imtx_PrepaidExpensesOfLicensesAndSoftware_866346" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_866343" xlink:to="loc_imtx_PrepaidExpensesOfLicensesAndSoftware_866346" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherAssets" xlink:label="loc_ifrs-full_OtherAssets_866348" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_866343" xlink:to="loc_ifrs-full_OtherAssets_866348" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentPrepayments" xlink:label="loc_ifrs-full_NoncurrentPrepayments_866349" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_866343" xlink:to="loc_ifrs-full_NoncurrentPrepayments_866349" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/OtherCurrentAndNonCurrentAssetsSummaryOfOtherNonCurrentAssetsDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentReceivablesAbstract" xlink:label="loc_ifrs-full_NoncurrentReceivablesAbstract_866331" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentPrepayments" xlink:label="loc_ifrs-full_NoncurrentPrepayments_866332" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentReceivablesAbstract_866331" xlink:to="loc_ifrs-full_NoncurrentPrepayments_866332" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_OtherNonCurrentAsset" xlink:label="loc_imtx_OtherNonCurrentAsset_870231" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentReceivablesAbstract_866331" xlink:to="loc_imtx_OtherNonCurrentAsset_870231" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="loc_ifrs-full_OtherNoncurrentAssets_866334" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentReceivablesAbstract_866331" xlink:to="loc_ifrs-full_OtherNoncurrentAssets_866334" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/PropertyPlantAndEquipmentSummaryOfChangesToPropertyPlantAndEquipmentDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_866353" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_866354" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_866353" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_866354" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_866355" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_866354" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_866355" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_866356" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_866355" xlink:to="loc_ifrs-full_CarryingAmountMember_866356" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_866357" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_866356" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_866357" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_866364" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_866356" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_866364" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TypeOfAdoptionsAxis" xlink:label="loc_imtx_TypeOfAdoptionsAxis_866358" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_866354" xlink:to="loc_imtx_TypeOfAdoptionsAxis_866358" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TypeOfAdoptionsMember" xlink:label="loc_imtx_TypeOfAdoptionsMember_866359" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TypeOfAdoptionsAxis_866358" xlink:to="loc_imtx_TypeOfAdoptionsMember_866359" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AdjustmentOnAdoptionIfrsSixteenMember" xlink:label="loc_imtx_AdjustmentOnAdoptionIfrsSixteenMember_866360" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TypeOfAdoptionsMember_866359" xlink:to="loc_imtx_AdjustmentOnAdoptionIfrsSixteenMember_866360" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:label="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_866361" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_866354" xlink:to="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_866361" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RestatedMember" xlink:label="loc_ifrs-full_RestatedMember_866362" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis_866361" xlink:to="loc_ifrs-full_RestatedMember_866362" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PreviouslyStatedMember" xlink:label="loc_ifrs-full_PreviouslyStatedMember_866363" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RestatedMember_866362" xlink:to="loc_ifrs-full_PreviouslyStatedMember_866363" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_866367" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_866354" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_866367" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_866368" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_866367" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_866368" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_LaboratoryEquipmentMember" xlink:label="loc_imtx_LaboratoryEquipmentMember_866369" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_866368" xlink:to="loc_imtx_LaboratoryEquipmentMember_866369" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_866370" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_866368" xlink:to="loc_ifrs-full_ComputerEquipmentMember_866370" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="loc_ifrs-full_OfficeEquipmentMember_866371" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_866368" xlink:to="loc_ifrs-full_OfficeEquipmentMember_866371" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_866365" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_866354" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_866365" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_866372" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_866365" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_866372" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AdditionsOtherPropertyPlantAndEquipment" xlink:label="loc_imtx_AdditionsOtherPropertyPlantAndEquipment_870282" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_866365" xlink:to="loc_imtx_AdditionsOtherPropertyPlantAndEquipment_870282" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisposalsOfPropertyPlantAndEquipment" xlink:label="loc_imtx_DisposalsOfPropertyPlantAndEquipment_870283" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_866365" xlink:to="loc_imtx_DisposalsOfPropertyPlantAndEquipment_870283" use="optional" order="20" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CurrencyTranslationDifferences" xlink:label="loc_imtx_CurrencyTranslationDifferences_870289" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_866365" xlink:to="loc_imtx_CurrencyTranslationDifferences_870289" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_866376" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_866365" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_866376" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/PropertyPlantAndEquipmentSummaryOfDepreciationExpenseDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDepreciationExpensesAbstract" xlink:label="loc_imtx_DisclosureOfDepreciationExpensesAbstract_865031" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_865032" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDepreciationExpensesAbstract_865031" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_865032" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncomeStatementLocationAxis" xlink:label="loc_imtx_IncomeStatementLocationAxis_865033" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_865032" xlink:to="loc_imtx_IncomeStatementLocationAxis_865033" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncomeStatementLocationMember" xlink:label="loc_imtx_IncomeStatementLocationMember_865034" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_IncomeStatementLocationAxis_865033" xlink:to="loc_imtx_IncomeStatementLocationMember_865034" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ResearchAndDevelopmentExpenseMember" xlink:label="loc_imtx_ResearchAndDevelopmentExpenseMember_865035" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_IncomeStatementLocationMember_865034" xlink:to="loc_imtx_ResearchAndDevelopmentExpenseMember_865035" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GeneralAndAdministrativeExpenseMember" xlink:label="loc_imtx_GeneralAndAdministrativeExpenseMember_865036" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_IncomeStatementLocationMember_865034" xlink:to="loc_imtx_GeneralAndAdministrativeExpenseMember_865036" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_865037" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_865032" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_865037" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_865038" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_865037" xlink:to="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_865038" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/IntangibleAssetsSummaryOfChangesToIntangibleAssetsDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillAbstract" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillAbstract_866420" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_866422" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillAbstract_866420" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_866422" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_866424" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_866422" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_866424" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_866425" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_866424" xlink:to="loc_ifrs-full_CarryingAmountMember_866425" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_866427" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_866425" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_866427" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AccumulatedImpairmentMember" xlink:label="loc_ifrs-full_AccumulatedImpairmentMember_866428" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_866425" xlink:to="loc_ifrs-full_AccumulatedImpairmentMember_866428" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_866445" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_866422" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_866445" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_866447" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_866445" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_866447" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PatentAndLicensesMember" xlink:label="loc_imtx_PatentAndLicensesMember_866448" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_866447" xlink:to="loc_imtx_PatentAndLicensesMember_866448" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_SoftwareLicensesMember" xlink:label="loc_imtx_SoftwareLicensesMember_866449" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillMember_866447" xlink:to="loc_imtx_SoftwareLicensesMember_866449" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_866431" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_866422" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_866431" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_866435" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_866431" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwill_866435" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_866437" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_866431" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_866437" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_866439" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_866431" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_866439" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_866440" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_866431" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwill_866440" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/IntangibleAssetsSummaryOfAmortizationExpenseDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfAmortizationExpensesAbstract" xlink:label="loc_imtx_DisclosureOfAmortizationExpensesAbstract_866451" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_866452" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfAmortizationExpensesAbstract_866451" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_866452" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncomeStatementLocationAxis" xlink:label="loc_imtx_IncomeStatementLocationAxis_866453" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_866452" xlink:to="loc_imtx_IncomeStatementLocationAxis_866453" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncomeStatementLocationMember" xlink:label="loc_imtx_IncomeStatementLocationMember_866454" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_IncomeStatementLocationAxis_866453" xlink:to="loc_imtx_IncomeStatementLocationMember_866454" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ResearchAndDevelopmentExpenseMember" xlink:label="loc_imtx_ResearchAndDevelopmentExpenseMember_866455" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_IncomeStatementLocationMember_866454" xlink:to="loc_imtx_ResearchAndDevelopmentExpenseMember_866455" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GeneralAndAdministrativeExpenseMember" xlink:label="loc_imtx_GeneralAndAdministrativeExpenseMember_866456" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_IncomeStatementLocationMember_866454" xlink:to="loc_imtx_GeneralAndAdministrativeExpenseMember_866456" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_866457" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_866452" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_866457" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_866458" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_866457" xlink:to="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_866458" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/LeasesSummaryOfRightOfUseAssetsDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_866484" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_866485" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_866484" xlink:to="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_866485" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_866486" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_866485" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_866486" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_866487" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_866486" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_866487" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_866488" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_866487" xlink:to="loc_ifrs-full_BuildingsMember_866488" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CommunicationAndNetworkEquipmentMember" xlink:label="loc_ifrs-full_CommunicationAndNetworkEquipmentMember_866490" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_866487" xlink:to="loc_ifrs-full_CommunicationAndNetworkEquipmentMember_866490" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_VehiclesMember" xlink:label="loc_ifrs-full_VehiclesMember_866491" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_866487" xlink:to="loc_ifrs-full_VehiclesMember_866491" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherAssetsMember" xlink:label="loc_ifrs-full_OtherAssetsMember_866492" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_866487" xlink:to="loc_ifrs-full_OtherAssetsMember_866492" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_866493" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_866485" xlink:to="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_866493" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_866494" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_866493" xlink:to="loc_ifrs-full_RightofuseAssets_866494" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/LeasesDetailsOfLeaseLiabilitiesDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LeaseLiabilitiesAbstract" xlink:label="loc_ifrs-full_LeaseLiabilitiesAbstract_866496" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_866497" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_866496" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_866497" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_866498" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_866496" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_866498" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_866499" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LeaseLiabilitiesAbstract_866496" xlink:to="loc_ifrs-full_LeaseLiabilities_866499" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/LeasesSummaryOfExpensesRelatedToRightOfUseAssetsAndLeaseLiabilitiesDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesAbstract" xlink:label="loc_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesAbstract_866506" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesTable" xlink:label="loc_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesTable_866507" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesAbstract_866506" xlink:to="loc_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesTable_866507" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_866508" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesTable_866507" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_866508" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-full_ClassesOfAssetsMember_866509" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_866508" xlink:to="loc_ifrs-full_ClassesOfAssetsMember_866509" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_866511" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_866509" xlink:to="loc_ifrs-full_BuildingsMember_866511" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CommunicationAndNetworkEquipmentMember" xlink:label="loc_ifrs-full_CommunicationAndNetworkEquipmentMember_866512" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_866509" xlink:to="loc_ifrs-full_CommunicationAndNetworkEquipmentMember_866512" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_VehiclesMember" xlink:label="loc_ifrs-full_VehiclesMember_866513" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_866509" xlink:to="loc_ifrs-full_VehiclesMember_866513" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherAssetsMember" xlink:label="loc_ifrs-full_OtherAssetsMember_866515" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsMember_866509" xlink:to="loc_ifrs-full_OtherAssetsMember_866515" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesLineItems" xlink:label="loc_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesLineItems_866517" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesTable_866507" xlink:to="loc_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesLineItems_866517" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets_866522" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesLineItems_866517" xlink:to="loc_ifrs-full_DepreciationRightofuseAssets_866522" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_InterestExpenseOnLease" xlink:label="loc_imtx_InterestExpenseOnLease_870408" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesLineItems_866517" xlink:to="loc_imtx_InterestExpenseOnLease_870408" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:label="loc_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_866524" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesLineItems_866517" xlink:to="loc_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_866524" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/LeasesAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:label="loc_ifrs-full_PresentationOfLeasesForLesseeAbstract_866541" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:label="loc_ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable_866542" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PresentationOfLeasesForLesseeAbstract_866541" xlink:to="loc_ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable_866542" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_866543" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable_866542" xlink:to="loc_ifrs-full_MaturityAxis_866543" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_866544" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_866543" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_866544" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_876339" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_866544" xlink:to="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_876339" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LaterThanOneYearMember" xlink:label="loc_ifrs-full_LaterThanOneYearMember_866546" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_866544" xlink:to="loc_ifrs-full_LaterThanOneYearMember_866546" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_866549" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable_866542" xlink:to="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_866549" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="loc_ifrs-full_AdditionsToRightofuseAssets_866550" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_866549" xlink:to="loc_ifrs-full_AdditionsToRightofuseAssets_866550" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TranslationDifferenceOnRightOfUseAsset" xlink:label="loc_imtx_TranslationDifferenceOnRightOfUseAsset_866551" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_866549" xlink:to="loc_imtx_TranslationDifferenceOnRightOfUseAsset_866551" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashOutflowForLeases" xlink:label="loc_ifrs-full_CashOutflowForLeases_866552" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_866549" xlink:to="loc_ifrs-full_CashOutflowForLeases_866552" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_876337" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_866549" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_876337" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/AccountsPayableSummaryOfAccountsPayableDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_866787" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:label="loc_ifrs-full_TradeAndOtherPayablesToTradeSuppliers_866788" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_866787" xlink:to="loc_ifrs-full_TradeAndOtherPayablesToTradeSuppliers_866788" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_OtherAccruedLiabilities" xlink:label="loc_imtx_OtherAccruedLiabilities_866789" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_866787" xlink:to="loc_imtx_OtherAccruedLiabilities_866789" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_866790" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_866787" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_866790" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/AccountsPayableAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_866792" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_OtherAccruedLiabilities" xlink:label="loc_imtx_OtherAccruedLiabilities_870419" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_866792" xlink:to="loc_imtx_OtherAccruedLiabilities_870419" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/RevenueFromCollaborationAgreementsAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RevenueAbstract" xlink:label="loc_ifrs-full_RevenueAbstract_866825" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfRevenueFromContractWithCustomersTable" xlink:label="loc_imtx_DisclosureOfRevenueFromContractWithCustomersTable_866827" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RevenueAbstract_866825" xlink:to="loc_imtx_DisclosureOfRevenueFromContractWithCustomersTable_866827" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AgreementAxis" xlink:label="loc_imtx_AgreementAxis_866839" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfRevenueFromContractWithCustomersTable_866827" xlink:to="loc_imtx_AgreementAxis_866839" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AgreementDomain" xlink:label="loc_imtx_AgreementDomain_866840" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_AgreementAxis_866839" xlink:to="loc_imtx_AgreementDomain_866840" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AmgenCollaborationAgreementMember" xlink:label="loc_imtx_AmgenCollaborationAgreementMember_866841" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_AgreementDomain_866840" xlink:to="loc_imtx_AmgenCollaborationAgreementMember_866841" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GenmabCollaborationAgreementMember" xlink:label="loc_imtx_GenmabCollaborationAgreementMember_866852" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_AgreementDomain_866840" xlink:to="loc_imtx_GenmabCollaborationAgreementMember_866852" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_BMSCollaborationAgreementMember" xlink:label="loc_imtx_BMSCollaborationAgreementMember_866853" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_AgreementDomain_866840" xlink:to="loc_imtx_BMSCollaborationAgreementMember_866853" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GSKCollaborationAgreementMember" xlink:label="loc_imtx_GSKCollaborationAgreementMember_866889" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_AgreementDomain_866840" xlink:to="loc_imtx_GSKCollaborationAgreementMember_866889" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MilestoneAxis" xlink:label="loc_imtx_MilestoneAxis_866842" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfRevenueFromContractWithCustomersTable_866827" xlink:to="loc_imtx_MilestoneAxis_866842" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MilestoneDomain" xlink:label="loc_imtx_MilestoneDomain_866843" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_MilestoneAxis_866842" xlink:to="loc_imtx_MilestoneDomain_866843" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DevelopmentAndCommercialMilestonePaymentsMember" xlink:label="loc_imtx_DevelopmentAndCommercialMilestonePaymentsMember_866844" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_MilestoneDomain_866843" xlink:to="loc_imtx_DevelopmentAndCommercialMilestonePaymentsMember_866844" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MilestonePaymentForLicensedProductMember" xlink:label="loc_imtx_MilestonePaymentForLicensedProductMember_866882" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_MilestoneDomain_866843" xlink:to="loc_imtx_MilestonePaymentForLicensedProductMember_866882" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_OptionExerciseDevelopmentCommecialAndRegulatoryMilestonePaymentsMember" xlink:label="loc_imtx_OptionExerciseDevelopmentCommecialAndRegulatoryMilestonePaymentsMember_870580" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_MilestoneDomain_866843" xlink:to="loc_imtx_OptionExerciseDevelopmentCommecialAndRegulatoryMilestonePaymentsMember_870580" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MilestoneProgramsBasedOnTheProgramMember" xlink:label="loc_imtx_MilestoneProgramsBasedOnTheProgramMember_866895" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_MilestoneDomain_866843" xlink:to="loc_imtx_MilestoneProgramsBasedOnTheProgramMember_866895" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_866845" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfRevenueFromContractWithCustomersTable_866827" xlink:to="loc_srt_StatementScenarioAxis_866845" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_866847" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_866845" xlink:to="loc_srt_ScenarioUnspecifiedDomain_866847" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfRevenueFromContractWithCustomersLineItems" xlink:label="loc_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems_866856" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfRevenueFromContractWithCustomersTable_866827" xlink:to="loc_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems_866856" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MilestonePaymentReceivable" xlink:label="loc_imtx_MilestonePaymentReceivable_866859" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems_866856" xlink:to="loc_imtx_MilestonePaymentReceivable_866859" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_UpfrontPaymentReceived" xlink:label="loc_imtx_UpfrontPaymentReceived_866860" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems_866856" xlink:to="loc_imtx_UpfrontPaymentReceived_866860" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xlink:label="loc_ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod_866862" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems_866856" xlink:to="loc_ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod_866862" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ContractLiabilities" xlink:label="loc_ifrs-full_ContractLiabilities_866863" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems_866856" xlink:to="loc_ifrs-full_ContractLiabilities_866863" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AssetsRecognisedFromCostsToObtainOrFulfilContractsWithCustomers" xlink:label="loc_ifrs-full_AssetsRecognisedFromCostsToObtainOrFulfilContractsWithCustomers_866865" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems_866856" xlink:to="loc_ifrs-full_AssetsRecognisedFromCostsToObtainOrFulfilContractsWithCustomers_866865" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AmortisationAssetsRecognisedFromCostsIncurredToObtainOrFulfilContractsWithCustomers" xlink:label="loc_ifrs-full_AmortisationAssetsRecognisedFromCostsIncurredToObtainOrFulfilContractsWithCustomers_866867" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems_866856" xlink:to="loc_ifrs-full_AmortisationAssetsRecognisedFromCostsIncurredToObtainOrFulfilContractsWithCustomers_866867" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PotentialMilestonePaymentPayable" xlink:label="loc_imtx_PotentialMilestonePaymentPayable_866870" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems_866856" xlink:to="loc_imtx_PotentialMilestonePaymentPayable_866870" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/RevenueFromCollaborationAgreementsSummaryOfDeferredRevenueRelatedToTheCollaborationAgreementsDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RevenueAbstract" xlink:label="loc_ifrs-full_RevenueAbstract_866820" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentContractLiabilities" xlink:label="loc_ifrs-full_CurrentContractLiabilities_866821" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RevenueAbstract_866820" xlink:to="loc_ifrs-full_CurrentContractLiabilities_866821" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentContractLiabilities" xlink:label="loc_ifrs-full_NoncurrentContractLiabilities_866823" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RevenueAbstract_866820" xlink:to="loc_ifrs-full_NoncurrentContractLiabilities_866823" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ContractLiabilities" xlink:label="loc_ifrs-full_ContractLiabilities_866822" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RevenueAbstract_866820" xlink:to="loc_ifrs-full_ContractLiabilities_866822" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/OtherIncomeSummaryOfOtherIncomeDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfOtherIncomeAbstract" xlink:label="loc_imtx_DisclosureOfOtherIncomeAbstract_866933" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GovernmentGrantReceivable" xlink:label="loc_imtx_GovernmentGrantReceivable_866934" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfOtherIncomeAbstract_866933" xlink:to="loc_imtx_GovernmentGrantReceivable_866934" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DeferredIncomeCurrent" xlink:label="loc_imtx_DeferredIncomeCurrent_876408" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfOtherIncomeAbstract_866933" xlink:to="loc_imtx_DeferredIncomeCurrent_876408" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TotalDeferredIncome" xlink:label="loc_imtx_TotalDeferredIncome_876399" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfOtherIncomeAbstract_866933" xlink:to="loc_imtx_TotalDeferredIncome_876399" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/OtherIncomeAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866945" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RevenueFromGovernmentGrants" xlink:label="loc_ifrs-full_RevenueFromGovernmentGrants_866946" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866945" xlink:to="loc_ifrs-full_RevenueFromGovernmentGrants_866946" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ContingenciesRelatedToGrant" xlink:label="loc_imtx_ContingenciesRelatedToGrant_866947" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866945" xlink:to="loc_imtx_ContingenciesRelatedToGrant_866947" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/OtherCurrentLiabilitiesSummaryOfOtherCurrentLiabilitiesDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesAbstract" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesAbstract_866854" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTable" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTable_866855" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesAbstract_866854" xlink:to="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTable_866855" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems_866857" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTable_866855" xlink:to="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems_866857" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="loc_ifrs-full_CurrentTaxLiabilitiesCurrent_866858" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems_866857" xlink:to="loc_ifrs-full_CurrentTaxLiabilitiesCurrent_866858" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AccrualsClassifiedAsCurrent" xlink:label="loc_ifrs-full_AccrualsClassifiedAsCurrent_866861" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems_866857" xlink:to="loc_ifrs-full_AccrualsClassifiedAsCurrent_866861" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DeferredGrantIncomeCurrent" xlink:label="loc_imtx_DeferredGrantIncomeCurrent_866864" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems_866857" xlink:to="loc_imtx_DeferredGrantIncomeCurrent_866864" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:label="loc_ifrs-full_CurrentProvisionsForEmployeeBenefits_866866" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems_866857" xlink:to="loc_ifrs-full_CurrentProvisionsForEmployeeBenefits_866866" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_OtherCurrent" xlink:label="loc_imtx_OtherCurrent_866869" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems_866857" xlink:to="loc_imtx_OtherCurrent_866869" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherCurrentLiabilities" xlink:label="loc_ifrs-full_OtherCurrentLiabilities_866871" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems_866857" xlink:to="loc_ifrs-full_OtherCurrentLiabilities_866871" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/OtherCurrentLiabilitiesAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866904" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTable" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTable_866907" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866904" xlink:to="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTable_866907" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_866910" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTable_866907" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_866910" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_866911" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_866910" xlink:to="loc_ifrs-full_BorrowingsByNameMember_866911" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_NonInterestBearingLiabilityMember" xlink:label="loc_imtx_NonInterestBearingLiabilityMember_866914" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_866911" xlink:to="loc_imtx_NonInterestBearingLiabilityMember_866914" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems_866917" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTable_866907" xlink:to="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems_866917" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BorrowingsMaturity" xlink:label="loc_ifrs-full_BorrowingsMaturity_866919" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems_866917" xlink:to="loc_ifrs-full_BorrowingsMaturity_866919" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/FinancialIncomeAndExpensesSummaryOfFinanceIncomeAndCostsDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseAbstract" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseAbstract_867289" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InterestIncomeOnDeposits" xlink:label="loc_ifrs-full_InterestIncomeOnDeposits_867305" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseAbstract_867289" xlink:to="loc_ifrs-full_InterestIncomeOnDeposits_867305" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NetForeignExchangeGain" xlink:label="loc_ifrs-full_NetForeignExchangeGain_867307" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseAbstract_867289" xlink:to="loc_ifrs-full_NetForeignExchangeGain_867307" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GainLossRecognisedOnFinancialInstrumentsWhoseFairValuePreviouslyCouldNotBeReliablyMeasured" xlink:label="loc_ifrs-full_GainLossRecognisedOnFinancialInstrumentsWhoseFairValuePreviouslyCouldNotBeReliablyMeasured_867309" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseAbstract_867289" xlink:to="loc_ifrs-full_GainLossRecognisedOnFinancialInstrumentsWhoseFairValuePreviouslyCouldNotBeReliablyMeasured_867309" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_867312" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseAbstract_867289" xlink:to="loc_ifrs-full_FinanceIncome_867312" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_867315" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseAbstract_867289" xlink:to="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_867315" use="optional" order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NetForeignExchangeLoss" xlink:label="loc_ifrs-full_NetForeignExchangeLoss_867316" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseAbstract_867289" xlink:to="loc_ifrs-full_NetForeignExchangeLoss_867316" use="optional" order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_867318" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseAbstract_867289" xlink:to="loc_ifrs-full_FinanceCosts_867318" use="optional" order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/FinancialIncomeAndExpensesAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseAbstract" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseAbstract_867359" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_RealisedGainLossFromForeignCurrencyForwardContracts" xlink:label="loc_imtx_RealisedGainLossFromForeignCurrencyForwardContracts_867360" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseAbstract_867359" xlink:to="loc_imtx_RealisedGainLossFromForeignCurrencyForwardContracts_867360" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_UnrealisedGainLossFromForeignCurrencyForwardContracts" xlink:label="loc_imtx_UnrealisedGainLossFromForeignCurrencyForwardContracts_867363" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseAbstract_867359" xlink:to="loc_imtx_UnrealisedGainLossFromForeignCurrencyForwardContracts_867363" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/ShareListingExpenseAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_867244" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_867245" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_867244" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_867245" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_867246" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_867245" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_867246" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_867247" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_867246" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_867247" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_867248" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_867247" xlink:to="loc_ifrs-full_OrdinarySharesMember_867248" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_867249" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_867245" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_867249" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_867250" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_867249" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_867250" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_WarrantsMember" xlink:label="loc_imtx_WarrantsMember_867252" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_867250" xlink:to="loc_imtx_WarrantsMember_867252" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_867253" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_867245" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_867253" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_867254" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_867253" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_867254" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AryaMember" xlink:label="loc_imtx_AryaMember_867255" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_867254" xlink:to="loc_imtx_AryaMember_867255" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfShareListingExpenseLineItems" xlink:label="loc_imtx_DisclosureOfShareListingExpenseLineItems_867256" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_867245" xlink:to="loc_imtx_DisclosureOfShareListingExpenseLineItems_867256" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_867319" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfShareListingExpenseLineItems_867256" xlink:to="loc_ifrs-full_EquityInterestsOfAcquirer_867319" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_867260" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfShareListingExpenseLineItems_867256" xlink:to="loc_ifrs-full_ParValuePerShare_867260" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/disclosureGuidance" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_WarrantsIssuedPricePerWarrant" xlink:label="loc_imtx_WarrantsIssuedPricePerWarrant_867275" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfShareListingExpenseLineItems_867256" xlink:to="loc_imtx_WarrantsIssuedPricePerWarrant_867275" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/disclosureGuidance" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_867276" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfShareListingExpenseLineItems_867256" xlink:to="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_867276" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AdjustmentsForShareListingExpense" xlink:label="loc_imtx_AdjustmentsForShareListingExpense_867277" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfShareListingExpenseLineItems_867256" xlink:to="loc_imtx_AdjustmentsForShareListingExpense_867277" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/ShareListingExpensesSummaryOfCalculationOfTheShareListingExpenseDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_866973" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_866975" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_866973" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_866975" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_866976" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_866975" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_866976" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_866977" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_866976" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_866977" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AryaMember" xlink:label="loc_imtx_AryaMember_866978" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_866977" xlink:to="loc_imtx_AryaMember_866978" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_866980" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_866975" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_866980" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_866981" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_866980" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_866981" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_866982" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_866981" xlink:to="loc_ifrs-full_OrdinarySharesMember_866982" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_866983" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_866975" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_866983" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_866984" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_866983" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_866984" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_WarrantsMember" xlink:label="loc_imtx_WarrantsMember_866985" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsMember_866984" xlink:to="loc_imtx_WarrantsMember_866985" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems_866987" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_866975" xlink:to="loc_imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems_866987" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable" xlink:label="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_866988" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems_866987" xlink:to="loc_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable_866988" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_866989" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems_866987" xlink:to="loc_ifrs-full_ParValuePerShare_866989" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_WarrantsIssuedPricePerWarrant" xlink:label="loc_imtx_WarrantsIssuedPricePerWarrant_866992" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems_866987" xlink:to="loc_imtx_WarrantsIssuedPricePerWarrant_866992" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_866993" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems_866987" xlink:to="loc_ifrs-full_EquityInterestsOfAcquirer_866993" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_866994" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems_866987" xlink:to="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_866994" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AdjustmentsForShareListingExpense" xlink:label="loc_imtx_AdjustmentsForShareListingExpense_866995" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems_866987" xlink:to="loc_imtx_AdjustmentsForShareListingExpense_866995" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/ShareBasedPaymentsSummaryOfOptionsGrantedPricedUsingBlackScholesForSarsTandemAwardsConvertedOptionsMatchingStockOptionsAndMonteCarloOptionPricingModelDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_867282" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_867283" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_867282" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_867283" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_867285" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_867283" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_867285" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_867286" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_867285" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_867286" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShareAppreciationRightsMember" xlink:label="loc_imtx_ShareAppreciationRightsMember_867290" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_867286" xlink:to="loc_imtx_ShareAppreciationRightsMember_867290" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember" xlink:label="loc_imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember_868840" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_867286" xlink:to="loc_imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember_868840" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PerformanceBasedOptionsMember" xlink:label="loc_imtx_PerformanceBasedOptionsMember_868841" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_867286" xlink:to="loc_imtx_PerformanceBasedOptionsMember_868841" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ConvertedOptionsMember" xlink:label="loc_imtx_ConvertedOptionsMember_868853" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_867286" xlink:to="loc_imtx_ConvertedOptionsMember_868853" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PlanAxis" xlink:label="loc_imtx_PlanAxis_868615" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_867283" xlink:to="loc_imtx_PlanAxis_868615" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PlanMember" xlink:label="loc_imtx_PlanMember_868616" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_PlanAxis_868615" xlink:to="loc_imtx_PlanMember_868616" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TwoThousandAndSixteenTandemAwardsMember" xlink:label="loc_imtx_TwoThousandAndSixteenTandemAwardsMember_868617" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_PlanMember_868616" xlink:to="loc_imtx_TwoThousandAndSixteenTandemAwardsMember_868617" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MatchingStockOptionsMember" xlink:label="loc_imtx_MatchingStockOptionsMember_868684" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_PlanMember_868616" xlink:to="loc_imtx_MatchingStockOptionsMember_868684" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867292" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_867283" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867292" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_867295" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867292" xlink:to="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_867295" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_867306" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867292" xlink:to="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_867306" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_867308" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867292" xlink:to="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_867308" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_867311" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867292" xlink:to="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_867311" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_867313" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867292" xlink:to="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_867313" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_867314" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867292" xlink:to="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_867314" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CombinedProbabilityOfExitEventsShareOptionsGranted" xlink:label="loc_imtx_CombinedProbabilityOfExitEventsShareOptionsGranted_867317" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867292" xlink:to="loc_imtx_CombinedProbabilityOfExitEventsShareOptionsGranted_867317" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/ShareBasedPaymentsSummaryOfEmployeeShareOptionsDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_867322" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_867323" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_867322" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_867323" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_867325" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_867323" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_867325" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_867326" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_867325" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_867326" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShareAppreciationRightsMember" xlink:label="loc_imtx_ShareAppreciationRightsMember_867327" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_867326" xlink:to="loc_imtx_ShareAppreciationRightsMember_867327" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PerformanceBasedOptionsMember" xlink:label="loc_imtx_PerformanceBasedOptionsMember_868808" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_867326" xlink:to="loc_imtx_PerformanceBasedOptionsMember_868808" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember" xlink:label="loc_imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember_868826" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_867326" xlink:to="loc_imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember_868826" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ConvertedOptionsMember" xlink:label="loc_imtx_ConvertedOptionsMember_868843" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_867326" xlink:to="loc_imtx_ConvertedOptionsMember_868843" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MatchingStockOptionsMember" xlink:label="loc_imtx_MatchingStockOptionsMember_868854" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_867326" xlink:to="loc_imtx_MatchingStockOptionsMember_868854" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DateOfGrantAxis" xlink:label="loc_imtx_DateOfGrantAxis_868809" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_867323" xlink:to="loc_imtx_DateOfGrantAxis_868809" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DateOfGrantMember" xlink:label="loc_imtx_DateOfGrantMember_868810" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DateOfGrantAxis_868809" xlink:to="loc_imtx_DateOfGrantMember_868810" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GrantedOnJuneTwoThousandAndTwentyMember" xlink:label="loc_imtx_GrantedOnJuneTwoThousandAndTwentyMember_868811" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DateOfGrantMember_868810" xlink:to="loc_imtx_GrantedOnJuneTwoThousandAndTwentyMember_868811" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GrantedOnSeptemberTwoThousandAndTwentyMember" xlink:label="loc_imtx_GrantedOnSeptemberTwoThousandAndTwentyMember_868814" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DateOfGrantMember_868810" xlink:to="loc_imtx_GrantedOnSeptemberTwoThousandAndTwentyMember_868814" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GrantedOnDecemberTwoThousandAndTwentyMember" xlink:label="loc_imtx_GrantedOnDecemberTwoThousandAndTwentyMember_868832" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DateOfGrantMember_868810" xlink:to="loc_imtx_GrantedOnDecemberTwoThousandAndTwentyMember_868832" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867324" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_867323" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867324" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_867328" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867324" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_867328" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_867330" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867324" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_867330" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_867331" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867324" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_867331" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_867329" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867324" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_867329" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_WeightedAverageExercisePriceOfShareOptionsVestedInSharebasedPaymentArrangement2019" xlink:label="loc_imtx_WeightedAverageExercisePriceOfShareOptionsVestedInSharebasedPaymentArrangement2019_867332" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867324" xlink:to="loc_imtx_WeightedAverageExercisePriceOfShareOptionsVestedInSharebasedPaymentArrangement2019_867332" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_867341" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867324" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_867341" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_867343" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867324" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_867343" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_867344" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867324" xlink:to="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_867344" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_867342" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867324" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_867342" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_NumberOfShareOptionsVestedInSharebasedPaymentArrangement" xlink:label="loc_imtx_NumberOfShareOptionsVestedInSharebasedPaymentArrangement_867347" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867324" xlink:to="loc_imtx_NumberOfShareOptionsVestedInSharebasedPaymentArrangement_867347" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_868812" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867324" xlink:to="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_868812" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare" xlink:label="loc_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare_868813" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_867324" xlink:to="loc_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare_868813" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/ShareBasedPaymentsSummaryOfActivitiesUnderShareBasedPaymentArrangementDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_867374" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsTable" xlink:label="loc_imtx_StatementsTable_867376" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_867374" xlink:to="loc_imtx_StatementsTable_867376" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DateOfGrantAxis" xlink:label="loc_imtx_DateOfGrantAxis_868766" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsTable_867376" xlink:to="loc_imtx_DateOfGrantAxis_868766" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DateOfGrantMember" xlink:label="loc_imtx_DateOfGrantMember_868767" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DateOfGrantAxis_868766" xlink:to="loc_imtx_DateOfGrantMember_868767" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GrantedOnJuneToSeptemberTwoThousandAndTwentyMember" xlink:label="loc_imtx_GrantedOnJuneToSeptemberTwoThousandAndTwentyMember_868769" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DateOfGrantMember_868767" xlink:to="loc_imtx_GrantedOnJuneToSeptemberTwoThousandAndTwentyMember_868769" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GrantedOnDecemberTwoThousandAndTwentyMember" xlink:label="loc_imtx_GrantedOnDecemberTwoThousandAndTwentyMember_868774" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DateOfGrantMember_868767" xlink:to="loc_imtx_GrantedOnDecemberTwoThousandAndTwentyMember_868774" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GrantedOnSeptemberTwoThousandAndTwentyMember" xlink:label="loc_imtx_GrantedOnSeptemberTwoThousandAndTwentyMember_868776" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DateOfGrantMember_868767" xlink:to="loc_imtx_GrantedOnSeptemberTwoThousandAndTwentyMember_868776" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PlanAxis" xlink:label="loc_imtx_PlanAxis_869271" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsTable_867376" xlink:to="loc_imtx_PlanAxis_869271" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PlanMember" xlink:label="loc_imtx_PlanMember_869272" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_PlanAxis_869271" xlink:to="loc_imtx_PlanMember_869272" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsLineItems" xlink:label="loc_imtx_StatementsLineItems_867379" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsTable_867376" xlink:to="loc_imtx_StatementsLineItems_867379" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_867383" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867379" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_867383" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_867385" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867379" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_867385" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_868746" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867379" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_868746" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_868748" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867379" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_868748" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_WeightedAverageExercisePriceOfShareOptionsVestedDuringThePeriod" xlink:label="loc_imtx_WeightedAverageExercisePriceOfShareOptionsVestedDuringThePeriod_868750" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867379" xlink:to="loc_imtx_WeightedAverageExercisePriceOfShareOptionsVestedDuringThePeriod_868750" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_868754" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867379" xlink:to="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_868754" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageSharePrice2019" xlink:label="loc_ifrs-full_WeightedAverageSharePrice2019_868756" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867379" xlink:to="loc_ifrs-full_WeightedAverageSharePrice2019_868756" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_868759" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867379" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_868759" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_868760" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867379" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_868760" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_868761" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867379" xlink:to="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_868761" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_868762" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867379" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_868762" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_NumberOfShareOptionsVestedDuringThePeriod" xlink:label="loc_imtx_NumberOfShareOptionsVestedDuringThePeriod_868763" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867379" xlink:to="loc_imtx_NumberOfShareOptionsVestedDuringThePeriod_868763" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/ShareBasedPaymentsAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_868358" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_868359" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_868358" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_868359" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PlanAxis" xlink:label="loc_imtx_PlanAxis_868360" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_868359" xlink:to="loc_imtx_PlanAxis_868360" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PlanMember" xlink:label="loc_imtx_PlanMember_868362" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_PlanAxis_868360" xlink:to="loc_imtx_PlanMember_868362" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShareAppreciationRightsTwoThousandAndTenPlanMember" xlink:label="loc_imtx_ShareAppreciationRightsTwoThousandAndTenPlanMember_868363" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_PlanMember_868362" xlink:to="loc_imtx_ShareAppreciationRightsTwoThousandAndTenPlanMember_868363" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TwoThousandAndSixteenTandemAwardsMember" xlink:label="loc_imtx_TwoThousandAndSixteenTandemAwardsMember_868365" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_PlanMember_868362" xlink:to="loc_imtx_TwoThousandAndSixteenTandemAwardsMember_868365" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMember" xlink:label="loc_imtx_ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMember_868366" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_PlanMember_868362" xlink:to="loc_imtx_ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMember_868366" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ModificationOfTwoThousandAndTenPlanMember" xlink:label="loc_imtx_ModificationOfTwoThousandAndTenPlanMember_868532" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_PlanMember_868362" xlink:to="loc_imtx_ModificationOfTwoThousandAndTenPlanMember_868532" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ModificationOfTwoThousandAndSixteenPlanMember" xlink:label="loc_imtx_ModificationOfTwoThousandAndSixteenPlanMember_868533" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_PlanMember_868362" xlink:to="loc_imtx_ModificationOfTwoThousandAndSixteenPlanMember_868533" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CategoryOfEmployeesAxis" xlink:label="loc_imtx_CategoryOfEmployeesAxis_868367" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_868359" xlink:to="loc_imtx_CategoryOfEmployeesAxis_868367" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CategoryOfEmployeesMember" xlink:label="loc_imtx_CategoryOfEmployeesMember_868368" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_CategoryOfEmployeesAxis_868367" xlink:to="loc_imtx_CategoryOfEmployeesMember_868368" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ActiveEmployeesMember" xlink:label="loc_imtx_ActiveEmployeesMember_868369" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_CategoryOfEmployeesMember_868368" xlink:to="loc_imtx_ActiveEmployeesMember_868369" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ManagementMembersMember" xlink:label="loc_imtx_ManagementMembersMember_868370" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_CategoryOfEmployeesMember_868368" xlink:to="loc_imtx_ManagementMembersMember_868370" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_868371" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_868359" xlink:to="loc_ifrs-full_RangeAxis_868371" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_868372" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_868371" xlink:to="loc_ifrs-full_RangesMember_868372" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_868373" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_868372" xlink:to="loc_ifrs-full_BottomOfRangeMember_868373" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_868374" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_868372" xlink:to="loc_ifrs-full_TopOfRangeMember_868374" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_SchemeAxis" xlink:label="loc_imtx_SchemeAxis_868375" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_868359" xlink:to="loc_imtx_SchemeAxis_868375" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_SchemeMember" xlink:label="loc_imtx_SchemeMember_868376" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_SchemeAxis_868375" xlink:to="loc_imtx_SchemeMember_868376" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShareReinvestmentMember" xlink:label="loc_imtx_ShareReinvestmentMember_868377" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_SchemeMember_868376" xlink:to="loc_imtx_ShareReinvestmentMember_868377" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShareReinvestmentSchemeAxis" xlink:label="loc_imtx_ShareReinvestmentSchemeAxis_868378" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_868359" xlink:to="loc_imtx_ShareReinvestmentSchemeAxis_868378" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShareReinvestmentSchemeMember" xlink:label="loc_imtx_ShareReinvestmentSchemeMember_868379" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_ShareReinvestmentSchemeAxis_868378" xlink:to="loc_imtx_ShareReinvestmentSchemeMember_868379" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MatchingStockOptionsMember" xlink:label="loc_imtx_MatchingStockOptionsMember_868380" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_ShareReinvestmentSchemeMember_868379" xlink:to="loc_imtx_MatchingStockOptionsMember_868380" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_868654" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_868359" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_868654" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_868656" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_868654" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_868656" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PerformanceBasedOptionsMember" xlink:label="loc_imtx_PerformanceBasedOptionsMember_868721" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_868656" xlink:to="loc_imtx_PerformanceBasedOptionsMember_868721" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember" xlink:label="loc_imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember_868786" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_868656" xlink:to="loc_imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember_868786" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ConvertedOptionsMember" xlink:label="loc_imtx_ConvertedOptionsMember_868787" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_868656" xlink:to="loc_imtx_ConvertedOptionsMember_868787" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DateOfGrantAxis" xlink:label="loc_imtx_DateOfGrantAxis_868724" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_868359" xlink:to="loc_imtx_DateOfGrantAxis_868724" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DateOfGrantMember" xlink:label="loc_imtx_DateOfGrantMember_868728" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DateOfGrantAxis_868724" xlink:to="loc_imtx_DateOfGrantMember_868728" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GrantedOnJuneTwoThousandAndTwentyMember" xlink:label="loc_imtx_GrantedOnJuneTwoThousandAndTwentyMember_868730" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DateOfGrantMember_868728" xlink:to="loc_imtx_GrantedOnJuneTwoThousandAndTwentyMember_868730" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GrantedOnSeptemberTwoThousandAndTwentyMember" xlink:label="loc_imtx_GrantedOnSeptemberTwoThousandAndTwentyMember_868806" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DateOfGrantMember_868728" xlink:to="loc_imtx_GrantedOnSeptemberTwoThousandAndTwentyMember_868806" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GrantedOnDecemberTwoThousandAndTwentyMember" xlink:label="loc_imtx_GrantedOnDecemberTwoThousandAndTwentyMember_868807" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DateOfGrantMember_868728" xlink:to="loc_imtx_GrantedOnDecemberTwoThousandAndTwentyMember_868807" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TrancheAxis" xlink:label="loc_imtx_TrancheAxis_868735" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_868359" xlink:to="loc_imtx_TrancheAxis_868735" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TrancheMember" xlink:label="loc_imtx_TrancheMember_868736" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TrancheAxis_868735" xlink:to="loc_imtx_TrancheMember_868736" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TrancheOneMember" xlink:label="loc_imtx_TrancheOneMember_868737" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TrancheMember_868736" xlink:to="loc_imtx_TrancheOneMember_868737" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TrancheTwoMember" xlink:label="loc_imtx_TrancheTwoMember_870914" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TrancheMember_868736" xlink:to="loc_imtx_TrancheTwoMember_870914" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TrancheThreeMember" xlink:label="loc_imtx_TrancheThreeMember_870916" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TrancheMember_868736" xlink:to="loc_imtx_TrancheThreeMember_870916" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_868780" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_868359" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_868780" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_868783" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_868780" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_868783" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AryaMember" xlink:label="loc_imtx_AryaMember_868785" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_868783" xlink:to="loc_imtx_AryaMember_868785" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_868359" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" use="optional" order="41" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PercentageOfOutstandingSharesToBePurchasedByThirdParty" xlink:label="loc_imtx_PercentageOfOutstandingSharesToBePurchasedByThirdParty_868382" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_imtx_PercentageOfOutstandingSharesToBePurchasedByThirdParty_868382" use="optional" order="42" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011" xlink:label="loc_ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011_868385" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011_868385" use="optional" order="43" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_868386" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_868386" use="optional" order="44" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CashPaymentAwardPerSharePayable" xlink:label="loc_imtx_CashPaymentAwardPerSharePayable_868388" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_imtx_CashPaymentAwardPerSharePayable_868388" use="optional" order="45" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PercentageOfCashProceedsToBeBeReinvested" xlink:label="loc_imtx_PercentageOfCashProceedsToBeBeReinvested_868389" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_imtx_PercentageOfCashProceedsToBeBeReinvested_868389" use="optional" order="46" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PaymentsToAndOnBehalfOfEmployees" xlink:label="loc_ifrs-full_PaymentsToAndOnBehalfOfEmployees_868390" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_ifrs-full_PaymentsToAndOnBehalfOfEmployees_868390" use="optional" order="47" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ExpenseFromTheModificationOfShareBasedAwards" xlink:label="loc_imtx_ExpenseFromTheModificationOfShareBasedAwards_868391" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_imtx_ExpenseFromTheModificationOfShareBasedAwards_868391" use="optional" order="48" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_868392" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_868392" use="optional" order="49" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_868397" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_868397" use="optional" order="50" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_868384" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_868384" use="optional" order="51" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_868430" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_868430" use="optional" order="52" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_868462" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_868462" use="optional" order="53" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement_868467" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement_868467" use="optional" order="54" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DateOfVestingOfStockOptions" xlink:label="loc_imtx_DateOfVestingOfStockOptions_868483" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_imtx_DateOfVestingOfStockOptions_868483" use="optional" order="55" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare" xlink:label="loc_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare_868488" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare_868488" use="optional" order="56" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DateOfGrantOfSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement_868491" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement_868491" use="optional" order="57" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MinimumMarketCapitalization" xlink:label="loc_imtx_MinimumMarketCapitalization_868734" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_868381" xlink:to="loc_imtx_MinimumMarketCapitalization_868734" use="optional" order="58" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/ShareBasedPaymentsSummaryOfEmployeeRelatedShareBasedCompensationExpenseDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseAbstract" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseAbstract_868791" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTable" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTable_868793" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseAbstract_868791" xlink:to="loc_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTable_868793" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncomeStatementLocationAxis" xlink:label="loc_imtx_IncomeStatementLocationAxis_868794" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTable_868793" xlink:to="loc_imtx_IncomeStatementLocationAxis_868794" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncomeStatementLocationMember" xlink:label="loc_imtx_IncomeStatementLocationMember_868795" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_IncomeStatementLocationAxis_868794" xlink:to="loc_imtx_IncomeStatementLocationMember_868795" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ResearchAndDevelopmentExpenseMember" xlink:label="loc_imtx_ResearchAndDevelopmentExpenseMember_868796" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_IncomeStatementLocationMember_868795" xlink:to="loc_imtx_ResearchAndDevelopmentExpenseMember_868796" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GeneralAndAdministrativeExpenseMember" xlink:label="loc_imtx_GeneralAndAdministrativeExpenseMember_868805" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_IncomeStatementLocationMember_868795" xlink:to="loc_imtx_GeneralAndAdministrativeExpenseMember_868805" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseLineItems" xlink:label="loc_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseLineItems_868798" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTable_868793" xlink:to="loc_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseLineItems_868798" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_868800" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseLineItems_868798" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_868800" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/ShareholdersEquityDeficitAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866838" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_866868" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866838" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_866868" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_866874" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_866868" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_866874" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_866875" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_866874" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_866875" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-full_OrdinarySharesMember_866876" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_866875" xlink:to="loc_ifrs-full_OrdinarySharesMember_866876" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_SeriesEShareCapitalMember" xlink:label="loc_imtx_SeriesEShareCapitalMember_866974" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_866875" xlink:to="loc_imtx_SeriesEShareCapitalMember_866974" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_866878" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_866868" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_866878" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_866879" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_866878" xlink:to="loc_ifrs-full_BorrowingsByNameMember_866879" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PipeFinancingMember" xlink:label="loc_imtx_PipeFinancingMember_866941" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_866879" xlink:to="loc_imtx_PipeFinancingMember_866941" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_866885" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_866868" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_866885" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_866888" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_866885" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_866888" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ImmaticsBiotechnologiesGmbhMember" xlink:label="loc_imtx_ImmaticsBiotechnologiesGmbhMember_866891" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_866888" xlink:to="loc_imtx_ImmaticsBiotechnologiesGmbhMember_866891" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_866935" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_866868" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_866935" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_866938" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_866935" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_866938" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShareListingExpenseAxis" xlink:label="loc_imtx_ShareListingExpenseAxis_876472" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_866868" xlink:to="loc_imtx_ShareListingExpenseAxis_876472" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShareListingExpenseDomain" xlink:label="loc_imtx_ShareListingExpenseDomain_876473" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_ShareListingExpenseAxis_876472" xlink:to="loc_imtx_ShareListingExpenseDomain_876473" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AryaMergerMember" xlink:label="loc_imtx_AryaMergerMember_876474" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_ShareListingExpenseDomain_876473" xlink:to="loc_imtx_AryaMergerMember_876474" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EventAxis" xlink:label="loc_imtx_EventAxis_876689" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_866868" xlink:to="loc_imtx_EventAxis_876689" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EventDomain" xlink:label="loc_imtx_EventDomain_876690" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_EventAxis_876689" xlink:to="loc_imtx_EventDomain_876690" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ReorganizationMember" xlink:label="loc_imtx_ReorganizationMember_876691" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_EventDomain_876690" xlink:to="loc_imtx_ReorganizationMember_876691" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_866897" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_866868" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_866897" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_imtx_StockIssuedDuringPeriodValueNewIssues_867389" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_866897" xlink:to="loc_imtx_StockIssuedDuringPeriodValueNewIssues_867389" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_866899" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_866897" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_866899" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_866900" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_866897" xlink:to="loc_ifrs-full_ParValuePerShare_866900" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_866901" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_866897" xlink:to="loc_ifrs-full_IssuedCapital_866901" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SharePremium" xlink:label="loc_ifrs-full_SharePremium_866903" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_866897" xlink:to="loc_ifrs-full_SharePremium_866903" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_NumberOfWarrantsOutsatnding" xlink:label="loc_imtx_NumberOfWarrantsOutsatnding_866913" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_866897" xlink:to="loc_imtx_NumberOfWarrantsOutsatnding_866913" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ExercisePriceOfWarrants" xlink:label="loc_imtx_ExercisePriceOfWarrants_866918" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_866897" xlink:to="loc_imtx_ExercisePriceOfWarrants_866918" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ClassOfWarrantOrRightTermPeriod" xlink:label="loc_imtx_ClassOfWarrantOrRightTermPeriod_866923" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_866897" xlink:to="loc_imtx_ClassOfWarrantOrRightTermPeriod_866923" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/NonControllingInterestsAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_867052" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsTable" xlink:label="loc_imtx_StatementsTable_867054" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_867052" xlink:to="loc_imtx_StatementsTable_867054" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_867058" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsTable_867054" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_867058" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_867059" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_867058" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_867059" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MdAndersonMember" xlink:label="loc_imtx_MdAndersonMember_867060" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_867059" xlink:to="loc_imtx_MdAndersonMember_867060" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_867061" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsTable_867054" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_867061" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_867062" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_867061" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_867062" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_RestrictedStockAcquisitionAgreementMember" xlink:label="loc_imtx_RestrictedStockAcquisitionAgreementMember_867063" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_867062" xlink:to="loc_imtx_RestrictedStockAcquisitionAgreementMember_867063" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AryaMember" xlink:label="loc_imtx_AryaMember_867064" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_867062" xlink:to="loc_imtx_AryaMember_867064" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsLineItems" xlink:label="loc_imtx_StatementsLineItems_867057" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsTable_867054" xlink:to="loc_imtx_StatementsLineItems_867057" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_NumberOfSharesExchangedInSubsidiaries" xlink:label="loc_imtx_NumberOfSharesExchangedInSubsidiaries_867065" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867057" xlink:to="loc_imtx_NumberOfSharesExchangedInSubsidiaries_867065" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_imtx_StockIssuedDuringPeriodSharesAcquisitions_867066" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867057" xlink:to="loc_imtx_StockIssuedDuringPeriodSharesAcquisitions_867066" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_867067" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867057" xlink:to="loc_ifrs-full_ParValuePerShare_867067" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_867068" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867057" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_867068" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_imtx_StockIssuedDuringPeriodValueNewIssues_867069" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867057" xlink:to="loc_imtx_StockIssuedDuringPeriodValueNewIssues_867069" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest" xlink:label="loc_imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest_867070" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867057" xlink:to="loc_imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest_867070" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/disclosureGuidance" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_LossOnNoncontrollingInterest" xlink:label="loc_imtx_LossOnNoncontrollingInterest_867071" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867057" xlink:to="loc_imtx_LossOnNoncontrollingInterest_867071" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncontrollingInterests" xlink:label="loc_ifrs-full_NoncontrollingInterests_867072" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867057" xlink:to="loc_ifrs-full_NoncontrollingInterests_867072" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncreasedecreaseThroughCompensationExpense" xlink:label="loc_imtx_IncreasedecreaseThroughCompensationExpense_867073" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867057" xlink:to="loc_imtx_IncreasedecreaseThroughCompensationExpense_867073" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/PersonnelExpensesSummaryOfPersonnelExpensesDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfEmployeeBenefitsExpenseAbstract" xlink:label="loc_ifrs-full_ClassesOfEmployeeBenefitsExpenseAbstract_867024" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsTable" xlink:label="loc_imtx_StatementsTable_867026" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfEmployeeBenefitsExpenseAbstract_867024" xlink:to="loc_imtx_StatementsTable_867026" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncomeStatementLocationAxis" xlink:label="loc_imtx_IncomeStatementLocationAxis_867030" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsTable_867026" xlink:to="loc_imtx_IncomeStatementLocationAxis_867030" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncomeStatementLocationMember" xlink:label="loc_imtx_IncomeStatementLocationMember_867031" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_IncomeStatementLocationAxis_867030" xlink:to="loc_imtx_IncomeStatementLocationMember_867031" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ResearchAndDevelopmentExpenseMember" xlink:label="loc_imtx_ResearchAndDevelopmentExpenseMember_867032" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_IncomeStatementLocationMember_867031" xlink:to="loc_imtx_ResearchAndDevelopmentExpenseMember_867032" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_GeneralAndAdministrativeExpenseMember" xlink:label="loc_imtx_GeneralAndAdministrativeExpenseMember_867033" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_IncomeStatementLocationMember_867031" xlink:to="loc_imtx_GeneralAndAdministrativeExpenseMember_867033" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsLineItems" xlink:label="loc_imtx_StatementsLineItems_867029" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsTable_867026" xlink:to="loc_imtx_StatementsLineItems_867029" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_WagesAndSalaries" xlink:label="loc_ifrs-full_WagesAndSalaries_867034" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867029" xlink:to="loc_ifrs-full_WagesAndSalaries_867034" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherShorttermEmployeeBenefits" xlink:label="loc_ifrs-full_OtherShorttermEmployeeBenefits_867035" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867029" xlink:to="loc_ifrs-full_OtherShorttermEmployeeBenefits_867035" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:label="loc_ifrs-full_ShorttermEmployeeBenefitsExpense_867036" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867029" xlink:to="loc_ifrs-full_ShorttermEmployeeBenefitsExpense_867036" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_867038" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867029" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_867038" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EmployeeBenefitsExpense" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense_867039" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867029" xlink:to="loc_ifrs-full_EmployeeBenefitsExpense_867039" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/PersonnelExpensesAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfEmployeeBenefitsExpenseAbstract" xlink:label="loc_ifrs-full_ClassesOfEmployeeBenefitsExpenseAbstract_867043" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_867044" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfEmployeeBenefitsExpenseAbstract_867043" xlink:to="loc_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_867044" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EmployeeHealthInsuranceCost" xlink:label="loc_imtx_EmployeeHealthInsuranceCost_867045" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfEmployeeBenefitsExpenseAbstract_867043" xlink:to="loc_imtx_EmployeeHealthInsuranceCost_867045" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SocialSecurityContributions" xlink:label="loc_ifrs-full_SocialSecurityContributions_867046" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfEmployeeBenefitsExpenseAbstract_867043" xlink:to="loc_ifrs-full_SocialSecurityContributions_867046" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherEmployeeExpense" xlink:label="loc_ifrs-full_OtherEmployeeExpense_867047" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfEmployeeBenefitsExpenseAbstract_867043" xlink:to="loc_ifrs-full_OtherEmployeeExpense_867047" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/IncomeTaxSummaryOfReconciliationBetweenTaxesOnIncomeAndExpectedIncomeTaxBenefitDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_866896" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_866898" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_866896" xlink:to="loc_ifrs-full_ProfitLoss_866898" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentTaxExpenseIncome" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncome_866905" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_866896" xlink:to="loc_ifrs-full_CurrentTaxExpenseIncome_866905" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TaxEffectFromChangeInTaxRate" xlink:label="loc_ifrs-full_TaxEffectFromChangeInTaxRate_866908" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_866896" xlink:to="loc_ifrs-full_TaxEffectFromChangeInTaxRate_866908" use="optional" order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:label="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_866916" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_866896" xlink:to="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_866916" use="optional" order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TaxEffectOfGovernmentGrantsExemptedFromTaxes" xlink:label="loc_imtx_TaxEffectOfGovernmentGrantsExemptedFromTaxes_866926" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_866896" xlink:to="loc_imtx_TaxEffectOfGovernmentGrantsExemptedFromTaxes_866926" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TaxEffectOfPermanentDifferences" xlink:label="loc_imtx_TaxEffectOfPermanentDifferences_876722" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_866896" xlink:to="loc_imtx_TaxEffectOfPermanentDifferences_876722" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_NonRecognitionOfDeferredTaxesOnTaxLossesAndTemporaryDifferences" xlink:label="loc_imtx_NonRecognitionOfDeferredTaxesOnTaxLossesAndTemporaryDifferences_866929" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_866896" xlink:to="loc_imtx_NonRecognitionOfDeferredTaxesOnTaxLossesAndTemporaryDifferences_866929" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_866930" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_866896" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_866930" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/IncomeTaxSummaryOfDeferredTaxAssetsDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="loc_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_866942" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsTable" xlink:label="loc_imtx_StatementsTable_866949" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_866942" xlink:to="loc_imtx_StatementsTable_866949" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AssetsAndLiabilitiesAxis" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesAxis_866953" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsTable_866949" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesAxis_866953" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AssetsAndLiabilitiesMember" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesMember_866954" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesAxis_866953" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesMember_866954" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IntangibleAssetsMember" xlink:label="loc_imtx_IntangibleAssetsMember_866956" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesMember_866954" xlink:to="loc_imtx_IntangibleAssetsMember_866956" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DeferredRevenueMember" xlink:label="loc_imtx_DeferredRevenueMember_866958" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesMember_866954" xlink:to="loc_imtx_DeferredRevenueMember_866958" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_LeaseLiabilityMember" xlink:label="loc_imtx_LeaseLiabilityMember_866961" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesMember_866954" xlink:to="loc_imtx_LeaseLiabilityMember_866961" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DeferredExpensesMember" xlink:label="loc_imtx_DeferredExpensesMember_866962" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesMember_866954" xlink:to="loc_imtx_DeferredExpensesMember_866962" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DeferredAssetRecognisedMember" xlink:label="loc_imtx_DeferredAssetRecognisedMember_866966" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesMember_866954" xlink:to="loc_imtx_DeferredAssetRecognisedMember_866966" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DeferredTaxLiabilitiesRightOfUseAssetMember" xlink:label="loc_imtx_DeferredTaxLiabilitiesRightOfUseAssetMember_866986" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesMember_866954" xlink:to="loc_imtx_DeferredTaxLiabilitiesRightOfUseAssetMember_866986" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DeferredTaxLiabilitiesDeferredExpensesMember" xlink:label="loc_imtx_DeferredTaxLiabilitiesDeferredExpensesMember_866997" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesMember_866954" xlink:to="loc_imtx_DeferredTaxLiabilitiesDeferredExpensesMember_866997" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_OtherLiabilitiesMember" xlink:label="loc_imtx_OtherLiabilitiesMember_867004" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesMember_866954" xlink:to="loc_imtx_OtherLiabilitiesMember_867004" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsLineItems" xlink:label="loc_imtx_StatementsLineItems_866952" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsTable_866949" xlink:to="loc_imtx_StatementsLineItems_866952" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-full_DeferredTaxAssets_867000" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_866952" xlink:to="loc_ifrs-full_DeferredTaxAssets_867000" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_867002" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_866952" xlink:to="loc_ifrs-full_DeferredTaxLiabilities_867002" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DeferredTaxAssetsNonrecognition" xlink:label="loc_imtx_DeferredTaxAssetsNonrecognition_871065" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_866952" xlink:to="loc_imtx_DeferredTaxAssetsNonrecognition_871065" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DeferredTaxAssetsOffset" xlink:label="loc_imtx_DeferredTaxAssetsOffset_871078" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_866952" xlink:to="loc_imtx_DeferredTaxAssetsOffset_871078" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DeferredTaxLiabilitiesOffSet" xlink:label="loc_imtx_DeferredTaxLiabilitiesOffSet_871083" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_866952" xlink:to="loc_imtx_DeferredTaxLiabilitiesOffSet_871083" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/IncomeTaxAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_867006" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsTable" xlink:label="loc_imtx_StatementsTable_867008" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_867006" xlink:to="loc_imtx_StatementsTable_867008" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TypeOfAdoptionsAxis" xlink:label="loc_imtx_TypeOfAdoptionsAxis_867009" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsTable_867008" xlink:to="loc_imtx_TypeOfAdoptionsAxis_867009" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TypeOfAdoptionsMember" xlink:label="loc_imtx_TypeOfAdoptionsMember_869226" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TypeOfAdoptionsAxis_867009" xlink:to="loc_imtx_TypeOfAdoptionsMember_869226" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_867423" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsTable_867008" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_867423" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_867424" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_867423" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_867424" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IndefiniteTaxLossesCarryforwardMember" xlink:label="loc_imtx_IndefiniteTaxLossesCarryforwardMember_867425" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_867424" xlink:to="loc_imtx_IndefiniteTaxLossesCarryforwardMember_867425" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TwentySixYearTaxLossesCarryforwardMember" xlink:label="loc_imtx_TwentySixYearTaxLossesCarryforwardMember_867426" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_867424" xlink:to="loc_imtx_TwentySixYearTaxLossesCarryforwardMember_867426" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsLineItems" xlink:label="loc_imtx_StatementsLineItems_867011" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsTable_867008" xlink:to="loc_imtx_StatementsLineItems_867011" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-full_ApplicableTaxRate_867012" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867011" xlink:to="loc_ifrs-full_ApplicableTaxRate_867012" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CorporateIncomeTaxRate" xlink:label="loc_imtx_CorporateIncomeTaxRate_867013" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867011" xlink:to="loc_imtx_CorporateIncomeTaxRate_867013" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TaxEffectOfTaxLosses" xlink:label="loc_ifrs-full_TaxEffectOfTaxLosses_867014" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867011" xlink:to="loc_ifrs-full_TaxEffectOfTaxLosses_867014" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PercentageOnLimitationOnTaxLossCarryforwardsAfterPriorPeriod" xlink:label="loc_imtx_PercentageOnLimitationOnTaxLossCarryforwardsAfterPriorPeriod_867015" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867011" xlink:to="loc_imtx_PercentageOnLimitationOnTaxLossCarryforwardsAfterPriorPeriod_867015" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PercentageOnLimitationOnTaxLossCarryforwardsBeforePriorPeriod" xlink:label="loc_imtx_PercentageOnLimitationOnTaxLossCarryforwardsBeforePriorPeriod_867016" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867011" xlink:to="loc_imtx_PercentageOnLimitationOnTaxLossCarryforwardsBeforePriorPeriod_867016" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EffectiveIncomeTaxReconciliationPermanentEffectShareListingExpense" xlink:label="loc_imtx_EffectiveIncomeTaxReconciliationPermanentEffectShareListingExpense_876755" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867011" xlink:to="loc_imtx_EffectiveIncomeTaxReconciliationPermanentEffectShareListingExpense_876755" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesSummaryOfCurrencyRiskExposureDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfCurrencyRiskExposureAbstract" xlink:label="loc_imtx_DisclosureOfCurrencyRiskExposureAbstract_867084" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfCurrencyRiskExposureTable" xlink:label="loc_imtx_DisclosureOfCurrencyRiskExposureTable_867085" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfCurrencyRiskExposureAbstract_867084" xlink:to="loc_imtx_DisclosureOfCurrencyRiskExposureTable_867085" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srt_OwnershipAxis_867087" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfCurrencyRiskExposureTable_867085" xlink:to="loc_srt_OwnershipAxis_867087" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_867088" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_867087" xlink:to="loc_srt_OwnershipDomain_867088" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ImmaticsNvMember" xlink:label="loc_imtx_ImmaticsNvMember_867089" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_867088" xlink:to="loc_imtx_ImmaticsNvMember_867089" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-full_TypesOfRisksAxis_867090" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfCurrencyRiskExposureTable_867085" xlink:to="loc_ifrs-full_TypesOfRisksAxis_867090" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-full_TypesOfRisksMember_867091" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfRisksAxis_867090" xlink:to="loc_ifrs-full_TypesOfRisksMember_867091" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrencyRiskMember" xlink:label="loc_ifrs-full_CurrencyRiskMember_867092" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfRisksMember_867091" xlink:to="loc_ifrs-full_CurrencyRiskMember_867092" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_867093" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfCurrencyRiskExposureTable_867085" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_867093" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_867094" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_867093" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_867094" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ImmaticsGmbhMember" xlink:label="loc_imtx_ImmaticsGmbhMember_867095" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_867094" xlink:to="loc_imtx_ImmaticsGmbhMember_867095" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfCurrencyRiskExposureLineItems" xlink:label="loc_imtx_DisclosureOfCurrencyRiskExposureLineItems_867086" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfCurrencyRiskExposureTable_867085" xlink:to="loc_imtx_DisclosureOfCurrencyRiskExposureLineItems_867086" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_867096" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfCurrencyRiskExposureLineItems_867086" xlink:to="loc_ifrs-full_CashAndCashEquivalents_867096" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssets" xlink:label="loc_ifrs-full_FinancialAssets_867097" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfCurrencyRiskExposureLineItems_867086" xlink:to="loc_ifrs-full_FinancialAssets_867097" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MaximumExposedToCurrencyRisk" xlink:label="loc_imtx_MaximumExposedToCurrencyRisk_867099" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfCurrencyRiskExposureLineItems_867086" xlink:to="loc_imtx_MaximumExposedToCurrencyRisk_867099" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesSummaryOfSensitivityAnalysisOfForeignCurrencyRiskDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_867102" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable" xlink:label="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable_867103" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_867102" xlink:to="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable_867103" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_SensitiveAnalaysisOfCurrencyAxis" xlink:label="loc_imtx_SensitiveAnalaysisOfCurrencyAxis_867105" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable_867103" xlink:to="loc_imtx_SensitiveAnalaysisOfCurrencyAxis_867105" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_SensitiveAnalaysisOfCurrencyDomain" xlink:label="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_867106" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyAxis_867105" xlink:to="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_867106" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EuroWeakensBy1AgainstUsDollarsMember" xlink:label="loc_imtx_EuroWeakensBy1AgainstUsDollarsMember_867108" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_867106" xlink:to="loc_imtx_EuroWeakensBy1AgainstUsDollarsMember_867108" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EuroStrengthsBy1AgainstUsDollarsMember" xlink:label="loc_imtx_EuroStrengthsBy1AgainstUsDollarsMember_867109" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_867106" xlink:to="loc_imtx_EuroStrengthsBy1AgainstUsDollarsMember_867109" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EuroWeakensBy5AgainstUsDollarsMember" xlink:label="loc_imtx_EuroWeakensBy5AgainstUsDollarsMember_867110" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_867106" xlink:to="loc_imtx_EuroWeakensBy5AgainstUsDollarsMember_867110" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EuroStrengthsBy5AgainstUsDollarsMember" xlink:label="loc_imtx_EuroStrengthsBy5AgainstUsDollarsMember_867111" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_867106" xlink:to="loc_imtx_EuroStrengthsBy5AgainstUsDollarsMember_867111" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EuroWeakensBy10AgainstUsDollarsMember" xlink:label="loc_imtx_EuroWeakensBy10AgainstUsDollarsMember_867112" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_867106" xlink:to="loc_imtx_EuroWeakensBy10AgainstUsDollarsMember_867112" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EuroStrengthsBy10AgainstUsDollarsMember" xlink:label="loc_imtx_EuroStrengthsBy10AgainstUsDollarsMember_867113" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_867106" xlink:to="loc_imtx_EuroStrengthsBy10AgainstUsDollarsMember_867113" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srt_OwnershipAxis_867114" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable_867103" xlink:to="loc_srt_OwnershipAxis_867114" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_867115" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_867114" xlink:to="loc_srt_OwnershipDomain_867115" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ImmaticsNvMember" xlink:label="loc_imtx_ImmaticsNvMember_867116" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_867115" xlink:to="loc_imtx_ImmaticsNvMember_867116" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_867117" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable_867103" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_867117" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_867118" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_867117" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_867118" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ImmaticsGmbhMember" xlink:label="loc_imtx_ImmaticsGmbhMember_867119" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_867118" xlink:to="loc_imtx_ImmaticsGmbhMember_867119" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems" xlink:label="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems_867104" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable_867103" xlink:to="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems_867104" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClosingForeignExchangeRate" xlink:label="loc_ifrs-full_ClosingForeignExchangeRate_867120" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems_867104" xlink:to="loc_ifrs-full_ClosingForeignExchangeRate_867120" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints" xlink:label="loc_imtx_IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints_867121" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems_867104" xlink:to="loc_imtx_IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints_867121" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ValueAtRisk" xlink:label="loc_ifrs-full_ValueAtRisk_867122" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems_867104" xlink:to="loc_ifrs-full_ValueAtRisk_867122" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesSummaryOfSensitivityAnalysisOfForeignCurrencyRiskParentheticalDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_867125" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable" xlink:label="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable_867127" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_867125" xlink:to="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable_867127" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_867130" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable_867127" xlink:to="loc_srt_CurrencyAxis_867130" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_867131" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_867130" xlink:to="loc_currency_AllCurrenciesDomain_867131" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srt_OwnershipAxis_867150" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable_867127" xlink:to="loc_srt_OwnershipAxis_867150" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_867151" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_867150" xlink:to="loc_srt_OwnershipDomain_867151" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ImmaticsNvMember" xlink:label="loc_imtx_ImmaticsNvMember_867152" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_867151" xlink:to="loc_imtx_ImmaticsNvMember_867152" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_867153" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable_867127" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_867153" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_867154" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_867153" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_867154" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ImmaticsGmbhMember" xlink:label="loc_imtx_ImmaticsGmbhMember_867155" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_867154" xlink:to="loc_imtx_ImmaticsGmbhMember_867155" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_SensitiveAnalaysisOfCurrencyAxis" xlink:label="loc_imtx_SensitiveAnalaysisOfCurrencyAxis_870425" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable_867127" xlink:to="loc_imtx_SensitiveAnalaysisOfCurrencyAxis_870425" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_SensitiveAnalaysisOfCurrencyDomain" xlink:label="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_870427" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyAxis_870425" xlink:to="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_870427" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EuroWeakensBy1AgainstUsDollarsMember" xlink:label="loc_imtx_EuroWeakensBy1AgainstUsDollarsMember_870428" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_870427" xlink:to="loc_imtx_EuroWeakensBy1AgainstUsDollarsMember_870428" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EuroStrengthsBy1AgainstUsDollarsMember" xlink:label="loc_imtx_EuroStrengthsBy1AgainstUsDollarsMember_870429" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_870427" xlink:to="loc_imtx_EuroStrengthsBy1AgainstUsDollarsMember_870429" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EuroWeakensBy5AgainstUsDollarsMember" xlink:label="loc_imtx_EuroWeakensBy5AgainstUsDollarsMember_870432" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_870427" xlink:to="loc_imtx_EuroWeakensBy5AgainstUsDollarsMember_870432" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EuroStrengthsBy5AgainstUsDollarsMember" xlink:label="loc_imtx_EuroStrengthsBy5AgainstUsDollarsMember_870433" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_870427" xlink:to="loc_imtx_EuroStrengthsBy5AgainstUsDollarsMember_870433" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EuroWeakensBy10AgainstUsDollarsMember" xlink:label="loc_imtx_EuroWeakensBy10AgainstUsDollarsMember_870434" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_870427" xlink:to="loc_imtx_EuroWeakensBy10AgainstUsDollarsMember_870434" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EuroStrengthsBy10AgainstUsDollarsMember" xlink:label="loc_imtx_EuroStrengthsBy10AgainstUsDollarsMember_870439" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_SensitiveAnalaysisOfCurrencyDomain_870427" xlink:to="loc_imtx_EuroStrengthsBy10AgainstUsDollarsMember_870439" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems" xlink:label="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems_867128" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskTable_867127" xlink:to="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems_867128" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk" xlink:label="loc_imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk_867140" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems_867128" xlink:to="loc_imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk_867140" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk" xlink:label="loc_imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk_867141" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems_867128" xlink:to="loc_imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk_867141" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesSummaryOfLiquidityRiskDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DescriptionOfManagingLiquidityRiskAbstract" xlink:label="loc_imtx_DescriptionOfManagingLiquidityRiskAbstract_867163" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsTable" xlink:label="loc_imtx_StatementsTable_867165" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DescriptionOfManagingLiquidityRiskAbstract_867163" xlink:to="loc_imtx_StatementsTable_867165" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_867169" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsTable_867165" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_867169" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-full_FinancialAssetsMember_867170" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_867169" xlink:to="loc_ifrs-full_FinancialAssetsMember_867170" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CashAndCashEquivalentsMember" xlink:label="loc_imtx_CashAndCashEquivalentsMember_876761" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsMember_867170" xlink:to="loc_imtx_CashAndCashEquivalentsMember_876761" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShorttermDepositsMember" xlink:label="loc_imtx_ShorttermDepositsMember_867172" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsMember_867170" xlink:to="loc_imtx_ShorttermDepositsMember_867172" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-full_TypesOfRisksAxis_867173" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsTable_867165" xlink:to="loc_ifrs-full_TypesOfRisksAxis_867173" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-full_TypesOfRisksMember_867174" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfRisksAxis_867173" xlink:to="loc_ifrs-full_TypesOfRisksMember_867174" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LiquidityRiskMember" xlink:label="loc_ifrs-full_LiquidityRiskMember_867175" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfRisksMember_867174" xlink:to="loc_ifrs-full_LiquidityRiskMember_867175" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsLineItems" xlink:label="loc_imtx_StatementsLineItems_867168" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsTable_867165" xlink:to="loc_imtx_StatementsLineItems_867168" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk" xlink:label="loc_ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk_867176" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867168" xlink:to="loc_ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk_867176" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_867179" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsTable" xlink:label="loc_imtx_StatementsTable_867182" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_867179" xlink:to="loc_imtx_StatementsTable_867182" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-full_TypesOfRisksAxis_867188" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsTable_867182" xlink:to="loc_ifrs-full_TypesOfRisksAxis_867188" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-full_TypesOfRisksMember_867189" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfRisksAxis_867188" xlink:to="loc_ifrs-full_TypesOfRisksMember_867189" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CreditRiskMember" xlink:label="loc_ifrs-full_CreditRiskMember_867190" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfRisksMember_867189" xlink:to="loc_ifrs-full_CreditRiskMember_867190" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrencyRiskMember" xlink:label="loc_ifrs-full_CurrencyRiskMember_867202" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfRisksMember_867189" xlink:to="loc_ifrs-full_CurrencyRiskMember_867202" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_867192" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsTable_867182" xlink:to="loc_srt_CurrencyAxis_867192" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_867193" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_867192" xlink:to="loc_currency_AllCurrenciesDomain_867193" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_EUR" xlink:label="loc_currency_EUR_867194" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_867193" xlink:to="loc_currency_EUR_867194" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_USD" xlink:label="loc_currency_USD_867195" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_867193" xlink:to="loc_currency_USD_867195" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_867204" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsTable_867182" xlink:to="loc_ifrs-full_RangeAxis_867204" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_867205" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_867204" xlink:to="loc_ifrs-full_RangesMember_867205" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_867207" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_867205" xlink:to="loc_ifrs-full_TopOfRangeMember_867207" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_867208" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_867205" xlink:to="loc_ifrs-full_BottomOfRangeMember_867208" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsLineItems" xlink:label="loc_imtx_StatementsLineItems_867185" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsTable_867182" xlink:to="loc_imtx_StatementsLineItems_867185" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_MaximumExposureToCreditRisk" xlink:label="loc_ifrs-full_MaximumExposureToCreditRisk_867210" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867185" xlink:to="loc_ifrs-full_MaximumExposureToCreditRisk_867210" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_867212" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867185" xlink:to="loc_ifrs-full_CashAndCashEquivalents_867212" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherFinancialAssets" xlink:label="loc_ifrs-full_OtherFinancialAssets_867214" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867185" xlink:to="loc_ifrs-full_OtherFinancialAssets_867214" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk" xlink:label="loc_imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk_867217" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867185" xlink:to="loc_imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk_867217" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk" xlink:label="loc_imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk_867218" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867185" xlink:to="loc_imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk_867218" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_867221" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_867185" xlink:to="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_867221" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/FinancialInstrumentsSummaryOfCarryingAmountsAndFairValuesOfGroupsFinancialInstrumentsDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_866752" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_866753" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_866752" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_866753" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_866754" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_866753" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_866754" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsCategoryMember" xlink:label="loc_ifrs-full_FinancialAssetsCategoryMember_866755" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_866754" xlink:to="loc_ifrs-full_FinancialAssetsCategoryMember_866755" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_866756" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_866755" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_866756" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_OtherFinancialAssetsAtAmortizedCostMember" xlink:label="loc_imtx_OtherFinancialAssetsAtAmortizedCostMember_866757" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsCategoryMember_866755" xlink:to="loc_imtx_OtherFinancialAssetsAtAmortizedCostMember_866757" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_866758" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_866753" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_866758" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-full_FinancialAssetsMember_866759" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_866758" xlink:to="loc_ifrs-full_FinancialAssetsMember_866759" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ShorttermDepositsMember" xlink:label="loc_imtx_ShorttermDepositsMember_866762" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsMember_866759" xlink:to="loc_imtx_ShorttermDepositsMember_866762" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PositiveMarketValueForwardContractsMember" xlink:label="loc_imtx_PositiveMarketValueForwardContractsMember_866763" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsMember_866759" xlink:to="loc_imtx_PositiveMarketValueForwardContractsMember_866763" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TradeReceivablesMember" xlink:label="loc_ifrs-full_TradeReceivablesMember_866764" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsMember_866759" xlink:to="loc_ifrs-full_TradeReceivablesMember_866764" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_OtherCurrentAssetMember" xlink:label="loc_imtx_OtherCurrentAssetMember_866765" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsMember_866759" xlink:to="loc_imtx_OtherCurrentAssetMember_866765" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AccountsPayableMember" xlink:label="loc_imtx_AccountsPayableMember_866766" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsMember_866759" xlink:to="loc_imtx_AccountsPayableMember_866766" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_OtherCurrentLiabilitiesMember" xlink:label="loc_imtx_OtherCurrentLiabilitiesMember_866767" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FinancialAssetsMember_866759" xlink:to="loc_imtx_OtherCurrentLiabilitiesMember_866767" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_866768" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_866753" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_866768" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssets" xlink:label="loc_ifrs-full_FinancialAssets_866769" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_866768" xlink:to="loc_ifrs-full_FinancialAssets_866769" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialLiabilities" xlink:label="loc_ifrs-full_FinancialLiabilities_866770" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_866768" xlink:to="loc_ifrs-full_FinancialLiabilities_866770" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialAssetsAtFairValue" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValue_866771" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_866768" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValue_866771" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinancialLiabilitiesAtFairValue" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValue_866772" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_866768" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValue_866772" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/CommitmentsAndContingenciesSummaryOfContractualObligationsDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfContractualObligationsAbstract" xlink:label="loc_imtx_DisclosureOfContractualObligationsAbstract_866721" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfContractualObligationsTable" xlink:label="loc_imtx_DisclosureOfContractualObligationsTable_866732" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfContractualObligationsAbstract_866721" xlink:to="loc_imtx_DisclosureOfContractualObligationsTable_866732" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_866733" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfContractualObligationsTable_866732" xlink:to="loc_ifrs-full_MaturityAxis_866733" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-full_AggregatedTimeBandsMember_866734" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_866733" xlink:to="loc_ifrs-full_AggregatedTimeBandsMember_866734" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_866735" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_866734" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_866735" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_866736" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_866734" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_866736" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_866737" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_866734" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_866737" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_866738" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AggregatedTimeBandsMember_866734" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_866738" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfContractualObligationsLineItems" xlink:label="loc_imtx_DisclosureOfContractualObligationsLineItems_866739" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfContractualObligationsTable_866732" xlink:to="loc_imtx_DisclosureOfContractualObligationsLineItems_866739" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ContractualObligationOfLeaseLiabilities" xlink:label="loc_imtx_ContractualObligationOfLeaseLiabilities_866724" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfContractualObligationsLineItems_866739" xlink:to="loc_imtx_ContractualObligationOfLeaseLiabilities_866724" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_OtherLeaseObligations" xlink:label="loc_imtx_OtherLeaseObligations_866725" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfContractualObligationsLineItems_866739" xlink:to="loc_imtx_OtherLeaseObligations_866725" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ContractualObligationOfInLicenseAgreements" xlink:label="loc_imtx_ContractualObligationOfInLicenseAgreements_866727" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfContractualObligationsLineItems_866739" xlink:to="loc_imtx_ContractualObligationOfInLicenseAgreements_866727" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ContractResearchOrganizationAgreements" xlink:label="loc_imtx_ContractResearchOrganizationAgreements_866728" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfContractualObligationsLineItems_866739" xlink:to="loc_imtx_ContractResearchOrganizationAgreements_866728" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ContractualCashObligation" xlink:label="loc_imtx_ContractualCashObligation_866729" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfContractualObligationsLineItems_866739" xlink:to="loc_imtx_ContractualCashObligation_866729" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/CommitmentsAndContingenciesAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_876786" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsTable" xlink:label="loc_imtx_StatementsTable_876791" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_876786" xlink:to="loc_imtx_StatementsTable_876791" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AgreementAxis" xlink:label="loc_imtx_AgreementAxis_876793" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsTable_876791" xlink:to="loc_imtx_AgreementAxis_876793" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AgreementDomain" xlink:label="loc_imtx_AgreementDomain_876794" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_AgreementAxis_876793" xlink:to="loc_imtx_AgreementDomain_876794" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_CollaborationAgreementsMember" xlink:label="loc_imtx_CollaborationAgreementsMember_876795" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_AgreementDomain_876794" xlink:to="loc_imtx_CollaborationAgreementsMember_876795" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_StatementsLineItems" xlink:label="loc_imtx_StatementsLineItems_876792" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsTable_876791" xlink:to="loc_imtx_StatementsLineItems_876792" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_UnrecordedContingentLiability" xlink:label="loc_imtx_UnrecordedContingentLiability_876798" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_StatementsLineItems_876792" xlink:to="loc_imtx_UnrecordedContingentLiability_876798" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/RelatedPartyDisclosuresSummaryOfCompensationOfKeyManagementPersonnelDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DisclosureOfCompensationOfKeyManagementPersonnelAbstract" xlink:label="loc_imtx_DisclosureOfCompensationOfKeyManagementPersonnelAbstract_866521" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_KeyManagementPersonnelCompensationFixed" xlink:label="loc_imtx_KeyManagementPersonnelCompensationFixed_866526" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfCompensationOfKeyManagementPersonnelAbstract_866521" xlink:to="loc_imtx_KeyManagementPersonnelCompensationFixed_866526" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_KeyManagementPersonnelCompensationOtherLongtermBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationOtherLongtermBenefits_866528" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfCompensationOfKeyManagementPersonnelAbstract_866521" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationOtherLongtermBenefits_866528" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_866529" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfCompensationOfKeyManagementPersonnelAbstract_866521" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_866529" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_866530" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_DisclosureOfCompensationOfKeyManagementPersonnelAbstract_866521" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensation_866530" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/RelatedPartyDisclosuresSummaryOfCompensationForTheSupervisoryBoardDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract_866534" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesTable" xlink:label="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesTable_866562" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract_866534" xlink:to="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesTable_866562" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_866563" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesTable_866562" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_866563" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866565" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_866563" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866565" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PeterChambreMember" xlink:label="loc_imtx_PeterChambreMember_866573" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866565" xlink:to="loc_imtx_PeterChambreMember_866573" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_HaraldFstockMember" xlink:label="loc_imtx_HaraldFstockMember_866574" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866565" xlink:to="loc_imtx_HaraldFstockMember_866574" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MichaelGAtiehMember" xlink:label="loc_imtx_MichaelGAtiehMember_866566" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866565" xlink:to="loc_imtx_MichaelGAtiehMember_866566" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PaulCarterMember" xlink:label="loc_imtx_PaulCarterMember_866567" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866565" xlink:to="loc_imtx_PaulCarterMember_866567" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_HeatherLMasonMember" xlink:label="loc_imtx_HeatherLMasonMember_866568" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866565" xlink:to="loc_imtx_HeatherLMasonMember_866568" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AdamStoneMember" xlink:label="loc_imtx_AdamStoneMember_866569" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866565" xlink:to="loc_imtx_AdamStoneMember_866569" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ChristophHettichMember" xlink:label="loc_imtx_ChristophHettichMember_866570" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866565" xlink:to="loc_imtx_ChristophHettichMember_866570" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EliotForsterMember" xlink:label="loc_imtx_EliotForsterMember_866571" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866565" xlink:to="loc_imtx_EliotForsterMember_866571" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems_866572" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesTable_866562" xlink:to="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems_866572" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_KeyManagementPersonnelCompensationSupervisoryBoardCompensation" xlink:label="loc_imtx_KeyManagementPersonnelCompensationSupervisoryBoardCompensation_866537" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems_866572" xlink:to="loc_imtx_KeyManagementPersonnelCompensationSupervisoryBoardCompensation_866537" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_KeyManagementPersonnelCompensationTravellingExpenses" xlink:label="loc_imtx_KeyManagementPersonnelCompensationTravellingExpenses_866553" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems_866572" xlink:to="loc_imtx_KeyManagementPersonnelCompensationTravellingExpenses_866553" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_KeyManagementPersonnelCompensationShareBasedCompensationExpense" xlink:label="loc_imtx_KeyManagementPersonnelCompensationShareBasedCompensationExpense_866555" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems_866572" xlink:to="loc_imtx_KeyManagementPersonnelCompensationShareBasedCompensationExpense_866555" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_KeyManagementPersonnelCompensationPaymentExitArrangement" xlink:label="loc_imtx_KeyManagementPersonnelCompensationPaymentExitArrangement_880588" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems_866572" xlink:to="loc_imtx_KeyManagementPersonnelCompensationPaymentExitArrangement_880588" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_KeyManagementPersonnelCompensations" xlink:label="loc_imtx_KeyManagementPersonnelCompensations_866556" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems_866572" xlink:to="loc_imtx_KeyManagementPersonnelCompensations_866556" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/RelatedPartyDisclosuresSummaryOfOptionsGrantedToManagingDirectorAndSupervisoryDirectorsDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_866580" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_866581" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_866580" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_866581" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TypeOfVestingAxis" xlink:label="loc_imtx_TypeOfVestingAxis_866584" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_866581" xlink:to="loc_imtx_TypeOfVestingAxis_866584" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TypeOfVestingDomain" xlink:label="loc_imtx_TypeOfVestingDomain_866586" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TypeOfVestingAxis_866584" xlink:to="loc_imtx_TypeOfVestingDomain_866586" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PerformanceBasedOptionsMember" xlink:label="loc_imtx_PerformanceBasedOptionsMember_866587" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TypeOfVestingDomain_866586" xlink:to="loc_imtx_PerformanceBasedOptionsMember_866587" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ServiceOptionsMember" xlink:label="loc_imtx_ServiceOptionsMember_866588" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TypeOfVestingDomain_866586" xlink:to="loc_imtx_ServiceOptionsMember_866588" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ServiceOptionsOneMember" xlink:label="loc_imtx_ServiceOptionsOneMember_870324" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TypeOfVestingDomain_866586" xlink:to="loc_imtx_ServiceOptionsOneMember_870324" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MatchingStockOptionsMember" xlink:label="loc_imtx_MatchingStockOptionsMember_866589" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TypeOfVestingDomain_866586" xlink:to="loc_imtx_MatchingStockOptionsMember_866589" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ConvertedOptionsMember" xlink:label="loc_imtx_ConvertedOptionsMember_866591" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TypeOfVestingDomain_866586" xlink:to="loc_imtx_ConvertedOptionsMember_866591" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ConvertedOptionsOneMember" xlink:label="loc_imtx_ConvertedOptionsOneMember_870321" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TypeOfVestingDomain_866586" xlink:to="loc_imtx_ConvertedOptionsOneMember_870321" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_866593" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_866581" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_866593" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866594" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_866593" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866594" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_HarpreetSinghMember" xlink:label="loc_imtx_HarpreetSinghMember_866595" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866594" xlink:to="loc_imtx_HarpreetSinghMember_866595" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PeterChambreMember" xlink:label="loc_imtx_PeterChambreMember_866596" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866594" xlink:to="loc_imtx_PeterChambreMember_866596" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AdamStoneMember" xlink:label="loc_imtx_AdamStoneMember_866597" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866594" xlink:to="loc_imtx_AdamStoneMember_866597" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ChristophHettichMember" xlink:label="loc_imtx_ChristophHettichMember_866598" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866594" xlink:to="loc_imtx_ChristophHettichMember_866598" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_HeatherLMasonMember" xlink:label="loc_imtx_HeatherLMasonMember_866602" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866594" xlink:to="loc_imtx_HeatherLMasonMember_866602" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_MichaelGAtiehMember" xlink:label="loc_imtx_MichaelGAtiehMember_866604" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866594" xlink:to="loc_imtx_MichaelGAtiehMember_866604" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PaulCarterMember" xlink:label="loc_imtx_PaulCarterMember_866605" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866594" xlink:to="loc_imtx_PaulCarterMember_866605" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_EliotForsterMember" xlink:label="loc_imtx_EliotForsterMember_866606" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866594" xlink:to="loc_imtx_EliotForsterMember_866606" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866608" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_866581" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866608" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfTransactionsWithRelatedParty" xlink:label="loc_ifrs-full_DescriptionOfTransactionsWithRelatedParty_866609" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866608" xlink:to="loc_ifrs-full_DescriptionOfTransactionsWithRelatedParty_866609" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement_866610" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866608" xlink:to="loc_ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement_866610" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DateOfGrantOfSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement_866611" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866608" xlink:to="loc_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement_866611" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_866612" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866608" xlink:to="loc_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_866612" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_866613" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866608" xlink:to="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_866613" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DateOfExpiryOfShareOptionsGranted" xlink:label="loc_imtx_DateOfExpiryOfShareOptionsGranted_866805" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866608" xlink:to="loc_imtx_DateOfExpiryOfShareOptionsGranted_866805" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/RelatedPartyDisclosuresSummaryOfCompensationForTheSupervisoryBoardParentheticalDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract_866635" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_866637" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract_866635" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_866637" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/RelatedPartyDisclosuresAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866645" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_866654" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866645" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_866654" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_866655" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_866654" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_866655" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866656" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_866655" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866656" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_866657" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_866656" xlink:to="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_866657" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PlanNameAxis" xlink:label="loc_imtx_PlanNameAxis_866658" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_866654" xlink:to="loc_imtx_PlanNameAxis_866658" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PlanNameDomain" xlink:label="loc_imtx_PlanNameDomain_866659" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_PlanNameAxis_866658" xlink:to="loc_imtx_PlanNameDomain_866659" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TwentyTwentyIncentivePlanMember" xlink:label="loc_imtx_TwentyTwentyIncentivePlanMember_866662" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_PlanNameDomain_866659" xlink:to="loc_imtx_TwentyTwentyIncentivePlanMember_866662" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TypeOfVestingAxis" xlink:label="loc_imtx_TypeOfVestingAxis_866666" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_866654" xlink:to="loc_imtx_TypeOfVestingAxis_866666" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TypeOfVestingDomain" xlink:label="loc_imtx_TypeOfVestingDomain_866667" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TypeOfVestingAxis_866666" xlink:to="loc_imtx_TypeOfVestingDomain_866667" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ServiceOptionsMember" xlink:label="loc_imtx_ServiceOptionsMember_866668" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TypeOfVestingDomain_866667" xlink:to="loc_imtx_ServiceOptionsMember_866668" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PerformanceBasedOptionsMember" xlink:label="loc_imtx_PerformanceBasedOptionsMember_866669" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TypeOfVestingDomain_866667" xlink:to="loc_imtx_PerformanceBasedOptionsMember_866669" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_866671" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_866654" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_866671" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_866673" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_866671" xlink:to="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_866673" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AryaMember" xlink:label="loc_imtx_AryaMember_866674" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForBusinessCombinationsMember_866673" xlink:to="loc_imtx_AryaMember_866674" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_866675" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_866654" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_866675" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-full_EntitysTotalForSubsidiariesMember_866677" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_866675" xlink:to="loc_ifrs-full_EntitysTotalForSubsidiariesMember_866677" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_ImmaticsGmbhMember" xlink:label="loc_imtx_ImmaticsGmbhMember_866678" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForSubsidiariesMember_866677" xlink:to="loc_imtx_ImmaticsGmbhMember_866678" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866680" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_866654" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866680" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_AccruedOfKeyManagementCompensation" xlink:label="loc_imtx_AccruedOfKeyManagementCompensation_866682" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866680" xlink:to="loc_imtx_AccruedOfKeyManagementCompensation_866682" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PercentageOfStockVestedOverThePeriodOfFourYearTimeBasedVestingSchedule" xlink:label="loc_imtx_PercentageOfStockVestedOverThePeriodOfFourYearTimeBasedVestingSchedule_866684" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866680" xlink:to="loc_imtx_PercentageOfStockVestedOverThePeriodOfFourYearTimeBasedVestingSchedule_866684" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_866686" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866680" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_866686" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_PaymentOfPayrollTaxOfTheEmployees" xlink:label="loc_imtx_PaymentOfPayrollTaxOfTheEmployees_866692" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866680" xlink:to="loc_imtx_PaymentOfPayrollTaxOfTheEmployees_866692" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_NumberOfConvertedStockOptionsInTheEntity" xlink:label="loc_imtx_NumberOfConvertedStockOptionsInTheEntity_866698" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866680" xlink:to="loc_imtx_NumberOfConvertedStockOptionsInTheEntity_866698" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_NumberOfMatchingStockOptionInTheEntity" xlink:label="loc_imtx_NumberOfMatchingStockOptionInTheEntity_866701" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_866680" xlink:to="loc_imtx_NumberOfMatchingStockOptionInTheEntity_866701" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://imtx.com/role/NetLossPerShareAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_TextBlockAbstract" xlink:label="loc_imtx_TextBlockAbstract_866466" />
<loc xlink:type="locator" xlink:href="imtx-20201231.xsd#imtx_DilutiveEffectOfShareOptionsOnNumberOfWarrants" xlink:label="loc_imtx_DilutiveEffectOfShareOptionsOnNumberOfWarrants_876461" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_imtx_TextBlockAbstract_866466" xlink:to="loc_imtx_DilutiveEffectOfShareOptionsOnNumberOfWarrants_876461" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g149615g04g99.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g149615g04g99.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1C<4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &,"^8S8X0DE-! 0       \< 5H  QLE1QP"   "2G\ .$))300E
M   0J0QSML/IS3>P4AO&!C1FM#A"24T$.@      Y0   !     !       +
M<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0    !)
M;G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E
M<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    , %
M<@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L
M=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M  (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P
M=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L
M      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L      !%
M;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0       %)'
M0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M      !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M     $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$!RP
M        "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S
M %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M                4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0
M<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O
M<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M"V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#O_XU
M  (  CA"24T$)@      #@             _@   .$))30/R       *  #_
M______\  #A"24T$#0      !    !XX0DE-!!D       0    >.$))30/S
M       )           ! #A"24TG$       "@ !          (X0DE- _4
M     $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8       $ ,@
M  $ 6@    8       $ -0    $ +0    8       $X0DE- _@      '
M /____________________________\#Z     #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z   .$))300(       0     0   D    )
M     #A"24T$'@      !      X0DE-!!H      S4    &
M  !!    L@         !                          $
M +(   !!                      $                         $
M  $       !N=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$
M   $     %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO
M;F<   !!     %)G:'1L;VYG    L@    9S;&EC97-6;$QS     4]B:F,
M   !       %<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U
M<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -
M875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM
M9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG    00    !29VAT
M;&]N9P   +(    #=7)L5$585     $       !N=6QL5$585     $
M  !-<V=E5$585     $       9A;'1486=415A4     0      #F-E;&Q4
M97AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!
M;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R
M=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB
M9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90
M  ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P         ,
M8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG       X
M0DE-!"@       P    "/_         X0DE-!!$       $! #A"24T$%
M    !     @X0DE-! P     #I0    !    H    #H   '@  !LP   #G@
M&  !_]C_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D@     '_VP"$  P(" @)
M" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,$0P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4% X.#@X4$0P,# P,$1$,
M# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_  !$( #H H ,!
M(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0         #  $"! 4&!P@)
M"@L!  $% 0$! 0$!          $  @,$!08'" D*"Q   00! P($ @4'!@@%
M PPS 0 "$0,$(1(Q!4%181,B<8$R!A21H;%"(R054L%B,S1R@M%#!R624_#A
M\6-S-1:BLH,F1)-49$7"HW0V%])5XF7RLX3#TW7C\T8GE*2%M)7$U.3TI;7%
MU>7U5F9VAI:FML;6YO8W1U=G=X>7I[?'U^?W$0 " @$"! 0#! 4&!P<&!34!
M  (1 R$Q$@1!46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:B
MLH,')C7"TD235*,79$55-G1EXO*SA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F
M=H:6IK;&UN;V)S='5V=WAY>GM\?_V@ , P$  A$#$0 _ /54DDDE*22224I)
M)))2DDDDE*22224UL[+=CU$4-;=EN:XX^,7M8ZPMU<UCG_NKDV?6#K63TGJ]
M]UIQ<C$=3Z+&,##67.]]3FWM>]W_ %Q5_KK=:>O,;N<W[/0QU+FDM+7/=87V
M5O;#F._1L]S?W$5_6K3]7L9_5:6]3&5D.K<'Q6[TZ@7L_25AOZ9KV>UZJ9,M
MSD+,> '^[^[?^,[7+\F(8<4^".66:4):_/"I>]P0X_U4HRQ8_P#5+=+^NN;C
MVM9U0C(QB8=>UH;8S_A',K_1W5_O[&,L_P"-79WY>/1C.RK'CT6MW[QJ"/S=
ML?2W?F+SK-Z=C'&=U+I5CKL%A#;ZK/Y['<?]-^_2[_2+7HN?;]6.E4W/+*G7
MNK?81.VNIUK*_;_P36M_[;0QYIQ$A+U4.*)_YOS,7Q?!AAA',X8B!XO:GCK@
M]<AZ>*'^3X4V9]9.HVESZG#%I:"0T .?'_"6/W,:[^HBOZQU/IME7JY-><RR
MMMCV$!A:':[?4;M]SF_0]1B?IF/T5G574NO^UD-<:=[!Z?M]UCO4G9<]K/S]
MGII\W.Z33U@Y->.,O0&VUKY;OC;^CJ\
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                      #_X4"!
M:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@8F5G:6X]
M(N^[OR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M
M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!8
M35 @0V]R92 U+C,M8S Q,2 V-BXQ-#4V-C$L(#(P,3(O,#(O,#8M,30Z-38Z
M,C<@(" @(" @("(^"B @(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W
M=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^"B @(" @(#QR
M9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS
M.GAM<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(^"B @(" @(" @
M(#QX;7 Z0W)E871O<E1O;VP^061O8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W
M<RD\+WAM<#I#<F5A=&]R5&]O;#X*(" @(" @(" @/'AM<#I#<F5A=&5$871E
M/C(P,C$M,#,M,C94,3<Z,S(Z,3$K,#4Z,S \+WAM<#I#<F5A=&5$871E/@H@
M(" @(" @(" \>&UP.DUO9&EF>41A=&4^,C R,2TP,RTR-E0Q-SHT-3HQ-BLP
M-3HS,#PO>&UP.DUO9&EF>41A=&4^"B @(" @(" @(#QX;7 Z365T861A=&%$
M871E/C(P,C$M,#,M,C94,3<Z-#4Z,38K,#4Z,S \+WAM<#I-971A9&%T841A
M=&4^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R
M:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SID8STB:'1T
M<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B/@H@(" @(" @(" \9&,Z
M9F]R;6%T/FEM86=E+V5P<V8\+V1C.F9O<FUA=#X*(" @(" @/"]R9&8Z1&5S
M8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B
M"B @(" @(" @(" @('AM;&YS.G!H;W1O<VAO<#TB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]P:&]T;W-H;W O,2XP+R(^"B @(" @(" @(#QP:&]T;W-H;W Z0V]L
M;W)-;V1E/C0\+W!H;W1O<VAO<#I#;VQO<DUO9&4^"B @(" @(#PO<F1F.D1E
M<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB
M(@H@(" @(" @(" @("!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87 O,2XP+VUM+R(*(" @(" @(" @(" @>&UL;G,Z<W1%=G0](FAT=' Z
M+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C945V96YT(R(*
M(" @(" @(" @(" @>&UL;G,Z<W12968](FAT=' Z+R]N<RYA9&]B92YC;VTO
M>&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B/@H@(" @(" @(" \>&UP34TZ
M26YS=&%N8V5)1#YX;7 N:6ED.C(U-$,R.#!",$$X145",3%",SDY.#9#,C@V
M03<R1CA#/"]X;7!-33I);G-T86YC94E$/@H@(" @(" @(" \>&UP34TZ1&]C
M=6UE;G1)1#YX;7 N9&ED.D%".4)$.#<Y,D(X145",3%"0D8V0S,V,4(S-34X
M-4(V/"]X;7!-33I$;V-U;65N=$E$/@H@(" @(" @(" \>&UP34TZ3W)I9VEN
M86Q$;V-U;65N=$E$/GAM<"YD:60Z04(Y0D0X-SDR0CA%14(Q,4)"1C9#,S8Q
M0C,U-3@U0C8\+WAM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#X*(" @(" @(" @
M/'AM<$U-.DAI<W1O<GD^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYC<F5A=&5D/"]S=$5V=#IA
M8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM
M<"YI:60Z04(Y0D0X-SDR0CA%14(Q,4)"1C9#,S8Q0C,U-3@U0C8\+W-T179T
M.FEN<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P
M,C$M,#,M,C94,3<Z,S(Z,3$K,#4Z,S \+W-T179T.G=H96X^"B @(" @(" @
M(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E(%!H;W1O<VAO
M<"!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @
M(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IA8W1I;VX^8V]N=F5R=&5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#IP87)A;65T97)S/F9R;VT@:6UA9V4O<&YG('1O(&%P
M<&QI8V%T:6]N+W9N9"YA9&]B92YP:&]T;W-H;W \+W-T179T.G!A<F%M971E
M<G,^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \
M<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @
M(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.D%#.4)$
M.#<Y,D(X145",3%"0D8V0S,V,4(S-34X-4(V/"]S=$5V=#II;G-T86YC94E$
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(Q+3 S+3(V5#$W
M.C,T.C4T*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD
M;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @
M/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @
M(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E
M5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T
M:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS
M=$5V=#II;G-T86YC94E$/GAM<"YI:60Z,C0T0S(X,$(P03A%14(Q,4(S.3DX
M-D,R.#9!-S)&.$,\+W-T179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IW:&5N/C(P,C$M,#,M,C94,3<Z-#4Z,38K,#4Z,S \+W-T
M179T.G=H96X^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G
M96YT/D%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T
M=V%R94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO
M/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @
M(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^8V]N=F5R=&5D/"]S
M=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IP87)A;65T
M97)S/F9R;VT@87!P;&EC871I;VXO=FYD+F%D;V)E+G!H;W1O<VAO<"!T;R!I
M;6%G92]E<'-F/"]S=$5V=#IP87)A;65T97)S/@H@(" @(" @(" @(" @(" \
M+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E
M/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^
M9&5R:79E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%
M=G0Z<&%R86UE=&5R<SYC;VYV97)T960@9G)O;2!A<'!L:6-A=&EO;B]V;F0N
M861O8F4N<&AO=&]S:&]P('1O(&EM86=E+V5P<V8\+W-T179T.G!A<F%M971E
M<G,^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \
M<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @
M(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.C(U-$,R
M.#!",$$X145",3%",SDY.#9#,C@V03<R1CA#/"]S=$5V=#II;G-T86YC94E$
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(Q+3 S+3(V5#$W
M.C0U.C$V*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD
M;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @
M/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @
M(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @
M/"]X;7!-33I(:7-T;W)Y/@H@(" @(" @(" \>&UP34TZ1&5R:79E9$9R;VT@
M<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" \<W12968Z
M:6YS=&%N8V5)1#YX;7 N:6ED.C(T-$,R.#!",$$X145",3%",SDY.#9#,C@V
M03<R1CA#/"]S=%)E9CII;G-T86YC94E$/@H@(" @(" @(" @(" \<W12968Z
M9&]C=6UE;G1)1#YX;7 N9&ED.D%".4)$.#<Y,D(X145",3%"0D8V0S,V,4(S
M-34X-4(V/"]S=%)E9CID;V-U;65N=$E$/@H@(" @(" @(" @(" \<W12968Z
M;W)I9VEN86Q$;V-U;65N=$E$/GAM<"YD:60Z04(Y0D0X-SDR0CA%14(Q,4)"
M1C9#,S8Q0C,U-3@U0C8\+W-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#X*(" @
M(" @(" @/"]X;7!-33I$97)I=F5D1G)O;3X*(" @(" @/"]R9&8Z1&5S8W)I
M<'1I;VX^"B @(#PO<F1F.E)$1CX*/"]X.GAM<&UE=&$^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"CP_>'!A8VME="!E;F0](G<B/S[_VP!#
M  $! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MP  1"  5 #D# 1$  A$! Q$!_\0 &P   @(# 0              !P@ "04&
M"@3_Q  N$  " @(! P(% @<!       %!@0' P@" 1,5%!8 "1$2%U;2)38W
M59.5EM7_Q  = 0$   <! 0               0,$!08'"0@"_\0 ,!$  @(!
M P," P8'         @,!! 4 !A$3%2$2% <((A8C5&'1\#1!DY2AL=+_V@ ,
M P$  A$#$0 _ ._CX::GPTU/AII)_F#6W8=):PN+[7 G,3(1"((4P2(LPH.G
M@U$W-\8;-C2@63$)B"<;I(C18!J)EZ\PLJ;C+=<67A"Y<.N%[_R^0PFV+N0Q
MR9<Q;*ZWR)M6::CFPI[UL00L4P8(1!PS]R1PZ8* D9WS\MFS-L[]^+.$V[NB
MX%2LZKD;F-4U%.U7R&:H5_=T*%JI?4ZI=J-Z;76:+@]-]2#IP02^"BKFB+FO
M 9?FPL6GWQ]>%%<7K&%."&]S,C:33"2>NS<"1<"CPR2>,5H@-,A>B<I/*!&#
M29Q4[B&FQ<S'-7SDG5N-S>>1F-T3A,A?OHITLHNUC[Q3==2?3K&-#,T0DX"X
MNU-82(0%),>^%/4<-KN+?7S*[=V]B_ESQFX;VV,#A=]=KQ^:V?N';&-"JK,S
MDWA8SFTLI1$(<B_MU.2LV:F/L/NJ:C$>JA<00Y+'J-=5V,RIEK4B$".UT/M@
MV7T&,C;!9R([(NEP;J6&9<$DK!XGF?'P&C*^@DF41CB2(Y9=)RNF2>0Z0LLY
M?'TNW,Q8QVX]J4 RNYLID\[->[E)N&EE4Z63LUYE]A V;L0FKAU6+M9:B6^L
M\XZK8%C*J^36+R5NAE,(FM=S>2R>3%=JRFVY?MK";S5$$M7[BV(J7C5LM)]!
M"ZLP_4QO3EE9::E+FV_ V.J6@69GV*TNYLCD5P?,K+R"C&40RY5XDI<$C!.R
M1XPR,=CY07)>F#(O/GEX=,F'%SS\N$SEUXK[:^'%O"Y#!UJ6(;0Q=5(W[8UU
MQ8K"^D-Q.1+*$D38\ZIC;BXI[(B)D3*!@E1Y)M;N^+5#<>+W);R6<7DLU>L3
MC:4V6G5M35R1T+&+'#+<2UUUW%G3]@VNN9(>1&2F&STL^08_[#A_V6']OQXC
MZ5/\67] _P!==%NODOP"_P"Z#_G575??,3NG8+J&7]:-85%T?AZ$QVK98>R+
MZD5JM+J=$O>Z**2 :BRC:D>IS;85@%:+=3<<:57%!/686"-@..O3++C<\M'J
MY:PR%\T5Q((U';&VQK9AJ[4C9?.4A5*]1;:C.MT Y$:OWJREZ9<%/CD<<M*X
MIT7*Z8> C(B6U9A$04D (;$.'XB4^4&::]?#?C<'*2U]!\=(T'"5W''D3&MO
M.1M-P\6O0 Z1SL\I'V:E1Z5SRZ[+8:\PR2\:-3\&_H$P]'RK'D\''L')#36:
M$?,%?+/(Y]<DK6@"Q[A0FZW$&U:A:K9Q#J(01-1BZQ(MM@G+GP5T=/,5;LHR
M[ZHPI4,53,AV8)SCF&&TU<PKC+.&_)@#!(#$3 QD3 Q@A(2C@A(9B8(9B9B8
MF)B8GB8U-2YU9RK%=S:]A# <AZ6&IR6K*#6U35R)K8LX@@,"@A*((9B8B=+_
M &MM9?\ 58/FB4IJQ1U&[*I^SNDE=7LM8[(&XD5LJ^][<1JXJ\Q6SX-H N0<
M:^LH; <*C*&V5#KY\IOBNG2818+RPZ]B+TU6A1HR<TZ=6I+87#)KH4F60E8J
M4)RL1DH4H!6N"Y@%C C$#$1%VS&YMQ[ABO&>SV8S45"M'5'*Y*Y?&L=ZTV[=
M- VG-A1W+CW6K1+@2?8:;6R9E)274?;W.R6,Q5KK9J%5T[:C,_[$K[7B*/L2
MNJW7J^U_M*/59FR7ZV M2L3ADZ/+E+B0E%,7*V9S!*3B*3"DD:,#2RO215P^
M)I67W:>+Q]2Y9Y]Q:K4ZZ;#N9YGJN6L6'S,1,P13$SYGF?.L6KXS'57MLU:%
M.O8=SU7HK)4YG,\SZV  F7JGS,3,\SYGF?.M5V+M*RY;;2-0$-;*EHW:_8",
M[$95F9-BPJ%'C0ZJ=4N%(6*'ON+1C ?L2U+% G>;$M(!M,KD[D0!C9S/YPF6
M'UQ=<F[WF>W]I[MD>U\\]N][8]EXGG^%ZG1XY\\>CCGSQSYU1_9S;_=8SG8\
M1WJ(X[MVZIW'S'IF?>=+W',C]//4Y]/T\\>-7&>$D?J$]_E&_P#E_%KU>M50
M_+BUV_#%E/!OWA[D\I0RJI>E]O\ A^QX_<'>.QO(=[SA7N]W\I>&]+VL?;\%
MY'U//R?H1\/YS'Y1_GG]--!]TU2\G\M#0^D/?O8_%4A7Y^Y_:W<\]Z#7J\%'
MZ>%]QX_%]WW1Y#Z^6(]OT/I/IS]3ZF/'33H\*>^C;\L8A[B_H: ;X?9\1_-'
MD=72Z)W.YY3^"=GU'E?L^POW/L]#]^/[O6=(1YXG\O\ ?[_?.FE/8->FNDK1
MVOWEJ>R@PNT%2^[6EF%UNKZ6U)3E4UGT]J,-/5N5AC7U3,CSPIKIA5<E:PA!
MF)U'9,Y8$54CPV;SY=(Z:$SA1M]N$VR=G7*_$,RV6[66KNSB^L1:(+"E"MB.
MA>P *WZZKX=@X7=).L*BY8W!@'.\HJ=PLG-D(YF<$8$!.$1%BM-$7!1SMKO%
MM3=VJ+)7XUD +>VO@NRLX5U.9$9_K.Y[^BV'B4NL098:P=66E";\.*8MO,$]
M-AS!T]@&'$PAQ(CI(-IK9-E%?8[9VCZGH"R;1U_YK&Y:JR+K.;@:R-&1CK/*
M;Y=#P9JJZ09V0+P!#LDJI..+4F8J/+RQ3X*@61@Q\..+BH\6FK:OQW"_4SS_
) -61_=\--?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>g149615g68r14.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g149615g68r14.jpg
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M\^)>4-<[VG_4!N[6^.:KWC+\X>;B17;_  8/^YC_ )DV_P!%O]W5/$^)+_\
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MG-L(=R6\TXZI#2DY*RZ#UJH:]'G_ "6_]M__ )8U=A=)_!(FT^@OBH>*@H4
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ME(0LRRB0M;#CB4J-)D>2HR.QWM86'AP_\!9^K(?F5]X^T/#A_P" L_5D/S*
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M?D=/V_L/2<WO\WLMS^JMC]OD?:NSK/1V?'Y";>HM/;\/F*BH*% "@!0 H 4
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M4T2D$_X?$I3O(!K*<O8LEI<6Q)AD<1L%)&-I?9.B#IE#(M%9*SB\H<;.67F
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M616TWYOG?:7:(=[E;1K^7,?9HOPB+?[GV\.(-L7,= XH$9?/V (5A#YDN_D
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M71YDAB2O1J+\AR9OU6*UT\&/,$+I]]1+NWY]G';R,;7RQY>65E/M]G90!3T
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M(S,R,R([V+096-1':QE>VL=VM- =BE^+?2Q6*[ZXRYKPX$N&[;$^7PW $(1
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M,27_ &>.?]TO_P"ST]2F?PDG_ =_R!ZK)_AW_P#!<_RA[F)+_L\<_P"Z7_\
M9Z>I3/X23_@._P"0/59/\.__ (+G^4/<Q)?]GCG_ '2__L]/4IG\))_P'?\
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MD,25Z)9QT[DSEU::O<28<P0NGWUTN7GSK..WIT[742[BF5L^W/L[EP"GH 4
M* % "@!0!,,$.Y+I(XZ)9+G!HNGU^2O>0=\AQ)+].BCRL>4HRYW?6SYJG-L[
M1MW$N5VJ79UGH[/C\A-O46GM^'S%/4%"@!0 H 4 * )@ CRBLVSZ-9KU,G:+
M<]57F8$>[#(BWZQMAR\.0BGR/#\DK9+=KA@NOS+76NBD 4] "@!0 H 4 :A_
M*J_Q#_SH?U=UR-[>KYCC<V=?R&Q/AS^][T1_(UK#^A .L%:SZ3^(S3J+H+X#
M,M04* % "@!0 H 4 * % "@!0 H 4 * % "@!0 H 4 * % "@!0 H 4 * %
M"@!0 H 4 * )AVAWIF <]$OGRHQ+D/$,5>QJUZ@K"5.B60Y.7,7?]-SVRO/3
MY*8YUAR5^?WVX!3T * % "@!0 H 4 3$10Z<4[3Z)=AWI/-E^0Y5YRF?4S,^
MYZW'/DH=B!'F^(-4NYER&KI%#G..7SU "GH 4 * % "@"8+H<R0Q);HEW'3N
M3.75IJ]Q%AS!"Z??<)<G/G8N.WITK<U'N*98Y]N?9W+@%/0 H 4 * % "@"8
M8(=R72-QT2Z7.#1=/K\U>\V><AQ)+].@CR<>4JRYW?<9\]7FXO$+<M'E=JMV
M=9Z.SX_(3:?07S_$4]04* % "@!0 H F "'**S93HEVO4R=HOSUE>8F1[L,B
M+;K6N')3Y""?3^'Y)=]QVNF#E?G8\[D( %/0 H 4 * % &H?RJO\0_\ .A_5
MW7(WMZOF.-S9U_(;$^'/[WO1'\C6L/Z$ ZP5K/I/XC-.HN@O@,RU!0H 4 *
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MR1RZA<JUVOF8:8OL%(/.%1"TQC-T5[YH8BY,H !W-(8IXW(6$#L'&6>#1#'
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MUAWI/-U^00S[Z^?53,^YZQ._2L^QD1YWB W#DY\L<Z:I]4^[O6N "GH 4 *
M% "@"8+H<R0Q%;HGR_3N3-^K;Y]UHQYHAPGWR&/2K=_!QV\AO;J&G=<98Y=Y
M;_$Y %/0 H 4 * % "@"78(=R7R1QT3Y+G!HNGUZN?:/=\AQ)+].SPZ5/NN6
M7.[S[+K'/?P=L[<EKW.\YNPND_D)M/H+YBHJ"A0 H 4 * % $P 0Y)6;J=&]
M:]5)VB_/=Y]Y CW89$6W6#;=*WY;)/I_#U,.<^[2+ @IU6'?Z)F 4] "@!0
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M%RS4^6B\=1"#&*86.E#K)D:(A!N+88]+-&I)RU5>-TEL #(= "@!0 H 4 *
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M7PCZ#I<^$^TP#WN/#U\ ^F?DOA'T'2Y\)]I@'O<>'KX!],_)?"/H.ESX3[3
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MOA'T'2Y\)]I@'O<>'KX!],_)?"/H.ESX3[3 />X\/7P#Z9^2^$?0=+GPGVF
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M-+!G($<X&9/^(=.1:ZOLWH)*:<[,*R'69%C?519NP%?88C$;FD$-HW6F 9-
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MN9*?G<G)2K^IG6\J]OZQ#3_I5H57K2J$=*@/SBC)J1/YDDGFL\<#-Y64I/\
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M+E/L[X.3-[*-[]C-+O"%\;W(VY>7;AGV]QM^O2['-\+]N7^!< J* % "@!0
MH 4 2[#"UI?),^4^QOF&B^-U5;_N<IW'$D[,&5N7;L<I=[M?7YF?;@HR_6)]
MG:I=FS6?3L\.#K$VGT%T;?L^H5%04* % "@!0 H F &%L2LWO9)\GS).TSOF
M[OVMU[VAD1PYHRW+P[&-K8614MWEOW21(7YENWE) %/0 H 4 * % &H?RJO\
M0_\ .A_5W7(WMZOF.-S9U_(;$^'/[WO1'\C6L/Z$ ZP5K/I/XC-.HN@O@(/B
MKX4()Q<1."12=22715/7.QT=H1LM#V6N"SJT@3@4_P!;+-2H7:^O=GPHP'=Q
M?9,E15:$(HNY;D+CB@YZQ>CT5:@R([?9\-]EN =35_)(</PD,!'0&8[6B:L-
M+,Y%$\<B\+*K)$PG#7HKA>!@R<V)P%YMM.".(#P[:]7FT5C>Q(\WV236D"6P
M%I,!7!@@(7*,RMS6\3/HUF>S1L$#"/(O:'9Q+5OV3]B['V7M2#@XX%/SN2@]
M%2T1( 0K4VJ-2N]<)0"?:0E,!;ZX0 Z>B"8)ZM%5-M-+M'+PCM D3+F7C\&4
M>PB(N#K,]96/;PVYAF0QY+;2,BA[G7AW9N]RD":M][C(3$UY!KE%AK2.\1"K
MUW/8U$'S+5K4\^&MR!%X_CKR>%YK(1ZBB+)V<)"&(\:U:PRC+25M-K\]OQVV
M%(IY.#4S:8[%F<;V3M^*NMP"-UQ_; )M;3<MB.Q8]NV?[%V>0 2B,;.TY/!3
MD+"YIM.8DHB-:(,VI)B_QCVRD]A1RRPE<)?PM;7LL6P]MB^5AVLT-IH!P]ZB
M@^FHL>ETFC\"&+BA9J=%69B3O&S@D^)]U\Z&"P@ANV9J/U&(<.#"!H_'PK8<
M! "!@8:Q8H ,[F9\(R[00* % "@!0 H 4 * % "@!0 H 4 * % "@!0 H 4
M* % "@!0 H 4 * )AWCVS,!GRWU^[&)=CS4[_N9AWBL)ORW=NY?M?*=SO#K\
MS#L;I%+=Q3M[R8/O[\!3T * % "@!0 H 4 3$1Q[HIW;EOD^V3S;+ND;]KB_
M?F9_/F)W[B?[15[W-%V[M^P9FTMWU.SF9@^_Q%/0 H 4 * % $P7Q[9#$<N6
M_P NZY,_KVU^QFGVB%[=I&W<R[<,O\%M;OI_MF^%^W+L[MP??W]_I3T * %
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M*/'9K#K=>A(BUA*4M+S+RF3?ITQII7JZE-/FVTPI60W^C"OS,/U>% 'Y;O\
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MV'_&>;W["%^UQ>^4S/Y7R3_6X_M'.][YC+=E^P;DTMWL_P##R *>@!0 H 4
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M?L<27[3+[5OVSCVWZ[]=?]9=E]JW^6[-FL^G9X<'6)M/JZ-OCP]0J*@H4 *
M% "@!0!, +=A6;W[KZW;)VE[W=_XC+_B9$;=X9]JW[1[+=U3[>7[I8D/M_\
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M_LZB2]G1_P#6?N]=_P"AT579LUGT[/#@ZQ-NW471M\>'J%14%"@!0 H 4 *
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M;;9M'HT.Z+!;EP=/AV:C[;#FY?P8;CV3)H*8*FR\'CD1'1IP.BP_BUXCYG(
M$H%Z^X](J9-M-GO$XU,BSLR3X@M'YJN'KS#-*.QF21BV2H./!!TB!<M//S$6
MU)ZNH_LS&08IJ'B4U[J;B+0E!LQ,=@%-.2-AKF;1K=^TS91<XWU>.%QH!&]3
M%!8R'P4X"D@YXDUFD7(7D<J?9,Y.2NF;DIUL*"'IM^!%X_Z6\1BP+PJ<79@
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M9OV7?7[).T[>K_>]K^XR(W[!GV[_ +1[+VNI]S]TKD/M?Y;@%/0 H 4 * %
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ML[6M]C>UKKLK!LD6]^[>]DW[JULL>V]LF;Y_#]0'*>=R^+[\Z_U:TS?/X?J
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..7)*<F^F]QQN;.OY#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>g149615g72f51.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g149615g72f51.jpg
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M 0$! 0$! 0$! ?_  !$( -T"70,!$0 "$0$#$0'_Q  >   !!0$! 0$!
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MEP1PD( G%$*[R8*6AS<O8NU<=:L8Y-=]M2B-86VFJN,#$D;&2H#8<+"".%!
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MDD8UG=^_%\9IX@X]@4YLJL+WR*]M;Y3832S(RK:*QQ7"W;6^,)2%IV?%K!6
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M5(;$RT<2ACV$(4&?"R2(?(>EJL ^I=UR$#T9WJB\>*&I%W&-9NM>W<C1R6-
MK8NG'ON]@H7?A=46K%35VUE;XC@91/473O?ZL3</&C6BWCV'N,,'>IWZ %9A
MO@W6NR4!<@*XL"%L"T!6>(]F4^9=/?#?&QM+F4NK8VDW(QJFO<7SO*\?RO*<
M2978UD$/;,+Y.=PJ67$M+&9/L,<CB,:7Y->L WD%!"GR934 N>/^D7!9!B8\
M-EZ=>S3R=VK>NT(53M+PPR>3778#FL:VHL3,X%7:* (5M,XZ=94M\X>Z:H[&
M4JHL5<A;K7+=+M5;(8L9.^"#!K38RL$$1]*^V720@PCCIU/=H?$7CF\F0W6-
MTN&;AXU,H\6Q;,I$G,*J@@09-!FXSR<2EQ"U&3WAE?>P8DR?%CRH\4X8\.2.
M<.)+'Z5>I@=V5-P6K%2OC\K396I4L@1WTU5K.KDA(Z+%E7NV2YLJ!C0 Q A!
M9PR ..C70PVY:N:LOJHI9*J:*E2\1W55EK.O?@CIF$IM6"Y>L#8 F($(@4'
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M5A*QP<_#[.'( X!J.S*Z(:#91XLX6V6RU*?<?1R+*A7\'C\-=4=*G<JVRQK
M[%ZS5M Q#FG4AM!RS#I*LXN@EM &#M3M1:W67T[QUBNXBCBK:RJ5;5>R6/,.
MS;?7L :FL.M#*;5F,B5=I=$K:(LBS=CMH*O8W;R!M_46LRYBQ+.^N'RY46%6
MQV2\AMY=S,BU%+6"#6T-)%D3'AJZ: -(T&,UK$<4CB%?V=MX%&V\4K%5WLL
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M2O<2['18G9R'Q135F#2K9%.I&@*M@C@%0ZB>,OE,C*<CFC(-Y%8@VE$K_,9
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MI.Y'JO=5>Y>?S<OM^'R_+MIIIXCJJ@'SW^[Q^B*J)^Y$XTT]--)OYTO^L?\
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MLS\^_5$;(1WCS&>A%5WET$\K5=RO'JY])(&B*OR:([FI]$[)V369^D?'_.L
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MG'=6JJ?>Y]_;ER*GW43W1>%76SKS_P#'KIPTU.F(;>) _P#6#3_J$1?^U_\
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M6]Q[7S/:AC8#B6R,1W"\AYY\^([& Q,8+#T<2+YLQ26:X?*X3+.MS&\RN#9
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M]5*-L6G]DY,X=WKHKLE!+5$2$+GJB8F+HVIV1R'#<YR/<_</<==R\^O<2QW
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MY5G-;%6V *7:Y%!Q6@2?'8.N*1(TH9K([)0TB\:W]&]*SD-Q7XR#5SGL*_%
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M+;Y%/O+*PQ[PZ45)61WR*2'3U]CCM/7YJ"QHLSHE!*EUF8?:2>=%GD@R*TT
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M3$\3$_=S^VH*)F)B-<,,H 4RY%,C6,6RCWV03K:.6(K7B""012-BN(PA!D(
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M--&FFC331IIHTTT:::---&FFC331IIHTTU2>]EK"%30*4J'=,FRTG@4+F(,
MH*>41TEKN%(ADE.''$CAHI&.,I>(_E&S"//G[OY^[6!SY1'Y_/S_ +\MD;6$
M^JLZ4:2&S(\Q;,KC*SRS"EL'&;Z=C%<HO3MAB8<;GD12E0S"*AE$$<><3^'S
M^^H"?*8]_K^VG_>$2/PF414Y]/85I>>/922$BHJ?3O(XY^BJGSU ?:C\]2?I
M^?\ G^^JRV(1375M)<SH5*CRVHO=486<!S5YX3L1H&/^7R^FLS](C\?G]]8A
MZS\/YC6G]5:MUD[=^WFR\MDU93/= JPPF1X3EZHGG2(0Y1)+X[^H))*^J4;3
M/8KQC8QHU9]Y76A$<<^^?G^-4G,\S'NC_&K6V:M9UEB\H,Z2:4M9;%@Q2'(\
MQ6P_109 @N*17$>@B',T?6]WEB\L3.D8V-;B<>?QCG]]9A/,<?=^VN6]4!TG
M%8\YKT;\,M(Q2-5%7S!2VDA<-X]G-,<#N5[="/3W5- ^U\8_W_C0_3X3\_/^
MVJJV=@NEYH&0CT8VLKI\UZ*G/F>8QE<T2?YJ\S_-ZE^05;Q][E,SGV?C/'\_
MQK (]KX1S_'\ZMC>F.,N) .K&J2-;Q7,(K4ZV-*&4(C6N_E(U_4SK:B\.5C%
M5%5K53 /7\M9GZ?G_G6.YV]*[6A6)BM3#R7=[.H<BCVSQ>>\HX##C*$M]F&5
MGBKZJOP/"HWI+#*)H'#DSI$BFQ2I([(\GI 'T,E<8B$UZH"Z_;(PJ)*9Z!Z(
MCNVK'3[0U*L$)N*.)(B6A<RYZHGVFRMKU,TS(YC/6G8O9VVUHM;CRE< .V?B
M"8./P.%!W]&QN+/-2VMC$'!*KI3>S%T1Q>)R#%L.%86W%F6]G:7$[+LZRZ>R
M[S_/KE@FW>7WR ;'9(,,*>GJJ6KC-968OB]:@J7%Z0,:JJP,&,I3VT* 45G[
M9/LO*&W+;(CNV7<<=1<>0+"/80@.%H5$+"(B)F=/=^[K6Z[E:(JHQ&!Q""H;
M:VW1(YQV!QDLEG83+/ZEJ[:9,VLOEK/5>R^0-MRVR2(%JV)L=4Q?1V]XX?5-
M67\+$1W_ #4=@(TLS1I[(IGF$I'+RO 1HU6HKT=MG/G$?ASKRP1ZS^7[:OO5
M>K-,F0Y#3XQ5GM[R6R' "K1JY6$,4YB\H*+%BA80\N2945!QP#(1R(YW2C&/
M<UIK#<ZLH)5C)3$;>!%K'$4D2FRJ2+&IL$)%51PJ^QFJZAMHP.'H 3K:);18
MK0BD0Y:L?.(TTZXF[$Z#((5IEEL*R;5''-CU^+!/D$ 4L3NJ++M+<00PYCH!
MF+(968ZMR1LP,8IY:*/T1FFMO5]A"M8,6RK909L":%DB+*CO0@3A(G+7L<G[
MG-7AS'(K'M:YJHC32S331IIJ.Y)E>/8E$#+R"R%!;+.D.NBL%(G6MQ/<-Y65
MM'2UX9=O>VA1#(0-73P9U@9@R.%&>C'*E37J0,$TX'JGI 8@B-A<3/0M803&
MG,1,P"Q(IB)XCRUT,=BLAEFFG'UB?*5]ZPV26BK3KP0@5F]=L&JI0J@1")VK
MCT5PDA@VC)1S^9.>[;W&S.22-R:NKMMKO"AE-^.5N3CT0U3,RW:"QN#RWSMT
ML?I4B6V/X'M7?71H)]R*0<G().)1["?N!'I\(XS%\'S9^*Q1F]4%2P3VP5E<
M=!OQS&24G=0OI-56DYDC-Q?+91!G;A=;_J2'[U5+!?2'51B,@RONKZ7,1CR5
M@;TQ<K8??%2DM(U]KY6X+:>3W!NW&T%O7MJ] 8R,R=>OMQEW/3&#78_2# L(
MQ'!Z;T>(U$2OC3WMF2YS#'L+.[-T= ;"ZOIYYEO?S%!T#'86MA.E>F:(33H%
M@V-](I*DQ/;'CJF",Y(C8R>.()C3DF-+CB((R*>(B(GB(C7P?)Y;)95@3D+!
M'%8236J@I56E17U3)HHX^JM%*@F6<F:*E="Y;)L()81%,U(O2QZHJ-5&KPJ^
MR+QVYY_'C5NN;/\ QS]_NTAAE>XCVN(KD5.41SN5ZN?\GE55.$YY1.$]NWT:
M:<=---$O^?=^3>/W)III1!]B?FW^QVFFN,_GS6JG;[C._P""$<J_P5>?[M-1
M/X?A^_GK+&'26XAXA,FKK%4"/*&S4KSD^X,S[HL2\B/8KE15:^4"74L7V)-$
MX;.51-8>A_\ W1\_M^ND>_\ "9_7S_G6O-9ZG1IIK./B6OHL##(5*YZ.F6]F
M*0T+45Q$@UC'F.9&-Y<J^H)$"QO')%(]&<JQR:P/TB/?,_/\>NFK9V]JC4F'
MXS426],JIQRBK9*<HO$B'6QP2$Y;RU?VPW=T547Y=O?/41Y1'PCRU-'-:Y.'
M(CD145$5$7A4[HO?YIIJ=#6M;STHC>55R\)QRY?=5_%?FNFFONFFF8CVK)4B
M.56H]J]7'=$;PB]/?NG;MRJ<]2\I[\M1Z^7$_P#''G[N//T^',>[3PBHJ(J+
MRBHBHOU1>Z+IJ=,SR,<?S$1RMZVO[<<KTJB]N5^?"<<^R=N>VFH\_N]_Z<>O
M]_TG3RBHY$<GLY$5/R5.4TU.F0[?VY%_TWIQ_37J3]_2O'X<Z:C_ 'CF/=Y_
M//XZ?--3HTTTQ%Y0I$7LJ/=V_5?[4X5/P7341Y?WG]9F=.T5%0 ^?FCE3\E<
MY47\E145/P734Z;)7:0_M_*<W]/V35Y_>G\=-1S^_'Z<^7S]^G4*<!$G_LV?
M[J::GY^[22:WEP>/_:)_$?\ X+_=IJ)\_+\_[<?/Y:[PTXCL_%2+_P#$=IJ?
MG^-$@ZA1O2U'*Y5[KSPB)Q]/=5Y[=T^:_+C343^'[<_XUU$3S1M?QTJY%Y3\
M4547CV[*J<I^'&FIUTTTT:::1GCO*17-XX\KI[KWZD<KD3\EZO?GY<<::CS_
M  ]WQ]_X3Y?YG2D;58-C%]VL:U>/;EK43^[34Z]Z::---&FFC331IIHTTT::
M:---&FFC331IIHTTT:::---&FFC331IIHTTT:::---9GWR1R7=*Y47I=5%1J
M]^%<V617HGR541[.KCNG4WGW35@>D_?\_P"^JC]8^&O&QR+\?N%X7CX0B*OR
MY6;&X1?Q5$7C\E_'4GZ1\?\ .@>L_#^8U:^ZP_,P*];QW:ZJ(GX>7=5SU7]S
M5_1=8!]J/S_:=9G]F?R_>-0#9:)Z>TR=G''IZ[&V?3_C09I53\_V**NLC]WY
M_O&L0]_Y?/YZT'JO5FLD;P021,UDR'N:YEI!@31=//+&B!\.<-_*)]_S(#B=
MN4Z"L[]74B7!]GX?\_SJD_M3^/\ Q_&K6V3A$CXI+E/5JLL;F4<"-555!@CQ
M8+E?RB(CE/%,B(G*=",=SRY43 _7X1_G681Y3/WS^WS.GW=<?F8%>)QRK75)
M$_#R[JN<J_\ 51WZ:@/M1^?[3J3^S/Y?O&JEV*BJ&[M7JB]Z9IN5^EC,C3FI
M^2M<G'X(FLS](C\?G]]8!ZS\/YC4]WZMZG'-JLKR>^G1ZNDQF*"^N+.6_P N
M+755?*"6QG22<+T B0U.<S^%Z1L<O"^VJ#<NNMCW&*TI6QK6%/ @M8$9F4^Z
M!&)F?PC70H8Z]F+]#$XRJV[DLI=JX['TT#U/MW;KUUJM9(^74U[VK4 S,1)%
M'GK\X]FZ"SM27.\^8UTFOS+<P44U926#427M_MM'*>7AN"H/VB6:@F%R;-FL
MZGFS.ZLH*R)-71T38NCBTL9+<K;"0MWX'MJ/GJIT!F2JU..9@6<%-BWQYS::
MP.HEI3 ^Y^D'*4J44?H^V]:59V]L]M@;F0JERC=&[WBM.X-R]<1'?IPU 8?;
MDE$"O;V/IV84F[DLF3[X(-XG(UZ<*K!D1/\ 0*-I1K_68]J_KKL?/]M?,]:F
MV4'T8E*=_P!+>3'_ +H=</\ [O\ MU4?VOR^?GR_F;0])^/\1JW]8:SUD??>
MV/-RZNI55?0TE.*<QO*]+[2W/+&=[V>ROC0(41D<O\H;)\T;>&F?UM-4F\C$
M>(2D&QQC1PIUJB\(<[ J]6=37/1J.<[I3A7=*M1>=;M&F=QP!TMA,GT,<"Y,
M5S,3T04^0#)%P,=11Z\^?I.E>NA329\J)T#UK2;163(B8ZY&/,BZ1Y*>D9].
M/+UUY 9IAL>CF*KF,>Y&.1W2KVH[A>._UXYXYXU0]!H9(D#!&9*5$Q9+EBXF
M8%D04>A1Q/E,QY^LZNKO!ZX,3611 PT5L%D+9(Q)+*1]"&9XF)B)^^(UISP^
M6YB0LFQTBN<"JEP+>&JK]T(K])S),43.>&M;/J95@141.L]F5R\N556G5^KV
MN;NFQVMDW%_:UU+4PT8Z596LR/ @QT*1@1(:5*((+'%,080M<]'%,08AHXCV
MM7!C%J"6-,%@/VC,H$8YGB.2F8B.9F(C[YF(CSG6U3I7,C953H5;%VVZ2A5:
MJEEA[)$2,^A2A(R@ $C.8&8$!(RF!&9B ?:#-<S_ &>(59</Q\G9^99E5R W
M4L2_=>[&,"E^CL8Y.QACMLY6D;"E"CRPXCE=3(1[M7NV+'D@)0J>>7V *&3'
MI_1K%TE$^L0=GM])1!0AZRB9[_U?A<-[67M!F+X^<8;#6EG24<><1E,\GO5F
M#/L$57!>-EZC8H\OB;:^(D..8+18W+/;L29=9/-C^FL<OR&0EIDLZ.XC#DAI
M.<,0:JH=*9ZP>-X_%I\8A2GD+74T-2.1;4UEI*3]ICBC@WMGK<43,3(]7$0"
M^J.J$J%:1+F16/.N?DL[>R2@J3V:6,2SNUL1CUS5QJ&0,K%TH@C.W<A4]DLE
MD&W,H]0@%FZZ!'B4S84.RARZZQB1I]?/C'A3H,T I4.;#E">"5$EQCL>&1&D
M@(\)P&8\1A/>,C',<J+>0B8D!C!"42)"400D)1Q(E$\Q,3$S$Q,3$Q/$ZY:7
M.K.58KN;7L5VK<AZ6&IR7*.&*<IJY$UM68B:V 0F!C!#,3$3K+>Q!I6T^77_
M (7KJ3(/58O2_;;8*TG&(>3;[*DL 5<O"RRCN>:;;;'W\VOQ"08CRG)@5_M;
M.GR9MU87)V\;&R5)[<.R9D$K\1C#*9F68^2@"KS,^9'CFD*)F>9\,VD1$3#9
M.OJ&^EIW7B,?])]%2U6LI=^I-_5*X M5/>HUV6TYH%+@014WSCTV<PM8"*PS
M^/W4BNI%&O1"=13/YG\WMY_BO]J(NNUKY3/N_&?XG3>#L87]-/X]E_@JIIJ=
M/>FFFR?V<QW;NQ4_'LY./][Z?/NJ::C\I]/P^??[_P O?I1"3@2K]7JO\&I_
M=IJ=<I;'.(SI:J_LB]T3GA6L>J=^.RJJHB>W*JB)IIJE=Y=N0Y11"R>%-C4V
M0XI#DS66$N0D&*>JB^9//&FSE5OHO1JPDZOGD=Y4(RR6D4()AY(<3D8&2,H
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MM<BP^D"$IZY;KP TPO3D([#+3*(#%:Y-HKB8F6UO 17F]#E#'4P)K1(!(F7
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M.*!34W*3@M[*R<F<P%>*NYTX^I=M3(RO!Y',HDQ59;!:0]1%GUX9L,XI424
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MG)8]8H[H,4(G#4PFN="]JY)TX K4[>I?4FX/KCL8/'6*-5Z?J^Q4D)4Q[O\
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M-1J9\HF?NU5.W^Y4O,+>;62ZP$1!PBV,4T4A2,8$4B,!T>2XB<$*[U3'C.Q
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M-DA*^)'J ^1(.H9'6X_+5@PUC-4__>%95!]],59@IM E)M@%3Q/!G(2'$C)
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M!CQ\E8SZ-_HM2L?<#+_T>[<SEX8CB..<GEKQ3]Y%)3S)3JM<Q'Y669,Q$_\
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M)[U,/3L?1E8NXG&8JSD:ZQI;0M;>:Y"V$17&7\??KV0 Q""K RCPX"(&F)S
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M-YEHJM&E2HXN\5I]^OUP&32;0"Q7C@JLA(BM1&91:(OZ,>7$OP?$1L9(9B1
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M]I&S<Z!*K,9B?!TOI!C=M5X6+?B74'6,C8LUW)FGVU6U39K@@0<Q+?ZTFY4
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MAUQ>OLH\L=SMN*8RVLKA@:6R=45-@9M7*@,K9%M(:2,)IXXEA1ROYC_HYO\
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M1I=7N#AD^)#Q!,]DRXF2U$B.'"7$E#7+#$%*<P6.C+ G!)</<V$(T22(I6O
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M!RV(Y>ISCV$$-E*1%X3LL@LI[$_R1HC>55O*W#]F/GWZI+[4_/KYZT[MS"%
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MRJ)IJ../GU]//]-.)NXB_P"K?_NKII/I/'W:;(:)Y[5^:H]W[N1\_P %^O\
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M56?PXRD:%K8Q9#J[&LN8-Y!IT6,C%K>-!C&D'M<MMY# $UB"U6^S,W$^Z)D
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M2/7IT8KOSXFL4"W^;#_AAL=P/+1/9OJ=Y:[<R<5$^LB69R\?><O?FCZG@/\
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M^MYZ9CJ'@IF9C.P%'@FVUY#H\5QNIQ&FE1S5=?58O0U&/4PY,HH'"<:OJ6@
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MXLV1BJ,3NI\EHREL+[!6-8TQY,R3(R/$:V%'65:YI ,<<%E'B&H\K:XZ(_\
MFD"1)_&7+F296CCF9(I:@!CD[ S,#K>^I<?E_;VW;.;)?_E_+-0O*S/I"\;>
M *]#.E,R"U(4O&Y>R]G:J81X+)Y65"FP[&)%L*^7&GP)L<,N%-A'%*B2XL@;
M2@DQ9('D#(CG$YI F$]XR#<U['.:J*NX)"8P0%!"400D,P0D,QS$Q,<Q,3'G
M$Q/$QZ:\TY+J[FU["F(>AAJ<ARR4Y+5E(,4U9P)K8!Q(F!C!"42)1$Q,:0N+
M_C77YB]"$3[_ -[I1B*G+>..>%:G'*)T*OWN>_.IU5^O/O\ +T_3RC\].^FI
MUR.U'!*B_)BN3\VIU-_BB::3\_/[Z1P5Y\U$^3AHO^TO]G'U_=W1II5):K@/
M1J*Y?NJB(G*KPYJKPB=U7A.>W?Z::3_CT^/SS^&JLW0W.J=FL2+F%[29-D "
M7F+8S I<1A0+"^M+G*[F+05$*OBV=I302O-93XPW^;8!Z6N7H1[^!NXV=S=?
M 4/K"S7N6AFU3IKK4%J;:=8O65U*ZU YU=<R3FA$]31XB9XYGB)Y67RR,+2\
M:]%JR,V*U5:*:ULLM?<>%= +!K4!,DU@Q/+!]9XYGRF4X'ETC-\=CY!)P[,L
M$*>1* N.YY7UE9D0$BF439$B)47%["9'E(GFQ7,L'O>)4<08G+TZV<9?/)5!
MM'C\AC"(S'PF34E-L8 NF#):+%E< ?V@F&S,CYS ^FMC'W"OUAL%2NX^2(Q\
M-D%J59'H+CJ($N>$"?J$PR9F/.8CTT_SOY8_Z*_V_P#T3]VNAK=^?GY]VJ@W
M/WHQC9X&._%ZS)<GR'-+C[.X9A.%58KG+,HMV@=,DBK84F97011:Z$(DRTLK
M*Q@UT".C7'DM>4(R\'/;BI8!=/Q";ERWD;/A,=C<<D;%ZZ^ EABE9L2N 2N)
M8]SFJ4H.)(XDAB>-F<Y5PH5>\JU:LWG^&HT**A=<MN@9,X4!FH(!01)M:QJU
MK'S(N9&)=:W>3"GXM495GA";.+<39]3'H=XI=%A%ZRP@R7Q3Q&CEW,BML$.C
M6R(<BHL[&+,A2 2(YW,+PDIW#C_ U[N3(MO>(:U 5<^RMC;,.4R5D$0=@TMZ
MN(-1UW.!BS Q*>KB)5FZ/A$6\A,X3OL8H:^:.O0L0U92!#$&\ELY\B D-8)@
M0D)3!:E%MN+MWCDB/ O<[PRBER/A3(L.WRBDK))UNW2F4C01YLX)BK;N@3F5
M:,8Y;!T.6D3SECF1FZ_+8JJ8KM9/'UF'V>A;[M9)GXF3BOT@QHD7B)4R$\1/
M=E9POJZ"XVG9/&UC%=C(4:[#[72#K:%&7?DX1TBQ@S/>E;(5Q$]R0/HZNDN*
MRW/\0F!8/B2Y/6VE+FT./G^)[?7+,:R2FF?9^VR;(*^B>MN>/(E"@&J73DF3
M($M02?)$]KD'U=:<G+;JQ>,H^.4^OD5AE:&)L13MUV>%L7K:JL^((3,5$B6=
MQBCZ3Z1F/9YYCFY/<>/Q]3QBG(O &1IXU\5K2#\.ZW977F7D)%"Y1+.MBSZ2
MZ1F/9YYB9Q=V-KA8X[+2[CX"/$737P$RQ^8X\S'%L1JK25WQQUBE6LT:M=S%
M25Y[>E_4-%1==*<YA(I_6,YC%QC^Y*?'3D*D4^]'/*O$][L]R.)Y#KZHXGF/
M+6_];XF*WCIRF.BE+)5%SQM:*LMCGE?B.[V99$1YAU]7E/EY>3'?>(G9?&<G
MQO$KK<3%8-IEN,SLOH9![RJ#33**$2*-DM;TTP52!+-TI%I4/+&VV;'FOA/*
MV(=6:-K=FW:=VG0LY:BIU^DW(53.R@:S*JR6,,\43!KCWI9_T_4R(? -E<E"
MRXU+&Y,'5MU:;\E46VY59<KD5A(H.N$A$'X@CA(]WK_H=1QWH$Y7)0!3"3&-
M[,#L\.QO-<JR#%]NFY!"?<#I\MS?"1RHD EH6IC'=85U_.I9D>5-BJ*/*K[&
M2!QBLBN>V:PT84TMS8I^-J9"[:IXCQ:>_%>_DL=!@N7F@"EJ;3:S 8P. -3C
M"2F%S,,@@B*F?QS:-:];L5,9XE7>A%R_1@P"7$F#EJ[#$L$S'@26PQDI@)F#
M@AB?7NYFV^+SH-9DVX&$8[96<8<VMK[W*Z&HG6$,KU$*7!B6$^/(EQB$11C/
M'&03WHK&O5R<:W[68Q%)JDW,KC:CGA#$JM7JJ&N IZ1-2VM V 4^4$$3$SY1
M/.MZQE,948M5K(T*S6C!J58N5TL8!3P)K!C!(QF?*"&)B9\HGG50[\^("JV(
M]#89!MYN;D]+8EK(KK["JG&K"J@6=O9AIJNIGDNLLQ^4.PL)QX[(S 1) '-.
M-221KU-;R-R[K1M@%.MXK,W:S22N;6-13<A3K#QK(0V;%ZJR&N:80$ LQF"C
MDX\XCF9[<:=OBMEG&Y6TADJ";%!-5J5M<Z$)2R7W*YPQC"&!@0(>"CDH](LC
M%=T<7N,7??7)4P$]9Z%F2XWG-GC=5D6'GN)BQ:*/ED:!?6U?32,A1\671B-9
MO=91;""Z/U&/Y+>E4S5*Q4*U8GZK),K&Y3R;J:+>/-[.W6"\"K+U5SM\@=82
M=,N!JI#DBZ8WZV6J/K%8=/U<2I"+56^VJFS2)Q]%<;@+L.6@K/(&B);,M!BY
M'VBZ8=)6Y^VL*S)23=P\&B7(EM&EJ)66T$>S&ZC"Z1=(2 6P9+8M/':X]HCA
M(M>%KBR_)8BNU:>9PZW369E<:NQ$NB4'>J@Z)K#)V(E1-@XE 1).Y'^D,21]
M,1SJP\KBUME#,E0!\=WE)W*XMCL#)/Y63(..R,23>8_IC$R?$:X66YFW$;$H
MV;2=P,(CX9.,P,++CY70BQB892F"@HM^2>VJD$4P#B1@9;W*0)6(G4-Z-'F<
M0ND&2/*XT,<TNE=\[U4:3"ZB'I"U+809=0D/ LF>H2CUB>!93&!5"\>1HA19
M,"%PK=<:IE)2,0%B60DIDA(>(.9YB8]8G20NX.!074I9N;XA#'?"AS*,DK):
M:.RZB3)T*OB2JEYIK&V,:5/L:^#&/#4PCS)T.,)SC2@,?D>6Q:H1+,ECUQ:
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M1%D%M&Q1A0;_ #'-Z'< R^)85P%Y3'&>/$SO@%VL1407SUG<$6S-80Z2ZR=
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MM(&@) 4043,CR,!N9.==:KC2M4G5J]&Y(O94>#*N163JC(;3L6%@PUCUDAA
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M^&?-O4;?W3\4LJ:4+Q,T>ZN>UV7YSA63EE459MG=8A+MHT;"\0Q+&HLB8:9
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M31%D <0$0IQ>I()KT5>C=S-"GC[&0BPFPM5&[D%+0])G;3023K'A?;Z6],#
MD0S( 1#UR,3K>M92G6INNPY3P73M75 ERB.RJFHFN\/[?2SIB.DB&9$9(>N8
MB=5;7^*W:*;1LD,N@BRI-HL:W>3 CSJR%?%J,JI'W-)CT.?:S:W').43$&V(
M.J6Y$5CY$.7)6/ F E.XBM\8%M?JBR(WOJ&GG_JLF*7:*O>KS8K55M<Q-0[C
M.(7"?$#,2:S.04P3UQU[OPQHZ^^(V_J:KF?J\F*78)-Q$O16!CC55.V?'1">
M_$Q) 9=*S@]6I:[@_"]OH&?APS-;])]716;,1Q>MKKS+V-O&0WI&2#'MF5D@
MU8V9U69(EO(B#%'D&BR)8FC<3M/RO9Q2LH./R-KNIK.BA22FS?B+,+GH[0/A
M)DF&<NE;S"( R S&(F>N[(]G'+R(T;]CN*KMBE44I]V(L0$]';%T*(E0?+9!
MQ!$"4@1Q$<U7MCXI]M]T\7-F+(>3;?8A(10TV4;I1J+#J+)I7K;.KE0\=L#9
M!+%92ZZ=5RH\\">4\#_+1J$ZG=/&PN]L1FJDY#MW,50*8&O=S85L?5N'W7)-
M=1Q6V"YB6(,6C[,C/''/,\<G$[MQF6JS=[=O&TBXA%O+!7I(M%W&J,*K)LLA
MIJ-1BP?*1GCCGGRN)F58M"LJ^NF9+01+"R9%=7P9-S7 F3_B;IC:WT44LEII
M7Q!(,[T/D,?ZOT4OT_F>F/T>E.]26Q:67*H-=V^TH["A8WO=SL]L"."/N]IO
M;Z8GK[3.GGH+COE<J 8*.U6!C.CMK)RQ-G=D^UT 101]SM,Z.F)Z^V?3STSQ
MT@[B[?68K(];G6&V *:.:7<&@Y/22Q542.3RCR;(D><1D&. O[,QI3A#&3[C
MW-=VU2K+8IPN).3Q[1K@3+!*N5F"@ G@S=(LF% ,^1$<C SY3,3JM>3QK8:2
MLA28*!(WDNV@X2 SP1MD63"Q&?(B/B(GRF>=1B_WSVDQDF"MM\^QP8=R;633
M8;.BV(+"KMYD.)*F2GMM8+I%?&A 9$( EC+D@@MFO!!60DN0$+].UN7!4RQD
M/RE01S#SKX]H-%J+#%K8PYAZI-0+&%D,M88JADBKK[AB,ZMC/8>K-"'9&K Y
M-III,%HL4\P S+ARY)8!$!(RPR%<,D5]760C/?>/=[$]CL$L-P<R9;2:J#-J
M*P%;C\%EG?V]I=V4>LKZVFK228C9LTII'G*'U U2*"29%=Y72[+<&>H[;QC<
MKD(>:%L0D4U50ZT]UEP)4FNF37#&$1]4CUCP F7/L\:G-YFG@<>S(W8<25L2
MH55EPVPYKV"I:D*D@@SF2ZNGJC@!(O=Q+I4;GX'<8?C&=MR>FK<:R_'(F54<
MZ[LX%0DBFE5T:U=(>DV2-@UA0Y07V+>MR07*K9#F<<ZO1F<98H4LG%VNFG?J
M+O5FV'*1!UV*!_7/<,8CMK8,MCF>W,\',:N3E<>ZE5R$6D*JW*P6T,>U:>I!
MJ%W5/<*(CH QED<_TY\BXTY3<\P:MA1[*QS/$Z^NEUXK:)/FY%3Q84JJ.<$4
M%G'E'F# :O-)E1HXI@R.C$/( )A%(8;76LR>-2L'.R%%26*%X-9;K@LT$0@+
M@,F0)*(S !9$R$D8C$S)1$V,R%!0"UMZFM1K%P,992 &DB$!:)D<"2R(P$61
M,C)$(Q,R41*P^5XM&GQ*J3DM!'M+!820*T]Q7"GS5LF3"5R1(9)+9$E9XZ^>
M2$@1O]4R#,<#S&QC*RPKU(&K0=RJ#FRN%)*PH6LET,E,+7)P9RV%-E?3$]<*
M9(\P!<6%;J"P$E:KBUG;[:B<N&,[L'*N@)*"+N0IDKZ8GKA9R//07":MS?"[
M@5N>HR_%[4&/J]+XU;?U,X5(HVD<1+<D665E:HVA*YZ37!5C1$5W",<J8)R6
M.L#8)%^D\:O/BB3:0T:W$3,^(D&%">($IGN2/$#,SZ3K!5^BZ'$F[4<-?GQ!
M*L)9"..9GO2!S"N(B9GKZ>.)^Z=>8V=81-H)650\QQ67B\%Q&3<DC9#4'H(;
MQ.&TK)5P*8^NCN$XHFD:60Q6.*-'(BO:B@R>-95.\O(4F4ES,,N!;0=5<C,0
M4'8%DJ"1DAB8(XF)*(GUC0,A097.V%VH=1<S#+064E7"8F(F#?!RH9B2&)@B
MCB2CGUC5;)X@]O6;G2=MY5Q501MP#&<^KLPF7](#&+J-E6076/UM34S236I,
ML2'I32!(!Q!R0E:D=7O8]-<?_56*C-'AS>E41BZ>45D&6JPTK 7K5BJA"&2V
M.XXBKD8P/,&,QT<S$ZY?^H\;&5+%FY*X^KJN05=.P@:KQMV75E)2<LCN-(D$
M0P/,&,^SS,3J\]>EUW]&FFC331IIHTTT:::---&FFC331IIHTTT:::---&FF
MC336.L)@>7E>,JJ<.)E-J%O;_)JH-4=4_JJ9Z]O;]>=7%/LS\(_M,\:I&/./
M?',_I\Q.MBZIU=HTTU3>\T?SJO&NW/7D\:)Q^$F%.=Q^JQT368>L_"?XU@?I
M'QT;( ]/BEBSCWR&5_\ #K:D/_=+H?K'P_F= ])^/\1JY-8:ST:::R_OH $6
M\JY_1T.E5:L,YJ+R58LIS6.5J=E>ULAC%=QU*Q&-55:QJ):'I/Q^?VU4<>?Q
M_O\ /^^K$V7BB#B19+6(A9EK*<4G=7/: 80#;RJKPUG2_AJ<(CG/=QU.<JXG
MZ_EK(/2?C_C5N:PUGHTTUG;?&'ZBPQ9O'/J(EX->W_Z9U:5J*O\ _<Y4^G==
M6![_ ,OYU6SW?G_&I_M&/HP.I?QPII%N1?ZMQ. B_JT+=8G]J?R_:-9!]F/S
M_?5CD&PHR"(U'C*QPR,7GAS'M5KFKQPO#FJJ+PO/?6.LM1FIPS'J.3!F5L)P
M9%=6&J(Q'29!>(9YI; J/:4CVO*Z7(D%\Y4ZT]05B+Y:L:R9F9]9]_/Y^FH@
M8CTCT\M2G4:G1IIHTTUG_?H)2P\=<%>#>9;A$[CG@IA05&O"HJ+]\2+PJ+[>
MVK%^_P#+^=5L]WY_QIWV,;_ZK6A?^ER$ZM7_ $&U51T_N<Y_[UU!^L?#^9U(
M>D_'_&KIUAK/2::%),.7'5.I#QCA5JIRBH43V<*G?GGJXXXTTGSB8^_6(<$5
M9.88VQ6<L;;5!D<O='/;(:=6\*G"*-!C=SRJ\O3LG"<WEZ3\)U0/K'QC6Y]4
M:OT:::---&FFH3D6#5N2V/Q&9)E!*E+,IV-!Y2-:V5YW1*17L<JE!Z@RM8O(
MWJYBN3ACD?E!3$<>7KS^W^-8R,3/,\ZDU37"J*NMJ@/>0-9 AUXB$X\P@X<<
M<=CR=*(WK>T:.?THB=2KPB)K&?.9G[]91Y1$?=IPTTT:::Q990%=G=TY6]G9
MPD1G*>WK[NS*J?KT#_/A-7<\#_\ UY_35,QR4_\ W<?WG6T]4ZNTV7%+3Y#6
MR:>^JJZZJ9K6-EUEK#CV$"2T9&&&AXDH90%\HPQF$KV*HRC&5BM>QKDP8M;0
ME;0!@%]H#&"&>)YCD9B8GB8B8^Z8B8\XULT[MS'V57*%JQ2MHDI39J.97L*D
MA("E;E$# Z@(@+I*.H"(2Y$IB6?&<8)BZS8P,AR"UIBI'6KJL@G)=&HE'YRR
M10[Z:,F1V,64X@R(/(;6ZD0G#4$&7'KT!!C8)3*>H8:TPGCH!I=R5^O5$-*)
M:<%S$_U39(\<"4#P,;F3R8Y3L-/'8^I<#N1:M8]'@@O]71VC=020XZLU,"0=
M6.J4EN@NX]++'<>R5ZNURM&FFC337(HFF:C7*J(CD=V]^W**GZHJI^'OWTTU
MDCQ,[17>:WVQN8XYMWC^YA]N-R9-QD&-W$G'JV1.QBVQNWJ3#CSLB"^O+%K[
M4]7:GKBO5\@L,)XP"RHXE'X3>>#M9.UMG(5,35S!8?+F^U3L'523:3Z=A!=+
M;8RJ14\T/),\R<K$@&3 >/';JQ%B_8P%VMC:V4+&9,G6*KSKJ)E1U5R2@66H
ME<@MQ*<2IGDI 2 ",8F*1Q[PJY;39=CN<"PK'(F6@\;^XN[-WE,>51MR NSF
M2 RYE>TML,OKY$62ZPJE)C#3O,$A'%+ 8]LEZ>;J[)OU[]/)#CJB[P?21E\[
M9N@=:+1;?N!D!5!/B>Z8'W4<TH*2&2DB5$P<QP:VTKJ+E:]%&L%P=^9+,/MB
M=?Q$X6R-R%Q+HGN$!RQ/-2"F1DI(EQ/7.HOC'A+S+!=IO#N<.TF'9;EVW^XF
M39;N_MVZPQ:$;<8<_P"W-;B5E-R*P0E#?6F$1,AASZ&)>S4BP@GE1(<B(1C@
MDTJ6Q<AC,'M0AP6/OW\5EKE[/XF6TESEQ;]9HH.;;;$UK3L:NVMM5=IG;6),
M6LEE$B6I4V?=Q^'VV0X>E<N8[)6KF:QLLJ 63AOCU4VLLLYKV'4 LK97"PSH
M 9, ()CIE3C^P&^NVI=EL[Q_ ,;MYV,YSXE[N?M9"S6LI:S;VAWV-4GQBCK+
MT\!U;+J<0?4<W0Z6 8B/L#?!8-@P:O?=1VON;#LV[DZN+J6'4\EO&RW"+R2:
MZ<35W,2#I5DV37*6(H37_P"H&NLIY:7AE-B-65-N[@Q9X/(5L=5>RK?W2]F)
M"^I"L;7W!*2JH58)<J--.4<O%"RGEA=A;>.9Q=F^)2MK'85MINO JNG$?#QA
M%'F>-1;_  R-E63I'WCS7*'T6UQ\LJ[1+Z]E-2K85<">&S01W0;(CI*5ZP/G
MF4HG@YQF'SB4SX':6-K9"FNS0"[=@<_DKLU<*=Y#O%6F?T(+ZKD71!=MQ2?:
M[7A\A2/$?5^+S"T_]'MJ@B[5"Q2&Y:B,WD+<U\05Q+H>\_Z4%./X;P7;9,GV
MY7N*Z\+.3WM]GV?5FWM#$R2]\3FR&Y>$W$M:"#DM/MIB<;#778!R7%]70NKD
MC7@2X\PP#R"#(P44Z/C*_P"BV-E7;-K*95.*JKN6=Y[:S..L,\*JZC#40QLV
M0@YGN595T6A*I!"1S$P('$AS[M^TK;[.0R*L;6"S8W5@<G1<?AEVDXNF-*7C
M!\]=?M=+QFM!"13$P(%R/.@_$?L59[V9OLN L$$G!Z>)O=3YY,?*B#D5<#<'
M:6[PVGF0H9RCD39++B>!PEAM>2&1@Y;U$P?FM]5NW;3MQY';PDH3QJ%[CKY-
MDFN"2K*X.QCZ[%K(H)AQ8:,QVXF5S$'/3$=4>CW-@&YV]A!E8G02&=1D#DP@
ME+R.'?208 101E#F#,=$3(3$'/$1S&=-G_#/OI59%LIN-ND*LM=Q*S=299[C
MV<:XKS-K\#Q'9NRVMV_&!S9#DL32Y"&O9@H"..D[*)TJ5%C%26P7DL!L[<R;
M>W,OFH2_+)SC'Y=H6%%"L90V\_"8J X.8:3#YLL%?)PRZPV"$PR!\UAMK9]5
MG!9/+0IV25EC;DVB]90JA3PK,3CH&8*>Z1E!/.%\E!VS(P">N!B&'^&[Q$BQ
MC;3!K[ **J@;0;*^)G:^'D$;.J6R^V5ONA3+%QJTBU;!1S4U1*)&@@:MA)=/
M"<TQUC"KHT8!IFAC]H;L&CA\99Q=9"L!MS>6$7:')UW?6%C-5X"F\$Q E7KF
M2UC$M+NB1,ERD@ DS2I;8W*-7%T+&.KJ7A<'NG%!8#((;XYV51TU6@KI"4).
M1 8[I=P2EDM!0B)&\S_"?G".-%D;/87E#LG\$F.[22+^7.P[U>%[S8A@^15L
M6>X5D)TJ?*LIS\=HH.3T\ARP01@2),P,&M#K8;L;)=1B> QUV;OT<T\$5IC,
M?UX[<./QMM*V\.B3:QK9J5E7*Y?TA 3-@J2.KSVA?B2$\-1MS:V+5PY6#.EU
MT<W2H65 SAL2;#8?AJZ[:2_IB(D1BM0ZVYM#M?E>'5^%3;W<+,RMJ]M<,Q:=
MMB5^'GP6DMZ7%,?II\JLE0L8'DYY'KJJ7*4LC*IL,DBPF."%(BPP1OH^!PU[
M'IQS+.5R$PG#X^DS#%./+&5K%>C5KM-)KI1=,^XAA]17V*DVLD1[?;$/=X;%
M6Z2Z3+&2O3"L92J'BBFD5"NY%.LAAJ-=2+9%W$F?)7&!)M9(QT= AB%OASW\
MK/#_ +$[7APK';&300-ZZS/&@7:BSR:DD9ID=G98BZHO]QJ'+**#BT\,MA,V
M?C5>?*G #7BK6K(C/:SYS_I/<Z=K;9PPXZHXZJ]QIR<#.#=<KED+;G8^:]K+
M5;U95-L'!9&::CNR(J%,=83$>$G;6X5;=V_BAH5FG77G%9"!^J&VT%=L-92E
M%C)U[E==1D'!7YK+*W(BJ%1U!,0E)X<\FPS$;;.]RL)I;4FW7_X?U7MS4RI#
MXF23Z/<_&8V72K!E*&K?,M(LJ%#EP1QLCIFC*()3#K+ ?^,<5SM*[CZ#\GF,
M=7?.)^BNOB$F<A<;6S5(,@;HKBF6/ UK8L0MU^"@2(4MCV]8EMJU3IMOY.@E
MQ8SZ.E8Q)E(6F(RM4;K&P@52;1-8&N!M)B"@9*$LCVM4#M7MW/W?P+.\6P&%
M77>XT.#X;\IO+7%+O:N;@UYAFW\\R1ML@W--BQ\1J<^(V,2[MZW-JB]A6LZM
MI'Y%"6O@C _R^$Q3<_C,I2Q:U6<JM>T;UEU&SA&8RUC\6TNC##9KT2H(RA0$
MV+"<C7M+>Q-:;:^TN GSF)QK,UC\A4QRU/R0!MFV]U1^(.A8I8YA=.+AZ*A4
MTY&>F7N5?386YBD%9#M (SI5WA<RJ!2[;Y/7[03,JN:/Q$7>Y668+N1D^S<F
MVFT.2X0S';,M=*P_&,?VZJ*MUW$K;N1BT"-(\Z;#=;(0TX[ 0_7ELJZNOA[J
M<"=VQ5W99S%[&9>Y@#L-JW,;X-TJ.A2JXE"9L FP=)8'U,7+^2:4 'J)VG;6
MC&6E88[;Z^Y+&4N4,I:PAO97M4?#-E1TJM;&)5+P4\JBQ+E@=[DC*!#37B#V
MJW0W;S[9N#BES68CAF!6&0;A7.3VE16Y8$V:Q( Z+"ZIN(R[6L).2-$N,DLW
MS#O6#&,V(_ETH0A$]CNK"9K.Y3;ZJ-A-#'8MMK+6+KD)O"616J*N.1]7FY,M
M@%V+;Y84]H"A<\R<",^IW'B,MF,AA%TWJIT<>RSD7VG)5<$KP+BO15%(VJEG
M0#[39,I[83T3YG C.$Y^U6Y&V%WX3]H<PV[Q[>46#;J>(^+M[CMK9X]7U>X>
MWK<';D]!-EBMW7-70V=,>38&K:.^5X(LJBJ8C9XX[@6(?FC,)E\+8V/@<AB:
MFX1QN:W<&*J.=42C*XGZNB[588OFPFLZL9ME-:U[(%60N&B,BT? ,Q&3Q3]H
M8:[C:V;C'Y;<X8VLUM92<EC? #;K,.'2]5=J2-LJKV.1 ZZ0AD#(M%B%LAG>
M&9+LQM=;[0XANQF$?PX;\S/\'UCD-("BP]^9[HI+K&T]O?Q#5<LN'1\GB5!7
M!)$>D,MJ:DF%>"%'F:H[<R>/N[>PMC T,[?#:.Z&?53;58:U"<AFQ8CL/M+)
M#"QXW01,Q*YA9/FLPI%8,UQP.0HV<)B6X:EF+H;8W ?U<RS7&O2F[EH-78=9
M DF5(;0)F8D)Z"<2#F1 3T%BW@XS4+K.-DT;')E] \&>)[,X/G\PL6R)BVZ$
M2+E<2=847FC)<U;*-ME5#@Y%&AQ)SJ\:L@D$5TF.WU5+Z/\ (C+@N#4;:5]'
MM#;N-RK)!TTLTL<@#75H*"L)BM#T0JV*P9*HF%S$R8:])4V7>CNA:"JRPO9-
M/"4,B<@V:N5 ;@L8CJB7JA'=3 61 #E<<+F)ZAU'*/PZ[WQZZTN<9V7VTVSO
M,;\,<79F)C5E8X=E-+NKF0\BQZS/D5K70HIJ$]?$@TUB:F-FS7SI%Y;1DN8Z
MUK)[GZE;:>XP2^Q2V]A\-9J;-#;P4FMQ]VOF\A%NHXK;DK JI*6JNZ:Y9+EA
MV7AX@)5#9G5K[:SH+<^K@\7BWU=JCA JM92MHR]Z+-9LV7+ "KDL 0V4E?B6
M$]H=\>UW--<3PO;VCJ\JMY&!QKR&3Q";/[O-VORB^VNKRY[C.(87.Q[(Z&V'
M@5)0[7UUFMN>!;!A+31J68E9&]?,N+!A+*90O9>XX3?L'C LK+=> S\86[9P
MJBRE.ACF5+E6Q&,JU<*IWB"78%?APK,[ =UEAL2UE0;4SL)MN+'@\)W'A<S&
M)M6,4N<A5I43K6:[8QZ*^)4V7$MT+[ H/LC##>R):<RW#\+&2[DS=T,A/LA@
MN-$N_"D3 MNL49/Q*SC8?N63,LWOAQ*F2&-!KZB=Y-I43Y-]7QHE<"?,EQ8E
MG)$(\@V_E=DW,NW-VRVWC*<V=C%B\11AM!P8_,E?R5F%H,06JNWI?7:=I0 D
M6,8 .,8,BW<CM*UDV96R6"Q]67[1+'XVG#*;1I96;M^P()(06M+.EJ6'86(*
M%C#$&G$$4_HWB$&PK,2Q>MME5;2OQVD@V2J9)"K81*R,"8JG:YS3*LD9.3(Y
MR$7[Z.5'<K]<H+:FC22__OJJ5ENY+KGN@D!9[43,%[<3[7,\^O,\Z^ETEL53
MJ*=_W5UD+;Y]7]0%")^U$S!>U$^<3//KSJ1:V];.C331IIHTTT:::---&FFC
M331IIHTTT:::---&FFC333%'QF@BGB28]5##(@RI\V(9@U1X)5FQ!SC,7G^5
M(&C!N1W+&L&)@VL:(:,GF?O]T1^4>FHXC[O?,_G/KI]U&IT::::[2FK;ID,=
MG%;*' GQ[.*QQ"L:.;%0B *J"(/S&M0I&N"7K"1KE:4;V]M3$S'/'OCC\M1,
M1/K[IY_/14TM911RQ*J*D2.:4>:0;2&(BR)+D<5Z*8A'-:O2UK!L5HAL:U@V
M-:U$TF9GUTB(CT^.G34:G1IIK/6^,/U,W$FHG/G#NQN3Z^4^H*SO_6)JP/?^
M7\ZK/W?G_&IWM$SIP.I>ON:1;O7^K;S@-_V0MUB?VI_+]HUD'V?C_P ?QJRM
M8ZRT:::B628A"R:932IL@XFU'Q%&B"@_\8;8 ")Z.>]'*/RW $1JHUW5PYBI
MW1R3!3'/IY\>OX:QD8+CGW:<,9HA8U1P:0)WR1P6G1#D8T;RND2CRB.5C5<U
MO[0[D1$5?NHG*JO*Z3/,S/WZF(XB(^[3[J-3HTTT:::---&FFJGW4@%FIAC1
M!(;KRV!$>@V.?TCEM>KW.Z47I8B Y<YW#6M1554360_^7_VS_&L#](^,?#WZ
M-FH1H.(E"<1 D^,SD5A6.&_D(8D1Z*UR-7EA([QNY3E'L<U>%:J))^OY:!Z?
MG.K8UAK/1IIK'.WT#R\KQ5%;W+>VS4[<<I6U48W'M[-Z%7CY<KJXI\I^$?K/
M'S_MJD?M1\^GGK8VJ=7:---&FFC331IIHTTT:::---5J?;.M/:EMEGRFG+E-
M?DZL08E'U0'%+Z%?\I1&.<KWF14>UOEL1BJQSR9=4\1'EZ3']_\ B-8],<\\
M^^)_M_S/SZV5K'66C331IIHTTT:::---&FFC331IIHTTU\5K7)PY$<G9>%1%
M3E%Y1>%^B]T_'337A0B5S7J(:O8Y7L>K&JYKW)TN<URIRURM^ZKD5%5.RKQJ
M)B)F)F(F8\XF8B9B?3F/N\ONU'$3,3,1,QYQ/$<Q/IS'W>6NFIU.C331IIHT
MTT:::---&FFC337A@V#16C8P;5<YRM8U&HKG*KG.5&HB*YSE57+[JJJJJJKJ
M(B(\HB(CF9XB./.9YF?+WS/G/WSJ(B(](B/?Y1QYSZS^>O>IU.C337Q6M56N
M5J*YO*M5415:JIPJM5>Z<HJHO''*=E[:<1]WIZ?AIQ'W>GI^&CI;U(_I;UHU
M6H[A.I&JJ*K4=[HU51%5.>%5$5>Z)J.(YYXCGCCGW\?=S]WE&GS\_P!HU]U.
MFC331IIHTTT:::---&FFC331IIHTTT:::---&FFC331IIHTTT:::---&FFC3
M31IIHTTT:::---&FFC3346R'$Z_)951)GED,^$/FO&("C:TZ30C$]I'/8]S4
M8X(B-5G'*M5KN4=VF)F.>/?Q^FL9'F8_#G\^?G_C2W&Z*/C5+"I(IBR PD.C
M3'1B%(Z1*/+(YZ#:UB?M#O1$:U$1J(B\KRJIGF>=3$<1Q\^NGS4:G1IIHTTT
M:::---&FFC331IIHTTT:::---&FFC333!%Q;'H1X<J+5102*\\^3#,QKD( ]
MFQ1SB-<KU5RG&OEJC^IHQHT8D&QC6I,S,^LS_P :CB/+R].?U]=/^HU.C331
MIIHTTT:::---&FFC331IIHTTT:::---&FFC331IIHTTT:::---&FFC331IIH
MTTT:::---&FFC331IIHTTT:::---&FFC331IIHTTT:::---&FFC331IIHTTT
8:::---&FFC331IIHTTT:::---&FFO__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>g149615g73d45.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g149615g73d45.jpg
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M\$1'559F='63H[3#_\0 ' $! 0 " P$!              $"!@,%!P0(_\0
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M/I"NG'P@5^EP5+H+">IJ^I>E>G),N,?;6Y+'Y79KM[^D: ..[3SN4E9BAXG
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ML#K#2=EZ?0&8;L/?FT(E!V)B,-\-X&#MJME'3K'KGFF:.Y4@(.86&%\*I/\
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MT.0&.SO2TP/]S.LD0_ZO(+1K&=-QWF.UFPM/>>TK[;V=+<\%TC"-RGK3S[3
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MX#X"/ACJ0-<L'!DH'\4><._B9IEC/LVOV)ELA=7VX25%K)_>-=\<U"XG&)"
M#)3N/\$V,L)[.;7=DEVBYMR\^3A$X1.$4;R2>^@#,3Z-MI;"^8W^,<6AL2[N
M&%R_Q?!%8,A<[\E=&JHB)Z)QZZ(I)PBUJUG6?0-1+>0Z^Z+K2]21<6-@)8=I
M;(,HM^@G)EL)AZB/41)(.Z0B9D*-!E'%'9&)&C QH8(^H=8K9)+)-) ^229[
MY)#)553@YSR2X%AGW-W7 ;NX#<, W0 -W9[1-JHHJ.&"JMT#:"EI*2D=%8+
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M[RO5J>GDED@I*2!\LLKXZ>FIJ>)SY))'N$<4$$,32Y[WN+61QQM+G.(:UI)
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MY;W3SYJNZG#RU+JB)ZKK[6V5U5H1-.-/L[8FPM:I]N1;5\+\95T94,)>>'L
M+H._816&,,K A.HHKZ:NXRT3H=R,NDCI9@!B5\+ZES]X&3?:#3LB+08VXD;/
MO'=,86];2^SZVVC9>EN]OO0K+Q2PT]5M+:96SM-M@JZ>PTL3*:86^.CJ9:>^
MUEQAJ'0W&I8^BEMKH1VD-:]^W/7&$&Z_SWW6TIUE:'%RVM_;R-<Q]G;DLBCF
MF:QSY'1#PPPP"BQ.D?)\&%LI$DQ<Q,\NQ  # 7E"S.F7YJ$&B9^)]\;$(2Q/
MJGW,/_7+Q9T;ZR,&*KH9*CX[41(S;4%BR1NF8]!]>'/Z:(I+RHJ0\A!83.MR
M1IT7X<MW0M56N5DD;OO"/V2Q/3ZQS1/]LD$K?1\4K62,5'L:J$6G@3IG"P_,
MR0S3M:L<TPZ^L,TD3EC=*QOHGP_B*WWN@]7_  'N=#\27X?Q'$5U=#^G^42;
M]?V+OO3_  ^_,EZ_R_/T_P#SZ\(MR.$6D?;^=,S^UL3YHGI4:<AEA5&>BJ/\
MZX2)EG523*B(P]I0Y-G# _T^. 6U1'3_ ")[1"*L))&1-]SU]$5S(VHB*Y[Y
M)7MCBBC8U%?+--*]D4,4;722RO9'&USW-:I%NWU#F3LQC1XK2%PMI;&$W1P;
M_H\)2F0#A"RM]5]A,-8&"AT?N>V,]2F1O=&UB\(K0X1%5$155?1$^JJOY(GZ
MKPBAZRS:U58+)(/EO54D.A>Z(C2HB^CHZZ5BM?!0._=?91N;-<M]?NU\=6L9
M]DXHN2[AB+=69(:*.(,V)TMG#"QL<,.;K5@CG 9&Q$C8RTFE#J/EE:QLE5-:
MO@<V0-$X12SA$X1.$3A$X1.$3A%57;I_MSP.?8[TDU=R'5SI^\BU ;9;N\9/
M$GXGAV%;6344[OI&V2Y';(OI(C7O7Y_3ZHJS<YK&N>]S6,:U7.<Y4:UK6IZN
M<YR^B(U$15555$1$]5^G"*<=?ZC)Y7'9\'1:G/4EE<LL=7'66]S75QXPFQN[
M/2!0$#%D0R1OABM&A/>YJ1RECS,A<]4].3(]>>?GQ19C4=+],]@DI<:[J_KG
M6V$\3'17MQD,[:VWPW-1T4PEW.!+8PN1JH^$@4N-[/H^*1J^B\^&IM=MK"75
M=OHJEQ_GFIH9'_)[V%X/0AP(Y%;59]NMM=GX&TMCVMVDM-(TY]RM][N-+0NS
MQ$E%%4-I96.R=YDD+F.!(<T@E5P7XA]%E*KHJ7:UGI_FXZ7N'N&H#@_1(*NO
MWD%5$Q/X1-!^"G_D^=5)LCL_(<F@+#R[*KK80/!D=2UGRW<=RVB'VS;?Q !]
M?8ZK^\^NV+V+K9Y.O:5=3L_)6/<>;S4;_P#I+#O\/.ND54#UW; $?]F-FYDL
M$8GZ)+>UUL2__&6>1W^^Y\QV*L9_A;5L&N@JY'<>^3?)[LDX7VM]M6TW_36?
M9"H=S<ZP,IMX]2R@J*.(>#(VCN7U'X=]9.5$L=+VM:L]?Q1R=AV]0CT^OX5E
MR[* AB?7]Z*:-_Y?C]>5NQ5B&-Z*JDP<_%63MSX]DZ/3PPH[VU;5#6FMFR-(
M[DYNS5%6[IZ[EV-QB=X/C<WN6=#\2.@Q%3YC(W5]#_:#V'8_9^WK)/U^+5:_
M97=9+[OR<D@CD5/PJGM^G/KBV5L$/\-N8_NJ)JFJ:<=6U,TK3Y+KY_;'[0Y@
M>SO5%;W\I[+LSLK8:IO3=J[+9*"J9CB-V8$'48.JMG(=8];=?-E;@^OL1B6S
MIZ3IDLI19SXZ?3U^,M. &LOK[4]5D]RKZ(J^JISMZ>BHZ,$4E)2TH/$4]/%
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MGW@2W,B  @K/\LPJQMM34U8#""4B(<,&PDR.8XF,8J8<*,B:$4J5C!Y(="/
M_<8^_P!44@3?]BPK\=SL98-C]9%K64MW52%(GU^5;</TMLP-S_W$,=2FM8OX
MU"<GX$NOS]>L_1%>%%<"Z&CIK\)LK [NJK[<1D[6LG8-9"0F0,G8Q\C&3-BF
M:V5K7O:UZ.1'.1/50U /5%E>$6N>RVVFK=!?QC7CZR>GFA93YYHM;+'9MD#@
ME!^-'.'-8VOW\8^0:-*XF![?7[LK_E[<0HF2?/'Z]1X_;0ZE%L4Q7.8QSV?#
M>YK5<SW([V.5$5S/<WZ.]J^J>Y/HOIZI].5%]<(J()W^Z&[9L,V-4TEKC/AP
MU0,?QIJS0?M)7T]-I;R >Q(FDJ3IYZ#2A'5%*3#6H3!1Z,F6]%4,<0V9U]9Y
M?G]?,KWY43A$X11G4)\L%!>L3^DS93;>3T^OOK&12C7D:M3T=,[[F(.G%@1[
M&R60X#WJJ1>U1Z]-44F_/\N$3A%$RV2YPPBU&BDFI#I%GN@8&/EEKBW>B27H
M$$:.>^&=$1;P&%KED>U+@2)#5M4M)Z\./S/1%*(9H2(8B!Y8YX)XV303PO;+
M#-#*U'QRQ2,5S)(Y&.:]CV.5KVJCFJJ*B\J*%]E=E8+IW":?L[M#54^(P&,K
M)+C4:N^)^4J:6MCDCA4DN;VO<B/GFA'ABB9),01-"/!')-+&QQ ,Z!4GL_-;
MQ<Z_LMC5:ON"A +P%=);:]PE=H[L*E!& SEM92S6E#2V=81)15&PR=QIA@C"
M2LO3Z?/6VAAK*ZYKB22N#Q^2[6X\R/&?K0@07L+MBEQ<Y?6PW;J,TU;HZ= N
MOCJ3;:*OO+AYM-#'13V5/UMORZVBNGU^BL78[1"A5,YE64/&3!_#T>',+&C^
M</BB0<'6)W5F(+$F1PY0!XU]6F9TQUI<40%;MQ[&H%EP%MH+O/7E-DJC;LS]
MGLK:I/K<H)<FC20-)@\<'''[?F%\T/EUXE;EP&BI^V<59&5;(GBS%16-?=T[
M+RRZYS0GS==:5H5Q4-NBNY>KV5[; 05+2M[!R]P$A%1;BGO)@\<>C_37PU7'
M4^<WBI?&Y&OHNW*^[*WVE@R.*;49O:V<6HNC:1^GJON0D+-3BGU%]EH3=7FM
M)!,_-Z;*U5YIJ"VLJ*AN3P28/0^CC[Z?U6V7"BJZST;=8<7G<Z&1=U8)$@>A
M-&<D%069"]8B,\^ZD:HB"C3(V+5("EE911/6H&JC)9+9]3#KW_/IU[N1^W%%
M*4H2K-$=I#4+A7\J*N^*'1L:OY0FI[OG;Q$:Z0>=EA+'3FQ>R1U -*GTOKUZ
M\D4DAAB'BB@@BC@@AC9%##"QL<444;49''%&Q&LCC8Q$:QC$1K6HC6HB(B<(
MH=V#DI-MES*" ]E:1,36F#ERC.+A9+76 YR1S#LG&>Z.=L#H%>R=CH5D;.C9
MDC6"0BU9T'4&NI+7,5<!0=NS2GRURV(E<7$-32PJ,2^0Z-YLCIHW53;<]GI,
M,BK4O'1[IBH&\(KBP76$W75N?K+W35Y<$-$;6?#'K9@(H8BS:PV<F>>>P+<]
M[75<,,$$<+5>LS_QO?\ #8I%'^]KFQ,H,S&E0375I6J8YL]C,R"P*9%G=!)$
MY*F)D[QA9%?#(J61(-G!,QL!%3$_WNC(M<.$3A%T[ ]*H(FV65L#JF);2(A[
MTC0>>M]#1B$D541CX)X(YHW^J*Q[&N1?5$X1>@\0I.DEB-M()A*.*1DU;1DQ
MNB(L)(W(^&TOX'HCXFM<C9:RAE1%%]&'7+%M5@KJ&<?#D/Q/X#SUX%+>5%@M
M*60)2FN#D6$XKY>KKIT1%0>RN"H*FN(>CD<BQ#FFP33?A>J11O5&/5$:I%E1
M!!P!!01(TA%#'@$&A17*D0X\;888T5RN<J,C8UJ*Y5<J)ZJJKZKPB['")PB<
M(G")PB<(G"+4[S <W*=/;'LRCB9!MZ@+/9^@L2$<13#V.EUE7F<Y;ZBGD7Y*
M]IL3>Z5FP4$Q(XY65Y@,Y#:JRM12^HOM;+;[36U=/@3QQM9"]P#FQR3RL@9*
MYIT<V%THE<TZ.#"#H2O0_91LY;-J_:#LY9+TR6:T2SUE?<Z6"5T%1<*"R6RM
MO=5:Z>=GQP5%U@MS[=!-&#)#+5,DC:Y[6@ZEQ>+'1<PCG:+ U&UUA2QE6O:&
MQB^_.V[>Z:B.=HY^S2/39@WK2/<4"92W%6VCD<V'/Q50D P\/F1H*9[C)-'V
M]0XASZR9QDK'R?\ 6FI)[9LF=6ECVAAP(PT  ?H)WM7V]CE#+9M#66.SQ!T-
M)LI9'_L_8ZCH2<"V1[*Q9L<] 8\13P5U%5FO +[B^LF?+*^4]$ZF\:#HJ74V
MUOJ3L?NMOUE/K3!BK*ZV"8H;$7F,L[9X TLM]NI\7V%6X_1V387VNGL^O9;9
M\#BY#FL] V8K:BKMTC:J1TTM%5S40J'G>DGCC;'+"^0_SS-BF;%*_&]))$Z1
MWQ.(7C'MHLEIMFTEFNUEM]-9Z/;+92U;62V2B88J&TW&KJ;C:[K3V^ D^ZVV
MJN5HJKK;:)I,=!07"FHH"8*>(G?OK2C+I<RDMF,\2WO;$Z_LQY?8DXZFO;!5
M!E-C<^)AE;GA*>K,;"^6+YH*9S)ID=\5^R?BO(58/")PB<(G")PB<(G")PB<
M(G")PB<(L?;5\=M66%9)(^%AX9(BS1HBRP+/$^-I$/N^B30.<V:%WT5LK&.1
M45$5"+BH["2TJ*X^>-D)1 L2FCL5502PC3X5@$ON_$CPC8R!9&N_$V2%S7?B
M1>$7S?'RUE-8FC-9(9$,]E?#(BJTFS(]!ZL14145REV$HPS6HYON=*B>YOKZ
MH1=FL AJJT"L'<]\%<$,%$^1465\8L+(6OE5J-1TKT8CY'(B>YZN=Z)Z\(N]
MPB<(G")PB<(G")PBZAP -H+,!9!"6()"-:0&<-"6+.UKVR-;,.0R2&5&O8U[
M4>QR(]K7)]414(N*LJ:NE%:#3UH%2$U[Y&AUH8X(K9)%19)$'%CBB1[U1%>]
M&>YRHBN5>$60X1.$6I"%C@)IBRI/A00[3?.>Y&/D>JKN;]C(XH8FOFGGFD<R
M* >".2<B9\<,$<DLC&.(J%UO?74U)<Z"IT/8N+SUY12T05I5GV%Y9QY<VKTE
M9>GA]D:#(9K493K8IH(B.B#T]] ;#\>)UP+3L][F])4[0V6EG=3SW&GCFC=N
M2MR][87#=<1421M?%3N &K9WQD#!=C*].L_L9]I]_ME)=[7L?<IJ*XPBHM1G
MDHJ"KO4!)#)[%;;A54MQOD,CFN9%):*2M9+(#'&YSP6J]Z2] OA8B@I8GLF$
M"L(70E@6 Q=9:0?-5-Q66=44=4W-);B_UBKN:DXVN,8V:*,A"A3!Q^XCDCE8
MV2)[)(WM:]CV.#V/8X9:]CFDM<UP.6N:2".!7G-71U=OJJFAKZ6HHJVCGEIJ
MNCJX)::JI:F![HYJ>IIYFLF@GAD:Z.6*5C9(WM<U[0X$*_\ JW_O9]>?\2,K
M_P!1 \S7SJ=\(N)\$$DL4[X8GS0>]()GQL=+"DB(V1(I%17Q_$:B-?[%3W(B
M([U1.$7+PB<(JU[38T/,1ZB-&QD8>^I-FI*(GO'K:HR.#6/:O\'$X@O25KGK
MZ^V$M_JCFI[5A^WH].6?U165RHG")PB_'-:]KF/:CFN16N:Y$<US7)Z*UR+Z
MHJ*BJBHJ*BHOHO"*.Y1SHZ>.ND<Y9J(@JB?\156=T%5.\:M()1?JD]A4-K[-
MR_1KVFLD8B1O;PBD?")PBB\E4=42REYWX3QII'SF9TB180III7.>054$HV3[
MH-F>Y9YQECDJ; E'/DBK3#CKA\]'UR151W-U+UAY/8MG5':#=.W/-TV3V5QD
M*W37N#NK0W!WX.HSS"[;,GUN@DI:O6UE+=QV.5O!AY[BCKU'NI8(9X)ZJ#A4
M=DOL].F\9U[N.HZK;=VD=4[_ *WLNN+GKVS[#:9GXX[S&Y#!7VSCD^Y([FRW
M-OG<11QRVVEMKZNK[.707E'3U5SK-0=;DR?GQSZ_#CSRI]W3X2^.WD#HNRM;
MVGB!=+I^S.B5\>#+\R"L)MLC@I0.Y*LTKKTXZM,(R&JM*OO7>5MGH 'NG, E
MK WQ(.)-&6XH"1YYQ^?DJD7[,;QB%-TT>=%V6+Q>VOL]H]EU5C+FFS_6>BLL
M-V'I.W.M$=G1<VI&>"ZV[/UU_MLS7XZSS89UJ6.)L8=525514@$WCC'CKSUX
MZ\]-->'+"ZE?]F'X^!DY^P+TG;MW:5I.>9J+.XU=!.1V7FL>3T07D,+MH!<@
M'709+-2^-73WW>/A@<7<$,SMHRWNK-NRVB: @)'KAQ_,JU,1XI=4]/U/3E1)
MN>U-+7=&;*MTW2U/LM@NA7)!YOI;<="9O"9NDK*4.2TSF>ZX[%T(S72 V>WO
M;1:^_P!EJ]*>!'/PF3KWC!\P?N%LRX>VT/X3V3T=&[]ZN9,UMW9M_+V6)0DK
MXJH%_P")S@J\B8\N/X'S5A7L^>J9RBDT$$(T,0PT,0XX\;(8(((V10PPQ-1D
M<444:-9''&QJ,9&QK6L:B-:B(B)PBY>$3A$X15=NK?3 Z'%1TF:2WKQ+F4^U
MGD.A$(*CFSNI&^[,_"[W,*MAQ8R[2=+&0 )S8JZMA)?-;3&4Y%*3&I::,.N?
M^(*C%AO2X7?N$6)9! M"CF_B9-$#\A;'R12-:L%A'2'0.64=%814]Y%HGW-D
M'?Q33S-1/\<_<+_^'A%K!PBX"28!(7D$2)%#&C?<Y4<Y5<]S61QL8Q'22RRR
M.9%##&U\LTKV11,?(]K5(HU:C3GU=F;81K%'%7'2@UCE:Y(7M%E6,L[VJZ.4
MUJHCX8D<^ %WHYCI26M(9./'Q_KU]=,HO5)O[K?^"G_LY47UPBC=M_6;S, )
M_P"!GL[Z9'?6.0>L!^ZTB5O\96GZ&O,A5R*UBAND3TD;&J$4DX1.$3A$X1.$
M3A$X1.$48VN-S?8F0TV#V-7#=97845GG-#53OEB8=46XDH1T"3COB)&E=!,]
M8"Q9H2A)TC)%FA(BCD;P5-/#5T\U+4,$D%1$^&5AR Z.1I:X9&"#@Z.!#FG!
M:00"NUL=[N>S=YM>T%EJWT-WLM?2W.VU<;6/=3UE%,R>"0QR-?%*P2,;VD,S
M'PS1ET4T;XWN8=)6>,GDG3QMR^?\A,(?E(6H'6[';]2VM[VP!4M3X<,=J14]
MAY_$:K2CP(C(M1-FZ0*<A(S+7*6DK"FV&EG9*O:XQQ7>$T^<,EGH725C&<@Y
MS*F.GFE T$IBC:3ASX7ZAWNY]JWLRK'?M6X^SB_4]W>>VJK+8ML*2W[(5%8?
MB>ZCBJ]F[E?;1:Y)"7/M++I7SQQ[\-'=Z1CH33;;=1=59OIG"56#S$MF<*$1
M9VEK>WI,9VCU6FT%D5=:;5Z0^* 6$R\T-T<99'/&%$!'=,P&K! JQ @1MMMU
MOI[9214=,'&./><Y\A#I9I9'%\LTSP '22R.<]Q :T9#6-:QK6CQO;+:VZ;;
M[05>T-U92P2SQTM)26^@B=!;+1:[=2Q4-KM%LIWR2OAH+;0T\%+3MDEFJ)!&
M:BKGJ*N:>HELOGW+5TX1.$3A$X1.$3A$X1.$3A$X1.$3A$X11O/_ -7)T=:G
MTC"OB"!FN_SCH+L42\GF55^KHW6]A:Q0N1/:C8%A156%R\(E_P#TY.<KE_%$
M;?P3DM;_ )Q(:8,V]'E14^K(V6]=51RN]/1S9DA5469O"*2<(G")PB<(G")P
MB<(M;[C&FZCN(*_$M[FS_P E]C4&I%86KHJD:UUJOAM*H"L"C#K89LQ@2)"6
MS$"%6EO'M16V%F7)7 ()C@YSG@=.'#.H\O,\2=,%LAS)$X1.$3A%H)Y57V;R
M.5[>_P GVQMX.X@>O.R=9E<5359-V##V16=8:K6T):E"4Y(M)J6,K_V]I\U9
MW8,M_;U5=:U]:Z<^<BQZ"]W2.FI+A34M0/VK[A624L,8>^031T<T\?\ "US&
M2AD9FCC>YKI-T;H<'#/KWLHV$FO>UNP]TVAMK/\  6;;'9BGOM5755)1T]19
MZG:>V6:N>V*>>*MJ;6:JK9;KA<**GJ*:A=+**B6-\,@9@>M*#%YK 9*GZ\C!
M3$PT-?-G2 )6E06E:<,PV*ZD.17/M2[SYA;8^W(DF+MS3)[$N><DF65^@4[(
MHX(FP8[+<:6$'.\'#>WR[4O<_.^YY)+W.+B222M_VGN%[NFT-XK=I'3F^27"
MI9<HZAIBDI:J"5T#Z%L!P*2&@[,4=/11M9#1P01TL,<<43&-K/HP[K3*Z#N'
M+6NU.PF H>V]!68AE,!,M'5BGX;JC6]LTD-O#3V=3DL?E.P-4ZV)N#IZNHR^
MBW^NJ!3JR>-T5=L.S%QI:&GK:>IJ&P4HN4C*+?WNR9_B])+61L< 8X8(JBHW
MW/>61LEGD9O MPV^UG93:+:^#8*_TEODN6TE3L/2':1_;TK+I<V-VBVIMFQ]
M5-3U$\=;=;W<K!8_<Z.GI(JJXU]KLU!6"&;WAM1/ZLUX05: #75L,0U< &,$
M /!_F1PA860"PP_5?Z**".../ZK^!J?5?SYOJ_,1!!((((."#H01Q!'(A=SA
M1.$3A$X15]VTV-_579K)7(V)_7VS;(Y5]$;&[.62/<JI]41&JJJJ?ER'@? ^
MM=/-%/!W/?! ^1%;(Z&-TC5^BH]S&J]%3]4<JHO*BY>$3A$X11NO_J^ET8C?
M\V6-1WJJ[]Y2R8C:0AC%^B+%&+GJU_M1%5DL\BN7TEC1'XHI)PB<(G"+HGUE
M?:PM'L@A3H62-FC85#',D4[6N:PB!7M5T!$:/=\(B)631*JK&]J_7A%B4HCA
M/K4Z&U'8W\40=JL=^"KU_?4B:P_[H9FN_-(V:&!D;O1(D9&BQK,=Y\/6OU1?
MOLUT'U^8SEGZ_P#@_D[.C]/_ +[Y_0^[U_/_ ##?3\OK^?&O=Q\-/KD^2)_W
M73_3TSE7_O\ UL[WU_E\+TSGM]?U^,[T_1>5%^?=%T7_ +9:6=C/W7CT  U.
M//$O[S9I3)+NVBE<GJWYBOM:^2-OHL7PY427A%WZZDJZITLH0C6$SM:TDZ:2
M8RR+:Q56-#+,R0BP,2+U5L2%$R_"9Z,C]K&M:A%E>$3A$X1.$3A%A[FO(-8#
M.%+##851\=B$I+'O%ED^6* )&);&K9&L*KSC1XYV>]P9$L)GP"D'42<B4];,
M PR8R>,JQM#''V$\,3H!_BH..&/ +"^29\8XH(@H[5=(YT\D<I<B,E)D:A%1
MWD7_ +2Y#]?VIE_[.WGK_P##A%K!PBPEJU!YP;:5/B"URD(3&[U5HT938XUM
M8VK^!)@&L<R65WM=%6E63HW^OK#.[T78N_\ ::W^OI_L8?\ 7]/ZK+]?]7"+
MTXC_ ,VS_@-_]B<(OOA%'(OZ;7&_$^OW=G*OY3_[/[ZL[C[P_P ?C?<-9^?[
MOP/I^\O)S^0^N?R12/E1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$
MX1.$3A$X1.$3A$X11N+^@UQGO^GWEG*U1O3^TM)9VJ'*OZ>U+^N1J^GU]SO5
M?PIPB_9OZ775R,_$@.<N5(_2-;2SHD"54_+UE2IL$:OYHD+T_)5XY^?X?DBD
M?")PB<(G")PB<(G"*M^L4^9J]+>2?4K0=@[PHB7\_CP4FD.QM)*BK]7-_9K,
M4D;%7\F1M:W\*-Y!^)^_R161RHG")PB<(O.I*E+N/:M0TNNLV]Q=H6H%X"L/
MWI676>[<TSL_:P/*B)')EJ%J:R&$2P',K2JX..FL RZ>28&3RZK+Q7UDC'N9
M*RY54D<@P7,?#5R=D[#@YK@P,8W<<"QS!V;FEA+3^F15^Y"QY@AJ:5VQ6RM)
M4T$X?[K54-RV.M8N-)((GQR1,K!5U3WS4TD%5#4SNK::>&M:RH;1)'6--G6W
M%4$;V5U_$1)3E#X7IKM:/,=5:$K4ZT'.G35U;K,#L]ET9736=PVUES?5NK*K
MJR*4IU,0AGHLG"*>WOCJ)G05E*^/L7OI;=7"&AG?45#87%C)Z>:>WL+W[YAI
M92QC21$[> SOK-J:^X.H:J>+9C:-S&UL,E_VVV2?=-KK;#:;//<J=E356C:&
MR67;VI92T1I&W/:RTQ5-4]D0K8C!HVY\+@*S( 0##55-3B"5KJ:DS-$IY5%E
MJ.8\RX-KQK&ZE(N]->7UU8&WFZWF@D71;_03?>]S&+"-5U57"0X,:V**"&*,
MQ04L)<Z*GC+W2/:'R9DFEED<Z2IJ9?WM3)A[PT!C&Z5?;_57BHDFEK*VNGGJ
M16U]UKQ3Q5]VKHZ>&B@J)::A9'0VN@M]#3P6^P;/VYHMFSUNC]SHG2R2U=75
M[D] N<_HGI1[W.>]W4G7#GO>Y7/>YV.IE<Y[G*KG.<JJKG*JJJJJJOJO/1[.
M2;1:R223;J$DGB2::(DGO)7A_M$ ;[0-NFM :UNV.TX:T   "]UP  &@ &@
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M(5:YLX43F2(S 15!.Z("YVOP1ST<TV@)(%/!4R5+G:?P-A+P="T+J9=F*J&
MU$E73Q1!C'F>LHK];+>&O+0US[Y=K-0[/Q1.WANU,UUCI'@@QSO#FEVZ/0".
M3H?I-'QRPO3J/K='Q$0RCSQ.3&TWNCF'G9'-!*Q?5LD,T;)8GHYDC&O:K4]%
MLX(M%J!!:1;J$%K@0X$4T0(((!!!T((!!T(7A?M%(/M!V[+7,>T[9;3EKXWL
MDC>#>Z[#HY(W.CD8X:M>QSF/:0YKBT@JW.=BM-6/MJV"YJK.H*=(T:UKS*TE
MT+D9,V X:069T3W-<C9$CE<K'*UR-<B*K51/12*C1NN-@46&#<.HHZP8X$@^
MW!-,>18# %PE^P*IDKXU!(LOEO@SMDM)&TR$K*&9;RC,61Z]>OGR1;!<(G")
MPB<(G")PBICO)[H\I721N<Q_[0BL][55KO:ZMM7.;ZIZ+[7*QBJGY*K6JOY)
MS%PR.&=?7,?=%<_,D3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$70M1$/J[
M(%R(J&@&"*B_DJ$CR0JBI^BH_P!%X1>;5=,I-> 0OYSABS+_ (RP,>O_ $NX
M1=SA%9?4-0ZTV\KQY6BV-?D[DNI-<Q7H'8MN<ND4CVM<Q[Q2(OC@V,$<D3RJ
MTLP1)HOCJ](1GS!\D6Y-/9MM0FD+"X4F.206P!D>CY:^P'=\,L.1Z-:DB12)
M[H"&-2$T5XYPRO%)@D?464X11VD_VSV'_&,7_LEEN$4BX1.$3A$X1.$3A$X1
M.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X11PK_=;1_K^SVH7U_WJ
M6.114_GZJK5_3Z?KZ<G/Y'\/U1?HJ_\ =;=I_P#PYEE_Y;/8?_+EY^7CS]#Y
MHI%PB<(G")PB<(G")PBZ@0 5=#(. + '!*6>?)$/&V*-YMH<196)3FM1$6<Z
MP+*-)D]/=,21-,]5?(Y5(NWPB<(H_K+,FERNFN0DB4RIS]S9B).USX%) KB2
MH$F8US'/B66)B2-:]CG,]41S55%2'0$] 44.T&?7,9RUTE?>ZHB[SM69>J39
M:>[/#MIJL:0XP6PHIS79V(6X9!,+/%75 3*QA3IJ-E;.,(^ = 2,\,\2>_AZ
M[D6J%:QAVA[ TIC&$7UGV-V'4&VLK6N,FJLCNM'ELW6),J>Z*OJ*2H"%$"B]
M@S)4*-=&XX\XDCS"N<9+A7RO.](:NIBWSJ>S@GDAB8.C&1L: T8&=YQ&\YQ/
MZ/G)I[9LY;("8[?2[-;.5D%(PD0LJ[S8;;=KG5;@T?45E?63RS3OWI2SLH X
M4]/3Q1073)]UEZ?.UW]2I.R8NOUV-8-_0A7+@^R*"J.D*%C]H\TNES]M/F=7
M++%))HLW !36;IP@ XX<(Y9(Z2Y0QO<R.H;0]JQIPUQ-;'%(<#@9HGF&8\98
M@UCLAK<=Y;<5;+1<JD=O7;,OVB%EJI?CFHFS;,W"KIVQ2NS(QMJN-)'=;.UC
MVMMMSDJ*VE$<]3.Z2P["@I+6HDH+&J!*I98&#.K)!HT#9#$C?@-AA8UK1W#*
MQCQ9(/AR"R1QRCOBDC8YO 6,<W<+1NZ8&, 8U&,<"#@@C!! (((704]PKJ2L
M;<*>JGBK6R.E%4V1W;.>\GM"]Y),@EWG"5LF\V5KG-D#FN<#=?2T]EV+U]A[
M?47FA)F'ZXZR^-\C?W%)-8WEU@J#27=_9FT9M:98%V$MS! D!4\H@JARDP0L
MG-G?STNUROGMEOFE<7R2T-')(\G5[Y*>)[W$]7.<25XYMS1TMOVVVQH**".F
MHZ':G:"CI*:)N[%3TM-=JN&G@C;_ "QQ1,9&QO)K0%;>2<3!/J*64PLX6AOX
M0:N>P(E-L&5Y>>HKAHI9Y#GE'O%+LRX8"S))C9 VC,,(*)CE*G^[KW']?Q6K
M*8\J)PB<(JTT78<E/;DU5?1K;?=J0):3/LF5SV3$#Q&M#KH7ADL-*:%./.Y2
MIZP+WE#PM-<Y#'!D4_KCQK2O!LPWND$L0QCQ7N8Z-SQC(&$0/<QR(YCG12-5
M6.1'-5?14147CBB[G")PB<(J7[T5$R5=Z_\ [QB?FGK_ .++?^:<Q=PY\>6?
MP!171S)$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1>9=='\&O!A_+X08
MT?\ S(6-_P#APBX*QQ+VERDROD2<\YXC'-8U(0Q2YZIL<?L8U7,4FM*E5TBO
M>LDCT5_M1K&$6P?04?OV%M*B?YC-S1N7]/F[2M<Q/_6^2?Z?K[5_3A%L=:?[
M!6":&/\ #6E)"+I8T_#'#&STC"T3O[#5KD5 [>9R1^ZF?&843\#/C#OG//7C
M^'K\D4JY44<KOZ#1Z05/R(AH[I?_ #A@Y=.Y/^9GHE]/Y^O\>/7KR**1\(G"
M)PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(HX3]==
M3>GU]F<TWO\ 3^S\6SR7P_=^GO\ A2^SU_>^&_T]?:OH1&?T&N*]_P#XSS@/
MR_\ /[BL['YSU_P_:('T_7U=^G'KUZ_%%(^$5!>0?>#^CZ+#3U^6CV&I[,[(
MINK<53'Z4'%9UVCMJ/2ZAQ6JV=@%:09JE'H<A>.C+946YEC=NI\_7UTYUR.K
M"H&<]P)]>M!JM1-#]HG=5])VY;T?CE?VR=*]4]?]TZXDOLW%19>TP/;-)2W?
M6Y^#W&4AV^6W9-XV+LFJL'YZP*I*JVZPL7PWMI0ZK'7UP3&//'EQSS'+EP*P
M^_\ M+#L%7=KV!/0<UDO5>+\A=.:")VM0LLK"Q\3:G(VW?E3-6KFI+&DK@H=
M2YO5^DL0T#[!;7BD6XN"&U./EO7!7=Z'I]>'ZXSCOUQD-S]I./UF=OX-MTN4
M(+UP[>T=\ZG[-S%C;2[GJ/J/)]X=F4@-#85M&:W.C8332B8'76;ZS]N]H'59
M^:CS-=L\;HKHH!GG]._'W^G?HL8!]J'G[^/-09KJ.0JVTG7E1W!$S1=N]<8W
M+A]:F=4U_<5J25V#=E,Q4&QK,O=4X<&>*N!<Z5;NO2;#<TF1S%OK(2;I_IXD
M?AZ.B]399)$&DE@B2:9('R0P+(V-)9$C5T<2R_C8Q)'>UBR?B:WU]WXD3ZE%
MKQB=EH++34@TE_-;D63R6Z*FDB$8VLCBKBYY9E B@:70+56$0U>L9#V^]\Z5
M]G\W;$#%QSGI\_KWZ:]/Z%L;RHG"*']AJB8#<JOT1,=IE5?T1*4WD.H/@43L
M-43 ;E5^B)C]-_U*;P>!\"BTQI?Z,[=!R?@+#[6[9^;&?^&<;[R[&TU[7?,0
MKZ21?/4MK5VPGQ&M^8K;$(V'WC%0R/\ ,*P%M=7M(PX5U82#H0'U$DK"1RWH
MWL>WJUS7#0A?HZK^.FL$S?BAFV1V0[&5NL<ONNS5KH*GLWCX7^[UU)54<VZ3
MV5533P/W989&-@>R7XE].5'^,?.C]8ONYF_5E:S4=OY\&A>5Z?6-EB33VC(G
M>BM:T$F658X8G/3B:UQIZ]P!+8FV[M".#.TN$883X[CSW!I)P!E=]9QNT4,3
MB&RW*3:IM"PZ.JG6G8VXU%P;%R<ZFBK:0O&02ZHB8P.>\--JSSP"P3$DS1#C
M#Q23D$3R,A@@@A8LDLTTLBMCBBBC:Y\DCW-8QC5<Y4:BKSC) !)(  )))P !
MJ22=  .)6K1QOED9%$Q\DLCVQQQQM+Y)'O(:QC&-!<Y[G$-:UH)<2  25;OC
M+!.)U?F!"H91BAL1U+"0-/&^&>"6+J#"0RQ30R(V2*2.6.2)['M:YDD;V.1'
M-<B>D6AKF6JVL>TM<VWT37-<""US:6$.!!U!!!!'(@A>5^T&2.;;W;>:&1DL
M4NU^TLD4L;FOCDC?>:US)&/:2U['M(<US26N:002"K8S:HM]V!Z+^6GK47^2
M_L3DE]%_1?147T_147^/.P'$^/X!:@IARHG")PBA-[@:6^L'64\]F#.1'%%8
MMK"VBQV<4+?AQ(2KH99AYVP>HWS]7-7V3AVP1N,<@0/RLQKGS[T4P''@$'@%
M%AC'&&AB''@A8V.*""%C8X88HVHC61Q1M:QC&HC6M:C41$3E1<W")PB<(JT[
M(HY=7!4YH=R1SR2EWB/<J-;\*J9 !(WW+]/5S[V%43\U1JJGT1>0]/'GCIT/
M?ZYE9?*B<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(O-N:+Y<DP7T]%".
M. <GZ/!+F#>G^I\#OI_#A$G&^6;1>B>C2,U,4[Z>GK++V'V.UR__ -J.!/7^
M2<(KZ\=H_=>[B54_S-3DHXU__F3-6Z5$_P ?E8?7_!.$6U#V,E8^.1C9(Y&N
M9)&]J/8]CT5KV/:Y%:YKFJK7-<BHY%5%147A%&:21]65)F"7O>T:!Q=!/(Y7
MN*HXY(X5$?(]?B2F4,LT )#WK(^8">H,G)(-+-2&#^GAW^OJBY%_JVO;Z?B^
M^,V_W?P^#^S=FSV^GZ_,?M4_U_N_*I_>Y?7KS123A$X1.$3A$X1.$3A$X1.$
M3A$X1.$3A$X1.$3A%YYZC[4+Q)QW89W5M]I]8+LP]S0=>15K,3<SQV>FT'>F
MR\=V0514;%@-%J>Q<+=MOS&O;%4YZ2KOB/ZI9#HI7=.,XTX\1X_98K+?:N^&
M6OJH+FIVVG8%*=T!63?/8?0"D5]AY&5^[N\@-9CN&=*"N5SO66]TO:4\[6B]
M=Y_*75K?SPC $.C)@].&<]V,9^X\2<#52JY^T8Z*S>LTV&T6;[AI=7GMTG6
M-*9U]+*5L>QIS^JJZMQF.4"U,BL[:V([PZFD#(,DK:B$/; 6%G9UX-=?$5),
M'Z9^77Z?AQ5B]8^9O4':O<EGT)2";ZA[0I,>)L;S+;G%V.-N*00FMS5LX&UH
MKMX^C#?$'K*EL%_)2_L/>'Q7-/F-9>7&>O0*XF-,Y'''KUGAIJ%MEPHG")PB
M<(G"*.!_TVIO9F_CB&J<_7*_\TB-;/=V!8Z?W7J&?43R(G[S)1U7U]$])S/'
MEX?+\47Y9?U?19DM?Q-*9=T",3\VR'"07C9U7^ZR/,2PJW\U<2Q?R:O'/Y'\
M/R14[Y&=YP]!477FILHJN+,:/MO(8397]U*4/6X_,:(:Z>9J2B!T^' P NO!
M&20UT87N-1LTC7NC]:J!G/<,^/<M'O\ +MY$=Z8/&A['H_H(O&[;RB(\;])G
M=QE]+VEFM52XZM-EN.ZZFO=:5]:'B+G>XO32=?UNC"L2URQ&+T=G9C6I9-3"
M5( (U/ '3D3KC.GG]%S>./E;J>\=]69#;].]58.'5]?8Z*XZPLLIMI>S-YG%
MZ:C[-&VV?)DSI..7J/*["\M>E!:C>K2UP>TK=,L6U#OSLY@]24( ^OAH<?KW
M=^=-,;?[0?M4NAW/8.3\,^J>P>R+[JV/8=T?<G7!#[!F"BZ,U?8M[T7V->WV
MBH[S2:7K&XQUOU5V /8BD[ 2SAE;4^-A,LM!2Z8LL:XSST\P,CN.21CIQ/%6
M+?\ GM<GLWG; '@C6Z;6#=VGYF2SL>K=:)N-YX<T/57>';?5?=]1:Z# UUSM
M2$V'CP1>@Y"B==U,@$%,#C3RNP;*B":4 Y9Y9QWYQ@ZZ9SQ^1''&8(\RZ$MM
M+4[#Q3Z<% S.QR^K[8#N,-)(+U(/9>2_AUUEU[V5<C'4+H:4VRZL\C^\NVLO
MHC60RO@ZDN#ZPS[I$U<PY ,\3CD->/PD@?8=V<%8W0?:N]OQ4/:.QRO7_7%Y
MF\?WWO,!F(8R*8FSTO6F3ON\J_*ZRK'C[P$OK:Q[.K^L\:50P6N1P]^?'N8R
M.F.O_(DW[GH+4A;TZ Z]=,CY$_+G@Y7N] ^.6-A#(W1_,1Q2JDL+X)_1S$<Q
MLT4K(YHY&-7VNBF8R2)45CV-<BM0L5S<(L-=Z.@S0S#-#=U5&++(D,,]J>*!
M'/.J>K1QU)EC^8(?]$C'A^)-(Y4:QCG*B*10<WL *X&("I\5K=6$7!,(6XBF
M@SE3)"3&Z)\9"[DK.$6 !$3U22>HK[B"2!ZJU)?<C%NZX\&Y\< '.>OY'BL2
MYHYC[_94357NXT.PL^OS;%E$/1,", S6EGMMC%95]?,R:.P)/!R&$,M*5D\E
M>)!!9;ZR)M9P34NFVHL[DG!A)P3C'(ZZ#@>&NO?QSQ4+P-0,CKPU\E0?:QTM
M[Y-9?"7MKBC[*RHZA+R;K&4WKGL45#I;$:"TW$M_J(:2^QU#6_*34U&!JM)N
M"#K @NIR$5>&YUEJUR913WRGI9H*:=SH6"7LI>QK&EY<&R5+GF")]-"S!CBC
MGFJGOD+F0!C/WGZ$V/I;_2>R6];0T]PN=##37&J_9IO%BIK]LP]M*R"6>BL$
M38+U7T-^NE49&5MSJK3:MG8*>C9!5W:6JJF^Y[/5/6>?R^<UN=K-7>19]\1D
MFT ?0=7VD5[(73Q*>W336V!L#-":31_*0%NT!1Q$U6\$661P?P8V[%#;J*GA
MDIX:>)D$F]VT88QS9=YNZ_MMYKC*7,PQQD+B6 -)P %XM7[5;17.XTEUK+M6
MON%O[']F5$4SZ4VP4\QJ(&VJ.E,,5L9#4.?411T$=.R.H>^=C1*][SJ#WGGL
MST]J.L0Q+J!U/<:*K)+L>VM%5675K0I#$ ?G'X2@"-MEL7"%2767L7X=O7]-
M85(+;2^J5^ Q-7NE):K;4T 91TL;75#'NDJI2:0#>+##[NTSRM>&N,L$GNON
ML;XF"25AP%[O[.JG:[;2S;7U+KO<ZBNI;3514E/LUL]01[4BI;&RK;>&W^2E
MM%')2%\'[.NU(-H_\(JZEN%1)16^L+7N.V79=IO<6,FO3=T05D2^NHV#56(N
M!2=.D4Y!05.43*?V!6B'O9)815EHS)P>THIHQ!+1'MB;N+F8&<Z\!I^OKJ,K
M\VA^2!CYY]?=6!E='J*.KCGL^NK8R>Y='<V)=/J:B[NYCRQ1VS3Z&#2"]?L&
M,'&@'"^[Z: P4" 0>LK18A!1X(YN'D..O]<IOM[Q\ORRIL!V7C328 )[5]%9
ME2)"+5ZH"PRM@;.OJBPUD&@%KDN',<BM62G>? Y6JL<SV>CEQX:'3Q&.*RR#
MP(*G?"J<(G")PB<(G")PBC?^DZ]?[/W/FV^G\?C?M+9N]WK_ '?EOV4;Z?W_
M )MWK^XG'/S_  _)%).$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A%YU
M7T?P=-KX_3T1-ILU:GZ,=J;=[$3^2-<B)_+A%D+X;X(&)G]/1I>+@(8OZL(U
M&KL&^GZ_@/8O_K(O\>$5T>.T?H7MI?[XV5C]?_-2Z=W_ /V_Z>$6SO"+#7=9
M)8BQN$D8/:5\[;"H*D1RQ0'Q1R1M80C$5[@C1Y9Z^P9'[9G@%DH/)"1\&>,B
MP1-G$:S,:!D;Q5$O$JK8=ZM4L-]HPB@GJ9O8JLE^#I)ZAT[HGO'E8'&</),.
MV&22=.74?3'GS_!%-N5$X1.$3A$X1.$3A$X1.$3A$X1:F]^EG7>SR^&FLK4/
M+KE+S26];4VMC3+?6*VM355<5H94D@G$5=8*ZV<ZGD)?5V1-E 58"335%<^+
M4-IZF=LM)2QRR10OBFFE$3WQNE<U\3(VN?&6N[-H<\F/.X]SFEP.XU>Q>SF"
MGHK+=K\REI)[J+M;[91U-924U:+?3>Z5M75OI8:R*>".KJIFT8;6MB;5TL5-
M)%3S,CK*EK\UU-W%5!5.<Z]['M74NWK6U>5K[J]<\>F['E:L-50VM)H)VMJY
M]1I?2#[QQLY<.E%T+K >OK[6C6HO[?[+/>Z>:&"DJYA#6L#*<&8[K:QPPR.2
M&1WP/EGT+H-X3-EWVM8^/LY9.OVQV)K)JRY[1[,T8KK#4FKNU116\-EK=F6$
M/J[A25UNC)JX[5:\R>[7N.%]LEMPII*BII*_WVW4>![5[9I.P:A^!ZVM'WP5
MR4&S7[>DE(_9>MS QD)5K3TVD%6,31WNHA'FS+X<R>0W-A&6MO<6-=8!4M1?
M_+>KW3RP/HJ"83R3$,GJ(7$PPP@@R-;.PALDTH!A#87DQ!SY)',<QC)>QV0V
M.K]GJUNT.T](+?-113NL]BKV1_M6JNLL+XJ.MK;9*'S6V@M3Y675K[K3QFZ3
MP4E'14U533U];;9'X]V5I%-N\<7:V=O59PR@L\])=6)MO8U=?HP"VD47WI93
ME69U>'94QMC7.L#"IP8;=U.(^"GK*H(7GV9J9IH*J"66284TL?9/E>Z21L<L
M>]V9D>7/>UKVN<TO<YS0_LP0QC&CK/:324CA8;U!24M%5W."X4UR90TT%%2U
M53;:B$QW 4E+'#2T]1-2UL%-4BF@ACG?1BMF;)6U57/-8YO;.1CV,77]-)8[
M#81FA"WU/D 5NF8D<QL1"6._N&20T&*A2NE=:!5VBM0-#HPH)TR-+H3(_E';
M,O+UX!]PT/81':>SW]-]G5A-C&-Y1]AX_KOL.2GL;+4V%CU]N/(#O(K5U^:/
M\G<*EZE[ML8W6E:?2$](YRNMM>E+DZOM:$VF!D+/0_S<A\AH,' /4\,\3GGF
MFR:_#75']VYK[./I/3WF];C,H9TZ7UUVML[SJP;1]O=6]6T/8VP*[%WG6F&U
M+.Q<9Y1=S;KIVY6QZ8U.1I 3XR-M,()OR\"0\?XM1SY<"> X< #Q\%;>Z[*[
MCM-U>5G=7@%FH;"PW?5T=K=U1O81)=1VOHK/[-G/]E:+-=H83M^YT)NNQ4.H
MK[7.:BGR>$J\N;XZU6LR/:VQN*O5+"4QT/(XTY?%X>?4\E-?&3L>]K1NDO)M
M_4./H*T'J[N6\[%HJW%]RZ;78)G5_4W7&DT5/EJ4?RN[>QC^V>QLZ768YV[T
M.;%[?UDN?C U=020;+41D[B?#3&?$G7 ^?#N!5QX3[0?S1W=UUAGI/&$;$VY
M1>*QO=G[2X+L :AZ^W6_[OV75U+8/-TNMPNY$RK<>!ANRZ\:KZNWIEE#K(J7
M86_5U,KMN$0M'7(U^>!GED>?CA>E'BCVEVIW1TW4]D]O=?UG5FGO[K1"P8
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M%3N;54\[8H6ON_OFBT"Y8:QK66,P]81*EM 'MTR0$X!L31O9="*.J:<&4CX
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MQ.&Z>[EZ^:YFNSX\PIY0 $!ARSGM:EK:DR6EJC'I(R,LAD4404<C?1DL54!
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MF;/;/OHZ^HIGS6^H?7"K[&DJ:MD=+#6&"KIHGNJF[ZMS5[=U=PN)PU-$0N?
M[)RV,L!ZJ8J=8*/(ILJSOO+UH]6VRF$SN<;95*GBB. !-L;<V)Q4_P MPV=;
M3-GJ8[A#2TP+G1QU44>Y&]SL,@%2^LI6-87EL4(>TN +6E[R,GN=G-M*;:RZ
M6^WUVQ^T%ZOU:]@N-7LQ<Y.TJF0LW[A>76*/96_UTM4*:.>Y74TE3V$LS:F>
M"FHH7"&.R.J[W&PXVHVF>M-=>7]QIUVMC<:;K#L'+T=G-!16.&?3"SC9R^#S
MF<JZV<IU)-#:Z,0@YDETZUNX;LBT+[RR4D%-0MD@?)-[RXS232QF)SI !#NB
M,Y[.-@9NL:'2-/Q2"23?[1VD>T>NN$FT#K-6T=-;(MG8OV;1V^EKV7-K(I9'
MU[ZFIKXV0MK+A6.JA)5RFEH9(0V&@DH*$T0HX+PRNYJ.R;VL)'N<K!'F2K$F
M*@ U%?<::6\>$;2I+9UXK8W5->+56%C+ /(I!=DMB$9*RLB!;'8]OQ/A^7TX
M^)\..@*Z>5$X1.$3A$X1.$3A%%&K^T%RCT_%2YTI[6+^]%9Z*+W12.3T]&2#
M9WUDA7ZS1OOI)$5HIV<:Z1ZX(I7PB<(G")PBBEDOW!9+?-_#5'_!'T;4_#&)
M)&UL(.B?Z?A:P:-&5UU.]J^E8@!Q! X5#(V2<^[G^&/Q^71%*^5%2XY/[?W<
M.DD=[\?0E2IC1_S@O;.-L@Q6VF]?H0%&CR*_'M1/EI!5,T\<AS+6AFJ\V-YD
M> (^OAT\UQO=R'S_ "4]AA?/(V-B?5?S7^#6_P 7+_)/^G\D^JISD)P,^BL
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M=U9!P%@(M]U_' ";'.(Z",P'769%O_E)&6(.**#1GSNOVP0P??'M4H1C.U8
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M\<:#@BME.L)Q 8)R8GK35"<:E5_/'K]?ZNNRRL902?N9JA/1FD,B=ZK[=#K
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M]>.Z(*$<4"OB9$*/[WOB" #8K(G1B#?%D@A][(7M&A]7LA>D:1KF &@!H
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M_;.RAJ!7?OU^>624E[?W'Q3Z Z"&=89F>YWK65-+8"O<WX%DJQ_$D>/T_/\
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%")PB_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>g149615g74x76.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g149615g74x76.jpg
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M/E0CY00;C"Y4^SWQ$%T.+=;5XY2[D=7$Z;[@<(BS(%T77QR*'-TJ2*8FVO\
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MZRB37)([5;"BKRN+-EDDM6['%U#%*O9D[*D;5+XB4$+E^U"A C5$:W:SQW=
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M7DOPCY(JF=)&FTY)'G#A45!R&&)(3A.)(E3=.2X21IS<#"B#V/Q\S2-(N"G
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M<]*<4,@X@8BC"Q%BV';L9Z^[E;O_ %<>4G9<Y->[.R?UEWD*MMD/G9@6DHJ
M4BG%.(VVD[%(LZ)1R/ :&2+N#^FK68U,G0RN/I6/R;(HZ1"9P\M9+(L(TE+
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M"F@ACE4Z]R)@R9)$GUILV55[,EKP763&\_/=Y_AD <YZ>&_@,XX^_P#$><W
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MLZB57P:9V7/WU'%X)7L5D,XFDE<?#>3X]$XHTJWV1/:[Q<H]1XHU-"!8N4^
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M5)NH/N^YN\\>>5S!:">!R03D'ADY&,>#?N^(%9^\^(W:/V4'DS4A,0?'FO)
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M[TPJ;;%1^BFB,S9<TNG?:YL'LHO:Q"/:HX:<@O:A.+:E02'PAA!0-CWLXXH
M>^,L&A#+"'O"#K6NN9+:8<#::=HD#>/5$;R!TD8R0.&%0^H5#=MPAF B8U\C
MNIR#J;'G9:]YQZACR=EKG8#B< G*T=YM2$,-BPZK')T\%,IVPSF1,*("<TY,
M)KKK<.^% W%>7H25L.3!GD;,2IEIA1JXI888F",!!N]>:2MIXJNGHGOQ45,=
M3+$T D;%+Z'ZL7N&YA'HF$M#B"X.R,@%9RCTK>Z_3MXU534FU9K%7V.VW"=T
MC&2BJU$+R;6VG@<1+5,E-AN399(&O9 ^%K92TR-SO8U*%,#H8H2$%EG%(^@S
M22@ /.\'HE+T$((0G&^$*T41Z!C\(7H =]X/7TES6C>6@ AN\@ $XPWPG(P.
M)R,+!"*:0Y$<LCG,?-D,>XF-FT9)=P)+&[#R]_K6[+MHC9.*VU13W&<N;R6U
MJI;6QSE+9+[1879P13&52)EB,WD,HVJM]%'XHZR!QB4$?G^5H!'38<38V-4\
M.)!FW,Q3WA][$T5#:!435M$QCYF3UD3WMGFEC@J)9MJN;%"^5\%-++,W-28(
MXW2/!VR=ZV3JS6/*8ZQVW2>JZFJI;556?2U?24T]FM5NK;Q8[?:Q%HZ>X76E
MM]-=[_;[?::@,L8NU=714=.]HI6Q8;BSG37XM?AW]'X=_3O_ %_AS,+6*_@0
M  '00!" .NN]!"'00ZWO>Q;WK6M:UKKO>][]'IWO>]^G>%))<<DDGI)).[<-
MYZ!N7UA0F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81>%
MU%]HC>CM&HC*Y\FB\F0JXS&'-[/*/C4<AS:NL)%Q?9CE4ZL"(ZG3;!6NH9G9
MEFODX:%C>GF,)K%K:E]@,9C@),XJ"Y%O'O''O G..^!N]U3RK[2EX2I#%7F5
M8!F)R'@HYN\[BL+DI1-<$ELT(O%J3:J\8EW#YP.C*9B3<AAZ3'>-O11@J]"<
ME*0.)0 #S_%W\ >'XN_QQ)$3YAR5JJ"GK!F[;!Y&*U>3EKU&N=HY.P',S-#T
M5^6=7]?OE>ID$,#*+F2&-#+"VIL-C4/2*G9N<RYY(3V>-DOC^B)C>>\,^[@9
M'>Y\J-HEVC%@6&C85,"H*&OI;K+VV,'.IUWO!$;,32>9\8(;%'EC=6JE'Y2X
M)Q'\G&U?+$#NVQUYBA<!E36L;#G[1S4U%..D^>_=[XP.GCWE@W#M%IO)PI(U
M&ZZC$6EBE\JQE=43?8IDTGD6'*856EE2.3N%>+:U9BMU&G!+'&JTEB*GM(M4
M3-=%][B[6>];3M101C/>..'/D[O#C?Y[[/<9^6KWR $6:]5U$ZP)7/"I TM+
MG=D/D\Z5EIXZ-]5,ZV"1UN4/$>L"+&%[1V'!I2-A6Q( P*"EKT>0X($)",>9
M_-S[_>*NOA0F$3")A$PB81,(F$3")A%1_DYVA/'3B/+2X;<"BR .95=>=^0+
M(55DWGS)"JF32PF%O5D3AYBS2XH8M$HT^*D9;ZX.AI1B=.L3G)4ZS8A@ 4@$
M\/,G@/"56*M.U\HT#WR$C?(<+W4I],6CS,9&B8!KNPS:RF5=<2)V-C?#X[-A
MMB]KEMD$1%;'I"^12*&KAG*W8#6S$&.P#69.SY^?G[RG9.[GSCX^G\_!2W'.
MU5XHRMR@$=8S+97S*P;(FM5)8.BJ.8.4HB\KKIEK6738R=)6I&O0Q6,QRO[8
MAMBN4Q7N.XLGARI<M$[:<&Y2V!(6D<=W/QX\>'AP5J;3VR'!]_CYS^Q2N>N@
ME3W5C3#6,JMY&D?K+1W8=.2JLDT#1N9*%.X1F8:K6<&H5SLL95*33&60Z(4"
MU]C25Z9\_?\ S)LGHZ?<P<'WN@?A6S1GM)*M#9SM4TT*<#YR_P#)B=T/542@
M$.GSK)53=7M:47/I4Z6 AD;!'BV5\BP+N83)&W,!KX26UK40VCRLM:I80QE!
M!&_O \W/G'.O2C"A,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$5
M;Z-IZ2UG,.4$@?'%F4)+LO<RT(KIF4+5"QL81U+5L#"F?"U[:B(3/('B$NJK
M2=":ZH?)Y[<;M=M0<I1I<3;J":CJ+S-(^,MN-R]&0]3+BYD?H&CIL2AS&@2=
M4IWNPTO;L%AVLES6[(USK"V:FL_)?;Z&GK8YM$Z";I:ZFMCACAJ:]NKM57\R
MT+H*J:26B-'?*2(R3MI)_1$=0P0"-D4TOF.=V;]T'5+64"4QKCR-QK>7+U<Z
M5LLH,0JN49+C#YW&=VE:SK.>-UGM#/9K<IEP71$E=X/:AQ1SA)SFV=,R[; J
M;Z@=)W T-)3&&U[=).YU0Z.;9=> Z"IB]&5KZFTUD<=8UT^VT24U:073%E1&
M[J3F_3C/HD=%LU=J>_QW+E#%-J.T00V&&NM;9X>2UU->;#<QI;2E)8^4G2]9
M6:8J(K0:6:6COFE&.93VQE38:V#TPBJ)_KK@[94*N6MYZ9(8J?&(3:=53(]*
MX2R22:7'L$"X)K^+ZY.J>E4)8T\ADBB<*2';3FJ)9B'>-Z4/BH#4]&ZC0<G2
MZ=JZ>OHZDRP&&FK**H(=/--.8Z;3;K.X.D=3Q"68U+A)MN$8DBS(X,D/45K_
M %'RXZ:O>C=1V!MONK+G>M*:KLK)8+3;;9:&7"_\O,'*E!)%117NNDM]MCL<
M<E'Z%B?6/H[D8Z&)U71,-S.T*.!VI%8G)>RIJ_C>7&?6-([ H^*E2I]+@44?
MGKCG&Z333.81DME2DG3E$,J5HDRTL^3(&Z-N"%8WDEO>S2TO<=-=5JKO5U$O
M5'U57-56Z$32>AH)9+5#;FU$\(C:#4MQ.T.!F:R%[2T"3(&,CY>?2[3G)IIF
MR6\45/8--V[3VN+JZU4#K_=J"CY1[EK>2RV>YNK97LL4P?:9Y8',M<]3<J>>
M&H>ZA#'2UL?>S&FB5IKR-PMCH5.411=#UZ[S5<LD#;*J.MBNIN.;6?=U+D(H
M$O%*99:J@XD+H[.KY7$B<')@8E4@>'!LV>TI\3)I"H:REBIX[8 +;;:62H<Z
M5D]NK:6I-167&W[-,XS3UI(VWODI)7/BB,LCF$L;LFA^B=LLU5J*Y7JNU](^
M37>O-14ED@BM]3:M<Z3U'8V6/2^A]:237^G%JM&E(XWNI:2DH=26VGIJ^OBM
MU%3U6Q5R8&3=F1<\C<+1V5N@FAQD46Y>,R:V"7:8J+(MUTOVSH_9%=+K?2Z@
M1!#:GKY$S;@X]H)+,#T+6,:MF+,3:(: =4VD+A,^M_DR-TT-]C%:'U!JZY]S
MK(JND=7-]"@,%*UAISL35!:S?&"W#!D+7]$[HNVT^E@X:_K*:W77D@K9=)/I
M+-'IK2%+H#2]QTUJ.#1\OI_(^IDU#-6^GK1/;+-'/5-$-:]LFU5F2W+A-R%D
M\Q56?/XAQBL14_\ (*S;8?:+ELPG#K5 $%AT)2=31]^$_.%0KU3O.JO=JSD"
MEJ"?!$:9V:)0M5MCY$G92$A!['Z>NDU0ZLJJ>SU;I;G5ULMMGJ*E]$&55LMU
M#%(974+C)4T;Z.4LS2M:]DSG,D@><,K%-RV\GMKL\6F-/WCE/TY%0<GVE])4
M.N[19['2:L-1IW7VN-6W&@%OI]84\5'8M44FI[?'5&._SRTE9:X8JJAN])$9
M*BX7$CCHLXZ'W\V#A]5L+-8-ZSVRHF^5Z$:5Z>8I,7]U?V5@FK1\#X^F:%$"
M3.?P;8DJ!]E3>)O <8D,9R1!1&9VQVHVHW-G4***.JN535P24N1))!42OECB
MJ&>AXA&:8/ZE$UDL[-C);U,>I.GN5SE&AY1F: J6WC5=?6:>T)8-,W:AU$6S
M45%=;-;Z6@K:^R5GIS<9:R._RTQN5?+44%JJ!4.8V9M8\&=MQ<SRTZF$3")A
M$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$42W!9JFLF6-C
M9XZ7+)=.IO'Z[A,>5//P::E\D?\ QQ7L]^DFFM\,8F%G8VE[?G9>E8GQR$D:
MC$3,R/#PK0-JHGY%!JSG)2[!)9'7$I6+M6S"-0UKF4%@Z!WGPDDRF4FJ6%(X
MJPN*%H;%3SLN5WC6384].3+'6U21(52T0DVHE/$\3*<'CS=/O_F*^8CSGJ&9
MC(-:6*SQM3U8,!KN&/&H$\'I)>XS_CZAY,IG1(G3A-<6-HC=6GN#I+3I4C8S
MF96UB;-D*'1R:$*XF//W<+7T_/&!R6'7[.*Y8QS!DHNA9)<2L1SV4UFO3Y%U
M5G)7&"C.2-SXWH@;\W9!Y,I;%TB1&IY 6(MO&8WFE*" ;P.&3CX\+$R;G+Q^
MK:;2U"T1]V<%),XE'GW>(Q'ESB[QWX"U;)7(R?/+='FYW.?426+4TY,"@"Q8
MV2%M;8HF2 :E*Q1&6A[(&D_D[^\;N]Q''\&]7S$W-*IP0/HD#>H=$2!>@;'@
M25,:X(VQY-;53FB0N BQ*4Z%U/9V=0O3$' 3KC6MM-4 -&A2B**%D<(F$3")
MA$PB81,(F$3")A%YA<J^S<8N7W)(BR;*LB;L--K>,:_C].*XKJ4K8DZV4A<K
M9:K"=8W-UH6QP3+ZU?VMN\D/;>VG-$G$;T"V/;<E4+O&"Y XX<<@CO8SO\._
M=Q6<G/95\3K(:'B/S)LG+LQ/LHY<RYP:=2L*!,)WYI*4ZVV]IC6YK2+$1+6L
M2)%< TD5$GQE0F),/4.NP>DHR1O'>^(8'Z^8K=JO[/FF*R>ZRDHI!8$Y?JIW
M<@&!?+A5VW%.22\HI!(9-$$B9JZKJ Q]R3EL-=L)#4<2THUX5!KHK=EKNH6]
M\HA.<]_'3S>$_A4+M'9#\<V"AIIQK9)W<J"HIH@C<;.CPC:9<SF> 1=!*&QO
MKI*XO5+N:R01T2*4FAV[V 9,Y\@6,<7=F29M3PPHG )3MG(/..??[_'=[F,\
MZS[SV4'&1XCR2%[=[7100N]67D(Z0TJ41YQ;WV=1J.4O%XT!6^2*'/<U9TK
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M2$VG*))Y.GB[G-8RW.!,;L^?G^4'&X95^,*$PB^1@ : 99@ F%F!$ PL8=#
M, ];", PBUL(@B#O81!%K>A:WO6];UO)!+2'-)#@0002""#D$$;P0=X(W@J'
M-:YKFN <UP+7-(!#FD8((.X@@X(.XA1O5H1)6-X90B$))&YA*&%M[XMB&6V(
MW(PU$0(0O3O2<E1I.#T] E%  'H$.M:SFH/5U=+5$ 25ULM]9/@  SRP!LK@
M!N&VZ,O/2YQ)WDE5W3'\70U=&"3%;KO<Z"GR22VGAJG.A82=YZFV0,;D[FM
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M3RB131_=93+'IRD4C?%AJ]V>794:M<%ZL[?49IZ@X0ABZ:Z +!KNEDE! 22
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M=^=XP$X0^_UWU[O@Q!UW>G3Z?3UZ_@Z81=?H\_\ 6;/_ ,M5^LPB_.E<??\
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M(0A#KH$(0ZUK00AUK6M:UK6M:UTUKIF$))))))))))R23O)).\DGB58
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M3)"]RYJ0NABHHLR0JW);KQD1F@:%I*D8E+:@&F* ,.E*QT4==[&G$+A+4T\
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MMZKFG/67K^D=X_OVJ2,P2L:815&IO_&IYE_Z7CW_ '9K<OVHOJ&Y._YNK/\
M&HUK72_^D3E1_G:*_P !E5N<H*V4F$3")A$PB81,(F$3")A$PB81,(F$3")A
M$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB811M/
MOYXK+^GI/Z.2',Y:/I6^^U)_':-5V^_3>G/;QGXA7J2<P:L2Z#L<<F:W)0F-
M\"H(;UAQ!WDQ:]^!.*3F#*-\C-IA+B[^#&$(_)B XI:OZ>*)3 'FEBT11#QQ
MFLPL.CZVE]A-SLTSQVC:;X9(7JOI95BXJ2HS#D#P/4"G"<B31U&H6IC5#>D<
M-JM&(#4ZA(X.*,Y.N4$6OS&?SQOY(4_74>;Y.;"Y!&ID_3]V,J^5ND$1)6QL
M<RV!N!:C6VJ(_'IXZ2$+<I0,;\X(6P469Y$6K\)(9)!25!%,4\<G%GA$O=FC
M:H+LVQE\7->T+*ZR19IQ2MBDY%M+'V)K>WIZ/\9 5X)L:F9V<%H^B=(VKCS
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MI &VUH)(B:-Y+G':<-D$N))+@P.VBXDG;!/')SF=:[4PBC>M_P"3G']9$O\
M][)S.WWUUH]HK9_=O5<TYZR]?TCO']^U21F"5C3"*HU-_P"-3S+_ -+Q[_NS
M6Y?M1?4-R=_S=6?XU&M:Z7_TB<J/\[17^ RJW.4%;*3")A$PB81,(F$3")A$
MPB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$
M3")A$PB81,(HVGW\\5E_3TG]')#F<M'TK??:D_CM&J[??IO3GMXS\0KU).8-
M6)5ZY+2^00Z!-2ACD!D-3/<T8(Y))P20B..B$?<BW 9C@08YIU;6@4O#JE:8
M@E=G%,>F:5,E)<=%[4)B.E<U/6U5#;F24LII^JU<%//5@,)I8)!(3(WJC7,:
MZ65L5*U[FD1NJ!(-[05L?DNLUNO6HJJ*OMS;W)0V2X7*VV%\D\;+S<:5U.UE
M/(VEDBJZB*CI):N\S4=-+'+616Q]-MB.5ZT+CK+9$JGL_@ILV=K B[!'8N\E
MK7Q20\NL1D3PN?"5$=4R<DDLYS+=FM&C>TK2[FK'IB 68H,5[9WYD2H\=I:O
MJZBIKJ66KDK:>"&GE;),1+)3S2NE#H75  VQ+&ULK8Y"Z2+!<'=2EC:VQ<IE
MFM<%@T[?H['1Z=NMQN5VHG4]!%)14EXMM%!0/BN<5KD>YE*ZCJYIZ":LHVPT
M5>YS8FPBMM]?-/'LMLZ=)E,^DH9RYLTFBDHE#0Q04O2(33OR0[KD41CRR,C2
M;<'M1/6Y.U.!9XC!O3A\("C8JL0$&-P2ZA<M07B.JNE2VY34]70U]934EJ#8
MNH.$$\D5!3249B,U4ZZ1-@F:_:-1**IIHI(VF+'R_4W"J:VX59KY8:NEJJN&
M"A!9U$&":6.CIGTNP9)W7"-D,@.3/+Z(!I'QM=&!8"])0_,Z:$-B-[50ULDS
MJL2/;^B&E*6A5$-VE#9%DCFJ)/(:U+Z<)6:%Q)"!<,MF.0-AR=:X$GE_1^DJ
M*EJW7">HI&5M124L4T%%+MNC#7RAM15R11.8ZH;2-V&F(DQ SB:9KXXG-//6
M-QK*.*UP0U;[;!7U4D-571&)L@<R$OIZ".:5CV4\E8\O(G:!+BF=# YDT['M
M^:(DSV\'S=D6R%7+F>-JV4IK?EXTRI:E7N!#@-XBBMT2E$A=#V,M*U./AU?A
M7,DJ0DI%Z@[9!0\[-64-+2^EM1%2,M]161U#IZ2(/9&^*)T0IZZ."1SC RI+
MYXMEFS"YU(Z2)C0YP7'1UPK*KTTIIZR2Y4M#+3,IJV8QOE;+*R9U5;Y)XF,;
M4/HPRGEVWAT[6UC8YGO<P%6&RGJ[*-8)_/\ 9_\ 38'Z-,.9R[?2=A]JS^/5
M:KMC^G=2>W7_ "^A4E9@U8DPB81,(F$3")A%&JP6B+=8AF_, N@$A1)1;]&C
ME*=^8%AQ(-_A&6F#LT6M==Z!Z>G3TYG(QMZ<JVMWF&\4<L@'^I&^CJXF./0'
M2>I!Z=RKLQ#-54)=N$UBN$,1/^O)'6T$SVCI+8P7$=&]25F#5B3"+Y& )@1
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MBT'<N%;,SG)&J;W&J9TO0+2#4JU"M:HRJ1JTIX!%GIE28^0&$J"#BQ"+-)-
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ME->7M&\[@X#>>E=UREOEE$H;7>I)JZMRL&BU3>Y,T77(E(-"T/0%"54_FD'
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M*RV>=>I,(JC4W_C4\R_]+Q[_ +LUN7[47U#<G?\ -U9_C4:UKI?_ $B<J/\
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M-7)3()-8"E/=6]Z;'(!FFI!.7)W:CT(D"]$_(6I:6M\"0>E4E(.."KBK[/\
MIQ6LCJDQXE9Z=AJ]-5*AG=D<!DD??V9K668YL3L]Q^2PAW9%+\TN=MS19L\+
M>!N=M+$Z5Y;5Z0DTE00'&[OYY^]T'O!;)7?%ZL:\E$16ZL^<S";QB>%31.JF
MTM8'R2O+TSTI*JH"SNINV<AX6-+7!;(,=B&_1P5K>87'%.UODG0TJ\F>/?\
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M+:JVUM4Y-I[)7^,6W+7Y@M>+/$EESRII]>Y5?M FLE/*T,,94EJ1A?*&!M\
M9&C4@7Q04YZ>C'@&0?=X=[BL7QQX0V?1;4W1XZ9Q!<? Z+O"JHI:+4ND*6P+
M!?KH>ZJDK?)YZD$R$;BPJF/K(J*Q(QLET[6N<<7HU10HH<T[:G IR.CGX= Z
M!X<][\T?V;Q6Y6U[$)([U1:-BSYR6FQ!L#$W/D#>KT>:S_"OATYR-4)9(YF!
MR1)RC*UY/KG=1%G,B8.$=MX$<:!G$N"EL9" CG'Q#_>\/.1S8[VY;U'.,-YV
M'#(LNF+_ &'5<F;XU5D 7)7"]I6NLAQK^"<9; ;@@EELU<ZM[Q))HKY06XXR
M69/1;DVHYHRUO%GM<WZ5IT#2(F1OY^.-V.)'?X8'AWX5G*1X^/U>[?5LUG<K
MF#X 9J"#/#G8D_F2N-,$BKBK$,Z3[-G#DXB-7N]LQ.83-N4'Z7;;FM[;FY$:
M@0E;9$)03GANZ1[^/B*J^S<:>2429>,->Q5PB=9-L'2,U3VE,:?E+^8FE=>P
M&/LLZ8;7?XZZ,$(VAFK_ &15$8KHZ%F+[&+15[>=P)%4T> '&+#RG(R[W2/"
M?//N#@L2+AYR8T@2N*::MB*1'0.IX5+D1/*#D>)PFZNOX_RC1+I*NN;49*LE
MG).FMVP6RVV((4BEHV[0UP93UJ8)J-^-)D?AQN!XXQNW#@%UHQQ Y&SIZ)';
M]CR,<78[;D#HZF*[OMP4BM!F8KP02:$RMNCC(M2,%$&L,)875LB[364DUN3,
M]AG)Y<*/CCJ5O4$R "!S@#.!T#/AR>/1Q&5VA\1^8QC I0N%]N3I) U["6<<
MJ0<B+EBYDHDK!$Z$;EC4Z,.X/)X]%X\7,ZXL*6.\TCC<HGUCM$\>8DZ"APYE
M*)&23(YAS\X'?X'P=(XC*X8]Q(Y&V-(=.%P35T:(PVW#*'UU:DE[W>M6SME:
MKT3RF$/,;9].YA5)(XG!V5R8X4AA$R6.DLCL]V5/5C0NCY2140D<W1CHQNP?
M#QWG [RRT9XC\ME;['@V1?Z]9&4T2IB-S8,2N^\FM?.%$#44DIEKT%*0G:%T
M1?)$&(6RWN[M')>01.T<X;S7IFCQYS_I249'1T_JW][/GNQQ-7#GE(PQ]@;R
M[\>92>W1:*IY&DD-[7H0METC+7<,'&R$P;$,*?IE$62=&45>:4A:Q%F&1\FW
M31MD>))D4M;RRG(Z/U<>'3Q'O8X+?.*7%.\:/FK&Y3NVWV2PQ@K*.PYEAK3;
M,G=(,S&MT#KR.N+097LIKH:B1'ZET6E,X06FLL9LE1YTQ6,[C%S"1KUBXH)S
M[Y/#CD^>[XSS>B^%"81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(
MF$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$P
MB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB\PINOYB0"Z;U?80GE<JC
M4SG!FJO0.4:=)?&@J8A3G'#S>5X2F3R0ALK:M;#FTMY"BG]I^26O3&^P1(H=
MW[PRUJ:G@N6X@<W_ %.2>G QN]Y9B]Q<WG_AC*!P=.L,OR1E6$XJ2(0-NKJ8
M0MC:F&8.$$8X-IP7O1+E(722,D&9'M:I<B'!P8Y-*EK!Y#<@,1+84 #.\[MW
MY,CO<_Y^=9'DI-.52&V8876T/FJN$QF.,4_VPPR-:=@S60EPKD+\,XE)IL*4
M,3"B\A2%KHIOCD6<]$(Y4NFBY<#3PE;EKQ7!-V#O]SW1^OWN^HB8^07.==M-
M#'.*QQEDZF#6/:!;ZN@<T<EA4/A5NV=5;"Q.<49HS\/6J4V)''6B;/A[V;3A
MQPTK=;H%54G&L9,-+*< <3GAN'@S[HX@X(\.]7;INNYR"9.=ZS*P;0T=:=65
M:E5T),%;0*,5#*&IFVJE F9&QFG("GUU7K=)I$$"IT1D.*!8)G<=MZW1(2@]
M'03OZ1Y_A5EL*$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F
M$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB
M81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3"
M)A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,
%(F$7_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>g149615g75a36.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g149615g75a36.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L
M0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@!!P&H P$1  (1 0,1 ?_$ !\
M 0 !!0$! 0$!           '! 4&" D* P(!"__$ %40  $$ @(  @8%"0((
M"@@'  0" P4& 0< "!$2"1,4%2%7&!DQEM86%R)!6).4U-4C420R-SAA=Y&V
M"C-"<71U=K2UMR4T-392<X*S57*!DJ2Q\?_$ !T! 0  !P$!
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MFWM2I@7X54@19" ;G%A,3RUD $R\.Z/-3<[.PT(1DV505(C$PS!=@'BG 2#
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M3#^6LFBSG..5?6M<YNP0%J:-S@LSA6DF'7+7JQV%W(FK\)JM<_955KP_I/\
M=#.N$&3I_1*E@VUXU#+O#U4,N2U,M>& S9V@L=C_ &AZN=A4>QB*J(GK1U]!
M%5BE5N -RUDB*C6A%I83A#+2$*7ED=IO"4):;&84VPAI"$-M);PVTA+:4XQZ
M_''N0C%AJ;MB-PQ,,1$Y(U$1J(U$PB(C41$3"(B<*Y",13%(5=I7$<KW*]RN
M<KG<7*YRJJN<JJJJY5RY>*\5KZ6>E0=L>BB99E:R(91J@'$+\,-XD&6V"TK1
MX92XEQ#+6<8S_BK;2K'P\<9K<.U$7@O/SIC[^:J*HJ\E5%[TK\BT:N"(2VV
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MY)Z:JM:T=C7]3"@O:524L\Z1+V>;=QXDV"T2KGM<W,DKSC"UJ*,6I(Z7/%3
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M\VV*8T<\A6DCB84^R"248D+_ "(GF$%X6RC\.KPU)UN1M-W 2;3<T8MANLT
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M'A1Z/_*FV^L_L:>![I-\CKM^3']O3Z"';[Y"7C]S&_U'CPH]'_E3;?6?V-/
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M-6H>D&*E'QE2#1E5$O-T!@RQR6B8\"VV0!AU(<W),$JCE4[5[?KYU#=HZT=
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M>;#$.'2P[[_?[^JHY1<^CN3FC5_7R_;BLMCNH'9QB$F):;O<Q.3#<3IN-KE
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M>ZE"C=>MCQU29N792N[H+M,_K^#V+J"%Z[:U:V>?99[5;EK7;!U6"KI.L<9
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M*:B7BETVZAT\B&,82@2&21':C[1<.MB D&%<)Q31%MS9,.(P<\+I1W,6'LE
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M2$4B.1A@'$,P3#<CQE$5J/&1CDRCF/8Y'-<BX5%14KY%R(YXD@\62(@),8I
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94XI3BE.*4XI3BE.*4XI3BE.*4XI3BE?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>g149615g76u27.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g149615g76u27.jpg
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M P$1  (1 0,1 ?_$ !X  0 " P$! 0$!           &!P0%" D# @$*_\0
M6!   00" @ !" 8$"@4&# <!!0(#! 8!!P ($0D2$Q05%QA6%B%5E=35,4%4
ME"(C,E%A<9&2I=)7@:33XC,U0E*3T1DD)C0V1F)V@I:QUB5R<X>AHK6G_\0
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MBXP/RU9+;U'IAT$I(BK@P9!U(ZH%^IIP,Q-OY6;YL_I55XE.T/F7E]><2V!
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MWP_^$X\#^Z7RM/["O^E3N2G\Z8;UIG:GPYD?](>O/OA_\)QX']TOE:?V%?\
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MG")PB<(J^N%H(QYD2G5!$:7=S494II<IM<@74PGI51W[=8FVG&EKALO(<CA
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MD[%J5W/WNF;#I<G8]PUE*<9*FM6ZX$Y+CCU36I]_79C:U!?3+?@P]A2"H@E
M:7^^GL6)%@.?9T>GCVV/,O23A1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X
M1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1?Y,^N&FNQ_
M7[IKN.'K356U],=FO>A',V A3>B96G7[9%,C[MVU:7];D>Q>OQ-NV1LH?L +
M/J[$790^K%96HH[\!A8N17)I4@/+,ZVWSL!M!&0&RXM8Y'.QMDNF<W_RF3NY
MQ)HN([3T$I&O&NR;U)+"M?6/JY6^GJNG8L[LZ1>]GC*B/A'>RP#L8Y9QLR4.
M*"S\ZS#0B:S5&-9RI#:">+8ZCD<S<&]\K#T>H[<]7'NF8/E .Z&G>MY@W9>X
MMHUE;S/DG=QGMH['INN EHJ&YY6P+'9M];)ZVOBJ2D/,TC6M7R-=VB%9K, L
MXV$7S&FDE3; NV1<S[O][?5;TK(EH+AD"-\&W,:@#GK.?%KRRLNAC5Z\JV$&
M=7ZK!KW;0M=:?L-V+9=@RQHN=5]@Z\ >4(N^O9$#:E2KNG5BW#\SIP'K-V,7
M6ZWNH"K%7[ &.ZUKLBYLV0H[5CXMS>P!])(.B3<6XCL]1L%RUJ3M]WYWL-VT
M9UMO';UMNIF7K6T^["HQ7[D5=ZTR>U%Z";:WKK*'6=4L0*@19J2-9:N%:WUN
M3VE;XE1&WJ^TXJ6LQEM\(61 ! (%A?\ %HFP-R-N9U#4-2[)=N_E0!UZZ0@H
M3?:"VX%63KL[M;9#M'(5S7U^U=;NVEYK.UA^Q-8S-.,3ZO<J!US73E7NT;.O
ME3LAAIX->*!KFOSQM[+22GBYZM1RY]$$$&XUNOD+VU&XLI)8.N.],>2GZQZT
M.Z1V#=AM"[A0]B]H^MHP8A5ZVGUJ@]JMJ7&UTUBFD)HQJZQR@TM3;N_0Y$M"
M+O7!;PA+4SVBB'(@_F?>2EQI$WM<9'B-AGJRXN8\2^&R+/V2K.UNK5<Z%]5^
MS767KQ N^C3Q"BC]9B]>ZFE5:Y]M#@?LG!L>CZ]K(M#U\[C6;\J]%)>P-CTX
MDFOV< =UWKX*<"W0Q*J@M8W()(=Z00+MSYSEEESZ@H-(=\KU5Z1;+.'LW9^W
M678VB>Q12PUDI4=<R)&JCU"[\:RIM"8TF-?I O$399_I08VM;J.(M$^T/WD\
M/#&&F)3H\7"8*^)S9.%CF+@M-P>8$ $\Y.5U9WMWR@D[M'H091;=V_KG6Q,;
M0LND'=RZ>F6"Q6^"[O;8K'8L#V7@5#7\6/4RQ'63=2$TTSM*;K^55J*Y6;@.
M42V:BZ-RRGB@&]B;D9'F%B.:Y)(%_0 %Z3>3?K7803U>J-C[2WK;5NWC?)AF
MQW01MF-71LVA+CEIP$)5*X$K]9KF1 1NMB Q)U!91@J3+SR)R636X34RU!>V
M>O:L76OEJV:_YKO/E43A$X1.$4,MM-8L>81.#.=K]M"8?57;3#90]*@9D9;5
M*'$(JEM-&JV4RPPDR EN(CS,,QYD1\<;'B3 Z@]'W[_O5=0B_I&H_?O6+5;B
M\1G/U:T06@%X'1LRI(M#RWAIP:VXAC-CJ<YU#2R@13SK+<QE;;96ORY$>";B
MQ\RALHD(VC,>\<QY_P ]B [#D1]W'-^2GO(JN"]CDI!O9-NGR<X6T+E1ZP&Q
MXY_\7&"8K*YJ,)SGS4NR+#),.O.)PE3["(#;F5IB,9211/A$X1="]<RDA/TT
MJZE^= &R1%A&M?HQ$^DV2[1**TG'U)9<)A)!9?U>*IA:8YG.<K^I]]*+H<T:
M%UT5/.&IK0\4,CKE39;WG90TTCPQC"4-I6Z\\ZO*&8\9AMV3*D.-1XS3K[K;
M:B*!5D*4LAB/L"XPG8$EA#Z:/4I?FY53QLQE3#Q8JVA2V7+T<AN+:(O)4ZU6
MA3ZZP)<SE^R%+'3ED/6>/^@]^OBM #>Y]0XN?T_[9JT>15.$3A$X1:&U#*\:
MK%C#VX? +5,L!,#+.+*14SAA*O3Q\B*:'D82VW43($P:[)CRXJFG$R([CC*F
MUX7E.<XHWS21PQMTI)7LCC;<#2>]P:QMR0!=Q N2 +YD!<<LL<$4L\KM"*&-
M\LC[$Z,<;2][K-!)T6M)L 2;9 E>> 6I>3 ZZ Q+0/66AM1!'-C46VC)436T
M6LHD;+I+<]O7)I93V)'D2CE0CRBF*J]+E.XK\:21R/Q#8?E97Z!^Y/'8P#)2
MQL!<&@OK*-H+CJ%S.!<V/J!.Q>:BW:;G:AQ;#6S2N:USRUE#B#W!C;:3K"F)
ML+CUD#60HJ1=\DE8S>R[.4K?70B8W;B\@]FDIE1BX;OCXIP19MCO%D.C4091
M6+,!@;%;[!&:;)Y*BA)@J242APY+?&-S&,&QWB"Q,C0>[J*Q,0#I0#W1;]6+
M%^=FBU[+E.Z[!!KJ:GQ6Q.(&'8B2ULSM&&X%+<&1WBL!\9VH!6#7M-^3A!2*
M$8KNDM3#)&N[&[>J'(B:NEQ\@+;-*1K'FUQF%!4H78D6&-&LL8O/9?)P+*W]
M((K\<VIR:KGX'[H.0MZU2?/76.[O<S<WQ)]]1_Y.N/-;_LVK6,LK7&HJ?5D'
MTBINM+GIFLZYUR(U'L0C:2MYUE'UJZNAVJ;=_-Q;%FZJ^"="SF#R4H;(0W86
M8;K*$,XCI:0A"7 _=!R)O6J3YZ<.]S%[]\GWX^XZ^^6K/N;8J31U3\E6W615
M.1UDT/BLA7[))@!\Z?\ /C8?M\:N1+&Y-RL&IXIDHQ3J<EW!1V8EE=/J;L7#
M#U9!N0' _=!R%O6J3YZ</-S/G)_4Z_G_ /;<YZ2K2O- Z$;,IY:@; U5K6W4
MT[LPKN8K7SFN)<V!*VP=>F/&MB>:X&]*Q;R^2)%DF=C.,SY\,D1@RGG84^7'
M><#]T'(6]:I/GH-W>Y@9C$GWM;_L==JU<F4EJVIND]E+O!JSJ362R9B'M)AZ
M(SK[ UJ5"VY7*Y7=M1?XT3%AH8O=7I=8#6>.G+:"HJNBX3J%LPV6\=2MW.XQ
MA].^JJZ41P,+&O>)Z>31+W!C;MCE<X@N(%PTV)%[#-=S#]U6!XI5,HZ&M,M3
M(U[F1FFJHM(1M+W6?+"Q@+6ASK%P)L;7.2F,7I;U*A;%&[;B=<]01]EB*Y!J
M0RZM48&D]! BZCG7XV+'F8B>*)$"A9S1X93"?:L:G9S5V9R ><P<Z1>BN;6N
M;<2W$3J=UI@CH B'H[6L86+KVD*F.@,U8:B-#K/6NP/6O00..UAGS6QNHK)(
M?-42*G^+ $'5OP\(5GA+GC.T].1Z1KXU]=3=5.MNB++8KCIK2.MM96FV1I,"
MQ'J;5QH,D4&RS<FR.B7Y$)EM2 R3\V:7C!V/1#(4^9+D0XC"Y3^7"$DJ_P#A
M1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3
MA$X1.$3A$X1.$3A$X1.$3A$X1.$7S>9:D-.L/M-OL/MK9>9>0EQIYIQ.4.-.
MMKPI#C;B%90M"TY2M.<I5C.,YQPBIK85F]TE9JPRF J^.$QDM Q@9D=B$&#A
MQ4!MB .$C!3H^- APX[;,:)%CI1%BQF4,,L(0E&$=*MJ7TS&.8&$N<0=,$BP
M%\K.;GZU['<=N=H]T5360UDU3"RF@CE8:9T37.>^31\8RQ2C1#0<@T$D@Z5A
M8TY\1-T^RZS^Z%/S?FN[Z5'[D/X7_,7T#P8X)RW%?:TGT2AU8V-#I$P\1I>L
MM45$A:IN"=GG5BFL )EC)84\O! ]*%2HCYB;A<A]6)9!<A_"GWE>D\7%Y4[Z
M5'[D/X7_ #$\&."<MQ7VM)]$IC\1-T^RZS^Z%/S?COI4?N0_A?\ ,3P8X)RW
M%?:TGT2?$3=/LNL_NA3\WX[Z5'[D/X7_ #$\&."<MQ7VM)]$GQ$W3[+K/[H4
M_-^.^E1^Y#^%_P Q/!C@G+<5]K2?1+G38G>C>E7N1:ITK3]#V,L=38%G6D9:
M+#!,"GYUVI]:CQ+,+2%(1Q;)0(9NMIKR8),L7.QM:'8,(.M^:VY!Y68C*YMW
M"%OC6S8^Q\5QR.^["&@WL!I@W70G_1[A44SXH7XG4:,+93H5E*U[2Z:&,-D9
MWK<&:3'S2QZ+WOD%-(UK+N&C!J/Y3NUV[8%7I\N@U(.$NM8I]UJ=S3)MDT8?
MK%R#,+$R&H#HL>3"2R5E+UP4';M$<)&D1R;\4K)"6YL54S5=7U#6EVC"2'.:
M6ECP0YISSWT@V -[;1E<7(X(=PV!2SQPF?%6,FCAFBF[HIG,DBF8"PAO>UKX
MW.D?&Q@E# 0XZ9CE#87^ENH]B&+\V>R7B#8RA2QN&,CFY+27$SDSO/PZF3*E
M9SE&8B?,RA2,>"U8RG/AC/.S0U4E3ON^-8-#0MH!POI:5[W<[5H^]>;W9[F:
M+<X[#A1SU4PK&U1D[I=$XM,!I]'0,4,(LX3'2#@[4+$9JX^=]>(3A$X1.$3A
M%&+54AEM@L1IJY4*>/DX( CPMU$8Y72S;;C310/,6T\AF1AIUV/)C2&9(TK
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MPZ5]95N<[Q)#)6S.>6M8^0!Y,+M-@$)(:"ZQ#?%&5L'7G?3JEL&UU2NA^KL
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M-,I#RG";!- Y&X -S<WU"QOJOJ(.0S7PJ'EJM'6>K2K.1T#V8IV2>NZ?>]7
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M]Y)<Y^\O<R-[G'-SWPB-TCMLA<N@.NGU%-@XQ^MFH*S_ /FRFQISG^ZA./\
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MF@A^[!6HS,?85ZA'*<-[$Q;+#W#!8-PKC'*EHUK:N%D<CM'YA5-6F%'"%/P
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MJNSX@L.NQCZKK6Z4P_:;/71NVZII*UV"MPL'FF286C[$N(BM7 HR_F$!..H
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M][6C2+6S0T[8R0+D!QAD#218EI S!7C-T!$>(LDD<&,DHHFL<XZ+7&&>I=(
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M?4M"G(JU-K3G*'$92M&5(4E6?'X\0<1>T'..&!C^9^]->6GB<W3#7#6UP+2
M00/8;GVD8<'_ -V:HJ)&']YF^&-KAQM?H:3'"X<QS7-):05?G73_ )TV!_\
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MST-'6 2"2&3-A#0X$G2L[1(LUQ&=KD21VN#X]M%<WHZW>48#UFNSP8;:1(L
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M<J_]3M3Z,;W^S=E?WS_^]X[W;M^3[H^FO^)-XQ+]RK_U.U/HQO?[-V5_?/\
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M_P"UOF9O[C 8_P#J+YNN"&Y[D!ZW6?4+S?#K=1YQ;U*A^F3W_;7^9F_N.O\
MY7QP0W/<@/6ZWZA.'6ZCSBWJ5#],GO\ MK_,S?W'7_ROC@AN>Y >MUOU"<.M
MU'G%O4J'Z9/?]M?YF;^XZ_\ E?'!#<]R ];K?J$X=;J/.+>I4/TR>_[:_P S
M-_<=?_*^."&Y[D!ZW6_4)PZW4><6]2H?ID]_VU_F9O[CK_Y7QP0W/<@/6ZWZ
MA.'6ZCSBWJ5#],GO^VO\S-_<=?\ ROC@AN>Y >MUOU"<.MU'G%O4J'Z9/?\
M;7^9F_N.O_E?'!#<]R ];K?J$X=;J/.+>I4/TR>_[:_S,W]QU_\ *^."&Y[D
M!ZW6_4)PZW4><6]2H?ID]_VU_F9O[CK_ .5\<$-SW(#UNM^H3AUNH\XMZE0_
M3)[_ +:_S,W]QU_\KXX(;GN0'K=;]0G#K=1YQ;U*A^F3W_;7^9F_N.O_ )7Q
MP0W/<@/6ZWZA.'6ZCSBWJ5#],GO^VO\ ,S?W'7_ROC@AN>Y >MUOU"<.MU'G
M%O4J'Z9/?]M?YF;^XZ_^5\<$-SW(#UNM^H3AUNH\XMZE0_3+N76YHC8J-6S1
M=U+Y(@/P]+>2RVPEUS#[S>',,LI0TCST(2K.&T(1XYSE*4ISC&/E..4L%%BU
M=2TS2R"&;1C:7.?H@L8XMTG$N.BYQ'C$NRL23<K[3N>K*BOP7#JRJ<'U$].'
MRO#&L#W:;VZ6@P-:W2#02&M#;G( 9*;\U2W*<(G")PB<(G")PB<(G")PB<(G
M")PB<(G")PB<(G")PB<(G")PB<(G")PBCUK#ECX @(!VLO2"<W$9#%I P:\1
M,B6VYD=Z6X-B6P-8JXN7)AMR(33I<$6BQE2?6LP9"V4(R1<37#&U:KMFMUVP
M7G=^P ,WK)OV+=CU7UK<AE)8OLJ]:R+ZMG#O=*!C/C[@S3V=J!XS5>MC]Q2,
M"C6!SL"V68&[82N5CZ1T9W_DN=;%9^QY/K]2*)"1V =V54Q&UG[$3I4:\LV^
M3:#XS=L+J>\5-$6VK,S7I\^MT^R62J[-GSS].&V+5C?9J9,%EK<5*$'J]?OY
M_P#8VN;*&GFNY*YAW);'97(IXE=H^STTJ3<6I.=GH3VN]TSNE/59")D75&7U
M==L%GJBIF@K97K_WEK4EG?\ ELKEQCF]U[YY;>/;;8NJMC1^Y"MAC%UHBEJJ
MM _)[8ND>",(RDSSJ>T=PSV=S19\$R/&BH[>JO9*]A9(B2J)E)4*8AHBK;4I
M13+_ /;;S9>_I535^]]Q30+I\2 TW;$A6E]?:J<[50[F.+T@CLF^VQ%/U_L6
M%''66NQR&R\ZSK+6V-BR':Q*0!-W:9K><',&DQI,3!7(7Y]6W+/^=O5?C5MV
MHEV_+]B:2554)U:TV($Q-5[#'TF\/6 .Z5V>+N$HML6OQ25/I=AN#6OCK/7Q
MH?<DQ:QBF#Y._1J!Q9"$E,%,K:\]F7\_6<N8')5H3UUV,U ?H-$3L_LENEBJ
MUO3#U>V7C,]YNT)SMO9D_MEC9<6K-L520<9T*Y0Q.I(=OAN3EVIH7[L_3VW%
MIFK*Y'/(:]7H%O>K/T(8[-^SM.Y$5<K+UN?OFRB>R(N\[-L<3MG5M,*/%B5(
MI2O>-1"5JOY"M1) AJ58U6J>-(V99*LBK"_2A8ZS**9>C5_7T="CNV=V]P*X
M-V(NB:[+';F+V@?$U2J)U#:I5/9I(:+?YU"DYV .E&$7-6V!@2F23DT1 $BM
M>'K!(J5HLU(DYC$DDL./TG+FV9'+UWV!8J=R]WGK_5@<>@@&*:YNB]@[%=2^
MNML-CB=*'6C4"ZJ/ A!E-G64,W+H5FVK'5;[A'!49[8M(COQ=F%:5'@+OY6P
MXSJYM>=_>!SV.I0V5OCL0F@N;8O((@/+]4M8G-R[:"-UJR581M%<R_$!DR)0
MZW84U"Q((1]!:^W2NFU;8H\,1A6G9FH; =%D,0X9<D3+IMMU97SRU7(SUY%;
MF-N3OZ/<OS%UUW6(+PBJ4!D3#I=&V59):;%8W='-'+0**P*?8JJ:KE>F6?=D
M:P" Y:YWZ%!J=4(1-;.0Q9TG;26;QGUVY[<7-?8.,;).]?>TY?K'O2\;FA(U
MN616-0MQ0=3 DJL;H]3*Z?T_9.QEL'V3%G,EYABL62W[@& )D#(J16/=\.8B
MJ(&(THU.*6SL,^C,WR]1R43N4KLF;39:JZ7W;2VJ?-[22[1:1=&V%9AQ499^
MX>L+;UO"5Q>O)0JWW,:8ZZQ;A3B9#3AMZ[:DJ9$^B5*K-VBA(L@KEZ=7-LSY
MM=M>1Z5T9U(LU_LB-J+O06R5B3$):;S+IMJMA&[$]>W$GUJTT8N^OH]E)^8^
M:@@9T^!/F&$L,9,6TY:R<QM!25/:;*&V5C?_ '/\N-=B<*)PB<(G")PB<(N+
M=SU:36KM)L2&5J!7A^*YF6G*EH@VJ&+:@OCY"<>.([!02(C3A[W_ "3T]@NP
M\MJ0\/;F$5:19,@?+<EQF8TCUF(J%,BRLK0U(9PI:XZLN(0[E.8[CKW\#+*T
M/-2'FU90K+;C>ZPK%10-EBEC?)&][)6&-P;)%*T:+B-(6+9&V#LP6N9&X$@.
M:[28MA+J]\4T4D<<K(WPR-E87,FB>0YH):=)KHG:1;DYKFR2-(!<U[,6,SF/
M&CL97ES+##3.7,XSC+F6VTHRO.%*6K&593YV<*6O./'ZU*S]>=742B>HGF$;
M8A--+*(F_LQB1[GB-M@!HL!T18#(#(:EM*:$T]-3P.D=,Z""*%TK[Z<ICC:P
MR.N7'2>6Z3KN<;DYG6LAE^=#?=D#Y#4=U^-F(\MR,F2I+7G^D0[&RIQ"69+:
MLKRA3B9$965)S(BO^C;PGOX?BCZ".:,0LF;(YLC=)SF:,C&N:-+1S?&0?&:"
MQXMXDC-)VET,1PIN(20R;^^!T;'QN+&->71O<QQT-/*.5I;XCR'L\;]9%)HL
MT<7*HP^'E;CB6(D&-E3CKR_!#,:,UXK<=<5GZDMM(RI:U9^K&,JSG]/-=+*^
M:62:0Z4DLCY9#:UWO<7N-AD+N)-@/0ME#$R"**"(:,<,;(HVWOHLC:&,%SF;
M- %R?2NNM$5.=7ZQ/,EHKT$G<"2#'J,E.$2H EB%&'AHLI'\IF0]'CN%GXKO
MFO0GBKL*0A$B.ZGG&N17?PB<(G")PB<(OXI*5I4A:4J0K&4J2K&%)4G./#*5
M)SXXSC./JSC.,XSCZL\H)!!!((-P1D01J(.PA0@$$$ @Y$$7!'$0=:YQL^_Z
M0!1>F!>O=EVTUKV <,&PD'7CU,9D@JT2:%G3H>[;>>UKJXD*AOYF/19+=\0H
M]!$&"%:;,PQ[SV,]^E\K)^-W:N/>(/(Q>S9^5KKY:\[$ZXV5L0GK8)6CL,P/
MUK5]KMRR4:G+COU*W11DH1DD&#V@O<Z*9D(*-8A ]G56CD3Z8)N756#X\"9F
M06_2^5D_&[M3>(/(Q>S;\*I6K]_=&6NE:]O\"F7-%:OL&(<FRVG=.GO=Q4YU
MHU_3H]IV6NH;4LD6OQ46#9 *&1K<&29OX%$*PR[!3Q40%.?0WZ7RLGXW=JO<
M\.?ZF+*__=MSM>]O%YE- O<G2<_6IC:UA"6/7E6!V32 6>J_P*<%D,!.PY>@
MB-7W^3(B6LF&&4HHK8@J:5D&2XVP5R*+L3)RNP2@O Z0WZ7RLGXW=J=SP^1B
MSO;]6S.VO8MQ3^V^A;S7]K6VOR7I=2T_2S^P;-:&( <B"(U*N;+W]JR<7J\\
M,3)MGHT@]UOOY(:Y'PAN> EUB<PM4DK)@#F_2^5D_&[M3N>$:X8O9LYN;G"D
MTOL!KN+U\:[%)K%IF5^2"'3HM$@UX9(V?)MQ8O%JD#4S5<P42-]Z3U_F,:W5
M7G#[<!B\*4*D&6H[;D]+?I?*R?C=VIW/#>V\Q>S;JUW_ &>+-5W/[C:MC6*<
M'&Z[V99 J]=::V%4+X!I8Y5"V+C?EQ"4/5M2J%L+EA /-IM-ELH.%$CV">"&
M1&GR!(P4%!Q,HCQOTOE9/QN[4[GA\E#Z-[;<6UW&C]^E;RM]J=:'"=>B%*1<
M*4(L-<V8:1:[;#H#0$07TQ86JGM>F'60-W/V(>?HMD4\$*%O8#U!GDXZ85?N
MIF22"-E&_2^5D_&[M3N>#R,7LV^K^[M5L.;:U W%U[,18PDMC:J&7Z![-@2B
MKUBA.J&-K*M1AL"7)@A(,@V$AESI1F"'"$#0<<8G09Q6!'D-^E\K)^-W:IO$
M.?ZF++_^MG8HHQV1Z\OXE?\ EH(C+&CK27.L$:\?%RZL+IHN"</$+E#) HDJ
MF0T!R8LH*D6ID.U8X)09*KBBK)"&I]OTOE9/QN[4WB'R,7LV=B^3_9+0^*[=
MK*./,FHNO-?6;95MB#:R:S/" :B0L 8V.+LS!$1 6X13U5L0%5&-NCK>@N%*
MPW0K:QTW+#?I?*R?C=VJ]SPWMO,69M_9L[-7/MV+&<[,Z#$!(I*WW&HUDDW$
M4NQ@\O8-2JM/'S[^&M$0LZ)@/X9A4XWJ;:T*S'7F8P@)%UO<C)>2/$ "4R,W
MZ7RLGXW=JG<\/D8O9L[%('M\Z,CVB/29-H&Q;A-N@^@#ZQ*KQR,=*68JS89(
M]L0+?"MS"P63$J%OFHM@UJ54\0*A;9RS:8E8.O0&_2^5D_&[M3N>'R,6J_\
M9L[% [#VIU15Y&T$%:^?7#U=4-]7N>3&B!$R(=KG6T7JR1M%03#I*(\LG /;
M3BU(9!G-PVYYJKV93LR'!8&RB3?I?*R?C=VJ]SP^1BV?]VS;JV+(K'9O7-ML
MRZ\-J9N,RQOBS=>)9DBY0O5XMZJP78A:8]/"B;:7ME?$SWM>.0 2KE7JN5L+
M=NI)T$*)5H^T8:;]+Y63\;NU#3PC_N8M0/\ 9LV__C^7:NGO4(/[%$_=F?\
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M*'.=*-+S32[*;<O-BL96RMVB\&3-QGNO[.E15ZJ6+'; A0VX0@P"$8TAJMB
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M<:=;^]5?BE[4[GW#^3W+_P#Q?:N+=U7?NJ-VEB'0"G8?% 15@&+:NO4<Z?6
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M93_UE9U?>UM?U^#Z&E8Q_.G'C]7"+6C'_6AH^3G/CF1!B/\ C_/Z:.VYX_\
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M9A(R%%B8VY-I?J5(YHKIT2GR21/KP-*2IMTV;L.=@H-'DHA"Y;FH$G5FTS1
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M%OYK4#>WVW&RX(%==4Z\UV36:8U?=TVO:$EB'1]M9ZLV'M84*$B@^L$A+FI
M=3 9KDNQ8((+/'9$UY<*!""R%RR6^^,7MEMU[+*V]3]I8UW.:CU[<M?WFI['
MVGK>Z;(81%HNPYVO8H*GFJ\-C3'+R3IP<8,Q;P]G#V88*L&1A>O(GPZI;XXB
MX$0X@JUZU+=GWQJ,2>WNHH3.MI\_6-RAA=NWN)2M?%W8NHW7+#")WNGZV#[
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MZXKSG'GEN/.K6ZXM:HL@+9!;+A%YM(9S%E&8F<>'J5FM<'&/^JF%92L5"?\
MX4,XQ_JX16SHUGSMGXD>/_(T.T,YQ^O_ ,8L-&7C/]'_ )JK^OZ_#Q\,^!%5
M&<>9./,XQX8BVNX0L8_FQ!M)B'C']6,,>&/Z./O[^_0BLO237G[;A._7_$Z_
MN7]7BX?H"?[?#Q\/Z/'A%V(:"";$,EACHZ(5%SD);E09K*7F'<(6EUI?FJQX
MH>8>;;?C/MY0_&D--2&'&WFFW$@;9A"+Y%5MZS9]:?P"2RUVU^WXX08\V06O
M%.8Q_(0:9:0[.NU?CH_B_;<5M^WCFT,.&HMG2X3L<#+(ZLC[CZ.(\VKT:ECF
M->8]X]/&.?7Z=:M$<1'EX$,H*G1"8PA':EP"$"2S,A38KZ,.,R8LJ.MQB0PZ
MA6%MNM+6VM.<*2K.,^/,5DLSA$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A
M$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.
M$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A%JS9L37!
M<PT<(1A@N VER5,E+\QIOSUH:9;3C&,K>D27W&HT2*PAR3+E.LQ8S3LAYMM0
M"^00FV95:(#&-G+3,N$&4$H.%)<&T*8C+).T(3G"VB6PVL9SF.,>\$N0Z!YV
M4*8SARZYE2I+E7!6]M6OCXO1_,]'&9:^O5Q<?I[.GB%O)2E*4I2G"4IQA*4I
MQC"4IQCPPE.,>&,8QC&,8QC'AC'U8Y%5_>$3A%YUEFLL6*X-Y_5>KVO']"7K
M@;?1C^K"'$XX16KH)O#M]/O>/UP:A&;SC]>,%#/G8S_1YWL?./Z?-S_-GA%4
MI%/H[%=6O-\WT>P+_P#5X>'U.W$W(3GP_I0\G./Y\9QG]?"*V=#,I<OY*1G'
M\.'3I;.,_P R21H0M6/]>1*?#^?PS_-PB[ X1.$57D::5KL^78];.0X<F;(>
MG'J00=<BU*T27EY=DSXJV&9"ZC:)#JENNG1L.1 +O.O*LH8I+<B%A=O?([-1
MVCM'-T64M;,;=8.H\_,?NRD=6N0JUIF,1VY@LX)4RT?JYEIN'8 +[^'/0HGP
MVWGV7HDG++V1QD;)G@C#3+D@.3GQD9=P(MZ]1X_OI0$'T\1U_?.I;R*IPB<(
MG")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")P
MB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(N)O*-[\O
MG6#I-V WGK' IJ]4:K"E 2QT:HP$JCMDMM=J,V^&127&4$16OAA^;>",*0ZW
M"DQ*^\U/5B$I_/"K1<@:^;C.P>LY+S/G]Z]O=-NP>Q:%;]^+[R=;:90NG>R=
MM;PN#.G:K9>MX_L1O2W:4M<\D4T%KJG4@_6(4)NJ;;%UTX!C6(-0V+)/>LLX
M/''RY!96! (L#<BU]=@#MS&L\8OQ;99K[RP]LNFPNJ8*3IBF0ZYV/M.J A<8
M/L^VYU]UH"[',[+M77RSV>=+T@-T_"G6_652JUSE4)6T'[HY#/F93(Z$/"CW
MSQ-$9YG*^P9VU[;^OFVW5=U/RJFXS 'KOV,VI4*3IZM;DZ>;[WM2=>0]P6RW
M:QFCQFR^GFN]?RMI1ZWU?L6V)6S"UNVU98%/ :M:.PXXLD)K\N!8[!:7YU.)
MHZ\]1 U#:''CM;+;[K9_4MY9[>2M92K34NKVN2MKH.M/*";1V\)M.V[]1!<"
MN^3ZV'0:M<FZ7&)Z6FVZ0?V&%N7IP=:NU=I\NK'DX@6&8ZR/DYEDT1?60+M&
MJ_[0)OKV6V:]:ZS[:]A]DF]^]%]"T;?<[J-KOLWKG>6V;/N: $U46O!"?K"M
MZT+4_3]0F[EJM\UL&)&6=@%;79I$ZI&3,X%3'X%>='I=)SD% !8FU[6%L[9W
MN38@Y6]^:Y^V7Y7LYI:]7_7@T#KSL76-:Z&[(6*!M^IV#8 15SVCU9ZLBNQ1
MZ'99R],!],IQ?8,EMN>*TU>]A1Z&R?K\V1(D*G2  DJ&7L;VN0#JRN;"PO?*
MVVW\SM1_E7-[3+I T03T#HRH;^L^YZ51:W.LW8&TQ>OXFDWGJ40[>CBUOV0O
M34:SL7.-5Q4K7Z:X-HCH\M;'4E1Q=0>*XP^0M'&; 7.6?[6CD+@'//7J.VQ6
MHL/EC-HC5]NK*&ZIMG]6]8Z]VQB*NL&YVW(Z3L3JK5F#<F$>L4S68^G.5':1
M..>@TZ94CI^RC \2LV,W7TQK?F+7R@;<@7UEO03:^O9EE_(77L_IH]LBT:QI
M]DVY6:?3-@G1KA8[5J':BUWJX-J=-E20D"#:C=7I9 S+:K[@K)J0NM#8K9Q1
M*,.]<',1)\HL59O"*+VJW"JE$CO3DRII E(S! @!3*99VQ$\MK=0-#P5.,I=
M=PTA;\N7)>BBQ,%J04,SQPJ)+FL-:A-OY#:?O:HT%J)4P5B7#82HLDS"<5(K
M55ANJE5ND9<;6WZRPXXVSD_;7&'%L2[3*CLI@L./#JW!%19):2<I-LAT\?\
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M84GJ^""8K(/J[J<-7,5BX4G%?%:[UZ."8IFP_9?T_J.!42N,P/HQ>/887Z8
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M$X1<=]@^L078%=NA8,[L<W:+ 3I1I^G2-FF"FOK!,J=\J%JCPR>M=AF2NIW
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M22HGB"T/#2ZX;9EO/PX\(8X+F-,QHN4$N1M(]RS,=>M$)KR:DG3>L45=$1B
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MQ3243H'54#AB$0%1W5+)5N>(F.?H0Q,D@ D<^T](]#]YZQNK%D(5VKHB1M5
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?)PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>g149615g77c85.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g149615g77c85.jpg
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M_P 2Q[K1]!_R:_[07W]F<3_[_"&E7GKY]W'@#P!X \ > / '@#P!X \ > /
M'@#P!X \ > / '@#P"$LO_ANG_V7#_[V[SY-\O?];<+_ &==?_)XL_,?^6?_
M &IX'^P>%_\ Z'M0COGI!\C'@#P!X \ > / '@#P!X \ > / '@#P!X \ >
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M&/ '@#P!X \ > <\;_O^O_U\_P#T\^>]?Y,O^L#Y)?VUPG_J9UGMG_57'_\
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MMB^^XX/^6'ZM"#_NKI_,&']AX^A<)^PL_OWOX@^NGRH^V+[[C@_Y8?JT(/\
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M_-7"B8G_ $;M3,+$YKKY)?)^X[7S7L^S8[<=J+_B7/9F,;YX2]383SHCV,>
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MK%/*U/7*R8Z[BXSGX"_&XQ+:-4"Z5"SPF-8\_)@2@$7/&04U1=.7&?(D/+'
MC9KM#U] A:>9YMLJ$A5OW?.PJ)L#$.6)3<X NN&FW"C)$9U_43 CTH77"6QM
MA-Z,D!R:.'0M&,PYHE$Q<>:+#K3#'IR)34=WTW?RQO=:.M2O;>48A>4 ELM;
MMX)S"0SD*/$ERP\LBOSI\6*3T0B Z=G!D;-<G[@1'SN-?,2=%W;A(:Q4%H^
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MDB;#3![AS7>U2*5C#7F@M#G.[UF':3<PYKSBCPC&&J\GC../;HSHUVJ+T?\
MJ\VJL5_.;>IGLL#/3ZG][: :QU!OE_=EU(I%L*;S,PFD";:JUY5R53-3M#XO
MR/L&"[;;F89?5N),A3'BNU9[4J8=OM/"4D_"KEN.5)G$WY]EWU?NCJY7%R@K
MERD[93];@EU5Y+?8L*X;CDAAM,U37$K9;5J"%5+"M<_270YL%&CCP7Q%RMHB
MH$(DII"+(UQ!FTY?<HHH6+=%R53T[\&1X \ > / '@#P!X \ > / '@#P!X
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MG%]W*N\7]UW\99K_ "3T[]<8EHAQ1+33=,K*T27P-^_!D> / '@#P!X \ >
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M> / '@&J?<^TK:I^CI#?1HA>8;/WV)4"JLKS1%DRA+%L<K14UB>N991"0K;
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MP<,M4(6)A1APZ'KRV9[<M<6%#U:8T?#+;LSV98:M6&/.S///GCG++GGD#(^
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M0=NC9Z^-'V,X^T>/@0-NG+CG7LA0HD7/'G1&TZ\ ,$P5TDM/ K$ZN#YV 5H
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MP[VZ8:$)JX-+2VN6/)"93/)(PANF9O89(HP7&;S6W=F2W#RI*'LDY1ITK7M
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MN#*K^<T.@X1@&PYPSY+S0%T*I82*3/-):37+SJ;R^"#P!X \ > / '@#P!X
M\ \;^OO=?LTQXJ,IA2(MCP;N88U?53,9%4MU\5X%R:-][.+0J8O$V&Y3VVM
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MF3&$W%B AD!:V%#B^4E" \8HQ;LE_:*GE)@LO+GKPD9+[\ > / '@#P!X \
M> ?SI>VSA]E)5KTYMHJ3?L7B%U;[0SEK*F1O:F=E.OB"]=>)U6@Q$SK7IFC
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M#'7KQQPQXXX$.SX \ > / '@'QLUX;=>>K9CQGKVX9:]F'/^66&>/..6//\
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M 0OR3#=$(.9Z9*5B!^,JJ \RTP$_9H93 8? QE\Q0BDTY=]5,]U8[S</P0>
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M+0H'ML)G60909K,"(N;+"W1QKLPX;YQ3--)\NO<35H[_ &@7UM87,>")<6O
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M%.O5-_ XY?M 06YF6EE/HNU[&R:RE;K(AA2&>@RBA*<+6ITA=RF%B,NZYHL
MN,Q3PY3(NX ,BRIKD:X&P&58(9+3)UA'5+%5GE'2>9M_4%F@;IJBM;@5XA6
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M^]D;6ES"@ V>Z)#P68,&;/U3&%W(B5M=UD]T_"1@(E/BIYYQR7I&\?@@\ >
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MNNRIQYK89:[RE 6U82 :]+9#Q>0"2D@ ^.@M*K\3MAHJA':3OX<71FPC)SV
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M '@#P!X \ > / '@#P!X \ > / '@#P!X \ > / '@#P!X \ > / '@#P!X
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M*1XF$AD,D6?3HT:8C))S.1Y_' CB:9+6%/G)?_@@\ > / '@#P!X \ J_P!
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M )^GEHL$K ^_BI\25]R)P89"+\7X$R+'DZ]FG ,#)Q3PV8;+KNC*9R4!PA!
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M"LA&9$+K(<Q]AT-C/%AY<D_!X&P7@@\ > / '@#P!X \ > / '@#P!X \ >
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MB<RLYE" !J817".APRI79:QC>K7?BLHQK*@S9OO1!6GVPEUBK7->2$HS<:=
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M*SB:)F]:ERLMD06*I3BERPFJQC-?"21 ^WA&;:X2N3E4[A B=;VCKF7<1[M
M-\"KVPH#/L.4"Q%W,&*)%:Z@+.B6L:7[/>--S&[1CGS7T5.V\.& D4\_"8]_
M]9H2%8[6"F3M$7ZV:5CC;Q&5G\^+?0ID@;$9DZO)U<+<E-C]RM 6PS''W6N$
MW0@P-U;S42,.*?C,2ERMH6(6"*3W><[&HB-WKL9,B2C-RKL5FD/';&YJL&*R
MLU0B<ZMZO1.VLGJ6LL88 MU!#*20\=BUQ9SD<M-P'C9LV,4FK3=HFG%^KA@K
M65%"KFXG/'NZ+G)>K'VD?F/J]9EXJZ9S6N8&Q=J8BR3!@*V$& 8M7=%J9C8B
M(>-!R&@]!>8./Y@QVZ<5G^B2!92?R(+[9(8:"4M+/:2%P/:)3CR_8+6L]:;B
M)J:W+RY4G.6IV=!2S@.!;'-4L+&UL4>I2>H"."\8Y6+OPKR-<4C16>J<PFL
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M.+')Y T;DP>(NTV6(D2);*;,GR]VX)>9\;^K'6^3J.Z-]'UCGH9!8(*5C\*
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MMY$$F]&_!."V1G:CKV:*(X<1:JT3EV. 7V9/VP,I\L81$-T0Q.4<Y9O1"S#
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MT)JG"IWU[ZZYG:2NFJ6F4>-H[0SG)(:!?ZMV)R*Q1"J V<MJOV/7.S&@%!"
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MB7*>6$X4]3WF*5O9YI2^_,=B$;1L1J.GWJM73.4<CJ6PEE^BN\#]Z+(XVP:
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M7)8NTHEX27-L,W%HL11L"=9$X:D0&4]K 46(H1C3C>:XJ@AVY*?UX5BTL2S
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M@#P!X \ > / '@#P!X \ > / '@#P!X \ > / '@#P!X \ > / '@#P!X \
M> / '@#P!X \ > / '@#P!X \ > / '@#P!X \ > / '@#P#Q&=NB7:)ZO>X
M!/W2E%VA[&]HKU\[XP[DR?F<K<:]%HBMNOH/17RM5'%6Z%^ R,[52>X9/>)=
MM:X8]%9S,;!=*R]_$7:-JTDEC*LVK,4BKM5F9IVL(Q6)KK1'LFNS0A<25.]W
M>4W1]5YT$RWWNY[$&B:I>JI6ZIV.#V4[1EI5I2K6L.V6B1M!+Y;XKU8#\6L$
M"/U++F=R'H0>4U"NTIHHHXHJ2TUBW,1X.JJS"S_9?=\_T=9*(EU1)#80]GT[
M]7#[R[76VM^Z&XZT-T7JLVU/+SJD>_5ELC'6,;KL8O*>6M8;%H,.,ZTZ(]08
MD_0#M695**U,0E2:IJ8?10HPP/CL#[/[L_3:CV#:.M82&KW/:?>S<Q5.]UB;
ML1VG,%3=P4HGU^M#"UTR,NP1B".H#&Q2=VQG$@=+K^HNC#C,H@&Q'PX1,1-.
M$YCLU[[*;6N$=V-#WZIF@ZWH045%5S!/0];!^%-K!O..3>U[2\],15JM@1/+
M2RG"L$7-TI2<L 9'H,05'EP@0O7(C[.($7X0Q\"YO '@#P!X \ > / '@&DY
M3N))@R[67<*<9(KTD=@*_P"NZ0JGVI5@86(QV2LJ[:OMD@V DM<%/2]:XP36
MDCLD8&FN&K Y.[-4R;9&I,P%C#NE](G;74K97]H>/:9T;F+3I^, 5+.KVCKT
M,2&T+E*K"Y+)['-?5,4IKXG1!V?I%$@K?5>/Q6S:IZKHA)#(M- 4>PRMIX"O
MA#[J3Y)^:9M;8-U;T"VZ'K'>@L!09>;4S)T2PHY1;CKBTP+]665:VD5-%[2N
M;62FDPM8FM6.V("U!8?WF'GO-92L_3^7Q$8]%/FE\2I[9[A#JKLHBJ2$*<81
M$D_U^5;9L?6Q0('*4P]G+!_1I5T,2J;8,B:V1X3!+7I]@S>28#!86VH,5"ZF
MZ5H.C H)-^?DI?EF4^M>T)*-A2N4P50I&+9=[KM66!0RN:L41"#-%;VPBW;9
M(HZ_,\->)[:\85E3H-QR<E@< >HT V<10X1B8>#I6:NBQC+PGKA&Z-C O;BI
MYM*TW=9WAN7QUW#1.Y12H*2VV)8NP],62;495=:9585W/%R:B, L>]FF@H!,
M(-B "13:3X%:\)F8D3AR\/?!U2_=GK, FML(U8LH9@E:&W>8+S$&R]*Q-SK]
MD$IS] 46_).X5K -(;6;'KCL!0S#(;4C?,P:PCQTL64U0PAX_%=_],^1C^>Z
M]&93!F[AEW10$D'8LDEK-J5HKUE"VNOK$I>L\T7FG#%=17O:S&VB\4@4'7Y4
M,<Y'B3*EQTQ1;X;=I)#0A^FO7+P)XC]GJ7LEF")R0Q,# R&Q!,WF-C5O9T?E
M7A!V9\22&JR)<Y.BP:H*ZW2KK$3M(&S92D<F-B:?6X0Z0:'[H7 0U[O6^!6%
M<=UJM:8.V6V$=BSS/C.[\%DP%IY8%8300EIL017-PV18(I9EH=:@+;5ZS8'Y
M+VN["N:3 3+B$*R(D8$S#P(?K/+JUS@@5I^T+K]/$;BZ"L&'W@:IVP?813/!
M=J;95TI6JI7+F/"%%*PJ^@M,;0X+MDABPLW(#1X/(W*/.'8F=,K+[J)$'H5X
M \ > / '@#P!X \ > / '@&IEX=I(--7-2%/RQB-ISN2(QSM+58MLAZL$0\E
MYNK53P65C66!&,GNPC^ZQ]4Q:2H.\5,+ZP9#3HF<;=F'.L6/(Q].]MM%LV:-
M1\Z\(K2Z]K5W.-.NFYB'EOQRL]>[54:AL(@= 1H4;<E;2!Y\4F!#B<DF+8Q)
MI381,9JQT?.6M(1S[O-3S[J\LI4,I G[2M/&.)Q/_1[LFSISA8E:U3!@OZSN
M97&QJV[25OT](@7E8RCZY55#&2X+459Z<?ERFG41K?69;C4)>(PX"P5?GY>M
MR]E[]T=J?!3)V-WM$L(O+I&D4J6]4H?B1-[30]#P)VZ:F7L;78ZJ''TV5L#:
M,[4CF_P:VV&,B;(J)+XKT%OW$<![I*@I,D.SYX=:3X<EUF5*-PG/L)4=?.6:
M$V,TT<PPU'%^/YQU)T,KB2D[N67"$UV0ZA%XDF5B +;4QNC@BEA'UF(?E+)V
M*%VSY(J;JTB0_7PS\"K-G>GK1J&QY^QJ><9LP]I6H2A^@F_>;+GDY*21LB)G
M JCBL>;,G")R*&-- ]BB*>Y>("09R1"*;_1B>,4(?IJ-</2S.'+O%U]@PV@X
M4=X$E7$%8F(,PC!K LR494=E(55>Y&P"8=,0R,M?30B=;BL3,-V&9A&#A32O
M/.MX@NR8K@X(?]:<VOAACT,^Y=L:U$5Q>3RE9F'V52D$I!W0H"PVBU]SL37M
MD!E^M4=^++\1)=&<X[8CT;=%3CK!D"92D(6<Q@3-^K1F&77Q\A'[<4["@D])
MY@.R3BPP::^/Y*%47.S+Y^T8128M-*15!04@3M5N'%9I#L(EF!UQM;#:=F .
M<.$(+F#,_<@CSZKTO'$@ 3NVL-UQUW7"4N:&93LIJ0 0"P])^7 XS&/G7;L5
M?F@QM59ZSI(1I8W] ?X1F@"4T<2CRV??,(^FS5O>!)A%)Z3YP;P^"#P!X \
M> / '@#P!X \ > :EVWVS!TF]/:\^(#= 34'K+</9V;8D>:L3H)Y8I#:B\O
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MTA9-3IR@LP8U(XU)K@")EAER\K>:K:28D;CC 7R.;3>(7= ">BC+Q3SGE&.
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M7OU93%->S73%JL:F6KIL1^MAL0JOIBNI?,DDK04\4$JI3= 6Q%3HP)!5362
M3GV,U2-DQHE%["EPM"U$DM^F,$CQ. ;K*4?UGGU70DPWV;=."JN&5%"<7*&J
M#&=7:,)0BONK*PT;I28.P&+7_.I2ZY 3@XV'T?>-HRR0<P3<(J7/GRA5C0=T
MG++@7M.9WW\L.A.@G3S3&5ZUWR;8>U*X4MGMMY-6Q6$9+A$&-AOT^0:[<"[
MME)]F@]:67.2QN "%L&YL*N)45$<#8A\<7MU2A)QHGW],*J/S,*L>SUHU0GL
M\D%*/083+:JE;^(^&L4L,G!F-/[&*O:&&+BOH>HQMJGE8C92B-T$@KV_-^.M
M8SS$AY F1!!D1 2Z=$UJH]1XR;4U-6@"FZU2JL59!66N(:_!7 TDY(BRR^^
M/U_#T[",F%"'1-TK+C_';LCP8NK+G_\ ;IPX_P /!"P_ '@#P!X \ J_T2XO
MS$0?E2;^K'EID]5L2N:T>X]$N+\Q$'Y4F_JQXID]5L*YK1[CT2XOS$0?E2;^
MK'BF3U6PKFM'N/1+B_,1!^5)OZL>*9/5;"N:T>X]$N+\Q$'Y4F_JQXID]5L*
MYK1[CT2XOS$0?E2;^K'BF3U6PKFM'N/1+B_,1!^5)OZL>*9/5;"N:T>X]$N+
M\Q$'Y4F_JQXID]5L*YK1[CT2XOS$0?E2;^K'BF3U6PKFM'N/1+B_,1!^5)OZ
ML>*9/5;"N:T>X]$N+\Q$'Y4F_JQXID]5L*YK1[CT2XOS$0?E2;^K'BF3U6PK
MFM'N/1+B_,1!^5)OZL>*9/5;"N:T>X]$N+\Q$'Y4F_JQXID]5L*YK1[CT2XO
MS$0?E2;^K'BF3U6PKFM'N/1+B_,1!^5)OZL>*9/5;"N:T>X]$N+\Q$'Y4F_J
MQXID]5L*YK1[CT2XOS$0?E2;^K'BF3U6PKFM'N/1+B_,1!^5)OZL>*9/5;"N
M:T>X]$N+\Q$'Y4F_JQXID]5L*YK1[CT2XOS$0?E2;^K'BF3U6PKFM'N/1+B_
M,1!^5)OZL>*9/5;"N:T>X]$N+\Q$'Y4F_JQXID]5L*YK1[CT2XOS$0?E2;^K
M'BF3U6PKFM'N/1+B_,1!^5)OZL>*9/5;"N:T>X]$N+\Q$'Y4F_JQXID]5L*Y
MK1[CT2XOS$0?E2;^K'BF3U6PKFM'N/1+B_,1!^5)OZL>*9/5;"N:T>X]$N+\
MQ$'Y4F_JQXID]5L*YK1[CT2XOS$0?E2;^K'BF3U6PKFM'N/1+B_,1!^5)OZL
M>*9/5;"N:T>X]$N+\Q$'Y4F_JQXID]5L*YK1[CT2XOS$0?E2;^K'BF3U6PKF
MM'N/1+B_,1!^5)OZL>*9/5;"N:T>X]$N+\Q$'Y4F_JQXID]5L*YK1[CT2XOS
M$0?E2;^K'BF3U6PKFM'N/1+B_,1!^5)OZL>*9/5;"N:T>X]$N+\Q$'Y4F_JQ
MXID]5L*YK1[CT2XOS$0?E2;^K'BF3U6PKFM'N/1+B_,1!^5)OZL>*9/5;"N:
MT>X]$N+\Q$'Y4F_JQXID]5L*YK1[CT2XOS$0?E2;^K'BF3U6PKFM'N/1+B_,
M1!^5)OZL>*9/5;"N:T>X]$N+\Q$'Y4F_JQXID]5L*YK1[CT2XOS$0?E2;^K'
MBF3U6PKFM'N/1+B_,1!^5)OZL>*9/5;"N:T>X]$N+\Q$'Y4F_JQXID]5L*YK
M1[CT2XOS$0?E2;^K'BF3U6PKFM'N/1+B_,1!^5)OZL>*9/5;"N:T>X]$N+\Q
M$'Y4F_JQXID]5L*YK1[CT2XOS$0?E2;^K'BF3U6PKFM'N/1+B_,1!^5)OZL>
M*9/5;"N:T>X]$N+\Q$'Y4F_JQXID]5L*YK1[CT2XOS$0?E2;^K'BF3U6PKFM
M'N/1+B_,1!^5)OZL>*9/5;"N:T>X]$N+\Q$'Y4F_JQXID]5L*YK1[CT2XOS$
M0?E2;^K'BF3U6PKFM'N/1+B_,1!^5)OZL>*9/5;"N:T>X]$N+\Q$'Y4F_JQX
MID]5L*YK1[CT2XOS$0?E2;^K'BF3U6PKFM'N/1+B_,1!^5)OZL>*9/5;"N:T
M>X]$N+\Q$'Y4F_JQXID]5L*YK1[CT2XOS$0?E2;^K'BF3U6PKFM'N/1+B_,1
M!^5)OZL>*9/5;"N:T>X]$N+\Q$'Y4F_JQXID]5L*YK1[CT2XOS$0?E2;^K'B
MF3U6PKFM'N/1+B_,1!^5)OZL>*9/5;"N:T>X]$N+\Q$'Y4F_JQXID]5L*YK1
M[CT2XOS$0?E2;^K'BF3U6PKFM'N/1+B_,1!^5)OZL>*9/5;"N:T>X]$N+\Q$
M'Y4F_JQXID]5L*YK1[CT2XOS$0?E2;^K'BF3U6PKFM'N/1+B_,1!^5)OZL>*
M9/5;"N:T>X]$N+\Q$'Y4F_JQXID]5L*YK1[CT2XOS$0?E2;^K'BF3U6PKFM'
MN/1+B_,1!^5)OZL>*9/5;"N:T>Y:'D*/ '@#P!X \ > / '@#P!X \ > / /
M"G#VY%2'4R'/4UA-R?8U-=V;7L15.68P[8--\=1I6S2)B/&]3J5E9"0RSX>K
M>8XF+*M.+K,.+NC0P+9*SU\<C?8<QU26;G)3UYM)YEV]@_:X4?5"_9<5'$M[
M_8]6SU_6>$ZZZM'!(GP8'8.HZ"M[\,.<1-V8-12N&.U(HK@4$@29YQICQ@8V
M))W2,N,!%9;]*<&U2><4DVZK_NMU]LNN"-CJ[*>SY$;[,'D:T))+<+O6.=I\
MT<7K%6==&2P^%ISV1;,+I:%)$#5:;*V\QOC1L=T;/'=R(TUORK@YPAGF;VE]
MN"DU0#5V.AZ=>+E$[:Q[>V+8&1M*MM3E)1'J?'7!)I#(:AE;LFD63D-[:'R;
MVLY(@IU?IN8UD,$M\9P5]DIZ]?'(U9L3S2JDJKGXUID6U6_M>JJB(# P]B +
M.F-H%U:4G)*K2G>R[>W<2JRH"G[UM4DRH3'2BJWID187[/VLVF1OC'5V17<4
M6P_BS(M*)@10G9?E.*S:6#>+4=^I+X_M5ZOUW(*J[\%-[X*=+C=JU2'.EE*S
M[$AQ R=UIIOL;B;?!^RMP6P68+@[<@[=0M2DN00:LZX[&29].R,RBUX2*3TF
ML*:M4KFGD^AN=0G:RCNS>)3=2C;L<H09)J%^GD] 8Q!%Z@5Y)N5@5[IQGD(4
M6/L.34_."=, ,,^2ZY$,!>#D2#M*1->P&FL>JY<J/ IUG]HYU?4YEKQ"!FPR
M&--VTI4.VREFH++;-$NXW4R/7 5<*NE;62<]L:]YXL,%8BP<*7MER)VG,9]_
MC8[I&H$F])Y88$3!>U8Z4,1JJ5X=8S#@7MN8OB1\*?6S^-VI!]LMYIZ_K"W:
MV,Y>T<UNP&[N2&ZL(@MFXAR-;*OS\IO$4/QH*[Q>S:K3#X)-^33RU15EJ^UJ
MJ=;0(-JU8J-=AH<U'[#.X2>>0KL1I-IB:2J@Y8PXY1TF141=;L))89 7?H,N
MLAA7Q"ZL<;&R)Z_'SA0I@*RVXZI<J2XK7^G.#%=>O:R)CRJ[=MRI["NV3O<$
MI$!5-5%4=DGFU3!LUU^5+^;)DFJ#-++S@/ +2L?DGH)\)RX@#:5RMFL#,4\T
MC57D'9:R?65&+2K,<L_*IL/?G:B_:H[1=?>OJ3UVK6P%SL-DWZURQ&#L8<K\
MH%SK5=U-MA\%D2'U[?-&>(]?WZ]BOE&=<^64E]J 0Q6-&/!#(1)0W-5RCK&,
M^NIJ<8]K#88[K&*[E?JR5\#ZWV<_UFG4.]V)VFT(^TT#L^ZPU1!K$O.%KH]C
M@T:FZQ9;99FZ:),6UN@J0Z7H8=*^6^%%S&E94]F7*F4E.";I6KI'*KI)L;U7
M]I15/9372*S(5&U+MZZTEPL<:BC!9]]6!]>*]B/]<"+-T6:/6@H0E5]E$:[+
M&ZR<90T+^(ELDN%IHH+I80_$T2U9:;R5)PK"<1C22,W+[4VCJI[$J%)<\EMZ
MV(=+J6>PUNET^P!M9U/HI/JH\]GVR*(?L%;>EN;@O@E]7U-*>(.;S0D<S[-^
MB)-(B2<"$*K#:;Z)I<W-I653EX^XG25[4#J181BO5=59'T@[638YNK@B%E5-
M@1G0<QKBS7KJ;E,8&0!UR H$>FVQ7+5M,2,LH^8-HU2]/&SD,RZPHCLM8KE.
M*Z]>A!JV]JOUX8QM1C7&<3TOUHZ17&46KTBWK KQ?G,TFW)"B.)/A6LDO</F
M'%>D;':,XYU>"[QPQ3,3)FO 9D&(F [+K')Q6$\4L\VN?.<)CO!O:Z])CR;N
M<QS;9/&C;.JJ&M+9.D;9 NK]&NQ,<[!K ]7ZH?4AA5L5&Q.K>QF :U#=.:_F
M,1S\WDAQ%P'[B =BUER;F5%(FJ[TNC=3$,GM6*(+V'UOKZA^35P97I9M!*Y1
MQAI5B#JZ3U+L'61^V4N5,?\ >J8JL2Q2*/" -4*M39,6Q<KQSB9,BQ9&C.+P
M)#4S2-X]/I!/"_M*J05;5[%U4Y*=R "?7U]J.L=1"-5+RR:;9?;I" 2J4GU=
M#7P,Z6QLQ/>>U:H0?1CENF!(1!UPSUI\*89CA&&%>N&/E3$F!KO)6,RJNOMT
MUV1&&4"\;UA4OE)=85A)1\&1AR+$$.X?\+:J^/'HEC)S/7#"MSE%R@I@C63%
M%HQ)M%[H\'62"(F>2VZ]>I62M[6GIFZ*?+8M';<)_?)]*PE-4PZ]W9JL&Q]/
M84(XL=2&*Q0]Z/J9WY>;0=<605AGUH=/%<#4%F)92O3X\.5.%[+RSYJD8IO!
M-4U7,Q_6OVHU'W)3E?/;UNDH3NUP^MV1U.@@VPO! D.W%RO-(4-#UEI *'EO
MQ:'%#+QB^6_1HR4M6'$ICQ'1,]6[-ZU#LM=56O<DWHFC,&/:P=-@-=@[5)L=
MH1D9OG,7Z/S6VB[>TZ[,5%)>F-C+9U<ZI"?IVN58!UR!O*R7(+C)'[<-X>)$
MQDD658A&0[+Z:K1Y/EWE[W=W1H;KZMUN[V(7;<4&T?1]P"P5>O'9P11HL_-6
MX 8TUM2X#(!UD:4D-@3,?P5E:2$Z#L(EH<#>*!'IHP1*<M<?7JK4XKL-W.K:
MASQVN.1[DXVZ/IMDN?4JJ=?O;4$7E0=J8H*V?LUK5E\L&KI7;6M9++8HVPRH
MFG9(%&I?.. \,1F1@AQ/*8GKZ9J4D^UTIV*G[V.ZAI $6WQ$+>$4*;3;FNEL
MW;3/3ZF^V[YI/! -5QM8GA*4[1E$\B 4HUKN::'UF"S (/<&5H.*[+E*E>;A
M*.T[.>:+9$>TNH[>Z-JO)ED&WXUCJ2?4 BE4>Y+;L%Z76#K74?9(HY'4@)5D
M62!%KRA:XDH0F@)S@$T!""WHFF(;L9V)<(.R^ZDU:S:SS4?E4QUL>TOJY3;L
MZN2 ;21M<-?W5RJ6=0L9(?:TX_ _87LPM==9ME*<UC786MF%KY,H5EC.8WV-
M!?9&$3<,^5XZ,+RQ$O<^:Y*3K]8O:?TK=R'5FYVW;D6X[$*5,O95D.#-)K'D
MY>$VT<*XV+Q3,-IQ/KT\93MB$#C'%QR%*_"8SX'I,'TK;SR*[+3?..=.G7JB
MQ;"]I%U;K%QM5$9S5A_B"GG=+K!LY%5%9!4%*M&PP*LUI]:*[7%7,E9G>"RJ
MW#6G< $&9$H*L13#&P>E!!4N?@(K+<=:X\JU[J.I28CVM_7:2TO4Z>1DR:AP
M3>JYNE&5877$\]VVT=CQ/8(_(3XU=X M)P.54 5"G29.*2T1) S1 9.#V(S>
M)QT;1>R_%-STB-_<7,J^TQZ?O40/)1WYC<][&4%#5H*J5E8[ U,NHYUIW]MA
M!=?3Q:O*:C 8A2D605BS( ??EM:M.5>XZ.7KG!?S$[+TZK.,\_*N%2"&_:X]
M,%Y.TN10]:_&C@A=0TROC*&MX^WJ6[KL)1F6YI+BN+ZB4G+8A%3;%574H>)8
MZ@>U9G9RX1&5*TYPO!>Q:Y0U2LJ*X0VU-4UT::>!:M+=\:JNC=V\D#ENQUE8
MZ>.Y-4<W1C26*&KN(H36*S:4IJ1"F8S7&.Q<@#%A+CAH>R0<D MJTVZX>2X\
MJ4XF(TU$\U/FU73TY((%]JMTU-&:F!<-S\%FW/'0"*=RU4Y:*IIT@K?>2=;T
MJS,V3"JCMBPMW0X"98ZLBYC5&BLD7F,;XRB@I<8EL%[+K3"?*KTYY2C&2/:S
M].M58I%OQRMP%T>RX-FG*^FKW7^XV(BWJ-/KZLVV"]"0H1.GE,$E?56X><F,
M9&+!@Z-< ^)D9:6,$2"Z$^=?6I.R\*:K&M.^A("7M2NF(TJQ0L[!9I@-=7WP
MUE80ZL+&G5>=(UE2VWL0\I*K8>A9R5F1_7J7CRGN6I"B,@GG!A$1D?#<P"R8
MB))\AV7EYK./?23X7O:C=2&F8N!@IJT-C8V6I&J($ADJ.MI??YC%.KQ?ML:5
MY3&)1%,&A5*UBU+KP(.;X.O67"E=' W1*(ZI4"/2NRUEA.*C+/DZ/)T+-I#O
M=UK[%/%@5W4;@69F>O!)MAFQ^4YJ&0VA<6W Q7QYA02),5%A.@<8[@IZWMEA
M-TCB1)S%SX6$H(>!%"0C356O6)3L#VKG3%I%Y\H%FYM;-.5:+9%Y8U*S9&)$
M]G9-=9V:I!TB/M#8R(,J0(4RY-YC[M7$FN1<?[XX:1..W1CL%[-K&*5KRIC#
MP>/+'D4177M@4"SZ*I)]75C$-:SJ.I/?958V."N&O-8.3=/6>WKY79=7EB-5
M$M-DKIDG3+HO*#;(V+:(R"5Q@,Z773OP7(+,'9JT^3C/_>2SIC/]9+ZZ[^TX
MZ\W62Z_5J4/;E^];HK*J&:<IP%]J()2[9-E=>Q?93BI<;"VA]*_L;8]73)3A
M!'29>G?) :(_QLM)B;%%[@=EJ7%%S\8G6A.+7]HSU?H^P6VM;5-OZ2>3EJ<X
M3)YNI;'B+1=9"'T1=:3JNQ[%O@8QAU"59"M.8RPS=O&10>XL<BS)HQ=/R1HB
MLMJ4I(^W>U#Z>)9TV!+.;E+V*3*Y+SX77JHLEE6J\AH-G<4NTNCVQ UF<(6:
M^'6MK)(O#D0E8!Y1I>:\HN[</5&.<,#LO++&%BI6/0UZMSVO%>U?5S<6CK?X
MXN(*_P!J+T!'0 =OM::(3ZX[<E^JFIMM!^SJH%%K7@PQ!"8_3F<@\+4UT%E0
MZNSLR_%TL\H566W&%$ZQSL]JBFOATE)N"S(/M6NN2[EL%6R4)!F+BQ;<6=N5
M:H5T64H+2;7':9MZK1GBP6[&JE^(CPN'T .#-DDQ&P71)\MCJ7F-K7LH3%-#
MLOR3JTL5VL\O'HG0V(ICO!U_ORQW^L:X,-TPU6Z^2;#QLY7SDK),M8$V$XU5
M,/+[FPAQP X+_']=OR_%DP9F>)#)..DH'$D-&UD=PC34//\ )^YK^LQI)=_M
MDZ; UB,8>NZ?85M6$XNW78#7BPS5'>:>+;J_[(O11/1+S7.8=9&F=UJTSRL-
M6E7(I@ M-:6:, 5X<?1/;5[D@+V7,.F,U7+'GBN>6."9F:P]JXM&.CMS=T[1
M0I*QPA2+\:$NC >MDUVTW5;31XJOQS/H+D 6R4R7(D #,AP900J:A)$>"9X-
M'(VQ1:^!@=A]I65SBO)3GC&7NDV=B>T*ZUYZ].LL8=E8OR\5]6I%;::U>0+$
M#>K-HLCV,5EXT') X\X=)VU8*GEI^R3IUZ!A#1P$G;-!7;KBY!V75XI)N96"
M<-ZLJRO?:X]*[,9DU77V.V1^]Z*UP-!'&[KW=Z6G8:+D6YK/3AXNY,Z(+60B
MU;,(68C5T=)DXT%KEABF8S9N'Q>9^0.RU5QSYKE1Q6L<X.33[6OIE*!ZCD4[
M;DKUC.L-Z"#T=?+KV-EN ;MWN$*G7&H%3A(]>L9.LHFALHE88%N!,B;)\6)@
M2Y':"PK?,#LVO?-52,4W@O74NVZ>]777KZ[:4*U#S@!-:Z;9.P3!+AUG8+ O
MH]-J$8[M8GM^80"X2$IPN!-!; .N,<DQ"A%E*@5\7 G%#$2-F(DWAG&*Q?)9
MXE42O:H=0X%;96S.-V?$2!;^6K5Z*;*4M+9C5+0%'HQJ;HM/F.L;M*7'VKUE
M)+(*S([_ (YY?,R"H*.2C+S1D$%[+F(KRJJU:]ZCOIBX,3;'M3:%K?3E+!(W
M8&U1D;LJK=79C#7E$6H:4YE@EWDQ7+3J3FO2IY@K VU^Y+YA6/"5&:3)3VJ-
MI7 .HF1F1L=@=EYI4FKKA*U6'G".&G?:E=>GU5UD'0MO3W":SXB!"6/4[8E%
M"D)G[@/73>O!\0<Y5HA,VY]V6>HQP5F)NE;VYUR:(<[I1$FH9C&TF#LM/.D\
MO_M5I\W@GC_0KJF?; 4J\380>Q%1P3\==3=9K-,V@JIUHM=$:<^T=H':E18$
M5\/5ND%AX70U#QD.4UN"LK"]DF0SQ<,<>:]<-HX'8?FU%)HDW26L'G/2J/2N
MH;@0[T2L;#K4G)-J&YH?5*$8WBR(K22)5N\L5=LLH9K)QHNZ>%Y9E8OK#&X^
MO,:>&ZXQ@3(E#9L63M&6HQ+.\ > / '@#P!X \ > / '@#P!X \ > / '@#P
M#SW8_9D]7FFK%6GBT!YR34VM.TE4!->AOW:26M2[@ROOER82)_$'+F01D;O\
M5N;EJXY!8_\ #AJD_P"?@UVG,S64Y[L.AJG6OL@N05W]A7*P;=&':FOM[;+!
M:4Q/2\UQU;SNSL:F=AJ=Y;WPL88IL&%1LI0V)HL<LX1(#L+.SYY/0!PCQ ^
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M6OM.YHZZV1V M)!W;VN9S"F,O8^S2UR.^EP@Z=.G2TA05EELF] %D??J4#$
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MSQYPWX8^_+5EQSCLXQYXYX\ [/@#P!X \ > / '@#P!X \ > / '@#P!X \
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M@T5&RN($?[Q )F(LF9&+$(>[[<>:3CS)>B?)U[96F3OU[<=N8R9SP!X \ >
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MME;QI(:-1XT3U?I4FN.1V#';VVUVPBE9,-@U['F/#ZKP$&S0(%%.U,I501?
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MD-SU#H\;1MS%+8<6.SE[<=LV;E&YESY4R;NWR=HC^"]U38'P0> / '@#P!X
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'@#P!X!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>g149615g79l42.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g149615g79l42.jpg
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M/(CR*6!T=@A)>6EG@OT"&O99*:_4EPMU[9<FT]=;K9>JR3X9:9(HZRBBMT-
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M)3"!3D"Z9#9+KGQ517'WY+?H.)B$XU+CH9PN1Y5J1E;>6NWI[U64MFN5BC;
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M5]3K8UHU8C#8^,\ZS&2C&4Y3P[]I;6:1QEUPMUH%?(ZG=57>GI9XKE6NIX1
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M"<#;S)/,E,']$\BJQ^*UV&_1+;_[BW^WYEVC/T@F#P/(I\5KL-^B6W_W%O\
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M$3A%1'8C\R:K_3CUT_SWUYS)N\_U7_X'*'=[6_>%>_,54X1.$4#J'YP[3_\
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MR\H]*E&2-:SU(;G:151.('$ Q-!/AK#UI\?-.PPRX[_Z0'9ZB-JV?JMF%7$
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M@ F5J S0'9+4R,*BNRT6&):'7&7F&] <>PY78M'2+5-MAW:$2/[ 9:O@/M.
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MIRX'<,X0'UYK9S1-FMC,2E6>!JJNW.SB1NZA=N$S!I:LV 5F?>I@UEVW?O\
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MT$[L MM&-;E>$K.R4]+L5P++#(\4SDBF!YG(<\89B$N1XDI3Z$^LMC?1Z:&
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M US1K!VLOMFV?[X$O[.%]EY[KY,V'ZM@YR_O%\Y^5^DGUM4?LP_ND]LVS_?
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M/5.J^[-?^AAWV;C)XGF4P. Y!/5.J^[-?^AAWV;C)XGF4P. Y!/5.J^[-?\
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MT^WAUAUMYI6582XTM+C:LI5E"L86C.4YRE:5)5X,_(I.4Y\&<9QPBY.$3_\
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MWJV$\<MR1W[LXWG&Q:M!-C?#4KH1 U+J49S8!O8N-93:/-J&NE0=9/[&INT
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M*Z^U7X)*%.=8DN%D&Y&<]^!LSMQGE]V]8PO\+1US"LDIDZF;FCB4DA::K8B
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MQN60&2Y19H3*M5CDQED'I+^9!LB^\ZX[)<7ECU<QU4+L[\\CW^Q26BE-9ZR
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M$A;A(FY*F+6^\I3V5.KRIJ'B//HG:#Q\NJB;'9+I)%ACAT;KC'CCP]OSL$3
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EUY?R?D_(6R1X?!YNOQ_&\3P>%/B^-X<^*U#Q'GT37' ^75?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>g149615g80j66.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g149615g80j66.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( +H"70,!$0 "$0$#$0'_Q  >  $
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M<(G")PBC7>?4VE>PAV%RRP(TGB:5\[0>1*<A&P9A-0RC-Y\2')L)0X$/C+)
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M +J/*BMW,2BHP=&HROLTRJ!CX]D&%;-!S1!LF3)ZRLO5Z$U&L[R06F5T*O\
M9_$"NSU6PU5'>2E?9WS B67.PO*V7\(RIOF(/,[^\1K.^_P91EZL^90O@7Z
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M.$3A$X1.$3A$X1.$3A$X1.$3A%#GMMUR?WP4ZR2,%HGN>HGLW55M8^(RJ1"
MR$6 'VKJ9N=8Z/<[1V1R?X,URRC;@\)=/1*;XRT"E R)TU[^4@XSV@C[OZJ&
M=B^'%=,KISLQ"Y=V$D%\%K1MB"6K3 &7RRWHQ'*=UBEL2F8)5_I[_:LY'RV#
M!0$GP\"M9.$?D7,R8MWQIZ2$1&G1%6E)/#  TQT:Z:GAQ/JTZR<6A_A@2F5W
MKVQ)78J"$5;<9J7&V4SKN0LW-E644,]IV/92IRDQ&R&"O0S!7KZ&##:GC[61
M?.C5Z$=$FXA <&VTT4*=[0=G7G T#3Z<9/H7<=;+7O\ &>,/W$ZL2JY)O/NO
MD)ZS55:=60V9M80Y4AQR5%P#,NV&R(%$04I+#F6BSI@RVEYF1%U$E-W!(J1>
M[>]\*"!NM.-27:]8&,:9[QP'G5T?"I3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A
M$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$5-;GP[
M[\0@EIP2GNPLBZZ:G.Z5DWZ+D@^96S.I'8-8S"I8]%%H/.I$VLZ+2K*TQES1
M\YD\D('C,ZC3)+4_74BBDWT#20456]PR,Z8ZNG0CN_UR..']G_#NL^;2+M ?
M@L3BEEQ>WKPZ[V^]K"S;&-$A]LMH+7MFQ6:1H^\FJ$O9  \=EDRB,O@\773W
MB8EG A(>.#P2(T,W0)O: <" 1G TR1P\VG1QRN9V9Z^7%U+Z#7#>53]@+*BW
M;"MNH]9"34SAD9KN8AI7,Z0KR$1PH7>QR0U)(S\\S+U(9KJL4FVTFE  2_+-
MH0]AC<P80<OO]O,I;@N&1D$G3/7VY' Z]"LHZ;SJ56AU#ZJV9.RVQZ;V)UOH
MZ=3([NT8,-S4JEM8Q<_(2V[$4U8BV6Q$N0>/-F@UDS8-LK919M6[?1-'0H<
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M3DC_ /+TTW1QR,ZYH#Q-K.Q(K"T[S]:+#ZH0!62Z9JFTRE?6=M6+4#NS;?\
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MAL,C'%V6.I*RT#1M1:B7<ZMK1"V;XC=IU&_2[:]@JX7D,<-O;9 7SU)C-S/
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M^>,9WV IZXVSC&,8_P"G/6IMA9+HW?9LQ<Z%H\J:BVFL-73MZSS%<Z*4XP<
M5QR-2<:KUY>4(VZ01_VZV9KW'R::];-7RS5KCD #PFEF?$2<X.+4"#P'0NEI
M[NL9FOQ#0]4EE'F^I+V34Y6=938V(&I.$$'2(PUNNTWU0(-D5TEEMO>DE\H+
M(^T')*8S[3L;3<FMNMKJ=M!M):J.1U,U\E+M!=*.DGF<'.:9J9S&M'-/+2T-
M<PL#VN J'#1O%L=RI;0W6&LEO&R-PKXH[A-!%6;)TWOA!!&S&(JJ&6L,KY(S
MD\["[?DC+7&D9Y3]TR7MG5L0=(,9&,LT6]=9TU0:.*MFWO*JF^//5/5#41LK
MZ_RXSKG7'UX^K.<9QG-K4O)]M!6QOFHG6BKACR7RTUZMLT8 _:+HZAP#>UV,
M=.%>DO*7LK32LIZZ:Y6RID(:VGNMFN=MF<\_L-;6TT(D/5S9>T_LDC"PM7NK
M%U;&"UV%J.]3SP[&7<A9.6]=D0KE?9%RHF@W;"I7O'UE6"K=H167/JN&PELN
MW09:K.5EW.S#L?\ P^KF6FINM3>=GZ6.EK8Z25K[G'4,87,#G%\]$*IK9FN?
M$&TH:^=[7.D+6-:P2]D;<VZ2YTULIJ"ZU,U51OK(!'2&*25C7EH=%!4N@>^#
M#)"ZJRV!CFMCWG.+MS9/TEWF8QYQKKB\%)*>7L'-GVA#(OC&NWU85790;6TW
MJ7IQGU;-]TTUL^6=,^C.<;<\?WIV=@QX7M5',X>4RSV>OK->D-DN)LT;NH.!
M+=<ZXPO7]\;U-^K[//B!\EURN='38!Z7,H1='C'$MQO=&BUU:D5[K3:'N!\0
MG%-5B;V(B'*68RE+S)+=NW)-E73;,O-M&;9LTU0QNNZ22@JBY5-O\,V7:-7K
MG&_JV:LV M]<V6NMU^N].(IV'PMU#!$'.A>&.\!IWR/>\NPUCG7(-A+^>W7O
MC9CS[G2[95M(Z.DK;/;9B^)P-,VKFD(;(TN;X5.UK6L#<N<!1%TH;S>6,>[,
MNQ*))N*&-S+UN3+H#V2)4DU9Y'-2!))LGH^>MA^7#O+!N[=:JKHL\NW66J:F
MJ&7"WH]IM9$SHGS3.@C=# Z61T,3Y.=?%$7DQQOEW(^<<QA#72;C-\@NW&YP
M+KB$C8HVS/;)*V-@ED:SFVR2!H#WMCWG\VU[LN#-]VZ"&[SL9/13&9!X6*R_
M)*Y4>.MMVH,.VT5<E9 6V3VV:B1+!JFN\>.G"GIUVP@@IJV2SLY<92;IJ*:]
MZU6JJNU3S-.S$48$E95/+8Z>BI@X"2IJ9I',BBC8W)&^]ID<!'&'/<UI\F^7
MVAL-'X35O+IIG&&WT,37RUERK7-)AHJ*FA9)//-*[ (BB>(F;TTN[$Q[AKVG
M+'E<M1*A;+C[2&3X:Y4=IQU+1VW]^BZV$-&)QGH\</,.D=7NSL:\59O7*:3A
MLENMHT]\;HY]O:FPVVV.IJNP5LMULM1&V(USC&_F;BPO,U'*8HXN:>81%41-
MEBC<Z.1P89>:>\6SL-M3>;U'64&UEL@L.TE+*^=MK8V:/PBT/YL4]P@$\LXF
M8)S-25#X)Y6,EB8Z1L'/Q1G=_+160$X1.$3A%J I6%(N)8'<%8K!M)6LB05%
M#EDA[1<LEG&ZA!UM'=%$6A[=#"FZJCQV-?JL]MLJZ*H[>6W.@^W6Y\S)7TM/
MSK0[=&ZT!P.=XNB&&2$9)WGL<6G4$%7)%RA[3T5.;&S:NOA;7!KXZ5]PS6O9
M2AIQ0S2O=7P0QM:T2LHI8HG,&[*US=%P[VC$ ,TS)8?-RT@B$!(MXZ ?;0--
MXD:5:.)"%8BHB&$!0YMT9;RQ_LPAKB&LP)9.6##+F)[B7S8NHS5[S6M:UK6M
M#6M :UK0 UK0,!K0,      8 T"\"6::HFDGGEDGGFD?+--,]TDLLLCB^266
M1Y+WR/<2]\CG%SG$N+LG*B,S3Z5KMYNG](DEEVL_J4M"B#!BSE11P4BUJ0:I
MA\]<P,)#H:W5)2>0Q(-31RP!<0'D%H'K\"D3R/0KYJ-.C\KCXZ::9Z?SSCVX
MK*IW%^GV+"%D7AEY&<VL*@\HE ^N0YH?5%FC)'8#\S Y+;LIAD4<1ANWG$](
M/FS<K*9?'D;-5<+1TTI*!:ZHQ0FN.[/'HZQ]X]8Z5E<)AG6X)#^L\%4L9>;1
M:3*9?]9(U/#8PIF31Y#KW- &\> ",A1;N31%C1QZ3O"#:2-26Z;=PW<&7V[U
M9DBL0\>&,=7KXG[M%AQ6-=)X.[MH$6E8J$A1\9+PDO%57SB)02"AIV^@K>:1
M^JDD18P)ES))&.K9.6@XD^/K 93M&1>!T=(G_AY8@SICCG3KTX>8>CT:6 <*
M$X1.$3A$X1.$7YC.,YSC&<9SKGRVQC.,YQGRQMY9_P#K/ISC/EGZ_+.,_DSC
MA%^\(G"*.7;\>X*]6.PPYK XW9SAU3M@)I0*7O60V-R7;$:(;^X%GQ$)(V39
MMKC7+G&[@&1T]LW2U]AC;;51,I;Q'>/6L/\ #Y^P1TA_5"ZU?P9A?"E_EN_>
M=ZRI>\*E.$3A$X1.$3A$X1.$3A%Y0OPBV<S:(VOUI0BDQE,80>5[.57B,>D)
M8*DZ52D@C1)5RF-=MM%U$]-MM--U<;[::[9UUSC&<XY9.U<LD<U'S<CV9BES
MN/<W.'MQG!&5J)[I6X5]%=]EVT==64C7VVO<]M-4S0->X54(!>(GL#B!H"<D
M#0*T/K/)2:_43PFWQ2>0X82D<]AC0@I8\?6F4AGRJW7GL"^4C,",NH_(G$6L
M1QLQUD&DO5(Q=3Y2CTNCN9+M\Q?+Y^Y;0YSK91.<2YQIV$EQ))..))U*V!Y,
M999^3[9.::22:62R4CY)97NDD>XC5SWO)<]QZ2XDDZGK5O7/15])PB<(G")P
MB<(G")PB<(J NSW?WLM6'<>5TY$)2"9P05,X*&9#W,1 /G>C Z$BKXBGN2<L
M]WBFZK@J\VT5W5SNEKOKJGG&J>F,;4;%<EFQM[Y/:':&X4-3)=)[==*B29E?
M511F6EJ:Z*%PA9((P&L@CRT-PX@DC4K2[E!Y:-O=G^5.X[+6RX4<5GI[K9Z2
M*&2V44TK8:VDMTT[3/)$97%SZF4M<7$M! !PT*_WFJZW13A%$OLAVL&]=BL8
M%OH8^E.TF'D"":S0RW%ZM-6#E!OLEOHL/>Y6RIE?&^-M=D\:XUSC.,^?GCIU
M58VF+ 6%^^"=' 8P1U@]:QSMQRA0[%5%!3RVN6X&OAFF:Z.J93B,0O8PM(=!
M+O;V_D$$8QC!7(ZV]I1W8MY+6C"'/8MF*-@[A7=V80*8>X+JD4M-$]46#+*.
M4,C]L[9VRIZ_:XQC&OISG*EJQ5%X#"S<#3JX'.]GJ X85>PW*!#MM+<8HK9+
M;S;HZ:1QDJF5 E%2Z=H #88MS<YG)SO;V]T8UUE:/<.;U[*)G'F%41*4,XZ6
M,"F,C;VB59 6Y".5A;MQ%(U,RF:S=L ,T<0*IOBVD>C[F8[QQ.:1=2:+@$7X
MG<[W%D3'W\.W5<HMW+(AHA?4H>P 1LG6T;E!6N' Z3R0J GTEC B='"]?2(^
ME7:#.'2N*B8S&5[ V'9EH2*GIFY@:1<O+H1(V.28U Z\??CV'Y+/*H[&R6<6
MQ9U,R> "!$MJ=L[U/.XC,EI0"-DM0E>2@<VCKHY&88X]+L%9(AN0^+MQV!$E
M8%Q'M2 YLW.NB$??_I^2UY(^Z[D+5T0DZ->#-K)DCFQ,D8 3F)4?'8^/K2*W
M=,33E>QF\#(#G^[UA1QL4P3;AM%4B9@>\>H("D5%U2$8] ^_!6]:5N0_:Y^R
M63R'#!$;AI-@.!RP))G\B'FR#@E*6I>*$??8K'&[":PH<'C3N=C@3V4!(W(I
M<X@*D@=2:$R=-,H]O;V]"HB?QJ(Q;QE*W,-R?8NUK4.6/:9%. =D:>7M<96=
M?2=^@+*V#0]E1JP%EJ,HZ(*",)U>ZD]3HA7VAIZ-6FN"I#?3#V]O2J_V3PX#
MAIJ/-J>O'W#5>@JUJ?BEQ-H$UE:QA%*NK4@5P ,AG;=GNK*ZZ+?&0")'+ED]
MPX#JN_Q2+1'#9PX1_$1>MMOQ^%1P]NM:6*]%^MKJ$7)!(]"%8$/O\V&D]ME(
M<6?-CDSE06:.IXE+#+HVH=:/Y8_-O'"!F4/6#D^7!IB@#XBJ)CD8:ABDDG&3
MPX=G<OYK+I)3%66_:]R"MY3(2MK[2OWF(S!Z",P2%I6'/UK7LMO"Q"<<8DM$
M;#LQ76;2/$L-2Q1N7;MFT;4CX5'45DA.0!IIT])ZL]W0JZZ&@*<2\?GNW(&@
M+0,PGW2:F3R:[<$7$LS1!K+8^-,%$WKH +"'7BS]#?4F0 EI#G5YKN@9=,2N
MBS!(I/D-':[_ *?;H'GRKT^%2G"*HOQ<)>-90_K17+[5JO\ /U]/2J[1XDDX
M0<CH%4EC%M<Y05UWTSNTDY&*/D%LZ_S9RV15USJIC3?7Q[Q(0**)HRZ6J)
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M5R-!T.S:G8INQ*1%D(ZZ^]/Z?'S.:O@(B4*;1^+/L5R'EDX#E]FY5HJQRY5
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MTOH-NKCM-0QM<? =H:R2DNL48&2*6^T,+HI7@9W!7VM\KRUG.5^<N62]5(^
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M):Y6$AE,<LVOE]C$R?PAD#"3.$#:^,PB#GIE'0VZQHF%ED9)GKU]'1C'0?\
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ME;^?6\?7VSGX?9EZSN:)+Z3)PBA5VKZ"]?\ N09B!ZYFTO7?P@83$ \QF2[
M4=699VW>.\.D\,G?O"F5FJ64]_5IZ-?5KY9\_/'')$R3&]G3.,''%8NY0>2#
M8_E,JK;5[3,N3IK5!/34G@%=X(T1U$C)9.<;S4F^[>C;NG(P,C!RN1U2Z'T)
MTT?34A2[:6H.)^T!,I!F32/8]ILC'5BBX[W/79DT]VVQN8>>VVQG?VN,I8\M
M?9_6CB9'G=SKC.3G@N3D]Y)-D>3*6Z3;,,N+'WB.DBK/#ZWPL%M$ZH?!S0YJ
M/FR#4R[YUWAN\,:_:5=4:WE)NQC4CM2PUR4OE2)T@JH9KE$A#7!F&R^M$(R!
M-9@6)*SC;V 65,(D C<C,G&H%.5D9!"] DU?[R;?D63L\-!I]_>N.ZZ>TH2A
M]U1>5R8[+PUA;3?!TI*%*W<&JVQ,XL3CAQO'I(S@PXFW:BX.781R/L+ =S!E
M%H8"C4>#MF,<8Y8.29U!ZL?=[:KO8EUFA0ER',1FU[ 2748 6AQW#G560AM8
M,1B<N+S**1XVWJVN(>.8@04FD<L6U?P)M$#AQK+)"%E9V0"'VH]$F<_ZG3[_
M %Y60'NOE.2(.L3]XV'$7<XS8,?L<:0"+R".2PC886P&SJ,E2PXL$RU5F@83
MLF&(C"XHHCID,19$6;M=JL4+-JTJ>OZW73Q"-G&,@JRJVD_=52WQ/ ^*4[I+
M7,,8.<;>IQH810L NH2=NE<N""*P]51/3V>%%B*F'Q#.L%(6[V7,/IIWMZK]
M>IA)X5$6@L!9)E49?D*.AH]-P<,?0'W3LM58O,2D1Z3#9(11*UX1EKPC&\MX
MU-QSE2,DH,50X>3G'3T=!.=#T:=G4K+.TMMW!2*W5EO7S>$EHO/^QU14Y:\@
MFKHRYEND<FYIB 2S#@HIBV$.39911\\*2(R<:-P&C!%!C&9"J=V=QLH !SG/
M X\PSJH>V%W^[3;T[V8FD8ZTC:>*4!:T&B+ ]<ZMJZAK,K8U:TK@AJTJR%$:
MF@:,D9D6X0$/C DG) 1-F0+2632)@VB@:MUKH*2 ,:YR,Z=!QH#KZ?1QSC!F
M?=#NY==D=VJ*Z_M*0<V?!0-U-J:$%&SX 9J8M5-]NZ6!.;%,%"4S!2&07)"V
M[FW:J9R&'P^,ZNV:+,PL8B"KTBW(0, YX\?0#H,#@<@\=5FE.7RI:GC1WS6Q
M.NY-7\FH/H[&8F;V.%8H9$RUO*[E'S,'*H@]C)HHY^7R(LFGA!"3L(U)D-T]
MM2<=&J9PC@HQH#GB2,=6,<?3T*Y7A0G"*AY^U^ESQF)AJKKATQJ8324);./+
M&Z33$2@TAOE^EC;Z_+TR&6!&^V-?+V;Q3;7?\;&?3U[/K>[W69WO>ZRR0M'1
MFN;';G@9TR&W@R=8W"0,C76^I9[^<OY81OQV"AMD.>+6>#4$UW('5NU5PA;V
M2$]*MGMRPD&&5(8.,*B%UD&JLND+'3=P0C@4CONBR% VZ&JJ[V>2_?15A%AC
M5)9Z@E[T=V1PDS;>WOO9FR/FW;K/2MJF-?(VUT4Q#(*ZK@ ?+4UCWEK(K-:P
M6SW&HD<R)[N;HP_>EDW,E;:[2QTV]8J6N?0R21Q.O5SIPZ2IM=!5.+(*.W11
MM?)4;1WLM?36>DA9)/&WGKB8]R"(2X+4\$%SDRZG)V-J@041=:0>!0%=PFX&
MCFD0<K;*&#:2.ZK4H=3/.R6N=55'2(\FU76V5?OD&S]+PY+Q4Q73:.>DKVUT
MUPECH)KVUCF3SPT['&X0T+G!KZ>BJ*Z::%SF!CZFEI*9F[!"7T[LA5FSU&S9
M/DZLM=:GVN&V4<^U3MF7RLDIZ:NO+XFV"6ZQL<^.KN5!L_14%9$R1TD5%77B
MX/#JFH$=6V6G/(7(G")PBT/7_P#Z"L.858K_ "00YE[9U=8S^*BDP+$-=)[&
MFN//&FN ,K>IG&[9+3&$ALO;HIX]DQV]/!'^CD?$>#LRQ]Q(YQH'_*\[W<_&
M@"M&S?\ @]ZN6S[CNTE7SM^L@.C6PU$P%XH8^ Q1W&5M6QC1AD%SC8WQ83C8
M-@5Y%[. XC4N:.'@K5\V):I-GCABKJ[:Z+)HJ86;;Z;YUQHX6UVTVSG3;U^>
M=?5KKG'O66^7'9^M-?;)615)AD@+I(HYFF*0L<YNY('-R2QI!&",<<$@][:7
M9BT;6VWWJO<,D]&*B*J#(IY:=XFA$C6.YR%S78#9'@M)+3G)&0"(N6;T&HB<
MM&!6)LC%-VJ!8H-(Y<]8/L!9XCAIC79NSE>ZNC@38T>65TUR1C<W'F1SC39;
M=E\,?[(D$.&XWBZW&YF]2U\L=V&^&5D38@X1..?!GQ/C=#4433C=HZB.6!@\
MAC7>,K0KN2+8R>WQ4MNHI+%6TT4;*6\6J9\%R#H0-QU7(2YEQ8]PS/'6LE$@
M+BUT4A$C=)HRTO02J<1[ALI3$8H[WT$B>TE73NRMZ$D.KG;#1!.V(H9DLA>T
M$;>X511<;R/<[5;MRJKHRGK-11,,G5_;*ZQ?H[Q1V*J8?%;6R;/6<Q.SIB9\
M5%'/3/=G4OD=$2?%E!\46X+9#LZ? MKI+_:Z-^((MJK)M/M,=FZIK_%:V\6^
MLNE<-GYY,AK_  IE1:)'.(9<&%X@'>?(/5OK9%59BU[AGJLC9EWOE LYMVNM
M D@(L=LM<M!X?8![C*"J"F<M4V+%D1*95V]T32VVV]EGP8I+;10/YUT9;(\N
M%0ZKDCE:0-TLA:V3P9Y)U(DI9GYT! T7/%LELCL?2FNHN4.\6&EG?D/-\LIH
MZN6+Q T4SK=N5DS"=QL<8DE).X 20%T#2_>S<T>#VW6..VA<H)1RAHO8EXTV
M%HFM=ANRFNBI)A().2KZ?R;377U9:K1"H)"/(8URKJ422SJMOQQ5TA>/!Z.2
MMA<=7U;7TK6LZV2M=3/<>HBCE:=3@A5>_.W=:Z)FR,]SOD.\T.N6TNS-)8;2
MZ/> ,K:J:>UW*I 'DNH;)4QRX)$S1XQXEEA_$*GU@"*Z=2]""11WYKE9%1+3
M$2CKX?L/<O=19>RYM#K$F(-^FX;X:.24-'QQVNHJV;,]6&Z^[O2)Q4S5>Z&R
MPTCMX[E/.QKP"QVZUU7+22NRV3!<64["YN& L<><'1NIY8Z^[TME?+0T=(]H
M=47+9^*HH;?*SFI)3%/=:^EN=?22;S!$Y]##"\O<QD9;OEX[J+=1YQ6<B3E\
M.J7KV3G.V4]G-M3\Y9-\71OOKG*FZR%BW 40/-5%5LY5W:M'[09HIG&4&:2:
M:26GJ6ZSV9_Z2KN1H:@_\62US71X.<_K+[A'* >/BQXX>(, +F;LGMC:*H5E
MKV<V*JJTGQ[S<+C>=H+^0"7;S+C?C#*Q[G$NW&RMA#N#6M  RRU*T["V5'6H
M62R2SQWNI=L5RI#@M1+"<;(,WS7.J;-A.HI+5-OY[G9/V\A=,M=-=\+#'+K+
M5PT]279ZW53=V#;.VL=O AM5;[Q2< 1Y45OJ&CCC!G(&,G(U'!M#;-O;W11T
MMRBVHA$=2RH+[/%L?-3 LCFCTBCOUJNCC^F);O54D0:#OT[Y.;DBU%.(M)1!
M-"S-Q,YHF[8)'!P47V9C, *F818\6"()MV<-[-UH/)E<R2-*:IZZX?:'B12,
MN5MB\,F,4<969N_*N-ADHY()([I:)97EL++A05C7PG PV.XTTPAJ&0G_ /&?
M'S4).]S\)R#UI:VNI#[Y5UJV@V9O5HHH88ML8+'55%ONM#2L;&RCVMM--/6B
MI@( R^.MJI:=[C/05U$[>C?NNFN_M?2A-*'W4RWIVXD![U\UCSI X[A=JB1:
M&5G$THR7$0XK$UC#M'75RJ*>M!4QC&ZN&4D"-D]6Q-_W**T76KN,=F-/3"YR
M,9)''!<*&JI:J%S@WPBBJZ>HE@JXF9#IF0O?/3-SS\3  YUSV;E?V<J*$/OS
MY+'<612O;#-27%M'=8X(S(ZLL5154=-)5TLK1O-BGBIZN N$<\(&Y+)*.N+Q
MKNT6[M:.&,-UFCO#/8>:RU&$UMLHIK:K-66[I19PVSA3V>%D\9U]KHHGG&,Z
M_7[%]V0OFSKXV5]+OMEB,HGI!)44[ '.:623")K&2#=WBPG.Z0[@5<FRW*%L
MQM?%-):J[FWPSBG--7F&DJY'%C) ^&G=,Y\L1#]T/:"-]KFXR-=N\MA7LNDU
MC<>T/*2C4&)UDBK+4<H>U'M<%U&&NVNVK/<AA+WK9OC.NG\EE7.OEIIKY>G3
M7&.V:^N-&VW&LJ30-E,[:,SR&E;,0091!O<V'ZGQ@W.23Q)ST!:K8+BZ[BWT
M0NKZ<4KKD*:$5SJ8$$0.JMSGC$"!XA?N^*T8P!CN^=1=].$4+)-U:MH[9T:G
M3#NC?H,$%1D";R(-6-=^[N\F$W&C--GHTB@Z'J-A>5M,)[3.!3LKE)#3+ N+
M>ZIODNJZGD,C7BJF#1G+?$USGAAH9IG]J-YZB"!C#MRY,]J:W:2W7J#EAVZH
MJ&C97MFM,<-@W)35MD$381%:Z>TNCIM]H:;O8[W5;K 8*NFF#9F[>N& 3.2T
M:4@,5UAE@S7(Z)LQ[Z[T4-HT9) CH%\O*)6UCD0)BU3;34<O)A;1I"U(\M+&
MHQ!T&;@]W"*79 P "2X@ %QQEV!C)P ,GB< #/  :++-%!)2T=)2S5=17RT]
M-!!+758IQ5ULD438WU52VD@I:45%0YIEF%-34\ D>[F8(H]V-M?:_0:R0PU5
MC$(W0SMOB'LH8@VG<B)R=^H'?Q_KU'E??S)&CB($I(*B$TJ?%TR>.U^<CB3B
M>-CKZN@*,8=QF52NUGUY/MG/>,]''JVT;Z@V2XM^ 3MJ9C!J/QF#P^#CTB9T
M QD]9"HS)S)=@A%3,AZ^V<:FR\:'%TM TDTE%1S(V3$I/3\@U<NFKT(3(QC'
M6>GL[1U:_=JNWAO44XSKV+0\U$*+AA"!S3J?(19:L\2E-Q-7O7>Q!4FD<WFZ
MZH>.-U"\LCJ)%C&(<]$RO:)FW"Y,M94N4>"G$3(3U$]/'MX_ZZ+X2;IO,9C,
MI^4F$JB\P;S>.35F]GSULXCL_)LI14X:L&5-%1,;#MAJ5-L"H?6T'R323*)%
MY8Y<,WL)4PX?&WQ,]G#AWYX_Z_T"G;$ R\<B<7CSE5)=R"CH0,X70]?L%EQ8
MQLQ551]IKJI[)11#;=/UZZ[^C;'JUQMYXP4+(N$3A$X1.$6E^QD*EUCT)<4"
M@$QS7LYE];S"/0^<ZFY#&=XE)"H-ZS#'TY+$GC"3QQ0:^51<Z'@#G4L'VTP0
M9(NEV^C58@XCI4*^@W6SLC2<QM656]=.\OA4Z8B_EVJ=>S?8#M@PKDTR>K)[
M-1EF]@VHN0*M=!*&I%1Z,CT84-NY4X#&0JJ4# R.1%)(.,='8!ZOSSW]5GG"
MA.$49NYSL2QZE]CG9R33&&B4*:L#=])Z_8/R<R#I?+C_ %PY ,!<?E3]R\SO
MG1'9-K'RBF&ZJVV6^-==E4REO$=XXK&_#Y^P1TA_5"ZU?P9A?"E_EN_>=ZRI
M>\*E.$3A$X1.$6)2F?P.#>X?.TVB,.^*>]?#/FF2!H_\1]R]W]]]P^+/6GO?
MNGO;3WKW?VGN_O3?VOH]LGZJ2YK<;SFMSPR0,]V5YMPO-HM/,^^MUMML\(YS
MF/?"NI:/GN:W.=YGPF6/G.;YR/G-S>W.<9O8WFY[D(<"246T.1PP*/A7^JF[
M$N$(-"HM[HDLHW5W:$&*R[1SJFX1504V16WQHLDHEMG&^FVN)!!&000>!!R#
MYPNU2U=+74\=715-/64LP)AJ:6:.HIY0USF.,<T+GQO#7M<PEKB YKFG4$+M
M.2NPO%A^$6_;?K?]5Z#?Q2NCF/MK/C&'Z%'_ !ZE:.>Z5^7EL^RE!^+7Q=5X
MS_YMO#,_4[C'^@P3D;0_!6CZ"W_#$N'EO^*^2W[%4G\O;U>[U6<;(=-?"0UU
M+50+]YF\*;[(68$U+FC.N>O/8%7X33CG8$8R M??*6'[8WHZCNV("/L 3\=]
M!78,9O"S_%=#]'9ZEM9R6?-WLAQ^(J/U=/9^>%</STE?JJ?[C221"[C5:C#Q
MH<V^6 :GNS$H^:(>TWR]]>_L6ZZ:?KV\L>K;T^K;RQYYSY8YLCR6T%#4[+"2
MHHJ2>3WQK&\Y-30ROW0(<-WGL<[ R<#.!DX6F7+I=KK1;=.AH[G<*2'WHMS^
M:IJVI@BWW&HWG<W%*QF\[ R[&3@9.BM%C.^ZD;C^^^VV^^X05OOOOMG;???9
M@WSMMMMG.<[;;9SG.VV<YSG.<YSGSYKS< &U]:UH :*NI     $SP  -  -
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M[UE2]X5*<(G")PB<(O-%^$1_EZ@?U7_^VD^=.K_X?_K_ .E:-^[/_P#IM_\
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M1F&""F^SE^2?K:H-FR.N<:XSMOM]>ZBF^VJ2"">-UW"^Z:"":BRFFFW,YS6
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MSE\?,C'',[FPC';F33M5A\I]::#D_P!JI0[==/:I;<P@X._=GQVMF[_S%U8
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M:)N"PV4KEVI\>%%.74AD&A_)-V_'BXY'QL==H.&JL8'A!3*/Y&M6#5%(F?;
M[].KN"X^_2[KXI#8_"]X@OHC%A:L>!REF7?BY^QBJX24QAQ$$YT)4827,54B
M\XE\?2!Y(>XL&4@?.AB;(OHT)-B9]NCT<%(&-PJ-Q%[+7\?'X'KS>0,9-(==
M%EMV[@N-AD2K]DJU;**;(#VZ$5@\;':,V*;=KZF.[K*.73IRLJ4*O.?(=6BO
M>\.,L:J^S+.Y&>:L.PF3QV+]MS/6*S3@M$TI$Y-.$*R'$>L>\QIUZKNV;2FZ
MDF96+*OHR^9E=/A(!4.56N.(QKU9^_7!ST:'53*MOL/4M'G:EB]BR? B27C8
M0FLJR!-A[\H3D4G+.6C37;W<<W<9' QRY <D8D1/+0,,<%!#%R\U(&!31X4
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M)8]H<TEKPU[200=US6N' @$$*$;3LG'C($TT8]0 _O#^K]SOR.6::I'"3*G
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MX5P_/25_*H7NK^>M7^ZH#]K[FSG)-\DQ]95OJ@6D7+[\OG?4UM]=2N=W&_\
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M&.A5?"-_<'^)R^>_NQ?E=LE]G)_Q.H6">)=]BOPEON%F7[JT#R)O@H/W7?\
M2K>Y<_FN]SM]D;G^';'J_P#\)S]'MUP_L2:_Q0G'.W!\$SN/K*W ]SS\S>Q/
MT6Z_C]U4E)3VJZW0A+9>7W=6T<03+F 2JQ>5#&:2!:.FK!CL@9.%%5]=&Z@(
MU4]FCS6ZV4TA:T!EN7RB"0(@HARK-&#U+R5?A$RZ#KNS6+ELLDX;..K,"7;N
M$%-%D%T%K/N91)9%5/.R:J2J>VNZ:FFVVF^FV-M<YUSC/,?;6?&,/T*/^/4K
M1SW2OR\MGV4H/Q:^+K_&?_-MX9GZG<8_T&"<C:'X*T?06_X8EP\M_P 5\EOV
M*I/Y>WJ]WJL.V?\ 37PD5=8K7TEP,F\*([O)S*,1PI#]=>O/8%IF55HRS(P7
MS?8*67F *47PRE6=H<>F,@^7,8C^9  O"S_%=#]'9ZEM9R6?-WLA]14?J5A$
ML[5];8*EHO,;OK6-(;EY !PL8E0QDEJ7B9J<QV4LE5%E]=$5(V:K*Q!Y[=7.
MB0A:$RC8@HW2"OU$/25_8/4?;_4>E5_]SET7-R8<MEDG#=Q$(ZNW<(*:*HKH
MJX>*)+(JIYVT525TVUW34TVVTWTVQMKG.,XSS9SDF^28^LJWU0+2'E]^7SOJ
M:V^NI79]QO\ R*K_ +JP?^>)<XN2W]1VA^T=9_!IUVN7;XTV0^R%#_,5*LEI
MW\TE7?=Y"_W<&\P-M5\I]HOKR[?S\ZVJV&^16R'V8L/X72K BW;+K.!4!IFK
MUK 5F2("703=_+A+5!^S.X(9$/TW"SC1NF/?X%$LH/UU4F><,G&=E]<)YYX*
MNE0X[)ZYVLVT_+3&W\RCF,_R>-_/TQ 2OC7_ /%<YSG&$,N,:^6WHPVR\PBA
MAEO((YL5L$<;/[.:X_35Q\K'&Z5+,_"1XSOB/.F3((MYYE%%7:@\J@)VLVQ\
M7>'@]L!\7>X6.CD ^!F)QS?.[N"&B$U'-L\'-SM,W#79;KY&5#Z$ANBM BT3
M,NXY*-"DP",LQT^/+5J!>AC>7#Q/ LFV,7'5(Y5F]RBOJYL2':>C_GX[*^NJ
MV_P>HK<SQXU',W9!\X2:,F+9=X\=.-]4T&S5LENLX<+*;9QJFDBCINHIOMG&
MNFFNVV<XQC/"A:-_XINN.)%'(EM=M;:227$!8F-"%)4+3=FBAP/7Q\&.8Z[K
MZZ*O38BV:Q=AFOKU6*XL"((#]'#D^-1<%.#U%>:SN_\ I&9Y]Y%7?NS!.;V\
MFGS16OZHOG\]=%\V.5OY];Q]?;.?A]F7HV9=RNJY \-B[:^:VS(#$F(0P8*7
MD39H[>RP6;CL8?QU#5W[#78NVDLOBD<W99VPMM()*""Z:[DRS%JOHDOI-@]7
MMQ]6JV=5EQU5>$;WF%06#$['C";M)@N:B)IF99-GS@2+/MF;O=HKOLT<N@)P
M(=:(.=$E'80R(+M]51Q-DY7)@CB,+97")PB<(G")PB<(G")PBAGV]K&U)\3Z
MP'*OD-@L]:[[15)*9[%8C)AL;CDCKI&1M,R\E/4EM6962B8P&0=K,XRU,ZC'
MRQ1P\(QR0DQ\?7"E((USC4'S::8\ZAE9W7CQ%I/2O9T-.[R.2PV4M>!S'K:!
MIF91B*FV-<![9E!%[5EB&M*BK!V4]C$RL>,R*3"9.*VE[("!@2PAB/B\O*W6
M0D:8&N,'/<-1KWZ='$'4!NM6/3'M1=UO]T(-:L@L6 5E9Q*4O&L]E4F0LRNI
MONQ[2#K.Z\(P.L-+*UW$B8+U^")5C/6>1U<X7)$6J*FTD5&[.4RJR &XP3T]
M!&@!UQJ"<D=7!24E72_NFIV=*=CZW[NT]%%-:G3HV*Q>:=,3UC/15;-I:G-&
MB<BE37MM!_FN8?&=,Y?2=&/QYJ]0WVTU -E,^TR5.6XX'.>.>CJQA=A(J0[[
M/2\0:3"\:YM8N@=U,1ZQX?2V*C@=4DQC-WL+-RZHSE^S\Y8*Z+E9SHFO&9</
M=FD"*<:=-8DQ1=2]7K3TTM1/;GB>G934E7X3502QN,M0UO-[K87M@D!=N\\U
MC9)8F,D<V3.\ YON6BZ6BVV[:J.IM-SJ[W=;13VVP7*EN$<-+:WS2U3+B^I@
MDGBYH/AE@YZ:"EKIZ^D;/:R:*":5]1EWT+^)U_3XZO?X>$L_WU\[*\/3J/I'
M]%AUBUCXM$<KZ=2&O^XG5RR)Z!ALG-0FN]NB9N'ZSV7"PCY]&X7M+C'>9<1%
MM92909 \R,J@L-"8??$WR2C5JKIDI&[D9R!D9.> Z3Y*[X+4/BF/@PEZ9[R=
M709=X,8.BH7'A_28G@.2<-4E7PO!)KWIT;$,#W6ZK3WUOIJ@[]C[=+75-37&
M"CQ>H^D?T79_0OXG7]/CJ]_AX2S_ 'U\)IU'TC^BUW JZ\7J0$;*;3GMAU<K
MX?&;%>QRNB.O2$I*\V=7Z$7BA5G9&S,3WD16A>SZ2EI3%?D\ULX,-L1'!Q5?
M+$\P33*?%TT/#77@<G_EZL+8GT+^)U_3XZO?X>$L_P!]?"C3J/I']%KL[77B
M],++KV,A.V'5P_7,B S]_/;/STA*"]JZ.1[,2Q! &L*==Y-S<NQ86"\JSL5$
M.$&L3^4-<%M%_F ?[(I\7!XYR,#/1KD^3T:>E;$^A?Q.OZ?'5[_#PEG^^OA1
MIU'TC^BUW;==>+U$*TFTGJKMAU<N"Q@8!\0AM8;]("E?ZS@ZAIC+*/;360]Y
M'(2,X?;^>GQ8FW5:-O+U*Z9QGA2-W(SD#I.?_P#*V)]"_B=?T^.KW^'A+/\
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MHIJR'I.WK?X@5=Y0&"6N^[\J\9L$5W*9%5K6_:SM)V<[71-[1,)/QCJ1%4B
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M;-TE%EE-LXUT3TVVS]6.$5:UG]TK;E=ZPVGNG5<#[40CD[^&7A*9*W:,HC@
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MQ#&UR=BX?L;$67#X\>&5R7K&SWH$E+Z_LR$1@_$ L@A"$8E^HLF'JZHY)34
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M@!2K(S5R*6ZK/30(=*8<0/L34<F&!O@&2,7N -?2]E%Y:]>P6,5VQB56E6"
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+X1.$3A$X1.$7_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>g149615g81l58.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g149615g81l58.jpg
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M.N4PR?Y"[D>I[E.0X X X X X X X X X X X X X X X X X X X X X X
MX X X X X X X X X X X X X X X X X X X X X X X X X X X X X X
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ML:K$R">Y]U>-E?;#2CQOY*8T]K[37?34145-2J6T]I39^#SW'6<Y[E>/??\
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M5-E ,;"I#08QZNU8)[Y&:G+;MU3'5-^TE9P0< KG\0KHQ.N\X>HHF'[&*4W
M:ZFVT_F->/:E"VS"KG/"MQCF"LK)CYV51P<>B,,)-'QO2%%VY>,2(TZ&OY -
M>9CXQ+4:I:4VGKB.1IB3>%*[G%ZQ^XICV4-%1,AE?4.U^R$!8U3%0K&\KLZ7
M#UVM6S4.7:&MMJHC)ETF%<S: B14D;%&T>&CA)T&CLZ47%U[1&QI.79-W7G>
M2[G_ (>70RUIB?L.SNF/5VPI[*WOPE)YI-*)K232F0D/8I-O?C1XQ&WA,F[]
MW000]X>.5E?9(II^KTZ:XP(JJDH5526Y-I'G_P#P?.%P^(]^_'XKR+1:/1V!
M1KM4 AT>A04./&Q4)$A%N]P0HN,"@#1ND+8 !PAN@+9"&S5-@V'HILT4-&^F
MJ>)M?)=]1O*W63GH(]/!6GJU)5^PK%O"(:'AH%(=F&@1\*AJX&"DP*FKN*G8
MC%3$?*Q 85B!1)L8C6^\?<LQI-FV7U9J::;);TY3Y\[RBTHMU&HZA)3+.V3W
M>UC,1[_=D*NJG-QS^)#I%=TG*R&7Z,:XM&S+ < 8NA57K17LN6"9*5 53'GT
M#C9O2.K;1:*Q9P-+6;>JMEXW*+POEO=C94@9516'A6V1 H';%*3V=6G )%+I
M1+:3GXDK$GL<L"[&5>264%)R%6(3.9=:^N8Z4-*DGEDD-EI,TH^M7HYZ]!R)
M!)F/!3K*940KJ,,%#P;C?B;R\.*&5V;@W8:N5@-'SVLZW[6LSE6:U *8'^JD
M9RUJ*F9 '8];PQ?<^SAR4$E.Q4C*1@,R::1RZ2D])@"PCX2S%XT%3NL9B\XN
M^V^.'5&V[L_5A\27E;2=K1:.+3A@#=QAC,E0@Q25LHT_>H$GT>:2+=KDNV!O
M"+5J_=B47FC!P];(.EF^ZZ*:FHR?$SKV #FLP8CX/#V+*PR!,M/V;.,A6K6<
ME33!$49)S!N@RT2DQ L+;MQI-Z:T>N7[!!%FZ45;I:)ZA+WX8'SKUC6SD!$H
MHYKV#N(M 7T>*06-+Q,"J A1.(ZXTBA&)!U!^PZ./HQIKKI'G8=LS<!==<:C
M5&V,8QP)>_'$[7:'Q+>6)3W>+1S>=(1]6)HS38(,VEB,57()EUHRE(\M<F$X
M^L522)JAM'F!RA!--[NVRYTU5P!U[6N*\8C)B%90.&,PUB$#A>P!+6+@VXR=
M%9.TT'R0G,6"3'1K)R$A8))LCCTVD^<EFB>C9^JX1TUTP!^7-;5T\$0Z/O(#
M"G8&NR  O7X1S%02XB#%8HVV91<G#AJK#=E&2$;9[[M #T*BR<AVV^R Y5LE
MMG3('98A\1Q+=I]B+1S$[WCVL1VFN @S$MVBFI')C6,;2/W7X8S'M2VVQ34+
MEYD;@CME[AMASG*O .K;UG7#0'+XPUK^$-HW8+^0E9['F\4 H@YN4EJ7L)62
MEXE-AJPDK^3(?\#(7AEN]<&DO^#)*.=/FX!S.Z[K\@QAPQ_!8<]&UV0$%J_'
MNXP$<L8,5C[%48!)PYHLQW;QD@$&KK#Q#T*FR<C6*RK1DJB@INGD#[TX?$DI
M6XGB46CB<Y> 6\6=S-,(,TE;J,-'RQ1I''$BU:X+K@6I-PX(MQ"KS8>B^76=
MIM]7"NZFP'3I5?6:$;E,.0KN"HQ"<O9 1FT52B0!.-S A+=M]Y4_E(/0?@9(
M'LFW54WD#HLU=KF=E-]B2CG.^V<@?8]K^!DTH@@1A,1((UZ_8E8"B]C89VE!
MR@P>N(&DH@FNR4TC3\>*<N1C%X%PR<-![A=D@HFV542V ^Q&'Q)M*GTZ;Q:.
M-YL4"LHX3F*(08E*B,>&NG+X<!?2%-KJ7=A1[YX\>,A;AXHQ:NG;EP@@FLNK
MON!TFE55>G%)%!$ZW@2<'F#HZ]EL-TA\>UBDI>REPJ\DSN11W4=@0;=2-VNL
MZ.N";-TJ7<+*KD-W"JF^V0.R?P.#E58BL4AL4)+0!ZF2@BK^.B'BL)(I#5PR
M3^(J.&:F\;>IAW3D4FZ#99+Z#7"['53#551+8#Z6L/B3*4%9NSBT<:30Z+&@
MS<O:A!C>4&0H95VN'#E3Z370J0%BEW[Y8:/=NUFC%5X[4:HI;N%MMP.AQ4]6
M:PTU76M:5_BOI(N8=2*"8AL<Q#3[F1/UBL@<&HQ@;\"%5SI1PN2,+/F*ZA-^
MNL\>[+N%-U-@EXS?>=P1A$++OHH4+1"+E"4#=+/H.1(@!+U]#'KD:J&</(H[
M<M%7$==+B%UQ2S@0HS55&K*L=]]FJFZ60.5E#XB-DQN:#HM'&$QDS$2,D<L9
M!!C632 :!PZP#'FSR#5,H58AL/7N!+1^Z<-QV';KW--'WA7U@=!^*.J<0@E6
M6*QKW%;F%2*Y>OOB7&_B056+E%#A98E%/@WX!?*E#2RQ@BHZ8*[O2BJA!SE5
MWOLMD)>,WWG>$87#C!:+'B\3C)0Y!EGSF$F2($6^+0]P4';AR:\6(N6JKR/K
M$1.^XM\J)6:;NQV^[)QLHVVRED#D80^)"I'()@+BT<&RV6MP[652E@$&,Y')
MFL>1<-@#:0&V[5,F9;@V[MT@'1(NG*8Q%RX29:H:+*:[ 8[^*"IOB&XJS\5]
M=_BQ=[N%'5<?$F-?$-RHZ,;2)UNXB'P9\7UMW,@WW..-E!VVRQC;8FIG9[ME
M?(&0$H=$#)V,2@O%8V5DL)R6VALB) QCX[$MCS'46<VC!=TU5( <F1FF@XMD
M4X:9(L==6CSVS?7"> /Z.AT1#GY+*Q,6C@N4S/ C6824<#&,C\KUC[-0< UD
MIALU2(G<!!ZJK$1@HY=8&LU5&K+V*&^VF0,>_%!4OQ"TJK\5U=?BO2WT43K?
MXDQKXA)[IFL21/?2'_!GQ>TW3D6,'M-M1V,Z&L8*:YP^QA?@&0D8?$2\BCDO
M+1:.$Y9#TC",2E!$(,>R*+(R)LBRD",<-N6JI((D=9MV[0PF,<M=";9!%![A
M=)+334#^#89#PYJ42,1%(T*D,W4&JS0\-!"V)J7JA1_P2'4E!1JU2?'U!(K_
M ),&[EEW>S ?_P 3:Y2;?\'P#H/Q15/\1657_BPKS\68U1DJ.KOXE1OXBL%1
MQ?0^/491+X,^ &JC \DD;9;H#T]FI=/0DAE-YIJM@)>\R%]#XD3D@&9$HM'"
M$OBS0NPC$J?!!CN21QC(-&R1YD!..&JA00T-ILF:9=L/=-T26C1MH\T6U02Q
MH!Q#H3# Y*5&1$1C LO.W#5Y-RHX *8DID[8CDP[%U*GS9HDZD+AF(12%-5R
MZKQ5N.238H[:-M-4L =+FI:JS"A-;9K.OLUT 6%. 4!S#(YF%!7 (DD8"+B8
MMD;\!#E@Q=! J*59L$=QY)%)\TV1<IZ*X []W#XD_DX>:OHM''LRCPXH' 2U
MV$&.9.#$'-VBAH6'/+-=RHP<748,=RC%D[0;$-V;39VDMLW1SH!P#X-"1+F6
M/!4.BPQY/GF",Z=#X\)9.9H0P-0#8?2Q=LT35D;S =LV%8=&-WB^!K=!CZ_=
M4DTM0.JVJBK=XB K_>MH#M HJX"/(O"-H='=HC&W<9>)$8VZ 1O([(8.XCY!
M!!\$7',FZHIXBDY8;-UT]-]0.[<0^).Y2-G+J+1QS-0X@A'Q$P<!!BTI% 2S
MAJ[*A!L@4:[%F(@FZ8LG) :U=I,WCAFU6<HJ*-TMM /F8P&"B_C=@9"XD.Q8
M#YR4GON,<#M/CN3>#D [PC+O=V:?QE?.Q#9L+<NS/OKA<<W08JJ;MDDTM0/@
M4JVL5HQ&82M7,$5AD*=@'\-B*D0C^\8B3^**IKQ9[&0&P_(H"[C2R*2P!R*:
M-%@RJ2:@[=MOIKG '<JP^)+RMI.UXM'%IP/!NXPPF2H08I*V4;?O6Y%]'FDA
MW:Y+M@;T@T:OW8E%YHP<O6S=TLWW713WU ^%G7L!'-9@R'P>'L&5AD"9:?M&
M<:"M6LY*FF"(HP3F#=!EHE)B!86W;C2;TUH]<OV""+-THJW2T3U"7OPP/G6K
M&MG(")11Q7L'7BT!?1XI!(TM$P*H"%$XCKKI%",2#[L-AT<?1C3772/.P[9F
MX"ZZZZC5&V,8QP)>_'$[7:'Q'>6)3[>+1S>=(1]6)H338(,VEB,57(:%EHRE
M(\M<F$X^L523)JAM'F!RA!/1[NVRYTU5P!U[6N*\8C)B%90.&,P]B$#A>P!+
M6+@VXR=%9,S3'R0G,6"+'1K)R$@8)),3CTVD^<EF::;9^JX1TUTP!^7-:UT\
M$0Z/O(#"G0"NR  O7X-S%02XB#%8HVV9Q8G#AJK#9E&2$::;[-0#T*@R<AFV
MVR Y5LEMG7(&:\ < < < < < < < < < < < < < \Q'8'K@UGO;#M_,.V?A
M2=G^]2LDM82RZ[6U#I[7+6)0"@P]15F*#1>MA\CO^O"L"-M;+:V3)RY<$ &D
M2)4PU*K%7+S3S1'1.$HK5-KIJJ[EXQ2T[1W079^'R&NN.=)>L$<[&HR9O=\=
MIV( +'1F9-J:EVD@",-1>WQG,LWI% P>V9M6FQ4M@@^5)/=EGKEVX<KJJ[C#
MB7&$N(PB>-S/X1:]MRFSYC#3O7&5P>"Q63G8\SM0W-H0Y%RMJP',"H.1QZ-#
MGRY]V#DC0FT12<93PJ'*I% IA)J3#D6Z(;,5RO/='Q)"\$' ' ' /+#X"G^D
ML_"$_P#?.8_WX=Q^3:^2[ZCKE,,G^0NY'IDL>QXC4\2(3B<$%1<;%K,4'KU!
MB])*)*$GJ ]IKAH/0<NE,*.G*2><IH[83QMG??.NFNVV-)-N$<B,NW?[JKOC
MRVFY#;'GG;RVA,NSCU9_Q[>60F?GS_SY_P >>74JW?%>(&.__5;7'EK."&N,
M8SKC&(3+L8].<^>=?+ 3_%G/SYQ_BSGY\_/QJ5;OBO$&V:<[$4W<SHH"JTTJ
M15CC%N]>L\QTP";M&;E?9NAE'!$>Q0WQLMC;'LF_JVU_]+;7&,^?(TUB@;[Y
M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
M . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 =U>
MS?>[KK>V2L/>^'G&^JS:GIM+]3G9WL!,:CE:Y6,%*K:&BI5F%@$Q,[(1IU(R
M X?\4A9R-D6DH$Z2LM%Y3M$ DL&TJ6OZVM.RE-;>*<^;[+ >J\DGTRZZ4W+[
M0GE5V?/)7! LED-@4>[6(5#*USJ.2C0K79-PW9KEHLJ.=,]!9=5DPW+(IX(Y
M8,?>O=$1EXO%7=GBN?$@3V&L?Q#ZE=6O:,G[(=#^NO7\59*D<JU*S^O]QVI-
M#$5(?!C2)N"I2$]B(AJ5EL@*."*"<9!0S!!%%E[QA!5'VJB0JU;6J;V_627^
M5VYLDWTCFO9BP8;*9=?=@]=+=A\@>Q@W0MK=;XK*(3%YO BT68/2[HS&9;8M
MEE!I85*E"8;77<VWV509>M<>U<>T13$<;$UO3<M.7P7#839X(. . >6'P%/]
M)9^$)_[YS'^_#N/R;7R7?4=<IAD_R%W(O,\0/^*U.O\ 6D+_ +7AN;H^TNON
M9R/.SSL!P"T_PL_\N[6_V2!_^,+<YY39U_(%U/.8' -&MNR%-O\ L*XZM"YF
MQ+7:-K@W:A^("M5'^\5B8,M7PE3XT$&^N[$&<(;6?#R8F./5TS;R/DT)!EBD
M(=C7CX6'$[//GRS$[)[>4W5=@NZZE+F7J$  V#F+ D@*$20[!JI%V9('\6KY
M_9DO',5A,7;R@V*(IIY45<[@!+-652[2.Q'9(\H$/'GCMC<2>X(. . . . .
M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
M . . . . . . . . . . . . . . . . . . 4%^+O$ZBE?8WI(QE&;T.S!Y
M)(T-D$&JF.569B!6JGW;#J>SCA>UR5G%!3H/&1W9QY0*&XJOOA61S8<Z-!"P
MQL$;[2 (V\;_ "GY&Z,*OLX/&<8>$6F)Q^YV/^'-I7J?1WK/BK2DP-0O>LAB
M[,G8(@/'YLZ,N';Y>7YE ".*KQL&92F"AY!Z&C3I[&Q:J>6,??OPZ#)XN,U2
MVYQG9@566!55P]INXE\T?%ZRG=-5@/DTEF)"1R8AV,F= 3&?PA_%WD;F9=NM
M&ZRAE?R>R]SA5T/)])NUL/MF.ZM7*UQQJ2:OY$(&O/=Y\LTG"3ZMB?P;=O\
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M_!P_^8L_ZLA^IRG(?!P_^8L_ZLA^IP!\'#_YBS_JR'ZG 'P</_F+/^K(?J<
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MW&,$$!NB31,0[W'53KM\:9',LU+$]S\K3F>IE91NZ5';N;':.V%B%AH!1UL
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M.NDRRLI9R^[;\-YK5W.;3NVQMX[=TO82NA-ZV#9'5\'=E>5I$+!L22C=?B_
MH?<($C7Q@GM+U(EL6;6ZX#-=$80S;I+S$RY7AF+!$1YF0!+5PO8[+:#J4D0X
M;CJOV??'&+GT]9KUDMTHW,)F$7BX&34A<I2FC9>OI81F]<2\H+A,%F;XG#Y&
M7C$1)*;QYU-U8!-0SL/LI%[%A\NC>Q(AN+46U!J(XJ>\DYP0I"\4?_.K7/\
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M$"+PFNJ^RNXQNY6!]?6Y^2-^\$*0O%'_ ,ZM<_T?*_VC+<ZT8/G\D"L3FP.
M>CGH7_%2JW_MFW]X4KYRRGVWRI_RH&B/%=_BX1;^F*-?V0GO/M_T?_YZY_\
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ME7";--M"CL=AKJ@D%)X6USAK[7*N54\XSOZ/9YQCU9^O^KCU79'T\T=I#/\
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M?I!XZE/:XEB0_0S$)<F #)F1CG1;1@EKKC;<1J''+ABI-_<$' ' ' ' ' '
M//Y;/A5WK+.V]N7AAMU6MBH"-MS+MK$*[M<;+-Y?;_8!+K0PH*CZGO\ >[1<
M['L4%1A%S-IE"" A>0F6"TS(,6L.9;KD7[UY9M5)*+IQ$XPIEM)_UG98I6Y1
M:YTAZ_&^JO4CK[UVDDD'RV0U)6@"(FSH=!XV!.2K1+==^VCC8AG+]","G+A0
M3&4GNJ3M,"Q':N$&ZV-T$QEN6WO;?:RO3Q0#%P[712<:&$^]CFD%*IM Z6BO
MAM26-"^PRESMY+!F$!D%C"W1-A+75*MP+F4#FK\;HM!6LZ=,D+(UV8N0NF1J
ME*'A,J]6$;ELG?-XPVEEW4O6\]>L- Z]FMD-NPF*C@>+DRCD7G;\87Q=8?&7
M#W8%Y =BV"/ML&MX_C #<OA[L#Q@5EIC@RXEQA-N1(3@@X X!Y1? [C@:8^(
M1^$9Q&1L_A&/2KMDXCAX?[PZ:>_!CEP]SAA1G[VQ7:OFOO3%TNA[PS<MW2'K
M]JW726UT4UFU\EWU'7*663_(7R+[7WA^]3B76^INI3ZLG"]"4?(8'*JUA>9S
M8*2X$]6Q[>2Q-\K)T)2E*R_N1=5=PX:F3;]F^T<*(.FZB&B":-.>LY=4W<WM
MMF>&TVR;ZV4S(NPL([4%XDHZO2NJ[D]51"98D,F;I"X-+R38L>$;QIL81BK]
M1T^;843)$0CHFVU553;O$]/982"7#IFS<M<48S%.GG7B$H=F6T;@2K!OW!D<
MDEG85+>631WB=')=%\0Z0ND=WDA74BFA #[1K[M#MP#=HHLHY8IME]45$@EV
MX8<+M][9BI/H1U5,T+1O64E6KAS2_7"4UI-:>B?QWGR*T7DU1.E7D$)+2%O)
MT9*?P*7<.=EV<B+E6!+5??4BU<XT0]D&LY;F[F>,X]IM CULIDKV,CG;%_$E
M%KZB=5&*4!37$ADR23.MCLB2E9(!M&$C&D2=**G$LO-"[H&L:1U4W;)D-6V$
MT4PEQ&QN=F/>8A&NF/7"(QOL_$0%?K,H]W(E=AS7L4/VETV=?'R1VK&]8G.W
MR+MW(EGL2T-@\;-=6D,<Q]H,44W<B$&#C":NCYB7;A98;._K.G-]$^KLCISK
MO01FN%WE5=4YC5,_HJ-_'6>-U8;+*3:.&-;E%C;63('I-J#:NW*2S"5$S0XO
M[;.Y=H^4T2W3"6IXIIV6W'EU&QG'6RF779$?VW7B2F]_"Z>=4(QF_P 89-JB
MC5;R6_'E>-YBVAC6(**;2?.Y#!M4%N>UUWV9ZD\,<:-]0EQ&R9CC@8/'^DG6
MB+P'L[6(.O%F<)[C3"U)[V(#YF,Y<[3R574$TCMDDD23J2+%(GK(!*>K;1E#
M7H!@(V\UPC8<OGVF EV<X1'"+KXG&>Z/]99/6G6>H3==K/*^Z@3*J)_U\!XF
M4Y;;P:64B(6!5H36*M9(@8E6L?&+JMU&,P?GAYC.WMC;4BOKJI@)=^,IX;>[
MJ,\TZUTRGV26[<Z1)3%_KTWI0*LX^,,FRCM5*<O^/FD:^*V3&8AA3$IQ@C\.
M:@<'\ZXPR^%/<?-MD)<1LF8XFO@?1CK!'*F[(4>&KE=I6?;:9VQ8%^1[,SG;
MA2;2V[AZ NRBB)EU)5C<7U/,6K=!)A$B(,<']EA4,T8+;J*;A+E.;J(X1@??
M(^EG6V61#K! SU?+/8KTVEM9SCKJ,UE\W:Y@4FI^/;1:O""SYI(T"$MT A<X
M:[,YF[D#(MOIJX--R#C.ZFP:SEN;U3.%YQ\[-AF3+K73([L>;[:,XDHE?DBJ
M0;1I>;9D,F42<UB)D^TQ91[6+J&-XBW43D.VK[8RW!)'%-4]6NY'9IE1#<)<
M1LF8XX?(UH*Z&]6 ='7YUQ%ULX:T_P!G);:,ZNJ+8FT]66ELIN39':P2:)]S
M)UI%'<&/=FV$&4:*B!XO"&OP8T:9W6RJ&LY3FZB,+1AV&0R?IMUTF(KK&$D,
M!5?"^G4FALOZ[M=9;-6GQ#/U_&=HA$7:RS.1(.99H) ^AKEK,EI V?J):.22
M3QQLJHH$N]\5#XIN3*Q/6RF0?8F7=K1D24;WO.:SC]02>:9D,F62(5_&#2\@
M#A-8RN85B;-1N57]X4*L0C<LXU2306?;H^T34"7$;$YV8]YJL=T"ZHB>O-R]
M5Q]9N&U&W_);$E]JP_$XL!5>1R*TRFAF9D$9*XE"LH"?"#]%NJW: C(YB/U;
MZ),VR*>Z^JP:SE53=1#Y*%\%U[3,Y=U"Z^3EUUI>2:"*OUNH1\9)NON=)5,F
M>L&+AXM\31JZVK.0(8E2;4!JBUPA,/AY%95!-TXT6<;+J+!+O?[6/&\]^XR&
M/];*:B_8&PNT8.)*,[PM."Q&MYQ,<R&3.4C$/@[ET[C8S2-NC"\6&J,EG>WM
M'XL*S(.]4TM73I7_ (7VH2XC9,QQP^1J%IX>W4EAUCLOIVSK!PAUZMXY,I)/
MH-B=V&HX,&9[*-9E)'B4K6E2DO%^\R!-!X@W%G6;5IHAHU00U:[KHK"ZSE53
M=1#A;%"M$8&QYEU.H2?2;K?,)3"%",@ZE%7AJ@GNDHE[+6$/W\4TA3E19JQ/
M-VLHTWCR+=IA*7(G=-%&^CK7&'.ZZJPDN]_M8\;SW[CM8KUJIB%7Y:O9V-Q)
M0?==UQ>#0VR9?M(9,\2D$>KANY:1!DG''IAS&!&XULZW14=A0P]V_P :)[OU
MG"OM%% EPEL4QUX]QIMOX=G4)KU0F72-O5CA/K3/BD@-2FOOC[8V[@@2DTXT
ML8LY3F"DLWFS+VLO20)I(LI$W01T1T8:)?!^RS54-9SK3>U^2A? VO->K-&6
M%8'7:T);"U"<VZHNY.]H<OI)I8QTA2\QBK:%2'*HX><:C)/J^CK-HRUUEK,Y
MAKNWU=M/8.E%UE@EW6_'J/NAW6NF8#>=S]D8I$E!EQ]@A->!+9E>TADSY*3C
M:K#.8_!T$X^0,.HV"V$"'2K11:/"!2Q+RU<$]WCK&5LA+:2V*8PVX\^LTFGX
M<?3M+J"5Z'IU2YUZM&GSPB1K?X_V3LX7>/K&TMA=76:[2[:>HXS.TTS.J:,F
MT2UTTP,QI\%;;LM@UG.M-^"2V1@K8&Y9MUBI*Q+8H"[Y?#U"EF=7L3O%(2'6
M1RE@G#M;*C#2'3/"H<<::@Y)@M'F+5CIF4CC61^R/O8W+1WNJON$M)K8\>JY
M^H5UEI2O+BOF^XC$%!=J]F4*_;73)=I%*'Z<N1JZ-NXC"-$PA$RZ 1WX( /7
M+'?:,"PVY'*GO1/9X[TT7U!MM)-V4QPF[-+[>'%TZVZ?-NA>U4N<]6&CQ(@A
M6WXP+)]XT=HV1FVM%<S;$N^/V^/C[ML:RGO)]D\I[9%^CX)QAE@-9SK;>2W1
MA$8<..)NJ:=:*6L*[:/[$RV(JE+>ZY,;#&T]*=9%)V"449VH ;Q><I* !QEI
M'#^3 -JDRT4D@DNH-SC9R+W9N\^WX$NZWX]1P0GJ]1]>69V%N"(PU0787:A6
M&+7H<WDDJ?Z3/>OXL[AD3]D*(FW0>-8&1U^\8[8BC )[]NOEV0RZ=IHKI/F)
M=ENPZS4*OAS]/E^H\<Z+JU4XWZP1,@** JZ^/UCZN&CX-8.]HL5]YGI+=9TY
M],W56+J).9*JBIHKL-RG@9JDS3#6<ZTWW]4=QNF7=;*:G5[U#V6E$24)7/1(
M"?QFKI;K(9,R2C@:SQ[45-&JD>8&&T9-;%1[1-NFX/!R;@=C;=4<HU7SJKH$
MNZWX]1U<,ZIT/7\R[&S^*0I4;*NV1$.4OHCO)Y:^TFSP#%%H4+W19/SKEC%]
M&\=<NF>VD2; M5E'&[I;VCI-NJB#;<*<,.&TUBY\/'J,\ZM5_P!+W57.5>N-
M8&(J?A<"S/+%3<"RT,F&T\ NE9:E*TYF1PA)U%GZR!&0.FSG1?=FJCEGH@@D
M&LY;F[E/C*A\#<,DZUTS+K_K7M!((DH^NZH8;,X#7\PQ(9,U2"1:?Y:YE(]2
M-LS"$7*[O\-=-4WI<,^?,L**99N$-O9[)A+AK8X;ZICO.DB'4B@(*5[)FHQ!
ME1Y'MT;6D'8!;>4S!YK.";B*YA:ZR*3T^X3BR:D?W7:91B&H%/15PHZ3UT<:
M(*(@VW%\%"X(P)]X?G4XEUNJ?J2^K)PO0=(R""2FMH7F<V"DN".UN?VDT3?+
M2A&4IRPO[D847<N&I@V^9O=%]V[ENHAH@FB+K.75-W,N%MQM@0.\4;&/QK5U
MMY?/FO=\9S_U:R0OG&/^CYL[9_\ ]^?_ )N=:,'S^2,E8O-@< O$Z.]:Z9+1
MZB>V+^)*+WU$JLLZE0$UQ(9,DBRK<]<<GE),!M&$3"<2=*+&T\N]"[L&N91U
M4W;)D-6V$DD^64^V^5/^5%EQ&R9CCA\S1/??K93/7^BK D-31)2,%NP?;MO=
M]M.E)#)CN)-9DE@LO9&I DA(3!5N"3>(CFWD'CZ0L(VWQOLU'(8WSC'V_P"C
M_P#SUS_]&\^_:.B#SA]*)M^KW1D[/2S1R7+^"M.>)2SSV,>!1P"XKPTZXAUP
MTMVPJ:PQ.QZ V<'$U_-@FA D)W,1.81B:Q^0C-2@9X/+CMGPD@[;:OA;]D0:
M95PNS=-W"::NGEGZ1?\ '?17\UTM^NS$]H?10MF'IJ__ .S0?ZG298H>Z/=9
M)-6?6BGS5=K/*]Z@3.I[ Z^ L3*<MMX-+*0$K ZT)K%6LD1,2K6/C%U6ZC&8
M/SP\QG?VQMJ17UU4QYM/7.LY;F[F>,X]I++@@X!"?L_TGBW9^4QR4'IM((NX
MCH#< @U$#QSQ%RCN1=$<N%=WN<;Z*XW=;)XUT_@^G7&?\><\^G^@GK/S_P!!
M,QSW,<TT7F>?T9[G=.=UY3.<MELG5153D:,BJ*5DK.F*-:7>7&!\;]97J<T9
MZRM):/TEGVF<_P!&UZ/S&K,:,EFF0S?*T92BK.,IG'M*GEKJJ<HZ85H2>)&7
MY(ZN/I=FW_P0%^MS]S^,1IK^[NB_\5G9\X_%4]'O[UZ9_P 'F/B2YKOI[!X/
MUSLOK00D,ADD)M85/@,G([>YB#F@:Q8KI$#C8:NV2<MVKE(7A7=B[W07RBZ5
MPINBIJGC3;Y-Z;>E^<^FVF*-,9UF>0S+*T9ED,R61S>O*93)NC(93+Y15NK*
M?6UJGEVFL$J5&T^X>KOT$S3U=Z!KT#F6?YSI'(UZ1SC2+SC.LGDLEE%7G&2S
M;)59/5R7U=2E9M2T\6ZFG@C=\GJF)RQ_4Y$FF^27IF<[6%#M&#A)JAF0[5W.
MZQVR62PWWP^99C-B2'.6Z>6VV2/N#OVWH;;(+?D#]WOX^*?R..IJDB=*QHA#
M(+DHTB2\KE,J#1QZ\T=BH=B7EW$@)QB'HX;HJ!X8T-OB;X!',JN6<:;D=P0+
M(^-, H46*W/8EV67P\R;.X(. . . . . . 4V^)O-.R<>MGKT&KB0=\XY2!:
M#W ]L0AT H6!V]8B=E#3-8)5NE.2UB0^8B@,*7CKVQL),1#9F8?'4F"RR)(>
MBJX!C5,7G5FT:S:6V<&KX;8QX%CW69V4?4%5#LT1N@N5<0X:J_)]B8T&AUX/
M7&V%/6O9T7CHD$#!RS?YOA!@,$#VB.<:>S;:>>?,1XO#'9AU3L*'NYCGM!9G
M>)#!GJ%XD,65J6#6]%*SO[P^;=HR%#[+J:33FMBP(?+BMF$4FKK9UD<F0.1
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MU/6<ZR5BGS\IS[V?1#U-_,JW_P#SQY];_%K]"/\ Y?TJ_P 9HC_9#YA_Z_\
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M5639!1,X5TVU?+MKY+OJ-96(HB6M6TV<'KSY3D. . . . . . . . . . .
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M&KW7X#Y<7PFOKRTU]M)_N[P-2OHU>Z_ ?+B^$U]>6FOMI/\ =W@:E?1J]U^
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M.,H+;MU\(O&:JS=7**Z2J"N-%-LIK)[I[^6^FVN .QX X X X X X X X X
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M<*!4TW-W@N%N<N(WN2SW@R. . . . . . . . . . . . . . . . . . .
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MAAE3]AY5!(W#4>P;BM]^B2E'S1GLR#A(^5-C9)<?8ZO!R=?L(_$K72KU:3#
M*R;=LJV&FEJRL?JMK&)UI^"I?"8.IJWO=V3*]$>R%S0HG)^S)<>9[ &:8NMG
M%Z*3)U!5\2BL>?U\Z[*51"Y%"CFECE=5)%/H]!854QLPSB;^'@K;'1.0(R3*
M00M9*(^S*F)WPW/Q>.&XP:(=WK[DEL=>*QC?:[26/95='8$0R5DD0HF'1SL5
MU:ATILV%5K9@2=*0@*,+7;8\_P!(77].M:?:!Z_/I1"761*(@]B"GFL#22;=
M,86O9[L;)K&6VI23E,NUZSL+;&T77C.]WIA_;:8M]O-53RL/=$FQ%P;*.6PM
M0C ]\Q@RU"BU6(<:?9I,GLA&L6ALZ+$GWY,8T&7&SAY\]1U_;F<S.K^J/9VR
MZY6RWL*N^O5TSF".,#4#.4)G$JWDI^+K8#NF[IJ6RD;'L=\#7+5R@^SK[JLW
M635V3V!7:YHJ%JCQ ;5 VY3XZ?=@!%@=53-Z"801[-2R#PJ%BYCO(^FUH60;
MK=S*HW&XQ "&:_O,) A@^900-']'[Z2:5R8<$S(<U[T-:JA[XP5X:J2XN],N
M_-6:)!5#W5N,W".\&D906[=6'3%]6Y%Z]5J<75@(##X:/I:*S"M]I;&WMD 9
M48ASZR$YU"6#^*;67/3) $7';).W(I;9JW_#L7SDC41-I5^V_P +Q\\8(B/$
M$[/:1"MS0GL>XLQ)WVVZ^P6-EF<'I!B>O^N)_$.GAKL!&0=:M:[%E[,4I.:6
MG<\"U2I,Q7TRA&1N5;"D$L*UE)VY<75EX1]5MW=FM:)<VF%CC9JS/37P8(<]
M_K2G5+=1[<LNMI+O#9A&TX1JPEJ8@(=WC(\W9$/CTC.ZBY(+- '&14:+%WN%
M# D@.:>Q]\=-E$F^V."K%<7'G KZH;O?9V.PU;U];-V1PC0DV?=U(/3=[3*$
M1Z#,NR!.OC/15&B94BLP8Q@(0*H';A[$UVRUKW6*12U&T"7E8D3JFW:.F;SS
MXNWGNUJ_5;VRI6Y/6^2IWQ-[G)$>^E]D_#VMRU(7\(=B;;A,L[NQAS?-?QNJ
M-Z^K@74%V6,-J"7S6M&DZ%RTBD?HY*"3J$BX)"[%1D@Q84;EI% (=S(B$4[=
M[[)M\!"UE-D]6UYO%I[]VZ5!\=#]V;8(WAU0A,Q[)Q.:UO9]S=PJW#%"D0KT
M'*+\K>!E)>-H*XE)!&V0./J,I,;%L8;&GM9PZ&Q:>%13XNQV+M3X\>-N(:4/
M?"?*;-?OOV,O3X,$$_$)MZ84O34$D<2L]6EVT@[$43 9W::(>&F5(-6DUG3$
M+.9!JG8,=E<.'^XA5EE/A<Z"?,AO_K&^F,ZXVP-4J9VPFXWLA#UM[Y6J?FQR
M$=A[G@]8#C?6BQ9725C6! 1T#'V*I!>RG:F$QSL3O#33N-D/=)3UZK.L;@D4
M&T/B "(A\H?$H1T(?;Y2>? .G=>\/;>%\VT?H1WOO&0^';UTMMNYDFLEG(7K
M(TO[N$%#TBXKNF/CM?M?U=V!)E(4_/N20*>UW"C,GF3I8M2I6H(.V;:FY<06
M: BT<V"/K-6LW"WVE=N&,[%<[OIEW-N2Q.P?6FM+CN.)%4K9Z>7+.=X'F%QR
M&RD[.8-<\(&539#[=+?4I@K<=%J32SV,3##8O&<1]@4+B8XJT"JOFHK2AN(A
MKXIRN,-)3XEUO!@KD\0B[Y=3;KJFQ$WLMUM@UG7M+8=:]NH1:"2E0!&0_6R]
MK$B['W>PXK, +;$AL^%00#G1 6D<,_"'Q= OV10NV6U&J4G,J84I7NY2V<&R
M!D*\26QVU*]@'_;.UWO6ZTH]U[ZK6A#XY$:UB:-IMB4ZB0US/5('6UH!SS=0
MC-9<_"@]1EEH'!53/Y:DVE3H<T!$7:+SYDNJK0I3;QF(F%+4=JCL,\L+N3V9
MC'4'J:8F4V2@!>;.*Y#=AN]]>CJ'G%',G9"C;;EYMQ6[)8].6R;MW=T'@E/&
MC4OJ(+"'1":.VT!<;$"4=58B0I=F\6J8<XVGJO9O#K-S]&NVMO6YV&D%67A8
M$0S)W71;I)>CJEQD9$Q4[4]UV(.L_/8R"D<;OB$H+E(VJTJLR9'&'+?,2'S:
M+M]0@U,NF^,@TDI4_:J4[THA[KW[&6U\&2IOQ)>Q]G49.*-"PN]7%#@)74W:
MZ7N"C>O(A8NT[M.KA50.J<K38))(M(S);$L(2J4-/BG ',?G,KSI[J",M73/
M7?0:I4[)NE&%GB^$6O@I(KR?Q%KO8]3NXY^96U *)[74]8$-(Q^K3L8C1"2Q
MJ(FZ;H*2NH*(C)U9OL3]\LR6SZ.,9:=82U]NDS*"FZ*KYFP>AQ53+6,.;];C
M9P1MSQ%>[UZUM&@!*C<RNH8R_@MYS*MK@>1NG;,B79JS8C4#.<=<J:KI ?(+
M*(YCU\R=^Z#;-2L:KFT95\#HBJR?LW3Y0KH(DMM\)B;+:]BMS@W5TS['SJY>
MVG<F%NKS%6+5M8NHQ'8Y 3@.OXY/H%:@V1S9&X \881,4%E):E8:@\K^O@LV
MLE(T9F<_ 3<K'32T4P,<$A&H2MC+G>MG7RV1M+1N"%+/B'=K[^HV]'$7J"T5
MP!89U>2L^G:.3KJ+S9+M!?7XW=XNPIM;9Q&G]@ZZ22/ZH#MEJ^DT8=Q/5]F9
MF'"X<6\24>?/GM-4I-WPE*;V5Y>ZT3#Q,+E7B&RL1UW^-;WL=6L.MJMO$X7I
M"W(N: P_:0XZ]._$>FE0C8Z_&/562$/0:]20)&?N)QN#?FG<0A92;8),M\D9
M*F+JJ8APZ)3XZB?7]:T<8,N[@=S>R<,O2JXC @\VI :^>A$X'#)A%Z@F*G<"
M3K]G*%K8]&H^4C)ZT78N&)4M.9O/A;0(9K6W!B;9>=S 8*A<**CR@B2:W[VM
MEF\+=N&Q7)6]">PIZ]4>T0J5VY#[=,5-V@G$( F(@(!1]DUK;(&+$(AJ@'"O
M"2F1/PLK,!8DP5+&R1+(1\@[-D70YQNF(U$6B5,=I/\ X(>=V3=X.R(Z8]HA
MQ._DH6 A_=@-1Y$FF+I:1.NL_6=Y9FX G>:M=_BGUEHS1LT2"15M9-P2BPZT
M15F>):1C&C  MHK/N\V\HW"M:;3MNXNL>NW(EA7/<"4,^U12J1%V)]O(C_@?
M0FS(%!H#'Z7B%GSB<*2[5H2,)E34GKF&%Y%)H*NA8*K;4M74(2A[H>0CT:1T
MV1(FZ2+3@]:-MK=;\W(6S[OWVT&M^^9-"WF%;%:FIGNC*!L+F57U\3QUOL.F
M+_C-?=/(/JNU30S))9W!JTB5DP=&9R>Q!AF1Y8&:Z&O(REJ!*O/GSNZ["MS5
M[WG'LPX;2WGKT?N6=VC,[.?2]*6=:9[3M&E:D6;N(0H(S-MA)EW89J)*QET5
M.E !](@"RZ<RA2+8&F!CIF"!'!CG4X@,N+6AJ9)E\$/,K"_$8[3#X*)FCV[4
M;%CFN:)D'823F*KA <9U;-G?$=H*C9+5SN01F) 8]@;.>LLUMV3$!\P;&;!K
MYK7NTXWDS-H7'*H#HJ5M4.'"O?ZC>V79PN,P3AK;NO*YKW;O6/U'9I+M12,1
MIN)F1])0IGU^CDWS9$ND$+),#%&&)=)JJ?SBJ8=5IY Q:<SG4X+!7\JF $+6
MKYV6 2B+CAF+*5#G&\1?'&^Z(P<XHA.4\0SM>-K/M1,WU[@(T5@ :'&W0V25
M9!]=:3N%UVAOVO2/5>/[*#0N7IHK3<!@TP7UL32Q9XR%Y(S%FJV!6##UP NJ
MI5FD]U]BO@YNVI5B[RA]K_)V5>DOLB3PF34A-G$!D'6=6#GVQH>TABS*2I/]
MUD\0Z/D&JYH,G!Y(_7>22=,7Y\P>4CA@?'D1PEL,N+1.%YWDI>"#@#@#@#@#
M@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@'\VVU
MTUSMMMC777'GG;;.,:XQ_P!.<Y\L8Q_UYX!_> . . . <2RZ+?7&ZZR2&FRJ
M*&NZRFB>NRSE9-NW1QMOG7&57#A5)!%/&?6JLHFDGC;??77('[]>GK]GZ]?:
M>GU^S]6/7Z,YSKC?T^?J].=L9U]7EY>>,X\_/@'ZX X X X X X X X X X
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M&,SC>73:5C40)(I838^^@I9[/8_7W7.O1T^!"8<N-$0\F(9]5:6+1D>%1P/
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/ X X X X X X X X!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>g149615g81o47.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g149615g81o47.jpg
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ML\A_?1+[3QX.J_ZCD?X:@_0GA6M/M++_ ,9E'[B>VZ5_K/(?WT2^T\>#JO\
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M-U&:;]))[HVVVRCH[23<ZZ86TUWQN')ZP@ $%!ED($1B AHZ>$"(PF$Q "$
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M1+[BG")PBU4[.]RZ3ZBI11>XEYNDA+15AR-KO":]EMA*BHG4T>;2RR)<>91
M86(#H[#XVZT-%WN&BZFC%)PJ@W7R@IKJ5 )N]..A4Z6]_>D<&$*'91VLH8<+
M:3N$UF7<)V7%R6\:G5B+OD(A'9BU%$'SN%NB>HHR]77E: 9D'$@CYHVZ'" 1
M=ZR(QP.*N6O^X/6ZQ1$"*"[CK42ZM%.:O:XCQ^Q:_:22=A(#(I''#\EAXME*
M2.91'$U8L6*)EP*Q%JD'2P[(;,54G;9L0@C09,Y:YYL=:IFW>7IOF15E%679
MZCS9VX[$(U)6[2,V/&)4C);+%1[24/(3H1C9 J-%R# ER+U;,33P:H_+R&)Q
MQA[)D4OC HL2R<#(/.4G;WYC@5M5PHG")PB<(M&Y-Y1OJ;#BMDQZ2R^P1$JJ
MJ31R*R6&NZ [ :38D^EHNRSL=)0*'>YCF2V=%"@"F;:D+::5T+D\3VCE=2J1
M9,X!CO6"A6R;Y-BX;1KOF)7S6;*J[,TC=LQFD#JV;:RV1P"%U+8DDT:@)0Q$
M:PJ\F4K(U=(@DD+!1\=E8Z3M8/*<X5BQ4SZH<"'# Y@8_P IM=R$$3(O)'2+
MUAH5Y1?J"77/-D;,.CU8^3W%[9D=171$V\B4;7:"ZY$R%?O)17H=G9H !=<G
MCL E$DKMQ* $6*G!+B1$A@PBS?+$LF^7E&#W/*6/I6P49O.L)A;UF43'Y Y>
M6C3\<@$LL".K1R3CFXB/V>M+6T)),I"3#,XU(T2SJ"RMHMB,F#&XAZ&=,3.H
M]YC1#8C%GT$D=(9_2%KL]\I!T['MK'>/;0+-V=6&! :3N]JLMW=L]R;G\OJM
MF;A2R4$43L6'(6)7\WB96<0+:1P\&0BQ9<R;8#4DGRQ&.PF\: _H6\G"B<(M
M/I[WOZT5A8$UJV=RJ:1R=0>.!)0X"/:7NG.)B,D4]@M5ATZD)(U^J)N@J]LR
MSJ]@&@:J'TQ*:S"8!H_NTU)*.&[<JQ,P/>9GA($ST!U(@'>?K59LWJJOH?+I
M6[/W=%CLLJYR5J&X8Q%9<WBK!8I+(\QG$G@8>&(3^),&SQQ+*W?'FL\C'L)Z
M@=CP]TU60T(QF<)&8TZK^FY4:6^4)ZEP256;#9A8YV.EJB2L/VZOBE2W(UB&
MA*J*JQ>%AQB+V I7^('/IO&*DPK/WL$@DDDDR6CC0B^9 W6HPCJU)9+/*>L/
M>USO>LV)=@:F6N*+4(G)7.UIS6JSUU1F/YC,KT9%*XC!N(QXZ;3E"@36)HO!
MI6=Q)%S&W!Q*3Z-S;)_D-@>I[*P1BSZ 0.DNWH*P]+._?52$2ZU81)K%+,#M
M,1N6RB<Y1K2U"@?#& (P%>>C8C(A,*? +%E,(3M.NL2R'5^2DTI K2\4V("$
M7.KY%F0 EFTR$QK\EQF9+:N,20-,HU'I?''F2$>E0,3) +_+=TTR^#'&#<H+
M>9:O46SQMERQ=(+9;NVZ#I'S_1N$4E==]-2ERL6ZKH@W7^O#=HV/B88B$=2W
M<F%H-6]AVJ<9LT6[AX\([Q.L(O+Y3L*&,6CL@8+:A\C X]LN^*.VC5+97!4!
MRPT]&TR6OC'RA_4\T=?QN,3F734NTA[>:L4(%2UW3I*4CUXS6LTW"P1W$J[,
M-)[.&$/N*L909KV'K&IN# S!@5+@&3-F85&DLG#:,2/2"'Q5X+]U.NB5$5KV
M3:R^2'*EN G&0=;$HG5=M3.62L]+W3M@! CZQB4'-6=J<</V#YB[$N8@@_%O
M&;EL409JH[ZX(Q<C2'>8T7SN7YBO=KK'-XW-Y;$K+S( 5<U9$;FF:XV&S]=\
M&@<XDEJPZ/+[@\17!UY*%)=2-HQ8K7H\8ZL&.2.)N@<BBXHH\&-7I&,I7EAS
MRWB=TU<4I[5TA$*4@'8$I)3;RM;590-[6J\:@4_E\NG7NF"D#L*81BMXK&#%
MB%3!<*ODNH&;1?8F)&-"1 RU'LQ1)9H1B[>L =),E0JR[H==;AL:.597TQ.F
M)1-J@87S 7;VM+0C<,L:IWS""$]I=7-BR>&AH%/6HQG9\ W/LXE)"Y./+R=D
MP-,F)!J4:,"$$3.@L9B1P(O%QYV6TW"BTVF/?CK) )Q/*UETGG@:?5^E$EG<
M3<4=>.QJ9ZSF<MZRBV:@:I5TIF[-2M@.D(GJK4NTR0:E-M_9JK9HW<ND2K$S
M]8Y_0JO6_=[K;;4]KRN(),9&3D-MUFM;E7O2-5VS&(?8$*9"8J<,KQ*?RF$!
MH.</QD9-XLO+H<PD"TNB2Q7 ^1A!A-B39LB,1/ MHOGN*@&N]_6D![I.2,DG
M_HZKL%K4DC<LJ(ODDP,VN^D;&),JQK4F/K5R-M^P'4A),QZ<1JEW,CFNNZSY
M5FF-:/'C<C'UWB[&^2R'7/9VG+5L G5<1-2;%B!*ZB5J&XC*ZTLROS :&S==
MRU ."S>>Q"-8'G-G+1= M$76R4LCBV$TY$%%[KHZJ$8CRMB'YQ[G0L,R3RC_
M $[B*-SNI#:!9@RH1N>>6&0UJRW7H_#*(S@Q6<U(0I\/@CIK9PV!V''SD,GY
M*N%94Q@QX2_:2MP(U;[JX)9,I7W>G:)C'0MY.%%A#L)V)J[J[6Y&V[C>RX37
MX3=?8^>B59V5:'M;&,1!60%Y+)QM81*8%8W#@ ,(4*2&9'&(^+A&S730D6;.
M7C!!T5 )+"_G ].G5>5A=]Y0OJLU-6-'64OG,H-5>*,&Y /@=&WG8"Q@;&)!
M&HI-'->[0NN3J5H)U])9C& ED[UVI)DZZ?&6Z<UW!:(O-VQ+)9Y-S@:'FYDX
M$GOT.KVE7<KKW$:II"ZG<KDT@KWLBO&V]'O:[JBW;4D5BJ2VL)3<P+(2!5I!
M99/M4W-80J4S!TJ_C#-,6-#.DRNS)[E%JJ1BY&D.[D!F+:=<N=1Q'=/KG*(7
M,9_!9B?LR.P:*U?-#?N5UE:-G'',=N9GJ_KEY'(M!(8?DTM4.,]MG#QG&!)9
MY&$$'BTM0!(L'RC8C%V]) U7F6A>$E[O=:(K1-7=DGL^(E*CNL>)*549B5?V
M/-I#.&!>"G[/37"5]$8D:L%7(VNHI*IM(4%HNBXC,<C)XB?2')"GGHB,7(:8
MOU3:?3+GDK]JKLG2UW2J=PRK9GB6'*W#5Y(97[& R9@)2!VL,,F($6"2$N&'
M@)8..L(^9VP]BA(TV'.A[D<459$4MVFI""+]+[+UG/A1:-R;RC?4V'%;)CTE
ME]@B)554FCD5DL-=T!V TFQ)]+1=EG8Z2@4.]S',ELZ*% %,VU(6TTKH7)XG
MM'*ZE4BR9P#'>L%"MDWR;%PVC7?,2OFLG5IV[H2W;0<T] Y2>)3?6M1MQ"$R
M=<67%XU,ZO*.0C)&<5U.95$ L)L>.MGTD ,"1&#2 ^B,?EFC)]L@Z],DB0@B
M>MM$CKPU/>Q:Y8Y8^47Z@OGY\;[IAT:YCQTE'=MI%45T19E)" *\@76N1JUX
M4DM>B1=H"8K>$GCM?RX[7#V4A(H4-BW<A(#1#]J05/[L>;W\MR63>WHTAQY0
M'"S&([*U&9OXUUB;E)2RN,+"B%B8!'ZTLJ,Q^0PT,1B@B0'(-8,BB0NO;!;1
MHK.H@,DF(1*#ZH(D?:#R6C=XB_0:$8L^CG&N_2+C>L$F_*4]0@0FUSCB;SPD
M*I3#QW8#R-4'?TM291L6<L:,GK !^UBLBV9?5T9D-166%E%HQ/!JOXZ0AY!N
M7D;39V']9$LF6NZ8G=KOF)7K=P*9%R,,)D(-ZB2"G1C R'(ML[;-WXLHU2?#
MWJ&=M==LHNFBZ*Z6=M==LZ*:YSKC/O<*+#/8/LK4?5V(-9]=!24Q^&+DFXU]
M)0%:6588B-)KK((;')L\KN)2I*#11HJY;IOI=+]@L:9JKH(."FBZR26Y4 F0
MO][L3@!,Z%ALGY1+JD,S;>-9?/#.:2T/.9[[5:(OB7ZIB(C*YA!9M)HJI&*V
M+)SZ(0.:P"9Q2=R^#;R&-0V01]T+D90<Z<CDWI&.J>L;UD2T>W]!T]&*PF$R
MDTH<@KE9.R=;*0*J+;M@G)1(^'+6"1,IQ^K(-,I"-##86W7D1$L8%CQ[ <BI
MN[<(J:Y3P0 E]5[D#TLK?,=[NJ@2J[6NU>UFY&K:57B"%A2^-Q6<2P>.TGM4
MUU>$2?AD8Q&BSZ7AB]4VO YK@]$&IP(P$&5MR9!DL%/(C",9!K[M&DCT@A7I
MV&[44=U8!!Y'=TL(QD6<VD*K/8/"YQ.WJ(B'1Y[+9M*BHN QR3$PD)@\7'/#
M\SFIAHQBT8&II*F2S3=XR3<D >Y7-6U\59;LHM:&U])%CTAI.5,859#3>/R4
M0W"R(D&;'V;1@3.!QHR3M%ACM%;4Q%GAH-A;"S/)##QNX02*-=KN67^$6A!_
MRF?3N*MIRI))U/@1&N)5O$YA%BO7_L&PG0M5*OSUKN)-I 757I3,A7;6LHM(
MYXYLL<"=P)&,AW1#>0XQNUT<%;)EKNF-^M9^KWLO4%H6;-Z?B)J1*3^ QT%,
M3 D_7MAPUB5A<E,2"/ IK")#+XL#CMB0XF<BI\:SE,$*R(&X6'Y62?;M';!R
M[(VU8<A7E%^H,_U8;1ZS#J.Y@U6 2/-Y345T0-W+-KDLUG3=<G88TG->QUS,
MX4>LT@SB"T_BJ1>$@B3A/,A/B6NV'&2&$B_7I&B_3+I6P,'O.L+'L*V*LAT@
M<E)Q2+N+LK*$K1R3B6X1Q,6A9Y'\,3)D,/!R=!VF#+HKO(J1-LQS\<[&$7#0
MDW5::$8L#H-W0M6B/E/^F R&3NPUK"G#F%UFY"[SB1":#[ G!X&*R+VW>H[4
M<J!JO?;*T@4Q 9K@?=[;5:J'JD9)H-)>LXU;HN#^[%6R92ONF+Y!K[YB5^I;
M_:[:[ZZ[Z;8VTWUQMIMKG&==M=L8SKMKG'O9QG&<9QG'O9QGQX65@B\.RM1]
M<O:,M;I24Q\98,L"0H-(Q=:V5,HB(/R63QB%1U.>3"%Q*01BM&!V7S.+QH,8
ML(M&11,N82:LGB_L4ALS*@/=HG>!=/3>L!OO*8].V$2LN=;3V</8E4/J]_81
MP/0U^G60"'%%; 08VMG<-63[8C2;EQ5-DMT+I%ZO:N<.H:7:-Y6LZRQ1>%;)
ME*^Z8OPOOF)7ZEE^^.W="=:G<396_)Y*&6F<9GDV#[1FK;7LM!I"*O\ :CFP
MYO)W58PB8MH3#(=I.XHN?E<Q5! !S4OH[7(ZMFKY5J4 )N]WN Q.H*!(.Z?6
MF,P:5V43LC"D(A5JAZ5D)\-$YQ(VS:QCS6,OA8AFC'XV3=EQCAA,(^0WE@AN
M^B#4>]4?.SJ#5B06:DLEV:;/T>^Y5V\NUE%=<"D)#6_+WL<(S_UFX H#H=-I
M?HU!@SD-C)^8RIQ#8Z?;PB!1Z16) PL@GDQ5!Q$(1EX% F9:Y?)YP0 FX>^^
M1E?(JLU/V)JRZI)9L.@I"4XE=/%PH:P(Y,ZWL:M#0=22L'!2-$FPVQHK%79N
M/2)@S>.@4E!)$@11)HXV9D%<)Y\2$$83P(/H*S8IOJEINIOX^8GIMOMYNNV^
MWFZ8SMMYNFF-M]\^&,^&NFNVVV?>UQG.<8X46@:OE/NF+46\)E+#FH#<3-Y!
M I*!DU#7]&)E"R<4C\"ELE.SZ#2"L1LP@5?@8K:5;R(Q94P"!8$-%3B-KO9$
MAL123PN6K)PO:;AINTW9Y&5\C@5L56_9"I[6E]M0&)DI2C,:06!8L:/S"MK(
MKLB+'RG$BS&)"*1G\4C695%))F(R? &517)F/E\!'BK BNAENJN4;:L.UEY1
M#J-;S>(+PFR3NRD_?5.UA0Z65'<U<FY2RO47(S%02H&!L2OHL:)U_8+"(2?>
M.6.T8*P)XY!DF&9&F_:J-<$((VZ0;K[BLM5UV:IZTK'MVI8L9DK6P:-T"N[$
MCTTKBR*V59@Y&2EP8!+8\]L.)Q<=.(.:+0*9CQ4WA+N010@K'GRK,NLT49N'
M1"" #H-TP?1<9W&:PY#_ "C74"=CHP4C=F&G#6:696M3Q;5_5%OA71J3W*P"
M%JF*-F1J!CW:=>V,*D8(A#[6=(MZS.(%&FC.6*.5/8^",9Z@YF-"W@X43A$X
M1.$6H'9/I947:VP*.EMRCT);%Z73M)-2M"[+V;$YXG9\>#1]VTE:.';?#T2.
M1#ZJJ@WB! .=3=+L3#)PSSLEN5!(=M*TT+>26V,6'.[2?=H)^8F!F?U].*]<
M2N,Z2\37R-8]F2O96(1?,=.RUR">1P8].$:]3!PL?6L>UB" IUH#UDVI\U(R
MMK -(B4G>%G../2URAA/(X5V G@68M+<DI%@@T?(GXN=#E5@[Q^SO#L->D$/
MQX>!G<<CPHY#3W8R4B4UY7')^Q6'B1SP".BA<@>?%"6BS7>1[@#/H5[5KY*N
M'U)-:"GL&M8@.-T.<Z\OV*#F 1QR*DPBDNKTNZI2 819)/6N[ C8L&F+\WF0
M,W&SF)R9D,=MVAI!IA#8AB=Y";^E]EW25U@X64X1.$3A%RID7DQG,FD-@SDE
MV@L=:QY?>;R\P-A+P2LW<FB)![55N4(C!\+NP:S4[7T:I*YI7!X-&7;9J/BC
M[5&9-T7<F)RA[("U:.JX!IBX@Z"[N'YUE*O/)]Q"!3J5F,VA8I6N#] =<>NH
MFLAY1W ',:A?59[+7]2/&EFUL2B5ANBC5Q8<]Q(\*&$1\E;GVS(DRW9"&[=4
MH8B0TKR?*P/H&O6L-$O)01<T$("C'82TB"P-Q/5*45WCM<HCZ93L[M=7G<"=
M+,!Z$:3<38J>LBJH('4?S$F_;L(>%W%BAS%V3*D'A+6H;9R;'![FOYFV 8=+
M'92Y+#MRTKTG]@XLZCZ6I.41H(AI3NVS2C97-9Y%).,F51DXG-Q!-Y,+.L<D
M;'C3K821'R-J <-E!(9NW7(\@)2).-[7O+0-"P$1\E)&U8=<,,#]@+($L;/%
MLH4"75C$ )JUS53:\[)[$.(&&PL$0P<6>V+9;U-252#9X81BT:BP9'75XB=,
M'RMHX#3C-P!C@%U7%-WK,8.:$B.Q<BU8,V[\MNU;L=RCU!NFDZ([,FN,-6>S
MU?51SLU;8PW;Y5RDCC">FN.%E3^$7->T?)WJ6M;ML7!(.PLZV/3HG1QNOTUX
M; 22M(/NN=J0*ZJK#P0@^%*+;P9"RH0M))M$GR7FV ZDQ122%'#D7%70 J]V
MH$2TNX/2TL)"5[TZM/)H :^GD)DCV][/FL1AE2RVJ6<%--@H+=CK9A8Y,+<F
M4,FL%3BDLKF8VE89=G*96?ASX<9R.C<=A(PFPB+#88L5,3Z!MG<SN[L/250K
M \E/ +*VM@))+LM=2M;#-6Q-0%<:)Q9XTA=EVUU1(=.24^<S$V'+S^;DHY4A
MN0[1QA)I,LPWDYQW()'I('Z ]1F4!;"3;"[>7T#6^8-.E4E,V72]B6'V+F\S
MQ4E&W303P(/BT:KS>90^\C$'*RIZM*(%L#E<2/LM*IJMF$+PXL(?CL1-X\0<
MZ/I&0<)D>3:P<9@'H:9T+&+WR7\/2/6J3B]UV: %3J%73$8< )-@$SQ6B_8P
M'3L:NB0HR25M"4PGA>2!J7"HB',[/&'(-[)IB4<NS3Y^)5"$>3,+W.N]N:_0
MSAM,UO[3\!=575=>UH\DSR9*P&(@H>G)R T<(?&6<>'HBQ[IX.$II#FSGV U
M;)+8:)Z)*;I[+>;C93;'"AF2<5C;M?U^>]H*5D5*(VA*JI$3!X)0EY:),!#]
MY*(:U>:.9#7A=(LCO_\ "<Y::>HI>@.<#WY2.."03+Y-@4?)+%06][M?.-"T
MV*^2[;N2LY/1OLW:]?&Y8 E>H1_ HS7,9WKVP;-K6E*CM>PH1D='DG(1:50:
MDV+&.Q]DZ;CZY(327E8DX:NT8;F)%;328=,W +@'F)Z>99((>3SB_N5U#"(M
M9\M@LPI4O5!.&S2-,F^D4'H4P\?*0<8-HL@_>TX!0:#72(I^_!15@;,)L]'1
M<H^<+N<JE',[I@CRWE[WYU;=>>3?3ILE-WU3=BK& :6C3&E5V?F1Q&N)<0FL
MAS979>X7UI.GJD>$-P\F+V3VKLZ2$P\?'"XMOYXH8S$LAC+1MPJ8B;P)%\-
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MG+?.K3&VI6$.69[RTYL"6E/R37*=?RN=M4U&9TV6?UEV3B,:F/9<M1W8J;R
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M "P#2G>SZ6>9&O%VDRZE<+*<(J"_DP4:YW:/'>4G">--M],-W*GAA37&^O\
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MNL;^/[?,WOV?BQ%AM&]+<..P[E%>RB'$FB[ BHW?L72>R+IF]&.'31REM_\
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M\N<PX>XK=N'DEHO&\.E(&8(+1UI!GC)L5)<6SJO#SOQO'^FM!1B<R9%I7,0
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M;M?/26QQ*Q$OVAZ>9LL]1Y41%66H5[(6!J2FHW"&E2ICQ?7BK;>,'7$I=O\
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MW38L6+L)+;;I%TY=T\J'N6?I22/VHYCUUPMG 7DJ2D8V$U=85]/;$KJ&EW+
MS(0).2UO5L;J2LD2$<*.A;!C$G@EH8D@=,&[8:AA:=QG+I?T,/3-9CC>0F'!
M=IDB%B=$B7,\?+TN%?UH-_O[/_,)\L5QYCZ%B&\<X]*@<JBY,RNFNS0/O?)N
MP("NI1-XF%-D9;'30RSX<&8RNI$^I[2MV?5YC&Y%-!BXPX\[-)N[JU)G8\/@
M#=NKH66F6#^<B-,$&T[.-$QAO74&&Q9=B;[[[3O(?-EBZU!FW27MT?(7,0<Q
M"P'B[R:S<P3:,IS7DOBG:0V8["7M,JJ.22)'NP56;":[K2EYM!HLY;G)#"IC
M%I&$C#"(PJ=1:O!Z)7-@X8SE,N<3A_HM6X93 T7$&$ 0Z1"9F(&X:7)G+(Q^
MAO*./Z0[+4=8RD\N&)D^H >K:%5A]JUQ$)6_[#,:NIF(R2;2R7*RBN95O"BM
MHL)+/XFD:EKP@I"V-NB['$R%>:5Q $Z!%,%V9A,7RP-U][R\BEJ!P0P)B>)P
M3XKFX,0[,[:6;254S'3?L3=_88H>GT,D$(A4JV"G'DSF<XCLJ#BJQ9=8JEB
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M:L#;E8U'3ME#K"E@]TLDF<IDO?+0+T$8AA !<@ 2E/QG+D:7&N6B17;<&*1
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M))"ZD1LZ:(2XY(9'(CF[N0[) VBPA@";- 3/=!VX?:AA83O+.,-ZQ'&(C(,
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M9*1!I$-U'"69'/)E.945>;90R3?'<N-V+1713TNH86>;DWKE%%:N# .W-_H
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M*.?'3?'_ &>_Q_\ +G\OL57WOR<S%_#_ #!%3_1J?![_ "=OHYI$]&I\'O\
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M)'%!LE"R2RKE[0QFGHJ<,Z+>PSBK"M(U#9NHD$!GPC,L]L!%Q(,$?5875F4
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M,[+KJ;9(2223,F962>%$X18TM>F*@O>*^T6[JMKRWX5ZS9&L1*S89'9U&]3
MW"VH\KJ%DPXF.T(LM'+E-L]U;X<HI.7*2:FJ3A;3<CD7%E:#+JKU@&VD'O$=
MUPH9A=4>',PX"WV50U\UM &('1;VCCQ8B?(1Y.5C1S&%?_"#-DS+(MFL7_[
M02T$_P#5.%7+,Y:]G+/BR\8CUBIN&V).K0'Q1B1E,XME6\DUY Q$&DH+:A"H
MP='268UFJ\&;$H.5F=< 4 DN7#D$]C6I&0;+9TTD1I)Z1S<Y9FZ!.>*N6J*5
MA=.+VF^B>"K@G<MM2BZ)\5-O4WY K,I.P!@L8T51:LTT!$?BD6BT/C;'"6RC
M&.1P4V<N7SM-P^<D));4&'-[E9;X43A%;DNA\2L",'(3/(M'9M#).-<AY+$I
M<$&22,R$0\TRF[%' )EL]%%ASI/.4W+%^T<-E],YU52VU][A%8\0H&B*_90
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MY! ',S(ML!]:IC+"0F'VD>I1O=$*_$A_R7/VCEL#$[-RELX#;O3W1"OQ(?\
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MLN32>8>F)70.<^B%0.51:5V!W\ZZUI/)C6,F/$=)Y"+#8UP6BK/0(N?<D7]
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MO7Z^S5!OZS1QE%=RMG?V-OX;87T:Z8U\/3>]G7V/G.<^.?'SL>]CP]];F[:
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MI< FD9JB4VQ X_94B=2A[ZMC+8%!2Q]I*"[B1$?^SP2(\6X4+O?^JC]7"_\
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M:S>26) )+@&4F"JJ7D?.JWM9>1-U+K<<B#@+L5%Y<S:&:QC(F61GLTSJK,\
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MHI5^O4T"&PQ<I%HC#":[!X8=K$H_!BTW/1MN05*D7^[U^W.V1.C1$ZYV5/2
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MH=R>?OUW<K-')7)X0'-2TG((G5<CG4C'C3$_D%<1$N"C)R9.$G+<P69O/5I
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M"NJ:>VNC;?;;'@5$,)(#">H+0XIY3MO5E@3VM.Q=01J#RRCR%E:6TRJPR:N
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M/?M'22B>FZ2VFV,9X2Y8&$]$^J\?&LF "L%P3M@3FYU&5A)_9HFQEI'8P@
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M+-1X]\NQT:ZI.576WF)*:**YVY& %PE.[#UJAXB +XB!?>\F*TZ$^4#ZTFG
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MDM@N5)$(B&+M" 2S.1IQZ3,WR6]7-+"GBOZT&_W]G_F$^2*X\Q]"L-XYQZ5
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ME'<&S[#_ -S%R_\ >$8G^&4B_P!I'N;Q-.O0P;^ZX3+\5SK:#\9?UJ_.G_\
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M\W7/AC^W/O<A[@^?9!E4UQ_Q&/LJH_VD.YP"#:KV1'^%P]J47\9?UJ_.G_\
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='*\B@R:B-#DU#E7"_P"].41BT.$ALPD3G.4__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>g149615g83n97.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g149615g83n97.jpg
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MZ?59>Y@;"(_=@A/#L^;2,O9Q,=)_0YO>1*??,EVD67=ZC.:6TUM/7QIIFH%
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M;U14_P 4]_[(GM_9/9ZI_P"LB^_NJZXC!!<*+8<+8H?G1''H*JQWHZ@^E?\
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M!4V?N']<@HR2X@H85CN>K(L8ACJJ*]%1\A[_ '5Q%_R]D3^T"4%@7D1>H66
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M\DYT/H^2>U@Y,5-;EHXV-BM:>,0E["$Y?O5O^04<K7^[5145'?V=\O5B4P
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MMFQKZ-&,^6T2G/9O!(<X(Y;F';&^^**:52A='(Z=% -KPJ@?NJEDB<@'K"=
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MS@2S=4BR!'6_RCE[=OFT?9_LV'C9>=AYNS1[,-VGVJ.-]Q3:XLOS-U7!A99
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MZ ,#\#==HIC" ])!H @!R#NKU+KD"2T).19R4C8(2$@Z+KIX<A0QQGJQ2?\
MT#SS2_KG<OR$60QZL(QKQO*U"L(W%(965C''"&)%EY&+"QVM8CQ5^MF_4 #5
M4S/(B/)4$(DFCB9%(0,SIDLC%5:24*K!D7D(74H  5TJ8G7>0VZ/'J(V$Y#7
MBA39LHDJ?U?:%;)*&.X?ZT,!>+08\EK7?6I(D.2,<EH2N&<#A&*3&0'%5[5"
MTE+U"9VZ"*!8J810 -@U8Y)#$@:U\Z-BZL\05(HD)$?02(FY3S72FZFH"Y/B
M4$#X1QIQV[.^V_VU\>QY%F[&?03""ETN9WERM@-[7%&A3NTF*1EE&EPAK (.
M&C"RAABE<W[2-=8@F #%HNA)5XD#2^6U42!U+:$2?'\1(!L>VN6>@$_BLC_4
M 1WY[&A0%\>G-GG4IV&5[6(\61;='Y$9\P C'4?CWN9PG-$GZ\B/+1_D?+&,
MZ,:(ZHZ(]Q9#$8)7*BL)SD;(8$12Q#I+*MKTOQ;(5;JY4\A>10KCG@>@@@AN
MP[N W)KOT#T/S()YX[N?Q]IM)$SES"Z5N8G1MS&O-,.9?1<)#YW!6K/):V!#
MC4=3>WL(K85<"-#=;NDQY=J@OY"1#"=[G/QR%RH8X%E=7'PNKKWYME4VH-@@
MUW!L  =M"5)("TH X/8BB./0W7(/ ]R *E!L6+/?2ROUJU7U\%P:R>29-*P1
M@':(["'&;V5$<-OUBED(92*47NA5>UTDM'YR]4I#2$R1A5L@J:-,.#P"2@ L
M=SK ]B*_RW\B?4#GN*^?'R&L[(&B_DY8GMC28!R%+$/- (S8"O%'2">(Q!,&
M1\&P"20R*=WV.8=I&S8ZL5CL6D@$:D$HX"APC4SBP7$A!+ NM+U+P/4-8J>/
M8]B#\@>:Y%<>Q( [<Z6(=A/BFJ(=PZ+(F%;.8Z<"/^L)TV*]J!CB"1/DT[XG
MW2'D8HQ_ )V-&K%1R4R(G3*\0954H>ECU,58$DDCFNH51Y[<DGF:[\"R#V]:
M% 'T/<=^/EZAP6,QT03)(FN.0;A2%:R(6<]XV$'\_A& GV2%:U556#9[N;[I
M[-:OR6F-0SHIX!/<-T4W)%L30Y%"N_ KOK&JH7[50%-V] !7IR#Q7%"M=LO6
MEK<T>FFCTTT>FFCTTT>FFCTTT>FFOS2^(]1\\3Q/*ZCXU-U6#Y?E.A]/Z!?;
M+.YW/YFD+,BV!@Q,Q2H//PHLB)H),4LO5"I$/+D1XZS?LKR/MCVCFJ L'@WS
M[>]V6H ^I ()]\^* )L"OA)+7S9+!NY!(()NB!54*^_ KR_\KJOLNIZES7(4
M6SN>LY;'P>BW_28-]I<?60.;"G9N-<-LW6-=9#U8X=*U:N3:7]K)",L> >+*
M]W6L;Z?X7\%8F\;0F<^7N4.7E">.%,8Q^2*R)<?_ !E,+RC'<XU2E&+-($A6
M*1I*CX6Y[U_=3N%:$^6A>6,R^7,8E17DZ48]+CF.U)2,K;LP\OE@;OSZ\L[;
MNM;:;*PL>C=&Q>AZE#R%)*ST2XK#7&QT5?2WM L"LCU%P7)1LS7S1541TZUN
M0W4"LG%MC44M88-W=/ ^T;9]V?#S=T^]OYP(^\X\OE9"M$8O+GBQHS(YEZ[0
MB)XZBE>2&*:*5HVK=)<]I%N%&A7&+1HLB.LK1EI!UM*0Z+8"OT!0WF1,/,B<
M*QO+CR#\G(&I+Q*9-D5,911;K.8G,9 $6EK(\A@XL,^6IB DRTN_VCWE?8$#
M'E1VEAP;"D?%E!9)9P\_PW)/TY6=F[CEYN3+\;22+F93(:*F4MU974H!(#QF
MQRB!+8]8S*3(Q J-:9F7H#=R1VZ2EEJ8D*388\$!\>2W?/,Z9PWFVTWV[Z9C
MN8Z:EWW(Z7)"SD?+Q]-1/SUA'H9O0*N17BJ+JUU,4+6WH9+Y*@IP).H00RR(
MZET9?#^"C1B7)R&,BL$BB:-ID(C)3K#01A0'#QGJZ>DAE!#AET28-\*IU^77
MQ=-+TLW(4@LQZ25)7BZ%JH "V!ZOYD>?>;\&N9KLV%YKD(#L734U?2$8&VV^
M$95_Q3+K>3R3IUH$L^[%!<VO@QX54>&25 N(4<DBO1=9_#B)C_>C/(\ EBB+
M1VRL74L;"+(%*TKW(O2!9C:4J"V=H).A;)(9W[U\-5\B#[V>PLV-48\<_*/R
M(JN/]_PO/]#MLK@PUNJZ/?W>0@16DRFFFR1N@5==HY(REH*G11G*^;&C%BW3
MYD8LNMG1!$F')YN=?)EGB0GH5Y%M@.H@$J#?2M< D@=//Q$ DG5U_@-_Z0"#
MQ2FZ[7PQ)'IR>!9OV1?Z9CIFFZIX5]LT&HO+'1'@^4^BH:JUNHM4&^/15'&^
M*1JA+V34QPCM+8<-!,FVDHDN;,,UQ)$PZ^SO57TU@11K][)N^>222>_KKRV9
M2+YG\J\<O*_7YE]]A. W^YZ5<Y"_AVE(V;H]OG]X$MS/JP/C3K,6>;B:>;6V
M0Q,#+'IZ^-:1)T=C9]>R5=T#!790PINEB"RGJZE:N65@QM38-FQVK,/5*&8!
MC\2@L%)(KFSR:X/?X/A[6"XOQ+SO-[>==Z"3BTV=1<OWLP9NAZR\BT]F-C:@
M1TBQLZ)];%CR]>@C5T&;=P*$$'ZA&//BMDMC"#@HJC^?)+4>.FKXXJQ79@&'
MQ<ZAZ[$7578%$CFR.>KN>X[$@DCC5&^D5WDI9^>]AG+"LUW7^O83J.AE,S[9
M9;R'/ 6YEWA6"%<B)44N7G4DR&EL&1%AUHX:G/8-$0CU9?B9>7@3+/A961AS
MQWY<^+-)CSQKTE"J30LDJAD8*P5@'%A@1WDA&3X@I#<D,H922;LK1!LCC@_2
MK&K%>9NK\T:'JO(.![D,H]W09WFG4LGQ'EPX;*O-6"SY"6L.''IH,R6&4Y13
M9H+%Q$#55B"?.%;MKQ6:LC(GRII<C*GER,B=B\TTTC2S2LP/4TDLC%W+"P2Q
M)KBZ'$CGJ8DW^$$^B@4% '956D5!\*H B@( NF[Y?<P\L/''FW-=YU_6[,6@
M[E%MG:+%VVL_JW*Y>W2PGW5''BTENRYA1H\7+V,N# BL-(/2V 9QZ^_D, ]$
MI(L $GVL=S[&^6X][X]3K% OX5  !!%#]2>QL_.^_;N=3I=>3GY'?)7QSU?;
M=O<;^EXYS+/9:PD3&9R@RV,VM))S4O.;*LB4]E5EJ-I NFRR&BI9U6AC":8K
MT.OZ;82/GS[USZFSQ= D\GCGF[O6/2H8T!U'CN?>@2!5'BOG5]JN*_&C#>;/
MD5P'4$%==5R?"<+=[SJ ]M%UEKF*FSV$:CA7M52Y6HCRZ>),K,_.@3[TKJR,
M:'7+(1M3^E(B!@R)] .U6!VL \\=^+[ \#GCWR8JIOOVH5Z&AS?-V;]3[Z[K
M\!T=IJ/]+=Y'6L>M&*WE/Z!6-'5QU9-L+ ?7<952+1[:T$1Q;FRE(:<IHT<9
MUDE$I'2Y32S).<4LD,D<T,CQ31.DL4L3%9(Y$8.DD;K3*Z, R,I!# ,.1J.S
M>]'^GUO@?,]M<,MGTOR\\:>(\D[//KM/CJ';6VMQ>,?T)[[/56.!L,^9N7J[
MF/-(1,X&5 B3I-R#. H)MS%BTTPI*T7\6Z1WMT\3[ENL$N/-'MN(F9DKG;H^
MU[5@[9/O>XJI W'>YL&"&3<\T7(PFR2Y#RR.%#->M#!VC:MNDF?;\#%Q))P1
M-) C!G4RR3&->IF$<7G323>5$J1F9VD*ECU:V,EH_,73>$,_8';LL7X\<EIZ
M*QHG0+D>>F:NGO)HX.T@0+/Z77(JN7=2C+DI@(!!5U4Y:J830NKUL%\X0.2?
MGR0&-$<_B#4/D*YY[U70;I+"P&;M=<@V30-V+))>S\5D$FR--+\;'<O+0*[G
MD_CM9Z>NN-36ZN^Z/?4U)76@:V-G\K#?S-Z6EF&7/I;"1K95[5W$XA#2Y%/;
M5H:E )63GI/<5[CT-'Y#J6C7?L>+:A3'63&J].?2@3=ANJN_PT.?0ZCC%>4O
ME3T;R.A="PU;M=;T/,8JVRD!^7Q)=7LAV-]E8]!,KM3,@Q9FHT.3_K:(XM(S
M76EU89FL="@1+0<@+7$ T;'IQ0Z>*/''I7<$45KBCJ*I>2.>>_:P!\-]C7P\
M#U[UH[=H^W5][;<*[M/[+KK_ %T7,:2OQ.DDDVE\V^M>?ZTD9@OF>;>U!9V^
MKN9,C5.>-&A-R[K\+X2G2$BPHKCOT@4"20#SVN^GTHUQQ7;0 &B*^'CU% 'B
MZ[T+J_E[:T/,69VO$WM77=*N^GP==T3F> 1M/=Z;;A^&7D9J]S6PH[*JF6P!
M$8NAK%%$KQQK.I.(EDTI9A#/]Q-=^.!V)KU]!7;W[T:OFM% /'^4$T+;BZ''
M-#B@/7@5VXN/GO*[\B',/$FMW-:[=\JY?QH_,*(EU?8"'5Z/<A>>MH-17V$J
M\!).>L2VG5X*VP+'II%A#D.$KYLG]LL.>:JKYZN1W8^O/-\"K_#Q7;44"QY_
M%=\DUQP1S0-<$C_W6?B.F]_Y4?4/_97//_N2V_\ U[U.E)[G^?EKU%L-9!?(
M'" !XQ&2*"0(@U*245ZN,C1/1?DYOR1OS8KE17?W5?;^_4^$TS%KHEA3!0 "
M%I@#5@6:OY"^_'X)OY71OB@;)H<<\\?ISQ@FR05\F=6V 3.,?Z9/LK1+'80\
M<?W-:17*J?$JJYCD7XJ5GLC7?W<N2 L%=&I1U#DD=B1\0%=SR>>U"ZXTJZ-T
M*(YOD#M7('IR..>?;66PM"UC_P!2$=D40HOUR@D]E<@V"0"R&?6UZL*XBL1S
MU]A_%7*UGQ54]0L:M?4"2SDJ>:ZBQ(!JNH#W^7J= H(]CS0Y[?N>/E?MW[,V
MFD1B6)9,>0K$CM7V(]4<DAWP^M@E<1'?%JI\GJCF(QSFM:__ !1OML3*P3E2
M22#QQQ=V!7N!Z=B;%$ZF[!XL-V[BC?<\<U[ \ ?(ZD:K8<'T+$C.9]2(K?@)
MQF!(WY.<Q7HI47W^:.1CT7XM5&(B?(?K4DH_B8D^QXKOR.00 !W 'T .L6L@
M77!)J^>:-UQ?/J/RX%Z==[#><([ ('L)!8%[2A8QAG*96>[1L1BO")".<]J/
M(Y1?)RJJ^Z+ZUXG4?"6!ZKM2"5%6>20">/G1KGCM"^PH#UX('!JZ%<V*L=R*
M]=-^MDM%-(.6.;*B+'>:7&<3[F&:K7/<(Z$9[&#[N1'-1HAJU55_]D5/5LB%
MU6@@8D%6_"1RI!4J31!Y_P W:NQO6:LR$.A"D-08<$7W]ZL<7=CTK2M- .Q$
M*:-\;XDB$C38BR6QI<,2N:,9QN(I!J)4'[._:"1Q _6I!O\ F_WUK\A9 ;"@
M$H2+C;W L!EXL@!@ P:B 0HV<9))9X1&LC2EXRAC1GDL$DD*/B8H.;!ZB/B8
M]0ZC&64Y.WFC[S39O0/MM!=W"RA)MK.9+A0<X5];'DT%4@@R$KJT:5WVQ4A0
M_8DI@S2'(AC%;R$AN2=EZY6F=YE#.3T)2J5C^&J0 -1OX@&^>OK>]>,9=ZAV
MS:=SPSM^U[?APXTK;5%'%++NZ).T&=)YKH!--Y@$R,Z*BO,8TZ[)VWGI[N[A
MXJID#QV1H;*./6TEY7UGZ%Z*YBE3,0:>?+4\)6CL:HAG CM?9&7Z5<[XR(Q'
MS-*RRQ*SA5A"=-%2)0QX56[]0Z2&  8CT(Y..VXF3B;1NN^RXN1O>^[O%E'
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M ;R?C#0?)"$*]'?4C/='%(J+_92/5/DO%9'B=XY%9'C9D=7!#*Z$JRL#R"K
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MKI&?K)LL2%^FZM:Z+*;%L9D8TE& LJRBZNN.J^P-$$W[7?IK%)(S*8Q(ADC
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MSUFRI5A(:R" _P"P_P" 6$>%WSDL.-HA'^\CWN>]&;77&6D92+KHH'GH'^9
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MS1LCR&,$$%.I9(^E2]CJ9N% 49>;S^D?: T-%0Z:NM(Z04%JJ6JOJYAD*R'
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M+B8DWE=<S0L8YI7=G5Y6,*@G'C5EB3XRI:,EF5NH1LP8\-Y-:^/'=&.#YM*
MC8$PJ$^PTIX$^U8X2N0(*T"0F"))BQY+'3!-/\RC/(:R\04Y,:_C9@03?(
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MHT<8#&E98UI[DA2-00:=SDVS:TC.3)+]X9V^[]/QS2M)9;RUC!8J4Z"0.H@
MV&;I&D+Q2Y;HZ>ST'9K?1W14K[Z7CYT_.3(5B>QN*FQI]!-E3+AD\5C&CE6
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M5E^B30P-171)$PU3:CBJR%+IGD%76X120UT+)( OBAR*KMR+KT^8J^=0S6;
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M=8*P7[IWS7')/O9]._/[_EQH'/437?C\NU_7@$CBQ=<ZY*_\2=G_ /2N9?\
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MWI,%T4LFLE+'E,%FN;SY;R1A1C$F#:YB:#8J2=#-!'99))' !>1H^KR>J_1
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M8TI8^DCJ-,2>X+&^#P94TR3.CRPQ,RPL_P#A]<&*$C 3JYJ).CCI^ "RI"R
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M811(I01R I- "R31-#BN=+"R*'% -9JAZ'DH%8]2<$!QQU]0KX>7_)T=.T+
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MWR&LI%<RYDE*.N !#.^QI!O*R4QG^2/:QKT+]OV-:B,<YK'O:B?;\%_QP[1
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MAR75V!M'(*FT;X%# 'Z;OOA#-R=LP_%VT86.VQ9V!$\OW?<8<H8NXH"F;C/
M_DYF,R2=$JQ-#+&//58LB;J"J\\9Y)<[T&DWL_=]1SN<IK*[A46*SVPIM5R^
M9'950(L:WAR3]'A9^MTV@DW[Y@%3,.F0A5\2 X;GD/)5<L8%Y9Y!+%+&)/+B
M$=$1]( D$C=1)D#EPP-=*A5Y-G7*\3(NV;7X>VF'8]RVK<8\%L_=)]SB,<^>
M^;*7QY,52B.NWI"MP&@6:616+%+U:GD]/DLAM^<5>7CPPUEKM:2T$:CAQ8M0
M8]CIXTV1(^$-S@$)-/)>0TD2+^R4W[#_ '5Q">M^- 4=TC1%#,>E:%LY+._
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MH[VRA$']I&-*SXF8BN1A$?\ )/7+7JBEDG211T.%!6@2H8*&"#@W?8V":OD
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MY!7)9'$\9:25))UQ_-B"F2)9=YC&X=F*]3HTC=192)BM%5'6Y()MK9B;)!
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MBJU2O(Y_M[*GL^1^7I\_S_Y'?YZ@\$_(G^7Q^NOSA/\ A=8?^\,'_P#K._\
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MZ\CD<:<;[@0:J6(<,9'A.PK1RF>_P<]XVN:JE5$:\958YK51RH@R_P!U>O\
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M7![HW7N:KH^C3K0^MS#&[[1R0MZ)S[H6#H)\DVEEJ1DNTV>9IZ9$A,F%;*C
MM1/&5CD4OL9Y'>NBR55(H[9#Y2$NT;1B-?+3CJ90*M>& ((Z31X.NG#\4V/-
M(Q"+%TJ_QET$2.J.K(JUUNA5>L$"V5R$4D2MS3J/)-SHP#JMKB]G/)716&@4
M6AH+\%=80I(E:T#*^SD1XT=7K).%CVN*P8T5B*KQ^^O-UF+IA>.4CK^)"I#
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MHI\FW!(DMI[ DZ,:ND4+=+9C%:-DI^V:)._21Z,%%&][5[_(]OE[<$?(^F@
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M02$5KV,&QGLSZF(]'/\ =49_DJTK&O23Y:C_ "]^:;@ CM8([D=QWO6) *\
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M9(V)\T1Y6>[7M14P/26CZF ')9@AZ@U,H]?B'4"%) NOSU9;$@$TW/#< 'D
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MI%(W/8/)W=:4JC@Z,Y!C*M+R_B5Q3*PX2K8]1)-D=0NATL%6CR& H:S*@#J
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M9"HY&&^A&A8(C/@UR&;]B*Y$20W50L%?BKD62W:Z(- FV%7VXX(.%'O1L@<
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M"_X2,\:A^FV*QDJI5).A2O2&(R5^I,?-G:PSA./*1 QW?L#F04$82'81B/\
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MMSK'LD?-?='C>Q/;_%45'.1:GR9'LWTL7#%E)!-=@>:(H $$$$ <:?=E[!F
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M$:B0,R55 6EHENKXBQ)/^8EC8JA55P#[ZP&,@/XF[V!Q0[UZ7P3??Z]]:/\
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M>!QD:1*QNLPNHH1?>A)9[COUGFB0#W [50UB)QUN[PQ2=;%F1P_2;L]/#A@
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M1<RK-I2V<S'BI':W3Q]/B8F1S1K4/=3SHMG96^HK)19.89X];Y-*"J@61JY
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M]'V'70X1;^\R7]36FCUU'MY-'8FIP\DK^31\Q6-<U%_G[W_U7_/?GDZ;</\
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MM HX5E>]CNJO:YZTQY,.)W8>D7V=K:63Y9=;U>X!M\]<7>@A=!F!\7-3AL7
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4Z::/331Z::/331Z::/331Z::_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>g149615g84a10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g149615g84a10.jpg
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M)28T4W6BL;4V0T14<W:3M,)&8F6"AI*SP<7_Q  ; 0$  @,! 0
M     0(#! 4&!__$ $L1  $# @0""0(#!08$! 0'  $  A$#(002,4%18043
M(G&!D:&Q\#+!0E+1%"-BX?$&,W)S@I(T0Z*R%20ULQ9$8\)%='6#A+3$_]H
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M;]M:WOOC7R_;C-VCCZ]* 3UC!;*^28Y.U'*9')9&U7-M]0X'['7W X*;CS[
MA]/&N_P[C?[?86WKG?6_[DU/]!3Y_P!-:WKO?^IK.Q0QM&O !R/_ "/L?])T
M=Z'D%L-J-=86/ _;C[^JS>;:R)A$PB8116<3J%5E$)%8%C2V-P2"Q$6Y-RF8
MR\T.CL9CH=GQ];HF:-EG#0<-8H<_+[CEVX22YWOGGZOJZYUL@!-@)/ +)1Z0
M@)< !RN*&Q,FB\G#C9#&Y& (LS (^!,LD2(<V%+#UG# H)*CW+=\.(LEUVCU
MFNBY;+*(J\=]$51^B_0]?^8:S<6?8B<C(L%9+#X-&(K"PJDEG4^L&PY(-A\#
M@,'CJ2S79B4RN2EF L:V6=L6*'W5B!4@.%,WS]L4@3;O/@!)\@%Y\V7\9_S+
M4 MRPM*)6/45O#+K@E)R*B+I*TU6$XB[N?Q)S/@]A&I.5MAY4?=6:AK!Z24F
M82QS+'@IRSC3GAH;?H-<*<A,Q< 3(DR+<IWW WX%6[57Q0/.%A^)9U\0&0$%
M*Y\ZP=_+>7)LP?B$G,.PT<--(^+<J"X,?D6ADGEI<@/%@Z\(.4IGV6)"AO8O
M;@L-_%$+3FRZFP\5)JN^)3Y&M>]Y'Y^ W%7368)(UB[JY5]8D'^S?H^T*X0L
MT<1IUB@>5*2UH(".$VQ15FS[Y_&[^AIM?C>NL*,KHF#&]C;OX+9>J?0=$WJK
M*D*6N.LK87@Q!N+F*5=S>.3!2,OGG3WAD@:X D7VQ^GZ@PFFP6<:X0?*#"2;
M15;M@[Y1(01J")TD0M8K?^)CX]I[J"/"=UUD?C,DO[_@\3>9@K)@JD6IB6_P
MXMZP]OK/+N3R+4$/^=-26)\([4[?K2I3@6@V5<,2234I#29@:">\2-..L]RO
MMOZR\ONY)6D.:>AZ5=RNY8^&E=31UK9D/<&+(C4D0>N8V>A3!$OVXD8F2(C2
M:D=?"^'+<]H83T)4>=#WFD"B#P-I!L;$:CPW6GWE+XK%&>OK=KJF*T %VLMF
M?F**^GI&T.2VN$"-? IN0?M8W#"\8;RQ>6&I9L<R:2(_J.A'XJ,Q^60(F4?<
M-Y>PZ3*2TB9_,6]Y&O\ +C?@MI"OMGQX$4L=(OZBH(>M3\@&1.T4'-L0E-Q
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MF@J8:;VTLJO;U:"2(K\UC?Y,J5*(."%TS8C7?8Z@B/*(CF;K;'Q'\/9CXR,
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M,R8EV[&/"@1>=Q'J#]EK6 ^%5'(DRDD2 6EV0KTS ]QL(PG 2QY1,(3*TO(
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MS-G#"89H?,RQR5<+:Y*2Z8MI'C  ^WJOV6_#LD<P1M>-O[Y'MJ\FL*]Y16%
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MXD-,D.[8:+EPO%[%5AE])@[F <I-COV@!J1M>05ZC9J+&H.(!N&3K3'I![^
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MYT5$"B4I'.^*RKJI%1<:/N&/1B/QU[$*NBO#\&P?<,7I/@B173[5?J\\E,F
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M5=CRPR-#J.(_7@5:K5RB\03<(=Z[24Y^?._ZZW_+?/6O^KWSOY\]<_TWK?\
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M,AH;KJ**T](J7"C?R@!'QPGET)!2DX?7)\M=."DE).=]\-8V@(C8J3B#H&M
MD.B2>UG#W&29[1 $: <R21>=  !,Q<P9DF><1W>)6W;<3Q%HB%&,>G+Y*&,H
MVHTTISSV\(I0U4<\10[TCQSSMR03%<H=;23USI5??7">M:USC#5,F)IU#8&I
M?D'RTGN <2H:Z'AQXR8]5LPBLDX12<(*<+(+I\+(K)=:[3525YUVFHGWSO?/
M?'?'6NN.N=[UUSO6];WK>>H6\JC[*S"=F33**&DHE&8Z2<!'1[@<S*F#)ICU
MI,DV8H$>%6+1@Q6WVT464;]N%5T]+MU=H];3YM8 3<G;8#;3??NX:JLDD@&
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M4'6P>. 3?+P3'%7Q67F79@D':-"17O;+EX[4X8->4\C:M1K0QKLH#B^UB7$
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M&K..)\!B8@3& TPY4U(1D=%CPK(B@-9-FR9)/'EX<%^-Z?J5HV$LVM75TV:
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MEMX6@S;72\$3>UPL]%Z1]ODK3!R>S'-Q14;S"*X<AFM)V@,/1Z$,Q_F<;#K
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M:"X@#4GX?!7&FGRDGPEQKZ>$^.4^.?[N>.=<\Z_V:UK6>K #0&@0&@ #@ (
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MEO\ L 8?5JV7F7./,K-YK*JG,2'[UI4BIS_I:V@W^>OZ?/7WE-?Y[UI/G?\
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M,PS>+DB;;D6U!F1).T1,1[A0:WKU]ABAELUA)[86&V)"ZVI.?/I?0T$%DXU
MDHQ)/-+*\^+ 0*#597$9'("\RM62PMBBXE4&FE'!7CI@1%&X)-$S! !KM>Q,
M$SFB.5@"=B5DIGZ]]BCG?JI[#R5<OMU)4_HDU7<(-@"#F9RH97]!.)K2%R1J
M(AXRV?RY&RY^@+>%=)2Q"!O8Y)E82 9BI[$7O)H@ D3,$BXVO<7Y:7X3RO\
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M[BA_DT^?X&[K'A_[BA_DT^?X&[KT[@'_ ,A(5_\ =*.?_!V6?;NB?_2NC/\
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MT)]2,\,FB+07%6 1BL&_@# HA%V(86.'#8<V79/&Q,M]HTGD&(<"(:T!I;E
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M8;%.O2;6=0=TGA7X1CJ;F-J#&-@84M:]KF%M45'TL34J,<SJZ=!E0M8N+TH
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>81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A%__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>g149615g85a75.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g149615g85a75.jpg
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M 0$! 0$! 0$! 0$!_\  $0@ _P)= P$1  (1 0,1 ?_$ !X  0 !! ,! 0
M           '! 4&" ,)"@(!_\0 71   00" @ # P<%!1,)!0D !0(#! 8!
M!P ($1(3%!4A"1935)34U1<9,9.6(D%65Y48(R0R,S4W1%%Q='5WA)>SM;;#
M)318=K&TM]'6-CA#H?!"1U)B<X&'D<;_Q  = 0$  04! 0$
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M1"G%-Q4_1@X<%8<,CG2%IF7R\@F&!'D9:6-7)E^W8=93%=?V^NI )[O[=_\
M4:M@;Y2#K'9=O=2-*U<U9[+:^Z.K,;DU#.#5[$BMP*+,H%PV17YU\*N3V'*M
M-MM>UY?&ZV-]CGRYA2G6&#*;A9'N.Y?TTP<$^K@U9:)\IUUEV3I7LGOBG-;5
M.T_JY<RU-OPH1K,\=NIY,2"'* ;G0JG7O>Y*PZYO HY#,U6\R4B@& #!:QV2
M57*^#,DX*FT\#'?W<C^V?F//=ZQ5);OE0.M]-G:E8GBML$!6S]:: V\;M(2D
MQB-8TIK[M#<(^OM'']U$<'FG:XW=[L[)KT>+7(MOF#'!9,L98'UZ.@PZJ=I^
M;O(^DJ,G'\W?C.<#FMAM&=IM;=A+KONA489L 6<ZYWP/KV^)OM&,T3$PP=JP
MZX"B59@6-N$=)UL@#*0Y@L]+#C(1N&_'+@5% $\:6FJ@C&.[D9]?]OZ/'%;)
M<5%.*4XI3BE:-VO=^Y2%AV)/H#^O1%7UI83-:8K]K!&")2YSZQ%8=/OE+'#L
MHEBF09<Q<B !6P".N1HC3%D(>\8TYL)']0T_I;IY++24U4:M/?:S:6]XUU8W
M-O%!IT5Z[K:I#:265P^HR1QA);H-<VH>1FLXNQ>(W+^0:GUAU1+?:Y-HS:+;
M:?H%[=6"V6HV=U/<:I-I\:->/<7T5_;)I<,DA>*S*6EVR1JE]/V\<PM$NFX.
MP]R:K>@X6HX@(':^PP]^PC3]_%SS8BCU093X5N,2'JV+,5V19+8XDN($B F3
MPB&VIXJ>FR)4,"\))>,]9W-YTU?2:1;FWDODU*_T]KJ17EM4&G.\<\R(DD33
M-(RJ($,B JS2L6$91_JOR,]-].=;Z)K'6W4JZPW3FAZ)T_J8T32+JVT_5]4O
MNIYDCTNRFU&ZL=2ATJPMHUNI]3O1IUY,7AMM.MXH9M02\M:K1.];V5D;HI.W
M$UP[:M+ JI<U6RAA9]?%VZFW6!;WPZ'ZL2.65X%<!LZA6.$6@,6 A G1'0!N
M&@8V8R)@Z.PZFE73]<N=3B65]!LFU&9[*-E\ZM1;W5P%C@>20I=#S.9#&)61
M\Q.I3M"B]!Y0/)]H%FG0^M]&MJ5AI/7.H:MH:Z1U!?6^HW>CZWHEQHL=XR:M
M:V&F)?Z+=0=0:9/9W,FFVUQ;S)J%A,;IK(7EPK.[MD9*T\K9D5&56KH;KP98
M((-(L$Z[FVRXP\(_#/O&9C%AQ!FSH:#67 PU$J)F42@^P(BXA2/%>F_+#U9>
M:YH9UBVT-]&Z@U+3M.%AIUM=I?:6VL3Q6NGRQ:C+?3QZD()[B!;_ '6%JLL)
MFN[?S581;R7-6Z Z7%EK5KI+:U%JNA6&IWZZA?W5J]IJ8T:&6YOXY].CL89-
M-,]O;SFQ"7UTT4PAM;CSEIC<1Q#V?[9[1U_M23K36$2GC&ZR$!&; :N ,K87
M2Y ^F7*ABAD ?8*XB$'BP(S2IY-4F7+G39+L*$D=D6\_,]BU_J/4+/46L-.%
MK%YO%#+/+=0R7!E><,R1QQQSV^R)$4;Y"S,[L401]D6?R>PT^&XA[:5G])F5
M50A<!>"Q)#9).<#& !DYS@3' [*F[!UPHFV@U<%P;E?SL*C0191^9(K FV9M
M12HERDI]A40A/KD24"+%!,=IZ%-.,Y%C,38#Y'VZ/=O>J9X>FK35X+6'SZ_N
MH=.ABF9VM(;Q[J2TDFE92DLEK&T$TL2(T<EP.RA$D32]JG+]274VC1[+58I;
MF>\M;&U:XWB!)+L@K+<",J[)%&6=HD=&FD585DC,@D6^:BVEL&;L-[6FQ)=9
ML,@C32UWKMEK &=6%,QJ\;KH,Z&.AI9ZR-9<4_; \L&3B$(V)4=LI#E0?7'I
MFS+'3?4&JW6J2:/JS6=S(^GS:E:W=E;2V>$MKFUMKBWN;>2YNUSNO;=[:9)4
MWJLZ/%NB[1]3IFHZD-2_!>I26ETTUC-?VUU:V\EH56UGMK>X@N('N+I<EKR!
M[>5)5WJ)D>/=$)'ZUK)\IMN<5<K#=H=:H.=+UFR'8;M%?"G5[ )TZM&Y@HD5
M^=R;(V/@W6;&@2"4 %BIR!<1]3%:E+F2LN'D_2D'0FF26T-J\]Y^%)X(6%VL
ML(LX[J>)9$C\V,!=[16=4>;SE9&4&=0BXAKTZ/0H&ME)ED\X>-7#@KV09E!"
M[2N2@S@MOR?E# .VIZ^4,[K;7Z^6S6FI=)P*= MMWJ]COIZ[7X$4LPP+6@)8
M."AB*[6AI^K^]#Y<F4>=GD2!C$"NC8+*%B2<L_#>&>,7=Q+')'##L5F1I&D=
M2P55(4!4#+N9F/)+ *!W,6&/&NL>IM0T>XLM/TQ+9;FZ@GNYKJ[B>>.*"&2.
M)8X8$EA[2:220EG>0)"B#*.TRE)TZ"]H;5VHTY8K'?@8,-?]<;),:KN4BJ,D
M(M1L10=6:A=(%CK4 K.+$14(A7+R#:(!I9DRZ(/Q3 ])6='88D+NVD[SQOV@
M4212&)R@(1B%1PR@EB 5=006.&##)Q6TZ2UV?7]-FGNXHHKNRO9;"Y-N'6WF
MDCAM[E9X%D>1XT>&ZB#QM)*8YEE3M&"@G>#F574TXI3BE.*4XI3BE.*4XI3B
ME.*4XI3BE.*4XI7E1[Y;7VD [<;K#@ME7\*)@V 4W"%B;C8AHZ&VNK 75HBP
MH9%F-'0IUQQU26FD)4XM:\XRI2LY^Y_)=H.AW70/3=Q=:-I5S<2VDYDGN-.L
MYII"+ZZ4%Y9(6=R% 4%F)  '<!7YU^6'J3J*R\I75=K9Z_K5I;0WMLL5O;:I
M?001*=.LV*QPQ3I&@+,S$*H!8D]Y-:E,;HW?)>:CQML;5D2'EI:988O=N=>=
M<7GRH;::;*J6XM6<XPE"$Y4K.?#&,YYWC=.=-(K.^@Z$B*"S,VEZ>JJHY)9C
M   !R23@5YLG5?5TCK''U)U'([D*B)K&IL[,>Y55;DEB?  $FN5>X=[-1TRW
M=I;:;BK]'R25W>XHCJ]I]I]G\KRB>&U>O[%,]'P5GU?9)/D\WH.^2!T]TNSF
M-=#T R#=E!IFG%QLV;\J(-PV=I'NX]'M$SC>N:FZHZQ5!*W474JQG;B1M7U0
M(=_:;,.;C:=_92[<'TNSDQG8V/B3N7>4-Y<:9M;:\20WA&7&)-YM[#R,.(2X
MWE;3I1"TX6VM#B/,G'F0I*\>*58SF4Z=Z9D4/'H6A2(<X=-,T]E."0<,L!!P
M00<'@@@\BHDZJZOB<QR]1]21NN-R2:QJ:.,@,,JUP",J01D<@@C@BN#\M^Z?
MXWMH?M_:_P 6Y5^IGIS^#^B?95A]WJC]5W5?\)^H?MK4OO-2CN7<&Y6=U;6%
MB]H[-:::VC>8 X= NUJ0VVVBV%(\2%"B1R>$H0A.&V(T9AO"4IPAII&,82GF
MDZ=Z?Z=;IS0IY]$T5F;1-,EFFETVQ))-A \DDLCPY))RSNQR3EF/>:Z'JGJC
MJE.J^H[>WZBZ@55ZAU>&""'5]1555=2N$BBBB2X   "HD:*   JCN%1Z1VUO
MP0^F,6V9M\7(6TE]$<C<[G"?6RI:T)>2U))-.*:4MMQ"7,)RC*VUIQGQ2K&-
MM#H/2MPI>WT7I^= Q4O#IVG2J& !*EDA8!@""1G(!!QR*TD_4W6=LXCN>H.I
M[>0J'"3ZKJL3E"2 P62X5BI*L P&"01G(-4'Y;]T_P ;VT/V_M?XMR[^IGIS
M^#^B?95A]WJS^J[JO^$_4/VUJ7WFGY;]T_QO;0_;^U_BW'ZF>G/X/Z)]E6'W
M>GZKNJ_X3]0_;6I?>:DVA[EV_(JNZW7]K;)?=@ZR%2H3KUYL[CD.2O<NI82Y
M$5:RBE1WU0YDN(IYK*'%1I4AC*LM/NH5I=5Z=Z?2^Z:5-"T95EUN>.55TRR4
M2(.G-?E"2 0 .@DCCD"MD!XT?&Y5(W^C=5=3OIW5;/U'KSM#H%M)$S:QJ#-%
M(>J>FHB\9-P2CF*62(LN&,<CH3M=@8R_+?NG^-[:'[?VO\6YNOU,].?P?T3[
M*L/N]:#]5W5?\)^H?MK4OO-7$=MC?QAQQD1LO<)1YI'JNM#KE=)SC;?FPCU'
M&XQ)U2$>96$^=6,)\V<8\?'.,<LS:#TI;J&N-&Z>@5CM5IM.TV)6;!.T%X5!
M. 3@'. 35^#J7K2Z9DMM?ZHN&4;F6#5=6E95R!N81SL0,D#)&,D"J!>[-V-K
M6VYMO:3;C:E(<;7?;:A:%HSE*D+2HMA25)5C.%)SC&<9QG&<8SCET=-]-D C
M0-#((!!&E6!!!Y!!$&"".01WU9/5O5BDJW4W408$@@ZSJ0((.""#<Y!!X(/(
M-7)>T^P:!B#2]C[D0'<]/TRR[?=DC%^M(F1&?)/R1Q%5ZLH<0C-^5W/GD09C
M*?%R*^E%D:'TF9S;#1^G3<C.;<:?IIG&U(Y&S%V/:#;'+$YRO"2QL?1=2;YZ
MBZV%N+LZ[U2+5MNVY.J:L+<[GEC7$QG[,[I()HUPW+PRH,M&X%K_ "W[I_C>
MVA^W]K_%N7_U,].?P?T3[*L/N]8_ZKNJ_P"$_4/VUJ7WFN>-N[=&9,?&=O;0
MSC+[6,XS?[7G&<9<3XXSCWM\<9Y2_373FUO_ .G]$^2?_P"U6'J/^@JY%U;U
M698P>INH2#(@(.M:E@C<.#_?-2!N+<VX(6W-IPX>UME1(D38]WC18L:]6AB-
M&C,68HTQ'CL-%$-,L,M(2VTTVE+;;:4H0G"<8QC4]/=.]/R:!H<DFA:-)))H
M^F.\CZ79.[N]E S.[- 69F8DLQ))))))-;CJ?JKJB+J7J&*+J37HHHM<U:..
M./6-02..-+^X5$1%N J(B@*JJ JJ   !6 Q-Q[T(26(4#:FV9TR2YAJ-$B7B
MX29,AU7]*VPPR46ZZXK]Y#:%*S^]CFUDZ>Z8A1I9=#T&*- 6>233-/1$4=[,
M[0!5 \22!6GBZIZPGD2*'J/J6:60[4BBU?5))'8]RHB7!9B?4 37"YNO=C2U
MMN[;VFVXVI2'&W+[;4+0M"LI6A:%%<*2I*L92I*L8RE6,XSC&<9Y4.F^FV 9
M= T,J0""-*L""",@@B#!!'((X(JANK.K58JW4W42LI*LK:SJ896!P00;G((/
M!!Y!X-?'Y;]T_P ;VT/V_M?XMR?U,].?P?T3[*L/N]1^J[JO^$_4/VUJ7WFG
MY;]T_P ;VT/V_M?XMQ^IGIS^#^B?95A]WI^J[JO^$_4/VUJ7WFI.TKN7;\[;
M^L8<W:VR9<25>ZM'E195YL\B-)8>,PT.L/L.E%M/,NH4I#C;B5(6C.4J3G&<
MXYI>I.G>GXNG]:DBT+1HY$TR]9)$TRR1T9;>0JRLL 96!Y!!!!Y!K?\ 2O57
M4\W4V@12]1Z]+%)K&G))')K&H/'(C7409'1K@JRL"0RL"""01BH^'[=WR6DI
MAB]G[=)2U(<<3%'W6Y3)*FVD9<=6EB.3<=RAIM*EN*PG*4(QE2LX3C.>;:7I
M_I:!#)/HF@0Q@@%Y=-TZ- 6.%!9X0N6)  SDDX'-:6'J?K*YD$5OU#U-/*0S
M".'5M5ED*J"6(1+AF(4 ECC  )/%<R=J=@EJ@H1L?<:EE(4DD,0FX792B(Z$
M]/CS)\%.".<RX420**,294?#C##PV>TZXA<.0EN@Z'TF!*QT?IT""1(9B=/T
MT"&:18GCBE)AQ')(D\#(CX9EFB901(A-8ZCZV)A4:[U26N(I)[<#5-6)G@B:
M9)9H0)\RQ1O;7"22)N1&@F5F!B<+;/RW[I_C>VA^W]K_ !;E_P#4STY_!_1/
MLJP^[UC_ *KNJ_X3]0_;6I?>:J7MQ[TCL19+^U-LL1IR'7(,AZ\7!IB8VP\N
M,^Y%=642W(0S(:<CNK94M+;S:VEYPXA2<4+T[TP[2(NAZ"SQ%5E1=,T\M&S*
M'42*("4+(RNH8 E2&&00:K;JGK!$CD?J/J5(Y@S0NVKZHJ2JCF-VC8W 5PKJ
MR,5)"N"IP015-^6_=/\ &]M#]O[7^+<K_4STY_!_1/LJP^[U1^J[JO\ A/U#
M]M:E]YI^6_=/\;VT/V_M?XMQ^IGIS^#^B?95A]WI^J[JO^$_4/VUJ7WFGY;]
MT_QO;0_;^U_BW'ZF>G/X/Z)]E6'W>GZKNJ_X3]0_;6I?>:?EOW3_ !O;0_;^
MU_BW'ZF>G/X/Z)]E6'W>GZKNJ_X3]0_;6I?>:?EOW3_&]M#]O[7^+<?J9Z<_
M@_HGV58?=Z?JNZK_ (3]0_;6I?>:?EOW3_&]M#]O[7^+<?J9Z<_@_HGV58?=
MZ?JNZK_A/U#]M:E]YI^6_=/\;VT/V_M?XMQ^IGIS^#^B?95A]WI^J[JO^$_4
M/VUJ7WFGY;]T_P ;VT/V_M?XMQ^IGIS^#^B?95A]WI^J[JO^$_4/VUJ7WFGY
M;]T_QO;0_;^U_BW'ZF>G/X/Z)]E6'W>GZKNJ_P"$_4/VUJ7WFGY;]T_QO;0_
M;^U_BW'ZF>G/X/Z)]E6'W>GZKNJ_X3]0_;6I?>:?EOW3_&]M#]O[7^+<?J9Z
M<_@_HGV58?=Z?JNZK_A/U#]M:E]YI^6_=/\ &]M#]O[7^+<?J9Z<_@_HGV58
M?=Z?JNZK_A/U#]M:E]YKLB^3YV5L:P_E<]_W^['/8_F#[)[XM1TG[+[1\]/7
M]G]MGO\ H>OZ#/K>EY?5]%KS^;TT>'COE9T?2+/\ >::5IMKVGX5[3S:QM8.
MTV?@W9O[*)=VW<VW=G;N;&,G/N/D8U_7;W]4GGFMZO=]E^!^S\ZU*\N.SW_A
M3?L[69]F_8F[;C=M7.=HQICW4UQ8=8]H-RAK!&D-8-WJQW4%+>0OTRM<N1>;
M8!$^.^K'DE82U-7 F.M94ELI!GQ%Y2]&=0CT;R<:Q::UT3T[<6CHWFVF6>FW
M4:D9@O-.MXK2>)U'*9:,2QJV"8)8G&5=2?,/*MH5[H'E!ZIM;V.1?.]7OM6L
MY7!Q<V.J74U[;3(YXD 64PRLI(6XAFC;#HP'#V%NM NE<T<S5+K8;:=H6MG*
M+:'3U9DAER9F+M<KG@NS/DFRKLW#V;A[L6RXG#J5C%RU/J1*;9:GI+3=5TV\
MZF:_TVTL+75-9&IV(M;U+D)'^#=.T[S=HDMH!'M_!_;AAZ.)A&%!0LU'6VK:
M+JMATBFFZM>ZE>:/H3:1J#7FGR6I>4ZKJFJ^<K-)=W+2[OPGYN58;LP&4N1(
M$7NI^1^UQ8:MHZ[WDU&D0H&R+A&=K3$A"V\S U7@.#G#3"58Q_0TTK-(P&E_
M#+N1"W<8RRIE:_G'^Z"UBTONIM-TNV=)9='T]UO'0@]G<WTJS"V8C]O%!'#*
MP[E\X"_*# ?5?]S'H=[I_2.K:O=1O%#KNJ1M8(X*]K:Z?"T!ND!_<Y;F6>%3
M^V\V+#*E2>W'G@=?2M=;';KY/-/:G9YG8^=N*HN2^AZ5I+(?%$Q9L1\4_M/J
MSLOBRX(9N(#U<D,ZT^9>0_L3>(F#7SB]Z2<CO<<X>?YOYCFJ@<>'CGO^8CU?
M/6K=:^1>5KDX=M^J^SI:J72/N??NP]2GRFKTV'&G-<[+Z\=AM,:?TI6XK6Q@
MCTNM=>K;V2OFS:X3<G0U6'UU5-0JO-OI/QGJ^;^HC^FI+9QQX8QG@G()/S9Q
M@X^GYJS*B?)(S=!UO<E4ZT]F3M6![JZC4#JQ8!>[J*3WF-%KUP_-K]9O@6.+
MVCJ67#2(U-:+[0@U0:(M01Y0S7+0^5)0*O)J5B5&[G)'<2>..3]?B!QW=^._
M-6!7R26PR8W7==LG:2J3:RO2_4S0?8J  Z\DJ_*VU0>D^Z3&VM(OZ^F$M\VI
M6H+03'$VZ+M$H43M(;9X2)9ZK@Z+.E1H8]_;^JIW#U>)(R?%@ ? 9'&?YO7G
M=3KEU?W'ISL9VOWE?=X:[V,$[0V6H6MVD570]AUJ3I)/7M(J^KZ>TW<2F^]F
M1K%!;H%4@Q["RJH!'S%L?E6(?* "E-55M5)(P..[QS^7U5O)Q44XI6(W(G80
M\ <0KXF0<RR<'I-#8+4=XD\!>]9F<L:W*F06%2X[JXS_ (+D8\6&W\)0I6<>
M$@ ]YQZOI^>H)(P0,\\X]7]L58?RC3?XLMF?R2 _]3<G;_G+]=1N_P UOJJ"
M;CK/65ZL9&S'M,[EQ+/9BYM8T09F@*Y=,PHK,&-FX5L)L" %L*L0(T<;*60A
M.N%!4>.(+KGBF&82.IT[K#7]+LXK&TN[7LK7?YC+<6-A=W>G=H[2O^#[RYMI
M;FT!E=YD$4BB"=WN+<13LTAX_5.ANFM8OI[^]LKOM+SL_P (P6VHZC9V.J]B
MBQ1G4[&TNH;6](B1()&FB9KBW1+:Y,UNBQ#(]H5VD;@K8RKW73.U7(0 G$-U
M<C7ULU"QU$W!B21\0O4[+5KJ(.5Z<T.FS1CBAD^.S-$S9P<@S+%3I<-_B=2T
MVUU:+LK]>V_&]NL@FECGCG](=M'/&R3)(0[AF5QO5W1]RLRGUGH[K37^@[Z6
M^Z;GAMO.;%M+O["[TW3]4T?4]+>2&9M.U/1]3MKO3;ZS$UM;SQ1W%LYMKJWM
M[NU:"ZMX)H_C5-;I6F Q8/2-/[<2JQDU&K2=LDE-QMEK+YAQQZ9]DM-JNY<Z
M67''Q(PX?&DSLP!(Z.R.%1(4%IN.FBPTBQTV"2WM(U5)F+SM+))/+.[*%+32
MS-)))Z("!68JJ (BJO%7>KNN^H^M[VSO=>N86&FVHL=)L-,TW3]%TC2+,327
M)M],TG2;:SL+-9;F:6YN98H!<7EU))<WDT]P[2FGK]1H58.Q+ )TSME$@6\]
M(!CI<A)$!79$AMUEQX!7YUWD"!3B&7WF(>8L-&!D=UR,+3"CN+:5QND>2KHC
M0M7BUK3=*,5W;/)+802ZEJ-SIVF22JZ/)IFF7-U+8V3A))(X3# OFD3O#9^;
MPL8S>U+RA]5:MITVFWM[$T5TB1W]S#ING6VHZG'&R.J:CJ5O;1WUXI>-))NV
MG8W<J++>&XE4.,/W71-+[5,5P[L[3FUV[ MV-4A1D'+E5<H78D.3"$:LD9E4
MNT!PA ]3WA*AI)*RD8X].<'RX+LV1F1U.I=/:9JTB37D3&:-!'VL%S<6LC0A
MBW92/;R1F2,,S,H?)C+,8V0NV[E(+ZXM@5B9E5CG:R*PW$8R P."0 #COP,@
MX&).EP:5-U^QJQ[1-Z;H$0:/%0:W#$!X$4=%$NL2!3@V3!ML>>.(#)<6-/'E
MH,M@K#),,DH\QN<VF1B_/HVFW.G'2)K6!M.[..(6JEHU18F5XC&\;)+%+%(B
M2Q31NDT<JK*DBR -6OOK>#4X9K>^B:XBG(,JL75BRNLB2))&R212QR*LD4L3
MI)%(JO&RLJD6S7@&I:RE%"5<U3N66;,L189*PVB?\[C[XZ"MUV$*:*V.[DI4
M(5&=?>?0-@KC1'93KDV0T]-<<D*Q=(Z;TO1&GEL4E-Q<*B375Y>75]=/%&6:
M.$3W<LSQP(SLPAC*1EV,C*TA+'!T[2+'3'EEMTNI+B=4CENKRZN;VY:*,LT<
M(FNI97CA1G9A%&40NQD96D)<P\0ZQ]<RFS7-L3>N&SW+'(L2;A-$I(2VJ,0M
MZ9J26;.0H#6P$5"85>))P4EY>#JA3S'B:GPY)A2IV>^CZIUV.P&G)?((5A\V
M67L;<W:6VSL_-TO#$;E8Q'^+7$H=(OQ2.L0"5T:ZI>K!YN)7$>W8/03>$QC8
M),;P,' ]+(' ('%91V(TOISM(,KT#;^BMM$YM0E3YE2LU=GN4NWUI99N*R9C
M"K/5+T(+(%FVH,%)D))D20I1< ;*FCWI@L;(B<M-:Q7&WM,90DHZ2,CKNP&
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MU-;]7:G;ZTEG/9W\MC'!JPEG2Y6XNK::>.WN(IECA8J--%C:LCPH4:V.TNK
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MFZE5[B6ZZ+_LT:I_R@U+_;D+F/U1_P"SFN?^%7W_ $\E9'2/_M3T[_XUIO\
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MS$DDDYKWV"""UAAMK:&*WM[>-(8(((TBAAAB4)'%%%&%2..- %1$4*J@*H
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M$+2QMKS(6E2?&XC/#Q2K&<>/@"QGP\<?'PS^CD'RT^4$@@OH.""/_L^;Q_\
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M*^[_  $>W&,>EWYXZ_I3R2=&=,>?_@E=7_O[S7SCSN^CF_Q;SGLNSV01[?\
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MA"1J%1 )IUPH[\$@L=Q)+,><8QU^@*$LYD!9MMW*"[L6=R4B.YB>,\X 4*H
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M@> K+IUU;R7$C-%JNI+'<)"UM(I,9D;\;"3(())U),+SJ9JZWS%S3%_<6%*
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MS,;;B0)J778T5*(S2TJG+83AEM"?1::RO"WO4=<W>B7=Q=VCM=.LLL5Q)"9
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M82U17LMK_=MXD1\9S-@+20BQ?'E^JM.NM6Z<N]/LH1-<W$"I#F2"/LI"A"3
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ME&;;S$BE@,*&QG@G')4@'/A@XY'([P,U7$P4MEBN0.0"<X8$C [\C/!X/<2
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M>3P<<;$[][._*>Z'B=A=WF;?L!NAUXE\HG5Z]43G7BEP]3Z^ ZCTS'N?5C:
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M:69XW1IU=)+66_DADG+-&+B.*WDAC,KR1;R\]@KO:JH/_/(O^$,_ZQ/*)/\
M!R?ZC?\ E-5)\M?]9?SBM/.U.\]B:<1186LZQ'MMCM[.P'H %5(O5YG6 I3:
MHJPA:C C460P]67+D32S7%7JPID5BGKGLF"\2<RRD?,B1F4#:,DYXVLV< G'
MH_)R>-Q]%<Y.>XUQ(K[MQP!MYW*H 9L$G=WX'.!R<8%:L["[(=QRTK8+.O\
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MQG/QQC*E9QCX9SG]/+<0E[*/#QX[-,9C8G&T=Y[49^G ^BJY"G:/E7SO;.'
M&<GP[,X^C)^FJ7SP?JTO[:S]PY<Q+[<?NF^-5&8_9?WB_#IYX/U:7]M9^X<8
ME]N/W3?&IF/V7]XOPZ>>#]6E_;6?N'&)?;C]TWQJ9C]E_>+\.JJ.N%Z4[PCR
ML8]E1YL9F-9SG'ML/X8SB#CRY\WESXYPK'AC*?#QSA2;;B7=%Z<?^$./Q;=_
M92=_XWGC/''/.>,&M2F)/1?Y SZ8[NT3N_%\<XYYXR,<Y%+YX/U:7]M9^X<N
M8E]N/W3?&JC,?LO[Q?AU:LA*KDTFR9KL7-B2/R)2>RV-R:2*R_[3D8DID5[=
M@?F3_1&86'\1LO\ \]RWZG[KC;+G.^+.,9[)LX]6>U[J;DQC;)C.<=H,9]>.
MS[ZNOG@_5I?VUG[AQB7VX_=-\:F8_9?WB_#IYX'U:7]M9^X<8E]N/W3?&IF/
MV7]XOPZ>>!]6E_;6?N'&)?;C]TWQJ9C]E_>+\.OW"X/CC^AI?Z<?VZS_ '?\
M XQ+[<?NF^-3,?LO[Q?AU43%PO;)?FCRLJ]I?\V<3&DXSGU5^.<)S!5G&,Y^
M.,94K.,?#QS^GE$8E[-,/'C8O[FWJ'^E'YJKD,?:/E7SO;]NOK/^C/YZMTJ.
M&G1W8DX:N9%?3A+T:4_%D1WDX5A6$NLO#5MN)PI*58PM.<84G&?TXQGB6$S1
MM%,+>6)QAXY;?M(W&0<,CRE6&0#@@\@&K3K!(I22(R(PPR.R,K#OP5:(@C//
M(KF1[M:0AMN));;;2E#;:);"$(0C&$H0A*1^$I2E.,)2E.,83C&,8QC&.5!)
M% 56B55 "J(6   P  )<  < #@"I'9  !&    #J  .  !'@ #N%4\B&#F.1
MG98K,IV$]B1#=D.PWW(DC&/##\9;HU2F'L8QC&'6LH7C&/Z;E$D E:-I5MI&
MA?M(FDM][1/W;XRTA*/CC<I!^>J62W<HSP[S&VY"Q1BC>TA,1*M\XP?GJJ\\
M'ZM+^VL_<.7,2^W'[IOC57F/V7]XOPZJ8:X7M<;RQY6%>NUX9S,:5C&?.GPS
MG&(*<YQ_=QA6/'^[CE$@E[-\O'C8W[FWJ/\ I3^:JD,>Y?1?Y0_;KZQ_HZMZ
MV1#KS$ET>XY(B^KB,^N1%6]'P^G"'\,.J'96SZR$I0[Z:D^HG&$K\<8QCE>)
M?;C]TWQJIS'[+^\7X=<_G@_5I?VUG[AQB7VX_=-\:F8_9?WB_#IYX/U:7]M9
M^X<8E]N/W3?&IF/V7]XOPZ>>!]6E_;6?N'&)?;C]TWQJ9C]E_>+\.GG@_5I?
MVUG[AQB7VX_=-\:F8_9?WB_#IYX/U:7]M9^X<8E]N/W3?&IF/V7]XOPZ>>#]
M6E_;6?N'&)?;C]TWQJ9C]E_>+\.GG@_5I?VUG[AQB7VX_=-\:F8_9?WB_#K\
M]2!X^'L\KQ\/'P]M9\?#]'CX>P>/AX_O\8E]N/W3?&IF/V7]XOPZ_?/!^K2_
MMK/W#C$OMQ^Z;XU,Q^R_O%^'3SP?JTO[:S]PXQ+[<?NF^-3,?LO[Q?AT\\'Z
MM+^VL_<.,2^W'[IOC4S'[+^\7X=4/N^O>NJ5[F1[2J=@FJ1YH/KJ))'I$)(*
M>]V>IF<D4E(S$O*O7P/2F%ASV;&&L-LOMQ^Z;XU,I[+^K_"#NSG'^#]?/TU7
M>>#]6E_;6?N'&)?;C]TWQJ9C]E_>+\.GG@_5I?VUG[AQB7VX_=-\:F8_9?WB
M_#IYX/U:7]M9^X<8E]N/W3?&IF/V7]XOPZR2O*C9]L])E]'_ #?S>I(;<\?Z
MOX>'EBM>7P^/CX^;Q\<>'AX?'$NA)Z&60_*[HV'L^N0UEVI3\9A6'R>]@?:]
M2"LV,!0]A&R@Q\2,.")S?HSA1B!%)C9C6<XSEJ5!FM/Q9#?CC&?(\TM/CC&?
M#QQCFLM[FXM)H[BUGFMKB([HI[>5X9HV[MT<L;*Z'!(RK UE75K:WL$EK>VU
MO=VLR[9K:ZACN()5R#MDAE5XY%R <,I&0#BL&J&E=.Z^(.%Z'JC6]++.I6AP
MI5*/6:^16V[C*7&LS1(R))]%>,YQEG#N&\XRK'D\,Y\=IJ'4G4.K0BWU37M9
MU*!2"(+_ %.]NX05[F[.>>1-P(!W;=V1G-:C3.E.E]%G:ZT?IS0M*N6!#7&G
M:3864Y#<,IEMK>.3:02"N[!SR*DSFEK?TXI6NF_.O(_>]BZU6"=9YE=<ZX=B
M0O80=%B#6""+20#:QVKK1%9FNO2HRAD-^/M&266281,>0\'8B8BJ1,<?85(.
M,_.,?S@_T5H?9?DLK&7TYV.ZN!NU5@"]4]\E]O685J&9J&EG36N3^ZK[)V;;
M(,+8SY6&5L-'@78O9#->K4H2-,Q,F4P2UO-#H6(DE50?D-@;ACG)YP,#(^KN
MQG'KYK8+0WR=^D="'33E<8=51@V\;AO#06MPN2]&JO7N;L@14<[ I54#TZPB
MJT?HQ:ZUF;=@-=.UK(VH/V0J$$1/=N494JDDG!\<8SZ_#\W%3=UEZ]#^M=+O
M--'6>9:V;OOKL#O5Z=-&LBW!\W?>W[?MJ;76F&)<Q+\6MR;8X$BD%N-O$F(2
M)KT6(X^J,TH3D_D ^H ?T5L7Q44XI3BE.*4XI3BE.*5H%;]>(V9NK<VI(E@;
M$H)!JGL0H4?&*ERH*3HY !L2/AMSF6I^(\^HCR;Y"5(&^,0T\,8AO/C\DGJ=
MOI9^;N^L?DJ1Q@_/Q^3'_P JDWK8ZB;9]W.NRF5DJM:@FL2,6(R[F$I^H#YI
MQPK%F/J0^\W.FW:</S%>A15Q,A<.>>2B6AW!1C/?^7^CZZ$8Q\XS_;ZOYZVP
MY544XI3BE.*5KS-_]A>RW^,KY_X9U_E9[T^A?SU0.Y_I;\U9-L+^Q_5/^O6B
MO_%6A<I'?^1OS&JCW?E7\XJY%?[,M$_R9[6_WHTWQX'Z1^9J>(^@_G6I.Y%3
M3BE.*4XI3BE.*4XI3BE.*4XI6H7>O<QW1/6;8%UJKZH=LE(&56M$$8QYQ9.S
M3V1SA=G.<*2F6*&+($!ZE)6C!&-$]1"F_/C/?^3'IVVZHZSTG3;Y!)8(9KZ]
MB.<3P6433"!L=\<\PBAEP0>R>3:0V*\S\KW5-YT?T#K6K:<YBU*06^G6$P[[
M>XOYE@:Y7/=);VYGFA.".WCCW KFO+WH?4LGL%LE%.D'K-#+&EIE**!Z4:V+
M/7+(%X,*27/,0)\!0P%"<)9)6.T%""6!\9"W5MRY#R&E?;/5&O)TGHQU%+6R
MDM[8%!!<:E;:1$(XK>61+>U:6*4374BPB&SL8(2TSD*#&BEA^??1W34G6NO#
M2WO+^*YNV$AN+;2KO7)FEFN8HI+F\2&:$P6<33]O?:A<3A(8P6(E=@IH]?7^
MS]<=T-6.JFV)TVCVF<((2!$IQ02W!1Y1<$M!\V4H]L"'XL9:XZWFL+;PY$GL
MX9F1H[K5S5M*LNL.G&L[ZV>*/4[&*XA6X11<Z?<S0"6WEP">SN;1W <*Q!(D
MB;=&[JU&AZWJ/0?5:7^FW:32Z1J,UM.]M(QM-3M(+@Q7,)SCM+2]CC)0L R[
MHYDV2HC+ZHME[*J^N->V+:UFD/,4^JT]FW&);28^'6 D0-&G2)/A,DPXR,,Q
M?%YQ4F5'9;0E:W74)3E6/@@J8.V23AH9KA' YP4GD5L'QP0:_32-UN5ADB.4
MGAMY(R>,K)"C(?'&01464GM'IO8)>V#ZK:(I053!EF-%[G$FAYU'6)J#PA@^
M1@64:5G0Y<."LPUAV0G"&VO8R*7U-+BY2LLB,3@Y"YR1@CC&<$$]V15;1.H4
MD8+$ #G=DYQP1\W\XQ52$[&T4_H9_L'"&V]JLQQI]YRIS@;<+8GSCKAXC49V
MODUE^>EI5]?N@Q^F#@>"?I$+([$@QIRVY34A02 IV@#8P3M(PV02"N"<;LC
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M"GI4,C-BA]?L(BFW.R4HZ,K9$<ME<(-+GJ:+&VFDS*MCE8P7;<&)<@^M&''
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M"(QB,!5CCA"*!PJK$@4 =V   !ZJ@FV=4=27(S:S!9BT,_/X=:PM^%#;66A
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M'%6V8L<G'<  !@ #@  =P'\_><DDUFG)J*JXW]1G_P""(_[]"Y;?Y4/^T/\
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MRBQDO@%L!MZ' _%'! 'I-AVW;250CDD DR2.WMVTESW)$77(@O3PQVL0O?\
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MC>6-)PKUVO#.9C:L8SYT^&<XQ"3G./[N,*QX_P!W'*)!+V;Y>/&QOW-O4?\
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M!&%1UHK<&M&J2?(Q8I*;+^> 0]0;-72YVR%Y@:\I^;%;$)*T.CE]R[<\;68
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M\)TI96X&P94E*E& =7L%8KV2!@=Y(W9QN.,;Q@=W/XO<#DGTL'/ (IWQE<%
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M0U20O !\#SP>YF[^1@D 8_\ 7-98U\H5W&4R(!9ZDF6[<;"VXX%,$=1]BQ=
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M ))P ZY4YX'&2V0Y WMC"\Y7'I, 6QR0%!)*$!N._GCB$[B[:6FUZA"'ZJT
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M+8T7:]BP5SF!ZNH!;)=;5J*PUR0&K:HL'8;5N&;7EV:!"I2\SHI((U.^8J>
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M4C*;F;TN3M#J,@*YQ@@E22%QW@@\<G QVD[4[1V_<>IZY=ZA-IM<$7 Y'NJ
M>IMBC@EQ!0-6;:@M7N5L(G8#--K%7*[#BUF.'U&0]ZWF'-;K]D<MQ4"4@>UT
MAI2Z C !]+"-@C8_I;B2 -V $.6S@YP>998@C%2&)48RZY4[D]$* &+!2<OP
MN,C:#W877-F=O05BUH5VC6K;'H3.:LJUJI5,MFP3Q(?,)[KADI-HJ]>U:T=!
METIC:S7.$U=)]J!$<@SWIS$61*D26Z8,A8';QNP"Q/RN\! 0?D\+G'KJIEA.
MX(1GTMN6V@?(Q@EL$?+Y.,^K@5DP/8?;D@&[9S,TR\ R9W7M[V%U6<L].K4^
M"&,U_-QJE:J" 8@BV9C/G08K4&Q6*IM/ VWS+O=]H"F6/FU6(HT:#2D2^BP)
M5FCR!P06 4#.02 C8?G<6\!BH*Q9B])3AE63#$=^TDYQC )=25R-H4YR:QFS
M=MM\AK-)J#8"N1(X2QZUKI"_N:+W'9I5D3MW7+]_K,VOZ-KUQ9V0+.53YL6X
M/?J"6)OV8;@A5##B1D)4UI\97!Q@ 94;BCG.]2PP@.X%<$,I.1D$X&:D1(5W
M9/(8[>T08V,%.7*[<-N!4@8X(R:G/KSMOLGL*\&QNY-5 M85^#3@I% A 38>
M3T"TS05#(/Q&KU,'OZNN8E^<:N$>1'KIB&?J[P0:*(0"\EPW,$UHTC,=RA1@
M'&&R#A?VV-A')[CD8Q@\D6Y%C4 HQ8Y/.5QC+#Y/RP< 'D8.<Y' K<CEVK5.
M*4XI3BE.*4XI3BE916_[=_S;_C\P[O\ <_\ C_[:S+3]T_X/^ZI0YHZVE.*4
MXI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*533)D:!%>F2W4LQHZ,N.N*\<X2GQQ
MC&,)3C*E*4K.$(0G&5+6I*$XRI6,9N11/-(D4:EW<[54>)^D\  9))(  ))
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M;FZM:7M/H/YMQFE,D310A^4*P30$X_G^<_V'Y*;@?J'[4>"D=V1GG!Y[N>/
M[,=8^I_;;7&S1-L[!]D).\:W-U>2UYL2NE;M?2U4MSZ-*=1:F&/P]3GAJ=>
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M1-W3]1DO+F=&C6.'LTEMP1B94R$;MB)'C+.QWH$"[%.UBS<B+QW8+,#WTY;
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M-0D"\@FW3I!Y W"YN923T>2H^P6PI<OVM4ELJTT=;:5*RC+B$,8_H;P;Y5)
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MR9Y>;#&SK+8S"3PL8F9,=BQH\ED*-CQXC<=21T,$B./D-,2)L1 8!.!S^?\
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M5*QCE<<<DKB.*-Y7;A4C1G=CZ@J@D_D%6Y)8H4:2:2.*-02SR.J(H'>69B%
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M7Z[_ /#BJ\^\/(C_ .[;0O\ ;:O_ /&+ZOSA_NA/_>MU#_N^B?\ P33ZZ_\
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MHSI;32;50V>LW$C&27M-@>TU&X+1V5RTD,B6]A<M-8<:["0!,,TO9-3]_P
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MZ5R\LR1N&T#E9G35Q97FES4X'^ ]A1/R[26T?\/='B*/4NT:&T,#//;&./\
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M4@^JM=K-U@USJ#8O6_(9.S3J+7N$<P7<D$ #\!@N"@6+8HXP:]W59$IEYPP
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,<4IQ2G%*<4IQ2O_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>g149615g86c04.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g149615g86c04.jpg
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M&5-5<H*3)D1C<W62EJ.QML'6-39%5&1T@X2BI+3"_\0 ' $! 0 " P$!
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MB#GHT6S&=[G,Y7Z<E_16!QG "Z0-@I#A#<<0W^HP1E8U2C83Q;ZC&/5S6O\
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MOO&8$+8$0H0+FP&O$VL+:VWB3Q)S-K:"]EJW9&]?M4J"WZF[[%+W<LBGLO\
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M89U.];ESIC>%UDG4'FV/["JMDP(C(%RW(>V.ZZB]1UCCEQ'FU^-_9CR!]/\
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M-:0,H=G)P["K#$L-(0P:XFR\PP.OLWOAV! &+)K=X\AS[<AYYGC8$\%RS?\
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M:?T_.LH_2)$WEK$;B9FVOR39R;LV506.)S?3R-Q)N.-T!JK/MOPUKI$.P*/
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M!<5N<M6D6_M,;+4B'5DHYU@>L)7#'"?%6,QHD)<Z7RY*VPM<:\K4MDKL#PR
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M;KAS3Y_.CT6%(ZFKAR+[3%JP+OZJR+"5*1/[VC#$5?\ !S><3]O*D_\ 1X?
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MGR33&:LJ6M$X8YPIHFM.\V*)AMOEI.=1(WXCS?<;%&XQGP']1-N*#:5U/A.
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M<YUFX>\6WB38.?B$CB!?(N+G$9DDYKN6_J]LDR)C(MAMHOV,:T&7;O"W7+0
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M031PR%DT$S&RPRMLTV#XWM=ND[S"2UUG @>9C%*)N]'4U5)2U4,DD%52S5<
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MLA;(6XGUU\E&BUQU\<@MJ\Q62<(G"+7&XT5=1;41J]E77&<(B_N7]&+3LO\
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M 4N..6NN7?WH.+(%!7(GA(E,6YLQ,G>#O00,JHQ@0K%Y.R-95DDTTN$V<Y4
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M# MX<R?(%"@JYT($&?"&>0X8$D )7)8G9ZC7D;9J5K'>G((EL2,AID;=YO\
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M=#8WXWZ'D/$$^(6.\<M,M,NM^WP*ME% J,BH8MA/23D<A8ZLD1K[*S9E''.
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M)%,6!%' +)^_A#='L"RJXUI!J&163(++8\6PMYIRUSP55@RS/IP.>G@3?/4
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MNYRHU$551%(H!02<B_SX)H="OTK3L<&9<L_);4+NQ(E81.SEJ"(R5,8J!MV
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M(TB--G39Q'-DM,R:K9LN0>>-LQI44HFRD&TS7R1M9*D23&QN3V],NS3DN8-
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MA%HY-;9'"5M753J5*8*)'@V4Q\U;.!!;^".(E2.&Z)92(0$8%#K<0&37,0Q
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J3UB#8UY5155W<CG*KE5RKW554E@%(<*IPB<(G")PB<(G")PB<(G"+__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>g149615g86c95.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g149615g86c95.jpg
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M            !@<("0($!0,!"O_$ %80  $#! $  PL) P<*! 0'  4#! 8
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M$Z^?SLOM7_.B)U\_G9?:O^=$3KY_.R^U?\Z(G7S^=E]J_P"=$3KY_.R^U?\
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M-?'Y0*="!+XO%#D'!X Y%)]:9-QD1FX^3EWC=X$\2AKK[Y:,#.!(QS)B<,H
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M^JZ0UI# ! +GG&,9@-&),'< ,21DM6TW-VE8ME65K'U[70JVM]:I+J5"RTL
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M>(<=BW:7:M\D,ETUEU:;8V;2V:^P-I5JE=MMV78MHE]2FVDYIM;7O%.XU]0
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M%"[QV8(OE;YOTQ"I5>UN\(L$U?!NEQWF[I6MMLS;-7%%A<\&G2>"Z))J,#X
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M+=/:NB&IX?O!Z, P35JVM0!,; A@Z0/G" ;&.QN9RTEB>7L>/0\0J0L!9M$
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M,^//+Q;?F_\ E1IE+7J,7!\;5M2Y#YPK+LBRVQA.X(J3F4;/M8[:,#$8Z+4
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MW0T8@"Z)<0))B25E=LRVU=H5;37VC2J6.M1=9WV)M@:UXL[J3FFDVUNM-1[
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M=;:54VE]:SN?5M+RZ\VN:;6-S8PL%,E[&.#7$%XOEC28+01LLKJJX]6WI_\
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M^[Q5KN(Q&()G'")S$3NT\%SF?=3H9J\9HM7:NB]JP21[DA+/9I.(JE-?2HC
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M4AIWBUK&3:UD6K8\H@,68F(-M\9>*-BKQU*0.0,,_F8I6/2!+(1TE>]YL8X
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M <#&>)CO_P#B@L()!@0 [/<8CUF<LUD%5E5*(E$4O;?S$+_UI!?W6>JOZ?\
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MVU#>ZV HY%)%-@BP?8VQVNJ6,1)D#Q]K$G#S76O\%I@ P!I'Y?(B30M<N,:
MJ&2X88#*2-<3PRXK("T,(O$..8#<"-PF<,<3YIG 2!).)_#/N9,AUC)HR-WR
M*C,JUSK;A7(N&V0ATZ:%AVTTCW)R7[DRFR(]LIDX#"FT7;P?P+$M<9(V,J(F
MDVC-!&/C3I: S'$8 $9YXSNQCQCPTL^H#);(+GW_  \T",LYG$;O%6EMOCGR
MBC<%M(^*PP1KB;$9)M0:C!PQB*M2T+UN3@^W2NODADFD2S^/.Y1,N3!N![WY
M!%KOW!.8KYWBQ0M/ 4)8M9&NNS C/ '(;L?'$\HQ4!S)ATD  @Q@3(F0(R;+
M6YQGO6TF((R9O$XNWFCL:_F*$="HRU^'2S;B'LF2&ML#SL4@K@FHB-<E<72S
M%)1-/--KFEAGACEC?&V09"<]ZQ&),93AX*141*(I5"_YP(_]-D'\/%*J_P!$
M^KWA69Z0]?N*BM654HBCDP(203%)*4AL<:2^6C@15]&HH_/819G)3K5DLN*!
M.9*J-,) $2SW!%BH85%D$AV*]W2K1=-+).X]V*D1(DP-YB8[X6G&0\!-J'I6
M3W& SF0!BYYR\2^:;/CY.]CM9N;&R#5(0I%=ZI"YB\DQ\ B0FXB1(KQ$&XEV
M4>1OKN,C;DH@((MA48QW3G&]IB9.&>/B=Y66^(@F?,>R\! QQ;A TQ,3COA6
MMHS@9EJGB/K"!RC7L!V)R"BAR;F QXY=$C'=>O\ ;O(1'>"RI+!9T,3FD8U1
M(F<+G#F(]+EE+9MK(*]#8L7Z@TX.7,,1)Y#K'KQR4.J7GD@D-,2!F;HN^HD2
M)W J;ZWU#R\UKRM&C LF:K\/1-B2N29,E'WA0^+*:M&K%7!]M@U2DQ#<TEY+
MNI9LR43=5M@-+1<R[:+%[NW"0)M(#@[NW]^&>LS\0H+FEN/I81AWG#0 -@1K
MZULDJZQI1%+H/_K^W_1Y+_#A6JO]$^KWA69Z0]?N*B-654HB41:O]L< A6SN
M64,V\$2*P6$C-WZOY-;D16DC1ZRV[N+1<++Q'2ZT5BZ+4DYBF I$PFXV#(UC
M(!,XC&@HMO#3KTFZEP2A;+IW2">\C*!W'.?4L@J0P@XFZ6C#($R<9X#$*)\9
M^Y^P6)R^<2%;0*W'_5VWM42V []XMOMJWW'J;8FP'<QBI2(;4BZOC1W9BZ#Q
MH9+A;PNY%0PZ_<2D>X2C8M\$<EBP-Q.$ C$2""=W?A&<[U+JA( D.(((=$.
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MH=.;QAR6Q-5Q.%1"=; G$NU\JP'$KSQO!(-&9%,1T*;-BXK!_*S0,:!&O23
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MA/*R*^DT?]LCOB:0=#P*2-1Q">5D5])H_P"V1WQ-(.AX%)&HXA/*R*^DT?\
M;([XFD'0\"DC4<0GE9%?2:/^V1WQ-(.AX%)&HXA/*R*^DT?]LCOB:0=#P*2-
M1Q">5D5])H_[9'?$T@Z'@4D:CB$\K(KZ31_VR.^)I!T/ I(U'$)Y617TFC_M
MD=\32#H>!21J.(3RLBOI-'_;([XFD'0\"DC4<0GE9%?2:/\ MD=\32#H>!21
MJ.(3RLBOI-'_ &R.^)I!T/ I(U'$)Y617TFC_MD=\32#H>!21J.(3RLBOI-'
M_;([XFD'0\"DC4<0GE9%?2:/^V1WQ-(.AX%)&HXA/*R*^DT?]LCOB:0=#P*2
M-1Q">5D5])H_[9'?$T@Z'@4D:CB$\K(KZ31_VR.^)I!T/ I(U'$)Y617TFC_
M +9'?$T@Z'@4D:CB%];26.70R<VD 2[;!7!#-Q8JPNABNIAFHFCDKW_O>*N:
M:2F>"=\K9Y8)YY8VOCAE>R#H>"2-1Q"^7E9%?2:/^V1WQ-(.AX%)&HXA/*R*
M^DT?]LCOB:0=#P*2-1Q">5D5])H_[9'?$T@Z'@4D:CB$\K(KZ31_VR.^)I!T
M/ I(U'$)Y617TFC_ +9'?$T@Z'@4D:CB$\K(KZ31_P!LCOB:0=#P*2-1Q">5
MD5])H_[9'?$T@Z'@4D:CB$\K(KZ31_VR.^)I!T/ I(U'$)Y617TFC_MD=\32
M#H>!21J.(7U1DT<<J62;R (NK?%3.R:)5@JI?!%/-97.V&#C+*^*26&:JF71
MT8)X9YY7MCC>]D'0\$D:CBOEY617TFC_ +9'?$T@Z'@4D:CB$\K(KZ31_P!L
MCOB:0=#P*2-1Q">5D5])H_[9'?$T@Z'@4D:CB$\K(KZ31_VR.^)I!T/ I(U'
M$)Y617TFC_MD=\32#H>!21J.(3RLBOI-'_;([XFD'0\"DC4<0GE9%?2:/^V1
MWQ-(.AX%)&HXA/*R*^DT?]LCOB:0=#P*2-1Q"^J,ECCE3O3<^$<*]153O:!5
MBJIWM%/-9;/J)KY9=1)%/-53+HZ,$\,\\KVQQO>R#H>"2-1Q"Z_EA$_28![7
M8?$4@Z'@4D:CB$\L(GZ3 /:[#XBD'0\"DC4<0GEA$_28![78?$4@Z'@4D:CB
M$\L(GZ3 /:[#XBD'0\"DC4<0GEA$_28![78?$4@Z'@4D:CB$\L(GZ3 /:[#X
MBD'0\"DC4<0GEA$_28![78?$4@Z'@4D:CB$\L(GZ3 /:[#XBD'0\"DC4<0GE
MA$_28![78?$4@Z'@4D:CB%]\9/&\T,W6,@"Y-DU4T%'%BC'O&"RN"BB2.:O?
M^]XJJ8)*YIIWRMGGBDIEC:]L,KV0=#P*2-1Q"^?E9%?2:/\ MD=\32#H>!21
MJ.(3RLBOI-'_ &R.^)I!T/ I(U'$)Y617TFC_MD=\32#H>!21J.(3RLBOI-'
M_;([XFD'0\"DC4<0GE9%?2:/^V1WQ-(.AX%)&HXA/*R*^DT?]LCOB:0=#P*2
M-1Q">5D5])H_[9'?$T@Z'@4D:CB$\K(KZ31_VR.^)I!T/ I(U'$)Y617TFC_
M +9'?$T@Z'@4D:CB$\K(KZ31_P!LCOB:0=#P*2-1Q"P24_TBG_KR_P#=>LZP
M*CI'R7XZ0\Y*HS+=\Z=C$C@K1D0FP"0;*AP<S#V!)&[@<^E P@8;O0#(@A:Z
M[)T51:(.T;75;J*86ZU02!F0I#7$ AI@F 8,$^.2NZI4)1%$W,]@S.:C=;.Y
MC%FNPS(!_*@\$<'Q:,P*Q@4[08$Y$-C:CK$P^!CGSILS?E6S-5BS=.6Z#A=-
M59/')(RG'13!B8,# F, 3D)4LHH2B)1%$H[/H-+RLM!1291:3&X$93CLY#@#
MXHN4AI]9DB11"2E@P=.'0 LJ/<MWZ0XJDT=J,G"+K!')!5-3)(.6Y201$@B<
M1(S&HU4.(\@-&"#YF+%-P:U'R*./60N1"'DTC[=Z +D\4<Q@0VDH_P ?%1TF
MFY;JC0;^[<L017269LUDE,,[Q> WCX_KW9J;KH!NF#EAGW^'?DK>J55*(HH
MGD)E1N81N,RV.2"0Z]+,@4["!C(\B5AQHD(9'QXN2L&CA5T%?O@A%B4:M2"2
M"J[%TDX2QR3RZ;)!GNS4D$02" 1([QE@I710E$2B)1$HB41*(E$2B)1$HB41
M*(I8C_,4A_6P/_<YRHWCP/O:IW'Q'N<HG4J$HB415>XW;IMIM)CHYUM;73;<
MQ,.I(!VJ%YG'DMB/@:*"SI0JTAN9#&0+L<6C9T\\(289)W9M';O&]VS5PJG$
MB8G'13=,7H,#"8PQ[U&VG*#C60.;"C+#D%I1](]2,C1+:@!GM&$NC6M1\;(8
M"9"]G@M VH^B+4&543&%USR#!,<04P9.\DG.5DKI&.(PS4W70#==!R,&#X88
M^I3\9LC7YH-'9"(FD8* Y<8SCT7*CS8]XQD!]%8DW<@Q*[==3!\89KA3*+\8
MWOF]'J!RV#U!#(8^L@D8&<\ H@R1&($GP^.*FM2H2B)1%*H7_.!'_IL@_AXI
M57^B?5[PK,](>OW%16K*J41?)99%LBLX<+)-V[=)19==93!)%%%+"ZBJRRJE
M\<$TD\,<LU%,\L<,,,;Y97M:U[T14U%.27'N>0PIL6#[PU/,H$$D",2+S&*S
M^+R"-CY4Z?,!C*,NBXDF[9)R D0*B60H-=;QB5<EA2(YLZS),;+Q>&.(P^/C
M56+' P6D'."",->NF]>R[W?IIBA!W+S:VNFS79J+1QKMTK,X]BVG#5^1!!F#
MN*.+D.\G6;TU*HL$:.QN;ALY-2>-B$5<R1X2U=I&HQRQS40<<#AG@</'3(\%
M.VIX(],%H^S*CW1P"W%NS0ENZ16?B6YNSW(0J0;)YY*M,26 YZHSLOCADNDW
M45PM=/JY7F=VG]5$;]?Z+UJ(E$4N@_\ K^W_ $>2_P .%:J_T3ZO>%9GI#U^
MXJ(U952B)1$HB41*(E$2B)1%+VW\Q"_]:07]UGJK^G_Q_JIW'Q'N<HA5E"41
M*(HRXFL0:23"'.90 1EF0G,_>,YEF/CY( GDX3S/.!-EKOFP.RS5PW\;N$$A
MUW2632SF[F^*5XD#?\? 4P2)@QKPP\<1@H2COW1SF)/9XVV]K=S"QQ4,">RE
MO,X^N";&I&@(=1L2H22?YMO&4E9R"/OHVRQ4NYD# \#?!TWK0N.6<KPSD?'Q
MZ]R773$&<XC=KZM^F]35E-8>2\E?%LICY*TZ%*GH7F.+L'R<K!(,F1%8Y'5&
MBZR9@,FP)#7>95ADNPL@2'9^$=#]IWZ9&'?DH@XX'#/N\=%)Z(E$2B)1%S4_
MTBG_ *\O_=>B+104BD]C_=-N9.U3D7W<QTF5UMQO;%DH]QSVGL>+[]"1"$S8
M7,]<!2<9@,@N1=#B!T.^S:A7&38RX:Y 2&2@]T_S:8R#>)@QAN.,1AE_TMB1
MV3!(O2^/. +22()QPP^,%U-[3;NC(N=<Q%M)1_94L2E>@9K+M#.;A)D$6TO-
M1#32P@KK52*R(8OJ?8D@>#;2J5Z/EFOGSN2%),XGP*8#3*C;!E&XETF+V,ZX
M;^,91J(QP4 4_,O71! .(APQ@X08GTO!0[8VV.243F6K!,HF6_8CHB;=TK;Z
MNUR[RPV6PVS-^.!'C<8D4J!NVEQRFURP2^T@A=6+'G3'*<M$T'^4:*M K4(X
M3$G &8G XS']>'@I#6$.(NEPIWB#!:'7L.[T<(F)SQ6-<[CO/F0PK1&UC<9Y
M/VY 0W@)S29@YM$]?SO"?93!QNH ]XY1V<.([%U5&>PY7 8W'3!N(D\6!\TX
M9NT)6.O9\7'.H-XW3C,9XZG^BL.S!<V6W34IR"0 ?--XQN ).66$1@LV#VUN
M:#[E_I? (#Y-L8#;9^A NQW9/4<X3U7:%[$XO2%_-[,QP>-IQ16+1O;> )W+
MI5*W&,ZB&P"+^+N%H5$H^/N?GSKPSW3ZQCA$:[E0!EQWHS!(Q$R'X;YDMG 8
M$1F<L0-7<I.1^P-0;:-::Y.G-W[]C7&N ^,=-A,-BD-I264-N2N2O(?=T!UE
M)XY%&019'1LECD6BL&B>+@I&)4U\!"#8^^LQ>2V 3!Q,QE)USTR]TJQ8V0"V
M&EQ\["[!;YC20?G"9D @D2=UZ\K9WS>BNK1B&@Y%RYVB??:]W%LW7,D"<=]L
M0IL'6MOG6\B@$$E %^UDVRSTZB>NU9A! X7>-PXB;Z_'DY$]%2F8NPN)F3>W
M7N!$8]Q)X[E5H9)O7!$#T@9P()W"#@<,08&L9Z<.8S+Q_)3ND\C*1.:Q,)L/
M>^LI! )!*X1)XT-E0AIQ^@4;<F8VK)10I ^S&R .1&OKL,U\6SQI=!U='OR-
MU+-!EV8DX$CQU57D7:6(,-((!!_2.!C+!4_W-&+G-+<4<>+G)/5NQ'F\!6U=
MOI;3=/-;3"1QO<A:=[6D4J%;88[+Q"*08^%-1\T!\(DQ*4M'0)R%NS->*2+%
MLVJ! %T@R3E&?ANC#.=5-0WGWVD!L",<@ !!&<@F,L?!8WO-H<YWNT>3^ H'
MR[;0]SQKY^CH H=U=L5LX6W5!]A(O^.;Z(I HQ>)A2"\6(NPNK/(1=TRV+&!
M@LA(2TFFSLB) 1YV/I9'<?$0!O[AX*Q%.!Z$WJ>1!P((=,XG<3.1RPQ-CGV?
M*F)0'A2VD^Q.9[V(;\@LG>\GY]%(E)Y;MS0>]#/'[7H;56+2!0G7ZTSC.N1.
MQ&,V*FXV6C1T+Y=NVJL_<.!;O-):3(NXN@YX&0=V.G=OW8JOFR_!DM/F@G!S
M9)._.(RW'4*'S9?F QVUMUA%&/)L9'#G=+N&0[RGCNNIFQ>&..!35\<$;VD%
MC(2)9#2<(8%F)5M(Y UR>QZ+KM&+(:Z&C40C>R#)SQ<,<L,9/Q@I\RZT^:3V
M3L"9AP.&$R#$0-_?BJW:SGND^7'77%R#+DLA(QFA.="4<>80B=([0+\FHWN]
M<=Q+:[.8KQ],P\CKK5&3)U'EYJRM IBFH2>3=4N]:LU$H\Z!Z61UF9,3R_IB
MK12OGT(O4SF(NW9?&.XS@,1X*<;),<^UN0\KSNOR@$ F?*#N;T?P9Z[B^P"&
MKVNLI[K95ES0(Q=RUC)< ;AP&07=*FCUW187""R(]\P6%$5D5%QO3FX8B8G_
M );M=/4H:&7?T)NU#B1,@RP8F1(]9\9553[9W=$&'%2-A(R&YI.]PC67."X
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MK96BX)!-./'X5PQ;0K:$_@,QV#O?:LQDC)R*8F8/A%R#(Q%M3-2;*)+8(&>
MG2<!AO.9Y#!/->7%SH,R8PDD&3OP:0&C#+'>MV]95@2B)1$HBF^>NIM?/.]H
MZ_O:^65[7_R/[KWOT?\ YU5OMUY'HI@Z'@5Q[.9OZ./_ ,'WU+[=>1Z)!T/
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M@4[.9OZ./_P??4OMUY'HD'0\"G9S-_1Q_P#@^^I?;KR/1(.AX%.SF;^CC_\
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M-@,X<5D),>V!G'1L@Z&MRN)NN!F"!$Y&';N_/+0K6AP+XP[LY-7OQ_V3)IS
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M_C?_ /EK/ T' +!)U/$KAXY,>=27KSKWM(&@X!).IXE/')CSJ2]>=>]I T'
M))U/$IXY,>=27KSKWM(&@X!).IXE/')CSJ2]>=>]I T' ))U/$IXY,>=27KS
MKWM(&@X!).IXE/')CSJ2]>=>]I T' ))U/$IXY,>=27KSKWM(&@X!).IXE/'
M)CSJ2]>=>]I T' ))U/$IXY,>=27KSKWM(&@X!).IXE/')CSJ2]>=>]I T'
M))U/$IXY,>=27KSKWM(&@X!).IXE/')CSJ2]>=>]I T' ))U/$IXY,>=27KS
MKWM(&@X!).IXE/')CSJ2]>=>]I T' ))U/$IXY,>=27KSKWM(&@X!).IXE/'
M)CSJ2]>=>]I T' ))U/$IXY,>=27KSKWM(&@X!).IXE/')CSJ2]>=>]I T'
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MFYD@9<1"<R EQKCTQWK!S))FH[=I-9]BG!YO*U46Y&Q*5O6L@.#B*TF+/'0
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>g149615g87d98.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g149615g87d98.jpg
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MHT#//B,>&&)J(UC43LTJQQL((!RUZR+6KKZ0P#PT_P#DP'.Y[EW9CN23GSU
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M4LS'LJJ"6)^0 ).35Z\]NQ!5K1//9LS15Z\,8YI)IYG6.*)%'5GDD944#NQ
MRH;/U&=%TU%3::U[3QP%!H>M+#N2CMB;:*,.TZMJHJ.>QW0<JIXESP<.EH9)
MC43VM;:B*C5^3Z\+ZMIL<4<SW:ZQ2TWOQR%QRO201E[*GSB431$MV_S%]<W&
MK[-N/;U^[I=3A/6K&HZ=Q17X*OTXJ;M/4XLMO?CK:!,@^YJ4SZ7J"I >I-28
M;_#UDV\[:ZSZO!R]GV'N<WC:_:ZBEQ63,T%F/7#W^KT3")*2AK99W-:186,0
MI,H\35\+%!+*]S8V.<DUF]3I+"]NS#72Q-'7@:5P@EGEW\.)">[N 2!Z D[
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M6PD[9?Q'1 'B&CCBH-&7V8CN/Y=!^]O7+PFX!['_ )[_ -_3RR2>EV\&O?\
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MC7NWV\XD-C!U]F["<D6K;7UY+7A6>VTTP-@W.@V#9:NK#KC]!=C&CP5M->W
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MB,%N%$A&!)T+:D0RSSFD%&$9I:ZMLQ;,2"]K6F:"NV^Y'XC^H^7R\OIE-]B
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M[QT-@F^%9$8QLJ1^U)6M:V1'-1$Y'N1V)&2; ]P#^&=\***"- &$- &(+$R
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M+*T]^.6:DE>O' UBV+4,%B6N]6*:.6*O8D1RD$Q2V,AK\YOLS3['(6D-WF=
M(A]-;CQ$PCV 3GOCC*@87"/.L$KHW.AD?"ULT?MFB5\3V/=@M0T^YI5VQI^H
M0-6NU)/"L5W9&>&0 ,4<QLZ\R@@,H8E6W5MF! V/3-3HZS0JZIIEA;="['XU
M6RBR(D\18J)$$J(_(Q4E&*@.NSKNK FE?4;VRW"YG^C*"O,ONR.R*?2U6/J
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M=_A%56Q0QO>J-17+X\-155$5WQVS&-N/=]P0MN]K87U-3$S,L<KC*>RGIFT
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MEC$J21F2,D.@DC>/F YT9=U,+J71T#O&SHRK)&$+QLP(#H)%="RD\RAT=20
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M5K>^P57F\=UIS.[497<PP;/:I^!:>+PQX#3&#GE\/Q7QKZT,.)J.T.@HF&K
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M44?VYVC5MU;^LX?2X1V852/Z.[8VTL'6ZV^%IL35Y_47.7K[ZIJ=/%:'LKZ
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ME7KNFH(M'TB)1LON0F/SDL333.Q]2>8+OZ(H[ 9P36)6GU_7YG)+?:35QO\
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M#/#BL7B1Z=J'#-A[$]G39ZZ+/(99:MH2*B32'FDDAEB5V596W=XFC*B0LRN
M_*.WZ-[2N';VEZ;IW&^GZV;^CTH=-I\0</M1GL7=+J((J%/5M,U&2I%//I\
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MQCC&9#[*D3M#9W^5M)B7X+#35]:34"%DA0Z/8$@#7)A%F0%*.3.!GP+"K&#
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M7Z\\V'A4J.(--YCMO),B?_>>M,D 'S,[1A?F1FJ<;J[<*ZOR GEA@DDV!/\
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MI:A3I56GBB7=YEK3Z<JS^&K&(68F8*A+936A@L-?EKNQI8GR9:N:,*RW<U[
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M=95*;?/F V^>=)U;UI<'Y5D.>E&%V>5J\N>M;92R0UNJQFXH!=?5@F$,CEF
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MQCC&.,8XQCC&.,8XQCC&>8-(?)J=CVSV 6Y9R]+V9K*0*=_E719?KJX-P&=
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MV]7G@=1219#16D--<XO]9#=)C;FPD^.NOJ6N<0LM75$&/8'H:B)D(8T9,5Y
M..T6P4BK+N-QW_G\L*VQV/;^7SRP>S]F_9:>;K:BNU!SM2,*3NK&JL$&L+DJ
MRB_(KL97&C2L)%&< K;/2%!2-)>&575D,\+2SE;:B^9_#^_[_MESMY#\?[?W
M_+UROI:6EZ\M,=K,C4U^>)K=9E**R;3"05[+?.:F_KLS9UEE$,R-EBQB6T=F
M(I;998+($<F&1DBR.?>P&Q^A/XY8IV(\NO7Z9N;D&3XXQCC&.,8XQCC&.,8X
MQCC&.,8XQCC&.,8XQCC&.,8XQGGEVG2NPOJ O4<SXJ+N>E#U]/+X1D";;'@
MYG8UK43]OY)N<@R%W"WRV0E1[N?VO_&FD29#NNWF"?R/4?KO^SD3CKOZYYC^
MONAL&WF!TZ1R/JIJJQH72M15B'L!3/U!D<CO'M9(8,7(Z!%7S*T$A43Q"[Q,
MGG^'[_7+,UEZ2;BHM?2MT/FJJ6&32Q>K3,BRB1.:IB%4VD;V!<3NB:OR_'%@
M S'S3*WXVBH]CW>WRWD4@(=SY<G\]E'Z].O7\!OEX[*//F'G]?7^G\\]%/54
M8$'Z;^ZT.1CDL>N=-1 1.5$<1=Z*NEH<\-"B_P!Q)-[8UT S6^7N(DC1B*Y4
M3D2;\R[>H/X#J?T[Y>WW3F:!F21CCQS/^26.&)DK_P"??(UC6O?Y7[_<Y%7_
M //)LASKK^\KLU26VAMYT'K*6O+LSIE\*K1@X7SRI&U53Y)7M9[(8FK[YI7,
MB8BO>U%8S5GIIQ-IB.HJ"+1#*'K=63:[_7C.14D#T&T/FO)JF5%1/WY\$D#.
M?M3V^RH9[55OA5A8[D^G8?3]]<F4; ?F?W^F7WRW+L<8QQC'&,<8QQC'&,<8
MQQC'&,<8QQC'&,<8QQC'&,<8QQC'&,RUV%V=?W=[8Y7$VDE%2T)+Z_0ZD.(:
M:TL+B+PA='0/+B(%"'K%7X+:V</,2I_R  (,\0@E^J:QK4D<K5:;A3&>6:8;
M%N?SC3<$+R]F;JW-N!R\I+=;X:X3T^E0K:OKU1;]W4(UL:;I,S2I4KTGZPW]
M1$+Q2SR6MN>G361(A7Y;%@RB:*):1M6!FA]D#[R:TW]D)US/9]=2Z2R)+6HN
MI3FYN,40&-X]9^I3Z"_S4@5[^$EU$LGXZ%N;!!XGX>U*Q9>:M8D,K(HFC=@
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MXC4@T^CH>J$;:==HB6"G),!_EU-2KO++'X,Y_P M;L02>O(R23FQ$'4;)K[
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MEY=C:11H'F(S'9;GI\LWQU&HQDCE='D+[WU**OE(L]I(/U@ 9OE5<D85BZY
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M;ZYUM[W_ )_.9G72'?C3;SK[#,U.TH$@U8^4H[5F< T)5#8;T7*7%."4T4^
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MOOFF^G^RO^+.:M=D& .-F9MAJJ;%V0Y;RF:?,9RTDHA]3X?!!^-#<V8%K,#
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,XQCC&.,8XQCC&?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>g149615g88g23.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g149615g88g23.jpg
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M 0$! 0'_P  1" #N ET# 1$  A$! Q$!_\0 'P !  (# 0$! 0$!
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M3+(;L"2,$XQDY.^#R!QZ_#)V7QQ+Y?Z+B%$3R2V>TNF53;G[GGBBU)BXTK:
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MFF"P5T1*EFY <#@9SOL-AN "<[C89\UN%?YGZ!)1;G(K7%'=2W'->GT^BF,
MJ*LH!"#=B!9ERV:C@.W8-.6[RRQL=!E@R\AV?LS(V0G8>1#AB+YM(]]WD;;'
MR<!WR6@#&Y)P>+<8VR<^FW7D5KX+\R:%G] ?'G#Z(YMN&Q*/[CJJQ;#VG/Z'
M#V$IB;J(R<5#R##4<^M(:P2;U 7P:?7WNJD2V'@74;?5HM/'+@@R;$X-G$D
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MZDV9JOMF6D5E<4LMW%RKO"^5WS<.P<.6FZ"SL<H6O:'.2 =@,=-L8.^=QA;
MOCX?J^L:]/ZYU//HE4A O4-=4K+8C-N9Z,Z5BJL6J9N[%P Q 6-T C&*[EH6
M.O,QMR^::F@)@6/#?JL9=.!V5G#'S^JR''&-S@D\R.>,@]QMTP>>^ZQ>\?AI
M:6S,>@/VOUE9]4T7TI:%0WI9O/T>KZM2T;)7%4"\(W%R!I+"8W24BHN9Q 8\
M2+0P*X%I9D@X<01,:A&.L96*AV,9 . 6@\L Y[;9W.YS^JL+[:Y;#=J\KW)R
MW():3@H>X8ZQC[Z6AAK4N3":,9"&D*;IJ->KM6KO?=8,DWW26<(X_"6WVUWQ
MOKKXLM):01S'=: ZJ^/-]T+:E(7+7W25B\Z3VIZOL:BCYR$1*!2YS.Z:M1&/
M)RV-IHSP48'1.2Z+QUN]C\R8CB3@,[<*+9%/5$6FS<@. 1@$$@^\9[;\B=EI
MVL_A^@E:@00)K=$M*I@_C*GOQHZ.'$7#MMW$2GDTVF;JTMDTR*FJ<C'N=\LF
M\?QMN,50^BJC["F,XR6N,[[<W\9]=]OQ7YE/PUTW/@$=B,YLV;%XP$^,&-_&
M2X9CA@<01>1:*RN$3(-<30CON2183-B<@@IXV K#R0#\7^'7YQOINV7('D<A
M_&'_  SMTVWW6*2CX<7MO0OHE#H_KZP[MN"]>9XGR('MQS64 @Z594?$ITVL
ME,2(@T5W0'2*2R*9M4C4KDYPOLX(K)-D6#02U1V05)QD$8 &#Q8WQD^_X8QY
MY5D_3?.8GI?EJW^7BTF(Q4/;E4G:L>2P<P;$285H;#;"-B[8<Y6;M7;EMKG"
M^&JJZ*2NV,IY53QG[L%D'!![$'X%0)??#91[WIBPNG?WU*4Y5/N/"/+*@'(L
M<H""R4Q6(NE2E]#T_P SIG,Z>5.#%0E4?LEHS4&INLKO5\N$-&9:#R !@;$'
M/7 ).,]LG/\ RL3,_#HZ% H&,H_KZR:0(M^':VX"N\J+K>O9EI<]-5F"5CX8
M\T82I-Q_36R=AQ$XT2E(1V618,R*"347^98Y>NR<6<Y /VB[KL3C/7<;#;\>
M:\&TO@_B!T;84'HKJ*V>=*?N?E2H>4KKK@#$:]G6UC1?GV'DX53I]:62X6H9
MCI,6#(9&39,#HU7FHK<DS2)1QT45))$#SL2,D.+@>6Y()V'F%F$@^'*&;=!F
M;X@UJQH)O8 >DA]LQBQ^8*#OI4T2I"'!:_$R"MI/:<?+DJE(2:) !S.3-QS:
M0CG1-+!Q!HB12;*(,#LG&<8[9Y$CGO\ @>7KCTGERYRL%Y@)=0$@\N*2O?IS
MJFQ.IBZ1,:T':Q0S8<9@<:=Q(;LU<+Y(C!J4%;NFY)UA!TNH0624;Z:H:;;E
MDG./(8_$G]5*WQ1/$3Q$\1/$3Q$\1/$3Q$\1/$3Q$\1/$3Q$\1/$3Q$\1/$3
MQ$\1/$3Q$\1/$3Q$\1/$3Q$\1/$3Q$\1/$3Q$\1/$3Q$\1/$3Q$\1/$3Q$\1
M/$3Q$\1/$3Q$\1/$3Q$\1/$3Q$\1/$3Q$\1/$3Q$\1/$3Q$\1/$3Q$\1/$3Q
M$\1/$3Q$\1/$3Q$\1/$3Q$\1/$3Q$\1/$49$NI(>KV6^XIUC\EQ/V/,HSJ-2
M59T%_L_>'E+3*U0C']-\$<FOW*F:$K$5==A.HO\ 2U$LZD-G?WMM77'K^&/Z
MJXVSYX4F_%%&&_\ L2@.9V<@5MB9JAB4?@Y*P% 3./R,L1?@1S8NO]6*PX2Y
M%_FGB@1^U;(.R#7.%T]-G&R""FBV2H!/(%:(5SW6VJ=3HI6U*V4F*,/VLI;E
M76O1V*K_ $-,1F1J56C;WZG_ %(_?NHO&0&EQJ.MH2I)L8D>U+)Q[;]MZ$VS
MUQT/4>>-_A^/5;]H7KV@NE$ V:EFBATB8A0^?:AG4?D8A^QC[](1OA1ZJ3$M
M1OYEJL<'-7+=J_=;?C*[;(9703W6U(01S'OZ*0AS8SH%,;1Q,<K(=19#8"D7
MW<)B53.K1;(M,INT^KK0=N^PAJ]W;8_,:MLJY1_YF-?%%3%7_P O8>1P3EF=
MS2)Q^!C9'074-_\ ;7YMX:(N>:H[RB\1JZ>#!8MB@L3,F#70SU&%1<8\07(E
M HLNHR:/2>66%2V6') WW 'GQ D9[;#?M^*^>Q/F0A^YKG[6F:ZLB3;2+J%.
MB;VJ,A59>27P+%2+FBQKQKY>N(W"Y>Z!.RDL> 8MOH6=EC84,$UEC26-HP_#
M%'@,H&YSO_""-]MW ;^F3[PL['?+M1+XTK.D#KLK1YWF:@[>KZ*!JMG#F_Y/
M8EZ] 610$<KYF)R5V#E#Q6<0I*&,84S#MB8J1M3!<O)U(ON@Z9DX#VY$@]M@
M#GTQOGDOGV^5@##;EOT9<<*EE>U?!:XX[=UA!C==F /1<@N'I:>7]!G==G8^
M6D^8YE91[5(AW'76FX..,@7ZY+B4Q(Q9PS*,BO#D CN[)SMAH:<\L]>6Y\E8
MAS?T76G5-3A[CJEV66C!,S+8P\'R 9L&D<<ED#E!:%S.+2$7E9RFT+QZ3 R8
MQSLT>/QCW5!,B((DA+QD_<%DC&WH?<1D?$%;V\43Q$\1/$3Q$\1/$3Q$\1/$
M3Q$\1/$3Q$\1/$3Q$\1/$3Q$\1/$3Q$\1/$3_P#[_O\ _P#7B*JES\MU,C=K
M5#':$ZLC%C5+-Z)A!>HY/ :\ V"=5Z20E+FHS\?3(VTA$D@A]"&R#=ZWE,LC
M$G ;L\-SD<8.5=$<EKA.,[8()SZ8SR[9_-;!E/R7TQ"+&A%:R^N+SCY(^EST
MA8A][%X6K$^>))U1("L4HR&7>68V&\5&2.920.Z$*;P%E84?CFZPY_)SP<03
M'D7!3!_/WX&3CT&YSA>USA\CW/\ TJ0DS4(PL"L18>K8U?,8E=SB(U"8K9U"
M2^2R>)1VZ(,6;2XYA"$D#<4((?@SM"$2UHV>!B+Z+MAY=BY5(01S[D'R(Y@_
M.#T.Q4MH7;]2V0[>#Z[M&NIZ_'-M'A!E"YM&I2[8-%%<(:.GC8&3?+-6VZVV
MJ.BZ^FB6RN<)XVSOG&/%%L7Q%\!4H.!C")HP^:C! A@\*%"3Y;1LR'CA[=1V
M^?/'"N=4T&K1LBJNX64VUT223WWWSC77.?$4#].NKQ7@G_$$TY.>N.9=@O[T
M2+?U4_#Z7=5E^4_5-;(:<WYK?8%N+5CW_P 6-X4O>3:WU0.=1^U;)SW;$&\6
ML#EG?MC;/;.>?3EC/7&ZG6#-B)*%$2, 1:%P1\6/-A"S!;1PQ*""K1%\-(LG
M&F<Z+M'K-=%RV6TSG15%73?7.<;8\65^C)#<0(*E4QQ$PH,&OB&@@.D@N7*;
MLFJKG4<+0=.6;98B^V2PV8I.';5!1RJEHLY03VV5U(H4UW\AW/-HAN/CL16E
MKEEVK$K$G-:_G!0AAO#8M4D/VE=EF+9W7D&&T1:0MYN/@YQ5@XD&C>=&!8C3
M91DNJ40?JJ6D$@]-C_LO@LWY)^2J\!TK-AMRU78M76_?BO/SZVX);-:FJRK&
M2M*OL.U"1:PYJA)MX^$&BPU>N&I%!4AJ_:+FA3A9OHTWW5\5#7;[8(&<$$$C
M.-MNZVJEU]2J\U4!I3"';UVGSVUZ3_KUI:-0;U%O7KJ7.XFF\U(Z6!M)\#?O
M9J%_WSM%M:QW89_*)3?<ZFL(3*8./?C&#G/PQ[LY\EA +O[G"16Q*(&*L.$/
M*]BW,L/ZG==%M;#@KJB7, EUHV54^$T)\W/*!=50LAK$SL6)JO-0R&KA%I^=
M_/(.VZ3KCT_'/]%>$XY'.<8QORRI40"Q*_M>(AY_5LYA]DP21(K. $U@4E"S
M")G$&[E9DX6$2*//2(@DD@\;.&B^[-XMJBZ07;J9U624TU+*S'Q$\1/$3Q$\
M1/$3Q$\1/$3Q$\1/$3Q$\1/$3Q$\1/$3Q%5/UWWPVBMK5[SGS1TUQ?$[U?6J
M,KRT '0C6>3US%%Y7&\.8$':0^L9Q R;0U*):5B<=R5/2%L"%NY&($O/M.FQ
M#%R6@TXS@D8)&".0Y_K\/AGD>'?+0'F$$=S2<\ SFOMYS%&=D!(+3%_0.:IU
M\\,-F\O+1.12GHB8@49 &"J.B(MF2CA)N0<H:--DL?BXVP4^SYC;;<'?X*1W
M7;V*#^:KA>3>YB?/L60B*^Q6VP\]"U<4BVFSQGHU096">TV9Q1>3OMFL1U*M
M%F$@3P>RG%2P:3JARS(@YC;/EC/X=5R^VQTS3-D_$1\<<>?]CR(/V):55AZW
MJ>>-.UI/2T-KVWQ@NO"=L7/T]/A%C  SQY1(3#1S^W[+=R"5/#LR3BT8B+V0
M2S+T:7(!A[B6_9#CD<(.V3@ $=<=,;!>U:M]6>GTW(S, Z5G%B]C1;N_DZL.
M?*WC5NR):)VUQ#(^2X?,YG/@]!@)0M74WKFRER-@6A)+,TBQQ%E)APC5C+!V
MC,<TW9Y>?)-L8P "TYV&SN(X!)P<@8'/KV)SN+XL[7M.53!LKS-=)3H6;S/X
MGZON:_Q%WWI95E5M&OD8D%A%&NHFQ';HK-B-*'C:6LW#RV 0L6"5816(!7:,
M/^K%@X7*/[$8PX@8 ^[Y<L]P3S[[E2!Y1)=;E/FZG2_945H*(V7I\5\=2 #N
M=97/)?#%X/KUJ8W'O2I&PHY&3#>3J'MY&@[9-6*PQ,4W#KI.]W3AXBA.H]#^
M;5#C@V)/VNHQT]2NA/U6%\!46-.#"(4RP:%!!A@\%E1C]!-TQ(C2#=1H^8/6
MJVNZ+EH[:K*MW*"NFR:R*FZ>^NVNV<9(H)YXTL;>$_T$6ZKGRO,&1'[3V@>T
M1CV+D5K7\M^G?TG6Z$P]_5]X3L!_^$E)!K"]+I4C7UVWM_,LVVENQ7/7&_7J
M#YX^1Y*=XX<P$#V D4R:C18MFU'#1S%!-JR8,&2&C9FR9MD==$6[5JW230;H
M)::)HI)Z)IZZZZXQ@HOL\15E#_B8Y-:&>Y"KY"PCS;OL*8CMK@#$H'[!(*&D
MQ66RB6L:83'Q\>_A*<LGDT,6(>R_(2/9W--&!-/*#9GJQW+7$?L\AP[@@;YV
MW.>?(>2]>K?C/JJM7M*%GEHVM.S5"W*K=,)*F8_SO"%'AK-036E6T?E3*E*%
MJL7(P+6+SPV5R_>LOWJ^D_Y<@1ESL?A80L0NYX &1@XSW!SN3OD+4S?X7N7F
M,2:Q@7/K^%/P=<U/ 83-6$OA"$P@)&DND;$ZHKBQXL\UK? O2?!+.LLXBHX,
M""\7>QAF*$N8ML[3(%"+DG&?+F3C'/(X3GU&VV.>RR2??$C1]JHS$G9UO]!S
M^QIDTYX7<VQ*S%2EI<+E_,LQM2:5W.AX-:GL5J\*.G5P2T!)8S(X$>K<C$,#
M(ZQA IHU6V=$#B.V,DXWQN ".><;#JIY4+38N@ZMCM6B9&8E[8 J:<JR>01^
MM(L9,O#IPB>=N'H&GX#6%=#L(+$MF+-O&H,";:#VK35RD[?8<OW196X?$3Q$
M\1/$3Q$\1/$3Q$\1/$3Q$\1/$46K#Z'E ^QRE/TC3AB[; BH,))+"<;2X!7=
M>5V/DV7VT8#R.:FTBCU[-Y.T&/BHF(Q:+2)R/"),S4S>1$7(8D[D)7&V<^@Z
MGE\/4\^G7&<TC=HVYA<J35BLFKJ?5S*=X/:%8S3 C:30B4X#B9&R15?QTH;C
M<A 2&,GP<GBDJCA@D'-@RS;[E6)IH:""2$8_/9;L\43Q$\1/$3Q$\1/$3Q%^
M=]]4]-U-\_;IIKMOOMGZ_3777&=MLY^GUS_&,9S_ !CZ^(JPQ/S%\$2 4-.@
M)Q>AT$:8,RP8V%XG[=*AS H@W3=CR@HFPYV<,2(U^T62=,GS-=9J[;*I+MU5
M$E--\EK@/_B/5S0?>,[*;=&7Q6'3%7BK>I:1/I#!CI*7 AQ4Q$)E""C<[!I6
M<@DL%EX=/P44F 4C'Y='#09^/-A!CG\P/5V3UV;J(N%"A!!P?Z\]^8V5:,%^
M,V[XQ6]T1";]'\X7Y+KSLUC:T_L"_.$6MEK3.3HMR@O[IY&#'2GZ,;'QJ.+1
M^-56$C68/'*Q#1ELP$@W[,H7;.RI=N" 1@8&#R]#C;?)//<]%AL(^%D- &]<
M0@-T?(R5)CA''6EV0&35XP+2FVI'Q+,SD\JE['+!;3 8E5L4*FB@P=+(<E#Y
MGMO%HR&!1F01K.'3]Q,?ECX<OU3B.^VYXM]_XA@\\^?O)\L;GY<^+.*4JQ,1
MR[+##]/01KS/!^-*^@TJJ8/&8^(YM@4LE$O&1FQ6*TGF+&T)F4>2 >PD$MPQ
MAP5\.C G5I"!SI<DZ>5"[._(\1=G/4]NWES/FH^\O4!1_-_S6]#0&@:FKZFH
M0\^.&CY,[B=;14/#X^XD)'H2SF#\TL*"-6;-0F\9"1C1P\V2RNLW8-$M]\Z(
M)XU+1),8)))XSS.>@[J][Q<:C7>G'W-/2GZDXNJG(-/#)&'/()K)C8%@\DPR
M-N\%MM60<RN@JZ'99.3A1^/W1V_ZH_=JND\?B;9SDJ"1R)'H<+038)WJ/JQ'
MG9K&*45)M(FG6S/K1:PS&K+6+H"\1UO9CN@M(#^I;VLD*UT**ULWG>M>.I+K
ME76RV(57])0)MY^GZ9S^./<MZ4'QIS-S*W YI>GH3"C8&%#X!K+18(<UEA6.
ML&XE'= V;;-T7)%8BL$'/RBJGTP](-]72FF-\8^A"2>9]W12=\45"<>^&^6-
MWO?4=,W4&85A>M-]$T=QV&CP<JH_YMAO6<_E=QWBW-L72C)D3;/[*)Q9F,'1
M\DVU=P>,["WCUFZ(*;IEOB^[MG!!(SL>' &W388)ZYY;;_SJSXDIPP*49)[0
M2IA:15_U72]XV?HC/KJN@99<6I#G*X*3B*#=.Y!N4(\>&$;$!/8\ 8C$Q  #
M'&S522&'@L+LW)Q#?L6\(V QN#OCGR_1:H_Z$FXDJI:P5E;E1H$8W0 *N(TQ
M>@902@Q650CY&3_<,7!R\'HS'JN*L,1IT'K21,F6^2#!QAV^8"B(]DU:O"O'
MN#CMGUX.$GX[_.5M7H?XL.B>EW\MG\EG= U?/Y!2G.<7;1&HV=D ZP_J#S_V
MO:74Z3)^[1T%RW2*3 %,@00Y,A6S&5:V,@9L%C&6>FH\-M,<_,8_/^J@<!RR
M1D\\9P6\/IU/ER5E_$'.1'F6FRD-/#(Z+EDOLR?VK,TXM8=EVD+>RR?%M21@
MOO-;829RTN3+JI:$3*R@D*PW*N'B[89HHLX<NJLDY/ER&<?ILIA^*)XB>(GB
M)XB>(GB)XB>(GB)XB>(GB)XB>(GB)XBT_:O0U!45D-K=MWU%3VTCV<:1_6T;
M(AT V.;,_P /\Y^D:RLR)R2PSPJGEWLSPMJVU4TV7RGKMC.2H!/($^@RMICB
M0XP/8EQ#]D5%%&;8B,)CG2#X>1'O4='+-\Q>ME%6SMF[;J)KMG+=51%=%315
M+??3;7;)1:(.<J\_2(F9-F:V%.RQ^3;3 L1P1/M73@VM+*AG3_=-5H60RR%F
M9=0U4'I%'V/Y:/2-_%,*'19#0W(]"Y7)[^7Z?J5M2/6' ):_=BHI.8?)B;!+
M=P^&QZ3!33]D@FMHV46=LQKURX;I)N%$T-U%D]--5E-$MML;[:ZY*+)" X>6
M9KCBK%F3'N===7+$@U0>LW&NF^JNFJ[9SHH@KKJIIHIKA33;&N^FN^/IMKC.
M"+'5*_@:K5NR5A,149-%'"S1HI&PV[5JJ[_!PZ5;M]F64D5'.&Z'YC=/379;
M\!'\3.WX6GVD7IIQF.(DVAM&/A$C+ 9@(Q+IBF"9-D&UVQOJ(:/]6^'389KO
MC&V&"*NC7&V,;82^O\^(OZBP ('L0W"A1(?<N_6*E=A8YF/V)E''T_,$B&S1
M%'+U^O\ ;K^,\<Y5<*_;C[U-OICQ%4HS_P ?:1?Z040_WFS3TZCT/YM6OX/\
MWZ*X'U65J.?G[L#$?NK^ 5')(PB+U=OS4_NN6UP1:/DU'>SU'])"4/9@_<6V
M9)-'.I9:1-5E%%G:*HMJDS3=/? JI+HR0"BHZ"HBX 2^JN511R!^79:(HK57
M-+ WA(>9@22X&-H:'.[EI^A\/JFB?)JK4^LK-<14R-CI=/Z$LFIJ)]((XC%.
M^X7'Q%TG/'4OE=.R2E;;98HXXXI6UDKIGPP<9[?Y;[2_Z27/<.VL?Q4[I'7G
M?:O][ D.E9)<SY+8:-Y_F7?T_P!BNJ*4_P#KT2I*]JK_ '3K!UW4(P"UVVPE
MK\T;K^H.LC9^"D^JF']F"/ZU)]4_;0>7%_UWZF9O8F8FWA_U/=P$OL^%?O!_
MT-K,WZ+S/$PU.HOV\VZ.UZ^L&GJ0ZB_Z5OIA"*?^RO\ :86S]J-MH;K%U.=4
M<+:=TE!]>=* NS* G;L+$M_ZB5_4L8CB@O=RP+P&Z);8Y)V1V6:?E&VX@Y1%
M8L$1;ADH\<[ED9 \7360:-TA3A%ZJ\8_2Z62Z/D(K:.@IXN EKZ6Y5%9(9.)
MN&F*6U4+6L+2XEXF<X.:UHC(<7,_!VH:'P_IJ*.32NI]8WJXFJ8R:EU#H6R:
M9HHZ,Q3&2HCK[;XB:MGEJF3MIXV4CK;#%)%+-,ZMB? R"IVU[SUTY<35.]E]
M-UDWX'ZPE_0%\S*K*&XCK&X^JX25L*<S039-86=V1>O.UDV!*8D]+O=)M.:X
M"R.#SH,<?I.S3,96J3!%UHS3TU1+E('$YH &2<$]" " /7EUW(PMF0WKKKJ*
MU7\@N9Y:-^D[X[%VX11Y^KP*<F<SD_/1'O'^OLX(1>A(6Q=NR$4D-,<Y,OU9
M$;#6K<BZEU6-R*V^"'VND"%K1P\L NR>AX<8]Q/+UZ=/ML3N'J%Q\;LWYN&.
M.X0UGT!-NLX%>/2(FO;F>]"PRL*+AF;HY>)VD:#CG4VJ4_T!')Y38^567,R0
MIHE H5>9'8Y@EAJJF0 <6?L[\.&G&-\@^7V2#Y<MMU_$7U=;$VL:)31;H2^H
MW?<.M+X:X%S=1$@LVP83K;%27K ZQ>=+F9;0Q(N.8VXC/RQVVGDPL:7Q>1%X
M^RA A^,D0- =APY?/S\A0#;&V,/). =P#C?<CIL,>\\K=/CPMUB7[K^4.G-^
MKCO1#.)SR@I#7;"8VU&YN]""2U.BR-HMX'&(QD9&HS$8M8L@UBQEA#HR+' R
MB(L1(]UY'^*Y=E'#9IQC.>A'([?JH!V\&N+GJ=?-3-*'NCKN8S3CF@*0EW.L
M2F_4G0UNQ2'E;KI:Q2%HRAS74ZL"2Q2;.HTU1<36)LY8"/,(J6CHYX%9-LLT
M]<%1@\ .,.)!V Z]\;>Y8SU/.*3@5%\D-N1/D'LN]A]G]?\ .H^]B\T^46WH
M6Q7 27G;J@ZWVGM\1B0S2:\Z"K2-QK0[)(V)'-(XL=@8-)C"!3D6NOL5 )+N
M)N,-.,-',.;R!P#CUS@\SE:G[-M>^8A=)0C4MV71'*MJ/E+XV9$^N: =XW5:
M53<V:VG?]@Q:QKHD@!\YV8]P0\H/&XC<IE%@!6Q8E&1K27%6;)KAZV%% !CE
MD\3Q@C!.&C V^[C.=NNR[%M-]%-==]-M=]-]==]-]-L;:[Z;8QG7;7;&<XVU
MVQG&==L9SC.,XSC/T\7&OUXB>(GB)XB>(GB)XB>(GB*MJ0S>QJ([+L^-5/4Q
M7H@=T! H]T!8L4B,HA<2FM/2J'#(C08(N^?V,<BT.,Q&Y(W#A2$6#;2<,?#E
MZ;M(NQ9REL4W:@2US&Y P<#.=P=^@/+]5(3G>N;&$2"XKFN%C'H[8MX2*,.\
MP**&5I(&KF!0.,MXU"8H\E*HT-I*Y:LHK(95+CC,2R%-BDFQ$@FYD+%!\F.E
M">0[#\<D_P"WNSY"4/BB>(GB)XB>(GB)XB>(HF=>5%T+<D,B4>YVZ *<Z2 7
M*#IX], C( _(D$&U7V$S@@E9E)(=-!A>.-[B?5N=F\;V: UY)"PY\8UDPYPH
MDR)E1CJ,^7+J/TSW]%[?)]-V!0=5*U9.[),VFRC$PE#>MI')R:)R6M*J4>)[
MPN/RHTVC43;$# =KERAKHU#X:"!FXZ/M7Y1L(2(N2'FI&,1P\6BHW&,&8YNL
M\($5D&+5!HBJ0+/G!,J_42;Z)Z*/"9)V[($'6VN5WCYRX=N=U'"RBFQ1?9XB
M>(GB*G^$_P".W?O^F+0?^X^WO%O^['\Y_P!+5<!XL)XB@O4/R TG<_8G0/&$
M6W?:6!08823<'G"[+>/3MVWW8L[,$1+9%7=RJ]J$U((C')GAUHE]AX\N/9Z*
M[ BVZ/BQUM)-5U-#'.Q]71L@DJ8 ?MPLJA(8"\<OWC8W. !)#>$D .;GL-=I
M34-MT[8=65UJJJ;3NIZJ\4=ANDK,4URJ+"^DBNK*=V22*26M@B<YP:U\GM61
ME[H)@R='O*77EAMBSH%5]?3JRY1EYB-5W#9/.I#D<WP[(8!1((^/ELL6FRB.
M'3S\@/<?EF^5DL++_8GE33&WW8)S4+*>^33EZ[K^B7-D2)31A9,YY\A'2D6Q
M)HIN'CA:"3Z'Q^?!Q"!_#]TU_>[:'R-J?*1O;379N/8F'"#QWH*=YT9_'=4M
M(&<;9QT^>GSE:]C_ ,P/&\IY@NGKF/$;)*U+2-NB:3*Z-($ZWF$YF\E4@'[.
M3J^*Y?X>S(;-6EF1(I%W:.[-8B(>+DU&C9HVW4R5X'9 VR1GF,8WR2>0Q@Y6
MT>@/DFY:YOYPJ7J6<R.1&:QO-K#B%6HP:.JR>5RL3-(MF;LS;2/I.FJB 0+$
M=53\H+/'+=B"9Z:(NELOG;!H[(&DDC&XSG.W+IZKY7'R4\W-.AG'/#E.S$7K
M>S3E&;6YF $=Z+4OF-5LI;9RDD+ 2<*;KV*.@:#@JJ.3#;"E'C9Q'VYE:0H[
MBL%,'&??YXSC/QV[\NA"VESAV-5'5=;V=:%0B++> ZJL6>5:=#2FOCD)FY&6
MU\+$ERK,3")1H,DJ.Y%J;&Z!V4B' #*SM?\ *$!0U?3;3!""" <;X]-U%J._
M+WS>2CU]3"6UKT]4\/YL>KQNUI/9U+/ XT39?YJ!,P]-CD IR1%C%M2E:S(9
MB,0QB-4=%M#"6^JR6NNV?%0TG'+[7+<<M]_+&.JR8O\ )]7('>KPICFGM<98
M]OR.QH[":=(\^N1UGD<5=$H?-Y2?2"D),U%OHPE'IN(6;F0QPJCJ_:G0K_1@
M9!$V#<G"=]P<8ZCJOL=_*/SL(O?>@9)%+UC!QK:].T.7G)BK'FU81VZKZ@T8
MGM7UC))4*)E%PDFD(Z7A!/W/Q*(9G(5U![LLDEIAWN3A.,],9&_, X/P5D/B
MRGB)XB>(GB)XB>(GB)XB>(GB)XB>(GB*M*O;2HFD.B^M_P#B4G5=59<4UG+*
M11256_)(]#$9WS&)KR$LH6UK212]X.9$:_K\_B8C)Q% CW;2,68^EDND8EE_
M44.:D9:P2!C<8_'KG'X9SMC?; V9PDU&ZPFY3$"%N ?/DLZ$FDHYC#[CG(4<
MWJ4G%(%H?+10(Z0:J"X!,[V;7//JY2;M6P=] Y5'#$;0TC1(/]2AZ=3@9/SY
M8!\P5M?K]+5QR7U$ANP4*Z+<ZW:EN+2D.T25):J5I)M-F"<JTT5WC*CS&V6^
MDAU24V"[*8):Z;Y;8UR0;D>H5&GP4EZ=>&T!\&>?'"YF3+F:*Z277E/CBU>?
MNA-<)/8(B1VN&QYT]U#3%I^J_A8E(P:$%.2<V_('46S)HQ5:8;^[T_7/Z+;\
M[Y+B,[9=Q#K\YZKI5\7&GB)XB>(J?F?^/M(O](*(?[S9IZ=1Z'\VK7\'^;]%
M<#ZK*\XN(%2 24 G!S(P$-CGH@P()M47HTH*)-E69 <09.-%&[MD^:++-G;5
M=/=%P@JHDKIMIOMKDB@]_P!%O\;^4_PL\+\J_A?9^'^'_0^O_P /\/[?M^S[
M/T+[?L^W^S]OT^W[?X^GT]P?5:;/%]7@XLYXO8QYSG.<\.<YWSSRO<?VAOYB
M]B;Y>/8^S]E[+]IUOLO9</![/V?M^#V?!]G@QP\/V<8V4Y!8L:#&#@H9@S%!
MQ#!H+%"QS9%F/&C1[=-HQ8,6C?1-!JS9M44F[9L@GHB@@GHDGIKIKKC'.O3K
M[O$6%Z5O7:;!46G H6F,7 ;Q1<=I%@>C!:+*.EWRD:59ZL<-U "CUTZ>;AMT
M\CMG3E=QLVRJLIOL1?;M"89N61/[Q&,;'6Z[!TW-; !6Q9!R*'D! MPB2RTR
M\27&BBQ08P6T6U49CR1!DWV3;/'*2A%]&\4BZF\D54C8!128H)-9<IN'';;R
MILB.R(1;R3?9MG8X@D)SD6DD3RZ33'9RRUUPV_Y7B+X,U_ ]CP*5;0F([2>+
MB]@<9D>8V&R>CH3=-1'<.",99?J @7LBJJEL/'N&[39-133*.==]L9(OF 5G
M6\4,O9'%J^A$:D)))RB1.@(H!#&2"+URD]>(O2@Y@V?.DG;Q!!VY3774T7<H
MI+JXW53TWU(LD;A S,B5+M! QJ6.ZL=#91NP:H$3&@Q%1L-T*O4DM7)#4>W6
M508ZNU5L-$55$D,)Z;[:Y(L#TI*F$PSF.)U%6&D>>&<R-V!T@,4U#.I#E%9M
MD\Y%ZB<,5S.6[EPADHJAL^RBNLEE?[%=]=B9/?YY_GNO<3KBO$F#P4E X8F+
M(@6<5(#4XN#T8/XP.V=[#XX\9ZL<-W0%AL_?;,PZZ>X]KL]=Y0;Z9<+9W(LP
M333133113T222TT3223TUT333TUQKHFGIKC&NFFFN,:Z::XQKKKC&,8QC&,>
M(OWXB>(GB)XB>(GB)XB>(O#E$FC\*C4BF4L+L8_%HD"+2:2GB:VK8:$CX%@X
M*F2Y!QO_ &6[$:.:.7CM;;^RD@BHIG^-<^(HN\?QF0$8M+NB;!$/0MF=0GVE
MEOP1='9 Q *N:CM!%%50];J8RJ,?0VN=&!>9AM=MFC>WIC:!-KC&IC?.2I[=
M!M_7\?PPI?>*)XB>(GB)XB>(GB)XB>(GB*@/M_ORZZO[.G?/T=Z@@G-T(@]0
MU%.0RHO@V_>Z9;+C%B$;!;'T)IO2TK%HU0H!3B0E:/AS@?7:3"#>IED4=_AN
MF8XMM:",D=?\36_Z@<]>797XL%=EF+);=7\?=5HV5W7PU5986V41TWV5_)KY
MV7:?B9SG?\JMMLJW^[\)3.=],Y\6%]?B)XB>(J?X3_CMW[_IBT'_ +C[>\6_
M[L?SG_2U7 >+"B;TQ18R4U];4VKRHH-8?0BT"/[5PVFA)P'"FYZQCBK&$M9"
M3_'PW:B$2" Q-]MLFGKNR0W2V61RIEQIZVIM%MJI7SU%%#-,\#B>\.R[A:&M
M!(/(-:!R.PY%=ZL?B5KG3U!36BSZGN5LM=,^1T5+2^P+(1/,^>=T;9(\N<^6
M220M=( 7N(XF@Y'*+1GQ ?);4MMTY8Z]'0*1*P*PP\DE6)'>,)62FX,N140M
M-E(U&#E5XNO-P)>2*N7B2#M5G(WC&0HLW3T8U2S\ZM.A[Y2Z@GNUPK;75TE>
M9&7"B9]:X7TY+7P10AT+6M^J/BI_8 N&(XO99#7N7[;\1OI:^$^H?!JS^&^C
M-*:]TYJ'1\5'4:.U54G3[I::\QQS4]WKKF8+C++-_:2FKKL;N61R<=;</KXB
MDFIH0.R2!U!6E8+$G$!AXJ+K%TFR))0=AQC9XDSW6W;:*_CKK8^B.[A;;3[<
M:Y^JFWUSG^/I]*I+=14)>:2FC@,@:'F,$<0;DM!R3RXCCU7X3U%K;5>K64L>
MI+W67=E"^5](VJ,9$#YQ&V9S/9QLWD$48=G/W1C"\R_Z_*6S1%UU6#>#QYNR
MZDLBOP[\MLYT%L2DRAQF.#WA+=FW=N]![9V216>;-6CISJVT4R@W65QJGMYJ
MZN-B#V(5 T_^%?H\] B&\ O6MJTO()4W!];5C9X=26+JQK2CN9+0Y5Z:1<J[
MQ1-VF(G]?VW(7T"T:H+K/C >/K2)*,*-M'36 8 '886^,=1D?:R.^2'#KW S
M\%MAK\/UK#IDSAD(NX%2?-@/L+?J2+IUHR!2*U :-:\DTKSCSO%D0%L5--JG
M>Z1LO$9](I2F>$G1Z#=&"/@*:TARJZB]3C&!MD\/"0=A]XDG8@[[?$Y\]+S/
MX,.@9'RAFAQW7ZS*1U+#+:Y_Y[2(A8:;@ACG.:WV*N".:V>J9ILG(H%9R88+
M%X;)WE+)"Q3D/7$*#,7F0"A8?L3C&22.>">?W@.?/??)W/4YRI)Q/XT>F([>
MH3]7M"I9GSY#^\)3\C0R6%MY('OZ:79(**,5NG7\LC$?A3.KH]"\SV1FYN4E
ML8++.UQ2C6.BH '22PJF4+@1RWQPGML001OGW'XJ5OQY<\]0<].NJ/\ B&TH
M51K?72M@=+Q_>F9C84F<!S=I_IJ<EB1E*;UU!D\"@24>#[ R[)9X[**/26C]
M@.U:-=W4WZX^.?T"CB#C&=@ <^77_;\5H.R_C+M"?5#W;#Q]E02-SR^^](?V
M_0$@68GCT;C!FLP_/3B'QNU ^68ATX;%I'3)<=(4HZY*I,09U@78.2))JJ(Q
M50X#AVR TM/O+LX_^7SE89U!Q#W#UW).6[0NJ%\,2.3<_2.^OU"HVUI])!*W
M.1>U(%7,< /?ZB"JU2FSR3B)+&Y*<=M$XI'0[<8XCXC#@VNB2)+M^GYX_0H"
MT9&^#CME>;(?BBM0QUE(NU6LAJAO;NW87,-^QB*DY-8Q^LE*PK[GF#4A<T(.
M1@M&G,9;S_#L=*)52EGM(<_E\<)CHB[WD,:P\,,&).(8#=]FN&>N221[N0/D
M3V!5\OBPGB)XB>(GB)XB>(GB)XB>(GB)XB>(GB*EJK+JGG3/3W55M4ISQ#KX
MCE1S1AS!$)G;=EHU;7(,=3^=C\[0K1XWK&X3LHL:86C)RY V6;1B.5^\@,6I
M)5*Q7)M(R'CI:(P!G;;/+??EVVQ[\YZ'*M"H^Y1=V1$@=0CL@A$GBLH-0"QZ
M[ENHW]T5[/XWEML8C)A8,_*A"*2K%^)D4=/@R9 )*(@>CTG#O%AIAKMXLG9?
M%TX=-Q?FSH231DU(8Y)([1UL'8_(8D 1E<K FQ$"/D!1J,19RLW;R60BW[=N
M^"@%W"")@D@V'*K):.=M]2HYCU]%4M\08^]2"@R?VU%>SV;2:<_18XG,>A?D
M*KGK6LY0;/*0\RJ_A590^7%BD))%DE7907('\>#-QX#+V/*ILW))-EL'(*N
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MR@)J%DI@A'49P>6?RS@?[_'&?_\ 'ORJI_\ H;$-F_[_ +<1FI[CE.=_I_\
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MD@)5LNJ.9=+.L'H$3)HK)!I =@5"9ER=01F.X!F1ITJL,5_5(V3C!-,J6L#
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M Q\0.'D)!+IM*R>%<!H7 8<#;/Y+-YF<W15T$1B-#"1=[A%POHUPU:NG"!0
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M.S&%"$\O(8'Q)W^/Z*47BB>(L'LYBY)UK88UFG!UG9"#2QBU1LYAN5K55R[
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MQ@$I*4I&0I2>U@/J$_N-_> <S#0;T<P;/:U<B5SLC91,N5 =G."#SWV_/O\
M.RFK^4Z5ZB_DGO*^0:!=_3Z"F#QBAUE9XS?^?_>9I@L4!\U1@HAG.-F(!Q);
MT<,'22_[CHB5CG W)38'H?RZ_'H>WD0I25=4U;TK$6D%JN'!83%FKEV0V'!V
M^VJA$P14_'+2$\2<;N"LDE!QU]SZ02F0/B<A/D5%B)DF^?+*N-R$DG)W*V'X
MHGB)XB>(GB)XBU==9AB&J>Q5GA.3"U7,'E[0:I!"<7$V(Y)JQHILT:5P[FCA
MM%=9^KLGG:(XD"NH74YHR5+9P.3=;:D^?G"I;^,89=2G6UF29RAW-FD'W/#
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MF[(FEI6B D5#MY7'(=OFFA;B/@=F6:_E0XV5C2<'0+Y:Z*&GSA\^?GYZK+@
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MG&!C.<]-O/;;X\@8YVT;2XCA& "7.<X8(:&[YR1L,GSQ@+3<;ZVN'G:*=?\
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M6,?JIX15?#A\M$%VC)XHCC"6[ELDDMNGC&FV^=<8QXF2.1PL[ @ 45"BXW&
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M)4?'$/J,%XK*6H,$@FK&R.>]E'4Q,H[I[,'B=+;'N<VCN]*UIXQ3>TAN=)$
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MISP>M-7I&@N5%&!]8FU)XD:EI[_XD:ELI:!/=;?<[%I73].&OGHX+0Q^:?G
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M\84SG./KZ2376E8W&-EU;52<A'14U96N<>@!IJ>5FYV&7 'NOJU#]$/Z0U7
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M&PLC+6I-]IMOA51DT<)M\;+[)ZY*@1DXP_D3S;T!/^'R4I?V9\[O_CM\7_\
MY$=*_P#J[XI^[[/^+?Z)^S/G=_\ ';XO_P#R(Z5_]7?$_=]G_%O]%1)U5\<G
M35,6AS^WG,"^-J5RCLWJ!>J$S((;WX):B9[/ D[LXS,CS%/K!BVRP?/(^74>
M-@S7178@4T42;ZHX4^WU<]CLM5,^HJ;1;*B>0@R33T--++(0 T%\DD3GN(:
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MS)98!A>J&MGQ,_'G+$$=DB#L.A)E0RI=X%U=L"*6%V.SA8>\;MUD-W-0 Y&
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MFC%YE$9O-XZ3"L;(M:1SJ&Q%B>:I$8S" +1 &"'EBY#@<(#@0,\^+F1O_",
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M]8"%@CN8#V#"85K'8TV@CZ9NW A<W#R..>^/7WJX:22>'/&<[[8QD8!/+/\
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MR/) <RP0S*"'*#5O\_TZ_$*8:2=N0#CC..0XAS[GN.N#R"ZU@H[<.&$B%")
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64\1/$3Q$\1/$3Q$\1/$3Q$\1/$7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>g149615g89j31.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g149615g89j31.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[10 4&AO=&]S:&]P(#,N,  X0DE-! 0
M    $^2^4)(X0DE-! 0      $ < 5H  QLE1QP"   "*?H< E  $%-A8G)I
M;F$@4V-H96-H97(< @4 %U!O=V5R4&]I;G0@4')E<V5N=&%T:6]N.$))300E
M       0@K2]B.Q&1P=_C=()@AM!(CA"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#
MO_XU  (  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #-0    8              G8   =5          $
M                     0             '50   G8
M     0                         0     0       &YU;&P    "
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   G8     4F=H=&QO;F<
M  =5    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(
M   '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG
M:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y
M<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   )V     %)G:'1L;VYG   '50    -U<FQ415A4
M     0       &YU;&Q415A4     0       $US9V5415A4     0
M!F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC
M96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(
M;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC
M959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%
M4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M    "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M      MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
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M# P,# P,# P,# P,# P,_\  $0@ -@"@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
M 0 " P0%!@<("0H+$  !! $# @0"!0<&" 4###,!  (1 P0A$C$%05%A$R)Q
M@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                _^%!NVAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\
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M)($_S=YQM2)UR>:\Z1'0\.B@4I$173_VM?BTU6"3'04GMS;VY*'!T!H:,/\
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MH9_3*%SRQ7&N,=,<GDTI*:T$N8F2I=BM)U-23@4 '*&1<*(7$HFYA@"(,GH
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M$1B(Q$8B,1&(C$1B(Q$8B,1&(C$2&'Q$/[E/HC_017^V8G$29^(C$3 >G_\
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MZN\-_,A_QM'^M'\@N.?]'\%_U"O_ !./U@YC^>G_ (:/]*/U=X;^9#_C:/\
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M+NP,>&3'.0*3QC2)9EP/0;XS9+:OI=>:;8<;=79_5;GKNZKCRNJ$C\J?EL+
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M]MIW2L=_U_CU^>OW?UQ*\.__ /MGZ%_^[@_[ A\K$DAR>$B!*% OCQXK9$J
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MGV,1+%O,_H>B^JN)TSNO.A+%%UJX*L8+D!<(\6)MU5LU+M<Y1+O3K5&@2$N
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3$8B,1&(C$1B(Q$8B,1&(C$3_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>g149615g90l65.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g149615g90l65.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_X3_A:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS
M.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835 @0V]R92 U+C,M8S Q,2 V-BXQ
M-#4V-C$L(#(P,3(O,#(O,#8M,30Z-38Z,C<@(" @(" @("(^"B @(#QR9&8Z
M4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR
M9&8M<WEN=&%X+6YS(R(^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B
M;W5T/2(B"B @(" @(" @(" @('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O
M9&,O96QE;65N=',O,2XQ+R(^"B @(" @(" @(#QD8SIF;W)M870^87!P;&EC
M871I;VXO<&]S='-C<FEP=#PO9&,Z9F]R;6%T/@H@(" @(" @(" \9&,Z=&ET
M;&4^"B @(" @(" @(" @(#QR9&8Z06QT/@H@(" @(" @(" @(" @(" \<F1F
M.FQI('AM;#IL86YG/2)X+61E9F%U;'0B/F<Y,&PV-3PO<F1F.FQI/@H@(" @
M(" @(" @(" \+W)D9CI!;'0^"B @(" @(" @(#PO9&,Z=&ET;&4^"B @(" @
M(" @(#QD8SID97-C<FEP=&EO;CX*(" @(" @(" @(" @/')D9CI!;'0^"B @
M(" @(" @(" @(" @(#QR9&8Z;&D@>&UL.FQA;F<](G@M<F5P86ER(CY&:6QE
M($YA;64Z(" @(" @(" @(" @(" @9SDP;#8U+F%I)B-X03M5<V5R;F%M93H@
M(" @(" @(" @(" @(')R,CDS-S0Y)B-X03M,;V-A;"!4:6UE.B @(" @(" @
M(" @(" R-BU-87)C:"TR,#(Q(#$V.C0W.C S)B-X03M%4U0@5&EM93H@(" @
M(" @(" @(" @(#(V+4UA<F-H+3(P,C$@,#<Z,3<Z,#,F(WA!.U-C<FEP="!6
M97)S:6]N.B @(" @(" @(#(N-B8C>$$[26QL=7-T<F%T;W(@5F5R<VEO;CH@
M(" @,38N,"XP)B-X03M'<F%P:&EC('1Y<&4Z(" @(" @(" @($%R='=O<FLF
M(WA!.R8C>$$[*BHJ5&AE('!R969L:6=H="!C:&5C:R!I<R!C;VUP;&5T92X@
M4&QE87-E(&5N<W5R92!M86YU86P@8VAE8VMS(&%R92!C;VUP;&5T960@<&5R
M('!R;V-E<W,N*BHJ)B-X03LF(WA!.U1H92!F;VQL;W=I;F<@9F]N=',@87)E
M('!R97-E;G0@:6X@=&AE(&1O8W5M96YT.B8C>$$[(" @(" @(" @($-A;&EB
M<FDF(WA!.R @(" @(" @("!#86QI8G)I+4)O;&0F(WA!.R8C>$$[5&AE(&9O
M;&QO=VEN9R!C;VQO<G,@87)E('!R97-E;G0@:6X@=&AE(&1O8W5M96YT.B8C
M>$$[(" @(" @(" @($)L86-K)B-X03L@(" @(" @(" @0TU92R8C>$$[)B-X
M03LM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TF(WA!.SPO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI!;'0^"B @
M(" @(" @(#PO9&,Z9&5S8W)I<'1I;VX^"B @(" @(#PO<F1F.D1E<V-R:7!T
M:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @
M(" @(" @("!X;6QN<SIX;7 ](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N
M,"\B"B @(" @(" @(" @('AM;&YS.GAM<$=);6<](FAT=' Z+R]N<RYA9&]B
M92YC;VTO>&%P+S$N,"]G+VEM9R\B/@H@(" @(" @(" \>&UP.DUE=&%D871A
M1&%T93XR,#(Q+3 S+3(V5#$W.C0U.C V*S U.C,P/"]X;7 Z365T861A=&%$
M871E/@H@(" @(" @(" \>&UP.DUO9&EF>41A=&4^,C R,2TP,RTR-E0Q-SHT
M-3HP-BLP-3HS,#PO>&UP.DUO9&EF>41A=&4^"B @(" @(" @(#QX;7 Z0W)E
M871E1&%T93XR,#(Q+3 S+3(V5#$W.C0U.C U*S U.C,P/"]X;7 Z0W)E871E
M1&%T93X*(" @(" @(" @/'AM<#I#<F5A=&]R5&]O;#Y!9&]B92!);&QU<W1R
M871O<B!#4S8@*%=I;F1O=W,I/"]X;7 Z0W)E871O<E1O;VP^"B @(" @(" @
M(#QX;7 Z5&AU;6)N86EL<SX*(" @(" @(" @(" @/')D9CI!;'0^"B @(" @
M(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@
M(" @(" @(" @(" @(" @(" \>&UP1TEM9SIW:61T:#XR-38\+WAM<$=);6<Z
M=VED=&@^"B @(" @(" @(" @(" @(" @(#QX;7!'26UG.FAE:6=H=#XX-#PO
M>&UP1TEM9SIH96EG:'0^"B @(" @(" @(" @(" @(" @(#QX;7!'26UG.F9O
M<FUA=#Y*4$5'/"]X;7!'26UG.F9O<FUA=#X*(" @(" @(" @(" @(" @(" @
M/'AM<$=);6<Z:6UA9V4^+SEJ+S1!05%3:UI*4F=!0D%G14%304))04%$+S=1
M07-51VAV9$<Y>F%'.7=)1$UU34%!-%%K;$Y!*S!!04%!04%"04%304%!04%%
M028C>$$[05%"24%!04%!44%"+RLT041K1FMB,DIL04=404%!04%!9B]B04E1
M04)G445"055%0F=51D)G:T="45E*0W=G1T)G9TQ$06]+0W=O2R8C>$$[1$)!
M341!=TU$07=11$$T4$5!.$]$0DU41D)15$5X=V)'>'-C2'@X9DAX.&9(>#AF
M2'=%2$)W8TY$03!914)!64=H55)&4F]F2'@X9B8C>$$[2'@X9DAX.&9(>#AF
M2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(
M>#AF+SA!04519T%6045!07=%4B8C>$$[04%)4D%135)!9B]%06%)04%!04A!
M445"05%%04%!04%!04%!04%11D%W24=!44%(0T%K2T-W14%!9TE$05%%0D%1
M14%!04%!04%!028C>$$[05%!0T%W449"9V-)0U%O3$5!04-!44U$06=10T)G
M8T1"04E'06Y-0D%G35)"04%&25))>%%614=%,D5I8UE%54UP1VA">%=X46E0
M0B8C>$$[571(:$UX6FDX0U)Y9W9%;%%Z4E1K<4MY63-00TY546YK-D]Z3FAD
M55I(5$0P=4E)2F]-2D-H9UIH2E)&4G%3,%9T3E9+0G)Y-"]0128C>$$[,4]4
M,%I85T9L85<Q>&18;#E76C)H<&%M='-B5S5V63-2,61N9#1E6' W9D@Q*V8S
M3T5H66%(:4EM2VDT>4YJ;RM#:S535FQP95EM6B8C>$$[<6)N2C)E;C5+:G!+
M5VUP-FEP<7%U<W)A-G9O4D%!24-!44E$0E%514)1645#04U$8E%%04%H141"
M0T53355%1E523FA)9UIX9UI%>28C>$$[;V)(=T9-2%(T4TY#1E9*:6-V17I*
M1%)$9VAA4U5Y5VE9-TQ#0C-04TYE2D5G>&15:W=G2D-H9UI*:EI&1VED:V1&
M53,X<4]Z=WEG<"8C>$$[,"M0>FA*4VMT3515-5!2;&195U9P8EA&,658,5)L
M6FUD;V%7<')B1S%U8C)2,61N9#1E6' W9D@Q*V8S3T5H66%(:4EM2VDT>4YJ
M;R8C>$$[*T1L2E=7;#5I6FUP=6-N6C9F:W%/:W!A86YQ2VUQ<39Y=')Q*W8O
M84%!=T1!44%#15%-4D%$.$$Y45A6>$QB=4A)2#%B:CA4,$Y5628C>$$[2'$Q
M4#)33RLQ2V4K>7$K3S1$1VHP2&=E,DMQ,DMU>%8R2W5X5C)+=7A6,DMT3S9O
M2W-F;&EQ1FMU-6A54G@K<$E14VM9,DIP-VMG9B8C>$$[5&EQ2UAL>$A)9W14
M-&E"444K=W%C5F)X5C)+=7A6,DMU>%8R2W5X5C)+<4XQ2E!%;G%X<GI69G1X
M:%-Z:U9'-C!)*WE+;6Q#5#)X5B8C>$$[6D1E3$E&8T97:EE65C$S0DAJ:7%*
M0G)U359D:7)S5F1I<G-69&ER<U9C4T%+:S!'2V]A5S@T8C="86=#=&%K:S!&
M4&XT67%R46U9<"8C>$$[5U5"5THR561H,G%F2"]0,WA69FEQ0VQT6&=11S)4
M;D=V*S9"449603)#5F]/;S9%+U0R>%9U0S9Q;TMN:W93:#))4&=A-V<K>'A6
M128C>$$[<$]J9#9(=T]+<$(U;SAI-D@U:DQ3,VAL9W5M=#)T5G4W6F=K<5)S
M=V(T4WEU2VHT9TYU:DA&56IB.&Y.1694+T%+:DIQ*W%Y2BLU2"8C>$$[<7E4
M>$TO0S-J4TU2-WAC3T1I1TEU=D@T:D=P-T=Q<6%R*UA/:$170G)";'57=GA0
M2F-'5G!1879*9$IC:6]+.45%66A7;BLV=F@S,B8C>$$[3TMP+W Q;D1P=6TR
M;&=K:G9&85%X=TI*2U$P:DQ%;U%--4%&5TE'*S)+<6HS22]:2#!N1E5+<W)8
M17!72VMH53!K979W<5%25E-26"8C>$$[-'%'=% Q67%I8F$P4T%S+TEV3$I4
M,4A096QA041O04LW9FI5-S1Q<C1Q-T9867$W1EA9<3=&6%EQ-T9867$W1E50
M3&%%<S!K4D%D>B8C>$$[5C%A=$-1=$]V-U!19C!X5E%T-V\Q2VEQ=74X:TPO
M85=T4G50;TY$,%!B1E57;'=J8D@T5#<Y3593>GI.-5DP>GI(<'AS-S%P67AU
M628C>$$[8FDS:V%+5TYI2V,P23)Q3S-)164R2W!$1BM73G-K=#%-,G-8.'(S
M5C=*<5A&-68S8TYX3#%A,U55-#A$=D=R;&Q7:3%$53-66$PK5R8C>$$[5FE)
M=%!J:S%'.'5"<#A+45)I95=2=WE2>79*.%%$3'4O<4%0+W%*>#1H8496:S)L
M5TUM;C)-3F\Y>#8X8T5A4G!+-$EK4$552F1I>"8C>$$[<50X:&EQ264T56),
M.%(O1$953$QC1G!&4VAD>5%!:4-T03,W4CA"=#%/2W%T=&%/<FEA9&<P;T9%
M4F$X17(Q<%AQ,V)L.7=&5&EQ2R8C>$$[>%8R2W5X5E)U3%=+8V(Q4U%#:7EP
M<S8W,3)0>DA1-UEQ;VTQ=48K>7EY1&M0=%91:&%B;6]$8VUR-T1&5G%F5T)Z
M2FEE34HP3E903"8C>$$[-4)#>'A6:C!7<6%N2C5O:T12>G<R,$525C!:2E=-
M:4UF,V-I<D=G<#A3:V9V4#A!2S0Y.'AG6DA,-58K4'=865-J:D=N2%=24'DW
M>"8C>$$[=B]V9DLP+VAU2&U*5D9L,D9F:E-20CDW:%)M4S8Y8VMD,#8Q15AP
M:TY1:5)G4&@W<T](<69C85EQ=EA4>7A5>GE&=W!0-W12=U)G928C>$$[;DE6
M66XW-F4R2V]T5E960W%!1D%O04YG04U69&ER<U9D:7)S5F1I<G-69&ER<U9D
M:7)S5F1I<G-65U-W>%-G0U)1,4ML5#!)2D)&5B8C>$$[23-";V5O>%9#;7IU
M63%P1DE*449!5EIA:&EA.51)=&4S*U(Y3TMU0S-):TMM2F=&05!Q07%62G P
M1R],+VAC5E-F5F)Y+V$T9U=!5"8C>$$[47%J0FIC1TMC:71D,%I1;TI5+U!&
M57E3+T1K0E)/83E$-E4Q4'8T,'A65DM84FM:4D-E;%9K6FQ#12M'>%IV*T9X
M5F-,2U=20TIN-"8C>$$[0F=T5FE*0D(O84A-,$Y$,#)!3TMO<$DT,$)#2T9"
M3E1157%4,T]+<G-69&ER<U9D:7)S5F1I<G-666YB6$UQ9E9*;%$S1GE&.5%+
M828C>$$[<WA*47%Z;G%D=64U>EAX:U)2-6PR.#1!.%$U4B]B>2MX3F1',4,U
M;6U-53!W=45E4#%9<$%&1W=)0C-866<X:%0K3UI'2$E384\W:28C>$$[86Y&
M14-W2S-P3CAY2$1D:7)S5E%/=%A6.6$R1%0R55-Z>G%Y1#!M1$=O6F=P<'@S
M,G)82W,P<%)J8U):65I*14-W:S%R-7EU-5AJ:B8C>$$[:S!3.&I:-4E)>3-!
M.%(V-FQU4G%"<W10:7I(:G%Y96-:9%!T84DV9VXK13E0=%%R*V5T4G-X270O
M;S@O2U Q5V%A3E=724I%>G)5<R8C>$$[-#9T-F12.'AK1')*4BMQ2EEN5D=0
M3TI2*VIE8G!D578T8F1D3'5)3&574#%0<F-N.3-U:75O0D%)3F58:FQU2%9'
M8V=/16=D-UIJ>B8C>$$[.%)Q:E1)<WDS261I<G-69&ER<U992$HK665S44TP
M1GAO-W!D4V)7:55F-'IU>#))0E!W,#)8>"MJ3E=D9DUB1T\O4G=4<35$67@S
M-B8C>$$[2FQ.-7(Q>#=23&TQ,&@Q<DDV4$1-2D,O15%#9%<K1F1Q+UIP=G9L
M>#%--G-2+T97,DA02W)%9GA6<&@U93%R5611;74T-WDP3G5S0B8C>$$[5#!*
M94UI<DMR8V=706M!22MZ."]B3&-'855Y8D96.7)::7E'4DYI:S9Z2F)N67$W
M1E5K,4IZ>79A=# K1DMN<%=.84%F4V-64DYN<28C>$$[3GA.4$='-&5N2U-V
M04%H:TE5=%%M<'%24V@R1TMP;&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5EEH
M8S)C370P0DI!6DQ.,3512R]&;R8C>$$[:TE90E%6*T@T<4@T9FA02#1V:3-Z
M1'E93BM6:#)72%9E;FY5=G10-#8Y*S(R>5HK5S1Y:6-P56M75C U24IM1%-)
M=%)65U!X2&PP<28C>$$[4S=63UA9<V9#3%!.>'14;31P54]8;#$O2%192C5L
M>FI/>%8R2W1/-DE+=7=594I.4&9&57(Q,C=V,C!M9CE"6$9R*VQA23%O3&PO
M,R8C>$$[3'-#2#1/5G%12D5"1E%.=75+<%(U36)Z9&)*97=E83<K=W4P2'!F
M55IB6FE#>7-P16AK1#E!>C T:7 X2VY%<7E5,W1I:$-M94I3428C>$$[=D93
M-FI:>497;2]C:T%9<7(T<71L36]J8WA+<GEG2&=R3595=#)"64)I0C<P3TMS
M5G1*=&(O>&1Q0E<P=&I/8E=$;6AU6D%G6&LY0R8C>$$[2#E!:VXR-#166EIG
M5C)+;U!5-50Y4W5"8EA%348W-F-G=%IP<49%;#1K2WI$=49055EQ>&IY9DPU
M-VHQ0U@O170U<#!L:3A$>6E/,B8C>$$[;$UK:V1W.7=X-$%S:V8W<$5B9W9Y
M2&5U1E=8<F,R>E-#3EI585)G>%9!=TI)46=.468U2DY$9U95>%8R2W5X5FIE
M<UA-0S9N=DA*-B8C>$$[8U1!>GEH=T5$0U!K4W<R,C1%8CAV154S*TMO-6=*
M55A*1VU*9TI$;65N,F9F,%@V8F,R-3%+24Q(255L4#=Q6&Y60WAI-4M66&MF
M:"8C>$$[.4U%9'%(<V5Q=FEJ:4%#4'DU141)-U8P*WHX9FDU1&QR:G5X5C)+
M=7A6,DMU>%8R2W5X5C)+<54Q=TET*T1/04MU5G X2RM*0DE0,R8C>$$[5GA6
M:C=R34553S9T040K-EI&4$DP*WA535)4;#!X5D<V93EZ2$UZ5$):1S0X66\T
M9V%M<'$Q4WA#:6Q02$95,U9U4V<P<%AQ1%-O.28C>$$[='-68GA6,DMV4#A!
M>G!Q=FM,>DAB9F]J5CE59E1M<V(Q;D-S9U(R:W1G63)+*W%J,6IR3'5W-FHO
M2G)H5FAT=C56+TIE1S1U<C-43B8C>$$[8VUC0TM3939T;W56=W!J:G,P:&-L
M4VA)3$DS4#1J.%1.-T%"5F)B95A0>6UM;&-N>DQC4E178E)#4T\T16%3:&]W
M1U!0.3)*2V9U:28C>$$[1U4W5D)R:6A&85@U8B])8E1,84M'-C%M4%591'=E
M,FIU6FEZ07=Z4G)'14U14U$X6D565E-V5&%H1TM8<U9H<49J<49Q=#-9>G!C
M5R8C>$$[>G,V<$Y'95-K>'5586@W,%I334-O:D96:3(X0WIT3W-A0V1W1F55
M2T]:5F5G3&130EA&5BM+<%(U9S@Q85)O2#%9-FLX:4QD1U)95R8C>$$[:FEE
M559J47E%2&=',TMJ8GAX5C56<5=M+VQL9%A/<EA5;7$S<TTQ,6942G%%6G16
M1%%Z369R3&=F=5$X450P4&E93EAR>4\Y8TM&5R8C>$$[4%$O>5IM,#E:24YB
M141Y<5),2U1'-W1*25A,0U)84U)3=T%98V5I.$LP*T=U2V\O>79(*U-8;'I7
M2DQQ,C%Q0S4Q:7DK<U Y6FUN3"8C>$$[=D)&27%*3EAH>%1G5$=0:6-(<E)4
M43!X4SE90D)!239(8UE&9&EQ,E-124)S5UIJ4D5&2W-A13!&4T(P1TMS43%W
M,T5L,V9',VMI3B8C>$$[;S%29&QL9C%%2WAH2$-J64Y25G%-,2ME*TDQ>2]9
M-VY31U!$1W=E3' S8R\Q=3!D<#1B-GE-.'-45U-61G$X879Z9CDP=UAK1#!Q
M=28C>$$[+W=!.7-C25!%3S<Y:39O>#1*541X9&9M4#!S=FIK1&<W14UP;S9M
M;%%306%';%(P3V)",'DW1EA9<3=&6%EQ-T9867$W1EA9<6=B,B8C>$$[-G0T
M-51B*V]N<C-#96UK6F1&24\K-41-1W!V,D)X5DQM4TUQ669604YU+T5N:35Q
M54A)9$8W+S4Q>%9%4C--341Y>G4V96YB,%9Y5R8C>$$[0V9A1F5S;D)D='4O
M.7%Q85%32DI%<VMB0FME<D%G9VIC,39G:UEQ=GA6,DMP4&4K5'9+,3=C3F,S
M5VQ7,'1Y-GE+,7=9,45T2F9T,"8C>$$[8U598W9'=4MV2W)8>34U-3!30V5W
M=%!*3VQ89&A*0GAT06]6:D=R0S12-#4R:VTY4U)M:FIG1WAP46=6<FA655A3
M=D]S9',T:R],:B8C>$$[4W)U-6IT4DE::6)E4#%:<6]O='=O8C1F9VMB-'E4
M,&]D.7EQ.4,P5'EF-69K,#9Y=7(W>359,D]P1EEP<#1)-&]Z-F,V0T]H5F=/
M<28C>$$[;4-0:64S165'0E4Y,'93-T13=$]T=$XP-D)B87AS-#%H=&]%<E)%
M455!,W%4.'IV:7%+>%8R2W5X5D,V:'!7;6%J1W-D+V%X6%-,>28C>$$[-')-
M:75">E5O,4]14%9724]+=DQD63!4>FYA*UE%4W@X;F%4<4]G=F-Y3$%V0TI*
M26=K:UEI=4IM6C$U07!.4%%!13EE5DYS2V],5"8C>$$[3DLX-U$K:S@S-65A
M4S X>&4T;&Y!9VI%3%%X=5E%-$(S6FEX:E9+.'%R6'=.07%Z4'EL-5 P<3DX
M=G=4834U5'-D1C%+4D9J=4Q'0B8C>$$[67E&:FAK:FMI5&Y(,55',VEQ2S!0
M158R=TMZ8D9867%G.5%U<F5"-$1*26]D2#5R15=53S1+<VYW0FE+;7)9<6MD
M.5IO2'5O5VU66B8C>$$[-S13>DI&>&1M0VM"5#EH6')X<79+;E-V>7)I-4U6
M:S<X,U!W-2M'35-186EF,#,K4&,V,7-6.65Z=#0U9S!L<'AL2W-K:UI:14)1
M2"8C>$$[-&Q!57-4=%4K4&AJ1$959TPU9C),;'HX55I'=G$O6&%F5T4P8S-R
M>6]Y:U!*6&E'5FET1E9#1S1K:7164&9-<'=%5FER<U9D:7)S5B8C>$$[9&ER
M5$UQ<5=99TM"56LW04%9<6A*3'E34E-,9&5!22M'6G@T9T5%2C$O-$MN,#1Q
M<"]6>DU#<VAA9FM!<FAZ5E1497!46DLO25EQ="8C>$$[=7)"-4=T>GE#1DI!
M45%">6]!4U%$,D)!;V9B8D962G1*5T(U1U=::DQC37I&<4%T46=H5G$Q4E)7
M9F)B=C@X5E=Y84]O=')L-%II1B8C>$$[=4]-:%5$-$)1.&TK16LQ-3<X=D5B
M92M+;WAR24%Q,W!Q5U%54G="5E)3;G=N<5!O>%99:EA-2DAP=GIJ5E-04VQ*
M2DHS<"LX3E=(=B8C>$$[6&QI<4MH=6\U2$UE-E-!1G5$9%-O3DMI;%%F-&)6
M>%97>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMO6G(U4U%)5CE15DE:
M>28C>$$[94MJ:6%';7A*4#!5.3A6431I;&QO2FYA5FE#1U565D-'-FIG1%%J
M+T%&<2]01E=R;E1P1W-*64E&5TUL0W-A04%#=$YH4VQ-5E58,"8C>$$[9%)0
M2F9*2U1*2F)*8GAK-W-T1UIG5DIR=7AC5DY/=S8U1&<Y6$8U53)N2V9$15!/
M+W4K-SE,9'9O.%188U8V2$AQ4G!,16%+5DQ#4B8C>$$[,613>'%/;35P4VQ7
M,G!I665R:55:4TE'2%%K2#<O>#A&5S(P,6QS-%EP<51M341D-D5H;"MJ=#0U
M3G%8,'5)-4%5;%IA3GEK4B]J1"8C>$$[5G!59D8X4S=D3TI!*V5+<7-6*W9W
M3&-!47E/47$O1GE2;5!25F%I-R]-1#)X5D99<3=&5FLX>7=X;#)"4%I66&-K
M;F]":7%$-'EZ3R8C>$$[<E-56FQR>%)A.%9Q9F9Q86)6*S9L8U92561U;S-B
M8RM(8D9654%!54A41EA9<7!Y46@R5G$P2SE0=D(O5V]X5F9'9U)&461&04%R
M-R8C>$$[8EEQ,VEQ,30P8G%0<#<T<6AB:3!6:%)L-4M$5E0S56IO45(P23A2
M:7)59#8P8VY#-&]),DE%53-A<"]:9G=*4#)4,S9D85964G5+=28C>$$[>%8R
M2W5X5C)+=7A6,DMU>%8R2W1/-F]P6FI24C%/2W!F2UAU>5)+<%-%16A982]B
M0C)Q+TAQ1'9283!P,3,R0W%+:G0K-R]D:7%U028C>$$[04M!54=+=7A6<#$U
M3%-T1%5%2#-"<FEQ,D=,,#%P5W!.2VYP,$%(-FAI<2]&5VU65T9#2S1Q:#5R
M645%06-L26]Y;F9B1E9*2C-G3B8C>$$[5TIA04)I=V]864=T9FAP56MD9'9L
M5$9586IO-DLV34=29T=6;$Y1461W45)I<4=M:$Q82$]H6G%C5E!903E14$-V
M9D954DA%<41B8R8C>$$[.7II<3=&6%EQ:S-M9GDT*W97:V1S=7(V:G!#>'-7
M36UM5$I"23E62S!:,E-1,$%*,D9..2MO1D970V5A+TY/;7A73G1R5BMF36QJ
M1B8C>$$[6C-6>D-,93!U<DM&-5AT<%E,4C-A,U<T2')2:59$4E9"2#(R6E%J
M2U-Q;6UM5RML82].9&%46F5:3F)I=4Q31THS;%<W:41S<W%W3"8C>$$[.$I#
M=E9O;71/36AP<S=Y03%,;D979%=D<TQ7>F=T:$Q*34E),&HY85IU8W(X1D,X
M;F,O85DP<50S3TMQ,DMU>%9$6$9S<DM2>#5O,B8C>$$[>DE25550=&ER<E)P
M12]C3TA015934F=45F5L0S-I4&9R-S<T<6EC5F1I<G-69&ER<U9D:7)S5F1I
M<4-N5U,T:U!*1#958F9U>#A1-28C>$$[1F8R;4)P,&(W4'DU949&55)$0T9&
M5RLQ*W)&5EA&6%EQ:$Y7<T@Q1%1B:7A3-FUS:F-O66ID5WI"2FM6=&U-5&M(
M9R]'=D9U>#-X5B8C>$$[9UAM2WHP3W=M97@Q4'I8<D=N>FQK95,V5S=K:41#
M+VUA84]R;'91:4,O55IO,"M&07%F1'533U-Q;#5A=$Y",4HW46%F-7DQ93=N
M=28C>$$[,&MN9VEU-W0K5'!31G%&14U1;W-92$5#:F)Y16MN;%)3>C-13DEB
M4TY)=#E/83EU9%)A1&QY=DPR47I4=5AC=654;F,P-558=U=G>"8C>$$[46U'
M2W5X5E-M:$)(2E(X6&-E3TMQ54AR4GEC4T=A2G1G2T-I2')8<V%(-F-64E=+
M=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5B8C>$$[,DMU>%8R2W5X5C)+
M=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8O+S)1/3T\
M+WAM<$=);6<Z:6UA9V4^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @
M(" @(" @(" \+W)D9CI!;'0^"B @(" @(" @(#PO>&UP.E1H=6UB;F%I;',^
M"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T
M:6]N(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIX;7!-33TB:'1T
M<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+VUM+R(*(" @(" @(" @(" @>&UL
M;G,Z<W12968](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]2
M97-O=7)C95)E9B,B"B @(" @(" @(" @('AM;&YS.G-T179T/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V5%=F5N=",B/@H@
M(" @(" @(" \>&UP34TZ26YS=&%N8V5)1#YX;7 N:6ED.C,Y-3A!13A$,CDX
M145",3%!1#0P.4)#1$0V1$9#,S0V/"]X;7!-33I);G-T86YC94E$/@H@(" @
M(" @(" \>&UP34TZ1&]C=6UE;G1)1#YX;7 N9&ED.C,Y-3A!13A$,CDX145"
M,3%!1#0P.4)#1$0V1$9#,S0V/"]X;7!-33I$;V-U;65N=$E$/@H@(" @(" @
M(" \>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/G5U:60Z-40R,#@Y,C0Y,T)&
M1$(Q,3DQ-$$X-3DP1#,Q-3 X0S@\+WAM<$U-.D]R:6=I;F%L1&]C=6UE;G1)
M1#X*(" @(" @(" @/'AM<$U-.E)E;F1I=&EO;D-L87-S/F1E9F%U;'0\+WAM
M<$U-.E)E;F1I=&EO;D-L87-S/@H@(" @(" @(" \>&UP34TZ1&5R:79E9$9R
M;VT@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" \<W12
M968Z:6YS=&%N8V5)1#YX;7 N:6ED.C,X-3A!13A$,CDX145",3%!1#0P.4)#
M1$0V1$9#,S0V/"]S=%)E9CII;G-T86YC94E$/@H@(" @(" @(" @(" \<W12
M968Z9&]C=6UE;G1)1#YX;7 N9&ED.C,X-3A!13A$,CDX145",3%!1#0P.4)#
M1$0V1$9#,S0V/"]S=%)E9CID;V-U;65N=$E$/@H@(" @(" @(" @(" \<W12
M968Z;W)I9VEN86Q$;V-U;65N=$E$/G5U:60Z-40R,#@Y,C0Y,T)&1$(Q,3DQ
M-$$X-3DP1#,Q-3 X0S@\+W-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#X*(" @
M(" @(" @(" @/'-T4F5F.G)E;F1I=&EO;D-L87-S/F1E9F%U;'0\+W-T4F5F
M.G)E;F1I=&EO;D-L87-S/@H@(" @(" @(" \+WAM<$U-.D1E<FEV961&<F]M
M/@H@(" @(" @(" \>&UP34TZ2&ES=&]R>3X*(" @(" @(" @(" @/')D9CI3
M97$^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S
M;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D
M/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T
M86YC94E$/GAM<"YI:60Z03DR-#(R,38R-#A%14(Q,4%$-# Y0D-$1#9$1D,S
M-#8\+W-T179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IW:&5N/C(P,C$M,#,M,C94,38Z-#(K,#4Z,S \+W-T179T.G=H96X^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E($EL
M;'5S=')A=&]R($-3-B H5VEN9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H
M86YG960^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @
M(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @
M(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@
M(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.C,Y
M-3A!13A$,CDX145",3%!1#0P.4)#1$0V1$9#,S0V/"]S=$5V=#II;G-T86YC
M94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(Q+3 S+3(V
M5#$W.C0U.C V*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!);&QU<W1R871O<B!#4S8@
M*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @
M(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @
M(" @(" \+WAM<$U-.DAI<W1O<GD^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N
M/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @
M(" @("!X;6QN<SII;&QU<W1R871O<CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]I
M;&QU<W1R871O<B\Q+C O(CX*(" @(" @(" @/&EL;'5S=')A=&]R.E-T87)T
M=7!0<F]F:6QE/E!R:6YT/"]I;&QU<W1R871O<CI3=&%R='5P4')O9FEL93X*
M(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I
M;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.GAM<%109STB:'1T
M<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W0O<&<O(@H@(" @(" @(" @("!X
M;6QN<SIS=$1I;3TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E
M+T1I;65N<VEO;G,C(@H@(" @(" @(" @("!X;6QN<SIS=$9N=#TB:'1T<#HO
M+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+T9O;G0C(@H@(" @(" @(" @
M("!X;6QN<SIX;7!'/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O9R\B
M/@H@(" @(" @(" \>&UP5%!G.DAA<U9I<VEB;&5/=F5R<')I;G0^5')U93PO
M>&UP5%!G.DAA<U9I<VEB;&5/=F5R<')I;G0^"B @(" @(" @(#QX;7!44&<Z
M2&%S5FES:6)L951R86YS<&%R96YC>3Y&86QS93PO>&UP5%!G.DAA<U9I<VEB
M;&54<F%N<W!A<F5N8WD^"B @(" @(" @(#QX;7!44&<Z3E!A9V5S/C$\+WAM
M<%109SI.4&%G97,^"B @(" @(" @(#QX;7!44&<Z36%X4&%G95-I>F4@<F1F
M.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" \<W1$:6TZ=SXV
M,3(N,# P,# P/"]S=$1I;3IW/@H@(" @(" @(" @(" \<W1$:6TZ:#XW.3(N
M,# P,# P/"]S=$1I;3IH/@H@(" @(" @(" @(" \<W1$:6TZ=6YI=#Y0;VEN
M=',\+W-T1&EM.G5N:70^"B @(" @(" @(#PO>&UP5%!G.DUA>%!A9V53:7IE
M/@H@(" @(" @(" \>&UP5%!G.D9O;G1S/@H@(" @(" @(" @(" \<F1F.D)A
M9SX*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O
M=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT3F%M93Y#86QI
M8G)I+4)O;&0\+W-T1FYT.F9O;G1.86UE/@H@(" @(" @(" @(" @(" @(" \
M<W1&;G0Z9F]N=$9A;6EL>3Y#86QI8G)I/"]S=$9N=#IF;VYT1F%M:6QY/@H@
M(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N=$9A8V4^0F]L9#PO<W1&;G0Z
M9F]N=$9A8V4^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT5'EP93Y/
M<&5N(%1Y<&4\+W-T1FYT.F9O;G14>7!E/@H@(" @(" @(" @(" @(" @(" \
M<W1&;G0Z=F5R<VEO;E-T<FEN9SY697)S:6]N(#8N,C,\+W-T1FYT.G9E<G-I
M;VY3=')I;F<^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IC;VUP;W-I=&4^
M1F%L<V4\+W-T1FYT.F-O;7!O<VET93X*(" @(" @(" @(" @(" @(" @/'-T
M1FYT.F9O;G1&:6QE3F%M93YC86QI8G)I8BYT=&8\+W-T1FYT.F9O;G1&:6QE
M3F%M93X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @
M(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @
M(" @(" @(" \<W1&;G0Z9F]N=$YA;64^0V%L:6)R:3PO<W1&;G0Z9F]N=$YA
M;64^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT1F%M:6QY/D-A;&EB
M<FD\+W-T1FYT.F9O;G1&86UI;'D^"B @(" @(" @(" @(" @(" @(#QS=$9N
M=#IF;VYT1F%C93Y296=U;&%R/"]S=$9N=#IF;VYT1F%C93X*(" @(" @(" @
M(" @(" @(" @/'-T1FYT.F9O;G14>7!E/D]P96X@5'EP93PO<W1&;G0Z9F]N
M=%1Y<&4^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IV97)S:6]N4W1R:6YG
M/E9E<G-I;VX@-BXR,SPO<W1&;G0Z=F5R<VEO;E-T<FEN9SX*(" @(" @(" @
M(" @(" @(" @/'-T1FYT.F-O;7!O<VET93Y&86QS93PO<W1&;G0Z8V]M<&]S
M:71E/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N=$9I;&5.86UE/F-A
M;&EB<FDN='1F/"]S=$9N=#IF;VYT1FEL94YA;64^"B @(" @(" @(" @(" @
M(#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI"86<^"B @(" @(" @(#PO
M>&UP5%!G.D9O;G1S/@H@(" @(" @(" \>&UP5%!G.E!L871E3F%M97,^"B @
M(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \<F1F.FQI/D-Y
M86X\+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:3Y-86=E;G1A/"]R
M9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D^665L;&]W/"]R9&8Z;&D^
M"B @(" @(" @(" @(" @(#QR9&8Z;&D^0FQA8VL\+W)D9CIL:3X*(" @(" @
M(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \+WAM<%109SI0;&%T94YA;65S
M/@H@(" @(" @(" \>&UP5%!G.E-W871C:$=R;W5P<SX*(" @(" @(" @(" @
M/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \>&UP1SIG<F]U<$YA
M;64^1&5F875L="!3=V%T8V@@1W)O=7 \+WAM<$<Z9W)O=7!.86UE/@H@(" @
M(" @(" @(" @(" @(" \>&UP1SIG<F]U<%1Y<&4^,#PO>&UP1SIG<F]U<%1Y
M<&4^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D
M9CI397$^"B @(" @(" @(#PO>&UP5%!G.E-W871C:$=R;W5P<SX*(" @(" @
M/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F
M.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.G!D9CTB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]P9&8O,2XS+R(^"B @(" @(" @(#QP9&8Z4')O9'5C97(^061O
M8F4@4$1&(&QI8G)A<GD@,3 N,#$\+W!D9CI0<F]D=6-E<CX*(" @(" @/"]R
M9&8Z1&5S8W)I<'1I;VX^"B @(#PO<F1F.E)$1CX*/"]X.GAM<&UE=&$^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
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MA2G(8IR& !*8H@8I@'V$!#D!#\P' /K & , 8 P!@# & , 8 P!@# & , 8
MP!@# .JH^9)',FH[;)G*/!B'63*8H\<\"43 (#P(#ZA@'Q\RC_\ +FG_ %A+
M_;P#C:3$2_>/(]E),'CZ.3:JR#-L[07<LDWP+"R.[13.91N5V5NN9N*I2 L5
M%0R?<!#" &1P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@'"X<-VB"[ITNB
MV:MD5'#ERX5(B@W01(919==90Q4TD4DRF.HHH8I"$*8QC 4!' .%.1CUDR*I
M/F:J2I"J)J)N43IJ)G*!B'(<IQ*<ARB!BF*(E,40$!$!P#[\ZS_RMM_KTO\
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M3:?*08 P#JNWK9DGXCE8J9?7M 1Y.<0^A"!R8P_H' >XB >N 0.4L#A]W(H
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M9=90QA,JX=.5U%'#MVX.JY=N557#E55=510UQ@&8P!@# & , 8 P!@# & ,
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MFRN4AP+NF[4G>X631+^)S  C^10_>,/Y% 1$?0 YP"+/K40O<FP2\0?4/'6
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MZ<] =V"LD%96QG<')M9%)(XHN2)'$CIBX+SWM)%BL5-[&O4A 2K,G[=L[0.
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M@V:*''Z&6.5, _/M(!Q$/R[BX!@W5ADW/( J#<@\_=;@)!]?Q4$3*?Z#!^F
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M@N-))-%--%%,B221"II))$*FFFF0 *0B9"@!2$*4 *4I0 I0     ,H/O &
M, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# (!:=95"
MV.OFKU@K&V(J)4$;57G2\%94D4Q$R3<\M'F16?LDSB)_EDH#^+4,(^,R4 1
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MR0OD&5:NE*MTNQY:G56348/&;9L)" 8JI@\/)QX_1=..J(O/*<\].>5&X<#
M[7>0L2X9+:OE6:\<S4;S+>?GE4I)(S=,2OTTF-29,@!V'[?L: @W*)Q*BFFF
M!2!>FN?/J#+C2-P+G 0LVMHI/@>XHU2T6 X#]  _VOK11#\3"0O\W+K\>?W!
MW4M67!T7B9VH_;F]>?L?4:["%$!^G_M.6]*EX_C$5*;Z@(#ZX!D&^D:>8##/
M/K=<#'Y\5.RVR86CE@$>1(O7XIQ$UI9,>>!34AC$,7[HE$OICOOW!8<!5ZU5
M&GR^L5Z$KK$3=XLX.*8Q38Q_J<Z+%!!,Z@^YE#%$YA]3&$1YP#.X P!@# &
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M*VN&GN]#75$%-$^>=:);A;X*2IGBACDD2D_-1U=3NI%10U50]D+MELRT\O&
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M2DFBC1)*FE6G<]U&]C4CAPQKO9//H(]K& , 8 P!@# & 5;MK^X,-_G5#_\
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M)_RC[58X7NK:.V;514UNN\-2ZF@M-LANL\43V14D%,[U=SV0^1Q@# & , 8
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MU'G"UB$;V%\XGBC+5YXLBWC!<R35JJ@C,L(F6(]BV>X;F%]?0N/!!@# & ,
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MBN9:S&*4!.*?R^D/CE#CG[T:A(QBC@"^YVS>?36, "1%VLIVB=KG&-.O]@?
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MKHJ?4'4670;HJN7"R2#=%,ZRSA90B2*2*91.=554XE333(0!.=0Y@*4H"81
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M%&X'\![3%-P/KP8!]A#-U.+O7[(<8F&4# & , 8 P!@# & , 8 P!@# & ,
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M%%UJ\H@:2I,@H?DQBKUTZZ'RDRAQ$YW58=PC@ZIA5=^= /!-,<TZ(GEA/+O
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M4AYCU]^\?# )+E P!@# & , X7#=!TF9)PD55,WN4P>WYE'W*8/H8H@(?0<
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M@4"*^IE&P !2*?412   "*#]2>A3_3M-^\!!3%,41*8!*8HB!BF 0$!#T$!
M?4! ?00'U# (M*Q4FUDT+=45D&-L8(%;'(Y.HE$VB)3.=8U=L7@IK'\J9115
M6+EDD%W]??*F=M".&CB3BY,"Y:=;XVZ1 2;!-PS<MUU(^9AGY4TY6 F&Y2&=
MQ,FBF=1,CA$%$U45T5%F<@R6:R4<X=1[QJY5 E> , 8 P!@# & , 8 P!@#
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M?%^;/HXQ>#($FSB@[?LP#P#29'4F0"NY-\=8"9X P!@# & , 8 P!@# & ,
M8 P!@# & , Q\LV?/8N0:1DC\HD'3-PW92H-4WQHYRLD9-)Z1FL=-%RHV,8%
MDTEC>"=0A05*HGW$,!"8'6T37(EG#1KIT#5F0P>(X'S+QVX64.X>2$@[5.*S
MV2D7:J[Z1?+F.X>O7"[I<YU53F$#,%J3<# )GBIB@(")03( B'/J'/</'(>G
M/ \>_ X!*TDDT4R))$*FFF4"D(4. *4/8 _\1$>1$>1$1$1' /O & , 8 P!
M@# & :W]76E8'J Z<MMZTFZ@WN[F5I%F=U* <.E&0JWV/@I)>E.FKLCZ.(V?
M-+#Y%9FNX>(M4G $4<F!$IA"*B+HH/+2S]%VP*1\/_H8U56]%V.Y0=(L.C=@
M]=73)2[I#15TW8*6G5(?9\4:8L-ZK]4M\A&;:-7+K9*@[O477;XA57,<W>.P
M7;-7VG'[4TT3"JG->UUQS+IE<::Z>_O]S6V*Z0]B(=:>M]HQ/0EO2C=/L;I_
M6U<UI091]I+9[O45QC]P;_G%Y.=GY3J\8O-5,(="XZ_OJD=0(O<)8J!*2@QD
M$R&JM(M:8PN=WFBZ(BJFJ^?/CSQ\$+IHN>'P7Y)Q\\].!/\ 44=UBTW3OPKH
MBP]$W5<XL?0Y,,&.]HMO9>FET_V(WD^E?<6IUI>@.%^I=%E:(R'O<W77<I]N
M'U-D 9R#.2CH^1=MW39IJ7.4PBX3/3IA,:DZZ_77_'^#^A*L3#JPUJO3[ZNS
ME0>SD'$S#RIV?Y/]I:NZDV#=ZXKMA^SLQ8:_\\A55SQLM\CGYR'\^V<?+)B3
M9> ]7U$,Y@# & , 8 P!@# ,')P+:25*N*AD%0#M.8A2F\4 X HF 1#[Q0#@
M# /J7T'V#@#&?9%#_+5?]43_ &L Z5;HR57L$],1THX!C9$VKB5@SH$\D,ZT
M(1J6?:'*H!FKU[&IH,)9,"'3?E81CC]@NV<'> 3S & , 8 P!@# & , 8 P!
M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
J, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>g149615g91m18.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g149615g91m18.jpg
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MEYBVTR0W.%'4U3-"4F%Q)28T1')#8J'"T?_$ !T! 0 !! ,!
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MID/$3ILPM3A8R5*.*SG*G")"7-6K.?SY4N2\ZK.<_P ><YSGDA#%C1T1L>.
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MZ2Z4PS%FD$Q&5)A#YLIQN,K-3(U-;-T?.D:EJ($*KT]5P[,:DDFM!%AS)IY
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M;TQ*F08U<*4=IC&](>#NK2>8<EK;:O63WD&5!B1SSGS @2,8#ZXXGB(+HO\
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M[V/)%?&'I/6,_4;618\.IC0YI9D.:R(0Z!IA>, 24V$P<I 1L*/ZOV*&%MT
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M1%3;;EOS]O/Z.ONV6M6V.V'B!NCN[LW:5EU);M&:2\4?1VCTBZA<MSZIVS5
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M"3\W'CH7RR+]H%^?CZ@ _P MB/[2A?ZW'A)?R:1_0D_-QXZ%\LB_:!?GX^H
M/\MB/[2A?ZW'A)?R:1_0D_-QXZ%\LB_:!?GX^H /\MB/[2A?ZW'A)?R:1_0D
M_-QXZ%\LB_:!?GX^H /\MB/[2A?ZW'A)?R:1_0D_-QXZ%\LB_:!?GX^H /\
M+8C^TH7^MQX27\FD?T)/S<>.A?+(OV@7Y^/J #_+8C^TH7^MQX27\FD?T)/S
M<>.A?+(OV@7Y^/J #_+8C^TH7^MQX27\FD?T)/S<>.A?+(OV@7Y^/J #_+8C
M^TH7^MQX27\FD?T)/S<>.A?+(OV@7Y^/J #_ "V(_M*%_K<>$E_)I']"3\W'
MCH7RR+]H%^?CZ@ _RV(_M*%_K<>$E_)I']"3\W'CH7RR+]H%^?GR<>(Q(8E=
MS]VOQGFI##D^FY;>8<0ZTO"=<T]*LH<;4I"O)25)SZ<Y\E8SC/WQG'/=_9"Q
M[.SG33'M<QR"L=VO:K7)O;V"INBHBINBHO-.B[Y\X>W%["=J>K'C>TC'&J^%
M['(YJ[4=8B[.:JHNRHJ+LO)45.N4U%%B@(E!,A"4\.7&26I@XH+F2!Y$?,85
MA;$J%-B.-28LEE>,+:?8=0XVK&%)5C.//FQ#@!*"6/)"*1',QPS .-A0E&Y-
MG,(,B.8]CDY.:YJHJ<E3-6QI,B&<,J(<T63'(TH)$<KPG"5B[L((HW-(-[5Y
MM>QR.1>:*F=DU.[MT;<U;'ZI[RTG&Q049OX.O;JK<5B!M.DJ=PEM,N0[%:;^
M<QFU8:>F.14H?EIC>X8"VV0O#>--V/9K9Z=F%O>S*R]$2GKWDO3<Q[BT=DB;
MJHV-(Y?#O7=S1M(JM&K]H\F Q-UWO5]K%1JF #3G:[4^G(8V]U"U7 &P.HJI
M7)PH1[AM;XIC5X7$<-$>1&<4J+9/5$RTU>T!^+GUKVUMOIX;<[%7/9+WTR#V
M-5H\+Y_K'5#\7$HY\$%C3'B\BZMRD(BEVQL2.4B/_*2[@45@%*BO0B7JOX7Z
MRH*#M"C)I"NIF^-DU$YY/"W5\TG=Q>\DO&T#*U1JI *8CP$;XB.DD_BF$;L.
M%HOX#:#U)J7LPENUO:WSO 1+RN8+QE!IQXT++[J(,KI+[5I$0<EH!LDB<L:2
MZ+'2(0;^B9S#F'',/87AW"UX=PYA6',.85GUX<PK\K"\*\_7A7Y7J\_/[^?/
M3[>'A3AVX=DX>';AX=N6VW+;;IMRVZ9Y =Q(YW%OQ;KQ<6_%Q;\^+?GOOOOO
MSWZY-NE]Q%==6"M#CQ^]R=0-7,3:KQKBLV6<*%6] YR-E^*0%XF1Q,[)"-#C
M#IN9K?J>'IRQAYI2&7&HUJ/3P+>),-%BU;-0.KCP:RXFPA'/7J9'\+Q'[MYQ
M=T\CS"[M=FF7C5KD5S72S2NJ)%'-@ F3+@FF6VD:QMZ*OGEC1[- *SC&:/WK
M(QE,P3 %[YN[P(K$<U4:YNH6S:5\N1&]3C%F,YC['MLB[6\+')SV01BPNS)\
MV/.F"4R/@Y+HUPE+:&+D-.N06'<M1UH3]N9"!1U=<&K%'A1^.G@,K:^2\(G2
MH\1HQ#>(9U9WC&F0(W'1CFH5S>)Z*N8VRU%<6A[@TFPE<%[9/MK.*R09D.5-
M<4Q6&+&1_=$<!3E;'5[7*%CN%BM3EEI.M72LUMP!,V[M2RQ-,]>*_A4DSL.P
M99BRCS,9[VI$&G19OI;EN./X^7I,/H=@H(.8ACHIXHR^)3"-9]H\:@E#H**&
M_46K9:HR/414<1D5SV\3"V+Q;N&U&KWJQV*TJB12&)% YIUV%H/LIEZEA%U-
MJ*>/2VB82*25=S>$9)C!NX7BJQEV:17/_ I*>C@H=>Z .9(:^,DU6CO1K?1
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MR2XXUCL(1&A-R<_#'[2M(@3QD:!=$NZ73^HM$T:C2(VDL=.3"3@44BS<8J6
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M WLR\GF*R/*RY>O+$.I=)3QD=.LY=-)M D>^&^"Z1:2#L!+-'D!=$\3%ER;
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M)5CVHH9H4ID*P)#<*>=8L-TF8.(Z+ [^2B@8V>6,[OD4;D1R*F63- ZM(2U
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MAR:-KX+7)6LZ[L.K4J7"5/7+$B-MV6LW/9_O2I4R1(,E+_;Z?7K3;; =<)V
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MLY7: 635RZU:MC$E:*H=&J9);E5C*.TCV;;#@\.B.?)6/W#HW$U!(]2(=^W
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M'-( P'&/2IMM_/I>PK559'L*KM8OZTE@V('5>GH-^UU?$$S>;6%=7/$SQ[K
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MWB2N'=*WTD^38(J$;_JO'ND+#2.CD\1OR#RXDSI8JEH.TFS ;?62#PJPUDM
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M5!K9D0CD53;:<: 2L(#*ASZ?8R23D=F7&>=DQG<K:3@R=J,X;+@K*^OG"BU
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M$$ JTLZ02$P,=[7QQI'<11<$=S&*!JM5 HUK1\+6HB>('<&U:M4#&OZWL6Z
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MGXYZ*!2))P13\X>B,/F6Q-1Z29'XA5;I=BTUJ=AY=%2!C][*C6K(G&".5S#
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MX8W8^ND&RA@H)F4 IKTA*@SR7Q%?G0JLIB/=DU/J9L'4"+=27R(-K!(D]@0
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MZV5?]AN/O@=<?)-._8)WZTQ][)V>?+-4?C*O_5&/W'_JS^D&Y/ULJ_[#<??
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M 4T)3ZAL<C2JH(=#:G)OXLH0#6@N8D:,RB?0FZ.3V>6Z=?/RY]>F6Z[\VS=
M.5UF'Z^*WD)I&P8V+C:]Q $MR5D[#L<&JUQW34*UVO4&N-B;0K 8L[)NY*:\
M^$"ABUR!U.M6TQ[9ENKV1A-ME]O+;YM^?FGNZ<^OEOE7[6]V0L%AJ&KKK?\
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M G_J^/25=\OA?:@?\3'CX/RV)]I#^?CZYI/Z85;]8!/_ %?'I*N^7POM0/\
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M#C'E+5A:T?C1=^]SV92OG:GEEIE%8RY$(HHG%.' >0!Y26TP-S'F(RJ11>%
M-D6.>2M<%&L26/OGN>Q,AK7._P"E#=-!5S-WG_@=KW@+L*LGJSF(]+@3=@AT
MC;$S?_H$D#=HP:JNSCCT(I/"1[,@W86*S<6"@4((%]E/\**X.GHRDU'*[N\L
MH]K#DP^!Q!%M8_<RVVBU9HRUL>$XLEPSEC-F)(ELA6#3QHT</.K^$4$5(!7W
MLCN[>>"RBR(JL5XWV0$%);8^CBQU@ AJ20HRE V4AY+8LUI01P"V+9FW;^QV
MH;H@^^EJS3A)"CBD01L.)/C&;!8*7:S42FOCV:4=?40LYE=8E9.$[;7DB0XV
M3#BAW$E$%W;NXOK1NMDK!6AX< !:T""",962)<JNG265[A-K93E-,D>"?X@T
M^)W$<3V,CN0Z'=<VMS8MU8E>.P-%A!)!"C!#85AY,F#+.R$\;8,AW>RCK$<A
MRS(W<A&]C0*TO?+JA&=V[#5"@+2?W(7N)[3M7M@U$6DU"5 _#N8)C?G]"V9B
M-3FFZE1*^&Q';864=#+5F99I$RPRS$,;'CV)2Z\CP*I4DZ@/82M/0IPFLKH!
M!?">08/BJNXX(") K8L?A1JG6.OX28Y\LAQB8VT*36085<J2+LTV1219@D9!
MA.%\(#%%XBOM$9"1(=?'!PHG?*!?7E.?)>=@FMYNS]I]D*N.VRXW%OP2-1(?
M:T_BVRZF-15, HXI!?1+@HV^/<AE?ET5$G#>&4O*;E-+A6!;DO+3*^=W=ZNA
M!O7-9:1F58];RO'$@A2$L9@&R-,N!)<)1F03$(B</$J/11RE5ZM:O9:VVIHH
M[A498 97CU?(\8^&)(GAV@0] H9#AJPO=M1^W#Q*CVJ.0JOX6KAB-K[:OB7E
M IVW4T>9?I;,.WV*@06]G1(;NKA$IOXFKU+7IZ8]2F-H/&DCYPZEN)EL1(,%
M\SBL/9FO])9VNG1W+&)?>C26CVLG2ZL3;E@UI0$3CAP*J21U<VZ?(010UZH1
M@QB61X)W>.Z"S-8*%RQR7/@'V#VLF2:YB6K&+4A>G%$AUIWK!;:N.@WB@JCV
ML8-9'A7<:[(Y#WW:-W:PQ>V-C$HM0V[2#[+(VECQ^H6*=C012 4N.3.1"3L6
MVN[)L%D%S0<HXM V#*98E"6VF!<I-VH]43=1TZ6;;8K(%]6RFM#7"%0-KTTN
M81YZR%!XED]UQ*F!)&?)7N1/:QX.%H7I=*S4$N^JO2#;,K8=S DM:*",=,V$
MFG3#--4ZA[]DQUI(DB(!\C\$Q[6N"C6B<D@W@+N5_<MFC4[-FIM=M^U-/BC5
MWJ53K&"K]"CZ?V-FS27#Q:LEVYC VU,UH>V4*MD%@9LF'#'KB)D>PYE+&/J!
MVH9K('C*^)/N]/@D64&!"[]]8R@MEF/64>&="-#-;$$ASH58I'C$)6(_@=D)
MX+MUW+9"\5!BS;:E">?#AQ>^=7MI;-93ED&BF1[13&Q1(8R%6,1[&#5B.X5X
MUW'W*]=0:@/VO5RA[8Q0/&C&8\_3<W9TZ#9VQ1R&T;)Z\"3068L]UO&/ARR6
MLCP1HA")*'MM-MKC\;$5A9Z"@"O(1Y-L:.QDAA=/ENBCF("2-))JF,2,K"N:
MGJ'1JBC23#-W2-1%92>.=/T9#';Q"R+,H&,.PE*^U(R6@3L0Y:V.^/P$<B>J
M9$[J.<HRJ-&HBMX>Q]1$KMTFI=9LFLWBNQZMK_7,4972:&[?: 1F$Y6!AC+!
M#V%/N%7!$>6DN]&2A?M*EL.94VA?GU7%">Q[.*Z%+IW&MX554##$,C9\V+($
ML($CA-P<3CK':1)#V(BJBD:[=$5<Z[2G-.T)"BR:MQ;2)75C QBHDR7'.-8H
M3<).'B4R@:_OG-1%V5Z+R3-"M!#L-4+/LZK:<I]_J](K>OMQBJ6!A5D9,JT0
MV)K0@CK I1&8.MPXB-@J:<,M#1,:TW:;*=R^S9VH,UP?!:QDTVK($RYA:?@6
MD*NAU=^"MBCA )"9(!# :F-6-'41X[4/(60T(&S;(I'*YDUHBJ(26$HNHX4N
MUB4L*QB0(M;=!@QV1 DB,.&*$E4:O0=8$#>^.ID$%LN>5[E<DMHR*,:8@ULO
M=0'>,G6\#:]D*+K*(04.D]"KRF[SL,YITY>PU&-0:_KQH:.<(6LD&F+-S+-6
MTC*L%^0)#K7.:LLCHD7&HXNI'TXKR69T-!QXZ2A0U;9VLK3\FSCUIQQ:IH1.
M+/+'(LHDV&@8,?POAU4K9K^@]I>1K]]6.WE&6*@P 22.-PS[&12'L 0#LC5K
M1"4LPH'^(?*BH*(%(Z!7C24[W!H_8ZPCM1V&YV/=+C '=M-E6,8)I,L99@XT
MEK.V#K0\5C3];@4V*N1[JL,QAT2()UL)#L)MQDI/C0@Q,!RC-U=+#0R["7J%
M6Q=1UY)@0UQ S !-2SPS7&86GBI+B-L5CM18\<\.,.7(5IRM%'-%Y1VZFDBI
MI,Z3>*V/>P7RA"@O%*"(E7,%+4S"5D?Q,5LY0-W"$L8 Y)U0I&C"6/-6R:G&
MD]DEV#9^J[=M*ER:#2QVI9H&NR;4(HET@68_*MS\J/&?;34#Y%$FK3HMUF)@
M,I&#%P4&V?A7(O)%;P6.U>LNYI)]U7/JZX-"2+$?.!66(ILM]@XC&/1($HR.
M@D98O034"%1>);P*Q<Y9Q&.U.LFUJ9EM!=7014[X\5TP-?.'*DOFN>UKD2'(
M*CHA&SG]VWNA*/OV\/ L)UF1V*HZ-.5.L579P>#%O2B-E0@0U*JDZOVOLW=T
M6Y@K QK\K*A2(NO9T(\^2,7VN(:$D11.KB9;T0W-5'(C]6UOP?@PH5S'$RS[
MZ8B1VO@EB3]9639[3B2K,0;QU)12G&D6D1&@* T(#W,DD7!17:E@>A8<6):A
M&RP4LI$"CXA(TS54])C3#]&F<QS*T@Y#BFL(J-"418H7N8=ZY5^W=HXM:G.I
MSML^3";2\TYATN37I>SJ_+%RW$AP3,_5DUS5S(*?)A)D3K#"/:_-RQF&H]\C
M#9<M;G>^?K0<,KD].RC1KOEW=:^*^YBD 1R1XS2TA74K8I7C1Q98Y=5(>'9M
MFT)'JO<Z9JMD5ZIZ8DE!;=60'1GVL=XGKW$=I*DBU+8Y',XB21R:X[Q\+;%H
MGN5<DDYVNED-S?,;%<*J_$1>& T)C6)ZT"HT9G9X*+0"-&F!=?O1YC<K7:B$
M8F@08OUB])*599H",6KZ1R^Y).N"%U%WTN?!<-+-L8;:63- QC;J,RJ+6DCU
M3FDXZA2L,D<]K*7OGS"11GB()W;XC5SRW?>R9L-S$GM -M5(EA8QMK'97$@/
M!6N:3CK>]85 FL9/X5THD=AHR"6TVEC=V-,BI%TA[&"3W]8TF=/KEO&@GQ(P
MY()VIH@XU;1P"O$"UKDQHX_)X1,&C$"!J $AP3!*$B3>)KIV38R& ?8CMHQ7
MTU<4L2>&,X 9+SSFE5LX46(4\Y[&"65'((21PI%>H!F,9,EE&><=H73F60".
MJH)"1I@H[@BD.++:16S!1HQ#2WL:+Q 7B$@1)'>H1E*5,GWDHR0XXQCC&.,8
MXQCC&.,8XQCC&.,8XQCC&.,8XQCC&.,8XQCC&.,8XQCC&.,8XQCC&.,8XQCC
M&.,8XQCC&.,8XQCC&.,8XQCC&.,8XQCC&.,8XQCC&.,8XQCC&.,8XQFA;/V!
M"U;0[-?R(6P6"!5A,PQ-%UB$Q.+.PX$=R7,>;1+E083$>)%9>E2Y4V;&CL1V
M7%9<4Y[;3F,N;0=+63+0L>5*%" 200,,;2'<,3%>1R(]XQM:QC7/>\A&,:QJ
MKNJ[-7'VMBRIKY5@0$F2.(%YGBBL:\RL&U7O<B/>,;6L8USWO(1C6M:J[JNS
M5V@$78/@PQV*VZS&-BAQ>.S(PC#[3!*&S,9;>PVMQO#J&WDI<PAQ:,+PKTK4
MGR5F\C'9*C1Y+$<UDD CL:_9'M88;2-1R(KD1R(Y$=LJIOOLJISRZCF;( "0
MQ'-8<(S-1VW$C2L:]J.V54XD1R(NRJF_153GF%V#;?H&@W>]_(C-H^BJA9;;
M]-5UN([8+%].!9ICY$":GRH,%PR7^#^7C&YLV'$7-D,)DRH[.5O([\[LZOIG
MC-=56EVUH<(V2<?K'1BC=[X3(L577%6RE[!^E\5_5=:4]9642]OJ5L#6R90&
M0J,&CYO]>RH]G#DC++.7 J==OC*WYE3_  Z]/8N3CN?Q(.N.K:GM6?7K?7MF
M[%T[-K,&Z:EKEE@Q[+">+;=HNF+0E@BIB:')KUO<;Z*$WQ(.07163WL5LZX+
M+D(C*F41%\^2<_R)O_9TSB3O$#K4#KQ=>PCNN3.1=+[E3.GLJNY/CT2Y9B'W
M1'=-EWELBJ!\,P*R8(IO?RAQA4I(MI07,WXI6)^&5X5WV_\ #Q?_ *\6W^&;
M](\0_I#$+4 %*[-ZHCE=J, )NNHK]B0UFX"K5?;'JZM'PCRV4QY=9.["JAJH
MBK1AU->FF6H$9@FOYV#4193A7KLOG^395^I%Y^SZ%S(N=^>F;5BOM47V/U<D
M_K%]V/>1_P!0(S\C=B7H)K$MG,K#681)JN;$L@*DVU\1(GL5"S%88>T.")KN
M&L,<*[;[+LO^6_\ 9S3VITS)GN\'4:L13TZP=A-9"H=6L&V:K994NPL(C@+#
MHB4#A;C%F'L)4V.D:XEV:O1[7F6IIH6\;%H><]4UC"V-E]B\]MN2^?3Z_+V^
M6;-0^UG7+9^J+7O*@;BI-JU+19EC'7&\B2GO!JT0J<=B8?@&<K;;E09L&#+@
MSTQ7HR7Y@\B+GP&Y4,G >DL;+OMMS7V\LA6Z>(7T @T$):-A=BM.QZ'=95]&
MBTV^3Z&2A'4Q"O1=DBIE<,#OF44GK]^S5^=:AA45&G !<YJP$(\<-'DD6.HX
M 21.!)"*0%^W&$XV%$_94<G$,C7,=LY$5-T79414YIG6:..0-P3A&<3MN,11
ML*-W[YO$QZ.:[FB*FZ+S1%3GMG&LW?[K53>Q6B.HE$M%0N^SMH;!?UY.J-(/
M"\*U<+CZ&OF]Q]A*P8<9Z#+'2:_404' @9*9F#F;]4S,Q# \F-21Y#&,(V""
M-@A#:C!C&QK!L8U-D:QC41K6HG)&M1$1.B9R&)@AM8(;1"&Q$8QC$8-K45&H
MUC6HC6M3HB(B(FVR)G[VG\17KGU?KNZLD;G6[GM#1=.&W>Y:A%6.*-L< .2E
MUWT(*E)$64'!$&P5E'6Q0HDZDOFL/,'?E^!$IF?GGG)$5=O8J[9S)/>SH#BN
M MZ2MZZ96!(G+12ANR5^R\\-)TMX9$N, L8P,63JHVL?4@-9\D?6)!BH5C"3
M9TUF"<&R)=LL.(Z0V8Z+&=+8W@9*4 ED-9LJ<+3JWO6MV54X4<B;*J;<USH6
M''=(22L4#I3&\+9"A&IVM5%3A:;A[Q&JBJG"CMEW5-NN;';/$#Z8T@W?:W9>
MPU @V#5QMNM[""1Y)$J5J5@<BF2&0I>"''3Y+!-@57C1N9#2VM^ !&R3TU$<
M.C$Y5SG>B*NW)>?3-7W?XBG2/4=1OT^][GI%GCU72CV[3=.J[L6[%+!K0A4Y
M5O"J&P8>7@A&9>:LRLM4PA G#=L8-W!QA/TZF059X$&,PWB,-A1$:YA!$8UX
MR,<BHYCV.16O:Y%5'-<BHJ*J*BIG%P6F8X1!M(,B.&]A&HYCVN39S'M<BM<U
M479S7(J*B[*BYN(#OGT_/DJ. ';XH;!W8%3%W&K ILYT?/>"EZ^=M(AB:A^.
MB,'-DZW5[(:$5LG(B'3 D 6(B!TZ!!>D)YIMMRZ>6W3;*[;=$Y)[NFVR?1MN
MB?2F1X)\2WJ=8"LLE7=J4H_IT;JHEL\INL-:AA*N0T#MC5+6N0R*W#]ZX3X[
MAFXB<N6P>'DU2(^XD9*)MD%Y:0RNR_3NB;?/O_EDI5SO-U"MUDH]1K?8769:
MP;)JX2Y4F%'/MI:.U^RU4I>JY(:(O-M#(DZP4@(8N0,(1F0SA:J"R%B@#9 >
M(_,0QLO/DO+KRZ>7/Z51/IS2^M_?W0O:_;.]-?:0LH:]U/1FO=)WTIM2OFV2
M%8.8W--W"Q'$0HWPC$J(L /U*D[DFZZ_!/A+<#*AU.#7&)DUA6JB(J\MU5-E
M39>6W^?Y,YM6\1?H]>:Q:+C2NR^LK=7Z:Q39-@EUDI*/28S&PLSD4QR$)%PI
M1<U@^^),08F D CE!(&=%R<,$0A6+#8X5]BI\Z;?MU3ZT]N9&1X@?2>))!Q)
M/9S4+#MDU,WO<(IRV0DQYVG71EE+IV,F7G_9&:JF'3['AXE)?9;8FC5"W\-D
MY,.'(8X7>Q>NW3S]GO7W=<T^R]^_#TJ,&L[8MV_])5M5JQ>A=>M1]Q@797UZ
MQ(5X-L<.^F<,9LXF517;< <MH@K'@2@ 8HDV3BQ@34H@S;+#B+)28L6-XM&]
MVDI0"\2C-E3@0_#WJ-X=TX4=MMNFVV='A(ZR/%>& LI&HQ)'=#4Z,5%1&(;A
M[SA5-TVXMMMTR3],]R=!;ZV/V%U7K>VN%+;UCMT:G[0:D0'8PYB9)K(2S?-
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M=%+)AW8Q2!KB5GY7-AF1HZ:RQO[D]O+ELJ(NW]N_OS:WO#MK( [8;/K#:-M
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M-;#RZA33[3 LP7-R8)IAE.%$7GNJ<*KNG3?A1>O/?GZJ^6>1'QDM^_"=JK.
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M;?KDS=@.P%RU1MK2])'QJ<*I6RI2JR3N]ABS[1('[$M5B 5#550?JU;LH:T
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M@&8<Z+8*:/'0"K;$:62.M 6<LY$R3(,LRFWQO=_FB?XY ],\1O:&SSD^HZR
M:FLLVQV7JZO6E[)LW*NU%^B=H/QA,BC)6M9+%KF0D50=HK%C'J*M:W)7V#:(
M4"55-<MH:.R&5X=DW7W^_FG#R_\ VY_XY@<>)MM.6]ODB#I6M[&$U7L@9I/
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M_P ,VHS^!_38BL$IP2I4@0Q; %%J3@FJ1XS0^U;DN@.GBA B.!%.."EW6Z'
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M87[F!2COPWS3(WW/WSX',K,7U_E>UZOOQC(- 6?JRX#L]2#1-8":B[8+O$N
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G&.,8XQCC&.,8XQCC&.,8XQCC&.,8XQCC&.,8XQCC&.,8XQCC&?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>g149615g92n34.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g149615g92n34.jpg
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M,S0U4F)R<W5V@K6VMT-7='>1DZ&TTR=$@]5CLO#_Q  = 0$!  (# 0$!
M         0(#!08'! @)_\0 6Q$  0,# @,$!@4%"@H(!00# 0 "$0,$(04Q
M$D%1!F%QH1,B@9'1\ <4,K'!%18CTN%"4E-456*"DM/Q%R4S-%9RDY2BU"1C
M<W1UL[2U-39VMM4F0T6R9);"_]H # ,!  (1 Q$ /P#^_CA$X1.$3A$X1.$3
MA$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1
M.$3A$X18"+:ZO-,RJY"L@"788*%N30,4P.D&8;;66L.+E"VI*YT=#>7V<+4\
MPA*,O-85G'K$>)%G^$3A%CBY<37Q)0\?*#@8((/FES)HO-C#1(@4-C.3"),H
M1FNL0X ^!$9>E39LMYJ-%C-./ONMM-J5@B"C DY%7."%!QB"W.*BUS!4Z,0B
MH)@RDP(;'+D1'7F4S@YH<0$%8F5XD#RD&9 EMLRXSS2"+(\(G")PB<(G")PB
M<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G"
M)PB<(G")PB<(G")PB<(G"*.VRX5*A )UJO-IKE+JXS,7!*R6PV,KH ?F;+8'
MPL3C!B5#'1,RY\J-"BXD2&_:)<EB,UYWGFT*(N.X72H:]J-BO][LX&G4>H R
M-FM-OLI6$%K==KHF(Y/*'#)D@\Q '"A\)EV5+G2GVH[$=M;KCB4)SGA-]EGH
MDN+/B1IT&2Q,A38[,N'+BNH?C2HLEM+T>3'?:4IIYA]E:'676U*0XVI*T*RE
M6,Y(N=2DI2I2E82E.,J4I6<82E.,>.5*SGPQC&,8SG.<Y\,8^>>$47A7FDD[
M<>U^-N%6(7RK"09^STF%8!,NW5P%9G23%;-'JVQ+<,B!-@>#&&09(A"CPRSH
MDDW >D+@RL-$4IX11*[7ZB:T /VO8]UJ5 J\5YB-)LEVL8>J@(\B4K*(S#Y@
M[,@#F7I*\90PTY)2MY6,I;2K./#A%GQA,::'0# 8A!+""L.,1%E!DN//'$A\
MQE$B'.@3HKCL:9#EQW&WXTF.ZXP^RM#K2UH4E62*L*%O_1VTR8\-K7;VN+Z7
M+5.7?18RHW(#8)Y"DC[:3H4ZVPHHN=)>DUV'=PI>I23#2%P&;&,G!W'TSXKS
M""L'H5%I_;GJH+BFYL_LMH./&K0DZ>L"U;?H"E!@M7&S3-D*$6F[ MZ+! B!
MQ F7DNMI;'084N5*4TS'=6@I!.PE7]$EQ9\6-.@R6)D*;'9EPY<9U#\:5%DM
MI>CR8[S:E-O,/M+0ZTZVI2'&U)6A64YQGA%V.$3A$X1.$3A$X1.$3A$X1.$3
MA$X1.$3A%TR*E('SUH4I"T0I2DJ3G*5)4EA>4J2K'AG"L9QC.,XSC.,X\<?/
MFNL2*-4@D$4ZA!!@@AI(((R"#L5OM0'7-NUP#FNKT0YI ((-1H((."",$'!"
MT^HW84H+2R.N+#IF$GRMI+1_(DLRC'AC&9+:LH8(83CP\5Y7'DYQXK<=DN9\
M,^::3VTN*'#1U-ANJ0@"XI@"Y:-OTC20RL .<LJ;ESJAPO:=?^C:TNR^YT2H
MVQKF7&SJ\1LZCMSZ)P#JEL29]4"I1V:UE)LE;5UVV5VUQ<2P!:(1;PG"G6FU
M^27'\?EC$J&[A$J-GQ^6/7-(PKZ494G.,Y]"LM1LM1I^DL[BG7; +FM,5&3R
MJ4W148<_NFB>4KR+4]'U/1ZOH=1LZULXDACW-XJ-6.=*NSBI51&3P/)&S@#A
M2+GVKC$X1>1/:/T?VZ+UOC9W8+K+L37VFKUL;6E2UO+,MXM=.L2L1]3]UM>6
M:SDK1K^(V8GDQEG[%Z:VG68KCR_>=JT2"40( R JJGQ3Y^?DK('D1/GS!Y[;
M'W^*C!3T>/;EZQ7"X5_N[M*N6RPF]FDPI)W<F^[+6*M\;[([6D #T'5ANX.:
MY=;INJ=L:$J0@ D'%"0#6G'"HI ^:N&9E$D1MTY#NY[]<]_NO/K!U"W[K#8+
M=ZVUOJVV00/JMV'T[64/=V^=CU6A'K42%MQY4HALTZB1MUL>*AFB0PKLX3/(
M5DI:Y@6M18(<&'F8(3B(&\S !V[A[=_?$K4&S^C.[F7NAD*';^UEDEC3G4?8
MF@; /QV$W78Z=9]IV_5.\=>GMS; J&Q:E=W[S!VT7V72K:>U_ LU%&Z:(Z\'
M? I*Z9PSG!.(=!N#MF-X'+'7<SG9>MG6O4172&LR-&-%1YJ;,W)V2V6B:+;D
MMQ4#=V]C-J[I##E)EH;=]M#![_ #E%X3EAPG EN1%N15,N+*$S[@/<(5^<*)
MPB<(HC:;U5J:QET\58CO91YF8#6?:",C_@^IA-9R]Y59_%]<[AN.G.<>L>1C
MY\XW4-6L-,877=PQCHEM%IXZ[^G!2;ZT';B/"P'=P7,Z3V?U;6Z@9I]G4JLX
MN%]P\>CMJ6<E]=\,EHR6,+ZA'V6..%&-;;+QL65951QONX<'6+;A>N=];-D8
MF^\<NNRO)GU#7RB->K8:]9ZK.7/-(>\R?)\&AZ[^6ZM\64#1H6QMQ2XW<55_
MI?3\3JD>HW_)MAK2Z,R]TXY;M1V6/9FCI8J77UFYO1=NK\#."A2]!]5#&4>+
M](_-9_%4?P<4-BDR#Q6KSL*Z@G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(
MG")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB\4O2]:CW9VRG=
M<NH6M]#2=R:PM!/96Y^P*K%:SNI-8NU[7=073M:T8ON)C7>QPHRTD]F;,$;-
M!U-%>(G"[6H9#Z&Q@]M\O&?)6;8$N)B,"!)D\P)&T;R-_8O&[L$2](5M;J0%
MT;NG7??NO3JYZ-G;>@1=$T#J#8-BKNYNY>KMC6_4EFD;GEC:&938M;;.T96Z
M3>Z,;-K%5.SC+=;R&N"KU^9#L)+(<(<""/M@Y(^R8((SN),\Q'+*WE!V/OI'
M[8U&O>N[F"+\'[G:!KM8H@_7]O9Z1*]&VUJ:B9VE9+5:G*@O4WX24$'-@X(N
M'KFC;PW9+-9K]=$1QK:HJ2@#>'/#]DG?UN*2 (W(V)Q&^<+SQH);O)W5ZE;2
M!5N[]^MOL;,]'KW91OMF_5\Z.U,=VI4;_!C=5Z=UIL6:>,"7<[?@H"T4S8@6
MD&+.5MU9F&@ES?9LSSS4 LO5!!/"(<R(B8@\4B9$8.1OMA;9U*O=QM3M[0W=
MH!7?2^535FL?1I;S!TS;-$V4G9FZ@M5V/O&J=J^MH47;:/6+69]DUK/]^B]:
MJA2YHLE&HYF)&:9/!Y\LH>$P/5F7@F0.0X22,>W8Y]D>O1?TM+;G7QVW[&[+
M:PF[4Z]YWH#.US5G8[: K7?:+:_8BZW^9I':5'T/JR^R?8-3Z5(ZMUH*UWN^
M/6-4PPX^[2$$(UD8F/"7S\RIZLF(,&#) EH !(D[DR<97I;Z22FOQNW?07>>
MV]"; [)]2M5#.QXC8],U]I\_V!30MNWNLTR%JO:5GTK6 ]G/VP3%'C+G6QA^
M%5CZJ*3,)G^ ]XJS)<*-V<! )C<@8$R)) '+'.%J2W8>X<SO?0P6KQV_.J_5
MJ!9^G<OK%JN)UR[!#]3R>OQ$$(D=A-=[ HVJ=6GM)ZVL[QPA< QY_L#:J!8]
M1CHU*)55(J-$EHDDY'9QSQ9$SF""3)$YP,QDP5GO1$:.W5K;>>FR^Q=0[/H0
MH7Z.S8]))D[I0;55QXZYSO2+[TNT*I3IAP5!CQ+-,IA85;HH)]QLH_628\\U
M%6+FQI3N(!!/SS<?Q"KB(.1]K_\ Y44[(=*&F;!Z>XKKSJ4TU+M_3W2@;K21
MIFAT(DV>X%^O^] 6S!.C98.JX=,V4H2+# ]Y@4)R24GSB< >?:=?FQF7<D!_
MR><!V<[01OTQUZ=RA.T('I)-$A]J:IHEP[CWO1P/>/14F<V-80&T+-LH5J"\
M]?=AD.P\#6UATOK65L]VF5[==?UA!NP31-8*V;60HJ6%!A80=.)*8G[,_/SG
ME$H(,'U08,# $\@9,#F9QR5WZ5#=\C5YUV5V-MON;?:1J+T>]YVR.9H]/NNB
MH^^]]@>P.[!6L]?W2-N[5(P\K9K^DY5.&2J]=J[7S=P(1:QL:W5J5#Q"0NJ8
M@P "7 9,P ,P1R)YCES6AT3L?WNJ>N[9.O=E[WZNUC=^V/HT@50>F =[V+=K
M '<T;<P;M3K34IO?NDZ'?=@V<7)KU8'2Z\!U]. P;B@<2UP&6+L=?]XED&C:
M6D@',B)!$3!.._F-SNIY;]O>DRU+IO3)VNWGLE*@=OMU=GO1[:%C[]9(@=RT
M<%M_;2#'2WM%L"N6 >#M O9E0UP VS@V=LHD<:556J;/,0VDQHCS93U9,@8#
M3@X,#([Y)C!COYK^M,&,R%"APRB!(NH2+'C,EC,K,TN3S B,Q<D"LU24JEDI
MN6O:9TI24YD2G77<IQE?A@M:RG")PB<(G")PB<(G")PB<(G"+H%?/[L)>J:<
M?<]@F>K89PE3SR_9W/(TTE2D)4XXKP0C"E)3E2L8RI./GC76!-&J&@DFG4
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M0R(5AN "<G.1@2X=\& #,D"9.(6)U7VN](3MHV%L^MXXT\[L*'J_7I[8_P"
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ML(EQ5X?3'D(>2N.C&7S\_(1>:YNFP+5V,OP/8#<*T1M*#:,[1@)*"A8-@YL
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MD "5JKUZ-M1JW-S5IT+>A3?6KUZSVTZ5&E3:7U*M6H\AC*;& N>]Q#6M!)(
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M?J=&Y?1MJ]5C!]:M+FWJ"G4%(5<^6*"[2=H-0KA. <LDW9FK+"V(%3(\^8T
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MN @N8\I_UC4A$J8P9R6D06LODH[R8S7NUB"B'"EL3US(XDG.(Y>/?S^Y9-
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M%9MDYFGVBNKHJ'!-PL#J@<R5$*YGBDQL .F229'= ^]:F\,9 DE^23@!H+<
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MA,VPB@)*>@L\VR[.(8SO,>PQ[/:A8X3B8 GVB8\5GBW<_JJ"-&*Z8WOKP:;
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M=CQ2E@<,CY\"E$]-! .OP;8$4!#UF=)B&1MC)H<+2A9))G?NVR#U[H5%2 !
M@$$YW@$><R>]?5D]'Q6[RFQ%[SLVPG+O;UW0U9+%#KH(2)F7(_L#K#?JP9B5
M7QG1(H2FN]3=8 OAF1/GILHERP+-%ED"BIC=X<'.\SXD@_@GI"(@1$1W !PW
M[^(YY*X'NK0Q>BH6H1YX/4S(W8M4VZ/MM'HHVOAV=BTG:X/;P$K(I$DH79(C
M9%AK@N#9(9"P22YP4J?G%A@%I$<K"<,")S,SWS.W-8\7K3$X(@GD1&_)4TYZ
M/V.[7[17G=VVR0QMBO[=I6^I3]3J7M.QJ3N7<FPMSV02 3&CQ8VO"L,KM.\U
M@8=&,%LHJYI/M0Z38A8:P#IP]_4'&X)GV++TG\T8(+=\$-#9[]@?'936Q]'Z
MC8ZW<:V_=K#'8N.MN_&M94EH>,6[#@=^-P ]P7(DPA>/(N70R8)D/6FG/WDC
M ><>*^,A*/#*._DX?UC/DH'D1CFP_P!0$#WRHV<Z$#+/LRW;(LFW[F;DV!-L
MBBXQ&#&FD HBV[TTWO90-TW.GRUS0]5):9!4>C#!\ $-K]#D)@OPRAN*\>(8
M\$DYW[N\'KW0KQX X1B/; (Z<YD[Y4C+=):U."PA;%GC37!P/?(6,S<J8+MU
M>DXWQV)HW8HG+) O> 9]V35SU&AB*W,&&!!8=F0W9!Q0=818Z8RX._E'G/=X
M?!0/CETVP<-+=X.\SMNI+L/J(!V=IC2NG[;L.]F5:=*4J8[>S,R,;N&P1P6I
M%M=7\+=YY-I_WI'V[KBT7.GW&8YE<_+%GDE([ZBD6/(Y2V0!)QSY]X]J!\$D
M ">0P!F0?81*J$3Z.'7HC6,_6;.PKF]'(ZQ[#ZI?L4B*%<.*KN\ &MZ)7%K7
MF+F(_*U!K#4>NM?51<F.]@N)K,22=]HEN/97.#OZQ[0 /="OI#,P!D$^PDF.
MDDF5>0KK%%9M\:^GKO/,VI>]ZSV!,R(@2"'%D;< ZOP.LD@=$'8E$'1@,D*A
MN6W#'M\V7")2,C$RY$-OUJ['?SGIRCY[L=ZQXN40.$MCNXB[\??E5)L'T?U3
MOVP[GLC&T;[5#MQ[)5OLHF75D"8!6N6:L=02O4,>-KIAQA^1"2P *KO40LMI
MZ;"M$:,RVVN E250LWS$D'PW^*R%3 !:##2W?<<7%G[E4NEO165+4UHJMT)[
MJO-\LU>VDC:L^>8#"F,6$TUU;N_5=+1%QZ44)NNRJS<W+@6*32A B2M\1U];
MS(^?F'%!D<^O+J(ZJFJ2"( D >YP=]XCP77USZ**F:WF:L'#-X;"F:[H;_5"
MS6:ARJ_3<?'NRNF]!!4#4=O<M'NUPY6!;T*IU,I:ZD)<=B%R0)O$4B,ADC$6
M>#.\\N7,;*&J3)+1)XNN XR1$^.>_K"RE6]%;KBK5&EU*-L^XR6*7J[HUJZ)
M.=$ D29D#HWO\[O^K%7TMH\C<V^&3KH"R--?O, ;':DCO-*RKC@VD[=W?/4]
M2LO3&28&2\G?=[0T^Z!"P OT2M)BC(H KO+89VNTL* I6F!<BO4R"[K?70SM
M5K#MF6K1 B.&QY=[*&[EJ*F5A-F-*BR!M6@OX:@2#4Z>5EN#?/<.X3*GI3R:
M))))SDEI9UP(),#GX+]#>B=K,?8A79%I[!;1OIR??]0W-N5:X0DH5>A::[00
M^S]<#'C<UZ7../RS$;-&FD$^[8,6GLBXX8",?'+5-!F9GG/GS3TIB.$#!;['
M-X3CEU\9F5ZW<S6I=X9,R/(PIN/'_8TEIU6,?6WA6/6I^W\=O*DY\/G\_ER.
M$@^"H,$>*V12K"DX4G.,I5C"DYQ\\9QG'CC.,_9G'SQS0MZ_>$3A%4NQ)OK)
MD& E7RCLKD.8Q]'K)"O(C"OTH;:\V/T._IYL8,$^SY^>2U/.0.@^_P"0JYYL
M6"<(G")PB\ED>A_T5 FT4[6=H;JH]MI?66^=87K=2+"$KARQ ;>$M $)?B;\
M,!E$?9.OH%TLK%3L0Y$93<29%'D&9D =%CIPX!UY$>^?C[5M]*<X!!>'P<[;
MCP/-2K6'HOJ#JB31"M;V[L!HW3]][ WG/E1Z[K,6*LF-LZDJFG-CZ]>KPRFQ
M186J':S4HBX! (W$MH:5,FRF[#*(N)(I!D1GF>7(B"/VJ&I,^J!ZH;N<09!S
MW\MO9A8;4GHI*!JZ51)<W>VX]A*UG(ZFPZ.BUP]9PFP5-Z9D]I2M/TAO%3HM
M=S.&^[]I$8-E+%,SK$6E#V2396&J0N*RX>_F#MTY*NJEW[D#[<P3DOCB.2>F
M ,+@.>B8UC9MA[DV+8MT;>-E-PB[R"F))IH\N< !WCL'JWL6L7%L;E5S9#4.
MK635HJF4N)82A&!6-;NQZV+A1WQR2<H69)G>>74@]>Y3TD #A&.\Y]4M^XRK
MMW=T(IF[=N&]ED=F[%JP#8<30<+=>L:^S2WJQMB/UDV08VIJ%N>8.58K<*E@
M?9SDZ-9LTP^&S90&(XU>8$IMPD]2V3O ,2.L;*!Y B 8F"9QQ  ]V8Y_=A2+
M]Q!K=WI_8NFDJS71=%L'QL_BVQI 6+=!)6X;/-[<C&!KN0[X',RLV\NU($LS
MPDX?*CC(L<Q#(M/3$R'#ZO#/M]LIQD/#P!B,=P$>86FFQ_1872V;!JMD#]E[
MS"GW&5VB,]E-O."M:QMD7 AOC4VEM*# =.I>-7$M:AZU!UUJ>."=RS"$FPLV
M,/LD,F8)22#69P'KS,F.HB/OZ+(51 ]6>'AX1)CU2XR3(,R5?,'T:6LPUQ;.
M MD['%T^+L?KGM4;KG#=/EAQ]OZV:9$Z&JDAH[)K2K4] -Z\KE<BG!\DNZS@
MJ/E%(.8JR"V6!8#S,8\A'S\Q/2'H)SG/-W%M,;^7GC:KZ+S4E3KE)K4/8.Q9
M,6CT3H;0H$B3FL^T3!_0/;A[<&NYLOU0-MO$VZF3\D7=,,H;8P+88R#;&2_6
M/K< Z].6>?Q^[HKZ5TDP,EYYP.-H:?=&/$]5%$^B<UR]$CUHIO#;Q;76.N^X
MNM$RAS(&M78B:)O.P7.T[ )UTY(H\@[4+87.6<%*FG:_,BOE(VO:8(+IGA(<
MP;,!G4R((B!S_$%/2G<  \0=,G=L 8G:!MWE<&/1-4*/4J^'![HN=&MPE_:X
MTML+6VK^OE'+6NB;IUG3]5WZHGP8O52JP0GSZ_1*W+@7B:*EV\.4C.MC24<&
M@:$&.#&^<YCD1$)Z4DR6@C'JDN(P21SF,[<UN!,ZHTZ;3M5TQRQV5,#5&@[M
MU]#RD>Z_:R5;O%*J%((&R?F@99]]Q!]-A2X?LK<>![9*E>OB.L>I:;O#MG8$
M>\0L.(RXQN9\Y5(E?1RZ_/E]@D3NS=B%&+YIS:FD\)DQJ8\; 5+;M J= /,#
M;3)K4DXY"KL*H1"-$KK\C-8KLXH:S)$%\2V518& <^1'O$++TAQ &"#SW!D<
M_8?P4_)]-6CNP8M]-[DODO$BW5S9ELK44)0H(2V;1K^E)^A<VR0^FLO'!$&;
M2)$!U=8#%H@Q@X)C3T+6R_,AOBR=SO$X&8^[YW0/@1 V(&3@$@^W(6*L?1*H
M621U_3*V-=\!>OH3KZ(KH"5"J9>!+E=<[_7=@U8_!46 S':?8+=.KD )L<Q4
M\C"5FK,(0%8EBX@Q2)MX=L[1RZ?<IQ_:P/6+C_6!$=X$X]O7%M8ZT57'7\)U
MX]_V#X9!RZI,CF_$;[]>74MA"MBPTO9]B]W^223$LP9/DAIS[ Z[ZK+<CR/)
M</J\,^WVRIQ>MQ1[/9"8Z^3!FT;UL"G;:N]- [7/A+=M#7, 30RU?M%K!4JN
M:Z09@E;%5"UDK.#U+IU1!6F$'*-L36JY"(@\UP[--EBUC,@P#N(^8[T+I !
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MV0!VR@*%7%J %'%R)5@$Y3I%%A1:,UJ\0+E6 V?PY3W3SWXHG??O_'*W'AR
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M:CN;)L>!&M3%5AD>V5<IHAO7=Y:*5'.A;I6PE;V!=3<;8,M-PKOP^2L-AN
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M0-$I-6"4FK5F*EQT:'JM<%1@84(PF6Y(==AP!,.-";]J=?=<::QE]QU:EK4
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M1E6E1T2XUE(143E/PJ_(BN-R6#,EMH<['<0\W)4VI*LI'4>](/0^Y1<_O/5
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M/=^;Y26](4O/TJ;;5EI/C_*[A]>/MPY\OE]/P:53(MW579=6J.<2>8:2T?\
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M!7#CRLM*0+4RI.''&G&\7"8C<&96371Q3D$1'M!_#S7GE"]&]M.34+$T8W:
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MX7.;,P8D+8_E6*<(G")PB@-Y;7&P'.,X\7!D]&%^'UMN*2XG"O\ B^=CU?\
M_-G'AG&?EQ.J-+/J]RT>M1J@&.8)XA.=I:1_2*](^CVHR[.N:!6/Z+5=.>6
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MJ@-'VCZ.JXM;S<!SA="G3,S*]!4KQRN.E<16<XS\\1U90WX9S]./4^KQG/\
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MS3FH=8TBSI\+OV%<9!>97M&Q(H6(L*EJ,65"(($$@3C)_=$XZXB?-9 @M)D
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M";$" A56.P*YM5\65VC,MJ U!'K]QFR$&\1D3$'N(S)P/VK'A!!())!.)!(
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M4N. MER@4\25K$"T%2%K,56MD(]>JU8A3L9.WBRL *N,CM^VE)XYE>$IO$
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M5,3T,M,=P<V?Z2]#^D.DRYJZ-KU ?H=6TZGQ$;>DI!M5O$=^(TKAC(.?T)$
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M9A9&DU:QR[A'O (Z69F)^ 1L\E9XM5-/"Z^0<6"8QR,Q.8]GM5X,Q.<R(,B
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M[!2M4%!NL7P=.C4'<M,W/7JU'.MZ_:N)NNB)U+CT@- /6&=F)02I(82=-&F
MI\3.'E.,0([Y]OSNLN/,QZT$$R9,M+9W[Y/?M PN4=TLI86QZV+ [E:0H75&
MQ;IL&DU\8*H\237(UXMTV[&-<5ZY,55N[ M42S!!\>1U^//( $:E#"5-<9D2
M$A-I<.V< DQ ZSCY]R<9SU< "9.<1)&Q/0[@YR5N9S)8)PB<(G")PB<(G"*X
M]?PO4"GYBL>"ITG.$Y\/I9C8RVC/_P Y3^/L^6/K\>:GG/@/VK:P8GJ?+YE3
MWF"S3A%5^Q87R'D4I_A(;JO_ (O,8_\ N/\ Z<V,.X]JUO&Q]GW\U5_-BUIP
MB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(H'?&%MQ!
MQ=G'[\*GM.>;P^>&W5(SC.<X^K#[3&/#/R_'S]'C\^*U1I%.C<-^U1J@SW.@
MY_I-;SC)ZKT7Z.KBG4O=4T6N?T&L:=5IEI_=5*37@M ZFWK7#CS]0=,3>.\B
M2PS(:SXMOM-O-Y^U#J,+3G^BK'.38X/8U[=GM#AX$2%T&YMZEI<W%K5$5;:O
M5H5!TJ4:CJ;Q['-*Y>9+0G"+6,CV]T*/V](T]^$:ER3(&@[8V%L$JU<*TD3K
M 7J$WK@%8H]\<=)(< O+E[%;3A^6EN*/>K=@A$W8LV)EC&/$)B>L]RSX'</%
M!Y0(R9G;YYJ?"-_Z0/OU&*$VQ0"LN^OFXU.AP;2(D3+!*K9!(>PQH$1N5F2N
M2"-+;!EX[C3;PXXZR&F(9*/-1%WB&,C/S[/:L2UPF01&^/GYRJ1V/MGJ3O&#
MK?7UE@Z=[)4?8NVET5Z$1:H>RZ34[($TUM;=XNU6$>;P5%LQ%UK5YI $U'86
MMU9:&1&R5C<2Y2(2T]")@]V^?VK(->"2):0V>8D2!'OY'IE3BN]A.I5/UP%G
MU3;>C*KJD$0AZ]KN0%IIH&E!IL.O-V$?5 T4?)B"1S<6F):M$(="99BLTK#=
MF80FM^4AP'-C!$>[R4+7DY#B?:?/R\<;J7ZY[!:?VJ#OMDI5Z!$0FL+5<J??
M23\Z/!AU<M0BA,58W"\F4ZTQ"%QG!$Z:R5D.-P9 MK!%#WLN?/B@@SW?,^"A
M:YL2") ([P=EAH?:OK//4*1$W[J%Y9L8>-BT8V!64KEA*M$F3[*;2APDA308
M!!@R99@J_AH>.C):>ER&FY,93TXF]?O5X'9]4XP<9]VZR(?LIU^L#%?D ]SZ
MU+(M=F>IM=1 N 23(+6N.D,N17XL5J8J5DJPW9*TX]$6RAUMJRUMQ>,(/AU3
M;Q#KN8]J<+ARY3[,_ ^XJ45[;NK;;5K!>*OL*GV"F5511-CM8BP#9]>#)"CV
MBY1X@8CR'(#$:$)?8*NRU/\ LV1K[,]#RHCK;R@(,P=M_G\5""(D;[?/X*M-
M?;DZG0I(<!J[86CH$C;9X_=@PNCFZ=!_"'9K18CZ3]OCL!'66[&:N-H!6A;M
MASB5,MY<.=?CS"D@?/<9 MY$9D^.?C^S94M=F0<8,YC'W $>$CJ%F<=HNN"J
MV1MZ=Z:IS5Q)^%5B!W%YKV1L>PDQRS(P1F3[?Y')I,(T\<&M,Y<]X F)!J'E
MX7'>EH<3>O.$X'3'"9.?./OQXX5=Q>]/6 C9R=5&[7IDJ97+?<JC<)<BXTH+
M!J>:'1"5_LMCG_$5E#SC57@"QRHCY*G0;,]#DN/D2,.%60UC/AIQMZ]?+G\.
M?<KZ-W3< CKDQM\<=ZN"S;\TC2R;@6V[:UW6R[%AS5) PU;@8Z=%L20]4L#H
MF7%E36WHDJ.#O=(*RL24-(B0;C5I$E;3=@%9ETD#<\X^?>L0UQV!.)]F?@?<
M5#]N=@Y6IKWK.B)T?M_8;^V33]8J-AHDW2C-?<M$*IWB^$Z^0QL'<E"L$*6-
MIFOK#89$[(!P$^PF$.'%IQV3[J;$P8@YVV^*H;()D"-P9G>!L",GO\5K5LK;
M?6[;U=&[BV-TW.;HI5/L-?#:1VC<M:=?+9#NM@O&XJ1J&O)T^N][$1:JNQ9+
MR?KQ48>NP?6P(W7@_P 7CBLT?$$R96)+2)(D=8'(QUGV'O60#@>$.@F9$D1@
MDSB#CI/O6S>M^T&H]CP:OA)UJE6NV6/8E/':YO!&N0+SBSZHNYC7-^$H@A#M
M@#ET KB#FAO?59.':V2D+AX$F9_MT7UN0<#'?\^'Q6)8X3C8 R.A$COVS!$C
MF%L+RK%.$3A%!+X^XN# $L9SZ\K/::PG'C^,VTI/RSC'SSXON1\_S9^GZN+U
M5Y-.E0;]JO5 CJ&D8_KN;[EZ)]'5O39J&HZS7$6^CZ?5JEQ_<U*K7Y!.,6]*
MX'7U@IK&81%CL1F\>#<=EIAO'T>"&D)0G_Z)QSDF,%-C&-V8UK1RPT #[ET*
MZN*EW<W%W5,U;FO5N*AZOK5'5'>SB<8[ES<R6A.$3A$X1.$3A$X1.$3A$X1.
M$3A$X1.$3A$X1.$3A$X1.$3A$X1.$7[C&<YQC&,YSG.,8QCZ<YS\L8Q^G.>$
M6QXJ'@>-A0L8QXQXS3:_#Z,N^7&7E?\ :=RM7\_-!,DGJMX$ #N\^:R'(JG"
M*.VN%[<!GMX3XN,M>UM?7G"HV?6J\N/M4UAQ&/\ E_+Y\K3!'BHX2"/GJJ!Y
MO6A.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A%C3,
M+WB*GPO#Q5(C.);_ .>3CSLY_F>2C/\ -]./IYIN:?IJ%6G$ES'!O^L!+?<X
M KEM"OSI>L:=?S#;>ZI.JG_J'GT=<>VB^H/:L'2)OM8".VK.<NP7'8;F,_3C
M#><.-?+Z<8PRXA&/^1GGRZ95]):M:?M4B:9\!EO_  D#V+L'T@6 LNT=Q58
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M7K_N*\"![EDWC5[;2 @]NUU:OD2$AX7[;)BP7(+"W&Y+T9_!Q(B#UZ#[UL8
M0XD3 '7F1T(*U\J7I%[L;&:N@5.K5+;EANFFH$KU.)9'5T^7NW]R>%[,Q0A.
M?:6$4H9!ML N'AI@ RYP/68=PJQ.;=GWI4P&/G&>[;<R,@9\^G<J:8DS(SW'
MU>+AGJ1YX)A9.;WWLXYRR7,?##FJA6J/J<YM$Y/3815;U6(8M_<ZK;8LS.LW
MZ['VO.(5BT=?1%.NXT7-NLH(W.>M0D24KE(*S;8XCOC,=8W(,#?I,)P#;.Y
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4G")PB<(G")PB<(G")PB<(G"+_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>g149615g93p54.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g149615g93p54.jpg
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MF&&S8$KS!6\Y@9.V(R1PNFA:_E+HP1@=AZ2ZS7J([$E3*"%F;#M-,N1*>P3
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MV0;3 UTA;=_C(:.HE]]M;*>'L(9S9.,J&<Y1^;,AC!<<M)0]BWWSLZ-AV/\
MXHYQ&C#[TCQ6A,]7NO<<9@,QJ2FLB,$G"N1C8[*(#DAS#*5QWHB7<,/BLI89
M3@$\A81*6D)2/QA.,<RKN-N+'3><.S^1=8[$0"<S;E#&EQ#FR<O.V?;G'SEI
M%DEQ)E)*P[?)]P4ROYJSAO%MK=NZP:[8-0N>X-!8Z,.Y'UB&,'F;@:@#0!
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M<0<7X]^"FAQ.1@=D,9'Y/+PCMWG7*E[V,QD#)8<13W'%2N8_(&-N58SM9;4
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MBOZ";+_J;Q[IW _PV?HS,?L]/=!X0^%C]'Y7ZBGV^?5#\JBOZ";+_J;Q[IW
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M>FA0_B^/4^_O*?O_ !Z_'L8_GD6=K./Y4XX1:O,]0W7L7S_^%FXD^//_ .<
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M,QGEE'OOMNO78WUZ^GK\BL/==?TC8X\2)OE6"6T8"ME3O0:">@,$8PRY4,_
MM5,LT-J0E:6#-8L@L<;"SD8P_ )0HTIA276DJP4?O\_>MPX1:?3-?4C740[
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M-\?+%HA72U;%/VJV&X$&#/GM!X$HVJ$"7.G20T>!*F27W2DN<2"3W=VNFOD
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M:\MPADG!)M:7:^'1,^:C,/1WRJ=[Z0@]VR.G@ /D]7[]Z[B%=E;@GU%F.GF
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M7 T('KL63UPVS9:\=F#EVF(-F%)(Y2 1KD:  .N^9I=OIW[!/?W:7I1[%:8
M]C-!;JT#:'UQ:_NC5E\U>6G--X>?&Q+Q6"==65BMY4C"I@I1!)&'GXT93*C,
MJPM.<85@J =$'T$'YEY8]6S+&5]$FT>FKO"2?U3V)T-W'Z[]%;J2@UB3:)57
M3>>Z.M+3JO<88&\Z+:M-%S2"+LRLR6R$.%<OL.?9B38J"D5[!>IUVG,-%I!?
MW_R>H]1WT](WO2[S:7TC[!C>W>O.XE_[: +?>8.A)G7S;-: =>X%-J]EIK.R
M FT0C.K4O;/LQ'6SC]A#NQ;I+N4S<1"P"3A^-69=#=<K3]2+SV-$:\=CK^?H
M-^K6N[J"J'7OT+2VP!?J^##&]J\G^$NV'J/9%$E-44GB3I ]J/9%PV,(=*.X
MLB5V=<N98X@YUX6H"M,.//1G#B)N&VRJ[3[3I]IOQ[]_BZ?E7]5+T,3M0K?I
M(AH>_0<LCZ<6ZMH[LV0<FT@J]/WQ8]J;5IVSS3D)]=E6_7);4BLOB432SI]Q
MV,] 4I.,0U-ND+]EYU]L-?(!W>'7H/4N-H.H/]R_7Q[&=QA+69VD>@6DQ_2Z
MEW!G&<C+3OLFHP=V4)#2?K:EYULQL+8=9MJ&\X=B$R5:7A2HLY&5D) C#?%Q
M+C\@Z#Y^\?\ =>BSA>:<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")P
MB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G
M")PB<(G")PB<(G")PB<(G"+&"@H<%'=B!!(P/%?E2)S\85 BCX[TZ6OW)<QU
MF(TRVY*E.?V21(6G+SR_NG%J5]?"+)\(G")PB<(G")PB<(G")PB<(G")PB<(
MG")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(JS6?LE K-A,
MU]RJ3):PY"2/7)059:0^J.YEO+J6E0EY;POQYPG*U9Q][SGF@Y#CN"A>M4G8
MZ65U6>2$R"PQH>6'7,&F(D ^@DZ]*P%C/,KSRP&L]QB>YA<)  >4ZWKD.M^C
M:P7VUPW_ ",G?],Q_P!G\L_='K_!4W]*9^I7C[8X_P#PK_\ :M_03[:X;_D9
M._Z9C_L_CW1Z_P %3?TIGZE/;''_ .%?_M6_H)]M<-_R,G?],Q_V?Q[H]?X*
MF_I3/U*>V./_ ,*__:M_03[:X;_D9._Z9C_L_CW1Z_P5-_2F?J4]L<?_ (5_
M^U;^@GVUPW_(R=_TS'_9_'NCU_@J;^E,_4I[8X__  K_ /:M_03[:X;_ )&3
MO^F8_P"S^/='K_!4W]*9^I3VQQ_^%?\ [5OZ"XN\NW S23],8F4F?8,W&MMV
M-I48W''X@-K6A'RKF'1TKWUX^/S[J<M)SX_N/KYY<8>4RMPC)BF2XF>[[*4!
M>:8[4</8M+@WLW!T,G.>OVPY1ZEYYGB>/#NJM?3?.;5<3@MF:SD!.N4[C=S'
MU]/D4#_PE0#\DYC^E<+]B<TWW?*/Q;M_2,/U587W0(/@R7^DL_4I_"5 /R3F
M/Z5POV)Q[OE'XMV_I&'ZJGN@0?!DO])9^I3^$J ?DG,?TKA?L3CW?*/Q;M_2
M,/U5/= @^#)?Z2S]2G\)4 _).8_I7"_8G'N^4?BW;^D8?JJ>Z!!\&2_TEGZE
M/X2H!^2<Q_2N%^Q./=\H_%NW](P_54]T"#X,E_I+/U*?PE0#\DYC^E<+]B<>
M[Y1^+=OZ1A^JI[H$'P9+_26?J4_A*@'Y)S']*X7[$X]WRC\6[?TC#]53W0(/
M@R7^DL_4I_"5 /R3F/Z5POV)Q[OE'XMV_I&'ZJGN@0?!DO\ 26?J4_A*@'Y)
MS']*X7[$X]WRC\6[?TC#]53W0(/@R7^DL_4J_>K[TSLR@5>^1QSHAFS#OI!L
M:])1+=B)^8?8]I<E#3"'L^6<J^)++>/"O'CZO.>T</9AG$&%Q^9C@=69D(.W
M; ]XD=$.=[.5SVM8''WF]AH[]:6[8VZW(T:UUL9B%AG.(W.#BWWSFZ+@ #U;
MO>A\BWWF95ZG")PB<(G")PB<(G")PB<(H:WUMO.D=<D+_BO_ &3?($!4#Z)R
M5^AO=^DYB(GN_/?1Q3X/8^/W/@^37[GCX?C;\_%C9>$^'O;1FH,1YWYCVT-B
M7SCS?SGE[")TG+V7;5]\VM;[0<O?H]RU3C3B?VH8&?-^8^R'8SUH?-O.?-.;
MSB41\W;=A9UR;WR]D>;NVWO5#_X3//Y%<?I%S_4;G6/</'QG/T,/VJN,_P (
M(_%(?3Q_8R?PF>?R*X_2+G^HW'N'CXSGZ&'[53^$$?BD/IX_L9/X3//Y%<?I
M%S_4;CW#Q\9S]##]JI_""/Q2'T\?V,G\)GG\BN/TBY_J-Q[AX^,Y^AA^U4_A
M!'XI#Z>/[&3^$SS^17'Z1<_U&X]P\?&<_0P_:J?P@C\4A]/']C)_"9Y_(KC]
M(N?ZC<>X>/C.?H8?M5/X01^*0^GC^QD_A,\_D5Q^D7/]1N/</'QG/T,/VJG\
M((_%(?3Q_8R?PF>?R*X_2+G^HW'N'CXSGZ&'[53^$$?BD/IX_L9/X3//Y%<?
MI%S_ %&X]P\?&<_0P_:J?P@C\4A]/']C)_"9Y_(KC](N?ZC<>X>/C.?H8?M5
M/X01^*0^GC^QD_A,\_D5Q^D7/]1N/</'QG/T,/VJG\((_%(?3Q_8R?PF>?R*
MX_2+G^HW'N'CXSGZ&'[53^$$?BD/IX_L9/X3//Y%<?I%S_4;CW#Q\9S]##]J
MI_""/Q2'T\?V,NRNBV;[-:13;E\E]&_9;5:]9OH[YGYSY#Z>$0ROR7S?L1?F
MOE?F_8^9^6C^_P"W[OL,_%[:>(Y6C[&93)8WM>W]C[]RCVW)V?;>:6)(.U[/
MGD[/M.SY^3G?R[Y>=VMGO^&R'LOA\5E>Q\W]D\;1R'8=IVO8>>U8K/8]KR1]
MIV?:\G:=G'S\O-R-WRC:N6"R2<(G")PB<(G")PB<(G")PB<(G"+JVVK_ (2+
MM_K&3_\ N%\^>>(_\/9;^?6/ZY7/,E_?]O\ S\G]8JA?:R_[*IB=.!]8RK.P
M:OVP;)79#-.K50M%A(I$Z<V==1 Z-"O#D:O1X,FRU<)@U-DD!"VA"9J&S0GW
M53F?/%UZTWGC[0C+(((Y 9I)HHV\]NM"]Q= #(7".1_(T->"_6V.UHJ<<3^W
M=*&%L<;'#M'O8P;FB8XDQ^^)Y'.Y0 ??$>]/<HG-=U[31YI:J6K6U<L-QJ^J
M3EF-9I]LN40+(V51X.IF[O1/I2PZLCT^(Q&-;.^7BS:S?MAS1<8;%18QPV82
M<9@7+,-%.UDT5F2.&6TR-@FBA<\5YW6NQFY8[1E)+*P)$D%=KB\]FYP:"[V;
M0;( ]DKFQNE:T=HR,N$4AF[.3E;,7G;8MZ?'$';):2 -Y*V=S[A3)VY(9'1,
MHLWHFLVR7?R5:LUQF@H=LJO7B-V#6.BV@OI\#4W*@5B$1%''6"4?B7==E+PI
MR]6)KBG"Z*8L/#,VFYMX--Z2)L#9(X6O,4M\T0XQ-MOF[5I:^9S&QN@[-A:+
M7:>\5+*,;Q"18UYP]@C#F1AQ8^SYOLL;.Y_.W1D+0TLY01VH?[U<_P"VBV>S
MM")23M UC4QU3.;3"[;G3MH6 G!%L4O4VH]QASE5/8UF)Q,AXJNU(J;%&- 1
M2HQ,<2CPI;\"''*DJ?8RL:SIHY[,KI65750VM&USC-:M5'LE9YR[3NUK.[,L
MD=MKFEP#B6M>9P]B9&RRO+VPNA#86@GM)YH"U[3*='GA/*0X]"TD;):/EJ+M
M%9MQ[?K-:2'13Q8J5MJNVH+'^R29!L4T-KWKGLJH'X4C8>L]7WH:PP&W$]$S
M$E54.S,?P_+;=+C7!4S$VL9'3IRR%_;/<*LD3SV8=&'V,A6EC<*]FS XE]0'
M8E>0- AC@X)-4;! ]^^<D0N8X\@+09;,4C2(I9HR>:'?VYUT&FD$*^/,&L<L
M3WV_]8:1_P!F,?\ [=CEGY:/[XX2_P!7V?UV*WXV_NN)_P!'C^L%U-;JMQVJ
MA:C$KY*+7YEVV+4:&];)L2//CU6'89$CWB;<28I(]XJ07$:K-;^DL/CF[.?#
M.S(!5AM8F=RS"4Z]J>X^S$^PREC;E]M1CW1NMOKM;RQ%[ 9!%&'FS8[+ED-:
MO,&21$]K'JM"".:2=TK'2MKU9K(A:XM,SH@W3"YOO@QH<99>33S%'(&N82'M
MCV9NLU2K"W3),>'L.#6CNJ*Q<+U*.CZ]972.Y]CD=?598FF!*Q(!F_L>GM1F
M[C-29J,?'R9MP.)>G#)(9O(LPD-VN;K7/QTEF#+6J=!D$EBL(\+C8\A:[:[/
M:;/!YRPN\S9V-P[? V:9K)6S&Y;0CL1&<.=5=+'=F@K"-TL(91JMLRA]B282
M1]JTGL&]G.>L8D>&O;(=3IG:>X65^FR"NIP80#:P&@[:[.B;,E&B@ZN]C3!^
MM4-38ES70B-.,CS]<GHM8Y1>#"'AWX)$47.379(B)=W>%:=9MQL.7GGL5+&?
MJ"-^+;#%)9X;AKV;X,PR,SF0R5[,9J2B%[Y)FR1RPP,#)G^]C#P1"<,NODDA
MDR,(:ZH(V/EQ<<<MG;_.7EK'1RM[%_(YSWAS7LC: \\O7?:V7<9^NH9JAB@*
M-F!M8V@-*%7[[)6!E=V?6=J'!N3RW:B!3!L ^=JV6)DAV5RH4A19MZ(<<DC)
MP[%&1X393CR3X+\M@XN?)U9FRX\UG2V<99Q4$@K@6Y^TKR,RC)FS$,>T0D.@
MY)8Y3%K#-@;:='9?+YI);A>'U>Q+Y:DM.-PC';R%T;A;#P\@.'9Z,>GM<L?6
M.T5J/QC=G<JE)B5230]%6:D1%VRXSSY,[N!V:RD'*CU765KFD$^Y$E-B7:^$
M(R'E0(SDB*B*8FR:QZVN%JE=\%46[S[;+^=K7GBI2CKQ5\0(R9VNMY2HR/H]
MAE%B:-K>T> \N@8VS5-AX8G,A$]ATPLY&&=PA@;&V.B&.,@,UR%K=!P+Q)(T
M#F< [<;1+A@O9W85NFBBL.H5T/0R<3JP3R_%MT_-T'+W9LDI2C$-P67UQ*%F
M1C9$8H<IO+U4,-@VI!2--@G2;(ZN>L_#&.ILEB?<L37XG<5Q\KJD?F4@PF-B
MNP/;+#DF2P2&.42@ZMPF=S8GQO@B,ECT?B*L+'L=/*^RPYAI#H&]@[V/JLG8
MX/9::^-_*_FV1,PR$,<UT;"Z7/ANU=E/(I3(W6 )PCLX-K6TT-AS9,G$/%8V
M<S<) E^\36-?2':L>'LU-:IX85!MD)];\]D6<GNAI&'[>;A.O7-XRY2<1XN;
M)U;[AC&\_G6+=3;*VBQV0:VU7D-L=G/+)4>T-C,L#!,TM\9,/#%VY?<D#:DE
MJ&R14'-VU4P!PKM-EHFC>9P&R/= X -+HVB0:PIOMW*F! # >N0QI.Z44](Q
M.AEK 9F4*\1M.[ VE%'$<R-<,T4E'9CT9],)#]RBV$A%G#B[U+8%NN^+B#@]
MC)YS/9?+%2OUVF-\->&._1?F<?BGR1\N2=?B<77FEY;2=7C<R2%MUTH;OTCP
M@;)*7RN>VO9C:6N9$QMFN;U:HY[=6C8:=V!S:KNB:6N8)R\!7*J4Z43JE9)3
MG??FD*\%G3'O@;;]Z5+&QGY#OMM(;:1[CKBU_ TA#:?/PH0E.,8QI=QC(K=J
M-@Y61V)V,;LGE8R5S6C9))T !LDD^))6"F:&32L:--;+(UHV3H->0!L[)T!W
MDD^E>CWJG_B\:I_U:Q_O"=S[9\F_W#<-_P P_P#GF7;^&?\  .-_S!_]V16#
MYNZSJ<(G")PB<(G")PB<(G")PBIKWS_Q<[!_K!5?][L\Z3Y)_NSI?S3(?\,]
M<I\L_P!PEW^?8W_B6KHAY]7KXU3A%4#=AS9E1OY$E2[E<"3<30&[=HB=7QQU
M-E SMQUHK64.K &W,TY^X+'GI-D)()Q(UD3/DS)S>!\R"TRQ'1J>9FR-2]++
M3N6Y S!9C)Q8UL=1T$]O'>Q[*T&_-#;,<SIY!(QM@/<]XY'L :T;G@:^*NXZ
M.&]1I1%_$6!Q,V6=+>98KTLK[+/MV2!>;2$E=M6$Q/=5,;61GM62%SW&*=D;
M%N@NJ4S.F-]6G=)<[FPE2;U6EZ,D&%I&ZFN%J%8@LM:]EC!XTL5%Q2R TH7/
M*2FH.1HAQ2%OQ7L9D,A<BK4O8C.6<Q-.;$LKJS\*Z4]GBK=J(,:*#HXXI98F
MRB%\<DCVL,<1/5KLOB\91FMWAG.'JF"AKBM%$VVSB!L(,N8I5)C(XY*.666&
M&9T)F9+%$PO[6< \KVV$L6YYU8B:&DK(U0P#V:BO12]SCN+6Q-GV&32P]>>K
M-7:(QSSPBUEK:C+9V+&-PZLI06/88,<<;<.A\]/EWUF8-QDK2PY(0-EN-ZM?
M).ZG% :]42-G,5J6UTG8V9E8]BVPQL<QGBUNMA&6W\0M$=N"QBC9?#0> '1Q
MUF7I[+;5MT;J[9J<-,\U=[H)+8$[JSW2UQ7GA$?VKM0*MZW^R690[+:['>)8
M*R#0Z9(IV*&SN %JW.6')91N%#-!7CS<N0,3@N6GJ:A1% X+$F:>AX6/B>U!
M7Q_G+Z-BU9N/AGBB#H7-A]EH<;T+Y>1DT)G#W1?999"&,[%C7/G;G9.$JEBS
MDS59D:M.KCV6*TL_+-SV/82QE_?".$O?7G;7+&RGL88PY[Q/(YK*[\9K3L9<
M2H&F BI4%8ITJ=K1V4?JEAP0+C6[#MB90YP*_IE#94>*5(,PW)S$6*W ?<3#
ML 1#B' B3I#SQW$%N2&G!++!8>Z7'%T]6QSS1BQE7T7P7P^-S6RR-87M:T,)
M#)X0=PB>3URO#-.&>]9ABL58V197DKVZQBAE-;#MR,=C'%DS'/AB<]K'/>9&
M#GK3EI%@UXN%J7>>W34/50^,>KTV0='5\03<OC^5+LEGE=4=(;.&QAA""R.=
M&O&+);C<F9'=49FRI2YLQA>(F4#8=.+S65E9BV-GKO=/'!%(;SNMBR[AC"Y&
M-L<C!&8S+8MS.<T]J]SC(\'EU&STS&!PT#\Q*ZO98*[[$\+<<W0K56\7Y[%2
MNECD=*V5L-6G UCFB"-C!&QPY^::2<P79)-EU!9MO,#8== QSE5JU6<-MSY:
MYEA-JI]=,P2L2+F&J/*K^S;&7UQ)BNS!L-@[5B+I@T&&*?(P<U!Q"+.)LY9L
M;((&SU:U8S<[R^>8U*\S)6MY.5T&1L2X]S2^-C9JTCI9H8RY\> L<,.JYFKA
MG2OLV'U[=NVVN8V!E: 7;,,D+W=ISLLXJK#E&/;'+(ZO;B$%>Q-RQ2:15.TM
MTL_T 4:J-517D-Z;C6I31N;**R2.V]Z;"T2R[6?DFY@;(X43ID2T?&^3(XG#
MY[XF-)6MM@PY95>)KEKS>5M6J*VL2VS]F>Z9TF4S>0P@-;D#X>SBDILL[=))
MSQR.B:XD-E-_<X3HU/.83=N&R79MU0&NQL+8L-P]C>(2+7:.9/VLT5Y]3388
M^26-LSF %T#=BZW;GL>XKK<"A0G6%")&F.OUS%U:KFGBZ::0OI7=<XJ$LJ7V
M6UQ+E$@"J^,/8\,)DX$PI"1HS"_EN7'#V8L9>Y;EEEK&)V(P5R*M6F,HIR7I
M<P^6&SS %EQL<4$<X]Z'=DQPCCWRJWXGP=;"4*4,45OMV9WB.C-<MUQ!Y]'C
MH<%'%/5Y7.#Z+Y)K,M<[<6&:1AEE(YU<'FV+2TX1>E317^!'3G^RO7O_ '1$
M<^)>*ONGXC_T]F/^86%]^<&_<APK_JW@_P#E=52IS K9$X1.$3A$X1.$3A$X
M1.$3A$X1.$75MM7_  D7;_6,G_\ <+Y\\\1_X>RW\^L?URN>9+^_[?\ GY/Z
MQ49R1HZ;)'3)D"%+EAY+LT3*DQ6'Y(N8_!EC'Y8Y]UM;L*2\-GSA[K\933KD
M&;+B+6IB0\VO#!SFAP#G / #P"0' .#@' =' .:UP!V X ]X"LP2 0"0' !P
M!(#@"" 1X@$ C?B >]5XV2>ZZZSN<2;=]>-KO&T_^(VSM>Z^7781>ZOQQLF?
MBND+)1-=V=1,BT$J,DDFO$R*R"0E=R13!^C1J7VLA69D+,+FP6#V-;WY9)?A
MKLA!<&]HV.>Q%RMYY0WM&MY>>3EYN9VC<Q-M2L(CE/9P^^Y768XA&-ZY@V25
MFAS/ YFC7,[6]NT<!9=E]4)-BN5EL5="GCP"+-U]9;PK1MLM+95,FQ0M:%M;
MB+Y#H!0=>B.+/96J0:U_5C9\I'*3"0,F$:=BE8\?TCK941PQ1R/8Q[FSQ0^?
M11\A$;K++#X#.UT#>SC,S)Y61M+6M>UY!:36V&Z&,8USFM=J5L?G#&<NF&9L
MKHS*#&.1AD;(]K1H!P=U&Y5KRM*[;&"[D*"4^SLR[09+09ANHQHIV+>JHV]K
MRQ29@JS"(5B"W>LL GZ0<02@P;($CB55T@B*S#^4;M9!<J.="]\T1;$QKFLE
M)88)2+$8#HWNC?#(9!/&6N=&\O[1I)=L^+O.("8RZ1FF-:0UY+3&_P"RL +'
M%KF.YNT;HEKB>8;)VMHJVM-<T9J.Q2:!2:>S$<G/16:M505?:C/%&!T8F[';
M$P(B&7",8.(CSEMX2J6P+'-2,N-P8R6O*6S8G),T\TQ( )EE?(2&EQ:"7N.P
MTO<1Z"YQ'5QW0^6639DDD>3H'G>YVP"2 >8G>BYQ'H).N\K=N>*\UB>^W_K#
M2/\ LQC_ /;L<L_+1_?'"7^K[/Z[%;\;?W7$_P"CQ_6"ZZ30@*?%3@UB%BS0
M,C'5')BC4*(1%3HJLXRMB=!G-/1),=64XRIJ0TMO.<8SE/U8YQB":>O-'-6E
MEAGC<'12P/?',Q_@Z-\9:]KO06D%:5&^2-[7Q/?'(T@L?&YS7M=X%KFD.!]!
M!VH^IU<T\>@4^W5&F4E+(2'/A48G&IXD7.KX]F;-B$(E=PZ,BSP</,Q<U+T>
M F(RZI]US*%)D94YD+MG,UY+E2Y=O%T[XWWHG7)I66)'1L?&^SJ5T<[^01\K
MI"]P#0-CET+F>6]&Z>":Q.3(YKK##/(]LKRUKFNE]\6R.Y0W1=S$<HZ].FQM
M"Z1'FQ@[%=$,N0PH1V(IFL);$PP]-).JK4)DLV-P&C?8N2F298 ,F:W*#N/R
MB R%';4_(Y;F6\Z-TSK$S@^>=K^:T3*^:[$WSE[H3)VSO.HF-;8F+"R8-9'(
M]Q#6KR+[!:7F60\TD@=N4E[I+#!VKBPNYSVS&@2/Y2)  U[CT"U:L:/T_4Z3
M"UT,H%-?J[4$!#E#25>!$?L@<J\.'"$%;'A^ I-@-16X,5[)<BW(F_,HQ)PZ
MESPK%U:SF8N7I,C+D+K;1DL.;)%9GC\V%I[WS0UN63=>!Y>]HAC+6<GO=$+V
MER%Z:=UI]F?M>:1P>V61O9"9SG/9%IWV*-Q<X<C2&ZZ:TLL=H>ITCYLFQ4B@
MNC1U6:%35$ZJ DL1J: EI-QA+C3P]W_T>$3XK92(+PC,"'/8;EQXZ)*$+QY5
M[^6,C&UKV0$DMHRL[*W88YUVPPP.E#FR#^,31O,3Y2>T?&XL<XM)"HCLW>9H
MBL60YTQ>WDFE:3/(.S+P0X?97M/(Y^^9S3HD@J.9MRT)7J_1M@3J:H8-L0\$
M$II./I.V32<0=]DXB740*HP6E3R=9:FVZ8#GT\(3:%J)6!V#* Q)!-I*V\BR
MEG[%F_CX[G:RUI)YKL3LW49&Z3S69ER?GFNLBM&.FR>.Y/$Z415Q(RP]L1T;
MIM?)2RV*S9P]\3I)+##D(&L<_LGMFDYI+#63%L+9&3R,+^6,.;(X,/5&O77.
MI2+4[ %@:ZH(F??KF3':P-#8 TN(K3]K)R[$;AU-H<QL =5YDDM,K\^;B]Q8
M,I[+PI&7UH6=0XDMMJB26Q8[<QX^E%)E(9))89K+:D3*T#[9D=CY;3&Q,L1L
M-![V-U*>4$'5\I.(>9\DHD+:L#76XWN<Q\HA8V)CIBXUG2M#&RM;YL7-&G]
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ML-1F&F4*PM#+;+:&D+PKX\+2VE.$)5A?W6%8QC.%?=>?/U\@-: &AK0 =@
M '>]@ :WOKOT]5)<YQ+G.)<>A)))((T02>IV.G7PZ=RP+E.K#IP-9%A8?TQ7
MQ)L(&E)2MML>,L9*O&#+#,)M:8&5S"=5 3/FG(RY<=V!CY1]A$F8F1XFI6,\
M-@PL[:"*:&%W4"..Q)7FE:U@(9M\E6!_,6E[3'[QS0YX=<"Y:%>>J)G]A9FK
MSSL.B99:L5F"!SGD&33(KEEG('ACFR>_:XL86YQ4.(IQMU46,IUI3BFG%,-9
M<:4\ZA]U3:\I^)"G7FVWG,ISC*W6T.*\K2G./;D9L'D;L$D'E&P7$%Q!UL%Q
M )UWD GJ O#G> 0'. =KF',='E:6MV-]>5I+1ON:2!T*U0+KRFUU8!P0$:BN
M5>/98P-Q<LA+<AXN!*,8L\I:YLN0N82-$HB)<TM.S)*+<>GX1,0@F11*M8<?
M3@,!BA#36;9; 2^1Q9YW(V6RX\[W<\DTC0Y\K^:7;I-/ DD#KR?)7;(L":<N
M%IU5TX#(V!_F43X*C (V-#(H(GEC(8^2$!L>V$Q1%FZ<O%8IPB<(O2IHK_ C
MIS_97KW_ +HB.?$O%7W3\1_Z>S'_ #"POOS@W[D.%?\ 5O!_\KJJ5.8%;(G"
M)PB<(G")PB<(G")PB<(G")PB_E:$.(4VXA*T+3E*T+3A2%I5CPI*DJQG"DYQ
M]6<9QG&<?5G'((#@6N ((T00""#W@@]"#Z"A (((V#T(/<1Z"HHLND=<V?W'
M'P38F8YYSF<!5@6[A6?OK5':0L<ZM6?K4M^$ZO.?.?B\YSYUR_PE@LAMSZ;:
MTI_QU,BN[9[R6-!@<2>I<^%QWX]3O&V,31L;+H1&X_?P_8S\N@.0GUN82J]V
M7JV<B^X_53L,LUCRI,$HC(Z;X_ VW);]^&^O/U?=NX@(^_\ >\?7I.0\GEN/
MF?C;D5EO>(;([";7X+9&\\3W=W5P@;W^CKA+'#TK=NK3-D'@R0<C_D#AMA/K
M/(._\<'3M9; '$&QDFH'OG'592RF- >FLO93_=99EPDR(CB48^Z6M#^4MI^Z
M7E*?KYJ,W#^;@G%>3%W.U<2&B.%\S'Z[^26(/B<!WN(>0T=3H+$/Q]V-XC=6
MFYB2&\K"]KM=^G,YFG7J/=U[E*-:ZTW@O[;QQ^!68JOARI#[F")'",_7Y3#A
MN?+XSX^^A^>PXG/C"D8SYQC8<?P%E[7*ZX^''QGO#R)Y]>D11.[/NZZ?.QP[
MBW>P,C7P%N71F<RNTZZ$]I)H_P EIY1\A>"#T([U8.M===>@O;>(L2[+,1X5
ME95[X(6%X_"V/B>RTIO/\5,7-Q]>?.<_5XW6AP-A*?*Z=DM^4=>:R[40/J@B
MY6EO\F4RA9NO@Z,.B]KK#AXRGWN_4QNAKU.YU-T$? %QD0QL&(/B-8\-Q8,9
MF)';Q]6/N&6$-MI^]C[R<?>YML,$->,15X8H(F_:QPQLBC;\C&!K1^(++,8R
M-H;&QK&CN:QH:T?(&@ ?,JX20FN%=JQYYRY3D;/1K5<)BD8$S,CW:[F5.4HP
MHSB%F$E_#BGD?*9GX>SAO"O8\*QG.B25,$?*/!<=E)AQ".'S"S$>;2F!U#M9
MB;1M=EV(?S%[>R,P=IH/+U&\"Z&@>)(YS;>,B,>6-I]F[D-?G?\ 9>UY.3FV
M2.7GWT^U\5.=GI%-ND;Y.WU6O6:/A.4(;.AX!3VL9\_6PJ8PZN.O&<YREQA3
M;B%?=(4E7C/-OR&(Q>6C[+)XZCD(]:#;E6&QRCO]X96.+"#U!86D'J"#U67L
M4ZEMO):K06&CN$T3)-?Y/.TEI]8T0>H55KGT-T+9_=>#P#M'F.?$O#E<+NOP
MLNY\^,N#CJ"[*&?/CRQ 7 3]6,(4WYSG/.<KY&^#,CS/JP7,1*[9YJ%ESXN;
MTF"X++ WTLA,(]!:>JUNWP7A;&S$R:F\]=UY2YF_7',)0!ZF%GJTJG7+TX[V
M/]U^C7BO65E/Q+1".19E;(Y3]?PM-.,9-0)#N/JQEQ^0/;7]:O#?U(YS7*^0
MC,0<S\/F*-]@V1%<CEH3D>#&N9YW"]WAS/? T]_O>Y:U;X"N,VZG<@L =0R9
MKZ\A]0+>V8X^MSHQ\G<JFW/KCN^A>ZNQZWLC<1GXLN$A41-A%H0GSG#KI$"X
M2B1T*QCRGYIUA?X%)2O&4XYME> ^+\+S&]@;XB;O=BK$+U<-&_?.GI&>.,$#
M8[1S#X$ ]%K%O 9BELSX^P&C>Y(FB>, >)? 9&M![_?%I](!Z*)A84P;G(&!
M1),N2<SE+8\7 E3YSBL9^'*41(C3KZLX5G&,X2WG.,Y\9^OFLUZEJW,*]2M8
MM3GH(*\,DTQ(.B!'&USSHD#HWO.EC(X99GB.**260]S(V.>\_(UH+OR*RE,Z
M8]@[E[3OV&9JT%WX?[>N4U@'[?Q>,_V45GYFP(\8SYS_ ,3YQCQE/GXON>;]
MBO)3QOE>5WL5['0NU]FRLS*G+OK[ZO\ 9+HT._\ BO3N[^BV"IPGG+>CYIYL
MP_?VWB'7RQ^^G'^R5LJ;Z;<1'M/[!V/(?S]S[XRG#&XV$YQ]:L-G#7S.7,9S
M]6/BK[6<8QY\^<^$]*Q7D%A'*_-YZ1_=SU\77;&!Z0VY;[4NWW=:3==_7?39
MJG #!IUZ^YWICJ1AOS33<V_'_$#T[\%;&F]0^OU*]IV+0(!Z<U\.<S[<Z_97
M'%)^M*U02*W S2\9^ZPJ,+8^OZ_P8\=*Q7DQX)Q/*Z+"07)FZ^S9-S\@YQ'<
M3#8+JK2._<==G7KZ-;-4X7P=31;19,\:]_:+K!)'CR2$P@^.VQMZ_B5BX,""
M,BM0AL*(/A,)^!B)!CLQ(K*/_=:CL(;:;3_\*$8Q_P G-ZBAB@C;%!%'#$P:
M9%$QL<;!Z&L8&M:/4  L\QC(VAD;&L8T::QC0UK1Z UH  ^0*M_64)K@(+V0
MWKBY3KE%F[*-S;"].$S!*A%B=CPDS0[")D*%F6Q&;2RM,ME+S+F7,X2^KX<X
MQH7D^J8&I7SXP.5FRL<N?MRWGS5I:QJWG,B$M5@EAB,C(P&D2M#V.YB XZ*P
M'#\-"&/("A;?;:_(3/L%\3XNRL%K.>)H>QG,UH (<.8'?VQ5F^=!6PIPB<(G
M")PB<(G")PB<(G"*FO?/_%SL'^L%5_WNSSI/DG^[.E_-,A_PSURGRS_<)=_G
MV-_XEJZ(>?5Z^-4X1.$3A$X1.$3A$X1.$3A$X1.$3A%Z5-%?X$=.?[*]>_\
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M:5)6G"DJQE*DJQA25)SCQG"L9\XSC./JSC./&<??X!(.P=$=01W@^E00"""
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M%9_FC+HB<(G")PB<(G")PB<(G")PB<(G"*,MSUN3<-4;!JT.<+&2SU6*C(Y
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M=2O42T]TXN_V6!K[ID]3*TW?8NS(9D>P/9NKD<8..0\S!A$P*(UXHY===[T
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M4>+%80MY]]Q6<)0TTA2U9^I.,YYL?"-B"KQ/@K-F:*O7@R=62:>9[8XHHV2
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M:#]CC#*/3XNG=U/;DT;6AT:_,3@LD'+5"J.QZJRD:0#S:^)-LLAB#"C*VT$
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M1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$6HK_\ ZS9__2<_]=WF,/\
MA5O\V_M*M?\ ]9__ $__ .EMW,FKI.$3A$X1.$3A$X1.$3A%J-1_O1;_ /5I
M'_51S&XW[2S_ #J3\S5:5.Z7_.N_,%MW,DKM.$3A$X1.$3A$X1.$3A$X1.$3
;A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169238377880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Immatics N.V.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001809196<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">62,908,617<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">International Financial Reporting Standards<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">P7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39363<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Paul-Ehrlich-Stra&#223;e 15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">T&#252;bingen<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">77030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Edward A. Sturchio<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2130 W. Holcombe Blvd., Suite 900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Houston<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">281<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">810-7545<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationDocumentAxis=imtx_OrdinaryShareMember', window );">Common Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary shares, nominal value &#8364;0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IMTX<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationDocumentAxis=imtx_WarrantsMember', window );">Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants to purchase ordinary shares<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IMTXW<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number Section<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationDocumentAxis=imtx_OrdinaryShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationDocumentAxis=imtx_OrdinaryShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationDocumentAxis=imtx_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationDocumentAxis=imtx_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169217131512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statement of Financial Position of Immatics N.V. - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssetsAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">&#8364; 207,530<span></span>
</td>
<td colspan="2" class="nump">&#8364; 103,353<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialAssets', window );">Other financial assets</a></td>
<td class="nump">24,448<span></span>
</td>
<td colspan="2" class="nump">16,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Accounts receivable</a></td>
<td class="nump">1,250<span></span>
</td>
<td colspan="2" class="nump">957<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentAssets', window );">Other current assets</a></td>
<td class="nump">5,763<span></span>
</td>
<td colspan="2" class="nump">3,667<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Total current assets</a></td>
<td class="nump">238,991<span></span>
</td>
<td colspan="2" class="nump">124,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">7,868<span></span>
</td>
<td colspan="2" class="nump">4,720<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">914<span></span>
</td>
<td colspan="2" class="nump">1,008<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">6,149<span></span>
</td>
<td colspan="2" class="nump">3,287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="nump">724<span></span>
</td>
<td colspan="2" class="nump">1,262<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Total non-current assets</a></td>
<td class="nump">15,655<span></span>
</td>
<td colspan="2" class="nump">10,277<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">254,646<span></span>
</td>
<td colspan="2" class="nump">134,277<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentProvisions', window );">Provisions</a></td>
<td class="nump">51<span></span>
</td>
<td colspan="2" class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers', window );">Accounts payable</a></td>
<td class="nump">10,052<span></span>
</td>
<td colspan="2" class="nump">7,082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentContractLiabilities', window );">Deferred revenue</a></td>
<td class="nump">46,600<span></span>
</td>
<td colspan="2" class="nump">59,465<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">1,881<span></span>
</td>
<td colspan="2" class="nump">1,411<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="nump">2,025<span></span>
</td>
<td colspan="2" class="nump">1,288<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">60,609<span></span>
</td>
<td colspan="2" class="nump">69,296<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentContractLiabilities', window );">Deferred revenue</a></td>
<td class="nump">85,475<span></span>
</td>
<td colspan="2" class="nump">101,909<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">4,306<span></span>
</td>
<td colspan="2" class="nump">1,823<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentLiabilities', window );">Other non-current liabilities</a></td>
<td class="text"> <span></span>
</td>
<td colspan="2" class="nump">2,084<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Total non-current liabilities</a></td>
<td class="nump">89,781<span></span>
</td>
<td colspan="2" class="nump">105,816<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>Shareholders' equity (deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="nump">629<span></span>
</td>
<td colspan="2" class="nump">1,164<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Share premium</a></td>
<td class="nump">573,339<span></span>
</td>
<td colspan="2" class="nump">190,945<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RetainedEarnings', window );">Accumulated deficit</a></td>
<td class="num">(462,253)<span></span>
</td>
<td colspan="2" class="num">(233,194)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherReserves', window );">Other reserves</a></td>
<td class="num">(7,459)<span></span>
</td>
<td colspan="2" class="num">(770)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAttributableToOwnersOfParent', window );">Total equity (deficit) attributable to shareholders of the parent</a></td>
<td class="nump">104,256<span></span>
</td>
<td colspan="2" class="num">(41,855)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Non-controlling interest</a></td>
<td class="nump">0<span></span>
</td>
<td colspan="2" class="nump">1,020<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total shareholders' equity (deficit)</a></td>
<td class="nump">104,256<span></span>
</td>
<td colspan="2" class="num">(40,835)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and shareholders' equity (deficit)</a></td>
<td class="nump">&#8364; 254,646<span></span>
</td>
<td colspan="2" class="nump">&#8364; 134,277<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See Note 2 for details regarding the change in presentation of Other financial assets</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2020-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2020-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2020-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current contract liabilities. [Refer: Contract liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2020-01-01<br> -Paragraph 105<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2020-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current provisions. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 54<br> -Subparagraph l<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_54_l&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2020-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2020-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2020-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 54<br> -Subparagraph r<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_54_r&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2020-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph 12<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_12_f&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 54<br> -Subparagraph q<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_54_q&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 10<br> -IssueDate 2020-01-01<br> -Paragraph 22<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=10&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_22&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current contract liabilities. [Refer: Contract liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2020-01-01<br> -Paragraph 105<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2020-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current assets that the entity does not separately disclose in the same statement or note. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets; Current financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 54<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_54_d&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing reserves within equity, not including retained earnings. [Refer: Retained earnings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2020-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the entity's cumulative undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph IG6<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2020-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SharePremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount received or receivable from the issuance of the entity's shares in excess of nominal value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SharePremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 70<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237646328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statement of Loss of Immatics N.V. - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeStatementAbstract', window );"><strong>Profit or loss [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_RevenueFromCollaborationAgreements', window );">Revenue from collaboration agreements</a></td>
<td class="nump">&#8364; 31,253<span></span>
</td>
<td class="nump">&#8364; 18,449<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 3,770<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="num">(67,085)<span></span>
</td>
<td class="num">(40,091)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(33,971)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="num">(34,186)<span></span>
</td>
<td class="num">(11,756)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(7,666)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherIncome', window );">Other income</a></td>
<td class="nump">303<span></span>
</td>
<td class="nump">385<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,458<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating result</a></td>
<td class="num">(69,715)<span></span>
</td>
<td class="num">(33,013)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(34,409)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Financial income</a></td>
<td class="nump">2,949<span></span>
</td>
<td class="nump">790<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,215<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Financial expenses</a></td>
<td class="num">(10,063)<span></span>
</td>
<td class="num">(264)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(161)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ShareListingExpense', window );">Share listing expense</a></td>
<td class="num">(152,787)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceIncomeCost', window );">Financial result</a></td>
<td class="num">(159,901)<span></span>
</td>
<td class="nump">526<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,054<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Loss before taxes</a></td>
<td class="num">(229,616)<span></span>
</td>
<td class="num">(32,487)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(32,355)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Taxes on income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss</a></td>
<td class="num">(229,616)<span></span>
</td>
<td class="num">(32,487)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(32,355)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToAbstract', window );"><strong>Attributable to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Equity holders of the parent</a></td>
<td class="num">(229,059)<span></span>
</td>
<td class="num">(31,571)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(31,444)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Non-controlling interest</a></td>
<td class="num">(557)<span></span>
</td>
<td class="num">(916)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(911)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss</a></td>
<td class="num">&#8364; (229,616)<span></span>
</td>
<td class="num">&#8364; (32,487)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">&#8364; (32,355)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BasicAndDilutedEarningsLossPerShare', window );">Net loss per share&#8212;basic and diluted</a></td>
<td class="num">&#8364; (4.77)<span></span>
</td>
<td class="num">&#8364; (0.95)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">&#8364; (0.95)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Weighted average shares outstanding&#8212;basic and diluted</a></td>
<td class="nump">48,001,228<span></span>
</td>
<td class="nump">33,093,838<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">33,093,838<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See Note 2 for details regarding the revision as a result of a correction in classification of Other financial assets</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicAndDilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of earnings per share when the basic and diluted measurements are equal. [Refer: Basic earnings (loss) per share; Diluted earnings (loss) per share]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicAndDilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income or cost associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2020-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2020-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_35_b_iv&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2020-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2020-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2021-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2020-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph 12<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_12_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81B_a_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81B_a_ii&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2020-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2020-01-01<br> -Paragraph IE33<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2020-01-01<br> -Paragraph 126<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2020-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_RevenueFromCollaborationAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue from collaboration agreements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_RevenueFromCollaborationAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_ShareListingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share listing expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_ShareListingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169238331976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statement of Comprehensive Loss of Immatics N.V. - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_StatementOfComprehensiveIncomeAbstract', window );"><strong>Statement of comprehensive income [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net Loss</a></td>
<td class="num">&#8364; (229,616)<span></span>
</td>
<td class="num">&#8364; (32,487)<span></span>
</td>
<td class="num">&#8364; (32,355)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract', window );"><strong>Items that may be reclassified subsequently to profit or loss, net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax', window );">Currency translation differences from foreign operations</a></td>
<td class="num">(6,689)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="nump">313<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss for the period</a></td>
<td class="num">(236,305)<span></span>
</td>
<td class="num">(32,516)<span></span>
</td>
<td class="num">(32,042)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToAbstract', window );"><strong>Attributable to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent', window );">Equity holders of the parent</a></td>
<td class="num">(235,748)<span></span>
</td>
<td class="num">(31,600)<span></span>
</td>
<td class="num">(31,131)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests', window );">Non-controlling interest</a></td>
<td class="num">(557)<span></span>
</td>
<td class="num">(916)<span></span>
</td>
<td class="num">(911)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss for the period</a></td>
<td class="num">&#8364; (236,305)<span></span>
</td>
<td class="num">&#8364; (32,516)<span></span>
</td>
<td class="num">&#8364; (32,042)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncomeAttributableToAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncomeAttributableToAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 81B<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81B_b_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 81B<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81B_b_ii&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, net of tax. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2020-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2020-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2021-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2020-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_StatementOfComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_StatementOfComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169238708040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statement of Cash Flows - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="6">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2019</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Loss before taxation</a></td>
<td class="num">&#8364; (229,616)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">&#8364; (32,487)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">&#8364; (32,355)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract', window );"><strong>Adjustments for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForInterestIncome', window );">Interest income</a></td>
<td class="num">(850)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(790)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(507)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense', window );">Depreciation and amortization</a></td>
<td class="nump">4,424<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,858<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,176<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForInterestExpense', window );">Interest expense</a></td>
<td class="nump">289<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">170<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_AdjustmentsForShareListingExpense', window );">Share listing expense</a></td>
<td class="nump">152,787<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_AdjustmentForEquitySettledSharebasedPayment', window );">Equity settled share-based payment</a></td>
<td class="nump">22,908<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">152<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">118<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">MD Anderson compensation expense</a></td>
<td class="nump">45<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">700<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,360<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities', window );">(Decrease) Increase in other liabilities resulting from share appreciation rights</a></td>
<td class="num">(2,036)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,864<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">220<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PaymentsForShareBasedCompensation', window );">Payment related to share-based compensation awards previously classified as equity-settled</a></td>
<td class="num">(4,322)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains', window );">Net foreign exchange differences</a></td>
<td class="num">(4,477)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ChangesInWorkingCapitalAbstract', window );"><strong>Changes in working capital</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable', window );">Increase in accounts receivable</a></td>
<td class="num">(294)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(563)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(175)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets', window );">Increase (decrease) in other assets</a></td>
<td class="num">(1,600)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,497)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">5,608<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables', window );">(Increase) decrease in accounts payable and other current liabilities</a></td>
<td class="num">(23,387)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">98,937<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">43,732<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestReceivedClassifiedAsOperatingActivities', window );">Interest received</a></td>
<td class="nump">808<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">790<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">507<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsOperatingActivities', window );">Interest paid</a></td>
<td class="num">(289)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(170)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(16)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Net cash provided by/(used in) operating activities</a></td>
<td class="num">(85,610)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">70,967<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">20,684<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Payments for property, plant and equipment</a></td>
<td class="num">(7,420)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,143)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(429)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Cash paid for investments in Other financial assets</a></td>
<td class="num">(82,930)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(20,473)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(13,101)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Cash received from maturity of investments classified in Other financial assets</a></td>
<td class="nump">74,505<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,551<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities', window );">Payments for intangible assets</a></td>
<td class="num">(104)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(91)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(78)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Proceeds from disposal of property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">97<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">94<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Net cash provided by/(used in) investing activities</a></td>
<td class="num">(15,949)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5,059)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(13,514)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from issuance of shares to equity holders of the parent</a></td>
<td class="nump">217,918<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,648<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsForShareIssueCosts', window );">Transaction cost deducted from equity</a></td>
<td class="num">(7,939)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Payments for leases</a></td>
<td class="num">(2,096)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,862)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">Net cash provided by/(used in) financing activities</a></td>
<td class="nump">207,883<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,862)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">23,648<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">106,324<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">64,046<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">30,818<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">103,353<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">39,367<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">8,415<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Effects of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(2,147)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(60)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">134<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">&#8364; 207,530<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 103,353<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">&#8364; 39,367<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See Note 2 for details regarding the revision as a result of a correction in classification of Other financial assets</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">See Note 2 for details regarding the change in presentation of Other financial assets</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in other assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other assets; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in other liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other liabilities; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for interest expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Interest expense; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForInterestIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for interest income expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Interest income; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForInterestIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForReconcileProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for unrealised foreign exchange losses (gains) to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 28<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents before the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestPaidClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for interest paid, classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 31<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestPaidClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestReceivedClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from interest received, classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 31<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestReceivedClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsForShareIssueCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for share issue costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsForShareIssueCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of investments other than investments accounted for using the equity method. [Refer: Investments accounted for using equity method; Investments other than investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2020-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of investments other than investments accounted for using equity method. [Refer: Investments accounted for using equity method; Investments other than investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_AdjustmentForEquitySettledSharebasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment for equity settled share-based payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_AdjustmentForEquitySettledSharebasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_AdjustmentsForShareListingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for share listing expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_AdjustmentsForShareListingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_ChangesInWorkingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Changes in working capital [Abstract].</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_ChangesInWorkingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_PaymentsForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for share based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_PaymentsForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169216165592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statement of Changes in Shareholders' equity (deficit) of Immatics N.V. - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="2"><div>Total</div></th>
<th class="th"><div>Share capital [member]</div></th>
<th class="th"><div>Share premium [member]</div></th>
<th class="th"><div>Accumulated deficit [member]</div></th>
<th class="th"><div>Other reserves [member]</div></th>
<th class="th"><div>Total equity attributable to shareholders of the parent [member]</div></th>
<th class="th"><div>Non-controlling interests [member]</div></th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Beginning Balance at Dec. 31, 2017</a></td>
<td class="num">&#8364; (2,255)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 1,164<span></span>
</td>
<td class="nump">&#8364; 167,027<span></span>
</td>
<td class="num">&#8364; (170,179)<span></span>
</td>
<td class="num">&#8364; (1,054)<span></span>
</td>
<td class="num">&#8364; (3,042)<span></span>
</td>
<td class="nump">&#8364; 787<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive loss</a></td>
<td class="nump">313<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313<span></span>
</td>
<td class="nump">313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net Loss</a></td>
<td class="num">(32,355)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31,444)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31,444)<span></span>
</td>
<td class="num">(911)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Comprehensive loss for the year</a></td>
<td class="num">(32,042)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31,444)<span></span>
</td>
<td class="nump">313<span></span>
</td>
<td class="num">(31,131)<span></span>
</td>
<td class="num">(911)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Equity-settled share-based compensation</a></td>
<td class="nump">118<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Issuance of ordinary shares</a></td>
<td class="nump">23,648<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncreasedecreaseThroughCompensationExpense', window );">MD Anderson compensation expense</a></td>
<td class="nump">1,360<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,360<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Ending Balance at Dec. 31, 2018</a></td>
<td class="num">(9,171)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,164<span></span>
</td>
<td class="nump">190,793<span></span>
</td>
<td class="num">(201,623)<span></span>
</td>
<td class="num">(741)<span></span>
</td>
<td class="num">(10,407)<span></span>
</td>
<td class="nump">1,236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive loss</a></td>
<td class="num">(29)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net Loss</a></td>
<td class="num">(32,487)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31,571)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31,571)<span></span>
</td>
<td class="num">(916)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Comprehensive loss for the year</a></td>
<td class="num">(32,516)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31,571)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="num">(31,600)<span></span>
</td>
<td class="num">(916)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Equity-settled share-based compensation</a></td>
<td class="nump">152<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncreasedecreaseThroughCompensationExpense', window );">MD Anderson compensation expense</a></td>
<td class="nump">700<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Ending Balance at Dec. 31, 2019</a></td>
<td class="num">(40,835)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,164<span></span>
</td>
<td class="nump">190,945<span></span>
</td>
<td class="num">(233,194)<span></span>
</td>
<td class="num">(770)<span></span>
</td>
<td class="num">(41,855)<span></span>
</td>
<td class="nump">1,020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive loss</a></td>
<td class="num">(6,689)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,689)<span></span>
</td>
<td class="num">(6,689)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net Loss</a></td>
<td class="num">(229,616)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(229,059)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(229,059)<span></span>
</td>
<td class="num">(557)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Comprehensive loss for the year</a></td>
<td class="num">(236,305)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(229,059)<span></span>
</td>
<td class="num">(6,689)<span></span>
</td>
<td class="num">(235,748)<span></span>
</td>
<td class="num">(557)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Equity-settled share-based compensation</a></td>
<td class="nump">22,908<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,908<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,908<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncreaseDecreaseThroughReorganizationEquity', window );">Reorganization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(833)<span></span>
</td>
<td class="nump">833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest', window );">MD Anderson Share Exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7<span></span>
</td>
<td class="nump">501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">508<span></span>
</td>
<td class="num">(508)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners', window );">PIPE Financing, net of transaction costs</a></td>
<td class="nump">90,077<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">104<span></span>
</td>
<td class="nump">89,973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,077<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncreaseThroughARYAMerger', window );">ARYA Merger, net of transaction costs</a></td>
<td class="nump">272,688<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">180<span></span>
</td>
<td class="nump">272,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_SARConversion', window );">SAR conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncreasedecreaseThroughIssuanceOfEquity', window );">Total issuance of share capital</a></td>
<td class="nump">362,765<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">298<span></span>
</td>
<td class="nump">362,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">363,273<span></span>
</td>
<td class="num">(508)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncreasedecreaseThroughShareBasedCompensationPreviouslyClassifiesAsEquitySettled', window );">Payment related to share-based compensation awards previously classified as equity-settled</a></td>
<td class="num">(4,322)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,322)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,322)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncreasedecreaseThroughCompensationExpense', window );">MD Anderson compensation expense</a></td>
<td class="nump">45<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 45<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Ending Balance at Dec. 31, 2020</a></td>
<td class="nump">&#8364; 104,256<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 629<span></span>
</td>
<td class="nump">&#8364; 573,339<span></span>
</td>
<td class="num">&#8364; (462,253)<span></span>
</td>
<td class="num">&#8364; (7,459)<span></span>
</td>
<td class="nump">&#8364; 104,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="9"></td></tr>
<tr><td colspan="9"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See Note 2 for details regarding the change in presentation of Other financial assets</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2020-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2020-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2020-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through other contributions by owners that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssueOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through the issue of equity instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssueOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2020-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2020-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2021-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2020-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_IncreaseDecreaseThroughReorganizationEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) through reorganization, equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_IncreaseDecreaseThroughReorganizationEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_IncreaseThroughARYAMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase through ARYA Merger.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_IncreaseThroughARYAMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) through changes in noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_IncreasedecreaseThroughCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) through compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_IncreasedecreaseThroughCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_IncreasedecreaseThroughIssuanceOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) through issuance of equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_IncreasedecreaseThroughIssuanceOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_IncreasedecreaseThroughShareBasedCompensationPreviouslyClassifiesAsEquitySettled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) through share based compensation previously classifies as equity settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_IncreasedecreaseThroughShareBasedCompensationPreviouslyClassifiesAsEquitySettled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_SARConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>SAR conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_SARConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237593672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Group information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfCompositionOfGroupExplanatory', window );">Group information</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">1.</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Group information </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; line-height: 12pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Immatics N.V, together with its German subsidiary Immatics Biotechnologies GmbH and its U.S. subsidiary, Immatics US Inc., (&#8220;Immatics&#8221; or &#8220;the Group&#8221;) is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer patients. Immatics N.V., a Dutch public limited liability company, was converted on July&#160;1, 2020 from Immatics B.V., a Dutch company with limited liability. Immatics Biotechnologies GmbH and Immatics US Inc. became subsidiaries of Immatics N.V. as part of the ARYA Merger (defined below) on July&#160;1, 2020. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Immatics N.V is registered with the commercial register at the Netherlands Chamber of Commerce under RSIN 861058926 with a corporate seat in Amsterdam and is located at Paul-Ehrlich Str. 15 in 72076 T&#252;bingen, Germany. Prior to July&#160;1, 2020, Immatics N.V. was a shell company with no active trade or business or subsidiaries and all relevant assets and liabilities as well as income and expenses were borne by Immatics Biotechnologies GmbH and its U.S. subsidiary Immatics US, Inc. Therefore, the comparable consolidated financial statements as of </div><div style="display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">December&#160;31, 2019 </div></div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">and for the years ended December&#160;31, 2019 and December&#160;31, 2018 represent consolidated financial statements of Immatics Biotechnologies GmbH. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">These annual consolidated financial statements of the Group for the year ended December&#160;31, 2020 were authorized for issue by the Management Board of Immatics N.V. on March&#160;30, 2021. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCompositionOfGroupExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the composition of the group (the parent and all its subsidiaries). [Refer: Subsidiaries [member]; Parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph 10<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_10_a_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCompositionOfGroupExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237547976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of presentation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory', window );">Basis of presentation</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">2.</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Basis of presentation </div></div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The consolidated financial statements of the Group have been prepared in accordance with International Financial Reporting Standards (&#8220;IFRS&#8221;) as issued by the International Accounting Standards Board (&#8220;IASB&#8221;), taking into account the recommendations of the International Financial Reporting Standards Interpretations Committee (&#8220;IFRS IC&#8221;). The consolidated financial statements are presented in Euro. Amounts are stated in thousands of Euros, unless otherwise indicated. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Group had a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-controlling</div> interest, representing approximately 3.96% of the Group&#8217;s Immatics US, Inc. subsidiary as of December&#160;31, 2019 and 2018. On July&#160;1, 2020 and as part of the ARYA Merger, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-controlling</div> interest of MD Anderson in Immatics US, Inc. was exchanged for ordinary shares in Immatics N.V. See note 3 for further details. </div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Short-term deposits, which have an original maturity between three and nine months, were previously classified within Other current assets and have been retrospectively presented as a separate line item, Other financial assets, within the Statement of Financial Position. This change resulted in a reclassification of &#8364;16.0&#160;million as of December&#160;31, 2019. This change in presentation was made after review of the Group&#8217;s financial statements subsequent to the ARYA Merger to ensure better comparability of the financial statements with peer companies and provide more relevant presentation within the Group&#8217;s financial statements. </div></div><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">2.1</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Going concern </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Since inception, the Group&#8217;s activities have consisted primarily of raising capital and performing research and development activities to advance its technologies. The Group is still in the development phase and has not yet marketed any products commercially. Immatics&#8217; ongoing success depends on the successful development and regulatory approval of its products and its ability to finance operations. The Group will seek additional funding to reach its development and commercialization objectives. </div></div></div> <div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Group plans to seek funds through further private or public equity financings, debt financings, collaboration agreements and marketing, distribution or licensing arrangements. The Group may not be able to obtain financing or enter into collaboration or other arrangements on acceptable terms. If the Group is unable to obtain funding, it could be forced to delay, reduce or eliminate some or all of its research and development programs, product portfolio expansion or commercialization efforts, which could adversely affect its business prospects. However, Immatics&#8217; cash and cash equivalents as well as short-term deposits will be sufficient to fund operating expenses and capital expenditure requirements for at least twelve months from the issuance date and expect a cash reach for at least twelve months. </div></div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying consolidated financial statements have been prepared on a going concern basis. This contemplates the Group will continue in operation for the foreseeable future and will be able to realize its assets and discharge its liabilities in the normal course of operations. The consolidated financial statements do not reflect any adjustments relating to the recoverability and classification of assets or the amounts and classification of liabilities that would be necessary, was the Group unable to continue as a going concern. </div></div>  <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>  <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">2.2</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Correction of classification of Statement of Cash Flows </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">During the third quarter of 2020, the Group identified and corrected the classification of short-term deposits with an original maturity dates between three and nine months within the Statement of Cash Flows which resulted in a misclassification within the Statement of Cash Flows since 2018. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has evaluated the effect of this misclassification, both qualitatively and quantitatively, and concluded that the correction did not have a material impact on, nor require amendment of, any previously filed financial statements. In the Statement of Cash Flows, the changes in short-term deposits were previously classified as (Increase) decrease in other assets within operating activities and has been retrospectively corrected and presented as separate line items within investing activities. </div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">This correction of classification resulted in the following impact to the Statement of Cash Flows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="width: 60%;"></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31, 2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31, 2018</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">As<br/>reported</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Adjustment</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">As<br/>revised</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">As<br/>reported</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Adjustment</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">As<br/>revised</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">(Increase) decrease in other assets</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(4,419</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2,922</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(1,497</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(7,493</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">13,101</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">5,608</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net cash provided by operating activities</div></div></div></td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">68,045</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2,922</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">70,967</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">7,583</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">13,101</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">20,684</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Cash paid for investments classified in Other financial assets</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(20,473</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(20,473</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(13,101</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(13,101</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash received from maturity of investments classified in Other financial assets</div></div></td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">17,551</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">17,551</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Net cash used in investing activities</div></div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(2,137</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(2,922</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(5,059</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(413</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(13,101</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(13,514</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 60%;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Total effect on Cash Flow</div></td><td style="vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-size: 1px;"><td style="width: 60%;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="width: 58%;"></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Three&#160;months&#160;ended&#160;March&#160;31,&#160;2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Six months ended June&#160;30, 2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">As<br/>reported</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Adjustment</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">As<br/>revised</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">As<br/>reported</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Adjustment</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">As<br/>revised</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 58%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">(Increase) decrease in other assets</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(17,209</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">16,836</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(373</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">14,917</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(16,023</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(1,106</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 58%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net cash provided by/ (used in) operating activities</div></div></div></td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(28,286</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,836</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(11,450</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(11,716</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(16,023</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(27,739</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 58%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Cash paid for investments classified in Other financial assets</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(32,859</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(32,859</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(32,859</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(32,859</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 58%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash received from maturity of investments classified in Other financial assets</div></div></td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,023</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,023</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">48,882</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">48,882</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 58%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Net cash provided by/ (used in) investing activities</div></div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(2,387</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(16,836</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(19,223</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(4,550</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">16,023</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">11,473</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 58%;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Total effect on Cash Flow</div></td><td style="vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-size: 1px;"><td style="width: 58%;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">There is no impact on the Group&#8217;s Consolidated Statement of Financial Position, Consolidated Statement of Changes in Shareholders&#8217; Deficit, Consolidated Statement of Loss, Net loss per share, Consolidated Statement of Comprehensive Loss, and no impact to financing cash flows for the any of the periods presented. </div></div>  <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>  <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">2.3</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In December 2019, a novel strain of coronavirus <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(&#8220;COVID-19&#8221;)</div> emerged. On January&#160;30, 2020, the World Health Organization declared the outbreak a pandemic and a global emergency. In response, many countries and businesses instituted travel restrictions, quarantines, and office closures that are still in place. The extent of the pandemic and governmental responses may impact our ability to obtain raw materials and equipment used for research and development, obtain sufficient additional funds to finance our operations, and conduct clinical trials, any of which could materially and adversely affect our business. </div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;">Management continues to monitor the situation and enacted significant measures to protect the Group&#8217;s supply chain, employees, and the execution of clinical trials. To date, the pandemic has resulted in a slowdown in activities related to the Group&#8217;s laboratory operations and at some of its suppliers. The ongoing spread of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> may also negatively impact the Group&#8217;s ability to conduct clinical trials, including potential delays and restrictions on the Group&#8217;s ability to recruit and retain patients, principal investigators and healthcare employees. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> could also affect the operations of contract research organizations, which may also result in delays or disruptions in the supply of product candidates. Immatics continues to expand its clinical programs with additional clinical trial sites opening in the U.S. and in Europe. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Due to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19,</div> the Group has also experienced delays in research activities performed under its collaboration agreements. Consequently, the Group recognized less revenue under these agreements in 2020 than previously planned. Management believes the declines in revenue associated with the delay in research activities are largely temporary, as the revenue is primarily associated with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-refundable</div> upfront payments recognized on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">cost-to-cost</div></div> basis. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> may continue to impact the timing and amount of revenue recognized under these agreements in the future. </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the basis used for the preparation of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169240016424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ARYA Merger<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_AryaMergerTransactionExplanatory', window );">ARYA Merger</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">3.</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">ARYA Merger </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On March&#160;17, 2020, Immatics entered into a definitive merger agreement with ARYA Sciences Acquisition Corp. (&#8220;ARYA&#8221;), a special purpose acquisition company sponsored by Perceptive Advisors. The transaction closed on July&#160;1, 2020. The merger (&#8220;ARYA Merger&#8221;) was effectuated as follows: </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:5%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:3%;">&#8226;</td><td style="vertical-align:top;;width:1%;">&#160;</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The shareholders of Immatics Biotechnologies GmbH exchanged their interest for ordinary shares in the share capital of Immatics B.V. (&#8220;the Reorganization&#8221;). The Reorganization is accounted for as a recapitalization, with Immatics Biotechnologies GmbH being the accounting predecessor. The Reorganization resulted in a &#8364;0.8&#160;million decrease in share capital and an offsetting increase in share premium. Subsequent to the Reorganization, Immatics B.V. was converted into Immatics N.V., after the share exchange of Immatics shareholders. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 9%;">As part of the Reorganization, the minority shareholder in Immatics US, Inc., MD Anderson Cancer Center (&#8220;MD Anderson&#8221;) exchanged its interest in Immatics US, Inc. for ordinary shares in the share capital of Immatics N.V. (&#8220;MD Anderson Share Exchange&#8221;). This resulted in a decrease to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-controlling</div> interest of &#8364;0.5&#160;million, with corresponding increases to share capital and share premium. (See note 20). </div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:5%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:3%;">&#8226;</td><td style="vertical-align:top;;width:1%;">&#160;</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ARYA merged into Immatics N.V., with former ARYA shareholders receiving one ordinary share of Immatics N.V. for each issued and outstanding ordinary share of ARYA and one warrant to purchase ordinary shares in Immatics N.V., for each issued and outstanding warrant to acquire ordinary shares in ARYA. The merger of ARYA constituted transaction by Immatics N.V., which is accounted for within the scope of IFRS 2. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 9%;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As part of the transaction, former shareholders of ARYA received 17,968,750 shares of Immatics N.V. and 7,187,500 warrants (&#8220;Immatics Warrants&#8221;) to purchase ordinary shares of Immatics N.V. In exchange, Immatics received the net assets held by ARYA, which had a fair value of &#8364;124.9&#160;million upon closing of the transaction on July&#160;1, 2020. The net assets included &#8364;128.8&#160;million of cash and cash equivalents held in ARYA&#8217;s trust account and current liabilities of &#8364;3.9&#160;million. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 9%;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In accordance with IFRS 2, the difference between the fair value of the net assets contributed by ARYA and the fair value of equity instruments provided to former ARYA shareholders is treated as an expense, resulting in a &#8364;152.8&#160;million Share listing expense classified within the Financial result (See Note 17</div><div style="display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">) and an increase in equity. The 7,187,500 Immatics Warrants give the holder the right, but not the obligation, to subscribe to Immatics&#8217; shares at a fixed or determinable price for a specified period of time subject to the provision of the Warrant Agreement. Those instruments were considered equity instruments according to IFRS 2 when they vested immediately on July 1, 2020. Management accounted for those instruments as equity instruments under IFRS 2 after the vesting date and has not applied the provisions of debt and equity classification under IAS 32. </div></div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:5%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:3%;">&#8226;</td><td style="vertical-align:top;;width:1%;">&#160;</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Immatics N.V. raised an additional net &#8364;90.1&#160;million in net equity proceeds through a private placement of ordinary shares with existing shareholders of Immatics, ARYA and other new investors (&#8220;PIPE Financing&#8221;). The PIPE Financing is treated as a capital contribution, which resulted in increases of &#8364;0.1&#160;million and &#8364;90.0&#160;million to share capital and share premium, respectively. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Both the ARYA Merger and PIPE Financing closed as of July&#160;1, 2020. </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Upon consummation of the transactions, Immatics N.V. became a publicly traded corporation at the Nasdaq Capital Market under the ticker IMTX. The Immatics Warrants are traded under the ticker IMTXW. Immatics incurred incremental transaction costs directly attributable to the issuance of new shares to ARYA shareholders and the PIPE Financing </div></div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">of &#8364;7.9&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">million, which it netted against the equity proceeds as a reduction in share premium. As part of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">year-end</div> closing, we adjusted the transaction cost netted against the equity proceeds by &#8364;0.6&#160;million. The adjustment was immaterial for our financial statements. The adjustment was due to a revised allocation of cost, both attributable to the issuance of new shares as well as listing of existing shares. </div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Immatics also amended existing share-based compensation agreements held by employees of Immatics GmbH prior to the ARYA Merger (See Note 18), in addition to making additional cash and share-based payments to key management personnel (See Note 26). </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_AryaMergerTransactionExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of ARYA Merger transaction explanatory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_AryaMergerTransactionExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237435320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Application of new and revised international financial reporting standards<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatory', window );">Disclosure of changes in accounting policies, accounting estimates and errors [text block]</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">4.</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Application of new and revised international financial reporting standards </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">4.1</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Application of new standards </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accounting policies adopted in the preparation of the consolidated financial statements are consistent with those followed in the preparation of the Group&#8217;s annual consolidated financial statements for the year ended December&#160;31, 2019, except for the adoption of new standards and interpretations effective as of January&#160;1, 2020. The Group has not early adopted any standard, interpretation or amendment that has been issued but is not yet effective. </div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">New standards and interpretations applied for the first time: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="font-family: &quot;times new roman&quot;;;width:87%;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:1%;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;"></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="white-space: nowrap; padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-family: &quot;times new roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Standard/interpretation</div></div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Effective&#160;date</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amendments to IFRS 3, &#8220;Business combinations&#8221;, - Definition of a business</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">January&#160;1,&#160;2020</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(255, 255, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amendments to IAS 1, &#8220;Presentation of financial statements&#8221;, and IAS 8, &#8220;Accounting policies, changes in accounting estimates and errors&#8221;</div></div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;">January&#160;1, 2020</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amendment to IFRS 9, IAS 39 and IFRS 17: - Interest rate benchmark reform</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">January&#160;1, 2020</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(255, 255, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amendment to the Conceptual framework</div></div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;">January&#160;1, 2020</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Those amendments on standards and interpretations had no effect on the consolidated financial statements of the Group. </div></div> <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">4.2</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Assessment of potential impact of future standards, amendments to existing standards and interpretations </div></div></div></td></tr></table>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following standards a<div style="display:inline;">n</div>d interpretations have been issued by the IASB, but were not yet mandatory for the year ended December&#160;31, 2020: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="font-family: &quot;times new roman&quot;;;width:72%;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:7%;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:7%;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;"></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="white-space: nowrap; padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-family: &quot;times new roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Standard/interpretation</div></div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Effective&#160;date</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Material effect expected<br/> on Immatics financial<br/> statements</div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">IFRS 16 <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19-Related</div></div> Rent Concessions Amendment</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">January&#160;1,&#160;2021</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">No</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amendments to IAS 1,&#8221; Presentation of financial statements&#8221;, on classification of liabilities</div></div></td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;">January&#160;1, 2022</td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;">No</td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">IFRS 17 Insurance contracts</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">January&#160;1, 2023</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">No</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for changes in accounting policies, accounting estimates and errors.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Section Accounting policies<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;doctype=Standard&amp;dita_xref=IAS08_g7-31_TI<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237865912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of accounting policies applied by the Group for the annual reporting period ending December 31, 2020<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory', window );">Disclosure of significant accounting policies [text block]</a></td>
<td class="text"> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-weight:bold;display:inline;">Summary of accounting policies applied by the Group for the annual reporting period ending December&#160;31, 2020</div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following are the significant accounting policies applied by the Group in preparing its consolidated financial statements: </div></div> <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>  <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.1</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Segment information </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Group manages its operations as a single segment for the purposes of assessing performance and making operating decisions. The Group&#8217;s focus is on the research and development of T cell redirecting immunotherapies for the treatment of cancer. The Chief Executive Officer is the chief operating decision maker who regularly reviews the consolidated operating results and makes decisions about the allocation of the Group&#8217;s resources. </div></div>  <div style="font-size: 1px; margin-top: 18px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>  <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.2</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cash and cash equivalents </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash and cash equivalents in the Consolidated Statement of Financial Position <div style="letter-spacing: 0px; top: 0px;;display:inline;">is comprised</div> of cash held at banks (including money market funds) and short-term deposits with an original maturity of three months or less. </div></div>  <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.3</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financial assets </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Initial recognition and measurement </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial assets within the scope of IFRS 9 include cash and cash equivalents, loans, short-term deposits and receivables. Immatics determines the classification of its financial assets at initial recognition. All financial assets are recognized initially at fair value plus transaction costs. Purchases and sales of financial assets are recognized on their trade date, on which the Group commits to purchase or sell the asset. The subsequent measurement of financial assets depends on their classification as described below. </div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Short-term deposits </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Immatics has short-term deposits with original maturities between three and nine months, which are classified as Other financial assets. Short-term deposits with an original maturity of three months or less are classified as cash and cash equivalents. Under IFRS 9 short-term deposits are classified within financial assets at fair value. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Receivables </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Group has receivables from collaboration agreements. A receivable must be capitalized at the point in time at which the Group has become a contractual partner and a claim to cash and cash equivalents has arisen. In subsequent reporting periods, a receivable is measured at amortized cost using the effective interest method. Since the receivables are short-term receivables without a fixed interest rate, these receivables are capitalized at the original invoice or contract amount. Receivable balances are classified as current assets, because all of the Group&#8217;s receivables have an expected maturity of less than 12 months. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Interest and other finance income </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments include money market funds and short-term deposits measured at fair value. Interest income is recorded using the effective interest rate (EIR). EIR is the rate that discounts the estimated future cash payments or receipts over the expected life of the financial instrument or a shorter period, where appropriate, to the net carrying amount of the financial asset or liability. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2020, Immatics is a counterparty in foreign exchange forward contracts. The contracts do not meet the criteria to apply hedge accounting and are therefore separately accounted for and measured at fair value. Any change in the fair value is accounted for within the Consolidated Statement of Loss. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><br/></div>  <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.4</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Property, plant and equipment </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property, plant and equipment is stated at cost, net of accumulated depreciation and accumulated impairment losses, if any. All repair and maintenance costs are recognized as expense when incurred. Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets. The estimated useful lives are generally within the following ranges: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>  <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"><tr style="font-size: 0px;"><td style="font-family: &quot;times new roman&quot;; width: 79%;"></td><td style="font-family: &quot;times new roman&quot;; width: 8%;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;"></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="white-space: nowrap; padding-bottom: 1pt; width: 79%;;vertical-align:bottom;"><div style="font-family: &quot;times new roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Category</div></div></div></td><td style="padding-bottom: 1pt; width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Estimated&#160;useful&#160;life</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 79%;;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Computer equipment</div></div></td><td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:center;;vertical-align:bottom;">1&#160;&#8211;&#160;10&#160;years</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgba(255, 255, 255, 0); width: 79%;;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Laboratory equipment</div></div></td><td style="background-color: rgba(255, 255, 255, 0); width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;text-align:center;;vertical-align:bottom;">1 &#8211;&#160;15&#160;years</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 79%;;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Office equipment</div></div></td><td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:center;;vertical-align:bottom;">2 &#8211;&#160;20&#160;years</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.5</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Intangible assets </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Acquired intangible assets are initially recognized at cost. Following initial recognition, intangible assets are carried at cost less accumulated amortization and accumulated impairment losses, if any. Intangible assets with finite lives are amortized over their useful economic lives and assessed for impairment, whenever there is an indication that the intangible asset may be impaired. The amortization period and the amortization method for an intangible asset with a finite useful life, is reviewed at least at the end of each reporting period. Immatics does not have any internally developed intangible assets or intangible assets with indefinite useful lives. </div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amortization is calculated on a straight-line basis over the estimated useful lives of the assets as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"><tr style="font-size: 0px;"><td style="font-family: &quot;times new roman&quot;;;width:79%;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:8%;"></td><td style="font-family: &quot;times new roman&quot;;"></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="white-space: nowrap; padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-family: &quot;times new roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Category</div></div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Estimated&#160;useful&#160;life</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Licenses</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:center;;vertical-align:bottom;">5&#160;&#8211;&#160;30&#160;years</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Software</div></div></td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;text-align:center;;vertical-align:bottom;">1 &#8211; 5&#160;years</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.6</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Research and development </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Research expenses are defined as costs incurred for current or planned investigations undertaken with the prospect of gaining new scientific or technical knowledge and understanding. All Research costs are expensed as incurred. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">An intangible asset arising from development expenditure on an individual project is recognized only when the Group can demonstrate the technical feasibility of completing the intangible asset so that it will be available for use or sale, its intention to complete and its ability to use or sell the asset, how the asset will generate future economic benefits, the availability of resources to complete and the ability to measure reliably the expenditure during the development. The Group did not recognize any intangible assets from development expenditures in 2020, 2019 and 2018 due to the existing uncertainties in connection with its development activities. Research and development expenses include the following types of costs: </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">1.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">salaries, benefits and other related costs, including stock-based compensation, for personnel engaged in research and development functions; </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">2.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">expenses incurred in connection with the preclinical development of our programs and clinical trials of our product candidates, including under agreements with third parties, such as consultants, contractors, academic institutions and contract research organizations; </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">3.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the cost of manufacturing product candidates for use in clinical trials, including under agreements with third parties, such as, consultants and contractors; </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">4.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">laboratory costs; </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">5.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">leased facility costs, equipment depreciation and other expenses, which include direct and allocated expenses; and </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">6.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">intellectual property costs incurred in connection with filing and prosecuting patent applications as well as third-party license fees. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div>  <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.7</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financial liabilities: Initial recognition and measurement </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial liabilities within the scope of IFRS 9 are classified as financial liabilities at fair value through profit or loss or at amortized cost, as appropriate. The Group determines the classification of its financial liabilities at initial recognition. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">All financial liabilities are recognized initially at fair value and, in the case of loans and borrowings, carried at amortized cost. This includes directly attributable transaction costs. Immatics only recognized accounts payable as other financial liabilities at amortized costs. The Group has not designated any financial liabilities upon initial recognition as fair value through profit or loss. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Group does not engage in hedging transactions that meet the criteria to apply hedge accounting. </div></div>  <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.8</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Leases </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Application of IAS 17 (&#8220;Leases&#8221;) until December&#160;31, 2018 </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Prior to 2019, the Group applied IAS 17 when accounting for leases. As a lessee under IAS 17, leases for which substantially all the risks and rewards of ownership transferred to the Group were classified as finance leases. Finance leases were capitalized at the lease&#8217;s inception at the fair value of the leased property or, if lower, the present value of the minimum lease payments. The corresponding rental obligations, net of finance charges, were included in other current liabilities and other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> liabilities. Each lease payment was allocated between the liability and finance cost. The finance cost was charged as an expense over the lease period so as to produce a constant periodic rate of interest on the remaining balance of the liability for each period. The assets associated with the finance leases are depreciated over the shorter of the asset&#8217;s useful life or the lease term if there is no reasonable certainty that the Group will obtain ownership at the end of the lease term. Leases in which a significant portion of the risks and rewards of ownership were not transferred to the Group as lessee were classified as operating leases. Payments made under operating leases (net of any incentives received from the lessor) were charged as an expense on a straight-line basis over the period of the lease. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Application of IFRS 16 (&#8220;Leases&#8221;) effective January&#160;1, 2019 </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Group adopted IFRS 16 (&#8220;Leases&#8221;) effective January&#160;1, 2019. The Group leases various offices, equipment and vehicles. Rental contracts are typically made for fixed periods of two to seven years but may have extension options as described in below. Contracts may contain both lease and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-lease</div> components. The Group has elected not to separate lease and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-lease</div> components and instead accounts for these as a single lease component. Lease terms are negotiated on an individual basis. The lease agreements do not impose any covenants other than the security interests in the leased assets that are held by the lessor. Leased assets may not be used as security for borrowing purposes. Under IFRS 16, leases are recognized as a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> asset with a corresponding liability on the date at which the leased asset is available for use by the Group. </div> <div style="font-family: times new roman;font-size: 10pt;margin-top: 0pt;margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets and liabilities arising from a lease are initially measured on a present value basis. Lease liabilities include the net present value of the following lease payments: </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">1.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;">fixed payments (including <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">in-substance</div> fixed payments), less any lease incentives received. </div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">2.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">amounts expected to be payable by the Group under residual value guarantees. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">3.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the exercise price of a purchase option if the Group is reasonably certain to exercise that option; and </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">4.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">payments of penalties for terminating the lease, if the lease term reflects the Group exercising that option. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Lease payments to be made under reasonably certain extension options are also included in the measurement of the liability. The lease payments are discounted using the interest rate implicit in the lease. If that rate cannot be readily determined, which is generally the case for the Group&#8217;s leases, the lessee&#8217;s incremental borrowing rate is used. The incremental borrowing rate is the rate that the individual lessee would have to pay to borrow the funds, necessary to obtain an asset of similar value to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> asset in a similar economic environment with similar terms, security and conditions. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">To determine the incremental borrowing rate, the Group: </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">1.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;">uses a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">build-up</div> approach that starts with a risk-free interest rate adjusted for credit risk for leases held by Immatics, and </div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">2.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">makes adjustments specific to the lease, including lease term, country, currency and security </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Right-of-use</div></div> assets are measured at cost comprising the following: </div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">1.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the amount of the initial measurement of lease liability </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">2.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">any lease payments made at or before the commencement date less any lease incentives received </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">3.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">any initial direct costs, and </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">4.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">restoration costs. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Right-of-use</div></div> assets are generally depreciated over the shorter of the asset&#8217;s useful life or the lease term on a straight-line basis. If the Group is reasonably certain to exercise a purchase option, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> asset is depreciated over the underlying asset&#8217;s useful life. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Payments associated with short-term leases of equipment and vehicles and all leases of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">low-value</div> assets are recognized on a straight-line basis as an expense. Short-term leases are leases with a lease term of 12 months or less. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Low-value</div> assets have a value of less than &#8364;5&#160;thousand. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Extension and termination options are included in a number of property and equipment leases across the Group. These are used to maximize operational flexibility in terms of managing the assets used in the Group&#8217;s operations. The extension and termination options held are exercisable only by the Group and not by the respective lessor. For relevant leases which include an extension option, Immatics performed an assessment as of December&#160;31, 2020 to determine whether option extensions are reasonably certain. </div></div>  <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.9</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Revenue from collaboration agreements </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Group earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. As of December&#160;31, 2020, the Group had four strategic collaboration agreements in place with Amgen Inc., Thousand Oaks/CA/USA (&#8220;Amgen&#8221;), Genmab A/S, Copenhagen/Denmark (&#8220;Genmab&#8221;), Celgene Switzerland LLC (&#8220;BMS&#8221;) and GlaxoSmithKline Intellectual Property Development Limited (&#8220;GSK&#8221;). Each of the Group&#8217;s four strategic collaboration agreements are in the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-clinical</div> stage. </div> <div style="font-family: times new roman;font-size: 10pt;margin-top: 0pt;margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">To determine the recognition of revenue from arrangements that fall within the scope of IFRS 15, the Group performs the following five steps: </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;">(i)</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">identify the contract(s) with a customer; </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;">(ii)</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">identify the performance obligations in the contract; </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;">(iii)</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">determine the transaction price; </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;">(iv)</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">allocate the transaction price to the performance obligations in the contract; and </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;">(v)</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">recognize revenue when (or as) the Group satisfies a performance obligation. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Under the terms of these agreements, Immatics agrees to collaborate in the development, manufacture, and commercialization of cancer immunotherapy treatments for specified targets identified through the use of Immatics XPRESIDENT technology. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">As part of the collaboration arrangements, Immatics grants exclusive licensing rights for the development and commercialization of future product candidates, developed for targets defined in the collaboration agreements. Additionally, Immatics agrees to perform certain research activities under the collaboration agreements, including screening of highly specific molecules for reactivity with the specified targets and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">off-targets</div> using Immatics&#8217; proprietary technology and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">know-how,</div> participation on steering committees, and preparation of data packages. The research activities are the predominant item in each of the Group&#8217;s collaboration agreements. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Group performs an analysis to identify the performance obligations under the contract, including licenses and rights to future intellectual property developed under the contract and research activities. As these agreements comprise several promises, it must be assessed whether these promises are capable of being distinct and distinct within the context of the contract. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Up-front</div> licensing payments and reimbursement for research and development expenses are initially deferred on our Consolidated Statement of Financial Position and subsequently recognized as costs are incurred using a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">cost-to-cost</div></div> method. Milestone payments are generally included in the transaction price at the amount stipulated in the respective agreement and recognized to the extent that it is highly probable that a&#160;significant reversal&#160;in the amount of cumulative revenue recognized will not occur. To date, no milestone has been included in the transaction price. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">As stated above, the licenses contributed under the collaboration agreements currently in place&#160;do not represent distinct performance obligations, because the Group&#8217;s collaboration partners would likely be unable to derive significant benefits from their access to these targets without Immatics&#8217; research activities. Identification of a viable product candidate that will bind to the targets specified in the agreements requires use of the Group&#8217;s XPRESIDENT technology and database of target and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">off-target</div> data. These agreements include a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-refundable</div> upfront payment, payments for research and development activities in certain circumstances, and payments based upon the achievement of defined milestones. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Under IFRS 15, the Group applies significant judgement when evaluating whether the obligations under these agreements represent one or more combined performance obligations, the allocation of the transaction price to identified performance obligations, and the determination of whether milestone payments should be included in the transaction price. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Upfront payment </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Each of the Group&#8217;s strategic collaboration agreements included a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-refundable</div> upfront payment, meant to subsidize research activities. The Group recorded these payments as deferred revenue, which it allocated to the combined performance obligations for each agreement. Such amounts are recognized as revenue over the performance period of the research activities on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">cost-to-cost</div></div> basis. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">cost-to-cost</div></div> basis using direct costs and directly attributable personal costs was considered the best measure of progress in which control of the combined performance obligations transfers to the Group&#8217;s collaboration partners, due to the nature of the work being performed. </div> <div style="font-size: 1px; margin-top: 18px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Reimbursement for services</div> Under the collaboration agreement with Genmab, the Group receives reimbursement for employee research and development costs. These employee costs are presented as research and development expenses, while reimbursements of those costs, which is based on an FTE rate defined in the contract, are presented as revenue and not deducted from expenses. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Development and Commercial Milestones </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The collaboration agreements include contingent payments related to development and commercial milestone events. These milestone payments represent variable consideration that are not initially recognized within the transaction price, due to the scientific uncertainties and the required commitment from the collaboration partners to develop and commercialize a product candidate. The Group assesses the probability of significant reversals for any amounts that become likely to be realized prior to recognizing the variable consideration, associated with these payments within the transaction price. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Sales-based milestones and royalty payments </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The collaboration agreements also include sales-based royalty payments upon successful commercialization of a licensed product. In accordance with IFRS 15.B63, the Group recognizes revenue from sales-based milestone and royalty payments at the later of (i)&#160;the occurrence of the subsequent sale; or (ii)&#160;the performance obligation to which some or all of the sales-based milestone, or royalty payments has been allocated has been satisfied. The Group anticipates recognizing these milestones and royalty payments, when subsequent sales are generated from a licensed product by the collaboration partner. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Cost to fulfill contracts </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Group incurs costs for personnel, supplies and other costs related to its laboratory operations as well as fees from third parties and license expenses in connection with its research and development obligations under the collaboration and licensing agreement. These costs are recognized as research and development expenses over the period in which services are performed. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Cost to obtain a contract </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For some collaboration agreements, the Group incurs incremental costs of obtaining a contract with a customer. The Group capitalizes those incremental costs if the costs are expected to be recovered. The recognized asset is amortized consistent with the method used to determine the pattern of revenue recognition of the underlying contract. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.10</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Share-based payment </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Group&#8217;s Employees as well as others providing similar services to the Group, receive remuneration in the form of share-based payments, which are equity-settled transactions. The Group`s equity-settled option plans include Matching Stock Options, Converted Stock Options, Service Options and PSUs and are described in detail in Note 18. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The costs of equity-settled transactions are determined by the fair value at grant date, using an appropriate valuation model. Share-based expenses for the respective vesting periods, are recognized in research and development expenses and general and administrative expenses, reflecting a corresponding increase in equity. </div></div>  <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.11</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Other income </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Group primarily earns other income from government research grants. Government grants are recognized as income when there is reasonable assurance that the grant will be received and all required conditions have been complied with. Grants from governmental agencies for the support of specific research and development projects are recorded as other income to the extent the related expenses have been incurred. Grant agreements include a budget that specifies the amount and nature of expenses allowed during the entire grant term. </div></div> <div style="font-family: times new roman;font-size: 10pt;margin-top: 0pt;margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expenses incurred under the grants are calculated according to agreed-upon terms on a quarterly basis, filed with the governmental agencies, and recorded as income. The governmental agencies make payments to the Group based on these calculations of expenses incurred under the grants. If these estimated calculations change, the Group will then adjust grant income in the subsequent period. The Group believes that its calculations are based on the agreed-upon terms as stated in the grant agreements. The governmental agencies generally have the right to audit the Group&#8217;s calculations. If the governmental agencies disagree with the Group&#8217;s calculations the amount of grant income recognized could change. </div></div>  <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.12</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Foreign currency </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transactions and balances in Germany and in the USA </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The consolidated financial statements are presented in Euro, which is the parents&#8217;, Immatics N.V. functional and presentation currency. Assets and liabilities of foreign operations are translated into Euros at the rate of exchange prevailing at the reporting. The Consolidated Statement of Loss is translated at average exchange rates. The currency translation differences are recognized in other comprehensive loss. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transactions in foreign currencies are initially recorded by the Group&#8217;s entities at their respective functional currency spot rates, at the date the transaction first qualifies for recognition. The Group used the following exchange rates to convert the financial statements of its U.S. subsidiary: </div></div>  <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="width:64%;"></td><td style="vertical-align:bottom;;width:1%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:1%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:1%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:1%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:1%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:1%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2018</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;&#160;</div></td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Year-end</div><br/> rate</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;&#160;</div></td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">Average<br/> rate</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;&#160;</div></td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Year-end</div><br/> rate</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;&#160;</div></td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">Average<br/> rate</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;&#160;</div></td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Year-end</div><br/> rate</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;&#160;</div></td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">Average<br/> rate</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Euros per U.S.&#160;Dollar</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.8149</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.8762</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.8902</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.8932</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.8738</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.8468</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.13</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value of financial instruments </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either: </div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;">&#160;</div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;">&#160;</div> <div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;"><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;">&#160;</div></td><td style="text-align:left;;vertical-align:top;;width:5%;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#8226;</div></div></div></td><td style="font-size: 10pt;;text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">in the principal market for the asset or liability or </div></div></div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="text-align:left;;vertical-align:top;;width:5%;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#8226;</div></div></div></td><td style="font-size: 10pt;;text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">in the absence of a principal market, in the most advantageous market for the asset or liability that is accessible by the Group. </div></div></div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest. The Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs. All assets and liabilities for which fair value is measured or disclosed in the consolidated financial statements are categorized within the fair value hierarchy, described as follows, based on the lowest level input that is significant to the fair value measurement as a whole: </div></div></div></div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="text-align:left;;vertical-align:top;;width:5%;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#8226;</div></div></div></td><td style="font-size: 10pt;;text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">Level&#160;1 &#8212; Quoted (unadjusted) market prices in active markets for identical assets or liabilities. </div></div></div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="text-align:left;;vertical-align:top;;width:5%;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#8226;</div></div></div></td><td style="font-size: 10pt;;text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">Level&#160;2 &#8212; Valuation techniques, for which the lowest level input that is significant to the fair value measurement is directly or indirectly observable. </div></div></div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="text-align:left;;vertical-align:top;;width:5%;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#8226;</div></div></div></td><td style="font-size: 10pt;;text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">Level&#160;3 &#8212; Valuation techniques, for which the lowest level input that is significant to the fair value measurement is unobservable. </div></div></div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><br/> For assets and liabilities that are recognized in the consolidated financial statements at fair value on a recurring basis, the Group determines whether transfers have occurred between levels in the hierarchy by <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-assessing</div> categorization (based on the lowest level input that is significant to the fair value measurement as a whole), at the end of each reporting period. </div>  <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.14</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Provisions </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Provisions are recognized when the Group has a present obligation (legal or constructive) as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation and a reliable estimate can be made of the amount of the obligation. Where the Group expects some or all of a provision to be reimbursed, for example under an insurance contract, the reimbursement is recognized as a separate asset but only when the reimbursement is virtually certain. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">If the effect of the time value of money is material, provisions are discounted using a current <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-tax</div> rate that reflects, when appropriate, the risks specific to the liability. </div>  <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.15</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Income Tax </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred income tax results from temporary differences between the carrying amount of an asset or a liability and its tax base. Deferred income tax is provided in full using the liability method on temporary differences. In accordance with IAS 12 (&#8220;Income Taxes&#8221;), the deferred tax assets and liabilities reflect all temporary valuation and accounting differences between financial statements prepared for tax purposes and our consolidated financial statements. Tax losses carried forward are considered in deferred tax assets calculation. The Group offsets tax assets and liabilities if and only if it has a legally enforceable right to set off current tax assets, current tax liabilities, deferred tax assets and deferred tax liabilities which relate to income taxes levied by the same tax authority. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant accounting policies applied by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 117<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237595800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting judgments, estimates and assumptions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory', window );">Disclosure of accounting judgements and estimates [text block]</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">6.</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant accounting judgements, estimates and assumptions </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the Group&#8217;s consolidated financial statements requires management to make judgements, estimates and assumptions that affect the reported amounts of revenue, expenses, assets and liabilities, income taxes and the accompanying disclosures. Uncertainty about these assumptions and estimates could result in outcomes that require a material adjustment to the carrying amount of the asset or liability affected in future periods. </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Estimates &#8211; Taxes </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Uncertainties exist with respect to the interpretation of complex tax regulations, changes in tax laws, and the amount and timing of future taxable income. Given the wide range and complexity of existing contractual agreements, differences arising between the actual results and the assumptions made, or future changes to such assumptions, could necessitate future adjustments to tax income and expense already recorded. Deferred tax assets are recognized for unused tax losses to the extent, that it is probable that taxable profit will be available which can be utilized against the losses. Significant management judgement is required to determine the amount of deferred tax assets that can be recognized, based upon the likely timing and the level of future taxable profits together with future tax planning strategies. Due to the Group&#8217;s history of loss-making over the last several years as well as the plans for the foreseeable future, the Group has not recognized any deferred tax assets on tax losses carried forward. Changes in the estimation of our potential to use tax losses carried forward can have a material effect on the Group`s net income. </div></div></div> <div style="font-size: 1px; margin-top: 18px; margin-bottom: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Revenue recognition from collaboration agreements </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">As the collaboration agreements comprise several promises, it must be assessed whether these promises are capable of being distinct within the context of the contract. For the four collaboration agreements the Group assessed that these promises are not capable of being distinct within the context of the contract, which results in accounting for all goods and services promised as a single performance obligation with a single measure of progress. The performance obligation is accounted for as a performance obligation, satisfied over time using a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">cost-to-cost</div></div> method as the customer simultaneously receives and consumes the benefits from Immatics&#8217; performance. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Up-front</div> licensing payments are initially deferred on our Consolidated Statement of Financial Position and subsequently recognized as revenue over time as costs are incurred. Milestone payments are generally included in the transaction price at the amount stipulated in the respective agreement and recognized as revenue to the extent that it is highly probable that a&#160;significant reversal&#160;in the amount of cumulative revenue recognized will not occur. To date, no milestone has been included in the transaction price. Changes in this estimate can have a material effect on revenue recognized. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Immatics provides development and manufacturing services to customers and recognizes revenue over time using an input-based method to measure progress toward complete satisfaction of the service, because the customer simultaneously receives and consumes the benefits provided. Forecast values are used for the calculation of expected future revenue for the remaining term of the contract. These costs estimated as part of the budgeting process must be reviewed and approved before the Group can use them for recognition purposes. Significant management judgment is </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">required to determine the level of effort required under an arrangement, and the period over which the Company expects to complete its performance obligations under the arrangement which includes total internal personnel costs and external costs to be incurred. Changes in these estimates can have a material effect on revenue recognized. </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Share-based payments </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Determining the fair value of share-based payment transactions requires the most appropriate valuation for the specific program, which depends on the underlying terms and conditions. This estimate also requires the determination of the most appropriate inputs to the valuation model, including the fair value of the share option. </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Management determined the value of share-based awards with the assistance of a third-party valuation specialist using certain assumptions, such as share price volatility, the determination of an appropriate risk-free interest rate, expected dividends and the probability of reaching certain exercisability criteria. Changes in these estimates can have a material effect on share-based expenses recognized. </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">For 2018 and 2019, the vested SARs under the 2010 Plan could only be exercised in an event that more than 50% of the shareholdings in the Company will be acquired by a third person (&#8220;Change of control&#8221;) and the vested SARs of the 2016 Plan might only be exercised upon the occurrence of a change in control or expiration of the applicable <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">lock-up</div> period following completion of an initial public offering (&#8220;IPO&#8221;). </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair values of these awards were discounted based on the probability of the awards becoming exercisable. It is necessary to look at different scenarios under which the award would be expected to be realized. Therefore, it was necessary to estimate the probability of each such scenario. The present value of the probability-weighted fair value under all scenarios represents the value of the awards. The difficulty in applying this method is the estimation of the different possible outcomes and the probabilities associated with such outcomes. Management&#8217;s assessment is updated at each </div></div><div style="display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">valuation date. </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Classification of Warrants </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As described in Note 3 AYA Merger Immatics Warrants give the holder the right, but not the obligation, to subscribe to Immatics&#8217; shares at a fixed or determinable price for a specified period of time subject to the provision of the Warrant Agreement. Those instruments were considered equity instruments according to IFRS 2 when they vested immediately on July 1, 2020. Management accounted for those instruments as equity instruments under IFRS 2 after the vesting date and has not applied the provisions of debt and equity classification under IAS 32.</div></div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169240170744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts receivable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfAccountReceivableExplanatoryTextBlock', window );">Disclosure Of Account Receivable Explanatory [Text Block]</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">7.</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accounts receivable </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>  <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width: 65%;"></td><td style="width: 13%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 13%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">As of</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;;width:;"><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">December&#160;31,</div><br/></div><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">2020</div><br/></div></td><td style="padding-bottom: 1pt; border-bottom: 0.75pt solid black;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">December&#160;31,</div><br/></div><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">2019</div><br/></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="6" style="text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); padding-bottom: 0.75pt; width: 65%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Receivables from collaboration agreements</div></div></td><td style="background-color: rgb(204, 238, 255); padding-bottom: 0.75pt; width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;">1,250</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;">957</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 65%;;vertical-align:bottom;"></td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 65%;;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accounts receivable</div></div></div></td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,250</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">957</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 65%;;vertical-align:bottom;"></td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2020, and 2019, no receivables were considered impaired. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfAccountReceivableExplanatoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of account receivable Explanatory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfAccountReceivableExplanatoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237451448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other current and non-current assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherAssetsExplanatory', window );">Disclosure of other assets [text block]</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">8.</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-weight:bold;display:inline;">Other current and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> assets </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Other current assets </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>  <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width: 64%;"></td><td style="width: 13%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 13%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">As of</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">2020</div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">2019</div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="6" style="text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 64%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Grant receivable</div></div></td><td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">875</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">998</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 64%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Prepaid expenses</div></div></td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2,389</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,236</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 64%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Positive market value forward contract</div></div></td><td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">914</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 64%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Value added tax receivable</div></div></td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">798</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">768</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 64%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Capitalized transaction costs</div></div></td><td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">48</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 64%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other assets</div></div></td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">787</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">617</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 64%;;vertical-align:bottom;">&#160;</td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 64%;;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Other current assets</div></div></div></td><td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">5,763</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">3,667</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 64%;;vertical-align:bottom;">&#160;</td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Group recognizes receivables for government grants when it is reasonably assured that the grant will be received, and all contractual conditions have been complied with. As of December&#160;31, 2020, and 2019, no receivables were considered impaired. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Prepaid expenses include prepaid insurance expenses of &#8364;1.0&#160;million and &#8364;0.1&#160;million as of December&#160;31, 2020 and 2019, respectively. The Group paid &#8364;0.5&#160;million and &#8364;0.6&#160;million of incremental cost for the successful arrangement of the Celgene Switzerland LLC (&#8220;BMS&#8221;) and Genmab A/S (&#8220;Genmab&#8221;) collaboration agreements as of December&#160;31, 2020 and 2019, respectively. Additionally, prepaid expenses include expenses for licenses and software of &#8364;0.6&#160;million and &#8364;0.2&#160;million as of December&#160;31, 2020 and 2019, respectively. The remaining amount is related to prepaid maintenance expenses. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other assets include receivables from capital gains tax of &#8364;0.4&#160;million and &#8364;0.3 million as of December&#160;31, 2020 and 2019, respectively. The remaining amount is related to prepaid deposit expenses. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;">Other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> assets </div></div>  <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; font-size: 8pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:65%;"></td><td style="vertical-align:bottom;;width:13%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:13%;"></td><td></td><td></td><td></td></tr><tr style="break-inside: avoid; font-family: 'times new roman'; font-size: 8pt;"><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of</div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">2020</div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">2019</div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="break-inside: avoid; font-family: 'times new roman'; font-size: 8pt;"><td style="vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td colspan="6" style="text-align:center;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></div></td><td style="vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr><tr style="break-inside: avoid; font-family: 'times new roman'; font-size: 10pt;"><td style="background-color: rgb(204, 238, 255); font-size: 10pt;;vertical-align:top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;times new roman&quot;; line-height: normal;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Prepaid expenses</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">724</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">937</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr><tr style="break-inside: avoid; font-family: 'times new roman'; font-size: 10pt;"><td style="vertical-align:top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;times new roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Other<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div>assets</div></div></td><td style="vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">325</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr><tr style="break-inside: avoid; font-family: 'times new roman'; font-size: 10pt;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;times new roman&quot;; line-height: normal;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total<div style="letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">&#160;</div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">non-current</div><div style="letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">&#160;</div>assets</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">724</div></div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,262</div></div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr><tr style="font-size: 1px;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Prepaid expenses consist of &#8364;0.7&#160;million and &#8364;0.9&#160;million of incremental cost paid for the successful arrangement of the BMS and Genmab collaboration agreements as of December&#160;31, 2020 and 2019, respectively. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other assets. [Refer: Other assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237454584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory', window );">Disclosure of property, plant and equipment [text block]</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">9.</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Property, plant and equipment </div></div></div></td></tr></table> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes to property, plant and equipment during 2020 and 2019 consisted of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:92%;"><tr style="font-size: 0px;"><td style="width:65%;"></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" rowspan="3" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Laboratory<br/> equipment</div></td><td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" rowspan="3" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Computer<br/> equipment</div></td><td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" rowspan="3" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Office<br/> equipment</div></td><td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" rowspan="3" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Total</div></td><td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="page-break-inside: avoid;"><td colspan="17"></td></tr><tr style="font-size: 1px;"><td colspan="17" style="font-family: &quot;times new roman&quot;;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Cost as of January&#160;1, 2019</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">11,222</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,439</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,455</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">15,116</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Impact of IFRS 16 adoption</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(441</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(441</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Cost as of January&#160;1, 2019, adjusted</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">10,781</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,439</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,455</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">14,675</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Additions</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2,204</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">515</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">297</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">3,016</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Disposals</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(314</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(2</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(316</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Currency translation differences</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">52</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">4</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">57</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Cost as of December&#160;31, 2019</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">12,723</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,956</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,753</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">17,432</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1pt;"><td style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">Accumulated depreciation as of January 1, 2019</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">8,279</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,793</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,037</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">11,109</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Additions</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,219</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">256</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">322</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,797</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Disposals</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(218</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(1</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(219</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Currency translation differences</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">23</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">25</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">Accumulated depreciation as of December 31, 2019</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">9,303</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,050</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,359</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">12,712</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Net book value as of December&#160;31, 2019</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">3,420</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">906</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">394</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">4,720</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost as of January&#160;1, 2020</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">12,723</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,956</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,753</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">17,432</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Additions</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">3,545</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">406</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,427</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">5,379</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Disposals</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">6</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">7</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Currency translation differences</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">299</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">40</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">28</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">367</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost as of December&#160;31, 2020</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">15,968</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">3,322</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">3,146</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">22,437</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1pt;"><td style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">Accumulated depreciation as of January 1, 2020</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">9,303</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,050</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,359</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">12,712</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Additions</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,384</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">404</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">315</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2,102</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Disposals</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">6</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">7</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Currency translation differences</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">210</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">26</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">3</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">239</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">Accumulated depreciation as of December 31, 2020</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">10,476</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,428</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,665</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">14,568</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net book value as of December&#160;31, 2020</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">5,493</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">894</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,481</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">7,868</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Depreciation expense is included in the following line items of the Consolidated Statement of Loss: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>  <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"><tr style="font-size: 0px;"><td style="width:79%;"></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2018</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="10" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Research and development expenses</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,503</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,315</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,757</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">General and administrative expenses</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">600</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">482</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">301</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,103</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,797</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,058</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2020-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2020-en-r&amp;doctype=Standard&amp;dita_xref=IAS16_g73-79_TI<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237430280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory', window );">Disclosure of intangible assets [text block]</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">10.</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Intangible assets </div></div></div></td></tr></table> <div style="font-family: times new roman;font-size: 10pt;margin-top: 12pt;margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes to intangible assets during 2020 and 2019 consisted of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"><tr style="font-size: 0px;"><td style="width:75%;"></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">Patents</div></div><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">and<br/> licenses</div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Software<br/> licenses</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Total</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Cost as of January&#160;1, 2019</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,201</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">551</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,752</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Additions</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">91</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">91</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Currency translation differences</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">19</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">20</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost as of December&#160;31, 2019</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,220</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">643</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,863</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1pt;"><td style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated amortization as of January&#160;1, 2019</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">314</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">399</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">713</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Additions</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">24</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">87</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">111</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Currency translation differences</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">31</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">31</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated amortization as of December&#160;31, 2019</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">369</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">486</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">855</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Net book value as of December&#160;31, 2019</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">851</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">157</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,008</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-size: 1pt;"><td style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost as of January&#160;1, 2020</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,220</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">643</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,863</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Additions</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">104</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">104</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Currency translation differences</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(88</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(9</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(97</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Cost as of December&#160;31, 2020</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,132</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">738</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,870</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated amortization as of January&#160;1, 2020</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">369</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">486</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">855</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Additions</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">56</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">71</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">126</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Currency translation differences</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(22</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(3</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(25</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated amortization as of December&#160;31, 2020</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">403</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">554</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">956</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net book value as of December&#160;31, 2020</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">730</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">184</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">914</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amortization expense is classified as follows within the Consolidated Statement of Loss: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"><tr style="font-size: 0px;"><td style="width:82%;"></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Year&#160;ended&#160;December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2018</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="10" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Research and development expenses</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">31</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">28</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">9</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">General and administrative expenses</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">95</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">83</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">109</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">126</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">111</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">118</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2020-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2020-en-r&amp;doctype=Standard&amp;dita_xref=IAS38_g118-128_TI<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237503240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PresentationOfLeasesForLesseeAbstract', window );"><strong>Presentation of leases for lessee [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfLeasesExplanatory', window );">Disclosure of leases [text block]</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">11.</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Leases </div></div></div></td></tr></table>  <div style="font-family: times new roman;font-size: 10pt;margin-top: 12pt;margin-bottom: 0pt;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Right-of</div> use assets consist of the following: </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:74%;"></td><td style="vertical-align:bottom;;width:8%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:8%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">As of</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2020</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2019</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Buildings</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">5,760</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2,799</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">IT and telecommunication</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">258</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">349</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Vehicles</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">90</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">90</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other assets</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">41</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">49</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">6,149</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">3,287</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Lease liabilities consist of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 8pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:74%;"></td><td style="vertical-align:bottom;;width:8%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:8%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">As of</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2020</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2019</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Lease liability &#8211; current</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,881</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,411</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Lease liability &#8211; <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">4,306</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,823</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">6,187</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">3,234</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Additions to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets were &#8364;5.1&#160;million and &#8364;0.3&#160;million as of December&#160;31, 2020 and 2019, respectively. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Currency translation differences included in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets were &#8364;0.3&#160;million and &#8364;0.05&#160;million as of December&#160;31, 2020 and 2019, respectively. </div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Expenses related to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets and lease liabilities consist of the following: </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:82%;"></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Year&#160;ended&#160;December&#160;31,</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.7pt;;vertical-align:bottom;"><div style="text-decoration:underline;display:inline;"><div style="font-weight:bold;display:inline;">Depreciation charges of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets</div></div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Buildings</div></div></td><td style="background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2,036</td><td style="white-space: nowrap; font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,804</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">IT and telecommunication</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">101</td><td style="white-space: nowrap; font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">101</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Vehicles</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">50</td><td style="white-space: nowrap; font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">37</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other assets</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">8</td><td style="white-space: nowrap; font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">8</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,195</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,950</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-size: 1pt;"><td style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Interest expenses form leases</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">260</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">170</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;">Expense relating to short-term leases and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">low-value</div> assets (included in administrative expenses)</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">51</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">27</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The total cash payments for leases were &#8364;2.4&#160;million and &#8364;2.1&#160;million as of December&#160;31, 2020 and 2019, respectively. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2020, the Group has committed lease payments of &#8364;6.9&#160;million, of which &#8364;2.1&#160;million will occur in the next 12 months. The remaining lease payments will occur between January&#160;1, 2022 and December&#160;31, 202<div style="display:inline;">6</div>. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2020-01-01<br> -Section Presentation<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2020-en-r&amp;doctype=Standard&amp;dita_xref=IFRS16_g47-50_TI<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2020-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2020-en-r&amp;doctype=Standard&amp;dita_xref=IFRS16_g51-60_TI<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PresentationOfLeasesForLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PresentationOfLeasesForLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237500232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts payable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory', window );">Accounts payable</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">12.</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accounts payable </div></div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:66%;"></td><td style="vertical-align:bottom;;width:5%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:5%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">As of</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Accounts payable</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2,554</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">4,866</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other accrued liabilities</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">7,498</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2,216</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total accounts payable</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">10,052</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">7,082</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other accrued liabilities classified within accounts payable mainly relate to outstanding invoices totaling &#8364;7&#160;million and &#8364;2&#160;million as of December&#160;31, 2020 and 2019, respectively. </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of trade and other payables. [Refer: Trade and other payables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169240022072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue from collaboration agreements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory', window );">Revenue from collaboration agreements</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">13.</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Revenue from collaboration agreements </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Group earns revenue through strategic collaboration agreements with third party pharmaceutical and biotechnology companies. As of December&#160;31, 2020, the Group had four strategic collaboration agreements in place. All collaboration agreements are still at <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-clinical</div> stage. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">As part of these collaboration arrangement, Immatics grants exclusive licensing rights or options thereto for the development and commercialization of future product candidates, developed for several targets defined in the respective collaboration agreements, in addition to research activities, including screening of highly specific molecules for reactivity with the specified targets and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">off-targets</div> using Immatics&#8217; proprietary technology and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">know-how,</div> participation on a joint steering committee, and preparation of data packages. For each collaboration agreement, these promises represent one combined performance obligation, because the research activities are mutually dependent and the respective collaboration partner is unable to derive significant benefits from their access to these targets without Immatics&#8217; research activities, which are highly specialized and cannot be performed by other organizations. Under each agreement, research activities were determined to be the predominant item under the contract. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Amgen Collaboration Agreement </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In December 2016, Immatics Biotechnologies GmbH entered into a research collaboration and license agreement with Amgen Inc. (&#8220;Amgen&#8221;) to develop next-generation, T cell engaging bispecific immunotherapies targeting multiple cancers. Under the terms of the agreement, Immatics contributed its XPRESIDENT target discovery and T cell receptor (TCR) capabilities to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-clinical</div> development of product candidates. Amgen Inc. contributed its validated Bispecific T cell Engager (BiTE<div style="font-size: 85%; vertical-align: top;;vertical-align: super;font-size: smaller;display:inline;">&#174;</div>) technology and will be responsible for the clinical development, manufacturing and commercialization worldwide. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In the collaboration agreement with Amgen development milestone payments and commercial milestone payments amount to a maximum <div style="display:inline;">up to</div> $525&#160;million for each program and tiered royalties up to a double-digit percentage of net sales. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Group received a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-refundable</div> upfront payment of $30&#160;<div style="letter-spacing: 0px; top: 0px;;display:inline;">million (&#8364;28 million) upon signing of the Amgen agreement. The Group classified the initial receipt of the upfront payment as deferred revenue, which recognizes into revenue as on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">cost-to-cost</div></div> basis using forecasted costs. A <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">cost-to-cost</div></div> basis was determined most representative of the transfer of benefits to Amgen. The Group recognized approximately </div>&#8364;4.9&#160;million, &#8364;6.2&#160;million and &#8364;1.5&#160;million of revenue associated with the upfront payment during the years ended December&#160;31, 2020, 2019 and 2018, respectively. Total deferred revenue under the agreement was &#8364;10&#160;million and &#8364;15&#160;million as of December&#160;31, 2020 and 2019, respectively. </div> <div style="font-size: 1px; margin-top: 18px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Genmab Collaboration Agreement </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In July 2018, Immatics Biotechnologies GmbH entered into a research collaboration and license agreement with Genmab A/S (&#8220;Genmab&#8221;) to develop next-generation, T cell engaging bispecific immunotherapies targeting multiple cancer indications. Under the agreement, Immatics and Genmab conduct joint research to combine Immatics&#8217; XPRESIDENT and Bispecific TCR technology platforms with Genmab&#8217;s proprietary antibody technologies to develop multiple bispecific immunotherapies in oncology. The two companies plan to develop immunotherapies directed against three proprietary targets. Genmab will be responsible for development, manufacturing and worldwide commercialization. Immatics will have an option to contribute certain promotion efforts at predetermined levels in selected countries in the EU. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Genmab collaboration agreement contains a maximum of $550&#160;million of milestone payments for each licensed product resulting from the collaboration. In addition, Immatics is entitled to receive royalty payments. Royalty rates are based on aggregate net sales of a licensed product. The agreement provides for higher royalty rates as annual net sales of a licensed product increases. Under the agreement, the royalty rates begin in the high single-digits, increasing to the low tens as a percentage of aggregate annual net sales of a licensed product. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Group received a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-refundable</div> upfront payment of $54&#160;<div style="letter-spacing: 0px; top: 0px;;display:inline;">million (&#8364;46 million) upon signing of the agreement. The Group classified the initial receipt of the upfront payment as deferred revenue. The Group recognized </div>approximately &#8364;11.2&#160;million, &#8364;11.2&#160;million and &#8364;2.3&#160;<div style="letter-spacing: 0px; top: 0px;;display:inline;">million of revenue associated with the upfront payment and with reimbursements for research and development costs performed, during the years ended December&#160;31, 2020, 2019 and 2018, respectively. Revenue for the Genmab collaboration agreement is recognized on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">cost-to-cost</div></div> basis using forecasted costs. A <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">cost-to-cost</div></div> basis was determined most representative of the transfer of benefits to Genmab. Total deferred revenue under the agreement was </div>&#8364;26&#160;million and &#8364;35&#160;million as of December&#160;31, 2020 and 2019, respectively. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">BMS Collaboration Agreement </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In August 2019, Immatics Biotechnologies GmbH and BMS entered into a collaboration and option agreement to develop novel adoptive cell therapies targeting multiple cancers. Under the agreement, Immatics may develop T Cell Receptor Engineered T Cell Therapy <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(TCR-T)</div> programs against solid tumor targets discovered with Immatics&#8217; XPRESIDENT technology. Programs would utilize proprietary T Cell Receptors (TCRs) identified by Immatics&#8217; XCEPTOR TCR discovery and engineering platform. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">If Immatics develops programs against the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">TCR-T</div> targets, Immatics will be responsible for the development and validation of these programs through lead candidate stage, at which time BMS may exercise <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">opt-in</div> rights and assume sole responsibility for further worldwide development, manufacturing and commercialization of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">TCR-T</div> cell therapies. </div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;">Immatics would have certain early stage <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">co-development</div> rights or <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">co-funding</div> rights for selected <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">TCR-T</div> cell therapies arising from the collaboration. With respect to this collaboration agreement with BMS, Immatics may be eligible to receive up to $505&#160;million for each licensed product in option exercise payments, development, regulatory and commercial milestone payments as well as tiered royalties on net sales. In addition, Immatics is entitled to royalty payments. Royalty rates are based on aggregate net sales of a licensed product resulting from the collaboration. The agreement provides for higher royalty rates as annual net sales of a licensed product increases. Under each contract, the royalty rates begin in the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">mid-single-digits,</div> increasing to the low teen-digits as a percentage of aggregate annual net sales of a licensed product. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Group received a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-refundable</div> upfront payment of $75&#160;<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">million (&#8364;68 million) upon signing of the agreement. The Group classified the initial receipt of the upfront payment as deferred revenue. The Group recognized </div></div>&#8364;11.5&#160;million and &#8364;1.1&#160;<div style="letter-spacing: 0px; top: 0px;;display:inline;">million of revenue associated with the upfront payment as of December&#160;31, 2020 and 2019, respectively. Revenue for the BMS collaboration agreement is recognized on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">cost-to-cost</div></div> basis using forecasted costs. A <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">cost-to-cost</div></div> basis was determined most representative of the transfer of benefits to BMS. Total deferred revenue under the agreement was </div>&#8364;55&#160;million and &#8364;66.5&#160;million as of December&#160;31, 2020 and 2019, respectively. </div> <div style="font-size: 1px; margin-top: 18px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">GSK </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In December 2019, Immatics entered into a collaboration agreement with GSK to develop novel adoptive cell therapies targeting multiple cancer indications. Immatics and GSK plan to collaborate on the identification, research and development of next-generation TCR Therapeutics focusing on solid tumors. The collaboration will initially focus on the development of autologous T cell therapies and GSK has an option to develop allogeneic T cell therapies using Immatics ACTallo approach. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Immatics and GSK intend to utilize proprietary TCRs identified by Immatics TCR discovery platform XCEPTOR which are planned to be directed against two proprietary targets. Those proprietary targets were discovered and validated by the respective XPRESIDENT technology. Immatics will be mainly responsible for the development and validation of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">TCR-T</div> up to designation of a clinical candidate. GSK will then assume sole responsibility for further development, manufacturing and commercialization of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">TCR-T</div> with the option for Immatics to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">co-develop</div> one or more <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">TCR-Ts</div> upon GSK&#180;s request. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Group received a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-refundable</div> upfront payment of &#8364;45&#160;million for two initial programs upon signing of the GSK agreement and is eligible to receive <div style="display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">up to &#8364;</div></div>575&#160;million of milestone payments per program. In addition, Immatics is entitled to royalty payments. Royalty rates are based on aggregate net sales of a licensed product resulting from the collaboration. The agreement provides for higher royalty rates as annual net sales of a licensed product increases. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Group classified the initial receipt of the upfront payment as deferred revenue. The Group recognized &#8364;3.7&#160;million of revenue associated with the upfront payment as of December&#160;31, 2020 and recognized no revenue associated with the upfront payment during 2019. Total deferred revenue under the agreement was &#8364;41&#160;million and &#8364;45&#160;million as of December&#160;31, 2020 and 2019, respectively. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Group has not recognized any royalty or milestone revenue under the collaboration agreements, due to the scientific uncertainty of achieving the milestones or the successful commercialization of a product. As of December 31, 2020, Immatics had not received any milestone or royalty payments in connection with the collaboration agreements. The Group plans to recognize the remaining deferred revenue balance into revenue as it performs the related performance obligations under each contract. </div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred revenue related to the collaboration agreements consists of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:74%;"></td><td style="vertical-align:bottom;;width:5%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:5%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">As of</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Current</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">46,600</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">59,465</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-current</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">85,475</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">101,909</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">132,075</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">161,374</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Cost to obtain a contract </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Group incurs costs from a third party, who assists in identifying collaboration partners. The Group recognizes an asset to the extent these costs are incremental and directly related to a specific contract. The Group then amortizes the asset consistently with the pattern of revenue recognition for the related contracts. Total assets, net of amortization, for these capitalized costs of obtaining a contract were &#8364;1.2&#160;million and &#8364;1.5&#160;million as of December&#160;31, 2020 and 2019, respectively, which are classified in other current assets and other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> assets. The Group recognized expenses related to the amortization of capitalized cost of obtaining a contract of &#8364;0.3&#160;million, &#8364;0.2&#160;million and &#8364;0.04&#160;million as of December&#160;31, 2020, 2019 and 2018, respectively. </div> <div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2020, the Group is potentially liable to pay &#8364;1.6&#160;million (</div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$2&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">million) to a third-party upon successful completing the milestone of the first clinical lead selection in connection with Immatics&#8217; collaboration agreements. The Group does not recognize a liability for these contingent payments due to the scientific uncertainty of achieving the related milestones. </div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Each of the Group&#8217;s strategic collaboration agreements included a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-refundable</div> upfront payment, meant to subsidize research activities, recognized as deferred revenue. For all collaboration agreements these upfront payments exceeded the Group&#8217;s right to consideration for services performed under each collaboration agreement. Therefore, only deferred revenue net of contract assets is presented as of December&#160;31, 2020, December&#160;31, 2019 and December&#160;31, 2018, respectively. </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for revenue from contracts with customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2020-01-01<br> -Section Presentation<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2020-en-r&amp;doctype=Standard&amp;dita_xref=IFRS15_g105-109_TI<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2020-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2020-en-r&amp;doctype=Standard&amp;dita_xref=IFRS15_g110-129_TI<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237492744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other income<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory', window );">Other income</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="background-color:#ffffff;;display:inline;">14. Other income </div></div></div></div></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Other income includes grant income, in addition immaterial amounts from other sources. The Group receives income through government grants for specific research and development projects. The Group recognizes grant income as it performs research and development activities specified by the grant agreements. Total grant income </div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">was &#8364;0.2&#160;million, &#8364;0.03&#160;million, and &#8364;2.9&#160;million during the years ended December&#160;31, 2020, 2019 and 2018, respectively. There are no unfulfilled conditions or contingencies attached to these grants. </div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Group had the following deferred income and receivable balances under these agreements: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:73%;"></td><td style="vertical-align:bottom;;width:9%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:9%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">As of</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Receivables</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">875</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">998</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred income</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">164</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">875</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,162</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Group classifies receivables under these agreements within other current assets, while it presents deferred income within other current liabilities. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other operating income. [Refer: Other operating income (expense)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237451448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other current liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherCurrentLiabilitiesExplanatory', window );">Other current liabilities</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">15.</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Other current liabilities </div></div></div></td></tr></table>   <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The components of other curre<div style="background-color:#ffffff;;display:inline;">n</div><div style="display:inline;"><div style="background-color:#ffffff;;display:inline;">t</div></div>&#160;liabilities are: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:74%;"></td><td style="vertical-align:bottom;;width:8%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:8%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">As of</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Payroll tax</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,185</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">727</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrual for vacation</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">525</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">330</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Deferred grant income</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">164</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued bonuses</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">154</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">52</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Other</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">161</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">15</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,025</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,288</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Other current liabilities are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-interest-bearing</div> and are due within one year. The carrying amounts of other current liabilities represents fair value due to their short-term nature. </div> <div style="font-size: 1px; margin-top: 18px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherCurrentLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other current liabilities. [Refer: Other current liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherCurrentLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237520264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial income and expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory', window );">Financial income and expenses</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">16.</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financial income and expenses </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div>   <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; line-height: 12pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial income and financial expenses consist of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"><tr style="font-size: 0px;"><td style="width:80%;"></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:1%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:1%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2018</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="10" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Interest income from short-term deposits</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">850</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">790</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">507</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Foreign currency gains</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,708</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Gain on other financial instruments</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2,099</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financial income</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,949</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">790</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,215</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1pt;"><td style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Interest expenses form leases</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(289</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(170</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(16</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Foreign currency losses</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(9,774</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(94</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(145</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Financial expenses</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(10,063</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(264</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(161</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td></tr></table> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Foreign currency losses mainly consist of unrealized losses in connection with our USD holdings. </div></div> <div style="font-family: times new roman;font-size: 10pt;margin-top: 0pt;margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Gain on other financial instruments includes an unrealized gain of 0.9&#160;million and a realized gain of 1.2&#160;million from foreign currency forward contracts for the year ended December&#160;31, 2020. </div></div> <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of finance income (cost). [Refer: Finance income (cost)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169240000616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share listing expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfShareListingExpenseTextBlock', window );">Share listing expense</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">17. Share listing expense </div></div></div></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">As described in Note 3, the ARYA Merger led to a share listing expense. Immatics issued shares and warrants with a fair value of &#8364;277.7&#160;million to ARYA shareholders, comprised of the fair value of Immatics shares, that were issued to ARYA shareholders of &#8364;13.53 per share, as well as a fair value of Immatics Warrants of &#8364;4.82 per share (price of ARYA shares at Closing of the ARYA Merger). In exchange, Immatics received the identifiable net assets held by ARYA, which had a fair value of upon closing of &#8364;124.9&#160;million. The excess of the fair value of the equity instruments issued over the fair value of the identified net assets contributed, represents a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> expense in accordance with IFRS 2. This <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-time</div> expense as a result of the ARYA Merger, in the amount of &#8364;152.8&#160;million, is recognized as Share listing expense presented as part of the Financial result within the Consolidated Statement of Loss. Details of the calculation of the Share listing expense are as follows: </div> <div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>  <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:73%;"></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(Euros in thousands, except share and per share data)</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="white-space: nowrap; padding-bottom: 0.45pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Description</div></td><td style="padding-bottom: 0.45pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Amount</div></td><td style="padding-bottom: 0.45pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.45pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="padding-bottom: 0.75pt; border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-family: &quot;times new roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:center;"><div style="font-family: &quot;times new roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Number of<br/> shares/warrants</div></div></div></div></td><td style="padding-bottom: 0.45pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">(a) ARYA Ordinary Shares</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">17,968,750</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(b) Closing price of ARYA Ordinary Shares on Nasdaq as of July&#160;1, 2020</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#8364;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">13.53</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">(c) Fair value of TopCo Shares issued to ARYA shareholders <div style="font-weight:bold;display:inline;width:100%;">(a * b)</div></div></td><td style="background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:bottom;">&#8364;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">243,071</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;text-align:right;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255);;display:inline;">&#8212;&#160;</div>&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(d) Outstanding ARYA Public Warrants</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">7,187,500</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">(e) Closing price of ARYA Public Warrants on Nasdaq as of July&#160;1, 2020</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#8364;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">4.82</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(f) Fair value of outstanding ARYA Public Warrants (d * e)</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#8364;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">34,644</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Total fair value of ARYA Ordinary Shares and ARYA Public Warrants (c + f)</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#8364;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">277,715</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ARYA&#8217;s identifiable net assets</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#8364;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">124,927</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">IFRS 2 Expense on the closing date</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#8364;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">152,787</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;"></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfShareListingExpenseTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of share listing expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfShareListingExpenseTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237518440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based payments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory', window );">Share-based payments</a></td>
<td class="text"><div><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">18.</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Share-based payments </div></div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Immatics Biotechnologies GmbH previously issued share-based awards to employees under two different plans. Under the Immatics Biotechnologies GmbH Stock Appreciation Program 2010 (the &#8220;2010 Plan&#8221;), the Company issued stock appreciation rights (&#8220;SARs&#8221;), which the Group accounted for as cash-settled awards. Under the Immatics Biotechnologies 2016 Equity Incentive Plan (&#8220;2016 Plan&#8221;), the Company issued tandem awards, which allowed employees to exercise their awards as either a SAR or a stock option. In 2020, prior to the ARYA Merger, Immatics N.V. established the new equity incentive plan (&#8220;2020 Equity Plan&#8221;). As part of the ARYA Merger, the 2010 Plan and the 2016 Plan were converted and were superseded by the 2020 Equity Plan as described below. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Share appreciation rights (&#8220;the 2010 Plan&#8221;) </div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Effective January&#160;1, 2005, in addition to performance-related compensation, certain Immatics employees became eligible to participate in a Stock Appreciation Rights (SAR) Program as part of a long-term equity incentive scheme. The aim of this program was to give employees a long-term stake in the success of the Company. The SAR program was adopted by resolutions by the supervisory board in January 2005 and was subsequently amended on February&#160;6, 2007 and September&#160;7, 2010. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Under the 2010 Plan, the beneficiaries received SAR awards, which did not require any cash investment into the company. SARs granted under this program carried no dividend or voting rights. The award holders had the right to execute the vested SARs only in a defined exit event. An exit event was defined as the acquisition of more than 50.00% of the outstanding shares by a third party. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SARs granted under the 2010 Plan vested based on the satisfaction of service requirements (time-based vesting). These awards generally had a five-year graded vesting period. Employees leaving the Group were able to retain any vested awards as of their termination date, unless they were terminated for cause. Per the terms of the SAR agreements, employees were not entitled to subscribe to shares in the Group. Therefore, SARs granted under the 2010 Plan might be settled in cash only. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As awards issued under the 2010 Plan were cash settled, the Group applied liability accounting and revalued the outstanding awards at each reporting date. The Group applied a Black Scholes pricing model to estimate the fair value of the SARs as of December&#160;31, 2019 and 2018 based on a company value of $350,000&#160;thousand and $160,000&#160;thousand, respectively. </div></div><div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:83%;"></td><td style="vertical-align:bottom;;width:5%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Amounts in USD</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2018</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Exercise price</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.12</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.12</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Underlying share price</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">67.87</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">27.21</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Volatility</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">73</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">64</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Time period (years)</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1.25</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">5.00</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Risk free rate</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.59</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2.77</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">0.00</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">0.00</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Combined probability of exit events</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">80.00</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">25.00</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Expected volatility was determined by calculating the historic volatility in share prices of peer companies within the biotechnology industry. The expected life in the model has been adjusted, based on management&#8217;s best estimate, for the effects of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-transferability</div> and exercise restrictions. Furthermore, the fair value of SARs issued under the 2010 Plan were discounted based on the probability of the awards becoming exercisable due to either a change in control or an IPO, as management expected to settle these awards also in case of an IPO. The Black Scholes model considered for an IPO event a time period of one year and for a trade sale event a time period of five years. Awards issued under the 2010 Plan did not expire. </div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Set out below are summaries of SARs issued during 2019 and 2018: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:92%;"><tr style="font-size: 0px;"><td style="width:68%;"></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2018</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Weighted<br/>average<br/>exercise<br/>price in<br/>USD</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Number</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Weighted<br/>average<br/>exercise<br/>price in<br/>USD</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Number</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">SARs outstanding at January&#160;1,</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.12</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">43,675</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.12</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">43,978</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SARs granted</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">SARs forfeited</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.12</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">220</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.12</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">303</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SARs outstanding at December&#160;31,</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1.12</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">43,455</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1.12</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">43,675</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">SARs vested</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.12</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">117</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.12</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">169</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SARs exercisable</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">There were no awards issued under the 2010 Plan as of December&#160;31, 2020, 2019 or 2018. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Resulting from these awards Immatics had other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> liabilities of &#8364;2.1&#160;million and &#8364;0.2&#160;million as of December&#160;31, 2019, and 2018, respectively. </div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As the 2010 Plan was converted in 2020, there were no SARs outstanding as of December&#160;31, 2020. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2016 Equity Incentive Plan (&#8220;the 2016 Plan&#8221;) </div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On February&#160;8, 2017, the Company established the &#8220;2016 Equity Incentive Plan&#8221; to provide employees and consultants of the Group the ability to share in the Company&#8217;s future success. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Awards issued under the 2016 Plan were tandem awards, which consisted of an option to acquire a stated the number of shares at a stated exercise price, or alternatively, the right to receive any appreciation in the value of the stated number of shares (&#8220;SAR portion&#8221;). </div></div><div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Generally, the tandem awards issued under the 2016 Plan had a five-year vesting period. The first annual tranche vested on the first anniversary of the grant date. Following the first anniversary, the awards continued to vest on a monthly basis. Vesting was contingent on the recipient&#8217;s continued service to the Group. Employees which left the Group were able to retain any awards vested as of their termination date, unless they were terminated for cause. Former employees forfeited their awards, if they remained unexercised more than three months after an IPO or change in control. In the event of a change in control, the unvested portion of the Tandem Award should immediately vest. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Tandem Award (to the extent vested) might only be exercised after the contribution of all Immatics shares to a holding company for purposes of an indirect IPO, a change in control, or the expiration of a certain <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">lock-up</div> period following the completion of a direct IPO. A change in control was defined as the acquisition of more than 50% of the outstanding shares by a third party. </div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Under the terms of the 2016 Plan, options had to be settled in equity shares of the Group, while SAR portions might be settled in either equity shares or cash, at the Group&#8217;s discretion. While the Group did not have a policy or prior history of settling these awards, it intended to settle outstanding awards in equity shares. As a result, the Group was treating awards issued under the 2016 plan as equity-settled. Subsequent settlements of SARs in cash, to the extent they occurred, would be recorded via an adjustment to equity. Each option or SAR issued under the plan might be settled for one common share of the Group in the event it is exercisable. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Set out below are summaries of tandem awards issued during 2019 and 2018: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="width:65%;"></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2018</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Weighted&#160;average<br/>exercise price in<br/>USD</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Number</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Weighted<br/>average&#160;exercise<br/>price in USD</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Number</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Tandem Awards outstanding at January&#160;1,</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">16.65</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">74,401</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">16.65</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">31,880</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Tandem awards granted in June to September</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">18.30</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">26,557</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16.65</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">43,964</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Tandem awards granted in December</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">23.82</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">5,447</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Tandem awards forfeited</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16.81</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2,936</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16.65</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,443</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Tandem awards outstanding at December&#160;31,</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">17.45</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">103,469</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">16.65</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">74,401</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Tandem awards vested</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16.76</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,238</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16.65</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">14,350</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Tandem awards exercisable</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted average remaining contract life (years)</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">8.56</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">9.12</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Weighted average fair value of options granted in USD till September</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10.27</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">4.51</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted average fair value of options granted in USD for December</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">53.41</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Group used a Black Scholes pricing model to estimate the fair value of equity settled tandem awards issued during 2019 until September 2019, based on a company valuation of $160&#160;million. </div></div><div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of tandem awards issued in December 2019 was based on a company valuation of $350&#160;million. </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="width:61%;"></td><td style="vertical-align:bottom;;width:9%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:9%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:9%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="white-space: nowrap; padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Amounts in USD</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">June&#160;2019&#160;-&#160;September&#160;2019</div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;2018</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Exercise price in USD</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#160;23.82</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#160;18.30</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#160;16.65</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Underlying share price in USD</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">67.87</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16.94</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">27.21</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Volatility</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">73</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">78</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">64</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Time period (years)</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1.25</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2.10</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">5.00</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Risk free rate</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.59</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2.04</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2.77</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">0.00</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">0.00</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">0.00</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Combined probability of exit events</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">80.00</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">60.00</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">25.00</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Expected volatility was determined by calculating the historic volatility in share prices of peer companies within the biotechnology industry. The expected life in the model has been adjusted, based on management&#8217;s best estimate, for the effects of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-transferability</div> and exercise restrictions. Furthermore, the fair value of awards issued under the 2016 Plan were discounted based on the probability of the awards becoming exercisable due to either a change in control or an IPO. <br/></div></div><div style="margin-block: 0em;">&#160;</div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Conversion of 2010 Plan and 2016 Plan in connection with ARYA Merger </div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As part of the ARYA Merger, all outstanding awards under the 2010 Plan and 2016 Plan were replaced by a combination of cash payments and share-based awards under the 2020 Equity Plan in Immatics N.V. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Cash Payments </div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In accordance with the employee award agreements, holders of vested awards under the 2010 Plan and 2016 Plan (including any awards scheduled to vest prior to 2021), agreed to receive a cash payment of $10.00 per award, less the applicable exercise price (&#8220;Award Cash Proceeds&#8221;). Per the terms of the employee award agreements, active employees were required to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-invest</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">25%-50%</div> of the Award Cash Proceeds, net of taxes, with management members required to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-invest</div> 50%. In total, employees elected to receive &#8364;8.9&#160;million in net Award Cash Proceeds before taxes, which were paid during the third quarter. These proceeds mainly covered wage tax obligations by the employees.</div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">These cash payments represent a modification of awards previously issued under the 2010 Plan and 2016 Plan. The Group recognized &#8364;2.6&#160;million in operating expense related to the modification of awards issued under the 2010 Plan and previously accounted for as a liability. The Group also recognized &#8364;4.3&#160;million as a reduction in share premium, associated with the modification from previously equity-settled tandem awards, which were settled in cash as part of the modification. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Share-based Awards </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The share-based awards, that were received by employees as part of the conversion, consisted of Re-investment Shares, Matching Stock Options and Converted Stock Options as described below. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In accordance with the employee <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-investment</div> elections, employees received 733,598 shares in Immatics N.V. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(&#8220;Re-investment</div> Shares&#8221;), which had a fair value of &#8364;8.5&#160;million based on the ARYA share price of $15.15, as of the merger on July&#160;1, 2020. The Re-investment Shares issued represented a modification of awards previously granted under the 2010 Plan and the 2016 Plan. This modification resulted in additional operating expense of &#8364;4.1&#160;million. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">For each ordinary Re-investment Share received, active employees and management members also received two stock options (&#8220;Matching Stock Options&#8221;) to acquire shares in Immatics N.V. The Matching Stock Options have an exercise price of $10.00 and vest in full on July&#160;31, 2021. The award recipient must remain employed by Immatics or one of its affiliates through the vesting date, to receive the option. The awards have a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ten-year</div> contract life. </div> <div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Matching Stock Options award agreements had a service commencement date in June 2020. However, the grant date criteria for these awards, as specified in IFRS 2 and the underlying award agreements, were not met until July&#160;1, 2020. Based on the July&#160;1, 2020 grant date the Group assigned a fair value of $10.59. </div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Immatics applied a Black Scholes pricing model to estimate the fair value of the Matching Stock Options, which the Group records as an expense over the four-year graded vesting period. </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"><tr style="font-size: 0px;"><td style="width:84%;"></td><td style="vertical-align:bottom;;width:12%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">As&#160;of&#160;June&#160;30,</div><br/> <div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Exercise price in USD</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10.00</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Underlying share price in USD</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">15.15</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Volatility</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">75</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Time period (years)</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">5.5</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Risk free rate</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.29</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">0.00</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Set out below are summaries of Matching Stock Options issued during 2020: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>  <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:71%;"></td><td style="vertical-align:bottom;;width:7%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:7%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Weighted&#160;average<br/> exercise price in<br/> USD</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Number</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Matching Stock Options outstanding on January&#160;1,</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Matching Stock Options granted in June</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10.00</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,430,818</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Matching Stock Options forfeited</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10.00</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">8,262</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Matching Stock Options outstanding at December&#160;31,</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10.00</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,422,556</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Matching Stock Options vested</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted average remaining contract life (years)</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">9.50</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Weighted average fair value of options granted in USD for June</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10.59</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For any outstanding 2016 Plan and 2010 Plan awards scheduled to vest on or after January&#160;1, 2021, employees received replacement stock options (&#8220;Converted Options&#8221;) to acquire shares in Immatics N.V. The Converted Options have comparable terms as the previous awards, with revised exercise prices reflecting the reorganized capital structure of Immatics. The options granted under the 2020 Equity Plan that gives employees the right to acquire shares in Immatics N.V., are accounted for as a modification under IFRS 2, with the incremental fair value expensed over the remaining vesting period. The incremental fair value is the difference between the fair value of the options to purchase ordinary shares under the 2020 Equity Plan to acquire shares in Immatics N.V., and the fair value of the exchanged unvested SAR (both measured at the date on which the replacement award is issued). </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Based on the terms of the Converted Options award agreements, the awards had a service commencement date in June 2020. However, the grant date criteria for these awards, as specified in IFRS 2 and the underlying award agreements, were not met until July&#160;1, 2020. Based on the July&#160;1, 2020 grant date the Group assigned an average fair value of $13.79. The incremental average fair value of the Converted Options compared to the share-based awards under the 2010 Plan and 2016 Plan was $4.83. Immatics applied a Black Scholes pricing model to estimate the fair value of the Converted Options. </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>  <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"><tr style="font-size: 0px;"><td style="width:90%;"></td><td style="vertical-align:bottom;;width:6%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">As of<br/> June&#160;30,<br/> 2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Average exercise price in USD</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2.47</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Underlying share price in USD</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">15.15</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Volatility</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">75</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Time period (years)</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">5.6</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Risk free rate</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.29</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">0.00</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Set out below are summaries of Converted Options issued during 2020: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:72%;"></td><td style="vertical-align:bottom;;width:8%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:8%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Weighted&#160;average<br/> exercise price in<br/> USD</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Number</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Converted Options outstanding on January&#160;1,</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Converted Options granted in June</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2.49</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">632,384</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Converted Options forfeited</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.08</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">37,540</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Converted Options outstanding on December&#160;31,</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2.58</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">594,844</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Converted Options vested</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#160;2.45</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">53,856</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted average remaining contract life (years)</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">7.01</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Weighted average fair value of options granted in USD for June</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">4.83</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Additional grants under the 2020 Equity Plan </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Service Options </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Prior to the ARYA Merger, Immatics N.V. established the 2020 Equity Plan. After closing the ARYA Merger, employees, directors and officers received 1,087,242 employee stock options under the 2020 Equity Plan with a service requirement (&#8220;Service Options&#8221;), to acquire shares of Immatics N.V. The service-based options will vest solely on a four-year time-based vesting schedule. </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The total amount of the Service options granted were accounted for by considering a fair value of $11.29, $9.25, and $6.73, as of grant date June&#160;30, 2020, September&#160;14, 2020, and December&#160;17, 2020, respectively. <div style="letter-spacing: 0px; top: 0px;;display:inline;">Immatics applied a Black Scholes pricing model to estimate the fair value of the Service Options.</div> </div></div> <div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>  <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="width:68%;"></td><td style="vertical-align:bottom;;width:7%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:7%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:7%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">As&#160;of&#160;June&#160;30,<br/> 2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">As&#160;of&#160;September&#160;14,<br/> 2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">As&#160;of<br/> December&#160;17,<br/> 2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Exercise price in USD</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#160;10.00</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#160;10.00</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#160;9.70</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Underlying share price in USD</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">15.15</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">9.16</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">9.70</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Volatility</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">75</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">79</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">84</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Time period (years)</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">7.0</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">6.2</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">6.0</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Risk free rate</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.29</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.37</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.49</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">0.00</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">0.00</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">0.00</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A total of 1,963,566 Service Options have been granted as of December&#160;31, 2020. Set out below are summaries of Service Options issued during 2020:</div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>  <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:73%;"></td><td style="vertical-align:bottom;;width:6%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:6%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Weighted<br/> average&#160;exercise<br/> price in USD</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Number</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Service Options outstanding on January&#160;1,</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Service Options granted in June</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10.00</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,087,417</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Service Options granted in September</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">9.72</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">74,000</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Service Options granted in December</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">9.70</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">802,149</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Service Options forfeited</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10.00</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">53,384</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Service Options outstanding on December&#160;31,</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">9.87</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,910,182</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Service Options vested</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted average remaining contract life (years)</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">9.72</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Weighted average fair value of options granted in USD for June</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">11.29</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted average fair value of options granted in USD for September</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">9.25</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Weighted average fair value of options granted in USD for December</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">6.73</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Performance-Based Options (&#8220;PSUs&#8221;) </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition, after the closing of the ARYA Merger certain executive officers and key personnel of the Group received under the 2020 Equity Plan PSUs, vesting based both on achievement of market capitalization milestones and satisfaction of a four-year time-based vesting schedule. The PSUs are split into three equal tranches. The performance criteria for each of the three respective tranches requires Immatics to achieve a market capitalization of at least $1.5&#160;billion, $2&#160;billion and $3&#160;billion, respectively. The amount of 3,644,000 of the PSUs granted on June&#160;30, 2020, were accounted for by considering a fair value of $11.10. </div></div> <div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The remaining amount of 255,000 PSUs granted on September&#160;14, 2020, were accounted for by considering a fair value of $6.41. </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A Monte-Carlo simulation model has been used to measure each fair value at grant date of the PSUs. The model incorporates the impact of the performance criteria regarding market capitalization described above in the calculation of the award&#8217;s fair value at grant </div></div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">date. In addition to the probability of achieving the market capitalization performance criteria, the inputs used in the measurements of the fair value at grant date of the PSUs were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>  <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:73%;"></td><td style="vertical-align:bottom;;width:10%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:9%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">As&#160;of&#160;June&#160;30,<br/> 2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">As of<br/> September&#160;14,<br/> 2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Exercise price in USD</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#160;10.00</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#160;10.00</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Underlying share price in USD</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">15.15</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">9.16</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Volatility</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">79</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">78</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Time period (years)</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">7.0</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">6.7</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Risk free rate</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.66</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.67</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">0.00</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">0.00</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A total of 3,644,000 PSUs have been granted as of December&#160;31, 2020. </div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Set out below are summaries of PSUs issued during 2020: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:73%;"></td><td style="vertical-align:bottom;;width:6%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:6%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Weighted<br/> average&#160;exercise<br/> price in USD</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Number</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">PSUs outstanding on January&#160;1,</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">PSUs granted in June</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10.00</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">3,644,000</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">PSUs granted in September</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10.00</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">255,000</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">PSUs forfeited</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10.00</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">255,000</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">PSUs outstanding on December&#160;31,</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10.00</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">3,644,000</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">PSUs vested</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Weighted average remaining contract life (years)</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">9.60</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted average fair value of options granted in USD for June</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">11.10</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Weighted average fair value of options granted in USD for September</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">6.41</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman;font-size: 10pt;margin-top: 12pt;margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Group recognized total employee-related share-based compensation expense from all plans for the years ended December&#160;31, 2020, 2019 and 2018 as set out below: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"><tr style="font-size: 0px;"><td style="width:80%;"></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Year&#160;ended&#160;December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2018</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="10" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Research and development expenses</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">14,546</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,556</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">238</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">General and administrative expenses</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10,973</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">460</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">100</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total share-based compensation</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">25,519</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,016</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">338</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 44<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_44&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169240169624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' equity (deficit)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory', window );">Shareholders' equity (deficit)</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">19.</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shareholders&#8217; equity (deficit) </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As described in Note 1 and Note 3, Immatics N.V. was founded in 2020 with a share capital of </div></div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8364;0.01<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">after the Reorganization. </div></div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On July&#160;1, 2020, upon closing of the ARYA Merger, Immatics N.V. had 62,908,617 outstanding ordinary shares with a par value of &#8364;0.01, resulting in a share capital of &#8364;629&#160;thousand. In 2020, the ARYA Merger and PIPE Financing led to an increase in share premium by &#8364;362,5&#160;million. As of December&#160;31, 2020, the total number of ordinary shares of Immatics N.V. outstanding is 62,908,617 with a par value of &#8364;0.01. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2019, the total number of ordinary shares of Immatics Biotechnologies GmbH outstanding is 1,163,625 with a par value of &#8364;1.00. </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Adjusted for the effect of the Reorganization as discussed in Note 3, which is applied retrospectively to all prior periods presented, the total number of ordinary shares outstanding as of December&#160;31, 2019 was 33,093,838 with a par value of &#8364;0.01. </div></div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In 2019, there was no capital increase and, hence, no change in share capital or share premium. In 2018, &#8364;23.6&#160;<div style="letter-spacing: 0px; top: 0px;;display:inline;">million</div> were paid into share premium by the shareholders based on the Series E financing round, which closed in 2017. The related Series E share capital was previously paid in full in 2017. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other reserves are related to accumulated foreign currency translation amounts associated with the Group&#8217;s US operations. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2020, there were 7,187,500 </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Immatics Warrants outstanding. The warrants entitle the holder to purchase one ordinary share of Immatics N.V. at an exercise price of </div></div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$11.50 per share. </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Until warrant holders acquire the Groups ordinary shares upon exercise of such warrants, they will have no rights with respect to the Groups ordinary shares. The warrants will expire on July&#160;1, 2025, </div></div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">five </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">years after the ARYA Merger close date, or earlier upon redemption or liquidation in accordance with their terms. </div></div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share capital, reserves and other equity interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237554472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-controlling interests<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory', window );">Non-controlling&#160;interests</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">20.</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-controlling</div> interests </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-controlling</div> interests related to those shares in Immatics US Inc. which have been provided to The University of Texas M.D. Anderson Cancer Center, Houston/Texas/USA, (&#8220;MD Anderson&#8221;) based on the restricted stock acquisition agreement described below. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Until June&#160;30, 2020, Immatics and MD Anderson were partners in a Restricted Stock Acquisition Agreement (the &#8220;RSAA&#8221;). Under the terms of the RSAA, MD Anderson was entitled to additional restricted shares in Immatics US, Inc. based on performance of certain work orders between August&#160;14, 2018 and August&#160;14, 2020. MD Anderson performed services in connection with our clinical trials in our ACT platform. The RSAA was canceled as part of the ARYA Merger (See Note 3).</div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">On July&#160;1, 2020 MD Anderson exchanged all of its 379,420 shares in Immatics US, Inc., that they acquired under the RSAA for 697,431 shares in Immatics N.V. The shares of Immatics N.V. had a fair value at the date of the exchange of $15.15 per share. Immediately prior to the exchange, the carrying amount of the existing 5.14% <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-controlling</div> interest in Immatics US Inc. was &#8364;0.5&#160;million. The exchange resulted in a decrease of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-controlling</div> interest of &#8364;0.5&#160;million and a corresponding increase of share capital and net increase to share premium for the issuance of shares and derecognition of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-controlling</div> interest. The RSAA was also canceled as of July&#160;1, 2020. Any future services rendered by MD Anderson will be paid in cash. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Loss allocated to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-controlling</div> interest amounted to </div>&#8364;0.6&#160;million in 2020, &#8364;0.9&#160;million in 2019 and &#8364;0.9&#160;million in 2018, respectively. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-controlling</div> interests on equity amounted to &#8364;1&#160;million as of December&#160;31, 2019 and &#8364;1.2&#160;million as of December&#160;31, 2018. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In total, the Group recognized expenses in relation to MD Anderson&#8217;s performance under the RSAA of &#8364;0.04&#160;million, &#8364;0.7&#160;million and &#8364;0.8&#160;million as of December&#160;31, 2020, 2019 and 2018, respectively. A corresponding increase in equity was recognized with an amount of &#8364;0.7&#160;million and &#8364;0.8&#160;million as of December&#160;31, 2019 and 2018, respectively for vested shares under the agreement. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of non-controlling interests. [Refer: Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237430280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Personnel expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfPersonnelExpensesExplanatoryTextBlock', window );">Personnel expenses</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">21.</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Personnel expenses </div></div></div></td></tr></table> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Group recognized the following personnel expenses: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"><tr style="font-size: 0px;"><td style="width:76%;"></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2018</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="10" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Wages and salaries</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Research and development expenses</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">15,277</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">11,635</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10,485</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">General and administrative expenses</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">6,968</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">3,596</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2,233</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total Wages and salaries</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">22,245</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">15,231</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">12,718</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Other employee benefits</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Research and development expenses</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2,624</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2,035</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,920</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">General and administrative expenses</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,015</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">728</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">607</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total other employee benefits</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">3,639</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,763</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,527</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Share-based compensation expense</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Research and development expenses</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">14,546</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,556</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">238</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">General and administrative expenses</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10,973</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">460</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">100</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total share-based compensation expense</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">25,519</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,016</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">338</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">51,403</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">20,010</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">15,583</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other employee benefit expenses include employee retirement fund contributions, health insurance, and statutory social expenses. Immatics US Inc. sponsors a defined contribution retirement plan for employees in the United States. During 2020, 2019 and 2018, total Group contributions to the defined contribution plan amounted to &#8364;0.2&#160;million, &#8364;0.1&#160;million and &#8364;0.1&#160;million, respectively. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the year ended December&#160;31, 2020, 2019 and 2018, other employee benefits also include employee health insurance costs amounting to &#8364;0.4&#160;million, &#8364;0.3&#160;million and &#8364;0.4&#160;million for Immatics US Inc., statutory social expenses amounting to &#8364;1.7&#160;million, &#8364;1.3&#160;million and &#8364;1.0&#160;million for our German operations and other miscellaneous expenses amounting to &#8364;0.1&#160;million, &#8364;0.07&#160;million and &#8364;0.2&#160;million, respectively. </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfPersonnelExpensesExplanatoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Personnel Expenses Explanatory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfPersonnelExpensesExplanatoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237557528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIncomeTaxExplanatory', window );">Income Tax</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">22.</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Income Tax </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the year ended December&#160;31, 2020, 2019 and 2018, the Group generated losses in both Germany and the U.S.</div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">During 2020, 2019 and 2018, the Group&#8217;s German operations were subject to a statutory tax rate of 29.1%. In the U.S., the Group was subject to a corporate income tax rate of 21% for the year ended December&#160;31, 2020, 2019 and 2018. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#160;</div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2020, 2019 and 2018, no deferred tax assets have been recognized in respect of these losses, due to the uncertainty of the Group&#8217;s ability to generate taxable profits in the foreseeable future. The current assessment regarding the usability of deferred tax assets may change, depending on the Group&#8217;s taxable income in future years. This may result in higher or lower deferred tax assets related to tax losses carried forward. Due to the ARYA Merger described in Note 3, there are certain limitations on tax losses carried forward for net operating losses incurred by Immatics US, Inc., under Section&#160;382 of the U.S. Internal Revenue Code. </div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A reconciliation between taxes on income reflected on the Consolidated Statement of Loss and the expected income tax benefit, based on the Group&#8217;s German statutory tax rate, for the years ended December&#160;31, 2020, 2019 and 2018 is as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"><tr style="font-size: 0px;"><td style="width:74%;"></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:1%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:1%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2018</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="10" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Loss before tax</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(229,616</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(32,487</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(32,355</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected tax benefit</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">66,818</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">9,454</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">9,415</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Effects</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Difference in tax rates</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(2,582</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(1,875</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(1,373</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Non-deductible&#160; tax-expenses</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(599</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(61</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(70</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Government grants exempted from taxes</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">45</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">8</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">853</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Permanent Differences</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(44,461</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="padding:0in 0in 0in 0in;vertical-align:top;"><div style="margin-top:0in; margin-right:0in; margin-bottom:.0001pt; margin-left:60.0pt; text-indent:-12.0pt; line-height:normal; font-family:calibri,sans-serif"><div style="font-size: 10pt; font-family: &quot;times new roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">Non-recognition&#160;of deferred taxes on tax losses and temporary differences</div></div></td><td style="padding:0in 0in 0in 0in;vertical-align:bottom;"><div style="margin:0in 0in 0.0001pt; line-height:normal; font-family:calibri,sans-serif">&#160;</div></td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;">(19,221</td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;">(7,526</td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;">(8,825</td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgba(255, 255, 255, 0);">&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgba(255, 255, 255, 0);">&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgba(255, 255, 255, 0);">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Taxes on income</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgba(255, 255, 255, 0);">&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgba(255, 255, 255, 0);">&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgba(255, 255, 255, 0);">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The main permanent difference relates to the Share listing expense of &#8364;153&#160;million, which does not have a corresponding taxable expense. Other permanent differences include transaction cost directly attributable and incremental to capital raises and expenses for equity-settled share-based compensation. </div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred tax assets consist of the following: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="width:70%;"></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td colspan="14" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of</div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31, 2020</div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31, 2019</div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td colspan="14" style="text-align:center;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></div></td><td style="vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Deferred<br/> tax<br/> assets</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Deferred<br/> tax<br/> liabilities</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Deferred<br/> tax<br/> assets</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Deferred<br/> tax<br/> liabilities</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr><tr style="font-size: 0px;"><td style="width: 60%;"></td><td style="width: 6%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 5%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 5%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 5%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Intangible assets</div></div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,770</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2,064</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Right-of-use</div></div> asset</div></td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(1,713</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(854</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Deferred revenue</div></div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">180</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">358</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other liabilities</div></div></td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">607</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Lease liability</div></div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,776</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">886</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred expenses</div></div></td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">3</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">14</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Recognized</div></div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">3,729</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(1,713</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">3,929</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(854</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Netting</div></div></td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(1,713</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,713</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(854</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">854</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Non-recognition</div> due to history of losses</div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(2,016</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(3,075</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 60%;;vertical-align:bottom;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Net tax</div></td><td style="vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-size: 1px;"><td style="width: 60%;;vertical-align:bottom;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div>   <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>  <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: times new roman;font-size: 10pt;margin-top: 0pt;margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2020, and 2019, the Group had accumulated tax losses of &#8364;288&#160;million and &#8364;219&#160;million, </div><div style="letter-spacing: 0px; top: 0px;;display:inline;">respectively, that may be offset against future taxable profits of the Group subject to certain limitations. </div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2020, &#8364;26&#160;million of total tax losses is subject to a twenty-year carryforward period. All other tax losses have an indefinite carryforward period. </div></div> <div style="font-family: times new roman;font-size: 0pt;margin-top: 12pt;margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Group has limited taxable temporary differences and no tax planning opportunities available that could partly support the recognition of these losses as deferred tax assets. On this basis, the Group has determined that it cannot recognize deferred tax assets on the tax losses carried forward as well as on temporary differences. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Limitation on tax loss carryforwards in the US Inc. is 80.00% starting with losses generated after January&#160;1, 2018. These have an indefinite carryforward period, but no carryback option. Any losses generated prior to January&#160;1, 2018 still can be utilized at 100.00% </div><div style="letter-spacing: 0px; top: 0px;;display:inline;">and are subject to a twenty-year carry forward expiration period. Due to the ARYA Merger described in Note 3, there are certain limitations on tax losses carried forward for net operating losses incurred by Immatics US, Inc., under Section&#160;382 of the U.S. Internal Revenue Code. For Immatics Biotechnologies GmbH, we believe that the ARYA Merger did not lead to a forfeiture of tax losses carried forward in accordance with &#167; 8c KStG. </div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred tax assets have not been recognized in respect of these losses due to the uncertainty of the Group&#8217;s ability to generate taxable profits in the foreseeable future. The current assessment regarding the usability of deferred tax assets may change depending on the income situation of future years and may result in higher deferred tax assets on net tax losses carried forward. </div></div> <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;doctype=Standard&amp;dita_xref=IAS12_g79-88_TI<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237856152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Risk Management Objectives and Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory', window );">Financial Risk Management Objectives and Policies</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">23.</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financial Risk Management Objectives and Policies </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Group&#8217;s principal financial instruments comprise cash, cash equivalents and short-term deposits. The main purpose of these financial instruments is to invest the proceeds of capital contributions and upfront payments from collaboration agreements. The Group has various other financial instruments such as other receivables and trade accounts payable, which arise directly from its operations. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The main risks arising from the Group&#8217;s financial instruments are market risk and liquidity risk. The Board of Management reviews and agrees <div style="letter-spacing: 0px; top: 0px;;display:inline;">on </div>policies for managing these risks as summarized below. The Group also monitors the market price risk arising from all financial instruments. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Interest rate risk </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The exposure of the Group to changes in interest rates relates to investments in deposits and to changes in the interest for overnight deposits. Changes in the general level of interest rates may lead to an increase or decrease in the fair value of these investments. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Regarding the liabilities shown in the Consolidated Statement of Financial Position, the Group is currently not subject to interest rate risks. The Group is subject to a limited risk resulting from negative interest rates on financial instruments, especially on cash and cash equivalents and Other </div></div><div style="display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">financial assets. </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Credit risk </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Group to concentrations of credit and liquidity risk consist primarily of cash and cash equivalents and short-term deposits. The Group&#8217;s cash and cash equivalents are denominated in Euros and US Dollars and maintained with two high-quality financial institutions in Germany and two in the United States. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The maximum default risk is &#8364;232&#160;million and &#8364;119&#160;million as of December&#160;31, 2020 and 2019, respectively. These amounts consist of &#8364;208&#160;million and &#8364;103&#160;million cash and cash equivalents as well as &#8364;24&#160;million and &#8364;16&#160;million Other financial assets as of December&#160;31, 2020 and 2019, respectively. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The cash and cash equivalents are held with banks, which are rated BBB+ to Aa3 <div style="letter-spacing: 0px; top: 0px;;display:inline;">by</div> S&amp;P and Moody`s. Short-term deposits are graded within the investment category from P1 to P2 by the rating agency Moody`s. </div></div> <div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">The Group continually monitors its positions with, and the credit quality of, the financial institutions and corporation, which are counterparts to its financial instruments and does not anticipate <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-performance.</div> The Group monitors the risk of a liquidity shortage. The main factors considered here are the maturities of financial assets as well as expected cash flows from equity measures<div style="font-weight:bold;display:inline;">.</div> </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Currency risk </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Currency risk shows the risk that the value of a financial instrument will fluctuate due to changes in foreign exchange rates. In particular it poses a threat if the value of the currency in which liabilities are priced appreciates relative to the currency of the assets. The business transactions of the Group are generally conducted in Euros and U.S. dollars. The Group aims to match EUR cash inflows with EUR cash outflows and U.S. dollar cash inflows with U.S.&#160;Dollar cash outflows where possible.</div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; line-height: 12pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The objective of currency risk management is to identify, manage and control currency risk exposures within acceptable parameters. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Due to the initial public offering in 2020, the Group has a significant U.S. dollar amount on its statements of financial position. In 2020 the Group recognized significant foreign exchange losses as Immatics N.V.`s and Immatics GmbH&#180;s functional currency is Euro, but both entities hold significant U.S. dollar amounts.</div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash, cash equivalents and financial assets balances denominated in U.S. dollars held by entities with functional currency of EUR are as follows: </div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cash, cash equivalents and financial assets Immatics N.V. </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"><tr style="font-size: 0px;"><td style="width:74%;"></td><td style="vertical-align:bottom;;width:19%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Year&#160;ended&#160;December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Cash and cash equivalents</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">42,528</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial assets</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total assets exposed to the risk</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">42,528</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="margin-bottom: 0px; margin-top: 0px;">&#160;</div> <div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Conversion rate EUR/USD as reporting date 1/1.2271</div></div></div></div> <div style="margin-bottom: 0px; margin-top: 0px;">&#160;</div> <div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Cash, cash equivalents and financial assets Immatics GmbH</div></div></div></div><br/> &#160;</div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"><tr style="font-size: 0px;"><td style="width:74%;"></td><td style="vertical-align:bottom;;width:19%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Year&#160;ended&#160;December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Cash and cash equivalents</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">52,015</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial assets</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">24,448</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total assets exposed to the risk</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">76,463</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Conversion rate EUR/USD as reporting date 1/1.2271 </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Since the Group is primarily exposed to changes in U.S. dollars/euro exchange rates, the sensitivity of profit or loss to changes in the exchange rates, results mainly from U.S. dollar financial instruments. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In 2020, if the euro had weakened/strengthened by 10% against U.S. dollars by considering that all other variables held constant, the Group`s loss would have been &#8364;10.9&#160;million higher/&#8364;13.2&#160;million lower, resulting from foreign exchange on translation of U.S. dollar assets of Immatics N.V. and Immatics GmbH. </div></div>  <div style="font-size: 1px; margin-top: 18px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Sensitivity analysis Immatics N.V.: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"><tr style="font-size: 0px;"><td style="width:71%;"></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Conversion<br/> rate</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); white-space: nowrap;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Profit/(loss)</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Carrying<br/> amount</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="10" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Euro weakens by 1% against U.S. dollars</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.2394</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(421</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">42,107</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Euro strengths by 1% against U.S. dollars</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1.2148</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">430</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">42,958</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Euro weakens by 5% against U.S. dollars</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.2885</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(2,025</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">40,503</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Euro strengths by 5% against U.S. dollars</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1.1657</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2,238</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">44,766</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Euro weakens by 10% against U.S. dollars</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.3498</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(3,866</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">38,662</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Euro strengths by 10% against U.S. dollars</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1.1044</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">4,725</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">47,253</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Sensitivity analysis Immatics GmbH: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"><tr style="font-size: 0px;"><td style="width:71%;"></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Conversion<br/> rate</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); white-space: nowrap;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Profit/(loss)</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Carrying<br/> amount</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="10" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Euro weakens by 1% against U.S. dollars</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.2394</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(757</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">75,706</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Euro strengths by 1% against U.S. dollars</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1.2148</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">772</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">77,235</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Euro weakens by 5% against U.S. dollars</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.2885</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(3,641</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">72,822</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Euro strengths by 5% against U.S. dollars</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1.1657</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">4,024</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">80,487</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Euro weakens by 10% against U.S. dollars</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.3498</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(6,951</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">69,512</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Euro strengths by 10% against U.S. dollars</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1.1044</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">8,496</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">84,959</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Liquidity risk </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Group continuously monitors its risk to a shortage of funds. The Group&#8217;s objective is to maintain a balance between continuity of funding and flexibility through the use of capital raises. All financial liabilities are due within six months. </div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2020, and 2019, the Group held the following funds which are expected to generate cash inflows in time, to counteract liquidity risk. </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:80%;"></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Year&#160;ended&#160;December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Cash and cash equivalents</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">207,530</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">103,353</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Short-term deposits</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">24,448</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,023</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total funds available</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">231,978</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">119,376</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the entity's financial risk management practices and policies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialRiskManagementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237868696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory', window );">Financial Instruments</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">24.</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financial Instruments </div></div></div></td></tr></table> <div style="font-family: times new roman;font-size: 10pt;margin-top: 6pt;margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Set out below are the carrying amounts and fair values of the Group&#8217;s financial instruments that are carried in the consolidated financial statements. </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="width:47%;"></td><td style="vertical-align:bottom;;width:3%;"></td><td style="width:18%;"></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td rowspan="2" style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Euros in thousands</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Carrying amount</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Fair value</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td style="padding-bottom: 1pt;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">IFRS 9</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Financial assets</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Short-term deposits*</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">At fair value through profit or loss (FVTPL)</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">24,448</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,023</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">24,448</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,023</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Positive market value</div></div><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">forward contracts*</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">At fair value through profit or loss (FVTPL)</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">914</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">914</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accounts receivable</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">other&#160;financial&#160;assets&#160;at amortized cost</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,250</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">957</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,250</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">957</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">current/non-current</div> assets</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">other financial assets at amortized cost</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,586</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,710</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,586</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,710</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total financial assets**</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">28,198</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">18,690</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">28,198</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">18,690</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Financial liabilities</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accounts payable</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">other&#160;financial&#160;liabilities at amortized cost</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10,052</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">7,082</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10,052</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">7,082</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Other current liabilities</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">other financial liabilities at amortized cost</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2,025</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,288</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2,025</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,288</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total financial liabilities</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">12,077</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">8,370</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">12,077</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">8,370</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:2%;">*</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Short-term deposits&#8221; are classified within Other financial assets. &#8220;Positive market value forward contract&#8221; are classified in other current assets. &#8220;Negative market value forward contracts&#8221; are classified in other current liabilities. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:2%;">**</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial assets, other than cash and cash equivalents. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The carrying value of financial instruments, such as cash and cash equivalents, deposits, accounts receivable and accounts payable approximate their fair value based on the short-term maturities of these instruments. The fair values of the financial assets and liabilities are included at the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced or liquidation sale. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following methods and assumptions were used to estimate the fair values: All financial assets, except for derivatives, which are categorized Level&#160;2, are categorized Level&#160;1 and therefore are valued using quoted (unadjusted) market prices. Except for derivatives, which are categorized Level&#160;2, all other financial liabilities are also categorized Level&#160;1. </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Section Scope<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;doctype=Standard&amp;dita_xref=IFRS07_g3-5A_TI<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237869256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory', window );">Commitments and contingencies</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">25.</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Commitments and contingencies </div></div></div></td></tr></table>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table summarizes contractual obligations as of December&#160;31, 2020: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="width:66%;"></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="18" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Payments due by period</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">(Euros in thousands)</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-top: 0.75pt solid black; border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Less&#160;than<br/>1&#160;year</div></div></td><td style="border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;</td><td style="border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-top: 0.75pt solid black; border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1&#160;-&#160;3</div></div><br/></div><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">years</div></div><br/></div></td><td style="border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;</td><td style="border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-top: 0.75pt solid black; border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">3&#160;-&#160;5&#160;</div></div><br/></div><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">years</div></div><br/></div></td><td style="border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;</td><td style="border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-top: 0.75pt solid black; border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">More&#160;than<br/> 5 years</div></td><td style="border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;</td><td style="border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-top: 0.75pt solid black; border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Total</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Lease liabilities</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2,103</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">3,453</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,157</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">150</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">6,863</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other lease obligations</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">97</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">185</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">185</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">46</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">513</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">In-license</div> agreements</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">249</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">249</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Contract research organization agreements</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,704</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">220</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,924</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total contractual cash obligation</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">4,153</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">3,858</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,342</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">196</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">9,549</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table summarizes contractual obligations as of December&#160;31, 2019: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="width:67%;"></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="18" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Payments due by period</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">(Euros in thousands)</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="padding-bottom: 0.75pt; border-bottom: 0.75pt solid black; border-top: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Less&#160;than<br/>1&#160;year</div></div></td><td style="padding-bottom: 0.75pt; border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt; border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black; border-top: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1&#160;-&#160;3</div></div><br/></div><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">years</div></div><br/></div></td><td style="border-bottom: 0.75pt solid black; border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt; border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black; border-top: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">3&#160;-&#160;5&#160;</div></div><br/></div><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">years</div></div><br/></div></td><td style="padding-bottom: 0.75pt; border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt; border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="padding-bottom: 0.75pt; border-bottom: 0.75pt solid black; border-top: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">More&#160;than&#160;</div><br/></div><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">5<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div>years</div><br/></div></td><td style="padding-bottom: 0.75pt; border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt; border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="padding-bottom: 0.75pt; border-bottom: 0.75pt solid black; border-top: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Total</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Lease liabilities</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,482</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,823</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">47</td><td style="white-space: nowrap; font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">3,352</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other lease obligations</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">172</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">324</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">300</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">300</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,096</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">In-license</div> agreements</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">455</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">200</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">655</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Contract research organization agreements</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,131</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,466</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2,597</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total contractual cash obligation</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">3,240</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">3,813</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">347</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">300</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">7,700</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2020, and 2019 the Group is potentially liable to pay &#8364;1.6&#160;million to a third-party upon successful completing the milestone of the first clinical lead selection in connection with Immatics&#8217; collaboration agreements. The Group does not recognize a liability for these contingent payments due to the scientific uncertainty of achieving the related milestones. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of commitments and contingent liabilities. [Refer: Contingent liabilities [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169240189880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related party disclosures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfRelatedPartyExplanatory', window );">Related party disclosures</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">26.</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Related party disclosures </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Key management personnel have been defined as the members of the Executive Committee of Immatics N.V.</div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Compensation of key management personnel: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 100%;;margin : 0px auto;;text-align:left;"><tr style="font-size: 0px;"><td style="width: 78%;"></td><td style="width: 2%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 2%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 2%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2018</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="10" style="text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 78%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Fixed</div></div></td><td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2,660</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,202</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,088</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 78%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Variable</div></div></td><td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">886</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">521</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">433</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 78%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Share-based compensation expense</div></div></td><td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">13,841</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">697</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">119</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 78%;;vertical-align:bottom;">&#160;</td><td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 78%;;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total key management compensation</div></div></div></td><td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">17,387</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,420</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,640</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 78%;;vertical-align:bottom;">&#160;</td><td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fixed and variable key management compensation represent short-term employee benefits. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2020, and 2019, amounts of &#8364;0.0&#160;million and &#8364;0.7&#160;million were accrued for key management compensation. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The members of the Supervisory Board of the Group received a fixed fee as well as reimbursed travel expenses. </div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total compensation for the Supervisory Board amounted to &#8364;2.7&#160;million in 2020: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="width:53%;"></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Peter<br/> Chambr&#233;</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Harald&#160;F.<br/> Stock</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Michael<br/> G.&#160;Atieh</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Paul<br/> Carter</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Heather<br/> L.&#160;Mason</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Adam<br/> Stone</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Christoph<br/> Hettich</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Eliot<br/> Forster</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Total</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Supervisory board compensation</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">140</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">16</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">28</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">26</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">20</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">20</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">20</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">12</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">282</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Travel expenses</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">4</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">4</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Payment Exit arrangement</div></div></td><td style="vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">2,394</div></div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="white-space: nowrap; text-align: right;">&#8212;</td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="white-space: nowrap; text-align: right;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#8212;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="white-space: nowrap; text-align: right;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#8212;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="white-space: nowrap; text-align: right;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#8212;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="white-space: nowrap; text-align: right;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#8212;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="white-space: nowrap; text-align: right;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#8212;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="white-space: nowrap; text-align: right;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#8212;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="vertical-align:bottom;"><div style="line-height: normal; text-align: right;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td><div style="line-height: normal; text-align: right;"><div style="font-weight:bold;display:inline;width:100%;">&#160;<div style="letter-spacing: 0px; top: 0px;;display:inline;">2,394</div></div></div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="line-height: normal; text-align: right;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Share-based compensation expense</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,046 </td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">70</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">70</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">70</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">70</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">70</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">40</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,436</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">Total cash compensation</div></div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">3,584</div></td><td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">16</div></td><td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">98</div></td><td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">96</div></td><td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">90</div></td><td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">90</div></td><td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">90</div></td><td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">52</div></td><td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">4,116</div></td><td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div>   <div style="clear: both; max-height: 0px;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Harald F. Stock and Peter Chambr&#233; were members of the Supervisory Board of Immatics in 2019 and in 2018. They received a fixed fee as Supervisory Board members and reimbursement for travel expenses. </div></div> <div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total compensation for the Supervisory Board amounted to &#8364;0.4&#160;million in 2019: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"><tr style="font-size: 0px;"><td style="width:77%;"></td><td style="vertical-align:bottom;;width:5%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:5%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:5%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Peter<br/> Chambr&#233;</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Harald<br/> F.&#160;Stock</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Total</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Supervisory board fee</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">300</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">9</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">309</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Travel expenses</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">87</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">20</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">107</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">387</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">29</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">416</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total compensation for the Supervisory Board amounted to &#8364;0.5&#160;million in 2018: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"><tr style="font-size: 0px;"><td style="width:77%;"></td><td style="vertical-align:bottom;;width:5%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:5%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:5%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Peter<br/> Chambr&#233;</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Harald<br/> F.&#160;Stock</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Total</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Supervisory board fee</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">400</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">410</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Travel expenses</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">52</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">16</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">68</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">452</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">26</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">478</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div>   <div style="clear: both; max-height: 0px;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Prior to the ARYA Merger, Immatics N.V. established the 2020 Incentive Plan. Immatics N.V. granted certain service-based options out of the 2020 Incentive Plan to its management and directors and in addition, performance-based options to its management upon closing of the ARYA Merger. The service-based options will vest based upon satisfaction of a four-year time-based vesting schedule, which provides for 25% vesting on the first anniversary of the vesting commencement date and quarterly vesting thereafter. The performance-based options will vest based both on achievement of certain market capitalization milestones and satisfaction of a four-year time-based vesting schedule, which provides for 25% vesting on the first anniversary of the vesting commencement date and quarterly vesting thereafter. The following options were granted to Immatics&#8217; Managing Director&#160;and Supervisory Directors: </div></div>  <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="font-family: &quot;times new roman&quot;;;width:35%;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:1%;"></td><td style="font-family: &quot;times new roman&quot;;;width:20%;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:1%;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:1%;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:1%;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:1%;"></td><td style="font-family: &quot;times new roman&quot;;;width:15%;"></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Type of options</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Grant date</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Number of<br/> Options</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Strike<br/> Price&#160;in<br/> USD</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Expiration date</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Managing Director</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Harpreet Singh</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="text-align:right;;vertical-align:top;">Performance-based&#160;options</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:top;">&#160;</td><td style="text-align:right;;vertical-align:top;">June&#160;30, 2020</td><td style="white-space: nowrap;;vertical-align:top;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">1,598,000</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">10</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="text-align:right;;vertical-align:top;">June&#160;30, 2030</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Harpreet Singh</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">Service options</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:top;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">June&#160;30, 2020</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:top;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">168,000</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">June&#160;30, 2030</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Harpreet Singh</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="text-align:right;;vertical-align:top;">Matching Stock options</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:top;">&#160;</td><td style="text-align:right;;vertical-align:top;">June&#160;30, 2020</td><td style="white-space: nowrap;;vertical-align:top;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">264,624</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">10</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="text-align:right;;vertical-align:top;">June&#160;30, 2030</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Harpreet Singh</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">Converted options</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:top;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">June&#160;30, 2020</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:top;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">30,939</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.06</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">July&#160;1, 2027</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Harpreet Singh</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="text-align:right;;vertical-align:top;">Converted options</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:top;">&#160;</td><td style="text-align:right;;vertical-align:top;">June&#160;30, 2020</td><td style="white-space: nowrap;;vertical-align:top;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">145,371</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">1.17</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="text-align:right;;vertical-align:top;">January&#160;1, 2028</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Harpreet Singh</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">Service options</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">December&#160;17,&#160;2020</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">168,000</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">9.70</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">December&#160;17,&#160;2030</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Supervisory Directors</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Peter Chambr&#233;</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">Service options</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:top;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">June&#160;30, 2020</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:top;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">25,000</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">June&#160;30, 2030</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Peter Chambr&#233;</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="text-align:right;;vertical-align:top;">Matching Stock options</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:top;">&#160;</td><td style="text-align:right;;vertical-align:top;">June&#160;30, 2020</td><td style="white-space: nowrap;;vertical-align:top;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">211,974</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">10</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="text-align:right;;vertical-align:top;">June&#160;30, 2030</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Adam Stone</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">Service options</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:top;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">June&#160;30, 2020</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:top;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">25,000</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">June&#160;30, 2030</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Christoph Hettich</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="text-align:right;;vertical-align:top;">Service options</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:top;">&#160;</td><td style="text-align:right;;vertical-align:top;">June&#160;30, 2020</td><td style="white-space: nowrap;;vertical-align:top;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">25,000</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">10</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="text-align:right;;vertical-align:top;">June&#160;30, 2030</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Heather L. Mason</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">Service options</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:top;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">June&#160;30, 2020</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:top;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">25,000</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">June&#160;30, 2030</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Michael G. Atieh</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="text-align:right;;vertical-align:top;">Service options</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:top;">&#160;</td><td style="text-align:right;;vertical-align:top;">June&#160;30, 2020</td><td style="white-space: nowrap;;vertical-align:top;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">25,000</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">10</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="text-align:right;;vertical-align:top;">June&#160;30, 2030</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Paul Carter</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">Service options</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:top;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">June&#160;30, 2020</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:top;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">25,000</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">June&#160;30, 2030</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Eliot Forster</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="text-align:right;;vertical-align:top;">Service options</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:top;">&#160;</td><td style="text-align:right;;vertical-align:top;">September&#160;14,&#160;2020</td><td style="white-space: nowrap;;vertical-align:top;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">25,000</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">9.16</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="text-align:right;;vertical-align:top;">September&#160;13,&#160;2030</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">An additional aggregate of 1,680,000 performance-based options and 539,000 </div><div style="letter-spacing: 0px; top: 0px;;display:inline;">service options to purchase ordinary shares, were granted to other Immatics&#8217; key management personnel, who are members of the Executive Committee but not Directors. Certain key management personnel were also participants in the share-based compensation plans of Immatics </div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">GmbH (2010 Plan and 2016 Plan). </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As part of the replacement awards issued in connection with the ARYA Merger (See Note 18), <div style="letter-spacing: 0px; top: 0px;;display:inline;">these</div> key management personnel received cash payments before taxes of &#8364;3.4&#160;million, 417,415 converted options in Immatics N.V. and 750,076 matching stock options in Immatics N.V. The cash payments mainly covered wage tax obligations of the employees. </div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; line-height: 12pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Group did not enter into transactions with related entities in 2020, 2019 and 2018 other than the mentioned compensation contracts. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRelatedPartyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2020-01-01<br> -Section Disclosures<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2020-en-r&amp;doctype=Standard&amp;dita_xref=IAS24_g13-24_TI<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRelatedPartyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237430280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net loss per share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory', window );">Net loss per share</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">27.</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net loss per share </div></div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic net loss per share is computed by dividing net loss by the weighted average number of common shares outstanding during the period, excluding common stock equivalents, adjusted for the effect of the corporate reorganization as discussed in Note 3 and applied retrospectively to all prior periods presented. The diluted net loss per share reflects the basic net loss per share, since the effects of potentially dilutive securities are antidilutive given the net loss for each period presented. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">For the periods included in these financial statements the Group was loss-making in all periods, therefore, anti-dilutive instruments are excluded in the calculation of diluted weighted average number of ordinary shares outstanding, including the outstanding equity awards during the periods and </div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the 7,187,500 </div><div style="letter-spacing: 0px; top: 0px;;display:inline;">Immatics Warrants issued in 2020 and outstanding as of December&#160;31, 2020. These warrants and options could potentially dilute basic earnings per share in the future. See Note 18 for details of outstanding share options. </div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2020-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2020-en-r&amp;doctype=Standard&amp;dita_xref=IAS33_g70-73A_TI<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169238303208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Events occurring after the reporting period<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory', window );">Events occurring after the reporting period</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">28.</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Events occurring after the reporting period </div></div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company evaluated subsequent events for recognition or disclosure through March&#160;30, 2021 and did not identify material subsequent events.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for events after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 10<br> -IssueDate 2020-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=10&amp;code=ifrs-tx-2020-en-r&amp;doctype=Standard&amp;dita_xref=IAS10_g17-22_TI<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169238116728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of accounting policies applied by the Group for the annual reporting period ending December 31, 2020 (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock', window );">Going concern</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">2.1</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Going concern </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Since inception, the Group&#8217;s activities have consisted primarily of raising capital and performing research and development activities to advance its technologies. The Group is still in the development phase and has not yet marketed any products commercially. Immatics&#8217; ongoing success depends on the successful development and regulatory approval of its products and its ability to finance operations. The Group will seek additional funding to reach its development and commercialization objectives. </div></div></div> <div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Group plans to seek funds through further private or public equity financings, debt financings, collaboration agreements and marketing, distribution or licensing arrangements. The Group may not be able to obtain financing or enter into collaboration or other arrangements on acceptable terms. If the Group is unable to obtain funding, it could be forced to delay, reduce or eliminate some or all of its research and development programs, product portfolio expansion or commercialization efforts, which could adversely affect its business prospects. However, Immatics&#8217; cash and cash equivalents as well as short-term deposits will be sufficient to fund operating expenses and capital expenditure requirements for at least twelve months from the issuance date and expect a cash reach for at least twelve months. </div></div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying consolidated financial statements have been prepared on a going concern basis. This contemplates the Group will continue in operation for the foreseeable future and will be able to realize its assets and discharge its liabilities in the normal course of operations. The consolidated financial statements do not reflect any adjustments relating to the recoverability and classification of assets or the amounts and classification of liabilities that would be necessary, was the Group unable to continue as a going concern. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForCashFlowsExplanatory', window );">Correction of classification of Statement of Cash Flows</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">2.2</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Correction of classification of Statement of Cash Flows </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">During the third quarter of 2020, the Group identified and corrected the classification of short-term deposits with an original maturity dates between three and nine months within the Statement of Cash Flows which resulted in a misclassification within the Statement of Cash Flows since 2018. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has evaluated the effect of this misclassification, both qualitatively and quantitatively, and concluded that the correction did not have a material impact on, nor require amendment of, any previously filed financial statements. In the Statement of Cash Flows, the changes in short-term deposits were previously classified as (Increase) decrease in other assets within operating activities and has been retrospectively corrected and presented as separate line items within investing activities. </div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">This correction of classification resulted in the following impact to the Statement of Cash Flows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="width: 60%;"></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31, 2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31, 2018</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">As<br/>reported</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Adjustment</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">As<br/>revised</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">As<br/>reported</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Adjustment</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">As<br/>revised</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">(Increase) decrease in other assets</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(4,419</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2,922</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(1,497</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(7,493</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">13,101</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">5,608</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net cash provided by operating activities</div></div></div></td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">68,045</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2,922</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">70,967</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">7,583</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">13,101</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">20,684</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Cash paid for investments classified in Other financial assets</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(20,473</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(20,473</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(13,101</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(13,101</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash received from maturity of investments classified in Other financial assets</div></div></td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">17,551</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">17,551</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Net cash used in investing activities</div></div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(2,137</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(2,922</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(5,059</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(413</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(13,101</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(13,514</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 60%;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Total effect on Cash Flow</div></td><td style="vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-size: 1px;"><td style="width: 60%;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="width: 58%;"></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Three&#160;months&#160;ended&#160;March&#160;31,&#160;2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Six months ended June&#160;30, 2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">As<br/>reported</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Adjustment</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">As<br/>revised</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">As<br/>reported</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Adjustment</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">As<br/>revised</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 58%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">(Increase) decrease in other assets</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(17,209</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">16,836</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(373</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">14,917</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(16,023</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(1,106</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 58%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net cash provided by/ (used in) operating activities</div></div></div></td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(28,286</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,836</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(11,450</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(11,716</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(16,023</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(27,739</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 58%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Cash paid for investments classified in Other financial assets</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(32,859</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(32,859</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(32,859</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(32,859</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 58%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash received from maturity of investments classified in Other financial assets</div></div></td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,023</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,023</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">48,882</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">48,882</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 58%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Net cash provided by/ (used in) investing activities</div></div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(2,387</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(16,836</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(19,223</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(4,550</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">16,023</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">11,473</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 58%;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Total effect on Cash Flow</div></td><td style="vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-size: 1px;"><td style="width: 58%;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">There is no impact on the Group&#8217;s Consolidated Statement of Financial Position, Consolidated Statement of Changes in Shareholders&#8217; Deficit, Consolidated Statement of Loss, Net loss per share, Consolidated Statement of Comprehensive Loss, and no impact to financing cash flows for the any of the periods presented. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DescriptionOfAccountingPolicyForCovidNineteenPolicyTextBlock', window );">Covid-19</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">2.3</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In December 2019, a novel strain of coronavirus <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(&#8220;COVID-19&#8221;)</div> emerged. On January&#160;30, 2020, the World Health Organization declared the outbreak a pandemic and a global emergency. In response, many countries and businesses instituted travel restrictions, quarantines, and office closures that are still in place. The extent of the pandemic and governmental responses may impact our ability to obtain raw materials and equipment used for research and development, obtain sufficient additional funds to finance our operations, and conduct clinical trials, any of which could materially and adversely affect our business. </div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;">Management continues to monitor the situation and enacted significant measures to protect the Group&#8217;s supply chain, employees, and the execution of clinical trials. To date, the pandemic has resulted in a slowdown in activities related to the Group&#8217;s laboratory operations and at some of its suppliers. The ongoing spread of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> may also negatively impact the Group&#8217;s ability to conduct clinical trials, including potential delays and restrictions on the Group&#8217;s ability to recruit and retain patients, principal investigators and healthcare employees. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> could also affect the operations of contract research organizations, which may also result in delays or disruptions in the supply of product candidates. Immatics continues to expand its clinical programs with additional clinical trial sites opening in the U.S. and in Europe. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Due to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19,</div> the Group has also experienced delays in research activities performed under its collaboration agreements. Consequently, the Group recognized less revenue under these agreements in 2020 than previously planned. Management believes the declines in revenue associated with the delay in research activities are largely temporary, as the revenue is primarily associated with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-refundable</div> upfront payments recognized on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">cost-to-cost</div></div> basis. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> may continue to impact the timing and amount of revenue recognized under these agreements in the future. </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory', window );">Segment information</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.1</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Segment information </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Group manages its operations as a single segment for the purposes of assessing performance and making operating decisions. The Group&#8217;s focus is on the research and development of T cell redirecting immunotherapies for the treatment of cancer. The Chief Executive Officer is the chief operating decision maker who regularly reviews the consolidated operating results and makes decisions about the allocation of the Group&#8217;s resources. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory', window );">Cash and cash equivalents</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.2</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cash and cash equivalents </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash and cash equivalents in the Consolidated Statement of Financial Position <div style="letter-spacing: 0px; top: 0px;;display:inline;">is comprised</div> of cash held at banks (including money market funds) and short-term deposits with an original maturity of three months or less. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory', window );">Financial assets</a></td>
<td class="text"><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.3</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financial assets </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Initial recognition and measurement </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial assets within the scope of IFRS 9 include cash and cash equivalents, loans, short-term deposits and receivables. Immatics determines the classification of its financial assets at initial recognition. All financial assets are recognized initially at fair value plus transaction costs. Purchases and sales of financial assets are recognized on their trade date, on which the Group commits to purchase or sell the asset. The subsequent measurement of financial assets depends on their classification as described below. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Short-term deposits </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Immatics has short-term deposits with original maturities between three and nine months, which are classified as Other financial assets. Short-term deposits with an original maturity of three months or less are classified as cash and cash equivalents. Under IFRS 9 short-term deposits are classified within financial assets at fair value. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Receivables </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Group has receivables from collaboration agreements. A receivable must be capitalized at the point in time at which the Group has become a contractual partner and a claim to cash and cash equivalents has arisen. In subsequent reporting periods, a receivable is measured at amortized cost using the effective interest method. Since the receivables are short-term receivables without a fixed interest rate, these receivables are capitalized at the original invoice or contract amount. Receivable balances are classified as current assets, because all of the Group&#8217;s receivables have an expected maturity of less than 12 months. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Interest and other finance income </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments include money market funds and short-term deposits measured at fair value. Interest income is recorded using the effective interest rate (EIR). EIR is the rate that discounts the estimated future cash payments or receipts over the expected life of the financial instrument or a shorter period, where appropriate, to the net carrying amount of the financial asset or liability. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2020, Immatics is a counterparty in foreign exchange forward contracts. The contracts do not meet the criteria to apply hedge accounting and are therefore separately accounted for and measured at fair value. Any change in the fair value is accounted for within the Consolidated Statement of Loss. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><br/></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory', window );">Property, plant and equipment</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.4</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Property, plant and equipment </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property, plant and equipment is stated at cost, net of accumulated depreciation and accumulated impairment losses, if any. All repair and maintenance costs are recognized as expense when incurred. Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets. The estimated useful lives are generally within the following ranges: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>  <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"><tr style="font-size: 0px;"><td style="font-family: &quot;times new roman&quot;; width: 79%;"></td><td style="font-family: &quot;times new roman&quot;; width: 8%;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;"></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="white-space: nowrap; padding-bottom: 1pt; width: 79%;;vertical-align:bottom;"><div style="font-family: &quot;times new roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Category</div></div></div></td><td style="padding-bottom: 1pt; width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Estimated&#160;useful&#160;life</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 79%;;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Computer equipment</div></div></td><td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:center;;vertical-align:bottom;">1&#160;&#8211;&#160;10&#160;years</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgba(255, 255, 255, 0); width: 79%;;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Laboratory equipment</div></div></td><td style="background-color: rgba(255, 255, 255, 0); width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;text-align:center;;vertical-align:bottom;">1 &#8211;&#160;15&#160;years</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 79%;;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Office equipment</div></div></td><td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:center;;vertical-align:bottom;">2 &#8211;&#160;20&#160;years</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory', window );">Intangible assets</a></td>
<td class="text"><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.5</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Intangible assets </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Acquired intangible assets are initially recognized at cost. Following initial recognition, intangible assets are carried at cost less accumulated amortization and accumulated impairment losses, if any. Intangible assets with finite lives are amortized over their useful economic lives and assessed for impairment, whenever there is an indication that the intangible asset may be impaired. The amortization period and the amortization method for an intangible asset with a finite useful life, is reviewed at least at the end of each reporting period. Immatics does not have any internally developed intangible assets or intangible assets with indefinite useful lives. </div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amortization is calculated on a straight-line basis over the estimated useful lives of the assets as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"><tr style="font-size: 0px;"><td style="font-family: &quot;times new roman&quot;;;width:79%;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:8%;"></td><td style="font-family: &quot;times new roman&quot;;"></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="white-space: nowrap; padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-family: &quot;times new roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Category</div></div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Estimated&#160;useful&#160;life</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Licenses</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:center;;vertical-align:bottom;">5&#160;&#8211;&#160;30&#160;years</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Software</div></div></td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;text-align:center;;vertical-align:bottom;">1 &#8211; 5&#160;years</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory', window );">Research and development</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.6</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Research and development </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Research expenses are defined as costs incurred for current or planned investigations undertaken with the prospect of gaining new scientific or technical knowledge and understanding. All Research costs are expensed as incurred. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">An intangible asset arising from development expenditure on an individual project is recognized only when the Group can demonstrate the technical feasibility of completing the intangible asset so that it will be available for use or sale, its intention to complete and its ability to use or sell the asset, how the asset will generate future economic benefits, the availability of resources to complete and the ability to measure reliably the expenditure during the development. The Group did not recognize any intangible assets from development expenditures in 2020, 2019 and 2018 due to the existing uncertainties in connection with its development activities. Research and development expenses include the following types of costs: </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">1.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">salaries, benefits and other related costs, including stock-based compensation, for personnel engaged in research and development functions; </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">2.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">expenses incurred in connection with the preclinical development of our programs and clinical trials of our product candidates, including under agreements with third parties, such as consultants, contractors, academic institutions and contract research organizations; </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">3.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the cost of manufacturing product candidates for use in clinical trials, including under agreements with third parties, such as, consultants and contractors; </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">4.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">laboratory costs; </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">5.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">leased facility costs, equipment depreciation and other expenses, which include direct and allocated expenses; and </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">6.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">intellectual property costs incurred in connection with filing and prosecuting patent applications as well as third-party license fees. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory', window );">Financial liabilities: Initial recognition and measurement</a></td>
<td class="text"><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.7</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financial liabilities: Initial recognition and measurement </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial liabilities within the scope of IFRS 9 are classified as financial liabilities at fair value through profit or loss or at amortized cost, as appropriate. The Group determines the classification of its financial liabilities at initial recognition. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">All financial liabilities are recognized initially at fair value and, in the case of loans and borrowings, carried at amortized cost. This includes directly attributable transaction costs. Immatics only recognized accounts payable as other financial liabilities at amortized costs. The Group has not designated any financial liabilities upon initial recognition as fair value through profit or loss. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Group does not engage in hedging transactions that meet the criteria to apply hedge accounting. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory', window );">Leases</a></td>
<td class="text"><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.8</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Leases </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Application of IAS 17 (&#8220;Leases&#8221;) until December&#160;31, 2018 </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Prior to 2019, the Group applied IAS 17 when accounting for leases. As a lessee under IAS 17, leases for which substantially all the risks and rewards of ownership transferred to the Group were classified as finance leases. Finance leases were capitalized at the lease&#8217;s inception at the fair value of the leased property or, if lower, the present value of the minimum lease payments. The corresponding rental obligations, net of finance charges, were included in other current liabilities and other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> liabilities. Each lease payment was allocated between the liability and finance cost. The finance cost was charged as an expense over the lease period so as to produce a constant periodic rate of interest on the remaining balance of the liability for each period. The assets associated with the finance leases are depreciated over the shorter of the asset&#8217;s useful life or the lease term if there is no reasonable certainty that the Group will obtain ownership at the end of the lease term. Leases in which a significant portion of the risks and rewards of ownership were not transferred to the Group as lessee were classified as operating leases. Payments made under operating leases (net of any incentives received from the lessor) were charged as an expense on a straight-line basis over the period of the lease. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Application of IFRS 16 (&#8220;Leases&#8221;) effective January&#160;1, 2019 </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Group adopted IFRS 16 (&#8220;Leases&#8221;) effective January&#160;1, 2019. The Group leases various offices, equipment and vehicles. Rental contracts are typically made for fixed periods of two to seven years but may have extension options as described in below. Contracts may contain both lease and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-lease</div> components. The Group has elected not to separate lease and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-lease</div> components and instead accounts for these as a single lease component. Lease terms are negotiated on an individual basis. The lease agreements do not impose any covenants other than the security interests in the leased assets that are held by the lessor. Leased assets may not be used as security for borrowing purposes. Under IFRS 16, leases are recognized as a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> asset with a corresponding liability on the date at which the leased asset is available for use by the Group. </div> <div style="font-family: times new roman;font-size: 10pt;margin-top: 0pt;margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets and liabilities arising from a lease are initially measured on a present value basis. Lease liabilities include the net present value of the following lease payments: </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">1.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;">fixed payments (including <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">in-substance</div> fixed payments), less any lease incentives received. </div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">2.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">amounts expected to be payable by the Group under residual value guarantees. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">3.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the exercise price of a purchase option if the Group is reasonably certain to exercise that option; and </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">4.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">payments of penalties for terminating the lease, if the lease term reflects the Group exercising that option. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Lease payments to be made under reasonably certain extension options are also included in the measurement of the liability. The lease payments are discounted using the interest rate implicit in the lease. If that rate cannot be readily determined, which is generally the case for the Group&#8217;s leases, the lessee&#8217;s incremental borrowing rate is used. The incremental borrowing rate is the rate that the individual lessee would have to pay to borrow the funds, necessary to obtain an asset of similar value to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> asset in a similar economic environment with similar terms, security and conditions. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">To determine the incremental borrowing rate, the Group: </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">1.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;">uses a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">build-up</div> approach that starts with a risk-free interest rate adjusted for credit risk for leases held by Immatics, and </div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">2.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">makes adjustments specific to the lease, including lease term, country, currency and security </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Right-of-use</div></div> assets are measured at cost comprising the following: </div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">1.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the amount of the initial measurement of lease liability </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">2.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">any lease payments made at or before the commencement date less any lease incentives received </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">3.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">any initial direct costs, and </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">4.</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">restoration costs. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Right-of-use</div></div> assets are generally depreciated over the shorter of the asset&#8217;s useful life or the lease term on a straight-line basis. If the Group is reasonably certain to exercise a purchase option, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> asset is depreciated over the underlying asset&#8217;s useful life. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Payments associated with short-term leases of equipment and vehicles and all leases of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">low-value</div> assets are recognized on a straight-line basis as an expense. Short-term leases are leases with a lease term of 12 months or less. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Low-value</div> assets have a value of less than &#8364;5&#160;thousand. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Extension and termination options are included in a number of property and equipment leases across the Group. These are used to maximize operational flexibility in terms of managing the assets used in the Group&#8217;s operations. The extension and termination options held are exercisable only by the Group and not by the respective lessor. For relevant leases which include an extension option, Immatics performed an assessment as of December&#160;31, 2020 to determine whether option extensions are reasonably certain. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue', window );">Revenue from collaboration agreements</a></td>
<td class="text"><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.9</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Revenue from collaboration agreements </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Group earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. As of December&#160;31, 2020, the Group had four strategic collaboration agreements in place with Amgen Inc., Thousand Oaks/CA/USA (&#8220;Amgen&#8221;), Genmab A/S, Copenhagen/Denmark (&#8220;Genmab&#8221;), Celgene Switzerland LLC (&#8220;BMS&#8221;) and GlaxoSmithKline Intellectual Property Development Limited (&#8220;GSK&#8221;). Each of the Group&#8217;s four strategic collaboration agreements are in the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-clinical</div> stage. </div> <div style="font-family: times new roman;font-size: 10pt;margin-top: 0pt;margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">To determine the recognition of revenue from arrangements that fall within the scope of IFRS 15, the Group performs the following five steps: </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;">(i)</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">identify the contract(s) with a customer; </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;">(ii)</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">identify the performance obligations in the contract; </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;">(iii)</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">determine the transaction price; </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;">(iv)</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">allocate the transaction price to the performance obligations in the contract; and </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;">(v)</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">recognize revenue when (or as) the Group satisfies a performance obligation. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Under the terms of these agreements, Immatics agrees to collaborate in the development, manufacture, and commercialization of cancer immunotherapy treatments for specified targets identified through the use of Immatics XPRESIDENT technology. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">As part of the collaboration arrangements, Immatics grants exclusive licensing rights for the development and commercialization of future product candidates, developed for targets defined in the collaboration agreements. Additionally, Immatics agrees to perform certain research activities under the collaboration agreements, including screening of highly specific molecules for reactivity with the specified targets and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">off-targets</div> using Immatics&#8217; proprietary technology and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">know-how,</div> participation on steering committees, and preparation of data packages. The research activities are the predominant item in each of the Group&#8217;s collaboration agreements. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Group performs an analysis to identify the performance obligations under the contract, including licenses and rights to future intellectual property developed under the contract and research activities. As these agreements comprise several promises, it must be assessed whether these promises are capable of being distinct and distinct within the context of the contract. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Up-front</div> licensing payments and reimbursement for research and development expenses are initially deferred on our Consolidated Statement of Financial Position and subsequently recognized as costs are incurred using a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">cost-to-cost</div></div> method. Milestone payments are generally included in the transaction price at the amount stipulated in the respective agreement and recognized to the extent that it is highly probable that a&#160;significant reversal&#160;in the amount of cumulative revenue recognized will not occur. To date, no milestone has been included in the transaction price. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">As stated above, the licenses contributed under the collaboration agreements currently in place&#160;do not represent distinct performance obligations, because the Group&#8217;s collaboration partners would likely be unable to derive significant benefits from their access to these targets without Immatics&#8217; research activities. Identification of a viable product candidate that will bind to the targets specified in the agreements requires use of the Group&#8217;s XPRESIDENT technology and database of target and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">off-target</div> data. These agreements include a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-refundable</div> upfront payment, payments for research and development activities in certain circumstances, and payments based upon the achievement of defined milestones. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Under IFRS 15, the Group applies significant judgement when evaluating whether the obligations under these agreements represent one or more combined performance obligations, the allocation of the transaction price to identified performance obligations, and the determination of whether milestone payments should be included in the transaction price. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Upfront payment </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Each of the Group&#8217;s strategic collaboration agreements included a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-refundable</div> upfront payment, meant to subsidize research activities. The Group recorded these payments as deferred revenue, which it allocated to the combined performance obligations for each agreement. Such amounts are recognized as revenue over the performance period of the research activities on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">cost-to-cost</div></div> basis. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">cost-to-cost</div></div> basis using direct costs and directly attributable personal costs was considered the best measure of progress in which control of the combined performance obligations transfers to the Group&#8217;s collaboration partners, due to the nature of the work being performed. </div> <div style="font-size: 1px; margin-top: 18px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Reimbursement for services</div> Under the collaboration agreement with Genmab, the Group receives reimbursement for employee research and development costs. These employee costs are presented as research and development expenses, while reimbursements of those costs, which is based on an FTE rate defined in the contract, are presented as revenue and not deducted from expenses. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Development and Commercial Milestones </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The collaboration agreements include contingent payments related to development and commercial milestone events. These milestone payments represent variable consideration that are not initially recognized within the transaction price, due to the scientific uncertainties and the required commitment from the collaboration partners to develop and commercialize a product candidate. The Group assesses the probability of significant reversals for any amounts that become likely to be realized prior to recognizing the variable consideration, associated with these payments within the transaction price. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Sales-based milestones and royalty payments </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The collaboration agreements also include sales-based royalty payments upon successful commercialization of a licensed product. In accordance with IFRS 15.B63, the Group recognizes revenue from sales-based milestone and royalty payments at the later of (i)&#160;the occurrence of the subsequent sale; or (ii)&#160;the performance obligation to which some or all of the sales-based milestone, or royalty payments has been allocated has been satisfied. The Group anticipates recognizing these milestones and royalty payments, when subsequent sales are generated from a licensed product by the collaboration partner. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Cost to fulfill contracts </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Group incurs costs for personnel, supplies and other costs related to its laboratory operations as well as fees from third parties and license expenses in connection with its research and development obligations under the collaboration and licensing agreement. These costs are recognized as research and development expenses over the period in which services are performed. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Cost to obtain a contract </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For some collaboration agreements, the Group incurs incremental costs of obtaining a contract with a customer. The Group capitalizes those incremental costs if the costs are expected to be recovered. The recognized asset is amortized consistent with the method used to determine the pattern of revenue recognition of the underlying contract. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory', window );">Share-based payment</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.10</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Share-based payment </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Group&#8217;s Employees as well as others providing similar services to the Group, receive remuneration in the form of share-based payments, which are equity-settled transactions. The Group`s equity-settled option plans include Matching Stock Options, Converted Stock Options, Service Options and PSUs and are described in detail in Note 18. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The costs of equity-settled transactions are determined by the fair value at grant date, using an appropriate valuation model. Share-based expenses for the respective vesting periods, are recognized in research and development expenses and general and administrative expenses, reflecting a corresponding increase in equity. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DescriptionOfAccountingPolicyForOtherIncomePolicyTextBlock', window );">Other income</a></td>
<td class="text"><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.11</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Other income </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Group primarily earns other income from government research grants. Government grants are recognized as income when there is reasonable assurance that the grant will be received and all required conditions have been complied with. Grants from governmental agencies for the support of specific research and development projects are recorded as other income to the extent the related expenses have been incurred. Grant agreements include a budget that specifies the amount and nature of expenses allowed during the entire grant term. </div></div> <div style="font-family: times new roman;font-size: 10pt;margin-top: 0pt;margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expenses incurred under the grants are calculated according to agreed-upon terms on a quarterly basis, filed with the governmental agencies, and recorded as income. The governmental agencies make payments to the Group based on these calculations of expenses incurred under the grants. If these estimated calculations change, the Group will then adjust grant income in the subsequent period. The Group believes that its calculations are based on the agreed-upon terms as stated in the grant agreements. The governmental agencies generally have the right to audit the Group&#8217;s calculations. If the governmental agencies disagree with the Group&#8217;s calculations the amount of grant income recognized could change. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory', window );">Foreign currency</a></td>
<td class="text"><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.12</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Foreign currency </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transactions and balances in Germany and in the USA </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The consolidated financial statements are presented in Euro, which is the parents&#8217;, Immatics N.V. functional and presentation currency. Assets and liabilities of foreign operations are translated into Euros at the rate of exchange prevailing at the reporting. The Consolidated Statement of Loss is translated at average exchange rates. The currency translation differences are recognized in other comprehensive loss. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transactions in foreign currencies are initially recorded by the Group&#8217;s entities at their respective functional currency spot rates, at the date the transaction first qualifies for recognition. The Group used the following exchange rates to convert the financial statements of its U.S. subsidiary: </div></div>  <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="width:64%;"></td><td style="vertical-align:bottom;;width:1%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:1%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:1%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:1%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:1%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:1%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2018</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;&#160;</div></td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Year-end</div><br/> rate</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;&#160;</div></td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">Average<br/> rate</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;&#160;</div></td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Year-end</div><br/> rate</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;&#160;</div></td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">Average<br/> rate</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;&#160;</div></td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Year-end</div><br/> rate</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;&#160;</div></td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">Average<br/> rate</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Euros per U.S.&#160;Dollar</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.8149</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.8762</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.8902</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.8932</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.8738</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.8468</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory', window );">Fair value of financial instruments</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.13</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value of financial instruments </div></div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either: </div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">&#8226;</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">in the principal market for the asset or liability or </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">&#8226;</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">in the absence of a principal market, in the most advantageous market for the asset or liability that is accessible by the Group. </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest. The Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs. All assets and liabilities for which fair value is measured or disclosed in the consolidated financial statements are categorized within the fair value hierarchy, described as follows, based on the lowest level input that is significant to the fair value measurement as a whole: </div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">&#8226;</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level&#160;1 &#8212; Quoted (unadjusted) market prices in active markets for identical assets or liabilities. </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">&#8226;</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level&#160;2 &#8212; Valuation techniques, for which the lowest level input that is significant to the fair value measurement is directly or indirectly observable. </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:5%;">&#8226;</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level&#160;3 &#8212; Valuation techniques, for which the lowest level input that is significant to the fair value measurement is unobservable. </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">For assets and liabilities that are recognized in the consolidated financial statements at fair value on a recurring basis, the Group determines whether transfers have occurred between levels in the hierarchy by <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-assessing</div> categorization (based on the lowest level input that is significant to the fair value measurement as a whole), at the end of each reporting period. </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory', window );">Provisions</a></td>
<td class="text"><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.14</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Provisions </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Provisions are recognized when the Group has a present obligation (legal or constructive) as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation and a reliable estimate can be made of the amount of the obligation. Where the Group expects some or all of a provision to be reimbursed, for example under an insurance contract, the reimbursement is recognized as a separate asset but only when the reimbursement is virtually certain. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">If the effect of the time value of money is material, provisions are discounted using a current <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-tax</div> rate that reflects, when appropriate, the risks specific to the liability. </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory', window );">Income Tax</a></td>
<td class="text"><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">5.15</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Income Tax </div></div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred income tax results from temporary differences between the carrying amount of an asset or a liability and its tax base. Deferred income tax is provided in full using the liability method on temporary differences. In accordance with IAS 12 (&#8220;Income Taxes&#8221;), the deferred tax assets and liabilities reflect all temporary valuation and accounting differences between financial statements prepared for tax purposes and our consolidated financial statements. Tax losses carried forward are considered in deferred tax assets calculation. The Group offsets tax assets and liabilities if and only if it has a legally enforceable right to set off current tax assets, current tax liabilities, deferred tax assets and deferred tax liabilities which relate to income taxes levied by the same tax authority. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForCashFlowsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for cash flows.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForCashFlowsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for financial instruments at fair value through profit or loss. [Refer: At fair value [member]; Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for financial liabilities. [Refer: Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for foreign currency translation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for income tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for provisions. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for recognising revenue. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for research and development expense. [Refer: Research and development expense]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for restricted cash and cash equivalents. [Refer: Restricted cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DescriptionOfAccountingPolicyForCovidNineteenPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of accounting policy for covid nineteen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DescriptionOfAccountingPolicyForCovidNineteenPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of accounting policy for going concern.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DescriptionOfAccountingPolicyForGoingConcernPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DescriptionOfAccountingPolicyForOtherIncomePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of accounting policy for other income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DescriptionOfAccountingPolicyForOtherIncomePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169238305608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of presentation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementTextBlock', window );">Summary of Reconciliation Of Changes In Cash Flow Statement</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">This correction of classification resulted in the following impact to the Statement of Cash Flows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="width: 60%;"></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31, 2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31, 2018</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">As<br/>reported</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Adjustment</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">As<br/>revised</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">As<br/>reported</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Adjustment</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">As<br/>revised</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">(Increase) decrease in other assets</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(4,419</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2,922</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(1,497</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(7,493</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">13,101</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">5,608</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net cash provided by operating activities</div></div></div></td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">68,045</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2,922</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">70,967</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">7,583</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">13,101</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">20,684</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Cash paid for investments classified in Other financial assets</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(20,473</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(20,473</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(13,101</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(13,101</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash received from maturity of investments classified in Other financial assets</div></div></td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">17,551</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">17,551</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Net cash used in investing activities</div></div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(2,137</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(2,922</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(5,059</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(413</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(13,101</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(13,514</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 60%;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Total effect on Cash Flow</div></td><td style="vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-size: 1px;"><td style="width: 60%;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="width: 58%;"></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Three&#160;months&#160;ended&#160;March&#160;31,&#160;2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Six months ended June&#160;30, 2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">As<br/>reported</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Adjustment</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">As<br/>revised</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">As<br/>reported</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Adjustment</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">As<br/>revised</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 58%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">(Increase) decrease in other assets</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(17,209</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">16,836</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(373</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">14,917</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(16,023</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(1,106</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 58%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net cash provided by/ (used in) operating activities</div></div></div></td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(28,286</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,836</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(11,450</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(11,716</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(16,023</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(27,739</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 58%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Cash paid for investments classified in Other financial assets</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(32,859</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(32,859</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(32,859</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(32,859</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 58%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash received from maturity of investments classified in Other financial assets</div></div></td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,023</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,023</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">48,882</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">48,882</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 58%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Net cash provided by/ (used in) investing activities</div></div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(2,387</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(16,836</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(19,223</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(4,550</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">16,023</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">11,473</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 58%;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Total effect on Cash Flow</div></td><td style="vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-size: 1px;"><td style="width: 58%;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of reconciliation of changes in cash flow statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237584904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Application of new and revised international financial reporting standards (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations', window );">Summary of Application of new standards</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">New standards and interpretations applied for the first time: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="font-family: &quot;times new roman&quot;;;width:87%;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:1%;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;"></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="white-space: nowrap; padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-family: &quot;times new roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Standard/interpretation</div></div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Effective&#160;date</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amendments to IFRS 3, &#8220;Business combinations&#8221;, - Definition of a business</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">January&#160;1,&#160;2020</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(255, 255, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amendments to IAS 1, &#8220;Presentation of financial statements&#8221;, and IAS 8, &#8220;Accounting policies, changes in accounting estimates and errors&#8221;</div></div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;">January&#160;1, 2020</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amendment to IFRS 9, IAS 39 and IFRS 17: - Interest rate benchmark reform</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">January&#160;1, 2020</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(255, 255, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amendment to the Conceptual framework</div></div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;">January&#160;1, 2020</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfNonMandatoryStandardsAndInterpretationsIssuedByTheIasbTableTextBlock', window );">Summary of Non Mandatory standards and interpretations issued by IASB</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following standards a<div style="display:inline;">n</div>d interpretations have been issued by the IASB, but were not yet mandatory for the year ended December&#160;31, 2020: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="font-family: &quot;times new roman&quot;;;width:72%;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:7%;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:7%;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;"></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="white-space: nowrap; padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-family: &quot;times new roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Standard/interpretation</div></div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Effective&#160;date</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Material effect expected<br/> on Immatics financial<br/> statements</div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">IFRS 16 <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19-Related</div></div> Rent Concessions Amendment</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">January&#160;1,&#160;2021</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">No</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amendments to IAS 1,&#8221; Presentation of financial statements&#8221;, on classification of liabilities</div></div></td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;">January&#160;1, 2022</td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;">No</td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">IFRS 17 Insurance contracts</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">January&#160;1, 2023</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">No</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the known or reasonably estimable information relevant to assessing the possible impact that the application of a new IFRS, that has been issued but is not yet effective, will have.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 30<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_30_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfNonMandatoryStandardsAndInterpretationsIssuedByTheIasbTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of non mandatory standards and interpretations issued by the IASB.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfNonMandatoryStandardsAndInterpretationsIssuedByTheIasbTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169240005304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of accounting policies applied by the Group for the annual reporting period ending December 31, 2020 (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesExplanatoryTableTextBlock', window );">Summary of estimated Useful Lives of Property, Plant and Equipment</a></td>
<td class="text">The estimated useful lives are generally within the following ranges:<table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"><tr style="font-size: 0px;"><td style="font-family: &quot;times new roman&quot;; width: 79%;"></td><td style="font-family: &quot;times new roman&quot;; width: 8%;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;"></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="white-space: nowrap; padding-bottom: 1pt; width: 79%;;vertical-align:bottom;"><div style="font-family: &quot;times new roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Category</div></div></div></td><td style="padding-bottom: 1pt; width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Estimated&#160;useful&#160;life</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 79%;;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Computer equipment</div></div></td><td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:center;;vertical-align:bottom;">1&#160;&#8211;&#160;10&#160;years</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgba(255, 255, 255, 0); width: 79%;;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Laboratory equipment</div></div></td><td style="background-color: rgba(255, 255, 255, 0); width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;text-align:center;;vertical-align:bottom;">1 &#8211;&#160;15&#160;years</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 79%;;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Office equipment</div></div></td><td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:center;;vertical-align:bottom;">2 &#8211;&#160;20&#160;years</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillExplanatoryTableTextBlock', window );">Summary of useful life of intangible assets other than goodwill</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amortization is calculated on a straight-line basis over the estimated useful lives of the assets as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"><tr style="font-size: 0px;"><td style="font-family: &quot;times new roman&quot;;;width:79%;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:8%;"></td><td style="font-family: &quot;times new roman&quot;;"></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="white-space: nowrap; padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-family: &quot;times new roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Category</div></div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Estimated&#160;useful&#160;life</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Licenses</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:center;;vertical-align:bottom;">5&#160;&#8211;&#160;30&#160;years</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Software</div></div></td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;text-align:center;;vertical-align:bottom;">1 &#8211; 5&#160;years</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesExplanatoryTableTextBlock', window );">Summary of foreign exchange rates</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Group used the following exchange rates to convert the financial statements of its U.S. subsidiary:</div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="width:64%;"></td><td style="vertical-align:bottom;;width:1%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:1%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:1%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:1%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:1%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:1%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2018</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;&#160;</div></td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Year-end</div><br/> rate</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;&#160;</div></td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">Average<br/> rate</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;&#160;</div></td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Year-end</div><br/> rate</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;&#160;</div></td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">Average<br/> rate</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;&#160;</div></td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Year-end</div><br/> rate</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;&#160;</div></td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">Average<br/> rate</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Euros per U.S.&#160;Dollar</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.8149</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.8762</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.8902</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.8932</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.8738</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.8468</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about foreign exchange rates explanatory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about useful life measured as period of time intangible assets other than goodwill explanatory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of property plant and equipment estimated useful lives explanatory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169278079144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts receivable (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfTradeAndOtherReceivableExplanatoryTableTextBlock', window );">Summary of Trade receivables</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width: 65%;"></td><td style="width: 13%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 13%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">As of</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;;width:;"><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">December&#160;31,</div><br/></div><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">2020</div><br/></div></td><td style="padding-bottom: 1pt; border-bottom: 0.75pt solid black;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">December&#160;31,</div><br/></div><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">2019</div><br/></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="6" style="text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); padding-bottom: 0.75pt; width: 65%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Receivables from collaboration agreements</div></div></td><td style="background-color: rgb(204, 238, 255); padding-bottom: 0.75pt; width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;">1,250</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;">957</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 65%;;vertical-align:bottom;"></td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 65%;;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accounts receivable</div></div></div></td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,250</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">957</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 65%;;vertical-align:bottom;"></td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfTradeAndOtherReceivableExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of trade and other receivable explanatory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfTradeAndOtherReceivableExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169240208200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other current and non-current assets  (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory', window );">Summary of Other current assets</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width: 64%;"></td><td style="width: 13%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 13%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">As of</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">2020</div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">2019</div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="6" style="text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 64%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Grant receivable</div></div></td><td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">875</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">998</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 64%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Prepaid expenses</div></div></td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2,389</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,236</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 64%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Positive market value forward contract</div></div></td><td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">914</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 64%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Value added tax receivable</div></div></td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">798</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">768</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 64%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Capitalized transaction costs</div></div></td><td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">48</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 64%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other assets</div></div></td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">787</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">617</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 64%;;vertical-align:bottom;">&#160;</td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 64%;;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Other current assets</div></div></div></td><td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">5,763</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255); width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">3,667</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 64%;;vertical-align:bottom;">&#160;</td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 13%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory', window );">Summary of Other&#160;non-current&#160;assets</a></td>
<td class="text"><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; font-size: 8pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:65%;"></td><td style="vertical-align:bottom;;width:13%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:13%;"></td><td></td><td></td><td></td></tr><tr style="break-inside: avoid; font-family: 'times new roman'; font-size: 8pt;"><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of</div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">2020</div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">2019</div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="break-inside: avoid; font-family: 'times new roman'; font-size: 8pt;"><td style="vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td colspan="6" style="text-align:center;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></div></td><td style="vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr><tr style="break-inside: avoid; font-family: 'times new roman'; font-size: 10pt;"><td style="background-color: rgb(204, 238, 255); font-size: 10pt;;vertical-align:top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;times new roman&quot;; line-height: normal;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Prepaid expenses</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">724</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">937</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr><tr style="break-inside: avoid; font-family: 'times new roman'; font-size: 10pt;"><td style="vertical-align:top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;times new roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Other<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div>assets</div></div></td><td style="vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">325</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr><tr style="break-inside: avoid; font-family: 'times new roman'; font-size: 10pt;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;times new roman&quot;; line-height: normal;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total<div style="letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">&#160;</div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">non-current</div><div style="letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">&#160;</div>assets</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">724</div></div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,262</div></div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr><tr style="font-size: 1px;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other current assets. [Refer: Other current assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other non-current assets. [Refer: Other non-current assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169240187368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory', window );">Disclosure of detailed information about property, plant and equipment [text block]</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes to property, plant and equipment during 2020 and 2019 consisted of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:92%;"><tr style="font-size: 0px;"><td style="width:65%;"></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" rowspan="3" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Laboratory<br/> equipment</div></td><td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" rowspan="3" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Computer<br/> equipment</div></td><td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" rowspan="3" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Office<br/> equipment</div></td><td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" rowspan="3" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Total</div></td><td rowspan="3" style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="page-break-inside: avoid;"><td colspan="17"></td></tr><tr style="font-size: 1px;"><td colspan="17" style="font-family: &quot;times new roman&quot;;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Cost as of January&#160;1, 2019</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">11,222</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,439</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,455</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">15,116</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Impact of IFRS 16 adoption</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(441</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(441</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Cost as of January&#160;1, 2019, adjusted</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">10,781</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,439</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,455</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">14,675</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Additions</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2,204</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">515</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">297</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">3,016</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Disposals</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(314</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(2</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(316</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Currency translation differences</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">52</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">4</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">57</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Cost as of December&#160;31, 2019</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">12,723</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,956</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,753</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">17,432</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1pt;"><td style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">Accumulated depreciation as of January 1, 2019</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">8,279</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,793</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,037</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">11,109</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Additions</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,219</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">256</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">322</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,797</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Disposals</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(218</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(1</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(219</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Currency translation differences</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">23</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">25</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">Accumulated depreciation as of December 31, 2019</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">9,303</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,050</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,359</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">12,712</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Net book value as of December&#160;31, 2019</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">3,420</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">906</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">394</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">4,720</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost as of January&#160;1, 2020</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">12,723</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,956</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,753</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">17,432</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Additions</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">3,545</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">406</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,427</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">5,379</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Disposals</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">6</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">7</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Currency translation differences</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">299</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">40</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">28</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">367</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost as of December&#160;31, 2020</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">15,968</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">3,322</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">3,146</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">22,437</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1pt;"><td style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">Accumulated depreciation as of January 1, 2020</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">9,303</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,050</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,359</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">12,712</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Additions</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,384</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">404</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">315</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2,102</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Disposals</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">6</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">7</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Currency translation differences</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">210</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">26</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">3</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">239</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">Accumulated depreciation as of December 31, 2020</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">10,476</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,428</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,665</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">14,568</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net book value as of December&#160;31, 2020</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">5,493</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">894</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,481</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">7,868</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfDepreciationExpensesTableTextBlock', window );">Disclosure Of Depreciation Expenses [Table Text Block]</a></td>
<td class="text">Depreciation expense is included in the following line items of the Consolidated Statement of Loss:<table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"><tr style="font-size: 0px;"><td style="width:79%;"></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2018</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="10" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Research and development expenses</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,503</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,315</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,757</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">General and administrative expenses</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">600</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">482</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">301</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,103</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,797</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,058</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2020-01-01<br> -Paragraph 73<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_73&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfDepreciationExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of depreciation expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfDepreciationExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237508328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory', window );">Disclosure of reconciliation of changes in intangible assets and goodwill [text block]</a></td>
<td class="text"><div style="font-family: times new roman;font-size: 10pt;margin-top: 12pt;margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes to intangible assets during 2020 and 2019 consisted of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"><tr style="font-size: 0px;"><td style="width:75%;"></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">Patents</div></div><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">and<br/> licenses</div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Software<br/> licenses</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Total</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Cost as of January&#160;1, 2019</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,201</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">551</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,752</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Additions</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">91</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">91</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Currency translation differences</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">19</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">20</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost as of December&#160;31, 2019</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,220</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">643</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,863</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1pt;"><td style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated amortization as of January&#160;1, 2019</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">314</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">399</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">713</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Additions</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">24</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">87</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">111</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Currency translation differences</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">31</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">31</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated amortization as of December&#160;31, 2019</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">369</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">486</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">855</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Net book value as of December&#160;31, 2019</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">851</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">157</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,008</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-size: 1pt;"><td style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost as of January&#160;1, 2020</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,220</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">643</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,863</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Additions</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">104</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">104</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Currency translation differences</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(88</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(9</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(97</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Cost as of December&#160;31, 2020</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,132</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">738</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,870</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated amortization as of January&#160;1, 2020</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">369</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">486</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">855</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Additions</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">56</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">71</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">126</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Currency translation differences</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(22</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(3</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(25</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated amortization as of December&#160;31, 2020</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">403</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">554</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">956</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net book value as of December&#160;31, 2020</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">730</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">184</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">914</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfAmortizationExpensesTableTextBlock', window );">Disclosure Of Amortization Expenses [Table Text Block]</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amortization expense is classified as follows within the Consolidated Statement of Loss: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"><tr style="font-size: 0px;"><td style="width:82%;"></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Year&#160;ended&#160;December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2018</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="10" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Research and development expenses</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">31</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">28</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">9</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">General and administrative expenses</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">95</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">83</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">109</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">126</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">111</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">118</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the reconciliation of changes in intangible assets and goodwill. [Refer: Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2020-01-01<br> -Paragraph 118<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_118&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfAmortizationExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of amortization expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfAmortizationExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237451448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PresentationOfLeasesForLesseeAbstract', window );"><strong>Presentation of leases for lessee [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory', window );">Summary of Right-of&#160;use assets</a></td>
<td class="text"><div style="font-family: times new roman;font-size: 10pt;margin-top: 12pt;margin-bottom: 0pt;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Right-of</div> use assets consist of the following: </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:74%;"></td><td style="vertical-align:bottom;;width:8%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:8%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">As of</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2020</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2019</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Buildings</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">5,760</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2,799</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">IT and telecommunication</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">258</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">349</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Vehicles</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">90</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">90</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other assets</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">41</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">49</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">6,149</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">3,287</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfLeaseLiabilitiesTableTextBlock', window );">Details of Lease liabilities</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Lease liabilities consist of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 8pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:74%;"></td><td style="vertical-align:bottom;;width:8%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:8%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">As of</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2020</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2019</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Lease liability &#8211; current</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,881</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,411</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Lease liability &#8211; <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">4,306</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,823</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">6,187</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">3,234</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfExpensesRelatedToRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock', window );">Summary of expenses related to&#160;right-of-use&#160;assets and lease liabilities</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Expenses related to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets and lease liabilities consist of the following: </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:82%;"></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Year&#160;ended&#160;December&#160;31,</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.7pt;;vertical-align:bottom;"><div style="text-decoration:underline;display:inline;"><div style="font-weight:bold;display:inline;">Depreciation charges of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets</div></div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Buildings</div></div></td><td style="background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2,036</td><td style="white-space: nowrap; font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,804</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">IT and telecommunication</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">101</td><td style="white-space: nowrap; font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">101</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Vehicles</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">50</td><td style="white-space: nowrap; font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">37</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other assets</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">8</td><td style="white-space: nowrap; font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">8</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,195</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,950</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-size: 1pt;"><td style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Interest expenses form leases</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">260</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">170</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;">Expense relating to short-term leases and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">low-value</div> assets (included in administrative expenses)</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">51</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">27</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2020-01-01<br> -Paragraph 53<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_53&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PresentationOfLeasesForLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PresentationOfLeasesForLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfExpensesRelatedToRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of expenses related to right of use assets and lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfExpensesRelatedToRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfLeaseLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfLeaseLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169262016824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfAccountsPayableExplanatoryTableTextBlock', window );">Summary of Accounts Payable</a></td>
<td class="text"><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:66%;"></td><td style="vertical-align:bottom;;width:5%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:5%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">As of</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Accounts payable</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2,554</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">4,866</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other accrued liabilities</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">7,498</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2,216</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total accounts payable</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">10,052</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">7,082</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfAccountsPayableExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounts payable explanatory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfAccountsPayableExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169261963176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue from collaboration agreements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfContractLiabilitiesTextBlock', window );">Summary of Deferred revenue related to the collaboration agreements</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred revenue related to the collaboration agreements consists of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:74%;"></td><td style="vertical-align:bottom;;width:5%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:5%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">As of</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Current</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">46,600</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">59,465</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-current</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">85,475</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">101,909</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">132,075</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">161,374</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfContractLiabilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of contract liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfContractLiabilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169261927144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other income (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfOtherIncomeExplanatoryTextBlock', window );">Summary of other income</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Group had the following deferred income and receivable balances under these agreements: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:73%;"></td><td style="vertical-align:bottom;;width:9%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:9%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">As of</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Receivables</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">875</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">998</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred income</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">164</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">875</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,162</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfOtherIncomeExplanatoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of other income explanatory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfOtherIncomeExplanatoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169261962328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other current liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTextBlock', window );">Summary of other current liabilities</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The components of other curre<div style="background-color:#ffffff;;display:inline;">n</div><div style="display:inline;"><div style="background-color:#ffffff;;display:inline;">t</div></div>&#160;liabilities are: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:74%;"></td><td style="vertical-align:bottom;;width:8%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:8%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">As of</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Payroll tax</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,185</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">727</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrual for vacation</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">525</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">330</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Deferred grant income</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">164</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued bonuses</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">154</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">52</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Other</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">161</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">15</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,025</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,288</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about other current liabilities abstract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169243149352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial income and expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseExplanatoryTextBlock', window );">Summary of finance income and costs</a></td>
<td class="text"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; line-height: 12pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial income and financial expenses consist of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"><tr style="font-size: 0px;"><td style="width:80%;"></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:1%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:1%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2018</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="10" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Interest income from short-term deposits</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">850</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">790</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">507</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Foreign currency gains</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,708</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Gain on other financial instruments</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2,099</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financial income</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,949</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">790</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,215</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1pt;"><td style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:8;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Interest expenses form leases</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(289</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(170</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(16</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Foreign currency losses</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(9,774</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(94</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(145</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Financial expenses</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(10,063</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(264</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(161</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">)&#160;</div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseExplanatoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about finance income expense explanatory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseExplanatoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169261996856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share listing expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfDetailedInformationAboutShareListingExpensesTextBlock', window );">Summary of Calculation of the Share listing expense</a></td>
<td class="text">Details of the calculation of the Share listing expense are as follows:<table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:73%;"></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(Euros in thousands, except share and per share data)</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="white-space: nowrap; padding-bottom: 0.45pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Description</div></td><td style="padding-bottom: 0.45pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Amount</div></td><td style="padding-bottom: 0.45pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.45pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="padding-bottom: 0.75pt; border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-family: &quot;times new roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:center;"><div style="font-family: &quot;times new roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Number of<br/> shares/warrants</div></div></div></div></td><td style="padding-bottom: 0.45pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">(a) ARYA Ordinary Shares</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">17,968,750</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(b) Closing price of ARYA Ordinary Shares on Nasdaq as of July&#160;1, 2020</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#8364;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">13.53</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">(c) Fair value of TopCo Shares issued to ARYA shareholders <div style="font-weight:bold;display:inline;width:100%;">(a * b)</div></div></td><td style="background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:bottom;">&#8364;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">243,071</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;text-align:right;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255);;display:inline;">&#8212;&#160;</div>&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.45pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(d) Outstanding ARYA Public Warrants</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">7,187,500</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">(e) Closing price of ARYA Public Warrants on Nasdaq as of July&#160;1, 2020</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#8364;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">4.82</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(f) Fair value of outstanding ARYA Public Warrants (d * e)</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#8364;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">34,644</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Total fair value of ARYA Ordinary Shares and ARYA Public Warrants (c + f)</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#8364;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">277,715</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ARYA&#8217;s identifiable net assets</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#8364;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">124,927</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">IFRS 2 Expense on the closing date</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#8364;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">152,787</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfDetailedInformationAboutShareListingExpensesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about Share listing expenses [text block].</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfDetailedInformationAboutShareListingExpensesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169216037560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based payments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTextBlock', window );">Summary of Employee Related Share Based Compensation Expense</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Group recognized total employee-related share-based compensation expense from all plans for the years ended December&#160;31, 2020, 2019 and 2018 as set out below: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"><tr style="font-size: 0px;"><td style="width:80%;"></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Year&#160;ended&#160;December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2018</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="10" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Research and development expenses</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">14,546</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,556</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">238</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">General and administrative expenses</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10,973</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">460</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">100</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total share-based compensation</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">25,519</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,016</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">338</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_ShareAppreciationRightsMember', window );">Share Appreciation Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory', window );">Summary of Options Granted Priced Using Black Scholes for SARs, Tandem Awards, Converted Options, Matching Stock Options and Monte Carlo Option Pricing Model</a></td>
<td class="text"><div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:83%;"></td><td style="vertical-align:bottom;;width:5%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Amounts in USD</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2018</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Exercise price</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.12</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.12</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Underlying share price</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">67.87</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">27.21</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Volatility</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">73</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">64</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Time period (years)</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1.25</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">5.00</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Risk free rate</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.59</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2.77</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">0.00</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">0.00</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Combined probability of exit events</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">80.00</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">25.00</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td></tr></table></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory', window );">Summary of Employee Share Options</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Set out below are summaries of SARs issued during 2019 and 2018: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:92%;"><tr style="font-size: 0px;"><td style="width:68%;"></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2018</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Weighted<br/>average<br/>exercise<br/>price in<br/>USD</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Number</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Weighted<br/>average<br/>exercise<br/>price in<br/>USD</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Number</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">SARs outstanding at January&#160;1,</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.12</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">43,675</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.12</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">43,978</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SARs granted</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">SARs forfeited</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.12</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">220</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.12</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">303</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SARs outstanding at December&#160;31,</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1.12</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">43,455</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1.12</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">43,675</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">SARs vested</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.12</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">117</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.12</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">169</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SARs exercisable</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr></table><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_TwoThousandAndSixteenTandemAwardsMember', window );">2016 Tandem Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory', window );">Summary of Options Granted Priced Using Black Scholes for SARs, Tandem Awards, Converted Options, Matching Stock Options and Monte Carlo Option Pricing Model</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of tandem awards issued in December 2019 was based on a company valuation of $350&#160;million. </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="width:61%;"></td><td style="vertical-align:bottom;;width:9%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:9%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:9%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="white-space: nowrap; padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Amounts in USD</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">June&#160;2019&#160;-&#160;September&#160;2019</div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;2018</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Exercise price in USD</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#160;23.82</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#160;18.30</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#160;16.65</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Underlying share price in USD</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">67.87</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16.94</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">27.21</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Volatility</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">73</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">78</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">64</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Time period (years)</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1.25</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2.10</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">5.00</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Risk free rate</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.59</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2.04</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2.77</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">0.00</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">0.00</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">0.00</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Combined probability of exit events</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">80.00</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">60.00</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">25.00</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td></tr></table><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureDetailsOfActivitiesUnderShareBasedPaymentArrangementTextBlock', window );">Summary of Activities Under Share Based Payment Arrangement</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Set out below are summaries of tandem awards issued during 2019 and 2018: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="width:65%;"></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2018</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Weighted&#160;average<br/>exercise price in<br/>USD</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Number</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Weighted<br/>average&#160;exercise<br/>price in USD</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Number</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Tandem Awards outstanding at January&#160;1,</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">16.65</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">74,401</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">16.65</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">31,880</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Tandem awards granted in June to September</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">18.30</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">26,557</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16.65</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">43,964</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Tandem awards granted in December</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">23.82</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">5,447</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Tandem awards forfeited</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16.81</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2,936</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16.65</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,443</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Tandem awards outstanding at December&#160;31,</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">17.45</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">103,469</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">16.65</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">74,401</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Tandem awards vested</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16.76</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,238</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16.65</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">14,350</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Tandem awards exercisable</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted average remaining contract life (years)</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">8.56</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">9.12</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Weighted average fair value of options granted in USD till September</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10.27</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">4.51</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted average fair value of options granted in USD for December</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">53.41</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td></tr></table><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_MatchingStockOptionsMember', window );">Matching Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory', window );">Summary of Options Granted Priced Using Black Scholes for SARs, Tandem Awards, Converted Options, Matching Stock Options and Monte Carlo Option Pricing Model</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Immatics applied a Black Scholes pricing model to estimate the fair value of the Matching Stock Options, which the Group records as an expense over the four-year graded vesting period. </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"><tr style="font-size: 0px;"><td style="width:84%;"></td><td style="vertical-align:bottom;;width:12%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">As&#160;of&#160;June&#160;30,</div><br/><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Exercise price in USD</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10.00</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Underlying share price in USD</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">15.15</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Volatility</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">75</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Time period (years)</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">5.5</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Risk free rate</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.29</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">0.00</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td></tr></table><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory', window );">Summary of Employee Share Options</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Set out below are summaries of Matching Stock Options issued during 2020: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:71%;"></td><td style="vertical-align:bottom;;width:7%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:7%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Weighted&#160;average<br/>exercise price in<br/>USD</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Number</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Matching Stock Options outstanding on January&#160;1,</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Matching Stock Options granted in June</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10.00</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,430,818</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Matching Stock Options forfeited</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10.00</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">8,262</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Matching Stock Options outstanding at December&#160;31,</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10.00</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,422,556</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Matching Stock Options vested</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted average remaining contract life (years)</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">9.50</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Weighted average fair value of options granted in USD for June</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10.59</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_ConvertedOptionsMember', window );">Converted Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory', window );">Summary of Options Granted Priced Using Black Scholes for SARs, Tandem Awards, Converted Options, Matching Stock Options and Monte Carlo Option Pricing Model</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> Immatics applied a Black Scholes pricing model to estimate the fair value of the Converted Options.</div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"><tr style="font-size: 0px;"><td style="width:90%;"></td><td style="vertical-align:bottom;;width:6%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">As of<br/>June&#160;30,<br/>2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Average exercise price in USD</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2.47</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Underlying share price in USD</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">15.15</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Volatility</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">75</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Time period (years)</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">5.6</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Risk free rate</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.29</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">0.00</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory', window );">Summary of Employee Share Options</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Set out below are summaries of Converted Options issued during 2020: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:73%;"></td><td style="vertical-align:bottom;;width:7%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:7%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Weighted&#160;average<br/>exercise price in<br/>USD</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Number</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Converted Options outstanding on January&#160;1,</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Converted Options granted in June</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2.49</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">632,384</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Converted Options forfeited</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.08</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">37,540</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Converted Options outstanding on December&#160;31,</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2.58</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">594,844</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Converted Options vested</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#160;2.45</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">53,856</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted average remaining contract life (years)</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">7.01</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Weighted average fair value of options granted in USD for June</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">4.83</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td></tr></table><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember', window );">Additional Grants Under 2020 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory', window );">Summary of Options Granted Priced Using Black Scholes for SARs, Tandem Awards, Converted Options, Matching Stock Options and Monte Carlo Option Pricing Model</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;">Immatics applied a Black Scholes pricing model to estimate the fair value of the Service Options.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="width:71%;"></td><td style="vertical-align:bottom;;width:6%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:6%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:6%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">As&#160;of&#160;June&#160;30,<br/>2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">As&#160;of&#160;September</div><br/><div style="font-weight:bold;display:inline;">14, 2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">As&#160;of</div><br/><div style="font-weight:bold;display:inline;">December&#160;17,<br/>2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Exercise price in USD</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#160;10.00</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#160;10.00</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#160;9.70</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Underlying share price in USD</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">15.15</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">9.16</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">9.70</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Volatility</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">75</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">79</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">84</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Time period (years)</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">7.0</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">6.2</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">6.0</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Risk free rate</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.29</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.37</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.49</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">0.00</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">0.00</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">0.00</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory', window );">Summary of Employee Share Options</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Set out below are summaries of Service Options issued during 2020:</div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:73%;"></td><td style="vertical-align:bottom;;width:6%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:6%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Weighted<br/>average&#160;exercise<br/>price in USD</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Number</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Service Options outstanding on January&#160;1,</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Service Options granted in June</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10.00</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,087,417</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Service Options granted in September</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">9.72</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">74,000</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Service Options granted in December</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">9.70</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">802,149</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Service Options forfeited</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10.00</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">53,384</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Service Options outstanding on December&#160;31,</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">9.87</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,910,182</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Service Options vested</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted average remaining contract life (years)</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">9.72</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Weighted average fair value of options granted in USD for June</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">11.29</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted average fair value of options granted in USD for September</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">9.25</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Weighted average fair value of options granted in USD for December</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">6.73</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_PerformanceBasedOptionsMember', window );">Performance Based Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory', window );">Summary of Options Granted Priced Using Black Scholes for SARs, Tandem Awards, Converted Options, Matching Stock Options and Monte Carlo Option Pricing Model</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">In addition to the probability of achieving the market capitalization performance criteria, the inputs used in the measurements of the fair value at grant date of the PSUs were as follows:</div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:73%;"></td><td style="vertical-align:bottom;;width:9%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:8%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">As&#160;of&#160;June&#160;30,<br/>2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">As of<br/>September&#160;14,<br/>2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Exercise price in USD</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#160;10.00</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#160;10.00</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Underlying share price in USD</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">15.15</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">9.16</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Volatility</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">79</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">78</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Time period (years)</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">7.0</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">6.7</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Risk free rate</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.66</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.67</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">0.00</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">0.00</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory', window );">Summary of Employee Share Options</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Set out below are summaries of PSUs issued during 2020: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:73%;"></td><td style="vertical-align:bottom;;width:6%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:6%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Weighted<br/>average&#160;exercise<br/>price in USD</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Number</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">PSUs outstanding on January&#160;1,</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">PSUs granted in June</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10.00</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">3,644,000</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">PSUs granted in September</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10.00</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">255,000</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">PSUs forfeited</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10.00</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">255,000</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">PSUs outstanding on December&#160;31,</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10.00</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">3,644,000</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">PSUs vested</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Weighted average remaining contract life (years)</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">9.60</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted average fair value of options granted in USD for June</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">11.10</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Weighted average fair value of options granted in USD for September</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">6.41</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td></tr></table><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the range of exercise prices for outstanding share options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureDetailsOfActivitiesUnderShareBasedPaymentArrangementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure details of activities under share based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureDetailsOfActivitiesUnderShareBasedPaymentArrangementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about share based compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_StatementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_StatementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_ShareAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_ShareAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_TwoThousandAndSixteenTandemAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_TwoThousandAndSixteenTandemAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_MatchingStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_MatchingStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_ConvertedOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_ConvertedOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_PerformanceBasedOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_PerformanceBasedOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169261961480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Personnel expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfPersonnelExpenesTextBlock', window );">Summary of Personnel Expenses</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Group recognized the following personnel expenses: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"><tr style="font-size: 0px;"><td style="width:76%;"></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2018</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="10" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Wages and salaries</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Research and development expenses</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">15,277</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">11,635</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10,485</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">General and administrative expenses</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">6,968</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">3,596</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2,233</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total Wages and salaries</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">22,245</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">15,231</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">12,718</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Other employee benefits</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Research and development expenses</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2,624</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2,035</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,920</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">General and administrative expenses</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,015</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">728</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">607</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total other employee benefits</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">3,639</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,763</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,527</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Share-based compensation expense</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Research and development expenses</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">14,546</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,556</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">238</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">General and administrative expenses</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10,973</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">460</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">100</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total share-based compensation expense</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">25,519</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,016</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">338</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">51,403</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">20,010</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">15,583</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfPersonnelExpenesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Personnel Expenses [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfPersonnelExpenesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237504360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfReconciliationBetweenTaxesOnIncomeAndExpectedIncomeTaxBenefitTableTextBlock', window );">Summary of Reconciliation Between Taxes On Income And Expected Income Tax Benefit</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A reconciliation between taxes on income reflected on the Consolidated Statement of Loss and the expected income tax benefit, based on the Group&#8217;s German statutory tax rate, for the years ended December&#160;31, 2020, 2019 and 2018 is as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"><tr style="font-size: 0px;"><td style="width:74%;"></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:1%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:1%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2018</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="10" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Loss before tax</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(229,616</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(32,487</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(32,355</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected tax benefit</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">66,818</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">9,454</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">9,415</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Effects</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Difference in tax rates</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(2,582</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(1,875</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(1,373</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Non-deductible&#160; tax-expenses</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(599</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(61</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(70</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Government grants exempted from taxes</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">45</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">8</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">853</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Permanent Differences</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(44,461</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="padding:0in 0in 0in 0in;vertical-align:top;"><div style="margin-top:0in; margin-right:0in; margin-bottom:.0001pt; margin-left:60.0pt; text-indent:-12.0pt; line-height:normal; font-family:calibri,sans-serif"><div style="font-size: 10pt; font-family: &quot;times new roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">Non-recognition&#160;of deferred taxes on tax losses and temporary differences</div></div></td><td style="padding:0in 0in 0in 0in;vertical-align:bottom;"><div style="margin:0in 0in 0.0001pt; line-height:normal; font-family:calibri,sans-serif">&#160;</div></td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;">(19,221</td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;">(7,526</td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;;vertical-align:bottom;">(8,825</td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgba(255, 255, 255, 0);">&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgba(255, 255, 255, 0);">&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgba(255, 255, 255, 0);">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Taxes on income</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgba(255, 255, 255, 0);">&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgba(255, 255, 255, 0);">&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgba(255, 255, 255, 0);">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Summary of Deferred Tax Assets</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred tax assets consist of the following: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="width:70%;"></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td colspan="14" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of</div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31, 2020</div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31, 2019</div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td colspan="14" style="text-align:center;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></div></td><td style="vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Deferred<br/> tax<br/> assets</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Deferred<br/> tax<br/> liabilities</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Deferred<br/> tax<br/> assets</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Deferred<br/> tax<br/> liabilities</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr><tr style="font-size: 0px;"><td style="width: 60%;"></td><td style="width: 6%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 5%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 5%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 5%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Intangible assets</div></div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,770</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2,064</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Right-of-use</div></div> asset</div></td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(1,713</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(854</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Deferred revenue</div></div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">180</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">358</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other liabilities</div></div></td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">607</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Lease liability</div></div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,776</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">886</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred expenses</div></div></td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">3</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">14</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Recognized</div></div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">3,729</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(1,713</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">3,929</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(854</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Netting</div></div></td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(1,713</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,713</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(854</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">854</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 60%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Non-recognition</div> due to history of losses</div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(2,016</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(3,075</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 60%;;vertical-align:bottom;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Net tax</div></td><td style="vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></td><td style="vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-size: 1px;"><td style="width: 60%;;vertical-align:bottom;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of deferred tax assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfReconciliationBetweenTaxesOnIncomeAndExpectedIncomeTaxBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of reconciliation between taxes on income and expected income tax benefit[Text Block].</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfReconciliationBetweenTaxesOnIncomeAndExpectedIncomeTaxBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237601192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Risk Management Objectives and Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfCurrencyRiskExposureExplanatoryTableTextBlock', window );">Summary of Currency Risk Exposure</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cash, cash equivalents and financial assets Immatics N.V. </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"><tr style="font-size: 0px;"><td style="width:74%;"></td><td style="vertical-align:bottom;;width:19%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Year&#160;ended&#160;December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Cash and cash equivalents</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">42,528</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial assets</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total assets exposed to the risk</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">42,528</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="margin-bottom: 0px; margin-top: 0px;">&#160;</div> <div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Conversion rate EUR/USD as reporting date 1/1.2271</div></div></div></div> <div style="margin-bottom: 0px; margin-top: 0px;">&#160;</div> <div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Cash, cash equivalents and financial assets Immatics GmbH</div></div></div></div><br/> &#160;</div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"><tr style="font-size: 0px;"><td style="width:74%;"></td><td style="vertical-align:bottom;;width:19%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Year&#160;ended&#160;December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Cash and cash equivalents</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">52,015</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial assets</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">24,448</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total assets exposed to the risk</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">76,463</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk', window );">Summary of Sensitivity Analysis of Foreign Currency Risk</a></td>
<td class="text"><div style="font-size: 1px; margin-top: 18px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Sensitivity analysis Immatics N.V.: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"><tr style="font-size: 0px;"><td style="width:71%;"></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Conversion<br/> rate</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); white-space: nowrap;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Profit/(loss)</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Carrying<br/> amount</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="10" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Euro weakens by 1% against U.S. dollars</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.2394</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(421</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">42,107</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Euro strengths by 1% against U.S. dollars</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1.2148</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">430</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">42,958</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Euro weakens by 5% against U.S. dollars</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.2885</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(2,025</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">40,503</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Euro strengths by 5% against U.S. dollars</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1.1657</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2,238</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">44,766</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Euro weakens by 10% against U.S. dollars</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.3498</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(3,866</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">38,662</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Euro strengths by 10% against U.S. dollars</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1.1044</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">4,725</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">47,253</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Sensitivity analysis Immatics GmbH: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"><tr style="font-size: 0px;"><td style="width:71%;"></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Conversion<br/> rate</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); white-space: nowrap;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Profit/(loss)</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Carrying<br/> amount</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="10" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Euro weakens by 1% against U.S. dollars</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.2394</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(757</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">75,706</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Euro strengths by 1% against U.S. dollars</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1.2148</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">772</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">77,235</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Euro weakens by 5% against U.S. dollars</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.2885</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(3,641</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">72,822</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Euro strengths by 5% against U.S. dollars</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1.1657</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">4,024</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">80,487</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Euro weakens by 10% against U.S. dollars</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.3498</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(6,951</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">69,512</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Euro strengths by 10% against U.S. dollars</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1.1044</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">8,496</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">84,959</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfManagingLiquidityRisk', window );">Summary of Liquidity Risk</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2020, and 2019, the Group held the following funds which are expected to generate cash inflows in time, to counteract liquidity risk. </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:80%;"></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Year&#160;ended&#160;December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Cash and cash equivalents</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">207,530</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">103,353</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Short-term deposits</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">24,448</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,023</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total funds available</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">231,978</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">119,376</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfManagingLiquidityRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of how the entity manages its liquidity risk. [Refer: Liquidity risk [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 39<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_39_c&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfManagingLiquidityRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the sensitivity analysis for types of market risk to which the entity is exposed, showing how profit or loss and equity would have been affected by changes in the relevant risk variable that were reasonably possible at that date. [Refer: Market risk [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 40<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_40_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfCurrencyRiskExposureExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Currency Risk Exposure Explanatory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfCurrencyRiskExposureExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169261909432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory', window );">Summary of Carrying Amounts and Fair values of Group's Financial Instruments</a></td>
<td class="text"><div style="font-family: times new roman;font-size: 10pt;margin-top: 6pt;margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Set out below are the carrying amounts and fair values of the Group&#8217;s financial instruments that are carried in the consolidated financial statements. </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="width:47%;"></td><td style="vertical-align:bottom;;width:3%;"></td><td style="width:18%;"></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td rowspan="2" style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Euros in thousands</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Carrying amount</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Fair value</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td style="padding-bottom: 1pt;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">IFRS 9</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Financial assets</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Short-term deposits*</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">At fair value through profit or loss (FVTPL)</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">24,448</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,023</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">24,448</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,023</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Positive market value</div></div><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">forward contracts*</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">At fair value through profit or loss (FVTPL)</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">914</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">914</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accounts receivable</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">other&#160;financial&#160;assets&#160;at amortized cost</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,250</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">957</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,250</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">957</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">current/non-current</div> assets</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">other financial assets at amortized cost</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,586</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,710</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,586</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,710</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total financial assets**</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">28,198</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">18,690</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">28,198</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">18,690</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Financial liabilities</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accounts payable</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">other&#160;financial&#160;liabilities at amortized cost</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10,052</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">7,082</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10,052</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">7,082</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Other current liabilities</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">other financial liabilities at amortized cost</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2,025</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,288</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2,025</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,288</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total financial liabilities</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">12,077</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">8,370</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">12,077</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">8,370</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:2%;">*</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Short-term deposits&#8221; are classified within Other financial assets. &#8220;Positive market value forward contract&#8221; are classified in other current assets. &#8220;Negative market value forward contracts&#8221; are classified in other current liabilities. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:2%;">**</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial assets, other than cash and cash equivalents. </div></div></td></tr></table><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about financial instruments. [Refer: Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 31<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 35K<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_35K&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169261973192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfContractualObligationsTableTextBlock', window );">Summary of Contractual Obligations</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table summarizes contractual obligations as of December&#160;31, 2020: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="width:66%;"></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="18" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Payments due by period</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">(Euros in thousands)</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-top: 0.75pt solid black; border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Less&#160;than<br/>1&#160;year</div></div></td><td style="border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;</td><td style="border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-top: 0.75pt solid black; border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1&#160;-&#160;3</div></div><br/></div><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">years</div></div><br/></div></td><td style="border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;</td><td style="border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-top: 0.75pt solid black; border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">3&#160;-&#160;5&#160;</div></div><br/></div><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">years</div></div><br/></div></td><td style="border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;</td><td style="border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-top: 0.75pt solid black; border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">More&#160;than<br/> 5 years</div></td><td style="border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;</td><td style="border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-top: 0.75pt solid black; border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Total</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Lease liabilities</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2,103</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">3,453</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,157</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">150</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">6,863</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other lease obligations</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">97</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">185</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">185</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">46</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">513</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">In-license</div> agreements</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">249</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">249</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Contract research organization agreements</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,704</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">220</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,924</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total contractual cash obligation</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">4,153</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">3,858</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,342</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">196</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">9,549</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table summarizes contractual obligations as of December&#160;31, 2019: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="width:67%;"></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td colspan="18" style="text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Payments due by period</div></td><td style="vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">(Euros in thousands)</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="padding-bottom: 0.75pt; border-bottom: 0.75pt solid black; border-top: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Less&#160;than<br/>1&#160;year</div></div></td><td style="padding-bottom: 0.75pt; border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt; border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black; border-top: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1&#160;-&#160;3</div></div><br/></div><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">years</div></div><br/></div></td><td style="border-bottom: 0.75pt solid black; border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt; border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black; border-top: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">3&#160;-&#160;5&#160;</div></div><br/></div><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">years</div></div><br/></div></td><td style="padding-bottom: 0.75pt; border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt; border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="padding-bottom: 0.75pt; border-bottom: 0.75pt solid black; border-top: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">More&#160;than&#160;</div><br/></div><div style="margin-top: 0px; margin-bottom: 0px; line-height: normal;"><div style="font-weight:bold;display:inline;">5<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div>years</div><br/></div></td><td style="padding-bottom: 0.75pt; border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt; border-top: 0.75pt solid black;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="padding-bottom: 0.75pt; border-bottom: 0.75pt solid black; border-top: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Total</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Lease liabilities</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,482</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,823</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">47</td><td style="white-space: nowrap; font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">3,352</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other lease obligations</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">172</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">324</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">300</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">300</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,096</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">In-license</div> agreements</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">455</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">200</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">655</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Contract research organization agreements</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,131</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,466</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2,597</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total contractual cash obligation</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">3,240</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">3,813</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">347</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">300</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">7,700</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfContractualObligationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of contractual obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfContractualObligationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237464296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related party disclosures (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfCompensationOfKeyManagementPersonnelTableTextBlock', window );">Summary of Compensation of Key Management Personnel</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Compensation of key management personnel: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 100%;;margin : 0px auto;;text-align:left;"><tr style="font-size: 0px;"><td style="width: 78%;"></td><td style="width: 2%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 2%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 2%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="10" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Year ended December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2018</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;;width:;">&#160;</td><td style="vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="10" style="text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 78%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Fixed</div></div></td><td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2,660</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,202</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,088</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 78%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Variable</div></div></td><td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">886</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">521</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">433</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 78%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Share-based compensation expense</div></div></td><td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">13,841</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">697</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">119</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 78%;;vertical-align:bottom;">&#160;</td><td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 78%;;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total key management compensation</div></div></div></td><td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">17,387</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">2,420</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,640</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 78%;;vertical-align:bottom;">&#160;</td><td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfCompensationSupervisoryBoardTextBlock', window );">Summary of Compensation for the Supervisory Board</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total compensation for the Supervisory Board amounted to &#8364;2.7&#160;million in 2020: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="width:53%;"></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:2%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Peter<br/> Chambr&#233;</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Harald&#160;F.<br/> Stock</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Michael<br/> G.&#160;Atieh</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Paul<br/> Carter</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Heather<br/> L.&#160;Mason</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Adam<br/> Stone</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Christoph<br/> Hettich</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Eliot<br/> Forster</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Total</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Supervisory board compensation</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">140</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">16</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">28</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">26</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">20</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">20</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">20</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">12</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">282</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Travel expenses</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">4</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">4</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Payment Exit arrangement</div></div></td><td style="vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">2,394</div></div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="white-space: nowrap; text-align: right;">&#8212;</td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="white-space: nowrap; text-align: right;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#8212;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="white-space: nowrap; text-align: right;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#8212;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="white-space: nowrap; text-align: right;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#8212;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="white-space: nowrap; text-align: right;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#8212;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="white-space: nowrap; text-align: right;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#8212;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="white-space: nowrap; text-align: right;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#8212;</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;</div></td><td style="vertical-align:bottom;"><div style="line-height: normal; text-align: right;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td><div style="line-height: normal; text-align: right;"><div style="font-weight:bold;display:inline;width:100%;">&#160;<div style="letter-spacing: 0px; top: 0px;;display:inline;">2,394</div></div></div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="line-height: normal; text-align: right;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Share-based compensation expense</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,046 </td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">70</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right;;vertical-align:bottom;">70</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">70</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">70</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">70</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">40</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">1,436</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">Total cash compensation</div></div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">3,584</div></td><td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">16</div></td><td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">98</div></td><td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">96</div></td><td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">90</div></td><td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">90</div></td><td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">90</div></td><td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">52</div></td><td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="padding-bottom: 0.75pt;;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">4,116</div></td><td style="white-space: nowrap; padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total compensation for the Supervisory Board amounted to &#8364;0.4&#160;million in 2019: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"><tr style="font-size: 0px;"><td style="width:77%;"></td><td style="vertical-align:bottom;;width:5%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:5%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:5%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Peter<br/> Chambr&#233;</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Harald<br/> F.&#160;Stock</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Total</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Supervisory board fee</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">300</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">9</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">309</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Travel expenses</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">87</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">20</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">107</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">387</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">29</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">416</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total compensation for the Supervisory Board amounted to &#8364;0.5&#160;million in 2018: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:84%;"><tr style="font-size: 0px;"><td style="width:77%;"></td><td style="vertical-align:bottom;;width:5%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:5%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:5%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.75pt;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">(Euros in thousands)</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Peter<br/> Chambr&#233;</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Harald<br/> F.&#160;Stock</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Total</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Supervisory board fee</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">400</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">410</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Travel expenses</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">52</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">16</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">68</div></td><td style="white-space: nowrap;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">452</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">26</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">478</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfCompensationManagingDirectorsAndSupervisoryBoardTextBlock', window );">Summary of Options Granted to Managing Director and Supervisory Directors</a></td>
<td class="text">The following options were granted to Immatics&#8217; Managing Director&#160;and Supervisory Directors:<table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="font-family: &quot;times new roman&quot;;;width:35%;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:1%;"></td><td style="font-family: &quot;times new roman&quot;;;width:20%;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:1%;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:1%;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:1%;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:1%;"></td><td style="font-family: &quot;times new roman&quot;;;width:15%;"></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Type of options</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Grant date</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Number of<br/> Options</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Strike<br/> Price&#160;in<br/> USD</div></td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 0.75pt;;vertical-align:bottom;">&#160;&#160;</td><td style="border-bottom: 0.75pt solid black;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Expiration date</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Managing Director</div></div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Harpreet Singh</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="text-align:right;;vertical-align:top;">Performance-based&#160;options</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:top;">&#160;</td><td style="text-align:right;;vertical-align:top;">June&#160;30, 2020</td><td style="white-space: nowrap;;vertical-align:top;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">1,598,000</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">10</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="text-align:right;;vertical-align:top;">June&#160;30, 2030</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Harpreet Singh</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">Service options</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:top;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">June&#160;30, 2020</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:top;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">168,000</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">June&#160;30, 2030</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Harpreet Singh</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="text-align:right;;vertical-align:top;">Matching Stock options</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:top;">&#160;</td><td style="text-align:right;;vertical-align:top;">June&#160;30, 2020</td><td style="white-space: nowrap;;vertical-align:top;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">264,624</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">10</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="text-align:right;;vertical-align:top;">June&#160;30, 2030</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Harpreet Singh</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">Converted options</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:top;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">June&#160;30, 2020</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:top;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">30,939</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.06</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">July&#160;1, 2027</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Harpreet Singh</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="text-align:right;;vertical-align:top;">Converted options</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:top;">&#160;</td><td style="text-align:right;;vertical-align:top;">June&#160;30, 2020</td><td style="white-space: nowrap;;vertical-align:top;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">145,371</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">1.17</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="text-align:right;;vertical-align:top;">January&#160;1, 2028</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Harpreet Singh</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">Service options</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">December&#160;17,&#160;2020</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">168,000</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">9.70</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">December&#160;17,&#160;2030</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Supervisory Directors</div></div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Peter Chambr&#233;</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">Service options</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:top;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">June&#160;30, 2020</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:top;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">25,000</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">June&#160;30, 2030</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Peter Chambr&#233;</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="text-align:right;;vertical-align:top;">Matching Stock options</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:top;">&#160;</td><td style="text-align:right;;vertical-align:top;">June&#160;30, 2020</td><td style="white-space: nowrap;;vertical-align:top;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">211,974</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">10</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="text-align:right;;vertical-align:top;">June&#160;30, 2030</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Adam Stone</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">Service options</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:top;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">June&#160;30, 2020</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:top;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">25,000</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">June&#160;30, 2030</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Christoph Hettich</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="text-align:right;;vertical-align:top;">Service options</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:top;">&#160;</td><td style="text-align:right;;vertical-align:top;">June&#160;30, 2020</td><td style="white-space: nowrap;;vertical-align:top;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">25,000</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">10</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="text-align:right;;vertical-align:top;">June&#160;30, 2030</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Heather L. Mason</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">Service options</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:top;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">June&#160;30, 2020</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:top;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">25,000</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">June&#160;30, 2030</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Michael G. Atieh</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="text-align:right;;vertical-align:top;">Service options</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:top;">&#160;</td><td style="text-align:right;;vertical-align:top;">June&#160;30, 2020</td><td style="white-space: nowrap;;vertical-align:top;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">25,000</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">10</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="text-align:right;;vertical-align:top;">June&#160;30, 2030</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Paul Carter</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">Service options</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:top;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">June&#160;30, 2020</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:top;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">25,000</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:top;">June&#160;30, 2030</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Eliot Forster</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="text-align:right;;vertical-align:top;">Service options</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:top;">&#160;</td><td style="text-align:right;;vertical-align:top;">September&#160;14,&#160;2020</td><td style="white-space: nowrap;;vertical-align:top;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">25,000</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;">&#160;</td><td style="text-align:right;;vertical-align:bottom;">9.16</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="text-align:right;;vertical-align:top;">September&#160;13,&#160;2030</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfCompensationManagingDirectorsAndSupervisoryBoardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of compensation Managing directors and supervisory board.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfCompensationManagingDirectorsAndSupervisoryBoardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfCompensationOfKeyManagementPersonnelTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of compensation of key management personnel.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfCompensationOfKeyManagementPersonnelTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfCompensationSupervisoryBoardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of compensation supervisory board.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfCompensationSupervisoryBoardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169238275512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Group information - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DateOfEndOfReportingPeriod2013', window );">Date of end of reporting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 31,  2020<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=imtx_AuthorizationOfFinancialStatementsMember', window );">Authorization Of Financial Statements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DateOfAuthorisationForIssueOfFinancialStatements2013', window );">Date of authorisation for issue of financial statements</a></td>
<td class="text">Mar. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DateOfAuthorisationForIssueOfFinancialStatements2013">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The date on which financial statements are authorised for issue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 10<br> -IssueDate 2020-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=10&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DateOfAuthorisationForIssueOfFinancialStatements2013</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DateOfEndOfReportingPeriod2013">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The date of the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 51<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_51_c&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DateOfEndOfReportingPeriod2013</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=imtx_AuthorizationOfFinancialStatementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=imtx_AuthorizationOfFinancialStatementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169238460120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of presentation - Summary of Reconciliation Of Changes In Cash Flow Statement (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementLineItems', window );"><strong>Disclosure Of Reconciliation Of Changes In Cash Flow Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets', window );">(Increase) decrease in other assets</a></td>
<td class="num">&#8364; (373)<span></span>
</td>
<td class="num">&#8364; (1,106)<span></span>
</td>
<td class="num">&#8364; (1,600)<span></span>
</td>
<td class="num">&#8364; (1,497)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 5,608<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Net cash provided by/ (used in) operating activities</a></td>
<td class="num">(11,450)<span></span>
</td>
<td class="num">(27,739)<span></span>
</td>
<td class="num">(85,610)<span></span>
</td>
<td class="nump">70,967<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">20,684<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Cash paid for investments in Other financial assets</a></td>
<td class="num">(32,859)<span></span>
</td>
<td class="num">(32,859)<span></span>
</td>
<td class="num">(82,930)<span></span>
</td>
<td class="num">(20,473)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(13,101)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Cash received from maturity of investments classified in Other financial assets</a></td>
<td class="nump">16,023<span></span>
</td>
<td class="nump">48,882<span></span>
</td>
<td class="nump">74,505<span></span>
</td>
<td class="nump">17,551<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Net cash provided by/ (used in) investing activities</a></td>
<td class="num">(19,223)<span></span>
</td>
<td class="nump">11,473<span></span>
</td>
<td class="num">&#8364; (15,949)<span></span>
</td>
<td class="num">(5,059)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(13,514)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_PreviouslyStatedMember', window );">Previously stated [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementLineItems', window );"><strong>Disclosure Of Reconciliation Of Changes In Cash Flow Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets', window );">(Increase) decrease in other assets</a></td>
<td class="num">(17,209)<span></span>
</td>
<td class="nump">14,917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,419)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(7,493)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Net cash provided by/ (used in) operating activities</a></td>
<td class="num">(28,286)<span></span>
</td>
<td class="num">(11,716)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,045<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,583<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Net cash provided by/ (used in) investing activities</a></td>
<td class="num">(2,387)<span></span>
</td>
<td class="num">(4,550)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,137)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(413)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember', window );">Increase (decrease) due to changes in accounting policy and corrections of prior period errors [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementLineItems', window );"><strong>Disclosure Of Reconciliation Of Changes In Cash Flow Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets', window );">(Increase) decrease in other assets</a></td>
<td class="nump">16,836<span></span>
</td>
<td class="num">(16,023)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,922<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Net cash provided by/ (used in) operating activities</a></td>
<td class="nump">16,836<span></span>
</td>
<td class="num">(16,023)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,922<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Cash paid for investments in Other financial assets</a></td>
<td class="num">(32,859)<span></span>
</td>
<td class="num">(32,859)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,473)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(13,101)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod', window );">Cash received from maturity of investments classified in Other financial assets</a></td>
<td class="nump">16,023<span></span>
</td>
<td class="nump">48,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,551<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Net cash provided by/ (used in) investing activities</a></td>
<td class="num">&#8364; (16,836)<span></span>
</td>
<td class="nump">&#8364; 16,023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (2,922)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">&#8364; (13,101)<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See Note 2 for details regarding the revision as a result of a correction in classification of Other financial assets</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in other assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other assets; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of investments other than investments accounted for using the equity method. [Refer: Investments accounted for using equity method; Investments other than investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of investments other than investments accounted for using equity method. [Refer: Investments accounted for using equity method; Investments other than investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of reconciliation of changes in cash flow statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfReconciliationOfChangesInCashFlowStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_PreviouslyStatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_PreviouslyStatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169238178232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of presentation - Additional Information (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership interests held by non-controlling interests</a></td>
<td class="nump">5.14%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialAssets', window );">Other financial assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 16,023<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 24,448<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imtx_ImmaticsUsIncMember', window );">Immatics US Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership interests held by non-controlling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.96%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3.96%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialAssets', window );">Other financial assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 16,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See Note 2 for details regarding the change in presentation of Other financial assets</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets; Current financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 54<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_54_d&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interests in a subsidiary held by non-controlling interests. [Refer: Subsidiaries [member]; Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph 12<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_12_c&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imtx_ImmaticsUsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imtx_ImmaticsUsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169214914904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ARYA Merger - Additional Information (Detail)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 01, 2020 </div>
<div>EUR (&#8364;) </div>
<div>shares </div>
<div>Warrants</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;) </div>
<div>shares </div>
<div>Warrants</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest', window );">Increase decrease through Changes in Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ShareListingExpense', window );">Share listing expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 152,787<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners', window );">Increase through other contributions by owners, equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,077<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Share issue related cost</a></td>
<td class="nump">&#8364; 7,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsForShareIssueCosts', window );">Payment for share issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,939<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_IssuedCapitalMember', window );">Issued capital [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncreaseDecreaseThroughReorganizationEquity', window );">Increase Decrease Through Reorganization Equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(833)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest', window );">Increase decrease through Changes in Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners', window );">Increase through other contributions by owners, equity</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_SharePremiumMember', window );">Share premium [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncreaseDecreaseThroughReorganizationEquity', window );">Increase Decrease Through Reorganization Equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">833<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest', window );">Increase decrease through Changes in Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">501<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners', window );">Increase through other contributions by owners, equity</a></td>
<td class="nump">90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,973<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfOrdinarySharesAxis=imtx_PipeFinancingMember', window );">PIPE Financing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares', window );">Proceeds from issue of ordinary shares</a></td>
<td class="nump">90,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imtx_AryaMember', window );">ARYA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncreaseDecreaseThroughReorganizationEquity', window );">Increase Decrease Through Reorganization Equity</a></td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest', window );">Increase decrease through Changes in Noncontrolling Interest</a></td>
<td class="nump">&#8364; 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfHowAcquirerObtainedControlOfAcquiree', window );">Description Of How Acquirer Obtained Control Of Acquire</a></td>
<td class="text">one ordinary share of Immatics N.V. for each issued and outstanding ordinary share of ARYA and one warrant to purchase ordinary shares in Immatics N.V., for each issued and outstanding warrant to acquire ordinary shares<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Net Assets Acquired (Liabilities Assumed)</a></td>
<td class="nump">&#8364; 124,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 124,927<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash and cash equivalents recognised as of acquisition date</a></td>
<td class="nump">128,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate', window );">Current liabilities recognised as of acquisition date</a></td>
<td class="nump">3,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ShareListingExpense', window );">Share listing expense</a></td>
<td class="nump">&#8364; 152,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imtx_AryaMember', window );">ARYA [Member] | Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable', window );">Number of instruments issued or issuable | Warrants</a></td>
<td class="nump">7,187,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,187,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imtx_AryaMember', window );">ARYA [Member] | Ordinary shares [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable', window );">Number of instruments issued or issuable | shares</a></td>
<td class="nump">17,968,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,968,750<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2020-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for current liabilities assumed in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2020-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfHowAcquirerObtainedControlOfAcquiree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of how the acquirer obtained the power to govern the financial and operating policies of the acquiree so as to obtain benefits from its activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2020-01-01<br> -Paragraph B64<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B64_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfHowAcquirerObtainedControlOfAcquiree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for net identifiable assets acquired or liabilities assumed in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2020-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2020-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through other contributions by owners that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2020-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B64_f_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsForShareIssueCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for share issue costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsForShareIssueCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssueOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareIssueRelatedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cost related to the issuance of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareIssueRelatedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_IncreaseDecreaseThroughReorganizationEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) through reorganization, equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_IncreaseDecreaseThroughReorganizationEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) through changes in noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_ShareListingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share listing expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_ShareListingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_IssuedCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_IssuedCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_SharePremiumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_SharePremiumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfOrdinarySharesAxis=imtx_PipeFinancingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfOrdinarySharesAxis=imtx_PipeFinancingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imtx_AryaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imtx_AryaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=imtx_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=imtx_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169214853256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Application of new and revised international financial reporting standards - Summary of Application of new standards  (Detail)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NewIFRSsAxis=imtx_AmendmentsToIfrsThreeMember', window );">Amendments To IFRS 3</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems', window );"><strong>Disclosure of expected impact of initial application of new standards or interpretations [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TitleOfNewIFRS', window );">Title of new IFRS</a></td>
<td class="text">Amendments to IFRS 3, &#8220;Business combinations&#8221;, - Definition of a business<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DateByWhichApplicationOfNewIFRSIsRequired', window );">Date by which application of new IFRS is required</a></td>
<td class="text">Jan.  01,  2020<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NewIFRSsAxis=imtx_AmendmentsToIasOneAndIasEightMember', window );">Amendments To IAS 1 And IAS 8</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems', window );"><strong>Disclosure of expected impact of initial application of new standards or interpretations [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TitleOfNewIFRS', window );">Title of new IFRS</a></td>
<td class="text">Amendments to IAS 1, &#8220;Presentation of financial statements&#8221;, and IAS 8, &#8220;Accounting policies, changes in accounting estimates and errors&#8221;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DateByWhichApplicationOfNewIFRSIsRequired', window );">Date by which application of new IFRS is required</a></td>
<td class="text">Jan.  01,  2020<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NewIFRSsAxis=imtx_AmendmentsToIfrsNineIasThirtyNineAndIfrsSeventeenMember', window );">Amendments To IFRS Nine IAS 39 And IFRS 17</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems', window );"><strong>Disclosure of expected impact of initial application of new standards or interpretations [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TitleOfNewIFRS', window );">Title of new IFRS</a></td>
<td class="text">Amendment to IFRS 9, IAS 39 and IFRS 17: - Interest rate benchmark reform<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DateByWhichApplicationOfNewIFRSIsRequired', window );">Date by which application of new IFRS is required</a></td>
<td class="text">Jan.  01,  2020<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NewIFRSsAxis=imtx_AmendmentsToConceptualFrameworkMember', window );">Amendments To Conceptual Framework [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems', window );"><strong>Disclosure of expected impact of initial application of new standards or interpretations [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TitleOfNewIFRS', window );">Title of new IFRS</a></td>
<td class="text">Amendment to the Conceptual framework<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DateByWhichApplicationOfNewIFRSIsRequired', window );">Date by which application of new IFRS is required</a></td>
<td class="text">Jan.  01,  2020<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DateByWhichApplicationOfNewIFRSIsRequired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The date by which the entity is required to apply a new IFRS that has been issued but is not yet effective.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 31<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_31_c&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DateByWhichApplicationOfNewIFRSIsRequired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TitleOfNewIFRS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The title of a new IFRS that has been issued but is not yet effective.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 31<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_31_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TitleOfNewIFRS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NewIFRSsAxis=imtx_AmendmentsToIfrsThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NewIFRSsAxis=imtx_AmendmentsToIfrsThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NewIFRSsAxis=imtx_AmendmentsToIasOneAndIasEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NewIFRSsAxis=imtx_AmendmentsToIasOneAndIasEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NewIFRSsAxis=imtx_AmendmentsToIfrsNineIasThirtyNineAndIfrsSeventeenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NewIFRSsAxis=imtx_AmendmentsToIfrsNineIasThirtyNineAndIfrsSeventeenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NewIFRSsAxis=imtx_AmendmentsToConceptualFrameworkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NewIFRSsAxis=imtx_AmendmentsToConceptualFrameworkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169238837800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Application of new and revised international financial reporting standards - Summary of Non Mandatory  standards and interpretations issued by  IASB (Detail)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NewIFRSsAxis=imtx_IfrsSixteenMember', window );">IFRS 16</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems', window );"><strong>Disclosure of expected impact of initial application of new standards or interpretations [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TitleOfNewIFRS', window );">Title of new IFRS</a></td>
<td class="text">IFRS 16 COVID-19-Related Rent Concessions Amendment<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DateByWhichApplicationOfNewIFRSIsRequired', window );">Date by which application of new IFRS is required</a></td>
<td class="text">Jan.  01,  2021<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NewIFRSsAxis=imtx_AmendmentsToIasOneMember', window );">Amendments To IAS 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems', window );"><strong>Disclosure of expected impact of initial application of new standards or interpretations [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TitleOfNewIFRS', window );">Title of new IFRS</a></td>
<td class="text">Amendments to IAS 1,&#8221; Presentation of financial statements&#8221;, on classification of liabilities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DateByWhichApplicationOfNewIFRSIsRequired', window );">Date by which application of new IFRS is required</a></td>
<td class="text">Jan.  01,  2022<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NewIFRSsAxis=imtx_IfrsSeventeenMember', window );">IFRS 17</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems', window );"><strong>Disclosure of expected impact of initial application of new standards or interpretations [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TitleOfNewIFRS', window );">Title of new IFRS</a></td>
<td class="text">IFRS 17 Insurance contracts<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DateByWhichApplicationOfNewIFRSIsRequired', window );">Date by which application of new IFRS is required</a></td>
<td class="text">Jan.  01,  2023<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DateByWhichApplicationOfNewIFRSIsRequired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The date by which the entity is required to apply a new IFRS that has been issued but is not yet effective.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 31<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_31_c&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DateByWhichApplicationOfNewIFRSIsRequired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TitleOfNewIFRS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The title of a new IFRS that has been issued but is not yet effective.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 31<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_31_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TitleOfNewIFRS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NewIFRSsAxis=imtx_IfrsSixteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NewIFRSsAxis=imtx_IfrsSixteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NewIFRSsAxis=imtx_AmendmentsToIasOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NewIFRSsAxis=imtx_AmendmentsToIasOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NewIFRSsAxis=imtx_IfrsSeventeenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NewIFRSsAxis=imtx_IfrsSeventeenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169238158632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of accounting policies applied by the Group for the annual reporting period ending December 31, 2020 - Summary of estimated Useful Lives of Property, Plant and Equipment (Detail)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [member] | Computer equipment [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesLineItems', window );"><strong>Disclosure Of Property Plant And Equipment Estimated Useful Lives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful life measured as period of time, property, plant and equipment</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [member] | Laboratory equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesLineItems', window );"><strong>Disclosure Of Property Plant And Equipment Estimated Useful Lives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful life measured as period of time, property, plant and equipment</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [member] | Office equipment [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesLineItems', window );"><strong>Disclosure Of Property Plant And Equipment Estimated Useful Lives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful life measured as period of time, property, plant and equipment</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member] | Computer equipment [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesLineItems', window );"><strong>Disclosure Of Property Plant And Equipment Estimated Useful Lives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful life measured as period of time, property, plant and equipment</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member] | Laboratory equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesLineItems', window );"><strong>Disclosure Of Property Plant And Equipment Estimated Useful Lives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful life measured as period of time, property, plant and equipment</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member] | Office equipment [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesLineItems', window );"><strong>Disclosure Of Property Plant And Equipment Estimated Useful Lives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful life measured as period of time, property, plant and equipment</a></td>
<td class="text">20 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2020-01-01<br> -Paragraph 73<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_73_c&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of property plant and equipment estimated useful lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLivesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=imtx_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=imtx_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169214831352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of accounting policies applied by the Group for the annual reporting period ending December 31, 2020 - Summary of useful life of intangible assets other than goodwill (Detail)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember', window );">Licences [member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillLineItems', window );"><strong>Disclosure Of Detailed Information About Useful Life Measured As Period Of Time Intangible Assets Other Than Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life measured as period of time, intangible assets other than goodwill</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember', window );">Licences [member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillLineItems', window );"><strong>Disclosure Of Detailed Information About Useful Life Measured As Period Of Time Intangible Assets Other Than Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life measured as period of time, intangible assets other than goodwill</a></td>
<td class="text">30 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember', window );">Computer software [member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillLineItems', window );"><strong>Disclosure Of Detailed Information About Useful Life Measured As Period Of Time Intangible Assets Other Than Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life measured as period of time, intangible assets other than goodwill</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember', window );">Computer software [member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillLineItems', window );"><strong>Disclosure Of Detailed Information About Useful Life Measured As Period Of Time Intangible Assets Other Than Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life measured as period of time, intangible assets other than goodwill</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2020-01-01<br> -Paragraph 118<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_118_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about useful life measured as period of time intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfDetailedInformationAboutUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169238670072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of accounting policies applied by the Group for the annual reporting period ending December 31, 2020 - Summary of foreign exchange rates (Detail)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesLineItems', window );"><strong>Disclosure Of Detailed Information About Foreign Exchange Rates [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClosingForeignExchangeRate', window );">Closing foreign exchange rate</a></td>
<td class="nump">0.8149<span></span>
</td>
<td class="nump">0.8902<span></span>
</td>
<td class="nump">0.8738<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AverageForeignExchangeRate', window );">Average foreign exchange rate</a></td>
<td class="nump">0.8762<span></span>
</td>
<td class="nump">0.8932<span></span>
</td>
<td class="nump">0.8468<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AverageForeignExchangeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average exchange rate used by the entity. Exchange rate is the ratio of exchange for two currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AverageForeignExchangeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClosingForeignExchangeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The spot exchange rate at the end of the reporting period. Exchange rate is the ratio of exchange for two currencies. Spot exchange rate is the exchange rate for immediate delivery.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClosingForeignExchangeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about foreign exchange rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfDetailedInformationAboutForeignExchangeRatesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237522968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of accounting policies applied by the Group for the annual reporting period ending December 31, 2020 - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_RentalContractTerm', window );">Rental Contract Term</a></td>
<td class="text">two<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_RentalContractTerm', window );">Rental Contract Term</a></td>
<td class="text">seven<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_RentalContractTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental contract term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_RentalContractTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_StatementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_StatementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237544392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts receivable - Summary of Trade receivables (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract', window );"><strong>Trade and other current receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ReceivablesFromCollaborationAgreements', window );">Receivables From Collaboration Agreements</a></td>
<td class="nump">&#8364; 1,250<span></span>
</td>
<td class="nump">&#8364; 957<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Accounts receivable</a></td>
<td class="nump">&#8364; 1,250<span></span>
</td>
<td class="nump">&#8364; 957<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See Note 2 for details regarding the change in presentation of Other financial assets</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_ReceivablesFromCollaborationAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Receivables from collaboration agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_ReceivablesFromCollaborationAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169215435240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts receivable - Additional Information (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract', window );"><strong>Trade and other current receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount due from customers for goods and services sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169241552360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other current and non-current assets -Summary of Other current assets (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivablesAbstract', window );"><strong>Trade and other receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_CurrentGrantReceivable', window );">Grant receivable</a></td>
<td class="nump">&#8364; 875<span></span>
</td>
<td class="nump">&#8364; 998<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentPrepaidExpenses', window );">Prepaid expenses</a></td>
<td class="nump">2,389<span></span>
</td>
<td class="nump">1,236<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PositiveMarketValueForwardContract', window );">Positive market value forward contract</a></td>
<td class="nump">914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentValueAddedTaxReceivables', window );">Value added tax receivable</a></td>
<td class="nump">798<span></span>
</td>
<td class="nump">768<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_CapitalizedTransactionCosts', window );">Capitalized transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherAssets', window );">Other assets</a></td>
<td class="nump">787<span></span>
</td>
<td class="nump">617<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentAssets', window );">Other current assets</a></td>
<td class="nump">&#8364; 5,763<span></span>
</td>
<td class="nump">&#8364; 3,667<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See Note 2 for details regarding the change in presentation of Other financial assets</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentValueAddedTaxReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current value added tax receivables. [Refer: Value added tax receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentValueAddedTaxReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current assets that the entity does not separately disclose in the same statement or note. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_CapitalizedTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Capitalized transaction costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_CapitalizedTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_CurrentGrantReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Current grant receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_CurrentGrantReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_PositiveMarketValueForwardContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Positive market value forward contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_PositiveMarketValueForwardContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169215425320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other current and non-current assets - Additional Information (Details) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_CurrentPrepaidInsurance', window );">Prepaid insurance expenses</a></td>
<td class="nump">&#8364; 1,000<span></span>
</td>
<td class="nump">&#8364; 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PrepaidExpensesOfLicensesAndSoftware', window );">Prepaid expenses of licenses and software</a></td>
<td class="nump">600<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherAssets', window );">Other assets</a></td>
<td class="nump">787<span></span>
</td>
<td class="nump">617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentPrepayments', window );">Non-current prepayments</a></td>
<td class="nump">724<span></span>
</td>
<td class="nump">937<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_BalanceSheetLocationAxis=imtx_ReceivablesFromCapitalGainsTaxMember', window );">Receivables From Capital Gains Tax [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherAssets', window );">Other assets</a></td>
<td class="nump">400<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_CollaborationAgreementAxis=imtx_CelgeneSwitzerlandLlcAndGenmabAsMember', window );">Celgene Switzerland LLC And Genmab AS [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_CurrentIncrementalCostForCollaborationAgreement', window );">Current Incremental cost for collaboration agreement</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentPrepayments', window );">Non-current prepayments</a></td>
<td class="nump">&#8364; 700<span></span>
</td>
<td class="nump">&#8364; 900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentPrepayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current prepayments. [Refer: Prepayments]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentPrepayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_CurrentIncrementalCostForCollaborationAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Current incremental cost for collaboration agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_CurrentIncrementalCostForCollaborationAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_CurrentPrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Current prepaid insurance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_CurrentPrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_PrepaidExpensesOfLicensesAndSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid expenses of licenses and software.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_PrepaidExpensesOfLicensesAndSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_BalanceSheetLocationAxis=imtx_ReceivablesFromCapitalGainsTaxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_BalanceSheetLocationAxis=imtx_ReceivablesFromCapitalGainsTaxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_CollaborationAgreementAxis=imtx_CelgeneSwitzerlandLlcAndGenmabAsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_CollaborationAgreementAxis=imtx_CelgeneSwitzerlandLlcAndGenmabAsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169240187368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other current and non-current assets - Summary of Other&amp;#160;non-current&amp;#160;assets (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentReceivablesAbstract', window );"><strong>Trade and other non-current receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentPrepayments', window );">Prepaid expenses</a></td>
<td class="nump">&#8364; 724<span></span>
</td>
<td class="nump">&#8364; 937<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_OtherNonCurrentAsset', window );">Other non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">325<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentAssets', window );">Total non-current assets</a></td>
<td class="nump">&#8364; 724<span></span>
</td>
<td class="nump">&#8364; 1,262<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See Note 2 for details regarding the change in presentation of Other financial assets</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentPrepayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current prepayments. [Refer: Prepayments]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentPrepayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_OtherNonCurrentAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other non current asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_OtherNonCurrentAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169213931848">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment - Summary of Changes to property, plant and equipment (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 4,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,868<span></span>
</td>
<td class="nump">&#8364; 4,720<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=imtx_LaboratoryEquipmentMember', window );">Laboratory Equipment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,493<span></span>
</td>
<td class="nump">3,420<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">Computer equipment [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">894<span></span>
</td>
<td class="nump">906<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember', window );">Office equipment [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,481<span></span>
</td>
<td class="nump">394<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TypeOfAdoptionsAxis=imtx_AdjustmentOnAdoptionIfrsSixteenMember', window );">Adjustment On Adoption IFRS 16</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(441)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17,432<span></span>
</td>
<td class="nump">15,116<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_AdditionsOtherPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,379<span></span>
</td>
<td class="nump">3,016<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisposalsOfPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7<span></span>
</td>
<td class="num">(316)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_CurrencyTranslationDifferences', window );">Currency translation differences</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">367<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">22,437<span></span>
</td>
<td class="nump">17,432<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Laboratory Equipment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,723<span></span>
</td>
<td class="nump">11,222<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_AdditionsOtherPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,545<span></span>
</td>
<td class="nump">2,204<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisposalsOfPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="num">(314)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_CurrencyTranslationDifferences', window );">Currency translation differences</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">299<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,968<span></span>
</td>
<td class="nump">12,723<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Computer equipment [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,956<span></span>
</td>
<td class="nump">2,439<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_AdditionsOtherPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">406<span></span>
</td>
<td class="nump">515<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisposalsOfPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_CurrencyTranslationDifferences', window );">Currency translation differences</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">40<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,322<span></span>
</td>
<td class="nump">2,956<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Office equipment [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,753<span></span>
</td>
<td class="nump">1,455<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_AdditionsOtherPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,427<span></span>
</td>
<td class="nump">297<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisposalsOfPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_CurrencyTranslationDifferences', window );">Currency translation differences</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">28<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,146<span></span>
</td>
<td class="nump">1,753<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Previously stated [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,675<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Previously stated [member] | Laboratory Equipment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,781<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Previously stated [member] | Computer equipment [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,439<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Previously stated [member] | Office equipment [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,455<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Adjustment On Adoption IFRS 16 | Laboratory Equipment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(441)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(12,712)<span></span>
</td>
<td class="num">(11,109)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_AdditionsOtherPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,102<span></span>
</td>
<td class="nump">1,797<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisposalsOfPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7<span></span>
</td>
<td class="num">(219)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_CurrencyTranslationDifferences', window );">Currency translation differences</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">239<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(14,568)<span></span>
</td>
<td class="num">(12,712)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation [member] | Laboratory Equipment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(9,303)<span></span>
</td>
<td class="num">(8,279)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_AdditionsOtherPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,384<span></span>
</td>
<td class="nump">1,219<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisposalsOfPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="num">(218)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_CurrencyTranslationDifferences', window );">Currency translation differences</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">210<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(10,476)<span></span>
</td>
<td class="num">(9,303)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation [member] | Computer equipment [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,050)<span></span>
</td>
<td class="num">(1,793)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_AdditionsOtherPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">404<span></span>
</td>
<td class="nump">256<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisposalsOfPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_CurrencyTranslationDifferences', window );">Currency translation differences</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">26<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,428)<span></span>
</td>
<td class="num">(2,050)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation [member] | Office equipment [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Beginning Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,359)<span></span>
</td>
<td class="num">(1,037)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_AdditionsOtherPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">315<span></span>
</td>
<td class="nump">322<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisposalsOfPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_CurrencyTranslationDifferences', window );">Currency translation differences</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Ending Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">&#8364; (1,665)<span></span>
</td>
<td class="num">&#8364; (1,359)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See Note 2 for details regarding the change in presentation of Other financial assets</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2020-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_AdditionsOtherPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additions other property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_AdditionsOtherPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_CurrencyTranslationDifferences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Currency translation differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_CurrencyTranslationDifferences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisposalsOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposals of property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisposalsOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=imtx_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=imtx_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TypeOfAdoptionsAxis=imtx_AdjustmentOnAdoptionIfrsSixteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TypeOfAdoptionsAxis=imtx_AdjustmentOnAdoptionIfrsSixteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_PreviouslyStatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_PreviouslyStatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169238580840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment - Summary of Depreciation expense (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation, property, plant and equipment</a></td>
<td class="nump">&#8364; 2,103<span></span>
</td>
<td class="nump">&#8364; 1,797<span></span>
</td>
<td class="nump">&#8364; 2,058<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncomeStatementLocationAxis=imtx_ResearchAndDevelopmentExpenseMember', window );">Research and development expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation, property, plant and equipment</a></td>
<td class="nump">1,503<span></span>
</td>
<td class="nump">1,315<span></span>
</td>
<td class="nump">1,757<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncomeStatementLocationAxis=imtx_GeneralAndAdministrativeExpenseMember', window );">General and administrative expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation, property, plant and equipment</a></td>
<td class="nump">&#8364; 600<span></span>
</td>
<td class="nump">&#8364; 482<span></span>
</td>
<td class="nump">&#8364; 301<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2020-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_73_e_vii&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2020-01-01<br> -Paragraph 75<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_75_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_IncomeStatementLocationAxis=imtx_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_IncomeStatementLocationAxis=imtx_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_IncomeStatementLocationAxis=imtx_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_IncomeStatementLocationAxis=imtx_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169215331352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets - Summary of Changes to intangible assets (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Beginning Balance</a></td>
<td class="nump">&#8364; 1,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Currency translation differences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Ending Balance</a></td>
<td class="nump">914<span></span>
</td>
<td class="nump">1,008<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=imtx_PatentAndLicensesMember', window );">Patent And Licenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Beginning Balance</a></td>
<td class="nump">851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Currency translation differences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Ending Balance</a></td>
<td class="nump">730<span></span>
</td>
<td class="nump">851<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=imtx_SoftwareLicensesMember', window );">Software Licenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Beginning Balance</a></td>
<td class="nump">157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Ending Balance</a></td>
<td class="nump">184<span></span>
</td>
<td class="nump">157<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Beginning Balance</a></td>
<td class="nump">1,863<span></span>
</td>
<td class="nump">1,752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Currency translation differences</a></td>
<td class="num">(97)<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Ending Balance</a></td>
<td class="nump">1,870<span></span>
</td>
<td class="nump">1,863<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Patent And Licenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Beginning Balance</a></td>
<td class="nump">1,220<span></span>
</td>
<td class="nump">1,201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Currency translation differences</a></td>
<td class="num">(88)<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Ending Balance</a></td>
<td class="nump">1,132<span></span>
</td>
<td class="nump">1,220<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Software Licenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Beginning Balance</a></td>
<td class="nump">643<span></span>
</td>
<td class="nump">551<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Currency translation differences</a></td>
<td class="num">(9)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Ending Balance</a></td>
<td class="nump">738<span></span>
</td>
<td class="nump">643<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedImpairmentMember', window );">Accumulated impairment [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Beginning Balance</a></td>
<td class="num">(855)<span></span>
</td>
<td class="num">(713)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">126<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Currency translation differences</a></td>
<td class="num">(25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Ending Balance</a></td>
<td class="num">(956)<span></span>
</td>
<td class="num">(855)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedImpairmentMember', window );">Accumulated impairment [member] | Patent And Licenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Beginning Balance</a></td>
<td class="num">(369)<span></span>
</td>
<td class="num">(314)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Currency translation differences</a></td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Ending Balance</a></td>
<td class="num">(403)<span></span>
</td>
<td class="num">(369)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedImpairmentMember', window );">Accumulated impairment [member] | Software Licenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Beginning Balance</a></td>
<td class="num">(486)<span></span>
</td>
<td class="num">(399)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Currency translation differences</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Ending Balance</a></td>
<td class="num">&#8364; (554)<span></span>
</td>
<td class="num">&#8364; (486)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2020-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in intangible assets and goodwill resulting from the net exchange differences arising when the financial statements are translated from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2020-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_118_e_vii&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of intangible assets and goodwill held by the entity. [Refer: Goodwill; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=imtx_PatentAndLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=imtx_PatentAndLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=imtx_SoftwareLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=imtx_SoftwareLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169278406360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets - Summary of Amortization expense (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortisation, intangible assets other than goodwill</a></td>
<td class="nump">&#8364; 126<span></span>
</td>
<td class="nump">&#8364; 111<span></span>
</td>
<td class="nump">&#8364; 118<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncomeStatementLocationAxis=imtx_ResearchAndDevelopmentExpenseMember', window );">Research and development expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortisation, intangible assets other than goodwill</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncomeStatementLocationAxis=imtx_GeneralAndAdministrativeExpenseMember', window );">General and administrative expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortisation, intangible assets other than goodwill</a></td>
<td class="nump">&#8364; 95<span></span>
</td>
<td class="nump">&#8364; 83<span></span>
</td>
<td class="nump">&#8364; 109<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2020-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_118_e_vi&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_IncomeStatementLocationAxis=imtx_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_IncomeStatementLocationAxis=imtx_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_IncomeStatementLocationAxis=imtx_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_IncomeStatementLocationAxis=imtx_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169215398888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Summary of Right-of&amp;#160;use assets (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">&#8364; 6,149<span></span>
</td>
<td class="nump">&#8364; 3,287<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_BuildingsMember', window );">Buildings [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">5,760<span></span>
</td>
<td class="nump">2,799<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_CommunicationAndNetworkEquipmentMember', window );">IT and telecommunication</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">258<span></span>
</td>
<td class="nump">349<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_VehiclesMember', window );">Vehicles [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">90<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_OtherAssetsMember', window );">Other assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">&#8364; 41<span></span>
</td>
<td class="nump">&#8364; 49<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See Note 2 for details regarding the change in presentation of Other financial assets</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2020-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_CommunicationAndNetworkEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_CommunicationAndNetworkEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169240187368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Details of Lease liabilities (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilitiesAbstract', window );"><strong>Lease liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Lease liability &#8211; current</a></td>
<td class="nump">&#8364; 1,881<span></span>
</td>
<td class="nump">&#8364; 1,411<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Lease liability &#8211; non-current</a></td>
<td class="nump">4,306<span></span>
</td>
<td class="nump">1,823<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Total</a></td>
<td class="nump">&#8364; 6,187<span></span>
</td>
<td class="nump">&#8364; 3,234<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See Note 2 for details regarding the change in presentation of Other financial assets</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2020-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2020-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2020-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169241904952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Summary of expenses related to&amp;#160;right-of-use&amp;#160;assets and lease liabilities (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesLineItems', window );"><strong>Disclosure Of Expenses Related ToRightOfUseAssets And Lease Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation, right-of-use assets</a></td>
<td class="nump">&#8364; 2,195<span></span>
</td>
<td class="nump">&#8364; 1,950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_InterestExpenseOnLease', window );">Interest expense form lease</a></td>
<td class="nump">260<span></span>
</td>
<td class="nump">170<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed', window );">Expense relating to short-term leases for which recognition exemption has been used</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_BuildingsMember', window );">Buildings [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesLineItems', window );"><strong>Disclosure Of Expenses Related ToRightOfUseAssets And Lease Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation, right-of-use assets</a></td>
<td class="nump">2,036<span></span>
</td>
<td class="nump">1,804<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_CommunicationAndNetworkEquipmentMember', window );">IT and telecommunication</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesLineItems', window );"><strong>Disclosure Of Expenses Related ToRightOfUseAssets And Lease Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation, right-of-use assets</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_VehiclesMember', window );">Vehicles [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesLineItems', window );"><strong>Disclosure Of Expenses Related ToRightOfUseAssets And Lease Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation, right-of-use assets</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_OtherAssetsMember', window );">Other assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesLineItems', window );"><strong>Disclosure Of Expenses Related ToRightOfUseAssets And Lease Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation, right-of-use assets</a></td>
<td class="nump">&#8364; 8<span></span>
</td>
<td class="nump">&#8364; 8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2020-01-01<br> -Paragraph 53<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_53_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the expense relating to short-term leases accounted for applying paragraph 6 of IFRS 16. This expense need not include the expense relating to leases with a lease term of one month or less. Short-term lease is a lease that, at the commencement date, has a lease term of 12 months or less. A lease that contains a purchase option is not a short-term lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2020-01-01<br> -Paragraph 53<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_53_c&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of expenses related to&#160;right-of-use&#160;assets and lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfExpensesRelatedTorightofuseassetsAndLeaseLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_InterestExpenseOnLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest expense on lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_InterestExpenseOnLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_CommunicationAndNetworkEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_CommunicationAndNetworkEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169215296472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Additional Information (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions to right-of-use assets</a></td>
<td class="nump">&#8364; 5,100<span></span>
</td>
<td class="nump">&#8364; 300<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TranslationDifferenceOnRightOfUseAsset', window );">Currency translation of &#160;right-of-use&#160;assets&#160;</a></td>
<td class="nump">300<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashOutflowForLeases', window );">Cash payments for leases</a></td>
<td class="nump">2,400<span></span>
</td>
<td class="nump">2,100<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Payments for leases</a></td>
<td class="nump">2,096<span></span>
</td>
<td class="nump">&#8364; 1,862<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember', window );">Until 2025 [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Payments for leases</a></td>
<td class="nump">6,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearMember', window );">Later than one year [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Payments for leases</a></td>
<td class="nump">&#8364; 2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See Note 2 for details regarding the revision as a result of a correction in classification of Other financial assets</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsToRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2020-01-01<br> -Paragraph 53<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_53_h&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsToRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashOutflowForLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2020-01-01<br> -Paragraph 53<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_53_g&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashOutflowForLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TranslationDifferenceOnRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Translation difference on right of use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TranslationDifferenceOnRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237462616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts payable - Summary of Accounts Payable (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract', window );"><strong>Trade and other current payables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Accounts payable</a></td>
<td class="nump">&#8364; 2,554<span></span>
</td>
<td class="nump">&#8364; 4,866<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_OtherAccruedLiabilities', window );">Other accrued liabilities</a></td>
<td class="nump">7,498<span></span>
</td>
<td class="nump">2,216<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers', window );">Total accounts payable</a></td>
<td class="nump">&#8364; 10,052<span></span>
</td>
<td class="nump">&#8364; 7,082<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See Note 2 for details regarding the change in presentation of Other financial assets</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 70<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of payment due to suppliers for goods and services used in the entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_OtherAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_OtherAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169270542872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts payable - Additional Information (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract', window );"><strong>Trade and other current payables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_OtherAccruedLiabilities', window );">Other accrued liabilities</a></td>
<td class="nump">&#8364; 7,498<span></span>
</td>
<td class="nump">&#8364; 2,216<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_OtherAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_OtherAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169214824008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue from collaboration agreements - Additional Information (Detail)<br> &#8364; in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems', window );"><strong>Disclosure Of Revenue From Contract With Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContractLiabilities', window );">Contract with customers liability</a></td>
<td class="nump">&#8364; 132,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 161,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsRecognisedFromCostsToObtainOrFulfilContractsWithCustomers', window );">Capitalized costs of contract net of amortization</a></td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationAssetsRecognisedFromCostsIncurredToObtainOrFulfilContractsWithCustomers', window );">Amortization of contract costs capitalized</a></td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">&#8364; 40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PotentialMilestonePaymentPayable', window );">Potential milestone payment payable</a></td>
<td class="nump">1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_AgreementAxis=imtx_AmgenCollaborationAgreementMember', window );">Amgen Collaboration Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems', window );"><strong>Disclosure Of Revenue From Contract With Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_UpfrontPaymentReceived', window );">Upfront payment received</a></td>
<td class="nump">28,000<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod', window );">Contract with customers liability revenue recognized</a></td>
<td class="nump">4,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,200<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContractLiabilities', window );">Contract with customers liability</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_AgreementAxis=imtx_AmgenCollaborationAgreementMember', window );">Amgen Collaboration Agreement [Member] | Development And Commercial Milestone Payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems', window );"><strong>Disclosure Of Revenue From Contract With Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_MilestonePaymentReceivable', window );">Milestone payment receivable | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">525<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_AgreementAxis=imtx_GenmabCollaborationAgreementMember', window );">Genmab Collaboration Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems', window );"><strong>Disclosure Of Revenue From Contract With Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_UpfrontPaymentReceived', window );">Upfront payment received</a></td>
<td class="nump">46,000<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod', window );">Contract with customers liability revenue recognized</a></td>
<td class="nump">11,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,200<span></span>
</td>
<td class="nump">&#8364; 2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContractLiabilities', window );">Contract with customers liability</a></td>
<td class="nump">26,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_AgreementAxis=imtx_GenmabCollaborationAgreementMember', window );">Genmab Collaboration Agreement [Member] | Milestone Payment For Licensed Product [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems', window );"><strong>Disclosure Of Revenue From Contract With Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_MilestonePaymentReceivable', window );">Milestone payment receivable | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">550<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_AgreementAxis=imtx_BMSCollaborationAgreementMember', window );">BMS Collaboration Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems', window );"><strong>Disclosure Of Revenue From Contract With Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_UpfrontPaymentReceived', window );">Upfront payment received</a></td>
<td class="nump">68,000<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod', window );">Contract with customers liability revenue recognized</a></td>
<td class="nump">11,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContractLiabilities', window );">Contract with customers liability</a></td>
<td class="nump">55,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_AgreementAxis=imtx_BMSCollaborationAgreementMember', window );">BMS Collaboration Agreement [Member] | Option Exercise Development Commecial And Regulatory Milestone Payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems', window );"><strong>Disclosure Of Revenue From Contract With Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_MilestonePaymentReceivable', window );">Milestone payment receivable | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">505<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_AgreementAxis=imtx_GSKCollaborationAgreementMember', window );">GSK Collaboration Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems', window );"><strong>Disclosure Of Revenue From Contract With Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_UpfrontPaymentReceived', window );">Upfront payment received | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod', window );">Contract with customers liability revenue recognized</a></td>
<td class="nump">3,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContractLiabilities', window );">Contract with customers liability</a></td>
<td class="nump">&#8364; 41,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_AgreementAxis=imtx_GSKCollaborationAgreementMember', window );">GSK Collaboration Agreement [Member] | Milestone Programs Based On The Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems', window );"><strong>Disclosure Of Revenue From Contract With Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_MilestonePaymentReceivable', window );">Milestone payment receivable | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 575<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationAssetsRecognisedFromCostsIncurredToObtainOrFulfilContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of amortisation for assets recognised from the costs incurred to obtain or fulfil contracts with customers. [Refer: Assets recognised from costs to obtain or fulfil contracts with customers; Amortisation expense]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2020-01-01<br> -Paragraph 128<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_128_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationAssetsRecognisedFromCostsIncurredToObtainOrFulfilContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsRecognisedFromCostsToObtainOrFulfilContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets recognised from the costs to obtain or fulfil contracts with customers. The costs to obtain a contract with a customer are the incremental costs of obtaining the contract that the entity would not have incurred if the contract had not been obtained. The costs to fulfil a contract with a customer are the costs that relate directly to a contract or to an anticipated contract that the entity can specifically identify.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2020-01-01<br> -Paragraph 128<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_128_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsRecognisedFromCostsToObtainOrFulfilContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of an entity&#8217;s obligation to transfer goods or services to a customer for which the entity has received consideration (or the amount is due) from the customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2020-01-01<br> -Paragraph 105<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2020-01-01<br> -Paragraph 116<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_116_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue that was included in the contract liability balance at the beginning of the period. [Refer: Contract liabilities; Revenue from contracts with customers]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2020-01-01<br> -Paragraph 116<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_116_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfRevenueFromContractWithCustomersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfRevenueFromContractWithCustomersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_MilestonePaymentReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Milestone payment receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_MilestonePaymentReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_PotentialMilestonePaymentPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Potential milestone payment payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_PotentialMilestonePaymentPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_UpfrontPaymentReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Upfront payment received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_UpfrontPaymentReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_AgreementAxis=imtx_AmgenCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_AgreementAxis=imtx_AmgenCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_MilestoneAxis=imtx_DevelopmentAndCommercialMilestonePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_MilestoneAxis=imtx_DevelopmentAndCommercialMilestonePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_AgreementAxis=imtx_GenmabCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_AgreementAxis=imtx_GenmabCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_MilestoneAxis=imtx_MilestonePaymentForLicensedProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_MilestoneAxis=imtx_MilestonePaymentForLicensedProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_AgreementAxis=imtx_BMSCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_AgreementAxis=imtx_BMSCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_MilestoneAxis=imtx_OptionExerciseDevelopmentCommecialAndRegulatoryMilestonePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_MilestoneAxis=imtx_OptionExerciseDevelopmentCommecialAndRegulatoryMilestonePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_AgreementAxis=imtx_GSKCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_AgreementAxis=imtx_GSKCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_MilestoneAxis=imtx_MilestoneProgramsBasedOnTheProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_MilestoneAxis=imtx_MilestoneProgramsBasedOnTheProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169240187368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue from collaboration agreements - Summary of Deferred revenue related to the collaboration agreements (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueAbstract', window );"><strong>Revenue [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentContractLiabilities', window );">Current</a></td>
<td class="nump">&#8364; 46,600<span></span>
</td>
<td class="nump">&#8364; 59,465<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentContractLiabilities', window );">Non-current</a></td>
<td class="nump">85,475<span></span>
</td>
<td class="nump">101,909<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContractLiabilities', window );">Total</a></td>
<td class="nump">&#8364; 132,075<span></span>
</td>
<td class="nump">&#8364; 161,374<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See Note 2 for details regarding the change in presentation of Other financial assets</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of an entity&#8217;s obligation to transfer goods or services to a customer for which the entity has received consideration (or the amount is due) from the customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2020-01-01<br> -Paragraph 105<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2020-01-01<br> -Paragraph 116<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_116_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current contract liabilities. [Refer: Contract liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2020-01-01<br> -Paragraph 105<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current contract liabilities. [Refer: Contract liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2020-01-01<br> -Paragraph 105<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237557528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other income - Summary of other income (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfOtherIncomeAbstract', window );"><strong>Disclosure of Other income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_GovernmentGrantReceivable', window );">Receivables</a></td>
<td class="nump">&#8364; 875<span></span>
</td>
<td class="nump">&#8364; 998<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DeferredIncomeCurrent', window );">Deferred income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">164<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TotalDeferredIncome', window );">Total</a></td>
<td class="nump">&#8364; 875<span></span>
</td>
<td class="nump">&#8364; 1,162<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DeferredIncomeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred income current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DeferredIncomeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfOtherIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfOtherIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_GovernmentGrantReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Government grant receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_GovernmentGrantReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TotalDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total deferred income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TotalDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237463176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other income - Additional Information (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromGovernmentGrants', window );">Revenue from grants</a></td>
<td class="nump">&#8364; 200<span></span>
</td>
<td class="nump">&#8364; 30<span></span>
</td>
<td class="nump">&#8364; 2,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ContingenciesRelatedToGrant', window );">Contingencies related to grant</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income recognised in relation to government grants. [Refer: Government grants]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 20<br> -IssueDate 2020-01-01<br> -Paragraph 39<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=20&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_39_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_ContingenciesRelatedToGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingencies related to grant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_ContingenciesRelatedToGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169215885816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other current liabilities - Summary of other current liabilities (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems', window );"><strong>Disclosure of detailed information about other current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTaxLiabilitiesCurrent', window );">Payroll tax</a></td>
<td class="nump">&#8364; 1,185<span></span>
</td>
<td class="nump">&#8364; 727<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AccrualsClassifiedAsCurrent', window );">Accrual for vacation</a></td>
<td class="nump">525<span></span>
</td>
<td class="nump">330<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DeferredGrantIncomeCurrent', window );">Deferred grant income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">164<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentProvisionsForEmployeeBenefits', window );">Accrued bonuses</a></td>
<td class="nump">154<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_OtherCurrent', window );">Other</a></td>
<td class="nump">161<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentLiabilities', window );">Total</a></td>
<td class="nump">&#8364; 2,025<span></span>
</td>
<td class="nump">&#8364; 1,288<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See Note 2 for details regarding the change in presentation of Other financial assets</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AccrualsClassifiedAsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of accruals classified as current. [Refer: Accruals]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AccrualsClassifiedAsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentProvisionsForEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current provisions for employee benefits. [Refer: Provisions for employee benefits]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 78<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_78_d&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentProvisionsForEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current amount of current tax liabilities. [Refer: Current tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 54<br> -Subparagraph n<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_54_n&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DeferredGrantIncomeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred grant income current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DeferredGrantIncomeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about other current liabilities line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_OtherCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_OtherCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169261943112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other current liabilities - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=imtx_NonInterestBearingLiabilityMember', window );">Non Interest Bearing Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems', window );"><strong>Disclosure of detailed information about other current liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Borrowings maturity</a></td>
<td class="text">one year<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsMaturity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maturity of borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsMaturity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about other current liabilities line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfDetailedInformationAboutOtherCurrentLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=imtx_NonInterestBearingLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=imtx_NonInterestBearingLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169262034600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial income and expenses - Summary of finance income and costs (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseAbstract', window );"><strong>Disclosure Of Detailed Information About Finance Income Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestIncomeOnDeposits', window );">Interest income from short-term deposits</a></td>
<td class="nump">&#8364; 850<span></span>
</td>
<td class="nump">&#8364; 790<span></span>
</td>
<td class="nump">&#8364; 507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetForeignExchangeGain', window );">Foreign currency gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,708<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GainLossRecognisedOnFinancialInstrumentsWhoseFairValuePreviouslyCouldNotBeReliablyMeasured', window );">Gain on other financial instruments</a></td>
<td class="nump">2,099<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Financial income</a></td>
<td class="nump">2,949<span></span>
</td>
<td class="nump">790<span></span>
</td>
<td class="nump">2,215<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Interest expenses form leases</a></td>
<td class="num">(289)<span></span>
</td>
<td class="num">(170)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetForeignExchangeLoss', window );">Foreign currency losses</a></td>
<td class="num">(9,774)<span></span>
</td>
<td class="num">(94)<span></span>
</td>
<td class="num">(145)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Financial expenses</a></td>
<td class="num">&#8364; (10,063)<span></span>
</td>
<td class="num">&#8364; (264)<span></span>
</td>
<td class="num">&#8364; (161)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainLossRecognisedOnFinancialInstrumentsWhoseFairValuePreviouslyCouldNotBeReliablyMeasured">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gain (loss) recognised on derecognition of financial instruments whose fair value previously could not be reliably measured. [Refer: Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2021-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 30<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2020-en-b&amp;anchor=para_30_e&amp;doctype=Standard&amp;book=b<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainLossRecognisedOnFinancialInstrumentsWhoseFairValuePreviouslyCouldNotBeReliablyMeasured</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2020-01-01<br> -Paragraph 53<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_53_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestIncomeOnDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income on deposits. [Refer: Interest income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestIncomeOnDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetForeignExchangeGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net gain arising from foreign exchange differences. [Refer: Foreign exchange gain (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2020-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetForeignExchangeGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetForeignExchangeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net loss arising from foreign exchange differences. [Refer: Foreign exchange gain (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2020-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetForeignExchangeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Detailed Information About Finance Income Expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169217108312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial income and expenses - Additional Information (Detail)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseAbstract', window );"><strong>Disclosure Of Detailed Information About Finance Income Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_RealisedGainLossFromForeignCurrencyForwardContracts', window );">Realised gain loss from foreign currency forward contracts</a></td>
<td class="nump">&#8364; 1.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_UnrealisedGainLossFromForeignCurrencyForwardContracts', window );">Unrealised gain loss from foreign currency forward contracts</a></td>
<td class="nump">&#8364; 0.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Detailed Information About Finance Income Expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_RealisedGainLossFromForeignCurrencyForwardContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Realised gain loss from foreign currency forward contracts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_RealisedGainLossFromForeignCurrencyForwardContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_UnrealisedGainLossFromForeignCurrencyForwardContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrealised gain loss from foreign currency forward contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_UnrealisedGainLossFromForeignCurrencyForwardContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169215463816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share listing expense - Additional Information (Detail)<br> &#8364; / shares in Units, &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Jul. 01, 2020 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Jul. 01, 2020 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfShareListingExpenseLineItems', window );"><strong>Disclosure of share listing expense [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Closing price of ARYA ordinary shares | &#8364; / shares</a></td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_AdjustmentsForShareListingExpense', window );">Expense on the closing date</a></td>
<td class="nump">&#8364; 152,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imtx_AryaMember', window );">ARYA [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfShareListingExpenseLineItems', window );"><strong>Disclosure of share listing expense [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Fair value of ARYA ordinary shares and warrants</a></td>
<td class="nump">277,715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Closing price of ARYA ordinary shares | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Identifiable net assets</a></td>
<td class="nump">124,927<span></span>
</td>
<td class="nump">&#8364; 124,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_AdjustmentsForShareListingExpense', window );">Expense on the closing date</a></td>
<td class="nump">152,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=imtx_WarrantsMember', window );">Warrants [member] | ARYA [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfShareListingExpenseLineItems', window );"><strong>Disclosure of share listing expense [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Fair value of ARYA ordinary shares and warrants</a></td>
<td class="nump">&#8364; 34,644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_WarrantsIssuedPricePerWarrant', window );">Closing price of ARYA public warrants | &#8364; / shares</a></td>
<td class="nump">&#8364; 4.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Ordinary shares [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfShareListingExpenseLineItems', window );"><strong>Disclosure of share listing expense [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Closing price of ARYA ordinary shares | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Ordinary shares [member] | ARYA [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfShareListingExpenseLineItems', window );"><strong>Disclosure of share listing expense [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Fair value of ARYA ordinary shares and warrants</a></td>
<td class="nump">&#8364; 243,071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Closing price of ARYA ordinary shares | &#8364; / shares</a></td>
<td class="nump">&#8364; 13.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityInterestsOfAcquirer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value, at the acquisition date, of equity interests of the acquirer transferred as consideration in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2020-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B64_f_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityInterestsOfAcquirer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for net identifiable assets acquired or liabilities assumed in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2020-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2020-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_AdjustmentsForShareListingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for share listing expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_AdjustmentsForShareListingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfShareListingExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of share listing expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfShareListingExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_WarrantsIssuedPricePerWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants issued price per warrant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_WarrantsIssuedPricePerWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imtx_AryaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imtx_AryaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=imtx_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=imtx_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169238524024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share listing expenses - Summary of Calculation of the Share listing expense (Detail)<br> &#8364; / shares in Units, &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;) </div>
<div>shares </div>
<div>Warrants </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Jul. 01, 2020 </div>
<div>EUR (&#8364;) </div>
<div>shares </div>
<div>Warrants </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Jul. 01, 2020 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems', window );"><strong>Disclosure of detailed information about share listing expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Closing price of ARYA Ordinary Shares on Nasdaq as of July 1, 2020 | &#8364; / shares</a></td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_AdjustmentsForShareListingExpense', window );">IFRS 2 Expense on the closing date</a></td>
<td class="nump">&#8364; 152,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Ordinary shares [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems', window );"><strong>Disclosure of detailed information about share listing expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Closing price of ARYA Ordinary Shares on Nasdaq as of July 1, 2020 | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imtx_AryaMember', window );">ARYA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems', window );"><strong>Disclosure of detailed information about share listing expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Closing price of ARYA Ordinary Shares on Nasdaq as of July 1, 2020 | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Fair value of outstanding ARYA</a></td>
<td class="nump">277,715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">ARYA's identifiable net assets</a></td>
<td class="nump">124,927<span></span>
</td>
<td class="nump">&#8364; 124,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_AdjustmentsForShareListingExpense', window );">IFRS 2 Expense on the closing date</a></td>
<td class="nump">&#8364; 152,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imtx_AryaMember', window );">ARYA [Member] | Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems', window );"><strong>Disclosure of detailed information about share listing expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable', window );">ARYA Shares | Warrants</a></td>
<td class="nump">7,187,500<span></span>
</td>
<td class="nump">7,187,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_WarrantsIssuedPricePerWarrant', window );">Closing price of ARYA Public Warrants on Nasdaq as of July 1, 2020 | &#8364; / shares</a></td>
<td class="nump">&#8364; 4.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Fair value of outstanding ARYA</a></td>
<td class="nump">&#8364; 34,644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imtx_AryaMember', window );">ARYA [Member] | Ordinary shares [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems', window );"><strong>Disclosure of detailed information about share listing expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable', window );">ARYA Shares | shares</a></td>
<td class="nump">17,968,750<span></span>
</td>
<td class="nump">17,968,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Closing price of ARYA Ordinary Shares on Nasdaq as of July 1, 2020 | &#8364; / shares</a></td>
<td class="nump">&#8364; 13.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Fair value of outstanding ARYA</a></td>
<td class="nump">&#8364; 243,071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityInterestsOfAcquirer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value, at the acquisition date, of equity interests of the acquirer transferred as consideration in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2020-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B64_f_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityInterestsOfAcquirer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for net identifiable assets acquired or liabilities assumed in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2020-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2020-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2020-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B64_f_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_AdjustmentsForShareListingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for share listing expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_AdjustmentsForShareListingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about share listing expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfDetailedInformationAboutShareListingExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_WarrantsIssuedPricePerWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants issued price per warrant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_WarrantsIssuedPricePerWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imtx_AryaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imtx_AryaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=imtx_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=imtx_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169214295624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based payments - Summary of Options Granted Priced Using Black Scholes for SARs, Tandem Awards, Converted Options, Matching Stock Options and Monte Carlo Option Pricing Model (Detail)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 17, 2020 </div>
<div>yr </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 14, 2020 </div>
<div>yr </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>yr </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>yr </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>yr </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>yr </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PlanAxis=imtx_TwoThousandAndSixteenTandemAwardsMember', window );">2016 Tandem Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.30<span></span>
</td>
<td class="nump">$ 23.82<span></span>
</td>
<td class="nump">$ 16.65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Underlying share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.94<span></span>
</td>
<td class="nump">$ 67.87<span></span>
</td>
<td class="nump">$ 27.21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78.00%<span></span>
</td>
<td class="nump">73.00%<span></span>
</td>
<td class="nump">64.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Time period (years) | yr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.10<span></span>
</td>
<td class="nump">1.25<span></span>
</td>
<td class="nump">5.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.04%<span></span>
</td>
<td class="nump">1.59%<span></span>
</td>
<td class="nump">2.77%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_CombinedProbabilityOfExitEventsShareOptionsGranted', window );">Combined probability of exit events</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00<span></span>
</td>
<td class="nump">80.00<span></span>
</td>
<td class="nump">25.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PlanAxis=imtx_MatchingStockOptionsMember', window );">Matching Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Underlying share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Time period (years) | yr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.29%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_ShareAppreciationRightsMember', window );">Share Appreciation Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.12<span></span>
</td>
<td class="nump">$ 1.12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Underlying share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67.87<span></span>
</td>
<td class="nump">$ 27.21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73.00%<span></span>
</td>
<td class="nump">64.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Time period (years) | yr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25<span></span>
</td>
<td class="nump">5.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.59%<span></span>
</td>
<td class="nump">2.77%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_CombinedProbabilityOfExitEventsShareOptionsGranted', window );">Combined probability of exit events</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00<span></span>
</td>
<td class="nump">25.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember', window );">Additional Grants Under 2020 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="nump">$ 9.70<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Underlying share price</a></td>
<td class="nump">$ 9.70<span></span>
</td>
<td class="nump">$ 9.16<span></span>
</td>
<td class="nump">$ 15.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Volatility</a></td>
<td class="nump">84.00%<span></span>
</td>
<td class="nump">79.00%<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Time period (years) | yr</a></td>
<td class="nump">6.0<span></span>
</td>
<td class="nump">6.2<span></span>
</td>
<td class="nump">7.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free rate</a></td>
<td class="nump">0.49%<span></span>
</td>
<td class="nump">0.37%<span></span>
</td>
<td class="nump">0.29%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_PerformanceBasedOptionsMember', window );">Performance Based Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Underlying share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.16<span></span>
</td>
<td class="nump">$ 15.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78.00%<span></span>
</td>
<td class="nump">79.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Time period (years) | yr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.7<span></span>
</td>
<td class="nump">7.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.67%<span></span>
</td>
<td class="nump">0.66%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_ConvertedOptionsMember', window );">Converted Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Underlying share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Time period (years) | yr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.29%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The option life of share options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfOptionLifeShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExercisePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exercise price of share options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExercisePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of an expected dividend used to calculate the fair value of share options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_CombinedProbabilityOfExitEventsShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Combined probability of exit events share options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_CombinedProbabilityOfExitEventsShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_PlanAxis=imtx_TwoThousandAndSixteenTandemAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_PlanAxis=imtx_TwoThousandAndSixteenTandemAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_PlanAxis=imtx_MatchingStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_PlanAxis=imtx_MatchingStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_ShareAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_ShareAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_PerformanceBasedOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_PerformanceBasedOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_ConvertedOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_ConvertedOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169212167976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based payments - Summary of Employee Share Options (Detail)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 17, 2020 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 14, 2020 </div>
<div>shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jul. 01, 2020 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>shares </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Outstanding at January&#160;1,</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.45<span></span>
</td>
<td class="nump">$ 16.65<span></span>
</td>
<td class="nump">$ 16.65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019', window );">SARs forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.81<span></span>
</td>
<td class="nump">16.65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Outstanding at December&#160;31,</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.45<span></span>
</td>
<td class="nump">$ 16.65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options, outstanding at January&#160;1, | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,469<span></span>
</td>
<td class="nump">74,401<span></span>
</td>
<td class="nump">31,880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">SARs forfeited | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,936<span></span>
</td>
<td class="nump">1,443<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options, outstanding at December&#160;31, | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,469<span></span>
</td>
<td class="nump">74,401<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contract life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 6 months 21 days<span></span>
</td>
<td class="text">9 years 1 month 13 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare', window );">Weighted average fair value of options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DateOfGrantAxis=imtx_GrantedOnDecemberTwoThousandAndTwentyMember', window );">Granted On December 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">SARs granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">SARs granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_ShareAppreciationRightsMember', window );">Share Appreciation Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Outstanding at January&#160;1,</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.12<span></span>
</td>
<td class="nump">$ 1.12<span></span>
</td>
<td class="nump">$ 1.12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019', window );">SARs forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.12<span></span>
</td>
<td class="nump">1.12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Outstanding at December&#160;31,</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.12<span></span>
</td>
<td class="nump">1.12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_WeightedAverageExercisePriceOfShareOptionsVestedInSharebasedPaymentArrangement2019', window );">SARs vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.12<span></span>
</td>
<td class="nump">$ 1.12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options, outstanding at January&#160;1, | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,455<span></span>
</td>
<td class="nump">43,675<span></span>
</td>
<td class="nump">43,978<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">SARs forfeited | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">220<span></span>
</td>
<td class="nump">303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options, outstanding at December&#160;31, | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,455<span></span>
</td>
<td class="nump">43,675<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_NumberOfShareOptionsVestedInSharebasedPaymentArrangement', window );">SARs vested | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="nump">169<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_PerformanceBasedOptionsMember', window );">Performance Based Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019', window );">SARs forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Outstanding at December&#160;31,</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">SARs forfeited | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">255,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options, outstanding at December&#160;31, | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,644,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contract life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_PerformanceBasedOptionsMember', window );">Performance Based Options [Member] | Granted On June 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">SARs granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">SARs granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,644,000<span></span>
</td>
<td class="nump">3,644,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare', window );">Weighted average fair value of options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.10<span></span>
</td>
<td class="nump">$ 11.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_PerformanceBasedOptionsMember', window );">Performance Based Options [Member] | Granted On September 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">SARs granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">SARs granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">255,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">255,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare', window );">Weighted average fair value of options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember', window );">Additional Grants Under 2020 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019', window );">SARs forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Outstanding at December&#160;31,</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">SARs granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,963,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">SARs forfeited | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options, outstanding at December&#160;31, | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,910,182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contract life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 8 months 19 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember', window );">Additional Grants Under 2020 Plan [Member] | Granted On June 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">SARs granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">SARs granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,087,417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare', window );">Weighted average fair value of options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.29<span></span>
</td>
<td class="nump">$ 11.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember', window );">Additional Grants Under 2020 Plan [Member] | Granted On September 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">SARs granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">SARs granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare', window );">Weighted average fair value of options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember', window );">Additional Grants Under 2020 Plan [Member] | Granted On December 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">SARs granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">SARs granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">802,149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare', window );">Weighted average fair value of options granted</a></td>
<td class="nump">$ 6.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_ConvertedOptionsMember', window );">Converted Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019', window );">SARs forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Outstanding at December&#160;31,</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_WeightedAverageExercisePriceOfShareOptionsVestedInSharebasedPaymentArrangement2019', window );">SARs vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">SARs forfeited | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options, outstanding at December&#160;31, | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">594,844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_NumberOfShareOptionsVestedInSharebasedPaymentArrangement', window );">SARs vested | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contract life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 3 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare', window );">Weighted average fair value of options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_ConvertedOptionsMember', window );">Converted Options [Member] | Granted On June 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">SARs granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">SARs granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">632,384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_MatchingStockOptionsMember', window );">Matching Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019', window );">SARs forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Outstanding at December&#160;31,</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">SARs forfeited | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options, outstanding at December&#160;31, | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,422,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contract life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_MatchingStockOptionsMember', window );">Matching Stock Options [Member] | Granted On June 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">SARs granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">SARs granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,430,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare', window );">Weighted average fair value of options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options forfeited in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_NumberOfShareOptionsVestedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options vested in sharebased payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_NumberOfShareOptionsVestedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation by share based payment arrangement weighted average fair value per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_WeightedAverageExercisePriceOfShareOptionsVestedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price of share options vested in sharebased payment arrangement 2019.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_WeightedAverageExercisePriceOfShareOptionsVestedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DateOfGrantAxis=imtx_GrantedOnDecemberTwoThousandAndTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DateOfGrantAxis=imtx_GrantedOnDecemberTwoThousandAndTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_ShareAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_ShareAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_PerformanceBasedOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_PerformanceBasedOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DateOfGrantAxis=imtx_GrantedOnJuneTwoThousandAndTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DateOfGrantAxis=imtx_GrantedOnJuneTwoThousandAndTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DateOfGrantAxis=imtx_GrantedOnSeptemberTwoThousandAndTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DateOfGrantAxis=imtx_GrantedOnSeptemberTwoThousandAndTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_ConvertedOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_ConvertedOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_MatchingStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_MatchingStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169238433608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based payments - Summary of Activities Under Share Based Payment Arrangement (Detail)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>shares </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Outstanding at January&#160;1,</a></td>
<td class="nump">$ 16.65<span></span>
</td>
<td class="nump">$ 16.65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Tandem awards forfeited</a></td>
<td class="nump">16.81<span></span>
</td>
<td class="nump">16.65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Outstanding at December&#160;31,</a></td>
<td class="nump">17.45<span></span>
</td>
<td class="nump">16.65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_WeightedAverageExercisePriceOfShareOptionsVestedDuringThePeriod', window );">Weighted average exercise price, Tandem awards vested</a></td>
<td class="nump">$ 16.76<span></span>
</td>
<td class="nump">$ 16.65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contract life (years)</a></td>
<td class="text">8 years 6 months 21 days<span></span>
</td>
<td class="text">9 years 1 month 13 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options, outstanding at January&#160;1, | shares</a></td>
<td class="nump">74,401<span></span>
</td>
<td class="nump">31,880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Number of share options, Tandem awards forfeited | shares</a></td>
<td class="nump">2,936<span></span>
</td>
<td class="nump">1,443<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options, outstanding at December&#160;31, | shares</a></td>
<td class="nump">103,469<span></span>
</td>
<td class="nump">74,401<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_NumberOfShareOptionsVestedDuringThePeriod', window );">Number of share options, Tandem awards vested | shares</a></td>
<td class="nump">16,238<span></span>
</td>
<td class="nump">14,350<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DateOfGrantAxis=imtx_GrantedOnJuneToSeptemberTwoThousandAndTwentyMember', window );">Granted On June 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Tandem awards granted</a></td>
<td class="nump">$ 18.30<span></span>
</td>
<td class="nump">$ 16.65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of share options, Tandem awards granted | shares</a></td>
<td class="nump">26,557<span></span>
</td>
<td class="nump">43,964<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DateOfGrantAxis=imtx_GrantedOnDecemberTwoThousandAndTwentyMember', window );">Granted On December 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Tandem awards granted</a></td>
<td class="nump">$ 23.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePrice2019', window );">Weighted average fair value of options granted</a></td>
<td class="nump">$ 53.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of share options, Tandem awards granted | shares</a></td>
<td class="nump">5,447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DateOfGrantAxis=imtx_GrantedOnSeptemberTwoThousandAndTwentyMember', window );">Granted On September 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePrice2019', window );">Weighted average fair value of options granted</a></td>
<td class="nump">$ 10.27<span></span>
</td>
<td class="nump">$ 4.51<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options forfeited in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharePrice2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_c&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharePrice2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_NumberOfShareOptionsVestedDuringThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options vested during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_NumberOfShareOptionsVestedDuringThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_StatementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_StatementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_WeightedAverageExercisePriceOfShareOptionsVestedDuringThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price of share options vested during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_WeightedAverageExercisePriceOfShareOptionsVestedDuringThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DateOfGrantAxis=imtx_GrantedOnJuneToSeptemberTwoThousandAndTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DateOfGrantAxis=imtx_GrantedOnJuneToSeptemberTwoThousandAndTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DateOfGrantAxis=imtx_GrantedOnDecemberTwoThousandAndTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DateOfGrantAxis=imtx_GrantedOnDecemberTwoThousandAndTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DateOfGrantAxis=imtx_GrantedOnSeptemberTwoThousandAndTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DateOfGrantAxis=imtx_GrantedOnSeptemberTwoThousandAndTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169207813208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based payments - Additional Information (Detail)<br> $ / shares in Units, $ in Thousands, &#8364; in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1">47 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 17, 2020 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 14, 2020 </div>
<div>shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jul. 01, 2020 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;) </div>
<div>shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>EUR (&#8364;) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare', window );">Share based compensation by share based payment arrangement fair value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DateOfGrantAxis=imtx_GrantedOnDecemberTwoThousandAndTwentyMember', window );">Granted On December 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Share based compensation by share based payment arrangement options granted during the period | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Share based compensation by share based payment arrangement exercise price per share granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_PerformanceBasedOptionsMember', window );">Performance Based Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Weighted average share price of share options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_PerformanceBasedOptionsMember', window );">Performance Based Options [Member] | Tranche One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_MinimumMarketCapitalization', window );">Minimum market capitalization | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_PerformanceBasedOptionsMember', window );">Performance Based Options [Member] | Tranche Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_MinimumMarketCapitalization', window );">Minimum market capitalization | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_PerformanceBasedOptionsMember', window );">Performance Based Options [Member] | Tranche Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_MinimumMarketCapitalization', window );">Minimum market capitalization | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_PerformanceBasedOptionsMember', window );">Performance Based Options [Member] | Granted On June 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Share based compensation by share based payment arrangement options granted during the period | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,644,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,644,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Share based compensation by share based payment arrangement exercise price per share granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare', window );">Share based compensation by share based payment arrangement fair value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_PerformanceBasedOptionsMember', window );">Performance Based Options [Member] | Granted On September 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Share based compensation by share based payment arrangement options granted during the period | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">255,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">255,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Share based compensation by share based payment arrangement exercise price per share granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare', window );">Share based compensation by share based payment arrangement fair value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember', window );">Additional Grants Under 2020 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Share based compensation by share based payment arrangement options granted during the period | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,963,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Weighted average share price of share options granted</a></td>
<td class="nump">$ 9.70<span></span>
</td>
<td class="nump">9.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember', window );">Additional Grants Under 2020 Plan [Member] | ARYA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Share based compensation by share based payment arrangement options granted during the period | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,087,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember', window );">Additional Grants Under 2020 Plan [Member] | Granted On June 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Share based compensation by share based payment arrangement options granted during the period | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,087,417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Share based compensation by share based payment arrangement exercise price per share granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare', window );">Share based compensation by share based payment arrangement fair value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember', window );">Additional Grants Under 2020 Plan [Member] | Granted On September 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Share based compensation by share based payment arrangement options granted during the period | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Share based compensation by share based payment arrangement exercise price per share granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare', window );">Share based compensation by share based payment arrangement fair value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember', window );">Additional Grants Under 2020 Plan [Member] | Granted On December 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Share based compensation by share based payment arrangement options granted during the period | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">802,149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Share based compensation by share based payment arrangement exercise price per share granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare', window );">Share based compensation by share based payment arrangement fair value per share</a></td>
<td class="nump">$ 6.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_ConvertedOptionsMember', window );">Converted Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Weighted average share price of share options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare', window );">Share based compensation by share based payment arrangement fair value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_ConvertedOptionsMember', window );">Converted Options [Member] | Granted On June 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Share based compensation by share based payment arrangement options granted during the period | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">632,384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Share based compensation by share based payment arrangement exercise price per share granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PlanAxis=imtx_ShareAppreciationRightsTwoThousandAndTenPlanMember', window );">Share Appreciation Rights Two Thousand And Ten Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfOutstandingSharesToBePurchasedByThirdParty', window );">Percentage of outstanding shares to be purchased by third party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011', window );">Liabilities arising from share based payment arrangement | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="nump">&#8364; 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted', window );">Fair value of stock appreciation rights | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000<span></span>
</td>
<td class="nump">$ 160,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PlanAxis=imtx_TwoThousandAndSixteenTandemAwardsMember', window );">2016 Tandem Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfOutstandingSharesToBePurchasedByThirdParty', window );">Percentage of outstanding shares to be purchased by third party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Share based compensation by share based payment equity instruments other than shares vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">five<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted', window );">Fair value of stock appreciation rights | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 160,000<span></span>
</td>
<td class="nump">$ 350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Weighted average share price of share options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67.87<span></span>
</td>
<td class="nump">&#8364; 27.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PlanAxis=imtx_ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMember', window );">Modification Of Awards Under Two Thousand Ten And Two Thousand And Sixteen Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_CashPaymentAwardPerSharePayable', window );">Cash payment award per share payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsToAndOnBehalfOfEmployees', window );">Cash payment to employees stock based awards | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 8.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PlanAxis=imtx_ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMember', window );">Modification Of Awards Under Two Thousand Ten And Two Thousand And Sixteen Plan [Member] | Active Employees [Member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfCashProceedsToBeBeReinvested', window );">Percentage of cash proceeds to be reinvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PlanAxis=imtx_ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMember', window );">Modification Of Awards Under Two Thousand Ten And Two Thousand And Sixteen Plan [Member] | Active Employees [Member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfCashProceedsToBeBeReinvested', window );">Percentage of cash proceeds to be reinvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PlanAxis=imtx_ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMember', window );">Modification Of Awards Under Two Thousand Ten And Two Thousand And Sixteen Plan [Member] | Management Members [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfCashProceedsToBeBeReinvested', window );">Percentage of cash proceeds to be reinvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PlanAxis=imtx_ModificationOfTwoThousandAndTenPlanMember', window );">Modification Of Two Thousand And Ten Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ExpenseFromTheModificationOfShareBasedAwards', window );">Share based compensation expenses modification of awards | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PlanAxis=imtx_ModificationOfTwoThousandAndSixteenPlanMember', window );">Modification Of Two Thousand And Sixteen Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Adjustment to additional paid in capital due to modification of previously settled equity awards | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PlanAxis=imtx_ModificationOfTwoThousandAndSixteenPlanMember', window );">Modification Of Two Thousand And Sixteen Plan [Member] | Share Reinvestment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ExpenseFromTheModificationOfShareBasedAwards', window );">Share based compensation expenses modification of awards | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 4.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Share based compensation by share based payment arrangement options granted during the period | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">733,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted', window );">Fair value of stock appreciation rights | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 8.5<span></span>
</td>
<td class="nump">$ 8.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 8.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Weighted average share price of share options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PlanAxis=imtx_ModificationOfTwoThousandAndSixteenPlanMember', window );">Modification Of Two Thousand And Sixteen Plan [Member] | Share Reinvestment [Member] | Matching Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Share based compensation by share based payment arrangement exercise price per share granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement', window );">Share based compensation by share based payment arrangement term of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">ten-year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DateOfVestingOfStockOptions', window );">Date of vesting of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare', window );">Share based compensation by share based payment arrangement fair value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement', window );">Share based compensation by share based payment arrangement grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">July 1, 2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The date on which share-based payment arrangements are granted. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph IG23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_IG23&amp;doctype=Implementation%20Guidance<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DateOfGrantOfSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the maximum term of options granted for a type of share-based payment arrangement that existed at any time during the period. An entity with substantially similar types of share-based payment arrangements may aggregate this information. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the vesting requirements for a type of share-based payment arrangement that existed at any time during the period. An entity with substantially similar types of share-based payment arrangements may aggregate this information. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from equity-settled share-based payment transactions in which the goods or services received did not qualify for recognition as assets. [Refer: Expense from share-based payment transactions in which goods or services received did not qualify for recognition as assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 51<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_51_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities arising from share-based payment transactions. Share-based payment transactions are transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 51<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_51_b_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsToAndOnBehalfOfEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to, and on behalf of, employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 14<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_14_d&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsToAndOnBehalfOfEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value of share options granted during the period at the measurement date. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_CashPaymentAwardPerSharePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash payment award per share payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_CashPaymentAwardPerSharePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DateOfVestingOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date of vesting of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DateOfVestingOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_ExpenseFromTheModificationOfShareBasedAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expense from the modification of share based awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_ExpenseFromTheModificationOfShareBasedAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_MinimumMarketCapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum market capitalization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_MinimumMarketCapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_PercentageOfCashProceedsToBeBeReinvested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of cash proceeds to be reinvested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_PercentageOfCashProceedsToBeBeReinvested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_PercentageOfOutstandingSharesToBePurchasedByThirdParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of outstanding shares to be purchased by third party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_PercentageOfOutstandingSharesToBePurchasedByThirdParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation by share based payment arrangement weighted average fair value per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_ShareBasedCompensationByShareBasedPaymentArrangementWeightedAverageFairValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DateOfGrantAxis=imtx_GrantedOnDecemberTwoThousandAndTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DateOfGrantAxis=imtx_GrantedOnDecemberTwoThousandAndTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_PerformanceBasedOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_PerformanceBasedOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TrancheAxis=imtx_TrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TrancheAxis=imtx_TrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TrancheAxis=imtx_TrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TrancheAxis=imtx_TrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TrancheAxis=imtx_TrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TrancheAxis=imtx_TrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DateOfGrantAxis=imtx_GrantedOnJuneTwoThousandAndTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DateOfGrantAxis=imtx_GrantedOnJuneTwoThousandAndTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DateOfGrantAxis=imtx_GrantedOnSeptemberTwoThousandAndTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DateOfGrantAxis=imtx_GrantedOnSeptemberTwoThousandAndTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_AdditionalGrantsUnderTwoThousandAndTwentyPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imtx_AryaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imtx_AryaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_ConvertedOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=imtx_ConvertedOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_PlanAxis=imtx_ShareAppreciationRightsTwoThousandAndTenPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_PlanAxis=imtx_ShareAppreciationRightsTwoThousandAndTenPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_PlanAxis=imtx_TwoThousandAndSixteenTandemAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_PlanAxis=imtx_TwoThousandAndSixteenTandemAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_PlanAxis=imtx_ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_PlanAxis=imtx_ModificationOfAwardsUnderTwoThousandTenAndTwoThousandAndSixteenPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_CategoryOfEmployeesAxis=imtx_ActiveEmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_CategoryOfEmployeesAxis=imtx_ActiveEmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_CategoryOfEmployeesAxis=imtx_ManagementMembersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_CategoryOfEmployeesAxis=imtx_ManagementMembersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_PlanAxis=imtx_ModificationOfTwoThousandAndTenPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_PlanAxis=imtx_ModificationOfTwoThousandAndTenPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_PlanAxis=imtx_ModificationOfTwoThousandAndSixteenPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_PlanAxis=imtx_ModificationOfTwoThousandAndSixteenPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_SchemeAxis=imtx_ShareReinvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_SchemeAxis=imtx_ShareReinvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_ShareReinvestmentSchemeAxis=imtx_MatchingStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_ShareReinvestmentSchemeAxis=imtx_MatchingStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169215936872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based payments - Summary of Employee Related Share Based Compensation Expense (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseLineItems', window );"><strong>Disclosure Of Detailed Information About Share Based Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Share-based compensation expense</a></td>
<td class="nump">&#8364; 25,519<span></span>
</td>
<td class="nump">&#8364; 2,016<span></span>
</td>
<td class="nump">&#8364; 338<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncomeStatementLocationAxis=imtx_ResearchAndDevelopmentExpenseMember', window );">Research And Development Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseLineItems', window );"><strong>Disclosure Of Detailed Information About Share Based Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Share-based compensation expense</a></td>
<td class="nump">14,546<span></span>
</td>
<td class="nump">1,556<span></span>
</td>
<td class="nump">238<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncomeStatementLocationAxis=imtx_GeneralAndAdministrativeExpenseMember', window );">General And Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseLineItems', window );"><strong>Disclosure Of Detailed Information About Share Based Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Share-based compensation expense</a></td>
<td class="nump">&#8364; 10,973<span></span>
</td>
<td class="nump">&#8364; 460<span></span>
</td>
<td class="nump">&#8364; 100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from share-based payment transactions with employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about share based compensation expense [Line Items].</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfDetailedInformationAboutShareBasedCompensationExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_IncomeStatementLocationAxis=imtx_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_IncomeStatementLocationAxis=imtx_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_IncomeStatementLocationAxis=imtx_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_IncomeStatementLocationAxis=imtx_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169215523464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' equity (deficit) - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jul. 01, 2020 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StockIssuedDuringPeriodValueNewIssues', window );">Stock issued during period, value, new issues | &#8364;</a></td>
<td class="nump">&#8364; 500,000<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Number of shares outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,908,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Number of shares value outstanding | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 629,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 629,000<span></span>
</td>
<td class="nump">&#8364; 1,164,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Share premium | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 573,339,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 190,945,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_EventAxis=imtx_ReorganizationMember', window );">Reorganization [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Number of shares outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,093,838<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ShareListingExpenseAxis=imtx_AryaMergerMember', window );">ARYA Merger [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_NumberOfWarrantsOutsatnding', window );">Number of warrants outsatnding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,187,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ExercisePriceOfWarrants', window );">Exercise price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ClassOfWarrantOrRightTermPeriod', window );">Class of warrant or right, term period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imtx_ImmaticsBiotechnologiesGmbhMember', window );">Immatics Biotechnologies GmbH [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Number of shares outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,163,625<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1.00<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=imtx_PipeFinancingMember', window );">PIPE Financing [member] | ARYA Merger [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Share premium | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 3,625,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Ordinary Shares [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Number of shares outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,908,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=imtx_SeriesEShareCapitalMember', window );">Series E Share Capital [member] | Immatics Biotechnologies GmbH [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Share premium | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 23,600,000<span></span>
</td>
</tr>
<tr><td colspan="9"></td></tr>
<tr><td colspan="9"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See Note 2 for details regarding the change in presentation of Other financial assets</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_79_a_iv&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SharePremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount received or receivable from the issuance of the entity's shares in excess of nominal value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SharePremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_ClassOfWarrantOrRightTermPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right, term period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_ClassOfWarrantOrRightTermPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_ExercisePriceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_ExercisePriceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_NumberOfWarrantsOutsatnding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants outsatnding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_NumberOfWarrantsOutsatnding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period, value, new issues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_EventAxis=imtx_ReorganizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_EventAxis=imtx_ReorganizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_ShareListingExpenseAxis=imtx_AryaMergerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_ShareListingExpenseAxis=imtx_AryaMergerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imtx_ImmaticsBiotechnologiesGmbhMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imtx_ImmaticsBiotechnologiesGmbhMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=imtx_PipeFinancingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=imtx_PipeFinancingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=imtx_SeriesEShareCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=imtx_SeriesEShareCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169215910424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-controlling interests - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 01, 2020 </div>
<div>EUR (&#8364;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jul. 01, 2020 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership interests held by non-controlling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.14%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StockIssuedDuringPeriodValueNewIssues', window );">Stock issued during period, value, new issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 500,000<span></span>
</td>
<td class="nump">&#8364; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest', window );">Increase (decrease) through changes in noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_LossOnNoncontrollingInterest', window );">Loss on non-controlling&#160;interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">&#8364; 900,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Non-controlling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,020,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncreasedecreaseThroughCompensationExpense', window );">MD Anderson compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 45,000<span></span>
</td>
<td class="nump">&#8364; 700,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 1,360,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imtx_RestrictedStockAcquisitionAgreementMember', window );">Restricted Stock Acquisition Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StockIssuedDuringPeriodSharesAcquisitions', window );">Stock issued during period, shares, acquisitions | shares</a></td>
<td class="nump">697,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imtx_AryaMember', window );">ARYA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest', window );">Increase (decrease) through changes in noncontrolling interest</a></td>
<td class="nump">&#8364; 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_MdAndersonMember', window );">MD Anderson [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_NumberOfSharesExchangedInSubsidiaries', window );">Number of shares exchanged in subsidiaries | shares</a></td>
<td class="nump">379,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="8"></td></tr>
<tr><td colspan="8"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See Note 2 for details regarding the change in presentation of Other financial assets</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph 12<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_12_f&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 54<br> -Subparagraph q<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_54_q&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 10<br> -IssueDate 2020-01-01<br> -Paragraph 22<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=10&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_22&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interests in a subsidiary held by non-controlling interests. [Refer: Subsidiaries [member]; Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph 12<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_12_c&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) through changes in noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_IncreasedecreaseThroughChangesInNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_IncreasedecreaseThroughCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) through compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_IncreasedecreaseThroughCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_LossOnNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss on non-controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_LossOnNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_NumberOfSharesExchangedInSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares exchanged in subsidiaries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_NumberOfSharesExchangedInSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_StatementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_StatementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period, value, new issues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imtx_RestrictedStockAcquisitionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imtx_RestrictedStockAcquisitionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imtx_AryaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imtx_AryaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_MdAndersonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_MdAndersonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169212101288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Personnel expenses - Summary of Personnel Expenses (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WagesAndSalaries', window );">Wages and salaries</a></td>
<td class="nump">&#8364; 22,245<span></span>
</td>
<td class="nump">&#8364; 15,231<span></span>
</td>
<td class="nump">&#8364; 12,718<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShorttermEmployeeBenefitsExpense', window );">Total other employee benefits</a></td>
<td class="nump">3,639<span></span>
</td>
<td class="nump">2,763<span></span>
</td>
<td class="nump">2,527<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Share-based compensation expense</a></td>
<td class="nump">25,519<span></span>
</td>
<td class="nump">2,016<span></span>
</td>
<td class="nump">338<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EmployeeBenefitsExpense', window );">Total</a></td>
<td class="nump">51,403<span></span>
</td>
<td class="nump">20,010<span></span>
</td>
<td class="nump">15,583<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncomeStatementLocationAxis=imtx_ResearchAndDevelopmentExpenseMember', window );">Research and development expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WagesAndSalaries', window );">Wages and salaries</a></td>
<td class="nump">15,277<span></span>
</td>
<td class="nump">11,635<span></span>
</td>
<td class="nump">10,485<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherShorttermEmployeeBenefits', window );">Other employee benefits</a></td>
<td class="nump">2,624<span></span>
</td>
<td class="nump">2,035<span></span>
</td>
<td class="nump">1,920<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Share-based compensation expense</a></td>
<td class="nump">14,546<span></span>
</td>
<td class="nump">1,556<span></span>
</td>
<td class="nump">238<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncomeStatementLocationAxis=imtx_GeneralAndAdministrativeExpenseMember', window );">General and administrative expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WagesAndSalaries', window );">Wages and salaries</a></td>
<td class="nump">6,968<span></span>
</td>
<td class="nump">3,596<span></span>
</td>
<td class="nump">2,233<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherShorttermEmployeeBenefits', window );">Other employee benefits</a></td>
<td class="nump">1,015<span></span>
</td>
<td class="nump">728<span></span>
</td>
<td class="nump">607<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Share-based compensation expense</a></td>
<td class="nump">&#8364; 10,973<span></span>
</td>
<td class="nump">&#8364; 460<span></span>
</td>
<td class="nump">&#8364; 100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EmployeeBenefitsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expense of all forms of consideration given by an entity in exchange for a service rendered by employees or for the termination of employment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 104<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_104&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EmployeeBenefitsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from share-based payment transactions with employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherShorttermEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from employee benefits (other than termination benefits), which are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services, that the entity does not separately disclose in the same statement or note. [Refer: Employee benefits expense]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2020-01-01<br> -Paragraph 9<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_9&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherShorttermEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermEmployeeBenefitsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermEmployeeBenefitsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WagesAndSalaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2020-01-01<br> -Paragraph 9<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_9&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WagesAndSalaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_StatementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_StatementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_IncomeStatementLocationAxis=imtx_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_IncomeStatementLocationAxis=imtx_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_IncomeStatementLocationAxis=imtx_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_IncomeStatementLocationAxis=imtx_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169271639288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Personnel expenses - Additional Information (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfEmployeeBenefitsExpenseAbstract', window );"><strong>Classes of employee benefits expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans', window );">Post-employment benefit expense, defined contribution plans</a></td>
<td class="nump">&#8364; 200<span></span>
</td>
<td class="nump">&#8364; 100<span></span>
</td>
<td class="nump">&#8364; 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_EmployeeHealthInsuranceCost', window );">Employee health insurance cost</a></td>
<td class="nump">400<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SocialSecurityContributions', window );">Social security contributions</a></td>
<td class="nump">1,700<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherEmployeeExpense', window );">other miscellaneous expenses</a></td>
<td class="nump">&#8364; 100<span></span>
</td>
<td class="nump">&#8364; 70<span></span>
</td>
<td class="nump">&#8364; 200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfEmployeeBenefitsExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfEmployeeBenefitsExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherEmployeeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of employee expenses that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2020-01-01<br> -Paragraph 5<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_5&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherEmployeeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of post-employment benefit expense relating to defined contribution plans. Defined contribution plans are post-employment benefit plans under which an entity pays fixed contributions into a separate entity (a fund) and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient assets to pay all employee benefits relating to employee service in the current and prior periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2020-01-01<br> -Paragraph 53<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_53&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SocialSecurityContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A class of employee benefits expense that represents social security contributions. [Refer: Employee benefits expense]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2020-01-01<br> -Paragraph 9<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_9&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SocialSecurityContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_EmployeeHealthInsuranceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee health insurance cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_EmployeeHealthInsuranceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169214831640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax - Summary of Reconciliation Between Taxes On Income And Expected Income Tax Benefit (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract', window );"><strong>Major components of tax expense (income) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss before tax</a></td>
<td class="num">&#8364; (229,616)<span></span>
</td>
<td class="num">&#8364; (32,487)<span></span>
</td>
<td class="num">&#8364; (32,355)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTaxExpenseIncome', window );">Expected tax benefit</a></td>
<td class="nump">66,818<span></span>
</td>
<td class="nump">9,454<span></span>
</td>
<td class="nump">9,415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TaxEffectFromChangeInTaxRate', window );">Difference in tax rates</a></td>
<td class="num">(2,582)<span></span>
</td>
<td class="num">(1,875)<span></span>
</td>
<td class="num">(1,373)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss', window );">Non-deductible&#160; tax-expenses</a></td>
<td class="num">(599)<span></span>
</td>
<td class="num">(61)<span></span>
</td>
<td class="num">(70)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TaxEffectOfGovernmentGrantsExemptedFromTaxes', window );">Government grants exempted from taxes</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">853<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TaxEffectOfPermanentDifferences', window );">Permanent Differences</a></td>
<td class="num">(44,461)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_NonRecognitionOfDeferredTaxesOnTaxLossesAndTemporaryDifferences', window );">Non-recognition&#160;of&#160;deferred taxes on tax losses and temporary differences</a></td>
<td class="num">(19,221)<span></span>
</td>
<td class="num">(7,526)<span></span>
</td>
<td class="num">(8,825)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Taxes on income</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph 80<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_80_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2020-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2020-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2020-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2020-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2021-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2020-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxEffectFromChangeInTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to changes in the tax rate. [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxEffectFromChangeInTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible in determining taxable profit (tax loss). [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_NonRecognitionOfDeferredTaxesOnTaxLossesAndTemporaryDifferences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-recognition&#160;of&#160;deferred taxes on tax losses and temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_NonRecognitionOfDeferredTaxesOnTaxLossesAndTemporaryDifferences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TaxEffectOfGovernmentGrantsExemptedFromTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax effect of government grants exempted from taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TaxEffectOfGovernmentGrantsExemptedFromTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TaxEffectOfPermanentDifferences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax effect of permanent differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TaxEffectOfPermanentDifferences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169213851416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Tax - Summary of Deferred Tax Assets (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DeferredTaxAssetsNonrecognition', window );">Non-recognition due to history of losses</a></td>
<td class="num">(2,016)<span></span>
</td>
<td class="num">(3,075)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DeferredTaxAssetsOffset', window );">Deferred tax assets netting</a></td>
<td class="num">(1,713)<span></span>
</td>
<td class="num">(854)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DeferredTaxLiabilitiesOffSet', window );">Deferred tax liabilities netting</a></td>
<td class="nump">1,713<span></span>
</td>
<td class="nump">854<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAndLiabilitiesAxis=imtx_IntangibleAssetsMember', window );">Intangible assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">1,770<span></span>
</td>
<td class="nump">2,064<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAndLiabilitiesAxis=imtx_DeferredRevenueMember', window );">Deferred revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">180<span></span>
</td>
<td class="nump">358<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAndLiabilitiesAxis=imtx_LeaseLiabilityMember', window );">Lease liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">1,776<span></span>
</td>
<td class="nump">886<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAndLiabilitiesAxis=imtx_DeferredExpensesMember', window );">Deferred expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAndLiabilitiesAxis=imtx_DeferredAssetRecognisedMember', window );">Recognized [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">3,729<span></span>
</td>
<td class="nump">3,929<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAndLiabilitiesAxis=imtx_DeferredTaxLiabilitiesRightOfUseAssetMember', window );">Right-of-use&#160;asset [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">1,713<span></span>
</td>
<td class="nump">854<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAndLiabilitiesAxis=imtx_DeferredTaxLiabilitiesDeferredExpensesMember', window );">Recognized [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">&#8364; 1,713<span></span>
</td>
<td class="nump">854<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAndLiabilitiesAxis=imtx_OtherLiabilitiesMember', window );">Other liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 607<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 56<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 56<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DeferredTaxAssetsNonrecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets nonrecognition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DeferredTaxAssetsNonrecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DeferredTaxAssetsOffset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DeferredTaxAssetsOffset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DeferredTaxLiabilitiesOffSet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liabilities off set.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DeferredTaxLiabilitiesOffSet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_StatementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_StatementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesAxis=imtx_IntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesAxis=imtx_IntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesAxis=imtx_DeferredRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesAxis=imtx_DeferredRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesAxis=imtx_LeaseLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesAxis=imtx_LeaseLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesAxis=imtx_DeferredExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesAxis=imtx_DeferredExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesAxis=imtx_DeferredAssetRecognisedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesAxis=imtx_DeferredAssetRecognisedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesAxis=imtx_DeferredTaxLiabilitiesRightOfUseAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesAxis=imtx_DeferredTaxLiabilitiesRightOfUseAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesAxis=imtx_DeferredTaxLiabilitiesDeferredExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesAxis=imtx_DeferredTaxLiabilitiesDeferredExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesAxis=imtx_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesAxis=imtx_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169214742536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax - Additional Information (Detail) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">statutory tax rate</a></td>
<td class="nump">29.10%<span></span>
</td>
<td class="nump">29.10%<span></span>
</td>
<td class="nump">29.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_CorporateIncomeTaxRate', window );">corporate income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOnLimitationOnTaxLossCarryforwardsAfterPriorPeriod', window );">Percentage on limitation on tax loss carryforwards after prior period</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOnLimitationOnTaxLossCarryforwardsBeforePriorPeriod', window );">Percentage on limitation on tax loss carryforwards before prior period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_EffectiveIncomeTaxReconciliationPermanentEffectShareListingExpense', window );">Effective income tax reconciliation permanent effect share listing expense</a></td>
<td class="nump">&#8364; 153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=imtx_IndefiniteTaxLossesCarryforwardMember', window );">Indefinite Tax Losses Carryforward [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TaxEffectOfTaxLosses', window );">Tax effect of tax losses</a></td>
<td class="nump">288<span></span>
</td>
<td class="nump">&#8364; 219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=imtx_TwentySixYearTaxLossesCarryforwardMember', window );">Twenty Six Year Tax Losses Carryforward [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TaxEffectOfTaxLosses', window );">Tax effect of tax losses</a></td>
<td class="nump">&#8364; 26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The applicable income tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxEffectOfTaxLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to tax losses. [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxEffectOfTaxLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_CorporateIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>corporate income tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_CorporateIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_EffectiveIncomeTaxReconciliationPermanentEffectShareListingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective income tax reconciliation permanent effect share listing expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_EffectiveIncomeTaxReconciliationPermanentEffectShareListingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_PercentageOnLimitationOnTaxLossCarryforwardsAfterPriorPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage on limitation on tax loss carryforwards after prior period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_PercentageOnLimitationOnTaxLossCarryforwardsAfterPriorPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_PercentageOnLimitationOnTaxLossCarryforwardsBeforePriorPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage on limitation on tax loss carryforwards before prior period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_PercentageOnLimitationOnTaxLossCarryforwardsBeforePriorPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_StatementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_StatementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=imtx_IndefiniteTaxLossesCarryforwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=imtx_IndefiniteTaxLossesCarryforwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=imtx_TwentySixYearTaxLossesCarryforwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=imtx_TwentySixYearTaxLossesCarryforwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169212054232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Risk Management Objectives and Policies - Summary of Currency Risk Exposure (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><sup>[2]</sup></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfCurrencyRiskExposureLineItems', window );"><strong>Disclosure Of Currency Risk Exposure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">&#8364; 207,530<span></span>
</td>
<td class="nump">&#8364; 103,353<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td colspan="2" class="nump">&#8364; 39,367<span></span>
</td>
<td class="nump">&#8364; 8,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">28,198<span></span>
</td>
<td class="nump">&#8364; 18,690<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember', window );">Currency risk [member] | Immatics GmbH [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfCurrencyRiskExposureLineItems', window );"><strong>Disclosure Of Currency Risk Exposure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">52,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">24,448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_MaximumExposedToCurrencyRisk', window );">Total assets exposed to the risk</a></td>
<td class="nump">76,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=imtx_ImmaticsNvMember', window );">Immatics N.V. [Member] | Currency risk [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfCurrencyRiskExposureLineItems', window );"><strong>Disclosure Of Currency Risk Exposure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">42,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_MaximumExposedToCurrencyRisk', window );">Total assets exposed to the risk</a></td>
<td class="nump">&#8364; 42,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See Note 2 for details regarding the change in presentation of Other financial assets</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">See Note 2 for details regarding the revision as a result of a correction in classification of Other financial assets</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose the entity&#8217;s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 35H<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 35I<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_35I&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 35M<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_35M&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 35N<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_35N&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfCurrencyRiskExposureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfCurrencyRiskExposureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_MaximumExposedToCurrencyRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum Exposed to Currency risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_MaximumExposedToCurrencyRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imtx_ImmaticsGmbhMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imtx_ImmaticsGmbhMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=imtx_ImmaticsNvMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=imtx_ImmaticsNvMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169207518472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Risk Management Objectives and Policies - Summary of Sensitivity Analysis of Foreign Currency Risk (Detail)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems', window );"><strong>Disclosure of Sensitivity Analysis For Each Type Of Market Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClosingForeignExchangeRate', window );">Conversion rate</a></td>
<td class="nump">0.8149<span></span>
</td>
<td class="nump">0.8902<span></span>
</td>
<td class="nump">0.8738<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroWeakensBy1AgainstUsDollarsMember', window );">Euro weakens by 1% against U.S. dollars [Member] | Immatics GmbH [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems', window );"><strong>Disclosure of Sensitivity Analysis For Each Type Of Market Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClosingForeignExchangeRate', window );">Conversion rate</a></td>
<td class="nump">1.2394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints', window );">Profit/(loss)</a></td>
<td class="num">&#8364; (757)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ValueAtRisk', window );">Carrying amount</a></td>
<td class="nump">&#8364; 75,706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroWeakensBy1AgainstUsDollarsMember', window );">Euro weakens by 1% against U.S. dollars [Member] | Immatics N.V. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems', window );"><strong>Disclosure of Sensitivity Analysis For Each Type Of Market Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClosingForeignExchangeRate', window );">Conversion rate</a></td>
<td class="nump">1.2394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints', window );">Profit/(loss)</a></td>
<td class="num">&#8364; (421)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ValueAtRisk', window );">Carrying amount</a></td>
<td class="nump">&#8364; 42,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroStrengthsBy1AgainstUsDollarsMember', window );">Euro strengths by 1% against U.S. dollars [Member] | Immatics GmbH [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems', window );"><strong>Disclosure of Sensitivity Analysis For Each Type Of Market Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClosingForeignExchangeRate', window );">Conversion rate</a></td>
<td class="nump">1.2148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints', window );">Profit/(loss)</a></td>
<td class="nump">&#8364; 772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ValueAtRisk', window );">Carrying amount</a></td>
<td class="nump">&#8364; 77,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroStrengthsBy1AgainstUsDollarsMember', window );">Euro strengths by 1% against U.S. dollars [Member] | Immatics N.V. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems', window );"><strong>Disclosure of Sensitivity Analysis For Each Type Of Market Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClosingForeignExchangeRate', window );">Conversion rate</a></td>
<td class="nump">1.2148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints', window );">Profit/(loss)</a></td>
<td class="nump">&#8364; 430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ValueAtRisk', window );">Carrying amount</a></td>
<td class="nump">&#8364; 42,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroWeakensBy5AgainstUsDollarsMember', window );">Euro weakens by 5% against U.S. dollars [Member] | Immatics GmbH [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems', window );"><strong>Disclosure of Sensitivity Analysis For Each Type Of Market Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClosingForeignExchangeRate', window );">Conversion rate</a></td>
<td class="nump">1.2885<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints', window );">Profit/(loss)</a></td>
<td class="num">&#8364; (3,641)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ValueAtRisk', window );">Carrying amount</a></td>
<td class="nump">&#8364; 72,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroWeakensBy5AgainstUsDollarsMember', window );">Euro weakens by 5% against U.S. dollars [Member] | Immatics N.V. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems', window );"><strong>Disclosure of Sensitivity Analysis For Each Type Of Market Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClosingForeignExchangeRate', window );">Conversion rate</a></td>
<td class="nump">1.2885<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints', window );">Profit/(loss)</a></td>
<td class="num">&#8364; (2,025)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ValueAtRisk', window );">Carrying amount</a></td>
<td class="nump">&#8364; 40,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroStrengthsBy5AgainstUsDollarsMember', window );">Euro strengths by 5% against U.S. dollars [Member] | Immatics GmbH [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems', window );"><strong>Disclosure of Sensitivity Analysis For Each Type Of Market Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClosingForeignExchangeRate', window );">Conversion rate</a></td>
<td class="nump">1.1657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints', window );">Profit/(loss)</a></td>
<td class="nump">&#8364; 4,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ValueAtRisk', window );">Carrying amount</a></td>
<td class="nump">&#8364; 80,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroStrengthsBy5AgainstUsDollarsMember', window );">Euro strengths by 5% against U.S. dollars [Member] | Immatics N.V. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems', window );"><strong>Disclosure of Sensitivity Analysis For Each Type Of Market Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClosingForeignExchangeRate', window );">Conversion rate</a></td>
<td class="nump">1.1657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints', window );">Profit/(loss)</a></td>
<td class="nump">&#8364; 2,238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ValueAtRisk', window );">Carrying amount</a></td>
<td class="nump">&#8364; 44,766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroWeakensBy10AgainstUsDollarsMember', window );">Euro weakens by 10% against U.S. dollars [Member] | Immatics GmbH [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems', window );"><strong>Disclosure of Sensitivity Analysis For Each Type Of Market Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClosingForeignExchangeRate', window );">Conversion rate</a></td>
<td class="nump">1.3498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints', window );">Profit/(loss)</a></td>
<td class="num">&#8364; (6,951)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ValueAtRisk', window );">Carrying amount</a></td>
<td class="nump">&#8364; 69,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroWeakensBy10AgainstUsDollarsMember', window );">Euro weakens by 10% against U.S. dollars [Member] | Immatics N.V. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems', window );"><strong>Disclosure of Sensitivity Analysis For Each Type Of Market Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClosingForeignExchangeRate', window );">Conversion rate</a></td>
<td class="nump">1.3498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints', window );">Profit/(loss)</a></td>
<td class="num">&#8364; (3,866)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ValueAtRisk', window );">Carrying amount</a></td>
<td class="nump">&#8364; 38,662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroStrengthsBy10AgainstUsDollarsMember', window );">Euro strengths by 10% against U.S. dollars [Member] | Immatics GmbH [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems', window );"><strong>Disclosure of Sensitivity Analysis For Each Type Of Market Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClosingForeignExchangeRate', window );">Conversion rate</a></td>
<td class="nump">1.1044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints', window );">Profit/(loss)</a></td>
<td class="nump">&#8364; 8,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ValueAtRisk', window );">Carrying amount</a></td>
<td class="nump">&#8364; 84,959<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroStrengthsBy10AgainstUsDollarsMember', window );">Euro strengths by 10% against U.S. dollars [Member] | Immatics N.V. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems', window );"><strong>Disclosure of Sensitivity Analysis For Each Type Of Market Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClosingForeignExchangeRate', window );">Conversion rate</a></td>
<td class="nump">1.1044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints', window );">Profit/(loss)</a></td>
<td class="nump">&#8364; 4,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ValueAtRisk', window );">Carrying amount</a></td>
<td class="nump">&#8364; 47,253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClosingForeignExchangeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The spot exchange rate at the end of the reporting period. Exchange rate is the ratio of exchange for two currencies. Spot exchange rate is the exchange rate for immediate delivery.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClosingForeignExchangeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ValueAtRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The measure of a potential loss exposure as a result of future market movements, based on a specified confidence interval and measurement horizon.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 41<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_41&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ValueAtRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase Decrease In Profit Loss Before Tax On Basis Of Higher Lower Basis Points.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_IncreaseDecreaseInProfitLossBeforeTaxOnBasisOfHigherLowerBasisPoints</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroWeakensBy1AgainstUsDollarsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroWeakensBy1AgainstUsDollarsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imtx_ImmaticsGmbhMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imtx_ImmaticsGmbhMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=imtx_ImmaticsNvMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=imtx_ImmaticsNvMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroStrengthsBy1AgainstUsDollarsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroStrengthsBy1AgainstUsDollarsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroWeakensBy5AgainstUsDollarsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroWeakensBy5AgainstUsDollarsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroStrengthsBy5AgainstUsDollarsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroStrengthsBy5AgainstUsDollarsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroWeakensBy10AgainstUsDollarsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroWeakensBy10AgainstUsDollarsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroStrengthsBy10AgainstUsDollarsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroStrengthsBy10AgainstUsDollarsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169215264408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Risk Management Objectives and Policies - Summary of Sensitivity Analysis of Foreign Currency Risk (Parenthetical) (Detail)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imtx_ImmaticsGmbhMember', window );">Immatics GmbH [Member] | Euro weakens by 1 against US dollars [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems', window );"><strong>Disclosure of Sensitivity Analysis For Each Type Of Market Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk', window );">Percentage Of Reasonably Possible Increase In Foreign Currency Risk</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk', window );">Percentage Of Reasonably Possible Decrease In Foreign Currency Risk</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imtx_ImmaticsGmbhMember', window );">Immatics GmbH [Member] | Euro strengths by 1 against US dollars [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems', window );"><strong>Disclosure of Sensitivity Analysis For Each Type Of Market Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk', window );">Percentage Of Reasonably Possible Increase In Foreign Currency Risk</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk', window );">Percentage Of Reasonably Possible Decrease In Foreign Currency Risk</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imtx_ImmaticsGmbhMember', window );">Immatics GmbH [Member] | Euro weakens by 5 against US dollars [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems', window );"><strong>Disclosure of Sensitivity Analysis For Each Type Of Market Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk', window );">Percentage Of Reasonably Possible Increase In Foreign Currency Risk</a></td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk', window );">Percentage Of Reasonably Possible Decrease In Foreign Currency Risk</a></td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imtx_ImmaticsGmbhMember', window );">Immatics GmbH [Member] | Euro strengths by 5 against US dollars [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems', window );"><strong>Disclosure of Sensitivity Analysis For Each Type Of Market Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk', window );">Percentage Of Reasonably Possible Increase In Foreign Currency Risk</a></td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk', window );">Percentage Of Reasonably Possible Decrease In Foreign Currency Risk</a></td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imtx_ImmaticsGmbhMember', window );">Immatics GmbH [Member] | Euro weakens by 10 against US dollars [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems', window );"><strong>Disclosure of Sensitivity Analysis For Each Type Of Market Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk', window );">Percentage Of Reasonably Possible Increase In Foreign Currency Risk</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk', window );">Percentage Of Reasonably Possible Decrease In Foreign Currency Risk</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imtx_ImmaticsGmbhMember', window );">Immatics GmbH [Member] | Euro strengths by 10 against US dollars [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems', window );"><strong>Disclosure of Sensitivity Analysis For Each Type Of Market Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk', window );">Percentage Of Reasonably Possible Increase In Foreign Currency Risk</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk', window );">Percentage Of Reasonably Possible Decrease In Foreign Currency Risk</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=imtx_ImmaticsNvMember', window );">Immatics N.V. [Member] | Euro weakens by 1 against US dollars [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems', window );"><strong>Disclosure of Sensitivity Analysis For Each Type Of Market Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk', window );">Percentage Of Reasonably Possible Increase In Foreign Currency Risk</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk', window );">Percentage Of Reasonably Possible Decrease In Foreign Currency Risk</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=imtx_ImmaticsNvMember', window );">Immatics N.V. [Member] | Euro strengths by 1 against US dollars [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems', window );"><strong>Disclosure of Sensitivity Analysis For Each Type Of Market Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk', window );">Percentage Of Reasonably Possible Increase In Foreign Currency Risk</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk', window );">Percentage Of Reasonably Possible Decrease In Foreign Currency Risk</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=imtx_ImmaticsNvMember', window );">Immatics N.V. [Member] | Euro weakens by 5 against US dollars [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems', window );"><strong>Disclosure of Sensitivity Analysis For Each Type Of Market Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk', window );">Percentage Of Reasonably Possible Increase In Foreign Currency Risk</a></td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk', window );">Percentage Of Reasonably Possible Decrease In Foreign Currency Risk</a></td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=imtx_ImmaticsNvMember', window );">Immatics N.V. [Member] | Euro strengths by 5 against US dollars [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems', window );"><strong>Disclosure of Sensitivity Analysis For Each Type Of Market Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk', window );">Percentage Of Reasonably Possible Increase In Foreign Currency Risk</a></td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk', window );">Percentage Of Reasonably Possible Decrease In Foreign Currency Risk</a></td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=imtx_ImmaticsNvMember', window );">Immatics N.V. [Member] | Euro weakens by 10 against US dollars [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems', window );"><strong>Disclosure of Sensitivity Analysis For Each Type Of Market Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk', window );">Percentage Of Reasonably Possible Increase In Foreign Currency Risk</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk', window );">Percentage Of Reasonably Possible Decrease In Foreign Currency Risk</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=imtx_ImmaticsNvMember', window );">Immatics N.V. [Member] | Euro strengths by 10 against US dollars [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems', window );"><strong>Disclosure of Sensitivity Analysis For Each Type Of Market Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk', window );">Percentage Of Reasonably Possible Increase In Foreign Currency Risk</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk', window );">Percentage Of Reasonably Possible Decrease In Foreign Currency Risk</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfSensitivityAnalysisForEachTypeOfMarketRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Reasonably Possible Decrease In Foreign Currency Risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Reasonably Possible Increase In Foreign Currency Risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imtx_ImmaticsGmbhMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imtx_ImmaticsGmbhMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroWeakensBy1AgainstUsDollarsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroWeakensBy1AgainstUsDollarsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroStrengthsBy1AgainstUsDollarsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroStrengthsBy1AgainstUsDollarsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroWeakensBy5AgainstUsDollarsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroWeakensBy5AgainstUsDollarsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroStrengthsBy5AgainstUsDollarsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroStrengthsBy5AgainstUsDollarsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroWeakensBy10AgainstUsDollarsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroWeakensBy10AgainstUsDollarsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroStrengthsBy10AgainstUsDollarsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_SensitiveAnalaysisOfCurrencyAxis=imtx_EuroStrengthsBy10AgainstUsDollarsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=imtx_ImmaticsNvMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=imtx_ImmaticsNvMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237770856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Risk Management Objectives and Policies - Summary of Liquidity Risk (Detail) - Liquidity risk [member] - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk', window );">Financial assets held for managing liquidity risk</a></td>
<td class="nump">&#8364; 231,978<span></span>
</td>
<td class="nump">&#8364; 119,376<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=imtx_CashAndCashEquivalentsMember', window );">Cash And Cash Equivalents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk', window );">Financial assets held for managing liquidity risk</a></td>
<td class="nump">207,530<span></span>
</td>
<td class="nump">103,353<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=imtx_ShorttermDepositsMember', window );">Short-Term Deposits [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk', window );">Financial assets held for managing liquidity risk</a></td>
<td class="nump">&#8364; 24,448<span></span>
</td>
<td class="nump">&#8364; 16,023<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets held for managing liquidity risk (for example, financial assets that are readily saleable or expected to generate cash inflows to meet cash outflows on financial liabilities). [Refer: Liquidity risk [member]; Financial assets; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph B11E<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B11E&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsHeldForManagingLiquidityRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_StatementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_StatementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=imtx_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=imtx_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=imtx_ShorttermDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=imtx_ShorttermDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169214262248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Risk Management Objectives and Policies - Additional Information (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><sup>[2]</sup></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">&#8364; 207,530<span></span>
</td>
<td class="nump">&#8364; 103,353<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td colspan="2" class="nump">&#8364; 39,367<span></span>
</td>
<td class="nump">&#8364; 8,415<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CreditRiskMember', window );">Credit risk [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaximumExposureToCreditRisk', window );">Maximum exposure to credit risk</a></td>
<td class="nump">232,000<span></span>
</td>
<td class="nump">119,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">208,000<span></span>
</td>
<td class="nump">103,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherFinancialAssets', window );">Other financial assets</a></td>
<td class="nump">24,000<span></span>
</td>
<td class="nump">&#8364; 16,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember', window );">Currency risk [member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss', window );">Foreign exchange gain (loss)</a></td>
<td class="nump">10,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember', window );">Currency risk [member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss', window );">Foreign exchange gain (loss)</a></td>
<td class="nump">&#8364; 13,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember', window );">Currency risk [member] | Euro [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk', window );">Percentage Of Reasonably Possible Decrease In Foreign Currency Risk</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember', window );">Currency risk [member] | US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk', window );">Percentage Of Reasonably Possible Increase In Foreign Currency Risk</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See Note 2 for details regarding the change in presentation of Other financial assets</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">See Note 2 for details regarding the revision as a result of a correction in classification of Other financial assets</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2020-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Section A Statement of cash flows for an entity other than a financial institution<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS07_IE_A_TI<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2020-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaximumExposureToCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount that best represents the maximum exposure to credit risk without taking into account any collateral held or other credit enhancements (for example, netting agreements that do not qualify for offset in accordance with IAS 32). [Refer: Credit risk [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 35K<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_35K_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2021-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 36<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_36_a&amp;doctype=Standard&amp;book=b<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaximumExposureToCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets that the entity does not separately disclose in the same statement or note. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2020-01-01<br> -Paragraph 54<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_54_d&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Reasonably Possible Decrease In Foreign Currency Risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_PercentageOfReasonablyPossibleDecreaseInForeignCurrencyRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Reasonably Possible Increase In Foreign Currency Risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_PercentageOfReasonablyPossibleIncreaseInForeignCurrencyRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_StatementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_StatementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CreditRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_CreditRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169238465928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments - Summary of Carrying Amounts and Fair values of Group's Financial Instruments (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets, Carrying amount</a></td>
<td class="nump">&#8364; 28,198<span></span>
</td>
<td class="nump">&#8364; 18,690<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities, Carrying amount</a></td>
<td class="nump">12,077<span></span>
</td>
<td class="nump">8,370<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, Fair value</a></td>
<td class="nump">28,198<span></span>
</td>
<td class="nump">18,690<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, Fair value</a></td>
<td class="nump">12,077<span></span>
</td>
<td class="nump">8,370<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember', window );">Financial assets at fair value through profit or loss, category [member] | ShortTerm Deposits [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets, Carrying amount</a></td>
<td class="nump">24,448<span></span>
</td>
<td class="nump">16,023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, Fair value</a></td>
<td class="nump">24,448<span></span>
</td>
<td class="nump">16,023<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember', window );">Financial assets at fair value through profit or loss, category [member] | Positive Market Value Forward Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets, Carrying amount</a></td>
<td class="nump">914<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, Fair value</a></td>
<td class="nump">914<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=imtx_OtherFinancialAssetsAtAmortizedCostMember', window );">Other Financial Assets At Amortized Cost [Member] | Trade receivables [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets, Carrying amount</a></td>
<td class="nump">1,250<span></span>
</td>
<td class="nump">957<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, Fair value</a></td>
<td class="nump">1,250<span></span>
</td>
<td class="nump">957<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=imtx_OtherFinancialAssetsAtAmortizedCostMember', window );">Other Financial Assets At Amortized Cost [Member] | Other Current Asset [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets, Carrying amount</a></td>
<td class="nump">1,586<span></span>
</td>
<td class="nump">1,710<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, Fair value</a></td>
<td class="nump">1,586<span></span>
</td>
<td class="nump">1,710<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=imtx_OtherFinancialAssetsAtAmortizedCostMember', window );">Other Financial Assets At Amortized Cost [Member] | Accounts Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities, Carrying amount</a></td>
<td class="nump">10,052<span></span>
</td>
<td class="nump">7,082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, Fair value</a></td>
<td class="nump">10,052<span></span>
</td>
<td class="nump">7,082<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=imtx_OtherFinancialAssetsAtAmortizedCostMember', window );">Other Financial Assets At Amortized Cost [Member] | Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities, Carrying amount</a></td>
<td class="nump">2,025<span></span>
</td>
<td class="nump">1,288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, Fair value</a></td>
<td class="nump">&#8364; 2,025<span></span>
</td>
<td class="nump">&#8364; 1,288<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose the entity&#8217;s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 35H<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 35I<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_35I&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 35M<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_35M&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 35N<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_35N&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of financial assets. [Refer: At fair value [member]; Financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity&#8217;s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity&#8217;s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2020-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=imtx_ShorttermDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=imtx_ShorttermDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=imtx_PositiveMarketValueForwardContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=imtx_PositiveMarketValueForwardContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialAssetsAxis=imtx_OtherFinancialAssetsAtAmortizedCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialAssetsAxis=imtx_OtherFinancialAssetsAtAmortizedCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_TradeReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_TradeReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=imtx_OtherCurrentAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=imtx_OtherCurrentAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=imtx_AccountsPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=imtx_AccountsPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=imtx_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=imtx_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169238502648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and contingencies - Summary of Contractual Obligations (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfContractualObligationsLineItems', window );"><strong>Disclosure Of Contractual Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ContractualObligationOfLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">&#8364; 6,863<span></span>
</td>
<td class="nump">&#8364; 3,352<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_OtherLeaseObligations', window );">Other Lease Obligations</a></td>
<td class="nump">513<span></span>
</td>
<td class="nump">1,096<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ContractualObligationOfInLicenseAgreements', window );">In-license agreements</a></td>
<td class="nump">249<span></span>
</td>
<td class="nump">655<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ContractResearchOrganizationAgreements', window );">Contract research organization agreements</a></td>
<td class="nump">1,924<span></span>
</td>
<td class="nump">2,597<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ContractualCashObligation', window );">Total contractual obligation</a></td>
<td class="nump">9,549<span></span>
</td>
<td class="nump">7,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Less than 1year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfContractualObligationsLineItems', window );"><strong>Disclosure Of Contractual Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ContractualObligationOfLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">2,103<span></span>
</td>
<td class="nump">1,482<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_OtherLeaseObligations', window );">Other Lease Obligations</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">172<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ContractualObligationOfInLicenseAgreements', window );">In-license agreements</a></td>
<td class="nump">249<span></span>
</td>
<td class="nump">455<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ContractResearchOrganizationAgreements', window );">Contract research organization agreements</a></td>
<td class="nump">1,704<span></span>
</td>
<td class="nump">1,131<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ContractualCashObligation', window );">Total contractual obligation</a></td>
<td class="nump">4,153<span></span>
</td>
<td class="nump">3,240<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember', window );">1 - 3 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfContractualObligationsLineItems', window );"><strong>Disclosure Of Contractual Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ContractualObligationOfLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">3,453<span></span>
</td>
<td class="nump">1,823<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_OtherLeaseObligations', window );">Other Lease Obligations</a></td>
<td class="nump">185<span></span>
</td>
<td class="nump">324<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ContractualObligationOfInLicenseAgreements', window );">In-license agreements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ContractResearchOrganizationAgreements', window );">Contract research organization agreements</a></td>
<td class="nump">220<span></span>
</td>
<td class="nump">1,466<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ContractualCashObligation', window );">Total contractual obligation</a></td>
<td class="nump">3,858<span></span>
</td>
<td class="nump">3,813<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember', window );">3 - 5 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfContractualObligationsLineItems', window );"><strong>Disclosure Of Contractual Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ContractualObligationOfLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">1,157<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_OtherLeaseObligations', window );">Other Lease Obligations</a></td>
<td class="nump">185<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ContractualObligationOfInLicenseAgreements', window );">In-license agreements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ContractResearchOrganizationAgreements', window );">Contract research organization agreements</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ContractualCashObligation', window );">Total contractual obligation</a></td>
<td class="nump">1,342<span></span>
</td>
<td class="nump">347<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">More than 5 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfContractualObligationsLineItems', window );"><strong>Disclosure Of Contractual Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ContractualObligationOfLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_OtherLeaseObligations', window );">Other Lease Obligations</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ContractualObligationOfInLicenseAgreements', window );">In-license agreements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ContractResearchOrganizationAgreements', window );">Contract research organization agreements</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_ContractualCashObligation', window );">Total contractual obligation</a></td>
<td class="nump">&#8364; 196<span></span>
</td>
<td class="nump">&#8364; 300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_ContractResearchOrganizationAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract research organization agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_ContractResearchOrganizationAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_ContractualCashObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual cash obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_ContractualCashObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_ContractualObligationOfInLicenseAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual obligation of in license agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_ContractualObligationOfInLicenseAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_ContractualObligationOfLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual obligation of lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_ContractualObligationOfLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfContractualObligationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfContractualObligationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_OtherLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_OtherLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>150
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169256004824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and contingencies - Additional Information (Detail) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_AgreementAxis=imtx_CollaborationAgreementsMember', window );">Collaboration Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_StatementsLineItems', window );"><strong>Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_UnrecordedContingentLiability', window );">Unrecorded contingent liability</a></td>
<td class="nump">&#8364; 1.6<span></span>
</td>
<td class="nump">&#8364; 1.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_StatementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_StatementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_UnrecordedContingentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecorded contingent liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_UnrecordedContingentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_AgreementAxis=imtx_CollaborationAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_AgreementAxis=imtx_CollaborationAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169242911576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related party disclosures - Summary of Compensation of Key Management Personnel (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DisclosureOfCompensationOfKeyManagementPersonnelAbstract', window );"><strong>Disclosure Of Compensation Of Key Management Personnel [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationFixed', window );">Fixed</a></td>
<td class="nump">&#8364; 2,660<span></span>
</td>
<td class="nump">&#8364; 1,202<span></span>
</td>
<td class="nump">&#8364; 1,088<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationOtherLongtermBenefits', window );">Variable</a></td>
<td class="nump">886<span></span>
</td>
<td class="nump">521<span></span>
</td>
<td class="nump">433<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment', window );">Share-based compensation expense</a></td>
<td class="nump">13,841<span></span>
</td>
<td class="nump">697<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensation', window );">Total</a></td>
<td class="nump">&#8364; 17,387<span></span>
</td>
<td class="nump">&#8364; 2,420<span></span>
</td>
<td class="nump">&#8364; 1,640<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2020-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationOtherLongtermBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of other long-term employee benefits. [Refer: Other long-term employee benefits; Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2020-01-01<br> -Paragraph 17<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_17_c&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationOtherLongtermBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2020-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DisclosureOfCompensationOfKeyManagementPersonnelAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DisclosureOfCompensationOfKeyManagementPersonnelAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_KeyManagementPersonnelCompensationFixed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Key management personnel compensation fixed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_KeyManagementPersonnelCompensationFixed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>152
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169215531640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related party disclosures - Summary of Compensation for the Supervisory Board (Detail) - EUR (&#8364;)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems', window );"><strong>Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationSupervisoryBoardCompensation', window );">Supervisory board compensation</a></td>
<td class="nump">&#8364; 282<span></span>
</td>
<td class="nump">&#8364; 309<span></span>
</td>
<td class="nump">&#8364; 410<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationTravellingExpenses', window );">Travel expenses</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">1,436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationPaymentExitArrangement', window );">Payment Exit arrangement</a></td>
<td class="nump">2,394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensations', window );">Total cash compensation</a></td>
<td class="nump">4,116<span></span>
</td>
<td class="nump">416<span></span>
</td>
<td class="nump">478<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_PeterChambreMember', window );">Peter Chambre</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems', window );"><strong>Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationSupervisoryBoardCompensation', window );">Supervisory board compensation</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationTravellingExpenses', window );">Travel expenses</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">1,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationPaymentExitArrangement', window );">Payment Exit arrangement</a></td>
<td class="nump">2,394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensations', window );">Total cash compensation</a></td>
<td class="nump">3,584<span></span>
</td>
<td class="nump">387<span></span>
</td>
<td class="nump">452<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_HaraldFstockMember', window );">Harald F.Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems', window );"><strong>Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationSupervisoryBoardCompensation', window );">Supervisory board compensation</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationTravellingExpenses', window );">Travel expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationPaymentExitArrangement', window );">Payment Exit arrangement</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensations', window );">Total cash compensation</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">&#8364; 29<span></span>
</td>
<td class="nump">&#8364; 26<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_MichaelGAtiehMember', window );">Michael G. Atieh</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems', window );"><strong>Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationSupervisoryBoardCompensation', window );">Supervisory board compensation</a></td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationTravellingExpenses', window );">Travel expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationPaymentExitArrangement', window );">Payment Exit arrangement</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensations', window );">Total cash compensation</a></td>
<td class="nump">98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_PaulCarterMember', window );">Paul Carter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems', window );"><strong>Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationSupervisoryBoardCompensation', window );">Supervisory board compensation</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationTravellingExpenses', window );">Travel expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationPaymentExitArrangement', window );">Payment Exit arrangement</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensations', window );">Total cash compensation</a></td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_HeatherLMasonMember', window );">Heather I. Mason</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems', window );"><strong>Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationSupervisoryBoardCompensation', window );">Supervisory board compensation</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationTravellingExpenses', window );">Travel expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationPaymentExitArrangement', window );">Payment Exit arrangement</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensations', window );">Total cash compensation</a></td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_AdamStoneMember', window );">Adam Stone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems', window );"><strong>Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationSupervisoryBoardCompensation', window );">Supervisory board compensation</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationTravellingExpenses', window );">Travel expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationPaymentExitArrangement', window );">Payment Exit arrangement</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensations', window );">Total cash compensation</a></td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_ChristophHettichMember', window );">Christoph Hettich</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems', window );"><strong>Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationSupervisoryBoardCompensation', window );">Supervisory board compensation</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationTravellingExpenses', window );">Travel expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationPaymentExitArrangement', window );">Payment Exit arrangement</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensations', window );">Total cash compensation</a></td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_EliotForsterMember', window );">Eliot Forster</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems', window );"><strong>Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationSupervisoryBoardCompensation', window );">Supervisory board compensation</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationTravellingExpenses', window );">Travel expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensationPaymentExitArrangement', window );">Payment Exit arrangement</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_KeyManagementPersonnelCompensations', window );">Total cash compensation</a></td>
<td class="nump">&#8364; 52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_KeyManagementPersonnelCompensationPaymentExitArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Key management personnel compensation payment exit arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_KeyManagementPersonnelCompensationPaymentExitArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_KeyManagementPersonnelCompensationShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Key management personnel compensation share based compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_KeyManagementPersonnelCompensationShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_KeyManagementPersonnelCompensationSupervisoryBoardCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Key management personnel compensation supervisory board compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_KeyManagementPersonnelCompensationSupervisoryBoardCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_KeyManagementPersonnelCompensationTravellingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Key management personnel compensation travelling expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_KeyManagementPersonnelCompensationTravellingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_KeyManagementPersonnelCompensations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Key management personnel compensations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_KeyManagementPersonnelCompensations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_PeterChambreMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_PeterChambreMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_HaraldFstockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_HaraldFstockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_MichaelGAtiehMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_MichaelGAtiehMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_PaulCarterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_PaulCarterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_HeatherLMasonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_HeatherLMasonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_AdamStoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_AdamStoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_ChristophHettichMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_ChristophHettichMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_EliotForsterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_EliotForsterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>153
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169214685496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related party disclosures - Summary of Options Granted to Managing Director and Supervisory Directors (Detail)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>shares </div>
<div>$ / shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TypeOfVestingAxis=imtx_PerformanceBasedOptionsMember', window );">Performance Based Options [Member] | Harpreet Singh</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfTransactionsWithRelatedParty', window );">Description of Transactions with related party</a></td>
<td class="text">Harpreet Singh<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement', window );">Type of option</a></td>
<td class="text">Performance-based options<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement', window );">Grant date</a></td>
<td class="text">June 30, 2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of Options | shares</a></td>
<td class="nump">1,598,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Strike Price in USD | $ / shares</a></td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DateOfExpiryOfShareOptionsGranted', window );">Expiration date</a></td>
<td class="text">Jun. 30,  2030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TypeOfVestingAxis=imtx_ServiceOptionsMember', window );">Service Options [Member] | Harpreet Singh</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfTransactionsWithRelatedParty', window );">Description of Transactions with related party</a></td>
<td class="text">Harpreet Singh<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement', window );">Type of option</a></td>
<td class="text">Service options<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement', window );">Grant date</a></td>
<td class="text">June 30, 2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of Options | shares</a></td>
<td class="nump">168,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Strike Price in USD | $ / shares</a></td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DateOfExpiryOfShareOptionsGranted', window );">Expiration date</a></td>
<td class="text">Jun. 30,  2030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TypeOfVestingAxis=imtx_ServiceOptionsMember', window );">Service Options [Member] | Peter Chambre</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfTransactionsWithRelatedParty', window );">Description of Transactions with related party</a></td>
<td class="text">Peter Chambr&#233;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement', window );">Type of option</a></td>
<td class="text">Service options<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement', window );">Grant date</a></td>
<td class="text">June 30, 2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of Options | shares</a></td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Strike Price in USD | $ / shares</a></td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DateOfExpiryOfShareOptionsGranted', window );">Expiration date</a></td>
<td class="text">Jun. 30,  2030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TypeOfVestingAxis=imtx_ServiceOptionsMember', window );">Service Options [Member] | Adam Stone</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfTransactionsWithRelatedParty', window );">Description of Transactions with related party</a></td>
<td class="text">Adam Stone<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement', window );">Type of option</a></td>
<td class="text">Service options<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement', window );">Grant date</a></td>
<td class="text">June 30, 2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of Options | shares</a></td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Strike Price in USD | $ / shares</a></td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DateOfExpiryOfShareOptionsGranted', window );">Expiration date</a></td>
<td class="text">Jun. 30,  2030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TypeOfVestingAxis=imtx_ServiceOptionsMember', window );">Service Options [Member] | Christoph Hettich</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfTransactionsWithRelatedParty', window );">Description of Transactions with related party</a></td>
<td class="text">Christoph Hettich<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement', window );">Type of option</a></td>
<td class="text">Service options<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement', window );">Grant date</a></td>
<td class="text">June 30, 2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of Options | shares</a></td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Strike Price in USD | $ / shares</a></td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DateOfExpiryOfShareOptionsGranted', window );">Expiration date</a></td>
<td class="text">Jun. 30,  2030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TypeOfVestingAxis=imtx_ServiceOptionsMember', window );">Service Options [Member] | Heather I. Mason</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfTransactionsWithRelatedParty', window );">Description of Transactions with related party</a></td>
<td class="text">Heather L. Mason<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement', window );">Type of option</a></td>
<td class="text">Service options<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement', window );">Grant date</a></td>
<td class="text">June 30, 2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of Options | shares</a></td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Strike Price in USD | $ / shares</a></td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DateOfExpiryOfShareOptionsGranted', window );">Expiration date</a></td>
<td class="text">Jun. 30,  2030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TypeOfVestingAxis=imtx_ServiceOptionsMember', window );">Service Options [Member] | Michael G. Atieh</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfTransactionsWithRelatedParty', window );">Description of Transactions with related party</a></td>
<td class="text">Michael G. Atieh<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement', window );">Type of option</a></td>
<td class="text">Service options<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement', window );">Grant date</a></td>
<td class="text">June 30, 2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of Options | shares</a></td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Strike Price in USD | $ / shares</a></td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DateOfExpiryOfShareOptionsGranted', window );">Expiration date</a></td>
<td class="text">Jun. 30,  2030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TypeOfVestingAxis=imtx_ServiceOptionsMember', window );">Service Options [Member] | Paul Carter</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfTransactionsWithRelatedParty', window );">Description of Transactions with related party</a></td>
<td class="text">Paul Carter<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement', window );">Type of option</a></td>
<td class="text">Service options<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement', window );">Grant date</a></td>
<td class="text">June 30, 2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of Options | shares</a></td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Strike Price in USD | $ / shares</a></td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DateOfExpiryOfShareOptionsGranted', window );">Expiration date</a></td>
<td class="text">Jun. 30,  2030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TypeOfVestingAxis=imtx_ServiceOptionsMember', window );">Service Options [Member] | Eliot Forster</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfTransactionsWithRelatedParty', window );">Description of Transactions with related party</a></td>
<td class="text">Eliot Forster<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement', window );">Type of option</a></td>
<td class="text">Service options<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement', window );">Grant date</a></td>
<td class="text">September 14, 2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of Options | shares</a></td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Strike Price in USD | $ / shares</a></td>
<td class="nump">$ 9.16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DateOfExpiryOfShareOptionsGranted', window );">Expiration date</a></td>
<td class="text">Sep. 13,  2030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TypeOfVestingAxis=imtx_ServiceOptionsOneMember', window );">Service Options One [Member] | Harpreet Singh</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfTransactionsWithRelatedParty', window );">Description of Transactions with related party</a></td>
<td class="text">Harpreet Singh<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement', window );">Type of option</a></td>
<td class="text">Service options<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement', window );">Grant date</a></td>
<td class="text">December 17, 2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of Options | shares</a></td>
<td class="nump">168,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Strike Price in USD | $ / shares</a></td>
<td class="nump">$ 9.70<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DateOfExpiryOfShareOptionsGranted', window );">Expiration date</a></td>
<td class="text">Dec. 17,  2030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TypeOfVestingAxis=imtx_MatchingStockOptionsMember', window );">Matching Stock Options [Member] | Harpreet Singh</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfTransactionsWithRelatedParty', window );">Description of Transactions with related party</a></td>
<td class="text">Harpreet Singh<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement', window );">Type of option</a></td>
<td class="text">Matching Stock options<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement', window );">Grant date</a></td>
<td class="text">June 30, 2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of Options | shares</a></td>
<td class="nump">264,624<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Strike Price in USD | $ / shares</a></td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DateOfExpiryOfShareOptionsGranted', window );">Expiration date</a></td>
<td class="text">Jun. 30,  2030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TypeOfVestingAxis=imtx_MatchingStockOptionsMember', window );">Matching Stock Options [Member] | Peter Chambre</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfTransactionsWithRelatedParty', window );">Description of Transactions with related party</a></td>
<td class="text">Peter Chambr&#233;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement', window );">Type of option</a></td>
<td class="text">Matching Stock options<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement', window );">Grant date</a></td>
<td class="text">June 30, 2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of Options | shares</a></td>
<td class="nump">211,974<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Strike Price in USD | $ / shares</a></td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DateOfExpiryOfShareOptionsGranted', window );">Expiration date</a></td>
<td class="text">Jun. 30,  2030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TypeOfVestingAxis=imtx_ConvertedOptionsMember', window );">Converted Options [Member] | Harpreet Singh</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfTransactionsWithRelatedParty', window );">Description of Transactions with related party</a></td>
<td class="text">Harpreet Singh<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement', window );">Type of option</a></td>
<td class="text">Converted options<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement', window );">Grant date</a></td>
<td class="text">June 30, 2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of Options | shares</a></td>
<td class="nump">30,939<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Strike Price in USD | $ / shares</a></td>
<td class="nump">$ 1.06<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DateOfExpiryOfShareOptionsGranted', window );">Expiration date</a></td>
<td class="text">Jul.  01,  2027<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TypeOfVestingAxis=imtx_ConvertedOptionsOneMember', window );">Converted Options One [Member] | Harpreet Singh</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfTransactionsWithRelatedParty', window );">Description of Transactions with related party</a></td>
<td class="text">Harpreet Singh<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement', window );">Type of option</a></td>
<td class="text">Converted options<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement', window );">Grant date</a></td>
<td class="text">June 30, 2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement', window );">Number of Options | shares</a></td>
<td class="nump">145,371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Strike Price in USD | $ / shares</a></td>
<td class="nump">$ 1.17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DateOfExpiryOfShareOptionsGranted', window );">Expiration date</a></td>
<td class="text">Jan.  01,  2028<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DateOfGrantOfSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The date on which share-based payment arrangements are granted. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph IG23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_IG23&amp;doctype=Implementation%20Guidance<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DateOfGrantOfSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the method of settlement (for example, whether in cash or equity) for a type of share-based payment arrangement that existed at any time during the period. An entity with substantially similar types of share-based payment arrangements may aggregate this information. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of related party transactions. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2020-01-01<br> -Paragraph 18<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_18&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExercisePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exercise price of share options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExercisePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of instruments granted in share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph IG23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_IG23&amp;doctype=Implementation%20Guidance<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DateOfExpiryOfShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date of expiry of share options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DateOfExpiryOfShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TypeOfVestingAxis=imtx_PerformanceBasedOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TypeOfVestingAxis=imtx_PerformanceBasedOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_HarpreetSinghMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_HarpreetSinghMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TypeOfVestingAxis=imtx_ServiceOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TypeOfVestingAxis=imtx_ServiceOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_PeterChambreMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_PeterChambreMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_AdamStoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_AdamStoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_ChristophHettichMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_ChristophHettichMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_HeatherLMasonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_HeatherLMasonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_MichaelGAtiehMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_MichaelGAtiehMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_PaulCarterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_PaulCarterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_EliotForsterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=imtx_EliotForsterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TypeOfVestingAxis=imtx_ServiceOptionsOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TypeOfVestingAxis=imtx_ServiceOptionsOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TypeOfVestingAxis=imtx_MatchingStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TypeOfVestingAxis=imtx_MatchingStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TypeOfVestingAxis=imtx_ConvertedOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TypeOfVestingAxis=imtx_ConvertedOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TypeOfVestingAxis=imtx_ConvertedOptionsOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TypeOfVestingAxis=imtx_ConvertedOptionsOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>154
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169237590312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related party disclosures - Summary of Compensation for the Supervisory Board (Parenthetical) (Detail) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract', window );"><strong>Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits', window );">Key management personnel compensation, short-term employee benefits</a></td>
<td class="nump">&#8364; 2.7<span></span>
</td>
<td class="nump">&#8364; 0.4<span></span>
</td>
<td class="nump">&#8364; 0.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2020-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>155
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169214618920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related party disclosures - Additional Information (Detail)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_AccruedOfKeyManagementCompensation', window );">Accrued of key management compensation | &#8364;</a></td>
<td class="nump">&#8364; 0.0<span></span>
</td>
<td class="nump">&#8364; 0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,469<span></span>
</td>
<td class="nump">74,401<span></span>
</td>
<td class="nump">31,880<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=imtx_AryaMember', window );">ARYA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_NumberOfConvertedStockOptionsInTheEntity', window );">Number of Converted Stock Options In The Entity</a></td>
<td class="nump">417,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_NumberOfMatchingStockOptionInTheEntity', window );">Number of matching stock option in the entity</a></td>
<td class="nump">750,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TypeOfVestingAxis=imtx_ServiceOptionsMember', window );">Service Options [Member] | Immatics GmbH [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding</a></td>
<td class="nump">1,680,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TypeOfVestingAxis=imtx_PerformanceBasedOptionsMember', window );">Performance Based Options [Member] | Immatics GmbH [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding</a></td>
<td class="nump">539,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PlanNameAxis=imtx_TwentyTwentyIncentivePlanMember', window );">Twenty Twenty Incentive Plan [Member] | Service Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfStockVestedOverThePeriodOfFourYearTimeBasedVestingSchedule', window );">Percentage of stock vested over the period of four-year time-based vesting schedule</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PlanNameAxis=imtx_TwentyTwentyIncentivePlanMember', window );">Twenty Twenty Incentive Plan [Member] | Performance Based Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PercentageOfStockVestedOverThePeriodOfFourYearTimeBasedVestingSchedule', window );">Percentage of stock vested over the period of four-year time-based vesting schedule</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember', window );">Key management personnel of entity or parent [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_PaymentOfPayrollTaxOfTheEmployees', window );">Payment of Payroll Tax of the employees | &#8364;</a></td>
<td class="nump">&#8364; 3.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2020-01-01<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2020-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2020-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2020-01-01<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_AccruedOfKeyManagementCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued of key management compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_AccruedOfKeyManagementCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_NumberOfConvertedStockOptionsInTheEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Converted stock options in the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_NumberOfConvertedStockOptionsInTheEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_NumberOfMatchingStockOptionInTheEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of matching stock option in the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_NumberOfMatchingStockOptionInTheEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_PaymentOfPayrollTaxOfTheEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment of Payroll Tax of the employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_PaymentOfPayrollTaxOfTheEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_PercentageOfStockVestedOverThePeriodOfFourYearTimeBasedVestingSchedule">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of stock vested over the period of four-year time-based vesting schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_PercentageOfStockVestedOverThePeriodOfFourYearTimeBasedVestingSchedule</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=imtx_AryaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=imtx_AryaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TypeOfVestingAxis=imtx_ServiceOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TypeOfVestingAxis=imtx_ServiceOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imtx_ImmaticsGmbhMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=imtx_ImmaticsGmbhMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TypeOfVestingAxis=imtx_PerformanceBasedOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TypeOfVestingAxis=imtx_PerformanceBasedOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_PlanNameAxis=imtx_TwentyTwentyIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_PlanNameAxis=imtx_TwentyTwentyIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>156
<FILENAME>R117.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140169242904200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net loss per share - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_imtx_DilutiveEffectOfShareOptionsOnNumberOfWarrants', window );">Dilutive effect of share options on number of warrants</a></td>
<td class="nump">7,187,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_DilutiveEffectOfShareOptionsOnNumberOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Dilutive effect of share options on number of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_DilutiveEffectOfShareOptionsOnNumberOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_imtx_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">imtx_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>imtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>157
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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ML\[$?7\Q<$R#_(TO$=^F>]?$#.5!RB=S,P_/.HYAQ&,>: /!X-\SG_(X-DC
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MG>X,83&H6 Q0F E0"',:LYBMZFC@[1]9G'*$Q[#B,6P7C057D0Q-?A!(S]K
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MQR6HU46_H>I\0X+B2%44M"0;8SDL-27Q=UF+4;9ZZ>-R]X9DQ($:DW%@I7.
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MPO$))Y]@TIS,FF/:G,R;8^*<S)QCZIS,G6/RG,R>8_J<S)\C 9QD@",%G.0
MD ,@.0#D $@.P'0\R0$@!T!R ,@!D!P <@ D!X < ,D!( = <@#( 9 < '(
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M)'3C-\4!): Y"A(8R&3G=>*=:L%U.\P%ZYI,52"VKALE_N?,J<0R(@Q).,+
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MN[-;Z6KQ*$? T.@$^)CN!;#W-=1!'6,C=M[4[':G.WLAU>XQ =@UP'950,+
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MKR]7C,KQI0#R_0.746IO5 /;ST!._P%02P,$%     @ :#Y^4KL(2%M[!
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MK#@I\,2_TT?C:3(8G46JDT%R/IZ(27(V';8$D5W&TU&PQ4H"VE1,@AM"3M[
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M7BZAH;*T <_G!EZ.%\2@^X!Y^6]02P,$%     @ :#Y^4A-;_T(0"   RA0
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MW^^J]%L)B [\/Z4#J4R5[EFA9,@6V[7&(:8^Z-!0T(>$"6+=C62AV8H=IJ
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M(=B*+PL%U#I:@/<K"U/3#2GH/E]>_ ]02P,$%     @ :#Y^4ITJIIY3!
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MPP:TGFFJEW;  ;I7\NP?4$L#!!0    ( &@^?E)^K$5\&AT  *E9   9
M>&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;,5<"8\;1W;^*PT%""2 P]&,#LN2
M+6 LRXZR\EK1R+L)%@%2["Z2M>J#V]4],]Q?G_>]]^IHLCF2%SD PQJ2757O
MOJN_N^WZSWYK[5#<-77KOW^P'8;=R_-S7VYM8_RRV]F6?EEW?6,&^MAOSOVN
MMZ;B14U]?OGX\?/SQKCVP>OO^+L/_>OONG&H76L_](4?F\;T^Q]LW=U^_^#B
M0?CBH]ML!WQQ_OJ[G=G8:SO\MOO0TZ?SN$OE&MMZU[5%;]??/[BZ>/G#4SS/
M#_S)V5N?_5T DU77?<:'=]7W#QX#(%O;<L .AOZYL6]L76,C N-ONN>#>"06
MYG^'W7]BW F7E?'V35?_V57#]OL'+QX4E5V;L1X^=K?_8A6?9]BO[&K/_R]N
M]=G'#XIR]$/7Z&*"H'&M_&ONE Y?L^!2%UPRW'(00_FC&<SK[_KNMNCQ-.V&
M/QA57DW N19,N1YZ^M71NN'UM3"CZ-9$H+(;V\&UFV+7U:YTUA=FMZN=K8K5
MOABVMOBY[\9=0:+ GTS;CJ8FUNRZ7I;9WG558=L*GWZTI6U6MB^>7"R*R\>7
MC[\['PABG'M>*G0_"'27)Z"[N"Q^Z=IAZXNW;66KZ0;GA&K$]S+@^\/EO3L2
M4,L3 $WV>Q+I]X3W>W)BOT_V;BA^J+OR<_&7JY4?>A*S_[QGWZ=QWZ>\[]-3
M<#I?UIT?>PO6>+=IW=J5IAUFV?27 6"L ,9_SE'YWK.@]R_]SI3V^P>DV-[V
M-_;!Z^+9LOB_%([B$RU:=S59"?QN"'%L\R7,9V%P;4&([$R/1]W@B[)K/:VH
MS$"/KEUKVM(1<'Z@+\C"#/XEH7M17-L-/M%ZL78P&Y_BKHUIR4QYWI",8L^_
M$P3T'X'9;FJ"5C<(1-B-_:[SM 84]/2'5TKP_FT),E6T\6=\K7O27Y4M':R>
M7Z;C__F?7EQ>?//*T]YD%@I'>[9\!CAF^G++6U7VANSLCH&@,S\5)=D[>J1R
M/<P@R-$T8]O1PM[L0,  ZD F?0CK2L#6R^EOMLZNB[=WMAQA0(M?U\0.8AQ!
M@'4E_WP,.["BIVZW'1V_&6O3UWOZZP9F51;F/$GK"1TRJ#X0AB",U"C,BMR*
M2!?)22D,(G"'(R+1+MW8EY8H^&QY6;PQ7NA3X@_[M]'=F!I\O^<7)^1]DX-Y
M'00&I_X4Y>A#YQW#XB!JS:YWGAY^MGR2/0/VTZ[O6GJ2]:+L-JVL8E2M@;+S
MWD>+;MVP57!\2:3"Z>]^^GA=?$M0EO5860%_#H]%47>FI7_\EA3Q;+!]0Q3=
M 6(A,D%BZ>%5#6*]:R#V)8B.)\E0*+-J H7U,- <R]>'@!KHSA&"R^**A/#X
MX=Z&I_Y.Y-*%)"6TR]JXOB ,1M*AFL2=[&KKC3CRLO,4AQ0?B+]; ^4"%IZP
M937[TC&B-;0[;4ET U\7^/)VZTB'D@TA/C; <>B@Q7Q20:KBH4\L@=A=-,2/
M*T\4!^MR-LX!0Y0G ^@3% >$-7C$E[U;P:8A9"(K/,.XR">":Y:S$!F"UVT(
M@IH4:1A[(B^1:&6'6VMQ?&_%_+3$Y:)A-[M0,H!F 3("A,[X%1;C")]YX/AL
MTQX=OQ==Q;ER' A*;/,SYYV4YV7Q&X4"?9#_6:F>[J;:,R>L2<R6Q<>D!YG1
M!WTS#2G6?=>0;-0UV:)>>;8AC!J![2I[N&@H?"-Z$PH[-YB:Q<^(_=IUCOU,
M,5"$BR\/Q0_GKDAJ\2M,)0<6<*CDU8:6\ =M#-!T#63T)+UX)P.+1'KXKLV%
M]= W$_M-#C]9,Y5GAMLT>!I(0 .+D7T9(+;KM>7@FA B3E@//1BV747BX>#D
MQ$TE(H)!&>/RG\ L&'E#_+ICJZ []JRHM),_WFN&P%'V7'O3D;^"J 4R A.*
M(W*64V1?P^?-BN+8]R"7B,T";#&C9Q]TRODD\+;F!EI6V+L=T<A6$UU@V1^V
M]#,%NJ(2X)%B#&YVF=J!O"P0R3^XEB+.L5%_)9Z ]K%[.J;_3"G=>H2U80,Y
MHR@Y=W-5B"#H@8YQZGH*P>]G.YA4/'S[[N.C94'_#S$"?TUX#D5%82UH+]_3
M$M=(3#8.8Z]>;&?V@A&QC$FYP]\W5N*42,C:K6V@_WJ&(EAN!&U:*A(.^T:0
M(FKL.W+3(E,=[]$2N4K3]WL./UE"CK=G&6"SY<S*U<1'TGGV.T<![2(9:>=9
MB4>0"?J[A^93X$4I(R2#G$N[0?#;WYJ^BF*JT5_\6%1=09$;<<V*C).;H V=
M 0:(@_?%UE:T418GLY604)JRW0YZA[B8\(:?E>= _J[/HY C@;AJ]X5"J7%(
MYJ"!W62G+%PY'3V][SP'9T^+#SVBOV&_(%?/83X! @,F4>S]O]+9',0SQ#!+
M"^:C)"QC0V$G?B.!)T%R)D9;^8^NV1$NO!LE7!1/+ I'R]N]A"W((YQ2QT#0
M114Y"#F,+<A80#Q;,@XD9RW4![:#[."/.02($DU=ZOD J4#BB/K!&7(SE!E<
M+O)13<CLK,>:A.]&@IT8B*BLG'@28&XL>0T.KS+VI'RK!W,I#7I#JS<=Y7QO
MC[=:@Y_-;H0^)19<%&SX+EX5%X^+/:4BOG@OSA';S#[W3)^35")[YC(^<QGV
M>K9\!GM$X#G8:?7=5R6MZ<4_'/P$9%,LF7-')&19_!2QG@E6%R>VA&EP:1>-
M6S(Y4O?XNX7L&#F.G]: S68,3.XW" :)I?*&P&^[QI7A<9S.Z:9J9#J>+6!K
M=8=>M!>26H40E.TTA..0#B3_>X0SLAFD&B(W05MS?)P_'/XF(8&:FN/-)6@,
M:&<RMQ#W@\11R%^3D1J"G[=PDNO"&HJ>#N.9/)WIB"PPGNJ/]^*S6I8139IG
MI0G$FV<0D<P>0GN#'.HJQ_I_0]=A9T1SOZRP[TG!6B1)SZ)J/0FJ==VMAUN(
M5E+-9U'KGE-T=**P$']08R?RR=30B(F-8[!^S/(01-&?L.,M$_L&V&ZTCC(B
MK!\HXV^%OAPF]YV'NP?^&[*^X&UK;RD+=K09TB9L.-ARVY+XUL7GMKNMQ0<2
MS+PCN0>N.(DUCZ G^ZU(,.#)8%_-B"BB:$# .4!.$-ZB<AS"L/*S/MVXB@/V
MOOLK4- @*J:AL,1;V^8I)RVL+,5OD)!!PN:$VYK$WDG,P24:LL2U'4(P=@2L
M[T23'52+,"?%-3?&U1SM@B.C)K24)BPXFV?G)B:@"]L+(3FITJ/IMW$N%5X4
MV^XV?91#Q>G0+AK?13NUHA_6#M$TKQ# (FZQ>G,$"3^=(-%XA18@'JOW,4(,
MW*C&/E H8UA65J.(M&+#$'D3K,.!SM_'="X62<QW^?CB6X:4_GA!Q]L07MH[
MYYE;(TIK T())PN))JWV*,2P<)T@'<2-"T[>EZ=U,JIB2 .F[GW8[\2*L-R_
M+"Z68#P)M.6$1IB191Q$4#8E_/A"-\5&?NC*SV?H@U3,&3K4B-N$3)'=]<"&
M/%*[,1M6\M,%2DI.&&U/[GXYP4#LQ@QMQ"C8DDPG*\5!O9.D!OJVZ4TCV,0'
M!XJ3:Y\]4XTEXGWB((+3"8YL-[*T/ASM*#A'^,Y$\R,PDM+R6).T@$XA5N]Z
MY-*E(6TF84=.0G*BY>(V1?B)-%V_,:WZ#"+'DZ662#VCU9AV7"/_9V$^!C[J
M,R@VQ?@?Q6N1(S8!FG![53Q=%G4*\EA*7J%C -\,BV]*T5&5GQ3A'87B(F^!
M^:$ %:18ZM82T$C)EW8/#[_B[Y\OV7+5Z/.IO>6$X= +S4C3FH#4) F>ABO<
M(+ 96._06BA3E?\6]LYX(=B9Y'&UN%<RSE)J_B9+SD.*Z!!7_[ZZ;[;TON+O
M<:UB/;O%M* Z;,GP;;9 F;2>DUD*23E=/BSR++B[D9+EB>'\?17B WB^HDP\
M6?%UM6*BZ")DJ"57;-=2_F9:D[SV; XAW2F<GZ(,%%TTHUXED$\BC5J- SO0
MF7ITC#79M>=Y1ZDECYW9&_$HD[K.#'6F(.5M("[GP5\1;&[32N9!#FM^JW&'
M$'1.]/R7)6+"[! _BUT'C5%K8->22.$EY/@=!0KHS(OBO>4Z_E52.!;RJ^OB
MXIOB(6+3R\>OY"'^</'J48'U]6'5A5SN!XK\>QP(3[S(HJO0*=1M.?;**B5K
MKD7C"*[H&$[PK%6C*8L6^H14.=A0H9P*&ZG2J!$1!8J?0W<%-1UQ/+<4#/FM
MVPG)UI;-DH8' N.M/:'1-L+VT^2SKCBN?_+/L2*)*NQ.&#\<EF\TM5#+':UG
MUW.*2O&#[1?![WJ8J<DR,@"N&1M9'DMWH7)%&'H2P4H:>Q13U46WJD/('VLU
M <=R:_H-.P'.3$4%V7*+OH0D8J(MT8>T77L6GC@4)=C+B^>G9"E5,O^5/"TZ
MWA<:R24-,%6W@[+]HUOEVJ2\NZ'XJQLA&RB#3-PDL+JQ)&&U1'U,NE0)Y)+>
M?@<_7Z/66TE(+R5S+>8SAVX[")BG**G5S(XL&"?RG C;NT'G:[I=]'.I 46$
MUQ[4FW@TU@(0@Q^)\,IY;B01 ^13^JOG3+=;GR$\N=+TM:T.C'N65YFPX:2,
M$PN3G$%/)9$SZ*48D<F^>2@,29L5X!0C3T688V0E:"A(/TRQE&O/5/5);BEZ
ME8*Q3^5I(OO*1I,_&4\0DT+ 2((HX&Q(6,B.<!RAX9^]LWWI %//'8PU4(^]
M2-%GES4@),4T%(%S+J1I!B").[%]EJ42/5$@E^KM:Y*=UM1#G M@!V]BDLD4
M6H0SA5[:P5DC_/(9+'JD+(V'!C;%,X5,+,&!+$<(S$@IZF$UI;BYC6!S-.V_
M,IBI4O\I0AW/Y\J%-B4FW8UI3\,UL"=N".?P+N3SUX(</T/Q.#SD"I&*J1P7
MEC1$JF)<Z[-";(Q2P@S&M(TD5F*AY\$9Y?9<D"3QB5&-0NJ1"6AQ[O[GIJT9
M03J6+=3]W79C78FQ0"?<<-HM6XGZH,$$0TX&S,/<T<_=BMEFVM NP0!30QE^
MC#<Z]9*9;?C4)7(I+*=@S[PZ:^G()2BR;*ZNSDCT2!UE<L14?QW]((Q&'8D+
M1GIXD.6HT4F<%]*KZ?<+]3CE7EIHE"!PZ^YC#OC%,M0ZLXY1B+D.Y+&>V*@]
M&PX*W@YDDK7!<!RVDJ:-)(,-_5S*7DC[M 0=U\/)MP.7"Z4#2?+\9*GE# %'
MTRG-RE3_(>6AEZWAY@3!"9L^1,7QOD,>IPWVO+^H[@UEV5F'%M*Y[$$RP6<B
M&^_C7V^CVG/E)]BB S.06P!3M"-'@[!D(9"9-HST2%/VG<_,%:N+>AVH#Q>7
MS!U)[=]M&O9"%:ZV=Z$*!UM 4'E-T<TFV XM&?%&KIU1[30^IGV;+Z*ZM76E
MY4JVJ^Q5.-.8N!9QPT/X$N&7AB,0EJY'\X.K._;&)&I,<VYS;'&S7J8.KW':
MH4T&8?!\%Q2$3'I-03>':NJ\XC$AP3LT_4@/OJ7PA\(7$HA[9R^R\(KBG)9;
M!KPJ)#=25-V0!3BY1:J':'J_HX"T,:4=!RZI<!+I.J[)=G6WV7,)S+1.DX;Y
M-G ^U(%B^-A_#2R88:SI: 'JJB&W4;QKR^6"$*6@$:#\:C[[\S=7Y[]=7\5P
ME!\,T>BB^-FVC5D55^?7"XKAR+MO*7MKSW_$U_WGN$H>2\O>V!INJKBFP_]N
M^QJGO7__)C[_PR_7,>+%;S_7YJZ[;@C2/W!3XUU>D D=7*)-*M:])]6"[8@0
M7/\A[+@LWJ*;,SM:\;74$\L0TI:S6!0[\C)Y4LR5YTS43,]=40U4MEQJJ.O3
M!9F+9SFS55'\092YAC+ZP>XHPGSH'A6NXD[&/LQ$<IC]T#\*#3&9 ;?]*WKZ
M\/%\D#3+JV(%1'?CI;1VBGE>PN  $X_=/(IUMOF'@OO\ZJ,A'@]IVU1?#S3F
M#/PARDZ$;:(;ZLE^S7G!B5/"")CT1]0 RV10$H',9/&7VDL(\A+%(ZL@+[)"
MJUUHT9.<;H^Z2FCHQ>G8R23M/LW/2NBLX08\"7):*+1PCK]2DX3S1ZE216#_
M_</'M]?O?GS[QT]%LC-L76"2@E8<"'XFJ!G>F]Y(2D)VW;,/X&HEAU'PZ6GX
M=])N.(6V]G#F:N>I@\H[*L:A(QAEXN347%4Y\:_U?I9O*@<Q(T@MA=@;T?3A
MOH,F?0P*+BWW$PFS+5&#G$X,$9N.;-=8:Q9$C)53]JD'<<Q>KD.LUV?A,UJ1
M9]ON=I$YIF@2X#H)VSU:OX3>5REUCI\HUR1Z#7U>+CH)=VEGY=E\@3QQ[7AO
M+5X=D9DE\5#7XM S5QIZ.:-Q,N8PQ#G(.)(0P@#9)SP;1ODDM%G3"IXGY[:9
M A0_9#88$./V0]0,08",Q.Z,S'@KX>[9T)UQ.^4J30RMNAO-)2+U>#6JO =$
M.>%FM-Q4[Y.[UB&MWH9J0X3Y!&/30.&QNYL>K*.?7I.RVGW&%-<*F;,4I>'<
M>O8OV:V)V-UCGR9C(Z8L>?2P4Q8$H0W3ET$%%9!Y07BG!BV5V4QQXQB2(QLA
M[E,:T:Z-5<]P;E(G96I&X][RJ(\/EO*82K,F4^3%#&:E?0 YZT!/N5+56V2Q
M#'@V6SSUYE(]]A/*_G6LQ.B**[-(6Z18D@GXO [[ Q2#L'0MM]8;)'VD5"NV
MGR<%AREU=!-BUF=GWN?D=J'!'N*$N&M AW)XY(IMEJM2V@=97-FC4LP1&-!(
M44A=?4^<]U4!LIYG#IDXT?=/VX,O/EK7K,;>VWA3!S>>4("=!*@@QIOH!HM?
M NI>=[P?*C8D) DV8>MC4YWU])3#S8B,.$EKZ=[.$3_)#4K)BCLY^$JS2]$Z
MF%68I-FAN,R0'C%LD<\O9",WTPF&(#6JIY7>G!#JJLDY9<@2)8["#LMUW@,S
MDA?1U9OX,"BTR@9(<BU%N-E[-/]E]&P?:[5,'1VR5V,JY4CR^-),V85F4J!8
MR/#GZ;TXJHJHAPL,NX_:R^(:=UATMJ))\L:>N-N;&@EIV.E>(<Q+HW(S1G<]
MVH8;A'YD=X"9L=G SP3_6 6.\$T"-,_ZBLT(XZI6<_G#\R>YY8S"YJ?9E9_#
M=A[9T-,R@]1VD#>Q:2VU/A<=0W:[ ?N_@C'EO.ET9 7V:B\/@@ 928/]LT N
M>#+]$$BYL8&F8AQ4B%^%G*::"##I3^EV/,!Q(%^YNL\+@,QQ'N*;C_KR-+9V
M5 [8%\I#LUJ)9@^920X>ZS4\=NH[)>!YK"),^DU&?S!"HLXR]>;DN<P (B#)
M)DBF]RG#I 6F*H(-R894M($DDQ?9V-#L)-7IZY$G8NN)3L6#>$XD:%@PR:>&
MP$^>&8&-\YXZ,>O"!;3HB[!KK+4EGH3:>@K44=!CR3V=]@R';,MKZX($^M.\
M-2.:=C^H0N3RF[K.,*6=MS/;NA"4Y].667\,="-2!,68D!&M TPG9[,0Q ?/
MLSDQ$=.IXE"SG98X2+<PY)L7=@[J/9R!@_DU7_M(R<.SY<7CXGI+(*OVAYCE
MTU&L\K;9U=T>HIJ)+HN]A\+=.$DXM0,2&9PW_A>A8D__-F,;W'><TJ?4%U[M
M&)S)C3TXX&%_1G0;:I C&\S(^/9?_O!!K<9B+C<%,+^8H=P"\&M,_!6_[C1(
M?-.UQ#"YSC'YX5H0"U^P['^X_LW'.RB3OC(QRCA<URG^V%%Z</%B&2.UV#DX
M@8MN%EIKP9CE8T"#U#[T=J<T]9!SITFF0H-U#*9WE:V7$V9'/0T%DJR0SD/+
MDSMSA[-)7Z'_^$$;@4*?"H,4'/6Z&YN-PVEG-6AE/E#!VB:-'R47B^V%WM74
MNUM9]:%W#84M%.5(@;S+'V,KNX$NMHW<#504I(BT+'Y.OVE=Z=CNZ5YAK+FW
MDXXT%P#&WLB-0/7IPJ<PH1S[5J%#E 65K=2(]$H=NU4>#0Y7/ E$@>L %5"8
M2%WFE]WAH3JIIL6BSTFFZ0!W0ICOP9D# L8Q7[9/(C/U9%PQ SS-F3/,<PD$
M^IG5A@>IB%0A0?9YKY&;/6;0=T0DV4*I&;>>TNPS(O<^$!N*LRS>'HW;)B>8
M,3B[O"#Q'F_9"<3HMG:Q"0:O]+?1X+H=RA*8REA@Q#*+A>?9L@CWT"-EA:9B
M$N8YB0;O9(H@^3A18;EA[1,&+#LYG4XBKGU]+$[7,2;;R%VXW+&R! \\4\9-
M9Z5UN$#9'D:GX89*4L^5)5&^L9J6\%LK\B/!C!RS&0Z86-K2\S8'PG4?0=-8
M@C3[0W^>F3V2[LV5IS(  ]%.;%\YSW D43B]U4$_?4+)S."47'D05K#ENT0L
MQ'<J8]O^T\1OH'T7[OD2B7ZV2 :D4J040RM-_- 77A@B\9EDWT+PMV/?96,>
M$G^@.ABJ:%EE^X_+/RWC^+NZ -U,^_"*P/+4S!3J\8IL'COWFECJK;.6F >X
M8@K%G0]6 KW.2:?B\@7[EV"V]!:5OO[CWAN<C&DZ$-4&%( W-IV (\- 8&!+
M6 )4*[=>6T[B9L9\8_K0$*!;Q.%H8\AP:L[:[#ZM'A*FAJ=5#S8P><<\"B!,
M9!B_E2)IYO,S5D4<R _+X _LEY"NFFN;K5U/YH ,8RT&7%H*V=1S,@$2Q4[:
MA5,R2@^+ S!Y;DXR=?3ZM^7UDBT.Q9^FW[^4=CQ/-?*@['^0MSO#];DKY=B7
MOQ!1(G&3S7]$PM$7CY<O+IY^BW^^>7Z)?[Y]+/\\X7^^>?("_SQ]_@(Z^J3X
M:3)Z.G=SV^?/!%620B97D4/%,48+/.*(N#M.'%$^:IR4F776EM-@DR8W^/T4
M'/A/N!5>CZ'WYSGC1)*>E2'RF9Y4E,K"S_P! G]BM:'E8[.;WK3, 0BX#&&.
MA&^X!22D61%O0/&4D_0=K(.FO.2;?)?/7Z7N-QE.@K^.;P0([V<ZNLF.#P>K
M#?FK-HX>'FP5)^T;Y*:FPD0)20DF6K]\EC@YKYT(=S@C>4130)!Q=\+,[$4&
M:7X/L6:SRZ?29S@JHC2&^]H0LLD,SP3FA>P9)QIG1:0,(X($>7;;C=^E( .%
M!PKOLTQ$+OM1@.!3Y3;/64+'R_7EV,CLJ7B&?!X=P\1.9=/(%O'>7W9E+M%V
M$2:= NK::(E30MT*2:N\$J3=C>'E3)C\/EHTMD=/R[T.,^_'$N33-PJD@=^>
MYS/)YN>=Y*_QSJ7<C#TL<V?G;!W9-0KY]XLL.4V7:Q=3U454S1>_*340U*(4
MY_5FC45/V -^6]CMMJMM4M7WO*->PKU\5?S;V/%HS-A*+&FK1U'8>J?!B[S.
M4+\7.DJ/ITQON,FDESMVTP,OXX%_FI' 1<::_S'L77:?AF]6IT]1:@[!?/+_
M F8NQQB1/$NO;R,OQB^MN-&WDF5_'L0O!_=[^4T\<0H]JT _K.T&5R/X%37P
M@LS;1R(L\D(T-<&X^<YM(6ZL.Z^-CUI=(YS:.*R)"--KM+99=157N(YNX&:Y
MMZ;:[(%0=CEH7^HKA_2N;<J-^-YR&.(.%]4GT[#YZ,Z?N2Z0B"(%07]8?#=2
M.O/J$AD^[=M5PG-[9W Q.-QJ1%(=J@MI0$("VKSA-[V&+2_OTU>BJ,W'#8GI
M]>RC'6Y<CU&*?%!1LQ^Y_Q%;L7B[4W1@\F8>&#?#UZ+J14+RQ"2ZB7=>,,8V
MF#M('UZ((;4=^ORCU8M$H0Y!WX5WZ$GIW#84T&,T.X^TTVO [-Q;;T[YVG ;
M'*>L> 1^[GP7"I]BLM<C\31YYK2;%F]9H6> G.\RX2;699P;3)1(EW 6VL4.
M-ZP(HA/>1ZMK<F\K@I <LK[&(]P1FR/@K/N1MT_&<:B[]")(;HF,_9==V)*Y
M*R\+B;<5PRN"V+UIYS'44X^QS7+J/.CHUFO^^1ZZ\+M)]"4%#NF$VBZV4R@@
MX@69I64S$*L$,NJ_CA*;]E],OLL.6ISDTN3[R758-O526^-&4A0[BRL3-]G+
M0+U1>30CR5G/!=*Y5[.>9Z_/;6R_X9<$>[D$(&_2C=_&]Q!?R>MWT^/R$N-?
M3+\A.T2 K&GIX^4WSQX(@<*'H=OQRWA7W3!T#?^YM60X>SQ OZ\[\OWZ 0?$
MMS.__F]02P,$%     @ :#Y^4GA[8NXY"@  .!H  !D   !X;"]W;W)K<VAE
M971S+W-H965T,3(N>&ULI5D-;]LX$OTKA ]WN /RX3AMM[=- Z3M=J\'=%$T
M[2T.BP6.EFB;#25J22J.]]?OFQE2DALG/6"!IK8D<C@?;][,R!=;'V[BQIBD
M[AK7QI>S34K=]Z>GL=J81L<3WYD63U8^-#KA,JQ/8Q>,KGE3XTX7\_FSTT;;
M=G9YP?<^A,L+WR=G6_,AJ-@WC0Z[5\;Y[<O9V:S<^&C7FT0W3B\O.KTVUR9]
M[CX$7)T.4FK;F#9:WZI@5B]G5V??OWI"ZWG!?ZS9QLEW198LO;^ABW?UR]F<
M%#+.5(DD:'S<FM?&.1($-7[+,F?#D;1Q^KU(?\NVPY:ECN:U=S_;.FU>SI[/
M5&U6NG?IH]_^RV1[GI*\RKO(_ZNMK'UV/E-5'Y-O\F9HT-A6/O5=]L-DP_/Y
M QL6><."]9:#6,LW.NG+B^"W*M!J2*,O;"KOAG*VI:!<IX"G%OO2Y;5=MW9E
M*]TF>*CR?9MLNU9?^GH-UZ=XI$Q,%M:;J'1;*QT1OHX<&B].$Q0@,:=5/NR5
M'+9XX+"SA7KOV[2)ZH>V-O6^@%-H/JB_*.J_6CPJ\8VI3M3YV9%:S!?S1^2=
M#^XX9WGG#\C[9.Z2>N5\=:-^N5K&%(":7Q^1^V20^X3E/GE(3QLKYV,?C/*K
MKQUMV-/LWM'9OR1294FJ_'K(TX^?]^Q$/1)9\ZW0JD\;HY#DG0Z:DP=*)]SZ
M,?B^^]M?GB_.OGL15865WMD:$FJULJUN*ZN=B@DWQ*1@?NMM@/Q&MUJ.5<GC
MZL;\GXJDC8;ZJQ62F#6 3C[0>;HABR)I%LRM:7L#,7?@JF@@$"),=JFS>FF=
M39;NV[;RC5%)W^6S2"9YI^ETNR/_U$.DXHGZW%8F)%!;VBF]!*?1^FCV--P/
M&_SL:F@4P0HX36$/G9@-R?Y06M'J0-[2]1=D>?$,J5/I$%@5,;'XGDU2/@P&
M[;)?X P<M.H3H:N#5%]#]1\&E3A>9R_4)S9Z- D.@<=L3*"<M"&=._:R:($%
M)@ ":0  .<F9.W(>%J][QT_@U&JCVS6$00MZYO26(E"<*T;PI6W(+(C*RF*U
M7CJ3HW*B?@1!M[P+)(A8DUC>F8\FF[&;E29) "!G:$]^7 =3X%1;."886(KP
M!!MI[=*DK<G2\Q:)T@0'DZ@VN@:@X.VL:K$1WHE]M9FN/<I!;PW.BY;07W:-
MP>6=Y)V,0$:-P%5I1^5T!WTJ'\"+)^J-@?X!@:4=!<O!\ ID]>^4;]"M;_N8
M%P&R4=0C2T =./-(0&?Q+R*;_9*=S?>*YW%W90D SL%#2M]JZ_C!=F-A)<B#
M;O<)>*-#]1K B9*)<N(^STS2?$AO.CSCOB;]:@-@ 0AF"@]$M3Y@,^N:E1AM
M/^(Z7*N^\Q)/9V^,VQ5\E7 ZT(([@#:QF7RU-E@7!/[C(M4YW;8DB?@_F;4E
M,]_TIGAWGP4W *,/#$QRR3'(C5%^"\FLAH;#(G0)@-S.Z(!01K5%'T*?M(+.
MBQQ0NL(G*,:PJJ+4T7BJVF!/Z],4"2"N@\[S[109Q"I6<+/5 1A[/<E:@HSP
M1<YUWP?5>0(1<13L!M >D<8QVNC;/68SPMHY1JS^_Z"\24.^?Q3B+L;PX:O@
M&R24 PQ]+CYC:JLK\=B#SXDHD/!F<#B"W5@N"8!Y@V1DF),-A*#M1A @K%[6
M<JI5NN,0P!E+DPL#2*<2MLQ.(P*B,ITINO#1B7H[!!..?%#;,:R#1I*=]]6A
MF/\9E8YR1A?.L^VT*2#L:0!R[5$[.(&B";>6^#-K0549P24J=5QE>!X PRJ_
M='8MIG$B#8L:HTO# R&P.B*-N+$XO!L\D57*],8G'EY\I"(^XXHP*)F&20$@
MY?R'T3$=)W],G^IS=PQ,@6/>-83OBDVZ17V)R!HPA.^8I<AHG-*OJ#@$SO[B
M L!?.G$3Q#E#\L72>]Q7 O:T79^.A:H:X,PS_16O%)?@GF00ESB4#C%,5].^
M*ZL"XC.5YE2DT&:=X.\&,=6M\7UT7$8,"FG,E;-%H3*"M:5I#5-?]D#-0(5(
MN.E6NSYCC8M*H:-*NRJ7>JF]G;0<F2^+_65Y,#0)D@>(Y>\GQB>&-@4F#ET3
M8PNMY@#:)=4.!B84I:(Z9"Z.PUS&I(>_CNS Q=(0:4[2B>@HNZEAU:8,T_6A
M\]\J7=^N7$-Y <^A)1U7]IAM @$ '$D4VW I+E5)&C3!BZ0DW7TM#6AVKT"N
M ((#=C +8CZ+"^EX6)8+9G!]S?A-8$)NZ%JB1,#8MRV4ES!(*Y(?RBT<O^2V
MK*>B\G6MB&;:\#[*_&&?X7\G8=<;@"SG1:=W0H5OLF\9.42<V@;!)+DXWM^B
M *@V2II,!@W:VU#:,SA0"Z@;(SF"X )3:G4I\I*&NBGT6!NT9'4L18O=ZW8%
MSD-*U8PDIC,[XA@4&OV^*@4R>U/4/?V8*8;F;=2V\;5Q1SF0ASW#QI!WE.=N
M]$2]'X$\ +8>!-]SIR;VB4+=N0E&51&@85+%/1OJ8\K.W40S]I]V-#P(W^6A
M8K\OSIUR5A#&0NBM)S*A\>7HL(<H<2:^036_ 8&;/)' UXJ:LJ.1B6I+7-;6
M8R,OO:[,2#P?ZFHS5=+<F5#96)94P3)P_P3.IQXM4^@>Z*DA6,S/GK..^/)/
ML1XT329<7WV<YC*>S]4'=(5YLO M:'UIBMXR\.$I)5>2EJ$1 L3-I_._[@%C
MXQUA9VCT"M4,/7^5>6NY*^'.%*'^3DWN8OY"W"(S((C<.[Y_]N(?@\>G=N3#
M8<0S,:*A-V,'C!CZ=U\QT0R8DV&+%,[GT2 &M]K]MQ& B0-Y4TM$KTF.0?R?
M]A*DZ$(S5H8Y$,0C?FXS)&)9C:]@PT?(-I1=S[/%@!R']O4=5P@9^S0F .2O
M\_Y&(1QE D7G7YD6,Z@O\1TYGV6K+4>8_9+Q+.0+T#J!#FP*7."XA]WJKXX<
MV.> "01\R<*BQDEYM1-)N3T:F>P]WO+;3"KS(]ODN@;4C#8%DT7%?889?2<'
MDC\L^@BH93F_,ZD2?>;>R,8#<TC*>\67*-O1<@=<WJK<SWAZJP$2\I7ESH)Y
MC3U0]DP9<ACBI/\N1;_OY)T6 LD>''F/[H,F'+$D-0Y%SY^Y_,J @I(+1EE*
MEOZ$(4J=JZO_7JGW)JSAP*$-'?:LT:VQ%92JF0("^1_]7I^X]><LF72__!IB
M*>?011&:#9+,CV2 5BM[1Q@/(]7*%$QLS&UVJ8:F'KJ3E?2R../+Y)T0MXUQ
M$IIL@KHJ,PU%&[V5HK<$H9?2SCE'?2A8FGB&ZB/C8%Q"?7^0"@=;WGZ\5@N:
MS3@M=X5<;-.8FJ(*'H$*_^[QF=_\[E6]_2$BW=,'"71 !4%W/ENO4HX#G<VC
M%M=WH*T,X$P^IM[W2Y07&4L9)_(IU3Y:\D%7U^I\<7+HU?+IY&U^0YBAWRSX
MS6*;Y,7^<'?X6>1*?@T8E\MO*N]U6,-(]*HK;)V??/=T)L@J%\EW_-O TB?,
M$OQU8S04I 5XOO+ ;[Z@ X8?BR[_ %!+ P04    " !H/GY2^Z8-)&X"  !L
M!0  &0   'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q]5$UOVS ,_2N$3QL0
MQ(Z3K!]( B1MA^TPK&CW<2AZ4&PZ%BJ+GB0WZ;\?)2>N-R2Y6*1$/CY2?IIM
MR;S8$M'!KE+:SJ/2N?HZCFU68B7LD&K4?%*0J81CUVQB6QL4>4BJ5)PFR:>X
M$E)'BUG8NS>+&35.28WW!FQ35<*\K5#1=AZ-HL/&@]R4SF_$BUDM-OB([F=]
M;]B+.Y1<5JBM) T&BWFT'%VO)CX^!/R2N+4]&WPG:Z(7[WS-YU'B":'"S'D$
MP<LKWJ!2'HAI_-EC1EU)G]BW#^B?0^_<RUI8O"'U6^:NG$>7$>18B$:Y!]I^
MP7T_4X^7D;+A"]LV=LK!66,=5?MD9E!)W:YBMY]#+^$R.9&0[A/2P+LM%%C>
M"B<6,T-;,#Z:T;P16@W93$YJ?RF/SO"IY#RW6&89-=I9'G"&\E6L%<YBQ\#^
M.,[V(*L6)#T!,DKA&VE76KC3.>;_ L3,J*.5'FBMTK.(MY@-83P:0)JDR1F\
M<=?F.."-3^#]P)V#E:+L!9Z6:^L,_PW/9W G'>XDX$Y.\90V4V0;@_"]@/TP
MX:&;)=SM:B6T<&3>X.F=Q?.Q(9\MY=5Y;6N1X3QB^5DTKQ@M+H9PY 9A:8$*
MX"%BM4;3#?+_G=$5?+AK#%F0&EQ)C14ZMQ][_"T4ABK@OTR)-1G1*FEC$%F8
M7',T2*<)7$TOCM+HG1XG-  N&(@,0%,OU<(6>:89L?ISMG*052TD&T,X=FUQ
M3P$5FDW0N85 J15#M]L])<M60>_A[3OT39B-U!84%IR:#"^F$9A6VZWCJ YZ
M6I-C=0:SY.<0C0_@\X+('1Q?H'M@%W\!4$L#!!0    ( &@^?E)3A@BG<@0
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M9_\OEF,'3_#]=[,L3=]1KUA+Z88TFLU2>A9I>E)6&SW<RQ=1GDQ8*\N?PZ%
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M.7O_[S9O'MC'*@7E0!@A_ATG-.2D1 V'Q4JSM&68%Q 6X<MN-W!KOHHZS95
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MA^H=K/[5PVA+$GC1KY"&98A?5XTN:$@3<JXE!A,?M%:(Q2O4(Z\:ES!UU"=
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MRV68S-D5XO.]J?VBW 8U3Z=8$D.!5_@[,PGC!9N%2?2-]- 3G":3:3B+_-K
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M/CR4E=^#&!;,!P@,VP]:G5$P \4OH3@Z,,UK(="$91#/X\<PN=<_L.O%<9!
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M -^OI6SL&US _?;,F_\%4$L#!!0    ( &@^?E)/X5^CS00  &$+   9
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MF2;Q_F34I7&S\*8)EZB%\70E"X\EW8'1\@':7QH:,OV" 89;]?P?4$L#!!0
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M65;*2'"(4T6,P5:5QII@:L%L!O-/*)*&6845V&QI(RQ3B1"IH8,)7TF+ PE
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MEY92#,FP+ALY[Q!AY%X*_2F[M?CC7 Z9V]R]H=L "D''H4B&I-(:>X&:4EF
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MK1W:0.A'PP".AZ/6ZKM3CDNE*$S]7.:?ZO5[8(?C(_H["H/.^E8:4ML&.#B
M:.R'QT3@V#\Z#K9VF^@)SA9<$+>4HHW;!7O:Z7-;>(>%@1\,(QCYP3CJ;CKN
M=U#>=T-$N3"TM(['G?4V!VV4D 1'(QC[AZ.@NSG8E;,V!:+PM"H_063RI:W
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M-J#URE)*PX #3/\7V_\ 4$L#!!0    ( &@^?E(0\9*40P(  "H%   9
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MEXU<9NA"@'ROB'AOA 3C];CZ"5!+ P04    " !H/GY2VOE(-&HD  "S=P
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MG/DRU[CZ:MF 5 KSXT#P&BS>E'"[NQ:X5]'&X@D2$AM($3RFK@N8]/TZXH6
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MK7GHWO]["X1U=BJW_R(,!6 N3G'7\\OT^NPR.3JCXYV?IR_F5W#[,CU=,#0
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MQS?1!6)J&@U=*FAXFS5Z/%B7PCBOD2-32'W,'T@SZBL\& ?B0#<B/UK:Q-"
M.;^)5X!*M<I7,C\%D,D]L=DVQQ2$H !R1(>>=H$78JI*CDD?CF*<>O!Y_$E<
MYD:#*".=+\*9$)B@O G[$LR'1F_0WG][.-2:0UXM$GDX G%HSU\E\]-D#W:D
M33X$M\'@<Q?R'-N!T3,+_\Q"QIK"VBA-;CZ)9<!D87L&A<^XW3$]QJCA<9$<
MC)[<K"C81B*U=PN/(JC?,>XP_LZ2=R%8=*C?IR-#(C<U8111]2(L%XWB3Y/
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M?E<7 $<'W(M\+9A4P#G371]D2D'*X,OI"( _%\#HK><)48S.&T\+90!$4^=
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MJY+L3#'A<"5^))(9_"IKIJ DAQ#5&G"G5'GC4XY(Z5#>@"<(I6Y.AI<$/:E
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MQ,.(=S9P LH[!66^30^YI@ :<E XL\,E8]!AMT![0XZ]:(&^R_?P\)FQM(Z
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M+?A%X%X?V6 C64KY9#NWJUD06T+88&4L J?F&6^P:2P0T?BKQPP&EW;CL7U
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M/"BP9#TW#W+W"<=^YI8OEUR[+^R&V 4%Y[TVLAW!5$';B.'/7L<Y' "NPB.
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MXW;&%(D!@C_MSHQCLY!XMD]?Z0\UH1E)W[4]>HC&TC;MI>YHJ [HR"%*VR;
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MJGOLC4^Y+AS(Z!OPZU+<\Y(RV>9OUB6::XVT^8E,,B+3\.O@RP#^0*X ;5J
M@HK5%%476.B?+Y74(&HPA5QJ@M,'8'4UR*_4A<R)6 H7_];XTP\I\]DO<"/-
MTR;:")!6(PD<0=FH; !.97V/JKW^W""<WUZ[MY,SDJ1RL)#*B'H.N7WCN_Z
ML<2'[PK AVKZ\3\-0,0<SX]>!X"%3ABF;_N?Q$X8!["'>%%'O.A;B3>QE93N
MLS!K.*YYN=9"VWTJ;E2ZZI?$W,;'O9JV\_&%4OZH] 7S#I^G^4K)F3!NOY2Z
M";!2:YOCK>&W>[!"?D<J8+H&_T?@<^I"VL#M8#* 7)8E5QJ(&<$PA'[(?#BP
MU/*]I!6F^XWUW-:C_>(^Y2P,/"L[C-)7BJ/=DFD:09_(P"*KVG,B+]BB>C>
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M]MZVP;S$B:C.^%[@!/:R%=3C?B;M%<V9U"7$4POQ8R)1L.DDK8?\GHO2CF;
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M1J$GT/B,<[7L: 7=O7KT+U!+ P04    " !H/GY2"/6%!UP"  !!!@  &0
M 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6S%5<MNVS 0/*=?0>C4 HTER[%3
M!+8!QT;:'((:,=H>@AYH:66QX4,E5W':K^^2D@6WL)W<>A&Y)&=V=OC0>&OL
MHRL!D#TKJ=TD*A&KJSAV60F*NYZI0--,8:SB2*'=Q*ZRP/, 4C).DV04*RYT
M-!V'L:6=CDV-4FA86N9JI;C]=0W2;"=1/]H-W(M-B7X@GHXKOH$5X)=J:2F*
M.Y9<*-!.&,TL%)-HUK^:C_SZL."K@*W;ZS-?R=J81Q_<YI,H\8) 0H:>@5/S
M!'.0TA.1C)\M9]2E],#]_H[])M1.M:RY@[F1WT2.Y23Z$+$<"EY+O#?;3]#6
M,_1\F9$N?-FV67M)&;/:H5$MF&(E=-/RY]:'/4!_= 20MH#TM8!!"QB$0AME
MH:P%1SX=6[-EUJ\F-M\)W@0T52.TW\456IH5A,/I1VOJB@G=G =O[#F;Y;GP
M72[9[=[$VP4@%_+=.$9*[.%QUB:Y;I*D1Y+<<=MC@^0]2Y.T?P ^/PU?0$;P
M?H G?\-C*K>K.>UJ3@/?X!B?<)DTKK; 3,&TT><\_T%6"[UA\ 0:'>,%@J53
M6AD;ABNPPN3LP5,Q@:#<]Q-"!IV001!R<4P(QR !=.Z;?],=<NH%PM:I-V=G
M+WAUT4F\.,DXJ[$T5OQNCL#G@MT(S74FZ&RLD.2K8-?#':@UV%.>#+N$P_^[
M.:-.R.A5F\,;!USC %T')IRKPU31>>$Z+P[=CM.)=K>CV;3^(>GQW@7WCRM!
M-D([)J$@RJ1W29[:YL%J C15N/-K@_2"A&Y);SQ8OX#F"V-P%_AGI/MK3/\
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MC$2I<\;A7!)5%@65]\>0B_78\9T'P05;9MH(W,EH19=P"?IJ=2YQYC964E8
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M\<FUPPP;-9!& =<7 O>HGAB"IO6;_ !02P,$%     @ :#Y^4F8L;86G!0
MB1@  !D   !X;"]W;W)K<VAE971S+W-H965T-C N>&ULS5EM;]LV$/XKA <,
M+=#:$F5;=N<8B.T63;&F1M(7#,$^T!)M$95$EZ3B9-B/WY&2)=EZB=L%;;XT
MDL6[>W@OS_'8R8Z+KS*@5*&[*(SE62=0:ONJUY->0",BNWQ+8_BRYB(B"E[%
MIB>W@A+?"$5A#UO6L!<1%G>F$_/;4DPG/%$AB^E2()E$$1'W,QKRW5G'[NQ_
MN&*;0.D?>M/)EFSH-56?MDL!;[U<B\\B&DO&8R3H^JQS;K]:. ,M8%9\9G0G
M2\](;V7%^5?]<N&?=2R-B(;44UH%@3^W=$[#4&L"'-\RI9W<IA8L/^^UOS&;
MA\VLB*1S'GYAO@K..J,.\NF:)*&ZXKNW--N0 >CQ4)I_T2Y=ZPXZR$NDXE$F
M# @B%J=_R5WFB)+ R&H0P)D /A+ =H. DPDX1P).$Z1^)M WGDFW8ORP((I,
M)X+OD-"K09M^,,XTTK!]%NNX7RL!7QG(J>GYU5_GZ#T5&RK02W3N^TR'@X3H
M(DZ32@?GV8(JPL+GZ/??1LZP_P=B,?H8\$22V)>3G@(<6EO/RVS.4INXP>:[
M).PBRWZ!L(6MUY^NT+-,[W,9$$'E%R($B56=YOE#FN,N<JP:S36Z%NVZ%M0#
M7=^+L@?^SX. \R!@8\II,L6D%W*9"(KX&K)6.YOZX.4B!&0%18M6B011*9''
MHQ6+TT\W6AUBBD;R[Q8P3@[&,6#Z#6 N8@\(1%+ D3VH0/!D$Z!Y0.(-E3KZ
MESSV>*P$#T%\ \FB*+A$U44LM38TUC0+W4X'EC7IW=9 [.<0^ZT0KW4 4,BD
MTL;I'9"@I'41[E=LVP/LCMQZ\X/<_. T#^T=PU4 Y6,<PE:)#HI$JWO$=S$5
M\@6BWQ*F[NOPI78&)7QCRW(;X US>,,3O,.D3"@P<T@4I)+':X,S&U8<Y(Z;
MHN/F]MU6^TMR#XU!(4A>)',L)/:H@5%7U@NWX@AW[(SK<8QR'*/V,&D/P-;)
MEBD@M)N(1BLJVDIDG&L>__IZM:V"PJW3\G&QK]B/66)>43@1D)C]DUI^W9B(
MF85R %Z.'*<^ ':IN=@_DTL6F;F#/&G 6'"OC7].-<\R0V5T=JF8LBW4+>HW
M;*+@;+N=M-.:AY-?Q)+HE%2W"ZZU^T\@V0ONM4\DW_^1[%7:;<[U@G7M=MI]
M]%P?5E .++L!9<'-=CLY/V*V5SD;6D<UWZO+1N.QV^3N@MSM=G9?7BQ?HS>0
M9K&G/7GS_N&4+^C=?@+\C@M^Q^W\OA3<H]27:"UXE#5VP,6%#R;%?=ID:\_A
MN$KK8\MN:O"XX'7<SNMF:CC!Y;AT GX"1V!<\"D^\1#\PRPSRRP<)'ZCYPLV
MQNU'WT=FF1FN'I$;C^>X(&G<3M(+*CW!ML9#'];H+<B?>^ I 53S806QC2&V
M\Q2B7I!]K 78;HE#W \+0>?/1:1SQI/HLONY:PZBE'A!6CH^@JD502I)!0_:
M/U5YD]]F&:C?I8,>4AQM$^$%VNE'M:>=?F#SQ8-&2UI)NOOV@CZ,1-&5<'M7
MNJ0*G4M)E=P[V4?/_F1DQ4*8] $Y?$PBZM<-R#-<'0]LW!]7.+YA'6XXF^&B
M6^'V;C4G,C">\_2#[D6W)(390L)@X_%-S*3VK-0A,TZ4YO8"^3#SU.ZGVHML
M/&JNRJ(9X?9F-$^$T"-/6'+LCR$<51 ZC0,9+AH:'C_*P#S+]!Q-S(T><HH>
MYK3WL(..@?Y%^]N34[J(4_0EQ_[U7<0IFIK3/EI<)GIK&@J+I1))9%(W(P3@
M!S,7KT):\D==4)SJR.#:(W=0J<,3%A[NI'0GU-X/C\/WX8C_3I@XG*+'.4]@
MXG"*9N:TMYCOB&+S2<RISARV.Q[JX!P'\825Z4YZI6M??4G_GH@-0$0A78.H
MU=6WVB*]]TY?%-^:F^ 55XI'YC&@Q*="+X#O:\[5_D5?+N?_^S#]#U!+ P04
M    " !H/GY20N,GJ<L#  !V#@  &0   'AL+W=O<FMS:&5E=',O<VAE970V
M,2YX;6S-5]]OVS80?F[_"D(%B@[P(E'.#R>Q#=A)@V5 AB#NMH=B#[1TLHA(
MI$I2=?K?[TC9E%,DC(MA11X24R3ON[N/'W6Z\5JJ>UT"&/)05T)/HM*8YBR.
M=59"S?2!;$#@2B%5S0P^JE6L&P4L=T9U%:=)<AS7C(MH.G9SMVHZEJVIN(!;
M171;UTQ]FT,EUY.(1MN).[XJC9V(I^.&K6 !YL_F5N%3[%%R7H/07 JBH)A$
M,WHVIR-KX';\Q6&M=\;$IK*4\MX^7.>3*+$10069L1 ,?[["!5251<(XOFQ
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MHYU]O'%4U;)5$R-+UR9-I<&FRPUS;'-!60/<GTEI5A,;H&F<^[\!4$L#!!0
M   ( &@^?E)@F5,:2 ,  -D.   9    >&PO=V]R:W-H965T<R]S:&5E=#8S
M+GAM;,U7;6_3,!#^*Z=\ FDL<;IU&VHKK=MXD391,08?$!_<Y-):.':P'<HD
M?CRVDSJ=1%,Q(;5?VOCEGKOG'ONL&ZVD^JZ7B 9^E5SH<;0TIGH=QSI;8DGU
ML:Q0V)5"JI(:.U2+6%<*:>Z-2AZG23*,2\I$-!GYN9F:C&1M.!,X4Z#KLJ3J
M<8I<KL81B=83']EB:=Q$/!E5=('W:!ZJF;*C.*#DK$2AF12@L!A'E^3U-$V<
M@=_QF>%*;WR#HS*7\KL;O,_'4>(B0HZ9<1#4_OW$*^3<(=DX?K2@4?#I##>_
MU^AO/'E+9DXU7DG^A>5F.8[.(\BQH#4W'^7J';:$3AU>)KGVO[!J]R819+4V
MLFR-;00E$\T__=4F8L. #+<8I*U!ZN-N'/DHKZFADY&2*U!NMT5S'YZJM[;!
M,>%4N3?*KC)K9R;WC1H@"YN@3-;",+& 2G*6,=1 JXHSS&'^"&:)\%;)N@)[
M%OR("E%3;K6II&K,4#&9 XK<C:XQPW*."@;D"-(D3> 5;+A#;9C-J@5_T%C4
M'&ZM/-JMS)0]=,H\'L&,4V&LGQQN?M2LLJ?!P(MK-)3QEZ/86/Z.19RU7*<-
MUW0+5Y+"G11FJ>%&Y)@_!8AMXD+VTG7VIFDOHJ5X'.CUX V"&@./=[(%;RJ-
M%=SE0%&Q0/A:^@Q^@]]P)<NJ-C:;&#*Q7NUQ?!(<GWC'@VU$F,ZXU+5"^- )
MT.;_\DG^;_ZNV]=;"PGO#9:Z+Z#3$-!I;R9:;,X*A!*IBRP'JM='S&;(1H%'
M4(6S4H6S$C+TMR/2[Y; (U+5$_\PQ#]\KI*W="X5-=)>@PTM[W9J>19<GQV&
MEN<AH//]:-GO=J>6%R'^B^=J^:$H6(;_=B=)TM7FY#"4)!O/!=F/ECO\IEY,
MW<<A[3BDO5B?9/4?2RSIBCL9'(B<7=DG)WN2L]\O27;KV3T5I+]H;]/SN866
M=$6># ]$T:[XD[,]*=KOEYSN5K1[,$A_Z=ZFZ+/*;5?FR<5AJ)EV+T":[$?-
M'7[3GOL9;W0;):J%[ZDT^.:A:3S";.C;+IMNI=O>-'UW5"V8T,"QL*;)\9F]
MZ*KIHYJ!D97O7>;^"?:?2]M[HG(;['HAI5D/G(/0S4[^ %!+ P04    " !H
M/GY2:Y5271X#   .#   &0   'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6S5
M5\ENVS 0_96!3BV01HN7++ -V$F;!D@0(TM["'J@I9%-A")5DJH3H!_?(67+
M+E K37L(<K$X)&=Y\X;D>+!4^L$L$"T\%D*:8;"PMCP.0Y,NL&!F7Y4H:257
MNF"61#T/3:F195ZI$&$21?VP8%P&HX&?F^K10%56<(E3#:8J"J:?)BC4<AC$
MP7KBFL\7UDV$HT')YGB#]JZ<:I+"QDK&"Y2&*PD:\V$PCH\G<=<I^!U?."[-
MUA@<E)E2#TXXSX9!Y")"@:EU)AA]?N )"N$L41S?5T:#QJ=3W!ZOK7_RX G,
MC!D\4>(KS^QB&!P&D&'.*F&OU?(SK@#UG+U4">-_8;G:&P605L:J8J5,$11<
MUE_VN$K$ED+<WZ&0K!02'W?MR$=YRBP;#;1:@G:[R9H;>*A>FX+CTK%R8S6M
M<M*SHYN:#5 Y)2A5E;1<SJ%4@J<<#;"R%!PSF#V!72"<:5650+7@)29EQ01Q
M4RI=JZ'F*@.4F9-.,<5BAAHZ\1XD41+!!]AR5QG,*P&"Y^A$+BV3<SX39-<8
MM 84^7".F(2Y4MF2"P'O3M$R+MX/0DO@'80P70&=U$"3'4#C!"Z5M L#'V6&
MV>\&0LI:D[IDG;I)TFJ1\.TWV%KL=1HJ.MY>=X>]"YZB3"GI]X7/VS?X"1-E
MJ0)<?C1E!YNE%G?=QEW7N^OL"I^;5"A3:82K'.J\$M/GLC[J[LB,9W2.X:XF
MZL(1=8G,:60P-C"MV2;E6SJGI-@0.*X)O/($WCH"S]8$WE]0&'!NL3!M('H-
MB%YKSNZVBJA8Q\;,NA(I;Y9BV_N[ZOI34;6[[\$3,FU:@/0;(/T7DW^KRA<Q
M?]#X.GB[S!\V( Y?E_EV]YWH6>J/&B1'K:9.5%%6ED(R*K=+IO$_+X XVMS]
MT=LMA'CK"8M?MQ2>\1_[4FB#DFR@)/]>"R^]#^+-RQ-WWG A;%ZTN/O*A=#N
MO^4Y"+=:M +UW#>B!GS'57=KS6S3[([K%F^SO>Z4+YF><VE 8$ZJT?X!O5&Z
M;CYKP:K2-WPS?W?XX8(:=M1N ZWG2MFUX!PT?P%&OP!02P,$%     @ :#Y^
M4M^YT3NR @  % <  !D   !X;"]W;W)K<VAE971S+W-H965T-C4N>&ULC57+
M;MLP$/P50J<6:*VG'2>P!?B1M $:-$C0]E#T0$MKBPA%JB1E)W_?)26KCB$;
MODA<:F<XLRNM)CNI7G0!8,AKR86>>H4QU8WOZZR DNJ!K$#@D[54)348JHVO
M*P4T=Z"2^U$0C/R2,N&E$[?WJ-*)K UG AX5T7594O4V!RYW4R_T]AM/;%,8
MN^&GDXINX!G,C^I18>1W+#DK06@F!5&PGGJS\&8YM/DNX2>#G3Y8$^MD)>6+
M#>[SJ1=80< A,Y:!XFT+"^#<$J&,ORVGUQUI@8?K/?N=\XY>5E3#0O)?+#?%
MU!M[)(<UK;EYDKNOT/IQ C/)M;N279L;>"2KM9%E"T8%)1/-G;ZV=3@ A*,3
M@*@%1,> Y 0@;@'QI8"D!22N,HT55X<E-32=*+DCRF8CFUVX8CHTVF?"MOW9
M*'S*$&?2YZ;=1*ZQ!9FLA6%B0RK)6<9 $UI5G$%.5F_$%$"^*%E7!%\V%U$A
M:LJQ^954#0P4DSD!D=MH"1F4*U D#C^1*(@"\ID<'(<LV!1!X#4KJ-@ 4=3@
MB1^68"CC'R>^07M6I)^U5N:-E>B$E3 B#U*80I-;D4/^GL#'NG3%B?;%F4=G
M&='!H%/?(VAQ,3R\[H$O+X>/S[B)NU;'CB\^Q<=TQJ6N%9#O:]*4&5M[+YKA
M8;_"V0HG [EK.W.[[\R3Z\SO;TA([@V4^L\9.4DG)W%RDA-R%JC%OB:][T%?
M]QNZL:.STVR;!H-QF&!EMX<]Z4V[#J+W:<O>M*MXW*6],S7L3 W/FIIM0>&T
MO-S4L%?&Z$CMHC?M.CXVU9N6C(Y-^0?SH@2U<7-7$_?Y-U]'M]N-]IF;:$?[
M<QSYS83^3]/\+QZHVC"A"8<U4@:#*Y2FFAG<!$96;BJMI,$9YY8%_K9 V01\
MOI;2[ -[0/<C3/\!4$L#!!0    ( &@^?E)<_]Z7;0(  %D&   9    >&PO
M=V]R:W-H965T<R]S:&5E=#8V+GAM;*U5VV[;, S]%<)/&[#5CM.F09$$:-I=
M"JQ T7;;0[$'Q69LH;IXDERW?S]*=K0,: P,Z$LL2N31X:'(+#IM'FV-Z.!9
M"F672>U<<Y:FMJA1,GND&U1TLM5&,D>FJ5+;&&1E")(BS;-LEDK&5;):A+T;
MLUKHU@FN\,: ;:5DYF6-0G?+9)+L-FYY53N_D:X6#:OP#MWWYL:0E4:4DDM4
MEFL%!K?+Y'QRMIY[_^#P@V-G]];@,]EH_>B-JW*99)X0"BR<1V#T><(+%,(#
M$8W? V82K_2!^^L=^N>0.^6R818OM/C)2U<ODWD")6Y9*]RM[K[BD,^)QRNT
ML.$7NL$W2Z!HK=-R""8&DJO^RYX''?8")K,# ?D0D ?>_46!Y25S;+4PN@/C
MO0G-+T*J(9K(<>6+<N<,G7**<ZN[OAB@MR10H5OEN*J@T8(7'"VPIA$<2]B\
M@*L1OAC=-D!/(5A,J98)*DVC31^&ANL24)7>NL0"Y08-3"<?(,_R##[">5ER
M7PT*NU+]D_*U>7>)CG'Q?I$ZRLDS2XN!_[KGGQ_@/\GA6BM76_BD2BS_!4A)
MC*A(OE-DG8\B$NVC2'D$;QH5G@:\XP-X:^VHB%Y@PU2%\""#*K]&H(\C]'&
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MCHK><XWVR4M>(^^ET[8\[S,YKN:^>ZP1O6#'D+9)IO]'6R=U'#1#A&_*(D1
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M8].VGQ4^Q$ : US?"%2I'9@ W=-N\1]02P,$%     @ :#Y^4HJH&"-[ P
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M1AH<>]PRQ\D4E!7 _[=2FM/&&JAGW>6_4$L#!!0    ( &@^?E)"Q]2"V@(
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M3HQVU0&,B1_&?C"@_Z%3TW@"L";G!&L*L*8C83VC)JPQD:2?6=O,,"&.L:,
M=>J'NA<<K6\GX#GC?6FF%2&!8XFGL!90?_;K!0<U$]]^XF$QT>!PR3JJ3_B7
M@E/ 04WJDZC/7XL1=PTOK O4ORX,@(.:S,<\,NH!-K-.C';5P=I _6O#(#A.
MN_.CL I0<4[8 -Y3/^_?@ T+\B,N^@-GL6(T<HP; )\.9=\^:)C%"188PDPC
MCKE#%ZP"U%_"\"%C3LWBQ(5C?C'@.QLH39Q  V:BG/6*:W.;C4,KH)[Y43_
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M%OC= -H9X/Y*(4O-Q!W0?HG,_@=02P,$%     @ :#Y^4BII\M_* @  L0<
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MN338@-VRQ)D*RB;@^5*B0\W&OJ"=TI,_4$L#!!0    ( &@^?E(^4>(RM0,
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M9KW(ZE90/6BQ=@?KA=#FF.Z&N;E)@;0&YOU2"+U]L!]H[F:S?P!02P,$%
M  @ :#Y^4DODT2&T P  !0P  !D   !X;"]W;W)K<VAE971S+W-H965T-SDN
M>&ULS591;]LX#/XK@@<,&W"M+3MQDBX)T"8[W(#MKFC7W4-Q#XK-Q,)L*9/D
M9/WW1\F.DS:VT8<]["619'[D1U*D.-U+]5UG (;\+'*A9UYFS/;*]W620<'T
MI=R"P"]KJ0IF<*LVOMXJ8*D#%;D?!D'L%XP+;SYU9[=J/I6ER;F 6T5T611,
M/=U +O<SCWJ'@SN^R8P]\.?3+=O /9B'[:W"G=]H27D!0G,IB(+US+NF5TLZ
MM  G\8W#7I^LB75E)>5WN_F4SKS ,H(<$F-5,/S;P0+RW&I"'C]JI5YCTP)/
MUP?M?SKGT9D5T["0^;\\-=G,&WLDA34K<W,G]W]![9 CF,A<NU^RKV1'*)R4
MVLBB!B.#@HOJG_VL W$"& <=@+ &A"\ =- !B&I ]!(0=0 &-6#@(E.YXN*P
M9(;-ITKNB;+2J,TN7# =&MWGPN;]WBC\RA%GYI\!@Z;)!;E.4VXSP7+R253W
MR>;EW1(,X_E[E/CX<$?>O7TSCN+!A_>D7A NR-=,EIJ)5$]]@Y2L8C^IS=]4
MYL,.\S0D7Z0PF28?10KI<P4^^M(X%!X<N@E[-2XAN201_8.$01BT$%J\&DXG
M/72B)KZ1TQ=UZ>,ZR:4N%1"Y)C]*)@PWS-YUC-PQS&R%-4F4O:07<GU1:B!,
M:S":/%J-A!LH]'\]? 8-GX'C,^C@<TBS)D:VV6M+8:4Q=AIM']G-AS3 V.Y.
MPWHN%)W(/.,Z;+@.^[C:EG>EMRR!F8<]38/:@3=?E$J!2)Z(44SHO H?AO;M
M&QH''TX]JDXJMZIUFW,5A6$'[\JW<YEAAVMQXUK<FX8%TQG9LB?LH)ACO <D
M=X78QC ^LQX.SBBV"-&N^(\:DJ->DK>OXS<Z-QU,XA?\1F?7@X[C\+G0LI_.
M(^TK@''CU+A7RP,68&Z;PY \%E"L0/5IG31:)[]%F=/@V->#7Y&\6LMI]N))
MU\6A)Z\*[;7^F1E0Q&0,:Q/]>@*F7A-N&AX-A+]'P(^-GD:_).#1625T5RJU
M;?WYR;%YTM[N>5XNM?U^U#T ^5L:(*'S(W6OO\8);\-4RL4&<PJXVW$W^#%-
M&.XT#EDV#8PD$KMS-='A8)#D&&R^YDG3I?]!N")K+IA(.(X:;8].Y:]_,M,4
MH#9N-M1HH!2F>D*:TV;^O'93UXOS&SN7MIPOPJMEF_PU'2!@T*II>!AQ_2.E
M:D#^PM2&XZN:PQKI!9<C#+.J9LYJ8^3636$K:7"F<\L,YW105@"_KR5&O=Y8
M \WD/_\?4$L#!!0    ( &@^?E(3K_V-V (  (T'   9    >&PO=V]R:W-H
M965T<R]S:&5E=#@P+GAM;)55VV[;, S]%<$#AA;8ZKN3=DF -MFP/6P+FG9[
M*/:@V(PM5)8R26G:OQ\ENUZ:V[H76Q<>\O!((@=KJ>YU!6#(8\V%'GJ5,<L+
MW]=Y!3759W() G<64M74X%25OEXJH(4#U=R/@B#S:\J$-QJXM:D:#>3*<"9@
MJHA>U3553U? Y7KHA=[SPC4K*V,7_-%@24N8@;E=3A7._,Y+P6H0FDE!%"R&
MWF5X,>E9>V?P@\%:;XR)S60NY;V=?"F&7F ) 8?<6 \4?P\P!LZM(Z3QN_7I
M=2$M<'/\[/V3RQUSF5,-8\E_LL)40Z_OD0(6=,7-M5Q_AC:?U/K+)=?N2]:M
M;>"1?*6-K%LP,JB9:/[TL=7A-8"H!41;@# Y (A;0+P-B \ DA:0.&6:5)P.
M$VKH:*#DFBAKC=[LP(GIT)@^$_;89T;A+D.<&5WFN5P)H\F2/M$Y!_*>S)H;
M0.2"=+O3=O=D H8R?HIF'V^OR<G;-_TX2SZ<DG9 F" WE5QI*@H]\ TRM''\
MO&5SU;")#K"90'Y&XO =B8(HV ,?OQH>GK^$^ZA+)T[4B1,Y?_$!?S>*%D P
M%2)-!0K/0RD0YEDK3>[H7!N%=_?7D6AQ%RUVT9)7'L4^^1H/F?-@7_3#*$K3
M9. _;(JT:Y3TLZPS>D$NZ<@E1\E]=P+0/%<K* AG=,XX,PSV'G+C*MT@T$O.
M^ULL=XVB*#S ,NU8ID=9WDA#N67Y3R'3'8W"($BC+8Z[5KV@OV4T.4[I+CQV
M-S)O:Z'79=K[/[=-6L=!,P#R31H@$<&&@>71OF6-U;NDJF"B)'C()*^H*,$^
M9.PC&J\[=04:JT%S!Q9,4)$SJ[/68/2^[/R-@E2#*EUAU\0=2_,@NM6F=XRQ
M=[@:N[5^F5U,LCWK5[VVU_A_W3>-ZBM5)1.:<%A@J."LA\>CFN+?3(Q<NG(X
MEP:+JQM6V"]!60/<7TA4J)W8 %T''OT!4$L#!!0    ( &@^?E(N%Q+[)P(
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MMDQHX+BQL' TO0A =?>@<XQL_"CETMC!]&9EGPY4+L#N;Z0T!\=-Y_ 897\
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MA#0FB: L 9PL3SMG[H<+--0.J<7?E.Q$Z1KH5!:,?=,WG\+3CJ,1D8@$4H?
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M[O3$O2QW0M/JD))XSW(_#+P]*0?"$C\<1%W8BZP29V=AT*4Y^#^Q39+]H#D
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M8; 02%9EB<7?*5!>3QS?V2TLR;I09L%-X@U>PR.HY\U"Z)G;L62D!"8)9TA
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M"]WO09@ O9]SKG83DZ#[@R3_ %!+ P04    " !H/GY294O0WG<"   R!@
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MOE5UQ>!!$+EM&BI^74/-=W/'=_8+C]6Z5'K!7<PV= U/H+YM'@3.W-Y*7C7
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MPI; #$ML\T!H 'XO.%?[B7;0-XZ+_P%02P,$%     @ :#Y^4C7\YF=N @
M?04  !D   !X;"]W;W)K<VAE971S+W-H965T.#DN>&ULK91+;]LP#,>_"N$!
M0PML\2-)VW6.@:0/K(=B18INAV$'Q:83H;*424K=?OM1DN.E6Y/3+K8>Y)\_
M4J+R5NE'LT*T\-P(:2;1RMKU>1R;<H4-,P.U1DD[M=(-LS35R]BL-;+*.S4B
MSI+D)&X8EU&1^[4[7>1J8P67>*?!;)J&Z9<9"M5.HC3:+LSY<F7=0ESD:[;$
M>[0/ZSM-L[A7J7B#TG E06,]B:;I^6SL[+W!-XZMV1F#RV2AU*.;W%23*'%
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M&T52^7<+FJ!$$U@T00.:L89BW*\%C2R@B^E?%^!W$5-F*#S+.:@Q_89EC+\
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MA+]/P@>3^"I&C&>[>E4WW3><C*^]_]SK9:,)"T)K%O:RT83AT,*./IM@GTT
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M35)^SAZO9#LA6NE;9$E1_P:/K6PP 8M-46:K=K#R8!6GS=_H6_L@.@,0L0Q
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M;13GX"%*-C4#M0L-[A2YF$'PHC70!P,\Y:%Y@6 G5X-.URX;F^!3NHVK.BD
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MRB\H);E&;7Y$J,T[5TQ?EF1S0Y*M\,A"\EQC-G^EO)KOYM4,(^O1#M= S-U
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MGBO%,SM<(8M1& -]?\&Y>IJ8!:I#J.DW4$L#!!0    ( &@^?E)Y2T=E^ H
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MUWM8]US#DBQ]F<"QIIICUT)ZTXK"!-XS>U3^F<!DYNZ8;$OD_5;D+2Q9NK6
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MKSSI(AL?(L=V[+-OM^C#^W=]-_ ^'<B8@-8:Q--=B%D7N78-8@W6I!UK0D/
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M3= XBV#70XQ#GL(Q4IK.2)_TF-8Q,=@*AN=O1W9[5:\NLMO+L!LT^X7MU6'
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M;"]W;W)K<VAE971S+W-H965T,3 P+GAM;(U6WV_:,!#^5ZQ,FEII;2 !TG6
M5*#3^E )M>OV,.W!) >QZMC,=DK[W^_L_!B0D/6%V,[WW=WGN]PQWDGUK%,
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M>PF#DC!P-U-(<?>PH(9.QTKNB+)HM&87[C(=&^4S8=/^:!2^9<@STR4H+84
M3N 52TF#)A?D)DF8S0KEY$X4I65S=+8 0QD_1\3MTP,Y^_CA*AP-OIR3<D&8
M(-]3F6LJ$CWV#89GG?AQ&<JL""4X$4H_(/=2F%236Y% <FC 1UVUN* 2-PLZ
M+2X@OB1A_Q,)>D&O):#YN^G]SRWTQ?OI5QUJPCI5H;,7GK WYU3;_,@U@6S+
MY1L 68& -3.ZRA[Y15?:*/R:?G=X'-0>!\[CX%1Q2&TN"E_XI9O*6^7LD_W
MD)*0&/.FV"IW9;+E5+2FOW V<LYL.WJ98G,:^R_[&6EB^L>813?F0.FP5CKL
M5'I;76@*E)L4*UGGBHH84)HV;6(*>\.]( 8-,4U,V!#3;>= S*@6,^H4\RAC
MAI^NACA7S+P=9*<U,:-&#/VH(:8%U%33 NJ=DA/5<J)..=*DH+#WZ1BG Q6
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M*6F7ADQE!MEC@A#EU)KB!TT7<2OC!-(.Z=+W)([BJ"&@RZ/A]+0!/CD>/FB
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MQ-%PKWHJ0"]\V8H?OEI+6Q8=]6A=&I_[@O#)^ 4]FY0%[HZFK+>OF%YP:8B
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M23 C@IM0)X *%["7?\X)0-]_W3Q5H"18$6E%"B+!6T@C.0A A?L;_(@TDH4
M5+B X%_DR#ST>^=+YR42.@E61%J1ATCP%M)((@)0H51!@A^11D(1@ KQ3X-]
MI4>FHB>U^2Q9/0U6E+8B%Z7!6M)&<A& "G9W[S]RC>0B !7D'[PK/3(707?.
M4U-1&EPH;44J2H.KI(VD(@ 52A5IL**TD50$H(+\@W.E1Z8B^,YYLCJ##:6M
MB$4T^ IM)!8!J%!W:; BVD@J E!!_L&YZ)&A"/S.>6HDHL&%:"LB$=W[9:B9
MGX;.C$0TF!%M)!(!J' !P;SH.9'H>3([#59$6Y&*:/ 6VD@J E#A_@8_HHW$
M(@#U< 'QWF,&_I$-U[V9DQ22?.I62CJ73OEZ^Q3$=F#5LGSR8*RL57EY..=L
MPK6_P+T_5<H^#OS##-6S*(/_ 5!+ P04    " !H/GY2:<TN;K<"  #8!P
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M;4!*V-$CQY6J'Z"MY\;Q%8H;_TOJ-C8*2'$TJ$0+M@H$D\V7/K5]Z 'BX05
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MS8-]G$"[ 'N_4PK/CMO_[KG+_P)02P,$%     @ :#Y^4A./P@[H @  .@@
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M^>8>*C\=PY=R*NTOVE2QGH/2M52\J,!:04%8^<3;*@][ #\^ @@J0- $1$<
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M<2OY!7J"^,6_CL* S-%@+QE1J%<CJS'#.10!J2/$@^!ROJQ69M_)?/YQT*+
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M0A35 >K]ASR7VR=5@MVM)2[^#U!+ P04    " !H/GY2ZUJ>P\@"  "3!@
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MD#OELN,.[HS\(4JL5]%-Q$JH>"OQR72?8<AGX?D*(UWXLJ[W72PB5K0.C1K
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M.X,TKF%9T_L UCO0>64,G@T?8'QQ\C]02P,$%     @ :#Y^4F>1<PU; P
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M6[3N_6.N\HL51U?_2K+Y5MD7[-18'QN.763O%$3&IR#R)'JR?PHBD^,7&9V
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M/(TX@BD #1@21>8]N/<^"M;OJ6#S7][1;U!+ P04    " !H/GY2EXJ[',
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M.PY@N'<FVG$ Q;TSV8X#..Z="7<<0'+O3+KC )9[9^(=!]#<.Y/O.(#GWIF
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M_A_'+]>XK]KA-3]9_N7AYB=02P$"% ,4    " !H/GY2!T%-8H$   "Q
M$               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (
M &@^?E(UIBOM[@   "L"   1              "  :\   !D;V-0<F]P<R]C
M;W)E+GAM;%!+ 0(4 Q0    ( &@^?E*97)PC$ 8  )PG   3
M  "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ :#Y^4D@^
MID"O!@  TAX  !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE
M970Q+GAM;%!+ 0(4 Q0    ( &@^?E+^,[YRW 8  (L=   8
M  " @?(.  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " !H
M/GY2!7]@(WL%  "(%   &               @($$%@  >&PO=V]R:W-H965T
M<R]S:&5E=#,N>&UL4$L! A0#%     @ :#Y^4J<N#@2> P  !@L  !@
M         ("!M1L  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0
M   ( &@^?E)PT$JNO0@  !PH   8              " @8D?  !X;"]W;W)K
M<VAE971S+W-H965T-2YX;6Q02P$"% ,4    " !H/GY2P-HIP6('   2(@
M&               @(%\*   >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L!
M A0#%     @ :#Y^4KL(2%M[!   60H  !@              ("!%#   'AL
M+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( &@^?E+"#&)KNPH
M ,P<   8              " @<4T  !X;"]W;W)K<VAE971S+W-H965T."YX
M;6Q02P$"% ,4    " !H/GY2$UO_0A (  #*%   &               @(&V
M/P  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ :#Y^4ITJ
MIIY3!   ,0L  !D              ("!_$<  'AL+W=O<FMS:&5E=',O<VAE
M970Q,"YX;6Q02P$"% ,4    " !H/GY2?JQ%?!H=  "I60  &0
M    @(&&3   >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    (
M &@^?E)X>V+N.0H  #@:   9              " @==I  !X;"]W;W)K<VAE
M971S+W-H965T,3(N>&UL4$L! A0#%     @ :#Y^4ONF#21N @  ; 4  !D
M             ("!1W0  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"
M% ,4    " !H/GY24X8(IW($  "K"P  &0              @('L=@  >&PO
M=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( &@^?E+6UZ$OD 0
M .@*   9              " @95[  !X;"]W;W)K<VAE971S+W-H965T,34N
M>&UL4$L! A0#%     @ :#Y^4@]/DQG, P  &@D  !D              ("!
M7(   'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " !H/GY2
M>3 ^XO(#  #C"   &0              @(%?A   >&PO=V]R:W-H965T<R]S
M:&5E=#$W+GAM;%!+ 0(4 Q0    ( &@^?E*X3ZZKF0(  +\%   9
M      " @8B(  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%
M  @ :#Y^4LVTZ?JW"@  -"$  !D              ("!6(L  'AL+W=O<FMS
M:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    " !H/GY2)Z3]V(L#  #?!P
M&0              @(%&E@  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+
M 0(4 Q0    ( &@^?E+YM/RADP(  )$%   9              " @0B:  !X
M;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ :#Y^4J5<FU(S
M P  ;P<  !D              ("!TIP  'AL+W=O<FMS:&5E=',O<VAE970R
M,BYX;6Q02P$"% ,4    " !H/GY2C^O]GT8$   D"@  &0
M@($\H   >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( &@^
M?E+7V!&7910  (=&   9              " @;FD  !X;"]W;W)K<VAE971S
M+W-H965T,C0N>&UL4$L! A0#%     @ :#Y^4D_A7Z/-!   80L  !D
M         ("!5;D  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4
M    " !H/GY20[L0/3X$  "V"0  &0              @(%9O@  >&PO=V]R
M:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( &@^?E(BL"WP, 0  'P*
M   9              " @<["  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL
M4$L! A0#%     @ :#Y^4O*1^;7Q!P  114  !D              ("!-<<
M 'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    " !H/GY2 L_/
MCM )  "5&P  &0              @(%=SP  >&PO=V]R:W-H965T<R]S:&5E
M=#(Y+GAM;%!+ 0(4 Q0    ( &@^?E(2Q/H9T 0  )T,   9
M  " @639  !X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @
M:#Y^4C7(R8@.!   <PD  !D              ("!:]X  'AL+W=O<FMS:&5E
M=',O<VAE970S,2YX;6Q02P$"% ,4    " !H/GY2GR[L6Y@'  #S%0  &0
M            @(&PX@  >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4
M Q0    ( &@^?E)<?)Z'M0,  &L(   9              " @7_J  !X;"]W
M;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ :#Y^4A#QDI1# @
M*@4  !D              ("!:^X  'AL+W=O<FMS:&5E=',O<VAE970S-"YX
M;6Q02P$"% ,4    " !H/GY2VOE(-&HD  "S=P  &0              @('E
M\   >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( &@^?E+:
M+6M&_0,  % *   9              " @885 0!X;"]W;W)K<VAE971S+W-H
M965T,S8N>&UL4$L! A0#%     @ :#Y^4O@Z0?6* P  M@@  !D
M     ("!NAD! 'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( &@^?E(*WIS* 00  /<)   9              "
M@>DK 0!X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ :#Y^
M4J%E_96  P  M0@  !D              ("!(3 ! 'AL+W=O<FMS:&5E=',O
M<VAE970T,RYX;6Q02P$"% ,4    " !H/GY2RLGR2%$"  #]!   &0
M        @('8,P$ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0
M   ( &@^?E*91<7N>P(  &T%   9              " @6 V 0!X;"]W;W)K
M<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @ :#Y^4M?QA#MR @  *04
M !D              ("!$CD! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q0
M2P$"% ,4    " !H/GY2J]2D'XD"  !4!0  &0              @(&[.P$
M>&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( &@^?E)TTI*;
MY (  #L&   9              " @7L^ 0!X;"]W;W)K<VAE971S+W-H965T
M-#@N>&UL4$L! A0#%     @ :#Y^4N^8SM!G P  O <  !D
M ("!ED$! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    " !H
M/GY2 IK(4G\)  "_*@  &0              @($T10$ >&PO=V]R:W-H965T
M<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( &@^?E(Z,Z\<* ,   T'   9
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M970U-2YX;6Q02P$"% ,4    " !H/GY2EWK%&!X%  !C#P  &0
M    @($58P$ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    (
M &@^?E((]84'7 (  $$&   9              " @6IH 0!X;"]W;W)K<VAE
M971S+W-H965T-3<N>&UL4$L! A0#%     @ :#Y^4HJBZSC,!0  V!D  !D
M             ("!_6H! 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q02P$"
M% ,4    " !H/GY2*/+6)"X#   &"@  &0              @($ <0$ >&PO
M=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    ( &@^?E)F+&V%IP4
M (D8   9              " @65T 0!X;"]W;W)K<VAE971S+W-H965T-C N
M>&UL4$L! A0#%     @ :#Y^4D+C)ZG+ P  =@X  !D              ("!
M0WH! 'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q02P$"% ,4    " !H/GY2
M(B45\U4#  !$"P  &0              @(%%?@$ >&PO=V]R:W-H965T<R]S
M:&5E=#8R+GAM;%!+ 0(4 Q0    ( &@^?E)@F5,:2 ,  -D.   9
M      " @=&! 0!X;"]W;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%
M  @ :#Y^4FN54ET> P  #@P  !D              ("!4(4! 'AL+W=O<FMS
M:&5E=',O<VAE970V-"YX;6Q02P$"% ,4    " !H/GY2W[G1.[("   4!P
M&0              @(&EB $ >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+
M 0(4 Q0    ( &@^?E)<_]Z7;0(  %D&   9              " @8Z+ 0!X
M;"]W;W)K<VAE971S+W-H965T-C8N>&UL4$L! A0#%     @ :#Y^4M7#]W*[
M @   0<  !D              ("!,HX! 'AL+W=O<FMS:&5E=',O<VAE970V
M-RYX;6Q02P$"% ,4    " !H/GY2[J@//1,"  "0!   &0
M@($DD0$ >&PO=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    ( &@^
M?E+IX@^/80,  .8)   9              " @6Z3 0!X;"]W;W)K<VAE971S
M+W-H965T-CDN>&UL4$L! A0#%     @ :#Y^4HJH&"-[ P  ]PH  !D
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M=#<T+GAM;%!+ 0(4 Q0    ( &@^?E([TZ09!0,  ,,)   9
M  " @9>O 0!X;"]W;W)K<VAE971S+W-H965T-S4N>&UL4$L! A0#%     @
M:#Y^4DU[NRYP P  E0P  !D              ("!T[(! 'AL+W=O<FMS:&5E
M=',O<VAE970W-BYX;6Q02P$"% ,4    " !H/GY2*FGRW\H"  "Q!P  &0
M            @(%ZM@$ >&PO=V]R:W-H965T<R]S:&5E=#<W+GAM;%!+ 0(4
M Q0    ( &@^?E(^4>(RM0,  *<-   9              " @7NY 0!X;"]W
M;W)K<VAE971S+W-H965T-S@N>&UL4$L! A0#%     @ :#Y^4DODT2&T P
M!0P  !D              ("!9[T! 'AL+W=O<FMS:&5E=',O<VAE970W.2YX
M;6Q02P$"% ,4    " !H/GY2$Z_]C=@"  "-!P  &0              @(%2
MP0$ >&PO=V]R:W-H965T<R]S:&5E=#@P+GAM;%!+ 0(4 Q0    ( &@^?E(N
M%Q+[)P(  )@$   9              " @6'$ 0!X;"]W;W)K<VAE971S+W-H
M965T.#$N>&UL4$L! A0#%     @ :#Y^4BO/+PBR!0  ;AP  !D
M     ("!O\8! 'AL+W=O<FMS:&5E=',O<VAE970X,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( &@^?E)/9G?,/ (  !$%   9              "
M@8G8 0!X;"]W;W)K<VAE971S+W-H965T.#<N>&UL4$L! A0#%     @ :#Y^
M4CU3YK5> P  1 H  !D              ("!_-H! 'AL+W=O<FMS:&5E=',O
M<VAE970X."YX;6Q02P$"% ,4    " !H/GY2-?SF9VX"  !]!0  &0
M        @(&1W@$ >&PO=V]R:W-H965T<R]S:&5E=#@Y+GAM;%!+ 0(4 Q0
M   ( &@^?E([DV)*U0,  &(/   9              " @3;A 0!X;"]W;W)K
M<VAE971S+W-H965T.3 N>&UL4$L! A0#%     @ :#Y^4M<VDME)!   \1$
M !D              ("!0N4! 'AL+W=O<FMS:&5E=',O<VAE970Y,2YX;6Q0
M2P$"% ,4    " !H/GY2@U2GNKD&  "D)@  &0              @('"Z0$
M>&PO=V]R:W-H965T<R]S:&5E=#DR+GAM;%!+ 0(4 Q0    ( &@^?E*.:,7E
MSP@   8\   9              " @;+P 0!X;"]W;W)K<VAE971S+W-H965T
M.3,N>&UL4$L! A0#%     @ :#Y^4CJW(I9T!   D!(  !D
M ("!N/D! 'AL+W=O<FMS:&5E=',O<VAE970Y-"YX;6Q02P$"% ,4    " !H
M/GY2>4M'9?@*  "B3P  &0              @(%C_@$ >&PO=V]R:W-H965T
M<R]S:&5E=#DU+GAM;%!+ 0(4 Q0    ( &@^?E+EZ57D#@,  .,)   9
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M970Q,# N>&UL4$L! A0#%     @ :#Y^4FA\"OK* P  C L  !H
M     ("!@AX" 'AL+W=O<FMS:&5E=',O<VAE970Q,#$N>&UL4$L! A0#%
M  @ :#Y^4MAYJRCJ P  Z!$  !H              ("!A"(" 'AL+W=O<FMS
M:&5E=',O<VAE970Q,#(N>&UL4$L! A0#%     @ :#Y^4K6()C&( P  5 P
M !H              ("!IB8" 'AL+W=O<FMS:&5E=',O<VAE970Q,#,N>&UL
M4$L! A0#%     @ :#Y^4F?>62A.!   X \  !H              ("!9BH"
M 'AL+W=O<FMS:&5E=',O<VAE970Q,#0N>&UL4$L! A0#%     @ :#Y^4ND-
M]A^S!0  Q20  !H              ("!["X" 'AL+W=O<FMS:&5E=',O<VAE
M970Q,#4N>&UL4$L! A0#%     @ :#Y^4INB%&%?!   ER(  !H
M     ("!US0" 'AL+W=O<FMS:&5E=',O<VAE970Q,#8N>&UL4$L! A0#%
M  @ :#Y^4FG-+FZW @  V <  !H              ("!;CD" 'AL+W=O<FMS
M:&5E=',O<VAE970Q,#<N>&UL4$L! A0#%     @ :#Y^4AN"]\0(!0  YA,
M !H              ("!73P" 'AL+W=O<FMS:&5E=',O<VAE970Q,#@N>&UL
M4$L! A0#%     @ :#Y^4F#.?8>&!   ;A8  !H              ("!G4$"
M 'AL+W=O<FMS:&5E=',O<VAE970Q,#DN>&UL4$L! A0#%     @ :#Y^4CTQ
M5=:I!   61<  !H              ("!6T8" 'AL+W=O<FMS:&5E=',O<VAE
M970Q,3 N>&UL4$L! A0#%     @ :#Y^4@%7-&$R @  ^@0  !H
M     ("!/$L" 'AL+W=O<FMS:&5E=',O<VAE970Q,3$N>&UL4$L! A0#%
M  @ :#Y^4A./P@[H @  .@@  !H              ("!IDT" 'AL+W=O<FMS
M:&5E=',O<VAE970Q,3(N>&UL4$L! A0#%     @ :#Y^4L,@M^N'!@  'R@
M !H              ("!QE " 'AL+W=O<FMS:&5E=',O<VAE970Q,3,N>&UL
M4$L! A0#%     @ :#Y^4C,?X9Q="   9D(  !H              ("!A5<"
M 'AL+W=O<FMS:&5E=',O<VAE970Q,30N>&UL4$L! A0#%     @ :#Y^4NM:
MGL/( @  DP8  !H              ("!&F " 'AL+W=O<FMS:&5E=',O<VAE
M970Q,34N>&UL4$L! A0#%     @ :#Y^4N'APJ%S!   JA$  !H
M     ("!&F," 'AL+W=O<FMS:&5E=',O<VAE970Q,38N>&UL4$L! A0#%
M  @ :#Y^4L!!I0TF @  ?00  !H              ("!Q6<" 'AL+W=O<FMS
M:&5E=',O<VAE970Q,3<N>&UL4$L! A0#%     @ :#Y^4F>1<PU; P  \A4
M  T              ( !(VH" 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !H
M/GY2EXJ[',     3 @  "P              @ &I;0( 7W)E;',O+G)E;'-0
M2P$"% ,4    " !H/GY2,Y ^1,T'  #(3   #P              @ &2;@(
M>&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ :#Y^4B%Q][([ P  K$0  !H
M             ( !C'8" 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L!
M A0#%     @ :#Y^4D:T3BJ/ @  [4$  !,              ( !_WD" %M#
G;VYT96YT7U1Y<&5S72YX;6Q02P4&     'T ?0!T(@  OWP"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>158
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>159
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>160
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>412</ContextCount>
  <ElementCount>450</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>140</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>1001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1002 - Statement - Consolidated Statement of Financial Position of Immatics N.V.</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/ConsolidatedStatementOfFinancialPositionOfImmaticsNV</Role>
      <ShortName>Consolidated Statement of Financial Position of Immatics N.V.</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1003 - Statement - Consolidated Statement of Loss of Immatics N.V.</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/ConsolidatedStatementOfLossOfImmaticsNV</Role>
      <ShortName>Consolidated Statement of Loss of Immatics N.V.</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1004 - Statement - Consolidated Statement of Comprehensive Loss of Immatics N.V.</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/ConsolidatedStatementOfComprehensiveLossOfImmaticsNV</Role>
      <ShortName>Consolidated Statement of Comprehensive Loss of Immatics N.V.</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1005 - Statement - Consolidated Statement of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/ConsolidatedStatementOfCashFlows</Role>
      <ShortName>Consolidated Statement of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1006 - Statement - Consolidated Statement of Changes in Shareholders' equity (deficit) of Immatics N.V.</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/ConsolidatedStatementOfChangesInShareholdersEquityDeficitOfImmaticsNV</Role>
      <ShortName>Consolidated Statement of Changes in Shareholders' equity (deficit) of Immatics N.V.</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1007 - Disclosure - Group information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/GroupInformation</Role>
      <ShortName>Group information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1008 - Disclosure - Basis of presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/BasisOfPresentation</Role>
      <ShortName>Basis of presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>1009 - Disclosure - ARYA Merger</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/AryaMerger</Role>
      <ShortName>ARYA Merger</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>1010 - Disclosure - Application of new and revised international financial reporting standards</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/ApplicationOfNewAndRevisedInternationalFinancialReportingStandards</Role>
      <ShortName>Application of new and revised international financial reporting standards</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>1011 - Disclosure - Summary of accounting policies applied by the Group for the annual reporting period ending December 31, 2020</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020</Role>
      <ShortName>Summary of accounting policies applied by the Group for the annual reporting period ending December 31, 2020</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>1012 - Disclosure - Significant accounting judgments, estimates and assumptions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/SignificantAccountingJudgmentsEstimatesAndAssumptions</Role>
      <ShortName>Significant accounting judgments, estimates and assumptions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>1013 - Disclosure - Accounts receivable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/AccountsReceivable</Role>
      <ShortName>Accounts receivable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>1014 - Disclosure - Other current and non-current assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/OtherCurrentAndNonCurrentAssets</Role>
      <ShortName>Other current and non-current assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>1015 - Disclosure - Property, plant and equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/PropertyPlantAndEquipment</Role>
      <ShortName>Property, plant and equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>1016 - Disclosure - Intangible assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/IntangibleAssets</Role>
      <ShortName>Intangible assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>1017 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>1018 - Disclosure - Accounts payable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/AccountsPayable</Role>
      <ShortName>Accounts payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>1019 - Disclosure - Revenue from collaboration agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/RevenueFromCollaborationAgreements</Role>
      <ShortName>Revenue from collaboration agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>1020 - Disclosure - Other income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/OtherIncome</Role>
      <ShortName>Other income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>1021 - Disclosure - Other current liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/OtherCurrentLiabilities</Role>
      <ShortName>Other current liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>1022 - Disclosure - Financial income and expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/FinancialIncomeAndExpenses</Role>
      <ShortName>Financial income and expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>1023 - Disclosure - Share listing expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/ShareListingExpenses</Role>
      <ShortName>Share listing expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>1024 - Disclosure - Share-based payments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/ShareBasedPayments</Role>
      <ShortName>Share-based payments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>1025 - Disclosure - Shareholders' equity (deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/ShareholdersEquityDeficit</Role>
      <ShortName>Shareholders' equity (deficit)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>1026 - Disclosure - Non-controlling interests</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/NonControllingInterests</Role>
      <ShortName>Non-controlling interests</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>1027 - Disclosure - Personnel expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/PersonnelExpenses</Role>
      <ShortName>Personnel expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>1028 - Disclosure - Income Tax</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/IncomeTax</Role>
      <ShortName>Income Tax</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>1029 - Disclosure - Financial Risk Management Objectives and Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/FinancialRiskManagementObjectivesAndPolicies</Role>
      <ShortName>Financial Risk Management Objectives and Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>1030 - Disclosure - Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/FinancialInstruments</Role>
      <ShortName>Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>1031 - Disclosure - Commitments and contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>1032 - Disclosure - Related party disclosures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/RelatedPartyDisclosures</Role>
      <ShortName>Related party disclosures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>1033 - Disclosure - Net loss per share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/NetLossPerShare</Role>
      <ShortName>Net loss per share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>1034 - Disclosure - Events occurring after the reporting period</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/EventsOccurringAfterTheReportingPeriod</Role>
      <ShortName>Events occurring after the reporting period</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>1035 - Disclosure - Summary of accounting policies applied by the Group for the annual reporting period ending December 31, 2020 (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020Policies</Role>
      <ShortName>Summary of accounting policies applied by the Group for the annual reporting period ending December 31, 2020 (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>1036 - Disclosure - Basis of presentation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/BasisOfPresentationTables</Role>
      <ShortName>Basis of presentation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imtx.com/role/BasisOfPresentation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>1037 - Disclosure - Application of new and revised international financial reporting standards (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/ApplicationOfNewAndRevisedInternationalFinancialReportingStandardsTables</Role>
      <ShortName>Application of new and revised international financial reporting standards (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imtx.com/role/ApplicationOfNewAndRevisedInternationalFinancialReportingStandards</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>1038 - Disclosure - Summary of accounting policies applied by the Group for the annual reporting period ending December 31, 2020 (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020Tables</Role>
      <ShortName>Summary of accounting policies applied by the Group for the annual reporting period ending December 31, 2020 (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>1039 - Disclosure - Accounts receivable (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/AccountsReceivableTables</Role>
      <ShortName>Accounts receivable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imtx.com/role/AccountsReceivable</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>1040 - Disclosure - Other current and non-current assets  (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/OtherCurrentAndNonCurrentAssetsTables</Role>
      <ShortName>Other current and non-current assets  (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imtx.com/role/OtherCurrentAndNonCurrentAssets</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>1041 - Disclosure - Property, plant and equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/PropertyPlantAndEquipmentTables</Role>
      <ShortName>Property, plant and equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imtx.com/role/PropertyPlantAndEquipment</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>1042 - Disclosure - Intangible assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/IntangibleAssetsTables</Role>
      <ShortName>Intangible assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imtx.com/role/IntangibleAssets</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>1043 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imtx.com/role/Leases</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>1044 - Disclosure - Accounts payable (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/AccountsPayableTables</Role>
      <ShortName>Accounts payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imtx.com/role/AccountsPayable</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>1045 - Disclosure - Revenue from collaboration agreements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/RevenueFromCollaborationAgreementsTables</Role>
      <ShortName>Revenue from collaboration agreements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imtx.com/role/RevenueFromCollaborationAgreements</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>1046 - Disclosure - Other income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/OtherIncomeTables</Role>
      <ShortName>Other income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imtx.com/role/OtherIncome</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>1047 - Disclosure - Other current liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/OtherCurrentLiabilitiesTables</Role>
      <ShortName>Other current liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imtx.com/role/OtherCurrentLiabilities</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>1048 - Disclosure - Financial income and expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/FinancialIncomeAndExpensesTables</Role>
      <ShortName>Financial income and expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imtx.com/role/FinancialIncomeAndExpenses</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>1049 - Disclosure - Share listing expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/ShareListingExpensesTables</Role>
      <ShortName>Share listing expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imtx.com/role/ShareListingExpenses</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>1050 - Disclosure - Share-based payments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/ShareBasedPaymentsTables</Role>
      <ShortName>Share-based payments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imtx.com/role/ShareBasedPayments</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>1051 - Disclosure - Personnel expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/PersonnelExpensesTables</Role>
      <ShortName>Personnel expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imtx.com/role/PersonnelExpenses</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>1052 - Disclosure - Income Tax (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/IncomeTaxTables</Role>
      <ShortName>Income Tax (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imtx.com/role/IncomeTax</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>1053 - Disclosure - Financial Risk Management Objectives and Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesTables</Role>
      <ShortName>Financial Risk Management Objectives and Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imtx.com/role/FinancialRiskManagementObjectivesAndPolicies</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>1054 - Disclosure - Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/FinancialInstrumentsTables</Role>
      <ShortName>Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imtx.com/role/FinancialInstruments</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>1055 - Disclosure - Commitments and contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/CommitmentsAndContingenciesTables</Role>
      <ShortName>Commitments and contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imtx.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>1056 - Disclosure - Related party disclosures (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/RelatedPartyDisclosuresTables</Role>
      <ShortName>Related party disclosures (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imtx.com/role/RelatedPartyDisclosures</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>1057 - Disclosure - Group information - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/GroupInformationAdditionalInformationDetail</Role>
      <ShortName>Group information - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>1058 - Disclosure - Basis of presentation - Summary of Reconciliation Of Changes In Cash Flow Statement (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/BasisOfPresentationSummaryOfReconciliationOfChangesInCashFlowStatementDetail</Role>
      <ShortName>Basis of presentation - Summary of Reconciliation Of Changes In Cash Flow Statement (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>1059 - Disclosure - Basis of presentation - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/BasisOfPresentationAdditionalInformationDetail</Role>
      <ShortName>Basis of presentation - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>1060 - Disclosure - ARYA Merger - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/AryaMergerAdditionalInformationDetail</Role>
      <ShortName>ARYA Merger - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>1061 - Disclosure - Application of new and revised international financial reporting standards - Summary of Application of new standards  (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/ApplicationOfNewAndRevisedInternationalFinancialReportingStandardsSummaryOfApplicationOfNewStandardsDetail</Role>
      <ShortName>Application of new and revised international financial reporting standards - Summary of Application of new standards  (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>1062 - Disclosure - Application of new and revised international financial reporting standards - Summary of Non Mandatory  standards and interpretations issued by  IASB (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/ApplicationOfNewAndRevisedInternationalFinancialReportingStandardsSummaryOfNonMandatoryStandardsAndInterpretationsIssuedByIasbDetail</Role>
      <ShortName>Application of new and revised international financial reporting standards - Summary of Non Mandatory  standards and interpretations issued by  IASB (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>1063 - Disclosure - Summary of accounting policies applied by the Group for the annual reporting period ending December 31, 2020 - Summary of estimated Useful Lives of Property, Plant and Equipment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentDetail</Role>
      <ShortName>Summary of accounting policies applied by the Group for the annual reporting period ending December 31, 2020 - Summary of estimated Useful Lives of Property, Plant and Equipment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>1064 - Disclosure - Summary of accounting policies applied by the Group for the annual reporting period ending December 31, 2020 - Summary of useful life of intangible assets other than goodwill (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020SummaryOfUsefulLifeOfIntangibleAssetsOtherThanGoodwillDetail</Role>
      <ShortName>Summary of accounting policies applied by the Group for the annual reporting period ending December 31, 2020 - Summary of useful life of intangible assets other than goodwill (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>1065 - Disclosure - Summary of accounting policies applied by the Group for the annual reporting period ending December 31, 2020 - Summary of foreign exchange rates (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020SummaryOfForeignExchangeRatesDetail</Role>
      <ShortName>Summary of accounting policies applied by the Group for the annual reporting period ending December 31, 2020 - Summary of foreign exchange rates (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>1066 - Disclosure - Summary of accounting policies applied by the Group for the annual reporting period ending December 31, 2020 - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020AdditionalInformationDetail</Role>
      <ShortName>Summary of accounting policies applied by the Group for the annual reporting period ending December 31, 2020 - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://imtx.com/role/SummaryOfAccountingPoliciesAppliedByTheGroupForTheAnnualReportingPeriodEndingDecember312020Tables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>1067 - Disclosure - Accounts receivable - Summary of Trade receivables (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/AccountsReceivableSummaryOfTradeReceivablesDetail</Role>
      <ShortName>Accounts receivable - Summary of Trade receivables (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>1068 - Disclosure - Accounts receivable - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/AccountsReceivableAdditionalInformationDetail</Role>
      <ShortName>Accounts receivable - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>1069 - Disclosure - Other current and non-current assets -Summary of Other current assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/OtherCurrentAndNonCurrentAssetsSummaryOfOtherCurrentAssetsDetail</Role>
      <ShortName>Other current and non-current assets -Summary of Other current assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>1070 - Disclosure - Other current and non-current assets - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/OtherCurrentAndNonCurrentAssetsAdditionalInformationDetails</Role>
      <ShortName>Other current and non-current assets - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>1071 - Disclosure - Other current and non-current assets - Summary of Other&amp;#160;non-current&amp;#160;assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/OtherCurrentAndNonCurrentAssetsSummaryOfOtherNonCurrentAssetsDetail</Role>
      <ShortName>Other current and non-current assets - Summary of Other&amp;#160;non-current&amp;#160;assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>1072 - Disclosure - Property, plant and equipment - Summary of Changes to property, plant and equipment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/PropertyPlantAndEquipmentSummaryOfChangesToPropertyPlantAndEquipmentDetail</Role>
      <ShortName>Property, plant and equipment - Summary of Changes to property, plant and equipment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>1073 - Disclosure - Property, plant and equipment - Summary of Depreciation expense (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/PropertyPlantAndEquipmentSummaryOfDepreciationExpenseDetail</Role>
      <ShortName>Property, plant and equipment - Summary of Depreciation expense (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>1074 - Disclosure - Intangible assets - Summary of Changes to intangible assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/IntangibleAssetsSummaryOfChangesToIntangibleAssetsDetail</Role>
      <ShortName>Intangible assets - Summary of Changes to intangible assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>1075 - Disclosure - Intangible assets - Summary of Amortization expense (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/IntangibleAssetsSummaryOfAmortizationExpenseDetail</Role>
      <ShortName>Intangible assets - Summary of Amortization expense (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>1076 - Disclosure - Leases - Summary of Right-of&amp;#160;use assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/LeasesSummaryOfRightOfUseAssetsDetail</Role>
      <ShortName>Leases - Summary of Right-of&amp;#160;use assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>1077 - Disclosure - Leases - Details of Lease liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/LeasesDetailsOfLeaseLiabilitiesDetail</Role>
      <ShortName>Leases - Details of Lease liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>1078 - Disclosure - Leases - Summary of expenses related to&amp;#160;right-of-use&amp;#160;assets and lease liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/LeasesSummaryOfExpensesRelatedToRightOfUseAssetsAndLeaseLiabilitiesDetail</Role>
      <ShortName>Leases - Summary of expenses related to&amp;#160;right-of-use&amp;#160;assets and lease liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>1079 - Disclosure - Leases - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/LeasesAdditionalInformationDetail</Role>
      <ShortName>Leases - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>1080 - Disclosure - Accounts payable - Summary of Accounts Payable (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/AccountsPayableSummaryOfAccountsPayableDetail</Role>
      <ShortName>Accounts payable - Summary of Accounts Payable (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>1081 - Disclosure - Accounts payable - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/AccountsPayableAdditionalInformationDetail</Role>
      <ShortName>Accounts payable - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>1082 - Disclosure - Revenue from collaboration agreements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/RevenueFromCollaborationAgreementsAdditionalInformationDetail</Role>
      <ShortName>Revenue from collaboration agreements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>1083 - Disclosure - Revenue from collaboration agreements - Summary of Deferred revenue related to the collaboration agreements (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/RevenueFromCollaborationAgreementsSummaryOfDeferredRevenueRelatedToTheCollaborationAgreementsDetail</Role>
      <ShortName>Revenue from collaboration agreements - Summary of Deferred revenue related to the collaboration agreements (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>1084 - Disclosure - Other income - Summary of other income (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/OtherIncomeSummaryOfOtherIncomeDetail</Role>
      <ShortName>Other income - Summary of other income (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>1085 - Disclosure - Other income - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/OtherIncomeAdditionalInformationDetail</Role>
      <ShortName>Other income - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>1086 - Disclosure - Other current liabilities - Summary of other current liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/OtherCurrentLiabilitiesSummaryOfOtherCurrentLiabilitiesDetail</Role>
      <ShortName>Other current liabilities - Summary of other current liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>1087 - Disclosure - Other current liabilities - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/OtherCurrentLiabilitiesAdditionalInformationDetail</Role>
      <ShortName>Other current liabilities - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>1088 - Disclosure - Financial income and expenses - Summary of finance income and costs (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/FinancialIncomeAndExpensesSummaryOfFinanceIncomeAndCostsDetail</Role>
      <ShortName>Financial income and expenses - Summary of finance income and costs (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>1089 - Disclosure - Financial income and expenses - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/FinancialIncomeAndExpensesAdditionalInformationDetail</Role>
      <ShortName>Financial income and expenses - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>1090 - Disclosure - Share listing expense - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/ShareListingExpenseAdditionalInformationDetail</Role>
      <ShortName>Share listing expense - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>1091 - Disclosure - Share listing expenses - Summary of Calculation of the Share listing expense (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/ShareListingExpensesSummaryOfCalculationOfTheShareListingExpenseDetail</Role>
      <ShortName>Share listing expenses - Summary of Calculation of the Share listing expense (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>1092 - Disclosure - Share-based payments - Summary of Options Granted Priced Using Black Scholes for SARs, Tandem Awards, Converted Options, Matching Stock Options and Monte Carlo Option Pricing Model (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/ShareBasedPaymentsSummaryOfOptionsGrantedPricedUsingBlackScholesForSarsTandemAwardsConvertedOptionsMatchingStockOptionsAndMonteCarloOptionPricingModelDetail</Role>
      <ShortName>Share-based payments - Summary of Options Granted Priced Using Black Scholes for SARs, Tandem Awards, Converted Options, Matching Stock Options and Monte Carlo Option Pricing Model (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>1093 - Disclosure - Share-based payments - Summary of Employee Share Options (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/ShareBasedPaymentsSummaryOfEmployeeShareOptionsDetail</Role>
      <ShortName>Share-based payments - Summary of Employee Share Options (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>1094 - Disclosure - Share-based payments - Summary of Activities Under Share Based Payment Arrangement (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/ShareBasedPaymentsSummaryOfActivitiesUnderShareBasedPaymentArrangementDetail</Role>
      <ShortName>Share-based payments - Summary of Activities Under Share Based Payment Arrangement (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>1095 - Disclosure - Share-based payments - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/ShareBasedPaymentsAdditionalInformationDetail</Role>
      <ShortName>Share-based payments - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>1096 - Disclosure - Share-based payments - Summary of Employee Related Share Based Compensation Expense (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/ShareBasedPaymentsSummaryOfEmployeeRelatedShareBasedCompensationExpenseDetail</Role>
      <ShortName>Share-based payments - Summary of Employee Related Share Based Compensation Expense (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>1097 - Disclosure - Shareholders' equity (deficit) - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/ShareholdersEquityDeficitAdditionalInformationDetail</Role>
      <ShortName>Shareholders' equity (deficit) - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://imtx.com/role/ShareholdersEquityDeficit</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>1098 - Disclosure - Non-controlling interests - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/NonControllingInterestsAdditionalInformationDetail</Role>
      <ShortName>Non-controlling interests - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>1099 - Disclosure - Personnel expenses - Summary of Personnel Expenses (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/PersonnelExpensesSummaryOfPersonnelExpensesDetail</Role>
      <ShortName>Personnel expenses - Summary of Personnel Expenses (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>1100 - Disclosure - Personnel expenses - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/PersonnelExpensesAdditionalInformationDetail</Role>
      <ShortName>Personnel expenses - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>1101 - Disclosure - Income Tax - Summary of Reconciliation Between Taxes On Income And Expected Income Tax Benefit (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/IncomeTaxSummaryOfReconciliationBetweenTaxesOnIncomeAndExpectedIncomeTaxBenefitDetail</Role>
      <ShortName>Income Tax - Summary of Reconciliation Between Taxes On Income And Expected Income Tax Benefit (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>1102 - Disclosure - Income Tax - Summary of Deferred Tax Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/IncomeTaxSummaryOfDeferredTaxAssetsDetail</Role>
      <ShortName>Income Tax - Summary of Deferred Tax Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>1103 - Disclosure - Income Tax - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/IncomeTaxAdditionalInformationDetail</Role>
      <ShortName>Income Tax - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>1104 - Disclosure - Financial Risk Management Objectives and Policies - Summary of Currency Risk Exposure (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesSummaryOfCurrencyRiskExposureDetail</Role>
      <ShortName>Financial Risk Management Objectives and Policies - Summary of Currency Risk Exposure (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>1105 - Disclosure - Financial Risk Management Objectives and Policies - Summary of Sensitivity Analysis of Foreign Currency Risk (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesSummaryOfSensitivityAnalysisOfForeignCurrencyRiskDetail</Role>
      <ShortName>Financial Risk Management Objectives and Policies - Summary of Sensitivity Analysis of Foreign Currency Risk (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>1106 - Disclosure - Financial Risk Management Objectives and Policies - Summary of Sensitivity Analysis of Foreign Currency Risk (Parenthetical) (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesSummaryOfSensitivityAnalysisOfForeignCurrencyRiskParentheticalDetail</Role>
      <ShortName>Financial Risk Management Objectives and Policies - Summary of Sensitivity Analysis of Foreign Currency Risk (Parenthetical) (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>106</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>1107 - Disclosure - Financial Risk Management Objectives and Policies - Summary of Liquidity Risk (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesSummaryOfLiquidityRiskDetail</Role>
      <ShortName>Financial Risk Management Objectives and Policies - Summary of Liquidity Risk (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>1108 - Disclosure - Financial Risk Management Objectives and Policies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/FinancialRiskManagementObjectivesAndPoliciesAdditionalInformationDetail</Role>
      <ShortName>Financial Risk Management Objectives and Policies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>108</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>1109 - Disclosure - Financial Instruments - Summary of Carrying Amounts and Fair values of Group's Financial Instruments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/FinancialInstrumentsSummaryOfCarryingAmountsAndFairValuesOfGroupsFinancialInstrumentsDetail</Role>
      <ShortName>Financial Instruments - Summary of Carrying Amounts and Fair values of Group's Financial Instruments (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>109</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>1110 - Disclosure - Commitments and contingencies - Summary of Contractual Obligations (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/CommitmentsAndContingenciesSummaryOfContractualObligationsDetail</Role>
      <ShortName>Commitments and contingencies - Summary of Contractual Obligations (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>110</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>1111 - Disclosure - Commitments and contingencies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/CommitmentsAndContingenciesAdditionalInformationDetail</Role>
      <ShortName>Commitments and contingencies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>111</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>1112 - Disclosure - Related party disclosures - Summary of Compensation of Key Management Personnel (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/RelatedPartyDisclosuresSummaryOfCompensationOfKeyManagementPersonnelDetail</Role>
      <ShortName>Related party disclosures - Summary of Compensation of Key Management Personnel (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>112</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>1113 - Disclosure - Related party disclosures - Summary of Compensation for the Supervisory Board (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/RelatedPartyDisclosuresSummaryOfCompensationForTheSupervisoryBoardDetail</Role>
      <ShortName>Related party disclosures - Summary of Compensation for the Supervisory Board (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>113</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>1114 - Disclosure - Related party disclosures - Summary of Options Granted to Managing Director and Supervisory Directors (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/RelatedPartyDisclosuresSummaryOfOptionsGrantedToManagingDirectorAndSupervisoryDirectorsDetail</Role>
      <ShortName>Related party disclosures - Summary of Options Granted to Managing Director and Supervisory Directors (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>114</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>1115 - Disclosure - Related party disclosures - Summary of Compensation for the Supervisory Board (Parenthetical) (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/RelatedPartyDisclosuresSummaryOfCompensationForTheSupervisoryBoardParentheticalDetail</Role>
      <ShortName>Related party disclosures - Summary of Compensation for the Supervisory Board (Parenthetical) (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>115</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>1116 - Disclosure - Related party disclosures - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/RelatedPartyDisclosuresAdditionalInformationDetail</Role>
      <ShortName>Related party disclosures - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>116</Position>
    </Report>
    <Report instance="imtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R117.htm</HtmlFileName>
      <LongName>1117 - Disclosure - Net loss per share - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imtx.com/role/NetLossPerShareAdditionalInformationDetail</Role>
      <ShortName>Net loss per share - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>117</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>imtx-20201231.xml</File>
    <File>imtx-20201231.xsd</File>
    <File>imtx-20201231_cal.xml</File>
    <File>imtx-20201231_def.xml</File>
    <File>imtx-20201231_lab.xml</File>
    <File>imtx-20201231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/currency/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>162
<FILENAME>0001193125-21-099162-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-21-099162-xbrl.zip
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MZG@ZK>^$X!MYNOIT>]>0W)L?6O=41RR.R'/)O-;)0E?@CX\L8]5FWD?CBC(
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M,'1$]61Y&8U"C2VR@E<X<H55_@UGH2*:LR-76'G@0)R&ND84B-Q.@.,Q*2Q
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MIOT 2DF50&'O[WBO&A:1U[JA&2LV+^+SYN%O@J0K_+[OK^]>>^[J'6[[?B>
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M5:X[?B2K')'89^I 6/G<^0>V [5+=K#-VPV\VV)>DM\?8+^INLU3(7NW85^
MP6JB0-ER/;*TN20S4=RMB9U^ 6&$->RX79[<$B LKX'ZS@_>*B_7]7+B*K;.
M88$SQ1)T7(Y30S&X>J5DJ?'5 1Z:LP'O_$Q!IUFN?[/;-@ =L?.9^'(-)9E<
M%%P:2+MT?>2U7JQX^>O33K'JA'EWO!"7I94.=#_HY3WQ>8;-Q\"$NI,D7ZH)
M*1C,P92>@QE@#J89.9A+@_)B=T>9A-6++WU^R0S_)\UX,C%;<ZYLS9E*=6W*
MC1@[^[!6J2+\VY:HY526.R7;'L]?8?N@?//'B=VYA#$7GQG4D(1%^[RL'#UJ
M(TKA/D3B=E3L[H]'?!W_WK_=LV%E:S[H4CS(Y$DH9PL6ZVYW'N6E6Z7/DE@$
MXAQ;VO&?."$4WV8"SS!$\QY??DR\P*>1W)U QF#X!J1J]U7/%2U=UFR%/]H]
M_2 ?])FB*MPU<W8UF0@1RIPW%6!C(,"[0*?O(B-PLR!8<CG<<S-M^PW-I:K%
M.( 0]B9*B%O1[[1798(6*>_Q^Z= P5]V)^=_%79GY[FW[(3ECJ_HBNHA(O3D
M)7?IQ,A=UL/R=+;R/'NNX1W7_7M4_9&8@?=D]1A;O )XS)-@6+V*QPES-) 5
MY\09%TXW6HB1J;?95(V+SJ HUWR NZ,NE@[Q!/Z)G0 PPN[A$>_= X+/RS@X
MR<[]PL1[?Z0W[5XH_B7D1SO,C;D]YY?X=GQ[U6_W1!*!E93&IO#,0I:HV=4]
M>QTI;L.AJHNLN]HC]5T4]0IX=,)+0'N!OM)_>R4>M*2KQYR',DUG0,A#5P^_
M@ _/_O_K7M6YE^P8[-&/[B_\B6\%GB#S*3Z9[R:D0^2$F/6?QT]EB?-4"8AZ
M<Q;YZ3DC>1Y^HJ;)J&D&;1+,A<GN>J!OV ?**_B)TFK%TB[V[?=AD&>-X9E_
MR3VJ)JZXQG(/%6;#V(<*LWD\JXW"S.<K.PFX+,[RX82NEW.#_@@"AN$,_C,>
M _\\Z;.TV\N<>:K.MK'>"A<BV;B 5K#C['[',H=P'WMSU![T65+=0BIZ1\IH
MB@V,D,@>$]],W#^6G4H5XR0=CDQ'FW0@E/!BCSJB3)(20?EEU!NY^9/J\/\U
M!0%*8GEG&3WHS0>#^J&/;"YX/8N]T7R*Z[G]C)X"HX?(Z-8S6ASVQ+Y8/_R1
MS\7R>=R;]&=U0;_J\ X#M[K5"G\CEG/VQVWXP%LM156<)09SQP*[BD*V$E1
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M.+&*8;,92(USP$N#O47Q%?(7^8O\1?ZV"G;D+_(7^=M<V-,Z\&T<W)UXMZ=
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MP3ZX-AP^V#8^:%>5X?#!L^.#4J.A->9@P<NYVL&"I^^>CPF  (K0!>E=PH"
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M1*U 1-L#_8OA8BV">]Y[]?[CU]?''OQ7A[3I8]@RN0>O0_ET_#E<$HTY/ZZ
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M[KM;R6CTL14X/-G>W7\6(9M_[ D26!7&C1HL&-6,%&5MBVFEA3H=5G^,##@
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M'>Z1<HLWF'JEE?K@9^QGTF<Q#XS]H;#Y<(^5CO**4],$!V;,P\KI*8-(.;?
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MVS1!34AYSI4_W/*+Z0\(HW^Y_5VQE6<8LY%!%@TY:@-'O!_%^-,_TUP 1NY
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M'NZF1*-VVZ??84[PX?R<X@XJ^+ ^AKX:#"X6G_?+YKXND+/5^H<"^#HK(YU
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M$$!2,;?_'3]6]T0P)P)V0%G8R.0N7+[! J&@D(AI4^V-DP(CG J?/(@XG=!
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M-LA(=4AV+U8B#<9T4Q@;'#M,;)-,Y]RJF""U1Y/^ELOWA9-*'H2U\35)#:?
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ML%^##CETSP/>1XB'UBLIWO(K&$G.V/Z$]_GP]=8;8+2?SL&IQG/1>"Q"5*,
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MUB >.-F",R-FRPR,:>>)O+RHK6T22XE6]G(9FGQ1%1G);R1<V%?WP"HPI)!
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M.YKHZ^Y&6]S,^[G?@^RZ\.W$3&LLLTG9R'O?AK2F9'3'UAGE;!VRYMT<"5\
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MPX2;8R6 1#V0(%(<+ *+&N>;$4^W,6OL.,'-+ D!"6AN;>R7PN-9ZX;YK5$
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M25XI64B4C#G85:L=5Z63W^#;GN_8Z%I_6<##-\A YB-!?KL@4BN<DOWS;/&
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M8Q[II_"DNZ%:QNT^X TSW72%1QR[%YS9QNRZ\?ADO+XOBZ?7P;($$O+*.6P
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M!J.S"J&*J46BP:D$C$K J*KF4OE3J_J:"]CWC:C;^@__GO'SAXG]&WZDPA#
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MZACMAC0'WP[E5@O\"F3ZTK.7EN/'/BJJ^"G8%LT-4&F32!_" "-VJ[H>4]+
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MZEH>]4/[2Y*^P&,VT]P 91VK?6YF:USVF]EGRYHZ-_8=LQ]QL%NF,?V131-
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MAL6CSOL*6V;A+;ZJ]D_FOE>7NJL:^G_YJ5+"JH]@6.1Z1O8#H5*T.;LQV89
MP6=I<.1&>)>DLP&2.[+:$RERZ$BG*(J #)U$D7&(T5D<11"\H0J*S&UVFI0
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ME+3*>YMA[XX]@>1%\B)YB\^+ER&%R?DGDEN+Z3#J7P*TX92OXV$)C9H^318
MB+?%6,GZ7I^IRTX+][853B\U57T&5A!_YAR..2\*+R?V P,3DYC,<1)C2;S'
M/\^I926?5X=;;H$EEO7+2WOB!^>3R'$NW]F!Z7A!Y+.OD^_,]%S3=FQQ7?IU
M\G9*W3L6?'(_N2'\9</K5T' PN#*M3YZGG5O.\[[!SB?71IZ_N.;O__M%WL6
M/F3&_,;\P'-=QA]D;L""U LWH+7\ZGCFG\2V7I]]H&9H6S^TL:$;@]$(5@QG
M,3SQG4U>GWU3M1_P#S?9;CQ-_]&+_SY[4XCC'*[6<%F?59LPKNDY#IT'\/7B
MK^5/&8/W58KL*1(N *KB<4BI?-R@+TQ32J;K/]M=V=*UBZH:Z$9P#N19*"5A
MBH3'JSS0[79]++<:8<E>(SNX-TH)PHJ>M#2%AALH) _N;Z:,?/2]:$Y\$(AW
M+HQFD1"^G,#>]NYA&#)?0_7E1EP7XBX!42_+OQNQDQYH%S[;?'1N/<7DE; Q
M\HCX1&@4>NO;/!&+1K]0"*<@4(N-Q/CUT3#U>@4E*9E=W_3VGE^>ZN3[>?R-
MJ@[_A/F7FY3W']LSG'^/(;<,ONSRI:VV9;)QXL'2E_PK93O[2$PX 5'N%S'B
M97S!D]EI)@/MS:_=^?,':."$N1:(Y$*O?BEEI3;B(=,]P71Z%WBN\*+HH'R%
M]*E&'ZU<L1JDS['H4ZYF7EOE\GXL=) C_O!4??X^\KV @*X=3KTHH*X5O-C;
M=RA+/ =6ANE:5L@_@?H! 2XE 76H;S^1HRY7Z'-U8M02Q(NP5( %.0)A08Y
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M=Q@)_RVWB39_P@7PM-*YQY!;!@>.!1YU7Y\-EQLC8=UXK+1W8*7091^)Z28
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M)E$(6O(%N8'OS0B@=D,!<A#,^)\^NZ.^R$L3@ 2+60",HE7.Z",QI]2]8[
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MW [<?</!N&$/X:^.!R>R;;T^^T!!_EL_M+&A&T-5A\4"@>")[VSR^NR;JOV
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MPMEYL+N9]%%(FB<$<:X"M7WRDSH1$Y'T86%6Q"H[P4[1)9S24 S.![:9%4<
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M+(0/S&*C7K(35MVHR(%Z_%Q9TM)C.U)-=BH &KDO%P005R "6)X5B$VUCJZ
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M'%AH@8>;)3C<Q$*+PB+O#2RT*,^,,B%G('"E/<0IX6'9#EW1R\MGK+30RR;
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M?E*&6"U_-R<  '+N 0 1    :6UT>"TR,#(P,3(S,2YX<V3M7>EOY+B5_[[
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M;HGE=*I];5"M,E6JW@&;AI+YE!Z'$?N;E5J()6U($[<UO30H6)DYW?))?D9
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M0^PYPA%TER$.\()1_[)Z6MJ_IK8"1/?=L"14CT_.0"0F9[WWOYJ'HFBY=YE
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MTB-)68>DRVY/L!'7NL5IK_*][3PL)YBV(6M;1$UD/J'\8BCPI_\#4$L#!!0
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MH;V2%LT..JQX%C_NY_\#4$L#!!0    ( &@^?E*5LO_\%F,  !M,!@ 5
M:6UT>"TR,#(P,3(S,5]D968N>&UL[;UI<R,YTB;X?<WV/]34?,Y.':FK;7K&
MJ"M;\RJ3&DE9-;UK:VFA($C&6\$(-2(HB;VV_WT!.$GQ@..(  *@NKYT95,
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M$!+\G^Y!IJL)H3QYUE=:OM9C$S:D-0#.;AYCU( 0?OP?\A>85D.]-8:7U:(
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MUU8)% 6B?O]'[060A>_?TAXSP>WORCH"TLX9X,T@(2QUYTV_>LMI=&NU70'
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M;9*"05(!H'HZ'MCDT?%-I5D?VE!*U*Z*+OD/;MZ,NB/LB$>D!+E!KT!K ?C
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MY*H]&4:>25W $-B4X(XY*\@(;4ZBWX4+=#I[I$E1Y1 NE@V'A(J7@##"U+5
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MFP,]!8Z7[.BZJKERXO:$6@,&"&ZSH6QDF'<>93.0HR6PL21 IS%32MQN5&N
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MD2=:/I>4"]<?]E\+=C8=9\]+V_[?23XXGWTOBU1B^%=3VKQ=T%R82]+&[#N
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M"=BH@Y7=)<I@8,/'31@18C@1;R"+.H+9+8T1;;Y\\>G4K])WOI/CD^-(\YW
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M]43*0[OYW>WXKD<2K *O7;.SS<Q4 P;ESTE9)D5=Z?$X_BM[*(Z/@X_"E@X
M?W 6 = [\KD+CKJ).66SNAC!FA=]IHW[E>NLM4I_>Z9*3X'<-8\FKVJZLXCB
M!I]@A'"#04/EB@1A(BG'C=V&6M4';A.SX"UJ$]O.&8ST?P+&1'\0CQ@09,+/
M]XF&1N9WJ$'\- ZGDPI:[_/D<2J%,_8;^_3-V"@>4C<M&2+H!,S9C"J)S<CO
MV4J[4]^W23UGKJ._!=OMZ&@>#5C1(YP@$13#V_*X^D:,6J-G;SAXGU6;)/\S
M3<KW_&_F%O>)7X.Q,#&>1S0HBD20)))F>#Q,*7$$$5I]>\:$0J,Y*D9^[XB+
MD1'](Z-Q%U&Q,:;*271,ZMW3T> M?<S$(751?TIV4TN'[J? 8\#QP;P=_AW)
M$4$O]&G?A.H&9WPZ%7L"P"6'7IGD5T5*O_P[?=$B8.*W0 A,C.8- PT](@D2
M3C$T"J;4-X"!5L_H.+@\E.7)ZJ2/(^=^;E\L-#.@A[HA1?$D? @?4<XJDIGK
MR*N+^)GF^;\7['-Q1Y.*%32]JJK#Y)FPT3= ES$SJC?7(>B^_E40)BUEHDB'
M]B%S>AWX$J.)\+6V*-3>TCTKZZQXO*N3>C+^-/D$NM)H!_6WX#1NIJ-+%.'@
MZXY>I\/EQV ./"'F?9;3\I([MD=6ZF.1T5\"\3$ZEC=82&JD)1<:#.-Z&V!
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M"W/6V_=9D12;C,?,3'&I><, -H!=2T 0"0^^IZ4NCE"W+7VR;Q@@OR1AWT4
MJIZY:#4F0M_][2!VZT5ZG24/6<[YHY41,DT^!"+29&@/CD]2)4F1DOQ(5P_
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MA6XN-X?+@>EIX!OIF%+H[Z:DN^RPTQ]'COP0>NPX,I2'XT6)Y;TB8XEE*(<
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MUBBH1$B1RMW'3?(BTB!N%3_:$3V5_6AI1JO]:5*(1=IL7O<-8\@E0,["P^J
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M87=0+^>)9^XW61W-"F8 ,; $$P#%L09YB?B65K1\IB:FH/D]T XT(^(;@;I
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M&ZI+\Q-Z]$'J9^? O$R[MN_-ZC"@MP+8H#U<S0I=45J[>A8<6+4:K>&K"_0
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M)KZ%3IQTV9LG#O, V[27P)=A&F""66D,O/1T1YI&6-;_VA['^O'P,3PXP 7
MUYUG '2M&/>%VIG99\9* J-UE::9&"_)Y;&OVIC??V;W3^Q0)46Z*M+[SWR)
MD.W2]5!V&,H>YP[$\(W@R(PJAFBS3)P?TC(D.R\IEN0KZ0 [\2PSP(BF!!<X
MFY72EU&YX)#AJ!MLCC>TE E\+J5,C!FM(48?V9N8T;#XQM0CVR1HX2L+F@@
MVP#)X<LFS"#";%5GMV]!FPW8OJ4_(2JGPLXF!+:!.74)=]F7FM)"U;FI,C>]
M]5I^;F_'E@0\Y%S/E\&&A]-B0(!Y>Y ,8.@<#_]D+HHO"[>%$8/KT<[J/4P2
MS/X%#.L6AN+_J@:&M9J[Y'3NW.\3<H=3L:*@N2P/L+PS./NQ6\G0[/"^JX$Z
M!DC# 4*-#XI0;B?-9V)5T7I$S.-GJO3&$'F0JAJ4"7(^Y1VB;^9JJ;WIG[[#
M<D'KS]+I?:'5NE#7KL7+8YSTIA8U1N(O^+]><)ULL]J^3Z<'<F[NQ0-#WBN8
M3]\8>E \\\7ABS@P+OIM"VC#>/MW_#?\]Y)WM+Z@D33HYOU.F28-UT2R3=9%
MVPE#Q( MZ^W?\=^0AOM('M.'$4WY6&\&"_'*D:"&4?B(8[1]UX_11D(UP^0Z
M.G:H=NF&#QK0M:(<0-)_ 7G3953XBGX_>P^=[+TI *G1ZE$%T>J_(:"<+O<&
M0QQ6W>UI=G&*N9LY%AZJWRL>LPNK:JFV>;G-JE^Y:Y=_Z]0J'C2@8UMG"$G?
M3JIEB@BN2,N6E];QWN1W;&$SJH%8K9Y!L)SL_0P'.:@9M*\)QMA"SP,]6DGT
M'=_19[)\^V55)/E+E57O6?DNV3R)XMCU]F-2_DIKP?>89W,8!EID:DW(0[G@
MD0>^VB@FY+W]NJV8WDDN2"FFV^'BKA]AW5Q67_B6*?'WG#&:/1:G6 ]>;&L/
MPV'-+1#*D>[WTVI39O)P3K!6)(]9\7B=_>V0I5R 6;LU_QQZ,]^8@.^DU1/[
M3*AX+/*%FR?G@UMJWO+A;*FX8KI9:$<VB@E:(&IX*=X2C?%;:NC;AF9)?E54
M=2D#"%!##<?Q$=II.'+@VZIG^Z!R#OF_=2QB]=$(H!;7[IAE^2+JC5<[]:"1
MV!>_[_H\R37[0\D.^W^L2,<TZ7$=L^&&*^RU[390;,JQV4;[=LTAR=</>?8H
MN0#D.VW&P7D8RH22]\3!D1?28P8O6X LJZ,ECTL;^4$H(\3-/0QE#EN7!Z*P
MIA'SH2@QF>S(%,;3<L>&%>OMO],7&3_)FX+="3[$OT!'=?4V4+K^?4^O,0C_
M;\X;.3+7JY; <T8^5>'JFGK*8-/*B.:KP.B=]EQN!@'S8SX1@./53G'P*VTW
MV1('^Y9+7#=W=]B+WHP5#\XN6%*F8,\V.Q">,YLEA>^_TNFIJH[<D ?!#LHS
MF\C2(KHHF:05[P3TY):,+<!!S8/0Q"<90MG5#:%,++KG&< 9U]^T&:FWLFTL
M*\51.)H/ @V.YY= Y'TG=TXFM^60I"V+JC+=LPOSIAC<CM(U.RJH957JI^_J
M.AD6X.Y@>#=Q@0Z6Y.H6O8$%W56:6E.T@^F^BC^Q(DG_>E"OS#S+KDQ;;CZW
M=,_*NNN\/?D "]:8"-ET %7?3K9@Q>N.)T(E4R017)&R9>O8V3_D2S!H\Z9-
M!X.!$.?TR8S=V2YV]L, T6]/"!_PGVP@'J67'6 Z!J"&3NE2<&S0Q&[N(S2,
M^K[G:X7(2)WK9I5M@$"LUBN'^HF5V=^;%%AW4G=\<6FFWXKE]X F*Y84/'16
MZ7,@,M/'4]W^$UH1FHS8*I\YZ-4NCO<Q:[!0_73VNB> Q>Q5'3-?43!^K7M#
M#W/<8$'Y@/*B O-<O(R7A7P9#W42$2+T"61$JA'C)KO>-D:MMMSO67E55>)A
MJ1$WPQ>\'_66XC @U$0<2'JP#4Y&-AOO\R,3^IG@:,IEVI9X>9;YF98/S#;M
MAR>Z7S_@ M&A W &?$S+?U>DXK+PB8,RM/&Y3YVL>6YP?W9+BU3=0CY=N>*
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M)JNHS#1*KM=[*8/LN$M3OH__O3[#9C$ --EF0<)#WJVAKG*AKYH=$5,<J-[
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M>K<P8.!8X#0?B)K'F#=M.!%UJ?N.%ZP4H#=I00G_1M*7C.;!MZM0G(UDU!P
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M<Q=1BASM+B@Y'=QE1-C [M*W[X"[:$" 6 ,V!/E'=N%ZX$L\ ONT F)0,'-
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M<Y3M,L2&8A,X7C[D!7*#C8]% W[O;'<WS.O?W?9IEHWY[;J'_:5-2ZU?3#?
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M/>1X[R+?U$;C<A$EP^>$3B.',W7S]ML#V$"KZ[;:SIN6"I/OQ[[AY#_)\GW
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M$Y71ZM"E'9/R*L!"6+X"]N/2@$DAV4!M1'?C23Y8Q)0_WBE+4H 8-'?2Z@K
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M"A7V7#:-ZFK &;JATI=6*.'YBK,;GDKL7+(Y;2"EU8 S=/MD,Y6P@(<:N/>
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M7Z9>/5"%2OTA[AI<'^/7:!!X[I>Q5HM3H4\^+@E:=2Z^B@I:\,1/[\V-1/8
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M&8IMW6+_VORAHZ>/ '/A;7<N=?9TW]@]3>-)*R=-UH<Q7;N7B;0-=8Z1IE:
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ML,$>/O^3\.TXX=#7P<]#F(_93NW2\S!9)]_C#+ 90/S:Z*&A4X,"TT5H@>J
M9L,PJ8<3==9LT;&(;;VI., N!PS8LJ#\=?-M-)YQ1YSAY$N4?R<EITKO7V3=
M#! :VF(L59PFZ-J:5;'-DM4\+F+>I>GTGOYK06-&CE%-S-6!P- 2.>O5PP&5
M)T<SM/<[F]29(2RJ9^<?G)XJX\:[E+'H,]2EH7W@*[A7<T*$-G;ZIK [:5.X
MSN9S6H+/:QKS!^-L9F%[ET!VM6?GQ[X?G*X?Q2^B9/B<T*F@L,:9SZ8=0!":
M#0U(->UA7>!U4O57(7(>HKQ<OB,/0^T_'OE^,5JU\P\G_TF6[V?:C;FTSB!P
M;56@.P[M6 >$&X=$;;"A6\2JT)X6+]QKHF!KVU46Y7%MA5 V!+0$%Z#550?,
M^%#/:(YB7Q\K;H1?39;S_8 W57!J'.@+SD#JJA[U,'?R_"8R/E;WS1N7WLJ/
ML+_&SK7],< #W5?&5/S/!3R2?A5[\4G)LPMMI<U4/L1MVB;P$MK!#41E<W"K
M [5_3WSM6# ^\K5O!KA$?W325!-4&E:#B/Z]"MXGP>(IL*J2X.D,:^O?1+#V
M.K*#-+!GOX-%.<OR55#YX61CV7KW,#.\4;*L#_C1'R89Q2/9S3E#]/08.*!!
M[SZCWNN>Q?AH%]A&?UW>UEKC@QE/CY1#TD,VXH:3U8"$,]6G++\K"O[ 0S(P
MV6QWJE? &@T"OUA1,KUJB%+[FM#BZ4EU@-D9!2NW:<Q]Y+:8M=0S556@#OTU
M9_L:923 TXONY%!FCJNHH,5P4@W8_[28SZ-\J4G:=!T5LT])]K89/Y[L(%89
MH_8^;C*:-&M52/;<=W1O^WYH8Y4U:!)P85I(/,G%8+ZL2TO_K"F/I,RSX@5\
M/0<O+PD=@[S3>.N?'DFQ(=MD6JG9)K",^83-AXJHEHJFI/3/YK)"&EM86K:+
M"D[0/&:]252M*5*P6":65M/1O=)L423+)UM%D%<!CM#-, K!J>1LP-(_>\M=
M.LYY2J8;LOKO@HRRS;RZ2EW#=]#\N<%2N&GE_$J1.^3PW2C-\E7X@CS/<AL+
M;2M?! FAGVL<M:U=*K",,EYWU5KKGH=F@2VL/(\M;7!\\N+)QA+0E#<0U@9A
M3?J4Y>NQMQZ+=ZE(5P%/S+03F4,[P":F5XDO=5!-977(0 VJUYY^K5DL>"ZT
M;P5WZAZ^$)X-+9V^A]/0JI9=$T DIH=OVUKER -J1+X6]^2+?#QCHXA'GGHE
MJU$F!M2(<5SY;;5C(#$;@M\*;D_]UX*6RR^DG&6Q?@_OY1,@B.Z9JNP5TC-/
M30,.7H+"IF3*=YTAJ6R>C0F)Q;A]BA(><ZH]W?7[+1!.]TQ>#DK<$F&^8C2&
M-O]*5B'@IM&"+FE",'F)^3X!84'7\=!:_,-#7]4%[)1\Z92RYS">/T]TFM()
M'4=I69F%[M*GQ7-!8QKEZR>"UCX_UBT")Y@& ;68;%QXW('V[P+-A@/CC9EM
M(\ C>EJ*9CJ@TBQG$OIW)7:;EFRK4XRR,DK8]J>*W,+:;:P-S*%[LCL+6J4Q
M]H #\T^^F_-5>5Q\8ZC'>E=D25&.ZO((_?[3GGV)R5@'JW\W7ZX3IO8FHGFK
MP#3Z?6D[RTAS5OKG8<Q.X<([D1^MAF\I.Z',Z,L=.V0ST9?%/T@27RV_L@,8
MCX60):Q+T\T_FLPA==L%MH/R=*^G+1K+1V-N>NMT7$W3OO&\MK@'T]0#TH)R
M8/>K4#;8/5US212F52O&(%]&7T@^)7FXQHO+(Z>DW(?93%PM"J8_17&=S9^9
M2KS'KK'>."A; ,RA)>D&,=BL_69@_3-&R# ;C0^J2H(GM @V-66JT@PCR-X;
M$V0,N!L5U*T D^B'"J.@+8T)%D #,RK (JI]UKPI 1C0=]_NG$M,"1)4_;,@
M7"<1V^GQ=$IYS*C)ER*SB7ERU]0#MH+:,->?WVUP]N]<OPW68C:750!^T/V9
M;22H/!KI8&%YE2JFZ0?Z0E;'MW1J2):Z7Q1085T9VA$NF:-U2%IX'8L]66?S
MERP5#BX3\%XQS]/2*L 1EB^O[RE:#]&30V5 :K!V7#+OL2L%@0_T'/4&82DW
MT3(DGE(=!R19$3,BOHY>*-NXVKQ#VB\/[*!?Y4L%II*N#D8/DR:+Q>TA)W.Z
MF%L(>;\XD(-^W^XD8PT*7QYR 8EXL^D4L%>:;7^HVJTEJ#KIB<G,C-)7OM[0
M%<)B\&OJ 5WHAC&S.)T480>;K_2[ :F"O\/U";JAS4:$SH?K$Z6ES3UC;D!R
MWW E2XABOS:H:@-U?3.[&=$J%*7+UC<M>)<U0UT?Z O'-F<4<RU%V<&J4!4T
MB]UO$4\\;XH9NUT*P*#;Z5QHEYCM%)@4 NJRR<XT'=X[>V1J6P$J>V+8<T>M
M4*#VC7TJ?^R=X"BC69XMIK-'PCX7I:L@R7",5OIIVS<!-*";?MS%)IDAZL!6
M2+]]@Z!!^O$VALT;1+F7IDD1W%H#<M!-15YUHB8#"D^<+EL2M_*:_B-[&XS9
MB,A)/GPN(\:HR$?(^CR<K/[!X+[GVIJ@]C1XLY11N3PPH% N9QMF>"[57Q=\
MC\:?UV\V>,-\XU(.IONAB'9M] ]U:PJX1;=O^=.NFO 5JN5L#0U/M>YBQ@&=
M4 X7',Y7XRJ^9[_11#RD9__ N-*'SW!I"'A%MYSY4ZM:X!5*Y6Q7#4^I>'@&
M'F:0_8?O#U^CA \T'@ABFE*V>1@4J^F[$ \">*AUO37%O3U@.7A3G+V*->%
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MEZR($MW1225ZF[J ']V^Y$_N3J 5KDCVEL=+$'I*IMS,Y?=1ZW@IPCXF$!V
M3EA_V(_R4*?F6H 9_>#H3]"6<!4B[L&SQ%:6?G3_L\,N_>K\V,[VQ)=UBMB
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M=# "0G[3H12O&[X_Q)N.W>7*W>ZN; &(#,J$Y+0XUT3;OUOVJB=<0QNE2TO
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M%I.8[WF%[]/JG>.JDW9O66T:X.IRO@GO%!+B=4]'F?CY:?'RDE"F,?:052T
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M,Z8!D&D-\RZ [%]0G,-;=AF3Z#XA1D'[L.P"T, BZC@:=1D&=/\-=\Y-1EU
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M>I0KJ<14XM7!Z*L?ZRA[L9?S;F%@!STRK9.0E1AP\\2H+@[&,[;4Z(Z<[R4
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MODXAK%'Y\K[A#EL!J40X&>P8S2'>Z>J4IQE47->?%E6JQN2B'7UA;" =U,(
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MK%>E1_)*TH7AX8RT,,!#-\?6DY@>48C&C7O^:'R-<:F7EZRL (<6!;BAN+2
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MR2YXZAYC/6U3TZ\1TTZ_T2X56W#5/<9Z1J8C6'.OO]?WOE[M'=S1Z_@XE,M
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M+7%V?H;ND*YG7G:U;8 36!:1APS"D4)(-['O^)3E;U'.%I]4G*@-XK-N !A
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M^, ,B>PJ.-4<*D75/\^FP72:$T8,B4=T3JZB]/]O[]IV&[>!Z"<UQ6X<YZ5
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MM?32>^=_5&N=Z[0E^(GK_<EV.9^&TE"IE8,N("WC<2YY/,[F7Y?H/(9 7;/
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MM[D*^X__ %!+ 0(4 Q0    ( &@^?E(4SP][LUH" "6F+@ 1
M  "  0    !I;71X+3(P,C Q,C,Q+GAM;%!+ 0(4 Q0    ( &@^?E*&6"U_
M-R<  '+N 0 1              "  >): @!I;71X+3(P,C Q,C,Q+GAS9%!+
M 0(4 Q0    ( &@^?E*<=$+HF T   ;(   5              "  4B" @!I
M;71X+3(P,C Q,C,Q7V-A;"YX;6Q02P$"% ,4    " !H/GY2E;+__!9C   ;
M3 8 %0              @ $3D ( :6UT>"TR,#(P,3(S,5]D968N>&UL4$L!
M A0#%     @ :#Y^4DQ7<#P^I@  -8X) !4              ( !7/," &EM
M='@M,C R,#$R,S%?;&%B+GAM;%!+ 0(4 Q0    ( &@^?E*SQP^%:X4  /KK
M"  5              "  <V9 P!I;71X+3(P,C Q,C,Q7W!R92YX;6Q02P4&
2      8 !@"* 0  :Q\$

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
